data_2ddy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ddy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.452 -0.954 0 N-CA-C 109.174 -1.125 . . . . 0.56999999999999995 109.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 pttt 101.19 138.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 130.174 3.389 . . . . 0.56999999999999995 109.305 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -64.89 162.27 16.69 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.69 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.9 p -91.46 6.42 45.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.697 -0.627 . . . . 0.56999999999999995 112.42 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -109.7 147.7 32.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.881 1.272 . . . . 0.56999999999999995 109.056 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -16.89 61.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.293 0.637 . . . . 0.56999999999999995 111.943 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.55 143.49 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.009 -1.108 . . . . 0.56999999999999995 108.009 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 172.24 13.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.893 -0.78 . . . . 0.56999999999999995 108.893 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -116.56 153.33 32.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.389 0.276 . . . . 0.56999999999999995 110.627 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -128.6 149.84 50.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 111.128 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.64 106.23 3.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.821 0.849 . . . . 1.2 108.884 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.5 mt -84.47 84.2 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 106.716 -1.587 . . . . 0.56999999999999995 106.716 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.38 -41.72 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 112.696 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -126.08 164.83 20.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.611 -2.366 . . . . 0.56999999999999995 104.611 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -136.35 155.0 50.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.46 -1.311 . . . . 0.56999999999999995 107.46 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -66.54 -172.02 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.906 0.883 . . . . 0.56999999999999995 111.132 168.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -33.46 0.83 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.874 1.67 . . . . 1.2 112.763 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -39.3 78.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.016 0.926 . . . . 0.66000000000000003 112.179 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 148.33 65.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.947 2.099 . . . . 0.56999999999999995 108.088 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.8 163.49 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.84 2.36 . . . . 0.56999999999999995 112.716 -171.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -62.48 -36.13 81.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.439 0.696 . . . . 0.65000000000000002 112.265 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.78 -38.63 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.549 0.34 . . . . 0.56999999999999995 110.744 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.9 m -69.65 -41.72 75.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.542 -1.218 . . . . 0.56999999999999995 109.5 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.1 t -53.98 -54.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 120.341 1.428 . . . . 0.56999999999999995 109.719 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -43.54 98.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.989 0.813 . . . . 0.66000000000000003 110.834 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -42.08 98.2 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.28 0.945 . . . . 1.2 112.029 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.02 -40.64 68.3 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.682 -1.151 . . . . 0.56999999999999995 109.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.24 -49.37 76.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 119.31 0.959 . . . . 0.56999999999999995 109.183 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -65.03 -44.48 88.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.599 0.76 . . . . 0.56999999999999995 110.437 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -66.3 -45.23 81.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.561 1.073 . . . . 0.56999999999999995 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -47.26 86.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.033 0.833 . . . . 0.56999999999999995 110.811 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 19.7 mt -67.8 -36.73 80.96 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.514 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.36 -38.39 89.36 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 119.16 0.891 . . . . 0.56999999999999995 109.651 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.28 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.032 0.933 . . . . 0.56999999999999995 112.514 173.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 40.9 m95 -68.13 -51.05 50.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.845 1.202 . . . . 0.56999999999999995 110.948 168.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.03 -11.65 58.86 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.563 1.077 . . . . 0.56999999999999995 113.318 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -31.17 72.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.377 -1.072 . . . . 0.56999999999999995 110.481 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -101.26 -21.17 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.016 0.825 . . . . 0.66000000000000003 111.803 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.7 pt -133.15 135.5 25.76 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.493 1.117 . . . . 0.56999999999999995 110.77 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.17 26.36 0.26 Allowed 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 123.814 3.009 . . . . 0.56999999999999995 114.57 -174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.24 136.53 34.37 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.038 1.335 . . . . 0.56999999999999995 108.239 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -117.24 165.15 13.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.664 0.785 . . . . 0.65000000000000002 109.638 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -140.15 148.02 41.02 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.234 -1.024 . . . . 0.56999999999999995 108.234 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -142.33 169.31 17.82 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.842 1.257 . . . . 1.2 109.661 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -103.75 149.39 25.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.571 -0.9 . . . . 0.56999999999999995 108.571 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.78 167.49 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.399 1.08 . . . . 0.56999999999999995 110.45 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.66 -40.83 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.514 0.726 . . . . 0.56999999999999995 110.867 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -164.9 87.23 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.059 1.343 . . . . 0.56999999999999995 107.392 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.41 160.5 11.56 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.219 -1.152 . . . . 0.56999999999999995 110.219 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.1 m -66.38 136.11 55.29 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.258 1.029 . . . . 0.56999999999999995 109.467 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.13 165.11 16.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.508 0.723 . . . . 0.56999999999999995 111.494 175.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.37 -29.04 65.6 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.936 -1.029 . . . . 0.66000000000000003 110.389 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.89 80.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.62 1.968 . . . . 0.56999999999999995 108.731 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.7 ttm -69.37 128.27 35.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 120.653 -1.279 . . . . 0.56999999999999995 107.684 163.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.18 127.1 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.163 -2.162 . . . . 0.56999999999999995 105.163 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.42 158.63 26.55 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.505 -0.638 . . . . 0.56999999999999995 111.505 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.8 m-85 -133.93 146.02 50.12 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 106.838 -1.542 . . . . 0.56999999999999995 106.838 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.3 173.73 11.51 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.06 1.744 . . . . 0.56999999999999995 108.537 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -134.12 66.77 1.53 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.461 1.028 . . . . 1.2 111.614 -169.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 105.37 0.49 Allowed Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.659 -0.976 . . . . 0.56999999999999995 110.659 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 57.91 160.33 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.423 2.689 . . . . 0.56999999999999995 114.474 -169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.435 ' CE1' ' HD1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER -168.11 170.24 10.46 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.998 1.319 . . . . 0.65000000000000002 110.547 175.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.84 61.42 3.69 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.466 1.508 . . . . 0.56999999999999995 112.37 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -131.47 -179.18 5.21 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.854 1.262 . . . . 0.66000000000000003 109.909 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 p -58.23 -36.9 73.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.671 0.669 . . . . 0.56999999999999995 111.25 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -135.57 112.12 10.74 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.447 0.699 . . . . 0.56999999999999995 110.517 -172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.95 130.32 18.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.918 1.745 . . . . 0.56999999999999995 111.288 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -59.1 170.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 113.585 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -115.41 -25.57 7.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.615 1.966 . . . . 0.66000000000000003 112.168 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.81 -139.38 14.49 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 120.139 1.336 . . . . 0.56999999999999995 111.408 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.19 98.28 1.19 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.361 2.707 . . . . 0.56999999999999995 112.2 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.11 -176.4 23.4 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 112.066 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 t30 52.27 -130.63 2.19 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 120.823 -1.398 . . . . 0.56999999999999995 110.683 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.3 m -69.08 132.19 46.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.66 2.784 . . . . 0.56999999999999995 110.828 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -102.27 -29.74 11.5 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.186 1.394 . . . . 0.56999999999999995 112.741 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.7 32.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.076 1.35 . . . . 0.56999999999999995 108.237 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.425 ' C ' ' HE2' ' A' ' 121' ' ' GLU . 3.1 p-80 -145.54 150.76 37.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.744 0.702 . . . . 0.65000000000000002 110.113 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.52 165.35 28.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.806 0.842 . . . . 0.56999999999999995 109.47 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -119.71 151.46 38.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.194 -1.039 . . . . 0.56999999999999995 108.194 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.86 150.44 97.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.43 -0.795 . . . . 0.56999999999999995 110.17 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 154.41 53.85 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.216 1.944 . . . . 0.56999999999999995 111.196 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.49 42.77 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.821 -0.989 . . . . 0.56999999999999995 111.484 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.2 m 63.8 161.01 0.1 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.003 2.121 . . . . 0.56999999999999995 112.491 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -140.39 28.65 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 121.06 -1.025 . . . . 0.56999999999999995 110.852 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.71 -23.8 44.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.371 0.668 . . . . 0.56999999999999995 111.525 171.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.77 139.61 31.84 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.002 -1.061 . . . . 0.56999999999999995 110.907 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.13 -19.79 16.02 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.425 1.488 . . . . 0.56999999999999995 113.286 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -71.92 155.92 39.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.954 1.377 . . . . 0.66000000000000003 108.739 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.72 145.6 36.67 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.026 0.917 . . . . 0.56999999999999995 109.598 -172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.435 ' HD1' ' CE1' ' A' ' 69' ' ' HIS . 10.7 m170 -138.07 147.1 43.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.002 -0.999 . . . . 0.65000000000000002 108.465 -170.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 41.4 m-85 -138.04 148.49 45.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.248 1.019 . . . . 0.56999999999999995 108.434 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -95.04 100.64 12.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 106.634 -1.617 . . . . 0.66000000000000003 106.634 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -59.61 -23.13 62.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.356 1.462 . . . . 0.66000000000000003 111.495 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -60.48 -28.85 68.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.504 0.722 . . . . 0.66000000000000003 111.088 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.4 129.68 34.73 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.177 -1.045 . . . . 0.66000000000000003 108.177 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -64.04 112.41 2.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.394 0.677 . . . . 1.2 111.799 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.07 146.76 24.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.56999999999999995 109.458 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -146.96 145.22 29.69 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.419 -0.956 . . . . 0.56999999999999995 108.419 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.19 -39.79 93.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.077 0.551 . . . . 0.66000000000000003 110.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.85 83.91 0.06 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.704 -1.758 . . . . 0.56999999999999995 108.704 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.9 t -118.06 -62.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.677 0.738 . . . . 0.56999999999999995 109.523 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -164.65 -45.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.85 1.26 . . . . 0.56999999999999995 110.703 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.31 142.89 41.88 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.598 1.159 . . . . 0.56999999999999995 109.441 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.3 -172.81 19.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.84 -1.704 . . . . 0.56999999999999995 108.84 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.42 115.44 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.631 -1.618 . . . . 0.56999999999999995 106.631 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.22 115.08 4.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.013 0.525 . . . . 0.56999999999999995 110.05 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -66.13 -42.93 88.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.534 1.134 . . . . 0.56999999999999995 111.693 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -42.65 90.66 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.078 0.951 . . . . 0.56999999999999995 109.573 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -65.96 -49.61 67.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.857 0.863 . . . . 0.56999999999999995 110.789 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -46.95 85.42 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.008 0.367 . . . . 0.56999999999999995 111.737 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -50.0 75.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 108.588 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -53.72 -45.88 70.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.567 1.076 . . . . 0.56999999999999995 111.307 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -58.09 -55.11 39.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.825 1.25 . . . . 0.65000000000000002 109.708 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.425 ' HE2' ' C ' ' A' ' 84' ' ' HIS . 17.4 mm-40 -70.73 -47.56 59.09 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.337 0.655 . . . . 0.66000000000000003 111.194 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.52 -29.11 68.9 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.666 1.186 . . . . 0.56999999999999995 110.799 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -61.1 -46.76 93.9 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 118.741 0.7 . . . . 0.56999999999999995 112.373 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.15 -42.54 99.46 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.956 -1.021 . . . . 0.65000000000000002 110.502 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.4 m -57.82 -32.67 67.81 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.086 0.866 . . . . 0.56999999999999995 113.266 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -50.06 64.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.903 0.881 . . . . 0.56999999999999995 109.928 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.21 32.34 0.03 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-O 117.862 -1.521 . . . . 0.56999999999999995 114.995 -172.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.01 171.42 0.2 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.046 1.338 . . . . 0.56999999999999995 111.713 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.26 43.6 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.53 -0.731 . . . . 0.56999999999999995 113.601 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 166.94 18.39 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.909 1.355 . . . . 0.65000000000000002 111.636 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -175.91 4.59 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 109.388 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 35.69 1.28 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 109.854 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.52 151.96 54.0 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.384 1.473 . . . . 0.66000000000000003 109.376 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.16 -22.56 61.23 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.797 2.331 . . . . 0.56999999999999995 113.219 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -130.44 27.48 5.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 109.246 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 132.54 54.25 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 121.704 -0.623 . . . . 0.56999999999999995 110.083 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.27 -23.45 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.554 0.742 . . . . 0.56999999999999995 111.545 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.27 20.5 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 111.381 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.01 133.32 80.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 119.511 1.05 . . . . 0.56999999999999995 111.389 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.8 128.01 9.83 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.832 2.355 . . . . 0.56999999999999995 110.753 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.5 m 70.78 115.15 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.094 2.158 . . . . 0.56999999999999995 111.143 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.47 148.22 9.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.336 1.054 . . . . 0.56999999999999995 112.939 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.91 -124.45 0.78 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.686 -0.966 . . . . 0.56999999999999995 110.686 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.6 -37.21 83.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.569 1.148 . . . . 0.56999999999999995 113.586 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.59 97.59 0.06 OUTLIER Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.817 1.198 . . . . 0.56999999999999995 110.745 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -65.24 116.52 31.27 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.885 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.4 -16.67 8.05 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 CA-C-O 117.53 -1.112 . . . . 0.56999999999999995 112.964 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -61.18 -37.2 82.08 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.703 1.592 . . . . 0.56999999999999995 109.279 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.14 122.35 14.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 107.975 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -131.7 -55.64 1.0 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.653 1.181 . . . . 0.56999999999999995 107.83 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 36.12 52.81 0.9 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.438 1.495 . . . . 0.56999999999999995 111.005 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.01 90.89 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.021 2.128 . . . . 0.56999999999999995 110.91 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -66.14 -83.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.829 1.418 . . . . 0.56999999999999995 114.829 -168.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -143.84 -44.57 0.27 Allowed 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.863 1.665 . . . . 0.56999999999999995 107.767 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.43 -51.69 33.74 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.81 1.244 . . . . 0.66000000000000003 111.544 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -50.52 73.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.501 0.592 . . . . 0.66000000000000003 111.598 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.81 -44.66 98.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 108.858 -0.793 . . . . 0.56999999999999995 108.858 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -65.16 -44.81 87.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.698 -1.144 . . . . 0.56999999999999995 108.971 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.47 -59.0 11.6 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.596 -1.002 . . . . 0.56999999999999995 110.596 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.1 mm -57.15 -48.65 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.361 1.08 . . . . 0.56999999999999995 111.384 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -73.06 -15.46 61.5 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 120.02 1.282 . . . . 0.56999999999999995 112.161 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -79.51 -32.11 42.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.678 1.126 . . . . 0.56999999999999995 111.49 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.94 -43.64 11.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.283 1.433 . . . . 0.56999999999999995 111.709 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 126.328 1.851 . . . . 0.56999999999999995 110.928 -177.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.455 -0.747 0 N-CA-C 108.842 -1.253 . . . . 0.56999999999999995 108.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 82.57 111.28 0.06 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.405 2.282 . . . . 0.56999999999999995 109.104 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -56.37 147.7 20.74 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.107 0.563 . . . . 0.56999999999999995 111.276 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -77.35 -28.22 52.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.489 0.715 . . . . 0.56999999999999995 111.514 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -84.37 144.25 28.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.798 0.839 . . . . 0.56999999999999995 109.902 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -81.49 -8.74 59.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 111.866 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.25 119.57 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.924 -2.25 . . . . 0.56999999999999995 104.924 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.21 142.98 36.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.122 -1.436 . . . . 0.56999999999999995 107.122 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -96.32 152.68 18.36 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.001 -0.437 . . . . 0.56999999999999995 111.028 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -128.2 155.04 45.15 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.809 0.844 . . . . 0.56999999999999995 111.662 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 114.07 4.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 1.2 109.566 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.8 mt -85.43 86.11 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.222 -1.77 . . . . 0.56999999999999995 106.222 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -68.25 -29.96 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.313 1.445 . . . . 0.56999999999999995 113.846 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -136.57 160.26 39.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 130.714 3.606 . . . . 0.56999999999999995 102.827 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -135.84 163.98 28.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 108.345 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 t -74.02 -175.07 2.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.94 0.896 . . . . 0.56999999999999995 111.409 171.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -44.2 1.86 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.667 1.187 . . . . 1.2 113.211 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -32.52 67.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.399 1.08 . . . . 0.66000000000000003 110.791 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.0 mt -123.2 143.51 41.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.311 1.444 . . . . 0.56999999999999995 109.243 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.35 152.09 38.73 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.789 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -62.18 -37.24 84.52 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 112.199 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.76 -42.86 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.819 . . . . 0.56999999999999995 109.847 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.5 m -70.55 -38.73 74.19 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 117.209 -1.377 . . . . 0.56999999999999995 110.042 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.39 -45.66 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.434 1.47 . . . . 0.56999999999999995 110.978 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.98 -41.09 78.37 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.93 0.786 . . . . 0.66000000000000003 110.788 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.17 87.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.933 -1.104 . . . . 1.2 112.631 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.79 -39.56 93.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.615 -0.883 . . . . 0.56999999999999995 108.615 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.66 -43.63 98.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 119.207 0.912 . . . . 0.56999999999999995 110.415 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -59.1 -48.53 81.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.831 -1.08 . . . . 0.56999999999999995 111.79 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -67.66 -34.45 76.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.583 1.538 . . . . 0.56999999999999995 112.173 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.57 -40.7 76.6 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.105 1.321 . . . . 0.56999999999999995 112.185 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.2 mt -72.98 -32.32 65.11 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 110.888 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.64 -47.38 86.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 119.138 0.881 . . . . 0.56999999999999995 109.252 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.0 mtp -54.24 -36.59 63.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 117.226 -1.368 . . . . 0.56999999999999995 112.442 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -72.5 -44.4 62.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.165 1.802 . . . . 0.56999999999999995 112.352 171.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.93 59.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.17 0.89 . . . . 0.56999999999999995 113.273 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -14.46 62.94 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.193 -1.18 . . . . 0.56999999999999995 111.809 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -115.88 -29.11 6.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.53 1.132 . . . . 0.66000000000000003 110.73 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 pt -123.66 132.72 24.3 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 110.982 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.0 34.9 0.37 Allowed 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.235 3.29 . . . . 0.56999999999999995 113.934 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.56 137.22 35.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 107.782 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -121.12 159.56 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.04 1.336 . . . . 0.65000000000000002 109.177 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 149.39 44.04 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.954 -1.091 . . . . 0.56999999999999995 109.882 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.21 179.3 7.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.988 0.915 . . . . 1.2 110.68 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -118.71 161.3 20.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.407 1.083 . . . . 0.56999999999999995 109.12 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.3 m -121.44 160.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.487 1.515 . . . . 0.56999999999999995 108.88 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.97 29.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.32 1.048 . . . . 0.56999999999999995 110.373 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -54.63 1.26 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.403 1.081 . . . . 0.56999999999999995 110.394 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.27 -135.91 2.31 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.227 -1.149 . . . . 0.56999999999999995 110.227 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m -83.65 176.94 8.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.922 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.76 173.46 11.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.894 1.678 . . . . 0.56999999999999995 110.285 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.19 -39.9 91.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.416 -0.802 . . . . 0.66000000000000003 109.868 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.4 mt -117.93 75.33 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.204 2.202 . . . . 0.56999999999999995 108.746 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.98 128.81 37.24 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.789 -1.194 . . . . 0.56999999999999995 108.854 166.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.95 129.85 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 104.784 -2.302 . . . . 0.56999999999999995 104.784 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.08 170.77 27.17 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.269 -0.733 . . . . 0.56999999999999995 111.269 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.7 m-85 -144.59 151.16 38.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.782 -1.192 . . . . 0.56999999999999995 107.782 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.3 171.01 18.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.822 1.326 . . . . 0.56999999999999995 110.417 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 57.17 1.67 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.613 0.765 . . . . 1.2 111.019 -173.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -46.33 1.1 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.743 1.163 . . . . 0.56999999999999995 111.482 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.69 157.45 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.558 1.179 . . . . 0.56999999999999995 109.573 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -153.6 163.44 39.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.211 1.805 . . . . 0.65000000000000002 108.336 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.21 85.59 1.53 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.88 -1.288 . . . . 0.56999999999999995 109.88 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.581 ' HD2' ' N ' ' A' ' 73' ' ' TYR . 10.0 p-10 -130.92 -55.11 1.06 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.834 0.854 . . . . 0.66000000000000003 110.998 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 157.76 -38.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.748 2.819 . . . . 0.56999999999999995 110.156 -166.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.581 ' N ' ' HD2' ' A' ' 71' ' ' ASP . 76.3 m-85 -129.93 110.5 17.06 Favored Pre-proline 0 C--N 1.345 0.382 0 CA-C-N 119.794 1.179 . . . . 0.56999999999999995 110.447 -172.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.25 133.12 36.46 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 108.736 -1.294 . . . . 0.56999999999999995 108.736 173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HB3' ' HD2' ' A' ' 99' ' ' ASP . 1.5 m-85 -70.55 -169.81 0.35 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.64 1.576 . . . . 0.56999999999999995 110.217 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -119.63 -35.01 3.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.266 2.226 . . . . 0.66000000000000003 109.815 -168.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.6 -146.37 18.18 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.925 1.25 . . . . 0.56999999999999995 110.203 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.99 111.31 3.21 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 112.22 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.31 160.09 13.92 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 128.099 2.762 . . . . 0.56999999999999995 109.71 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.271 33.3 t30 70.57 -143.51 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.112 1.765 . . . . 0.56999999999999995 112.528 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -49.92 138.79 14.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.324 1.85 . . . . 0.56999999999999995 110.795 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.2 mt -108.74 -28.96 8.93 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.72 -1.863 . . . . 0.56999999999999995 112.303 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.22 165.41 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.573 1.149 . . . . 0.56999999999999995 108.13 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -146.51 161.71 39.86 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.547 -0.538 . . . . 0.65000000000000002 109.547 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.34 161.7 39.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 109.106 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.52 150.7 34.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.393 -0.965 . . . . 0.56999999999999995 108.393 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.9 91.17 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.562 -0.732 . . . . 0.56999999999999995 109.856 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.4 161.21 45.81 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.29 1.994 . . . . 0.56999999999999995 110.91 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.25 -83.48 0.18 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.835 -0.906 . . . . 0.56999999999999995 110.835 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.7 p -78.15 -177.72 5.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.5 1.52 . . . . 0.56999999999999995 111.272 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.81 -52.49 50.55 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.253 -1.304 . . . . 0.56999999999999995 112.854 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -20.21 61.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.297 1.049 . . . . 0.56999999999999995 110.967 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.51 148.74 11.29 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 111.18 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.11 1.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 117.259 -1.856 . . . . 0.56999999999999995 114.924 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -68.22 156.18 38.15 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 125.306 1.239 . . . . 0.66000000000000003 109.833 -160.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.78 144.48 31.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.56999999999999995 110.956 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -131.19 157.79 42.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.024 -0.989 . . . . 0.65000000000000002 109.437 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.436 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 69.1 m-85 -140.01 145.79 38.24 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.308 1.443 . . . . 0.56999999999999995 108.516 -170.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.485 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 5.9 m-20 -78.21 93.62 4.63 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.29 -0.633 . . . . 0.66000000000000003 109.29 172.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -53.45 -28.04 28.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.799 1.24 . . . . 0.66000000000000003 111.27 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.01 -33.62 76.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.758 0.281 . . . . 0.66000000000000003 111.758 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.89 138.61 46.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.115 -1.439 . . . . 0.66000000000000003 107.115 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -62.93 134.16 55.76 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.468 -0.77 . . . . 1.2 109.656 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -118.49 143.32 46.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.622 0.769 . . . . 0.56999999999999995 109.444 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.6 t -138.89 151.75 47.21 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.339 0.656 . . . . 0.56999999999999995 110.761 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.75 -38.19 83.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.467 0.707 . . . . 0.66000000000000003 109.898 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.46 101.44 0.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.006 -1.638 . . . . 0.56999999999999995 109.006 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.27 170.43 21.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.759 2.024 . . . . 0.56999999999999995 108.647 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.74 72.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.247 1.419 . . . . 0.56999999999999995 114.447 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.72 149.77 34.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.997 -0.742 . . . . 0.56999999999999995 108.997 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.42 153.37 14.65 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.534 -1.426 . . . . 0.56999999999999995 109.534 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mm -78.36 130.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.78 -1.563 . . . . 0.56999999999999995 106.78 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -65.53 109.04 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.428 -0.582 . . . . 0.56999999999999995 109.428 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -56.07 -43.57 78.09 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.24 1.416 . . . . 0.56999999999999995 109.01 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.83 -38.54 79.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.589 0.631 . . . . 0.56999999999999995 111.943 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -65.01 -44.4 89.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.835 -0.802 . . . . 0.56999999999999995 108.835 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -50.42 70.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.646 0.379 . . . . 0.56999999999999995 111.23 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.09 75.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.109 -0.948 . . . . 0.56999999999999995 109.86 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -60.52 -33.46 72.67 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.795 1.179 . . . . 0.56999999999999995 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.3 -58.62 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.338 0.972 . . . . 0.65000000000000002 109.978 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -64.3 -43.1 95.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.449 0.7 . . . . 0.66000000000000003 111.272 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.09 -27.76 69.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.885 1.274 . . . . 0.56999999999999995 110.971 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.33 -50.91 62.68 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.389 -0.684 . . . . 0.56999999999999995 111.389 171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -59.18 -43.02 92.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.191 -0.909 . . . . 0.65000000000000002 110.666 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -38.44 64.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.438 1.711 . . . . 0.56999999999999995 114.035 174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -44.96 86.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.789 0.836 . . . . 0.56999999999999995 110.949 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.67 43.32 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-O 118.688 -1.062 . . . . 0.56999999999999995 114.338 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -121.77 150.77 41.37 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.926 1.363 . . . . 0.56999999999999995 110.416 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -98.55 -43.32 2.74 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.455 -1.747 . . . . 0.56999999999999995 113.191 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m170 163.75 179.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.95 2.9 . . . . 0.65000000000000002 109.899 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 3.9 m -147.62 179.03 7.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 109.508 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -146.52 81.83 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.437 1.095 . . . . 0.56999999999999995 109.996 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.11 146.38 25.43 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.24 -32.25 42.56 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 CA-C-N 121.407 1.538 . . . . 0.56999999999999995 111.882 -171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -116.84 23.86 11.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.031 1.332 . . . . 0.56999999999999995 109.254 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.48 57.69 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.017 0.927 . . . . 0.56999999999999995 109.266 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.43 -32.37 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 118.927 -1.109 . . . . 0.56999999999999995 109.631 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.73 7.55 10.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.575 1.08 . . . . 0.56999999999999995 113.17 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.03 145.8 96.8 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.895 1.679 . . . . 0.56999999999999995 110.967 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.04 166.21 30.65 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 110.971 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 m 65.56 -67.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.662 1.985 . . . . 0.56999999999999995 111.673 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 161.84 1.17 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.285 2.234 . . . . 0.56999999999999995 107.366 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.1 136.22 12.81 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.061 -1.616 . . . . 0.56999999999999995 109.061 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -71.89 -16.25 62.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.463 1.105 . . . . 0.56999999999999995 112.394 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -78.29 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.573 -1.411 . . . . 0.56999999999999995 109.573 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -174.85 144.74 0.87 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.955 1.302 . . . . 0.66000000000000003 108.776 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.36 -23.24 8.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.275 1.983 . . . . 0.56999999999999995 114.992 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -103.24 -39.31 6.88 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.456 1.48 . . . . 0.56999999999999995 110.308 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.9 70.28 10.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.967 1.307 . . . . 0.56999999999999995 109.563 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.5 150.77 40.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.44 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.29 62.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.869 1.268 . . . . 0.56999999999999995 110.052 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mp 62.69 87.45 0.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.224 1.41 . . . . 0.56999999999999995 111.237 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.5 m -71.83 -97.51 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.802 1.241 . . . . 0.56999999999999995 113.424 -171.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -122.99 -51.79 1.89 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 120.879 -1.138 . . . . 0.56999999999999995 108.166 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 0.6 OUTLIER -51.06 -39.55 56.25 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.536 0.939 . . . . 0.66000000000000003 113.536 177.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -69.07 -55.36 11.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.437 1.095 . . . . 0.66000000000000003 110.748 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.58 -38.99 81.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-O 117.959 -1.02 . . . . 0.56999999999999995 108.598 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.38 86.89 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 120.167 1.349 . . . . 0.56999999999999995 109.51 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.33 31.47 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.247 -0.741 . . . . 0.56999999999999995 111.247 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.3 -48.82 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.009 0.524 . . . . 0.56999999999999995 111.803 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -17.56 64.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.426 1.09 . . . . 0.56999999999999995 111.894 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -42.92 17.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.869 -1.062 . . . . 0.56999999999999995 109.662 172.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.78 -49.23 60.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.559 1.144 . . . . 0.56999999999999995 111.426 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 . . . . . 0 C--O 1.235 0.302 0 C-N-CA 124.941 1.296 . . . . 0.56999999999999995 111.302 -175.051 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.449 -1.112 0 N-CA-C 110.821 -0.492 . . . . 0.56999999999999995 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt 83.51 115.91 0.05 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 127.429 2.292 . . . . 0.56999999999999995 108.997 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 4.2 m95 -64.93 163.03 15.27 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 111.558 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.9 m -89.35 -24.46 21.97 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.997 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -91.28 149.11 21.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.585 0.754 . . . . 0.56999999999999995 109.797 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -5.84 52.98 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.961 0.726 . . . . 0.56999999999999995 112.961 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.56 139.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.56999999999999995 107.189 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.58 148.3 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.452 -1.314 . . . . 0.56999999999999995 107.452 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.9 p -97.52 139.61 33.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.852 -0.795 . . . . 0.56999999999999995 108.852 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -126.97 159.9 32.7 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.822 -0.549 . . . . 0.56999999999999995 110.995 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -153.09 160.25 42.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.103 1.361 . . . . 1.2 108.301 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.56 94.24 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.086 -2.561 . . . . 0.56999999999999995 104.086 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -40.69 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.112 0.965 . . . . 0.56999999999999995 112.152 -170.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.12 153.4 41.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.146 -2.168 . . . . 0.56999999999999995 105.146 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -134.98 143.19 46.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 108.463 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -72.18 169.02 17.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.256 -1.338 . . . . 0.56999999999999995 110.165 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -24.89 5.89 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.731 0.812 . . . . 1.2 112.881 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -35.43 80.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.942 0.877 . . . . 0.66000000000000003 111.224 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.58 154.14 78.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.122 1.769 . . . . 0.56999999999999995 109.629 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.19 161.15 29.4 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.702 1.602 . . . . 0.56999999999999995 112.933 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.84 -35.45 80.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.65000000000000002 111.342 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -64.84 -35.68 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.523 0.729 . . . . 0.56999999999999995 110.55 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -64.73 -51.11 64.1 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.296 -1.335 . . . . 0.56999999999999995 108.15 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.51 -49.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 120.398 1.454 . . . . 0.56999999999999995 110.856 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.19 -39.86 90.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.519 1.054 . . . . 0.66000000000000003 111.487 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -65.05 -42.98 93.74 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.642 1.11 . . . . 1.2 111.818 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.53 -43.64 89.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.599 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.61 -45.12 99.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.017 -0.992 . . . . 0.56999999999999995 110.035 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -60.96 -45.2 95.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.72 1.145 . . . . 0.56999999999999995 111.504 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -36.95 73.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.66 1.118 . . . . 0.56999999999999995 111.418 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.374 0.988 . . . . 0.56999999999999995 111.519 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.4 -33.26 72.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.252 -0.88 . . . . 0.56999999999999995 110.557 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.38 -42.36 91.48 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 119.439 1.018 . . . . 0.56999999999999995 110.211 167.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.2 mtp -64.74 -33.38 75.83 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 119.912 1.233 . . . . 0.56999999999999995 111.592 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -70.72 -44.47 66.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.2 1.364 . . . . 0.56999999999999995 111.147 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.89 -8.1 77.08 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.205 -0.934 . . . . 0.56999999999999995 113.734 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -65.92 -24.43 66.83 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.017 -1.284 . . . . 0.56999999999999995 111.047 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.39 -41.29 7.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.958 -0.544 . . . . 0.66000000000000003 110.789 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -117.25 139.21 25.71 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 110.248 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.05 35.26 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.898 3.066 . . . . 0.56999999999999995 114.13 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -90.87 132.0 36.17 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.695 1.598 . . . . 0.56999999999999995 107.476 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -123.7 165.95 16.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.971 0.909 . . . . 0.65000000000000002 109.411 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.26 144.86 33.5 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.343 -0.984 . . . . 0.56999999999999995 108.343 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -143.05 165.33 27.67 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.861 0.865 . . . . 1.2 108.982 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -107.89 140.31 41.19 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.934 -1.135 . . . . 0.56999999999999995 107.934 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -90.53 161.26 2.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.354 0.597 . . . . 0.56999999999999995 110.112 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.31 -14.85 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 111.602 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -58.96 2.98 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.829 0.852 . . . . 0.56999999999999995 109.956 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.39 146.54 4.83 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.864 -1.295 . . . . 0.56999999999999995 109.864 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.3 m 59.55 144.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.164 2.186 . . . . 0.56999999999999995 112.709 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.2 170.32 15.97 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 120.857 -1.152 . . . . 0.56999999999999995 110.119 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -58.68 -48.96 79.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.121 -1.066 . . . . 0.66000000000000003 108.121 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.39 87.2 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.56999999999999995 108.335 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 ttm -84.59 111.87 19.92 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.014 -1.106 . . . . 0.56999999999999995 108.014 170.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.53 132.03 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 106.392 -1.707 . . . . 0.56999999999999995 106.392 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -156.4 154.41 25.51 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 112.094 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -129.37 153.08 48.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.366 1.083 . . . . 0.56999999999999995 110.672 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.95 178.14 7.31 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 109.915 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -132.25 66.95 1.54 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.677 -1.231 . . . . 1.2 107.677 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.34 -40.99 2.3 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.11 -0.828 . . . . 0.56999999999999995 112.759 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.36 164.84 12.92 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.261 1.53 . . . . 0.56999999999999995 110.933 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 -109.71 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.508 2.323 . . . . 0.65000000000000002 106.349 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.41 71.33 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.691 -1.764 . . . . 0.56999999999999995 108.691 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.62 -56.68 2.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.716 1.206 . . . . 0.66000000000000003 109.116 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.9 t 177.43 -39.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.795 2.038 . . . . 0.56999999999999995 108.983 -169.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.84 102.13 44.65 Favored Pre-proline 0 C--N 1.345 0.395 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 109.455 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.67 144.39 84.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.943 1.015 . . . . 0.56999999999999995 109.504 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -69.84 -168.02 0.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.777 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.41 -31.68 4.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.485 3.114 . . . . 0.66000000000000003 110.755 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -152.24 17.35 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 119.97 1.259 . . . . 0.56999999999999995 111.816 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.18 61.94 4.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 125.168 3.912 . . . . 0.56999999999999995 114.776 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.52 18.6 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.637 1.589 . . . . 0.56999999999999995 112.521 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 31.4 -130.34 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.322 2.649 . . . . 0.56999999999999995 114.225 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -61.43 119.54 8.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.651 1.981 . . . . 0.56999999999999995 110.535 171.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.16 -34.6 22.07 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 113.51 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.64 161.36 38.63 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.201 1.0 . . . . 0.56999999999999995 108.644 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.522 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 2.5 p-80 -149.11 151.73 34.91 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 122.955 0.502 . . . . 0.65000000000000002 109.878 173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.7 157.74 44.36 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.475 0.71 . . . . 0.56999999999999995 109.502 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -109.95 145.06 37.56 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.734 -0.839 . . . . 0.56999999999999995 108.734 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 151.11 92.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.56999999999999995 109.887 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 48.9 Cg_endo -67.94 157.68 60.71 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.338 2.025 . . . . 0.56999999999999995 111.887 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.34 21.43 0.02 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.226 1.251 . . . . 0.56999999999999995 116.226 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.309 37.0 p 64.8 71.57 0.46 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.28 2.232 . . . . 0.56999999999999995 113.743 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.39 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 120.783 -1.198 . . . . 0.56999999999999995 112.38 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.54 -6.05 37.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.733 1.613 . . . . 0.56999999999999995 111.211 164.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.93 129.75 13.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.115 -1.594 . . . . 0.56999999999999995 109.115 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.3 -27.01 20.04 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.012 1.768 . . . . 0.56999999999999995 112.758 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.07 147.26 53.8 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.795 -1.187 . . . . 0.66000000000000003 107.795 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.58 141.15 35.23 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 109.39 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 46.6 m170 -129.92 152.68 49.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 110.411 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.08 154.75 42.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.036 0.934 . . . . 0.56999999999999995 108.485 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.45 98.94 11.22 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.781 -0.822 . . . . 0.66000000000000003 108.781 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -56.63 -25.77 54.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.651 1.981 . . . . 0.66000000000000003 112.299 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -56.25 -40.63 74.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.594 1.157 . . . . 0.66000000000000003 110.218 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.49 126.9 31.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.035 0.934 . . . . 0.66000000000000003 108.575 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.97 98.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.617 1.167 . . . . 1.2 111.818 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.59 145.82 28.64 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.932 -1.136 . . . . 0.56999999999999995 107.932 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -141.73 147.09 36.83 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.759 -1.2 . . . . 0.56999999999999995 107.759 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.77 17.08 5.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.506 1.122 . . . . 0.66000000000000003 112.365 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.39 -151.7 23.35 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.76 2.124 . . . . 0.56999999999999995 108.006 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.81 -173.52 0.19 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 110.934 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 p -109.23 179.52 4.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.228 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.94 -58.87 0.57 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.499 2.32 . . . . 0.56999999999999995 113.686 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 169.93 53.33 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.766 1.651 . . . . 0.56999999999999995 110.36 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.1 120.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.976 -0.749 . . . . 0.56999999999999995 108.976 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.05 112.73 3.11 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.822 0.701 . . . . 0.56999999999999995 109.595 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.18 -40.13 64.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.587 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.94 -42.98 84.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.168 0.44 . . . . 0.56999999999999995 110.088 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.17 -45.12 95.94 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.97 66.29 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.393 0.677 . . . . 0.56999999999999995 111.443 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -53.36 55.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.166 -0.921 . . . . 0.56999999999999995 109.433 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 84.8 m -57.57 -37.76 73.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.684 1.129 . . . . 0.56999999999999995 111.309 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -62.71 -54.36 40.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.935 0.789 . . . . 0.65000000000000002 110.461 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 4.6 mm-40 -66.81 -43.15 84.58 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.149 0.979 . . . . 0.66000000000000003 110.795 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.33 -30.36 71.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 0.56999999999999995 111.226 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.05 -51.6 57.35 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.581 -1.008 . . . . 0.56999999999999995 110.581 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.21 -46.08 89.41 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.243 -0.884 . . . . 0.65000000000000002 111.016 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.8 p -61.94 -32.39 72.8 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 123.969 0.793 . . . . 0.56999999999999995 112.364 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -46.38 89.82 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.561 0.744 . . . . 0.56999999999999995 110.54 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.91 36.66 0.02 OUTLIER Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.796 -1.002 . . . . 0.56999999999999995 114.372 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -124.99 163.59 21.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 109.613 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.97 -47.0 0.17 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.61 -1.661 . . . . 0.56999999999999995 111.788 -169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m170 167.38 -177.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.707 2.803 . . . . 0.65000000000000002 107.964 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.461 ' OG ' ' OD2' ' A' ' 155' ' ' ASP . 14.6 p -152.07 -174.44 4.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.394 1.078 . . . . 0.56999999999999995 108.478 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.7 m -137.04 67.61 1.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 108.759 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.92 143.64 48.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.528 -0.916 . . . . 0.66000000000000003 108.528 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.89 -14.91 21.29 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 112.981 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 32.83 4.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.379 1.472 . . . . 0.56999999999999995 109.462 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.59 143.18 26.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.56999999999999995 109.875 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -67.46 -31.85 54.56 Favored 'Isoleucine or valine' 0 C--O 1.23 0.044 0 N-CA-C 109.401 -0.592 . . . . 0.56999999999999995 109.401 166.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -19.2 64.85 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 117.057 -1.449 . . . . 0.56999999999999995 112.236 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -49.9 109.81 1.4 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.266 1.394 . . . . 0.56999999999999995 110.524 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.1 38.91 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.215 2.61 . . . . 0.56999999999999995 113.331 -171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.2 m -150.28 132.58 15.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.666 1.586 . . . . 0.56999999999999995 107.032 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -81.7 101.57 10.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.68 -108.66 0.31 Allowed Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.572 -0.571 . . . . 0.56999999999999995 112.585 -171.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -38.03 87.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.714 0.806 . . . . 0.56999999999999995 112.352 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.05 90.82 0.06 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 124.967 1.27 . . . . 0.56999999999999995 110.767 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -52.68 115.53 7.34 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.758 2.023 . . . . 0.66000000000000003 109.883 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.3 -23.58 5.06 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.44 2.093 . . . . 0.56999999999999995 113.269 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -69.43 -39.59 77.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.863 1.211 . . . . 0.56999999999999995 110.524 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -141.17 116.64 10.16 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.415 1.086 . . . . 0.56999999999999995 108.902 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 15.0 p90 -147.2 -49.36 0.18 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 111.207 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER 30.61 52.98 0.14 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 127.321 2.248 . . . . 0.56999999999999995 113.113 -176.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp 63.32 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.006 1.722 . . . . 0.56999999999999995 110.935 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -70.65 -82.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.051 0.94 . . . . 0.56999999999999995 112.974 -165.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -144.63 -48.51 0.26 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 108.566 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.461 ' OD2' ' OG ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -49.87 -47.3 51.93 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.473 1.909 . . . . 0.66000000000000003 112.913 172.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.61 -54.42 47.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.756 0.822 . . . . 0.66000000000000003 110.827 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.15 -45.73 92.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.329 1.052 . . . . 0.56999999999999995 108.921 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -63.71 -41.91 98.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.812 1.245 . . . . 0.56999999999999995 109.368 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.03 -49.03 69.93 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.743 -0.943 . . . . 0.56999999999999995 110.743 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.65 -47.19 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 117.774 0.787 . . . . 0.56999999999999995 110.995 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -66.79 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.904 -0.569 . . . . 0.56999999999999995 112.063 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.45 43.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.292 0.951 . . . . 0.56999999999999995 110.612 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mp -78.45 -41.94 31.34 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.959 0.8 . . . . 0.56999999999999995 112.554 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.202 0.815 . . . . 0.56999999999999995 113.202 -169.451 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 N--CA 1.449 -1.107 0 N-CA-C 110.171 -0.742 . . . . 0.56999999999999995 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.58 110.45 0.05 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 108.25 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -48.38 150.81 1.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.441 0.696 . . . . 0.56999999999999995 110.577 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.6 p -60.95 -24.23 65.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.56999999999999995 111.807 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.0 t -99.88 152.29 20.32 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.752 1.621 . . . . 0.56999999999999995 109.79 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -8.48 55.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 112.715 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.89 119.04 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.833 -2.284 . . . . 0.56999999999999995 104.833 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.87 142.41 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.347 -1.353 . . . . 0.56999999999999995 107.347 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -109.15 150.17 28.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.399 -0.813 . . . . 0.56999999999999995 110.432 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -127.0 148.71 50.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.665 -0.698 . . . . 0.56999999999999995 111.14 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.73 114.43 7.24 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.521 -0.918 . . . . 1.2 108.521 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.81 89.12 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 106.132 -1.803 . . . . 0.56999999999999995 106.132 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.08 -30.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 113.486 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.11 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.245 -2.502 . . . . 0.56999999999999995 104.245 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.47 -178.88 5.32 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.547 1.139 . . . . 0.56999999999999995 108.367 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 t -97.63 -162.69 0.98 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.56999999999999995 109.817 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -136.54 -31.52 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.053 1.131 . . . . 1.2 114.053 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.15 -38.8 65.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.826 1.25 . . . . 0.66000000000000003 109.957 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.64 153.28 81.05 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.267 2.227 . . . . 0.56999999999999995 109.85 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.85 158.24 42.9 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.803 2.335 . . . . 0.56999999999999995 113.475 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -62.38 -36.72 83.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.748 1.219 . . . . 0.65000000000000002 113.193 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -65.79 -37.17 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.081 0.552 . . . . 0.56999999999999995 110.52 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -63.27 -47.67 81.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 116.894 -1.527 . . . . 0.56999999999999995 108.101 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.24 -50.19 48.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 CA-C-N 120.41 1.459 . . . . 0.56999999999999995 110.762 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.36 -46.07 91.73 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.939 1.245 . . . . 0.66000000000000003 111.989 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -45.43 94.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.728 -0.607 . . . . 1.2 111.55 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.88 -43.11 94.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.408 -1.282 . . . . 0.56999999999999995 109.068 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -45.17 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 120.321 1.419 . . . . 0.56999999999999995 109.918 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.1 91.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.063 0.847 . . . . 0.56999999999999995 110.379 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -70.33 -37.08 74.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.972 0.909 . . . . 0.56999999999999995 112.389 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -48.4 74.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 110.908 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -67.57 -30.05 69.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.159 -0.924 . . . . 0.56999999999999995 110.825 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.62 -36.94 77.32 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.342 0.974 . . . . 0.56999999999999995 110.165 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.66 -38.22 88.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.406 -1.283 . . . . 0.56999999999999995 111.69 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -73.76 -41.27 62.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.851 1.205 . . . . 0.56999999999999995 111.677 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -5.46 55.66 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.915 -1.116 . . . . 0.56999999999999995 112.362 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -19.56 64.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 118.552 1.176 . . . . 0.56999999999999995 111.319 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.21 -35.55 5.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.313 1.045 . . . . 0.66000000000000003 112.023 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 16.3 pt -106.2 129.55 24.37 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 119.616 1.098 . . . . 0.56999999999999995 110.627 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.47 40.43 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.956 3.104 . . . . 0.56999999999999995 112.332 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.47 143.78 28.35 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 107.786 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -125.83 162.41 25.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.572 -0.899 . . . . 0.65000000000000002 108.572 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 160.05 40.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.631 -0.877 . . . . 0.56999999999999995 108.631 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -143.65 174.96 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -123.48 162.08 23.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.767 -1.197 . . . . 0.56999999999999995 107.767 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.54 175.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.153 1.781 . . . . 0.56999999999999995 108.494 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.3 -29.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.212 1.005 . . . . 0.56999999999999995 111.901 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -63.39 -62.08 1.92 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.094 1.358 . . . . 0.56999999999999995 112.512 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.39 38.14 0.15 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.354 0.502 . . . . 0.56999999999999995 113.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.6 t -166.47 149.06 6.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.355 1.462 . . . . 0.56999999999999995 107.316 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.19 -178.62 3.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.878 1.271 . . . . 0.56999999999999995 109.983 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.31 -35.33 75.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.297 0.639 . . . . 0.66000000000000003 109.915 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.27 69.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.595 1.958 . . . . 0.56999999999999995 107.748 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.12 118.9 16.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.099 -1.626 . . . . 0.56999999999999995 107.205 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.55 125.93 65.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.564 -2.013 . . . . 0.56999999999999995 105.564 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.63 165.69 26.39 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 110.702 -0.959 . . . . 0.56999999999999995 110.702 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.4 m-85 -133.2 148.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.042 -1.466 . . . . 0.56999999999999995 107.042 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.86 -171.65 3.49 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.494 1.517 . . . . 0.56999999999999995 108.767 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -122.59 179.92 4.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 1.2 108.953 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -39.84 106.41 0.06 OUTLIER Glycine 0 C--N 1.342 0.872 0 C-N-CA 126.084 1.802 . . . . 0.56999999999999995 110.615 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 56.05 137.06 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.429 2.692 . . . . 0.56999999999999995 115.169 -166.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 11.8 p-80 -154.21 159.08 41.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.003 0.921 . . . . 0.65000000000000002 109.99 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.62 55.04 1.99 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 111.321 -170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -108.58 -50.16 3.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.515 0.726 . . . . 0.66000000000000003 110.511 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.13 -35.47 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.862 2.065 . . . . 0.56999999999999995 110.874 -166.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.2 100.43 7.07 Favored Pre-proline 0 C--N 1.347 0.492 0 CA-C-N 119.975 1.262 . . . . 0.56999999999999995 109.958 -170.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.97 120.27 7.47 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.076 1.184 . . . . 0.56999999999999995 110.591 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 12.5 m-85 -63.44 164.15 9.72 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 125.195 1.398 . . . . 0.56999999999999995 110.594 167.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.28 -37.29 11.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.891 2.476 . . . . 0.66000000000000003 112.017 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.41 -147.01 18.91 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 119.444 1.02 . . . . 0.56999999999999995 112.018 -170.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.96 72.17 4.01 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.857 3.704 . . . . 0.56999999999999995 115.04 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.87 37.15 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.49 -1.381 . . . . 0.56999999999999995 111.815 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 38.6 -129.48 0.23 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.56999999999999995 114.016 167.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -64.7 118.63 9.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 111.154 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.71 -33.57 13.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 112.795 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.83 29.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.928 1.291 . . . . 0.56999999999999995 107.625 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -142.6 159.65 41.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.649 0.779 . . . . 0.65000000000000002 108.938 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.71 167.12 30.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.263 0.625 . . . . 0.56999999999999995 109.42 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -120.07 152.75 37.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.742 -0.663 . . . . 0.56999999999999995 109.512 -171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.33 153.63 85.62 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.098 -0.953 . . . . 0.56999999999999995 110.011 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.33 162.98 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.889 1.726 . . . . 0.56999999999999995 111.38 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 -100.02 0.15 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.168 -1.573 . . . . 0.56999999999999995 109.168 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -157.24 120.14 3.99 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.262 -1.385 . . . . 0.56999999999999995 107.262 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.96 -121.49 6.69 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.046 -1.419 . . . . 0.56999999999999995 110.275 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.45 -27.9 58.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.637 1.175 . . . . 0.56999999999999995 111.546 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.92 144.26 7.68 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.754 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.21 -26.72 2.89 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.48 1.514 . . . . 0.56999999999999995 113.917 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.48 150.66 48.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.461 1.131 . . . . 0.66000000000000003 108.936 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.1 146.22 48.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.611 1.196 . . . . 0.56999999999999995 109.055 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 144.78 37.94 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.409 -1.269 . . . . 0.65000000000000002 108.795 -169.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 50.9 m-85 -139.02 149.63 44.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.288 -1.375 . . . . 0.56999999999999995 107.288 -166.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -94.69 99.05 11.23 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.091 -1.077 . . . . 0.66000000000000003 108.091 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.24 -24.37 41.96 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.718 2.007 . . . . 0.66000000000000003 111.785 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -59.21 -41.92 89.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.179 -0.304 . . . . 0.66000000000000003 110.179 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.34 134.42 47.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.746 -0.835 . . . . 0.66000000000000003 108.746 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -61.19 133.3 55.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.827 -0.434 . . . . 1.2 109.827 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -117.95 140.72 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.102 -1.444 . . . . 0.56999999999999995 107.102 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -140.12 148.75 42.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.988 0.813 . . . . 0.56999999999999995 109.431 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.79 -40.0 78.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.332 1.053 . . . . 0.66000000000000003 111.338 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 155.69 58.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.394 0.997 . . . . 0.56999999999999995 110.926 -170.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -153.1 170.81 19.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.926 0.863 . . . . 0.56999999999999995 110.093 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -70.15 77.34 0.51 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.56999999999999995 111.41 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -48.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.585 1.154 . . . . 0.56999999999999995 112.995 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.53 -152.0 6.69 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.466 -1.454 . . . . 0.56999999999999995 109.466 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.52 131.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.234 -0.654 . . . . 0.56999999999999995 109.234 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -57.37 104.1 0.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.56999999999999995 109.439 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.09 -41.69 79.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 109.496 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.48 -46.17 89.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.09 -41.41 99.4 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.901 -0.777 . . . . 0.56999999999999995 108.901 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.58 -53.08 60.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.294 0.638 . . . . 0.56999999999999995 111.524 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.02 71.08 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.597 -0.716 . . . . 0.56999999999999995 109.478 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.6 m -58.06 -40.05 80.01 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.872 0.76 . . . . 0.56999999999999995 111.664 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -60.17 -54.47 45.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.665 0.666 . . . . 0.65000000000000002 109.766 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.99 -45.21 82.46 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.555 -0.715 . . . . 0.66000000000000003 111.671 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.1 -32.93 74.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.447 1.099 . . . . 0.56999999999999995 111.341 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.4 -43.77 52.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.276 -0.73 . . . . 0.56999999999999995 111.276 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -75.94 -35.62 59.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.698 -0.667 . . . . 0.65000000000000002 112.26 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -37.49 70.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.763 0.825 . . . . 0.56999999999999995 111.189 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.02 -41.15 99.48 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.934 -0.479 . . . . 0.56999999999999995 111.77 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 165.7 45.12 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.681 -1.066 . . . . 0.56999999999999995 114.431 -172.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.5 mmt 55.09 -168.28 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.587 1.193 . . . . 0.56999999999999995 110.793 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.65 33.2 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.422 -0.799 . . . . 0.56999999999999995 113.936 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 170.28 2.47 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.304 1.052 . . . . 0.65000000000000002 113.686 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 p -151.35 -159.17 0.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 110.935 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.2 t -168.93 80.14 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 104.03 -2.582 . . . . 0.56999999999999995 104.03 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.67 147.56 55.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 108.315 -0.994 . . . . 0.66000000000000003 108.315 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.21 -20.19 33.05 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.112 2.541 . . . . 0.56999999999999995 112.951 -170.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -125.3 34.94 4.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.88 1.272 . . . . 0.56999999999999995 108.614 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.02 30.34 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.563 0.745 . . . . 0.56999999999999995 109.542 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.61 -31.22 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.876 -0.416 . . . . 0.56999999999999995 109.876 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.7 mmt -69.25 -4.61 18.5 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 112.402 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.422 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 31.1 t80 -60.94 145.14 89.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.781 1.173 . . . . 0.56999999999999995 109.956 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 73.0 Cg_endo -79.82 162.78 23.84 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.459 2.106 . . . . 0.56999999999999995 111.556 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.9 m 53.64 58.93 4.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.001 0.905 . . . . 0.56999999999999995 109.72 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 71.51 -177.86 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 110.173 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.31 137.0 11.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 107.493 -2.243 . . . . 0.56999999999999995 107.493 166.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -39.81 94.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.447 0.624 . . . . 0.56999999999999995 110.521 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.76 135.8 29.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.269 1.414 . . . . 0.56999999999999995 110.811 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -41.12 111.91 0.88 Allowed Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 126.764 2.026 . . . . 0.66000000000000003 111.819 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.77 -19.39 18.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.073 1.849 . . . . 0.56999999999999995 112.226 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -46.67 25.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.995 -1.113 . . . . 0.56999999999999995 107.995 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -91.99 71.99 5.56 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 111.046 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -33.48 -72.42 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.74 2.016 . . . . 0.56999999999999995 116.003 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 38.9 72.74 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.214 2.206 . . . . 0.56999999999999995 112.543 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp -35.72 114.49 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.261 2.225 . . . . 0.56999999999999995 110.091 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 p -82.93 -83.15 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 110.711 -163.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -140.04 -44.52 0.42 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 117.425 -1.274 . . . . 0.56999999999999995 111.711 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 -43.77 64.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 111.654 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.11 -52.8 62.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.63 0.772 . . . . 0.66000000000000003 110.198 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.98 -39.75 81.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 C-N-CA 123.359 0.664 . . . . 0.56999999999999995 109.504 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.68 97.13 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.132 1.373 . . . . 0.56999999999999995 109.071 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.18 -56.34 22.67 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.883 -1.287 . . . . 0.56999999999999995 109.883 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -50.34 -56.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.979 1.712 . . . . 0.56999999999999995 111.106 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -72.31 -11.5 60.73 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.196 -0.94 . . . . 0.56999999999999995 112.035 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 -15.53 27.84 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 0.56999999999999995 110.967 167.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.92 -52.86 6.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.929 1.692 . . . . 0.56999999999999995 109.692 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.413 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 3.8 p90 . . . . . 0 N--CA 1.468 0.463 0 C-N-CA 123.31 0.644 . . . . 0.56999999999999995 110.999 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.402 -1.038 . . . . 0.56999999999999995 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttt 86.79 138.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.449 2.7 . . . . 0.56999999999999995 108.98 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -75.96 167.71 21.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.638 0.732 . . . . 0.56999999999999995 110.689 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 p -73.66 -13.97 61.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.479 1.112 . . . . 0.56999999999999995 112.507 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -134.34 150.58 50.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.975 1.31 . . . . 0.56999999999999995 109.284 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.91 -3.12 37.06 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.557 1.543 . . . . 0.56999999999999995 112.804 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.65 128.1 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.458 -1.682 . . . . 0.56999999999999995 106.458 172.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.47 139.16 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.784 -1.932 . . . . 0.56999999999999995 105.784 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -115.08 133.76 55.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -114.92 164.07 14.66 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.684 -0.689 . . . . 0.56999999999999995 110.223 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.88 165.66 35.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.979 169.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.0 mt -126.61 78.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 104.272 -2.492 . . . . 0.56999999999999995 104.272 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -30.94 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 112.134 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -133.09 165.17 25.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.086 -2.19 . . . . 0.56999999999999995 105.086 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.72 158.19 43.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.068 1.347 . . . . 0.56999999999999995 109.423 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 t -77.41 -15.08 59.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.255 1.206 . . . . 0.56999999999999995 114.255 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 66.63 -19.88 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.573 1.949 . . . . 1.2 115.03 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -66.88 -31.49 72.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.664 1.586 . . . . 0.66000000000000003 111.951 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 148.05 62.24 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 125.962 1.705 . . . . 0.56999999999999995 108.201 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.34 161.06 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.898 2.398 . . . . 0.56999999999999995 112.128 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.02 -35.95 78.24 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.907 0.883 . . . . 0.65000000000000002 111.831 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.44 -35.78 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.149 0.58 . . . . 0.56999999999999995 110.194 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.7 m -78.97 -37.75 38.64 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 117.882 -1.056 . . . . 0.56999999999999995 110.045 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.91 -44.32 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.202 1.365 . . . . 0.56999999999999995 109.37 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -69.66 -42.39 74.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.78 0.718 . . . . 0.66000000000000003 110.555 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -42.9 84.04 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.846 -1.159 . . . . 1.2 113.259 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.99 -40.82 97.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.56999999999999995 108.338 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.11 -40.6 89.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 119.25 0.932 . . . . 0.56999999999999995 110.604 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -56.89 -52.71 64.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.152 0.887 . . . . 0.56999999999999995 109.119 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -69.76 -36.31 75.67 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.696 -1.145 . . . . 0.56999999999999995 112.002 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.16 91.32 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.522 1.51 . . . . 0.56999999999999995 111.917 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.35 -36.03 76.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.498 -0.763 . . . . 0.56999999999999995 109.913 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.85 -39.1 90.66 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 109.815 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.24 -38.06 89.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.14 1.337 . . . . 0.56999999999999995 112.252 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -66.37 -54.76 20.71 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.404 1.002 . . . . 0.56999999999999995 109.989 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.63 -8.91 49.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.054 1.312 . . . . 0.56999999999999995 114.349 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -68.13 -18.3 64.59 Favored 'General case' 0 C--O 1.226 -0.134 0 O-C-N 120.928 -1.337 . . . . 0.56999999999999995 111.454 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.12 -12.53 11.91 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.59 0.632 . . . . 0.66000000000000003 111.052 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.62 127.54 19.6 Favored Pre-proline 0 C--N 1.347 0.483 0 C-N-CA 124.582 1.153 . . . . 0.56999999999999995 108.763 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 41.18 0.65 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.141 3.228 . . . . 0.56999999999999995 112.804 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 tt -92.75 146.62 23.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.685 1.994 . . . . 0.56999999999999995 108.598 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -124.48 160.95 27.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.438 -0.949 . . . . 0.65000000000000002 108.438 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 161.47 37.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.604 -0.517 . . . . 0.56999999999999995 109.604 -171.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -144.52 177.4 8.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.2 1.4 . . . . 1.2 109.335 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.52 136.83 41.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.232 -1.396 . . . . 0.56999999999999995 107.232 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.98 166.31 2.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.997 0.427 . . . . 0.56999999999999995 110.044 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.89 25.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 111.515 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -55.0 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 112.262 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.91 -153.1 5.79 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.825 -1.31 . . . . 0.56999999999999995 109.825 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -68.94 175.28 3.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.316 0.579 . . . . 0.56999999999999995 110.339 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.79 -178.29 5.19 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.528 1.531 . . . . 0.56999999999999995 109.972 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.96 -32.85 74.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 117.554 -1.212 . . . . 0.66000000000000003 110.834 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.31 73.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.893 1.277 . . . . 0.56999999999999995 107.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.39 155.35 30.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.175 -1.578 . . . . 0.56999999999999995 110.93 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.31 127.63 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.945 -2.613 . . . . 0.56999999999999995 103.945 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.17 162.4 28.38 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.995 -0.842 . . . . 0.56999999999999995 110.995 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -134.88 140.04 45.48 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.823 -1.917 . . . . 0.56999999999999995 105.823 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.67 -178.0 5.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.444 1.498 . . . . 0.56999999999999995 108.698 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 52.18 2.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.926 0.891 . . . . 1.2 110.295 -169.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.66 -141.0 16.64 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.768 -1.333 . . . . 0.56999999999999995 109.768 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 131.43 8.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.367 1.067 . . . . 0.56999999999999995 110.843 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.45 156.72 40.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 125.168 1.387 . . . . 0.65000000000000002 109.493 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 93.4 0.38 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 109.237 -1.545 . . . . 0.56999999999999995 109.237 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -149.63 -85.05 0.09 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.497 1.519 . . . . 0.66000000000000003 108.034 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.22 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.392 1.477 . . . . 0.56999999999999995 109.259 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.19 139.49 31.79 Favored Pre-proline 0 C--N 1.342 0.252 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 108.755 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -68.36 143.37 57.88 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.021 1.147 . . . . 0.56999999999999995 109.264 167.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -73.84 -177.1 2.68 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.87 1.319 . . . . 0.56999999999999995 109.759 163.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.526 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 25.0 p-10 -108.88 -38.03 5.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.211 3.405 . . . . 0.66000000000000003 111.341 -171.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.4 -151.02 19.66 Favored Glycine 0 CA--C 1.54 1.603 0 CA-C-O 117.706 -1.608 . . . . 0.56999999999999995 111.198 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.92 75.69 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.17 1 C-N-CA 125.549 4.166 . . . . 0.56999999999999995 114.653 -168.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.66 172.32 25.63 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.561 2.505 . . . . 0.56999999999999995 108.971 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 76' ' ' ASP . 2.7 m-20 58.01 -143.56 0.65 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.715 1.606 . . . . 0.56999999999999995 112.735 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -41.75 130.29 3.3 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 128.055 2.542 . . . . 0.56999999999999995 110.856 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.77 -28.37 13.53 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.446 -1.409 . . . . 0.56999999999999995 112.567 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.72 161.27 37.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 108.851 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.03 151.11 36.39 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.545 0.688 . . . . 0.65000000000000002 110.127 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.47 172.59 12.48 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 109.189 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -124.18 139.26 54.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.93 159.11 11.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.963 0.905 . . . . 0.56999999999999995 110.043 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.99 158.64 55.77 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.552 1.501 . . . . 0.56999999999999995 110.691 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.55 -138.49 5.15 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.573 -1.011 . . . . 0.56999999999999995 110.573 -172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -138.58 96.68 3.2 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.444 -1.317 . . . . 0.56999999999999995 107.444 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 125.33 -118.54 3.28 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 108.701 -1.759 . . . . 0.56999999999999995 108.701 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -27.56 65.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.888 2.075 . . . . 0.56999999999999995 112.473 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.66 145.09 10.64 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.208 -0.933 . . . . 0.56999999999999995 111.433 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.34 -27.44 4.62 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 125.397 1.475 . . . . 0.56999999999999995 114.117 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.61 156.06 39.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.66000000000000003 108.97 -168.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.25 145.22 38.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.899 0.857 . . . . 0.56999999999999995 110.061 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.11 146.65 39.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.396 1.078 . . . . 0.65000000000000002 109.265 -171.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.453 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 38.3 m-85 -139.55 146.91 40.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.833 -0.803 . . . . 0.56999999999999995 108.833 -167.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -83.95 99.71 10.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.23 -0.656 . . . . 0.66000000000000003 109.23 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -58.91 -24.6 62.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.292 1.437 . . . . 0.66000000000000003 111.337 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.29 -43.62 98.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.515 1.526 . . . . 0.66000000000000003 110.309 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.42 134.23 49.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.223 -1.769 . . . . 0.66000000000000003 106.223 174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 149.55 41.39 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.226 -1.546 . . . . 1.2 109.434 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -129.98 168.22 17.02 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.273 1.029 . . . . 0.56999999999999995 108.294 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.303 -0.999 . . . . 0.56999999999999995 108.303 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.02 38.63 0.72 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.205 1.002 . . . . 0.66000000000000003 110.683 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.02 60.32 2.06 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.985 1.279 . . . . 0.56999999999999995 111.029 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 91.42 3.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 110.236 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m 64.72 -71.53 0.07 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 127.835 2.454 . . . . 0.56999999999999995 113.781 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.98 166.54 26.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.56999999999999995 107.998 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.37 -156.71 21.02 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.093 -1.603 . . . . 0.56999999999999995 109.093 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.06 112.15 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.283 -1.377 . . . . 0.56999999999999995 107.283 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.39 101.94 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.35 0.66 . . . . 0.56999999999999995 111.501 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -58.59 -38.44 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 109.439 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -43.87 97.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.793 0.724 . . . . 0.56999999999999995 110.667 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.17 -48.39 81.8 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 109.528 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.27 76.96 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.545 0.338 . . . . 0.56999999999999995 111.303 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.54 63.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.338 -0.839 . . . . 0.56999999999999995 109.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.8 m -58.2 -37.81 75.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.282 0.946 . . . . 0.56999999999999995 111.577 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.55 -57.14 13.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.652 1.181 . . . . 0.65000000000000002 109.648 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.52 -45.43 90.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.331 0.653 . . . . 0.66000000000000003 110.487 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.36 -28.67 69.39 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.621 1.169 . . . . 0.56999999999999995 111.843 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.45 -45.71 95.72 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.638 0.654 . . . . 0.56999999999999995 111.897 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -68.58 -37.32 79.75 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-O 118.292 -0.861 . . . . 0.65000000000000002 110.93 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.6 m -59.85 -31.64 69.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.058 0.844 . . . . 0.56999999999999995 112.361 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -34.56 66.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.515 1.052 . . . . 0.56999999999999995 111.802 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.25 -56.68 0.13 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-O 119.198 -0.779 . . . . 0.56999999999999995 111.45 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.99 178.04 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.855 2.062 . . . . 0.56999999999999995 108.695 -169.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.12 22.68 0.02 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.028 -0.873 . . . . 0.56999999999999995 112.812 172.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 161.05 30.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.871 1.335 . . . . 0.65000000000000002 111.716 -174.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.44 -170.54 1.47 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.336 1.854 . . . . 0.56999999999999995 108.777 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.71 48.56 1.81 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.442 1.097 . . . . 0.56999999999999995 110.79 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -98.35 144.45 28.11 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 118.004 -0.998 . . . . 0.66000000000000003 110.671 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 -20.58 68.21 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 113.564 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -128.57 25.31 5.73 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.115 1.366 . . . . 0.56999999999999995 110.776 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.09 55.64 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.138 0.97 . . . . 0.56999999999999995 111.093 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.21 -24.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 111.429 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -106.6 22.81 15.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.14 0.976 . . . . 0.56999999999999995 111.38 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.411 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 3.6 t80 -60.67 131.28 90.98 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.488 1.495 . . . . 0.56999999999999995 110.437 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 49.5 Cg_endo -79.58 -38.95 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.405 1.403 . . . . 0.56999999999999995 112.625 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.402 ' HB ' ' CZ ' ' A' ' 139' ' ' TYR . 87.2 m -80.12 67.78 6.05 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.675 -1.266 . . . . 0.56999999999999995 110.03 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -50.03 136.99 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.983 1.313 . . . . 0.56999999999999995 112.054 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.71 107.74 2.99 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.024 0.821 . . . . 0.56999999999999995 111.297 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -165.99 -56.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.608 1.563 . . . . 0.56999999999999995 108.575 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -117.14 -100.84 2.14 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 108.852 -1.699 . . . . 0.56999999999999995 108.852 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -156.52 111.89 2.03 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.66000000000000003 109.463 -170.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.17 -9.14 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.4 2.733 . . . . 0.56999999999999995 113.039 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.74 -18.37 61.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.138 1.335 . . . . 0.56999999999999995 111.039 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -116.63 74.13 0.89 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.618 1.967 . . . . 0.56999999999999995 109.494 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -128.8 122.66 30.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.492 1.517 . . . . 0.56999999999999995 107.914 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 69.11 1.06 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.625 -1.25 . . . . 0.56999999999999995 107.625 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp 52.59 79.77 0.11 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 0.56999999999999995 110.798 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -78.36 0.05 OUTLIER 'General case' 0 C--N 1.342 0.261 0 N-CA-C 114.27 1.211 . . . . 0.56999999999999995 114.27 -166.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -148.79 -49.23 0.15 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.861 1.264 . . . . 0.56999999999999995 108.214 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -45.69 -42.64 11.92 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 128.294 2.638 . . . . 0.66000000000000003 112.14 166.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -66.86 -58.36 5.17 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.8 0.84 . . . . 0.66000000000000003 111.218 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.48 -37.04 67.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 119.014 -0.517 . . . . 0.56999999999999995 109.694 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -59.82 -41.55 91.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.679 0.792 . . . . 0.56999999999999995 108.9 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.26 -52.91 24.47 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.305 -1.118 . . . . 0.56999999999999995 110.305 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.7 mm -56.2 -51.03 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.152 0.981 . . . . 0.56999999999999995 111.641 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.63 -28.88 68.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.393 0.542 . . . . 0.56999999999999995 110.783 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -23.32 56.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.01 -0.519 . . . . 0.56999999999999995 111.603 175.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.1 mt -85.92 -48.46 8.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.56999999999999995 110.901 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.729 0.64 . . . . 0.56999999999999995 112.729 -168.72 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.444 -1.395 0 N-CA-C 108.443 -1.406 . . . . 0.56999999999999995 108.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.19 113.85 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 108.672 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -46.88 147.42 1.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.537 0.735 . . . . 0.56999999999999995 109.988 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -62.29 -27.91 69.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.572 0.749 . . . . 0.56999999999999995 111.701 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.2 t -82.87 149.09 27.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.013 1.325 . . . . 0.56999999999999995 110.963 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -10.59 59.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.331 1.052 . . . . 0.56999999999999995 112.868 172.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.45 144.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.71 1.204 . . . . 0.56999999999999995 107.946 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -130.98 145.53 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.278 -1.378 . . . . 0.56999999999999995 107.278 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -94.39 142.49 27.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.294 -0.632 . . . . 0.56999999999999995 109.294 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -123.07 147.92 46.19 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.235 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 100.71 3.36 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.861 0.839 . . . . 1.2 109.586 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.18 101.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 105.122 -2.177 . . . . 0.56999999999999995 105.122 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -48.89 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.458 1.503 . . . . 0.56999999999999995 111.174 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.9 p -130.59 174.45 9.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.4 -1.704 . . . . 0.56999999999999995 106.4 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.407 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 22.3 m-85 -140.34 167.56 21.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.015 -1.476 . . . . 0.56999999999999995 107.015 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -65.63 178.6 0.97 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.891 0.476 . . . . 0.56999999999999995 111.03 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -34.45 2.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.393 1.077 . . . . 1.2 112.508 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -39.85 82.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.305 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.3 mt -113.66 148.91 40.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.759 1.223 . . . . 0.56999999999999995 108.646 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.21 150.82 33.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.103 1.868 . . . . 0.56999999999999995 112.423 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -59.87 -40.14 87.64 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.698 1.199 . . . . 0.65000000000000002 111.932 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.8 tt -62.95 -36.44 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.191 0.596 . . . . 0.56999999999999995 111.048 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 m -69.05 -42.4 76.34 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.081 -1.438 . . . . 0.56999999999999995 108.984 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -55.74 -47.59 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 121.154 1.797 . . . . 0.56999999999999995 110.095 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.07 -48.73 80.5 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.876 0.87 . . . . 0.66000000000000003 110.548 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.93 -46.29 88.34 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.509 -0.744 . . . . 1.2 112.48 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.86 -41.79 82.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.416 1.086 . . . . 0.56999999999999995 109.346 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.87 -50.15 76.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 118.034 -0.984 . . . . 0.56999999999999995 109.269 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -41.28 99.42 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 111.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -65.03 -46.3 81.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.7 1.136 . . . . 0.56999999999999995 110.864 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.74 92.06 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.889 1.276 . . . . 0.56999999999999995 112.405 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.98 -37.34 75.73 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.512 0.725 . . . . 0.56999999999999995 110.614 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.23 -41.14 87.98 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.828 0.74 . . . . 0.56999999999999995 109.87 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.7 mtp -66.02 -33.1 75.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.677 0.791 . . . . 0.56999999999999995 112.544 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -70.81 -49.34 47.5 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.369 0.986 . . . . 0.56999999999999995 111.112 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.63 -10.78 71.92 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.0 1.286 . . . . 0.56999999999999995 113.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -62.18 -26.63 68.45 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.667 -1.49 . . . . 0.56999999999999995 111.022 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -97.94 -38.29 9.46 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.975 -0.535 . . . . 0.66000000000000003 110.886 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.92 136.41 23.26 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 110.576 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 38.32 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 124.195 3.264 . . . . 0.56999999999999995 112.906 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.15 138.36 31.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.933 1.693 . . . . 0.56999999999999995 107.601 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -120.59 170.82 9.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.65000000000000002 108.662 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.51 153.92 45.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.396 -0.964 . . . . 0.56999999999999995 108.396 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 161.04 37.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.14 0.576 . . . . 1.2 110.803 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -104.08 145.56 30.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.822 -0.807 . . . . 0.56999999999999995 108.822 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.73 170.86 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.114 0.965 . . . . 0.56999999999999995 110.32 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.93 37.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.852 1.261 . . . . 0.56999999999999995 110.215 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -146.46 -72.58 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.028 0.931 . . . . 0.56999999999999995 110.665 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.8 25.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.421 -1.211 . . . . 0.56999999999999995 115.557 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -154.09 135.27 14.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.56999999999999995 106.848 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.63 177.2 11.65 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.074 0.95 . . . . 0.56999999999999995 110.598 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.15 -37.09 72.25 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.297 -0.858 . . . . 0.66000000000000003 110.516 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.99 77.76 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.182 2.193 . . . . 0.56999999999999995 107.82 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -75.28 125.17 28.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.574 -1.269 . . . . 0.56999999999999995 107.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.42 123.12 67.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.999 -2.223 . . . . 0.56999999999999995 104.999 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.9 162.98 26.31 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.843 -0.503 . . . . 0.56999999999999995 111.843 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 13.9 m-85 -137.32 126.8 25.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.546 -1.65 . . . . 0.56999999999999995 106.546 -172.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.74 -174.41 4.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 108.194 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.9 140.29 18.68 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.6 -0.889 . . . . 1.2 108.6 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.95 -90.4 0.41 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.251 0.453 . . . . 0.56999999999999995 112.341 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.79 172.59 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.868 0.834 . . . . 0.56999999999999995 110.049 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -153.75 142.87 21.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.65000000000000002 109.466 175.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.72 45.73 1.58 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.024 1.297 . . . . 0.56999999999999995 112.622 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.4 28.11 0.99 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.302 2.241 . . . . 0.66000000000000003 110.139 -172.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.82 -38.86 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.174 1.79 . . . . 0.56999999999999995 112.029 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -91.25 104.8 10.62 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.604 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.43 143.01 74.55 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.16 1.24 . . . . 0.56999999999999995 109.366 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -72.61 -170.57 0.69 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.719 1.247 . . . . 0.56999999999999995 109.776 170.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 17.0 p-10 -124.65 -45.19 1.93 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.617 2.367 . . . . 0.66000000000000003 108.617 -172.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.29 -148.98 16.56 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.068 1.318 . . . . 0.56999999999999995 110.953 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.74 68.76 2.95 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 125.969 4.446 . . . . 0.56999999999999995 112.933 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.02 166.01 16.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 126.421 1.962 . . . . 0.56999999999999995 108.933 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 4.2 t30 49.73 -160.97 0.06 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.502 1.521 . . . . 0.56999999999999995 112.924 -171.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.2 m -31.8 104.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.913 2.885 . . . . 0.56999999999999995 114.583 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.44 -29.74 57.09 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.104 -1.623 . . . . 0.56999999999999995 114.0 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.7 161.99 40.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 108.239 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.503 ' HE2' ' CE1' ' A' ' 69' ' ' HIS . 0.7 OUTLIER -149.62 158.56 44.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.472 -0.566 . . . . 0.65000000000000002 109.472 177.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.32 170.37 19.7 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 108.824 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -124.09 149.22 46.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.212 -1.033 . . . . 0.56999999999999995 108.212 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.72 154.54 80.12 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.593 -0.717 . . . . 0.56999999999999995 110.137 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.48 166.34 24.12 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.396 2.064 . . . . 0.56999999999999995 111.784 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.45 -116.75 0.67 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.3 p -149.03 65.68 1.04 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.625 0.77 . . . . 0.56999999999999995 111.046 -167.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.99 -121.67 1.4 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.5 -1.44 . . . . 0.56999999999999995 109.5 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.91 -25.9 32.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.053 1.341 . . . . 0.56999999999999995 112.024 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 140.33 11.79 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.852 -1.155 . . . . 0.56999999999999995 111.089 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.4 -24.32 4.97 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.283 1.42 . . . . 0.56999999999999995 113.776 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -68.63 153.24 44.15 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.987 0.893 . . . . 0.66000000000000003 108.726 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.0 146.13 31.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.56999999999999995 109.176 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -140.96 155.59 46.21 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.28 -0.873 . . . . 0.65000000000000002 111.258 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 46.6 m-85 -137.25 141.9 42.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.877 -1.157 . . . . 0.56999999999999995 107.877 -163.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -80.9 104.36 11.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.716 -1.216 . . . . 0.66000000000000003 107.716 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.4 -23.74 67.39 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.33 -0.856 . . . . 0.66000000000000003 110.844 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.29 -24.18 60.38 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 110.117 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.92 132.48 39.1 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.16 -1.052 . . . . 0.66000000000000003 108.16 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -65.98 143.36 57.43 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.352 -0.61 . . . . 1.2 109.352 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -126.36 137.38 53.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.609 -1.256 . . . . 0.56999999999999995 107.609 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.3 t -113.53 147.41 37.99 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.869 -0.789 . . . . 0.56999999999999995 108.869 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -74.52 21.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.166 1.786 . . . . 0.66000000000000003 112.981 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.13 124.86 0.25 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.406 1.955 . . . . 0.56999999999999995 109.998 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 t 74.74 58.49 0.07 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.987 1.715 . . . . 0.56999999999999995 113.004 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 41.11 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.299 1.04 . . . . 0.56999999999999995 112.538 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp 55.52 -178.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 111.843 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.01 -168.33 52.06 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.011 -1.056 . . . . 0.56999999999999995 111.653 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.9 121.16 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.847 -0.797 . . . . 0.56999999999999995 108.847 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -56.8 106.72 0.33 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.872 1.269 . . . . 0.56999999999999995 109.209 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.84 -38.29 75.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.481 0.712 . . . . 0.56999999999999995 109.958 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.28 -51.42 66.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.596 -1.261 . . . . 0.56999999999999995 107.596 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -54.92 -42.51 72.3 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.876 -0.583 . . . . 0.56999999999999995 111.042 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.5 5.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.277 0.631 . . . . 0.56999999999999995 110.275 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.79 -50.16 75.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 118.349 -0.834 . . . . 0.56999999999999995 109.492 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 m -57.34 -36.45 71.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.597 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.7 -55.39 17.65 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.19 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.11 -40.74 90.96 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.61 -0.681 . . . . 0.66000000000000003 110.749 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.81 -32.28 73.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.472 1.509 . . . . 0.56999999999999995 111.692 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.25 94.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.466 -0.654 . . . . 0.56999999999999995 111.466 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -69.33 -37.11 77.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 117.594 -1.193 . . . . 0.65000000000000002 111.916 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.2 p -59.08 -33.19 70.53 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.18 0.925 . . . . 0.56999999999999995 111.269 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.63 -33.97 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 112.023 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 151.78 53.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.605 1.093 . . . . 0.56999999999999995 114.404 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 mmt 58.06 -177.17 0.07 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.489 0.661 . . . . 0.56999999999999995 111.452 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.13 57.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.527 -1.429 . . . . 0.56999999999999995 109.527 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.36 167.32 11.6 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.93 0.871 . . . . 0.65000000000000002 110.467 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 t -160.69 -170.31 2.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.917 1.287 . . . . 0.56999999999999995 109.74 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.23 30.36 1.14 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.571 1.948 . . . . 0.56999999999999995 109.999 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.49 148.43 35.48 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.739 1.216 . . . . 0.66000000000000003 109.974 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.94 -21.53 43.56 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.287 2.658 . . . . 0.56999999999999995 113.279 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -132.59 29.05 4.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.376 1.871 . . . . 0.56999999999999995 108.661 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.1 133.03 49.05 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.658 -1.276 . . . . 0.56999999999999995 109.026 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 156' ' ' ASP . 4.3 p -55.8 -28.73 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.371 1.468 . . . . 0.56999999999999995 112.68 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.49 27.9 9.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.099 . . . . 0.56999999999999995 110.338 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -56.49 129.17 75.45 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 109.971 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.59 178.38 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.942 2.428 . . . . 0.56999999999999995 110.573 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m 71.08 -40.99 0.49 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.504 1.522 . . . . 0.56999999999999995 113.321 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.9 t80 55.39 92.21 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.275 2.23 . . . . 0.56999999999999995 113.722 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.75 105.75 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.598 -1.001 . . . . 0.56999999999999995 110.598 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -172.65 -50.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.093 1.357 . . . . 0.56999999999999995 110.565 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.88 -113.1 2.94 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.25 -1.94 . . . . 0.56999999999999995 108.25 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.68 134.59 9.19 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 106.529 -1.656 . . . . 0.66000000000000003 106.529 174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.09 -8.43 6.63 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.023 3.149 . . . . 0.56999999999999995 113.559 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -71.01 -28.16 64.21 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.151 -1.593 . . . . 0.56999999999999995 111.368 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -106.96 61.79 0.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.56999999999999995 110.916 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -126.44 141.26 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.575 1.15 . . . . 0.56999999999999995 110.311 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.66 51.68 0.08 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.866 0.866 . . . . 0.56999999999999995 110.956 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 69.27 76.64 0.23 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.554 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.3 t -69.57 -94.42 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.918 0.887 . . . . 0.56999999999999995 112.044 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -131.12 -44.69 1.03 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.986 0.914 . . . . 0.56999999999999995 109.641 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -46.04 49.96 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.96 0.904 . . . . 0.66000000000000003 110.615 166.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.42 ' HB2' HG13 ' A' ' 137' ' ' VAL . 1.2 t0 -60.23 -56.58 19.82 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.524 -0.75 . . . . 0.66000000000000003 110.403 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.39 -43.84 87.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 N-CA-C 109.044 -0.724 . . . . 0.56999999999999995 109.044 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -64.43 -38.66 91.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.675 0.79 . . . . 0.56999999999999995 110.72 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.93 -49.73 39.75 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.689 -0.965 . . . . 0.56999999999999995 110.689 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -56.54 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 C-N-CA 126.144 1.777 . . . . 0.56999999999999995 110.254 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.6 -20.53 65.74 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.845 -0.534 . . . . 0.56999999999999995 110.777 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -88.1 -29.83 20.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.201 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.27 -58.02 8.51 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 125.717 1.607 . . . . 0.56999999999999995 109.747 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 113.155 0.798 . . . . 0.56999999999999995 113.155 -177.167 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.457 -0.622 0 N-CA-C 109.884 -0.852 . . . . 0.56999999999999995 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 pttt 67.01 141.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.759 2.023 . . . . 0.56999999999999995 110.881 -165.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -56.5 149.2 17.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.046 0.939 . . . . 0.56999999999999995 110.371 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 p -62.63 -20.03 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.305 0.854 . . . . 0.56999999999999995 113.305 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -96.7 140.98 30.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.849 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -72.96 -14.09 61.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 113.064 171.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 m -114.2 119.54 61.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.759 -1.941 . . . . 0.56999999999999995 105.759 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.17 155.59 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.31 -1.367 . . . . 0.56999999999999995 107.31 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -106.88 143.6 34.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.56999999999999995 109.758 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -126.64 145.46 50.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.601 -0.518 . . . . 0.56999999999999995 109.601 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.1 115.13 3.48 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.758 0.79 . . . . 1.2 111.921 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.0 95.17 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 105.718 -1.956 . . . . 0.56999999999999995 105.718 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 m -67.0 -39.02 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.132 0.973 . . . . 0.56999999999999995 112.067 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -130.0 152.49 49.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.089 -2.56 . . . . 0.56999999999999995 104.089 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.401 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 84.8 m-85 -127.41 167.34 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.977 1.311 . . . . 0.56999999999999995 107.858 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 t -64.63 -179.99 0.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 110.901 173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -40.13 3.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.83 0.852 . . . . 1.2 111.585 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -41.97 77.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.654 0.661 . . . . 0.66000000000000003 111.583 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.69 152.86 38.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.56999999999999995 108.587 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.42 149.53 39.79 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.897 1.731 . . . . 0.56999999999999995 112.41 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -58.86 -37.42 76.47 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 113.08 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -43.52 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.773 -0.455 . . . . 0.56999999999999995 109.773 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 m -66.61 -39.99 88.62 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.945 -1.026 . . . . 0.56999999999999995 109.577 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.5 -51.08 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.709 1.14 . . . . 0.56999999999999995 110.704 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -63.35 -43.05 98.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.87 1.214 . . . . 0.66000000000000003 110.482 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -46.75 87.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.216 -0.927 . . . . 1.2 111.207 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.79 -38.27 86.19 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.263 -1.351 . . . . 0.56999999999999995 109.904 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -59.62 -46.55 93.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 110.076 170.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.266 0.939 . . . . 0.56999999999999995 109.502 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -68.47 -41.86 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.363 -0.827 . . . . 0.56999999999999995 111.688 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.27 -46.62 87.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.735 1.152 . . . . 0.56999999999999995 111.504 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.2 mt -67.91 -37.53 81.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.934 0.894 . . . . 0.56999999999999995 110.162 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.39 -39.73 84.29 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.209 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -43.94 97.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.725 0.81 . . . . 0.56999999999999995 111.349 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 33.9 m95 -61.76 -47.84 83.38 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.852 0.751 . . . . 0.56999999999999995 111.285 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.21 -2.07 71.6 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.298 -0.876 . . . . 0.56999999999999995 113.695 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -81.82 -11.59 58.9 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.347 1.573 . . . . 0.56999999999999995 110.071 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.62 -21.8 12.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.356 0.526 . . . . 0.66000000000000003 111.353 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.4 pt -136.52 146.46 55.8 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.731 1.213 . . . . 0.56999999999999995 110.302 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.99 58.43 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 111.937 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.03 138.19 54.21 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.613 1.965 . . . . 0.56999999999999995 106.631 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -123.23 160.46 26.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.291 -1.003 . . . . 0.65000000000000002 108.291 -171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.43 149.98 38.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.829 -1.175 . . . . 0.56999999999999995 107.829 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -134.2 157.34 46.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.149 0.979 . . . . 1.2 109.046 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -115.81 108.85 16.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 -174.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.46 133.76 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.555 -1.276 . . . . 0.56999999999999995 107.555 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -37.18 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.179 -0.325 . . . . 0.56999999999999995 110.208 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.63 162.17 39.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.312 1.045 . . . . 0.56999999999999995 109.003 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.84 156.83 18.15 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.964 -1.255 . . . . 0.56999999999999995 109.964 -164.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -64.32 168.53 5.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.517 0.675 . . . . 0.56999999999999995 110.696 168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.2 17.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.766 1.226 . . . . 0.56999999999999995 109.937 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -67.96 -44.04 77.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.987 -1.006 . . . . 0.66000000000000003 109.341 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.4 mt -116.53 78.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.082 1.753 . . . . 0.56999999999999995 107.74 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.0 ttm -76.3 153.66 35.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.848 -1.158 . . . . 0.56999999999999995 109.612 171.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.75 134.83 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.73 -1.952 . . . . 0.56999999999999995 105.73 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.56 166.54 30.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.779 -0.928 . . . . 0.56999999999999995 110.779 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -138.6 149.99 45.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.661 -0.866 . . . . 0.56999999999999995 108.661 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.42 175.92 11.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.969 1.308 . . . . 0.56999999999999995 110.249 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -140.46 63.0 1.48 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.765 1.226 . . . . 1.2 109.812 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.79 -70.64 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.644 -0.583 . . . . 0.56999999999999995 111.644 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.13 174.72 8.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.942 -1.328 . . . . 0.56999999999999995 110.398 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -149.45 137.86 20.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.427 -0.583 . . . . 0.65000000000000002 109.427 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.91 37.52 3.39 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.235 0.922 . . . . 0.56999999999999995 112.021 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.78 -72.05 0.46 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.1 1.36 . . . . 0.66000000000000003 108.574 -171.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -172.55 -36.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.979 -0.534 . . . . 0.56999999999999995 111.677 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -102.76 101.64 21.96 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-O 118.286 -0.864 . . . . 0.56999999999999995 108.732 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.79 129.27 28.46 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 108.26 -1.477 . . . . 0.56999999999999995 108.26 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.5 OUTLIER -64.66 -167.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.769 1.747 . . . . 0.56999999999999995 109.146 165.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.506 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 9.2 p-10 -134.75 -46.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 129.773 3.229 . . . . 0.66000000000000003 107.655 -163.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.01 -146.37 16.06 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.052 -1.416 . . . . 0.56999999999999995 110.159 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 83.06 1.9 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.431 3.421 . . . . 0.56999999999999995 112.437 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.87 169.24 17.86 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 127.749 2.595 . . . . 0.56999999999999995 109.852 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 16.2 t30 54.5 -144.69 0.66 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.675 1.59 . . . . 0.56999999999999995 112.604 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.5 m -47.33 135.81 10.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.578 2.351 . . . . 0.56999999999999995 111.577 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.38 -33.18 10.11 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 112.519 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.9 158.47 28.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.56999999999999995 108.812 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.671 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.1 p-80 -141.56 164.75 29.39 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.023 0.829 . . . . 0.65000000000000002 111.792 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.76 156.38 44.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.433 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.08 152.87 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.925 -1.034 . . . . 0.56999999999999995 108.894 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.05 95.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.701 -0.666 . . . . 0.56999999999999995 110.186 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.47 149.7 69.08 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.077 2.518 . . . . 0.56999999999999995 112.033 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.17 -70.65 0.32 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.406 0.527 . . . . 0.56999999999999995 112.077 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -75.1 166.36 23.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.382 1.073 . . . . 0.56999999999999995 109.796 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.46 45.35 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 117.554 -1.692 . . . . 0.56999999999999995 114.797 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.78 -26.71 60.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.419 1.609 . . . . 0.56999999999999995 111.049 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.15 149.11 6.21 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 110.925 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.75 -28.84 1.82 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.257 1.408 . . . . 0.56999999999999995 113.624 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.97 152.95 44.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.242 1.021 . . . . 0.66000000000000003 109.004 -170.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 149.7 52.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.608 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -140.39 151.34 44.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.836 -0.62 . . . . 0.65000000000000002 110.957 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 40.6 m-85 -138.43 144.9 40.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.462 1.105 . . . . 0.56999999999999995 109.007 -165.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.07 107.07 6.9 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.006 -1.109 . . . . 0.66000000000000003 108.006 171.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.22 -19.11 62.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.524 1.511 . . . . 0.66000000000000003 111.581 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.44 -44.96 81.41 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.398 1.479 . . . . 0.66000000000000003 111.629 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.55 122.5 17.73 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 106.219 -1.771 . . . . 0.66000000000000003 106.219 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 129.57 40.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.101 -0.952 . . . . 1.2 109.622 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -106.73 153.63 22.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.631 1.172 . . . . 0.56999999999999995 109.465 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 141.85 51.46 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.558 -0.905 . . . . 0.56999999999999995 108.558 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.23 42.27 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.055 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.64 75.47 0.89 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.825 -0.91 . . . . 0.56999999999999995 110.825 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.36 177.78 7.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.073 0.949 . . . . 0.56999999999999995 108.967 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 m -57.17 122.65 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.836 0.855 . . . . 0.56999999999999995 110.576 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.44 172.66 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.024 1.729 . . . . 0.56999999999999995 112.577 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.08 169.69 42.09 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.561 -0.745 . . . . 0.56999999999999995 111.447 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.25 123.59 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -64.58 120.36 12.21 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.482 -0.327 . . . . 0.56999999999999995 110.729 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -52.65 -43.07 65.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.913 0.885 . . . . 0.56999999999999995 111.869 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -64.77 -46.3 82.71 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.54 0.609 . . . . 0.56999999999999995 109.839 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.69 -48.62 77.25 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.801 -0.444 . . . . 0.56999999999999995 109.801 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.76 85.32 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 122.8 0.44 . . . . 0.56999999999999995 110.824 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -52.17 66.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 117.853 -1.07 . . . . 0.56999999999999995 109.409 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.5 m -53.91 -40.25 66.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.174 1.352 . . . . 0.56999999999999995 111.89 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -60.3 -56.37 22.32 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.206 0.602 . . . . 0.65000000000000002 110.536 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.671 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 5.9 mm-40 -67.51 -44.51 78.24 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.931 0.892 . . . . 0.66000000000000003 111.322 -172.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.57 -25.91 68.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.584 1.554 . . . . 0.56999999999999995 110.943 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.402 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.62 -51.72 57.21 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.713 -0.955 . . . . 0.56999999999999995 110.713 169.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.07 -38.81 90.21 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 117.658 -1.163 . . . . 0.65000000000000002 111.265 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.3 p -58.18 -31.3 67.15 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 118.559 0.618 . . . . 0.56999999999999995 112.424 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -36.9 72.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.501 0.32 . . . . 0.56999999999999995 111.815 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.16 43.24 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.691 -1.061 . . . . 0.56999999999999995 113.342 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -116.58 149.59 39.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.594 1.197 . . . . 0.56999999999999995 110.649 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.08 -45.62 4.09 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 117.786 -1.563 . . . . 0.56999999999999995 111.928 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m80 156.24 174.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 129.739 3.216 . . . . 0.65000000000000002 110.103 -171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 m -117.41 176.71 5.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.042 1.737 . . . . 0.56999999999999995 110.807 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.27 58.99 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.625 1.17 . . . . 0.56999999999999995 109.45 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.13 142.72 42.94 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 107.297 -1.372 . . . . 0.66000000000000003 107.297 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.8 -34.58 30.49 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.696 1.597 . . . . 0.56999999999999995 111.188 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -105.18 24.3 12.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 110.071 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.54 130.64 47.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.97 -0.752 . . . . 0.56999999999999995 108.97 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 155' ' ' ASP . 7.2 p -67.29 -24.39 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.411 -0.515 . . . . 0.56999999999999995 109.815 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.4 16.54 14.93 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.483 -0.761 . . . . 0.56999999999999995 112.318 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.18 144.46 87.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.857 1.662 . . . . 0.56999999999999995 111.673 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.25 163.52 36.27 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.48 2.12 . . . . 0.56999999999999995 111.041 167.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.6 m 56.09 94.06 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.638 1.575 . . . . 0.56999999999999995 112.034 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.37 105.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.491 1.516 . . . . 0.56999999999999995 112.564 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.12 166.54 33.61 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.523 -1.831 . . . . 0.56999999999999995 108.523 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.17 -47.89 0.22 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.88 2.472 . . . . 0.56999999999999995 114.769 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.54 175.59 7.25 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.118 1.342 . . . . 0.56999999999999995 112.142 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -121.0 101.15 45.3 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.939 -1.134 . . . . 0.66000000000000003 107.939 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.79 40.29 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 113.077 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.87 -54.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.638 -1.289 . . . . 0.56999999999999995 107.994 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.07 88.22 2.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.964 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -121.45 -45.98 2.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 110.279 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 30.34 55.43 0.18 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.546 2.338 . . . . 0.56999999999999995 113.574 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mp 63.46 100.22 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.617 1.967 . . . . 0.56999999999999995 109.948 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.7 m -70.84 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.376 0.88 . . . . 0.56999999999999995 113.376 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -143.94 -42.68 0.27 Allowed 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.938 0.895 . . . . 0.56999999999999995 109.145 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.522 ' HD2' ' N ' ' A' ' 137' ' ' VAL . 15.0 p-10 -59.95 -39.97 87.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.667 0.667 . . . . 0.66000000000000003 112.172 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -54.56 29.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.7 1.2 . . . . 0.66000000000000003 109.134 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.9 -46.25 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 124.826 1.251 . . . . 0.56999999999999995 108.746 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -62.56 -47.71 82.69 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 117.971 -1.014 . . . . 0.56999999999999995 108.761 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.55 -62.32 6.44 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.807 -1.717 . . . . 0.56999999999999995 108.807 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.3 mm -56.93 -43.61 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.242 1.021 . . . . 0.56999999999999995 113.132 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -71.34 -27.75 63.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.58 -0.7 . . . . 0.56999999999999995 111.662 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -36.01 68.13 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.964 0.906 . . . . 0.56999999999999995 110.363 169.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -61.53 2.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.994 -1.003 . . . . 0.56999999999999995 110.289 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 114.229 1.196 . . . . 0.56999999999999995 114.229 -170.854 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 CA--C 1.552 1.377 0 N-CA-C 115.013 1.12 . . . . 0.56999999999999995 115.013 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -162.06 31.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 110.81 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.408 ' CH2' ' HA3' ' A' ' 94' ' ' GLY . 89.4 m95 51.93 -111.53 0.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.762 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -154.57 -40.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.613 1.565 . . . . 0.56999999999999995 108.428 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -95.97 153.35 17.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.312 0.645 . . . . 0.56999999999999995 109.506 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -9.93 20.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.988 0.915 . . . . 0.56999999999999995 112.667 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.54 147.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.905 -1.517 . . . . 0.56999999999999995 106.905 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.21 161.65 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.4 -1.333 . . . . 0.56999999999999995 107.4 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -107.46 139.1 42.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.541 -1.281 . . . . 0.56999999999999995 107.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -126.11 151.5 47.14 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 109.561 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -153.57 118.25 4.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.171 0.51 . . . . 1.2 109.803 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.3 mt -82.62 86.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.424 -1.695 . . . . 0.56999999999999995 106.424 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.76 -49.59 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 112.2 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.82 153.1 33.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.417 -2.438 . . . . 0.56999999999999995 104.417 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -125.75 149.68 48.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.173 -1.788 . . . . 0.56999999999999995 106.173 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -159.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 O-C-N 125.032 1.458 . . . . 0.56999999999999995 111.084 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -148.04 -29.34 0.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 114.244 1.202 . . . . 1.2 114.244 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -52.61 -57.54 9.69 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.205 0.941 . . . . 0.66000000000000003 110.915 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.31 164.41 14.99 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 109.466 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -77.97 149.55 25.89 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.149 1.899 . . . . 0.56999999999999995 112.618 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -60.6 -35.65 76.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.398 1.079 . . . . 0.65000000000000002 112.408 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.17 -38.98 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.011 0.524 . . . . 0.56999999999999995 110.275 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -69.58 -41.32 75.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 117.222 -1.371 . . . . 0.56999999999999995 109.069 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.54 -53.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 120.563 1.528 . . . . 0.56999999999999995 109.96 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.21 -34.35 77.88 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 118.598 -0.715 . . . . 0.66000000000000003 110.757 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -46.44 80.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.625 1.102 . . . . 1.2 111.717 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.1 mt -65.09 -45.22 86.14 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.223 1.009 . . . . 0.56999999999999995 108.337 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.37 -44.86 99.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.94 -1.029 . . . . 0.56999999999999995 110.565 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 m -60.27 -46.89 88.26 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 120.036 1.289 . . . . 0.56999999999999995 109.895 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -36.89 69.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.508 -0.758 . . . . 0.56999999999999995 111.501 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.69 91.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 111.308 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 26.3 mt -72.11 -35.8 69.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.629 0.772 . . . . 0.56999999999999995 110.493 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.52 -42.87 88.68 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.089 -0.958 . . . . 0.56999999999999995 109.944 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.9 mtp -60.81 -36.93 80.32 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.928 0.891 . . . . 0.56999999999999995 111.321 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.0 -47.04 66.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.975 1.261 . . . . 0.56999999999999995 111.309 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.44 -3.86 59.08 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 123.94 0.781 . . . . 0.56999999999999995 113.301 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -70.46 -19.81 62.93 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.984 -1.303 . . . . 0.56999999999999995 111.043 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.6 mp0 -110.52 -34.8 6.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.503 1.521 . . . . 0.66000000000000003 111.056 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 21.7 pt -114.07 143.06 28.96 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 111.04 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.26 21.16 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.248 2.632 . . . . 0.56999999999999995 112.488 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 126.38 34.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.188 -1.412 . . . . 0.56999999999999995 107.188 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -126.68 -178.55 4.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.867 0.867 . . . . 0.65000000000000002 109.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -147.83 147.53 29.9 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.704 -0.85 . . . . 0.56999999999999995 108.704 -170.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.95 160.0 39.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.381 1.072 . . . . 1.2 109.722 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -110.05 116.08 30.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.286 -1.376 . . . . 0.56999999999999995 107.286 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.58 161.21 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.585 -0.894 . . . . 0.56999999999999995 108.585 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.79 39.44 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.208 1.003 . . . . 0.56999999999999995 110.179 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -90.58 -65.57 1.0 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.045 0.538 . . . . 0.56999999999999995 109.917 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.07 -70.55 0.02 OUTLIER Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.298 -1.521 . . . . 0.56999999999999995 109.298 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -125.52 139.68 53.4 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.319 -1.363 . . . . 0.56999999999999995 107.319 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.59 171.27 7.42 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.069 0.947 . . . . 0.56999999999999995 110.012 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -62.48 -50.54 71.01 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.176 -1.046 . . . . 0.66000000000000003 108.176 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.64 81.88 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.775 -1.565 . . . . 0.56999999999999995 106.775 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -78.54 121.4 24.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.96 127.2 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 106.687 -1.597 . . . . 0.56999999999999995 106.687 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.38 25.81 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 111.204 -0.758 . . . . 0.56999999999999995 111.204 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 21.3 m-85 -132.62 137.32 46.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.948 -1.871 . . . . 0.56999999999999995 105.948 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 160.22 36.59 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.826 1.65 . . . . 0.56999999999999995 107.873 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -116.67 50.99 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.201 -0.937 . . . . 1.2 110.137 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.85 -127.35 6.31 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.254 -1.538 . . . . 0.56999999999999995 109.254 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.94 139.46 0.46 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.14 1.376 . . . . 0.56999999999999995 112.621 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -120.9 -62.27 1.47 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.485 -0.78 . . . . 0.65000000000000002 109.836 -173.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.99 71.83 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.354 -0.692 . . . . 0.56999999999999995 112.647 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.3 121.35 41.73 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.632 1.173 . . . . 0.66000000000000003 108.485 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.82 -73.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.381 . . . . 0.56999999999999995 111.689 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -148.23 144.12 18.38 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 108.638 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.02 149.55 77.2 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.815 1.676 . . . . 0.56999999999999995 110.405 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 1.4 m-85 -70.44 -174.18 0.82 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.738 -1.119 . . . . 0.56999999999999995 110.749 170.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.63 -32.16 4.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.688 2.395 . . . . 0.66000000000000003 110.975 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.42 -139.94 15.83 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 112.351 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.07 86.67 1.62 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.353 3.369 . . . . 0.56999999999999995 112.036 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.04 -174.99 33.92 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.565 1.555 . . . . 0.56999999999999995 111.226 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 m120 45.82 -134.71 0.82 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.829 1.314 . . . . 0.56999999999999995 112.478 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -59.13 118.56 6.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.14 2.176 . . . . 0.56999999999999995 111.449 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.68 -34.87 12.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.736 1.214 . . . . 0.56999999999999995 112.195 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.25 157.97 33.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.292 1.037 . . . . 0.56999999999999995 108.826 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.41 ' HE2' ' CE1' ' A' ' 69' ' ' HIS . 0.7 OUTLIER -143.68 161.93 37.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.341 -0.615 . . . . 0.65000000000000002 109.341 178.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.46 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.696 -0.853 . . . . 0.56999999999999995 108.696 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.58 153.82 32.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.317 -0.994 . . . . 0.56999999999999995 108.317 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.38 149.56 96.94 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.072 -0.966 . . . . 0.56999999999999995 109.63 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.35 160.82 45.96 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.295 1.997 . . . . 0.56999999999999995 111.47 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 -106.88 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.315 -1.914 . . . . 0.56999999999999995 108.315 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.3 p -151.71 69.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.744 0.818 . . . . 0.56999999999999995 110.948 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.36 -121.45 1.6 Allowed Glycine 0 C--N 1.342 0.904 0 N-CA-C 110.404 -1.079 . . . . 0.56999999999999995 110.404 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.86 -21.76 61.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.167 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.78 130.59 43.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.447 -1.196 . . . . 0.56999999999999995 110.959 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.408 ' HA3' ' CH2' ' A' ' 10' ' ' TRP . . . 96.38 -36.86 3.65 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.084 2.278 . . . . 0.56999999999999995 113.09 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.1 145.91 19.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.998 2.119 . . . . 0.66000000000000003 107.092 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.29 146.61 36.99 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.871 -0.789 . . . . 0.56999999999999995 108.871 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -139.56 160.6 39.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 110.236 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.448 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 57.5 m-85 -142.44 148.58 38.01 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.361 1.064 . . . . 0.56999999999999995 108.323 -163.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.38 100.56 10.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.81 -1.552 . . . . 0.66000000000000003 106.81 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.9 -25.73 31.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.463 -1.398 . . . . 0.66000000000000003 111.43 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.18 -37.18 76.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.66000000000000003 110.478 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.24 120.2 20.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.192 -1.41 . . . . 0.66000000000000003 107.192 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -56.28 122.58 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.873 0.469 . . . . 1.2 110.254 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' HB3' ' CD2' ' A' ' 114' ' ' PHE . 98.4 m95 -109.63 133.94 52.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 108.339 -0.985 . . . . 0.56999999999999995 108.339 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.5 t -137.28 148.39 46.36 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.188 -0.671 . . . . 0.56999999999999995 109.188 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.47 -26.04 67.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.844 0.857 . . . . 0.66000000000000003 111.863 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.61 -141.19 11.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.088 1.327 . . . . 0.56999999999999995 110.248 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -160.56 103.77 1.39 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.584 0.692 . . . . 0.56999999999999995 109.566 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.51 -36.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.043 0.937 . . . . 0.56999999999999995 112.231 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -104.04 -58.84 1.82 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.094 0.558 . . . . 0.56999999999999995 109.516 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.9 -165.17 21.48 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.165 -1.174 . . . . 0.56999999999999995 110.165 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.58 143.96 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 109.416 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.84 108.88 1.89 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.156 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -60.53 -34.42 74.09 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 112.121 174.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -51.33 63.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.7 -1.222 . . . . 0.56999999999999995 107.7 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -57.55 -46.71 83.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.627 0.771 . . . . 0.56999999999999995 110.147 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.65 19.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.515 0.509 . . . . 0.56999999999999995 111.022 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.5 -55.52 34.03 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 117.933 -1.032 . . . . 0.56999999999999995 109.907 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -58.18 -34.45 70.35 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.906 1.23 . . . . 0.56999999999999995 111.841 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.01 -60.27 3.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.102 0.961 . . . . 0.65000000000000002 109.79 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.88 -45.79 80.75 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.569 -0.707 . . . . 0.66000000000000003 111.42 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.63 -30.8 71.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.421 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.51 80.67 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.156 -0.778 . . . . 0.56999999999999995 111.156 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -74.52 -37.59 63.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 117.16 -1.4 . . . . 0.65000000000000002 112.354 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 p -54.42 -38.65 66.5 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 124.453 1.096 . . . . 0.56999999999999995 109.685 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -43.38 95.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 112.337 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.2 43.39 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.862 -0.966 . . . . 0.56999999999999995 114.332 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.06 176.17 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.054 0.941 . . . . 0.56999999999999995 111.45 -171.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.01 66.33 0.01 OUTLIER Glycine 0 C--N 1.342 0.882 0 O-C-N 121.473 -0.767 . . . . 0.56999999999999995 111.735 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 174.24 7.11 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.626 1.171 . . . . 0.65000000000000002 110.636 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 t -160.33 -177.16 6.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.36 -0.836 . . . . 0.56999999999999995 110.773 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -146.8 56.37 1.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.306 2.642 . . . . 0.56999999999999995 107.46 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.35 150.65 44.86 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 124.647 1.179 . . . . 0.66000000000000003 108.278 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.0 -26.91 58.18 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.628 2.218 . . . . 0.56999999999999995 111.607 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.94 30.29 5.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.27 -1.011 . . . . 0.56999999999999995 108.27 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.42 131.04 46.05 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.294 -1.373 . . . . 0.56999999999999995 107.294 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.32 -32.26 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 110.68 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -99.21 25.86 6.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.827 0.451 . . . . 0.56999999999999995 111.362 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -65.26 131.64 95.08 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 120.766 -1.209 . . . . 0.56999999999999995 110.385 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.28 171.79 17.6 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.662 2.241 . . . . 0.56999999999999995 111.007 166.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 m 52.13 76.81 0.17 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.474 1.13 . . . . 0.56999999999999995 110.657 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -46.92 125.52 7.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.234 1.014 . . . . 0.56999999999999995 112.485 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.45 1.86 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.08 -1.208 . . . . 0.56999999999999995 110.08 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.79 -44.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.55 0.74 . . . . 0.56999999999999995 111.635 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -143.51 -137.14 3.23 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.208 -1.957 . . . . 0.56999999999999995 108.208 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -126.03 112.0 24.31 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.589 -0.893 . . . . 0.66000000000000003 108.589 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.41 -14.76 22.59 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.423 2.082 . . . . 0.56999999999999995 112.035 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -64.65 -48.68 73.93 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 121.894 2.133 . . . . 0.56999999999999995 109.87 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -92.5 69.91 4.98 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.643 1.177 . . . . 0.56999999999999995 111.169 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.44 125.72 28.03 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.293 -0.632 . . . . 0.56999999999999995 109.293 -174.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 83.04 1.54 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.539 -1.282 . . . . 0.56999999999999995 107.539 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 48.58 80.93 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.815 1.646 . . . . 0.56999999999999995 111.629 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.6 t -67.95 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.128 0.571 . . . . 0.56999999999999995 112.322 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.59 -57.37 0.69 Allowed 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.386 -0.968 . . . . 0.56999999999999995 108.386 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -51.06 -39.43 55.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.277 1.431 . . . . 0.66000000000000003 112.266 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -63.57 -53.83 45.61 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.64 -0.695 . . . . 0.66000000000000003 109.366 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -48.92 86.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 118.752 -0.642 . . . . 0.56999999999999995 109.843 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -32.76 74.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.12 1.768 . . . . 0.56999999999999995 110.626 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.84 -60.45 3.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.98 -2.048 . . . . 0.56999999999999995 107.98 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.55 -58.35 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 119.342 1.571 . . . . 0.56999999999999995 111.151 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.423 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 10.6 pt20 -58.56 -22.56 56.16 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.705 0.684 . . . . 0.56999999999999995 112.148 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -31.4 19.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.948 1.299 . . . . 0.56999999999999995 110.777 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.14 -46.14 88.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.157 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.1 p90 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 123.379 0.672 . . . . 0.56999999999999995 112.674 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 CA--C 1.541 0.87 0 N-CA-C 111.011 -0.419 . . . . 0.56999999999999995 111.011 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt 91.44 132.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 130.395 3.478 . . . . 0.56999999999999995 109.9 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -64.41 159.46 21.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 110.743 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -76.28 -25.33 54.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.715 0.635 . . . . 0.56999999999999995 112.715 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -94.06 143.03 26.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.9 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 pttm -76.48 -12.22 60.0 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.963 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.85 109.49 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.735 -2.32 . . . . 0.56999999999999995 104.735 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.11 163.86 3.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.67 -1.604 . . . . 0.56999999999999995 106.67 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 p -114.37 147.45 39.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.694 -0.629 . . . . 0.56999999999999995 111.351 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -123.77 155.42 37.96 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.474 0.71 . . . . 0.56999999999999995 110.763 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 120.06 5.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.488 0.661 . . . . 1.2 110.052 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 mt -87.02 113.8 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 105.842 -1.91 . . . . 0.56999999999999995 105.842 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.48 -45.66 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.291 0.951 . . . . 0.56999999999999995 111.237 -171.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.7 178.41 4.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.388 -1.708 . . . . 0.56999999999999995 106.388 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.66 173.81 11.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.454 1.025 . . . . 0.56999999999999995 109.306 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -90.28 -175.5 4.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.476 1.11 . . . . 0.56999999999999995 111.251 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -123.96 -34.7 2.95 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.909 1.284 . . . . 1.2 113.491 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -61.86 -27.46 68.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.069 1.348 . . . . 0.66000000000000003 111.648 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.47 144.31 20.65 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 126.957 2.103 . . . . 0.56999999999999995 108.436 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 167.45 24.85 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.946 2.431 . . . . 0.56999999999999995 112.863 -166.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.29 -36.24 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.859 0.864 . . . . 0.65000000000000002 111.903 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.54 -36.87 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.724 0.81 . . . . 0.56999999999999995 110.353 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -67.27 -49.84 62.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.846 -1.549 . . . . 0.56999999999999995 108.39 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.97 -51.03 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 121.217 1.826 . . . . 0.56999999999999995 110.66 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.8 -41.15 96.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.676 0.791 . . . . 0.66000000000000003 111.986 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -62.98 -45.45 92.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.07 0.85 . . . . 1.2 111.772 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.14 -35.08 73.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.45 -0.786 . . . . 0.56999999999999995 109.257 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.23 -49.45 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 117.886 -1.054 . . . . 0.56999999999999995 110.204 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -60.17 -42.79 95.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.945 1.248 . . . . 0.56999999999999995 111.076 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -65.05 -47.58 76.87 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.004 0.82 . . . . 0.56999999999999995 111.234 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.99 99.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.127 0.971 . . . . 0.56999999999999995 111.96 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.29 -35.54 71.33 Favored 'General case' 0 C--O 1.228 -0.044 0 O-C-N 121.531 -0.731 . . . . 0.56999999999999995 111.427 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -61.96 -41.04 97.54 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.092 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 36.0 mtp -60.71 -40.1 91.03 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.022 -0.99 . . . . 0.56999999999999995 111.206 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.45 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 46.7 m95 -61.89 -50.24 73.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.45 1.477 . . . . 0.56999999999999995 111.844 168.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.24 -8.97 53.22 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.424 1.012 . . . . 0.56999999999999995 114.258 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -66.79 -24.2 66.15 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -1.225 . . . . 0.56999999999999995 111.315 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -111.36 -11.34 14.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 118.445 -0.788 . . . . 0.66000000000000003 111.023 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 pt -140.23 135.41 16.15 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 120.38 1.446 . . . . 0.56999999999999995 110.96 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.87 48.36 2.2 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.52 3.48 . . . . 0.56999999999999995 113.462 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tt -109.43 141.97 41.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.507 1.923 . . . . 0.56999999999999995 107.842 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -133.0 163.77 28.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.785 0.834 . . . . 0.65000000000000002 109.002 -168.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.75 145.49 32.43 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.573 -0.899 . . . . 0.56999999999999995 108.573 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -145.33 175.23 10.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.331 1.052 . . . . 1.2 110.274 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -112.17 138.19 49.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.093 -0.706 . . . . 0.56999999999999995 109.093 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.51 -28.96 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.097 0.959 . . . . 0.56999999999999995 111.21 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.258 3.7 m 44.88 40.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.565 1.946 . . . . 0.56999999999999995 112.72 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -156.47 -38.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.544 1.312 . . . . 0.56999999999999995 114.544 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.83 -146.26 4.52 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.974 -1.25 . . . . 0.56999999999999995 109.974 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -70.72 -173.64 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.0 0.9 . . . . 0.56999999999999995 111.536 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.77 177.37 11.33 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.123 1.369 . . . . 0.56999999999999995 110.403 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -63.66 -36.15 82.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.746 0.819 . . . . 0.66000000000000003 110.097 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mt -120.33 76.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 126.769 2.027 . . . . 0.56999999999999995 107.804 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -72.63 124.07 24.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.973 -1.121 . . . . 0.56999999999999995 107.973 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.27 117.72 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 105.286 -2.116 . . . . 0.56999999999999995 105.286 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.03 161.82 19.47 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.923 -0.871 . . . . 0.56999999999999995 110.923 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -133.83 142.76 47.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.472 -2.048 . . . . 0.56999999999999995 105.472 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.31 166.25 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.962 2.505 . . . . 0.56999999999999995 107.535 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -130.0 93.96 3.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.06 -49.85 2.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.91 -0.939 . . . . 0.56999999999999995 111.814 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.25 153.04 38.18 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.639 1.72 . . . . 0.56999999999999995 110.897 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -152.04 159.69 43.64 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 125.568 1.547 . . . . 0.65000000000000002 109.158 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.75 44.9 3.04 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.369 1.462 . . . . 0.56999999999999995 112.872 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.67 -179.78 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.577 1.551 . . . . 0.66000000000000003 110.409 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -39.82 -50.07 2.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.333 1.453 . . . . 0.56999999999999995 111.791 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.89 132.06 13.7 Favored Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 124.611 1.164 . . . . 0.56999999999999995 109.801 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.01 158.76 54.46 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.033 1.822 . . . . 0.56999999999999995 111.204 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.33 -164.48 0.77 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 111.061 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -121.73 -14.08 8.19 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.928 2.491 . . . . 0.66000000000000003 112.408 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.71 -134.82 12.71 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.397 0.999 . . . . 0.56999999999999995 110.678 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.51 100.51 1.16 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 112.322 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.91 -163.85 25.55 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.516 1.055 . . . . 0.56999999999999995 112.518 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 t30 45.42 -125.53 1.19 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.465 1.506 . . . . 0.56999999999999995 114.346 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.6 m -74.48 131.91 41.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.635 2.374 . . . . 0.56999999999999995 108.614 173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.76 -31.9 10.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 112.194 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.34 37.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.945 1.298 . . . . 0.56999999999999995 108.008 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -143.23 161.38 38.41 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.964 -0.46 . . . . 0.65000000000000002 110.029 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.66 144.58 27.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.363 1.065 . . . . 0.56999999999999995 109.167 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.04 146.4 27.96 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.849 -1.167 . . . . 0.56999999999999995 107.849 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.86 155.15 12.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.502 -0.761 . . . . 0.56999999999999995 110.891 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.48 166.07 26.92 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.121 1.881 . . . . 0.56999999999999995 112.043 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.23 -101.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.3 p -151.36 -54.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.423 1.089 . . . . 0.56999999999999995 110.599 -166.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.7 -108.56 3.24 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 125.086 1.327 . . . . 0.56999999999999995 110.01 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -29.06 64.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.754 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.33 141.75 6.95 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.201 -0.76 . . . . 0.56999999999999995 111.201 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.99 4.61 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.664 -1.631 . . . . 0.56999999999999995 114.504 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.25 159.47 33.38 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.043 1.921 . . . . 0.66000000000000003 109.074 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.81 145.36 27.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 109.867 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -130.94 155.22 47.16 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.334 -0.617 . . . . 0.65000000000000002 109.334 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -138.08 147.99 44.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.778 1.631 . . . . 0.56999999999999995 108.631 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.39 93.99 8.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.795 0.838 . . . . 0.66000000000000003 108.882 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.85 -22.36 14.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.77 1.628 . . . . 0.66000000000000003 111.568 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.61 -28.81 68.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.115 0.416 . . . . 0.66000000000000003 111.572 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -79.89 167.86 19.98 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 111.502 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -79.55 156.39 27.76 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.69 -0.686 . . . . 1.2 110.157 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -151.28 121.7 7.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.817 -1.919 . . . . 0.56999999999999995 105.817 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -136.15 144.56 45.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.871 1.669 . . . . 0.56999999999999995 109.342 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -68.07 -45.5 73.66 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.957 0.503 . . . . 0.66000000000000003 110.596 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.95 39.27 0.02 OUTLIER Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.826 1.679 . . . . 0.56999999999999995 111.43 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 -66.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.012 1.325 . . . . 0.56999999999999995 110.199 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -84.44 168.23 15.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.461 0.704 . . . . 0.56999999999999995 110.314 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.74 150.21 20.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.241 1.016 . . . . 0.56999999999999995 111.371 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -145.88 15.29 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.709 -0.556 . . . . 0.56999999999999995 111.709 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.83 142.66 38.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.453 1.101 . . . . 0.56999999999999995 108.21 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.7 110.39 1.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.273 0.629 . . . . 0.56999999999999995 111.615 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.04 -34.87 78.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.203 1.801 . . . . 0.56999999999999995 113.104 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -39.97 84.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.434 0.561 . . . . 0.56999999999999995 110.217 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.76 -45.72 81.49 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 124.038 0.836 . . . . 0.56999999999999995 108.77 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.42 22.06 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 111.114 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.9 74.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.749 -1.12 . . . . 0.56999999999999995 109.866 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -51.89 -46.06 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.85 1.205 . . . . 0.56999999999999995 111.029 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -61.76 -55.18 32.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.692 0.797 . . . . 0.65000000000000002 109.773 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.43 -41.01 89.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.343 0.519 . . . . 0.66000000000000003 110.96 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.14 -26.08 68.65 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.42 -0.8 . . . . 0.56999999999999995 111.801 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.45 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -66.58 -44.59 89.54 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 113.003 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -64.28 -38.56 91.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.042 -0.504 . . . . 0.65000000000000002 110.025 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 t -59.4 -33.81 71.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.358 0.503 . . . . 0.56999999999999995 112.358 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -38.43 65.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.992 0.917 . . . . 0.56999999999999995 111.534 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.3 9.75 0.65 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.426 1.013 . . . . 0.56999999999999995 115.224 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -93.99 157.96 15.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.681 1.24 . . . . 0.56999999999999995 110.845 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.35 178.01 21.69 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.513 -1.035 . . . . 0.56999999999999995 110.513 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -72.61 166.66 22.29 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.054 0.542 . . . . 0.65000000000000002 111.439 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.0 t -123.55 -46.35 2.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 112.299 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.72 43.71 0.32 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.366 1.467 . . . . 0.56999999999999995 112.831 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -117.29 154.8 50.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.609 1.163 . . . . 0.66000000000000003 109.48 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.71 -6.29 18.23 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 114.353 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -137.5 17.62 2.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.039 1.336 . . . . 0.56999999999999995 110.378 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.17 130.71 43.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 111.077 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.79 -25.28 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 111.752 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.95 21.55 11.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.453 1.501 . . . . 0.56999999999999995 111.357 169.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -58.85 136.3 87.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 120.667 -1.271 . . . . 0.56999999999999995 110.194 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.99 -163.76 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.729 2.953 . . . . 0.56999999999999995 111.819 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t 36.29 77.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.524 1.929 . . . . 0.56999999999999995 115.215 168.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -38.91 109.63 0.11 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.919 2.088 . . . . 0.56999999999999995 113.341 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.34 111.34 1.2 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.747 1.165 . . . . 0.56999999999999995 110.684 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -179.84 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.61 1.164 . . . . 0.56999999999999995 112.279 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.0 -162.29 11.46 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.475 1.512 . . . . 0.56999999999999995 110.024 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.04 108.88 56.55 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 106.846 -1.538 . . . . 0.66000000000000003 106.846 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.44 -7.6 9.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.31 2.674 . . . . 0.56999999999999995 112.922 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -69.48 -33.38 72.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 121.041 1.746 . . . . 0.56999999999999995 109.684 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.74 86.8 2.26 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.288 1.035 . . . . 0.56999999999999995 112.001 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.76 -50.75 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 111.618 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.99 45.1 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.027 2.131 . . . . 0.56999999999999995 114.85 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp 64.98 79.96 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.841 1.656 . . . . 0.56999999999999995 109.893 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -58.82 -83.48 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.644 1.177 . . . . 0.56999999999999995 113.448 -170.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -142.88 -49.45 0.34 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.738 1.615 . . . . 0.56999999999999995 106.643 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.18 -53.4 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.66000000000000003 112.953 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -51.67 69.08 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.874 0.469 . . . . 0.66000000000000003 110.772 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.07 -38.58 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 109.699 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -49.69 66.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.046 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.6 -52.74 51.28 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.89 0.768 . . . . 0.56999999999999995 111.311 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 mm -61.6 -50.74 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.438 -0.791 . . . . 0.56999999999999995 111.052 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -70.81 -14.08 62.28 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 112.143 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -83.26 -25.08 31.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.618 1.099 . . . . 0.56999999999999995 111.829 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.27 -37.44 12.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.571 1.078 . . . . 0.56999999999999995 111.9 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 126.148 1.779 . . . . 0.56999999999999995 109.517 -173.448 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.444 -1.421 0 N-CA-C 110.042 -0.792 . . . . 0.56999999999999995 110.042 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.23 132.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.425 2.29 . . . . 0.56999999999999995 108.186 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 13.0 m95 -71.72 175.02 6.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.699 0.8 . . . . 0.56999999999999995 110.422 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.0 p -97.38 -11.7 23.65 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.672 0.619 . . . . 0.56999999999999995 112.672 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.0 t -104.49 151.25 23.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.85 1.66 . . . . 0.56999999999999995 108.675 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -8.91 57.85 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.201 1.001 . . . . 0.56999999999999995 112.449 172.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.66 144.62 37.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.568 1.547 . . . . 0.56999999999999995 108.775 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.2 t -130.37 153.73 39.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 108.098 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 p -103.39 144.02 31.93 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.739 -0.467 . . . . 0.56999999999999995 109.739 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -133.31 152.74 51.94 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.257 -1.527 . . . . 0.56999999999999995 110.895 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.63 111.77 4.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.313 1.054 . . . . 1.2 109.626 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.28 101.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 104.152 -2.536 . . . . 0.56999999999999995 104.152 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.45 -44.87 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.692 1.197 . . . . 0.56999999999999995 111.651 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.44 174.86 6.12 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.362 1.865 . . . . 0.56999999999999995 106.411 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -146.29 161.16 40.9 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.5 -0.926 . . . . 0.56999999999999995 108.5 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.8 t -63.25 177.73 0.6 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.597 0.713 . . . . 0.56999999999999995 110.913 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -117.67 -39.61 3.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.436 1.094 . . . . 1.2 112.836 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.07 -33.55 73.5 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.231 0.923 . . . . 0.66000000000000003 110.084 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.35 149.7 44.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.56999999999999995 109.811 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -76.73 164.81 29.69 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.918 2.412 . . . . 0.56999999999999995 113.609 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -62.38 -45.52 92.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.898 1.279 . . . . 0.65000000000000002 112.06 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 tp -57.86 -42.21 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 109.672 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -62.46 -48.35 80.04 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 117.759 -1.115 . . . . 0.56999999999999995 109.251 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.43 -49.74 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 120.72 1.6 . . . . 0.56999999999999995 110.679 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.59 -41.34 96.3 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.167 0.894 . . . . 0.66000000000000003 111.404 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.275 -0.891 . . . . 1.2 112.307 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.11 -35.92 74.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.998 -1.001 . . . . 0.56999999999999995 109.274 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.03 -51.56 60.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.05 -0.976 . . . . 0.56999999999999995 108.773 166.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -43.61 88.76 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.08 1.309 . . . . 0.56999999999999995 110.878 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -66.89 -38.51 86.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.565 1.075 . . . . 0.56999999999999995 112.807 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.16 76.44 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 111.554 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.5 -30.96 68.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.086 -0.959 . . . . 0.56999999999999995 110.278 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.34 -31.76 72.44 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.339 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.8 mtm -74.28 -37.55 63.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.328 -0.844 . . . . 0.56999999999999995 111.66 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -64.9 -50.19 67.49 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 110.681 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -4.91 55.24 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.511 1.529 . . . . 0.56999999999999995 113.956 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -25.68 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.548 -0.972 . . . . 0.56999999999999995 110.211 168.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -110.71 -19.06 12.99 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.695 -0.669 . . . . 0.66000000000000003 112.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.5 pt -126.35 126.3 24.64 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 123.951 0.9 . . . . 0.56999999999999995 109.028 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.95 32.64 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.504 2.803 . . . . 0.56999999999999995 113.557 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.89 145.9 31.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.147 1.379 . . . . 0.56999999999999995 108.241 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -126.54 165.92 18.25 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.65000000000000002 108.47 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.06 157.33 46.56 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.723 -1.236 . . . . 0.56999999999999995 108.511 -172.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.76 160.78 39.12 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.33 1.052 . . . . 1.2 108.857 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -106.9 146.7 30.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.438 -1.319 . . . . 0.56999999999999995 107.438 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.1 169.01 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.927 0.491 . . . . 0.56999999999999995 109.793 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.31 -13.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.56999999999999995 111.504 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -93.23 -66.02 0.95 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.56999999999999995 108.845 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.48 -27.38 0.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.843 0.292 . . . . 0.56999999999999995 113.05 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -78.56 125.72 29.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.845 -1.169 . . . . 0.56999999999999995 107.845 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.3 166.17 26.3 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.973 0.909 . . . . 0.56999999999999995 109.321 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 74.1 m-20 -64.1 -47.19 81.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.11 0.964 . . . . 0.66000000000000003 108.706 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.92 80.0 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.766 1.627 . . . . 0.56999999999999995 107.282 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 ttm -75.48 134.26 40.87 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.77 -1.206 . . . . 0.56999999999999995 107.841 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.59 119.63 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.963 -1.865 . . . . 0.56999999999999995 105.963 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.94 163.92 23.35 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 111.841 -0.504 . . . . 0.56999999999999995 111.841 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.31 134.01 33.74 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.467 -2.049 . . . . 0.56999999999999995 105.467 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.03 -174.04 4.74 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 109.27 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 3.04 8.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.893 0.77 . . . . 1.2 112.813 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.75 -130.67 2.12 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.175 -1.57 . . . . 0.56999999999999995 109.175 -166.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.7 117.13 7.01 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.376 -0.485 . . . . 0.56999999999999995 110.385 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -112.19 -46.8 3.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.558 0.743 . . . . 0.65000000000000002 111.316 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.41 23.41 0.59 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.2 0.905 . . . . 0.56999999999999995 113.893 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -53.18 4.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.515 1.926 . . . . 0.66000000000000003 111.773 -170.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -178.38 -45.41 0.01 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.848 2.059 . . . . 0.56999999999999995 107.646 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.56 139.5 35.48 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 123.852 0.861 . . . . 0.56999999999999995 109.039 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.34 141.4 46.85 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.454 1.436 . . . . 0.56999999999999995 109.965 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.75 -179.24 0.84 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.953 1.358 . . . . 0.56999999999999995 111.121 163.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 21.9 p-10 -115.52 -31.23 5.96 Favored 'General case' 0 CA--C 1.542 0.666 1 C-N-CA 131.92 4.088 . . . . 0.66000000000000003 109.931 -171.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.08 -138.03 15.65 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.668 -0.973 . . . . 0.56999999999999995 110.668 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 104.1 1.69 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.803 3.002 . . . . 0.56999999999999995 112.148 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -179.75 16.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 126.004 1.764 . . . . 0.56999999999999995 108.891 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 76' ' ' ASP . 0.8 OUTLIER 44.74 -155.66 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 112.86 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.7 m -44.87 120.39 2.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.365 2.266 . . . . 0.56999999999999995 111.534 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.18 -25.13 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.888 1.275 . . . . 0.56999999999999995 113.106 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.22 164.34 25.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.353 1.461 . . . . 0.56999999999999995 108.367 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.03 158.74 44.42 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.998 -0.371 . . . . 0.65000000000000002 109.998 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.0 155.74 39.68 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.725 1.21 . . . . 0.56999999999999995 109.808 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.05 171.65 7.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.596 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.55 139.08 26.48 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-O 118.245 -0.884 . . . . 0.56999999999999995 109.363 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.49 159.37 52.77 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.578 2.186 . . . . 0.56999999999999995 112.166 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.28 12.72 21.09 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.351 -0.694 . . . . 0.56999999999999995 113.752 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -153.47 43.73 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.55 1.675 . . . . 0.56999999999999995 111.933 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.37 -71.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.168 1.842 . . . . 0.56999999999999995 114.69 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.06 -5.05 39.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.372 1.869 . . . . 0.56999999999999995 111.437 163.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 126.92 31.59 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.979 -1.075 . . . . 0.56999999999999995 110.446 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.28 -44.33 1.5 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 126.046 1.784 . . . . 0.56999999999999995 110.845 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.09 143.75 13.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.105 2.162 . . . . 0.66000000000000003 109.199 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.07 150.36 42.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.633 0.73 . . . . 0.56999999999999995 109.535 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.47 162.96 31.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.943 -0.762 . . . . 0.65000000000000002 108.943 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -139.59 158.45 44.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.497 1.919 . . . . 0.56999999999999995 109.344 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -84.45 102.35 12.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.655 0.382 . . . . 0.66000000000000003 110.999 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -58.23 -28.44 64.87 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.605 -1.309 . . . . 0.66000000000000003 111.116 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.46 -26.71 66.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.609 0.763 . . . . 0.66000000000000003 111.581 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -72.37 138.93 47.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.203 1.002 . . . . 0.66000000000000003 109.608 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.12 111.79 4.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -94.24 158.64 15.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.409 -0.96 . . . . 0.56999999999999995 108.409 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.3 t -141.19 153.53 45.37 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.313 -0.995 . . . . 0.56999999999999995 108.313 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.55 -36.43 70.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.331 0.652 . . . . 0.66000000000000003 110.162 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.65 -97.36 1.47 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.102 -1.199 . . . . 0.56999999999999995 110.102 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -158.17 139.31 13.29 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.728 -1.212 . . . . 0.56999999999999995 107.728 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 t -163.82 -51.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.836 -0.602 . . . . 0.56999999999999995 110.491 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -160.38 -44.12 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.001 1.72 . . . . 0.56999999999999995 110.895 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.77 173.43 54.71 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.536 -1.026 . . . . 0.56999999999999995 110.536 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 148.78 4.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.236 0.541 . . . . 0.56999999999999995 109.816 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -65.39 114.58 4.91 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.67 -0.695 . . . . 0.56999999999999995 109.488 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -60.92 -41.11 95.52 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.573 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -47.44 84.61 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 108.787 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -60.56 -39.25 87.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.061 0.944 . . . . 0.56999999999999995 110.051 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.42 49.48 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 112.765 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.76 68.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.219 -1.03 . . . . 0.56999999999999995 108.219 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 m -56.1 -41.23 74.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.336 0.654 . . . . 0.56999999999999995 111.758 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.08 -57.79 11.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.953 0.342 . . . . 0.65000000000000002 110.109 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -68.11 -39.96 82.68 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.042 -1.036 . . . . 0.66000000000000003 111.609 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.38 -32.72 74.51 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 110.818 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.57 -47.35 57.67 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.166 -0.774 . . . . 0.56999999999999995 111.166 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.48 -35.35 70.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.556 0.576 . . . . 0.65000000000000002 112.556 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -35.85 73.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 0.56999999999999995 111.02 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -46.5 89.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 110.71 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.51 49.19 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.533 -0.593 . . . . 0.56999999999999995 113.951 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.72 -160.1 0.17 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.029 1.414 . . . . 0.56999999999999995 110.724 -173.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 132.65 35.22 0.32 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 121.427 -0.796 . . . . 0.56999999999999995 113.659 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 167.8 7.2 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.219 1.009 . . . . 0.65000000000000002 112.856 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.9 p -152.95 -173.33 4.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.584 1.153 . . . . 0.56999999999999995 110.208 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.8 p -143.48 49.73 1.41 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.703 1.201 . . . . 0.56999999999999995 110.949 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 143.87 27.91 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.08 1.352 . . . . 0.66000000000000003 110.239 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.28 -12.27 29.7 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.455 2.103 . . . . 0.56999999999999995 113.743 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -137.22 51.14 1.96 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.685 1.594 . . . . 0.56999999999999995 107.909 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.21 43.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.059 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.86 -27.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.56999999999999995 109.381 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.2 mmt -78.14 -14.96 59.27 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.649 1.979 . . . . 0.56999999999999995 114.154 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -58.8 128.25 83.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.009 1.277 . . . . 0.56999999999999995 110.605 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.05 156.8 47.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.248 1.966 . . . . 0.56999999999999995 110.642 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.5 m 61.14 99.35 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.207 1.403 . . . . 0.56999999999999995 111.473 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.89 123.98 2.05 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 111.883 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.68 -130.86 2.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.162 -1.575 . . . . 0.56999999999999995 109.162 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -65.12 -61.55 2.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.537 0.668 . . . . 0.56999999999999995 110.446 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 39.88 -150.45 0.11 Allowed Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.305 1.431 . . . . 0.56999999999999995 113.409 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.24 75.36 4.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 167.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.0 39.8 0.3 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.962 3.108 . . . . 0.56999999999999995 112.822 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -144.76 -54.51 0.32 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 108.436 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.03 89.11 3.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 108.43 -170.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -44.34 -63.24 0.92 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.479 1.511 . . . . 0.56999999999999995 114.906 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt 31.49 63.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.915 2.486 . . . . 0.56999999999999995 113.479 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp -25.8 115.13 0.05 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 128.781 2.832 . . . . 0.56999999999999995 110.874 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.3 t -82.66 -82.26 0.14 Allowed 'General case' 0 C--N 1.341 0.204 0 CA-C-O 119.051 -0.5 . . . . 0.56999999999999995 111.022 -162.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -147.94 -44.12 0.16 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 118.531 0.605 . . . . 0.56999999999999995 110.364 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.26 -49.22 9.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.903 2.081 . . . . 0.66000000000000003 112.933 164.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.53 -54.76 23.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.808 0.843 . . . . 0.66000000000000003 109.833 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.98 -41.68 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.349 1.06 . . . . 0.56999999999999995 109.108 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -57.14 13.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.916 -1.142 . . . . 0.56999999999999995 107.916 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -51.1 -53.9 25.32 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.523 -1.031 . . . . 0.56999999999999995 110.523 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.1 mm -50.86 -50.73 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.479 0.712 . . . . 0.56999999999999995 111.294 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.37 -31.01 70.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.43 0.559 . . . . 0.56999999999999995 112.241 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -24.41 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.653 -1.165 . . . . 0.56999999999999995 110.814 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.01 -49.78 5.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 110.667 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 112.077 -173.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.448 -1.192 0 N-CA-C 109.115 -1.148 . . . . 0.56999999999999995 109.115 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 80.38 128.5 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 129.05 2.94 . . . . 0.56999999999999995 111.075 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -61.59 157.86 16.48 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.605 0.762 . . . . 0.56999999999999995 110.491 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.1 p -78.28 -34.38 48.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.475 . . . . 0.56999999999999995 111.508 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -82.93 139.12 33.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.197 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -76.29 -2.79 33.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.5 0.72 . . . . 0.56999999999999995 112.75 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.96 113.84 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.855 -2.276 . . . . 0.56999999999999995 104.855 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.71 139.85 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.876 -1.527 . . . . 0.56999999999999995 106.876 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 149.31 35.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.603 -0.686 . . . . 0.56999999999999995 111.283 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.44 157.12 35.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.56999999999999995 110.571 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 119.62 11.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.941 -0.763 . . . . 1.2 108.941 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -87.82 99.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 104.982 -2.229 . . . . 0.56999999999999995 104.982 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -48.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.504 1.122 . . . . 0.56999999999999995 111.712 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.84 175.46 5.57 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.151 1.78 . . . . 0.56999999999999995 106.455 174.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -144.42 164.87 29.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.6 t -67.84 -175.32 0.54 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.57 0.748 . . . . 0.56999999999999995 111.632 171.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.23 -38.16 1.8 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.704 1.202 . . . . 1.2 113.12 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.7 -43.9 93.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.345 0.658 . . . . 0.66000000000000003 109.985 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.0 149.1 39.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.627 1.971 . . . . 0.56999999999999995 108.606 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -75.11 160.31 39.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.311 2.007 . . . . 0.56999999999999995 112.66 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.84 -38.99 83.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.353 1.061 . . . . 0.65000000000000002 111.669 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.75 -39.58 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.296 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.8 m -68.01 -43.62 78.42 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 116.442 -1.742 . . . . 0.56999999999999995 109.013 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.97 -51.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 121.455 1.934 . . . . 0.56999999999999995 110.736 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.33 -40.99 94.4 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.197 0.908 . . . . 0.66000000000000003 111.352 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -42.74 97.65 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.852 1.206 . . . . 1.2 112.048 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mp -63.55 -48.65 76.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.598 1.559 . . . . 0.56999999999999995 108.402 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -56.64 -41.61 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.977 0.808 . . . . 0.56999999999999995 110.763 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -60.51 -53.25 59.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.499 1.045 . . . . 0.56999999999999995 109.644 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -39.19 93.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.285 0.948 . . . . 0.56999999999999995 111.624 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.96 93.74 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.943 1.297 . . . . 0.56999999999999995 111.984 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 mt -70.42 -33.78 71.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.396 -0.812 . . . . 0.56999999999999995 110.322 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.97 -37.3 76.48 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 118.808 0.731 . . . . 0.56999999999999995 110.546 171.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.52 80.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.91 0.777 . . . . 0.56999999999999995 112.268 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.427 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 17.7 m95 -73.03 -47.56 43.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.764 0.711 . . . . 0.56999999999999995 110.823 171.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.87 63.54 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.562 1.077 . . . . 0.56999999999999995 113.53 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.32 -17.47 64.78 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.113 -1.227 . . . . 0.56999999999999995 111.863 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.41 -33.86 7.6 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.75 -0.643 . . . . 0.66000000000000003 111.332 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.4 pt -121.54 134.17 24.47 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 119.455 1.025 . . . . 0.56999999999999995 110.39 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 37.27 0.38 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.9 3.067 . . . . 0.56999999999999995 113.055 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.06 132.84 36.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.021 -1.474 . . . . 0.56999999999999995 107.021 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -116.44 163.97 15.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.89 1.276 . . . . 0.65000000000000002 108.915 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.6 153.47 47.37 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 108.962 -170.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -141.04 178.68 7.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.179 0.991 . . . . 1.2 109.461 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -125.35 156.07 39.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.538 -0.912 . . . . 0.56999999999999995 108.538 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 m -108.19 169.53 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.998 1.319 . . . . 0.56999999999999995 109.319 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.77 -29.37 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.71 -1.586 . . . . 0.56999999999999995 110.948 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -62.69 -51.83 65.67 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.187 0.903 . . . . 0.56999999999999995 111.719 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.64 -125.2 1.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.072 -1.611 . . . . 0.56999999999999995 109.072 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -47.14 154.85 0.34 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.443 1.097 . . . . 0.56999999999999995 113.744 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.87 -174.18 4.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.176 1.39 . . . . 0.56999999999999995 110.943 -170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -60.51 -42.09 95.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.54 -0.743 . . . . 0.66000000000000003 109.001 172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -124.19 82.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.56999999999999995 108.375 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.3 ttp -79.89 117.32 20.65 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 120.294 -1.504 . . . . 0.56999999999999995 107.116 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -108.62 129.09 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.25 -2.13 . . . . 0.56999999999999995 105.25 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 164.77 27.64 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-O 121.962 0.756 . . . . 0.56999999999999995 112.176 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -132.43 141.4 48.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.026 -1.842 . . . . 0.56999999999999995 106.026 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.38 164.69 30.08 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 107.916 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 42.08 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.564 -0.71 . . . . 1.2 111.182 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.15 -46.29 0.61 Allowed Glycine 0 C--O 1.223 -0.586 0 CA-C-O 119.53 -0.594 . . . . 0.56999999999999995 111.658 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.03 169.32 21.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.567 1.184 . . . . 0.56999999999999995 110.245 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.76 159.92 33.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.969 1.708 . . . . 0.65000000000000002 108.829 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.65 60.78 3.19 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.888 1.232 . . . . 0.56999999999999995 111.412 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -105.78 -61.84 1.45 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.111 0.965 . . . . 0.66000000000000003 110.406 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.5 t -179.74 -35.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.364 2.665 . . . . 0.56999999999999995 110.003 -173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.75 122.7 14.54 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 119.193 0.906 . . . . 0.56999999999999995 108.992 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.99 133.13 34.56 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 N-CA-C 108.423 -1.414 . . . . 0.56999999999999995 108.423 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -166.93 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 123.257 1.504 . . . . 0.56999999999999995 110.809 166.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 21.3 p-10 -134.01 -38.25 0.88 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.76 3.224 . . . . 0.66000000000000003 109.172 -168.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.74 -139.68 14.97 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.672 -1.071 . . . . 0.56999999999999995 110.509 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.1 95.43 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 124.466 3.444 . . . . 0.56999999999999995 111.281 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.64 170.85 12.33 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.849 1.69 . . . . 0.56999999999999995 109.29 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 8.1 t-20 49.33 -159.6 0.06 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.485 1.514 . . . . 0.56999999999999995 112.377 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -43.05 128.18 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.242 2.217 . . . . 0.56999999999999995 112.848 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -95.53 -24.33 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 113.062 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.09 162.0 33.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.629 -1.249 . . . . 0.56999999999999995 107.629 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.3 167.83 22.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.321 -0.622 . . . . 0.65000000000000002 109.321 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.39 160.28 42.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.285 -1.006 . . . . 0.56999999999999995 108.285 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -111.45 147.07 36.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.688 -1.227 . . . . 0.56999999999999995 107.688 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 151.4 53.22 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.268 -0.872 . . . . 0.56999999999999995 110.249 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.13 164.85 23.72 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.95 1.767 . . . . 0.56999999999999995 111.585 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.12 -93.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 109.357 -1.497 . . . . 0.56999999999999995 109.357 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -158.92 -50.61 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.503 1.521 . . . . 0.56999999999999995 109.709 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.52 -119.73 2.13 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.707 -0.957 . . . . 0.56999999999999995 110.707 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -31.49 40.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.996 0.898 . . . . 0.56999999999999995 111.879 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.2 142.44 7.97 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.509 -0.744 . . . . 0.56999999999999995 112.135 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.4 -38.9 3.12 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.186 1.851 . . . . 0.56999999999999995 112.625 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -60.36 149.78 32.71 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.759 -0.83 . . . . 0.66000000000000003 108.759 -167.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.61 146.98 38.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.522 0.677 . . . . 0.56999999999999995 109.25 -171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -135.39 156.2 49.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.265 -0.879 . . . . 0.65000000000000002 109.975 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -137.82 146.15 43.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.019 1.327 . . . . 0.56999999999999995 108.081 -169.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.02 101.61 7.91 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.455 -0.942 . . . . 0.66000000000000003 108.455 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -59.08 -24.34 62.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.66000000000000003 111.885 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -69.12 -36.05 77.08 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.577 0.751 . . . . 0.66000000000000003 111.215 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.86 131.26 44.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.441 -1.689 . . . . 0.66000000000000003 106.441 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 139.69 48.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.635 0.774 . . . . 1.2 110.441 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -129.32 118.27 21.99 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.232 -1.395 . . . . 0.56999999999999995 107.232 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -114.93 147.99 39.28 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.38 -0.97 . . . . 0.56999999999999995 108.38 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.94 21.83 2.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.624 0.77 . . . . 0.66000000000000003 111.981 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.03 68.95 1.29 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.399 -1.08 . . . . 0.56999999999999995 110.399 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -40.04 4.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.984 -1.007 . . . . 0.56999999999999995 113.697 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.0 -47.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.209 1.804 . . . . 0.56999999999999995 110.621 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -139.09 155.2 48.09 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.354 1.462 . . . . 0.56999999999999995 108.131 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.63 -161.47 12.85 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.236 -1.546 . . . . 0.56999999999999995 109.236 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.2 mm -113.36 121.19 65.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.712 -1.959 . . . . 0.56999999999999995 105.712 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.23 103.47 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.984 0.803 . . . . 0.56999999999999995 109.072 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -53.27 -41.16 65.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.607 1.563 . . . . 0.56999999999999995 110.399 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -64.42 -50.36 67.9 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.694 -1.225 . . . . 0.56999999999999995 107.694 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -60.35 -39.51 87.41 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.232 -0.655 . . . . 0.56999999999999995 109.232 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.04 -61.69 2.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 110.458 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.85 -51.49 65.74 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.235 0.614 . . . . 0.56999999999999995 110.095 -175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.8 m -62.51 -37.71 87.09 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.438 0.695 . . . . 0.56999999999999995 112.062 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -60.65 -53.95 51.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.196 0.598 . . . . 0.65000000000000002 109.393 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.78 -40.43 96.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.258 0.481 . . . . 0.66000000000000003 110.652 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.26 -30.0 70.19 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.878 0.871 . . . . 0.56999999999999995 111.37 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.427 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -56.29 -51.83 53.55 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 118.472 0.578 . . . . 0.56999999999999995 112.083 170.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.01 -40.42 93.47 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.203 1.001 . . . . 0.65000000000000002 110.635 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -33.36 65.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.115 0.966 . . . . 0.56999999999999995 112.173 172.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.91 66.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 111.648 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.82 63.88 0.88 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.446 -0.662 . . . . 0.56999999999999995 111.446 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.6 176.84 8.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 109.141 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -95.44 148.44 18.99 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.868 -0.605 . . . . 0.56999999999999995 111.929 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 174.86 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.117 1.367 . . . . 0.65000000000000002 113.045 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -133.74 178.31 7.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.983 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -165.39 47.06 0.09 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.358 1.863 . . . . 0.56999999999999995 108.212 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.63 143.23 37.56 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-O 118.269 -0.872 . . . . 0.66000000000000003 109.708 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.7 2.49 2.92 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.696 2.931 . . . . 0.56999999999999995 114.098 -171.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -146.98 20.57 1.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.432 1.093 . . . . 0.56999999999999995 110.358 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.11 140.57 48.94 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.463 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.56 -35.25 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.37 -0.974 . . . . 0.56999999999999995 108.37 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -86.85 14.15 7.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.949 1.092 . . . . 0.56999999999999995 113.949 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.07 128.26 93.61 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.496 -1.377 . . . . 0.56999999999999995 111.137 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.62 -46.51 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.551 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 p -81.32 52.05 1.75 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.141 1.377 . . . . 0.56999999999999995 110.323 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -39.86 131.91 1.82 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 112.902 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.7 114.9 2.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.212 1.387 . . . . 0.56999999999999995 109.657 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 179.61 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.183 1.393 . . . . 0.56999999999999995 109.349 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.38 -138.52 9.65 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.841 1.21 . . . . 0.56999999999999995 110.343 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -127.38 111.29 21.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 0.66000000000000003 108.853 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.33 -15.22 22.65 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.814 2.342 . . . . 0.56999999999999995 113.015 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -62.57 -36.46 82.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.487 1.04 . . . . 0.56999999999999995 110.252 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -90.53 70.0 6.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.947 1.299 . . . . 0.56999999999999995 108.772 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -41.73 -68.45 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.773 1.629 . . . . 0.56999999999999995 115.23 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 21.58 74.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.386 2.674 . . . . 0.56999999999999995 112.633 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mp -31.37 116.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 128.022 2.529 . . . . 0.56999999999999995 109.742 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.6 t -82.2 -88.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.843 0.354 . . . . 0.56999999999999995 110.998 -162.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -142.43 -30.51 0.55 Allowed 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 124.315 1.046 . . . . 0.56999999999999995 110.774 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -51.54 -45.71 63.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 120.027 1.285 . . . . 0.66000000000000003 110.795 167.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -58.59 3.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.479 1.112 . . . . 0.66000000000000003 111.023 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.56 -46.72 89.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.892 -0.781 . . . . 0.56999999999999995 108.892 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -60.51 -49.8 76.12 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.046 -1.454 . . . . 0.56999999999999995 108.864 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -54.18 -59.54 9.83 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.937 -1.265 . . . . 0.56999999999999995 109.937 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.22 -50.22 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.933 1.293 . . . . 0.56999999999999995 112.776 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -69.28 -19.75 63.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.476 0.71 . . . . 0.56999999999999995 111.55 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -81.77 -25.96 34.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.13 0.972 . . . . 0.56999999999999995 111.178 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 -50.59 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.348 0.976 . . . . 0.56999999999999995 111.237 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.74 -177.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.532 0.423 0 N-CA-C 110.988 -0.428 . . . . 0.56999999999999995 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.78 95.52 0.04 OUTLIER 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.696 1.198 . . . . 0.56999999999999995 110.384 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -46.21 142.71 2.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.571 1.148 . . . . 0.56999999999999995 110.7 172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.9 m -62.06 -21.13 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.039 0.936 . . . . 0.56999999999999995 112.456 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -94.94 143.7 26.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.886 1.275 . . . . 0.56999999999999995 109.536 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -77.19 0.18 22.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.539 0.736 . . . . 0.56999999999999995 112.533 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.34 144.05 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.113 -1.439 . . . . 0.56999999999999995 107.113 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.07 145.8 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.412 -1.699 . . . . 0.56999999999999995 106.412 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -109.11 139.07 44.5 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.431 1.014 . . . . 0.56999999999999995 110.131 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -122.37 157.5 31.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.697 0.761 . . . . 0.56999999999999995 111.088 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.552 1.141 . . . . 1.2 109.114 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 mm -122.22 97.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.472 -2.418 . . . . 0.56999999999999995 104.472 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.19 -34.71 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.391 0.676 . . . . 0.56999999999999995 111.954 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -130.44 141.31 50.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.357 -2.46 . . . . 0.56999999999999995 104.357 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -129.86 146.56 51.59 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.581 1.152 . . . . 0.56999999999999995 108.931 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 t -75.9 -175.67 3.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.525 1.93 . . . . 0.56999999999999995 111.063 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -128.25 -27.75 2.66 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.595 0.961 . . . . 1.2 113.595 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.82 -23.56 67.33 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.848 1.204 . . . . 0.66000000000000003 111.519 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.36 146.95 24.15 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.097 1.759 . . . . 0.56999999999999995 109.43 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -75.29 161.73 37.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.736 2.291 . . . . 0.56999999999999995 112.96 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -70.42 -38.58 74.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.364 -0.835 . . . . 0.65000000000000002 110.315 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.52 -37.13 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 110.44 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 m -66.37 -46.33 77.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.419 -1.277 . . . . 0.56999999999999995 109.057 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.5 t -55.59 -50.65 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 110.121 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.36 -35.29 80.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 111.736 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -44.28 74.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.426 1.012 . . . . 1.2 112.314 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.09 -46.88 82.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.56999999999999995 108.112 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.86 -44.53 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 117.568 -1.206 . . . . 0.56999999999999995 111.244 173.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -54.64 -49.97 69.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.48 1.491 . . . . 0.56999999999999995 111.388 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -74.57 -33.36 62.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.155 0.889 . . . . 0.56999999999999995 112.198 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.5 78.88 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.373 1.069 . . . . 0.56999999999999995 110.949 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.76 -41.06 88.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.151 -0.928 . . . . 0.56999999999999995 109.397 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -52.88 -43.19 65.97 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 119.402 1.001 . . . . 0.56999999999999995 110.684 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.5 mtp -59.32 -39.03 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.062 1.301 . . . . 0.56999999999999995 112.597 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -65.39 -43.44 90.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.861 1.209 . . . . 0.56999999999999995 110.964 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.9 88.09 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.66 -1.275 . . . . 0.56999999999999995 113.528 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -77.45 -12.89 60.01 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 110.104 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -109.06 -21.04 12.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.828 1.251 . . . . 0.66000000000000003 111.909 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.18 152.94 70.74 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 110.137 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.06 13.55 1.25 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.11 2.54 . . . . 0.56999999999999995 113.021 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tt -82.18 135.23 35.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.455 -1.313 . . . . 0.56999999999999995 107.455 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -116.79 170.45 8.59 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.553 0.741 . . . . 0.65000000000000002 109.516 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 157.76 41.92 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.472 -0.768 . . . . 0.56999999999999995 109.203 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.16 164.57 26.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.366 1.466 . . . . 1.2 108.357 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -135.65 115.83 13.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.123 -2.177 . . . . 0.56999999999999995 105.123 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.46 164.92 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 109.023 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.02 -36.51 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.265 0.626 . . . . 0.56999999999999995 111.084 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 153.31 19.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.148 0.579 . . . . 0.56999999999999995 110.662 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.48 40.57 2.42 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.358 0.98 . . . . 0.56999999999999995 113.076 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -163.8 143.13 8.03 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.687 -1.227 . . . . 0.56999999999999995 107.687 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.54 6.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.669 1.188 . . . . 0.56999999999999995 109.596 -174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -64.48 -32.29 73.86 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.18 -0.674 . . . . 0.66000000000000003 109.18 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 mt -124.43 97.12 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.724 2.01 . . . . 0.56999999999999995 107.728 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 ttp -100.23 100.15 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.305 2.642 . . . . 0.56999999999999995 106.341 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mt -92.77 128.08 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.005 -1.85 . . . . 0.56999999999999995 106.005 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.47 145.11 11.61 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.424 -0.67 . . . . 0.56999999999999995 111.424 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 142.21 47.45 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.23 165.59 26.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.565 1.546 . . . . 0.56999999999999995 108.373 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.9 22.82 11.54 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.559 -0.713 . . . . 1.2 111.481 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 156.59 31.2 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.593 1.568 . . . . 0.56999999999999995 109.81 -164.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 49.86 102.38 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.059 2.144 . . . . 0.56999999999999995 114.201 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -147.33 157.44 43.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.476 1.111 . . . . 0.65000000000000002 109.035 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.59 62.23 4.05 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.3 0.952 . . . . 0.56999999999999995 111.192 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -106.83 -55.28 2.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.381 0.591 . . . . 0.66000000000000003 111.105 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.86 -43.18 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.814 2.846 . . . . 0.56999999999999995 109.594 -168.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -142.83 121.61 7.47 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.019 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.53 140.25 35.92 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.972 1.781 . . . . 0.56999999999999995 111.544 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -72.41 173.39 8.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.304 1.042 . . . . 0.56999999999999995 111.797 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.78 -31.51 15.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.937 2.095 . . . . 0.66000000000000003 112.41 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.04 -132.47 11.11 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 120.862 1.664 . . . . 0.56999999999999995 111.516 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.48 103.86 1.43 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 112.171 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.46 -167.06 25.65 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.682 2.087 . . . . 0.56999999999999995 111.428 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.99 -140.43 0.71 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.025 -1.279 . . . . 0.56999999999999995 114.152 164.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -51.18 137.2 22.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.042 2.137 . . . . 0.56999999999999995 110.535 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.68 -30.54 10.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.618 1.567 . . . . 0.56999999999999995 111.294 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.39 165.6 28.65 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.059 1.344 . . . . 0.56999999999999995 108.987 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.624 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -145.85 159.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.565 0.62 . . . . 0.65000000000000002 111.447 173.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.13 147.09 34.41 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.446 0.698 . . . . 0.56999999999999995 110.011 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -98.67 150.86 21.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.005 -0.998 . . . . 0.56999999999999995 109.414 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.49 150.23 86.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.543 -0.741 . . . . 0.56999999999999995 110.298 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -69.29 162.53 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.234 1.956 . . . . 0.56999999999999995 111.509 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.71 -93.35 0.1 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.258 -1.537 . . . . 0.56999999999999995 109.258 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -160.61 123.0 3.22 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.653 0.726 . . . . 0.56999999999999995 110.14 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.42 -123.32 7.47 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-O 118.187 -1.34 . . . . 0.56999999999999995 110.23 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.04 -24.4 39.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 112.364 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.25 143.14 12.75 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 120.939 -1.101 . . . . 0.56999999999999995 111.468 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.99 -21.63 2.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.371 1.462 . . . . 0.56999999999999995 114.13 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -70.51 159.47 34.23 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.02 1.91 . . . . 0.66000000000000003 108.692 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.65 141.3 28.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.198 -0.668 . . . . 0.56999999999999995 109.198 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -130.7 158.4 40.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.713 -0.477 . . . . 0.65000000000000002 109.713 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.08 146.83 34.16 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.744 -1.206 . . . . 0.56999999999999995 107.744 -169.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.96 98.35 3.57 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.823 -0.806 . . . . 0.66000000000000003 108.823 174.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.12 -16.82 62.65 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.431 -1.418 . . . . 0.66000000000000003 111.87 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.64 -33.74 76.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.564 1.546 . . . . 0.66000000000000003 110.961 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.4 157.17 32.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.629 0.728 . . . . 0.66000000000000003 109.82 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 135.73 38.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.282 -0.636 . . . . 1.2 109.282 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -126.98 151.87 47.96 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.147 -1.057 . . . . 0.56999999999999995 108.147 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -154.1 167.94 28.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.801 0.728 . . . . 0.56999999999999995 110.435 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.0 -32.1 45.04 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.396 1.079 . . . . 0.66000000000000003 112.258 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.97 88.01 0.74 Allowed Glycine 0 C--N 1.343 0.92 0 C-N-CA 123.633 0.635 . . . . 0.56999999999999995 112.614 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.3 m -120.47 -42.77 2.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.521 -0.752 . . . . 0.56999999999999995 112.751 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 p -171.85 -43.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.23 0.923 . . . . 0.56999999999999995 111.881 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.6 166.03 24.49 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.273 1.429 . . . . 0.56999999999999995 109.313 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 179.09 35.59 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 110.694 -0.962 . . . . 0.56999999999999995 110.694 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.6 mm -103.58 118.38 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.134 -1.062 . . . . 0.56999999999999995 108.134 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -70.59 121.85 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.747 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -37.97 76.23 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.132 1.16 . . . . 0.56999999999999995 114.132 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.37 -39.77 91.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.691 -0.855 . . . . 0.56999999999999995 108.691 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.519 ' HH ' ' N ' ' A' ' 149' ' ' ASN . 1.7 m-85 -75.63 -41.57 53.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.495 -0.928 . . . . 0.56999999999999995 108.495 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.39 86.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.016 -0.516 . . . . 0.56999999999999995 110.583 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.32 -55.84 29.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.863 -1.065 . . . . 0.56999999999999995 109.789 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 m -53.67 -42.14 67.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.534 1.516 . . . . 0.56999999999999995 112.335 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -62.01 -54.38 42.43 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.938 0.79 . . . . 0.65000000000000002 110.088 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.624 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 12.9 mm-40 -68.41 -45.96 71.21 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.318 1.047 . . . . 0.66000000000000003 111.528 -172.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.22 -31.59 72.85 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.045 1.338 . . . . 0.56999999999999995 110.959 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.59 -52.91 38.63 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.61 -0.996 . . . . 0.56999999999999995 110.61 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -58.55 -45.49 88.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.569 0.684 . . . . 0.65000000000000002 111.545 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.5 t -54.81 -38.6 67.55 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.15 0.906 . . . . 0.56999999999999995 112.726 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -27.65 68.73 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.8 0.84 . . . . 0.56999999999999995 111.777 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.24 44.44 0.13 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.839 1.209 . . . . 0.56999999999999995 113.334 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.04 156.66 42.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.573 1.187 . . . . 0.56999999999999995 111.013 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.44 -13.12 2.91 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 115.795 -2.67 . . . . 0.56999999999999995 114.821 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.6 m170 137.37 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 1 C-N-CA 131.836 4.054 . . . . 0.65000000000000002 111.434 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.9 m -131.79 -173.09 3.04 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.833 2.853 . . . . 0.56999999999999995 109.081 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.8 t -148.78 61.17 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.999 0.92 . . . . 0.56999999999999995 110.17 -171.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -133.97 149.06 70.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 108.798 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.03 -4.88 14.22 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.648 . . . . 0.56999999999999995 112.972 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.52 28.93 4.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.56999999999999995 109.101 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.09 130.18 34.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.645 1.578 . . . . 0.56999999999999995 109.926 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.74 -19.65 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.052 0.387 . . . . 0.56999999999999995 110.884 165.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.99 -14.56 63.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 117.66 -1.162 . . . . 0.56999999999999995 112.962 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.11 133.09 87.53 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 121.246 1.839 . . . . 0.56999999999999995 110.671 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.79 144.25 24.4 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.613 2.208 . . . . 0.56999999999999995 110.301 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 52.6 m 66.67 116.03 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.197 1.799 . . . . 0.56999999999999995 110.468 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -54.89 116.73 2.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.267 -0.896 . . . . 0.56999999999999995 110.924 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.7 -121.03 2.19 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.213 1.863 . . . . 0.56999999999999995 109.851 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.84 -26.59 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.455 1.502 . . . . 0.56999999999999995 113.914 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.5 151.84 27.49 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.874 -0.891 . . . . 0.56999999999999995 110.874 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.18 110.99 42.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.764 -1.939 . . . . 0.66000000000000003 105.764 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -79.62 29.17 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.688 2.926 . . . . 0.56999999999999995 115.499 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -129.61 -28.11 2.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.085 1.354 . . . . 0.56999999999999995 111.446 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.519 ' N ' ' HH ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -156.03 94.31 1.52 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 109.327 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -138.41 169.04 18.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.828 1.251 . . . . 0.56999999999999995 109.405 177.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.88 57.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 111.127 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp 63.72 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 110.254 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -68.7 -86.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.138 0.975 . . . . 0.56999999999999995 112.234 -165.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -144.54 -35.8 0.34 Allowed 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.34 1.456 . . . . 0.56999999999999995 108.817 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -55.61 -48.37 74.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.269 1.827 . . . . 0.66000000000000003 111.378 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.54 -49.4 54.72 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.643 0.777 . . . . 0.66000000000000003 109.424 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -46.49 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 109.645 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -71.42 -40.48 70.41 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.73 -1.128 . . . . 0.56999999999999995 109.306 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -50.0 -61.06 6.03 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 mm -57.08 -50.08 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 117.711 0.755 . . . . 0.56999999999999995 111.5 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.86 -13.47 62.17 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.199 -0.938 . . . . 0.56999999999999995 113.14 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -92.11 -25.31 18.8 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 111.047 171.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.39 -35.95 65.98 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.554 1.142 . . . . 0.56999999999999995 112.773 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.551 1.141 . . . . 0.56999999999999995 109.969 -173.676 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.453 -0.881 0 N-CA-C 108.659 -1.323 . . . . 0.56999999999999995 108.659 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 83.58 134.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 111.077 -172.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.401 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 63.9 m95 -66.24 169.2 7.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.963 0.887 . . . . 0.56999999999999995 111.305 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -80.07 -33.84 38.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.478 0.711 . . . . 0.56999999999999995 111.424 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.8 t -86.99 146.42 26.14 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.171 0.988 . . . . 0.56999999999999995 109.379 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -75.3 -12.19 60.22 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.56999999999999995 112.012 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -116.24 111.68 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.306 -1.738 . . . . 0.56999999999999995 106.306 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 60' ' ' ILE . 72.7 t -104.04 129.05 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.792 -1.188 . . . . 0.56999999999999995 107.792 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -104.65 138.38 41.05 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.73 -0.606 . . . . 0.56999999999999995 110.285 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -125.08 160.11 29.82 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.906 0.482 . . . . 0.56999999999999995 110.869 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -152.14 166.4 31.78 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 122.758 0.423 . . . . 1.2 110.673 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.5 mt -130.26 94.67 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 103.806 -2.665 . . . . 0.56999999999999995 103.806 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 t -76.8 -45.44 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.528 0.731 . . . . 0.56999999999999995 109.597 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -112.63 156.19 23.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 104.651 -2.351 . . . . 0.56999999999999995 104.651 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.38 154.48 50.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.788 -1.56 . . . . 0.56999999999999995 106.788 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 t -64.05 173.31 1.95 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.875 1.322 . . . . 0.56999999999999995 111.827 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' N ' ' HE2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -106.42 -37.22 6.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.99 -1.459 . . . . 1.2 112.397 178.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.16 -35.76 76.68 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.357 0.526 . . . . 0.66000000000000003 111.307 -172.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 mt -114.12 151.93 45.38 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 126.884 2.074 . . . . 0.56999999999999995 108.153 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -78.23 154.01 28.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 111.974 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.81 -37.94 74.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.57 1.148 . . . . 0.65000000000000002 113.174 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tp -59.36 -43.4 90.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.773 -0.454 . . . . 0.56999999999999995 109.773 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -70.48 -41.08 73.2 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.895 -1.05 . . . . 0.56999999999999995 108.988 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 114' ' ' PHE . 47.4 t -54.5 -52.14 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 119.83 1.196 . . . . 0.56999999999999995 109.698 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -65.96 -43.94 86.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.774 0.716 . . . . 0.66000000000000003 111.096 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.71 92.64 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.368 -0.833 . . . . 1.2 112.099 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.94 -47.26 66.13 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.98 -44.49 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.393 1.451 . . . . 0.56999999999999995 110.835 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -39.31 92.15 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 117.499 -1.239 . . . . 0.56999999999999995 111.057 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -67.21 -44.37 79.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.48 1.112 . . . . 0.56999999999999995 111.509 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.04 96.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.799 1.24 . . . . 0.56999999999999995 111.023 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 mt -68.8 -34.17 75.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.975 0.51 . . . . 0.56999999999999995 111.039 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -46.97 81.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 118.679 -0.677 . . . . 0.56999999999999995 109.319 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -42.03 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.368 -0.825 . . . . 0.56999999999999995 111.607 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.405 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 32.9 m95 -63.19 -46.77 85.49 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.441 1.019 . . . . 0.56999999999999995 111.372 173.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.44 -10.81 63.86 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.337 -0.852 . . . . 0.56999999999999995 114.317 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -80.96 -5.38 57.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.253 -1.145 . . . . 0.56999999999999995 111.177 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.06 -20.28 11.56 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.872 0.869 . . . . 0.66000000000000003 111.636 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.42 150.22 69.94 Favored Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 124.57 1.148 . . . . 0.56999999999999995 110.184 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.49 16.64 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 113.113 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tt -82.04 142.69 32.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 107.591 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -125.4 170.63 11.17 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.851 0.834 . . . . 0.65000000000000002 109.487 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.02 162.09 36.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.912 -0.773 . . . . 0.56999999999999995 108.912 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.75 -179.94 6.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.654 -1.157 . . . . 1.2 108.995 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -135.78 133.97 38.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.504 -1.665 . . . . 0.56999999999999995 106.504 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.35 162.65 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 O-C-N 124.174 0.921 . . . . 0.56999999999999995 109.526 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.9 m -110.72 -30.04 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.769 -1.105 . . . . 0.56999999999999995 110.696 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -60.69 3.13 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.596 1.158 . . . . 0.56999999999999995 110.695 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.87 -91.23 0.1 OUTLIER Glycine 0 C--O 1.219 -0.823 0 N-CA-C 109.896 -1.282 . . . . 0.56999999999999995 109.896 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -62.22 153.76 29.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.379 1.589 . . . . 0.56999999999999995 111.904 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.35 -170.55 3.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 109.972 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.24 -38.5 71.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.286 -1.005 . . . . 0.66000000000000003 108.286 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 HD11 ' CG1' ' A' ' 15' ' ' VAL . 5.6 mt -127.66 90.8 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 107.938 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 154.04 26.93 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 109.111 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.06 137.41 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.487 -2.042 . . . . 0.56999999999999995 105.487 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.47 164.88 29.46 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.899 -0.88 . . . . 0.56999999999999995 110.899 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 5.4 m-85 -138.29 133.91 33.66 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.235 -1.765 . . . . 0.56999999999999995 106.235 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.69 178.89 8.1 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.56999999999999995 109.512 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.71 85.69 2.39 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 107.123 -1.436 . . . . 1.2 107.123 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.56 -139.68 15.61 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.47 -0.652 . . . . 0.56999999999999995 111.47 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.77 122.13 9.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.56999999999999995 111.398 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -125.2 -39.86 2.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.65000000000000002 112.2 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.71 44.85 0.8 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.886 -0.486 . . . . 0.56999999999999995 111.886 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.79 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.173 1.389 . . . . 0.66000000000000003 107.672 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -173.55 -34.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.616 1.966 . . . . 0.56999999999999995 110.484 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -132.21 132.15 22.82 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 108.176 -1.046 . . . . 0.56999999999999995 108.176 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.32 133.53 28.61 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 N-CA-C 108.857 -1.247 . . . . 0.56999999999999995 108.857 171.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -64.41 178.36 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.917 1.342 . . . . 0.56999999999999995 109.92 165.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 13.7 p-10 -98.88 -43.36 6.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 131.436 3.894 . . . . 0.66000000000000003 110.092 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.96 -139.28 14.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.832 -1.538 . . . . 0.56999999999999995 110.363 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.18 96.48 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 112.055 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 177.82 15.04 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 110.334 -1.106 . . . . 0.56999999999999995 110.334 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HB3' ' HD2' ' A' ' 76' ' ' ASP 0.254 15.3 t30 60.05 -142.69 0.56 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 112.489 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.4 m -45.42 144.35 1.52 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.628 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -107.62 -29.01 9.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.471 1.941 . . . . 0.56999999999999995 112.462 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.26 166.08 25.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.522 1.129 . . . . 0.56999999999999995 108.332 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.76 161.84 38.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.176 0.512 . . . . 0.65000000000000002 109.715 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 160.82 43.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.981 0.912 . . . . 0.56999999999999995 108.799 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -112.56 151.08 30.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.762 -0.829 . . . . 0.56999999999999995 108.762 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.33 156.33 22.41 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.531 -0.747 . . . . 0.56999999999999995 111.004 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 17.6 Cg_endo -68.52 148.26 72.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.888 1.725 . . . . 0.56999999999999995 111.921 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.2 175.22 13.79 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.6 1.095 . . . . 0.56999999999999995 110.84 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t 43.31 -148.54 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.603 1.561 . . . . 0.56999999999999995 112.703 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.29 -56.62 1.45 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 117.182 -1.899 . . . . 0.56999999999999995 110.482 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -44.37 74.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.44 1.62 . . . . 0.56999999999999995 112.075 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 151.15 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.619 1.1 . . . . 0.56999999999999995 112.659 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.89 -26.32 1.73 Allowed Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.853 -1.526 . . . . 0.56999999999999995 114.641 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.05 150.11 49.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.971 -1.122 . . . . 0.66000000000000003 107.971 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.14 148.51 35.16 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.424 -0.807 . . . . 0.56999999999999995 109.341 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -132.47 159.69 38.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.659 -0.867 . . . . 0.65000000000000002 108.659 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.408 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.2 m-85 -138.35 155.87 48.14 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.454 1.502 . . . . 0.56999999999999995 108.868 -170.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.17 97.76 10.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.898 0.479 . . . . 0.66000000000000003 109.952 172.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HE2' ' N ' ' A' ' 24' ' ' ARG . 3.8 tp10 -58.25 -25.66 61.98 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.061 0.945 . . . . 0.66000000000000003 111.676 171.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.01 -34.99 70.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.305 0.574 . . . . 0.66000000000000003 111.075 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -82.48 150.26 27.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.636 1.175 . . . . 0.66000000000000003 109.085 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -71.88 147.5 47.04 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.511 -0.743 . . . . 1.2 110.647 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -135.35 134.53 39.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.267 -1.383 . . . . 0.56999999999999995 107.267 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -133.85 150.18 51.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 0.56999999999999995 110.389 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.64 -29.45 64.65 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.191 0.997 . . . . 0.66000000000000003 111.374 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.01 75.88 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.387 -1.085 . . . . 0.56999999999999995 110.387 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.29 155.92 38.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.401 -1.333 . . . . 0.56999999999999995 107.401 172.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -62.47 167.28 4.41 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.529 0.732 . . . . 0.56999999999999995 110.509 170.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.35 -64.22 0.4 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.935 2.094 . . . . 0.56999999999999995 111.016 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.28 147.76 49.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.052 -1.219 . . . . 0.56999999999999995 110.052 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.32 129.82 36.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.004 -1.11 . . . . 0.56999999999999995 108.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -66.62 113.19 4.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.388 -0.597 . . . . 0.56999999999999995 109.388 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 31' ' ' VAL . 9.6 t80 -58.5 -46.09 87.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.2 1.0 . . . . 0.56999999999999995 111.372 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -63.43 -41.69 98.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 109.745 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.36 -45.0 96.19 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.444 0.698 . . . . 0.56999999999999995 109.934 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.66 72.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.035 0.534 . . . . 0.56999999999999995 111.316 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.82 -55.37 33.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 117.366 -1.302 . . . . 0.56999999999999995 109.086 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 m -52.35 -41.49 63.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.407 1.458 . . . . 0.56999999999999995 111.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.15 -60.57 3.55 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.557 0.617 . . . . 0.65000000000000002 110.058 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.47 -43.7 96.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.385 0.539 . . . . 0.66000000000000003 110.9 -173.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.08 -26.98 68.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.681 1.193 . . . . 0.56999999999999995 111.775 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.22 -45.95 92.16 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.009 -0.836 . . . . 0.56999999999999995 111.009 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -68.71 -39.78 80.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.957 -1.02 . . . . 0.65000000000000002 111.582 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -55.17 -30.69 60.38 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 124.159 0.912 . . . . 0.56999999999999995 111.966 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -34.32 66.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.338 0.972 . . . . 0.56999999999999995 111.406 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.41 52.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.416 -1.214 . . . . 0.56999999999999995 113.093 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 28.6 mmt 61.12 173.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 112.106 -171.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.81 70.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.785 -1.008 . . . . 0.56999999999999995 111.153 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.27 172.78 6.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.73 1.265 . . . . 0.65000000000000002 110.175 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.57 -179.16 5.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.35 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.5 m -138.14 54.7 1.78 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.015 1.726 . . . . 0.56999999999999995 108.892 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.61 148.39 41.79 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.249 1.02 . . . . 0.66000000000000003 109.233 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.68 -19.26 41.88 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.228 2.618 . . . . 0.56999999999999995 113.004 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -130.76 28.22 4.87 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.839 1.656 . . . . 0.56999999999999995 108.607 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.51 129.33 38.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.373 -0.973 . . . . 0.56999999999999995 108.373 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.88 -26.78 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.635 0.374 . . . . 0.56999999999999995 110.506 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -105.1 29.21 6.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.604 1.162 . . . . 0.56999999999999995 111.811 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.29 128.62 87.98 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 120.606 -1.309 . . . . 0.56999999999999995 110.554 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.21 177.76 8.2 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.421 2.747 . . . . 0.56999999999999995 111.065 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m 48.59 77.57 0.1 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.225 1.41 . . . . 0.56999999999999995 111.608 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -50.69 125.76 13.96 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.797 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.93 164.8 13.64 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 108.482 -1.847 . . . . 0.56999999999999995 108.482 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.02 -51.37 0.47 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.867 2.467 . . . . 0.56999999999999995 113.825 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.65 145.86 42.2 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.646 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 26.6 t0 -94.99 112.8 59.61 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.859 -1.904 . . . . 0.66000000000000003 105.859 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -80.31 -31.39 1.68 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.803 1.669 . . . . 0.56999999999999995 112.668 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -42.15 72.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.074 1.306 . . . . 0.56999999999999995 110.322 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.646 ' ND2' ' HD2' ' A' ' 146' ' ' ASP . 1.4 m-80 -122.98 89.82 3.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.193 -1.41 . . . . 0.56999999999999995 107.193 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -120.96 159.74 24.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.97 0.89 . . . . 0.56999999999999995 109.465 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.09 156.28 10.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.689 1.996 . . . . 0.56999999999999995 105.996 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp -56.07 108.31 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.141 1.376 . . . . 0.56999999999999995 107.69 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.8 t -86.04 -101.41 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.77 -0.826 . . . . 0.56999999999999995 108.77 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.3 -49.43 1.55 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-O 116.268 -1.825 . . . . 0.56999999999999995 108.134 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -48.83 -38.95 23.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.911 1.687 . . . . 0.66000000000000003 112.132 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -67.65 -58.89 3.88 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.354 0.661 . . . . 0.66000000000000003 111.549 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.74 -40.26 84.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-O 117.811 -1.09 . . . . 0.56999999999999995 108.369 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.48 74.91 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.671 1.588 . . . . 0.56999999999999995 108.73 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.29 -56.79 22.57 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.5 mm -58.72 -49.1 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.386 1.093 . . . . 0.56999999999999995 112.949 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.59 -29.88 70.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.458 1.103 . . . . 0.56999999999999995 110.115 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -29.21 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.56999999999999995 110.17 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 3.2 mt -74.46 -48.7 25.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.14 -0.933 . . . . 0.56999999999999995 111.585 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 163' ' ' LEU . 3.2 m-85 . . . . . 0 N--CA 1.48 1.041 0 CA-C-N 119.911 1.232 . . . . 0.56999999999999995 113.887 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 N--CA 1.455 -0.752 0 N-CA-C 111.104 -0.383 . . . . 0.56999999999999995 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 pttt 68.4 118.02 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.896 2.078 . . . . 0.56999999999999995 110.073 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -62.17 150.35 39.01 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.56999999999999995 109.704 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.1 p -88.43 28.66 1.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.471 0.708 . . . . 0.56999999999999995 111.069 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -130.55 159.64 36.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.539 1.936 . . . . 0.56999999999999995 108.851 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -90.54 -8.55 49.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 112.748 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.46 145.76 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 0.56999999999999995 106.747 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.0 t -131.06 134.48 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.075 -1.824 . . . . 0.56999999999999995 106.075 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -100.4 147.86 25.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.651 -0.5 . . . . 0.56999999999999995 109.651 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -125.15 153.73 42.57 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.424 0.689 . . . . 0.56999999999999995 111.7 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.09 109.97 6.42 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.013 0.911 . . . . 1.2 110.59 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.0 mt -76.03 95.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.674 -1.602 . . . . 0.56999999999999995 106.674 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 m -75.23 -46.41 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.709 0.803 . . . . 0.56999999999999995 111.365 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -115.96 160.31 20.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.263 -1.384 . . . . 0.56999999999999995 107.263 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.6 179.9 5.27 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.17 0.988 . . . . 0.56999999999999995 108.597 -172.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -119.95 -178.45 3.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.808 1.243 . . . . 0.56999999999999995 109.711 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -131.42 -31.59 1.6 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.152 1.781 . . . . 1.2 111.713 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -31.4 71.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.374 1.07 . . . . 0.66000000000000003 111.914 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.31 145.33 56.19 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 126.733 2.013 . . . . 0.56999999999999995 106.733 -175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -72.97 153.76 52.71 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.587 1.525 . . . . 0.56999999999999995 111.523 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.27 -34.73 74.15 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.245 1.018 . . . . 0.65000000000000002 113.121 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.57 -39.56 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.624 0.37 . . . . 0.56999999999999995 110.016 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -68.52 -42.49 78.44 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.332 -1.318 . . . . 0.56999999999999995 110.152 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 t -57.23 -51.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 120.584 1.538 . . . . 0.56999999999999995 109.398 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -43.56 98.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.145 0.578 . . . . 0.66000000000000003 110.222 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.15 -46.6 88.27 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 117.957 -1.021 . . . . 1.2 112.139 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.8 mp -65.07 -41.87 94.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.783 1.174 . . . . 0.56999999999999995 109.658 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.31 -48.82 79.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 108.792 -0.818 . . . . 0.56999999999999995 108.792 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -39.06 81.42 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.537 0.608 . . . . 0.56999999999999995 111.738 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -65.21 -46.22 81.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.821 1.191 . . . . 0.56999999999999995 110.438 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.98 95.29 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 111.245 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 25.9 mt -68.22 -33.43 74.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.576 -0.726 . . . . 0.56999999999999995 111.327 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -65.03 -33.33 75.79 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.424 1.011 . . . . 0.56999999999999995 110.315 173.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.4 mtp -71.23 -28.83 64.47 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.857 0.753 . . . . 0.56999999999999995 111.996 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.14 -48.83 40.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.502 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.03 62.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.14 1.352 . . . . 0.56999999999999995 113.65 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -64.58 -22.41 66.96 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.886 -1.361 . . . . 0.56999999999999995 111.673 170.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -108.37 -21.3 12.81 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.796 0.725 . . . . 0.66000000000000003 112.255 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.88 135.48 27.56 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 123.872 0.869 . . . . 0.56999999999999995 110.761 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.12 61.26 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.821 3.014 . . . . 0.56999999999999995 110.65 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 124.46 48.85 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.059 -1.83 . . . . 0.56999999999999995 106.059 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -105.57 175.29 5.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.924 1.289 . . . . 0.65000000000000002 108.623 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 1.2 m-85 -139.36 153.86 47.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.18 -0.95 . . . . 0.56999999999999995 108.483 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.63 174.44 10.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.711 0.804 . . . . 1.2 109.009 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -124.29 155.69 38.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.05 -1.092 . . . . 0.56999999999999995 108.05 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.06 -179.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.172 -0.922 . . . . 0.56999999999999995 108.977 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.72 -38.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.795 -0.622 . . . . 0.56999999999999995 110.34 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -175.65 92.95 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.291 1.436 . . . . 0.56999999999999995 108.975 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.83 172.78 38.13 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.92 2.2 . . . . 0.56999999999999995 108.122 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 p -67.92 167.05 14.43 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.583 0.692 . . . . 0.56999999999999995 110.123 168.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.13 173.76 11.91 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.551 0.741 . . . . 0.56999999999999995 110.145 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.93 -33.94 66.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 118.071 -0.966 . . . . 0.66000000000000003 109.142 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.93 76.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.612 1.965 . . . . 0.56999999999999995 108.586 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -70.03 133.58 47.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 119.522 -1.986 . . . . 0.56999999999999995 107.959 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.73 105.89 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.037 -1.838 . . . . 0.56999999999999995 106.037 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 73.92 0.26 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.775 1.655 . . . . 0.56999999999999995 111.223 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -109.44 132.96 53.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 110.157 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.33 172.0 17.33 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.56999999999999995 108.449 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -91.74 113.48 25.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.286 -0.864 . . . . 1.2 110.222 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.66 71.2 0.86 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.376 -0.69 . . . . 0.56999999999999995 111.376 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 81.21 147.58 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.009 2.924 . . . . 0.56999999999999995 111.521 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.14 -11.52 4.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.944 1.297 . . . . 0.65000000000000002 112.816 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.96 3.04 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 118.801 -1.0 . . . . 0.56999999999999995 112.505 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.64 -55.89 1.61 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.718 0.759 . . . . 0.66000000000000003 110.375 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.51 -44.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.536 1.934 . . . . 0.56999999999999995 108.055 -177.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -97.42 121.24 59.02 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.467 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.74 3.82 6.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 113.204 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 56.17 -155.76 0.29 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.139 0.881 . . . . 0.56999999999999995 110.651 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.453 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 14.8 p-10 -143.18 -41.48 0.3 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.644 2.777 . . . . 0.66000000000000003 108.524 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.12 -149.78 16.66 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.213 1.387 . . . . 0.56999999999999995 110.195 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.6 94.3 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.589 3.526 . . . . 0.56999999999999995 111.414 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 167.95 11.45 Favored Glycine 0 C--O 1.22 -0.749 0 N-CA-C 109.411 -1.476 . . . . 0.56999999999999995 109.411 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.453 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 24.4 t30 48.31 -150.52 0.15 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 119.813 1.806 . . . . 0.56999999999999995 112.241 -173.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -47.09 111.06 0.35 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.12 2.168 . . . . 0.56999999999999995 113.306 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.97 -31.96 34.6 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.796 -1.19 . . . . 0.56999999999999995 112.497 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.49 39.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.56999999999999995 109.737 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -146.57 144.96 29.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.457 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.76 164.4 30.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 109.521 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -115.21 156.95 24.39 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.961 -0.563 . . . . 0.56999999999999995 109.515 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.65 98.73 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.358 -0.829 . . . . 0.56999999999999995 109.359 176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -72.47 159.3 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.672 2.248 . . . . 0.56999999999999995 111.178 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.32 -83.62 0.08 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.872 -1.691 . . . . 0.56999999999999995 108.872 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -159.2 146.26 17.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.316 -0.994 . . . . 0.56999999999999995 108.316 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -130.9 11.77 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 118.453 -1.193 . . . . 0.56999999999999995 110.297 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.02 -25.34 58.42 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.342 1.071 . . . . 0.56999999999999995 111.994 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.94 142.44 5.85 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.085 -1.009 . . . . 0.56999999999999995 112.121 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.61 -26.79 3.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.526 2.012 . . . . 0.56999999999999995 113.901 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -66.31 148.72 51.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.787 0.794 . . . . 0.66000000000000003 109.399 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.57 140.77 49.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 108.773 -168.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.78 139.68 29.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.234 -1.765 . . . . 0.65000000000000002 106.234 -160.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.67 148.26 37.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -166.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.69 105.99 12.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.199 -1.408 . . . . 0.66000000000000003 107.199 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.52 -19.79 27.27 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.489 -0.757 . . . . 0.66000000000000003 110.713 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -28.13 64.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.242 1.017 . . . . 0.66000000000000003 111.141 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.28 110.72 9.86 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.289 -1.745 . . . . 0.66000000000000003 106.289 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.95 110.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.151 0.887 . . . . 1.2 111.502 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.12 133.88 34.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.048 -1.093 . . . . 0.56999999999999995 108.048 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -123.33 143.49 50.06 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.491 -1.299 . . . . 0.56999999999999995 107.491 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.37 32.8 0.4 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.478 1.511 . . . . 0.66000000000000003 111.599 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.66 69.56 1.37 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.625 -0.99 . . . . 0.56999999999999995 110.625 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -57.31 2.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.478 0.639 . . . . 0.56999999999999995 110.785 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 108.617 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.93 159.22 16.43 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.56999999999999995 109.075 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.2 -172.35 38.06 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.35 -1.1 . . . . 0.56999999999999995 110.35 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.06 120.31 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.511 -1.292 . . . . 0.56999999999999995 107.511 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -62.05 109.16 1.2 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.584 0.353 . . . . 0.56999999999999995 110.237 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.81 -37.33 81.63 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.539 0.735 . . . . 0.56999999999999995 110.686 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -65.95 -46.16 79.15 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 118.481 0.582 . . . . 0.56999999999999995 110.256 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.44 -48.89 79.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.836 0.743 . . . . 0.56999999999999995 109.18 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.33 90.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.114 0.566 . . . . 0.56999999999999995 111.319 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.09 -54.56 43.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.892 -1.051 . . . . 0.56999999999999995 109.517 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.5 m -57.17 -37.88 72.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.043 1.292 . . . . 0.56999999999999995 111.33 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.45 -58.54 7.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.409 0.549 . . . . 0.65000000000000002 109.935 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.3 -41.38 98.95 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.559 -0.713 . . . . 0.66000000000000003 111.303 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.55 -26.2 68.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.56999999999999995 111.666 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.81 99.35 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.73 1.15 . . . . 0.56999999999999995 112.053 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -69.89 -39.89 75.97 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 118.279 -0.867 . . . . 0.65000000000000002 110.067 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 t -57.23 -39.61 75.86 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.52 0.513 . . . . 0.56999999999999995 111.859 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -39.56 82.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.536 -0.728 . . . . 0.56999999999999995 110.476 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.2 51.1 0.52 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 123.877 0.751 . . . . 0.56999999999999995 112.079 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 tpp -99.84 -55.82 2.55 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.069 0.935 . . . . 0.56999999999999995 111.018 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.64 167.6 21.77 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.288 -1.125 . . . . 0.56999999999999995 110.288 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -74.06 178.08 5.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.995 0.902 . . . . 0.65000000000000002 111.465 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -145.26 -173.46 4.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 108.531 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 82.26 1.64 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.162 -1.792 . . . . 0.56999999999999995 106.162 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -151.36 145.26 17.78 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.456 -0.942 . . . . 0.66000000000000003 108.456 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.77 -9.25 21.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 113.269 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.01 9.51 13.69 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 110.749 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 134.56 39.99 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 109.171 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.07 -28.24 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.59 -0.444 . . . . 0.56999999999999995 110.148 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 37.1 mmt -66.01 -12.2 53.43 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.681 1.593 . . . . 0.56999999999999995 113.589 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -50.69 124.87 20.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.318 0.963 . . . . 0.56999999999999995 110.589 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.58 175.21 9.09 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.018 2.479 . . . . 0.56999999999999995 110.783 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER 52.13 -158.7 0.12 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 111.864 -174.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 131.21 41.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.99 -1.485 . . . . 0.56999999999999995 106.99 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -157.5 -120.9 0.64 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.125 -1.59 . . . . 0.56999999999999995 109.125 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -64.75 0.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.318 1.047 . . . . 0.56999999999999995 110.934 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 34.44 -140.6 0.12 Allowed Glycine 0 C--N 1.345 1.079 0 C-N-CA 126.277 1.894 . . . . 0.56999999999999995 113.198 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.634 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 37.5 t0 178.71 77.13 0.15 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 128.134 2.573 . . . . 0.66000000000000003 106.467 168.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.08 35.86 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.515 2.81 . . . . 0.56999999999999995 113.554 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -132.0 -47.87 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 109.89 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.634 ' ND2' ' HD2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -160.99 43.5 0.17 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.063 0.945 . . . . 0.56999999999999995 111.304 -171.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -40.3 -54.52 2.37 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.202 1.001 . . . . 0.56999999999999995 111.972 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 55.53 156.03 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.966 1.306 . . . . 0.56999999999999995 111.075 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp -65.88 116.74 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.907 -1.146 . . . . 0.56999999999999995 107.907 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.8 m -82.2 -91.51 0.07 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.41 0.684 . . . . 0.56999999999999995 112.226 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -134.49 -51.97 0.81 Allowed 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.853 -1.546 . . . . 0.56999999999999995 107.465 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -45.4 -44.22 11.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.55 1.523 . . . . 0.66000000000000003 113.823 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.55 -63.59 1.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.055 2.142 . . . . 0.66000000000000003 110.9 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.06 -41.39 92.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 108.699 -0.852 . . . . 0.56999999999999995 108.699 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -59.33 -44.84 92.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 108.942 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.95 -56.16 26.65 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.972 -1.251 . . . . 0.56999999999999995 109.972 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 mm -55.51 -51.15 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 117.88 0.84 . . . . 0.56999999999999995 111.8 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.25 -18.72 64.62 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 111.34 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -87.87 -20.84 25.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 111.89 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.47 -43.84 9.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.918 . . . . 0.56999999999999995 111.669 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 126.285 1.834 . . . . 0.56999999999999995 111.333 -174.903 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 N--CA 1.453 -0.888 0 N-CA-C 110.729 -0.527 . . . . 0.56999999999999995 110.729 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 76.21 107.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.378 1.871 . . . . 0.56999999999999995 109.302 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -52.13 -70.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 113.94 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m 173.88 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.406 2.282 . . . . 0.56999999999999995 108.434 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t -102.5 161.98 13.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.213 1.005 . . . . 0.56999999999999995 109.938 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -5.51 40.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.945 0.898 . . . . 0.56999999999999995 113.36 168.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.35 143.56 39.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.241 -1.392 . . . . 0.56999999999999995 107.241 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -128.95 146.61 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.36 -1.348 . . . . 0.56999999999999995 107.36 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 p -94.84 137.21 34.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.679 -0.86 . . . . 0.56999999999999995 108.679 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -125.54 152.56 44.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.668 -0.645 . . . . 0.56999999999999995 109.309 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -154.57 113.88 3.7 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.352 0.596 . . . . 1.2 110.011 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.03 82.61 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 107.161 -1.422 . . . . 0.56999999999999995 107.161 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 m -56.11 -41.61 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.994 1.318 . . . . 0.56999999999999995 112.922 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -124.39 153.97 41.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.37 -2.826 . . . . 0.56999999999999995 103.37 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -131.23 158.05 41.59 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 107.293 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -61.93 172.92 1.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.05 0.929 . . . . 0.56999999999999995 111.624 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 -33.8 5.14 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.659 1.183 . . . . 1.2 112.262 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.41 -33.87 76.97 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.43 0.559 . . . . 0.66000000000000003 109.997 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.32 154.78 62.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.971 1.709 . . . . 0.56999999999999995 109.873 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.24 161.91 25.82 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.96 2.44 . . . . 0.56999999999999995 113.049 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -40.25 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.307 1.043 . . . . 0.65000000000000002 113.135 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.53 -33.85 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.342 0.257 . . . . 0.56999999999999995 111.037 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.8 m -71.59 -43.96 65.31 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.402 -0.809 . . . . 0.56999999999999995 109.359 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.69 -48.07 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 117.559 -1.21 . . . . 0.56999999999999995 110.048 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.65 -35.07 79.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.896 1.225 . . . . 0.66000000000000003 111.81 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -61.19 -51.06 70.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.557 1.071 . . . . 1.2 110.92 173.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.76 -45.36 93.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.447 -0.787 . . . . 0.56999999999999995 109.111 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.66 -45.1 98.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-O 118.196 -0.907 . . . . 0.56999999999999995 110.737 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 m -58.61 -47.74 83.34 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 109.858 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.53 73.24 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.976 -0.535 . . . . 0.56999999999999995 110.911 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.0 -47.55 84.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.99 1.316 . . . . 0.56999999999999995 111.983 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 mp -69.78 -32.13 70.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 118.577 -0.725 . . . . 0.56999999999999995 109.693 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -63.59 -33.37 75.45 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.089 0.859 . . . . 0.56999999999999995 111.319 170.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.0 mtp -68.68 -42.73 77.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.649 1.113 . . . . 0.56999999999999995 110.98 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -62.91 -51.75 65.72 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.503 1.047 . . . . 0.56999999999999995 110.336 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.59 -10.92 61.53 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.654 1.597 . . . . 0.56999999999999995 113.959 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -61.8 -30.87 71.1 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.449 1.125 . . . . 0.56999999999999995 110.38 170.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -101.45 -31.04 11.1 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.69 0.796 . . . . 0.66000000000000003 111.271 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.8 pt -115.66 126.08 28.09 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.662 0.785 . . . . 0.56999999999999995 110.382 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.49 46.2 1.38 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.762 2.975 . . . . 0.56999999999999995 112.941 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tt -103.3 141.96 35.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.672 1.989 . . . . 0.56999999999999995 107.484 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -123.85 169.33 11.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.913 0.885 . . . . 0.65000000000000002 108.996 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.49 149.87 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.63 -1.294 . . . . 0.56999999999999995 109.154 -173.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.93 36.72 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.43 1.092 . . . . 1.2 109.202 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.53 99.02 6.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.52 158.18 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.415 -0.587 . . . . 0.56999999999999995 109.415 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.52 23.17 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 110.953 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.21 75.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.93 1.292 . . . . 0.56999999999999995 109.087 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.25 168.74 16.32 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.005 0.812 . . . . 0.56999999999999995 111.575 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 p -64.72 171.89 3.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.806 1.242 . . . . 0.56999999999999995 110.033 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.96 175.24 8.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.596 0.713 . . . . 0.56999999999999995 109.626 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -68.95 -40.55 78.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.857 -0.61 . . . . 0.66000000000000003 109.372 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -119.8 87.31 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 108.0 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -83.91 120.66 26.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.814 1.246 . . . . 0.56999999999999995 108.286 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.58 128.97 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 106.36 -1.719 . . . . 0.56999999999999995 106.36 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.13 162.68 26.78 Favored Glycine 0 C--O 1.222 -0.6 0 N-CA-C 111.695 -0.562 . . . . 0.56999999999999995 111.695 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -134.54 141.63 46.75 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.009 -1.849 . . . . 0.56999999999999995 106.009 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.47 -173.49 4.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.86 1.664 . . . . 0.56999999999999995 109.635 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.42 52.52 2.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.173 0.989 . . . . 1.2 110.55 -175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.4 -120.97 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.45 138.28 55.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.273 -0.545 . . . . 0.56999999999999995 110.569 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.59 -63.03 0.85 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.116 -0.945 . . . . 0.65000000000000002 110.687 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.78 57.39 0.02 OUTLIER Glycine 0 C--N 1.341 0.834 0 CA-C-N 119.231 0.923 . . . . 0.56999999999999995 112.474 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -126.33 -67.31 0.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.69 1.196 . . . . 0.66000000000000003 109.094 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.67 -30.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.353 2.661 . . . . 0.56999999999999995 110.156 -175.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.26 98.71 20.42 Favored Pre-proline 0 C--N 1.347 0.47 0 N-CA-C 108.51 -0.922 . . . . 0.56999999999999995 108.51 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.14 139.42 55.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 120.881 1.054 . . . . 0.56999999999999995 109.424 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.41 174.37 7.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.584 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -95.27 -40.9 9.32 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.574 1.95 . . . . 0.66000000000000003 111.898 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.62 -139.15 13.32 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 120.366 1.439 . . . . 0.56999999999999995 111.969 -168.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -81.64 94.42 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.128 2.552 . . . . 0.56999999999999995 110.567 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.65 174.46 22.43 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.132 1.825 . . . . 0.56999999999999995 111.708 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.3 t30 47.39 -138.71 0.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 120.972 -1.31 . . . . 0.56999999999999995 112.817 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -51.73 124.8 13.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.874 2.07 . . . . 0.56999999999999995 111.207 173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.81 -31.12 11.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.56999999999999995 113.015 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.3 159.19 33.72 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.466 1.106 . . . . 0.56999999999999995 108.091 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.492 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -145.1 154.93 43.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.29 0.567 . . . . 0.65000000000000002 111.007 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.14 148.01 44.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.11 -1.07 . . . . 0.56999999999999995 108.11 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.38 150.22 25.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.14 -1.059 . . . . 0.56999999999999995 108.14 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.39 153.66 92.0 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 109.961 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.73 165.09 30.78 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.579 1.52 . . . . 0.56999999999999995 111.969 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 -70.8 0.15 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.652 -1.779 . . . . 0.56999999999999995 108.652 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -173.52 144.02 1.09 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.257 -1.386 . . . . 0.56999999999999995 107.257 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.15 -130.21 24.12 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.537 1.065 . . . . 0.56999999999999995 111.615 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 95' ' ' ASP . 2.4 tp -51.89 -26.48 10.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 112.345 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.17 143.67 8.74 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.191 -0.943 . . . . 0.56999999999999995 111.633 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.1 -22.3 2.01 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.162 1.839 . . . . 0.56999999999999995 114.553 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.413 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 55.4 m-20 -70.49 157.69 37.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.787 1.294 . . . . 0.66000000000000003 108.305 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.96 148.41 31.71 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.242 0.544 . . . . 0.56999999999999995 109.63 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -132.02 160.5 35.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.65000000000000002 109.282 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -141.82 146.61 36.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.879 1.272 . . . . 0.56999999999999995 108.155 -171.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.78 103.83 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.922 -1.14 . . . . 0.66000000000000003 107.922 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.77 -23.01 64.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.848 1.659 . . . . 0.66000000000000003 111.395 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -65.38 -37.17 86.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.703 1.601 . . . . 0.66000000000000003 110.157 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.0 133.39 48.96 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.327 -1.731 . . . . 0.66000000000000003 106.327 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -54.94 151.89 8.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 118.905 -0.569 . . . . 1.2 109.72 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -133.93 135.88 43.87 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.749 -1.574 . . . . 0.56999999999999995 106.749 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -132.52 140.77 48.47 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.494 -1.299 . . . . 0.56999999999999995 107.494 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -57.16 -51.37 69.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.711 0.805 . . . . 0.66000000000000003 109.396 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.45 56.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.889 -1.284 . . . . 0.56999999999999995 109.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 t -154.71 164.31 38.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.656 -0.868 . . . . 0.56999999999999995 108.656 173.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -76.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.502 2.321 . . . . 0.56999999999999995 112.589 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -178.77 171.88 1.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.256 2.223 . . . . 0.56999999999999995 107.348 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 123.85 -146.95 16.52 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.56999999999999995 110.422 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 pt -116.65 119.55 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 109.113 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -61.77 117.71 6.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.188 -0.914 . . . . 0.56999999999999995 109.615 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.16 -40.05 96.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.319 1.448 . . . . 0.56999999999999995 110.848 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -42.81 79.75 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.096 -1.076 . . . . 0.56999999999999995 108.096 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -66.07 -47.61 73.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.021 0.828 . . . . 0.56999999999999995 110.036 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.33 -50.09 70.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 123.531 0.52 . . . . 0.56999999999999995 110.581 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.97 -57.88 10.0 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 117.908 -1.044 . . . . 0.56999999999999995 109.74 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -55.82 -37.69 69.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 111.333 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.97 -57.12 14.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.529 1.132 . . . . 0.65000000000000002 110.518 173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 15.0 mm-40 -72.72 -44.52 61.61 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.605 -0.684 . . . . 0.66000000000000003 111.248 -171.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.2 -29.0 68.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 111.036 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.34 -47.11 90.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.55 -1.02 . . . . 0.56999999999999995 110.55 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -70.16 -36.29 74.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.255 -0.879 . . . . 0.65000000000000002 112.191 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 p -57.74 -33.48 68.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.316 0.507 . . . . 0.56999999999999995 111.251 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -36.34 79.81 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 112.493 0.553 . . . . 0.56999999999999995 112.493 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 162.11 50.08 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 CA-C-O 117.993 -1.449 . . . . 0.56999999999999995 113.271 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.73 -158.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.949 1.299 . . . . 0.56999999999999995 112.024 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.08 62.6 0.22 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.091 -1.604 . . . . 0.56999999999999995 109.091 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 169.62 17.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.675 0.75 . . . . 0.65000000000000002 109.624 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -157.15 -179.99 8.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.701 1.2 . . . . 0.56999999999999995 107.91 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t -144.17 78.16 1.57 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.771 -1.566 . . . . 0.56999999999999995 106.771 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -131.08 145.91 59.81 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 106.545 -1.65 . . . . 0.66000000000000003 106.545 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.71 -26.72 75.4 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.165 1.91 . . . . 0.56999999999999995 112.427 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -125.11 29.37 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.572 1.549 . . . . 0.56999999999999995 109.685 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.06 129.16 39.56 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 109.08 -0.711 . . . . 0.56999999999999995 109.08 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.56 -17.5 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 111.646 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 22.5 13.98 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.307 1.843 . . . . 0.56999999999999995 110.326 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.24 123.97 78.38 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 119.999 1.272 . . . . 0.56999999999999995 110.292 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.7 48.3 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.728 2.952 . . . . 0.56999999999999995 112.661 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -148.36 -45.48 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 110.373 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.3 t80 56.7 95.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.768 1.627 . . . . 0.56999999999999995 112.305 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.41 -73.7 0.03 OUTLIER Glycine 0 C--N 1.346 1.101 0 O-C-N 120.751 -1.218 . . . . 0.56999999999999995 115.706 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -35.52 61.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.503 1.151 . . . . 0.56999999999999995 112.375 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.7 152.0 13.59 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.59 -1.004 . . . . 0.56999999999999995 110.59 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.83 105.51 51.29 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 107.467 -1.309 . . . . 0.66000000000000003 107.467 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.6 57.4 6.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.564 2.843 . . . . 0.56999999999999995 109.92 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.5 -48.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.655 -0.653 . . . . 0.56999999999999995 110.481 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -77.49 50.66 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.261 1.424 . . . . 0.56999999999999995 110.886 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -41.86 -82.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 112.917 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 43.91 22.82 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.16 2.584 . . . . 0.56999999999999995 113.489 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 42.93 90.45 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.724 2.81 . . . . 0.56999999999999995 111.222 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.9 t -56.12 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 114.46 -170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -142.35 -46.24 0.33 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.424 1.09 . . . . 0.56999999999999995 109.311 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.18 -51.56 10.4 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.886 1.274 . . . . 0.66000000000000003 111.427 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -48.14 75.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.44 0.696 . . . . 0.66000000000000003 111.964 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.4 mm -62.55 -46.57 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.886 0.874 . . . . 0.56999999999999995 109.178 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -63.48 -44.1 95.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.049 1.339 . . . . 0.56999999999999995 109.096 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.76 -62.59 6.14 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.1 -1.2 . . . . 0.56999999999999995 110.1 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 mm -52.67 -48.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.518 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -65.79 -28.53 69.07 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.436 -0.79 . . . . 0.56999999999999995 111.875 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.2 -20.23 35.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.959 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.97 -45.39 24.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.064 0.946 . . . . 0.56999999999999995 110.982 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -171.333 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 CA-C-O 121.077 0.365 . . . . 0.56999999999999995 111.263 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 77.92 -11.24 1.23 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.253 1.421 . . . . 0.56999999999999995 112.252 -174.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.6 m95 60.92 19.2 9.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.813 1.188 . . . . 0.56999999999999995 113.055 -168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m 68.47 -43.07 0.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.23 1.812 . . . . 0.56999999999999995 112.811 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 t -75.91 -178.15 4.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 111.079 173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -10.29 20.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.541 1.137 . . . . 0.56999999999999995 111.865 168.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -127.13 146.3 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 177.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.33 156.69 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 125.586 1.554 . . . . 0.56999999999999995 107.06 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.7 p -108.46 138.12 45.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.275 -1.009 . . . . 0.56999999999999995 108.275 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -126.59 143.21 51.29 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.075 -1.016 . . . . 0.56999999999999995 108.725 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -150.66 110.94 4.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.755 0.788 . . . . 1.2 108.993 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 mt -80.6 95.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 105.874 -1.898 . . . . 0.56999999999999995 105.874 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -69.82 -36.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.06 1.344 . . . . 0.56999999999999995 112.557 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -130.04 158.38 39.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.129 -2.545 . . . . 0.56999999999999995 104.129 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -133.45 175.99 8.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.188 1.395 . . . . 0.56999999999999995 108.154 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -87.23 -154.68 0.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.847 0.859 . . . . 0.56999999999999995 109.258 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -132.31 -28.8 1.65 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 116.412 -1.756 . . . . 1.2 115.074 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.82 -47.89 84.29 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.263 1.392 . . . . 0.66000000000000003 110.696 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.52 158.11 35.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.344 1.458 . . . . 0.56999999999999995 109.199 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -77.54 156.44 32.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.79 1.66 . . . . 0.56999999999999995 112.672 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -59.87 -35.37 74.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.712 1.205 . . . . 0.65000000000000002 113.514 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.69 -37.29 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 110.34 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -69.51 -39.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 116.965 -1.493 . . . . 0.56999999999999995 109.313 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.18 -56.84 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.761 1.619 . . . . 0.56999999999999995 109.773 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.37 -41.4 97.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.959 -0.543 . . . . 0.66000000000000003 111.323 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.65 -45.1 80.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.674 0.67 . . . . 1.2 111.904 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.24 -41.07 86.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.32 0.648 . . . . 0.56999999999999995 109.413 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.1 -50.09 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 117.511 -1.233 . . . . 0.56999999999999995 109.504 168.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -46.51 75.21 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 121.454 1.934 . . . . 0.56999999999999995 110.946 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.58 -35.05 79.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.743 0.701 . . . . 0.56999999999999995 112.335 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.71 -47.54 62.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.459 1.104 . . . . 0.56999999999999995 112.605 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.52 -31.36 70.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.135 1.374 . . . . 0.56999999999999995 109.514 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -59.77 -38.88 83.07 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.221 -0.895 . . . . 0.56999999999999995 110.226 168.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 37.2 mtm -67.47 -33.98 76.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.265 1.393 . . . . 0.56999999999999995 112.123 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 9.4 m95 -66.24 -54.58 23.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.07 0.85 . . . . 0.56999999999999995 110.269 170.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.62 -4.01 43.99 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.806 1.193 . . . . 0.56999999999999995 113.616 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -69.01 -25.92 64.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.685 1.242 . . . . 0.56999999999999995 110.346 172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.26 -15.4 13.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.218 1.007 . . . . 0.66000000000000003 111.553 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 pt -131.5 140.66 39.09 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 119.466 1.03 . . . . 0.56999999999999995 109.204 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.8 9.1 1.4 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.715 2.277 . . . . 0.56999999999999995 112.963 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.48 135.03 46.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 108.348 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -125.27 -179.76 4.73 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.25 1.02 . . . . 0.65000000000000002 109.663 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.54 157.07 44.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.158 -0.682 . . . . 0.56999999999999995 109.158 -171.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 154.46 49.15 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.346 1.458 . . . . 1.2 110.121 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -114.56 109.31 18.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.086 -1.079 . . . . 0.56999999999999995 108.086 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.02 161.05 4.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.494 -0.558 . . . . 0.56999999999999995 109.494 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.61 -53.14 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 118.767 -0.635 . . . . 0.56999999999999995 110.524 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 165.88 58.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.292 2.237 . . . . 0.56999999999999995 111.749 -172.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.09 38.85 1.7 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.752 -1.218 . . . . 0.56999999999999995 113.588 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m 64.97 142.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.59 1.956 . . . . 0.56999999999999995 110.28 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.18 168.03 20.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.773 0.796 . . . . 0.56999999999999995 109.288 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -65.72 -45.02 84.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.582 -1.19 . . . . 0.66000000000000003 108.545 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -112.34 81.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.051 1.74 . . . . 0.56999999999999995 107.658 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -78.11 118.73 20.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.029 -1.1 . . . . 0.56999999999999995 108.029 168.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.28 130.57 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.787 -1.931 . . . . 0.56999999999999995 105.787 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.81 161.54 28.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.428 -0.669 . . . . 0.56999999999999995 111.428 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.3 m-85 -132.02 143.35 50.01 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.881 -1.526 . . . . 0.56999999999999995 106.881 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.02 179.98 6.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.433 1.493 . . . . 0.56999999999999995 109.186 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -141.15 57.47 1.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.319 -0.623 . . . . 1.2 109.319 -171.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.04 -58.55 0.66 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.627 1.108 . . . . 0.56999999999999995 111.889 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.86 155.01 45.91 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.684 0.794 . . . . 0.56999999999999995 109.279 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -157.76 147.25 19.95 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.037 0.935 . . . . 0.65000000000000002 109.127 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 74.63 1.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.371 -1.491 . . . . 0.56999999999999995 109.371 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.74 -92.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.614 1.565 . . . . 0.66000000000000003 107.169 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.9 p -158.92 -38.19 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.8 1.24 . . . . 0.56999999999999995 110.024 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.88 131.42 23.99 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 109.541 -0.54 . . . . 0.56999999999999995 109.541 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.0 137.08 43.36 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.036 -1.563 . . . . 0.56999999999999995 108.036 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -158.22 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 123.622 1.677 . . . . 0.56999999999999995 109.233 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 23.9 p-10 -136.78 -22.64 1.22 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 130.205 3.402 . . . . 0.66000000000000003 109.058 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 -141.43 26.42 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.079 -1.208 . . . . 0.56999999999999995 110.079 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.06 95.21 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.965 3.11 . . . . 0.56999999999999995 110.855 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.27 -176.15 21.89 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.622 -0.991 . . . . 0.56999999999999995 110.622 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.496 ' HB3' ' HD2' ' A' ' 76' ' ' ASP 0.25 31.8 t30 46.85 -135.72 0.88 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.451 1.5 . . . . 0.56999999999999995 114.092 173.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -61.86 125.52 24.14 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.274 2.23 . . . . 0.56999999999999995 110.909 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -82.48 -30.13 30.13 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.289 -1.507 . . . . 0.56999999999999995 113.734 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.1 166.84 25.22 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.374 1.07 . . . . 0.56999999999999995 109.377 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.08 163.93 32.13 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.799 -0.563 . . . . 0.65000000000000002 109.783 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.44 155.24 40.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.958 1.303 . . . . 0.56999999999999995 109.3 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.78 163.61 13.12 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.774 0.671 . . . . 0.56999999999999995 110.11 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.4 153.92 83.96 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.7 -0.667 . . . . 0.56999999999999995 109.946 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.93 155.59 70.09 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.955 2.436 . . . . 0.56999999999999995 112.176 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.81 -118.41 0.55 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.289 -1.925 . . . . 0.56999999999999995 108.289 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 m -151.59 106.57 3.28 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 104.667 -2.345 . . . . 0.56999999999999995 104.667 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.67 -132.57 10.51 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 117.483 -1.732 . . . . 0.56999999999999995 109.301 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -31.13 12.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.662 1.585 . . . . 0.56999999999999995 112.809 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -45.96 144.27 3.73 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.72 -0.552 . . . . 0.56999999999999995 111.72 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.44 -18.81 0.71 Allowed Glycine 0 C--N 1.337 0.61 0 C-N-CA 126.546 2.022 . . . . 0.56999999999999995 116.738 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -68.1 155.51 39.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.785 -1.191 . . . . 0.66000000000000003 107.785 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.58 29.89 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.371 -0.832 . . . . 0.56999999999999995 108.96 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.93 159.27 35.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.196 -0.911 . . . . 0.65000000000000002 109.156 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.454 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 28.9 m-85 -144.56 154.74 43.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.566 1.546 . . . . 0.56999999999999995 108.095 -170.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.06 99.15 12.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.672 0.389 . . . . 0.66000000000000003 110.28 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.97 -28.14 49.31 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.741 -1.224 . . . . 0.66000000000000003 111.977 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -54.67 -38.52 67.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.592 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.79 151.14 37.6 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.881 1.272 . . . . 0.66000000000000003 109.844 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -80.13 125.21 29.53 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.712 -1.243 . . . . 1.2 109.709 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -107.17 166.05 10.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.832 0.853 . . . . 0.56999999999999995 109.118 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -158.8 164.4 35.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 109.438 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -65.01 -48.03 75.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.326 0.65 . . . . 0.66000000000000003 110.237 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.61 40.25 0.02 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.149 -0.806 . . . . 0.56999999999999995 112.777 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -77.36 32.61 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.02 1.41 . . . . 0.56999999999999995 113.827 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.1 m 53.51 35.09 19.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 113.559 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -160.66 -175.16 4.81 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.551 1.54 . . . . 0.56999999999999995 108.622 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.37 -144.76 24.32 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 124.237 0.922 . . . . 0.56999999999999995 112.033 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -120.67 113.47 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.821 -1.548 . . . . 0.56999999999999995 106.821 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -61.08 110.48 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.148 0.979 . . . . 0.56999999999999995 111.304 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.21 -42.98 99.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.507 1.123 . . . . 0.56999999999999995 111.355 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -55.11 22.77 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.86 -1.163 . . . . 0.56999999999999995 107.86 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.47 -43.25 94.81 Favored 'General case' 0 CA--C 1.526 0.02 0 C-N-CA 122.949 0.499 . . . . 0.56999999999999995 111.004 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.2 70.82 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.085 0.554 . . . . 0.56999999999999995 110.906 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.1 -55.66 31.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.191 -0.909 . . . . 0.56999999999999995 109.607 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 m -53.93 -38.72 65.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 111.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.96 -59.29 4.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.252 0.621 . . . . 0.65000000000000002 109.788 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -64.69 -46.71 81.19 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.232 0.469 . . . . 0.66000000000000003 111.104 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.01 -31.48 71.86 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.4 1.08 . . . . 0.56999999999999995 112.103 177.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.406 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -55.87 -41.89 84.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.219 -0.752 . . . . 0.56999999999999995 111.219 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -72.33 -36.33 68.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.062 -0.971 . . . . 0.65000000000000002 111.81 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -56.37 -36.33 68.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.283 0.947 . . . . 0.56999999999999995 112.293 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.87 -21.04 66.43 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.611 1.096 . . . . 0.56999999999999995 112.942 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.33 -54.59 0.28 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 124.343 0.973 . . . . 0.56999999999999995 110.895 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.74 176.89 0.09 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.38 2.272 . . . . 0.56999999999999995 107.7 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.4 70.65 0.02 OUTLIER Glycine 0 C--O 1.218 -0.874 0 N-CA-C 107.152 -2.379 . . . . 0.56999999999999995 107.152 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 162.11 27.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.425 1.112 . . . . 0.65000000000000002 108.651 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 t -157.95 -161.89 1.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.984 1.314 . . . . 0.56999999999999995 108.388 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -152.74 58.43 0.8 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.119 1.768 . . . . 0.56999999999999995 109.288 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -143.44 135.16 12.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 117.037 -1.458 . . . . 0.66000000000000003 108.751 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.37 41.92 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.051 1 C-N-CA 125.981 4.454 . . . . 0.56999999999999995 114.041 -174.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -154.02 -27.15 0.13 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 127.931 2.492 . . . . 0.56999999999999995 111.566 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -50.7 133.35 25.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.96 -25.44 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.852 -0.53 . . . . 0.56999999999999995 110.745 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -109.63 28.61 8.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 111.49 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -50.5 128.69 25.35 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 120.698 -1.251 . . . . 0.56999999999999995 110.054 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.35 168.1 24.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.995 2.463 . . . . 0.56999999999999995 110.542 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.4 m 62.0 70.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.871 0.759 . . . . 0.56999999999999995 110.552 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -41.18 123.68 2.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.856 1.662 . . . . 0.56999999999999995 112.115 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.1 -111.42 0.33 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.909 -1.277 . . . . 0.56999999999999995 109.909 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -50.44 -39.97 49.16 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.667 0.988 . . . . 0.56999999999999995 113.667 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.85 89.14 0.01 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.225 1.869 . . . . 0.56999999999999995 112.115 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.99 107.91 1.06 Allowed Pre-proline 0 C--N 1.344 0.349 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 109.987 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -72.19 -25.17 19.22 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.37 1.38 . . . . 0.56999999999999995 112.145 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.9 2.42 38.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.448 -0.787 . . . . 0.56999999999999995 110.941 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.65 75.47 1.66 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.223 1.809 . . . . 0.56999999999999995 108.418 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.11 -64.98 0.64 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 113.291 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 22.61 77.55 0.02 OUTLIER 'General case' 0 C--N 1.343 0.296 0 C-N-CA 129.279 3.032 . . . . 0.56999999999999995 112.657 174.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 mp -38.26 97.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.571 2.348 . . . . 0.56999999999999995 109.97 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 m -74.13 -87.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.558 0.743 . . . . 0.56999999999999995 112.546 -162.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -137.5 -28.02 0.92 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 116.779 -1.581 . . . . 0.56999999999999995 110.248 168.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.17 -54.11 50.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.154 1.797 . . . . 0.66000000000000003 111.299 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -62.68 -53.11 59.36 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 109.799 -0.445 . . . . 0.66000000000000003 109.799 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.12 -40.62 83.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 123.865 0.866 . . . . 0.56999999999999995 109.112 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -64.95 -43.03 94.02 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.823 -1.085 . . . . 0.56999999999999995 110.653 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.48 -61.63 7.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.373 -1.491 . . . . 0.56999999999999995 109.373 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.0 mm -53.47 -47.2 59.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.383 1.473 . . . . 0.56999999999999995 112.748 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.14 -31.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.037 0.535 . . . . 0.56999999999999995 111.017 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -29.61 64.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.702 0.683 . . . . 0.56999999999999995 111.183 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.59 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.482 -0.77 . . . . 0.56999999999999995 109.709 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.65 0.611 . . . . 0.56999999999999995 112.65 -171.794 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.455 -0.738 0 N-CA-C 109.668 -0.935 . . . . 0.56999999999999995 109.668 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 pttt 85.73 151.26 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.239 2.615 . . . . 0.56999999999999995 108.937 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -65.76 170.11 5.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.265 1.026 . . . . 0.56999999999999995 109.938 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 m -62.05 -29.66 70.45 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 120.94 -1.1 . . . . 0.56999999999999995 111.252 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.6 t -97.62 156.87 16.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 112.163 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -75.1 -6.08 47.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.682 1.593 . . . . 0.56999999999999995 112.754 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.63 151.94 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.523 -0.918 . . . . 0.56999999999999995 108.523 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 150.16 33.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.047 -1.094 . . . . 0.56999999999999995 108.047 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.8 p -104.54 136.78 43.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.605 -0.887 . . . . 0.56999999999999995 108.605 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -118.79 163.2 17.23 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.801 0.84 . . . . 0.56999999999999995 110.481 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.37 160.45 41.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.046 -1.094 . . . . 1.2 108.046 169.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.6 mt -123.2 94.25 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 103.663 -2.717 . . . . 0.56999999999999995 103.663 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 m -73.29 -30.68 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.593 0.357 . . . . 0.56999999999999995 111.263 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -142.63 147.27 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.161 -2.163 . . . . 0.56999999999999995 105.161 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -131.9 159.19 39.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.357 1.063 . . . . 0.56999999999999995 109.207 -166.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -91.74 -175.52 4.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.876 1.27 . . . . 0.56999999999999995 109.437 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.61 -26.3 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.128 1.159 . . . . 1.2 114.128 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -59.19 -40.68 86.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.265 0.626 . . . . 0.66000000000000003 110.305 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.65 152.57 80.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 128.767 2.827 . . . . 0.56999999999999995 110.248 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.31 161.19 28.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.962 2.441 . . . . 0.56999999999999995 114.453 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.82 -39.05 93.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.833 1.653 . . . . 0.65000000000000002 112.027 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 tt -65.89 -35.96 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.424 0.69 . . . . 0.56999999999999995 110.794 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -66.39 -46.62 76.03 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 116.703 -1.617 . . . . 0.56999999999999995 108.723 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.56 -52.54 25.78 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.568 1.531 . . . . 0.56999999999999995 110.043 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -63.04 -42.49 99.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 110.955 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -63.32 -46.88 84.63 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.95 . . . . 1.2 112.062 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.15 -45.61 87.72 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.239 -0.886 . . . . 0.56999999999999995 109.022 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -46.75 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 124.267 1.027 . . . . 0.56999999999999995 109.574 172.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -46.06 89.47 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.047 0.839 . . . . 0.56999999999999995 110.95 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -63.67 -42.95 98.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.912 1.285 . . . . 0.56999999999999995 112.033 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.29 75.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.094 1.357 . . . . 0.56999999999999995 111.447 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.92 -34.19 77.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.607 -0.711 . . . . 0.56999999999999995 110.258 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -40.76 85.38 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.262 0.937 . . . . 0.56999999999999995 110.613 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 39.4 mtm -63.85 -38.93 92.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.047 0.84 . . . . 0.56999999999999995 111.293 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -64.29 -49.67 70.87 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.26 0.936 . . . . 0.56999999999999995 111.405 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.16 -9.08 66.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.913 1.244 . . . . 0.56999999999999995 113.174 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -23.77 63.08 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.506 1.653 . . . . 0.56999999999999995 110.864 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -105.85 -14.03 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.258 1.023 . . . . 0.66000000000000003 111.706 -171.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.36 149.56 60.92 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.636 1.174 . . . . 0.56999999999999995 111.445 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.37 10.32 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.313 2.675 . . . . 0.56999999999999995 113.018 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.26 133.9 35.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.736 1.615 . . . . 0.56999999999999995 107.513 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.12 170.88 10.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.002 0.921 . . . . 0.65000000000000002 110.006 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.08 146.16 31.73 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.426 -0.953 . . . . 0.56999999999999995 108.426 -172.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -143.6 166.53 24.58 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.875 1.27 . . . . 1.2 109.242 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -105.37 143.35 33.66 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.86 -0.793 . . . . 0.56999999999999995 108.86 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.66 157.01 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.71 0.404 . . . . 0.56999999999999995 110.98 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.86 -43.81 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.779 0.832 . . . . 0.56999999999999995 111.509 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -176.64 146.98 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.97 2.908 . . . . 0.56999999999999995 104.622 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.18 -116.87 3.07 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.523 -0.631 . . . . 0.56999999999999995 111.523 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 43.9 p -132.88 164.64 26.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.635 1.974 . . . . 0.56999999999999995 108.556 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.51 21.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.126 0.97 . . . . 0.56999999999999995 110.121 -174.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -63.01 -33.08 74.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.611 0.764 . . . . 0.66000000000000003 109.806 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.3 mt -123.53 76.94 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.068 2.147 . . . . 0.56999999999999995 108.235 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -73.22 110.75 7.74 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.737 1.615 . . . . 0.56999999999999995 108.519 167.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.91 128.13 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 104.568 -2.382 . . . . 0.56999999999999995 104.568 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.62 148.9 19.07 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 110.111 -1.196 . . . . 0.56999999999999995 110.111 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -113.38 167.28 10.7 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 118.299 1.05 . . . . 0.56999999999999995 108.594 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.58 155.28 43.57 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.513 1.125 . . . . 0.56999999999999995 108.162 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -105.13 110.03 22.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.521 -1.289 . . . . 1.2 107.521 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.73 -46.95 2.4 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.015 -1.436 . . . . 0.56999999999999995 113.665 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.53 165.53 36.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.554 1.677 . . . . 0.56999999999999995 111.56 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.13 162.51 33.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.411 1.085 . . . . 0.65000000000000002 111.777 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.57 58.62 3.0 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.798 1.665 . . . . 0.56999999999999995 112.307 -174.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.99 -52.71 2.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.561 0.745 . . . . 0.66000000000000003 111.276 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 t 174.73 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 110.65 -167.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -122.54 114.16 30.28 Favored Pre-proline 0 C--N 1.347 0.471 0 C-N-CA 123.388 0.675 . . . . 0.56999999999999995 109.538 -170.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 28.88 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.941 2.427 . . . . 0.56999999999999995 112.552 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 41.96 -136.3 0.27 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 111.326 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 21.7 p-10 -162.77 -40.46 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.779 2.432 . . . . 0.66000000000000003 108.449 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.39 -153.91 21.98 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.687 -1.365 . . . . 0.56999999999999995 109.687 -170.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.77 101.98 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.096 3.198 . . . . 0.56999999999999995 113.561 -167.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.88 -178.79 17.05 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 109.839 -1.304 . . . . 0.56999999999999995 109.839 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 4.6 t30 49.14 -145.01 0.42 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.195 0.997 . . . . 0.56999999999999995 112.428 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.3 m -46.5 110.68 0.3 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.374 2.27 . . . . 0.56999999999999995 112.577 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -83.83 -34.12 24.75 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.259 -0.9 . . . . 0.56999999999999995 113.041 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.84 167.62 29.82 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 109.382 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -150.98 150.44 30.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.876 -0.515 . . . . 0.65000000000000002 110.053 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.95 163.2 32.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 109.628 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.31 140.3 49.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.007 -1.109 . . . . 0.56999999999999995 108.007 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.09 160.07 3.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.56999999999999995 112.444 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.6 152.87 74.46 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.538 2.158 . . . . 0.56999999999999995 111.183 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.17 -78.57 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -172.21 -49.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.584 1.154 . . . . 0.56999999999999995 109.497 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.69 -101.99 2.73 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.218 -1.153 . . . . 0.56999999999999995 110.218 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -27.18 68.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.048 0.939 . . . . 0.56999999999999995 111.828 175.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.54 146.77 15.67 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.148 -0.97 . . . . 0.56999999999999995 111.411 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 -21.37 4.24 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.579 2.037 . . . . 0.56999999999999995 114.506 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -74.76 160.14 31.1 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.975 1.388 . . . . 0.66000000000000003 108.891 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.09 139.86 20.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.3 -169.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -132.77 149.52 52.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.437 0.695 . . . . 0.65000000000000002 110.6 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -142.07 146.88 35.95 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 -166.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -86.55 103.89 15.48 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.02 0.914 . . . . 0.66000000000000003 109.277 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.65 -15.54 62.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.316 1.446 . . . . 0.66000000000000003 111.374 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -69.56 -20.58 63.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.436 1.016 . . . . 0.66000000000000003 110.267 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -85.38 158.91 20.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 110.325 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.27 138.66 35.73 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -131.47 144.84 51.45 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -138.48 153.07 48.79 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.14 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -97.18 11.57 35.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.626 2.371 . . . . 0.66000000000000003 110.741 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.74 -134.31 2.98 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.81 1.672 . . . . 0.56999999999999995 111.674 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 t -143.33 171.5 14.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.309 1.444 . . . . 0.56999999999999995 108.713 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 t 51.76 42.9 30.25 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.892 1.441 . . . . 0.56999999999999995 114.892 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.56 -38.59 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 119.914 -1.741 . . . . 0.56999999999999995 113.542 -172.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.35 -154.9 10.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 108.587 -1.805 . . . . 0.56999999999999995 108.587 -172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.94 119.51 34.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 108.289 -1.004 . . . . 0.56999999999999995 108.289 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -63.98 103.56 0.61 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.945 0.498 . . . . 0.56999999999999995 109.675 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.24 -36.35 65.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.874 1.27 . . . . 0.56999999999999995 110.645 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -65.44 -48.35 73.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.849 -0.797 . . . . 0.56999999999999995 108.849 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.52 -39.07 93.47 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.558 -0.904 . . . . 0.56999999999999995 108.558 -176.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.56 -56.3 22.97 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.58 0.752 . . . . 0.56999999999999995 110.999 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.25 58.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.137 0.575 . . . . 0.56999999999999995 109.71 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.7 m -58.73 -44.02 90.35 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.173 0.897 . . . . 0.56999999999999995 111.732 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.66 -52.03 67.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.034 0.534 . . . . 0.65000000000000002 109.723 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.23 -48.66 72.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.466 1.106 . . . . 0.66000000000000003 110.393 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.14 -29.12 69.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 126.113 1.765 . . . . 0.56999999999999995 111.534 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -45.32 96.27 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.691 -0.564 . . . . 0.56999999999999995 111.691 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -62.32 -39.76 94.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 117.213 -1.375 . . . . 0.65000000000000002 109.911 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -60.44 -29.1 68.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.825 1.193 . . . . 0.56999999999999995 113.774 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -25.22 57.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 112.71 172.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.89 -1.63 4.29 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.808 1.194 . . . . 0.56999999999999995 114.5 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.43 164.68 20.5 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.951 1.375 . . . . 0.56999999999999995 113.678 -166.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.38 166.49 12.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.227 1.394 . . . . 0.56999999999999995 109.755 172.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -68.37 174.35 4.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.195 0.998 . . . . 0.65000000000000002 112.558 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.08 179.83 7.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.735 1.614 . . . . 0.56999999999999995 108.519 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.08 71.55 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.826 2.05 . . . . 0.56999999999999995 107.51 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -136.72 140.49 32.13 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 107.668 -1.234 . . . . 0.66000000000000003 107.668 176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.34 -26.32 41.53 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.456 2.104 . . . . 0.56999999999999995 112.317 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.2 22.87 14.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.981 1.313 . . . . 0.56999999999999995 109.991 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.61 124.42 21.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.258 -1.016 . . . . 0.56999999999999995 108.258 166.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.93 -31.03 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 109.871 166.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -84.51 8.54 16.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.94 1.089 . . . . 0.56999999999999995 113.94 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -56.78 130.85 78.43 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.652 1.569 . . . . 0.56999999999999995 110.565 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 150.01 26.53 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.197 1.931 . . . . 0.56999999999999995 110.27 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.8 m 73.12 156.42 0.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 111.545 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.79 132.73 53.88 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.252 1.021 . . . . 0.56999999999999995 109.55 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 141.62 97.51 0.29 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.511 1.053 . . . . 0.56999999999999995 110.53 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.25 -43.23 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.659 1.229 . . . . 0.56999999999999995 113.443 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.66 -177.22 48.39 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.862 -1.695 . . . . 0.56999999999999995 108.862 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -51.7 111.56 2.52 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.579 1.552 . . . . 0.66000000000000003 110.969 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -3.86 12.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.21 1.94 . . . . 0.56999999999999995 112.304 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -73.7 -9.99 59.23 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.706 1.139 . . . . 0.56999999999999995 112.91 168.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -62.61 -6.58 3.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.721 1.749 . . . . 0.56999999999999995 115.721 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 19.77 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.346 3.058 . . . . 0.56999999999999995 116.83 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt 20.39 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.677 3.191 . . . . 0.56999999999999995 112.859 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 mp -26.11 106.09 0.03 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 127.876 2.471 . . . . 0.56999999999999995 110.165 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.8 t -81.67 -87.54 0.09 Allowed 'General case' 0 C--N 1.343 0.316 0 O-C-N 123.853 0.721 . . . . 0.56999999999999995 110.147 -160.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.75 -37.5 0.45 Allowed 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.252 -1.356 . . . . 0.56999999999999995 109.376 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -47.85 -49.32 29.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.205 1.366 . . . . 0.66000000000000003 110.571 171.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -77.57 -54.15 6.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.66000000000000003 109.746 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mm -57.68 -45.64 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.76 0.709 . . . . 0.56999999999999995 111.079 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -44.16 79.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 109.565 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.43 -51.25 58.87 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.123 -1.191 . . . . 0.56999999999999995 110.123 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -60.22 -51.97 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.456 1.102 . . . . 0.56999999999999995 110.223 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.08 -25.28 61.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.877 0.762 . . . . 0.56999999999999995 112.498 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -43.79 18.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.577 -1.201 . . . . 0.56999999999999995 110.064 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.25 -56.67 6.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.666 2.386 . . . . 0.56999999999999995 111.624 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 p90 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 119.02 -0.514 . . . . 0.56999999999999995 112.143 -179.539 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.45 -1.085 0 N-CA-C 110.187 -0.736 . . . . 0.56999999999999995 110.187 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.5 111.55 0.07 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.48 1.912 . . . . 0.56999999999999995 111.288 -174.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -58.02 152.29 16.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.996 0.918 . . . . 0.56999999999999995 111.436 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.4 p -77.47 -20.69 54.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.56999999999999995 112.764 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -94.19 142.41 27.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.236 1.415 . . . . 0.56999999999999995 109.325 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -10.62 59.7 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.406 1.482 . . . . 0.56999999999999995 112.577 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.87 109.91 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.614 -1.995 . . . . 0.56999999999999995 105.614 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.02 159.0 4.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.607 -1.627 . . . . 0.56999999999999995 106.607 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 p -106.96 139.8 40.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.277 -0.638 . . . . 0.56999999999999995 109.277 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -128.08 157.37 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.409 -0.807 . . . . 0.56999999999999995 110.092 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -158.48 115.88 2.88 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.057 0.456 . . . . 1.2 110.361 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.65 90.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 106.623 -1.621 . . . . 0.56999999999999995 106.623 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.12 -25.46 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.408 -1.432 . . . . 0.56999999999999995 113.901 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -147.6 154.72 41.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 103.241 -2.874 . . . . 0.56999999999999995 103.241 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -135.78 43.95 2.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.756 0.707 . . . . 0.56999999999999995 110.148 -164.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.45 ' HB ' ' CD2' ' A' ' 64' ' ' PHE . 15.4 t 47.73 -153.98 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.779 1.232 . . . . 0.56999999999999995 110.186 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -22.79 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.54 -0.743 . . . . 1.2 112.784 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -64.04 -39.72 94.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.04 0.836 . . . . 0.66000000000000003 111.536 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.19 150.7 57.41 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 109.062 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.28 159.67 40.09 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.82 2.347 . . . . 0.56999999999999995 113.011 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -59.53 -36.78 76.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.98 1.312 . . . . 0.65000000000000002 113.689 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -39.3 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.185 0.448 . . . . 0.56999999999999995 110.039 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -69.74 -46.39 66.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.297 -1.335 . . . . 0.56999999999999995 109.475 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.4 -48.14 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.985 1.721 . . . . 0.56999999999999995 110.403 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.72 -45.67 91.65 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 119.019 0.827 . . . . 0.66000000000000003 110.781 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -40.54 94.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.8 1.182 . . . . 1.2 113.189 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.23 -47.77 63.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.04 1.336 . . . . 0.56999999999999995 109.235 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.2 -37.84 70.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.375 0.989 . . . . 0.56999999999999995 110.809 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.0 t -61.49 -56.75 16.61 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.227 1.011 . . . . 0.56999999999999995 109.95 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -62.34 -32.72 73.54 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.353 1.433 . . . . 0.56999999999999995 112.338 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.95 62.0 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.451 1.1 . . . . 0.56999999999999995 112.316 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.62 -31.16 70.99 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 118.228 -0.891 . . . . 0.56999999999999995 110.165 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -59.85 -43.57 94.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.901 -1.047 . . . . 0.56999999999999995 109.609 171.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.1 mtp -61.31 -45.26 95.18 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 111.733 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -60.48 -47.75 84.77 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.085 1.311 . . . . 0.56999999999999995 111.565 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.57 -17.01 68.37 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.64 1.114 . . . . 0.56999999999999995 113.071 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -29.57 70.73 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.478 -1.013 . . . . 0.56999999999999995 110.182 174.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.91 -32.26 13.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.72 -0.657 . . . . 0.66000000000000003 111.808 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.89 132.87 24.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.757 0.823 . . . . 0.56999999999999995 110.659 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.34 35.7 0.4 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 124.111 3.208 . . . . 0.56999999999999995 113.991 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -78.81 146.26 33.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.718 1.607 . . . . 0.56999999999999995 107.85 174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -130.59 160.17 34.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.02 1.328 . . . . 0.65000000000000002 108.191 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 149.87 43.97 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 120.927 -1.108 . . . . 0.56999999999999995 108.26 -173.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -137.18 170.33 16.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.926 0.89 . . . . 1.2 109.357 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -117.33 128.22 54.83 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.14 163.23 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.95 1.3 . . . . 0.56999999999999995 110.444 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.36 -60.21 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 109.895 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -164.57 154.12 13.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.415 2.686 . . . . 0.56999999999999995 105.616 167.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.05 17.79 1.42 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.433 1.333 . . . . 0.56999999999999995 116.433 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.6 m 68.0 159.04 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 111.021 -168.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -131.82 177.26 7.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 109.071 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.86 -34.97 79.36 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.921 0.488 . . . . 0.66000000000000003 109.946 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mt -126.84 82.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.139 -1.8 . . . . 0.56999999999999995 106.139 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.47 140.21 44.44 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.208 -0.932 . . . . 0.56999999999999995 108.777 164.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.67 120.36 61.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 N-CA-C 105.705 -1.961 . . . . 0.56999999999999995 105.705 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.74 161.12 24.74 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.697 -0.561 . . . . 0.56999999999999995 111.697 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.5 m-85 -132.45 129.9 39.84 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 104.978 -2.23 . . . . 0.56999999999999995 104.978 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.1 17.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.647 1.979 . . . . 0.56999999999999995 108.223 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 ttp-105 -97.36 -14.15 21.43 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.69 0.996 . . . . 1.2 113.69 -168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.22 -44.07 0.03 OUTLIER Glycine 0 C--O 1.221 -0.669 0 CA-C-O 119.067 -0.852 . . . . 0.56999999999999995 111.034 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.57 27.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.314 1.046 . . . . 0.56999999999999995 109.143 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 -75.31 0.63 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.145 1.778 . . . . 0.65000000000000002 109.096 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.44 46.52 0.02 OUTLIER Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.594 0.616 . . . . 0.56999999999999995 112.371 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 -172.46 2.05 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.832 1.653 . . . . 0.66000000000000003 108.098 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.1 -36.73 2.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.56999999999999995 113.322 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.8 101.3 6.49 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.332 -0.988 . . . . 0.56999999999999995 108.332 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.52 155.26 67.37 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.412 1.408 . . . . 0.56999999999999995 111.155 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.03 177.23 3.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.53 1.157 . . . . 0.56999999999999995 111.734 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.0 -26.6 8.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.828 3.251 . . . . 0.66000000000000003 111.798 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.57 -146.0 18.06 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 120.89 1.677 . . . . 0.56999999999999995 112.632 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.5 82.28 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 0.56999999999999995 113.753 -172.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -165.02 35.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.984 1.754 . . . . 0.56999999999999995 111.743 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 t30 38.41 -129.65 0.22 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.364 2.266 . . . . 0.56999999999999995 115.755 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.2 m -65.67 131.26 45.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.153 2.181 . . . . 0.56999999999999995 109.135 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.17 -27.15 13.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 113.496 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.91 159.69 32.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.153 -1.425 . . . . 0.56999999999999995 107.153 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.89 157.1 43.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.65000000000000002 109.553 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.72 155.13 43.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.519 1.128 . . . . 0.56999999999999995 108.709 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.97 143.73 42.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.522 -0.918 . . . . 0.56999999999999995 108.522 -175.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.09 151.72 33.44 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 118.122 -0.942 . . . . 0.56999999999999995 110.193 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.15 155.52 64.44 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.678 1.585 . . . . 0.56999999999999995 112.014 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.72 174.7 14.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.81 1.195 . . . . 0.56999999999999995 110.733 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.257 7.1 t 43.52 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.049 1.74 . . . . 0.56999999999999995 113.055 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.51 -53.06 2.69 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.945 -0.92 . . . . 0.56999999999999995 111.178 172.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.16 -35.27 80.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.089 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.0 153.62 30.15 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.889 -1.132 . . . . 0.56999999999999995 111.007 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.61 -21.48 1.96 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.204 1.383 . . . . 0.56999999999999995 114.091 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -74.72 155.07 38.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 120.138 1.969 . . . . 0.66000000000000003 108.614 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.29 26.02 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.507 -0.769 . . . . 0.56999999999999995 109.487 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -132.82 162.33 31.8 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.65000000000000002 109.248 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.464 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.5 m-85 -143.03 155.44 44.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.732 1.613 . . . . 0.56999999999999995 108.718 -171.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.63 96.29 7.85 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.552 -1.277 . . . . 0.66000000000000003 107.552 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.13 -32.76 68.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.068 1.747 . . . . 0.66000000000000003 111.74 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.74 -32.27 73.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.423 -0.584 . . . . 0.66000000000000003 109.423 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.88 124.01 23.33 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.276 1.03 . . . . 0.66000000000000003 109.471 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -54.48 131.06 41.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.301 1.04 . . . . 1.2 109.745 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.38 149.07 39.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.658 -1.238 . . . . 0.56999999999999995 107.658 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -145.1 149.3 34.8 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.508 -0.745 . . . . 0.56999999999999995 109.185 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.35 -39.25 75.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.385 0.538 . . . . 0.66000000000000003 110.728 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.87 -35.47 0.1 OUTLIER Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.367 -0.685 . . . . 0.56999999999999995 112.866 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.1 m -54.91 137.64 45.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.293 1.037 . . . . 0.56999999999999995 111.633 174.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -56.12 110.44 0.75 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 111.936 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -32.88 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 111.804 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.98 -146.21 5.5 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 108.06 -2.016 . . . . 0.56999999999999995 108.06 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.39 135.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.727 1.211 . . . . 0.56999999999999995 109.523 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.71 103.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.896 0.878 . . . . 0.56999999999999995 110.623 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.05 -41.39 74.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.085 2.154 . . . . 0.56999999999999995 110.817 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 tp -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.088 -0.708 . . . . 0.56999999999999995 109.088 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -57.93 -48.86 78.68 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.719 0.807 . . . . 0.56999999999999995 109.183 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.54 -57.05 14.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.464 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -51.37 70.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.512 -0.756 . . . . 0.56999999999999995 110.333 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.1 m -56.75 -41.21 77.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 110.904 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -67.12 -52.89 36.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.348 0.659 . . . . 0.65000000000000002 110.306 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.03 -41.92 94.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.9 0.773 . . . . 0.66000000000000003 111.037 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.06 -27.91 66.06 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.275 0.63 . . . . 0.56999999999999995 110.734 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.05 -44.01 88.28 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 118.855 0.752 . . . . 0.56999999999999995 111.398 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -68.33 -39.56 81.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.18 -0.914 . . . . 0.65000000000000002 112.067 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 p -65.05 -26.94 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 123.688 0.617 . . . . 0.56999999999999995 111.955 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -44.18 85.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 0.56999999999999995 111.08 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 168.84 41.64 0.03 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.411 -1.216 . . . . 0.56999999999999995 115.128 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.7 mmt 54.39 -167.17 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.665 1.232 . . . . 0.56999999999999995 111.072 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.8 24.44 0.34 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.17 -1.35 . . . . 0.56999999999999995 114.917 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 163.69 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.402 1.601 . . . . 0.65000000000000002 113.013 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.2 178.97 9.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 109.235 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.5 m -147.52 75.7 1.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.165 1.786 . . . . 0.56999999999999995 106.815 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.38 143.04 41.8 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.703 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.72 3.73 3.05 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.257 2.638 . . . . 0.56999999999999995 114.725 -169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -135.67 -1.53 2.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 111.534 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.82 121.54 26.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.463 1.905 . . . . 0.56999999999999995 108.851 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 p -53.59 -29.06 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 120.948 1.703 . . . . 0.56999999999999995 112.422 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 39.0 mmt -65.12 -15.37 62.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.308 -1.33 . . . . 0.56999999999999995 113.854 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.34 126.55 82.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 120.726 1.603 . . . . 0.56999999999999995 109.31 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.44 -165.33 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.543 2.162 . . . . 0.56999999999999995 110.148 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m 79.92 -31.05 0.13 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.232 -1.543 . . . . 0.56999999999999995 113.015 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.3 t80 45.21 80.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.668 1.587 . . . . 0.56999999999999995 111.471 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.65 -92.04 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.587 1.565 . . . . 0.56999999999999995 112.36 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -64.94 -49.18 71.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.172 1.389 . . . . 0.56999999999999995 113.928 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.85 109.03 2.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 107.196 -2.362 . . . . 0.56999999999999995 107.196 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.5 118.66 62.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.783 1.633 . . . . 0.66000000000000003 112.218 -166.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.51 -1.47 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.97 3.113 . . . . 0.56999999999999995 113.537 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.41 -30.03 53.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.55 1.068 . . . . 0.56999999999999995 110.68 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -116.87 75.12 0.95 Allowed 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.532 -0.73 . . . . 0.56999999999999995 109.305 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -126.31 145.88 50.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.284 0.634 . . . . 0.56999999999999995 110.929 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 52.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 111.157 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp 56.92 73.94 0.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.218 1.407 . . . . 0.56999999999999995 111.458 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -61.5 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 C-N-CA 124.932 1.293 . . . . 0.56999999999999995 113.645 -168.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -144.52 -50.85 0.28 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 116.621 -1.656 . . . . 0.56999999999999995 108.429 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -42.73 -48.29 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.95 1.7 . . . . 0.66000000000000003 112.994 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -49.52 62.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.953 0.901 . . . . 0.66000000000000003 109.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.39 -40.83 82.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 118.23 -0.89 . . . . 0.56999999999999995 108.95 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -40.25 97.04 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.989 1.315 . . . . 0.56999999999999995 109.281 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.66 -55.55 29.89 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.235 -1.146 . . . . 0.56999999999999995 110.235 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -62.3 -47.84 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.32 1.06 . . . . 0.56999999999999995 112.481 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.25 -11.86 60.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.749 1.22 . . . . 0.56999999999999995 111.92 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -80.46 -51.81 8.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.279 0.945 . . . . 0.56999999999999995 108.666 164.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.42 -51.44 68.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.977 . . . . 0.56999999999999995 112.301 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 124.153 0.981 . . . . 0.56999999999999995 109.634 -176.676 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 CA-C-O 118.723 -0.615 . . . . 0.56999999999999995 110.649 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.6 102.93 0.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 108.958 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -51.2 148.15 4.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.476 0.711 . . . . 0.56999999999999995 110.866 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -59.24 -33.14 70.65 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 112.344 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 t -82.66 146.42 29.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.552 0.691 . . . . 0.56999999999999995 109.326 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -19.01 61.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.387 0.675 . . . . 0.56999999999999995 111.528 170.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 136.52 52.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.006 -1.109 . . . . 0.56999999999999995 108.006 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.62 157.74 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.399 1.88 . . . . 0.56999999999999995 108.417 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.7 p -113.18 138.4 50.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.071 -1.085 . . . . 0.56999999999999995 108.071 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -126.06 153.56 44.28 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.756 0.423 . . . . 0.56999999999999995 110.199 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -154.26 119.55 5.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.28 89.03 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 105.542 -2.021 . . . . 0.56999999999999995 105.542 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -47.88 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 112.428 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.49 145.37 41.99 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.522 -2.029 . . . . 0.56999999999999995 105.522 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.42 143.55 51.14 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 109.031 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -69.84 -172.64 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.696 1.599 . . . . 0.56999999999999995 110.542 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -136.73 -29.37 0.94 Allowed 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.479 0.918 . . . . 1.2 113.479 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -53.96 -36.55 62.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.406 1.082 . . . . 0.66000000000000003 110.702 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.29 154.57 73.91 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 110.252 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 151.44 46.71 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.68 2.253 . . . . 0.56999999999999995 112.925 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -60.58 -39.44 88.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.502 1.521 . . . . 0.65000000000000002 113.324 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.2 tt -64.13 -36.38 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 119.202 -0.428 . . . . 0.56999999999999995 110.597 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -67.55 -39.17 84.99 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 116.87 -1.538 . . . . 0.56999999999999995 109.972 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.9 -52.98 51.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 120.069 1.304 . . . . 0.56999999999999995 109.922 172.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -61.54 -39.54 91.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.343 0.52 . . . . 0.66000000000000003 111.001 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -61.71 -47.1 86.78 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.399 -0.813 . . . . 1.2 112.402 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -38.2 78.52 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 123.959 0.903 . . . . 0.56999999999999995 110.269 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.49 -44.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.117 -1.068 . . . . 0.56999999999999995 108.117 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.87 -48.86 74.81 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.823 1.192 . . . . 0.56999999999999995 110.903 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -40.59 75.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.943 1.247 . . . . 0.56999999999999995 112.134 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.4 98.6 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.56999999999999995 111.294 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 49.8 mt -72.4 -31.61 65.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.146 -0.93 . . . . 0.56999999999999995 111.114 176.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.87 -40.86 94.54 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.37 0.986 . . . . 0.56999999999999995 109.602 169.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -64.09 -33.74 76.45 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.548 -0.72 . . . . 0.56999999999999995 112.577 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.4 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 5.8 m95 -71.72 -47.3 54.8 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.275 0.943 . . . . 0.56999999999999995 111.261 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.56 2.17 32.42 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.165 1.364 . . . . 0.56999999999999995 113.62 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -22.68 61.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.346 -1.091 . . . . 0.56999999999999995 111.242 172.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.7 -39.75 5.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.516 -0.754 . . . . 0.66000000000000003 110.397 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 19.2 pt -101.94 135.27 19.73 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 119.427 1.012 . . . . 0.56999999999999995 110.58 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.73 40.55 0.56 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.314 2.676 . . . . 0.56999999999999995 112.628 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -101.66 134.49 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.651 1.58 . . . . 0.56999999999999995 107.63 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -130.16 170.44 14.05 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.512 0.725 . . . . 0.65000000000000002 109.652 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -137.59 158.37 44.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.843 -0.799 . . . . 0.56999999999999995 108.843 -168.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -146.93 157.83 43.75 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.61 1.164 . . . . 1.2 110.36 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.3 105.81 14.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 108.452 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.08 157.34 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.767 -1.106 . . . . 0.56999999999999995 109.729 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 m -92.87 31.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 110.913 -174.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.02 155.59 45.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 109.747 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.96 34.71 2.13 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.999 1.285 . . . . 0.56999999999999995 114.091 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.1 m -150.65 132.63 15.18 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 106.101 -1.815 . . . . 0.56999999999999995 106.101 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.61 174.09 13.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.047 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 -31.46 66.16 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.863 -0.589 . . . . 0.66000000000000003 110.391 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 mm -123.25 67.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.328 2.251 . . . . 0.56999999999999995 107.847 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.87 116.9 10.79 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.615 -1.254 . . . . 0.56999999999999995 107.615 169.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.59 129.97 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.482 -2.414 . . . . 0.56999999999999995 104.482 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.88 150.45 22.23 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.222 -0.924 . . . . 0.56999999999999995 111.543 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.18 143.9 51.15 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.27 -0.641 . . . . 0.56999999999999995 109.27 -171.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.03 166.78 24.03 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 124.74 1.216 . . . . 0.56999999999999995 109.658 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -94.19 -29.55 15.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.526 0.565 . . . . 1.2 112.526 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.5 -38.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.787 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 112.06 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.1 49.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 108.797 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -156.98 155.18 30.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.347 1.059 . . . . 0.65000000000000002 109.182 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.28 57.63 2.82 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.99 1.757 . . . . 0.56999999999999995 112.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.24 -82.43 0.62 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.56 1.544 . . . . 0.66000000000000003 109.079 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.76 -29.35 0.01 OUTLIER 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.506 1.122 . . . . 0.56999999999999995 110.527 -171.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.46 120.92 11.67 Favored Pre-proline 0 C--N 1.343 0.305 0 N-CA-C 107.929 -1.137 . . . . 0.56999999999999995 107.929 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.6 144.22 77.92 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.894 -1.233 . . . . 0.56999999999999995 108.894 169.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.68 -171.11 0.09 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.393 1.477 . . . . 0.56999999999999995 111.077 166.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.499 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 20.4 p-10 -118.77 -33.21 4.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.693 2.797 . . . . 0.66000000000000003 110.32 -169.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.22 -150.91 19.66 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.556 1.071 . . . . 0.56999999999999995 111.146 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.96 102.45 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 125.008 3.805 . . . . 0.56999999999999995 111.968 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.38 12.99 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.244 1.878 . . . . 0.56999999999999995 109.329 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 4.9 t30 58.45 -156.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.734 1.214 . . . . 0.56999999999999995 111.752 -175.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 m -39.66 116.56 0.64 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.927 2.491 . . . . 0.56999999999999995 113.337 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.07 -33.16 29.97 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.143 -1.598 . . . . 0.56999999999999995 112.676 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.99 166.62 29.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.438 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -144.47 163.31 34.21 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.992 0.517 . . . . 0.65000000000000002 110.058 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.69 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.642 0.777 . . . . 0.56999999999999995 109.804 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.93 152.12 32.88 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.732 -0.667 . . . . 0.56999999999999995 109.33 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.36 151.61 90.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.657 -0.687 . . . . 0.56999999999999995 109.761 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.06 162.63 40.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.183 1.922 . . . . 0.56999999999999995 111.452 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.42 -109.52 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.824 -2.111 . . . . 0.56999999999999995 107.824 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -152.27 118.75 5.64 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.635 -1.617 . . . . 0.56999999999999995 106.635 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 -131.74 10.76 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.4 -1.08 . . . . 0.56999999999999995 110.4 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 tp -51.22 -28.25 11.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.126 1.37 . . . . 0.56999999999999995 112.711 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.79 145.17 8.76 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.614 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.83 -24.27 3.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.032 1.301 . . . . 0.56999999999999995 113.719 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.87 155.94 39.81 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.473 1.137 . . . . 0.66000000000000003 108.45 -172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.09 140.74 34.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.934 -0.765 . . . . 0.56999999999999995 108.934 -173.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -128.28 153.13 47.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.604 -0.725 . . . . 0.65000000000000002 109.568 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.05 153.76 44.45 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.651 -1.24 . . . . 0.56999999999999995 107.651 -173.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -92.37 100.64 13.17 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.608 -0.724 . . . . 0.66000000000000003 109.31 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -21.89 66.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.138 0.975 . . . . 0.66000000000000003 112.151 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.16 -23.49 63.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.38 0.991 . . . . 0.66000000000000003 110.153 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -80.93 130.13 34.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.654 -1.239 . . . . 0.66000000000000003 107.654 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 147.6 4.35 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.335 1.054 . . . . 1.2 111.006 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -140.95 147.2 38.42 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.298 -1.001 . . . . 0.56999999999999995 108.298 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -148.82 139.5 22.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.15 13.68 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.831 1.196 . . . . 0.66000000000000003 111.553 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.03 -87.48 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 108.091 -2.004 . . . . 0.56999999999999995 108.091 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.08 -67.12 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.301 2.24 . . . . 0.56999999999999995 113.608 -176.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -175.43 -48.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.855 1.662 . . . . 0.56999999999999995 110.778 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -142.18 158.2 44.01 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.554 1.541 . . . . 0.56999999999999995 108.993 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.53 178.66 15.86 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 109.787 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.1 mm -80.45 102.89 6.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.241 -1.022 . . . . 0.56999999999999995 108.241 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -50.97 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.925 1.69 . . . . 0.56999999999999995 110.655 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -65.61 -29.18 69.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.985 1.714 . . . . 0.56999999999999995 110.389 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -48.27 68.8 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.684 -1.598 . . . . 0.56999999999999995 106.684 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.17 -47.49 84.27 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.483 0.713 . . . . 0.56999999999999995 110.721 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.38 -49.45 76.15 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 122.745 0.418 . . . . 0.56999999999999995 110.933 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.99 63.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 109.085 -0.709 . . . . 0.56999999999999995 109.085 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -55.7 -39.28 70.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.022 0.828 . . . . 0.56999999999999995 111.344 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -60.76 -59.88 4.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.324 0.65 . . . . 0.65000000000000002 110.209 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.49 -42.37 95.9 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.177 0.898 . . . . 0.66000000000000003 111.692 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.92 -26.96 67.11 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.136 1.375 . . . . 0.56999999999999995 111.293 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.4 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.31 -41.88 93.27 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.29 -0.724 . . . . 0.56999999999999995 111.29 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -73.01 -37.78 66.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.459 -1.258 . . . . 0.65000000000000002 112.259 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 p -59.06 -31.58 69.0 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 124.101 0.875 . . . . 0.56999999999999995 111.851 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.89 82.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.328 0.651 . . . . 0.56999999999999995 111.752 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 160.51 43.08 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.06 -0.856 . . . . 0.56999999999999995 114.488 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 176.63 0.1 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 117.883 0.842 . . . . 0.56999999999999995 111.925 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.09 46.12 0.01 OUTLIER Glycine 0 C--N 1.342 0.912 0 O-C-N 120.943 -1.098 . . . . 0.56999999999999995 112.903 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.8 169.7 13.93 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.361 1.081 . . . . 0.65000000000000002 110.4 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.6 t -161.65 -164.19 1.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.013 0.925 . . . . 0.56999999999999995 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.07 57.26 0.59 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.897 1.279 . . . . 0.56999999999999995 110.517 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -120.73 146.4 43.43 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.66000000000000003 109.463 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -21.63 63.59 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.839 2.359 . . . . 0.56999999999999995 113.056 -171.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -125.14 27.45 6.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.444 1.897 . . . . 0.56999999999999995 109.602 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.89 124.61 24.18 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.145 -0.972 . . . . 0.56999999999999995 108.916 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.05 -22.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 121.528 0.68 . . . . 0.56999999999999995 110.461 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 19.08 18.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.098 1.759 . . . . 0.56999999999999995 112.233 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.499 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.44 141.42 94.48 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.17 1.35 . . . . 0.56999999999999995 111.288 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 70.8 Cg_endo -75.63 46.02 1.58 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 124.212 3.275 . . . . 0.56999999999999995 113.007 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.29 153.14 7.71 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.77 2.428 . . . . 0.56999999999999995 106.476 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -47.96 137.59 9.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.023 1.329 . . . . 0.56999999999999995 111.265 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -47.14 99.75 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.705 1.621 . . . . 0.56999999999999995 113.542 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.23 -37.41 77.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.063 1.345 . . . . 0.56999999999999995 112.221 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.98 -85.87 0.95 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.27 0.938 . . . . 0.56999999999999995 110.936 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.69 109.36 2.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.711 -0.848 . . . . 0.66000000000000003 108.711 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.96 -16.4 18.18 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.807 2.338 . . . . 0.56999999999999995 113.534 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -38.86 62.74 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.962 1.305 . . . . 0.56999999999999995 109.125 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -77.57 74.08 4.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.79 0.836 . . . . 0.56999999999999995 110.905 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -43.7 -70.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.791 1.637 . . . . 0.56999999999999995 114.554 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.64 74.53 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.512 3.125 . . . . 0.56999999999999995 112.071 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -30.93 111.78 0.08 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.529 2.331 . . . . 0.56999999999999995 110.777 -176.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 t -83.87 -99.71 0.05 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.181 0.301 . . . . 0.56999999999999995 111.074 -166.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -127.75 -49.93 1.37 Allowed 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 117.216 -1.373 . . . . 0.56999999999999995 109.443 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -44.07 -45.11 7.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.014 1.326 . . . . 0.66000000000000003 112.116 169.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -66.43 -54.8 20.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 123.728 0.642 . . . . 0.66000000000000003 109.995 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -37.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.418 0.687 . . . . 0.56999999999999995 110.727 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -65.95 -45.41 81.89 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.664 1.586 . . . . 0.56999999999999995 108.504 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.93 -51.02 61.21 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.204 -1.158 . . . . 0.56999999999999995 110.204 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -56.46 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.488 1.115 . . . . 0.56999999999999995 111.136 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.74 -24.46 67.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.112 0.869 . . . . 0.56999999999999995 111.517 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -37.02 36.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.25 -0.881 . . . . 0.56999999999999995 110.889 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -54.7 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.661 1.585 . . . . 0.56999999999999995 110.942 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.407 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 19.3 p90 . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 123.854 0.862 . . . . 0.56999999999999995 113.159 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 111.021 -0.415 . . . . 0.56999999999999995 111.021 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt 72.03 100.8 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.242 1.417 . . . . 0.56999999999999995 109.715 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -53.08 157.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.045 0.938 . . . . 0.56999999999999995 111.755 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.3 p -67.58 -19.54 65.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.875 1.27 . . . . 0.56999999999999995 112.083 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -109.67 144.53 37.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.68 1.992 . . . . 0.56999999999999995 108.75 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -12.39 61.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.304 1.442 . . . . 0.56999999999999995 113.167 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.75 134.1 67.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.799 -1.926 . . . . 0.56999999999999995 105.799 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.48 155.15 19.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.23 1.412 . . . . 0.56999999999999995 108.621 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 p -106.54 141.22 38.18 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.912 -0.493 . . . . 0.56999999999999995 109.774 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -132.75 158.24 42.91 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.596 -0.69 . . . . 0.56999999999999995 111.0 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.42 163.15 40.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.687 0.795 . . . . 1.2 109.149 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.9 mt -127.93 105.08 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.199 -2.149 . . . . 0.56999999999999995 105.199 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.85 -57.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.106 . . . . 0.56999999999999995 112.385 -169.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -177.14 4.76 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.195 -1.409 . . . . 0.56999999999999995 107.195 164.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -144.58 152.03 39.93 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.314 -0.995 . . . . 0.56999999999999995 108.314 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -62.37 165.35 6.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.314 0.578 . . . . 0.56999999999999995 110.938 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -100.25 -47.09 5.07 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.841 -0.618 . . . . 1.2 112.053 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.78 -32.61 73.81 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.031 0.532 . . . . 0.66000000000000003 110.387 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.96 153.71 52.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.96 1.704 . . . . 0.56999999999999995 109.652 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.57 161.29 37.3 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.145 1.897 . . . . 0.56999999999999995 113.182 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.33 -40.6 94.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.659 1.184 . . . . 0.65000000000000002 112.89 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.98 -35.95 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 119.181 -0.438 . . . . 0.56999999999999995 111.155 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m -67.36 -45.65 75.69 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 117.688 -1.149 . . . . 0.56999999999999995 109.264 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.25 -49.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 117.646 -1.169 . . . . 0.56999999999999995 110.699 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.16 -35.93 82.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.1 1.318 . . . . 0.66000000000000003 111.364 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -43.4 89.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.289 1.404 . . . . 1.2 112.524 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.95 -48.34 76.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.592 -0.892 . . . . 0.56999999999999995 108.592 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.0 -41.63 89.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.719 -1.134 . . . . 0.56999999999999995 111.021 173.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -58.48 -53.11 62.02 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.548 1.522 . . . . 0.56999999999999995 110.056 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -36.06 78.52 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.679 1.127 . . . . 0.56999999999999995 111.054 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.64 76.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.76 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.38 -36.17 83.18 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 118.213 -0.898 . . . . 0.56999999999999995 110.163 172.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -49.05 76.82 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 118.899 0.772 . . . . 0.56999999999999995 109.153 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.401 ' HB3' HD13 ' A' ' 152' ' ' LEU . 50.4 mtp -61.73 -35.91 79.44 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.544 0.738 . . . . 0.56999999999999995 111.498 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -68.61 -50.59 50.34 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.56999999999999995 112.369 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.25 -8.09 69.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.885 1.231 . . . . 0.56999999999999995 112.99 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -75.17 -8.31 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.214 -1.168 . . . . 0.56999999999999995 111.765 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -109.54 -15.32 14.22 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.842 0.746 . . . . 0.66000000000000003 112.259 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt -142.58 148.75 48.03 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.52 1.128 . . . . 0.56999999999999995 111.019 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.89 18.69 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.714 2.943 . . . . 0.56999999999999995 113.286 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.91 138.22 35.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.16 1.784 . . . . 0.56999999999999995 107.314 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.95 170.31 11.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.766 0.826 . . . . 0.65000000000000002 109.217 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.35 150.85 45.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.271 -1.381 . . . . 0.56999999999999995 107.271 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.85 149.42 46.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.866 -0.79 . . . . 1.2 108.866 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -107.24 129.26 54.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.031 -1.47 . . . . 0.56999999999999995 107.031 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.43 171.84 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.533 1.133 . . . . 0.56999999999999995 109.823 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.45 -38.77 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.769 0.828 . . . . 0.56999999999999995 110.651 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -167.25 74.63 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.888 1.675 . . . . 0.56999999999999995 107.694 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.35 163.06 36.84 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.511 -1.836 . . . . 0.56999999999999995 108.511 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -68.63 144.98 54.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 117.987 0.893 . . . . 0.56999999999999995 109.275 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.24 153.17 37.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 108.96 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.64 -32.97 72.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.772 0.429 . . . . 0.66000000000000003 110.069 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -121.01 80.97 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 127.513 2.325 . . . . 0.56999999999999995 107.871 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 ttm -78.02 111.85 14.33 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.805 1.242 . . . . 0.56999999999999995 107.956 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 127.66 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.052 -1.832 . . . . 0.56999999999999995 106.052 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.62 162.85 25.52 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.226 -0.75 . . . . 0.56999999999999995 111.226 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -126.95 141.42 51.81 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.29 -1.744 . . . . 0.56999999999999995 106.29 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.18 169.17 18.71 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.098 2.159 . . . . 0.56999999999999995 106.8 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -111.02 -0.95 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.715 0.689 . . . . 1.2 112.652 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.32 -144.58 8.29 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.53 -1.828 . . . . 0.56999999999999995 108.53 -165.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.49 142.64 13.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.746 0.784 . . . . 0.56999999999999995 111.398 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -152.05 152.49 32.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.094 1.758 . . . . 0.65000000000000002 106.562 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.35 80.48 1.82 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 110.155 -1.178 . . . . 0.56999999999999995 110.155 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.6 -56.52 1.49 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.794 0.837 . . . . 0.66000000000000003 111.343 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.95 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.959 2.503 . . . . 0.56999999999999995 109.854 -167.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -147.57 123.1 5.28 Favored Pre-proline 0 C--N 1.349 0.545 0 CA-C-N 120.122 1.328 . . . . 0.56999999999999995 110.437 -173.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.75 139.32 52.04 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.188 1.259 . . . . 0.56999999999999995 110.367 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.83 -175.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.365 1.555 . . . . 0.56999999999999995 111.161 167.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 19.0 p-10 -115.12 -36.02 4.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 131.116 3.767 . . . . 0.66000000000000003 109.75 -171.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.11 -147.9 18.81 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 119.659 1.118 . . . . 0.56999999999999995 110.841 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.65 70.3 6.45 Favored 'Trans proline' 0 CA--C 1.548 1.198 1 C-N-CA 125.645 4.23 . . . . 0.56999999999999995 114.114 -171.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.41 167.07 20.43 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.409 2.909 . . . . 0.56999999999999995 109.625 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 76' ' ' ASP 0.279 19.6 t30 64.81 -143.97 0.24 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.304 1.842 . . . . 0.56999999999999995 113.503 -178.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 m -47.03 153.23 0.45 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 127.767 2.427 . . . . 0.56999999999999995 111.22 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.88 -27.47 6.18 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 112.759 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.61 158.48 26.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.01 1.324 . . . . 0.56999999999999995 107.644 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.486 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.6 p-80 -139.38 159.17 42.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.478 . . . . 0.65000000000000002 109.711 172.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.87 36.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.741 1.216 . . . . 0.56999999999999995 109.078 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.57 146.83 41.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.348 0.659 . . . . 0.56999999999999995 109.495 -177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.84 157.89 64.84 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.795 0.838 . . . . 0.56999999999999995 111.031 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.41 155.45 69.12 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.188 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.07 -111.67 0.59 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.388 0.994 . . . . 0.56999999999999995 110.891 174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.7 m -45.76 156.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.854 2.062 . . . . 0.56999999999999995 111.542 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.93 -41.97 7.68 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.174 -1.348 . . . . 0.56999999999999995 115.412 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -33.55 74.39 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.075 1.438 . . . . 0.56999999999999995 112.247 174.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.26 145.5 12.21 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.873 -1.142 . . . . 0.56999999999999995 111.498 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.86 -18.93 5.53 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 117.847 -1.529 . . . . 0.56999999999999995 114.426 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.78 156.24 36.76 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.348 1.574 . . . . 0.66000000000000003 108.045 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.06 146.05 27.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.818 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -129.81 152.28 49.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.575 -0.898 . . . . 0.65000000000000002 108.575 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -137.91 145.37 42.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 107.38 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -87.07 98.63 11.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.425 0.631 . . . . 0.66000000000000003 109.608 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -60.84 -25.61 66.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.07 1.348 . . . . 0.66000000000000003 111.85 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.39 -38.85 81.71 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.92 0.391 . . . . 0.66000000000000003 110.406 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.16 126.7 29.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.771 -1.566 . . . . 0.66000000000000003 106.771 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -59.01 147.16 35.61 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.702 -0.624 . . . . 1.2 109.473 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -124.03 158.21 32.68 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.359 -0.978 . . . . 0.56999999999999995 108.359 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.2 t -133.54 142.34 48.14 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.635 0.652 . . . . 0.56999999999999995 109.681 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.05 -46.89 72.99 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.046 1.339 . . . . 0.66000000000000003 109.275 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.96 50.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.858 -0.897 . . . . 0.56999999999999995 110.858 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -152.84 150.34 29.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.965 0.906 . . . . 0.56999999999999995 109.854 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.17 108.37 0.78 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.615 0.766 . . . . 0.56999999999999995 109.814 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -61.69 0.05 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.726 0.81 . . . . 0.56999999999999995 110.213 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.98 -111.75 1.19 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.714 -1.354 . . . . 0.56999999999999995 109.714 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 134.39 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 110.271 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.85 115.77 5.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.777 -1.102 . . . . 0.56999999999999995 109.697 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.67 -37.32 83.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.047 -0.501 . . . . 0.56999999999999995 110.895 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 -45.35 89.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.129 0.877 . . . . 0.56999999999999995 109.673 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -64.03 -42.56 97.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.384 0.674 . . . . 0.56999999999999995 110.791 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.86 67.99 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.215 0.606 . . . . 0.56999999999999995 110.516 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.43 64.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.063 -0.97 . . . . 0.56999999999999995 110.053 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.1 m -53.78 -41.74 67.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.512 1.051 . . . . 0.56999999999999995 111.46 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -61.48 -56.36 21.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.819 0.448 . . . . 0.65000000000000002 110.023 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 6.0 mm-40 -65.43 -48.08 74.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.734 0.814 . . . . 0.66000000000000003 110.963 -172.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.74 -30.77 70.99 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 125.312 1.445 . . . . 0.56999999999999995 110.968 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.68 -46.81 73.66 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.913 -0.875 . . . . 0.56999999999999995 110.913 170.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -66.27 -39.33 89.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.752 -0.642 . . . . 0.65000000000000002 111.646 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 m -57.78 -37.37 73.59 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.524 0.565 . . . . 0.56999999999999995 112.524 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.37 -27.22 68.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.737 1.153 . . . . 0.56999999999999995 112.638 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.98 -13.97 2.37 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 118.529 -1.15 . . . . 0.56999999999999995 114.285 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpp -61.79 152.25 31.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.168 1.484 . . . . 0.56999999999999995 110.295 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.56 -23.6 3.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 115.58 -2.789 . . . . 0.56999999999999995 114.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 m80 148.99 173.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 131.185 3.794 . . . . 0.65000000000000002 110.151 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -145.33 -172.77 3.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.484 2.313 . . . . 0.56999999999999995 109.607 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -147.12 67.33 1.15 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.43 1.492 . . . . 0.56999999999999995 110.761 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -133.5 149.98 73.74 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 117.306 -1.33 . . . . 0.66000000000000003 107.604 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.86 -35.96 42.01 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.927 1.752 . . . . 0.56999999999999995 111.091 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -119.01 35.23 4.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.754 1.222 . . . . 0.56999999999999995 108.394 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.62 131.98 49.71 Favored 'General case' 0 C--N 1.344 0.363 0 N-CA-C 108.156 -1.053 . . . . 0.56999999999999995 108.156 171.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 155' ' ' ASP . 8.5 p -58.7 -30.33 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.592 0.234 . . . . 0.56999999999999995 110.986 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -105.58 35.19 2.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 110.075 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -74.46 130.3 82.26 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 120.433 -1.417 . . . . 0.56999999999999995 110.875 173.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.34 168.64 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.962 1.775 . . . . 0.56999999999999995 111.056 166.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m 58.03 72.93 0.49 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.113 0.965 . . . . 0.56999999999999995 110.792 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -45.61 126.08 6.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 113.175 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.01 96.43 0.89 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.095 0.855 . . . . 0.56999999999999995 111.201 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -157.42 -49.88 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.022 0.911 . . . . 0.56999999999999995 111.03 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.88 -171.33 13.05 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 125.595 1.569 . . . . 0.56999999999999995 109.575 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.02 116.54 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 119.092 -0.48 . . . . 0.66000000000000003 110.053 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.08 -18.03 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.853 2.369 . . . . 0.56999999999999995 112.671 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.24 -36.63 83.52 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.002 0.819 . . . . 0.56999999999999995 109.936 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.15 68.87 1.23 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.342 0.657 . . . . 0.56999999999999995 109.507 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -60.04 -52.69 64.29 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.488 0.715 . . . . 0.56999999999999995 110.323 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.94 158.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.991 2.517 . . . . 0.56999999999999995 112.567 -159.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 41' ' ' MET . 5.4 mp -58.95 121.49 11.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.593 -1.262 . . . . 0.56999999999999995 107.593 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -96.83 -94.25 0.21 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.545 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -138.24 -46.44 0.51 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.08 -0.962 . . . . 0.56999999999999995 110.273 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.487 ' HD2' ' N ' ' A' ' 137' ' ' VAL . 10.5 p-10 -56.38 -34.09 66.35 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.75 0.705 . . . . 0.66000000000000003 111.02 171.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -60.18 3.77 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.571 1.148 . . . . 0.66000000000000003 110.305 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.84 -50.47 80.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.56999999999999995 107.756 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -59.3 -41.69 89.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.476 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.69 50.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.456 -1.457 . . . . 0.56999999999999995 109.456 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -53.91 -52.99 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.259 1.023 . . . . 0.56999999999999995 110.482 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -58.5 -28.63 65.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.086 -0.709 . . . . 0.56999999999999995 109.086 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -80.64 -38.9 28.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 117.921 -1.038 . . . . 0.56999999999999995 112.428 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.62 -52.06 61.08 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 112.174 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.0 p90 . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 118.487 0.585 . . . . 0.56999999999999995 112.38 179.716 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 110.751 -0.519 . . . . 0.56999999999999995 110.751 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.89 10.88 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.216 2.206 . . . . 0.56999999999999995 112.432 -173.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 56.5 m95 56.37 -166.01 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.656 1.183 . . . . 0.56999999999999995 110.584 -169.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -101.53 -10.85 19.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.782 0.833 . . . . 0.56999999999999995 110.97 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -118.8 149.58 41.26 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 108.705 176.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -71.96 -11.83 60.96 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.448 0.699 . . . . 0.56999999999999995 112.575 172.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.26 117.25 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.035 -1.839 . . . . 0.56999999999999995 106.035 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.85 141.23 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.365 -0.976 . . . . 0.56999999999999995 108.365 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -102.49 147.63 26.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.648 0.658 . . . . 0.56999999999999995 111.238 -177.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -128.96 157.1 42.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 111.884 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.88 112.13 4.95 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.597 0.713 . . . . 1.2 110.159 174.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 mt -77.68 82.69 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.233 -1.395 . . . . 0.56999999999999995 107.233 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.05 -28.62 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 113.458 -175.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -139.58 154.42 47.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 128.925 2.89 . . . . 0.56999999999999995 103.604 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -132.16 174.67 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.703 1.601 . . . . 0.56999999999999995 108.203 -173.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -90.82 -176.39 4.66 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.921 0.888 . . . . 0.56999999999999995 111.399 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -129.62 -26.62 2.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.364 1.866 . . . . 1.2 113.651 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -24.0 67.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.725 0.81 . . . . 0.66000000000000003 110.86 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.83 154.99 71.35 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 127.464 2.306 . . . . 0.56999999999999995 108.582 177.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -75.58 158.51 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.189 2.592 . . . . 0.56999999999999995 113.047 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -62.23 -34.6 76.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.953 1.301 . . . . 0.65000000000000002 112.66 -176.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.46 -37.64 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.004 0.522 . . . . 0.56999999999999995 110.251 175.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.4 m -67.59 -39.56 84.83 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 117.955 -1.021 . . . . 0.56999999999999995 109.54 173.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.69 -56.1 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.769 1.168 . . . . 0.56999999999999995 110.126 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.64 -34.95 78.1 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.631 1.105 . . . . 0.66000000000000003 111.031 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.25 -48.89 63.87 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.087 0.858 . . . . 1.2 112.066 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -63.97 -43.67 95.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.815 -0.809 . . . . 0.56999999999999995 108.815 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.3 -44.28 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 117.599 -1.191 . . . . 0.56999999999999995 110.807 171.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -50.25 73.45 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 120.274 1.397 . . . . 0.56999999999999995 110.894 178.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -34.86 73.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.167 0.894 . . . . 0.56999999999999995 112.268 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.98 81.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.745 1.157 . . . . 0.56999999999999995 111.153 177.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.83 -37.84 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.471 -0.776 . . . . 0.56999999999999995 110.218 173.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.73 -37.41 84.11 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 110.654 172.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 mtp -64.36 -36.93 85.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.077 0.853 . . . . 0.56999999999999995 112.189 173.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -69.76 -49.36 53.83 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.251 0.932 . . . . 0.56999999999999995 110.89 172.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.73 -5.1 63.41 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.983 1.278 . . . . 0.56999999999999995 113.786 178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -67.99 -26.1 65.75 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.095 -1.238 . . . . 0.56999999999999995 110.888 172.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -100.35 -36.72 9.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.541 0.737 . . . . 0.66000000000000003 110.855 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 12.9 pt -114.05 136.81 22.21 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 118.569 0.622 . . . . 0.56999999999999995 110.819 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 34.21 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.676 2.917 . . . . 0.56999999999999995 111.912 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.42 131.95 34.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.311 -1.737 . . . . 0.56999999999999995 106.311 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -116.0 171.08 8.01 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.803 1.241 . . . . 0.65000000000000002 108.509 -173.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.85 156.1 45.54 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -170.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -142.61 175.92 9.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.91 . . . . 1.2 109.273 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.6 16.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.56999999999999995 108.23 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.76 158.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 109.219 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.44 -41.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.256 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -118.57 -66.34 1.08 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.939 0.876 . . . . 0.56999999999999995 108.891 -172.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.38 -156.57 10.89 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.616 -1.793 . . . . 0.56999999999999995 108.616 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 80.4 p 60.28 72.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.69 1.596 . . . . 0.56999999999999995 111.826 173.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.67 172.37 7.16 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.351 1.06 . . . . 0.56999999999999995 112.012 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -71.55 -39.44 70.65 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.274 -1.01 . . . . 0.66000000000000003 108.274 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.14 84.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.58 1.952 . . . . 0.56999999999999995 108.641 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.23 124.58 27.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.458 -1.401 . . . . 0.56999999999999995 108.417 170.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.55 127.85 66.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 174.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.09 164.91 27.48 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.833 -0.507 . . . . 0.56999999999999995 111.833 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.7 m-85 -136.03 150.65 49.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.609 -0.886 . . . . 0.56999999999999995 108.609 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.29 157.67 44.15 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.754 1.221 . . . . 0.56999999999999995 110.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -5.28 24.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.498 1.119 . . . . 1.2 113.443 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.47 106.85 0.49 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 108.341 -1.904 . . . . 0.56999999999999995 108.341 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.12 126.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.062 2.945 . . . . 0.56999999999999995 112.741 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.1 163.49 30.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.732 1.213 . . . . 0.65000000000000002 110.909 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 76.68 0.9 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.269 -1.132 . . . . 0.56999999999999995 110.269 173.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -135.15 177.58 7.7 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.66000000000000003 110.157 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -44.47 12.61 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 112.043 168.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -139.24 145.91 46.65 Favored Pre-proline 0 C--N 1.345 0.374 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 109.401 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.47 146.95 76.17 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.235 1.29 . . . . 0.56999999999999995 110.29 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -67.78 -178.95 1.04 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.908 1.337 . . . . 0.56999999999999995 111.428 162.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 22.4 p-10 -117.4 -35.07 4.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 131.181 3.793 . . . . 0.66000000000000003 109.332 -172.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 -140.9 15.6 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.561 -1.133 . . . . 0.56999999999999995 110.689 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.96 87.06 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.894 3.73 . . . . 0.56999999999999995 112.575 -171.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.29 172.56 12.92 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.446 1.974 . . . . 0.56999999999999995 109.539 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 15.6 t30 48.7 -153.5 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 119.432 1.616 . . . . 0.56999999999999995 111.848 -174.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.3 m -48.64 126.52 11.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.716 2.406 . . . . 0.56999999999999995 112.908 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.02 -27.4 17.02 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.234 1.414 . . . . 0.56999999999999995 113.45 -173.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.93 161.83 40.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 108.344 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.96 163.34 37.16 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.029 -0.36 . . . . 0.65000000000000002 110.029 174.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.73 163.19 37.46 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.244 1.018 . . . . 0.56999999999999995 110.438 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.23 161.84 18.38 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.144 0.978 . . . . 0.56999999999999995 110.653 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.83 142.83 45.6 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-O 118.224 -0.893 . . . . 0.56999999999999995 109.383 -176.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.31 156.83 63.16 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.528 1.485 . . . . 0.56999999999999995 110.893 175.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.9 9.18 8.38 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.968 0.794 . . . . 0.56999999999999995 113.81 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.1 t -160.78 168.49 24.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.823 1.649 . . . . 0.56999999999999995 107.993 176.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.89 -57.78 16.56 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 125.591 1.567 . . . . 0.56999999999999995 113.079 -177.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 95' ' ' ASP . 5.9 tp -66.09 -17.61 64.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.395 1.078 . . . . 0.56999999999999995 110.997 173.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.0 147.79 33.5 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.793 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.32 -21.31 0.54 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.571 1.558 . . . . 0.56999999999999995 115.119 -176.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 63.4 m-20 -69.07 153.6 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.776 1.288 . . . . 0.66000000000000003 108.156 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.09 144.87 29.38 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.56999999999999995 109.083 -171.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -131.84 159.23 39.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.371 -0.831 . . . . 0.65000000000000002 109.304 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 52.2 m-85 -137.65 147.19 44.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.821 1.648 . . . . 0.56999999999999995 109.002 -171.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.29 105.46 12.49 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 171.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.19 -27.66 64.07 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.468 1.107 . . . . 0.66000000000000003 111.069 171.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.62 -33.94 75.98 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.827 0.851 . . . . 0.66000000000000003 111.282 -178.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.84 120.55 20.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.767 -1.568 . . . . 0.66000000000000003 106.767 178.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 131.42 48.41 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.362 0.528 . . . . 1.2 110.699 -174.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.78 150.54 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.082 -1.081 . . . . 0.56999999999999995 108.082 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -145.06 145.72 31.57 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.92 -0.77 . . . . 0.56999999999999995 108.92 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.21 -39.73 93.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.164 0.986 . . . . 0.66000000000000003 112.052 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.05 173.42 27.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.934 1.254 . . . . 0.56999999999999995 110.034 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.13 30.29 5.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.681 1.192 . . . . 0.56999999999999995 114.174 176.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.04 168.63 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 109.315 -174.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.09 167.27 10.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 111.706 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.81 -160.97 22.64 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.434 -1.466 . . . . 0.56999999999999995 109.434 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.71 122.84 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.889 -1.152 . . . . 0.56999999999999995 107.889 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -55.53 105.23 0.16 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 109.999 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.75 -36.41 76.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 110.989 178.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.2 tp -71.12 -40.74 71.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.312 0.505 . . . . 0.56999999999999995 109.931 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.09 -44.31 96.93 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.473 0.709 . . . . 0.56999999999999995 109.375 173.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.23 -54.71 42.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.56999999999999995 110.043 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.75 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 117.891 -1.052 . . . . 0.56999999999999995 109.184 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.8 m -53.64 -43.99 69.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.116 1.325 . . . . 0.56999999999999995 111.452 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -64.32 -55.17 23.08 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.844 1.202 . . . . 0.65000000000000002 110.62 176.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.2 -39.66 86.38 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.412 -0.805 . . . . 0.66000000000000003 111.474 -172.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.65 -30.71 71.73 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.462 0.705 . . . . 0.56999999999999995 110.628 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.71 -43.96 60.17 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 119.194 0.906 . . . . 0.56999999999999995 111.411 170.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -74.86 -33.53 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.734 -0.65 . . . . 0.65000000000000002 112.452 176.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -33.58 75.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.837 0.744 . . . . 0.56999999999999995 111.428 174.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.13 -29.55 69.88 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.325 0.65 . . . . 0.56999999999999995 112.053 175.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 153.09 56.07 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.292 -1.282 . . . . 0.56999999999999995 113.202 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 mmt 48.99 -156.14 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.936 0.868 . . . . 0.56999999999999995 111.475 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.82 81.11 1.22 Allowed Glycine 0 C--O 1.219 -0.842 0 N-CA-C 108.703 -1.759 . . . . 0.56999999999999995 108.703 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.31 172.09 8.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.833 0.817 . . . . 0.65000000000000002 109.847 172.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.99 -177.3 6.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.853 2.061 . . . . 0.56999999999999995 107.946 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 99.24 3.04 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.188 -2.153 . . . . 0.56999999999999995 105.188 173.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.9 141.37 17.31 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 107.861 -1.163 . . . . 0.66000000000000003 107.861 170.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.59 -4.5 14.72 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.935 2.423 . . . . 0.56999999999999995 113.73 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.31 13.7 7.7 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.121 1.768 . . . . 0.56999999999999995 111.23 -174.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.82 40.73 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 109.866 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.98 -28.95 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.969 0.804 . . . . 0.56999999999999995 110.313 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 35.1 tpp -74.46 -11.37 60.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.404 1.082 . . . . 0.56999999999999995 113.33 -174.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.35 136.29 41.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.461 -0.57 . . . . 0.56999999999999995 109.461 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 -169.28 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.973 1.782 . . . . 0.56999999999999995 109.432 168.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.0 p 50.22 79.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.209 1.404 . . . . 0.56999999999999995 114.224 172.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -56.18 93.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 113.832 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.4 109.96 0.43 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.841 1.686 . . . . 0.56999999999999995 109.59 -177.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -170.14 -50.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 108.582 169.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.52 -122.57 3.16 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.084 -1.606 . . . . 0.56999999999999995 109.084 -177.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -147.01 124.1 5.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.65 -0.871 . . . . 0.66000000000000003 108.65 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -80.53 -8.17 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.948 3.098 . . . . 0.56999999999999995 114.166 177.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -67.15 -27.36 67.23 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.578 -1.326 . . . . 0.56999999999999995 110.738 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.83 80.47 1.38 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.11 1.364 . . . . 0.56999999999999995 111.199 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.47 148.0 38.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.578 1.551 . . . . 0.56999999999999995 109.629 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.2 47.54 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.47 1.108 . . . . 0.56999999999999995 111.213 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 61.85 79.27 0.26 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.968 1.307 . . . . 0.56999999999999995 111.581 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -64.46 -86.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.206 1.187 . . . . 0.56999999999999995 114.206 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -138.42 -46.04 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 110.058 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -45.81 64.28 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.654 172.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -53.71 55.05 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.708 0.63 . . . . 0.66000000000000003 109.955 177.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.12 -45.98 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.071 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -47.53 76.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.908 1.283 . . . . 0.56999999999999995 109.459 -178.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.71 97.19 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.924 -1.27 . . . . 0.56999999999999995 109.924 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -51.18 74.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.53 1.165 . . . . 0.56999999999999995 110.282 175.212 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.78 -37.81 77.12 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.902 0.481 . . . . 0.56999999999999995 110.204 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -39.01 73.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.101 -0.952 . . . . 0.56999999999999995 111.916 175.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -58.92 5.46 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.731 2.012 . . . . 0.56999999999999995 109.999 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.4 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.9 p90 . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 120.264 -0.574 . . . . 0.56999999999999995 111.779 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.448 -1.161 0 N-CA-C 110.97 -0.435 . . . . 0.56999999999999995 110.97 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt 80.7 115.69 0.06 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.022 2.129 . . . . 0.56999999999999995 108.296 -177.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.416 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 79.7 m95 -58.54 163.53 3.12 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.243 1.021 . . . . 0.56999999999999995 111.939 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -69.31 -31.95 70.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.565 0.746 . . . . 0.56999999999999995 111.521 -174.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 t -123.65 150.49 44.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.39 2.276 . . . . 0.56999999999999995 107.264 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -71.97 3.02 4.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.283 -0.865 . . . . 0.56999999999999995 112.142 171.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -121.86 108.24 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.984 -1.488 . . . . 0.56999999999999995 106.984 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.71 143.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 107.964 -1.125 . . . . 0.56999999999999995 107.964 -172.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.1 p -97.32 152.6 18.74 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.644 -0.66 . . . . 0.56999999999999995 110.455 -176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -131.21 157.83 42.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.948 -1.095 . . . . 0.56999999999999995 110.681 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -144.73 119.11 9.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.425 0.69 . . . . 1.2 109.491 174.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.12 86.13 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 105.165 -2.161 . . . . 0.56999999999999995 105.165 176.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.07 -38.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.539 1.935 . . . . 0.56999999999999995 110.728 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -152.61 164.3 37.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.309 -2.108 . . . . 0.56999999999999995 105.309 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -132.1 169.09 16.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.812 1.645 . . . . 0.56999999999999995 106.82 -172.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.1 t -72.0 -168.07 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.56999999999999995 111.203 171.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -43.51 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 1.2 113.463 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -60.78 -41.78 96.23 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 -177.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.4 150.32 38.81 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 124.055 0.942 . . . . 0.56999999999999995 111.26 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -75.14 158.11 41.82 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.561 2.174 . . . . 0.56999999999999995 112.444 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -61.71 -38.62 88.53 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 112.536 -176.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.33 -40.96 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.77 -0.456 . . . . 0.56999999999999995 109.77 174.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -68.68 -38.9 80.71 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.237 -1.364 . . . . 0.56999999999999995 109.371 176.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.11 -53.55 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.875 1.671 . . . . 0.56999999999999995 110.053 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.0 -41.24 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.823 0.738 . . . . 0.66000000000000003 111.154 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -46.8 86.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 118.549 0.613 . . . . 1.2 111.719 178.042 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 mp -62.57 -44.81 95.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 116.598 -1.668 . . . . 0.56999999999999995 107.797 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.95 -47.04 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 121.049 1.749 . . . . 0.56999999999999995 110.698 174.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -48.6 76.44 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.949 0.795 . . . . 0.56999999999999995 109.303 -178.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -69.62 -36.88 76.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 112.104 -177.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.44 74.81 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 126.83 2.052 . . . . 0.56999999999999995 109.847 174.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.58 -33.42 75.64 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 118.505 -0.759 . . . . 0.56999999999999995 111.03 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -60.24 -33.87 72.89 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.383 -0.818 . . . . 0.56999999999999995 109.605 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.9 mtm -69.64 -23.5 63.49 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 115.925 -1.988 . . . . 0.56999999999999995 113.281 175.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -84.45 -34.51 23.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.529 1.513 . . . . 0.56999999999999995 111.157 169.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.95 83.0 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.839 -1.163 . . . . 0.56999999999999995 112.236 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.25 -25.98 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 111.13 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -100.35 -29.84 12.19 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.147 -0.93 . . . . 0.66000000000000003 111.468 176.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.7 131.23 24.4 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 119.364 0.984 . . . . 0.56999999999999995 111.255 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.11 43.39 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.694 2.93 . . . . 0.56999999999999995 112.234 178.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.73 145.33 29.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.146 1.378 . . . . 0.56999999999999995 108.593 175.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -126.78 162.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.315 1.046 . . . . 0.65000000000000002 108.208 -175.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 152.97 41.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.002 -1.481 . . . . 0.56999999999999995 107.002 -169.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 171.31 14.67 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.105 0.962 . . . . 1.2 109.083 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -115.04 163.93 14.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.976 -0.75 . . . . 0.56999999999999995 108.976 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.47 171.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.738 1.215 . . . . 0.56999999999999995 109.94 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -115.74 36.26 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 111.46 -171.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 92.02 107.5 0.03 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 128.739 2.816 . . . . 0.56999999999999995 108.99 -177.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.98 -124.41 1.43 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.078 -1.609 . . . . 0.56999999999999995 109.078 -173.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.9 p -138.0 143.17 40.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.39 0.676 . . . . 0.56999999999999995 109.803 -171.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.22 -177.33 4.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.056 1.743 . . . . 0.56999999999999995 109.357 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.416 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 35.9 m-20 -83.74 -39.78 19.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.544 0.738 . . . . 0.66000000000000003 110.88 -177.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.05 79.98 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.306 1.442 . . . . 0.56999999999999995 107.213 -175.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -78.86 126.62 30.94 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.695 -1.253 . . . . 0.56999999999999995 108.998 171.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.17 124.98 66.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.616 -1.994 . . . . 0.56999999999999995 105.616 173.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.97 162.94 27.45 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.221 -0.752 . . . . 0.56999999999999995 111.221 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.77 148.01 46.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.994 -1.113 . . . . 0.56999999999999995 107.994 -175.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.61 179.86 6.58 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 125.936 1.694 . . . . 0.56999999999999995 110.291 -175.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 71.2 1.4 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 122.487 1.137 . . . . 1.2 108.422 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.37 -65.14 0.78 Allowed Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.311 -1.115 . . . . 0.56999999999999995 110.311 -178.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.95 159.5 33.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.863 1.832 . . . . 0.56999999999999995 110.963 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -157.87 155.19 29.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.628 1.171 . . . . 0.65000000000000002 108.923 -178.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.98 52.13 3.94 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.733 1.635 . . . . 0.56999999999999995 112.752 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -109.68 -77.18 0.6 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.533 1.133 . . . . 0.66000000000000003 108.411 -176.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -177.93 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 110.107 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -130.43 99.13 19.43 Favored Pre-proline 0 C--N 1.344 0.357 0 N-CA-C 108.523 -0.917 . . . . 0.56999999999999995 108.523 -174.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 141.71 72.63 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 109.199 -1.116 . . . . 0.56999999999999995 109.199 174.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -61.85 177.3 0.45 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.192 1.472 . . . . 0.56999999999999995 111.041 167.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -99.34 -37.41 9.25 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.694 1.998 . . . . 0.66000000000000003 110.855 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.41 -150.11 18.19 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 120.461 1.482 . . . . 0.56999999999999995 112.422 -172.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.01 81.77 1.63 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.744 3.63 . . . . 0.56999999999999995 112.949 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.17 -168.29 37.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.756 1.646 . . . . 0.56999999999999995 110.705 176.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 41.72 -137.1 0.21 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.307 1.443 . . . . 0.56999999999999995 113.788 167.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -59.42 123.53 17.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.938 2.095 . . . . 0.56999999999999995 110.936 174.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.93 -28.81 13.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.7 1.2 . . . . 0.56999999999999995 113.21 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.72 159.09 36.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -143.7 156.57 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.65000000000000002 109.306 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.42 35.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.364 0.665 . . . . 0.56999999999999995 109.592 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -117.05 153.15 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.673 -0.862 . . . . 0.56999999999999995 108.673 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 158.89 50.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 110.835 176.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.79 161.46 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 112.175 177.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.06 -127.18 1.29 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.078 -2.009 . . . . 0.56999999999999995 108.078 -177.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.9 m -141.38 99.22 3.52 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 106.193 -1.78 . . . . 0.56999999999999995 106.193 -178.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.37 -125.62 6.34 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.177 -1.569 . . . . 0.56999999999999995 109.177 176.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 95' ' ' ASP . 1.3 tp -51.52 -35.43 40.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 111.842 178.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.17 136.97 8.32 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.574 -0.704 . . . . 0.56999999999999995 112.316 176.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.03 -22.15 8.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 126.384 1.945 . . . . 0.56999999999999995 114.464 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 68.3 m-20 -68.47 151.83 46.26 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.651 -1.24 . . . . 0.66000000000000003 107.651 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.05 147.7 32.88 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.374 1.069 . . . . 0.56999999999999995 108.973 -172.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -131.62 154.66 48.66 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.888 -1.051 . . . . 0.65000000000000002 108.523 -178.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.47 151.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.825 -1.176 . . . . 0.56999999999999995 107.825 -171.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.26 94.9 9.4 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.874 -1.158 . . . . 0.66000000000000003 107.874 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.81 -28.11 46.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.654 1.582 . . . . 0.66000000000000003 111.256 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.87 -36.27 81.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.181 0.593 . . . . 0.66000000000000003 110.79 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.71 130.55 43.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.918 -1.142 . . . . 0.66000000000000003 107.918 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -57.49 140.95 49.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.249 0.547 . . . . 1.2 110.66 178.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -123.68 150.15 44.61 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.927 -1.508 . . . . 0.56999999999999995 106.927 178.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -137.84 147.76 44.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 175.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.72 -54.0 48.51 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.343 0.974 . . . . 0.66000000000000003 108.684 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.81 72.73 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.437 -1.465 . . . . 0.56999999999999995 109.437 -169.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.3 p -159.44 151.22 20.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.218 0.607 . . . . 0.56999999999999995 109.668 173.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 m -67.66 87.2 0.22 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.007 0.923 . . . . 0.56999999999999995 110.604 174.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.33 -55.47 0.06 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 125.989 1.716 . . . . 0.56999999999999995 111.406 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.47 -147.87 7.41 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.211 -1.156 . . . . 0.56999999999999995 110.211 -176.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.61 124.7 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.437 -1.32 . . . . 0.56999999999999995 107.437 -177.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.86 107.63 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.822 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -60.28 -47.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.391 1.476 . . . . 0.56999999999999995 110.337 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.72 -44.76 81.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -72.92 -41.73 64.25 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.36 0.664 . . . . 0.56999999999999995 110.578 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.35 74.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.609 0.764 . . . . 0.56999999999999995 109.951 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.86 -56.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 118.289 -0.862 . . . . 0.56999999999999995 109.486 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.5 m -51.89 -36.57 49.15 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.686 1.13 . . . . 0.56999999999999995 112.522 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.4 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.7 t60 -64.12 -61.53 2.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.229 -0.656 . . . . 0.65000000000000002 109.229 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.95 -43.11 99.52 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.462 -0.773 . . . . 0.66000000000000003 111.036 -172.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.63 -32.76 72.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 112.027 177.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.84 -44.95 81.45 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.634 -0.986 . . . . 0.56999999999999995 110.634 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -67.02 -44.21 80.86 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 118.479 -0.772 . . . . 0.65000000000000002 111.885 175.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.3 m -53.7 -38.52 64.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 123.755 0.659 . . . . 0.56999999999999995 111.085 176.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -38.31 87.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 112.217 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 152.19 -21.95 0.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.262 -0.743 . . . . 0.56999999999999995 113.028 -175.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.6 158.79 4.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.689 1.244 . . . . 0.56999999999999995 110.927 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.03 -41.37 0.48 Allowed Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.73 -2.15 . . . . 0.56999999999999995 112.68 176.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 167.39 177.61 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 128.247 2.619 . . . . 0.65000000000000002 107.259 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 t -150.76 -175.73 5.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.992 -1.485 . . . . 0.56999999999999995 106.992 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.3 p -134.86 63.26 1.62 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.078 -174.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.06 147.65 65.75 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.66000000000000003 110.155 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.86 -27.11 21.66 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.842 2.362 . . . . 0.56999999999999995 112.158 -175.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -122.6 33.35 5.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.704 1.602 . . . . 0.56999999999999995 109.053 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.48 54.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.559 -0.713 . . . . 0.56999999999999995 110.567 176.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.74 -24.7 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 121.424 -0.797 . . . . 0.56999999999999995 110.336 168.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.4 ' CE ' ' HA ' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -96.6 11.84 33.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 112.157 177.117 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.55 137.11 9.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 119.764 1.166 . . . . 0.56999999999999995 112.48 174.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.04 -66.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.966 1.778 . . . . 0.56999999999999995 111.869 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -55.78 139.94 43.7 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 110.52 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -95.53 77.1 3.33 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.291 -0.633 . . . . 0.56999999999999995 109.291 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 96.75 0.12 Allowed Glycine 0 CA--C 1.536 1.374 0 N-CA-C 115.617 1.007 . . . . 0.56999999999999995 115.617 172.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -159.48 -46.68 0.05 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.399 1.1 . . . . 0.56999999999999995 113.105 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.76 -129.81 4.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.955 -2.058 . . . . 0.56999999999999995 107.955 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -147.57 114.2 4.08 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.537 -0.912 . . . . 0.66000000000000003 108.537 -178.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -12.6 23.04 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.198 1.932 . . . . 0.56999999999999995 112.706 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.03 -25.67 61.9 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.074 -1.016 . . . . 0.56999999999999995 111.167 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.88 93.28 4.3 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 108.735 174.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -52.43 -73.89 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.622 1.169 . . . . 0.56999999999999995 114.035 -177.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.36 67.04 0.2 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.504 2.321 . . . . 0.56999999999999995 110.979 176.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -40.13 121.97 1.43 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.866 1.666 . . . . 0.56999999999999995 109.121 -174.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.3 t -77.03 -101.63 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.626 0.771 . . . . 0.56999999999999995 109.272 -168.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -122.91 -8.26 8.37 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 125.102 1.361 . . . . 0.56999999999999995 110.838 172.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.22 -63.29 1.35 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 121.208 1.822 . . . . 0.66000000000000003 110.873 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.66 -50.84 61.61 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 117.616 -1.183 . . . . 0.66000000000000003 108.829 175.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.93 -48.83 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.199 0.909 . . . . 0.56999999999999995 110.314 -174.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -66.91 -49.82 64.37 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.057 -0.72 . . . . 0.56999999999999995 109.057 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.19 -58.84 11.91 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.682 -0.967 . . . . 0.56999999999999995 110.682 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.9 mm -50.39 -48.13 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 126.343 1.857 . . . . 0.56999999999999995 112.141 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.44 -33.6 75.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.438 0.563 . . . . 0.56999999999999995 111.714 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -76.05 -30.79 58.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.804 0.842 . . . . 0.56999999999999995 111.801 176.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.76 -53.19 12.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 110.065 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.778 -174.17 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 N-CA-C 110.946 -0.444 . . . . 0.56999999999999995 110.946 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.2 99.26 0.07 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 126.243 1.817 . . . . 0.56999999999999995 108.912 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.3 m95 -53.86 154.06 4.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.511 0.672 . . . . 0.56999999999999995 111.651 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -72.76 -31.05 64.63 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.747 0.819 . . . . 0.56999999999999995 111.702 -176.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -92.44 155.62 17.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.137 2.175 . . . . 0.56999999999999995 111.162 174.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -79.68 -10.98 59.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 111.808 173.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.29 144.7 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.777 -1.194 . . . . 0.56999999999999995 107.777 175.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.76 150.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.7 p -102.52 148.78 25.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 119.015 -0.516 . . . . 0.56999999999999995 110.651 -174.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -127.38 158.19 37.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.865 1.211 . . . . 0.56999999999999995 111.915 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.74 116.56 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.988 0.423 . . . . 1.2 110.945 171.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.8 mt -79.19 96.63 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 N-CA-C 106.581 -1.637 . . . . 0.56999999999999995 106.581 176.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -33.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.878 2.071 . . . . 0.56999999999999995 112.007 -175.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 t -150.04 162.26 40.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.384 -2.821 . . . . 0.56999999999999995 103.384 -177.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.36 161.29 35.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.909 -1.515 . . . . 0.56999999999999995 106.909 -173.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -72.81 173.15 9.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.668 0.387 . . . . 0.56999999999999995 111.295 176.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -41.06 3.83 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.433 1.093 . . . . 1.2 111.221 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -35.1 74.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.057 0.389 . . . . 0.66000000000000003 110.81 -176.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.52 151.77 52.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.531 1.932 . . . . 0.56999999999999995 108.356 -176.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.23 155.92 46.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.198 1.265 . . . . 0.56999999999999995 112.422 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -59.33 -37.59 78.18 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.565 1.146 . . . . 0.65000000000000002 112.343 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 tt -63.6 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.28 -0.867 . . . . 0.56999999999999995 110.078 174.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -62.77 -42.81 99.86 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.63 -1.176 . . . . 0.56999999999999995 109.195 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.28 -53.51 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 120.607 1.549 . . . . 0.56999999999999995 111.667 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -59.79 -45.03 93.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.654 1.115 . . . . 0.66000000000000003 110.438 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.17 96.78 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 117.845 -1.074 . . . . 1.2 111.402 176.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mp -64.19 -46.24 84.8 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.518 1.054 . . . . 0.56999999999999995 108.472 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -49.75 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.244 0.929 . . . . 0.56999999999999995 109.709 172.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.26 -46.75 87.41 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.95 -1.024 . . . . 0.56999999999999995 111.887 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -65.62 -42.54 91.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.333 1.424 . . . . 0.56999999999999995 111.712 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.05 94.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 110.049 177.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.45 -32.39 73.73 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.934 -0.555 . . . . 0.56999999999999995 111.511 173.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -43.45 98.27 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.025 172.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 mtm -67.12 -37.44 83.87 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.483 -0.77 . . . . 0.56999999999999995 112.133 176.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.422 ' CZ3' ' HG3' ' A' ' 128' ' ' MET . 23.7 m95 -69.11 -43.92 73.47 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.862 1.21 . . . . 0.56999999999999995 112.004 173.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.04 -0.87 66.46 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.959 1.266 . . . . 0.56999999999999995 113.197 177.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -23.48 65.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.11 -1.23 . . . . 0.56999999999999995 110.953 171.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -105.47 -32.1 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.978 -1.01 . . . . 0.66000000000000003 112.331 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.2 pt -116.6 132.29 23.44 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 119.312 0.96 . . . . 0.56999999999999995 110.875 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.27 49.44 2.84 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.971 3.114 . . . . 0.56999999999999995 111.76 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -98.49 142.11 30.51 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.122 2.169 . . . . 0.56999999999999995 107.357 176.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -125.18 164.7 19.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.65000000000000002 109.329 -172.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.65 147.87 47.1 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.685 -1.228 . . . . 0.56999999999999995 107.685 -170.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.97 168.98 18.7 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.709 1.204 . . . . 1.2 109.048 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -110.77 150.39 29.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.793 -0.817 . . . . 0.56999999999999995 108.793 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.5 170.33 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.867 0.867 . . . . 0.56999999999999995 109.941 174.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.1 -48.71 7.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 109.17 177.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -146.58 139.61 25.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.106 1.362 . . . . 0.56999999999999995 107.387 173.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.43 166.4 22.79 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.571 0.605 . . . . 0.56999999999999995 111.808 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 164.54 21.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.914 0.387 . . . . 0.56999999999999995 110.369 174.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.51 173.71 8.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 110.8 -176.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -73.53 -35.89 65.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.09 -0.959 . . . . 0.66000000000000003 110.298 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.09 71.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.549 2.34 . . . . 0.56999999999999995 108.364 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.9 ttp -78.31 122.02 25.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.577 -1.327 . . . . 0.56999999999999995 108.229 173.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.93 135.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.473 -1.677 . . . . 0.56999999999999995 106.473 178.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.3 165.93 28.17 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 118.821 0.737 . . . . 0.56999999999999995 112.015 176.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 6.4 m-85 -139.12 137.54 36.24 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.172 -1.788 . . . . 0.56999999999999995 106.172 -175.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.8 175.85 9.27 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 109.318 -176.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -133.55 88.8 2.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.722 -1.214 . . . . 1.2 107.722 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.76 -40.89 2.27 Favored Glycine 0 C--N 1.343 0.933 0 C-N-CA 124.359 0.981 . . . . 0.56999999999999995 113.089 170.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.96 23.94 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.376 1.088 . . . . 0.56999999999999995 109.421 175.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 159.33 25.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.957 1.303 . . . . 0.65000000000000002 109.763 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.49 55.71 4.42 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 126.21 1.862 . . . . 0.56999999999999995 112.23 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -105.08 -78.39 0.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.176 1.39 . . . . 0.66000000000000003 109.094 -175.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.17 -50.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 106.52 -176.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -108.36 126.19 30.17 Favored Pre-proline 0 C--N 1.344 0.352 0 CA-C-O 118.798 -0.62 . . . . 0.56999999999999995 109.942 -174.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.08 133.37 26.66 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.272 1.315 . . . . 0.56999999999999995 108.836 170.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.64 -163.43 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.645 1.212 . . . . 0.56999999999999995 110.459 166.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.512 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 21.2 p-10 -132.53 -35.77 1.12 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.605 3.562 . . . . 0.66000000000000003 109.416 -162.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.37 -148.64 18.93 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.808 1.671 . . . . 0.56999999999999995 111.453 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.04 59.57 2.96 Favored 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.227 4.618 . . . . 0.56999999999999995 115.103 -169.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.0 40.55 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.552 1.549 . . . . 0.56999999999999995 110.053 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 33.8 t30 42.63 -139.76 0.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.229 1.812 . . . . 0.56999999999999995 113.593 173.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -49.57 112.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.436 2.694 . . . . 0.56999999999999995 111.989 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.23 -32.11 61.04 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.56999999999999995 114.352 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.12 166.37 28.09 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.84 -1.162 . . . . 0.56999999999999995 109.223 -178.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.509 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.9 p-80 -149.09 155.98 41.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.003 0.82 . . . . 0.65000000000000002 111.161 174.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.44 158.56 43.93 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.203 1.001 . . . . 0.56999999999999995 109.875 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.7 148.52 32.1 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.429 -0.582 . . . . 0.56999999999999995 109.429 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.42 96.5 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 110.242 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 21.9 Cg_endo -70.33 157.66 58.6 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.476 2.117 . . . . 0.56999999999999995 111.099 176.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.68 -53.52 0.6 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.414 1.007 . . . . 0.56999999999999995 111.141 173.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -96.64 177.67 5.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.704 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.96 -40.39 97.14 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.267 -1.296 . . . . 0.56999999999999995 112.488 -176.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.22 -29.38 66.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.881 1.34 . . . . 0.56999999999999995 110.875 168.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.13 152.19 14.69 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.85 -1.157 . . . . 0.56999999999999995 111.152 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.35 -20.55 4.89 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.436 1.017 . . . . 0.56999999999999995 113.391 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -75.39 157.22 34.52 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.483 1.141 . . . . 0.66000000000000003 108.867 -173.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.41 149.94 36.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.815 0.817 . . . . 0.56999999999999995 110.314 -172.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.83 151.56 48.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.602 -176.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 36.2 m-85 -138.07 150.01 46.51 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 108.034 -171.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -85.51 104.09 14.97 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.87 -0.789 . . . . 0.66000000000000003 108.87 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.86 -23.75 66.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.929 -1.107 . . . . 0.66000000000000003 111.671 175.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -56.72 -29.5 62.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.793 0.837 . . . . 0.66000000000000003 111.642 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -82.68 135.03 35.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.587 1.555 . . . . 0.66000000000000003 109.157 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.83 120.7 14.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.753 -0.592 . . . . 1.2 109.62 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -103.58 138.51 40.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -123.64 147.08 47.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.711 -1.218 . . . . 0.56999999999999995 107.711 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -88.26 21.23 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.396 0.998 . . . . 0.66000000000000003 112.081 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.86 25.6 37.52 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.252 1.406 . . . . 0.56999999999999995 112.834 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -64.76 -56.18 15.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.746 -172.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.1 m -151.68 -43.1 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.582 0.753 . . . . 0.56999999999999995 112.827 -176.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -167.84 166.4 13.54 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 108.078 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.84 -152.4 16.88 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.166 -1.574 . . . . 0.56999999999999995 109.166 -175.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.93 111.63 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.107 -1.442 . . . . 0.56999999999999995 107.107 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -66.28 111.65 3.58 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.074 -0.713 . . . . 0.56999999999999995 109.074 -177.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.43 -43.93 75.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.449 -0.796 . . . . 0.56999999999999995 111.464 177.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -59.7 -40.3 87.45 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -66.54 -44.61 81.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.569 0.748 . . . . 0.56999999999999995 109.662 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.098 0.559 . . . . 0.56999999999999995 110.327 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -50.95 72.09 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.861 -1.066 . . . . 0.56999999999999995 109.845 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 65.5 m -50.82 -46.33 59.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.175 1.352 . . . . 0.56999999999999995 111.714 175.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.91 -52.27 64.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.401 0.546 . . . . 0.65000000000000002 110.281 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 4.9 mm-40 -66.5 -43.37 85.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.195 0.998 . . . . 0.66000000000000003 110.9 -172.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -64.85 -28.68 69.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.202 1.401 . . . . 0.56999999999999995 111.282 176.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -46.33 80.46 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.127 -0.789 . . . . 0.56999999999999995 111.127 169.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -68.7 -40.46 80.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.537 -1.22 . . . . 0.65000000000000002 110.889 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.8 p -59.98 -26.44 66.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.136 0.88 . . . . 0.56999999999999995 112.838 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -41.59 78.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 111.773 173.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.73 25.91 1.2 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.478 1.037 . . . . 0.56999999999999995 113.621 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.422 ' HG3' ' CZ3' ' A' ' 42' ' ' TRP . 36.3 mmt -84.26 -176.94 6.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.855 0.836 . . . . 0.56999999999999995 111.052 -175.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.47 146.49 18.15 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.267 -0.879 . . . . 0.56999999999999995 111.44 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.23 164.33 1.81 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.036 0.922 . . . . 0.65000000000000002 111.25 166.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.26 179.97 7.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.515 1.926 . . . . 0.56999999999999995 107.538 -177.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.3 t -151.59 97.06 2.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.917 -1.883 . . . . 0.56999999999999995 105.917 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.1 137.62 31.09 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 105.587 -2.005 . . . . 0.66000000000000003 105.587 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.76 38.12 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.959 3.106 . . . . 0.56999999999999995 111.714 -176.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.46 32.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.9 1.68 . . . . 0.56999999999999995 111.291 170.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.64 142.91 49.0 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.98 -1.075 . . . . 0.56999999999999995 110.543 -170.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.47 -29.6 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 120.172 -0.611 . . . . 0.56999999999999995 109.514 177.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 tpp -61.39 -18.13 57.35 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 114.455 173.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -54.71 129.11 63.69 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.534 0.734 . . . . 0.56999999999999995 109.502 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.06 134.98 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.793 1.662 . . . . 0.56999999999999995 109.277 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.1 m 66.88 149.55 0.05 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.107 1.763 . . . . 0.56999999999999995 111.895 -173.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.84 131.48 48.93 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.017 -1.052 . . . . 0.56999999999999995 109.51 173.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.86 -104.72 0.18 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.161 -1.176 . . . . 0.56999999999999995 110.161 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -64.2 -33.61 76.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.923 0.712 . . . . 0.56999999999999995 112.923 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.59 142.93 36.08 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.613 -0.995 . . . . 0.56999999999999995 110.613 178.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -109.77 111.51 58.85 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.408 0.683 . . . . 0.66000000000000003 109.288 -169.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 -15.63 51.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.576 2.184 . . . . 0.56999999999999995 113.6 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.54 -1.24 28.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.024 0.93 . . . . 0.56999999999999995 110.675 177.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -142.51 77.42 1.58 Allowed 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 109.586 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.86 -63.15 1.2 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.67 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.11 72.96 0.03 OUTLIER 'General case' 0 C--N 1.346 0.436 0 O-C-N 126.369 2.293 . . . . 0.56999999999999995 111.364 -176.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp -33.16 116.07 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.965 2.106 . . . . 0.56999999999999995 108.55 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.4 p -93.7 -75.52 0.5 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.326 -0.55 . . . . 0.56999999999999995 110.382 -160.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -141.76 -49.51 0.39 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 109.351 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -51.84 -32.47 31.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.901 1.228 . . . . 0.66000000000000003 112.441 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -78.19 -82.94 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.902 1.681 . . . . 0.66000000000000003 110.404 168.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.62 -50.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.183 0.993 . . . . 0.56999999999999995 110.648 -169.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -69.05 -35.9 77.09 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 117.528 -1.225 . . . . 0.56999999999999995 109.684 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.71 95.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 120.416 1.462 . . . . 0.56999999999999995 111.049 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.03 -48.81 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.902 0.881 . . . . 0.56999999999999995 110.676 171.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -67.09 -16.86 64.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 112.89 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -82.57 -35.64 26.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.324 1.45 . . . . 0.56999999999999995 110.43 171.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -47.13 8.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.867 0.758 . . . . 0.56999999999999995 112.762 -175.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 N--CA 1.465 0.323 0 C-N-CA 124.285 1.034 . . . . 0.56999999999999995 110.484 -175.044 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 CA-C-O 120.676 0.198 . . . . 0.56999999999999995 111.856 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 pttt 86.81 133.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 129.406 3.082 . . . . 0.56999999999999995 108.548 -170.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -73.31 177.67 5.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.619 0.767 . . . . 0.56999999999999995 110.074 173.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -101.6 -14.77 17.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.728 -0.608 . . . . 0.56999999999999995 111.485 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -100.8 162.64 12.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.726 1.21 . . . . 0.56999999999999995 110.116 176.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -87.42 -4.08 59.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.13 1.372 . . . . 0.56999999999999995 112.549 171.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -133.1 140.93 46.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.868 -1.16 . . . . 0.56999999999999995 107.868 176.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.68 143.5 39.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.738 -1.578 . . . . 0.56999999999999995 106.738 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.94 140.43 33.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.69 -0.485 . . . . 0.56999999999999995 109.69 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.21 161.04 29.48 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.631 0.772 . . . . 0.56999999999999995 110.544 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.91 160.7 43.73 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.987 0.915 . . . . 1.2 109.599 172.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.25 85.92 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.239 -2.134 . . . . 0.56999999999999995 105.239 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.64 -56.27 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.021 0.529 . . . . 0.56999999999999995 109.985 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.5 111.82 22.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.733 -1.951 . . . . 0.56999999999999995 105.733 176.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.09 148.95 22.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.395 1.878 . . . . 0.56999999999999995 107.911 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -73.88 -170.05 0.84 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 109.799 -176.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.28 -14.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.869 1.433 . . . . 1.2 114.869 176.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -64.59 -29.87 70.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.085 1.354 . . . . 0.66000000000000003 110.846 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.28 150.82 73.48 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 126.55 1.94 . . . . 0.56999999999999995 108.488 175.13 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -70.81 157.3 58.72 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.537 2.825 . . . . 0.56999999999999995 112.736 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -65.59 -32.92 74.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.705 0.802 . . . . 0.65000000000000002 112.172 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -43.96 98.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.55 -0.907 . . . . 0.56999999999999995 108.55 174.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -64.95 -42.37 94.7 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.206 -1.378 . . . . 0.56999999999999995 109.839 172.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.3 -48.59 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 121.157 1.798 . . . . 0.56999999999999995 110.365 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.8 -42.19 90.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.19 0.904 . . . . 0.66000000000000003 109.672 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -67.34 -46.87 72.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.333 -0.855 . . . . 1.2 113.146 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -31.62 72.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.048 -0.977 . . . . 0.56999999999999995 109.676 177.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.15 -50.42 74.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.878 -1.156 . . . . 0.56999999999999995 107.878 173.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -38.88 91.55 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.244 -0.884 . . . . 0.56999999999999995 110.826 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.46 -47.71 69.31 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.473 1.488 . . . . 0.56999999999999995 111.105 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.96 86.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.075 0.95 . . . . 0.56999999999999995 111.726 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.21 -31.87 68.13 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.216 -0.897 . . . . 0.56999999999999995 111.156 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.63 -43.98 93.63 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 109.233 170.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.2 mtp -60.1 -35.34 75.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 112.86 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -70.55 -48.09 57.1 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.421 1.009 . . . . 0.56999999999999995 111.669 170.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -9.36 64.73 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.106 1.336 . . . . 0.56999999999999995 113.668 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -66.38 -20.16 66.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 110.499 170.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.89 -20.39 12.47 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.205 -0.902 . . . . 0.66000000000000003 112.691 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.8 pt -127.67 129.75 23.75 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.464 175.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.82 41.45 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.295 3.33 . . . . 0.56999999999999995 112.407 178.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.9 147.72 23.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.295 1.838 . . . . 0.56999999999999995 108.079 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -122.93 166.36 15.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.51 0.724 . . . . 0.65000000000000002 109.25 -172.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.84 39.5 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.111 -0.993 . . . . 0.56999999999999995 109.458 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 165.24 21.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.756 0.823 . . . . 1.2 109.217 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -130.3 114.1 15.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.812 -1.551 . . . . 0.56999999999999995 106.812 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.05 160.76 2.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.383 0.673 . . . . 0.56999999999999995 109.759 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.71 -14.76 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 112.227 -176.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -52.5 64.04 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.664 0.785 . . . . 0.56999999999999995 111.099 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.37 -152.81 6.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.965 1.745 . . . . 0.56999999999999995 109.431 -172.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -60.84 178.88 0.2 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.328 1.051 . . . . 0.56999999999999995 112.477 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.22 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.734 1.614 . . . . 0.56999999999999995 110.382 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.43 -31.62 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.494 -0.765 . . . . 0.66000000000000003 109.138 176.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 mt -125.45 79.13 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 126.641 1.976 . . . . 0.56999999999999995 108.471 -178.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -72.54 117.95 14.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.134 1.773 . . . . 0.56999999999999995 108.226 166.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.88 122.8 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.096 -2.187 . . . . 0.56999999999999995 105.096 177.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.55 138.73 8.06 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 118.149 0.431 . . . . 0.56999999999999995 112.024 -174.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.48 145.69 37.25 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.936 -1.135 . . . . 0.56999999999999995 107.936 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.94 151.7 51.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.685 1.194 . . . . 0.56999999999999995 108.34 -178.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -110.68 70.86 0.73 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.271 0.558 . . . . 1.2 109.608 -174.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.28 -53.79 0.66 Allowed Glycine 0 C--O 1.219 -0.805 0 N-CA-C 110.351 -1.099 . . . . 0.56999999999999995 110.351 174.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 171.66 19.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.328 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 159.56 22.17 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.429 1.892 . . . . 0.65000000000000002 108.537 -174.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.23 46.22 2.22 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.085 1.326 . . . . 0.56999999999999995 111.788 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.42 105.66 7.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.488 -1.301 . . . . 0.66000000000000003 107.488 -172.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.9 m 55.99 -71.72 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.113 2.165 . . . . 0.56999999999999995 113.034 -175.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.75 130.02 15.31 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.351 1.86 . . . . 0.56999999999999995 107.911 -173.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.7 137.75 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.833 175.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -66.48 -173.81 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.973 1.309 . . . . 0.56999999999999995 111.202 169.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.63 -33.52 6.75 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.136 2.574 . . . . 0.66000000000000003 111.962 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.02 -123.54 7.94 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 120.586 -1.321 . . . . 0.56999999999999995 111.965 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.67 95.72 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.83 2.315 . . . . 0.56999999999999995 112.327 -176.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.89 -160.45 25.73 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.966 0.793 . . . . 0.56999999999999995 112.232 173.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 43.57 -129.91 0.78 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 112.904 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -68.3 129.11 38.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.307 2.643 . . . . 0.56999999999999995 109.186 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.67 -30.44 12.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.104 1.361 . . . . 0.56999999999999995 112.049 -175.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.2 37.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.839 1.255 . . . . 0.56999999999999995 108.352 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.74 161.54 38.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.625 -0.88 . . . . 0.65000000000000002 108.625 173.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.36 159.91 43.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.966 0.506 . . . . 0.56999999999999995 109.651 175.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -114.32 152.62 31.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.49 -0.777 . . . . 0.56999999999999995 109.606 -173.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.25 146.57 83.44 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.203 -0.903 . . . . 0.56999999999999995 110.117 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.83 157.98 58.62 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.345 2.03 . . . . 0.56999999999999995 112.335 -176.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.36 -101.7 0.15 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.042 -1.223 . . . . 0.56999999999999995 110.042 176.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -147.05 -41.25 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.901 0.88 . . . . 0.56999999999999995 111.194 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.02 4.57 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.812 -1.315 . . . . 0.56999999999999995 109.812 -175.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -29.95 17.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.224 1.01 . . . . 0.56999999999999995 112.423 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.55 134.79 14.47 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 120.964 -1.085 . . . . 0.56999999999999995 112.865 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.58 9.26 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.217 1.865 . . . . 0.56999999999999995 112.203 -176.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.72 148.44 47.98 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.1 0.95 . . . . 0.66000000000000003 108.885 -166.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.38 137.85 46.02 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.691 0.796 . . . . 0.56999999999999995 109.13 -168.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -135.33 141.24 45.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.299 -1.0 . . . . 0.65000000000000002 108.299 -164.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.29 151.73 42.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.735 -0.839 . . . . 0.56999999999999995 108.735 -169.288 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.56 102.2 11.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.852 -0.796 . . . . 0.66000000000000003 108.852 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.85 -21.72 63.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.095 0.958 . . . . 0.66000000000000003 111.487 172.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.23 -38.83 88.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.611 0.642 . . . . 0.66000000000000003 110.436 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.68 126.37 29.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.345 -1.354 . . . . 0.66000000000000003 107.345 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.82 132.53 22.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.465 -0.939 . . . . 1.2 108.465 176.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -120.78 129.69 53.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.739 -1.948 . . . . 0.56999999999999995 105.739 -177.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -141.02 161.84 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.619 -0.882 . . . . 0.56999999999999995 108.619 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.78 -22.77 58.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.857 0.863 . . . . 0.66000000000000003 111.136 172.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 152.47 96.68 0.14 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.177 0.894 . . . . 0.56999999999999995 111.33 175.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.0 t -120.37 -68.54 0.9 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 118.658 -0.687 . . . . 0.56999999999999995 110.562 -178.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.79 -64.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.06 0.944 . . . . 0.56999999999999995 108.877 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 tt -94.56 -46.1 7.11 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 110.327 -170.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.67 145.58 32.22 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.077 -1.209 . . . . 0.56999999999999995 110.077 173.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.5 mm -77.62 138.26 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.594 -1.262 . . . . 0.56999999999999995 107.594 -171.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -74.16 105.57 5.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.684 -0.487 . . . . 0.56999999999999995 109.684 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.31 -33.73 76.51 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.288 0.635 . . . . 0.56999999999999995 110.887 178.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.51 -51.52 65.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.624 -1.25 . . . . 0.56999999999999995 107.624 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.82 -38.89 92.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.449 0.7 . . . . 0.56999999999999995 109.205 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.31 47.12 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.547 0.739 . . . . 0.56999999999999995 112.252 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.43 77.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.628 -0.879 . . . . 0.56999999999999995 108.628 179.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -60.88 -37.73 83.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 111.382 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.42 -58.8 6.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.17 0.441 . . . . 0.65000000000000002 109.871 172.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -68.63 -41.69 79.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.298 -0.876 . . . . 0.66000000000000003 111.635 -171.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.99 -24.85 66.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.943 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.89 93.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.56999999999999995 110.917 169.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -70.13 -32.96 71.22 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 117.729 -1.129 . . . . 0.65000000000000002 112.239 174.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 p -60.09 -38.1 81.93 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.657 1.117 . . . . 0.56999999999999995 110.894 174.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -33.07 73.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.014 0.435 . . . . 0.56999999999999995 111.181 176.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.48 -55.01 0.12 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 123.782 0.706 . . . . 0.56999999999999995 111.611 175.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 176.09 172.56 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 107.632 -166.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 161.24 75.22 0.02 OUTLIER Glycine 0 C--O 1.218 -0.847 0 N-CA-C 104.137 -3.585 . . . . 0.56999999999999995 104.137 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.14 45.13 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.314 -1.365 . . . . 0.65000000000000002 107.314 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.3 -177.13 0.99 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.966 2.106 . . . . 0.56999999999999995 106.469 -173.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -132.25 39.29 3.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.56999999999999995 109.696 -174.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -104.14 137.69 19.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.66000000000000003 111.197 -172.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.47 -9.49 25.96 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.837 2.358 . . . . 0.56999999999999995 113.573 -174.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -121.52 24.75 9.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 109.599 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.63 133.18 45.53 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.082 -1.011 . . . . 0.56999999999999995 110.115 172.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -22.26 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.069 0.548 . . . . 0.56999999999999995 110.442 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.2 24.75 12.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.43 1.892 . . . . 0.56999999999999995 110.622 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.453 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.12 142.89 92.87 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.137 -0.977 . . . . 0.56999999999999995 109.967 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.9 Cg_endo -69.53 -171.48 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.315 2.01 . . . . 0.56999999999999995 111.235 166.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 t 43.59 68.89 0.46 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.497 1.519 . . . . 0.56999999999999995 113.151 173.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -43.38 129.22 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.772 1.629 . . . . 0.56999999999999995 113.458 -173.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.42 113.86 3.51 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.28 -1.528 . . . . 0.56999999999999995 109.28 -178.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 168.4 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.063 2.145 . . . . 0.56999999999999995 108.48 175.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.96 -145.24 18.34 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.556 -1.017 . . . . 0.56999999999999995 110.556 177.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -128.06 102.25 21.85 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.833 -1.543 . . . . 0.66000000000000003 106.833 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.81 67.09 6.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.985 2.457 . . . . 0.56999999999999995 109.481 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -165.1 -48.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.326 1.85 . . . . 0.56999999999999995 108.961 178.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -77.4 43.11 0.37 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.9 1.444 . . . . 0.56999999999999995 114.9 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -14.4 -71.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 128.352 2.661 . . . . 0.56999999999999995 117.06 -177.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 17.81 79.03 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 128.324 2.649 . . . . 0.56999999999999995 112.309 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 mp -31.66 117.4 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.421 1.889 . . . . 0.56999999999999995 109.762 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -92.2 -87.85 0.21 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.101 -0.476 . . . . 0.56999999999999995 110.481 -163.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -139.57 -39.06 0.47 Allowed 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 117.644 -1.17 . . . . 0.56999999999999995 111.721 177.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -58.93 -37.2 76.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 120.174 1.352 . . . . 0.66000000000000003 110.87 174.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.42 -59.31 2.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 124.118 0.886 . . . . 0.66000000000000003 109.109 175.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.47 -46.0 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.574 1.149 . . . . 0.56999999999999995 110.237 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.37 -47.45 76.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.495 1.118 . . . . 0.56999999999999995 109.749 -177.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.53 58.14 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.995 -1.242 . . . . 0.56999999999999995 109.995 176.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -54.4 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.365 1.066 . . . . 0.56999999999999995 110.896 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -56.29 -43.5 78.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.546 1.139 . . . . 0.56999999999999995 109.569 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -65.14 -36.92 85.76 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.575 0.625 . . . . 0.56999999999999995 111.15 176.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.21 -46.57 79.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.813 1.645 . . . . 0.56999999999999995 112.153 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 20.4 p90 . . . . . 0 N--CA 1.473 0.694 0 C-N-CA 123.406 0.683 . . . . 0.56999999999999995 112.636 -179.063 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 N-CA-C 109.328 -1.066 . . . . 0.56999999999999995 109.328 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 71.47 115.84 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.043 1.737 . . . . 0.56999999999999995 109.48 -171.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -57.12 150.11 18.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.742 0.817 . . . . 0.56999999999999995 110.251 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -65.9 -23.89 66.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.841 0.857 . . . . 0.56999999999999995 111.392 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -94.16 152.63 18.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.99 0.916 . . . . 0.56999999999999995 110.364 173.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -85.62 -3.4 58.87 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.654 1.182 . . . . 0.56999999999999995 112.636 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.56 111.03 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.107 -1.072 . . . . 0.56999999999999995 108.107 177.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.15 124.78 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.551 -1.277 . . . . 0.56999999999999995 107.551 -170.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -92.6 152.23 19.7 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.599 -0.688 . . . . 0.56999999999999995 110.441 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -123.09 153.45 39.9 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.696 0.799 . . . . 0.56999999999999995 111.506 175.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.28 117.77 6.52 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.649 0.738 . . . . 1.2 110.549 174.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mt -87.74 89.46 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 105.05 -2.204 . . . . 0.56999999999999995 105.05 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.89 -31.78 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.135 0.974 . . . . 0.56999999999999995 112.097 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 t -136.2 157.65 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.589 -2.375 . . . . 0.56999999999999995 104.589 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -135.21 167.42 21.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 107.663 -173.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -68.49 -175.03 0.6 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 0.56999999999999995 111.459 172.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -41.49 2.56 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.544 1.138 . . . . 1.2 111.241 -176.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -41.43 77.48 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.875 1.27 . . . . 0.66000000000000003 111.739 178.137 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.41 142.56 29.66 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 108.015 -172.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.42 158.46 56.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.769 1.646 . . . . 0.56999999999999995 112.192 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -67.98 -36.83 80.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.374 -0.83 . . . . 0.65000000000000002 110.592 -171.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.3 tt -65.84 -40.72 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 110.814 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -62.5 -46.08 90.08 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 117.717 -1.135 . . . . 0.56999999999999995 108.272 173.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 t -54.86 -49.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.467 -1.254 . . . . 0.56999999999999995 110.701 175.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.24 -40.25 96.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.498 1.499 . . . . 0.66000000000000003 111.778 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -62.85 -46.21 88.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.487 1.04 . . . . 1.2 111.553 175.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.88 -42.79 89.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.483 1.113 . . . . 0.56999999999999995 109.531 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.44 -43.47 96.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.985 -1.007 . . . . 0.56999999999999995 110.637 170.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -53.5 57.7 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.071 1.305 . . . . 0.56999999999999995 110.692 177.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -63.98 -35.93 82.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.065 1.302 . . . . 0.56999999999999995 111.928 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -41.88 69.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.34 0.973 . . . . 0.56999999999999995 111.907 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -65.91 -35.17 79.88 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.519 -0.753 . . . . 0.56999999999999995 109.88 171.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -59.35 -43.22 92.83 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.113 0.87 . . . . 0.56999999999999995 109.851 171.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.8 mtp -62.16 -41.41 98.27 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.279 -0.867 . . . . 0.56999999999999995 110.971 176.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -61.03 -49.93 75.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.838 1.199 . . . . 0.56999999999999995 111.576 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.64 -5.63 79.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.45 1.024 . . . . 0.56999999999999995 113.88 -178.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -77.6 -21.25 52.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.831 1.315 . . . . 0.56999999999999995 110.741 170.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -97.1 -13.29 22.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.862 0.865 . . . . 0.66000000000000003 111.235 -177.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 164' ' ' TYR . 17.9 pt -142.33 150.66 55.79 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.708 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.51 12.64 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.219 2.613 . . . . 0.56999999999999995 113.452 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -79.67 137.67 37.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -119.18 165.68 13.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.571 0.701 . . . . 0.65000000000000002 109.636 -173.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.7 161.95 35.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.092 -0.707 . . . . 0.56999999999999995 109.092 -173.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -179.8 6.82 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.638 -0.875 . . . . 1.2 108.638 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -131.16 154.84 47.94 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.881 -1.155 . . . . 0.56999999999999995 107.881 177.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.46 164.6 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 124.301 1.041 . . . . 0.56999999999999995 109.256 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.79 -22.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.168 -176.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -64.81 0.81 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.381 -0.97 . . . . 0.56999999999999995 108.381 174.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.24 157.57 7.92 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.078 1.799 . . . . 0.56999999999999995 109.253 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.8 m 61.17 135.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 112.761 178.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.12 177.68 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 121.243 -0.911 . . . . 0.56999999999999995 110.586 -173.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.11 -53.89 32.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.275 -1.38 . . . . 0.66000000000000003 107.275 177.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -103.47 77.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.211 2.204 . . . . 0.56999999999999995 108.358 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.9 ttp -76.72 148.51 36.71 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 119.167 -2.208 . . . . 0.56999999999999995 109.564 173.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.2 140.34 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.736 -1.579 . . . . 0.56999999999999995 106.736 173.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.25 162.3 31.76 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.461 -0.656 . . . . 0.56999999999999995 111.461 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.8 m-85 -137.2 141.46 42.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.052 -1.462 . . . . 0.56999999999999995 107.052 -174.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.3 -174.34 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.713 1.605 . . . . 0.56999999999999995 109.305 -177.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 50.15 1.28 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.224 . . . . 1.2 112.461 -172.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.09 123.58 3.77 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.794 -1.322 . . . . 0.56999999999999995 109.794 -173.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 52.14 122.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.593 2.357 . . . . 0.56999999999999995 115.514 -172.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.14 159.37 44.3 Favored 'General case' 0 C--N 1.341 0.222 0 O-C-N 120.39 -1.444 . . . . 0.65000000000000002 112.193 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.9 80.86 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.522 1.534 . . . . 0.56999999999999995 110.195 175.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.57 -84.36 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.942 1.297 . . . . 0.66000000000000003 110.663 -174.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 t -171.05 -37.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.122 1.369 . . . . 0.56999999999999995 110.126 -177.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.76 142.0 38.16 Favored Pre-proline 0 C--N 1.343 0.284 0 C-N-CA 123.728 0.811 . . . . 0.56999999999999995 109.478 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 124.15 10.28 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.54 1.493 . . . . 0.56999999999999995 109.521 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 171.64 3.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.409 1.1 . . . . 0.56999999999999995 110.398 161.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.537 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 18.6 p-10 -108.81 -44.37 4.03 Favored 'General case' 0 CA--C 1.542 0.645 1 C-N-CA 131.763 4.025 . . . . 0.66000000000000003 109.979 -171.055 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.96 -145.21 17.61 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.226 -1.319 . . . . 0.56999999999999995 111.166 -174.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.94 74.66 2.32 Favored 'Trans proline' 0 C--N 1.354 0.818 1 C-N-CA 125.588 4.192 . . . . 0.56999999999999995 114.042 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.48 -177.76 36.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.183 -1.967 . . . . 0.56999999999999995 108.183 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 9.1 t-20 45.01 -150.19 0.06 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 113.453 174.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -43.0 109.81 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.471 2.308 . . . . 0.56999999999999995 111.513 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.542 ' CG ' ' HE2' ' A' ' 102' ' ' GLU . 5.6 mp -79.25 -29.65 42.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.616 1.166 . . . . 0.56999999999999995 113.319 -172.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.67 157.8 27.74 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.79 1.236 . . . . 0.56999999999999995 108.337 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -142.53 160.44 40.28 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.427 -0.795 . . . . 0.65000000000000002 110.303 174.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.63 172.85 12.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.937 0.895 . . . . 0.56999999999999995 108.723 176.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.95 153.96 46.1 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.527 -0.916 . . . . 0.56999999999999995 108.527 -177.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.23 135.56 76.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.424 -0.798 . . . . 0.56999999999999995 110.111 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -71.16 169.74 19.9 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.394 2.729 . . . . 0.56999999999999995 113.456 -177.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.05 -8.97 27.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.52 1.533 . . . . 0.56999999999999995 113.632 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -136.81 45.41 2.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.246 1.023 . . . . 0.56999999999999995 111.255 -163.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -77.05 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.211 1.386 . . . . 0.56999999999999995 114.185 173.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.85 -21.12 63.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.56999999999999995 110.268 167.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.2 145.65 4.39 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.211 -0.931 . . . . 0.56999999999999995 111.087 170.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.44 -34.29 3.88 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 110.922 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.24 152.53 40.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.292 1.046 . . . . 0.66000000000000003 110.449 -164.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.83 146.01 50.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.824 0.821 . . . . 0.56999999999999995 109.506 -175.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -138.44 152.84 48.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.001 0.92 . . . . 0.65000000000000002 110.093 -177.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 51.3 m-85 -140.09 155.82 46.85 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.633 1.173 . . . . 0.56999999999999995 108.995 -168.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -87.32 102.58 14.65 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.187 -0.301 . . . . 0.66000000000000003 110.187 172.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -53.98 -30.71 48.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.772 1.629 . . . . 0.66000000000000003 111.733 171.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.56 -35.28 79.96 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.341 0.657 . . . . 0.66000000000000003 111.522 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.542 ' HE2' ' CG ' ' A' ' 82' ' ' LEU . 88.5 mt-10 -73.73 150.69 41.01 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.744 0.818 . . . . 0.66000000000000003 109.068 177.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -72.67 144.44 47.74 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.743 -0.598 . . . . 1.2 110.698 175.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.87 128.28 36.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.8 -1.556 . . . . 0.56999999999999995 106.8 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -124.04 144.69 49.69 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.547 -0.538 . . . . 0.56999999999999995 109.547 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.21 -33.51 75.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.66000000000000003 111.284 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.42 95.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.88 -0.888 . . . . 0.56999999999999995 110.88 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.04 138.24 8.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.45 0.7 . . . . 0.56999999999999995 109.276 172.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 t -76.25 54.49 0.89 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.383 2.273 . . . . 0.56999999999999995 110.786 -175.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -158.15 -44.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.486 0.714 . . . . 0.56999999999999995 112.164 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.65 -176.2 38.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.545 -1.022 . . . . 0.56999999999999995 110.545 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.25 118.27 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 105.782 -1.933 . . . . 0.56999999999999995 105.782 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.82 113.01 2.79 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.891 -0.781 . . . . 0.56999999999999995 108.891 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -54.14 -42.37 69.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.25 1.02 . . . . 0.56999999999999995 110.823 177.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.97 -34.06 57.6 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.451 0.569 . . . . 0.56999999999999995 111.469 -171.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -64.48 -48.55 74.79 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.569 -0.9 . . . . 0.56999999999999995 108.569 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.27 74.34 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.804 0.442 . . . . 0.56999999999999995 110.548 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.24 78.16 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.948 -176.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.7 m -61.89 -37.42 84.53 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 0.899 . . . . 0.56999999999999995 110.961 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.51 -53.8 53.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.63 0.772 . . . . 0.65000000000000002 109.817 172.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.8 -44.28 73.88 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.628 0.771 . . . . 0.66000000000000003 111.914 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.26 -28.93 70.06 Favored 'General case' 0 CA--C 1.526 0.036 0 C-N-CA 124.389 1.076 . . . . 0.56999999999999995 111.239 176.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.78 -46.56 93.3 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.623 -0.591 . . . . 0.56999999999999995 111.623 171.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -64.2 -38.41 90.96 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 117.161 0.48 . . . . 0.65000000000000002 111.243 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -34.38 69.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.707 0.632 . . . . 0.56999999999999995 112.707 174.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -22.69 65.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.343 -0.848 . . . . 0.56999999999999995 112.856 174.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.04 -13.61 4.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.709 1.147 . . . . 0.56999999999999995 113.464 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.3 tpp -65.15 144.59 57.11 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.817 1.309 . . . . 0.56999999999999995 110.862 -171.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -97.7 -38.96 4.01 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 117.762 -1.577 . . . . 0.56999999999999995 112.038 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 m80 156.52 -176.4 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.893 3.677 . . . . 0.65000000000000002 108.111 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.4 m -145.45 179.88 7.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 107.829 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.61 94.39 2.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.785 -1.561 . . . . 0.56999999999999995 106.785 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -154.24 138.02 10.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 107.211 -1.403 . . . . 0.66000000000000003 107.211 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.9 -19.57 46.21 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.978 1.785 . . . . 0.56999999999999995 113.37 -173.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -124.39 27.21 7.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.783 1.233 . . . . 0.56999999999999995 109.108 -177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.42 138.52 57.63 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.315 0.646 . . . . 0.56999999999999995 110.369 175.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.5 p -75.02 -26.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.815 -0.439 . . . . 0.56999999999999995 109.815 168.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 13.41 15.53 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.615 -0.678 . . . . 0.56999999999999995 112.148 174.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -70.46 146.35 93.98 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.552 1.524 . . . . 0.56999999999999995 111.528 -174.369 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 38.2 Cg_endo -78.81 -50.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.181 1.921 . . . . 0.56999999999999995 112.693 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.5 t -67.62 120.13 13.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.921 -0.77 . . . . 0.56999999999999995 108.921 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.52 112.77 9.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.899 -0.778 . . . . 0.56999999999999995 108.899 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.76 170.54 21.91 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.805 -1.318 . . . . 0.56999999999999995 109.805 172.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.28 -53.67 0.47 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.507 2.323 . . . . 0.56999999999999995 114.029 174.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.65 108.39 2.48 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 127.162 2.315 . . . . 0.56999999999999995 108.883 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.718 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 49.1 t0 -53.94 111.07 2.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.758 1.623 . . . . 0.66000000000000003 110.751 177.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.05 -10.07 13.99 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.804 2.336 . . . . 0.56999999999999995 112.733 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -96.43 -27.49 14.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.719 1.145 . . . . 0.56999999999999995 110.965 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.718 ' ND2' ' HD2' ' A' ' 146' ' ' ASP . 18.9 m-80 -116.15 71.1 0.77 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.069 -1.086 . . . . 0.56999999999999995 108.069 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -120.95 139.0 53.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.225 1.01 . . . . 0.56999999999999995 108.871 -178.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.96 42.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.36 1.064 . . . . 0.56999999999999995 110.592 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 64.44 92.89 0.06 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.213 1.805 . . . . 0.56999999999999995 110.638 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 75.3 m -75.23 -79.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.374 0.879 . . . . 0.56999999999999995 113.374 -169.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -149.1 -49.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.333 1.053 . . . . 0.56999999999999995 108.248 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -47.54 -46.48 27.76 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 126.151 1.78 . . . . 0.66000000000000003 111.749 167.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.79 -47.84 50.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.801 0.841 . . . . 0.66000000000000003 109.326 -174.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.16 -45.43 92.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 124.311 1.044 . . . . 0.56999999999999995 109.693 175.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -49.1 72.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.261 1.024 . . . . 0.56999999999999995 109.703 -178.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.74 72.79 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.705 -1.358 . . . . 0.56999999999999995 109.705 177.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.3 -53.99 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.178 -0.915 . . . . 0.56999999999999995 111.21 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.56 64.14 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.601 1.091 . . . . 0.56999999999999995 111.459 -178.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -77.33 -35.08 55.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.158 0.583 . . . . 0.56999999999999995 112.131 173.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.3 -40.85 98.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.992 1.717 . . . . 0.56999999999999995 112.749 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.443 ' CD1' HG21 ' A' ' 46' ' ' ILE . 16.8 p90 . . . . . 0 N--CA 1.474 0.762 0 C-N-CA 123.363 0.665 . . . . 0.56999999999999995 112.503 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.272 0 CA-C-O 117.248 -1.358 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m 49.92 75.49 0.17 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.815 1.246 . . . . 0.56999999999999995 112.776 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.91 128.69 56.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.147 -1.427 . . . . 0.56999999999999995 107.147 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -144.61 156.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.186 1.395 . . . . 0.56999999999999995 108.774 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.31 33.91 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.286 3.324 . . . . 0.56999999999999995 114.344 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -135.23 139.57 44.57 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 126.33 1.852 . . . . 0.56999999999999995 106.994 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.5 m -56.27 106.78 0.72 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.648 1.179 . . . . 0.56999999999999995 110.945 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.42 96.4 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.924 1.749 . . . . 0.56999999999999995 109.174 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 pttt 101.19 138.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 130.174 3.389 . . . . 0.56999999999999995 109.305 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -64.89 162.27 16.69 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.69 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.9 p -91.46 6.42 45.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.697 -0.627 . . . . 0.56999999999999995 112.42 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -109.7 147.7 32.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.881 1.272 . . . . 0.56999999999999995 109.056 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -16.89 61.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.293 0.637 . . . . 0.56999999999999995 111.943 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.55 143.49 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.009 -1.108 . . . . 0.56999999999999995 108.009 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 172.24 13.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.893 -0.78 . . . . 0.56999999999999995 108.893 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -116.56 153.33 32.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.389 0.276 . . . . 0.56999999999999995 110.627 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -128.6 149.84 50.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 111.128 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.64 106.23 3.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.821 0.849 . . . . 1.2 108.884 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.5 mt -84.47 84.2 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 106.716 -1.587 . . . . 0.56999999999999995 106.716 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.38 -41.72 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 112.696 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -126.08 164.83 20.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.611 -2.366 . . . . 0.56999999999999995 104.611 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -136.35 155.0 50.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.46 -1.311 . . . . 0.56999999999999995 107.46 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -66.54 -172.02 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.906 0.883 . . . . 0.56999999999999995 111.132 168.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -33.46 0.83 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.874 1.67 . . . . 1.2 112.763 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -39.3 78.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.016 0.926 . . . . 0.66000000000000003 112.179 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 148.33 65.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.947 2.099 . . . . 0.56999999999999995 108.088 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.8 163.49 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.84 2.36 . . . . 0.56999999999999995 112.716 -171.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -62.48 -36.13 81.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.439 0.696 . . . . 0.65000000000000002 112.265 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.78 -38.63 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.549 0.34 . . . . 0.56999999999999995 110.744 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.9 m -69.65 -41.72 75.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.542 -1.218 . . . . 0.56999999999999995 109.5 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.1 t -53.98 -54.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 120.341 1.428 . . . . 0.56999999999999995 109.719 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -43.54 98.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.989 0.813 . . . . 0.66000000000000003 110.834 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -42.08 98.2 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.28 0.945 . . . . 1.2 112.029 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.02 -40.64 68.3 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.682 -1.151 . . . . 0.56999999999999995 109.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.24 -49.37 76.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 119.31 0.959 . . . . 0.56999999999999995 109.183 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -65.03 -44.48 88.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.599 0.76 . . . . 0.56999999999999995 110.437 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -66.3 -45.23 81.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.561 1.073 . . . . 0.56999999999999995 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -47.26 86.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.033 0.833 . . . . 0.56999999999999995 110.811 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 19.7 mt -67.8 -36.73 80.96 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.514 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.36 -38.39 89.36 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 119.16 0.891 . . . . 0.56999999999999995 109.651 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.28 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.032 0.933 . . . . 0.56999999999999995 112.514 173.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 40.9 m95 -68.13 -51.05 50.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.845 1.202 . . . . 0.56999999999999995 110.948 168.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.03 -11.65 58.86 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.563 1.077 . . . . 0.56999999999999995 113.318 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -31.17 72.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.377 -1.072 . . . . 0.56999999999999995 110.481 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -101.26 -21.17 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.016 0.825 . . . . 0.66000000000000003 111.803 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.7 pt -133.15 135.5 25.76 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.493 1.117 . . . . 0.56999999999999995 110.77 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.17 26.36 0.26 Allowed 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 123.814 3.009 . . . . 0.56999999999999995 114.57 -174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.24 136.53 34.37 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.038 1.335 . . . . 0.56999999999999995 108.239 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -117.24 165.15 13.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.664 0.785 . . . . 0.65000000000000002 109.638 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -140.15 148.02 41.02 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.234 -1.024 . . . . 0.56999999999999995 108.234 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -142.33 169.31 17.82 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.842 1.257 . . . . 1.2 109.661 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -103.75 149.39 25.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.571 -0.9 . . . . 0.56999999999999995 108.571 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.78 167.49 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.399 1.08 . . . . 0.56999999999999995 110.45 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.66 -40.83 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.514 0.726 . . . . 0.56999999999999995 110.867 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -164.9 87.23 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.059 1.343 . . . . 0.56999999999999995 107.392 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.41 160.5 11.56 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.219 -1.152 . . . . 0.56999999999999995 110.219 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.1 m -66.38 136.11 55.29 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.258 1.029 . . . . 0.56999999999999995 109.467 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.13 165.11 16.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.508 0.723 . . . . 0.56999999999999995 111.494 175.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.37 -29.04 65.6 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.936 -1.029 . . . . 0.66000000000000003 110.389 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.89 80.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.62 1.968 . . . . 0.56999999999999995 108.731 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.7 ttm -69.37 128.27 35.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 120.653 -1.279 . . . . 0.56999999999999995 107.684 163.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.18 127.1 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.163 -2.162 . . . . 0.56999999999999995 105.163 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.42 158.63 26.55 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.505 -0.638 . . . . 0.56999999999999995 111.505 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.8 m-85 -133.93 146.02 50.12 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 106.838 -1.542 . . . . 0.56999999999999995 106.838 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.3 173.73 11.51 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.06 1.744 . . . . 0.56999999999999995 108.537 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -134.12 66.77 1.53 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.461 1.028 . . . . 1.2 111.614 -169.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 105.37 0.49 Allowed Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.659 -0.976 . . . . 0.56999999999999995 110.659 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 57.91 160.33 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.423 2.689 . . . . 0.56999999999999995 114.474 -169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.435 ' CE1' ' HD1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER -168.11 170.24 10.46 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.998 1.319 . . . . 0.65000000000000002 110.547 175.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.84 61.42 3.69 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.466 1.508 . . . . 0.56999999999999995 112.37 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -131.47 -179.18 5.21 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.854 1.262 . . . . 0.66000000000000003 109.909 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 p -58.23 -36.9 73.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.671 0.669 . . . . 0.56999999999999995 111.25 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -135.57 112.12 10.74 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.447 0.699 . . . . 0.56999999999999995 110.517 -172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.95 130.32 18.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.918 1.745 . . . . 0.56999999999999995 111.288 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -59.1 170.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 113.585 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -115.41 -25.57 7.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.615 1.966 . . . . 0.66000000000000003 112.168 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.81 -139.38 14.49 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 120.139 1.336 . . . . 0.56999999999999995 111.408 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.19 98.28 1.19 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.361 2.707 . . . . 0.56999999999999995 112.2 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.11 -176.4 23.4 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 112.066 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 t30 52.27 -130.63 2.19 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 120.823 -1.398 . . . . 0.56999999999999995 110.683 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.3 m -69.08 132.19 46.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.66 2.784 . . . . 0.56999999999999995 110.828 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -102.27 -29.74 11.5 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.186 1.394 . . . . 0.56999999999999995 112.741 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.7 32.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.076 1.35 . . . . 0.56999999999999995 108.237 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.425 ' C ' ' HE2' ' A' ' 121' ' ' GLU . 3.1 p-80 -145.54 150.76 37.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.744 0.702 . . . . 0.65000000000000002 110.113 173.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.52 165.35 28.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.806 0.842 . . . . 0.56999999999999995 109.47 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -119.71 151.46 38.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.194 -1.039 . . . . 0.56999999999999995 108.194 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.86 150.44 97.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.43 -0.795 . . . . 0.56999999999999995 110.17 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 154.41 53.85 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.216 1.944 . . . . 0.56999999999999995 111.196 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.49 42.77 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.821 -0.989 . . . . 0.56999999999999995 111.484 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.2 m 63.8 161.01 0.1 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.003 2.121 . . . . 0.56999999999999995 112.491 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -140.39 28.65 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 121.06 -1.025 . . . . 0.56999999999999995 110.852 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.71 -23.8 44.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.371 0.668 . . . . 0.56999999999999995 111.525 171.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.77 139.61 31.84 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.002 -1.061 . . . . 0.56999999999999995 110.907 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.13 -19.79 16.02 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.425 1.488 . . . . 0.56999999999999995 113.286 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -71.92 155.92 39.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.954 1.377 . . . . 0.66000000000000003 108.739 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.72 145.6 36.67 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.026 0.917 . . . . 0.56999999999999995 109.598 -172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.435 ' HD1' ' CE1' ' A' ' 69' ' ' HIS . 10.7 m170 -138.07 147.1 43.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.002 -0.999 . . . . 0.65000000000000002 108.465 -170.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 41.4 m-85 -138.04 148.49 45.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.248 1.019 . . . . 0.56999999999999995 108.434 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -95.04 100.64 12.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 106.634 -1.617 . . . . 0.66000000000000003 106.634 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -59.61 -23.13 62.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.356 1.462 . . . . 0.66000000000000003 111.495 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -60.48 -28.85 68.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.504 0.722 . . . . 0.66000000000000003 111.088 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.4 129.68 34.73 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.177 -1.045 . . . . 0.66000000000000003 108.177 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -64.04 112.41 2.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.394 0.677 . . . . 1.2 111.799 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.07 146.76 24.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.56999999999999995 109.458 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -146.96 145.22 29.69 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.419 -0.956 . . . . 0.56999999999999995 108.419 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.19 -39.79 93.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.077 0.551 . . . . 0.66000000000000003 110.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.85 83.91 0.06 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.704 -1.758 . . . . 0.56999999999999995 108.704 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.9 t -118.06 -62.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.677 0.738 . . . . 0.56999999999999995 109.523 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -164.65 -45.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.85 1.26 . . . . 0.56999999999999995 110.703 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.31 142.89 41.88 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.598 1.159 . . . . 0.56999999999999995 109.441 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.3 -172.81 19.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.84 -1.704 . . . . 0.56999999999999995 108.84 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.42 115.44 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.631 -1.618 . . . . 0.56999999999999995 106.631 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.22 115.08 4.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.013 0.525 . . . . 0.56999999999999995 110.05 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -66.13 -42.93 88.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.534 1.134 . . . . 0.56999999999999995 111.693 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -42.65 90.66 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.078 0.951 . . . . 0.56999999999999995 109.573 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -65.96 -49.61 67.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.857 0.863 . . . . 0.56999999999999995 110.789 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -46.95 85.42 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.008 0.367 . . . . 0.56999999999999995 111.737 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -50.0 75.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 108.588 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -53.72 -45.88 70.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.567 1.076 . . . . 0.56999999999999995 111.307 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -58.09 -55.11 39.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.825 1.25 . . . . 0.65000000000000002 109.708 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' HE2' ' C ' ' A' ' 84' ' ' HIS . 17.4 mm-40 -70.73 -47.56 59.09 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.337 0.655 . . . . 0.66000000000000003 111.194 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.52 -29.11 68.9 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.666 1.186 . . . . 0.56999999999999995 110.799 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -61.1 -46.76 93.9 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 118.741 0.7 . . . . 0.56999999999999995 112.373 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.15 -42.54 99.46 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.956 -1.021 . . . . 0.65000000000000002 110.502 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.4 m -57.82 -32.67 67.81 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.086 0.866 . . . . 0.56999999999999995 113.266 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -50.06 64.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.903 0.881 . . . . 0.56999999999999995 109.928 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.21 32.34 0.03 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-O 117.862 -1.521 . . . . 0.56999999999999995 114.995 -172.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.01 171.42 0.2 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.046 1.338 . . . . 0.56999999999999995 111.713 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.26 43.6 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.53 -0.731 . . . . 0.56999999999999995 113.601 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 166.94 18.39 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.909 1.355 . . . . 0.65000000000000002 111.636 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -175.91 4.59 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 109.388 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 35.69 1.28 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 109.854 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.52 151.96 54.0 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.384 1.473 . . . . 0.66000000000000003 109.376 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.16 -22.56 61.23 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.797 2.331 . . . . 0.56999999999999995 113.219 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -130.44 27.48 5.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 109.246 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 132.54 54.25 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 121.704 -0.623 . . . . 0.56999999999999995 110.083 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.27 -23.45 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.554 0.742 . . . . 0.56999999999999995 111.545 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.27 20.5 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 111.381 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.01 133.32 80.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 119.511 1.05 . . . . 0.56999999999999995 111.389 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.8 128.01 9.83 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.832 2.355 . . . . 0.56999999999999995 110.753 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.5 m 70.78 115.15 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.094 2.158 . . . . 0.56999999999999995 111.143 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.47 148.22 9.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.336 1.054 . . . . 0.56999999999999995 112.939 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.91 -124.45 0.78 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.686 -0.966 . . . . 0.56999999999999995 110.686 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.6 -37.21 83.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.569 1.148 . . . . 0.56999999999999995 113.586 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.59 97.59 0.06 OUTLIER Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.817 1.198 . . . . 0.56999999999999995 110.745 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -65.24 116.52 31.27 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.885 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.4 -16.67 8.05 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 CA-C-O 117.53 -1.112 . . . . 0.56999999999999995 112.964 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -61.18 -37.2 82.08 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.703 1.592 . . . . 0.56999999999999995 109.279 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.14 122.35 14.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 107.975 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -131.7 -55.64 1.0 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.653 1.181 . . . . 0.56999999999999995 107.83 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 36.12 52.81 0.9 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.438 1.495 . . . . 0.56999999999999995 111.005 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.01 90.89 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.021 2.128 . . . . 0.56999999999999995 110.91 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -66.14 -83.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.829 1.418 . . . . 0.56999999999999995 114.829 -168.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -143.84 -44.57 0.27 Allowed 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.863 1.665 . . . . 0.56999999999999995 107.767 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.43 -51.69 33.74 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.81 1.244 . . . . 0.66000000000000003 111.544 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -50.52 73.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.501 0.592 . . . . 0.66000000000000003 111.598 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.81 -44.66 98.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 108.858 -0.793 . . . . 0.56999999999999995 108.858 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -65.16 -44.81 87.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.698 -1.144 . . . . 0.56999999999999995 108.971 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.47 -59.0 11.6 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.596 -1.002 . . . . 0.56999999999999995 110.596 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.1 mm -57.15 -48.65 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.361 1.08 . . . . 0.56999999999999995 111.384 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -73.06 -15.46 61.5 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 120.02 1.282 . . . . 0.56999999999999995 112.161 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -79.51 -32.11 42.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.678 1.126 . . . . 0.56999999999999995 111.49 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.94 -43.64 11.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.283 1.433 . . . . 0.56999999999999995 111.709 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -103.75 24.65 10.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.328 1.851 . . . . 0.56999999999999995 110.928 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.0 -137.33 2.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 107.13 -2.388 . . . . 0.56999999999999995 107.13 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -157.77 -54.78 0.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 117.956 0.878 . . . . 0.56999999999999995 111.043 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? -46.33 137.7 6.15 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.167 1.787 . . . . 1.2 111.005 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 76.2 p -158.66 151.0 21.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.262 1.025 . . . . 0.56999999999999995 109.072 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -84.2 156.08 22.21 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.264 0.555 . . . . 0.56999999999999995 109.568 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.9 m -87.67 132.76 33.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.929 0.892 . . . . 0.56999999999999995 108.875 170.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -158.7 160.63 36.63 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.106 -1.442 . . . . 1.2 107.106 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 134.39 24.82 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.127 -1.434 . . . . 0.56999999999999995 107.127 168.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 125.63 1.572 . . . . 0.5 . 172.765 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.863 -0.113 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m -99.9 -68.12 0.82 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.301 -0.874 . . . . 0.56999999999999995 109.46 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.5 tp -167.36 -61.12 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 CA-C-O 117.994 -1.003 . . . . 0.56999999999999995 110.537 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 17.96 70.1 0.21 Allowed Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 128.472 2.709 . . . . 0.56999999999999995 113.217 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.88 69.31 7.47 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.757 2.971 . . . . 0.56999999999999995 109.3 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -131.16 -79.16 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.788 2.035 . . . . 0.56999999999999995 107.825 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 p -167.15 60.67 0.55 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.509 1.124 . . . . 0.56999999999999995 110.662 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.04 134.03 32.9 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.151 1.901 . . . . 0.56999999999999995 108.842 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 82.57 111.28 0.06 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.405 2.282 . . . . 0.56999999999999995 109.104 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -56.37 147.7 20.74 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.107 0.563 . . . . 0.56999999999999995 111.276 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -77.35 -28.22 52.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.489 0.715 . . . . 0.56999999999999995 111.514 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -84.37 144.25 28.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.798 0.839 . . . . 0.56999999999999995 109.902 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -81.49 -8.74 59.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 111.866 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.25 119.57 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.924 -2.25 . . . . 0.56999999999999995 104.924 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.21 142.98 36.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.122 -1.436 . . . . 0.56999999999999995 107.122 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -96.32 152.68 18.36 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.001 -0.437 . . . . 0.56999999999999995 111.028 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -128.2 155.04 45.15 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.809 0.844 . . . . 0.56999999999999995 111.662 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 114.07 4.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 1.2 109.566 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.8 mt -85.43 86.11 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.222 -1.77 . . . . 0.56999999999999995 106.222 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -68.25 -29.96 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.313 1.445 . . . . 0.56999999999999995 113.846 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -136.57 160.26 39.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 130.714 3.606 . . . . 0.56999999999999995 102.827 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -135.84 163.98 28.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 108.345 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 t -74.02 -175.07 2.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.94 0.896 . . . . 0.56999999999999995 111.409 171.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -44.2 1.86 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.667 1.187 . . . . 1.2 113.211 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -32.52 67.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.399 1.08 . . . . 0.66000000000000003 110.791 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.0 mt -123.2 143.51 41.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.311 1.444 . . . . 0.56999999999999995 109.243 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.35 152.09 38.73 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.789 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -62.18 -37.24 84.52 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 112.199 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.76 -42.86 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.819 . . . . 0.56999999999999995 109.847 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.5 m -70.55 -38.73 74.19 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 117.209 -1.377 . . . . 0.56999999999999995 110.042 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.39 -45.66 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.434 1.47 . . . . 0.56999999999999995 110.978 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.98 -41.09 78.37 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.93 0.786 . . . . 0.66000000000000003 110.788 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.17 87.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.933 -1.104 . . . . 1.2 112.631 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.79 -39.56 93.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.615 -0.883 . . . . 0.56999999999999995 108.615 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.66 -43.63 98.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 119.207 0.912 . . . . 0.56999999999999995 110.415 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -59.1 -48.53 81.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.831 -1.08 . . . . 0.56999999999999995 111.79 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -67.66 -34.45 76.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.583 1.538 . . . . 0.56999999999999995 112.173 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.57 -40.7 76.6 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.105 1.321 . . . . 0.56999999999999995 112.185 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.2 mt -72.98 -32.32 65.11 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 110.888 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.64 -47.38 86.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 119.138 0.881 . . . . 0.56999999999999995 109.252 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.0 mtp -54.24 -36.59 63.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 117.226 -1.368 . . . . 0.56999999999999995 112.442 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -72.5 -44.4 62.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.165 1.802 . . . . 0.56999999999999995 112.352 171.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.93 59.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.17 0.89 . . . . 0.56999999999999995 113.273 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -14.46 62.94 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.193 -1.18 . . . . 0.56999999999999995 111.809 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -115.88 -29.11 6.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.53 1.132 . . . . 0.66000000000000003 110.73 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 pt -123.66 132.72 24.3 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 110.982 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.0 34.9 0.37 Allowed 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.235 3.29 . . . . 0.56999999999999995 113.934 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.56 137.22 35.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 107.782 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -121.12 159.56 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.04 1.336 . . . . 0.65000000000000002 109.177 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 149.39 44.04 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.954 -1.091 . . . . 0.56999999999999995 109.882 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.21 179.3 7.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.988 0.915 . . . . 1.2 110.68 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -118.71 161.3 20.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.407 1.083 . . . . 0.56999999999999995 109.12 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.3 m -121.44 160.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.487 1.515 . . . . 0.56999999999999995 108.88 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.97 29.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.32 1.048 . . . . 0.56999999999999995 110.373 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -54.63 1.26 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.403 1.081 . . . . 0.56999999999999995 110.394 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.27 -135.91 2.31 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.227 -1.149 . . . . 0.56999999999999995 110.227 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m -83.65 176.94 8.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.922 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.76 173.46 11.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.894 1.678 . . . . 0.56999999999999995 110.285 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.19 -39.9 91.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.416 -0.802 . . . . 0.66000000000000003 109.868 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.4 mt -117.93 75.33 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.204 2.202 . . . . 0.56999999999999995 108.746 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.98 128.81 37.24 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.789 -1.194 . . . . 0.56999999999999995 108.854 166.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.95 129.85 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 104.784 -2.302 . . . . 0.56999999999999995 104.784 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.08 170.77 27.17 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.269 -0.733 . . . . 0.56999999999999995 111.269 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.7 m-85 -144.59 151.16 38.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.782 -1.192 . . . . 0.56999999999999995 107.782 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.3 171.01 18.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.822 1.326 . . . . 0.56999999999999995 110.417 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 57.17 1.67 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.613 0.765 . . . . 1.2 111.019 -173.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -46.33 1.1 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.743 1.163 . . . . 0.56999999999999995 111.482 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.69 157.45 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.558 1.179 . . . . 0.56999999999999995 109.573 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -153.6 163.44 39.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.211 1.805 . . . . 0.65000000000000002 108.336 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.21 85.59 1.53 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.88 -1.288 . . . . 0.56999999999999995 109.88 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.581 ' HD2' ' N ' ' A' ' 73' ' ' TYR . 10.0 p-10 -130.92 -55.11 1.06 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.834 0.854 . . . . 0.66000000000000003 110.998 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 157.76 -38.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.748 2.819 . . . . 0.56999999999999995 110.156 -166.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.581 ' N ' ' HD2' ' A' ' 71' ' ' ASP . 76.3 m-85 -129.93 110.5 17.06 Favored Pre-proline 0 C--N 1.345 0.382 0 CA-C-N 119.794 1.179 . . . . 0.56999999999999995 110.447 -172.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.25 133.12 36.46 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 108.736 -1.294 . . . . 0.56999999999999995 108.736 173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HB3' ' HD2' ' A' ' 99' ' ' ASP . 1.5 m-85 -70.55 -169.81 0.35 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.64 1.576 . . . . 0.56999999999999995 110.217 172.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -119.63 -35.01 3.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.266 2.226 . . . . 0.66000000000000003 109.815 -168.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.6 -146.37 18.18 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.925 1.25 . . . . 0.56999999999999995 110.203 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.99 111.31 3.21 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 112.22 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.31 160.09 13.92 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 128.099 2.762 . . . . 0.56999999999999995 109.71 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.271 33.3 t30 70.57 -143.51 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.112 1.765 . . . . 0.56999999999999995 112.528 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -49.92 138.79 14.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.324 1.85 . . . . 0.56999999999999995 110.795 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.2 mt -108.74 -28.96 8.93 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.72 -1.863 . . . . 0.56999999999999995 112.303 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.22 165.41 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.573 1.149 . . . . 0.56999999999999995 108.13 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -146.51 161.71 39.86 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.547 -0.538 . . . . 0.65000000000000002 109.547 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.34 161.7 39.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 109.106 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.52 150.7 34.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.393 -0.965 . . . . 0.56999999999999995 108.393 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.9 91.17 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.562 -0.732 . . . . 0.56999999999999995 109.856 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.4 161.21 45.81 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.29 1.994 . . . . 0.56999999999999995 110.91 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.25 -83.48 0.18 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.835 -0.906 . . . . 0.56999999999999995 110.835 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.7 p -78.15 -177.72 5.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.5 1.52 . . . . 0.56999999999999995 111.272 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.81 -52.49 50.55 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.253 -1.304 . . . . 0.56999999999999995 112.854 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -20.21 61.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.297 1.049 . . . . 0.56999999999999995 110.967 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.51 148.74 11.29 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 111.18 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.11 1.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 117.259 -1.856 . . . . 0.56999999999999995 114.924 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -68.22 156.18 38.15 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 125.306 1.239 . . . . 0.66000000000000003 109.833 -160.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.78 144.48 31.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.56999999999999995 110.956 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -131.19 157.79 42.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.024 -0.989 . . . . 0.65000000000000002 109.437 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.436 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 69.1 m-85 -140.01 145.79 38.24 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.308 1.443 . . . . 0.56999999999999995 108.516 -170.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.485 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 5.9 m-20 -78.21 93.62 4.63 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.29 -0.633 . . . . 0.66000000000000003 109.29 172.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -53.45 -28.04 28.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.799 1.24 . . . . 0.66000000000000003 111.27 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.01 -33.62 76.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.758 0.281 . . . . 0.66000000000000003 111.758 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.89 138.61 46.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.115 -1.439 . . . . 0.66000000000000003 107.115 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -62.93 134.16 55.76 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.468 -0.77 . . . . 1.2 109.656 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -118.49 143.32 46.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.622 0.769 . . . . 0.56999999999999995 109.444 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.6 t -138.89 151.75 47.21 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.339 0.656 . . . . 0.56999999999999995 110.761 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.75 -38.19 83.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.467 0.707 . . . . 0.66000000000000003 109.898 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.46 101.44 0.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.006 -1.638 . . . . 0.56999999999999995 109.006 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.27 170.43 21.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.759 2.024 . . . . 0.56999999999999995 108.647 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.74 72.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.247 1.419 . . . . 0.56999999999999995 114.447 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.72 149.77 34.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.997 -0.742 . . . . 0.56999999999999995 108.997 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.42 153.37 14.65 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.534 -1.426 . . . . 0.56999999999999995 109.534 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mm -78.36 130.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.78 -1.563 . . . . 0.56999999999999995 106.78 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -65.53 109.04 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.428 -0.582 . . . . 0.56999999999999995 109.428 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -56.07 -43.57 78.09 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.24 1.416 . . . . 0.56999999999999995 109.01 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.83 -38.54 79.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.589 0.631 . . . . 0.56999999999999995 111.943 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -65.01 -44.4 89.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.835 -0.802 . . . . 0.56999999999999995 108.835 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -50.42 70.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.646 0.379 . . . . 0.56999999999999995 111.23 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.09 75.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.109 -0.948 . . . . 0.56999999999999995 109.86 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -60.52 -33.46 72.67 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.795 1.179 . . . . 0.56999999999999995 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.3 -58.62 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.338 0.972 . . . . 0.65000000000000002 109.978 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -64.3 -43.1 95.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.449 0.7 . . . . 0.66000000000000003 111.272 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.09 -27.76 69.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.885 1.274 . . . . 0.56999999999999995 110.971 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.33 -50.91 62.68 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.389 -0.684 . . . . 0.56999999999999995 111.389 171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -59.18 -43.02 92.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.191 -0.909 . . . . 0.65000000000000002 110.666 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -38.44 64.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.438 1.711 . . . . 0.56999999999999995 114.035 174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -44.96 86.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.789 0.836 . . . . 0.56999999999999995 110.949 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.67 43.32 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-O 118.688 -1.062 . . . . 0.56999999999999995 114.338 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -121.77 150.77 41.37 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.926 1.363 . . . . 0.56999999999999995 110.416 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -98.55 -43.32 2.74 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.455 -1.747 . . . . 0.56999999999999995 113.191 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m170 163.75 179.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.95 2.9 . . . . 0.65000000000000002 109.899 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 3.9 m -147.62 179.03 7.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 109.508 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -146.52 81.83 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.437 1.095 . . . . 0.56999999999999995 109.996 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.11 146.38 25.43 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.24 -32.25 42.56 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 CA-C-N 121.407 1.538 . . . . 0.56999999999999995 111.882 -171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -116.84 23.86 11.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.031 1.332 . . . . 0.56999999999999995 109.254 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.33 136.48 57.69 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.017 0.927 . . . . 0.56999999999999995 109.266 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.43 -32.37 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 118.927 -1.109 . . . . 0.56999999999999995 109.631 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.73 7.55 10.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.575 1.08 . . . . 0.56999999999999995 113.17 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.03 145.8 96.8 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.895 1.679 . . . . 0.56999999999999995 110.967 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.04 166.21 30.65 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 110.971 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 m 65.56 -67.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.662 1.985 . . . . 0.56999999999999995 111.673 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 161.84 1.17 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.285 2.234 . . . . 0.56999999999999995 107.366 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.1 136.22 12.81 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.061 -1.616 . . . . 0.56999999999999995 109.061 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -71.89 -16.25 62.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.463 1.105 . . . . 0.56999999999999995 112.394 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -78.29 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.573 -1.411 . . . . 0.56999999999999995 109.573 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -174.85 144.74 0.87 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.955 1.302 . . . . 0.66000000000000003 108.776 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.36 -23.24 8.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.275 1.983 . . . . 0.56999999999999995 114.992 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -103.24 -39.31 6.88 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.456 1.48 . . . . 0.56999999999999995 110.308 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.9 70.28 10.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.967 1.307 . . . . 0.56999999999999995 109.563 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.5 150.77 40.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.44 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.29 62.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.869 1.268 . . . . 0.56999999999999995 110.052 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mp 62.69 87.45 0.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.224 1.41 . . . . 0.56999999999999995 111.237 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.5 m -71.83 -97.51 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.802 1.241 . . . . 0.56999999999999995 113.424 -171.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -122.99 -51.79 1.89 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 120.879 -1.138 . . . . 0.56999999999999995 108.166 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 0.6 OUTLIER -51.06 -39.55 56.25 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.536 0.939 . . . . 0.66000000000000003 113.536 177.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -69.07 -55.36 11.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.437 1.095 . . . . 0.66000000000000003 110.748 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.58 -38.99 81.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-O 117.959 -1.02 . . . . 0.56999999999999995 108.598 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.38 86.89 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 120.167 1.349 . . . . 0.56999999999999995 109.51 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.33 31.47 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.247 -0.741 . . . . 0.56999999999999995 111.247 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.3 -48.82 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.009 0.524 . . . . 0.56999999999999995 111.803 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -17.56 64.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.426 1.09 . . . . 0.56999999999999995 111.894 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -42.92 17.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.869 -1.062 . . . . 0.56999999999999995 109.662 172.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.78 -49.23 60.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.559 1.144 . . . . 0.56999999999999995 111.426 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -97.54 3.88 50.49 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.941 1.296 . . . . 0.56999999999999995 111.302 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.46 94.11 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.757 1.17 . . . . 0.56999999999999995 113.868 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -152.02 -45.54 0.11 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.47 0.708 . . . . 0.56999999999999995 112.256 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.6 128.24 10.81 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.228 -1.397 . . . . 1.2 107.228 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.8 t -86.25 160.11 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.56999999999999995 107.497 167.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -67.17 164.19 18.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.888 -0.597 . . . . 0.56999999999999995 110.557 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.6 t 70.71 -167.89 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.131 1.372 . . . . 0.56999999999999995 110.691 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.0 126.76 29.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.409 -0.807 . . . . 1.2 109.29 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -76.02 168.98 19.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.916 1.687 . . . . 0.56999999999999995 110.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 129.217 3.007 . . . . 0.5 . 172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 119.363 -0.351 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t -162.96 -78.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.437 -2.801 . . . . 0.56999999999999995 103.437 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.87 72.41 0.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.959 0.904 . . . . 0.56999999999999995 109.703 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 36.79 57.4 3.58 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 114.074 -175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.94 175.34 11.35 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.979 2.453 . . . . 0.56999999999999995 111.819 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -77.81 -71.12 0.44 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.102 0.561 . . . . 0.56999999999999995 111.554 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -160.44 68.53 2.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.903 1.681 . . . . 0.56999999999999995 106.82 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.23 167.61 21.57 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 120.888 1.059 . . . . 0.56999999999999995 110.821 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt 83.51 115.91 0.05 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 127.429 2.292 . . . . 0.56999999999999995 108.997 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 4.2 m95 -64.93 163.03 15.27 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 111.558 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.9 m -89.35 -24.46 21.97 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.997 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -91.28 149.11 21.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.585 0.754 . . . . 0.56999999999999995 109.797 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -5.84 52.98 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.961 0.726 . . . . 0.56999999999999995 112.961 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.56 139.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.56999999999999995 107.189 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.58 148.3 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.452 -1.314 . . . . 0.56999999999999995 107.452 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.9 p -97.52 139.61 33.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.852 -0.795 . . . . 0.56999999999999995 108.852 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -126.97 159.9 32.7 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.822 -0.549 . . . . 0.56999999999999995 110.995 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -153.09 160.25 42.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.103 1.361 . . . . 1.2 108.301 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.56 94.24 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.086 -2.561 . . . . 0.56999999999999995 104.086 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -40.69 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.112 0.965 . . . . 0.56999999999999995 112.152 -170.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.12 153.4 41.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.146 -2.168 . . . . 0.56999999999999995 105.146 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -134.98 143.19 46.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 108.463 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -72.18 169.02 17.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.256 -1.338 . . . . 0.56999999999999995 110.165 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -24.89 5.89 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.731 0.812 . . . . 1.2 112.881 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -35.43 80.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.942 0.877 . . . . 0.66000000000000003 111.224 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.58 154.14 78.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.122 1.769 . . . . 0.56999999999999995 109.629 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.19 161.15 29.4 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.702 1.602 . . . . 0.56999999999999995 112.933 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.84 -35.45 80.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.65000000000000002 111.342 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -64.84 -35.68 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.523 0.729 . . . . 0.56999999999999995 110.55 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -64.73 -51.11 64.1 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.296 -1.335 . . . . 0.56999999999999995 108.15 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.51 -49.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 120.398 1.454 . . . . 0.56999999999999995 110.856 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.19 -39.86 90.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.519 1.054 . . . . 0.66000000000000003 111.487 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -65.05 -42.98 93.74 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.642 1.11 . . . . 1.2 111.818 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.53 -43.64 89.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.599 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.61 -45.12 99.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.017 -0.992 . . . . 0.56999999999999995 110.035 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -60.96 -45.2 95.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.72 1.145 . . . . 0.56999999999999995 111.504 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -36.95 73.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.66 1.118 . . . . 0.56999999999999995 111.418 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.374 0.988 . . . . 0.56999999999999995 111.519 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.4 -33.26 72.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.252 -0.88 . . . . 0.56999999999999995 110.557 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.38 -42.36 91.48 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 119.439 1.018 . . . . 0.56999999999999995 110.211 167.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.2 mtp -64.74 -33.38 75.83 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 119.912 1.233 . . . . 0.56999999999999995 111.592 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -70.72 -44.47 66.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.2 1.364 . . . . 0.56999999999999995 111.147 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.89 -8.1 77.08 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.205 -0.934 . . . . 0.56999999999999995 113.734 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -65.92 -24.43 66.83 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.017 -1.284 . . . . 0.56999999999999995 111.047 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.39 -41.29 7.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.958 -0.544 . . . . 0.66000000000000003 110.789 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -117.25 139.21 25.71 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 110.248 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.05 35.26 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.898 3.066 . . . . 0.56999999999999995 114.13 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -90.87 132.0 36.17 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.695 1.598 . . . . 0.56999999999999995 107.476 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -123.7 165.95 16.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.971 0.909 . . . . 0.65000000000000002 109.411 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.26 144.86 33.5 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.343 -0.984 . . . . 0.56999999999999995 108.343 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -143.05 165.33 27.67 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.861 0.865 . . . . 1.2 108.982 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -107.89 140.31 41.19 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.934 -1.135 . . . . 0.56999999999999995 107.934 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -90.53 161.26 2.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.354 0.597 . . . . 0.56999999999999995 110.112 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.31 -14.85 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 111.602 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -58.96 2.98 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.829 0.852 . . . . 0.56999999999999995 109.956 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.39 146.54 4.83 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.864 -1.295 . . . . 0.56999999999999995 109.864 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.3 m 59.55 144.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.164 2.186 . . . . 0.56999999999999995 112.709 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.2 170.32 15.97 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 120.857 -1.152 . . . . 0.56999999999999995 110.119 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -58.68 -48.96 79.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.121 -1.066 . . . . 0.66000000000000003 108.121 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.39 87.2 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.56999999999999995 108.335 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 ttm -84.59 111.87 19.92 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.014 -1.106 . . . . 0.56999999999999995 108.014 170.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.53 132.03 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 106.392 -1.707 . . . . 0.56999999999999995 106.392 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -156.4 154.41 25.51 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 112.094 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -129.37 153.08 48.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.366 1.083 . . . . 0.56999999999999995 110.672 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.95 178.14 7.31 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 109.915 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -132.25 66.95 1.54 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.677 -1.231 . . . . 1.2 107.677 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.34 -40.99 2.3 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.11 -0.828 . . . . 0.56999999999999995 112.759 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.36 164.84 12.92 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.261 1.53 . . . . 0.56999999999999995 110.933 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 -109.71 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.508 2.323 . . . . 0.65000000000000002 106.349 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.41 71.33 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.691 -1.764 . . . . 0.56999999999999995 108.691 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.62 -56.68 2.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.716 1.206 . . . . 0.66000000000000003 109.116 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.9 t 177.43 -39.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.795 2.038 . . . . 0.56999999999999995 108.983 -169.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.84 102.13 44.65 Favored Pre-proline 0 C--N 1.345 0.395 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 109.455 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.67 144.39 84.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.943 1.015 . . . . 0.56999999999999995 109.504 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -69.84 -168.02 0.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.777 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.41 -31.68 4.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.485 3.114 . . . . 0.66000000000000003 110.755 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -152.24 17.35 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 119.97 1.259 . . . . 0.56999999999999995 111.816 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.18 61.94 4.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 125.168 3.912 . . . . 0.56999999999999995 114.776 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.52 18.6 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.637 1.589 . . . . 0.56999999999999995 112.521 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 31.4 -130.34 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.322 2.649 . . . . 0.56999999999999995 114.225 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -61.43 119.54 8.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.651 1.981 . . . . 0.56999999999999995 110.535 171.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.16 -34.6 22.07 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 113.51 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.64 161.36 38.63 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.201 1.0 . . . . 0.56999999999999995 108.644 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.522 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 2.5 p-80 -149.11 151.73 34.91 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 122.955 0.502 . . . . 0.65000000000000002 109.878 173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.7 157.74 44.36 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.475 0.71 . . . . 0.56999999999999995 109.502 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -109.95 145.06 37.56 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.734 -0.839 . . . . 0.56999999999999995 108.734 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 151.11 92.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.56999999999999995 109.887 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 48.9 Cg_endo -67.94 157.68 60.71 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.338 2.025 . . . . 0.56999999999999995 111.887 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.34 21.43 0.02 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.226 1.251 . . . . 0.56999999999999995 116.226 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.309 37.0 p 64.8 71.57 0.46 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.28 2.232 . . . . 0.56999999999999995 113.743 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.39 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 120.783 -1.198 . . . . 0.56999999999999995 112.38 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.54 -6.05 37.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.733 1.613 . . . . 0.56999999999999995 111.211 164.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.93 129.75 13.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.115 -1.594 . . . . 0.56999999999999995 109.115 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.3 -27.01 20.04 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.012 1.768 . . . . 0.56999999999999995 112.758 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.07 147.26 53.8 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.795 -1.187 . . . . 0.66000000000000003 107.795 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.58 141.15 35.23 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 109.39 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 46.6 m170 -129.92 152.68 49.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 110.411 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.08 154.75 42.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.036 0.934 . . . . 0.56999999999999995 108.485 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.45 98.94 11.22 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.781 -0.822 . . . . 0.66000000000000003 108.781 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -56.63 -25.77 54.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.651 1.981 . . . . 0.66000000000000003 112.299 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -56.25 -40.63 74.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.594 1.157 . . . . 0.66000000000000003 110.218 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.49 126.9 31.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.035 0.934 . . . . 0.66000000000000003 108.575 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.97 98.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.617 1.167 . . . . 1.2 111.818 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.59 145.82 28.64 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.932 -1.136 . . . . 0.56999999999999995 107.932 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -141.73 147.09 36.83 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.759 -1.2 . . . . 0.56999999999999995 107.759 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.77 17.08 5.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.506 1.122 . . . . 0.66000000000000003 112.365 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.39 -151.7 23.35 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.76 2.124 . . . . 0.56999999999999995 108.006 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.81 -173.52 0.19 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 110.934 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 p -109.23 179.52 4.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.228 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.94 -58.87 0.57 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.499 2.32 . . . . 0.56999999999999995 113.686 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 169.93 53.33 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.766 1.651 . . . . 0.56999999999999995 110.36 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.1 120.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.976 -0.749 . . . . 0.56999999999999995 108.976 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.05 112.73 3.11 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.822 0.701 . . . . 0.56999999999999995 109.595 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.18 -40.13 64.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.587 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.94 -42.98 84.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.168 0.44 . . . . 0.56999999999999995 110.088 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.17 -45.12 95.94 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.97 66.29 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.393 0.677 . . . . 0.56999999999999995 111.443 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -53.36 55.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.166 -0.921 . . . . 0.56999999999999995 109.433 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 84.8 m -57.57 -37.76 73.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.684 1.129 . . . . 0.56999999999999995 111.309 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -62.71 -54.36 40.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.935 0.789 . . . . 0.65000000000000002 110.461 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 4.6 mm-40 -66.81 -43.15 84.58 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.149 0.979 . . . . 0.66000000000000003 110.795 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.33 -30.36 71.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 0.56999999999999995 111.226 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.05 -51.6 57.35 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.581 -1.008 . . . . 0.56999999999999995 110.581 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.21 -46.08 89.41 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.243 -0.884 . . . . 0.65000000000000002 111.016 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.8 p -61.94 -32.39 72.8 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 123.969 0.793 . . . . 0.56999999999999995 112.364 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -46.38 89.82 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.561 0.744 . . . . 0.56999999999999995 110.54 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.91 36.66 0.02 OUTLIER Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.796 -1.002 . . . . 0.56999999999999995 114.372 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -124.99 163.59 21.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 109.613 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.97 -47.0 0.17 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.61 -1.661 . . . . 0.56999999999999995 111.788 -169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m170 167.38 -177.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.707 2.803 . . . . 0.65000000000000002 107.964 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.461 ' OG ' ' OD2' ' A' ' 155' ' ' ASP . 14.6 p -152.07 -174.44 4.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.394 1.078 . . . . 0.56999999999999995 108.478 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.7 m -137.04 67.61 1.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 108.759 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.92 143.64 48.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.528 -0.916 . . . . 0.66000000000000003 108.528 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.89 -14.91 21.29 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 112.981 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 32.83 4.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.379 1.472 . . . . 0.56999999999999995 109.462 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.59 143.18 26.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.56999999999999995 109.875 173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -67.46 -31.85 54.56 Favored 'Isoleucine or valine' 0 C--O 1.23 0.044 0 N-CA-C 109.401 -0.592 . . . . 0.56999999999999995 109.401 166.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -19.2 64.85 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 117.057 -1.449 . . . . 0.56999999999999995 112.236 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -49.9 109.81 1.4 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.266 1.394 . . . . 0.56999999999999995 110.524 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.1 38.91 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.215 2.61 . . . . 0.56999999999999995 113.331 -171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.2 m -150.28 132.58 15.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.666 1.586 . . . . 0.56999999999999995 107.032 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -81.7 101.57 10.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.68 -108.66 0.31 Allowed Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.572 -0.571 . . . . 0.56999999999999995 112.585 -171.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -38.03 87.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.714 0.806 . . . . 0.56999999999999995 112.352 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.05 90.82 0.06 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 124.967 1.27 . . . . 0.56999999999999995 110.767 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -52.68 115.53 7.34 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.758 2.023 . . . . 0.66000000000000003 109.883 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.3 -23.58 5.06 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.44 2.093 . . . . 0.56999999999999995 113.269 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -69.43 -39.59 77.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.863 1.211 . . . . 0.56999999999999995 110.524 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -141.17 116.64 10.16 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.415 1.086 . . . . 0.56999999999999995 108.902 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 15.0 p90 -147.2 -49.36 0.18 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 111.207 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER 30.61 52.98 0.14 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 127.321 2.248 . . . . 0.56999999999999995 113.113 -176.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp 63.32 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.006 1.722 . . . . 0.56999999999999995 110.935 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -70.65 -82.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.051 0.94 . . . . 0.56999999999999995 112.974 -165.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -144.63 -48.51 0.26 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 108.566 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.461 ' OD2' ' OG ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -49.87 -47.3 51.93 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.473 1.909 . . . . 0.66000000000000003 112.913 172.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.61 -54.42 47.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.756 0.822 . . . . 0.66000000000000003 110.827 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.15 -45.73 92.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.329 1.052 . . . . 0.56999999999999995 108.921 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -63.71 -41.91 98.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.812 1.245 . . . . 0.56999999999999995 109.368 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.03 -49.03 69.93 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.743 -0.943 . . . . 0.56999999999999995 110.743 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.65 -47.19 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 117.774 0.787 . . . . 0.56999999999999995 110.995 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -66.79 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.904 -0.569 . . . . 0.56999999999999995 112.063 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.45 43.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.292 0.951 . . . . 0.56999999999999995 110.612 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mp -78.45 -41.94 31.34 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.959 0.8 . . . . 0.56999999999999995 112.554 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -131.13 -29.13 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.202 0.815 . . . . 0.56999999999999995 113.202 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.24 172.35 34.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.618 -1.393 . . . . 0.56999999999999995 109.618 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -72.58 -49.49 31.94 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.096 -0.649 . . . . 0.56999999999999995 110.898 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 11.3 ptt-85 177.68 160.63 0.5 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.773 2.029 . . . . 1.2 107.525 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 t -139.34 -52.53 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.013 0.525 . . . . 0.56999999999999995 110.331 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.17 142.69 14.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.606 -1.627 . . . . 0.56999999999999995 106.606 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.4 80.75 1.76 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.328 -0.99 . . . . 0.56999999999999995 108.328 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -157.07 152.75 26.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.8 -0.815 . . . . 1.2 108.8 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.5 174.41 14.71 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.917 1.687 . . . . 0.56999999999999995 108.635 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 C-N-CA 124.905 1.282 . . . . 0.5 . 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 117.511 -1.233 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -125.88 57.37 1.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.443 1.497 . . . . 0.56999999999999995 108.221 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.55 129.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.909 2.084 . . . . 0.56999999999999995 110.037 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 55.27 96.84 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.624 1.57 . . . . 0.56999999999999995 113.069 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 89.2 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.178 2.585 . . . . 0.56999999999999995 110.594 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -113.85 175.03 5.64 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.967 1.307 . . . . 0.56999999999999995 109.677 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.27 116.76 66.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.795 -1.558 . . . . 0.56999999999999995 106.795 168.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.24 158.04 45.41 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.61 1.54 . . . . 0.56999999999999995 110.171 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.58 110.45 0.05 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 108.25 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -48.38 150.81 1.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.441 0.696 . . . . 0.56999999999999995 110.577 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.6 p -60.95 -24.23 65.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.56999999999999995 111.807 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.0 t -99.88 152.29 20.32 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.752 1.621 . . . . 0.56999999999999995 109.79 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -8.48 55.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 112.715 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.89 119.04 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.833 -2.284 . . . . 0.56999999999999995 104.833 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.87 142.41 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.347 -1.353 . . . . 0.56999999999999995 107.347 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -109.15 150.17 28.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.399 -0.813 . . . . 0.56999999999999995 110.432 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -127.0 148.71 50.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.665 -0.698 . . . . 0.56999999999999995 111.14 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.73 114.43 7.24 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.521 -0.918 . . . . 1.2 108.521 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.81 89.12 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 106.132 -1.803 . . . . 0.56999999999999995 106.132 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.08 -30.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 113.486 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.11 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.245 -2.502 . . . . 0.56999999999999995 104.245 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.47 -178.88 5.32 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.547 1.139 . . . . 0.56999999999999995 108.367 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 t -97.63 -162.69 0.98 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.56999999999999995 109.817 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -136.54 -31.52 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.053 1.131 . . . . 1.2 114.053 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.15 -38.8 65.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.826 1.25 . . . . 0.66000000000000003 109.957 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.64 153.28 81.05 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.267 2.227 . . . . 0.56999999999999995 109.85 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.85 158.24 42.9 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.803 2.335 . . . . 0.56999999999999995 113.475 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -62.38 -36.72 83.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.748 1.219 . . . . 0.65000000000000002 113.193 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -65.79 -37.17 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.081 0.552 . . . . 0.56999999999999995 110.52 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -63.27 -47.67 81.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 116.894 -1.527 . . . . 0.56999999999999995 108.101 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.24 -50.19 48.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 CA-C-N 120.41 1.459 . . . . 0.56999999999999995 110.762 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.36 -46.07 91.73 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.939 1.245 . . . . 0.66000000000000003 111.989 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -45.43 94.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.728 -0.607 . . . . 1.2 111.55 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.88 -43.11 94.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.408 -1.282 . . . . 0.56999999999999995 109.068 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -45.17 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 120.321 1.419 . . . . 0.56999999999999995 109.918 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.1 91.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.063 0.847 . . . . 0.56999999999999995 110.379 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -70.33 -37.08 74.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.972 0.909 . . . . 0.56999999999999995 112.389 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -48.4 74.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 110.908 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -67.57 -30.05 69.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.159 -0.924 . . . . 0.56999999999999995 110.825 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.62 -36.94 77.32 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.342 0.974 . . . . 0.56999999999999995 110.165 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.66 -38.22 88.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.406 -1.283 . . . . 0.56999999999999995 111.69 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -73.76 -41.27 62.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.851 1.205 . . . . 0.56999999999999995 111.677 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -5.46 55.66 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.915 -1.116 . . . . 0.56999999999999995 112.362 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -19.56 64.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 118.552 1.176 . . . . 0.56999999999999995 111.319 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.21 -35.55 5.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.313 1.045 . . . . 0.66000000000000003 112.023 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 16.3 pt -106.2 129.55 24.37 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 119.616 1.098 . . . . 0.56999999999999995 110.627 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.47 40.43 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.956 3.104 . . . . 0.56999999999999995 112.332 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.47 143.78 28.35 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 107.786 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -125.83 162.41 25.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.572 -0.899 . . . . 0.65000000000000002 108.572 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 160.05 40.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.631 -0.877 . . . . 0.56999999999999995 108.631 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -143.65 174.96 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -123.48 162.08 23.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.767 -1.197 . . . . 0.56999999999999995 107.767 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.54 175.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.153 1.781 . . . . 0.56999999999999995 108.494 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.3 -29.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.212 1.005 . . . . 0.56999999999999995 111.901 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -63.39 -62.08 1.92 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.094 1.358 . . . . 0.56999999999999995 112.512 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.39 38.14 0.15 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.354 0.502 . . . . 0.56999999999999995 113.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.6 t -166.47 149.06 6.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.355 1.462 . . . . 0.56999999999999995 107.316 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.19 -178.62 3.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.878 1.271 . . . . 0.56999999999999995 109.983 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.31 -35.33 75.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.297 0.639 . . . . 0.66000000000000003 109.915 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.27 69.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.595 1.958 . . . . 0.56999999999999995 107.748 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.12 118.9 16.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.099 -1.626 . . . . 0.56999999999999995 107.205 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.55 125.93 65.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.564 -2.013 . . . . 0.56999999999999995 105.564 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.63 165.69 26.39 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 110.702 -0.959 . . . . 0.56999999999999995 110.702 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.4 m-85 -133.2 148.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.042 -1.466 . . . . 0.56999999999999995 107.042 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.86 -171.65 3.49 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.494 1.517 . . . . 0.56999999999999995 108.767 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -122.59 179.92 4.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 1.2 108.953 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -39.84 106.41 0.06 OUTLIER Glycine 0 C--N 1.342 0.872 0 C-N-CA 126.084 1.802 . . . . 0.56999999999999995 110.615 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 56.05 137.06 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.429 2.692 . . . . 0.56999999999999995 115.169 -166.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 11.8 p-80 -154.21 159.08 41.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.003 0.921 . . . . 0.65000000000000002 109.99 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.62 55.04 1.99 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 111.321 -170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -108.58 -50.16 3.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.515 0.726 . . . . 0.66000000000000003 110.511 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.13 -35.47 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.862 2.065 . . . . 0.56999999999999995 110.874 -166.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.2 100.43 7.07 Favored Pre-proline 0 C--N 1.347 0.492 0 CA-C-N 119.975 1.262 . . . . 0.56999999999999995 109.958 -170.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.97 120.27 7.47 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.076 1.184 . . . . 0.56999999999999995 110.591 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 12.5 m-85 -63.44 164.15 9.72 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 125.195 1.398 . . . . 0.56999999999999995 110.594 167.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.28 -37.29 11.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.891 2.476 . . . . 0.66000000000000003 112.017 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.41 -147.01 18.91 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 119.444 1.02 . . . . 0.56999999999999995 112.018 -170.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.96 72.17 4.01 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.857 3.704 . . . . 0.56999999999999995 115.04 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.87 37.15 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.49 -1.381 . . . . 0.56999999999999995 111.815 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 38.6 -129.48 0.23 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.56999999999999995 114.016 167.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -64.7 118.63 9.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 111.154 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD12 ' C24' ' A' ' 178' ' ' MDW . 5.1 mp -93.71 -33.57 13.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 112.795 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.83 29.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.928 1.291 . . . . 0.56999999999999995 107.625 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -142.6 159.65 41.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.649 0.779 . . . . 0.65000000000000002 108.938 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.71 167.12 30.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.263 0.625 . . . . 0.56999999999999995 109.42 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -120.07 152.75 37.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.742 -0.663 . . . . 0.56999999999999995 109.512 -171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.33 153.63 85.62 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.098 -0.953 . . . . 0.56999999999999995 110.011 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.33 162.98 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.889 1.726 . . . . 0.56999999999999995 111.38 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 -100.02 0.15 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.168 -1.573 . . . . 0.56999999999999995 109.168 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -157.24 120.14 3.99 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.262 -1.385 . . . . 0.56999999999999995 107.262 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.96 -121.49 6.69 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.046 -1.419 . . . . 0.56999999999999995 110.275 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.45 -27.9 58.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.637 1.175 . . . . 0.56999999999999995 111.546 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.92 144.26 7.68 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.754 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.21 -26.72 2.89 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.48 1.514 . . . . 0.56999999999999995 113.917 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.48 150.66 48.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.461 1.131 . . . . 0.66000000000000003 108.936 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.1 146.22 48.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.611 1.196 . . . . 0.56999999999999995 109.055 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 144.78 37.94 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.409 -1.269 . . . . 0.65000000000000002 108.795 -169.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 50.9 m-85 -139.02 149.63 44.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.288 -1.375 . . . . 0.56999999999999995 107.288 -166.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -94.69 99.05 11.23 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.091 -1.077 . . . . 0.66000000000000003 108.091 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.24 -24.37 41.96 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.718 2.007 . . . . 0.66000000000000003 111.785 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -59.21 -41.92 89.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.179 -0.304 . . . . 0.66000000000000003 110.179 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.34 134.42 47.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.746 -0.835 . . . . 0.66000000000000003 108.746 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -61.19 133.3 55.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.827 -0.434 . . . . 1.2 109.827 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -117.95 140.72 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.102 -1.444 . . . . 0.56999999999999995 107.102 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -140.12 148.75 42.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.988 0.813 . . . . 0.56999999999999995 109.431 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.79 -40.0 78.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.332 1.053 . . . . 0.66000000000000003 111.338 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 155.69 58.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.394 0.997 . . . . 0.56999999999999995 110.926 -170.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -153.1 170.81 19.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.926 0.863 . . . . 0.56999999999999995 110.093 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -70.15 77.34 0.51 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.56999999999999995 111.41 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -48.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.585 1.154 . . . . 0.56999999999999995 112.995 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.53 -152.0 6.69 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.466 -1.454 . . . . 0.56999999999999995 109.466 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.52 131.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.234 -0.654 . . . . 0.56999999999999995 109.234 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -57.37 104.1 0.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.56999999999999995 109.439 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.09 -41.69 79.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 109.496 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.48 -46.17 89.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.09 -41.41 99.4 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.901 -0.777 . . . . 0.56999999999999995 108.901 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.58 -53.08 60.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.294 0.638 . . . . 0.56999999999999995 111.524 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.02 71.08 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.597 -0.716 . . . . 0.56999999999999995 109.478 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.6 m -58.06 -40.05 80.01 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.872 0.76 . . . . 0.56999999999999995 111.664 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -60.17 -54.47 45.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.665 0.666 . . . . 0.65000000000000002 109.766 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.99 -45.21 82.46 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.555 -0.715 . . . . 0.66000000000000003 111.671 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.1 -32.93 74.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.447 1.099 . . . . 0.56999999999999995 111.341 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.4 -43.77 52.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.276 -0.73 . . . . 0.56999999999999995 111.276 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -75.94 -35.62 59.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.698 -0.667 . . . . 0.65000000000000002 112.26 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -37.49 70.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.763 0.825 . . . . 0.56999999999999995 111.189 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.02 -41.15 99.48 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.934 -0.479 . . . . 0.56999999999999995 111.77 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 165.7 45.12 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.681 -1.066 . . . . 0.56999999999999995 114.431 -172.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.5 mmt 55.09 -168.28 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.587 1.193 . . . . 0.56999999999999995 110.793 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.65 33.2 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.422 -0.799 . . . . 0.56999999999999995 113.936 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 170.28 2.47 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.304 1.052 . . . . 0.65000000000000002 113.686 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 p -151.35 -159.17 0.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 110.935 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.2 t -168.93 80.14 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 104.03 -2.582 . . . . 0.56999999999999995 104.03 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.67 147.56 55.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 108.315 -0.994 . . . . 0.66000000000000003 108.315 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.21 -20.19 33.05 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.112 2.541 . . . . 0.56999999999999995 112.951 -170.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -125.3 34.94 4.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.88 1.272 . . . . 0.56999999999999995 108.614 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.02 30.34 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.563 0.745 . . . . 0.56999999999999995 109.542 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.61 -31.22 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.876 -0.416 . . . . 0.56999999999999995 109.876 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.7 mmt -69.25 -4.61 18.5 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 112.402 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.422 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 31.1 t80 -60.94 145.14 89.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.781 1.173 . . . . 0.56999999999999995 109.956 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 73.0 Cg_endo -79.82 162.78 23.84 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.459 2.106 . . . . 0.56999999999999995 111.556 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.9 m 53.64 58.93 4.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.001 0.905 . . . . 0.56999999999999995 109.72 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 71.51 -177.86 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 110.173 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.31 137.0 11.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 107.493 -2.243 . . . . 0.56999999999999995 107.493 166.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -39.81 94.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.447 0.624 . . . . 0.56999999999999995 110.521 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.76 135.8 29.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.269 1.414 . . . . 0.56999999999999995 110.811 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -41.12 111.91 0.88 Allowed Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 126.764 2.026 . . . . 0.66000000000000003 111.819 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.77 -19.39 18.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.073 1.849 . . . . 0.56999999999999995 112.226 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -46.67 25.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.995 -1.113 . . . . 0.56999999999999995 107.995 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -91.99 71.99 5.56 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 111.046 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -33.48 -72.42 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.74 2.016 . . . . 0.56999999999999995 116.003 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 38.9 72.74 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.214 2.206 . . . . 0.56999999999999995 112.543 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp -35.72 114.49 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.261 2.225 . . . . 0.56999999999999995 110.091 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 p -82.93 -83.15 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 110.711 -163.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -140.04 -44.52 0.42 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 117.425 -1.274 . . . . 0.56999999999999995 111.711 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 -43.77 64.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 111.654 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.11 -52.8 62.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.63 0.772 . . . . 0.66000000000000003 110.198 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.98 -39.75 81.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 C-N-CA 123.359 0.664 . . . . 0.56999999999999995 109.504 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.68 97.13 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.132 1.373 . . . . 0.56999999999999995 109.071 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.18 -56.34 22.67 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.883 -1.287 . . . . 0.56999999999999995 109.883 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -50.34 -56.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.979 1.712 . . . . 0.56999999999999995 111.106 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -72.31 -11.5 60.73 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.196 -0.94 . . . . 0.56999999999999995 112.035 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 -15.53 27.84 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 0.56999999999999995 110.967 167.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.92 -52.86 6.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.929 1.692 . . . . 0.56999999999999995 109.692 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.413 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 3.8 p90 -113.35 -37.96 4.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.31 0.644 . . . . 0.56999999999999995 110.999 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 146.09 50.1 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.047 -1.221 . . . . 0.56999999999999995 110.047 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -81.0 -49.29 11.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 120.234 -0.587 . . . . 0.56999999999999995 110.538 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 120.8 7.19 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 124.365 1.041 . . . . 1.2 108.727 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.0 p -105.13 125.59 51.14 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.916 -1.142 . . . . 0.56999999999999995 107.916 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -151.02 102.92 3.0 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.493 1.917 . . . . 0.56999999999999995 106.584 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -162.45 155.87 20.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.053 -1.091 . . . . 0.56999999999999995 108.053 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.06 125.3 4.5 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 105.205 -2.146 . . . . 1.2 105.205 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -161.4 147.92 14.43 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.826 1.25 . . . . 0.56999999999999995 109.32 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.194 0 C-N-CA 126.792 2.037 . . . . 0.5 . -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.409 ' C24' HD12 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 118.858 -0.591 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -69.67 87.29 0.49 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.443 1.019 . . . . 0.56999999999999995 111.116 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt 60.63 -174.15 0.12 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.053 1.341 . . . . 0.56999999999999995 110.582 -171.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 51.22 84.93 0.2 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.846 1.659 . . . . 0.56999999999999995 113.129 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.01 85.1 0.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.466 2.777 . . . . 0.56999999999999995 110.896 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -135.02 133.2 39.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.841 -2.651 . . . . 0.56999999999999995 103.841 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.05 103.49 0.36 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.532 1.133 . . . . 0.56999999999999995 109.942 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.58 157.41 16.44 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.813 1.675 . . . . 0.56999999999999995 109.402 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttt 86.79 138.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.449 2.7 . . . . 0.56999999999999995 108.98 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -75.96 167.71 21.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.638 0.732 . . . . 0.56999999999999995 110.689 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 p -73.66 -13.97 61.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.479 1.112 . . . . 0.56999999999999995 112.507 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -134.34 150.58 50.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.975 1.31 . . . . 0.56999999999999995 109.284 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.91 -3.12 37.06 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.557 1.543 . . . . 0.56999999999999995 112.804 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.65 128.1 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.458 -1.682 . . . . 0.56999999999999995 106.458 172.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.47 139.16 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.784 -1.932 . . . . 0.56999999999999995 105.784 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -115.08 133.76 55.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -114.92 164.07 14.66 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.684 -0.689 . . . . 0.56999999999999995 110.223 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.88 165.66 35.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.979 169.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.0 mt -126.61 78.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 104.272 -2.492 . . . . 0.56999999999999995 104.272 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.57 -30.94 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 112.134 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -133.09 165.17 25.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.086 -2.19 . . . . 0.56999999999999995 105.086 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.72 158.19 43.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.068 1.347 . . . . 0.56999999999999995 109.423 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 t -77.41 -15.08 59.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.255 1.206 . . . . 0.56999999999999995 114.255 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 66.63 -19.88 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.573 1.949 . . . . 1.2 115.03 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -66.88 -31.49 72.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.664 1.586 . . . . 0.66000000000000003 111.951 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 148.05 62.24 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 125.962 1.705 . . . . 0.56999999999999995 108.201 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.34 161.06 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.898 2.398 . . . . 0.56999999999999995 112.128 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.02 -35.95 78.24 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.907 0.883 . . . . 0.65000000000000002 111.831 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.44 -35.78 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.149 0.58 . . . . 0.56999999999999995 110.194 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.7 m -78.97 -37.75 38.64 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 117.882 -1.056 . . . . 0.56999999999999995 110.045 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.91 -44.32 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.202 1.365 . . . . 0.56999999999999995 109.37 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -69.66 -42.39 74.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.78 0.718 . . . . 0.66000000000000003 110.555 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -42.9 84.04 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.846 -1.159 . . . . 1.2 113.259 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.99 -40.82 97.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.56999999999999995 108.338 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.11 -40.6 89.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 119.25 0.932 . . . . 0.56999999999999995 110.604 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -56.89 -52.71 64.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.152 0.887 . . . . 0.56999999999999995 109.119 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -69.76 -36.31 75.67 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.696 -1.145 . . . . 0.56999999999999995 112.002 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.16 91.32 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.522 1.51 . . . . 0.56999999999999995 111.917 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.35 -36.03 76.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.498 -0.763 . . . . 0.56999999999999995 109.913 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.85 -39.1 90.66 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 109.815 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.24 -38.06 89.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.14 1.337 . . . . 0.56999999999999995 112.252 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -66.37 -54.76 20.71 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.404 1.002 . . . . 0.56999999999999995 109.989 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.63 -8.91 49.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.054 1.312 . . . . 0.56999999999999995 114.349 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -68.13 -18.3 64.59 Favored 'General case' 0 C--O 1.226 -0.134 0 O-C-N 120.928 -1.337 . . . . 0.56999999999999995 111.454 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.12 -12.53 11.91 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.59 0.632 . . . . 0.66000000000000003 111.052 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.62 127.54 19.6 Favored Pre-proline 0 C--N 1.347 0.483 0 C-N-CA 124.582 1.153 . . . . 0.56999999999999995 108.763 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 41.18 0.65 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.141 3.228 . . . . 0.56999999999999995 112.804 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 tt -92.75 146.62 23.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.685 1.994 . . . . 0.56999999999999995 108.598 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -124.48 160.95 27.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.438 -0.949 . . . . 0.65000000000000002 108.438 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 161.47 37.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.604 -0.517 . . . . 0.56999999999999995 109.604 -171.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -144.52 177.4 8.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.2 1.4 . . . . 1.2 109.335 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.52 136.83 41.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.232 -1.396 . . . . 0.56999999999999995 107.232 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.98 166.31 2.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.997 0.427 . . . . 0.56999999999999995 110.044 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.89 25.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 111.515 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -55.0 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 112.262 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.91 -153.1 5.79 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.825 -1.31 . . . . 0.56999999999999995 109.825 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -68.94 175.28 3.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.316 0.579 . . . . 0.56999999999999995 110.339 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.79 -178.29 5.19 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.528 1.531 . . . . 0.56999999999999995 109.972 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.96 -32.85 74.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 117.554 -1.212 . . . . 0.66000000000000003 110.834 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.31 73.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.893 1.277 . . . . 0.56999999999999995 107.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.39 155.35 30.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.175 -1.578 . . . . 0.56999999999999995 110.93 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.31 127.63 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.945 -2.613 . . . . 0.56999999999999995 103.945 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.17 162.4 28.38 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.995 -0.842 . . . . 0.56999999999999995 110.995 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -134.88 140.04 45.48 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.823 -1.917 . . . . 0.56999999999999995 105.823 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.67 -178.0 5.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.444 1.498 . . . . 0.56999999999999995 108.698 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 52.18 2.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.926 0.891 . . . . 1.2 110.295 -169.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.66 -141.0 16.64 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.768 -1.333 . . . . 0.56999999999999995 109.768 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 131.43 8.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.367 1.067 . . . . 0.56999999999999995 110.843 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.45 156.72 40.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 125.168 1.387 . . . . 0.65000000000000002 109.493 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 93.4 0.38 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 109.237 -1.545 . . . . 0.56999999999999995 109.237 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -149.63 -85.05 0.09 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.497 1.519 . . . . 0.66000000000000003 108.034 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.22 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.392 1.477 . . . . 0.56999999999999995 109.259 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.19 139.49 31.79 Favored Pre-proline 0 C--N 1.342 0.252 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 108.755 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -68.36 143.37 57.88 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.021 1.147 . . . . 0.56999999999999995 109.264 167.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -73.84 -177.1 2.68 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.87 1.319 . . . . 0.56999999999999995 109.759 163.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.526 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 25.0 p-10 -108.88 -38.03 5.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.211 3.405 . . . . 0.66000000000000003 111.341 -171.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.4 -151.02 19.66 Favored Glycine 0 CA--C 1.54 1.603 0 CA-C-O 117.706 -1.608 . . . . 0.56999999999999995 111.198 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.92 75.69 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.17 1 C-N-CA 125.549 4.166 . . . . 0.56999999999999995 114.653 -168.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.66 172.32 25.63 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.561 2.505 . . . . 0.56999999999999995 108.971 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 76' ' ' ASP . 2.7 m-20 58.01 -143.56 0.65 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.715 1.606 . . . . 0.56999999999999995 112.735 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -41.75 130.29 3.3 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 128.055 2.542 . . . . 0.56999999999999995 110.856 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.77 -28.37 13.53 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.446 -1.409 . . . . 0.56999999999999995 112.567 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.72 161.27 37.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 108.851 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.03 151.11 36.39 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.545 0.688 . . . . 0.65000000000000002 110.127 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.47 172.59 12.48 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 109.189 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -124.18 139.26 54.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.93 159.11 11.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.963 0.905 . . . . 0.56999999999999995 110.043 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.99 158.64 55.77 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.552 1.501 . . . . 0.56999999999999995 110.691 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.55 -138.49 5.15 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.573 -1.011 . . . . 0.56999999999999995 110.573 -172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -138.58 96.68 3.2 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.444 -1.317 . . . . 0.56999999999999995 107.444 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 125.33 -118.54 3.28 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 108.701 -1.759 . . . . 0.56999999999999995 108.701 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -27.56 65.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.888 2.075 . . . . 0.56999999999999995 112.473 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.66 145.09 10.64 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.208 -0.933 . . . . 0.56999999999999995 111.433 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.34 -27.44 4.62 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 125.397 1.475 . . . . 0.56999999999999995 114.117 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.61 156.06 39.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.66000000000000003 108.97 -168.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.25 145.22 38.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.899 0.857 . . . . 0.56999999999999995 110.061 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.11 146.65 39.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.396 1.078 . . . . 0.65000000000000002 109.265 -171.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.453 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 38.3 m-85 -139.55 146.91 40.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.833 -0.803 . . . . 0.56999999999999995 108.833 -167.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -83.95 99.71 10.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.23 -0.656 . . . . 0.66000000000000003 109.23 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -58.91 -24.6 62.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.292 1.437 . . . . 0.66000000000000003 111.337 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.29 -43.62 98.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.515 1.526 . . . . 0.66000000000000003 110.309 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.42 134.23 49.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.223 -1.769 . . . . 0.66000000000000003 106.223 174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 149.55 41.39 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.226 -1.546 . . . . 1.2 109.434 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -129.98 168.22 17.02 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.273 1.029 . . . . 0.56999999999999995 108.294 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.303 -0.999 . . . . 0.56999999999999995 108.303 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.02 38.63 0.72 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.205 1.002 . . . . 0.66000000000000003 110.683 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.02 60.32 2.06 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.985 1.279 . . . . 0.56999999999999995 111.029 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 91.42 3.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 110.236 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m 64.72 -71.53 0.07 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 127.835 2.454 . . . . 0.56999999999999995 113.781 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.98 166.54 26.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.56999999999999995 107.998 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.37 -156.71 21.02 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.093 -1.603 . . . . 0.56999999999999995 109.093 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.06 112.15 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.283 -1.377 . . . . 0.56999999999999995 107.283 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.39 101.94 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.35 0.66 . . . . 0.56999999999999995 111.501 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -58.59 -38.44 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 109.439 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -43.87 97.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.793 0.724 . . . . 0.56999999999999995 110.667 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.17 -48.39 81.8 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 109.528 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.27 76.96 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.545 0.338 . . . . 0.56999999999999995 111.303 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.54 63.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.338 -0.839 . . . . 0.56999999999999995 109.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.8 m -58.2 -37.81 75.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.282 0.946 . . . . 0.56999999999999995 111.577 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.55 -57.14 13.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.652 1.181 . . . . 0.65000000000000002 109.648 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.52 -45.43 90.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.331 0.653 . . . . 0.66000000000000003 110.487 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.36 -28.67 69.39 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.621 1.169 . . . . 0.56999999999999995 111.843 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.45 -45.71 95.72 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.638 0.654 . . . . 0.56999999999999995 111.897 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -68.58 -37.32 79.75 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-O 118.292 -0.861 . . . . 0.65000000000000002 110.93 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.6 m -59.85 -31.64 69.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.058 0.844 . . . . 0.56999999999999995 112.361 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -34.56 66.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.515 1.052 . . . . 0.56999999999999995 111.802 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.25 -56.68 0.13 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-O 119.198 -0.779 . . . . 0.56999999999999995 111.45 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.99 178.04 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.855 2.062 . . . . 0.56999999999999995 108.695 -169.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.12 22.68 0.02 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.028 -0.873 . . . . 0.56999999999999995 112.812 172.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 161.05 30.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.871 1.335 . . . . 0.65000000000000002 111.716 -174.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.44 -170.54 1.47 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.336 1.854 . . . . 0.56999999999999995 108.777 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.71 48.56 1.81 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.442 1.097 . . . . 0.56999999999999995 110.79 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -98.35 144.45 28.11 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 118.004 -0.998 . . . . 0.66000000000000003 110.671 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 -20.58 68.21 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 113.564 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -128.57 25.31 5.73 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.115 1.366 . . . . 0.56999999999999995 110.776 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.09 55.64 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.138 0.97 . . . . 0.56999999999999995 111.093 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.21 -24.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 111.429 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -106.6 22.81 15.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.14 0.976 . . . . 0.56999999999999995 111.38 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.411 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 3.6 t80 -60.67 131.28 90.98 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.488 1.495 . . . . 0.56999999999999995 110.437 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 49.5 Cg_endo -79.58 -38.95 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.405 1.403 . . . . 0.56999999999999995 112.625 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.402 ' HB ' ' CZ ' ' A' ' 139' ' ' TYR . 87.2 m -80.12 67.78 6.05 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.675 -1.266 . . . . 0.56999999999999995 110.03 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -50.03 136.99 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.983 1.313 . . . . 0.56999999999999995 112.054 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.71 107.74 2.99 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.024 0.821 . . . . 0.56999999999999995 111.297 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -165.99 -56.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.608 1.563 . . . . 0.56999999999999995 108.575 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -117.14 -100.84 2.14 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 108.852 -1.699 . . . . 0.56999999999999995 108.852 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -156.52 111.89 2.03 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.66000000000000003 109.463 -170.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.17 -9.14 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.4 2.733 . . . . 0.56999999999999995 113.039 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.74 -18.37 61.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.138 1.335 . . . . 0.56999999999999995 111.039 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -116.63 74.13 0.89 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.618 1.967 . . . . 0.56999999999999995 109.494 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -128.8 122.66 30.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.492 1.517 . . . . 0.56999999999999995 107.914 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 69.11 1.06 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.625 -1.25 . . . . 0.56999999999999995 107.625 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp 52.59 79.77 0.11 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 0.56999999999999995 110.798 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -78.36 0.05 OUTLIER 'General case' 0 C--N 1.342 0.261 0 N-CA-C 114.27 1.211 . . . . 0.56999999999999995 114.27 -166.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -148.79 -49.23 0.15 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.861 1.264 . . . . 0.56999999999999995 108.214 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -45.69 -42.64 11.92 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 128.294 2.638 . . . . 0.66000000000000003 112.14 166.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -66.86 -58.36 5.17 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.8 0.84 . . . . 0.66000000000000003 111.218 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.48 -37.04 67.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 119.014 -0.517 . . . . 0.56999999999999995 109.694 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -59.82 -41.55 91.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.679 0.792 . . . . 0.56999999999999995 108.9 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.26 -52.91 24.47 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.305 -1.118 . . . . 0.56999999999999995 110.305 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.7 mm -56.2 -51.03 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.152 0.981 . . . . 0.56999999999999995 111.641 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.63 -28.88 68.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.393 0.542 . . . . 0.56999999999999995 110.783 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -23.32 56.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.01 -0.519 . . . . 0.56999999999999995 111.603 175.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.1 mt -85.92 -48.46 8.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.56999999999999995 110.901 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -139.9 19.26 2.48 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.729 0.64 . . . . 0.56999999999999995 112.729 -168.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.61 -142.69 12.48 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.832 1.206 . . . . 0.56999999999999995 111.327 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -142.31 -30.54 0.55 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.144 1.164 . . . . 0.56999999999999995 114.144 -161.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.49 164.81 35.01 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.418 1.887 . . . . 1.2 107.396 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 94.2 p -146.13 134.86 22.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.32 -0.622 . . . . 0.56999999999999995 109.32 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -157.08 89.14 1.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 105.857 -1.905 . . . . 0.56999999999999995 105.857 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 42.4 t -165.18 137.59 4.36 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.153 1.381 . . . . 0.56999999999999995 107.304 171.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.52 173.03 8.99 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.144 1.778 . . . . 1.2 107.372 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.71 173.16 12.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.106 1.362 . . . . 0.56999999999999995 108.715 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.6 tptt . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 125.582 1.553 . . . . 0.5 . -171.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.335 0 CA-C-O 118.716 -0.659 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -160.31 67.29 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.623 1.169 . . . . 0.56999999999999995 108.447 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.8 77.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.002 1.721 . . . . 0.56999999999999995 113.828 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 76.53 81.38 0.12 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 126.791 2.036 . . . . 0.56999999999999995 110.765 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.46 145.85 54.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.779 1.652 . . . . 0.56999999999999995 111.194 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.22 167.68 29.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.975 1.31 . . . . 0.56999999999999995 107.717 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.19 103.77 0.39 Allowed Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 124.563 1.165 . . . . 0.56999999999999995 108.893 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -78.66 138.3 15.06 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 108.443 -1.406 . . . . 0.56999999999999995 108.443 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.19 113.85 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 108.672 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -46.88 147.42 1.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.537 0.735 . . . . 0.56999999999999995 109.988 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -62.29 -27.91 69.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.572 0.749 . . . . 0.56999999999999995 111.701 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.2 t -82.87 149.09 27.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.013 1.325 . . . . 0.56999999999999995 110.963 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -10.59 59.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.331 1.052 . . . . 0.56999999999999995 112.868 172.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.45 144.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.71 1.204 . . . . 0.56999999999999995 107.946 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -130.98 145.53 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.278 -1.378 . . . . 0.56999999999999995 107.278 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -94.39 142.49 27.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.294 -0.632 . . . . 0.56999999999999995 109.294 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -123.07 147.92 46.19 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.235 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 100.71 3.36 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.861 0.839 . . . . 1.2 109.586 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.18 101.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 105.122 -2.177 . . . . 0.56999999999999995 105.122 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -48.89 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.458 1.503 . . . . 0.56999999999999995 111.174 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.9 p -130.59 174.45 9.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.4 -1.704 . . . . 0.56999999999999995 106.4 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.407 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 22.3 m-85 -140.34 167.56 21.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.015 -1.476 . . . . 0.56999999999999995 107.015 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -65.63 178.6 0.97 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.891 0.476 . . . . 0.56999999999999995 111.03 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -34.45 2.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.393 1.077 . . . . 1.2 112.508 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -39.85 82.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.305 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.3 mt -113.66 148.91 40.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.759 1.223 . . . . 0.56999999999999995 108.646 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.21 150.82 33.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.103 1.868 . . . . 0.56999999999999995 112.423 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -59.87 -40.14 87.64 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.698 1.199 . . . . 0.65000000000000002 111.932 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.8 tt -62.95 -36.44 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.191 0.596 . . . . 0.56999999999999995 111.048 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 m -69.05 -42.4 76.34 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.081 -1.438 . . . . 0.56999999999999995 108.984 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -55.74 -47.59 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 121.154 1.797 . . . . 0.56999999999999995 110.095 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.07 -48.73 80.5 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.876 0.87 . . . . 0.66000000000000003 110.548 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.93 -46.29 88.34 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.509 -0.744 . . . . 1.2 112.48 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.86 -41.79 82.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.416 1.086 . . . . 0.56999999999999995 109.346 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.87 -50.15 76.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 118.034 -0.984 . . . . 0.56999999999999995 109.269 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -41.28 99.42 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 111.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -65.03 -46.3 81.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.7 1.136 . . . . 0.56999999999999995 110.864 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.74 92.06 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.889 1.276 . . . . 0.56999999999999995 112.405 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.98 -37.34 75.73 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.512 0.725 . . . . 0.56999999999999995 110.614 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.23 -41.14 87.98 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.828 0.74 . . . . 0.56999999999999995 109.87 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.7 mtp -66.02 -33.1 75.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.677 0.791 . . . . 0.56999999999999995 112.544 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -70.81 -49.34 47.5 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.369 0.986 . . . . 0.56999999999999995 111.112 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.63 -10.78 71.92 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.0 1.286 . . . . 0.56999999999999995 113.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -62.18 -26.63 68.45 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.667 -1.49 . . . . 0.56999999999999995 111.022 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -97.94 -38.29 9.46 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.975 -0.535 . . . . 0.66000000000000003 110.886 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.92 136.41 23.26 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 110.576 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 38.32 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 124.195 3.264 . . . . 0.56999999999999995 112.906 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.15 138.36 31.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.933 1.693 . . . . 0.56999999999999995 107.601 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -120.59 170.82 9.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.65000000000000002 108.662 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.51 153.92 45.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.396 -0.964 . . . . 0.56999999999999995 108.396 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 161.04 37.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.14 0.576 . . . . 1.2 110.803 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -104.08 145.56 30.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.822 -0.807 . . . . 0.56999999999999995 108.822 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.73 170.86 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.114 0.965 . . . . 0.56999999999999995 110.32 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.93 37.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.852 1.261 . . . . 0.56999999999999995 110.215 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -146.46 -72.58 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.028 0.931 . . . . 0.56999999999999995 110.665 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.8 25.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.421 -1.211 . . . . 0.56999999999999995 115.557 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -154.09 135.27 14.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.56999999999999995 106.848 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.63 177.2 11.65 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.074 0.95 . . . . 0.56999999999999995 110.598 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -71.15 -37.09 72.25 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.297 -0.858 . . . . 0.66000000000000003 110.516 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.99 77.76 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.182 2.193 . . . . 0.56999999999999995 107.82 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -75.28 125.17 28.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.574 -1.269 . . . . 0.56999999999999995 107.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.42 123.12 67.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.999 -2.223 . . . . 0.56999999999999995 104.999 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.9 162.98 26.31 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.843 -0.503 . . . . 0.56999999999999995 111.843 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 13.9 m-85 -137.32 126.8 25.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.546 -1.65 . . . . 0.56999999999999995 106.546 -172.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.74 -174.41 4.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 108.194 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.9 140.29 18.68 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.6 -0.889 . . . . 1.2 108.6 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.95 -90.4 0.41 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.251 0.453 . . . . 0.56999999999999995 112.341 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.79 172.59 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.868 0.834 . . . . 0.56999999999999995 110.049 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -153.75 142.87 21.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.65000000000000002 109.466 175.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.72 45.73 1.58 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.024 1.297 . . . . 0.56999999999999995 112.622 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.4 28.11 0.99 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.302 2.241 . . . . 0.66000000000000003 110.139 -172.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.82 -38.86 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.174 1.79 . . . . 0.56999999999999995 112.029 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -91.25 104.8 10.62 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.604 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.43 143.01 74.55 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.16 1.24 . . . . 0.56999999999999995 109.366 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -72.61 -170.57 0.69 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.719 1.247 . . . . 0.56999999999999995 109.776 170.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 17.0 p-10 -124.65 -45.19 1.93 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.617 2.367 . . . . 0.66000000000000003 108.617 -172.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.29 -148.98 16.56 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.068 1.318 . . . . 0.56999999999999995 110.953 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.74 68.76 2.95 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 125.969 4.446 . . . . 0.56999999999999995 112.933 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.02 166.01 16.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 126.421 1.962 . . . . 0.56999999999999995 108.933 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 4.2 t30 49.73 -160.97 0.06 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.502 1.521 . . . . 0.56999999999999995 112.924 -171.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.2 m -31.8 104.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.913 2.885 . . . . 0.56999999999999995 114.583 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.44 -29.74 57.09 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.104 -1.623 . . . . 0.56999999999999995 114.0 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.7 161.99 40.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 108.239 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.503 ' HE2' ' CE1' ' A' ' 69' ' ' HIS . 0.7 OUTLIER -149.62 158.56 44.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.472 -0.566 . . . . 0.65000000000000002 109.472 177.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.32 170.37 19.7 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 108.824 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -124.09 149.22 46.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.212 -1.033 . . . . 0.56999999999999995 108.212 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.72 154.54 80.12 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.593 -0.717 . . . . 0.56999999999999995 110.137 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.48 166.34 24.12 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.396 2.064 . . . . 0.56999999999999995 111.784 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.45 -116.75 0.67 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.3 p -149.03 65.68 1.04 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.625 0.77 . . . . 0.56999999999999995 111.046 -167.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.99 -121.67 1.4 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.5 -1.44 . . . . 0.56999999999999995 109.5 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.91 -25.9 32.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.053 1.341 . . . . 0.56999999999999995 112.024 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 140.33 11.79 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.852 -1.155 . . . . 0.56999999999999995 111.089 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.4 -24.32 4.97 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.283 1.42 . . . . 0.56999999999999995 113.776 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -68.63 153.24 44.15 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.987 0.893 . . . . 0.66000000000000003 108.726 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.0 146.13 31.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.56999999999999995 109.176 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -140.96 155.59 46.21 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.28 -0.873 . . . . 0.65000000000000002 111.258 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 46.6 m-85 -137.25 141.9 42.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.877 -1.157 . . . . 0.56999999999999995 107.877 -163.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -80.9 104.36 11.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.716 -1.216 . . . . 0.66000000000000003 107.716 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.4 -23.74 67.39 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.33 -0.856 . . . . 0.66000000000000003 110.844 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.29 -24.18 60.38 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 110.117 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.92 132.48 39.1 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.16 -1.052 . . . . 0.66000000000000003 108.16 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -65.98 143.36 57.43 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.352 -0.61 . . . . 1.2 109.352 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -126.36 137.38 53.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.609 -1.256 . . . . 0.56999999999999995 107.609 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.3 t -113.53 147.41 37.99 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.869 -0.789 . . . . 0.56999999999999995 108.869 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -74.52 21.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.166 1.786 . . . . 0.66000000000000003 112.981 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.13 124.86 0.25 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.406 1.955 . . . . 0.56999999999999995 109.998 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 t 74.74 58.49 0.07 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.987 1.715 . . . . 0.56999999999999995 113.004 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 41.11 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.299 1.04 . . . . 0.56999999999999995 112.538 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp 55.52 -178.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 111.843 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.01 -168.33 52.06 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.011 -1.056 . . . . 0.56999999999999995 111.653 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.9 121.16 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.847 -0.797 . . . . 0.56999999999999995 108.847 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -56.8 106.72 0.33 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.872 1.269 . . . . 0.56999999999999995 109.209 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.84 -38.29 75.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.481 0.712 . . . . 0.56999999999999995 109.958 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.28 -51.42 66.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.596 -1.261 . . . . 0.56999999999999995 107.596 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -54.92 -42.51 72.3 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.876 -0.583 . . . . 0.56999999999999995 111.042 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.5 5.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.277 0.631 . . . . 0.56999999999999995 110.275 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.79 -50.16 75.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 118.349 -0.834 . . . . 0.56999999999999995 109.492 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 m -57.34 -36.45 71.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.597 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.7 -55.39 17.65 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.19 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.11 -40.74 90.96 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.61 -0.681 . . . . 0.66000000000000003 110.749 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.81 -32.28 73.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.472 1.509 . . . . 0.56999999999999995 111.692 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.25 94.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.466 -0.654 . . . . 0.56999999999999995 111.466 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -69.33 -37.11 77.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 117.594 -1.193 . . . . 0.65000000000000002 111.916 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.2 p -59.08 -33.19 70.53 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.18 0.925 . . . . 0.56999999999999995 111.269 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.63 -33.97 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 112.023 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 151.78 53.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.605 1.093 . . . . 0.56999999999999995 114.404 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 mmt 58.06 -177.17 0.07 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.489 0.661 . . . . 0.56999999999999995 111.452 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.13 57.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.527 -1.429 . . . . 0.56999999999999995 109.527 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.36 167.32 11.6 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.93 0.871 . . . . 0.65000000000000002 110.467 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 t -160.69 -170.31 2.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.917 1.287 . . . . 0.56999999999999995 109.74 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.23 30.36 1.14 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.571 1.948 . . . . 0.56999999999999995 109.999 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.49 148.43 35.48 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.739 1.216 . . . . 0.66000000000000003 109.974 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.94 -21.53 43.56 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.287 2.658 . . . . 0.56999999999999995 113.279 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -132.59 29.05 4.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.376 1.871 . . . . 0.56999999999999995 108.661 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.1 133.03 49.05 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.658 -1.276 . . . . 0.56999999999999995 109.026 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 156' ' ' ASP . 4.3 p -55.8 -28.73 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.371 1.468 . . . . 0.56999999999999995 112.68 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.49 27.9 9.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.099 . . . . 0.56999999999999995 110.338 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -56.49 129.17 75.45 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 109.971 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.59 178.38 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.942 2.428 . . . . 0.56999999999999995 110.573 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m 71.08 -40.99 0.49 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.504 1.522 . . . . 0.56999999999999995 113.321 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.431 ' CE1' ' H47' ' A' ' 178' ' ' MDW . 59.9 t80 55.39 92.21 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.275 2.23 . . . . 0.56999999999999995 113.722 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.75 105.75 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.598 -1.001 . . . . 0.56999999999999995 110.598 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -172.65 -50.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.093 1.357 . . . . 0.56999999999999995 110.565 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.88 -113.1 2.94 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.25 -1.94 . . . . 0.56999999999999995 108.25 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.68 134.59 9.19 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 106.529 -1.656 . . . . 0.66000000000000003 106.529 174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.09 -8.43 6.63 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.023 3.149 . . . . 0.56999999999999995 113.559 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -71.01 -28.16 64.21 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.151 -1.593 . . . . 0.56999999999999995 111.368 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -106.96 61.79 0.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.56999999999999995 110.916 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -126.44 141.26 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.575 1.15 . . . . 0.56999999999999995 110.311 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.66 51.68 0.08 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.866 0.866 . . . . 0.56999999999999995 110.956 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 69.27 76.64 0.23 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.554 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.3 t -69.57 -94.42 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.918 0.887 . . . . 0.56999999999999995 112.044 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -131.12 -44.69 1.03 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.986 0.914 . . . . 0.56999999999999995 109.641 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -46.04 49.96 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.96 0.904 . . . . 0.66000000000000003 110.615 166.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.42 ' HB2' HG13 ' A' ' 137' ' ' VAL . 1.2 t0 -60.23 -56.58 19.82 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.524 -0.75 . . . . 0.66000000000000003 110.403 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.39 -43.84 87.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 N-CA-C 109.044 -0.724 . . . . 0.56999999999999995 109.044 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -64.43 -38.66 91.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.675 0.79 . . . . 0.56999999999999995 110.72 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.93 -49.73 39.75 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.689 -0.965 . . . . 0.56999999999999995 110.689 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -56.54 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 C-N-CA 126.144 1.777 . . . . 0.56999999999999995 110.254 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.6 -20.53 65.74 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.845 -0.534 . . . . 0.56999999999999995 110.777 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -88.1 -29.83 20.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.201 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.27 -58.02 8.51 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 125.717 1.607 . . . . 0.56999999999999995 109.747 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -92.14 -0.11 57.45 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.155 0.798 . . . . 0.56999999999999995 113.155 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.24 -82.37 0.63 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.637 -0.585 . . . . 0.56999999999999995 111.637 -171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.19 -56.84 0.06 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.103 0.409 . . . . 0.56999999999999995 112.103 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.57 177.98 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.526 1.53 . . . . 1.2 112.726 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 92.56 2.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.655 -1.98 . . . . 0.56999999999999995 105.655 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -162.28 131.87 4.5 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 105.027 -2.212 . . . . 0.56999999999999995 105.027 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.01 138.07 45.78 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.56999999999999995 108.621 172.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -64.16 140.4 58.87 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.79 0.328 . . . . 1.2 110.485 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.7 142.34 26.61 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.717 1.207 . . . . 0.56999999999999995 108.012 173.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 125.488 1.515 . . . . 0.5 . -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.431 ' H47' ' CE1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 118.127 -0.94 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m 55.91 38.28 29.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.302 0.955 . . . . 0.56999999999999995 113.195 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 -68.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.38 -0.6 . . . . 0.56999999999999995 109.38 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -157.2 83.15 3.05 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 126.009 1.723 . . . . 0.56999999999999995 107.042 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.34 -171.42 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.324 2.682 . . . . 0.56999999999999995 111.912 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -67.43 -58.25 5.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.032 0.933 . . . . 0.56999999999999995 112.069 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.71 98.28 0.61 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 127.071 2.149 . . . . 0.56999999999999995 105.235 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.52 170.83 19.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.935 2.423 . . . . 0.56999999999999995 109.884 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 pttt 67.01 141.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.759 2.023 . . . . 0.56999999999999995 110.881 -165.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -56.5 149.2 17.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.046 0.939 . . . . 0.56999999999999995 110.371 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 p -62.63 -20.03 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.305 0.854 . . . . 0.56999999999999995 113.305 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -96.7 140.98 30.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.849 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -72.96 -14.09 61.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 113.064 171.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 m -114.2 119.54 61.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.759 -1.941 . . . . 0.56999999999999995 105.759 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.17 155.59 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.31 -1.367 . . . . 0.56999999999999995 107.31 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -106.88 143.6 34.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.56999999999999995 109.758 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -126.64 145.46 50.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.601 -0.518 . . . . 0.56999999999999995 109.601 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.1 115.13 3.48 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.758 0.79 . . . . 1.2 111.921 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.0 95.17 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 105.718 -1.956 . . . . 0.56999999999999995 105.718 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 m -67.0 -39.02 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.132 0.973 . . . . 0.56999999999999995 112.067 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -130.0 152.49 49.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.089 -2.56 . . . . 0.56999999999999995 104.089 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.401 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 84.8 m-85 -127.41 167.34 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.977 1.311 . . . . 0.56999999999999995 107.858 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 t -64.63 -179.99 0.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 110.901 173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -40.13 3.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.83 0.852 . . . . 1.2 111.585 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -41.97 77.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.654 0.661 . . . . 0.66000000000000003 111.583 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.69 152.86 38.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.56999999999999995 108.587 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.42 149.53 39.79 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.897 1.731 . . . . 0.56999999999999995 112.41 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -58.86 -37.42 76.47 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 113.08 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -43.52 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.773 -0.455 . . . . 0.56999999999999995 109.773 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 m -66.61 -39.99 88.62 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.945 -1.026 . . . . 0.56999999999999995 109.577 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.5 -51.08 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.709 1.14 . . . . 0.56999999999999995 110.704 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -63.35 -43.05 98.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.87 1.214 . . . . 0.66000000000000003 110.482 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -46.75 87.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.216 -0.927 . . . . 1.2 111.207 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.79 -38.27 86.19 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.263 -1.351 . . . . 0.56999999999999995 109.904 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -59.62 -46.55 93.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 110.076 170.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.266 0.939 . . . . 0.56999999999999995 109.502 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -68.47 -41.86 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.363 -0.827 . . . . 0.56999999999999995 111.688 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.27 -46.62 87.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.735 1.152 . . . . 0.56999999999999995 111.504 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.2 mt -67.91 -37.53 81.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.934 0.894 . . . . 0.56999999999999995 110.162 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.39 -39.73 84.29 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.209 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -43.94 97.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.725 0.81 . . . . 0.56999999999999995 111.349 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 33.9 m95 -61.76 -47.84 83.38 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.852 0.751 . . . . 0.56999999999999995 111.285 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.21 -2.07 71.6 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.298 -0.876 . . . . 0.56999999999999995 113.695 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -81.82 -11.59 58.9 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.347 1.573 . . . . 0.56999999999999995 110.071 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.62 -21.8 12.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.356 0.526 . . . . 0.66000000000000003 111.353 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.4 pt -136.52 146.46 55.8 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.731 1.213 . . . . 0.56999999999999995 110.302 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.99 58.43 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 111.937 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.03 138.19 54.21 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.613 1.965 . . . . 0.56999999999999995 106.631 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -123.23 160.46 26.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.291 -1.003 . . . . 0.65000000000000002 108.291 -171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.43 149.98 38.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.829 -1.175 . . . . 0.56999999999999995 107.829 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -134.2 157.34 46.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.149 0.979 . . . . 1.2 109.046 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -115.81 108.85 16.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 -174.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.46 133.76 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.555 -1.276 . . . . 0.56999999999999995 107.555 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -37.18 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.179 -0.325 . . . . 0.56999999999999995 110.208 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.63 162.17 39.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.312 1.045 . . . . 0.56999999999999995 109.003 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.84 156.83 18.15 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.964 -1.255 . . . . 0.56999999999999995 109.964 -164.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -64.32 168.53 5.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.517 0.675 . . . . 0.56999999999999995 110.696 168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.2 17.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.766 1.226 . . . . 0.56999999999999995 109.937 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -67.96 -44.04 77.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.987 -1.006 . . . . 0.66000000000000003 109.341 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.4 mt -116.53 78.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.082 1.753 . . . . 0.56999999999999995 107.74 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.0 ttm -76.3 153.66 35.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.848 -1.158 . . . . 0.56999999999999995 109.612 171.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.75 134.83 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.73 -1.952 . . . . 0.56999999999999995 105.73 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.56 166.54 30.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.779 -0.928 . . . . 0.56999999999999995 110.779 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -138.6 149.99 45.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.661 -0.866 . . . . 0.56999999999999995 108.661 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.42 175.92 11.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.969 1.308 . . . . 0.56999999999999995 110.249 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -140.46 63.0 1.48 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.765 1.226 . . . . 1.2 109.812 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.79 -70.64 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.644 -0.583 . . . . 0.56999999999999995 111.644 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.13 174.72 8.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.942 -1.328 . . . . 0.56999999999999995 110.398 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -149.45 137.86 20.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.427 -0.583 . . . . 0.65000000000000002 109.427 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.91 37.52 3.39 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.235 0.922 . . . . 0.56999999999999995 112.021 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.78 -72.05 0.46 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.1 1.36 . . . . 0.66000000000000003 108.574 -171.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -172.55 -36.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.979 -0.534 . . . . 0.56999999999999995 111.677 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -102.76 101.64 21.96 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-O 118.286 -0.864 . . . . 0.56999999999999995 108.732 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.79 129.27 28.46 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 108.26 -1.477 . . . . 0.56999999999999995 108.26 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.5 OUTLIER -64.66 -167.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.769 1.747 . . . . 0.56999999999999995 109.146 165.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.506 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 9.2 p-10 -134.75 -46.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 129.773 3.229 . . . . 0.66000000000000003 107.655 -163.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.01 -146.37 16.06 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.052 -1.416 . . . . 0.56999999999999995 110.159 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 83.06 1.9 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.431 3.421 . . . . 0.56999999999999995 112.437 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.87 169.24 17.86 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 127.749 2.595 . . . . 0.56999999999999995 109.852 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 16.2 t30 54.5 -144.69 0.66 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.675 1.59 . . . . 0.56999999999999995 112.604 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.5 m -47.33 135.81 10.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.578 2.351 . . . . 0.56999999999999995 111.577 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.38 -33.18 10.11 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 112.519 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.9 158.47 28.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.56999999999999995 108.812 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.671 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.1 p-80 -141.56 164.75 29.39 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.023 0.829 . . . . 0.65000000000000002 111.792 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.76 156.38 44.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.433 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.08 152.87 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.925 -1.034 . . . . 0.56999999999999995 108.894 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.05 95.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.701 -0.666 . . . . 0.56999999999999995 110.186 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.47 149.7 69.08 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.077 2.518 . . . . 0.56999999999999995 112.033 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.17 -70.65 0.32 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.406 0.527 . . . . 0.56999999999999995 112.077 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -75.1 166.36 23.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.382 1.073 . . . . 0.56999999999999995 109.796 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.46 45.35 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 117.554 -1.692 . . . . 0.56999999999999995 114.797 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.78 -26.71 60.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.419 1.609 . . . . 0.56999999999999995 111.049 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.15 149.11 6.21 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 110.925 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.75 -28.84 1.82 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.257 1.408 . . . . 0.56999999999999995 113.624 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.97 152.95 44.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.242 1.021 . . . . 0.66000000000000003 109.004 -170.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 149.7 52.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.608 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -140.39 151.34 44.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.836 -0.62 . . . . 0.65000000000000002 110.957 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 40.6 m-85 -138.43 144.9 40.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.462 1.105 . . . . 0.56999999999999995 109.007 -165.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.07 107.07 6.9 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.006 -1.109 . . . . 0.66000000000000003 108.006 171.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.22 -19.11 62.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.524 1.511 . . . . 0.66000000000000003 111.581 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.44 -44.96 81.41 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.398 1.479 . . . . 0.66000000000000003 111.629 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.55 122.5 17.73 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 106.219 -1.771 . . . . 0.66000000000000003 106.219 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 129.57 40.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.101 -0.952 . . . . 1.2 109.622 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -106.73 153.63 22.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.631 1.172 . . . . 0.56999999999999995 109.465 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 141.85 51.46 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.558 -0.905 . . . . 0.56999999999999995 108.558 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.23 42.27 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.055 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.64 75.47 0.89 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.825 -0.91 . . . . 0.56999999999999995 110.825 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.36 177.78 7.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.073 0.949 . . . . 0.56999999999999995 108.967 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 m -57.17 122.65 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.836 0.855 . . . . 0.56999999999999995 110.576 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.44 172.66 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.024 1.729 . . . . 0.56999999999999995 112.577 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.08 169.69 42.09 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.561 -0.745 . . . . 0.56999999999999995 111.447 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.25 123.59 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -64.58 120.36 12.21 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.482 -0.327 . . . . 0.56999999999999995 110.729 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -52.65 -43.07 65.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.913 0.885 . . . . 0.56999999999999995 111.869 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -64.77 -46.3 82.71 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.54 0.609 . . . . 0.56999999999999995 109.839 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.69 -48.62 77.25 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.801 -0.444 . . . . 0.56999999999999995 109.801 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.76 85.32 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 122.8 0.44 . . . . 0.56999999999999995 110.824 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -52.17 66.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 117.853 -1.07 . . . . 0.56999999999999995 109.409 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.5 m -53.91 -40.25 66.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.174 1.352 . . . . 0.56999999999999995 111.89 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -60.3 -56.37 22.32 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.206 0.602 . . . . 0.65000000000000002 110.536 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.671 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 5.9 mm-40 -67.51 -44.51 78.24 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.931 0.892 . . . . 0.66000000000000003 111.322 -172.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.57 -25.91 68.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.584 1.554 . . . . 0.56999999999999995 110.943 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.402 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.62 -51.72 57.21 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.713 -0.955 . . . . 0.56999999999999995 110.713 169.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.07 -38.81 90.21 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 117.658 -1.163 . . . . 0.65000000000000002 111.265 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.3 p -58.18 -31.3 67.15 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 118.559 0.618 . . . . 0.56999999999999995 112.424 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -36.9 72.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.501 0.32 . . . . 0.56999999999999995 111.815 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.16 43.24 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.691 -1.061 . . . . 0.56999999999999995 113.342 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -116.58 149.59 39.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.594 1.197 . . . . 0.56999999999999995 110.649 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.08 -45.62 4.09 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 117.786 -1.563 . . . . 0.56999999999999995 111.928 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m80 156.24 174.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 129.739 3.216 . . . . 0.65000000000000002 110.103 -171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 m -117.41 176.71 5.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.042 1.737 . . . . 0.56999999999999995 110.807 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.27 58.99 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.625 1.17 . . . . 0.56999999999999995 109.45 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.13 142.72 42.94 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 107.297 -1.372 . . . . 0.66000000000000003 107.297 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.8 -34.58 30.49 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.696 1.597 . . . . 0.56999999999999995 111.188 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -105.18 24.3 12.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 110.071 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.54 130.64 47.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.97 -0.752 . . . . 0.56999999999999995 108.97 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 155' ' ' ASP . 7.2 p -67.29 -24.39 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.411 -0.515 . . . . 0.56999999999999995 109.815 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.4 16.54 14.93 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.483 -0.761 . . . . 0.56999999999999995 112.318 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.18 144.46 87.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.857 1.662 . . . . 0.56999999999999995 111.673 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.25 163.52 36.27 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.48 2.12 . . . . 0.56999999999999995 111.041 167.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.6 m 56.09 94.06 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.638 1.575 . . . . 0.56999999999999995 112.034 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.443 ' CD1' ' H43' ' A' ' 178' ' ' MDW . 0.3 OUTLIER -50.37 105.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.491 1.516 . . . . 0.56999999999999995 112.564 -176.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.12 166.54 33.61 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.523 -1.831 . . . . 0.56999999999999995 108.523 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.17 -47.89 0.22 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.88 2.472 . . . . 0.56999999999999995 114.769 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.54 175.59 7.25 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.118 1.342 . . . . 0.56999999999999995 112.142 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -121.0 101.15 45.3 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.939 -1.134 . . . . 0.66000000000000003 107.939 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.79 40.29 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 113.077 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.87 -54.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.638 -1.289 . . . . 0.56999999999999995 107.994 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.07 88.22 2.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.964 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -121.45 -45.98 2.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 110.279 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 30.34 55.43 0.18 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.546 2.338 . . . . 0.56999999999999995 113.574 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mp 63.46 100.22 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.617 1.967 . . . . 0.56999999999999995 109.948 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.7 m -70.84 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.376 0.88 . . . . 0.56999999999999995 113.376 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -143.94 -42.68 0.27 Allowed 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.938 0.895 . . . . 0.56999999999999995 109.145 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.522 ' HD2' ' N ' ' A' ' 137' ' ' VAL . 15.0 p-10 -59.95 -39.97 87.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.667 0.667 . . . . 0.66000000000000003 112.172 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -54.56 29.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.7 1.2 . . . . 0.66000000000000003 109.134 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.9 -46.25 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 124.826 1.251 . . . . 0.56999999999999995 108.746 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -62.56 -47.71 82.69 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 117.971 -1.014 . . . . 0.56999999999999995 108.761 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.55 -62.32 6.44 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.807 -1.717 . . . . 0.56999999999999995 108.807 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.3 mm -56.93 -43.61 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.242 1.021 . . . . 0.56999999999999995 113.132 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -71.34 -27.75 63.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.58 -0.7 . . . . 0.56999999999999995 111.662 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -36.01 68.13 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.964 0.906 . . . . 0.56999999999999995 110.363 169.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -61.53 2.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.994 -1.003 . . . . 0.56999999999999995 110.289 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -142.38 18.24 2.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.229 1.196 . . . . 0.56999999999999995 114.229 -170.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -93.64 -87.01 1.62 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.385 -0.686 . . . . 0.56999999999999995 111.385 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -158.83 -69.73 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.719 0.807 . . . . 0.56999999999999995 110.665 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.22 154.1 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.393 1.477 . . . . 1.2 108.318 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.1 t -165.08 176.72 8.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.563 -1.644 . . . . 0.56999999999999995 106.563 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.21 164.79 26.28 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.649 -1.612 . . . . 0.56999999999999995 106.649 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 p -125.31 168.4 13.57 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.804 0.841 . . . . 0.56999999999999995 108.792 171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.81 147.45 26.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.501 -1.666 . . . . 1.2 106.501 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.38 170.86 7.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.288 -0.634 . . . . 0.56999999999999995 109.288 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.346 0.428 0 C-N-CA 122.88 0.472 . . . . 0.5 . 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.443 ' H43' ' CD1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 118.572 -0.728 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -104.78 -58.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.297 1.439 . . . . 0.56999999999999995 108.643 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -173.76 122.85 0.34 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 104.284 -2.487 . . . . 0.56999999999999995 104.284 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.24 80.58 0.29 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 114.141 1.163 . . . . 0.56999999999999995 114.141 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.72 109.55 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.929 1.753 . . . . 0.56999999999999995 110.276 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -145.2 105.24 4.04 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 107.6 -1.259 . . . . 0.56999999999999995 107.6 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.5 m 36.7 70.52 1.08 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.08 1.352 . . . . 0.56999999999999995 113.349 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -67.77 31.21 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.123 3.215 . . . . 0.56999999999999995 115.013 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -162.06 31.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 110.81 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.408 ' CH2' ' HA3' ' A' ' 94' ' ' GLY . 89.4 m95 51.93 -111.53 0.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.762 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -154.57 -40.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.613 1.565 . . . . 0.56999999999999995 108.428 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -95.97 153.35 17.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.312 0.645 . . . . 0.56999999999999995 109.506 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -9.93 20.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.988 0.915 . . . . 0.56999999999999995 112.667 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.54 147.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.905 -1.517 . . . . 0.56999999999999995 106.905 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.21 161.65 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.4 -1.333 . . . . 0.56999999999999995 107.4 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -107.46 139.1 42.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.541 -1.281 . . . . 0.56999999999999995 107.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -126.11 151.5 47.14 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 109.561 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -153.57 118.25 4.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.171 0.51 . . . . 1.2 109.803 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.3 mt -82.62 86.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.424 -1.695 . . . . 0.56999999999999995 106.424 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.76 -49.59 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 112.2 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.82 153.1 33.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.417 -2.438 . . . . 0.56999999999999995 104.417 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -125.75 149.68 48.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.173 -1.788 . . . . 0.56999999999999995 106.173 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -159.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 O-C-N 125.032 1.458 . . . . 0.56999999999999995 111.084 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -148.04 -29.34 0.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 114.244 1.202 . . . . 1.2 114.244 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -52.61 -57.54 9.69 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.205 0.941 . . . . 0.66000000000000003 110.915 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.31 164.41 14.99 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 109.466 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -77.97 149.55 25.89 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.149 1.899 . . . . 0.56999999999999995 112.618 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -60.6 -35.65 76.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.398 1.079 . . . . 0.65000000000000002 112.408 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.17 -38.98 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.011 0.524 . . . . 0.56999999999999995 110.275 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -69.58 -41.32 75.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 117.222 -1.371 . . . . 0.56999999999999995 109.069 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.54 -53.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 120.563 1.528 . . . . 0.56999999999999995 109.96 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.21 -34.35 77.88 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 118.598 -0.715 . . . . 0.66000000000000003 110.757 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -46.44 80.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.625 1.102 . . . . 1.2 111.717 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.1 mt -65.09 -45.22 86.14 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.223 1.009 . . . . 0.56999999999999995 108.337 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.37 -44.86 99.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.94 -1.029 . . . . 0.56999999999999995 110.565 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 m -60.27 -46.89 88.26 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 120.036 1.289 . . . . 0.56999999999999995 109.895 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -36.89 69.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.508 -0.758 . . . . 0.56999999999999995 111.501 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.69 91.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 111.308 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 26.3 mt -72.11 -35.8 69.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.629 0.772 . . . . 0.56999999999999995 110.493 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.52 -42.87 88.68 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.089 -0.958 . . . . 0.56999999999999995 109.944 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.9 mtp -60.81 -36.93 80.32 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.928 0.891 . . . . 0.56999999999999995 111.321 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.0 -47.04 66.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.975 1.261 . . . . 0.56999999999999995 111.309 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.44 -3.86 59.08 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 123.94 0.781 . . . . 0.56999999999999995 113.301 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -70.46 -19.81 62.93 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.984 -1.303 . . . . 0.56999999999999995 111.043 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.6 mp0 -110.52 -34.8 6.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.503 1.521 . . . . 0.66000000000000003 111.056 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 21.7 pt -114.07 143.06 28.96 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 111.04 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.26 21.16 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.248 2.632 . . . . 0.56999999999999995 112.488 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 126.38 34.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.188 -1.412 . . . . 0.56999999999999995 107.188 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -126.68 -178.55 4.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.867 0.867 . . . . 0.65000000000000002 109.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -147.83 147.53 29.9 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.704 -0.85 . . . . 0.56999999999999995 108.704 -170.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.95 160.0 39.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.381 1.072 . . . . 1.2 109.722 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -110.05 116.08 30.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.286 -1.376 . . . . 0.56999999999999995 107.286 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.58 161.21 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.585 -0.894 . . . . 0.56999999999999995 108.585 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.79 39.44 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.208 1.003 . . . . 0.56999999999999995 110.179 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -90.58 -65.57 1.0 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.045 0.538 . . . . 0.56999999999999995 109.917 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.07 -70.55 0.02 OUTLIER Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.298 -1.521 . . . . 0.56999999999999995 109.298 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -125.52 139.68 53.4 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.319 -1.363 . . . . 0.56999999999999995 107.319 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.59 171.27 7.42 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.069 0.947 . . . . 0.56999999999999995 110.012 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -62.48 -50.54 71.01 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.176 -1.046 . . . . 0.66000000000000003 108.176 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.64 81.88 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.775 -1.565 . . . . 0.56999999999999995 106.775 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -78.54 121.4 24.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.96 127.2 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 106.687 -1.597 . . . . 0.56999999999999995 106.687 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.38 25.81 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 111.204 -0.758 . . . . 0.56999999999999995 111.204 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 21.3 m-85 -132.62 137.32 46.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.948 -1.871 . . . . 0.56999999999999995 105.948 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 160.22 36.59 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.826 1.65 . . . . 0.56999999999999995 107.873 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -116.67 50.99 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.201 -0.937 . . . . 1.2 110.137 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.85 -127.35 6.31 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.254 -1.538 . . . . 0.56999999999999995 109.254 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.94 139.46 0.46 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.14 1.376 . . . . 0.56999999999999995 112.621 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -120.9 -62.27 1.47 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.485 -0.78 . . . . 0.65000000000000002 109.836 -173.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.99 71.83 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.354 -0.692 . . . . 0.56999999999999995 112.647 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.3 121.35 41.73 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.632 1.173 . . . . 0.66000000000000003 108.485 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.82 -73.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.381 . . . . 0.56999999999999995 111.689 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -148.23 144.12 18.38 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 108.638 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.02 149.55 77.2 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.815 1.676 . . . . 0.56999999999999995 110.405 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 1.4 m-85 -70.44 -174.18 0.82 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.738 -1.119 . . . . 0.56999999999999995 110.749 170.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.63 -32.16 4.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.688 2.395 . . . . 0.66000000000000003 110.975 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.42 -139.94 15.83 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 112.351 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.07 86.67 1.62 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.353 3.369 . . . . 0.56999999999999995 112.036 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.04 -174.99 33.92 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.565 1.555 . . . . 0.56999999999999995 111.226 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 m120 45.82 -134.71 0.82 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.829 1.314 . . . . 0.56999999999999995 112.478 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -59.13 118.56 6.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.14 2.176 . . . . 0.56999999999999995 111.449 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD12 ' C24' ' A' ' 178' ' ' MDW . 5.3 mp -94.68 -34.87 12.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.736 1.214 . . . . 0.56999999999999995 112.195 -175.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.25 157.97 33.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.292 1.037 . . . . 0.56999999999999995 108.826 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.41 ' HE2' ' CE1' ' A' ' 69' ' ' HIS . 0.7 OUTLIER -143.68 161.93 37.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.341 -0.615 . . . . 0.65000000000000002 109.341 178.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.46 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.696 -0.853 . . . . 0.56999999999999995 108.696 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.58 153.82 32.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.317 -0.994 . . . . 0.56999999999999995 108.317 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.38 149.56 96.94 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.072 -0.966 . . . . 0.56999999999999995 109.63 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.35 160.82 45.96 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.295 1.997 . . . . 0.56999999999999995 111.47 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 -106.88 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.315 -1.914 . . . . 0.56999999999999995 108.315 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.3 p -151.71 69.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.744 0.818 . . . . 0.56999999999999995 110.948 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.36 -121.45 1.6 Allowed Glycine 0 C--N 1.342 0.904 0 N-CA-C 110.404 -1.079 . . . . 0.56999999999999995 110.404 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.86 -21.76 61.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.167 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.78 130.59 43.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.447 -1.196 . . . . 0.56999999999999995 110.959 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' HA3' ' CH2' ' A' ' 10' ' ' TRP . . . 96.38 -36.86 3.65 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.084 2.278 . . . . 0.56999999999999995 113.09 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.1 145.91 19.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.998 2.119 . . . . 0.66000000000000003 107.092 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.29 146.61 36.99 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.871 -0.789 . . . . 0.56999999999999995 108.871 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -139.56 160.6 39.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 110.236 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.448 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 57.5 m-85 -142.44 148.58 38.01 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.361 1.064 . . . . 0.56999999999999995 108.323 -163.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.38 100.56 10.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.81 -1.552 . . . . 0.66000000000000003 106.81 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.9 -25.73 31.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.463 -1.398 . . . . 0.66000000000000003 111.43 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.18 -37.18 76.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.66000000000000003 110.478 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.24 120.2 20.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.192 -1.41 . . . . 0.66000000000000003 107.192 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -56.28 122.58 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.873 0.469 . . . . 1.2 110.254 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' HB3' ' CD2' ' A' ' 114' ' ' PHE . 98.4 m95 -109.63 133.94 52.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 108.339 -0.985 . . . . 0.56999999999999995 108.339 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.5 t -137.28 148.39 46.36 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.188 -0.671 . . . . 0.56999999999999995 109.188 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.47 -26.04 67.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.844 0.857 . . . . 0.66000000000000003 111.863 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.61 -141.19 11.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.088 1.327 . . . . 0.56999999999999995 110.248 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -160.56 103.77 1.39 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.584 0.692 . . . . 0.56999999999999995 109.566 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.51 -36.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.043 0.937 . . . . 0.56999999999999995 112.231 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -104.04 -58.84 1.82 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.094 0.558 . . . . 0.56999999999999995 109.516 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.9 -165.17 21.48 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.165 -1.174 . . . . 0.56999999999999995 110.165 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.58 143.96 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 109.416 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.84 108.88 1.89 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.156 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -60.53 -34.42 74.09 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 112.121 174.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -51.33 63.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.7 -1.222 . . . . 0.56999999999999995 107.7 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -57.55 -46.71 83.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.627 0.771 . . . . 0.56999999999999995 110.147 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.65 19.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.515 0.509 . . . . 0.56999999999999995 111.022 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.5 -55.52 34.03 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 117.933 -1.032 . . . . 0.56999999999999995 109.907 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -58.18 -34.45 70.35 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.906 1.23 . . . . 0.56999999999999995 111.841 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.01 -60.27 3.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.102 0.961 . . . . 0.65000000000000002 109.79 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.88 -45.79 80.75 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.569 -0.707 . . . . 0.66000000000000003 111.42 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.63 -30.8 71.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.421 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.96 -42.51 80.67 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.156 -0.778 . . . . 0.56999999999999995 111.156 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -74.52 -37.59 63.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 117.16 -1.4 . . . . 0.65000000000000002 112.354 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 p -54.42 -38.65 66.5 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 124.453 1.096 . . . . 0.56999999999999995 109.685 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -43.38 95.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 112.337 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.2 43.39 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.862 -0.966 . . . . 0.56999999999999995 114.332 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.06 176.17 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.054 0.941 . . . . 0.56999999999999995 111.45 -171.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.01 66.33 0.01 OUTLIER Glycine 0 C--N 1.342 0.882 0 O-C-N 121.473 -0.767 . . . . 0.56999999999999995 111.735 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 174.24 7.11 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.626 1.171 . . . . 0.65000000000000002 110.636 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 t -160.33 -177.16 6.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.36 -0.836 . . . . 0.56999999999999995 110.773 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -146.8 56.37 1.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.306 2.642 . . . . 0.56999999999999995 107.46 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.35 150.65 44.86 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 124.647 1.179 . . . . 0.66000000000000003 108.278 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.0 -26.91 58.18 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.628 2.218 . . . . 0.56999999999999995 111.607 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.94 30.29 5.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.27 -1.011 . . . . 0.56999999999999995 108.27 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.42 131.04 46.05 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.294 -1.373 . . . . 0.56999999999999995 107.294 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.32 -32.26 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 110.68 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -99.21 25.86 6.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.827 0.451 . . . . 0.56999999999999995 111.362 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -65.26 131.64 95.08 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 120.766 -1.209 . . . . 0.56999999999999995 110.385 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.28 171.79 17.6 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.662 2.241 . . . . 0.56999999999999995 111.007 166.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 m 52.13 76.81 0.17 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.474 1.13 . . . . 0.56999999999999995 110.657 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -46.92 125.52 7.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.234 1.014 . . . . 0.56999999999999995 112.485 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.45 1.86 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.08 -1.208 . . . . 0.56999999999999995 110.08 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.79 -44.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.55 0.74 . . . . 0.56999999999999995 111.635 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -143.51 -137.14 3.23 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.208 -1.957 . . . . 0.56999999999999995 108.208 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -126.03 112.0 24.31 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.589 -0.893 . . . . 0.66000000000000003 108.589 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.41 -14.76 22.59 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.423 2.082 . . . . 0.56999999999999995 112.035 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -64.65 -48.68 73.93 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 121.894 2.133 . . . . 0.56999999999999995 109.87 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -92.5 69.91 4.98 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.643 1.177 . . . . 0.56999999999999995 111.169 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.44 125.72 28.03 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.293 -0.632 . . . . 0.56999999999999995 109.293 -174.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 83.04 1.54 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.539 -1.282 . . . . 0.56999999999999995 107.539 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 48.58 80.93 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.815 1.646 . . . . 0.56999999999999995 111.629 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.6 t -67.95 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.128 0.571 . . . . 0.56999999999999995 112.322 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.59 -57.37 0.69 Allowed 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.386 -0.968 . . . . 0.56999999999999995 108.386 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -51.06 -39.43 55.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.277 1.431 . . . . 0.66000000000000003 112.266 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -63.57 -53.83 45.61 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.64 -0.695 . . . . 0.66000000000000003 109.366 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -48.92 86.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 118.752 -0.642 . . . . 0.56999999999999995 109.843 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -32.76 74.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.12 1.768 . . . . 0.56999999999999995 110.626 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.84 -60.45 3.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.98 -2.048 . . . . 0.56999999999999995 107.98 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.55 -58.35 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 119.342 1.571 . . . . 0.56999999999999995 111.151 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.423 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 10.6 pt20 -58.56 -22.56 56.16 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.705 0.684 . . . . 0.56999999999999995 112.148 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -31.4 19.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.948 1.299 . . . . 0.56999999999999995 110.777 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.14 -46.14 88.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.157 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.1 p90 -104.88 12.73 32.18 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.379 0.672 . . . . 0.56999999999999995 112.674 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.85 -141.85 12.36 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 122.163 0.868 . . . . 0.56999999999999995 112.039 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -143.9 -60.51 0.4 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.039 -1.08 . . . . 0.56999999999999995 110.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 160.61 39.05 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.863 0.865 . . . . 1.2 108.834 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -164.0 160.58 21.98 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.103 -1.814 . . . . 0.56999999999999995 106.103 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -47.34 14.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.655 -0.498 . . . . 0.56999999999999995 109.655 172.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.3 t 56.61 171.89 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.013 1.387 . . . . 0.56999999999999995 112.641 -170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.06 159.52 41.82 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.922 -1.14 . . . . 1.2 107.922 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.65 171.04 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.943 1.697 . . . . 0.56999999999999995 107.28 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.164 0 C-N-CA 127.124 2.17 . . . . 0.5 . -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.453 ' C24' HD12 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 117.386 -1.293 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 t -138.34 -51.24 0.58 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.991 1.269 . . . . 0.56999999999999995 109.31 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 tp -164.34 173.56 12.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.519 1.528 . . . . 0.56999999999999995 107.258 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -31.36 96.99 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.393 2.277 . . . . 0.56999999999999995 113.404 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.5 84.01 2.03 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.275 2.65 . . . . 0.56999999999999995 110.416 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.14 97.97 7.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.888 -1.051 . . . . 0.56999999999999995 108.988 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 m 44.43 69.76 2.3 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.76 1.624 . . . . 0.56999999999999995 113.727 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 108.13 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.53 2.153 . . . . 0.56999999999999995 111.011 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt 91.44 132.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 130.395 3.478 . . . . 0.56999999999999995 109.9 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -64.41 159.46 21.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 110.743 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -76.28 -25.33 54.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.715 0.635 . . . . 0.56999999999999995 112.715 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -94.06 143.03 26.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.9 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 pttm -76.48 -12.22 60.0 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.963 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.85 109.49 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.735 -2.32 . . . . 0.56999999999999995 104.735 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.11 163.86 3.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.67 -1.604 . . . . 0.56999999999999995 106.67 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 p -114.37 147.45 39.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.694 -0.629 . . . . 0.56999999999999995 111.351 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -123.77 155.42 37.96 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.474 0.71 . . . . 0.56999999999999995 110.763 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 120.06 5.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.488 0.661 . . . . 1.2 110.052 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 mt -87.02 113.8 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 105.842 -1.91 . . . . 0.56999999999999995 105.842 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.48 -45.66 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.291 0.951 . . . . 0.56999999999999995 111.237 -171.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.7 178.41 4.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.388 -1.708 . . . . 0.56999999999999995 106.388 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.66 173.81 11.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.454 1.025 . . . . 0.56999999999999995 109.306 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -90.28 -175.5 4.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.476 1.11 . . . . 0.56999999999999995 111.251 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -123.96 -34.7 2.95 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.909 1.284 . . . . 1.2 113.491 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -61.86 -27.46 68.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.069 1.348 . . . . 0.66000000000000003 111.648 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.47 144.31 20.65 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 126.957 2.103 . . . . 0.56999999999999995 108.436 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 167.45 24.85 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.946 2.431 . . . . 0.56999999999999995 112.863 -166.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.29 -36.24 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.859 0.864 . . . . 0.65000000000000002 111.903 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.54 -36.87 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.724 0.81 . . . . 0.56999999999999995 110.353 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -67.27 -49.84 62.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.846 -1.549 . . . . 0.56999999999999995 108.39 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.97 -51.03 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 121.217 1.826 . . . . 0.56999999999999995 110.66 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.8 -41.15 96.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.676 0.791 . . . . 0.66000000000000003 111.986 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -62.98 -45.45 92.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.07 0.85 . . . . 1.2 111.772 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.14 -35.08 73.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.45 -0.786 . . . . 0.56999999999999995 109.257 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.23 -49.45 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 117.886 -1.054 . . . . 0.56999999999999995 110.204 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -60.17 -42.79 95.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.945 1.248 . . . . 0.56999999999999995 111.076 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -65.05 -47.58 76.87 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.004 0.82 . . . . 0.56999999999999995 111.234 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.99 99.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.127 0.971 . . . . 0.56999999999999995 111.96 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.29 -35.54 71.33 Favored 'General case' 0 C--O 1.228 -0.044 0 O-C-N 121.531 -0.731 . . . . 0.56999999999999995 111.427 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -61.96 -41.04 97.54 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.092 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 36.0 mtp -60.71 -40.1 91.03 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.022 -0.99 . . . . 0.56999999999999995 111.206 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.45 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 46.7 m95 -61.89 -50.24 73.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.45 1.477 . . . . 0.56999999999999995 111.844 168.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.24 -8.97 53.22 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.424 1.012 . . . . 0.56999999999999995 114.258 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -66.79 -24.2 66.15 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -1.225 . . . . 0.56999999999999995 111.315 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -111.36 -11.34 14.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 118.445 -0.788 . . . . 0.66000000000000003 111.023 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 pt -140.23 135.41 16.15 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 120.38 1.446 . . . . 0.56999999999999995 110.96 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.87 48.36 2.2 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.52 3.48 . . . . 0.56999999999999995 113.462 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tt -109.43 141.97 41.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.507 1.923 . . . . 0.56999999999999995 107.842 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -133.0 163.77 28.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.785 0.834 . . . . 0.65000000000000002 109.002 -168.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.75 145.49 32.43 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.573 -0.899 . . . . 0.56999999999999995 108.573 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -145.33 175.23 10.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.331 1.052 . . . . 1.2 110.274 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -112.17 138.19 49.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.093 -0.706 . . . . 0.56999999999999995 109.093 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.51 -28.96 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.097 0.959 . . . . 0.56999999999999995 111.21 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.258 3.7 m 44.88 40.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.565 1.946 . . . . 0.56999999999999995 112.72 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -156.47 -38.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.544 1.312 . . . . 0.56999999999999995 114.544 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.83 -146.26 4.52 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.974 -1.25 . . . . 0.56999999999999995 109.974 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -70.72 -173.64 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.0 0.9 . . . . 0.56999999999999995 111.536 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.77 177.37 11.33 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.123 1.369 . . . . 0.56999999999999995 110.403 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -63.66 -36.15 82.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.746 0.819 . . . . 0.66000000000000003 110.097 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mt -120.33 76.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 126.769 2.027 . . . . 0.56999999999999995 107.804 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -72.63 124.07 24.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.973 -1.121 . . . . 0.56999999999999995 107.973 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.27 117.72 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 105.286 -2.116 . . . . 0.56999999999999995 105.286 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.03 161.82 19.47 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.923 -0.871 . . . . 0.56999999999999995 110.923 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -133.83 142.76 47.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.472 -2.048 . . . . 0.56999999999999995 105.472 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.31 166.25 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.962 2.505 . . . . 0.56999999999999995 107.535 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -130.0 93.96 3.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.06 -49.85 2.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.91 -0.939 . . . . 0.56999999999999995 111.814 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.25 153.04 38.18 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.639 1.72 . . . . 0.56999999999999995 110.897 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -152.04 159.69 43.64 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 125.568 1.547 . . . . 0.65000000000000002 109.158 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.75 44.9 3.04 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.369 1.462 . . . . 0.56999999999999995 112.872 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.67 -179.78 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.577 1.551 . . . . 0.66000000000000003 110.409 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -39.82 -50.07 2.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.333 1.453 . . . . 0.56999999999999995 111.791 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.89 132.06 13.7 Favored Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 124.611 1.164 . . . . 0.56999999999999995 109.801 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.01 158.76 54.46 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.033 1.822 . . . . 0.56999999999999995 111.204 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.33 -164.48 0.77 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 111.061 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -121.73 -14.08 8.19 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.928 2.491 . . . . 0.66000000000000003 112.408 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.71 -134.82 12.71 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.397 0.999 . . . . 0.56999999999999995 110.678 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.51 100.51 1.16 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 112.322 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.91 -163.85 25.55 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.516 1.055 . . . . 0.56999999999999995 112.518 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 t30 45.42 -125.53 1.19 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.465 1.506 . . . . 0.56999999999999995 114.346 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.6 m -74.48 131.91 41.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.635 2.374 . . . . 0.56999999999999995 108.614 173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.76 -31.9 10.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 112.194 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.34 37.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.945 1.298 . . . . 0.56999999999999995 108.008 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -143.23 161.38 38.41 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.964 -0.46 . . . . 0.65000000000000002 110.029 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.66 144.58 27.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.363 1.065 . . . . 0.56999999999999995 109.167 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.04 146.4 27.96 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.849 -1.167 . . . . 0.56999999999999995 107.849 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.86 155.15 12.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.502 -0.761 . . . . 0.56999999999999995 110.891 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.48 166.07 26.92 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.121 1.881 . . . . 0.56999999999999995 112.043 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.23 -101.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.3 p -151.36 -54.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.423 1.089 . . . . 0.56999999999999995 110.599 -166.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.7 -108.56 3.24 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 125.086 1.327 . . . . 0.56999999999999995 110.01 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -29.06 64.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.754 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.33 141.75 6.95 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.201 -0.76 . . . . 0.56999999999999995 111.201 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.99 4.61 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.664 -1.631 . . . . 0.56999999999999995 114.504 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.25 159.47 33.38 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.043 1.921 . . . . 0.66000000000000003 109.074 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.81 145.36 27.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 109.867 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -130.94 155.22 47.16 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.334 -0.617 . . . . 0.65000000000000002 109.334 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -138.08 147.99 44.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.778 1.631 . . . . 0.56999999999999995 108.631 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.39 93.99 8.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.795 0.838 . . . . 0.66000000000000003 108.882 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.85 -22.36 14.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.77 1.628 . . . . 0.66000000000000003 111.568 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.61 -28.81 68.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.115 0.416 . . . . 0.66000000000000003 111.572 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -79.89 167.86 19.98 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 111.502 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -79.55 156.39 27.76 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.69 -0.686 . . . . 1.2 110.157 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -151.28 121.7 7.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.817 -1.919 . . . . 0.56999999999999995 105.817 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -136.15 144.56 45.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.871 1.669 . . . . 0.56999999999999995 109.342 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -68.07 -45.5 73.66 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.957 0.503 . . . . 0.66000000000000003 110.596 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.95 39.27 0.02 OUTLIER Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.826 1.679 . . . . 0.56999999999999995 111.43 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 -66.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.012 1.325 . . . . 0.56999999999999995 110.199 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -84.44 168.23 15.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.461 0.704 . . . . 0.56999999999999995 110.314 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.74 150.21 20.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.241 1.016 . . . . 0.56999999999999995 111.371 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -145.88 15.29 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.709 -0.556 . . . . 0.56999999999999995 111.709 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.83 142.66 38.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.453 1.101 . . . . 0.56999999999999995 108.21 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.7 110.39 1.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.273 0.629 . . . . 0.56999999999999995 111.615 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.04 -34.87 78.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.203 1.801 . . . . 0.56999999999999995 113.104 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -39.97 84.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.434 0.561 . . . . 0.56999999999999995 110.217 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.76 -45.72 81.49 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 124.038 0.836 . . . . 0.56999999999999995 108.77 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.42 22.06 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 111.114 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.9 74.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.749 -1.12 . . . . 0.56999999999999995 109.866 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -51.89 -46.06 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.85 1.205 . . . . 0.56999999999999995 111.029 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -61.76 -55.18 32.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.692 0.797 . . . . 0.65000000000000002 109.773 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.43 -41.01 89.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.343 0.519 . . . . 0.66000000000000003 110.96 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.14 -26.08 68.65 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.42 -0.8 . . . . 0.56999999999999995 111.801 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.45 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -66.58 -44.59 89.54 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 113.003 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -64.28 -38.56 91.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.042 -0.504 . . . . 0.65000000000000002 110.025 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 t -59.4 -33.81 71.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.358 0.503 . . . . 0.56999999999999995 112.358 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -38.43 65.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.992 0.917 . . . . 0.56999999999999995 111.534 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.3 9.75 0.65 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.426 1.013 . . . . 0.56999999999999995 115.224 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -93.99 157.96 15.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.681 1.24 . . . . 0.56999999999999995 110.845 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.35 178.01 21.69 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.513 -1.035 . . . . 0.56999999999999995 110.513 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -72.61 166.66 22.29 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.054 0.542 . . . . 0.65000000000000002 111.439 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.0 t -123.55 -46.35 2.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 112.299 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.72 43.71 0.32 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.366 1.467 . . . . 0.56999999999999995 112.831 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -117.29 154.8 50.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.609 1.163 . . . . 0.66000000000000003 109.48 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.71 -6.29 18.23 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 114.353 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -137.5 17.62 2.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.039 1.336 . . . . 0.56999999999999995 110.378 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.17 130.71 43.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 111.077 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.79 -25.28 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 111.752 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.95 21.55 11.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.453 1.501 . . . . 0.56999999999999995 111.357 169.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -58.85 136.3 87.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 120.667 -1.271 . . . . 0.56999999999999995 110.194 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.99 -163.76 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.729 2.953 . . . . 0.56999999999999995 111.819 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t 36.29 77.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.524 1.929 . . . . 0.56999999999999995 115.215 168.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -38.91 109.63 0.11 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.919 2.088 . . . . 0.56999999999999995 113.341 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.34 111.34 1.2 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.747 1.165 . . . . 0.56999999999999995 110.684 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -179.84 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.61 1.164 . . . . 0.56999999999999995 112.279 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.0 -162.29 11.46 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.475 1.512 . . . . 0.56999999999999995 110.024 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.04 108.88 56.55 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 106.846 -1.538 . . . . 0.66000000000000003 106.846 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.44 -7.6 9.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.31 2.674 . . . . 0.56999999999999995 112.922 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -69.48 -33.38 72.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 121.041 1.746 . . . . 0.56999999999999995 109.684 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.74 86.8 2.26 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.288 1.035 . . . . 0.56999999999999995 112.001 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.76 -50.75 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 111.618 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.99 45.1 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.027 2.131 . . . . 0.56999999999999995 114.85 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp 64.98 79.96 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.841 1.656 . . . . 0.56999999999999995 109.893 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -58.82 -83.48 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.644 1.177 . . . . 0.56999999999999995 113.448 -170.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -142.88 -49.45 0.34 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.738 1.615 . . . . 0.56999999999999995 106.643 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.18 -53.4 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.66000000000000003 112.953 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -51.67 69.08 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.874 0.469 . . . . 0.66000000000000003 110.772 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.07 -38.58 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 109.699 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -49.69 66.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.046 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.6 -52.74 51.28 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.89 0.768 . . . . 0.56999999999999995 111.311 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 mm -61.6 -50.74 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.438 -0.791 . . . . 0.56999999999999995 111.052 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -70.81 -14.08 62.28 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 112.143 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -83.26 -25.08 31.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.618 1.099 . . . . 0.56999999999999995 111.829 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.27 -37.44 12.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.571 1.078 . . . . 0.56999999999999995 111.9 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -113.06 28.67 8.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.148 1.779 . . . . 0.56999999999999995 109.517 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.73 -137.24 2.66 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.997 2.237 . . . . 0.56999999999999995 108.163 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -135.3 -52.04 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 0.56999999999999995 112.097 -164.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -145.65 142.12 28.76 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.354 1.062 . . . . 1.2 109.124 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.71 125.13 2.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.393 -2.077 . . . . 0.56999999999999995 105.393 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.94 -174.94 0.15 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.941 1.296 . . . . 0.56999999999999995 113.333 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.4 t -130.94 177.81 7.15 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.734 1.614 . . . . 0.56999999999999995 108.689 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -83.19 131.19 35.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.79 -1.189 . . . . 1.2 107.79 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -159.52 128.44 5.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.143 0.883 . . . . 0.56999999999999995 109.322 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? . . . . . 0 N--CA 1.468 0.444 0 C-N-CA 123.618 0.767 . . . . 0.5 . -169.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 119.469 -0.301 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -142.71 -36.39 0.39 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.019 0.928 . . . . 0.56999999999999995 110.82 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -60.86 99.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.618 1.199 . . . . 0.56999999999999995 110.111 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -45.59 1.25 Allowed Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.361 1.864 . . . . 0.56999999999999995 112.289 172.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.44 -169.03 0.63 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.75 2.3 . . . . 0.56999999999999995 111.973 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -55.06 166.82 0.48 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.675 0.79 . . . . 0.56999999999999995 110.823 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -45.31 113.79 2.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.115 0.966 . . . . 0.56999999999999995 110.499 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.77 176.41 8.28 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.205 1.27 . . . . 0.56999999999999995 110.042 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.23 132.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.425 2.29 . . . . 0.56999999999999995 108.186 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 13.0 m95 -71.72 175.02 6.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.699 0.8 . . . . 0.56999999999999995 110.422 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.0 p -97.38 -11.7 23.65 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.672 0.619 . . . . 0.56999999999999995 112.672 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.0 t -104.49 151.25 23.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.85 1.66 . . . . 0.56999999999999995 108.675 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -8.91 57.85 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.201 1.001 . . . . 0.56999999999999995 112.449 172.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.66 144.62 37.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.568 1.547 . . . . 0.56999999999999995 108.775 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.2 t -130.37 153.73 39.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 108.098 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 p -103.39 144.02 31.93 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.739 -0.467 . . . . 0.56999999999999995 109.739 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -133.31 152.74 51.94 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.257 -1.527 . . . . 0.56999999999999995 110.895 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.63 111.77 4.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.313 1.054 . . . . 1.2 109.626 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.28 101.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 104.152 -2.536 . . . . 0.56999999999999995 104.152 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.45 -44.87 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.692 1.197 . . . . 0.56999999999999995 111.651 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.44 174.86 6.12 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.362 1.865 . . . . 0.56999999999999995 106.411 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -146.29 161.16 40.9 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.5 -0.926 . . . . 0.56999999999999995 108.5 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.8 t -63.25 177.73 0.6 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.597 0.713 . . . . 0.56999999999999995 110.913 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -117.67 -39.61 3.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.436 1.094 . . . . 1.2 112.836 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.07 -33.55 73.5 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.231 0.923 . . . . 0.66000000000000003 110.084 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.35 149.7 44.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.56999999999999995 109.811 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -76.73 164.81 29.69 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.918 2.412 . . . . 0.56999999999999995 113.609 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -62.38 -45.52 92.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.898 1.279 . . . . 0.65000000000000002 112.06 -177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 tp -57.86 -42.21 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 109.672 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -62.46 -48.35 80.04 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 117.759 -1.115 . . . . 0.56999999999999995 109.251 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.43 -49.74 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 120.72 1.6 . . . . 0.56999999999999995 110.679 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.59 -41.34 96.3 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.167 0.894 . . . . 0.66000000000000003 111.404 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.275 -0.891 . . . . 1.2 112.307 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.11 -35.92 74.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.998 -1.001 . . . . 0.56999999999999995 109.274 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.03 -51.56 60.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.05 -0.976 . . . . 0.56999999999999995 108.773 166.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -43.61 88.76 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.08 1.309 . . . . 0.56999999999999995 110.878 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -66.89 -38.51 86.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.565 1.075 . . . . 0.56999999999999995 112.807 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.16 76.44 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 111.554 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.5 -30.96 68.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.086 -0.959 . . . . 0.56999999999999995 110.278 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.34 -31.76 72.44 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.339 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.8 mtm -74.28 -37.55 63.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.328 -0.844 . . . . 0.56999999999999995 111.66 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -64.9 -50.19 67.49 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 110.681 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -4.91 55.24 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.511 1.529 . . . . 0.56999999999999995 113.956 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -25.68 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.548 -0.972 . . . . 0.56999999999999995 110.211 168.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -110.71 -19.06 12.99 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.695 -0.669 . . . . 0.66000000000000003 112.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.5 pt -126.35 126.3 24.64 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 123.951 0.9 . . . . 0.56999999999999995 109.028 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.95 32.64 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.504 2.803 . . . . 0.56999999999999995 113.557 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.89 145.9 31.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.147 1.379 . . . . 0.56999999999999995 108.241 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -126.54 165.92 18.25 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.65000000000000002 108.47 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.06 157.33 46.56 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.723 -1.236 . . . . 0.56999999999999995 108.511 -172.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.76 160.78 39.12 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.33 1.052 . . . . 1.2 108.857 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -106.9 146.7 30.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.438 -1.319 . . . . 0.56999999999999995 107.438 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.1 169.01 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.927 0.491 . . . . 0.56999999999999995 109.793 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.31 -13.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.56999999999999995 111.504 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -93.23 -66.02 0.95 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.56999999999999995 108.845 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.48 -27.38 0.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.843 0.292 . . . . 0.56999999999999995 113.05 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -78.56 125.72 29.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.845 -1.169 . . . . 0.56999999999999995 107.845 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.3 166.17 26.3 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.973 0.909 . . . . 0.56999999999999995 109.321 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 74.1 m-20 -64.1 -47.19 81.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.11 0.964 . . . . 0.66000000000000003 108.706 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.92 80.0 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.766 1.627 . . . . 0.56999999999999995 107.282 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 ttm -75.48 134.26 40.87 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.77 -1.206 . . . . 0.56999999999999995 107.841 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.59 119.63 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.963 -1.865 . . . . 0.56999999999999995 105.963 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.94 163.92 23.35 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 111.841 -0.504 . . . . 0.56999999999999995 111.841 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.31 134.01 33.74 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.467 -2.049 . . . . 0.56999999999999995 105.467 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.03 -174.04 4.74 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 109.27 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 3.04 8.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.893 0.77 . . . . 1.2 112.813 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.75 -130.67 2.12 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.175 -1.57 . . . . 0.56999999999999995 109.175 -166.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.7 117.13 7.01 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.376 -0.485 . . . . 0.56999999999999995 110.385 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -112.19 -46.8 3.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.558 0.743 . . . . 0.65000000000000002 111.316 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.41 23.41 0.59 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.2 0.905 . . . . 0.56999999999999995 113.893 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -53.18 4.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.515 1.926 . . . . 0.66000000000000003 111.773 -170.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -178.38 -45.41 0.01 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.848 2.059 . . . . 0.56999999999999995 107.646 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.56 139.5 35.48 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 123.852 0.861 . . . . 0.56999999999999995 109.039 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.34 141.4 46.85 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.454 1.436 . . . . 0.56999999999999995 109.965 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.75 -179.24 0.84 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.953 1.358 . . . . 0.56999999999999995 111.121 163.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 21.9 p-10 -115.52 -31.23 5.96 Favored 'General case' 0 CA--C 1.542 0.666 1 C-N-CA 131.92 4.088 . . . . 0.66000000000000003 109.931 -171.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.08 -138.03 15.65 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.668 -0.973 . . . . 0.56999999999999995 110.668 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 104.1 1.69 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.803 3.002 . . . . 0.56999999999999995 112.148 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -179.75 16.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 126.004 1.764 . . . . 0.56999999999999995 108.891 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 76' ' ' ASP . 0.8 OUTLIER 44.74 -155.66 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 112.86 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.7 m -44.87 120.39 2.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.365 2.266 . . . . 0.56999999999999995 111.534 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.18 -25.13 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.888 1.275 . . . . 0.56999999999999995 113.106 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.22 164.34 25.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.353 1.461 . . . . 0.56999999999999995 108.367 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.03 158.74 44.42 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.998 -0.371 . . . . 0.65000000000000002 109.998 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.0 155.74 39.68 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.725 1.21 . . . . 0.56999999999999995 109.808 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.05 171.65 7.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.596 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.55 139.08 26.48 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-O 118.245 -0.884 . . . . 0.56999999999999995 109.363 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.49 159.37 52.77 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.578 2.186 . . . . 0.56999999999999995 112.166 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.28 12.72 21.09 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.351 -0.694 . . . . 0.56999999999999995 113.752 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -153.47 43.73 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.55 1.675 . . . . 0.56999999999999995 111.933 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.37 -71.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.168 1.842 . . . . 0.56999999999999995 114.69 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.06 -5.05 39.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.372 1.869 . . . . 0.56999999999999995 111.437 163.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 126.92 31.59 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.979 -1.075 . . . . 0.56999999999999995 110.446 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.28 -44.33 1.5 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 126.046 1.784 . . . . 0.56999999999999995 110.845 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.09 143.75 13.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.105 2.162 . . . . 0.66000000000000003 109.199 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.07 150.36 42.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.633 0.73 . . . . 0.56999999999999995 109.535 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.47 162.96 31.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.943 -0.762 . . . . 0.65000000000000002 108.943 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -139.59 158.45 44.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.497 1.919 . . . . 0.56999999999999995 109.344 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -84.45 102.35 12.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.655 0.382 . . . . 0.66000000000000003 110.999 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -58.23 -28.44 64.87 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.605 -1.309 . . . . 0.66000000000000003 111.116 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.46 -26.71 66.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.609 0.763 . . . . 0.66000000000000003 111.581 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -72.37 138.93 47.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.203 1.002 . . . . 0.66000000000000003 109.608 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.12 111.79 4.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -94.24 158.64 15.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.409 -0.96 . . . . 0.56999999999999995 108.409 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.3 t -141.19 153.53 45.37 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.313 -0.995 . . . . 0.56999999999999995 108.313 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.55 -36.43 70.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.331 0.652 . . . . 0.66000000000000003 110.162 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.65 -97.36 1.47 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.102 -1.199 . . . . 0.56999999999999995 110.102 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -158.17 139.31 13.29 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.728 -1.212 . . . . 0.56999999999999995 107.728 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 t -163.82 -51.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.836 -0.602 . . . . 0.56999999999999995 110.491 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -160.38 -44.12 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.001 1.72 . . . . 0.56999999999999995 110.895 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.77 173.43 54.71 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.536 -1.026 . . . . 0.56999999999999995 110.536 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.66 148.78 4.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.236 0.541 . . . . 0.56999999999999995 109.816 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -65.39 114.58 4.91 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.67 -0.695 . . . . 0.56999999999999995 109.488 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -60.92 -41.11 95.52 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.573 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -47.44 84.61 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 108.787 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -60.56 -39.25 87.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.061 0.944 . . . . 0.56999999999999995 110.051 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.42 49.48 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 112.765 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.76 68.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.219 -1.03 . . . . 0.56999999999999995 108.219 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 m -56.1 -41.23 74.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.336 0.654 . . . . 0.56999999999999995 111.758 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.08 -57.79 11.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.953 0.342 . . . . 0.65000000000000002 110.109 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -68.11 -39.96 82.68 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.042 -1.036 . . . . 0.66000000000000003 111.609 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.38 -32.72 74.51 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 110.818 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.57 -47.35 57.67 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.166 -0.774 . . . . 0.56999999999999995 111.166 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.48 -35.35 70.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.556 0.576 . . . . 0.65000000000000002 112.556 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -35.85 73.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 0.56999999999999995 111.02 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -46.5 89.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 110.71 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.51 49.19 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.533 -0.593 . . . . 0.56999999999999995 113.951 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.72 -160.1 0.17 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.029 1.414 . . . . 0.56999999999999995 110.724 -173.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 132.65 35.22 0.32 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 121.427 -0.796 . . . . 0.56999999999999995 113.659 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 167.8 7.2 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.219 1.009 . . . . 0.65000000000000002 112.856 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.9 p -152.95 -173.33 4.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.584 1.153 . . . . 0.56999999999999995 110.208 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.8 p -143.48 49.73 1.41 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.703 1.201 . . . . 0.56999999999999995 110.949 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 143.87 27.91 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.08 1.352 . . . . 0.66000000000000003 110.239 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.28 -12.27 29.7 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.455 2.103 . . . . 0.56999999999999995 113.743 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -137.22 51.14 1.96 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.685 1.594 . . . . 0.56999999999999995 107.909 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.21 43.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.059 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.86 -27.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.56999999999999995 109.381 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.2 mmt -78.14 -14.96 59.27 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.649 1.979 . . . . 0.56999999999999995 114.154 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -58.8 128.25 83.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.009 1.277 . . . . 0.56999999999999995 110.605 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.05 156.8 47.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.248 1.966 . . . . 0.56999999999999995 110.642 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.5 m 61.14 99.35 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.207 1.403 . . . . 0.56999999999999995 111.473 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.89 123.98 2.05 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 111.883 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.68 -130.86 2.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.162 -1.575 . . . . 0.56999999999999995 109.162 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -65.12 -61.55 2.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.537 0.668 . . . . 0.56999999999999995 110.446 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 39.88 -150.45 0.11 Allowed Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.305 1.431 . . . . 0.56999999999999995 113.409 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.24 75.36 4.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 167.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.0 39.8 0.3 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.962 3.108 . . . . 0.56999999999999995 112.822 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -144.76 -54.51 0.32 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 108.436 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.03 89.11 3.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 108.43 -170.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -44.34 -63.24 0.92 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.479 1.511 . . . . 0.56999999999999995 114.906 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt 31.49 63.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.915 2.486 . . . . 0.56999999999999995 113.479 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp -25.8 115.13 0.05 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 128.781 2.832 . . . . 0.56999999999999995 110.874 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.3 t -82.66 -82.26 0.14 Allowed 'General case' 0 C--N 1.341 0.204 0 CA-C-O 119.051 -0.5 . . . . 0.56999999999999995 111.022 -162.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -147.94 -44.12 0.16 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 118.531 0.605 . . . . 0.56999999999999995 110.364 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.26 -49.22 9.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.903 2.081 . . . . 0.66000000000000003 112.933 164.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.53 -54.76 23.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.808 0.843 . . . . 0.66000000000000003 109.833 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.98 -41.68 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.349 1.06 . . . . 0.56999999999999995 109.108 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -57.14 13.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.916 -1.142 . . . . 0.56999999999999995 107.916 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -51.1 -53.9 25.32 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.523 -1.031 . . . . 0.56999999999999995 110.523 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.1 mm -50.86 -50.73 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.479 0.712 . . . . 0.56999999999999995 111.294 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.37 -31.01 70.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.43 0.559 . . . . 0.56999999999999995 112.241 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -24.41 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.653 -1.165 . . . . 0.56999999999999995 110.814 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.01 -49.78 5.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 110.667 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -144.43 30.07 1.25 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 112.077 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.54 -124.04 1.64 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.253 -1.139 . . . . 0.56999999999999995 110.253 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.79 -58.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.595 . . . . 0.56999999999999995 111.06 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.01 131.34 15.6 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 107.255 -1.387 . . . . 1.2 107.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.19 81.34 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.96 -1.867 . . . . 0.56999999999999995 105.96 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -161.16 141.1 10.77 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.488 -1.301 . . . . 0.56999999999999995 107.488 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.0 t -169.95 -57.34 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.036 0.935 . . . . 0.56999999999999995 108.846 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 57.15 171.76 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.809 2.044 . . . . 1.2 111.806 -170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.58 56.9 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.868 -1.145 . . . . 0.56999999999999995 110.578 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.47 0.566 0 C-N-CA 125.392 1.477 . . . . 0.5 . -175.454 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.249 0.071 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 t -76.21 -91.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 108.42 169.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.46 24.13 0.41 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.619 1.1 . . . . 0.56999999999999995 113.613 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -139.85 66.84 34.38 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 110.632 -175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 64.15 5.12 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.539 2.826 . . . . 0.56999999999999995 111.507 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.81 73.15 1.52 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 125.299 1.44 . . . . 0.56999999999999995 108.559 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m 42.36 75.13 0.66 Allowed Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 112.385 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.89 123.8 11.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.363 2.042 . . . . 0.56999999999999995 109.115 -173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 80.38 128.5 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 129.05 2.94 . . . . 0.56999999999999995 111.075 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -61.59 157.86 16.48 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.605 0.762 . . . . 0.56999999999999995 110.491 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.1 p -78.28 -34.38 48.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.475 . . . . 0.56999999999999995 111.508 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -82.93 139.12 33.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.197 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -76.29 -2.79 33.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.5 0.72 . . . . 0.56999999999999995 112.75 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.96 113.84 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.855 -2.276 . . . . 0.56999999999999995 104.855 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.71 139.85 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.876 -1.527 . . . . 0.56999999999999995 106.876 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 149.31 35.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.603 -0.686 . . . . 0.56999999999999995 111.283 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.44 157.12 35.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.56999999999999995 110.571 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 119.62 11.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.941 -0.763 . . . . 1.2 108.941 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -87.82 99.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 104.982 -2.229 . . . . 0.56999999999999995 104.982 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -48.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.504 1.122 . . . . 0.56999999999999995 111.712 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.84 175.46 5.57 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.151 1.78 . . . . 0.56999999999999995 106.455 174.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -144.42 164.87 29.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.6 t -67.84 -175.32 0.54 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.57 0.748 . . . . 0.56999999999999995 111.632 171.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.23 -38.16 1.8 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.704 1.202 . . . . 1.2 113.12 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.7 -43.9 93.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.345 0.658 . . . . 0.66000000000000003 109.985 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.0 149.1 39.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.627 1.971 . . . . 0.56999999999999995 108.606 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -75.11 160.31 39.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.311 2.007 . . . . 0.56999999999999995 112.66 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.84 -38.99 83.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.353 1.061 . . . . 0.65000000000000002 111.669 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.75 -39.58 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.296 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.8 m -68.01 -43.62 78.42 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 116.442 -1.742 . . . . 0.56999999999999995 109.013 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.97 -51.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 121.455 1.934 . . . . 0.56999999999999995 110.736 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.33 -40.99 94.4 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.197 0.908 . . . . 0.66000000000000003 111.352 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -42.74 97.65 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.852 1.206 . . . . 1.2 112.048 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mp -63.55 -48.65 76.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.598 1.559 . . . . 0.56999999999999995 108.402 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -56.64 -41.61 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.977 0.808 . . . . 0.56999999999999995 110.763 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -60.51 -53.25 59.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.499 1.045 . . . . 0.56999999999999995 109.644 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -39.19 93.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.285 0.948 . . . . 0.56999999999999995 111.624 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.96 93.74 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.943 1.297 . . . . 0.56999999999999995 111.984 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 mt -70.42 -33.78 71.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.396 -0.812 . . . . 0.56999999999999995 110.322 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.97 -37.3 76.48 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 118.808 0.731 . . . . 0.56999999999999995 110.546 171.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.52 80.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.91 0.777 . . . . 0.56999999999999995 112.268 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.427 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 17.7 m95 -73.03 -47.56 43.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.764 0.711 . . . . 0.56999999999999995 110.823 171.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.87 63.54 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.562 1.077 . . . . 0.56999999999999995 113.53 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.32 -17.47 64.78 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.113 -1.227 . . . . 0.56999999999999995 111.863 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.41 -33.86 7.6 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.75 -0.643 . . . . 0.66000000000000003 111.332 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.4 pt -121.54 134.17 24.47 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 119.455 1.025 . . . . 0.56999999999999995 110.39 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 37.27 0.38 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.9 3.067 . . . . 0.56999999999999995 113.055 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.06 132.84 36.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.021 -1.474 . . . . 0.56999999999999995 107.021 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -116.44 163.97 15.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.89 1.276 . . . . 0.65000000000000002 108.915 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.6 153.47 47.37 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 108.962 -170.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -141.04 178.68 7.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.179 0.991 . . . . 1.2 109.461 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -125.35 156.07 39.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.538 -0.912 . . . . 0.56999999999999995 108.538 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 m -108.19 169.53 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.998 1.319 . . . . 0.56999999999999995 109.319 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.77 -29.37 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.71 -1.586 . . . . 0.56999999999999995 110.948 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -62.69 -51.83 65.67 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.187 0.903 . . . . 0.56999999999999995 111.719 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.64 -125.2 1.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.072 -1.611 . . . . 0.56999999999999995 109.072 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -47.14 154.85 0.34 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.443 1.097 . . . . 0.56999999999999995 113.744 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.87 -174.18 4.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.176 1.39 . . . . 0.56999999999999995 110.943 -170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -60.51 -42.09 95.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.54 -0.743 . . . . 0.66000000000000003 109.001 172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -124.19 82.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.56999999999999995 108.375 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.3 ttp -79.89 117.32 20.65 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 120.294 -1.504 . . . . 0.56999999999999995 107.116 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -108.62 129.09 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.25 -2.13 . . . . 0.56999999999999995 105.25 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 164.77 27.64 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-O 121.962 0.756 . . . . 0.56999999999999995 112.176 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -132.43 141.4 48.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.026 -1.842 . . . . 0.56999999999999995 106.026 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.38 164.69 30.08 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 107.916 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 42.08 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.564 -0.71 . . . . 1.2 111.182 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.15 -46.29 0.61 Allowed Glycine 0 C--O 1.223 -0.586 0 CA-C-O 119.53 -0.594 . . . . 0.56999999999999995 111.658 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.03 169.32 21.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.567 1.184 . . . . 0.56999999999999995 110.245 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.76 159.92 33.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.969 1.708 . . . . 0.65000000000000002 108.829 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.65 60.78 3.19 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.888 1.232 . . . . 0.56999999999999995 111.412 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -105.78 -61.84 1.45 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.111 0.965 . . . . 0.66000000000000003 110.406 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.5 t -179.74 -35.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.364 2.665 . . . . 0.56999999999999995 110.003 -173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.75 122.7 14.54 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 119.193 0.906 . . . . 0.56999999999999995 108.992 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.99 133.13 34.56 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 N-CA-C 108.423 -1.414 . . . . 0.56999999999999995 108.423 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -166.93 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 123.257 1.504 . . . . 0.56999999999999995 110.809 166.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 21.3 p-10 -134.01 -38.25 0.88 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.76 3.224 . . . . 0.66000000000000003 109.172 -168.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.74 -139.68 14.97 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.672 -1.071 . . . . 0.56999999999999995 110.509 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.1 95.43 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 124.466 3.444 . . . . 0.56999999999999995 111.281 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.64 170.85 12.33 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.849 1.69 . . . . 0.56999999999999995 109.29 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 8.1 t-20 49.33 -159.6 0.06 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.485 1.514 . . . . 0.56999999999999995 112.377 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -43.05 128.18 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.242 2.217 . . . . 0.56999999999999995 112.848 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -95.53 -24.33 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 113.062 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.09 162.0 33.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.629 -1.249 . . . . 0.56999999999999995 107.629 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.3 167.83 22.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.321 -0.622 . . . . 0.65000000000000002 109.321 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.39 160.28 42.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.285 -1.006 . . . . 0.56999999999999995 108.285 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -111.45 147.07 36.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.688 -1.227 . . . . 0.56999999999999995 107.688 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 151.4 53.22 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.268 -0.872 . . . . 0.56999999999999995 110.249 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.13 164.85 23.72 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.95 1.767 . . . . 0.56999999999999995 111.585 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.12 -93.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 109.357 -1.497 . . . . 0.56999999999999995 109.357 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -158.92 -50.61 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.503 1.521 . . . . 0.56999999999999995 109.709 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.52 -119.73 2.13 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.707 -0.957 . . . . 0.56999999999999995 110.707 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -31.49 40.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.996 0.898 . . . . 0.56999999999999995 111.879 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.2 142.44 7.97 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.509 -0.744 . . . . 0.56999999999999995 112.135 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.4 -38.9 3.12 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.186 1.851 . . . . 0.56999999999999995 112.625 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -60.36 149.78 32.71 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.759 -0.83 . . . . 0.66000000000000003 108.759 -167.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.61 146.98 38.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.522 0.677 . . . . 0.56999999999999995 109.25 -171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -135.39 156.2 49.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.265 -0.879 . . . . 0.65000000000000002 109.975 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -137.82 146.15 43.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.019 1.327 . . . . 0.56999999999999995 108.081 -169.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.02 101.61 7.91 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.455 -0.942 . . . . 0.66000000000000003 108.455 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -59.08 -24.34 62.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.66000000000000003 111.885 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -69.12 -36.05 77.08 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.577 0.751 . . . . 0.66000000000000003 111.215 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.86 131.26 44.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.441 -1.689 . . . . 0.66000000000000003 106.441 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 139.69 48.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.635 0.774 . . . . 1.2 110.441 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -129.32 118.27 21.99 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.232 -1.395 . . . . 0.56999999999999995 107.232 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -114.93 147.99 39.28 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.38 -0.97 . . . . 0.56999999999999995 108.38 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.94 21.83 2.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.624 0.77 . . . . 0.66000000000000003 111.981 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.03 68.95 1.29 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.399 -1.08 . . . . 0.56999999999999995 110.399 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -40.04 4.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.984 -1.007 . . . . 0.56999999999999995 113.697 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.0 -47.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.209 1.804 . . . . 0.56999999999999995 110.621 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -139.09 155.2 48.09 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.354 1.462 . . . . 0.56999999999999995 108.131 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.63 -161.47 12.85 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.236 -1.546 . . . . 0.56999999999999995 109.236 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.2 mm -113.36 121.19 65.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.712 -1.959 . . . . 0.56999999999999995 105.712 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.23 103.47 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.984 0.803 . . . . 0.56999999999999995 109.072 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -53.27 -41.16 65.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.607 1.563 . . . . 0.56999999999999995 110.399 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -64.42 -50.36 67.9 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.694 -1.225 . . . . 0.56999999999999995 107.694 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -60.35 -39.51 87.41 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.232 -0.655 . . . . 0.56999999999999995 109.232 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.04 -61.69 2.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 110.458 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.85 -51.49 65.74 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.235 0.614 . . . . 0.56999999999999995 110.095 -175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.8 m -62.51 -37.71 87.09 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.438 0.695 . . . . 0.56999999999999995 112.062 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -60.65 -53.95 51.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.196 0.598 . . . . 0.65000000000000002 109.393 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.78 -40.43 96.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.258 0.481 . . . . 0.66000000000000003 110.652 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.26 -30.0 70.19 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.878 0.871 . . . . 0.56999999999999995 111.37 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.427 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -56.29 -51.83 53.55 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 118.472 0.578 . . . . 0.56999999999999995 112.083 170.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.01 -40.42 93.47 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.203 1.001 . . . . 0.65000000000000002 110.635 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -33.36 65.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.115 0.966 . . . . 0.56999999999999995 112.173 172.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.91 66.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 111.648 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.82 63.88 0.88 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.446 -0.662 . . . . 0.56999999999999995 111.446 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.6 176.84 8.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 109.141 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -95.44 148.44 18.99 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.868 -0.605 . . . . 0.56999999999999995 111.929 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 174.86 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.117 1.367 . . . . 0.65000000000000002 113.045 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -133.74 178.31 7.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.983 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.43 ' HB3' ' HE3' ' A' ' 172' ' ' LYS . 1.3 t -165.39 47.06 0.09 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.358 1.863 . . . . 0.56999999999999995 108.212 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.63 143.23 37.56 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-O 118.269 -0.872 . . . . 0.66000000000000003 109.708 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.7 2.49 2.92 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.696 2.931 . . . . 0.56999999999999995 114.098 -171.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -146.98 20.57 1.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.432 1.093 . . . . 0.56999999999999995 110.358 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.11 140.57 48.94 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.463 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.56 -35.25 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.37 -0.974 . . . . 0.56999999999999995 108.37 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -86.85 14.15 7.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.949 1.092 . . . . 0.56999999999999995 113.949 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.07 128.26 93.61 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.496 -1.377 . . . . 0.56999999999999995 111.137 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.62 -46.51 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.551 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 p -81.32 52.05 1.75 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.141 1.377 . . . . 0.56999999999999995 110.323 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -39.86 131.91 1.82 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 112.902 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.7 114.9 2.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.212 1.387 . . . . 0.56999999999999995 109.657 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 179.61 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.183 1.393 . . . . 0.56999999999999995 109.349 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.38 -138.52 9.65 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.841 1.21 . . . . 0.56999999999999995 110.343 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -127.38 111.29 21.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 0.66000000000000003 108.853 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.33 -15.22 22.65 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.814 2.342 . . . . 0.56999999999999995 113.015 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -62.57 -36.46 82.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.487 1.04 . . . . 0.56999999999999995 110.252 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -90.53 70.0 6.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.947 1.299 . . . . 0.56999999999999995 108.772 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -41.73 -68.45 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.773 1.629 . . . . 0.56999999999999995 115.23 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 21.58 74.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.386 2.674 . . . . 0.56999999999999995 112.633 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mp -31.37 116.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 128.022 2.529 . . . . 0.56999999999999995 109.742 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.6 t -82.2 -88.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.843 0.354 . . . . 0.56999999999999995 110.998 -162.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -142.43 -30.51 0.55 Allowed 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 124.315 1.046 . . . . 0.56999999999999995 110.774 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -51.54 -45.71 63.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 120.027 1.285 . . . . 0.66000000000000003 110.795 167.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -58.59 3.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.479 1.112 . . . . 0.66000000000000003 111.023 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.56 -46.72 89.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.892 -0.781 . . . . 0.56999999999999995 108.892 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -60.51 -49.8 76.12 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.046 -1.454 . . . . 0.56999999999999995 108.864 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -54.18 -59.54 9.83 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.937 -1.265 . . . . 0.56999999999999995 109.937 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.22 -50.22 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.933 1.293 . . . . 0.56999999999999995 112.776 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -69.28 -19.75 63.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.476 0.71 . . . . 0.56999999999999995 111.55 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -81.77 -25.96 34.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.13 0.972 . . . . 0.56999999999999995 111.178 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 -50.59 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.348 0.976 . . . . 0.56999999999999995 111.237 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -105.0 41.63 1.32 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.74 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.26 0.15 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 109.52 -1.432 . . . . 0.56999999999999995 109.52 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.904 1.075 . . . . 0.56999999999999995 113.904 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -178.41 164.27 1.67 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.325 2.25 . . . . 1.2 108.054 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -160.71 136.84 8.43 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.266 -1.383 . . . . 0.56999999999999995 107.266 168.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.13 162.68 0.07 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.574 1.549 . . . . 0.56999999999999995 112.951 -173.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.0 p -162.81 89.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.843 0.83 . . . . 0.56999999999999995 109.082 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.39 157.98 43.12 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.579 -0.897 . . . . 1.2 108.579 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 132' ' ' SER . 0.2 OUTLIER -157.83 139.35 13.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.62 -1.622 . . . . 0.56999999999999995 106.62 173.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 125.575 1.55 . . . . 0.5 . 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 119.982 -0.056 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -69.87 -51.61 31.8 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 121.032 -1.043 . . . . 0.56999999999999995 111.662 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -146.44 -61.68 0.31 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.848 0.859 . . . . 0.56999999999999995 109.585 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -69.08 120.71 78.33 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.188 -0.911 . . . . 0.56999999999999995 109.461 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.07 -25.66 7.16 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.58 2.187 . . . . 0.56999999999999995 112.412 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -117.35 126.07 52.09 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 105.171 -2.159 . . . . 0.56999999999999995 105.171 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m 135.35 -56.58 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 1 C-N-CA 132.181 4.192 . . . . 0.56999999999999995 111.21 -170.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 163.37 33.98 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.974 1.741 . . . . 0.56999999999999995 110.988 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.78 95.52 0.04 OUTLIER 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.696 1.198 . . . . 0.56999999999999995 110.384 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -46.21 142.71 2.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.571 1.148 . . . . 0.56999999999999995 110.7 172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.9 m -62.06 -21.13 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.039 0.936 . . . . 0.56999999999999995 112.456 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -94.94 143.7 26.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.886 1.275 . . . . 0.56999999999999995 109.536 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -77.19 0.18 22.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.539 0.736 . . . . 0.56999999999999995 112.533 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.34 144.05 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.113 -1.439 . . . . 0.56999999999999995 107.113 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.07 145.8 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.412 -1.699 . . . . 0.56999999999999995 106.412 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -109.11 139.07 44.5 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.431 1.014 . . . . 0.56999999999999995 110.131 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -122.37 157.5 31.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.697 0.761 . . . . 0.56999999999999995 111.088 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.552 1.141 . . . . 1.2 109.114 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 mm -122.22 97.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.472 -2.418 . . . . 0.56999999999999995 104.472 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.19 -34.71 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.391 0.676 . . . . 0.56999999999999995 111.954 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -130.44 141.31 50.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.357 -2.46 . . . . 0.56999999999999995 104.357 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -129.86 146.56 51.59 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.581 1.152 . . . . 0.56999999999999995 108.931 -173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 t -75.9 -175.67 3.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.525 1.93 . . . . 0.56999999999999995 111.063 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -128.25 -27.75 2.66 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.595 0.961 . . . . 1.2 113.595 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.82 -23.56 67.33 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.848 1.204 . . . . 0.66000000000000003 111.519 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.36 146.95 24.15 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.097 1.759 . . . . 0.56999999999999995 109.43 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -75.29 161.73 37.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.736 2.291 . . . . 0.56999999999999995 112.96 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -70.42 -38.58 74.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.364 -0.835 . . . . 0.65000000000000002 110.315 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.52 -37.13 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 110.44 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 m -66.37 -46.33 77.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.419 -1.277 . . . . 0.56999999999999995 109.057 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.5 t -55.59 -50.65 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 110.121 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.36 -35.29 80.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 111.736 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -44.28 74.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.426 1.012 . . . . 1.2 112.314 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.09 -46.88 82.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.56999999999999995 108.112 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.86 -44.53 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 117.568 -1.206 . . . . 0.56999999999999995 111.244 173.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -54.64 -49.97 69.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.48 1.491 . . . . 0.56999999999999995 111.388 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -74.57 -33.36 62.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.155 0.889 . . . . 0.56999999999999995 112.198 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.5 78.88 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.373 1.069 . . . . 0.56999999999999995 110.949 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.76 -41.06 88.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.151 -0.928 . . . . 0.56999999999999995 109.397 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -52.88 -43.19 65.97 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 119.402 1.001 . . . . 0.56999999999999995 110.684 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.5 mtp -59.32 -39.03 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.062 1.301 . . . . 0.56999999999999995 112.597 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -65.39 -43.44 90.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.861 1.209 . . . . 0.56999999999999995 110.964 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.9 88.09 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.66 -1.275 . . . . 0.56999999999999995 113.528 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -77.45 -12.89 60.01 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 110.104 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -109.06 -21.04 12.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.828 1.251 . . . . 0.66000000000000003 111.909 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.18 152.94 70.74 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 110.137 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.06 13.55 1.25 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.11 2.54 . . . . 0.56999999999999995 113.021 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tt -82.18 135.23 35.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.455 -1.313 . . . . 0.56999999999999995 107.455 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -116.79 170.45 8.59 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.553 0.741 . . . . 0.65000000000000002 109.516 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 157.76 41.92 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.472 -0.768 . . . . 0.56999999999999995 109.203 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.16 164.57 26.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.366 1.466 . . . . 1.2 108.357 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -135.65 115.83 13.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.123 -2.177 . . . . 0.56999999999999995 105.123 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.46 164.92 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 109.023 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.02 -36.51 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.265 0.626 . . . . 0.56999999999999995 111.084 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 153.31 19.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.148 0.579 . . . . 0.56999999999999995 110.662 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.48 40.57 2.42 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.358 0.98 . . . . 0.56999999999999995 113.076 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -163.8 143.13 8.03 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.687 -1.227 . . . . 0.56999999999999995 107.687 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.54 6.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.669 1.188 . . . . 0.56999999999999995 109.596 -174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -64.48 -32.29 73.86 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.18 -0.674 . . . . 0.66000000000000003 109.18 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 mt -124.43 97.12 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.724 2.01 . . . . 0.56999999999999995 107.728 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 ttp -100.23 100.15 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.305 2.642 . . . . 0.56999999999999995 106.341 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mt -92.77 128.08 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.005 -1.85 . . . . 0.56999999999999995 106.005 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.47 145.11 11.61 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.424 -0.67 . . . . 0.56999999999999995 111.424 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 142.21 47.45 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.23 165.59 26.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.565 1.546 . . . . 0.56999999999999995 108.373 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.9 22.82 11.54 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.559 -0.713 . . . . 1.2 111.481 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 156.59 31.2 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.593 1.568 . . . . 0.56999999999999995 109.81 -164.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 49.86 102.38 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.059 2.144 . . . . 0.56999999999999995 114.201 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -147.33 157.44 43.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.476 1.111 . . . . 0.65000000000000002 109.035 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.59 62.23 4.05 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.3 0.952 . . . . 0.56999999999999995 111.192 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -106.83 -55.28 2.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.381 0.591 . . . . 0.66000000000000003 111.105 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.86 -43.18 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.814 2.846 . . . . 0.56999999999999995 109.594 -168.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -142.83 121.61 7.47 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.019 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.53 140.25 35.92 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.972 1.781 . . . . 0.56999999999999995 111.544 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -72.41 173.39 8.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.304 1.042 . . . . 0.56999999999999995 111.797 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.78 -31.51 15.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.937 2.095 . . . . 0.66000000000000003 112.41 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.04 -132.47 11.11 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 120.862 1.664 . . . . 0.56999999999999995 111.516 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.48 103.86 1.43 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 112.171 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.46 -167.06 25.65 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.682 2.087 . . . . 0.56999999999999995 111.428 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.99 -140.43 0.71 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.025 -1.279 . . . . 0.56999999999999995 114.152 164.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -51.18 137.2 22.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.042 2.137 . . . . 0.56999999999999995 110.535 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.68 -30.54 10.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.618 1.567 . . . . 0.56999999999999995 111.294 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.39 165.6 28.65 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.059 1.344 . . . . 0.56999999999999995 108.987 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.624 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.0 OUTLIER -145.85 159.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.565 0.62 . . . . 0.65000000000000002 111.447 173.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.13 147.09 34.41 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.446 0.698 . . . . 0.56999999999999995 110.011 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -98.67 150.86 21.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.005 -0.998 . . . . 0.56999999999999995 109.414 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.49 150.23 86.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.543 -0.741 . . . . 0.56999999999999995 110.298 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -69.29 162.53 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.234 1.956 . . . . 0.56999999999999995 111.509 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.71 -93.35 0.1 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.258 -1.537 . . . . 0.56999999999999995 109.258 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -160.61 123.0 3.22 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.653 0.726 . . . . 0.56999999999999995 110.14 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.42 -123.32 7.47 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-O 118.187 -1.34 . . . . 0.56999999999999995 110.23 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.04 -24.4 39.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 112.364 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.25 143.14 12.75 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 120.939 -1.101 . . . . 0.56999999999999995 111.468 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.99 -21.63 2.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.371 1.462 . . . . 0.56999999999999995 114.13 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -70.51 159.47 34.23 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.02 1.91 . . . . 0.66000000000000003 108.692 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.65 141.3 28.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.198 -0.668 . . . . 0.56999999999999995 109.198 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -130.7 158.4 40.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.713 -0.477 . . . . 0.65000000000000002 109.713 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.08 146.83 34.16 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.744 -1.206 . . . . 0.56999999999999995 107.744 -169.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.96 98.35 3.57 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.823 -0.806 . . . . 0.66000000000000003 108.823 174.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.12 -16.82 62.65 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.431 -1.418 . . . . 0.66000000000000003 111.87 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.64 -33.74 76.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.564 1.546 . . . . 0.66000000000000003 110.961 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.4 157.17 32.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.629 0.728 . . . . 0.66000000000000003 109.82 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 135.73 38.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.282 -0.636 . . . . 1.2 109.282 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -126.98 151.87 47.96 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.147 -1.057 . . . . 0.56999999999999995 108.147 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -154.1 167.94 28.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.801 0.728 . . . . 0.56999999999999995 110.435 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.0 -32.1 45.04 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.396 1.079 . . . . 0.66000000000000003 112.258 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.97 88.01 0.74 Allowed Glycine 0 C--N 1.343 0.92 0 C-N-CA 123.633 0.635 . . . . 0.56999999999999995 112.614 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.3 m -120.47 -42.77 2.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.521 -0.752 . . . . 0.56999999999999995 112.751 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 p -171.85 -43.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.23 0.923 . . . . 0.56999999999999995 111.881 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.6 166.03 24.49 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.273 1.429 . . . . 0.56999999999999995 109.313 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 179.09 35.59 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 110.694 -0.962 . . . . 0.56999999999999995 110.694 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.6 mm -103.58 118.38 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.134 -1.062 . . . . 0.56999999999999995 108.134 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -70.59 121.85 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.747 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -37.97 76.23 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.132 1.16 . . . . 0.56999999999999995 114.132 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.37 -39.77 91.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.691 -0.855 . . . . 0.56999999999999995 108.691 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.519 ' HH ' ' N ' ' A' ' 149' ' ' ASN . 1.7 m-85 -75.63 -41.57 53.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.495 -0.928 . . . . 0.56999999999999995 108.495 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.39 86.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.016 -0.516 . . . . 0.56999999999999995 110.583 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.32 -55.84 29.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.863 -1.065 . . . . 0.56999999999999995 109.789 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 m -53.67 -42.14 67.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.534 1.516 . . . . 0.56999999999999995 112.335 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -62.01 -54.38 42.43 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.938 0.79 . . . . 0.65000000000000002 110.088 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.624 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 12.9 mm-40 -68.41 -45.96 71.21 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.318 1.047 . . . . 0.66000000000000003 111.528 -172.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.22 -31.59 72.85 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.045 1.338 . . . . 0.56999999999999995 110.959 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.59 -52.91 38.63 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.61 -0.996 . . . . 0.56999999999999995 110.61 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -58.55 -45.49 88.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.569 0.684 . . . . 0.65000000000000002 111.545 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.5 t -54.81 -38.6 67.55 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.15 0.906 . . . . 0.56999999999999995 112.726 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -27.65 68.73 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.8 0.84 . . . . 0.56999999999999995 111.777 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.24 44.44 0.13 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.839 1.209 . . . . 0.56999999999999995 113.334 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.04 156.66 42.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.573 1.187 . . . . 0.56999999999999995 111.013 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.44 -13.12 2.91 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 115.795 -2.67 . . . . 0.56999999999999995 114.821 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.6 m170 137.37 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 1 C-N-CA 131.836 4.054 . . . . 0.65000000000000002 111.434 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.9 m -131.79 -173.09 3.04 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.833 2.853 . . . . 0.56999999999999995 109.081 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.8 t -148.78 61.17 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.999 0.92 . . . . 0.56999999999999995 110.17 -171.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -133.97 149.06 70.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 108.798 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.03 -4.88 14.22 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.648 . . . . 0.56999999999999995 112.972 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.52 28.93 4.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.56999999999999995 109.101 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.09 130.18 34.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.645 1.578 . . . . 0.56999999999999995 109.926 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.74 -19.65 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.052 0.387 . . . . 0.56999999999999995 110.884 165.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.99 -14.56 63.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 117.66 -1.162 . . . . 0.56999999999999995 112.962 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.11 133.09 87.53 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 121.246 1.839 . . . . 0.56999999999999995 110.671 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.79 144.25 24.4 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.613 2.208 . . . . 0.56999999999999995 110.301 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 52.6 m 66.67 116.03 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.197 1.799 . . . . 0.56999999999999995 110.468 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -54.89 116.73 2.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.267 -0.896 . . . . 0.56999999999999995 110.924 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.7 -121.03 2.19 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.213 1.863 . . . . 0.56999999999999995 109.851 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.84 -26.59 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.455 1.502 . . . . 0.56999999999999995 113.914 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.5 151.84 27.49 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.874 -0.891 . . . . 0.56999999999999995 110.874 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.18 110.99 42.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.764 -1.939 . . . . 0.66000000000000003 105.764 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -79.62 29.17 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.688 2.926 . . . . 0.56999999999999995 115.499 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -129.61 -28.11 2.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.085 1.354 . . . . 0.56999999999999995 111.446 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.519 ' N ' ' HH ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -156.03 94.31 1.52 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 109.327 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -138.41 169.04 18.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.828 1.251 . . . . 0.56999999999999995 109.405 177.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.88 57.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 111.127 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp 63.72 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 110.254 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -68.7 -86.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.138 0.975 . . . . 0.56999999999999995 112.234 -165.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -144.54 -35.8 0.34 Allowed 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.34 1.456 . . . . 0.56999999999999995 108.817 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -55.61 -48.37 74.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.269 1.827 . . . . 0.66000000000000003 111.378 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.54 -49.4 54.72 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.643 0.777 . . . . 0.66000000000000003 109.424 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -46.49 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 109.645 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -71.42 -40.48 70.41 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.73 -1.128 . . . . 0.56999999999999995 109.306 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -50.0 -61.06 6.03 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 mm -57.08 -50.08 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 117.711 0.755 . . . . 0.56999999999999995 111.5 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.86 -13.47 62.17 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.199 -0.938 . . . . 0.56999999999999995 113.14 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -92.11 -25.31 18.8 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 111.047 171.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.39 -35.95 65.98 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.554 1.142 . . . . 0.56999999999999995 112.773 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -126.52 29.2 5.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.551 1.141 . . . . 0.56999999999999995 109.969 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.31 -124.78 0.75 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.573 -1.411 . . . . 0.56999999999999995 109.573 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -148.66 -57.31 0.22 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.067 1.506 . . . . 0.56999999999999995 115.067 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 39.29 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.616 2.367 . . . . 1.2 113.871 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.3 p -59.5 114.59 2.78 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.95 -0.469 . . . . 0.56999999999999995 110.228 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.62 153.3 14.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.741 1.616 . . . . 0.56999999999999995 107.074 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 p -70.03 -179.16 1.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.738 0.78 . . . . 0.56999999999999995 110.743 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -138.31 165.46 26.68 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.064 1.345 . . . . 1.2 107.436 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 -62.98 0.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.311 -0.852 . . . . 0.56999999999999995 109.886 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 C-N-CA 128.162 2.585 . . . . 0.5 . 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.213 0 CA-C-O 118.84 -0.6 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -67.35 -63.23 1.1 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.046 -0.502 . . . . 0.56999999999999995 110.218 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -169.64 -57.1 0.02 OUTLIER 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.86 2.064 . . . . 0.56999999999999995 109.851 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.54 139.81 12.11 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.61 0.764 . . . . 0.56999999999999995 109.512 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.88 60.99 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.431 3.421 . . . . 0.56999999999999995 110.423 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.86 90.25 1.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.617 -0.882 . . . . 0.56999999999999995 108.617 177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 41.96 61.72 8.15 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 126.055 1.742 . . . . 0.56999999999999995 112.661 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 117.88 5.04 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.257 1.972 . . . . 0.56999999999999995 108.659 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 83.58 134.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 111.077 -172.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.401 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 63.9 m95 -66.24 169.2 7.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.963 0.887 . . . . 0.56999999999999995 111.305 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -80.07 -33.84 38.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.478 0.711 . . . . 0.56999999999999995 111.424 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.8 t -86.99 146.42 26.14 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.171 0.988 . . . . 0.56999999999999995 109.379 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -75.3 -12.19 60.22 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.56999999999999995 112.012 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -116.24 111.68 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.306 -1.738 . . . . 0.56999999999999995 106.306 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 60' ' ' ILE . 72.7 t -104.04 129.05 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.792 -1.188 . . . . 0.56999999999999995 107.792 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -104.65 138.38 41.05 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.73 -0.606 . . . . 0.56999999999999995 110.285 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -125.08 160.11 29.82 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.906 0.482 . . . . 0.56999999999999995 110.869 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -152.14 166.4 31.78 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 122.758 0.423 . . . . 1.2 110.673 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.5 mt -130.26 94.67 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 103.806 -2.665 . . . . 0.56999999999999995 103.806 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 t -76.8 -45.44 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.528 0.731 . . . . 0.56999999999999995 109.597 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -112.63 156.19 23.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 104.651 -2.351 . . . . 0.56999999999999995 104.651 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.38 154.48 50.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.788 -1.56 . . . . 0.56999999999999995 106.788 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 t -64.05 173.31 1.95 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.875 1.322 . . . . 0.56999999999999995 111.827 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' N ' ' HE2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -106.42 -37.22 6.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.99 -1.459 . . . . 1.2 112.397 178.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.16 -35.76 76.68 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.357 0.526 . . . . 0.66000000000000003 111.307 -172.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 mt -114.12 151.93 45.38 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 126.884 2.074 . . . . 0.56999999999999995 108.153 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -78.23 154.01 28.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 111.974 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.81 -37.94 74.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.57 1.148 . . . . 0.65000000000000002 113.174 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tp -59.36 -43.4 90.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.773 -0.454 . . . . 0.56999999999999995 109.773 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -70.48 -41.08 73.2 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.895 -1.05 . . . . 0.56999999999999995 108.988 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 114' ' ' PHE . 47.4 t -54.5 -52.14 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 119.83 1.196 . . . . 0.56999999999999995 109.698 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -65.96 -43.94 86.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.774 0.716 . . . . 0.66000000000000003 111.096 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.71 92.64 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.368 -0.833 . . . . 1.2 112.099 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.94 -47.26 66.13 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.98 -44.49 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.393 1.451 . . . . 0.56999999999999995 110.835 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -39.31 92.15 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 117.499 -1.239 . . . . 0.56999999999999995 111.057 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -67.21 -44.37 79.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.48 1.112 . . . . 0.56999999999999995 111.509 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.04 96.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.799 1.24 . . . . 0.56999999999999995 111.023 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 mt -68.8 -34.17 75.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.975 0.51 . . . . 0.56999999999999995 111.039 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -46.97 81.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 118.679 -0.677 . . . . 0.56999999999999995 109.319 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -42.03 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.368 -0.825 . . . . 0.56999999999999995 111.607 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.405 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 32.9 m95 -63.19 -46.77 85.49 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.441 1.019 . . . . 0.56999999999999995 111.372 173.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.44 -10.81 63.86 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.337 -0.852 . . . . 0.56999999999999995 114.317 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -80.96 -5.38 57.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.253 -1.145 . . . . 0.56999999999999995 111.177 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.06 -20.28 11.56 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.872 0.869 . . . . 0.66000000000000003 111.636 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.42 150.22 69.94 Favored Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 124.57 1.148 . . . . 0.56999999999999995 110.184 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.49 16.64 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 113.113 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tt -82.04 142.69 32.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 107.591 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -125.4 170.63 11.17 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.851 0.834 . . . . 0.65000000000000002 109.487 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.02 162.09 36.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.912 -0.773 . . . . 0.56999999999999995 108.912 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.75 -179.94 6.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.654 -1.157 . . . . 1.2 108.995 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -135.78 133.97 38.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.504 -1.665 . . . . 0.56999999999999995 106.504 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.35 162.65 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 O-C-N 124.174 0.921 . . . . 0.56999999999999995 109.526 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.9 m -110.72 -30.04 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.769 -1.105 . . . . 0.56999999999999995 110.696 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -60.69 3.13 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.596 1.158 . . . . 0.56999999999999995 110.695 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.87 -91.23 0.1 OUTLIER Glycine 0 C--O 1.219 -0.823 0 N-CA-C 109.896 -1.282 . . . . 0.56999999999999995 109.896 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -62.22 153.76 29.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.379 1.589 . . . . 0.56999999999999995 111.904 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.35 -170.55 3.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 109.972 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.24 -38.5 71.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.286 -1.005 . . . . 0.66000000000000003 108.286 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 HD11 ' CG1' ' A' ' 15' ' ' VAL . 5.6 mt -127.66 90.8 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 107.938 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 154.04 26.93 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 109.111 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.06 137.41 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.487 -2.042 . . . . 0.56999999999999995 105.487 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.47 164.88 29.46 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.899 -0.88 . . . . 0.56999999999999995 110.899 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 5.4 m-85 -138.29 133.91 33.66 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.235 -1.765 . . . . 0.56999999999999995 106.235 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.69 178.89 8.1 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.56999999999999995 109.512 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.71 85.69 2.39 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 107.123 -1.436 . . . . 1.2 107.123 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.56 -139.68 15.61 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.47 -0.652 . . . . 0.56999999999999995 111.47 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.77 122.13 9.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.56999999999999995 111.398 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -125.2 -39.86 2.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.65000000000000002 112.2 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.71 44.85 0.8 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.886 -0.486 . . . . 0.56999999999999995 111.886 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.79 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.173 1.389 . . . . 0.66000000000000003 107.672 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -173.55 -34.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.616 1.966 . . . . 0.56999999999999995 110.484 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -132.21 132.15 22.82 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 108.176 -1.046 . . . . 0.56999999999999995 108.176 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.32 133.53 28.61 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 N-CA-C 108.857 -1.247 . . . . 0.56999999999999995 108.857 171.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -64.41 178.36 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.917 1.342 . . . . 0.56999999999999995 109.92 165.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 13.7 p-10 -98.88 -43.36 6.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 131.436 3.894 . . . . 0.66000000000000003 110.092 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.96 -139.28 14.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.832 -1.538 . . . . 0.56999999999999995 110.363 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.18 96.48 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 112.055 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 177.82 15.04 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 110.334 -1.106 . . . . 0.56999999999999995 110.334 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HB3' ' HD2' ' A' ' 76' ' ' ASP 0.254 15.3 t30 60.05 -142.69 0.56 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 112.489 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.4 m -45.42 144.35 1.52 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.628 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -107.62 -29.01 9.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.471 1.941 . . . . 0.56999999999999995 112.462 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.26 166.08 25.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.522 1.129 . . . . 0.56999999999999995 108.332 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.76 161.84 38.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.176 0.512 . . . . 0.65000000000000002 109.715 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 160.82 43.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.981 0.912 . . . . 0.56999999999999995 108.799 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -112.56 151.08 30.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.762 -0.829 . . . . 0.56999999999999995 108.762 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.33 156.33 22.41 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.531 -0.747 . . . . 0.56999999999999995 111.004 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 17.6 Cg_endo -68.52 148.26 72.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.888 1.725 . . . . 0.56999999999999995 111.921 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.2 175.22 13.79 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.6 1.095 . . . . 0.56999999999999995 110.84 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t 43.31 -148.54 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.603 1.561 . . . . 0.56999999999999995 112.703 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.29 -56.62 1.45 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 117.182 -1.899 . . . . 0.56999999999999995 110.482 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -44.37 74.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.44 1.62 . . . . 0.56999999999999995 112.075 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 151.15 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.619 1.1 . . . . 0.56999999999999995 112.659 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.89 -26.32 1.73 Allowed Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.853 -1.526 . . . . 0.56999999999999995 114.641 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.05 150.11 49.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.971 -1.122 . . . . 0.66000000000000003 107.971 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.14 148.51 35.16 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.424 -0.807 . . . . 0.56999999999999995 109.341 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -132.47 159.69 38.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.659 -0.867 . . . . 0.65000000000000002 108.659 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.408 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.2 m-85 -138.35 155.87 48.14 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.454 1.502 . . . . 0.56999999999999995 108.868 -170.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.17 97.76 10.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.898 0.479 . . . . 0.66000000000000003 109.952 172.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HE2' ' N ' ' A' ' 24' ' ' ARG . 3.8 tp10 -58.25 -25.66 61.98 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.061 0.945 . . . . 0.66000000000000003 111.676 171.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.01 -34.99 70.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.305 0.574 . . . . 0.66000000000000003 111.075 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -82.48 150.26 27.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.636 1.175 . . . . 0.66000000000000003 109.085 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -71.88 147.5 47.04 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.511 -0.743 . . . . 1.2 110.647 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -135.35 134.53 39.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.267 -1.383 . . . . 0.56999999999999995 107.267 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -133.85 150.18 51.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 0.56999999999999995 110.389 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.64 -29.45 64.65 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.191 0.997 . . . . 0.66000000000000003 111.374 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.01 75.88 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.387 -1.085 . . . . 0.56999999999999995 110.387 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.29 155.92 38.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.401 -1.333 . . . . 0.56999999999999995 107.401 172.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -62.47 167.28 4.41 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.529 0.732 . . . . 0.56999999999999995 110.509 170.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.35 -64.22 0.4 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.935 2.094 . . . . 0.56999999999999995 111.016 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.28 147.76 49.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.052 -1.219 . . . . 0.56999999999999995 110.052 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.32 129.82 36.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.004 -1.11 . . . . 0.56999999999999995 108.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -66.62 113.19 4.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.388 -0.597 . . . . 0.56999999999999995 109.388 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 31' ' ' VAL . 9.6 t80 -58.5 -46.09 87.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.2 1.0 . . . . 0.56999999999999995 111.372 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -63.43 -41.69 98.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 109.745 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.36 -45.0 96.19 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.444 0.698 . . . . 0.56999999999999995 109.934 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.66 72.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.035 0.534 . . . . 0.56999999999999995 111.316 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.82 -55.37 33.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 117.366 -1.302 . . . . 0.56999999999999995 109.086 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 m -52.35 -41.49 63.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.407 1.458 . . . . 0.56999999999999995 111.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.15 -60.57 3.55 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.557 0.617 . . . . 0.65000000000000002 110.058 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.47 -43.7 96.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.385 0.539 . . . . 0.66000000000000003 110.9 -173.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.08 -26.98 68.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.681 1.193 . . . . 0.56999999999999995 111.775 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.405 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.22 -45.95 92.16 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.009 -0.836 . . . . 0.56999999999999995 111.009 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -68.71 -39.78 80.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.957 -1.02 . . . . 0.65000000000000002 111.582 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -55.17 -30.69 60.38 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 124.159 0.912 . . . . 0.56999999999999995 111.966 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -34.32 66.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.338 0.972 . . . . 0.56999999999999995 111.406 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.41 52.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.416 -1.214 . . . . 0.56999999999999995 113.093 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 28.6 mmt 61.12 173.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 112.106 -171.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.81 70.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.785 -1.008 . . . . 0.56999999999999995 111.153 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.27 172.78 6.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.73 1.265 . . . . 0.65000000000000002 110.175 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.57 -179.16 5.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.35 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.5 m -138.14 54.7 1.78 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.015 1.726 . . . . 0.56999999999999995 108.892 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.61 148.39 41.79 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.249 1.02 . . . . 0.66000000000000003 109.233 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.68 -19.26 41.88 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.228 2.618 . . . . 0.56999999999999995 113.004 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -130.76 28.22 4.87 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.839 1.656 . . . . 0.56999999999999995 108.607 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.51 129.33 38.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.373 -0.973 . . . . 0.56999999999999995 108.373 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.88 -26.78 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.635 0.374 . . . . 0.56999999999999995 110.506 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -105.1 29.21 6.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.604 1.162 . . . . 0.56999999999999995 111.811 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.29 128.62 87.98 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 120.606 -1.309 . . . . 0.56999999999999995 110.554 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.21 177.76 8.2 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.421 2.747 . . . . 0.56999999999999995 111.065 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m 48.59 77.57 0.1 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.225 1.41 . . . . 0.56999999999999995 111.608 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -50.69 125.76 13.96 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.797 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.93 164.8 13.64 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 108.482 -1.847 . . . . 0.56999999999999995 108.482 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.02 -51.37 0.47 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.867 2.467 . . . . 0.56999999999999995 113.825 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.65 145.86 42.2 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.646 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 26.6 t0 -94.99 112.8 59.61 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.859 -1.904 . . . . 0.66000000000000003 105.859 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -80.31 -31.39 1.68 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.803 1.669 . . . . 0.56999999999999995 112.668 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -42.15 72.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.074 1.306 . . . . 0.56999999999999995 110.322 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.646 ' ND2' ' HD2' ' A' ' 146' ' ' ASP . 1.4 m-80 -122.98 89.82 3.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.193 -1.41 . . . . 0.56999999999999995 107.193 -173.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -120.96 159.74 24.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.97 0.89 . . . . 0.56999999999999995 109.465 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.09 156.28 10.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.689 1.996 . . . . 0.56999999999999995 105.996 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp -56.07 108.31 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.141 1.376 . . . . 0.56999999999999995 107.69 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.8 t -86.04 -101.41 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.77 -0.826 . . . . 0.56999999999999995 108.77 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.3 -49.43 1.55 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-O 116.268 -1.825 . . . . 0.56999999999999995 108.134 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -48.83 -38.95 23.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.911 1.687 . . . . 0.66000000000000003 112.132 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -67.65 -58.89 3.88 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.354 0.661 . . . . 0.66000000000000003 111.549 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.74 -40.26 84.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-O 117.811 -1.09 . . . . 0.56999999999999995 108.369 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.48 74.91 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.671 1.588 . . . . 0.56999999999999995 108.73 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.29 -56.79 22.57 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.5 mm -58.72 -49.1 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.386 1.093 . . . . 0.56999999999999995 112.949 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.59 -29.88 70.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.458 1.103 . . . . 0.56999999999999995 110.115 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -29.21 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.56999999999999995 110.17 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 3.2 mt -74.46 -48.7 25.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.14 -0.933 . . . . 0.56999999999999995 111.585 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 163' ' ' LEU . 3.2 m-85 -144.44 24.38 1.58 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.911 1.232 . . . . 0.56999999999999995 113.887 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.91 -155.55 7.87 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.682 -1.367 . . . . 0.56999999999999995 109.682 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.63 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.478 0.711 . . . . 0.56999999999999995 111.4 173.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.7 162.55 28.61 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.376 -0.972 . . . . 1.2 108.376 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.4 p -135.85 163.13 30.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.583 -1.265 . . . . 0.56999999999999995 107.583 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -178.07 162.36 1.61 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.524 1.93 . . . . 0.56999999999999995 106.5 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t 62.41 99.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.095 1.758 . . . . 0.56999999999999995 112.148 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -155.85 94.88 1.59 Allowed 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.456 -1.313 . . . . 1.2 107.456 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.62 -63.55 1.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.699 -0.852 . . . . 0.56999999999999995 108.699 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.2 tttt . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 127.972 2.509 . . . . 0.5 . -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 118.244 -0.884 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p -78.25 65.56 3.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.309 0.959 . . . . 0.56999999999999995 111.633 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.51 168.26 21.01 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.871 0.869 . . . . 0.56999999999999995 111.468 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -95.92 153.72 39.17 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.953 1.301 . . . . 0.56999999999999995 110.743 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -76.05 -7.66 18.34 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.678 2.919 . . . . 0.56999999999999995 113.598 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.05 108.28 1.48 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.919 -2.622 . . . . 0.56999999999999995 103.919 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.88 -63.54 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 129.308 3.043 . . . . 0.56999999999999995 108.909 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.8 163.81 34.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 0.56999999999999995 111.104 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 pttt 68.4 118.02 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.896 2.078 . . . . 0.56999999999999995 110.073 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -62.17 150.35 39.01 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.56999999999999995 109.704 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.1 p -88.43 28.66 1.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.471 0.708 . . . . 0.56999999999999995 111.069 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -130.55 159.64 36.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.539 1.936 . . . . 0.56999999999999995 108.851 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -90.54 -8.55 49.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 112.748 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.46 145.76 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 0.56999999999999995 106.747 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.0 t -131.06 134.48 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.075 -1.824 . . . . 0.56999999999999995 106.075 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -100.4 147.86 25.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.651 -0.5 . . . . 0.56999999999999995 109.651 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -125.15 153.73 42.57 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.424 0.689 . . . . 0.56999999999999995 111.7 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.09 109.97 6.42 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.013 0.911 . . . . 1.2 110.59 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.0 mt -76.03 95.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.674 -1.602 . . . . 0.56999999999999995 106.674 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 m -75.23 -46.41 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.709 0.803 . . . . 0.56999999999999995 111.365 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -115.96 160.31 20.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.263 -1.384 . . . . 0.56999999999999995 107.263 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.6 179.9 5.27 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.17 0.988 . . . . 0.56999999999999995 108.597 -172.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -119.95 -178.45 3.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.808 1.243 . . . . 0.56999999999999995 109.711 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -131.42 -31.59 1.6 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.152 1.781 . . . . 1.2 111.713 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -31.4 71.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.374 1.07 . . . . 0.66000000000000003 111.914 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.31 145.33 56.19 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 126.733 2.013 . . . . 0.56999999999999995 106.733 -175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -72.97 153.76 52.71 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.587 1.525 . . . . 0.56999999999999995 111.523 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.27 -34.73 74.15 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.245 1.018 . . . . 0.65000000000000002 113.121 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.57 -39.56 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.624 0.37 . . . . 0.56999999999999995 110.016 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -68.52 -42.49 78.44 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.332 -1.318 . . . . 0.56999999999999995 110.152 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 t -57.23 -51.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 120.584 1.538 . . . . 0.56999999999999995 109.398 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -43.56 98.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.145 0.578 . . . . 0.66000000000000003 110.222 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.15 -46.6 88.27 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 117.957 -1.021 . . . . 1.2 112.139 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.8 mp -65.07 -41.87 94.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.783 1.174 . . . . 0.56999999999999995 109.658 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.31 -48.82 79.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 108.792 -0.818 . . . . 0.56999999999999995 108.792 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -39.06 81.42 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.537 0.608 . . . . 0.56999999999999995 111.738 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -65.21 -46.22 81.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.821 1.191 . . . . 0.56999999999999995 110.438 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.98 95.29 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 111.245 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 25.9 mt -68.22 -33.43 74.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.576 -0.726 . . . . 0.56999999999999995 111.327 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -65.03 -33.33 75.79 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.424 1.011 . . . . 0.56999999999999995 110.315 173.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.4 mtp -71.23 -28.83 64.47 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.857 0.753 . . . . 0.56999999999999995 111.996 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.14 -48.83 40.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.502 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.03 62.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.14 1.352 . . . . 0.56999999999999995 113.65 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -64.58 -22.41 66.96 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.886 -1.361 . . . . 0.56999999999999995 111.673 170.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -108.37 -21.3 12.81 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.796 0.725 . . . . 0.66000000000000003 112.255 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.88 135.48 27.56 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 123.872 0.869 . . . . 0.56999999999999995 110.761 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.12 61.26 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.821 3.014 . . . . 0.56999999999999995 110.65 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 124.46 48.85 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.059 -1.83 . . . . 0.56999999999999995 106.059 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -105.57 175.29 5.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.924 1.289 . . . . 0.65000000000000002 108.623 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 1.2 m-85 -139.36 153.86 47.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.18 -0.95 . . . . 0.56999999999999995 108.483 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.63 174.44 10.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.711 0.804 . . . . 1.2 109.009 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -124.29 155.69 38.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.05 -1.092 . . . . 0.56999999999999995 108.05 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.06 -179.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.172 -0.922 . . . . 0.56999999999999995 108.977 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.72 -38.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.795 -0.622 . . . . 0.56999999999999995 110.34 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -175.65 92.95 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.291 1.436 . . . . 0.56999999999999995 108.975 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.83 172.78 38.13 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.92 2.2 . . . . 0.56999999999999995 108.122 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 p -67.92 167.05 14.43 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.583 0.692 . . . . 0.56999999999999995 110.123 168.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.13 173.76 11.91 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.551 0.741 . . . . 0.56999999999999995 110.145 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.93 -33.94 66.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 118.071 -0.966 . . . . 0.66000000000000003 109.142 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.93 76.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.612 1.965 . . . . 0.56999999999999995 108.586 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -70.03 133.58 47.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 119.522 -1.986 . . . . 0.56999999999999995 107.959 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.73 105.89 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.037 -1.838 . . . . 0.56999999999999995 106.037 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 73.92 0.26 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.775 1.655 . . . . 0.56999999999999995 111.223 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -109.44 132.96 53.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 110.157 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.33 172.0 17.33 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.56999999999999995 108.449 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -91.74 113.48 25.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.286 -0.864 . . . . 1.2 110.222 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.66 71.2 0.86 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.376 -0.69 . . . . 0.56999999999999995 111.376 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 81.21 147.58 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.009 2.924 . . . . 0.56999999999999995 111.521 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.14 -11.52 4.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.944 1.297 . . . . 0.65000000000000002 112.816 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.96 3.04 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 118.801 -1.0 . . . . 0.56999999999999995 112.505 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.64 -55.89 1.61 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.718 0.759 . . . . 0.66000000000000003 110.375 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.51 -44.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.536 1.934 . . . . 0.56999999999999995 108.055 -177.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -97.42 121.24 59.02 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.467 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.74 3.82 6.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 113.204 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 56.17 -155.76 0.29 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.139 0.881 . . . . 0.56999999999999995 110.651 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 14.8 p-10 -143.18 -41.48 0.3 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.644 2.777 . . . . 0.66000000000000003 108.524 -167.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.12 -149.78 16.66 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.213 1.387 . . . . 0.56999999999999995 110.195 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.6 94.3 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.589 3.526 . . . . 0.56999999999999995 111.414 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 167.95 11.45 Favored Glycine 0 C--O 1.22 -0.749 0 N-CA-C 109.411 -1.476 . . . . 0.56999999999999995 109.411 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.453 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 24.4 t30 48.31 -150.52 0.15 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 119.813 1.806 . . . . 0.56999999999999995 112.241 -173.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -47.09 111.06 0.35 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.12 2.168 . . . . 0.56999999999999995 113.306 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD12 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -80.97 -31.96 34.6 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.796 -1.19 . . . . 0.56999999999999995 112.497 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.49 39.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.56999999999999995 109.737 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -146.57 144.96 29.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.457 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.76 164.4 30.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 109.521 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -115.21 156.95 24.39 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.961 -0.563 . . . . 0.56999999999999995 109.515 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.65 98.73 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.358 -0.829 . . . . 0.56999999999999995 109.359 176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -72.47 159.3 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.672 2.248 . . . . 0.56999999999999995 111.178 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.32 -83.62 0.08 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.872 -1.691 . . . . 0.56999999999999995 108.872 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -159.2 146.26 17.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.316 -0.994 . . . . 0.56999999999999995 108.316 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -130.9 11.77 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 118.453 -1.193 . . . . 0.56999999999999995 110.297 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.02 -25.34 58.42 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.342 1.071 . . . . 0.56999999999999995 111.994 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.94 142.44 5.85 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.085 -1.009 . . . . 0.56999999999999995 112.121 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.61 -26.79 3.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.526 2.012 . . . . 0.56999999999999995 113.901 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -66.31 148.72 51.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.787 0.794 . . . . 0.66000000000000003 109.399 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.57 140.77 49.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 108.773 -168.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.78 139.68 29.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.234 -1.765 . . . . 0.65000000000000002 106.234 -160.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.67 148.26 37.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -166.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.69 105.99 12.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.199 -1.408 . . . . 0.66000000000000003 107.199 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.52 -19.79 27.27 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.489 -0.757 . . . . 0.66000000000000003 110.713 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -28.13 64.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.242 1.017 . . . . 0.66000000000000003 111.141 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.28 110.72 9.86 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.289 -1.745 . . . . 0.66000000000000003 106.289 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.95 110.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.151 0.887 . . . . 1.2 111.502 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.12 133.88 34.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.048 -1.093 . . . . 0.56999999999999995 108.048 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -123.33 143.49 50.06 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.491 -1.299 . . . . 0.56999999999999995 107.491 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.37 32.8 0.4 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.478 1.511 . . . . 0.66000000000000003 111.599 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.66 69.56 1.37 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.625 -0.99 . . . . 0.56999999999999995 110.625 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -57.31 2.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.478 0.639 . . . . 0.56999999999999995 110.785 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 108.617 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.93 159.22 16.43 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.56999999999999995 109.075 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.2 -172.35 38.06 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.35 -1.1 . . . . 0.56999999999999995 110.35 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.06 120.31 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.511 -1.292 . . . . 0.56999999999999995 107.511 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -62.05 109.16 1.2 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.584 0.353 . . . . 0.56999999999999995 110.237 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.81 -37.33 81.63 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.539 0.735 . . . . 0.56999999999999995 110.686 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -65.95 -46.16 79.15 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 118.481 0.582 . . . . 0.56999999999999995 110.256 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.44 -48.89 79.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.836 0.743 . . . . 0.56999999999999995 109.18 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.33 90.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.114 0.566 . . . . 0.56999999999999995 111.319 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.09 -54.56 43.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.892 -1.051 . . . . 0.56999999999999995 109.517 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.5 m -57.17 -37.88 72.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.043 1.292 . . . . 0.56999999999999995 111.33 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.45 -58.54 7.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.409 0.549 . . . . 0.65000000000000002 109.935 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.3 -41.38 98.95 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.559 -0.713 . . . . 0.66000000000000003 111.303 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.55 -26.2 68.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.56999999999999995 111.666 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.81 99.35 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.73 1.15 . . . . 0.56999999999999995 112.053 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -69.89 -39.89 75.97 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 118.279 -0.867 . . . . 0.65000000000000002 110.067 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 t -57.23 -39.61 75.86 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.52 0.513 . . . . 0.56999999999999995 111.859 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -39.56 82.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.536 -0.728 . . . . 0.56999999999999995 110.476 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.2 51.1 0.52 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 123.877 0.751 . . . . 0.56999999999999995 112.079 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 tpp -99.84 -55.82 2.55 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.069 0.935 . . . . 0.56999999999999995 111.018 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.64 167.6 21.77 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.288 -1.125 . . . . 0.56999999999999995 110.288 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -74.06 178.08 5.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.995 0.902 . . . . 0.65000000000000002 111.465 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -145.26 -173.46 4.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 108.531 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 82.26 1.64 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.162 -1.792 . . . . 0.56999999999999995 106.162 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -151.36 145.26 17.78 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.456 -0.942 . . . . 0.66000000000000003 108.456 176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.77 -9.25 21.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 113.269 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.01 9.51 13.69 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 110.749 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 134.56 39.99 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 109.171 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.07 -28.24 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.59 -0.444 . . . . 0.56999999999999995 110.148 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 37.1 mmt -66.01 -12.2 53.43 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.681 1.593 . . . . 0.56999999999999995 113.589 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -50.69 124.87 20.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.318 0.963 . . . . 0.56999999999999995 110.589 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.58 175.21 9.09 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.018 2.479 . . . . 0.56999999999999995 110.783 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER 52.13 -158.7 0.12 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 111.864 -174.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 131.21 41.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.99 -1.485 . . . . 0.56999999999999995 106.99 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -157.5 -120.9 0.64 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.125 -1.59 . . . . 0.56999999999999995 109.125 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -64.75 0.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.318 1.047 . . . . 0.56999999999999995 110.934 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 34.44 -140.6 0.12 Allowed Glycine 0 C--N 1.345 1.079 0 C-N-CA 126.277 1.894 . . . . 0.56999999999999995 113.198 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.634 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 37.5 t0 178.71 77.13 0.15 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 128.134 2.573 . . . . 0.66000000000000003 106.467 168.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.08 35.86 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.515 2.81 . . . . 0.56999999999999995 113.554 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -132.0 -47.87 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 109.89 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.634 ' ND2' ' HD2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -160.99 43.5 0.17 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.063 0.945 . . . . 0.56999999999999995 111.304 -171.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -40.3 -54.52 2.37 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.202 1.001 . . . . 0.56999999999999995 111.972 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 55.53 156.03 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.966 1.306 . . . . 0.56999999999999995 111.075 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp -65.88 116.74 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.907 -1.146 . . . . 0.56999999999999995 107.907 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.8 m -82.2 -91.51 0.07 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.41 0.684 . . . . 0.56999999999999995 112.226 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -134.49 -51.97 0.81 Allowed 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.853 -1.546 . . . . 0.56999999999999995 107.465 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -45.4 -44.22 11.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.55 1.523 . . . . 0.66000000000000003 113.823 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.55 -63.59 1.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.055 2.142 . . . . 0.66000000000000003 110.9 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.06 -41.39 92.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 108.699 -0.852 . . . . 0.56999999999999995 108.699 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -59.33 -44.84 92.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 108.942 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.95 -56.16 26.65 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.972 -1.251 . . . . 0.56999999999999995 109.972 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 mm -55.51 -51.15 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 117.88 0.84 . . . . 0.56999999999999995 111.8 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.25 -18.72 64.62 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 111.34 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -87.87 -20.84 25.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 111.89 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.47 -43.84 9.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.918 . . . . 0.56999999999999995 111.669 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.41 9.53 31.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.285 1.834 . . . . 0.56999999999999995 111.333 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.22 -135.92 2.24 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.893 2.187 . . . . 0.56999999999999995 107.869 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -44.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.456 1.502 . . . . 0.56999999999999995 111.657 167.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 140.19 55.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.022 0.929 . . . . 1.2 110.354 -171.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 p -142.25 166.85 23.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.534 1.133 . . . . 0.56999999999999995 110.583 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.23 136.21 35.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.191 -1.411 . . . . 0.56999999999999995 107.191 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.17 162.09 17.81 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.206 0.527 . . . . 0.56999999999999995 111.708 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.36 159.62 40.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.088 1.355 . . . . 1.2 109.42 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 129.06 53.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.492 -0.559 . . . . 0.56999999999999995 109.492 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.754 1.621 . . . . 0.5 . -175.523 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.415 ' C24' HD12 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 119.38 -0.343 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 t -112.82 -53.36 2.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.539 0.736 . . . . 0.56999999999999995 109.292 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.63 -104.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.56999999999999995 107.45 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.68 -56.13 3.08 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 126.347 1.859 . . . . 0.56999999999999995 110.07 174.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.56 163.87 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.251 1.301 . . . . 0.56999999999999995 111.888 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -166.0 84.49 0.32 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.839 1.656 . . . . 0.56999999999999995 107.443 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.43 65.9 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 128.022 2.529 . . . . 0.56999999999999995 108.76 171.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.28 161.95 44.13 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.108 1.206 . . . . 0.56999999999999995 110.729 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 76.21 107.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.378 1.871 . . . . 0.56999999999999995 109.302 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -52.13 -70.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 113.94 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m 173.88 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.406 2.282 . . . . 0.56999999999999995 108.434 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t -102.5 161.98 13.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.213 1.005 . . . . 0.56999999999999995 109.938 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -5.51 40.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.945 0.898 . . . . 0.56999999999999995 113.36 168.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.35 143.56 39.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.241 -1.392 . . . . 0.56999999999999995 107.241 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -128.95 146.61 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.36 -1.348 . . . . 0.56999999999999995 107.36 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 p -94.84 137.21 34.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.679 -0.86 . . . . 0.56999999999999995 108.679 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -125.54 152.56 44.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.668 -0.645 . . . . 0.56999999999999995 109.309 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -154.57 113.88 3.7 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.352 0.596 . . . . 1.2 110.011 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.03 82.61 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 107.161 -1.422 . . . . 0.56999999999999995 107.161 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 m -56.11 -41.61 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.994 1.318 . . . . 0.56999999999999995 112.922 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -124.39 153.97 41.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.37 -2.826 . . . . 0.56999999999999995 103.37 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -131.23 158.05 41.59 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 107.293 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -61.93 172.92 1.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.05 0.929 . . . . 0.56999999999999995 111.624 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 -33.8 5.14 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.659 1.183 . . . . 1.2 112.262 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.41 -33.87 76.97 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.43 0.559 . . . . 0.66000000000000003 109.997 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.32 154.78 62.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.971 1.709 . . . . 0.56999999999999995 109.873 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.24 161.91 25.82 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.96 2.44 . . . . 0.56999999999999995 113.049 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -40.25 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.307 1.043 . . . . 0.65000000000000002 113.135 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.53 -33.85 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.342 0.257 . . . . 0.56999999999999995 111.037 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.8 m -71.59 -43.96 65.31 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.402 -0.809 . . . . 0.56999999999999995 109.359 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.69 -48.07 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 117.559 -1.21 . . . . 0.56999999999999995 110.048 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.65 -35.07 79.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.896 1.225 . . . . 0.66000000000000003 111.81 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -61.19 -51.06 70.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.557 1.071 . . . . 1.2 110.92 173.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.76 -45.36 93.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.447 -0.787 . . . . 0.56999999999999995 109.111 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.66 -45.1 98.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-O 118.196 -0.907 . . . . 0.56999999999999995 110.737 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 m -58.61 -47.74 83.34 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 109.858 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.53 73.24 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.976 -0.535 . . . . 0.56999999999999995 110.911 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.0 -47.55 84.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.99 1.316 . . . . 0.56999999999999995 111.983 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 mp -69.78 -32.13 70.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 118.577 -0.725 . . . . 0.56999999999999995 109.693 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -63.59 -33.37 75.45 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.089 0.859 . . . . 0.56999999999999995 111.319 170.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.0 mtp -68.68 -42.73 77.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.649 1.113 . . . . 0.56999999999999995 110.98 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -62.91 -51.75 65.72 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.503 1.047 . . . . 0.56999999999999995 110.336 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.59 -10.92 61.53 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.654 1.597 . . . . 0.56999999999999995 113.959 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -61.8 -30.87 71.1 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.449 1.125 . . . . 0.56999999999999995 110.38 170.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -101.45 -31.04 11.1 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.69 0.796 . . . . 0.66000000000000003 111.271 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.8 pt -115.66 126.08 28.09 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.662 0.785 . . . . 0.56999999999999995 110.382 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.49 46.2 1.38 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.762 2.975 . . . . 0.56999999999999995 112.941 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tt -103.3 141.96 35.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.672 1.989 . . . . 0.56999999999999995 107.484 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -123.85 169.33 11.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.913 0.885 . . . . 0.65000000000000002 108.996 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.49 149.87 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.63 -1.294 . . . . 0.56999999999999995 109.154 -173.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.93 36.72 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.43 1.092 . . . . 1.2 109.202 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.53 99.02 6.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.52 158.18 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.415 -0.587 . . . . 0.56999999999999995 109.415 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.52 23.17 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 110.953 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.21 75.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.93 1.292 . . . . 0.56999999999999995 109.087 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.25 168.74 16.32 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.005 0.812 . . . . 0.56999999999999995 111.575 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 p -64.72 171.89 3.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.806 1.242 . . . . 0.56999999999999995 110.033 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.96 175.24 8.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.596 0.713 . . . . 0.56999999999999995 109.626 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -68.95 -40.55 78.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.857 -0.61 . . . . 0.66000000000000003 109.372 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -119.8 87.31 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 108.0 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -83.91 120.66 26.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.814 1.246 . . . . 0.56999999999999995 108.286 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.58 128.97 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 106.36 -1.719 . . . . 0.56999999999999995 106.36 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.13 162.68 26.78 Favored Glycine 0 C--O 1.222 -0.6 0 N-CA-C 111.695 -0.562 . . . . 0.56999999999999995 111.695 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -134.54 141.63 46.75 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.009 -1.849 . . . . 0.56999999999999995 106.009 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.47 -173.49 4.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.86 1.664 . . . . 0.56999999999999995 109.635 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.42 52.52 2.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.173 0.989 . . . . 1.2 110.55 -175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.4 -120.97 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.45 138.28 55.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.273 -0.545 . . . . 0.56999999999999995 110.569 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.59 -63.03 0.85 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.116 -0.945 . . . . 0.65000000000000002 110.687 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.78 57.39 0.02 OUTLIER Glycine 0 C--N 1.341 0.834 0 CA-C-N 119.231 0.923 . . . . 0.56999999999999995 112.474 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -126.33 -67.31 0.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.69 1.196 . . . . 0.66000000000000003 109.094 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.67 -30.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.353 2.661 . . . . 0.56999999999999995 110.156 -175.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.26 98.71 20.42 Favored Pre-proline 0 C--N 1.347 0.47 0 N-CA-C 108.51 -0.922 . . . . 0.56999999999999995 108.51 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.14 139.42 55.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 120.881 1.054 . . . . 0.56999999999999995 109.424 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.41 174.37 7.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.584 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -95.27 -40.9 9.32 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.574 1.95 . . . . 0.66000000000000003 111.898 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.62 -139.15 13.32 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 120.366 1.439 . . . . 0.56999999999999995 111.969 -168.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -81.64 94.42 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.128 2.552 . . . . 0.56999999999999995 110.567 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.65 174.46 22.43 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.132 1.825 . . . . 0.56999999999999995 111.708 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.3 t30 47.39 -138.71 0.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 120.972 -1.31 . . . . 0.56999999999999995 112.817 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -51.73 124.8 13.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.874 2.07 . . . . 0.56999999999999995 111.207 173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.81 -31.12 11.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.56999999999999995 113.015 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.3 159.19 33.72 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.466 1.106 . . . . 0.56999999999999995 108.091 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.492 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -145.1 154.93 43.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.29 0.567 . . . . 0.65000000000000002 111.007 174.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.14 148.01 44.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.11 -1.07 . . . . 0.56999999999999995 108.11 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.38 150.22 25.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.14 -1.059 . . . . 0.56999999999999995 108.14 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.39 153.66 92.0 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 109.961 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.73 165.09 30.78 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.579 1.52 . . . . 0.56999999999999995 111.969 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 -70.8 0.15 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.652 -1.779 . . . . 0.56999999999999995 108.652 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -173.52 144.02 1.09 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.257 -1.386 . . . . 0.56999999999999995 107.257 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.15 -130.21 24.12 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.537 1.065 . . . . 0.56999999999999995 111.615 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 95' ' ' ASP . 2.4 tp -51.89 -26.48 10.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 112.345 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.17 143.67 8.74 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.191 -0.943 . . . . 0.56999999999999995 111.633 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.1 -22.3 2.01 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.162 1.839 . . . . 0.56999999999999995 114.553 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.413 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 55.4 m-20 -70.49 157.69 37.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.787 1.294 . . . . 0.66000000000000003 108.305 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.96 148.41 31.71 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.242 0.544 . . . . 0.56999999999999995 109.63 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -132.02 160.5 35.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.65000000000000002 109.282 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -141.82 146.61 36.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.879 1.272 . . . . 0.56999999999999995 108.155 -171.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.78 103.83 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.922 -1.14 . . . . 0.66000000000000003 107.922 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.77 -23.01 64.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.848 1.659 . . . . 0.66000000000000003 111.395 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -65.38 -37.17 86.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.703 1.601 . . . . 0.66000000000000003 110.157 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.0 133.39 48.96 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.327 -1.731 . . . . 0.66000000000000003 106.327 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -54.94 151.89 8.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 118.905 -0.569 . . . . 1.2 109.72 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -133.93 135.88 43.87 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.749 -1.574 . . . . 0.56999999999999995 106.749 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -132.52 140.77 48.47 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.494 -1.299 . . . . 0.56999999999999995 107.494 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -57.16 -51.37 69.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.711 0.805 . . . . 0.66000000000000003 109.396 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.45 56.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.889 -1.284 . . . . 0.56999999999999995 109.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 t -154.71 164.31 38.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.656 -0.868 . . . . 0.56999999999999995 108.656 173.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -76.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.502 2.321 . . . . 0.56999999999999995 112.589 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -178.77 171.88 1.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.256 2.223 . . . . 0.56999999999999995 107.348 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 123.85 -146.95 16.52 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.56999999999999995 110.422 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 pt -116.65 119.55 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 109.113 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -61.77 117.71 6.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.188 -0.914 . . . . 0.56999999999999995 109.615 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.16 -40.05 96.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.319 1.448 . . . . 0.56999999999999995 110.848 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -42.81 79.75 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.096 -1.076 . . . . 0.56999999999999995 108.096 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -66.07 -47.61 73.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.021 0.828 . . . . 0.56999999999999995 110.036 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.33 -50.09 70.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 123.531 0.52 . . . . 0.56999999999999995 110.581 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.97 -57.88 10.0 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 117.908 -1.044 . . . . 0.56999999999999995 109.74 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -55.82 -37.69 69.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 111.333 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.97 -57.12 14.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.529 1.132 . . . . 0.65000000000000002 110.518 173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 15.0 mm-40 -72.72 -44.52 61.61 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.605 -0.684 . . . . 0.66000000000000003 111.248 -171.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.2 -29.0 68.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 111.036 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.34 -47.11 90.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.55 -1.02 . . . . 0.56999999999999995 110.55 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -70.16 -36.29 74.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.255 -0.879 . . . . 0.65000000000000002 112.191 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 p -57.74 -33.48 68.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.316 0.507 . . . . 0.56999999999999995 111.251 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -36.34 79.81 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 112.493 0.553 . . . . 0.56999999999999995 112.493 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 162.11 50.08 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 CA-C-O 117.993 -1.449 . . . . 0.56999999999999995 113.271 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.73 -158.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.949 1.299 . . . . 0.56999999999999995 112.024 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.08 62.6 0.22 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.091 -1.604 . . . . 0.56999999999999995 109.091 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 169.62 17.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.675 0.75 . . . . 0.65000000000000002 109.624 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -157.15 -179.99 8.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.701 1.2 . . . . 0.56999999999999995 107.91 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t -144.17 78.16 1.57 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.771 -1.566 . . . . 0.56999999999999995 106.771 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -131.08 145.91 59.81 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 106.545 -1.65 . . . . 0.66000000000000003 106.545 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.71 -26.72 75.4 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.165 1.91 . . . . 0.56999999999999995 112.427 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -125.11 29.37 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.572 1.549 . . . . 0.56999999999999995 109.685 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.06 129.16 39.56 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 109.08 -0.711 . . . . 0.56999999999999995 109.08 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.56 -17.5 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 111.646 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 22.5 13.98 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.307 1.843 . . . . 0.56999999999999995 110.326 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.24 123.97 78.38 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 119.999 1.272 . . . . 0.56999999999999995 110.292 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.7 48.3 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.728 2.952 . . . . 0.56999999999999995 112.661 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -148.36 -45.48 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 110.373 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.3 t80 56.7 95.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.768 1.627 . . . . 0.56999999999999995 112.305 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.41 -73.7 0.03 OUTLIER Glycine 0 C--N 1.346 1.101 0 O-C-N 120.751 -1.218 . . . . 0.56999999999999995 115.706 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -35.52 61.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.503 1.151 . . . . 0.56999999999999995 112.375 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.7 152.0 13.59 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.59 -1.004 . . . . 0.56999999999999995 110.59 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.83 105.51 51.29 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 107.467 -1.309 . . . . 0.66000000000000003 107.467 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.6 57.4 6.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.564 2.843 . . . . 0.56999999999999995 109.92 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.5 -48.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.655 -0.653 . . . . 0.56999999999999995 110.481 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -77.49 50.66 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.261 1.424 . . . . 0.56999999999999995 110.886 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -41.86 -82.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 112.917 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 43.91 22.82 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.16 2.584 . . . . 0.56999999999999995 113.489 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 42.93 90.45 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.724 2.81 . . . . 0.56999999999999995 111.222 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.9 t -56.12 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 114.46 -170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -142.35 -46.24 0.33 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.424 1.09 . . . . 0.56999999999999995 109.311 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.18 -51.56 10.4 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.886 1.274 . . . . 0.66000000000000003 111.427 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -48.14 75.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.44 0.696 . . . . 0.66000000000000003 111.964 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.4 mm -62.55 -46.57 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.886 0.874 . . . . 0.56999999999999995 109.178 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -63.48 -44.1 95.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.049 1.339 . . . . 0.56999999999999995 109.096 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.76 -62.59 6.14 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.1 -1.2 . . . . 0.56999999999999995 110.1 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 mm -52.67 -48.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.518 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -65.79 -28.53 69.07 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.436 -0.79 . . . . 0.56999999999999995 111.875 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.2 -20.23 35.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.959 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.97 -45.39 24.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.064 0.946 . . . . 0.56999999999999995 110.982 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -138.17 -22.86 1.03 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -171.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.78 -81.97 0.13 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.556 -1.417 . . . . 0.56999999999999995 109.556 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -154.78 -70.44 0.13 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.14 1.376 . . . . 0.56999999999999995 112.14 173.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.46 -178.99 2.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.639 1.176 . . . . 1.2 110.047 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -142.44 130.7 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.859 0.837 . . . . 0.56999999999999995 109.686 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.11 91.53 8.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.806 1.242 . . . . 0.56999999999999995 108.032 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.26 149.44 21.76 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.656 -0.868 . . . . 0.56999999999999995 108.656 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -136.59 155.82 49.4 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.561 1.145 . . . . 1.2 108.446 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.8 tttt 64.71 -172.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.745 1.618 . . . . 0.56999999999999995 111.614 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? . . . . . 0 N--CA 1.457 -0.104 0 C-N-CA 127.137 2.175 . . . . 0.5 . 174.413 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 117.853 -1.07 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -93.49 -33.03 13.95 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.827 0.739 . . . . 0.56999999999999995 111.69 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.28 87.98 1.14 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.884 -1.154 . . . . 0.56999999999999995 107.884 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 t80 61.77 90.58 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.112 1.365 . . . . 0.56999999999999995 113.383 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.72 171.95 8.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.572 2.181 . . . . 0.56999999999999995 112.252 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -154.3 -62.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.049 -0.5 . . . . 0.56999999999999995 110.827 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.03 63.53 1.55 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.962 1.705 . . . . 0.56999999999999995 109.068 176.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.08 165.86 15.81 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.959 1.773 . . . . 0.56999999999999995 111.263 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 77.92 -11.24 1.23 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.253 1.421 . . . . 0.56999999999999995 112.252 -174.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.6 m95 60.92 19.2 9.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.813 1.188 . . . . 0.56999999999999995 113.055 -168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m 68.47 -43.07 0.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.23 1.812 . . . . 0.56999999999999995 112.811 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 t -75.91 -178.15 4.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 111.079 173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -10.29 20.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.541 1.137 . . . . 0.56999999999999995 111.865 168.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -127.13 146.3 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 177.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.33 156.69 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 125.586 1.554 . . . . 0.56999999999999995 107.06 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.7 p -108.46 138.12 45.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.275 -1.009 . . . . 0.56999999999999995 108.275 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -126.59 143.21 51.29 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.075 -1.016 . . . . 0.56999999999999995 108.725 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -150.66 110.94 4.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.755 0.788 . . . . 1.2 108.993 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 mt -80.6 95.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 105.874 -1.898 . . . . 0.56999999999999995 105.874 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -69.82 -36.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.06 1.344 . . . . 0.56999999999999995 112.557 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -130.04 158.38 39.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.129 -2.545 . . . . 0.56999999999999995 104.129 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -133.45 175.99 8.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.188 1.395 . . . . 0.56999999999999995 108.154 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -87.23 -154.68 0.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.847 0.859 . . . . 0.56999999999999995 109.258 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -132.31 -28.8 1.65 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 116.412 -1.756 . . . . 1.2 115.074 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.82 -47.89 84.29 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.263 1.392 . . . . 0.66000000000000003 110.696 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.52 158.11 35.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.344 1.458 . . . . 0.56999999999999995 109.199 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -77.54 156.44 32.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.79 1.66 . . . . 0.56999999999999995 112.672 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -59.87 -35.37 74.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.712 1.205 . . . . 0.65000000000000002 113.514 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.69 -37.29 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 110.34 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -69.51 -39.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 116.965 -1.493 . . . . 0.56999999999999995 109.313 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.18 -56.84 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.761 1.619 . . . . 0.56999999999999995 109.773 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.37 -41.4 97.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.959 -0.543 . . . . 0.66000000000000003 111.323 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.65 -45.1 80.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.674 0.67 . . . . 1.2 111.904 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.24 -41.07 86.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.32 0.648 . . . . 0.56999999999999995 109.413 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.1 -50.09 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 117.511 -1.233 . . . . 0.56999999999999995 109.504 168.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -46.51 75.21 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 121.454 1.934 . . . . 0.56999999999999995 110.946 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.58 -35.05 79.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.743 0.701 . . . . 0.56999999999999995 112.335 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.71 -47.54 62.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.459 1.104 . . . . 0.56999999999999995 112.605 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.52 -31.36 70.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.135 1.374 . . . . 0.56999999999999995 109.514 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -59.77 -38.88 83.07 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.221 -0.895 . . . . 0.56999999999999995 110.226 168.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 37.2 mtm -67.47 -33.98 76.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.265 1.393 . . . . 0.56999999999999995 112.123 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 9.4 m95 -66.24 -54.58 23.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.07 0.85 . . . . 0.56999999999999995 110.269 170.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.62 -4.01 43.99 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.806 1.193 . . . . 0.56999999999999995 113.616 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -69.01 -25.92 64.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.685 1.242 . . . . 0.56999999999999995 110.346 172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.26 -15.4 13.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.218 1.007 . . . . 0.66000000000000003 111.553 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 pt -131.5 140.66 39.09 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 119.466 1.03 . . . . 0.56999999999999995 109.204 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.8 9.1 1.4 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.715 2.277 . . . . 0.56999999999999995 112.963 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.48 135.03 46.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 108.348 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -125.27 -179.76 4.73 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.25 1.02 . . . . 0.65000000000000002 109.663 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.54 157.07 44.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.158 -0.682 . . . . 0.56999999999999995 109.158 -171.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 154.46 49.15 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.346 1.458 . . . . 1.2 110.121 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -114.56 109.31 18.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.086 -1.079 . . . . 0.56999999999999995 108.086 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.02 161.05 4.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.494 -0.558 . . . . 0.56999999999999995 109.494 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.61 -53.14 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 118.767 -0.635 . . . . 0.56999999999999995 110.524 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 165.88 58.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.292 2.237 . . . . 0.56999999999999995 111.749 -172.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.09 38.85 1.7 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.752 -1.218 . . . . 0.56999999999999995 113.588 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m 64.97 142.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.59 1.956 . . . . 0.56999999999999995 110.28 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.18 168.03 20.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.773 0.796 . . . . 0.56999999999999995 109.288 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -65.72 -45.02 84.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.582 -1.19 . . . . 0.66000000000000003 108.545 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -112.34 81.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.051 1.74 . . . . 0.56999999999999995 107.658 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -78.11 118.73 20.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.029 -1.1 . . . . 0.56999999999999995 108.029 168.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.28 130.57 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.787 -1.931 . . . . 0.56999999999999995 105.787 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.81 161.54 28.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.428 -0.669 . . . . 0.56999999999999995 111.428 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.3 m-85 -132.02 143.35 50.01 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.881 -1.526 . . . . 0.56999999999999995 106.881 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.02 179.98 6.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.433 1.493 . . . . 0.56999999999999995 109.186 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -141.15 57.47 1.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.319 -0.623 . . . . 1.2 109.319 -171.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.04 -58.55 0.66 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.627 1.108 . . . . 0.56999999999999995 111.889 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.86 155.01 45.91 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.684 0.794 . . . . 0.56999999999999995 109.279 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -157.76 147.25 19.95 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.037 0.935 . . . . 0.65000000000000002 109.127 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 74.63 1.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.371 -1.491 . . . . 0.56999999999999995 109.371 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.74 -92.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.614 1.565 . . . . 0.66000000000000003 107.169 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.9 p -158.92 -38.19 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.8 1.24 . . . . 0.56999999999999995 110.024 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.88 131.42 23.99 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 109.541 -0.54 . . . . 0.56999999999999995 109.541 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.0 137.08 43.36 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.036 -1.563 . . . . 0.56999999999999995 108.036 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -158.22 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 123.622 1.677 . . . . 0.56999999999999995 109.233 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 23.9 p-10 -136.78 -22.64 1.22 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 130.205 3.402 . . . . 0.66000000000000003 109.058 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 -141.43 26.42 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.079 -1.208 . . . . 0.56999999999999995 110.079 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.06 95.21 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.965 3.11 . . . . 0.56999999999999995 110.855 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.27 -176.15 21.89 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.622 -0.991 . . . . 0.56999999999999995 110.622 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.496 ' HB3' ' HD2' ' A' ' 76' ' ' ASP 0.25 31.8 t30 46.85 -135.72 0.88 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.451 1.5 . . . . 0.56999999999999995 114.092 173.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -61.86 125.52 24.14 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.274 2.23 . . . . 0.56999999999999995 110.909 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -82.48 -30.13 30.13 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.289 -1.507 . . . . 0.56999999999999995 113.734 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.1 166.84 25.22 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.374 1.07 . . . . 0.56999999999999995 109.377 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.08 163.93 32.13 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.799 -0.563 . . . . 0.65000000000000002 109.783 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.44 155.24 40.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.958 1.303 . . . . 0.56999999999999995 109.3 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.78 163.61 13.12 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.774 0.671 . . . . 0.56999999999999995 110.11 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.4 153.92 83.96 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.7 -0.667 . . . . 0.56999999999999995 109.946 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.93 155.59 70.09 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.955 2.436 . . . . 0.56999999999999995 112.176 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.81 -118.41 0.55 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.289 -1.925 . . . . 0.56999999999999995 108.289 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 m -151.59 106.57 3.28 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 104.667 -2.345 . . . . 0.56999999999999995 104.667 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.67 -132.57 10.51 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 117.483 -1.732 . . . . 0.56999999999999995 109.301 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -31.13 12.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.662 1.585 . . . . 0.56999999999999995 112.809 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -45.96 144.27 3.73 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.72 -0.552 . . . . 0.56999999999999995 111.72 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.44 -18.81 0.71 Allowed Glycine 0 C--N 1.337 0.61 0 C-N-CA 126.546 2.022 . . . . 0.56999999999999995 116.738 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -68.1 155.51 39.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.785 -1.191 . . . . 0.66000000000000003 107.785 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.58 29.89 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.371 -0.832 . . . . 0.56999999999999995 108.96 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.93 159.27 35.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.196 -0.911 . . . . 0.65000000000000002 109.156 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.454 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 28.9 m-85 -144.56 154.74 43.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.566 1.546 . . . . 0.56999999999999995 108.095 -170.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.06 99.15 12.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.672 0.389 . . . . 0.66000000000000003 110.28 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.97 -28.14 49.31 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.741 -1.224 . . . . 0.66000000000000003 111.977 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -54.67 -38.52 67.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.592 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.79 151.14 37.6 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.881 1.272 . . . . 0.66000000000000003 109.844 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -80.13 125.21 29.53 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.712 -1.243 . . . . 1.2 109.709 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -107.17 166.05 10.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.832 0.853 . . . . 0.56999999999999995 109.118 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -158.8 164.4 35.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 109.438 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -65.01 -48.03 75.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.326 0.65 . . . . 0.66000000000000003 110.237 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.61 40.25 0.02 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.149 -0.806 . . . . 0.56999999999999995 112.777 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -77.36 32.61 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.02 1.41 . . . . 0.56999999999999995 113.827 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.1 m 53.51 35.09 19.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 113.559 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -160.66 -175.16 4.81 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.551 1.54 . . . . 0.56999999999999995 108.622 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.37 -144.76 24.32 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 124.237 0.922 . . . . 0.56999999999999995 112.033 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -120.67 113.47 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.821 -1.548 . . . . 0.56999999999999995 106.821 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -61.08 110.48 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.148 0.979 . . . . 0.56999999999999995 111.304 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.21 -42.98 99.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.507 1.123 . . . . 0.56999999999999995 111.355 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -55.11 22.77 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.86 -1.163 . . . . 0.56999999999999995 107.86 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.47 -43.25 94.81 Favored 'General case' 0 CA--C 1.526 0.02 0 C-N-CA 122.949 0.499 . . . . 0.56999999999999995 111.004 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.2 70.82 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.085 0.554 . . . . 0.56999999999999995 110.906 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.1 -55.66 31.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.191 -0.909 . . . . 0.56999999999999995 109.607 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 m -53.93 -38.72 65.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 111.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.96 -59.29 4.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.252 0.621 . . . . 0.65000000000000002 109.788 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -64.69 -46.71 81.19 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.232 0.469 . . . . 0.66000000000000003 111.104 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.01 -31.48 71.86 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.4 1.08 . . . . 0.56999999999999995 112.103 177.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.406 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -55.87 -41.89 84.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.219 -0.752 . . . . 0.56999999999999995 111.219 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -72.33 -36.33 68.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.062 -0.971 . . . . 0.65000000000000002 111.81 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -56.37 -36.33 68.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.283 0.947 . . . . 0.56999999999999995 112.293 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.87 -21.04 66.43 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.611 1.096 . . . . 0.56999999999999995 112.942 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.33 -54.59 0.28 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 124.343 0.973 . . . . 0.56999999999999995 110.895 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.74 176.89 0.09 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.38 2.272 . . . . 0.56999999999999995 107.7 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.4 70.65 0.02 OUTLIER Glycine 0 C--O 1.218 -0.874 0 N-CA-C 107.152 -2.379 . . . . 0.56999999999999995 107.152 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 162.11 27.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.425 1.112 . . . . 0.65000000000000002 108.651 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 t -157.95 -161.89 1.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.984 1.314 . . . . 0.56999999999999995 108.388 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -152.74 58.43 0.8 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.119 1.768 . . . . 0.56999999999999995 109.288 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -143.44 135.16 12.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 117.037 -1.458 . . . . 0.66000000000000003 108.751 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.37 41.92 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.051 1 C-N-CA 125.981 4.454 . . . . 0.56999999999999995 114.041 -174.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -154.02 -27.15 0.13 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 127.931 2.492 . . . . 0.56999999999999995 111.566 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -50.7 133.35 25.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.96 -25.44 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.852 -0.53 . . . . 0.56999999999999995 110.745 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -109.63 28.61 8.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 111.49 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -50.5 128.69 25.35 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 120.698 -1.251 . . . . 0.56999999999999995 110.054 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.35 168.1 24.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.995 2.463 . . . . 0.56999999999999995 110.542 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.4 m 62.0 70.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.871 0.759 . . . . 0.56999999999999995 110.552 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -41.18 123.68 2.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.856 1.662 . . . . 0.56999999999999995 112.115 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.1 -111.42 0.33 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.909 -1.277 . . . . 0.56999999999999995 109.909 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -50.44 -39.97 49.16 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.667 0.988 . . . . 0.56999999999999995 113.667 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.85 89.14 0.01 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.225 1.869 . . . . 0.56999999999999995 112.115 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.99 107.91 1.06 Allowed Pre-proline 0 C--N 1.344 0.349 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 109.987 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -72.19 -25.17 19.22 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.37 1.38 . . . . 0.56999999999999995 112.145 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.9 2.42 38.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.448 -0.787 . . . . 0.56999999999999995 110.941 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.65 75.47 1.66 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.223 1.809 . . . . 0.56999999999999995 108.418 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.11 -64.98 0.64 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 113.291 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 22.61 77.55 0.02 OUTLIER 'General case' 0 C--N 1.343 0.296 0 C-N-CA 129.279 3.032 . . . . 0.56999999999999995 112.657 174.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 mp -38.26 97.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.571 2.348 . . . . 0.56999999999999995 109.97 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 m -74.13 -87.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.558 0.743 . . . . 0.56999999999999995 112.546 -162.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -137.5 -28.02 0.92 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 116.779 -1.581 . . . . 0.56999999999999995 110.248 168.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.17 -54.11 50.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.154 1.797 . . . . 0.66000000000000003 111.299 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -62.68 -53.11 59.36 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 109.799 -0.445 . . . . 0.66000000000000003 109.799 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.12 -40.62 83.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 123.865 0.866 . . . . 0.56999999999999995 109.112 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -64.95 -43.03 94.02 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.823 -1.085 . . . . 0.56999999999999995 110.653 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.48 -61.63 7.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.373 -1.491 . . . . 0.56999999999999995 109.373 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.0 mm -53.47 -47.2 59.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.383 1.473 . . . . 0.56999999999999995 112.748 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.14 -31.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.037 0.535 . . . . 0.56999999999999995 111.017 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -29.61 64.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.702 0.683 . . . . 0.56999999999999995 111.183 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.59 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.482 -0.77 . . . . 0.56999999999999995 109.709 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -143.31 22.64 1.86 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.65 0.611 . . . . 0.56999999999999995 112.65 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.14 -153.99 12.96 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.139 0.876 . . . . 0.56999999999999995 113.04 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -120.83 -43.89 2.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.355 1.462 . . . . 0.56999999999999995 112.942 -171.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -73.73 123.68 24.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.625 -0.88 . . . . 1.2 108.625 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.9 p -126.0 74.64 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.22 1.408 . . . . 0.56999999999999995 109.056 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.13 100.74 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.604 1.162 . . . . 0.56999999999999995 108.051 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.07 110.02 0.69 Allowed 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.28 -1.007 . . . . 0.56999999999999995 108.28 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -123.11 113.14 18.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.556 -1.275 . . . . 1.2 107.556 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.46 -179.34 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.379 1.049 . . . . 0.56999999999999995 108.798 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tttp . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 125.429 1.492 . . . . 0.5 . -179.551 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.14 -0.457 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 m -70.72 -63.59 1.06 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 119.939 -1.725 . . . . 0.56999999999999995 112.132 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -176.0 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.174 1.789 . . . . 0.56999999999999995 106.559 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 165.63 -52.8 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 127.889 2.476 . . . . 0.56999999999999995 110.502 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.67 150.5 5.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.405 1.403 . . . . 0.56999999999999995 112.625 -171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -150.41 76.66 1.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.407 0.683 . . . . 0.56999999999999995 110.514 -169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.88 84.51 3.37 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 108.601 -0.889 . . . . 0.56999999999999995 108.601 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.24 85.24 1.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.114 2.543 . . . . 0.56999999999999995 109.668 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 pttt 85.73 151.26 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.239 2.615 . . . . 0.56999999999999995 108.937 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -65.76 170.11 5.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.265 1.026 . . . . 0.56999999999999995 109.938 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 m -62.05 -29.66 70.45 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 120.94 -1.1 . . . . 0.56999999999999995 111.252 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.6 t -97.62 156.87 16.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 112.163 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -75.1 -6.08 47.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.682 1.593 . . . . 0.56999999999999995 112.754 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.63 151.94 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.523 -0.918 . . . . 0.56999999999999995 108.523 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 150.16 33.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.047 -1.094 . . . . 0.56999999999999995 108.047 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.8 p -104.54 136.78 43.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.605 -0.887 . . . . 0.56999999999999995 108.605 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -118.79 163.2 17.23 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.801 0.84 . . . . 0.56999999999999995 110.481 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.37 160.45 41.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.046 -1.094 . . . . 1.2 108.046 169.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.6 mt -123.2 94.25 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 103.663 -2.717 . . . . 0.56999999999999995 103.663 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 m -73.29 -30.68 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.593 0.357 . . . . 0.56999999999999995 111.263 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -142.63 147.27 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.161 -2.163 . . . . 0.56999999999999995 105.161 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -131.9 159.19 39.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.357 1.063 . . . . 0.56999999999999995 109.207 -166.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -91.74 -175.52 4.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.876 1.27 . . . . 0.56999999999999995 109.437 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.61 -26.3 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.128 1.159 . . . . 1.2 114.128 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -59.19 -40.68 86.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.265 0.626 . . . . 0.66000000000000003 110.305 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.65 152.57 80.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 128.767 2.827 . . . . 0.56999999999999995 110.248 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.31 161.19 28.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.962 2.441 . . . . 0.56999999999999995 114.453 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.82 -39.05 93.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.833 1.653 . . . . 0.65000000000000002 112.027 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 tt -65.89 -35.96 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.424 0.69 . . . . 0.56999999999999995 110.794 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -66.39 -46.62 76.03 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 116.703 -1.617 . . . . 0.56999999999999995 108.723 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.56 -52.54 25.78 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.568 1.531 . . . . 0.56999999999999995 110.043 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -63.04 -42.49 99.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 110.955 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -63.32 -46.88 84.63 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.95 . . . . 1.2 112.062 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.15 -45.61 87.72 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.239 -0.886 . . . . 0.56999999999999995 109.022 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -46.75 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 124.267 1.027 . . . . 0.56999999999999995 109.574 172.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -46.06 89.47 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.047 0.839 . . . . 0.56999999999999995 110.95 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -63.67 -42.95 98.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.912 1.285 . . . . 0.56999999999999995 112.033 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.29 75.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.094 1.357 . . . . 0.56999999999999995 111.447 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.92 -34.19 77.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.607 -0.711 . . . . 0.56999999999999995 110.258 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -40.76 85.38 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.262 0.937 . . . . 0.56999999999999995 110.613 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 39.4 mtm -63.85 -38.93 92.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.047 0.84 . . . . 0.56999999999999995 111.293 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -64.29 -49.67 70.87 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.26 0.936 . . . . 0.56999999999999995 111.405 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.16 -9.08 66.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.913 1.244 . . . . 0.56999999999999995 113.174 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -23.77 63.08 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.506 1.653 . . . . 0.56999999999999995 110.864 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -105.85 -14.03 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.258 1.023 . . . . 0.66000000000000003 111.706 -171.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.36 149.56 60.92 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.636 1.174 . . . . 0.56999999999999995 111.445 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.37 10.32 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.313 2.675 . . . . 0.56999999999999995 113.018 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.26 133.9 35.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.736 1.615 . . . . 0.56999999999999995 107.513 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.12 170.88 10.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.002 0.921 . . . . 0.65000000000000002 110.006 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.08 146.16 31.73 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.426 -0.953 . . . . 0.56999999999999995 108.426 -172.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -143.6 166.53 24.58 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.875 1.27 . . . . 1.2 109.242 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -105.37 143.35 33.66 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.86 -0.793 . . . . 0.56999999999999995 108.86 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.66 157.01 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.71 0.404 . . . . 0.56999999999999995 110.98 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.86 -43.81 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.779 0.832 . . . . 0.56999999999999995 111.509 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -176.64 146.98 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.97 2.908 . . . . 0.56999999999999995 104.622 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.18 -116.87 3.07 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.523 -0.631 . . . . 0.56999999999999995 111.523 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 43.9 p -132.88 164.64 26.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.635 1.974 . . . . 0.56999999999999995 108.556 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.51 21.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.126 0.97 . . . . 0.56999999999999995 110.121 -174.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -63.01 -33.08 74.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.611 0.764 . . . . 0.66000000000000003 109.806 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.3 mt -123.53 76.94 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.068 2.147 . . . . 0.56999999999999995 108.235 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -73.22 110.75 7.74 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.737 1.615 . . . . 0.56999999999999995 108.519 167.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.91 128.13 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 104.568 -2.382 . . . . 0.56999999999999995 104.568 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.62 148.9 19.07 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 110.111 -1.196 . . . . 0.56999999999999995 110.111 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -113.38 167.28 10.7 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 118.299 1.05 . . . . 0.56999999999999995 108.594 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.58 155.28 43.57 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.513 1.125 . . . . 0.56999999999999995 108.162 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -105.13 110.03 22.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.521 -1.289 . . . . 1.2 107.521 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.73 -46.95 2.4 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.015 -1.436 . . . . 0.56999999999999995 113.665 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.53 165.53 36.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.554 1.677 . . . . 0.56999999999999995 111.56 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.13 162.51 33.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.411 1.085 . . . . 0.65000000000000002 111.777 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.57 58.62 3.0 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.798 1.665 . . . . 0.56999999999999995 112.307 -174.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.99 -52.71 2.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.561 0.745 . . . . 0.66000000000000003 111.276 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 t 174.73 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 110.65 -167.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -122.54 114.16 30.28 Favored Pre-proline 0 C--N 1.347 0.471 0 C-N-CA 123.388 0.675 . . . . 0.56999999999999995 109.538 -170.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 28.88 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.941 2.427 . . . . 0.56999999999999995 112.552 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 41.96 -136.3 0.27 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 111.326 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 21.7 p-10 -162.77 -40.46 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.779 2.432 . . . . 0.66000000000000003 108.449 -163.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.39 -153.91 21.98 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.687 -1.365 . . . . 0.56999999999999995 109.687 -170.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.77 101.98 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.096 3.198 . . . . 0.56999999999999995 113.561 -167.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.88 -178.79 17.05 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 109.839 -1.304 . . . . 0.56999999999999995 109.839 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 4.6 t30 49.14 -145.01 0.42 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.195 0.997 . . . . 0.56999999999999995 112.428 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.3 m -46.5 110.68 0.3 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.374 2.27 . . . . 0.56999999999999995 112.577 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -83.83 -34.12 24.75 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.259 -0.9 . . . . 0.56999999999999995 113.041 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.84 167.62 29.82 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 109.382 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -150.98 150.44 30.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.876 -0.515 . . . . 0.65000000000000002 110.053 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.95 163.2 32.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 109.628 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.31 140.3 49.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.007 -1.109 . . . . 0.56999999999999995 108.007 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.09 160.07 3.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.56999999999999995 112.444 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.6 152.87 74.46 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.538 2.158 . . . . 0.56999999999999995 111.183 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.17 -78.57 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -172.21 -49.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.584 1.154 . . . . 0.56999999999999995 109.497 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.69 -101.99 2.73 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.218 -1.153 . . . . 0.56999999999999995 110.218 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -27.18 68.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.048 0.939 . . . . 0.56999999999999995 111.828 175.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.54 146.77 15.67 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.148 -0.97 . . . . 0.56999999999999995 111.411 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 -21.37 4.24 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.579 2.037 . . . . 0.56999999999999995 114.506 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -74.76 160.14 31.1 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.975 1.388 . . . . 0.66000000000000003 108.891 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.09 139.86 20.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.3 -169.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -132.77 149.52 52.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.437 0.695 . . . . 0.65000000000000002 110.6 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -142.07 146.88 35.95 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 -166.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -86.55 103.89 15.48 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.02 0.914 . . . . 0.66000000000000003 109.277 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.65 -15.54 62.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.316 1.446 . . . . 0.66000000000000003 111.374 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -69.56 -20.58 63.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.436 1.016 . . . . 0.66000000000000003 110.267 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -85.38 158.91 20.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 110.325 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.27 138.66 35.73 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -131.47 144.84 51.45 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -138.48 153.07 48.79 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.14 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -97.18 11.57 35.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.626 2.371 . . . . 0.66000000000000003 110.741 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.74 -134.31 2.98 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.81 1.672 . . . . 0.56999999999999995 111.674 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 t -143.33 171.5 14.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.309 1.444 . . . . 0.56999999999999995 108.713 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 t 51.76 42.9 30.25 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.892 1.441 . . . . 0.56999999999999995 114.892 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.56 -38.59 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 119.914 -1.741 . . . . 0.56999999999999995 113.542 -172.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.35 -154.9 10.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 108.587 -1.805 . . . . 0.56999999999999995 108.587 -172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.94 119.51 34.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 108.289 -1.004 . . . . 0.56999999999999995 108.289 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -63.98 103.56 0.61 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.945 0.498 . . . . 0.56999999999999995 109.675 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.24 -36.35 65.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.874 1.27 . . . . 0.56999999999999995 110.645 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -65.44 -48.35 73.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.849 -0.797 . . . . 0.56999999999999995 108.849 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.52 -39.07 93.47 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.558 -0.904 . . . . 0.56999999999999995 108.558 -176.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.56 -56.3 22.97 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.58 0.752 . . . . 0.56999999999999995 110.999 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.25 58.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.137 0.575 . . . . 0.56999999999999995 109.71 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.7 m -58.73 -44.02 90.35 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.173 0.897 . . . . 0.56999999999999995 111.732 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.66 -52.03 67.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.034 0.534 . . . . 0.65000000000000002 109.723 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.23 -48.66 72.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.466 1.106 . . . . 0.66000000000000003 110.393 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.14 -29.12 69.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 126.113 1.765 . . . . 0.56999999999999995 111.534 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.19 -45.32 96.27 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.691 -0.564 . . . . 0.56999999999999995 111.691 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -62.32 -39.76 94.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 117.213 -1.375 . . . . 0.65000000000000002 109.911 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -60.44 -29.1 68.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.825 1.193 . . . . 0.56999999999999995 113.774 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -25.22 57.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 112.71 172.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.89 -1.63 4.29 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.808 1.194 . . . . 0.56999999999999995 114.5 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.43 164.68 20.5 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.951 1.375 . . . . 0.56999999999999995 113.678 -166.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.38 166.49 12.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.227 1.394 . . . . 0.56999999999999995 109.755 172.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -68.37 174.35 4.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.195 0.998 . . . . 0.65000000000000002 112.558 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.08 179.83 7.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.735 1.614 . . . . 0.56999999999999995 108.519 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.08 71.55 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.826 2.05 . . . . 0.56999999999999995 107.51 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -136.72 140.49 32.13 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 107.668 -1.234 . . . . 0.66000000000000003 107.668 176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.34 -26.32 41.53 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.456 2.104 . . . . 0.56999999999999995 112.317 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.2 22.87 14.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.981 1.313 . . . . 0.56999999999999995 109.991 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.61 124.42 21.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.258 -1.016 . . . . 0.56999999999999995 108.258 166.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.93 -31.03 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 109.871 166.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -84.51 8.54 16.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.94 1.089 . . . . 0.56999999999999995 113.94 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -56.78 130.85 78.43 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.652 1.569 . . . . 0.56999999999999995 110.565 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 150.01 26.53 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.197 1.931 . . . . 0.56999999999999995 110.27 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.8 m 73.12 156.42 0.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 111.545 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.79 132.73 53.88 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.252 1.021 . . . . 0.56999999999999995 109.55 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 141.62 97.51 0.29 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.511 1.053 . . . . 0.56999999999999995 110.53 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.25 -43.23 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.659 1.229 . . . . 0.56999999999999995 113.443 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.66 -177.22 48.39 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.862 -1.695 . . . . 0.56999999999999995 108.862 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -51.7 111.56 2.52 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.579 1.552 . . . . 0.66000000000000003 110.969 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -3.86 12.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.21 1.94 . . . . 0.56999999999999995 112.304 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -73.7 -9.99 59.23 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.706 1.139 . . . . 0.56999999999999995 112.91 168.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -62.61 -6.58 3.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.721 1.749 . . . . 0.56999999999999995 115.721 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 19.77 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.346 3.058 . . . . 0.56999999999999995 116.83 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt 20.39 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.677 3.191 . . . . 0.56999999999999995 112.859 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 mp -26.11 106.09 0.03 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 127.876 2.471 . . . . 0.56999999999999995 110.165 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.8 t -81.67 -87.54 0.09 Allowed 'General case' 0 C--N 1.343 0.316 0 O-C-N 123.853 0.721 . . . . 0.56999999999999995 110.147 -160.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.75 -37.5 0.45 Allowed 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.252 -1.356 . . . . 0.56999999999999995 109.376 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -47.85 -49.32 29.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.205 1.366 . . . . 0.66000000000000003 110.571 171.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -77.57 -54.15 6.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.66000000000000003 109.746 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mm -57.68 -45.64 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.76 0.709 . . . . 0.56999999999999995 111.079 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -44.16 79.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 109.565 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.43 -51.25 58.87 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.123 -1.191 . . . . 0.56999999999999995 110.123 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -60.22 -51.97 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.456 1.102 . . . . 0.56999999999999995 110.223 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.08 -25.28 61.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.877 0.762 . . . . 0.56999999999999995 112.498 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -43.79 18.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.577 -1.201 . . . . 0.56999999999999995 110.064 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.25 -56.67 6.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.666 2.386 . . . . 0.56999999999999995 111.624 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -93.6 1.15 56.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 119.02 -0.514 . . . . 0.56999999999999995 112.143 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.21 -115.38 4.07 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.718 -1.753 . . . . 0.56999999999999995 108.718 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -61.62 -63.07 1.39 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.22 -0.895 . . . . 0.56999999999999995 111.741 -172.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -169.18 -79.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.012 2.125 . . . . 1.2 107.382 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 158.69 8.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.825 0.85 . . . . 0.56999999999999995 109.489 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 159.15 39.56 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.607 1.163 . . . . 0.56999999999999995 108.77 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.0 t -163.7 178.81 7.61 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.547 1.139 . . . . 0.56999999999999995 108.519 168.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.64 129.39 55.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.323 -2.102 . . . . 1.2 105.323 167.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -47.82 140.85 6.15 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.163 0.985 . . . . 0.56999999999999995 110.788 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 126.365 1.866 . . . . 0.5 . -179.32 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 120.409 0.147 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.4 t -62.89 -54.07 44.27 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.263 1.025 . . . . 0.56999999999999995 111.241 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.85 173.13 15.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.884 2.073 . . . . 0.56999999999999995 109.043 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -45.0 138.78 4.13 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.05 2.14 . . . . 0.56999999999999995 113.069 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.09 -4.45 15.44 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.827 2.351 . . . . 0.56999999999999995 113.518 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -134.73 101.17 4.84 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.014 1.326 . . . . 0.56999999999999995 108.048 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.68 -61.48 0.0 OUTLIER Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 129.259 3.024 . . . . 0.56999999999999995 107.622 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.01 158.17 58.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.56999999999999995 110.187 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.5 111.55 0.07 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.48 1.912 . . . . 0.56999999999999995 111.288 -174.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -58.02 152.29 16.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.996 0.918 . . . . 0.56999999999999995 111.436 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.4 p -77.47 -20.69 54.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.56999999999999995 112.764 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -94.19 142.41 27.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.236 1.415 . . . . 0.56999999999999995 109.325 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -10.62 59.7 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.406 1.482 . . . . 0.56999999999999995 112.577 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.87 109.91 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.614 -1.995 . . . . 0.56999999999999995 105.614 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.02 159.0 4.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.607 -1.627 . . . . 0.56999999999999995 106.607 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 p -106.96 139.8 40.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.277 -0.638 . . . . 0.56999999999999995 109.277 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -128.08 157.37 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.409 -0.807 . . . . 0.56999999999999995 110.092 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -158.48 115.88 2.88 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.057 0.456 . . . . 1.2 110.361 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.65 90.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 106.623 -1.621 . . . . 0.56999999999999995 106.623 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.12 -25.46 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.408 -1.432 . . . . 0.56999999999999995 113.901 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -147.6 154.72 41.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 103.241 -2.874 . . . . 0.56999999999999995 103.241 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -135.78 43.95 2.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.756 0.707 . . . . 0.56999999999999995 110.148 -164.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.45 ' HB ' ' CD2' ' A' ' 64' ' ' PHE . 15.4 t 47.73 -153.98 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.779 1.232 . . . . 0.56999999999999995 110.186 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -22.79 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.54 -0.743 . . . . 1.2 112.784 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -64.04 -39.72 94.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.04 0.836 . . . . 0.66000000000000003 111.536 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.19 150.7 57.41 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 109.062 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.28 159.67 40.09 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.82 2.347 . . . . 0.56999999999999995 113.011 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -59.53 -36.78 76.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.98 1.312 . . . . 0.65000000000000002 113.689 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -39.3 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.185 0.448 . . . . 0.56999999999999995 110.039 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -69.74 -46.39 66.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.297 -1.335 . . . . 0.56999999999999995 109.475 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.4 -48.14 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.985 1.721 . . . . 0.56999999999999995 110.403 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.72 -45.67 91.65 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 119.019 0.827 . . . . 0.66000000000000003 110.781 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -40.54 94.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.8 1.182 . . . . 1.2 113.189 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.23 -47.77 63.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.04 1.336 . . . . 0.56999999999999995 109.235 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.2 -37.84 70.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.375 0.989 . . . . 0.56999999999999995 110.809 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.0 t -61.49 -56.75 16.61 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.227 1.011 . . . . 0.56999999999999995 109.95 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -62.34 -32.72 73.54 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.353 1.433 . . . . 0.56999999999999995 112.338 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.95 62.0 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.451 1.1 . . . . 0.56999999999999995 112.316 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.62 -31.16 70.99 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 118.228 -0.891 . . . . 0.56999999999999995 110.165 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -59.85 -43.57 94.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.901 -1.047 . . . . 0.56999999999999995 109.609 171.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.1 mtp -61.31 -45.26 95.18 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 111.733 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -60.48 -47.75 84.77 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.085 1.311 . . . . 0.56999999999999995 111.565 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.57 -17.01 68.37 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.64 1.114 . . . . 0.56999999999999995 113.071 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -29.57 70.73 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.478 -1.013 . . . . 0.56999999999999995 110.182 174.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.91 -32.26 13.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.72 -0.657 . . . . 0.66000000000000003 111.808 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.89 132.87 24.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.757 0.823 . . . . 0.56999999999999995 110.659 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.34 35.7 0.4 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 124.111 3.208 . . . . 0.56999999999999995 113.991 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -78.81 146.26 33.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.718 1.607 . . . . 0.56999999999999995 107.85 174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -130.59 160.17 34.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.02 1.328 . . . . 0.65000000000000002 108.191 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 149.87 43.97 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 120.927 -1.108 . . . . 0.56999999999999995 108.26 -173.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -137.18 170.33 16.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.926 0.89 . . . . 1.2 109.357 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -117.33 128.22 54.83 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.14 163.23 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.95 1.3 . . . . 0.56999999999999995 110.444 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.36 -60.21 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 109.895 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -164.57 154.12 13.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.415 2.686 . . . . 0.56999999999999995 105.616 167.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.05 17.79 1.42 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.433 1.333 . . . . 0.56999999999999995 116.433 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.6 m 68.0 159.04 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 111.021 -168.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -131.82 177.26 7.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 109.071 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.86 -34.97 79.36 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.921 0.488 . . . . 0.66000000000000003 109.946 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mt -126.84 82.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.139 -1.8 . . . . 0.56999999999999995 106.139 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.47 140.21 44.44 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.208 -0.932 . . . . 0.56999999999999995 108.777 164.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.67 120.36 61.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 N-CA-C 105.705 -1.961 . . . . 0.56999999999999995 105.705 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.74 161.12 24.74 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.697 -0.561 . . . . 0.56999999999999995 111.697 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.5 m-85 -132.45 129.9 39.84 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 104.978 -2.23 . . . . 0.56999999999999995 104.978 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.1 17.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.647 1.979 . . . . 0.56999999999999995 108.223 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 ttp-105 -97.36 -14.15 21.43 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.69 0.996 . . . . 1.2 113.69 -168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.22 -44.07 0.03 OUTLIER Glycine 0 C--O 1.221 -0.669 0 CA-C-O 119.067 -0.852 . . . . 0.56999999999999995 111.034 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.57 27.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.314 1.046 . . . . 0.56999999999999995 109.143 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 -75.31 0.63 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.145 1.778 . . . . 0.65000000000000002 109.096 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.44 46.52 0.02 OUTLIER Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.594 0.616 . . . . 0.56999999999999995 112.371 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 -172.46 2.05 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.832 1.653 . . . . 0.66000000000000003 108.098 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.1 -36.73 2.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.56999999999999995 113.322 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.8 101.3 6.49 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.332 -0.988 . . . . 0.56999999999999995 108.332 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.52 155.26 67.37 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.412 1.408 . . . . 0.56999999999999995 111.155 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.03 177.23 3.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.53 1.157 . . . . 0.56999999999999995 111.734 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.0 -26.6 8.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.828 3.251 . . . . 0.66000000000000003 111.798 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.57 -146.0 18.06 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 120.89 1.677 . . . . 0.56999999999999995 112.632 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.5 82.28 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 0.56999999999999995 113.753 -172.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -165.02 35.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.984 1.754 . . . . 0.56999999999999995 111.743 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 t30 38.41 -129.65 0.22 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.364 2.266 . . . . 0.56999999999999995 115.755 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.2 m -65.67 131.26 45.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.153 2.181 . . . . 0.56999999999999995 109.135 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 HD12 ' C24' ' A' ' 178' ' ' MDW . 5.5 mp -101.17 -27.15 13.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 113.496 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.91 159.69 32.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.153 -1.425 . . . . 0.56999999999999995 107.153 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.89 157.1 43.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.65000000000000002 109.553 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.72 155.13 43.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.519 1.128 . . . . 0.56999999999999995 108.709 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.97 143.73 42.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.522 -0.918 . . . . 0.56999999999999995 108.522 -175.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.09 151.72 33.44 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 118.122 -0.942 . . . . 0.56999999999999995 110.193 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.15 155.52 64.44 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.678 1.585 . . . . 0.56999999999999995 112.014 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.72 174.7 14.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.81 1.195 . . . . 0.56999999999999995 110.733 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.257 7.1 t 43.52 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.049 1.74 . . . . 0.56999999999999995 113.055 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.51 -53.06 2.69 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.945 -0.92 . . . . 0.56999999999999995 111.178 172.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.16 -35.27 80.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.089 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.0 153.62 30.15 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.889 -1.132 . . . . 0.56999999999999995 111.007 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.61 -21.48 1.96 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.204 1.383 . . . . 0.56999999999999995 114.091 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -74.72 155.07 38.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 120.138 1.969 . . . . 0.66000000000000003 108.614 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.29 26.02 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.507 -0.769 . . . . 0.56999999999999995 109.487 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -132.82 162.33 31.8 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.65000000000000002 109.248 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.464 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.5 m-85 -143.03 155.44 44.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.732 1.613 . . . . 0.56999999999999995 108.718 -171.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.63 96.29 7.85 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.552 -1.277 . . . . 0.66000000000000003 107.552 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.13 -32.76 68.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.068 1.747 . . . . 0.66000000000000003 111.74 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.74 -32.27 73.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.423 -0.584 . . . . 0.66000000000000003 109.423 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.88 124.01 23.33 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.276 1.03 . . . . 0.66000000000000003 109.471 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -54.48 131.06 41.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.301 1.04 . . . . 1.2 109.745 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.38 149.07 39.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.658 -1.238 . . . . 0.56999999999999995 107.658 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -145.1 149.3 34.8 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.508 -0.745 . . . . 0.56999999999999995 109.185 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.35 -39.25 75.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.385 0.538 . . . . 0.66000000000000003 110.728 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.87 -35.47 0.1 OUTLIER Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.367 -0.685 . . . . 0.56999999999999995 112.866 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.1 m -54.91 137.64 45.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.293 1.037 . . . . 0.56999999999999995 111.633 174.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -56.12 110.44 0.75 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 111.936 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -32.88 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 111.804 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.98 -146.21 5.5 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 108.06 -2.016 . . . . 0.56999999999999995 108.06 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.39 135.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.727 1.211 . . . . 0.56999999999999995 109.523 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.71 103.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.896 0.878 . . . . 0.56999999999999995 110.623 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.05 -41.39 74.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.085 2.154 . . . . 0.56999999999999995 110.817 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 tp -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.088 -0.708 . . . . 0.56999999999999995 109.088 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -57.93 -48.86 78.68 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.719 0.807 . . . . 0.56999999999999995 109.183 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.54 -57.05 14.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.464 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -51.37 70.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.512 -0.756 . . . . 0.56999999999999995 110.333 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.1 m -56.75 -41.21 77.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 110.904 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -67.12 -52.89 36.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.348 0.659 . . . . 0.65000000000000002 110.306 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.03 -41.92 94.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.9 0.773 . . . . 0.66000000000000003 111.037 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.06 -27.91 66.06 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.275 0.63 . . . . 0.56999999999999995 110.734 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.05 -44.01 88.28 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 118.855 0.752 . . . . 0.56999999999999995 111.398 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -68.33 -39.56 81.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.18 -0.914 . . . . 0.65000000000000002 112.067 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 p -65.05 -26.94 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 123.688 0.617 . . . . 0.56999999999999995 111.955 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -44.18 85.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 0.56999999999999995 111.08 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 168.84 41.64 0.03 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.411 -1.216 . . . . 0.56999999999999995 115.128 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.7 mmt 54.39 -167.17 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.665 1.232 . . . . 0.56999999999999995 111.072 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.8 24.44 0.34 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.17 -1.35 . . . . 0.56999999999999995 114.917 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 163.69 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.402 1.601 . . . . 0.65000000000000002 113.013 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.2 178.97 9.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 109.235 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.5 m -147.52 75.7 1.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.165 1.786 . . . . 0.56999999999999995 106.815 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.38 143.04 41.8 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.703 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.72 3.73 3.05 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.257 2.638 . . . . 0.56999999999999995 114.725 -169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -135.67 -1.53 2.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 111.534 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.82 121.54 26.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.463 1.905 . . . . 0.56999999999999995 108.851 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 p -53.59 -29.06 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 120.948 1.703 . . . . 0.56999999999999995 112.422 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 39.0 mmt -65.12 -15.37 62.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.308 -1.33 . . . . 0.56999999999999995 113.854 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.34 126.55 82.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 120.726 1.603 . . . . 0.56999999999999995 109.31 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.44 -165.33 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.543 2.162 . . . . 0.56999999999999995 110.148 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m 79.92 -31.05 0.13 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.232 -1.543 . . . . 0.56999999999999995 113.015 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.3 t80 45.21 80.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.668 1.587 . . . . 0.56999999999999995 111.471 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.65 -92.04 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.587 1.565 . . . . 0.56999999999999995 112.36 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -64.94 -49.18 71.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.172 1.389 . . . . 0.56999999999999995 113.928 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.85 109.03 2.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 107.196 -2.362 . . . . 0.56999999999999995 107.196 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.5 118.66 62.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.783 1.633 . . . . 0.66000000000000003 112.218 -166.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.51 -1.47 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.97 3.113 . . . . 0.56999999999999995 113.537 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.41 -30.03 53.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.55 1.068 . . . . 0.56999999999999995 110.68 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -116.87 75.12 0.95 Allowed 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.532 -0.73 . . . . 0.56999999999999995 109.305 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -126.31 145.88 50.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.284 0.634 . . . . 0.56999999999999995 110.929 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 52.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 111.157 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp 56.92 73.94 0.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.218 1.407 . . . . 0.56999999999999995 111.458 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -61.5 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 C-N-CA 124.932 1.293 . . . . 0.56999999999999995 113.645 -168.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -144.52 -50.85 0.28 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 116.621 -1.656 . . . . 0.56999999999999995 108.429 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -42.73 -48.29 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.95 1.7 . . . . 0.66000000000000003 112.994 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -49.52 62.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.953 0.901 . . . . 0.66000000000000003 109.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.39 -40.83 82.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 118.23 -0.89 . . . . 0.56999999999999995 108.95 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -40.25 97.04 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.989 1.315 . . . . 0.56999999999999995 109.281 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.66 -55.55 29.89 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.235 -1.146 . . . . 0.56999999999999995 110.235 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -62.3 -47.84 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.32 1.06 . . . . 0.56999999999999995 112.481 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.25 -11.86 60.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.749 1.22 . . . . 0.56999999999999995 111.92 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -80.46 -51.81 8.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.279 0.945 . . . . 0.56999999999999995 108.666 164.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.42 -51.44 68.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.977 . . . . 0.56999999999999995 112.301 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -106.29 27.81 8.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.153 0.981 . . . . 0.56999999999999995 109.634 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 -68.73 1.43 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.37 -0.692 . . . . 0.56999999999999995 111.37 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -137.84 -67.65 0.48 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.345 1.058 . . . . 0.56999999999999995 109.168 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -176.08 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.092 1.145 . . . . 1.2 114.092 -175.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -173.81 146.03 1.21 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.946 2.099 . . . . 0.56999999999999995 105.608 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -171.03 86.34 0.1 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.841 1.656 . . . . 0.56999999999999995 108.561 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -162.43 174.85 12.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.925 1.69 . . . . 0.56999999999999995 107.491 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.33 142.15 25.71 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.201 -1.407 . . . . 1.2 107.201 171.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.52 -178.28 0.12 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.026 1.331 . . . . 0.56999999999999995 112.249 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 126.522 1.929 . . . . 0.5 . -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.443 ' C24' HD12 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.015 0.436 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -68.75 -57.09 6.12 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.239 0.616 . . . . 0.56999999999999995 111.685 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 tp -174.89 108.64 0.11 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.363 2.265 . . . . 0.56999999999999995 106.029 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 49.91 80.76 0.28 Allowed Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.378 1.471 . . . . 0.56999999999999995 114.473 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.13 102.54 0.67 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.985 2.456 . . . . 0.56999999999999995 110.901 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.26 -49.84 31.82 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.415 0.524 . . . . 0.56999999999999995 112.415 -171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 t -174.41 66.07 0.28 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 127.55 2.34 . . . . 0.56999999999999995 108.379 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.75 141.83 50.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.629 2.219 . . . . 0.56999999999999995 110.649 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.6 102.93 0.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 108.958 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -51.2 148.15 4.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.476 0.711 . . . . 0.56999999999999995 110.866 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -59.24 -33.14 70.65 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 112.344 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 t -82.66 146.42 29.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.552 0.691 . . . . 0.56999999999999995 109.326 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -19.01 61.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.387 0.675 . . . . 0.56999999999999995 111.528 170.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 136.52 52.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.006 -1.109 . . . . 0.56999999999999995 108.006 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.62 157.74 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.399 1.88 . . . . 0.56999999999999995 108.417 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.7 p -113.18 138.4 50.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.071 -1.085 . . . . 0.56999999999999995 108.071 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -126.06 153.56 44.28 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.756 0.423 . . . . 0.56999999999999995 110.199 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -154.26 119.55 5.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.28 89.03 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 105.542 -2.021 . . . . 0.56999999999999995 105.542 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -47.88 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 112.428 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.49 145.37 41.99 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.522 -2.029 . . . . 0.56999999999999995 105.522 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.42 143.55 51.14 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 109.031 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -69.84 -172.64 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.696 1.599 . . . . 0.56999999999999995 110.542 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -136.73 -29.37 0.94 Allowed 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.479 0.918 . . . . 1.2 113.479 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -53.96 -36.55 62.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.406 1.082 . . . . 0.66000000000000003 110.702 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.29 154.57 73.91 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 110.252 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 151.44 46.71 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.68 2.253 . . . . 0.56999999999999995 112.925 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -60.58 -39.44 88.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.502 1.521 . . . . 0.65000000000000002 113.324 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.2 tt -64.13 -36.38 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 119.202 -0.428 . . . . 0.56999999999999995 110.597 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -67.55 -39.17 84.99 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 116.87 -1.538 . . . . 0.56999999999999995 109.972 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.9 -52.98 51.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 120.069 1.304 . . . . 0.56999999999999995 109.922 172.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -61.54 -39.54 91.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.343 0.52 . . . . 0.66000000000000003 111.001 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -61.71 -47.1 86.78 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.399 -0.813 . . . . 1.2 112.402 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -38.2 78.52 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 123.959 0.903 . . . . 0.56999999999999995 110.269 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.49 -44.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.117 -1.068 . . . . 0.56999999999999995 108.117 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.87 -48.86 74.81 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.823 1.192 . . . . 0.56999999999999995 110.903 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -40.59 75.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.943 1.247 . . . . 0.56999999999999995 112.134 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.4 98.6 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.56999999999999995 111.294 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 49.8 mt -72.4 -31.61 65.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.146 -0.93 . . . . 0.56999999999999995 111.114 176.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.87 -40.86 94.54 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.37 0.986 . . . . 0.56999999999999995 109.602 169.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -64.09 -33.74 76.45 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.548 -0.72 . . . . 0.56999999999999995 112.577 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.4 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 5.8 m95 -71.72 -47.3 54.8 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.275 0.943 . . . . 0.56999999999999995 111.261 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.56 2.17 32.42 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.165 1.364 . . . . 0.56999999999999995 113.62 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -22.68 61.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.346 -1.091 . . . . 0.56999999999999995 111.242 172.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.7 -39.75 5.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.516 -0.754 . . . . 0.66000000000000003 110.397 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 19.2 pt -101.94 135.27 19.73 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 119.427 1.012 . . . . 0.56999999999999995 110.58 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.73 40.55 0.56 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.314 2.676 . . . . 0.56999999999999995 112.628 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -101.66 134.49 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.651 1.58 . . . . 0.56999999999999995 107.63 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -130.16 170.44 14.05 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.512 0.725 . . . . 0.65000000000000002 109.652 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -137.59 158.37 44.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.843 -0.799 . . . . 0.56999999999999995 108.843 -168.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -146.93 157.83 43.75 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.61 1.164 . . . . 1.2 110.36 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.3 105.81 14.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 108.452 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.08 157.34 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.767 -1.106 . . . . 0.56999999999999995 109.729 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 m -92.87 31.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 110.913 -174.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.02 155.59 45.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 109.747 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.96 34.71 2.13 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.999 1.285 . . . . 0.56999999999999995 114.091 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.1 m -150.65 132.63 15.18 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 106.101 -1.815 . . . . 0.56999999999999995 106.101 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.61 174.09 13.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.047 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 -31.46 66.16 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.863 -0.589 . . . . 0.66000000000000003 110.391 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 mm -123.25 67.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.328 2.251 . . . . 0.56999999999999995 107.847 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.87 116.9 10.79 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.615 -1.254 . . . . 0.56999999999999995 107.615 169.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.59 129.97 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.482 -2.414 . . . . 0.56999999999999995 104.482 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.88 150.45 22.23 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.222 -0.924 . . . . 0.56999999999999995 111.543 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.18 143.9 51.15 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.27 -0.641 . . . . 0.56999999999999995 109.27 -171.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.03 166.78 24.03 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 124.74 1.216 . . . . 0.56999999999999995 109.658 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -94.19 -29.55 15.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.526 0.565 . . . . 1.2 112.526 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.5 -38.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.787 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 112.06 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.1 49.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 108.797 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -156.98 155.18 30.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.347 1.059 . . . . 0.65000000000000002 109.182 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.28 57.63 2.82 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.99 1.757 . . . . 0.56999999999999995 112.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.24 -82.43 0.62 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.56 1.544 . . . . 0.66000000000000003 109.079 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.76 -29.35 0.01 OUTLIER 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.506 1.122 . . . . 0.56999999999999995 110.527 -171.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.46 120.92 11.67 Favored Pre-proline 0 C--N 1.343 0.305 0 N-CA-C 107.929 -1.137 . . . . 0.56999999999999995 107.929 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.6 144.22 77.92 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.894 -1.233 . . . . 0.56999999999999995 108.894 169.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.68 -171.11 0.09 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.393 1.477 . . . . 0.56999999999999995 111.077 166.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.499 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 20.4 p-10 -118.77 -33.21 4.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.693 2.797 . . . . 0.66000000000000003 110.32 -169.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.22 -150.91 19.66 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.556 1.071 . . . . 0.56999999999999995 111.146 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.96 102.45 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 125.008 3.805 . . . . 0.56999999999999995 111.968 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.6 165.38 12.99 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.244 1.878 . . . . 0.56999999999999995 109.329 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 4.9 t30 58.45 -156.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.734 1.214 . . . . 0.56999999999999995 111.752 -175.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 m -39.66 116.56 0.64 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.927 2.491 . . . . 0.56999999999999995 113.337 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.07 -33.16 29.97 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.143 -1.598 . . . . 0.56999999999999995 112.676 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.99 166.62 29.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.438 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -144.47 163.31 34.21 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.992 0.517 . . . . 0.65000000000000002 110.058 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.69 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.642 0.777 . . . . 0.56999999999999995 109.804 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.93 152.12 32.88 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.732 -0.667 . . . . 0.56999999999999995 109.33 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.36 151.61 90.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.657 -0.687 . . . . 0.56999999999999995 109.761 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.06 162.63 40.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.183 1.922 . . . . 0.56999999999999995 111.452 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.42 -109.52 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.824 -2.111 . . . . 0.56999999999999995 107.824 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -152.27 118.75 5.64 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.635 -1.617 . . . . 0.56999999999999995 106.635 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 -131.74 10.76 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.4 -1.08 . . . . 0.56999999999999995 110.4 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 tp -51.22 -28.25 11.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.126 1.37 . . . . 0.56999999999999995 112.711 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.79 145.17 8.76 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.614 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.83 -24.27 3.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.032 1.301 . . . . 0.56999999999999995 113.719 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.87 155.94 39.81 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.473 1.137 . . . . 0.66000000000000003 108.45 -172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.09 140.74 34.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.934 -0.765 . . . . 0.56999999999999995 108.934 -173.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -128.28 153.13 47.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.604 -0.725 . . . . 0.65000000000000002 109.568 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.05 153.76 44.45 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.651 -1.24 . . . . 0.56999999999999995 107.651 -173.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -92.37 100.64 13.17 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.608 -0.724 . . . . 0.66000000000000003 109.31 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -21.89 66.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.138 0.975 . . . . 0.66000000000000003 112.151 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.16 -23.49 63.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.38 0.991 . . . . 0.66000000000000003 110.153 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -80.93 130.13 34.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.654 -1.239 . . . . 0.66000000000000003 107.654 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 147.6 4.35 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.335 1.054 . . . . 1.2 111.006 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -140.95 147.2 38.42 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.298 -1.001 . . . . 0.56999999999999995 108.298 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -148.82 139.5 22.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.15 13.68 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.831 1.196 . . . . 0.66000000000000003 111.553 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.03 -87.48 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 108.091 -2.004 . . . . 0.56999999999999995 108.091 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.08 -67.12 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.301 2.24 . . . . 0.56999999999999995 113.608 -176.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -175.43 -48.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.855 1.662 . . . . 0.56999999999999995 110.778 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -142.18 158.2 44.01 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.554 1.541 . . . . 0.56999999999999995 108.993 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.53 178.66 15.86 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 109.787 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.1 mm -80.45 102.89 6.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.241 -1.022 . . . . 0.56999999999999995 108.241 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -50.97 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.925 1.69 . . . . 0.56999999999999995 110.655 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -65.61 -29.18 69.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.985 1.714 . . . . 0.56999999999999995 110.389 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -48.27 68.8 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.684 -1.598 . . . . 0.56999999999999995 106.684 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.17 -47.49 84.27 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.483 0.713 . . . . 0.56999999999999995 110.721 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.38 -49.45 76.15 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 122.745 0.418 . . . . 0.56999999999999995 110.933 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.99 63.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 109.085 -0.709 . . . . 0.56999999999999995 109.085 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -55.7 -39.28 70.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.022 0.828 . . . . 0.56999999999999995 111.344 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -60.76 -59.88 4.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.324 0.65 . . . . 0.65000000000000002 110.209 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.49 -42.37 95.9 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.177 0.898 . . . . 0.66000000000000003 111.692 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.92 -26.96 67.11 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.136 1.375 . . . . 0.56999999999999995 111.293 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.4 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.31 -41.88 93.27 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.29 -0.724 . . . . 0.56999999999999995 111.29 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -73.01 -37.78 66.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.459 -1.258 . . . . 0.65000000000000002 112.259 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 p -59.06 -31.58 69.0 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 124.101 0.875 . . . . 0.56999999999999995 111.851 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.89 82.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.328 0.651 . . . . 0.56999999999999995 111.752 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 160.51 43.08 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.06 -0.856 . . . . 0.56999999999999995 114.488 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 176.63 0.1 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 117.883 0.842 . . . . 0.56999999999999995 111.925 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.09 46.12 0.01 OUTLIER Glycine 0 C--N 1.342 0.912 0 O-C-N 120.943 -1.098 . . . . 0.56999999999999995 112.903 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.8 169.7 13.93 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.361 1.081 . . . . 0.65000000000000002 110.4 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.6 t -161.65 -164.19 1.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.013 0.925 . . . . 0.56999999999999995 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.07 57.26 0.59 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.897 1.279 . . . . 0.56999999999999995 110.517 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -120.73 146.4 43.43 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.66000000000000003 109.463 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -21.63 63.59 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.839 2.359 . . . . 0.56999999999999995 113.056 -171.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -125.14 27.45 6.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.444 1.897 . . . . 0.56999999999999995 109.602 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.89 124.61 24.18 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.145 -0.972 . . . . 0.56999999999999995 108.916 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.05 -22.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 121.528 0.68 . . . . 0.56999999999999995 110.461 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 19.08 18.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.098 1.759 . . . . 0.56999999999999995 112.233 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.499 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.44 141.42 94.48 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.17 1.35 . . . . 0.56999999999999995 111.288 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 70.8 Cg_endo -75.63 46.02 1.58 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 124.212 3.275 . . . . 0.56999999999999995 113.007 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.29 153.14 7.71 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.77 2.428 . . . . 0.56999999999999995 106.476 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -47.96 137.59 9.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.023 1.329 . . . . 0.56999999999999995 111.265 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -47.14 99.75 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.705 1.621 . . . . 0.56999999999999995 113.542 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.23 -37.41 77.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.063 1.345 . . . . 0.56999999999999995 112.221 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.98 -85.87 0.95 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.27 0.938 . . . . 0.56999999999999995 110.936 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.69 109.36 2.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.711 -0.848 . . . . 0.66000000000000003 108.711 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.96 -16.4 18.18 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.807 2.338 . . . . 0.56999999999999995 113.534 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -38.86 62.74 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.962 1.305 . . . . 0.56999999999999995 109.125 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -77.57 74.08 4.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.79 0.836 . . . . 0.56999999999999995 110.905 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -43.7 -70.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.791 1.637 . . . . 0.56999999999999995 114.554 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.64 74.53 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.512 3.125 . . . . 0.56999999999999995 112.071 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -30.93 111.78 0.08 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.529 2.331 . . . . 0.56999999999999995 110.777 -176.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 t -83.87 -99.71 0.05 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.181 0.301 . . . . 0.56999999999999995 111.074 -166.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -127.75 -49.93 1.37 Allowed 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 117.216 -1.373 . . . . 0.56999999999999995 109.443 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -44.07 -45.11 7.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.014 1.326 . . . . 0.66000000000000003 112.116 169.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -66.43 -54.8 20.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 123.728 0.642 . . . . 0.66000000000000003 109.995 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -37.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.418 0.687 . . . . 0.56999999999999995 110.727 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -65.95 -45.41 81.89 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.664 1.586 . . . . 0.56999999999999995 108.504 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.93 -51.02 61.21 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.204 -1.158 . . . . 0.56999999999999995 110.204 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -56.46 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.488 1.115 . . . . 0.56999999999999995 111.136 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.74 -24.46 67.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.112 0.869 . . . . 0.56999999999999995 111.517 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -79.7 -37.02 36.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.25 -0.881 . . . . 0.56999999999999995 110.889 175.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -54.7 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.661 1.585 . . . . 0.56999999999999995 110.942 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.407 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 19.3 p90 -98.29 5.85 47.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.854 0.862 . . . . 0.56999999999999995 113.159 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -113.19 -145.37 9.32 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.532 1.063 . . . . 0.56999999999999995 111.083 -172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -137.99 -62.32 0.59 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.41 0.684 . . . . 0.56999999999999995 112.306 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.402 ' HA ' ' HE2' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -161.47 153.68 19.82 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.841 1.657 . . . . 1.2 107.902 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.78 129.7 0.15 Allowed 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.827 -1.916 . . . . 0.56999999999999995 105.827 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.65 165.4 0.08 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.286 1.835 . . . . 0.56999999999999995 113.511 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.8 t -169.67 107.61 0.39 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.211 1.404 . . . . 0.56999999999999995 107.519 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 155.66 30.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.101 0.96 . . . . 1.2 108.884 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.78 56.76 0.09 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.271 1.028 . . . . 0.56999999999999995 112.141 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tttt . . . . . 0 C--N 1.338 0.072 0 C-N-CA 123.948 0.899 . . . . 0.5 . -177.649 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.374 0 CA-C-O 118.647 -0.692 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -30.82 52.06 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.726 1.21 . . . . 0.56999999999999995 113.818 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 tt -144.55 -78.19 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.036 -1.468 . . . . 0.56999999999999995 107.036 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.15 -53.36 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.52 1.928 . . . . 0.56999999999999995 111.318 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -77.51 49.72 2.98 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.227 3.285 . . . . 0.56999999999999995 111.963 -175.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -148.11 149.43 32.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.643 1.577 . . . . 0.56999999999999995 106.816 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -117.85 80.13 14.07 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 107.99 -1.115 . . . . 0.56999999999999995 107.99 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.65 152.12 79.78 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.365 2.043 . . . . 0.56999999999999995 111.021 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt 72.03 100.8 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.242 1.417 . . . . 0.56999999999999995 109.715 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -53.08 157.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.045 0.938 . . . . 0.56999999999999995 111.755 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.3 p -67.58 -19.54 65.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.875 1.27 . . . . 0.56999999999999995 112.083 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -109.67 144.53 37.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.68 1.992 . . . . 0.56999999999999995 108.75 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -12.39 61.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.304 1.442 . . . . 0.56999999999999995 113.167 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.75 134.1 67.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.799 -1.926 . . . . 0.56999999999999995 105.799 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.48 155.15 19.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.23 1.412 . . . . 0.56999999999999995 108.621 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 p -106.54 141.22 38.18 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.912 -0.493 . . . . 0.56999999999999995 109.774 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -132.75 158.24 42.91 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.596 -0.69 . . . . 0.56999999999999995 111.0 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.42 163.15 40.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.687 0.795 . . . . 1.2 109.149 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.9 mt -127.93 105.08 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.199 -2.149 . . . . 0.56999999999999995 105.199 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.85 -57.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.106 . . . . 0.56999999999999995 112.385 -169.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -177.14 4.76 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.195 -1.409 . . . . 0.56999999999999995 107.195 164.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -144.58 152.03 39.93 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.314 -0.995 . . . . 0.56999999999999995 108.314 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -62.37 165.35 6.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.314 0.578 . . . . 0.56999999999999995 110.938 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -100.25 -47.09 5.07 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.841 -0.618 . . . . 1.2 112.053 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.78 -32.61 73.81 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.031 0.532 . . . . 0.66000000000000003 110.387 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.96 153.71 52.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.96 1.704 . . . . 0.56999999999999995 109.652 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.57 161.29 37.3 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.145 1.897 . . . . 0.56999999999999995 113.182 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.33 -40.6 94.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.659 1.184 . . . . 0.65000000000000002 112.89 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.98 -35.95 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 119.181 -0.438 . . . . 0.56999999999999995 111.155 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m -67.36 -45.65 75.69 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 117.688 -1.149 . . . . 0.56999999999999995 109.264 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.25 -49.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 117.646 -1.169 . . . . 0.56999999999999995 110.699 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.16 -35.93 82.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.1 1.318 . . . . 0.66000000000000003 111.364 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -43.4 89.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.289 1.404 . . . . 1.2 112.524 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.95 -48.34 76.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.592 -0.892 . . . . 0.56999999999999995 108.592 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.0 -41.63 89.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.719 -1.134 . . . . 0.56999999999999995 111.021 173.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -58.48 -53.11 62.02 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.548 1.522 . . . . 0.56999999999999995 110.056 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -36.06 78.52 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.679 1.127 . . . . 0.56999999999999995 111.054 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.64 76.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.76 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.38 -36.17 83.18 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 118.213 -0.898 . . . . 0.56999999999999995 110.163 172.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -49.05 76.82 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 118.899 0.772 . . . . 0.56999999999999995 109.153 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.401 ' HB3' HD13 ' A' ' 152' ' ' LEU . 50.4 mtp -61.73 -35.91 79.44 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.544 0.738 . . . . 0.56999999999999995 111.498 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -68.61 -50.59 50.34 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.56999999999999995 112.369 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.25 -8.09 69.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.885 1.231 . . . . 0.56999999999999995 112.99 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -75.17 -8.31 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.214 -1.168 . . . . 0.56999999999999995 111.765 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -109.54 -15.32 14.22 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.842 0.746 . . . . 0.66000000000000003 112.259 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt -142.58 148.75 48.03 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.52 1.128 . . . . 0.56999999999999995 111.019 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.89 18.69 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.714 2.943 . . . . 0.56999999999999995 113.286 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.91 138.22 35.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.16 1.784 . . . . 0.56999999999999995 107.314 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.95 170.31 11.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.766 0.826 . . . . 0.65000000000000002 109.217 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.35 150.85 45.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.271 -1.381 . . . . 0.56999999999999995 107.271 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.85 149.42 46.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.866 -0.79 . . . . 1.2 108.866 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -107.24 129.26 54.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.031 -1.47 . . . . 0.56999999999999995 107.031 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.43 171.84 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.533 1.133 . . . . 0.56999999999999995 109.823 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.45 -38.77 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.769 0.828 . . . . 0.56999999999999995 110.651 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -167.25 74.63 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.888 1.675 . . . . 0.56999999999999995 107.694 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.35 163.06 36.84 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.511 -1.836 . . . . 0.56999999999999995 108.511 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -68.63 144.98 54.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 117.987 0.893 . . . . 0.56999999999999995 109.275 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.24 153.17 37.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 108.96 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.64 -32.97 72.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.772 0.429 . . . . 0.66000000000000003 110.069 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -121.01 80.97 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 127.513 2.325 . . . . 0.56999999999999995 107.871 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 ttm -78.02 111.85 14.33 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.805 1.242 . . . . 0.56999999999999995 107.956 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 127.66 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.052 -1.832 . . . . 0.56999999999999995 106.052 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.62 162.85 25.52 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.226 -0.75 . . . . 0.56999999999999995 111.226 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -126.95 141.42 51.81 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.29 -1.744 . . . . 0.56999999999999995 106.29 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.18 169.17 18.71 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.098 2.159 . . . . 0.56999999999999995 106.8 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -111.02 -0.95 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.715 0.689 . . . . 1.2 112.652 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.32 -144.58 8.29 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.53 -1.828 . . . . 0.56999999999999995 108.53 -165.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.49 142.64 13.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.746 0.784 . . . . 0.56999999999999995 111.398 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -152.05 152.49 32.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.094 1.758 . . . . 0.65000000000000002 106.562 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.35 80.48 1.82 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 110.155 -1.178 . . . . 0.56999999999999995 110.155 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.6 -56.52 1.49 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.794 0.837 . . . . 0.66000000000000003 111.343 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.95 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.959 2.503 . . . . 0.56999999999999995 109.854 -167.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -147.57 123.1 5.28 Favored Pre-proline 0 C--N 1.349 0.545 0 CA-C-N 120.122 1.328 . . . . 0.56999999999999995 110.437 -173.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.75 139.32 52.04 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.188 1.259 . . . . 0.56999999999999995 110.367 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.83 -175.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.365 1.555 . . . . 0.56999999999999995 111.161 167.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 19.0 p-10 -115.12 -36.02 4.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 131.116 3.767 . . . . 0.66000000000000003 109.75 -171.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.11 -147.9 18.81 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 119.659 1.118 . . . . 0.56999999999999995 110.841 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.65 70.3 6.45 Favored 'Trans proline' 0 CA--C 1.548 1.198 1 C-N-CA 125.645 4.23 . . . . 0.56999999999999995 114.114 -171.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.41 167.07 20.43 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.409 2.909 . . . . 0.56999999999999995 109.625 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 76' ' ' ASP 0.279 19.6 t30 64.81 -143.97 0.24 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.304 1.842 . . . . 0.56999999999999995 113.503 -178.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 m -47.03 153.23 0.45 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 127.767 2.427 . . . . 0.56999999999999995 111.22 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.88 -27.47 6.18 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 112.759 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.61 158.48 26.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.01 1.324 . . . . 0.56999999999999995 107.644 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.486 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.6 p-80 -139.38 159.17 42.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.478 . . . . 0.65000000000000002 109.711 172.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.87 36.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.741 1.216 . . . . 0.56999999999999995 109.078 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.57 146.83 41.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.348 0.659 . . . . 0.56999999999999995 109.495 -177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.84 157.89 64.84 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.795 0.838 . . . . 0.56999999999999995 111.031 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.41 155.45 69.12 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.188 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.07 -111.67 0.59 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.388 0.994 . . . . 0.56999999999999995 110.891 174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.7 m -45.76 156.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.854 2.062 . . . . 0.56999999999999995 111.542 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.93 -41.97 7.68 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.174 -1.348 . . . . 0.56999999999999995 115.412 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -33.55 74.39 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.075 1.438 . . . . 0.56999999999999995 112.247 174.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.26 145.5 12.21 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.873 -1.142 . . . . 0.56999999999999995 111.498 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.86 -18.93 5.53 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 117.847 -1.529 . . . . 0.56999999999999995 114.426 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.78 156.24 36.76 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.348 1.574 . . . . 0.66000000000000003 108.045 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.06 146.05 27.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.818 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -129.81 152.28 49.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.575 -0.898 . . . . 0.65000000000000002 108.575 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -137.91 145.37 42.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 107.38 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -87.07 98.63 11.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.425 0.631 . . . . 0.66000000000000003 109.608 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -60.84 -25.61 66.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.07 1.348 . . . . 0.66000000000000003 111.85 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.39 -38.85 81.71 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.92 0.391 . . . . 0.66000000000000003 110.406 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.16 126.7 29.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.771 -1.566 . . . . 0.66000000000000003 106.771 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -59.01 147.16 35.61 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.702 -0.624 . . . . 1.2 109.473 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -124.03 158.21 32.68 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.359 -0.978 . . . . 0.56999999999999995 108.359 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.2 t -133.54 142.34 48.14 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.635 0.652 . . . . 0.56999999999999995 109.681 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.05 -46.89 72.99 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.046 1.339 . . . . 0.66000000000000003 109.275 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.96 50.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.858 -0.897 . . . . 0.56999999999999995 110.858 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -152.84 150.34 29.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.965 0.906 . . . . 0.56999999999999995 109.854 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.17 108.37 0.78 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.615 0.766 . . . . 0.56999999999999995 109.814 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -61.69 0.05 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.726 0.81 . . . . 0.56999999999999995 110.213 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.98 -111.75 1.19 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.714 -1.354 . . . . 0.56999999999999995 109.714 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.95 134.39 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 110.271 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.85 115.77 5.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.777 -1.102 . . . . 0.56999999999999995 109.697 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.67 -37.32 83.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.047 -0.501 . . . . 0.56999999999999995 110.895 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 -45.35 89.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.129 0.877 . . . . 0.56999999999999995 109.673 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -64.03 -42.56 97.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.384 0.674 . . . . 0.56999999999999995 110.791 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.86 67.99 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.215 0.606 . . . . 0.56999999999999995 110.516 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.43 64.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.063 -0.97 . . . . 0.56999999999999995 110.053 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.1 m -53.78 -41.74 67.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.512 1.051 . . . . 0.56999999999999995 111.46 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -61.48 -56.36 21.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.819 0.448 . . . . 0.65000000000000002 110.023 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 6.0 mm-40 -65.43 -48.08 74.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.734 0.814 . . . . 0.66000000000000003 110.963 -172.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.74 -30.77 70.99 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 125.312 1.445 . . . . 0.56999999999999995 110.968 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.68 -46.81 73.66 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.913 -0.875 . . . . 0.56999999999999995 110.913 170.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -66.27 -39.33 89.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.752 -0.642 . . . . 0.65000000000000002 111.646 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 m -57.78 -37.37 73.59 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.524 0.565 . . . . 0.56999999999999995 112.524 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.37 -27.22 68.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.737 1.153 . . . . 0.56999999999999995 112.638 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.98 -13.97 2.37 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 118.529 -1.15 . . . . 0.56999999999999995 114.285 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpp -61.79 152.25 31.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.168 1.484 . . . . 0.56999999999999995 110.295 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.56 -23.6 3.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 115.58 -2.789 . . . . 0.56999999999999995 114.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 m80 148.99 173.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 131.185 3.794 . . . . 0.65000000000000002 110.151 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -145.33 -172.77 3.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.484 2.313 . . . . 0.56999999999999995 109.607 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -147.12 67.33 1.15 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.43 1.492 . . . . 0.56999999999999995 110.761 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -133.5 149.98 73.74 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 117.306 -1.33 . . . . 0.66000000000000003 107.604 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.86 -35.96 42.01 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.927 1.752 . . . . 0.56999999999999995 111.091 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -119.01 35.23 4.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.754 1.222 . . . . 0.56999999999999995 108.394 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.62 131.98 49.71 Favored 'General case' 0 C--N 1.344 0.363 0 N-CA-C 108.156 -1.053 . . . . 0.56999999999999995 108.156 171.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 155' ' ' ASP . 8.5 p -58.7 -30.33 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.592 0.234 . . . . 0.56999999999999995 110.986 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -105.58 35.19 2.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 110.075 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -74.46 130.3 82.26 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 120.433 -1.417 . . . . 0.56999999999999995 110.875 173.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.34 168.64 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.962 1.775 . . . . 0.56999999999999995 111.056 166.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m 58.03 72.93 0.49 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.113 0.965 . . . . 0.56999999999999995 110.792 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -45.61 126.08 6.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 113.175 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.01 96.43 0.89 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.095 0.855 . . . . 0.56999999999999995 111.201 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -157.42 -49.88 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.022 0.911 . . . . 0.56999999999999995 111.03 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.88 -171.33 13.05 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 125.595 1.569 . . . . 0.56999999999999995 109.575 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.02 116.54 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 119.092 -0.48 . . . . 0.66000000000000003 110.053 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.08 -18.03 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.853 2.369 . . . . 0.56999999999999995 112.671 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.24 -36.63 83.52 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.002 0.819 . . . . 0.56999999999999995 109.936 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.15 68.87 1.23 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.342 0.657 . . . . 0.56999999999999995 109.507 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -60.04 -52.69 64.29 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.488 0.715 . . . . 0.56999999999999995 110.323 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.94 158.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.991 2.517 . . . . 0.56999999999999995 112.567 -159.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 41' ' ' MET . 5.4 mp -58.95 121.49 11.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.593 -1.262 . . . . 0.56999999999999995 107.593 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -96.83 -94.25 0.21 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.545 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -138.24 -46.44 0.51 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.08 -0.962 . . . . 0.56999999999999995 110.273 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.487 ' HD2' ' N ' ' A' ' 137' ' ' VAL . 10.5 p-10 -56.38 -34.09 66.35 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.75 0.705 . . . . 0.66000000000000003 111.02 171.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -60.18 3.77 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.571 1.148 . . . . 0.66000000000000003 110.305 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.84 -50.47 80.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.56999999999999995 107.756 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -59.3 -41.69 89.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.476 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.69 50.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.456 -1.457 . . . . 0.56999999999999995 109.456 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -53.91 -52.99 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.259 1.023 . . . . 0.56999999999999995 110.482 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -58.5 -28.63 65.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.086 -0.709 . . . . 0.56999999999999995 109.086 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -80.64 -38.9 28.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 117.921 -1.038 . . . . 0.56999999999999995 112.428 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.62 -52.06 61.08 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 112.174 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -90.84 3.83 53.42 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.487 0.585 . . . . 0.56999999999999995 112.38 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.0 155.85 0.7 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.931 1.253 . . . . 0.56999999999999995 111.639 -169.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -129.86 -69.55 0.67 Allowed 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.41 -1.053 . . . . 0.56999999999999995 109.737 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -155.57 -54.22 0.09 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.713 1.205 . . . . 1.2 109.315 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.01 158.99 38.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 109.414 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.09 172.32 4.71 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.533 -1.212 . . . . 0.56999999999999995 110.01 173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -55.93 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.675 -1.602 . . . . 0.56999999999999995 106.675 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.4 -179.01 0.08 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 1.2 110.414 -170.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.9 tptp 68.11 149.15 0.06 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.99 2.116 . . . . 0.56999999999999995 112.566 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.557 1.543 . . . . 0.5 . 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.981 0.419 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -60.12 72.63 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.951 2.5 . . . . 0.56999999999999995 111.082 168.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -118.25 -71.0 0.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.984 1.714 . . . . 0.56999999999999995 111.873 177.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 46.76 164.42 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.286 2.634 . . . . 0.56999999999999995 115.62 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -75.61 137.45 20.41 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 O-C-N 117.656 -1.813 . . . . 0.56999999999999995 109.488 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -176.24 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.532 1.933 . . . . 0.56999999999999995 111.175 174.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.2 m 57.67 82.0 0.24 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.921 1.288 . . . . 0.56999999999999995 110.864 -172.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.86 174.98 6.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.183 2.589 . . . . 0.56999999999999995 110.751 174.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.89 10.88 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.216 2.206 . . . . 0.56999999999999995 112.432 -173.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 56.5 m95 56.37 -166.01 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.656 1.183 . . . . 0.56999999999999995 110.584 -169.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -101.53 -10.85 19.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.782 0.833 . . . . 0.56999999999999995 110.97 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -118.8 149.58 41.26 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 108.705 176.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -71.96 -11.83 60.96 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.448 0.699 . . . . 0.56999999999999995 112.575 172.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.26 117.25 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.035 -1.839 . . . . 0.56999999999999995 106.035 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.85 141.23 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.365 -0.976 . . . . 0.56999999999999995 108.365 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -102.49 147.63 26.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.648 0.658 . . . . 0.56999999999999995 111.238 -177.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -128.96 157.1 42.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 111.884 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.88 112.13 4.95 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.597 0.713 . . . . 1.2 110.159 174.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 mt -77.68 82.69 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.233 -1.395 . . . . 0.56999999999999995 107.233 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.05 -28.62 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 113.458 -175.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -139.58 154.42 47.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 128.925 2.89 . . . . 0.56999999999999995 103.604 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -132.16 174.67 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.703 1.601 . . . . 0.56999999999999995 108.203 -173.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -90.82 -176.39 4.66 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.921 0.888 . . . . 0.56999999999999995 111.399 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -129.62 -26.62 2.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.364 1.866 . . . . 1.2 113.651 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -24.0 67.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.725 0.81 . . . . 0.66000000000000003 110.86 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.83 154.99 71.35 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 127.464 2.306 . . . . 0.56999999999999995 108.582 177.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -75.58 158.51 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.189 2.592 . . . . 0.56999999999999995 113.047 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -62.23 -34.6 76.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.953 1.301 . . . . 0.65000000000000002 112.66 -176.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.46 -37.64 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.004 0.522 . . . . 0.56999999999999995 110.251 175.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.4 m -67.59 -39.56 84.83 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 117.955 -1.021 . . . . 0.56999999999999995 109.54 173.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.69 -56.1 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.769 1.168 . . . . 0.56999999999999995 110.126 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.64 -34.95 78.1 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.631 1.105 . . . . 0.66000000000000003 111.031 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.25 -48.89 63.87 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.087 0.858 . . . . 1.2 112.066 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -63.97 -43.67 95.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.815 -0.809 . . . . 0.56999999999999995 108.815 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.3 -44.28 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 117.599 -1.191 . . . . 0.56999999999999995 110.807 171.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -50.25 73.45 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 120.274 1.397 . . . . 0.56999999999999995 110.894 178.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -34.86 73.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.167 0.894 . . . . 0.56999999999999995 112.268 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.98 81.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.745 1.157 . . . . 0.56999999999999995 111.153 177.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.83 -37.84 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.471 -0.776 . . . . 0.56999999999999995 110.218 173.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.73 -37.41 84.11 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 110.654 172.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 mtp -64.36 -36.93 85.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.077 0.853 . . . . 0.56999999999999995 112.189 173.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -69.76 -49.36 53.83 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.251 0.932 . . . . 0.56999999999999995 110.89 172.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.73 -5.1 63.41 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.983 1.278 . . . . 0.56999999999999995 113.786 178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -67.99 -26.1 65.75 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.095 -1.238 . . . . 0.56999999999999995 110.888 172.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -100.35 -36.72 9.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.541 0.737 . . . . 0.66000000000000003 110.855 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 12.9 pt -114.05 136.81 22.21 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 118.569 0.622 . . . . 0.56999999999999995 110.819 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 34.21 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.676 2.917 . . . . 0.56999999999999995 111.912 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.42 131.95 34.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.311 -1.737 . . . . 0.56999999999999995 106.311 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -116.0 171.08 8.01 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.803 1.241 . . . . 0.65000000000000002 108.509 -173.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.85 156.1 45.54 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -170.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -142.61 175.92 9.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.91 . . . . 1.2 109.273 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.6 16.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.56999999999999995 108.23 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.76 158.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 109.219 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.44 -41.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.256 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -118.57 -66.34 1.08 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.939 0.876 . . . . 0.56999999999999995 108.891 -172.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.38 -156.57 10.89 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.616 -1.793 . . . . 0.56999999999999995 108.616 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 80.4 p 60.28 72.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.69 1.596 . . . . 0.56999999999999995 111.826 173.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.67 172.37 7.16 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.351 1.06 . . . . 0.56999999999999995 112.012 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -71.55 -39.44 70.65 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.274 -1.01 . . . . 0.66000000000000003 108.274 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.14 84.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.58 1.952 . . . . 0.56999999999999995 108.641 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.23 124.58 27.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.458 -1.401 . . . . 0.56999999999999995 108.417 170.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.55 127.85 66.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 174.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.09 164.91 27.48 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.833 -0.507 . . . . 0.56999999999999995 111.833 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.7 m-85 -136.03 150.65 49.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.609 -0.886 . . . . 0.56999999999999995 108.609 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.29 157.67 44.15 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.754 1.221 . . . . 0.56999999999999995 110.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -5.28 24.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.498 1.119 . . . . 1.2 113.443 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.47 106.85 0.49 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 108.341 -1.904 . . . . 0.56999999999999995 108.341 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.12 126.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.062 2.945 . . . . 0.56999999999999995 112.741 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.1 163.49 30.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.732 1.213 . . . . 0.65000000000000002 110.909 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 76.68 0.9 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.269 -1.132 . . . . 0.56999999999999995 110.269 173.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -135.15 177.58 7.7 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.66000000000000003 110.157 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -44.47 12.61 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 112.043 168.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -139.24 145.91 46.65 Favored Pre-proline 0 C--N 1.345 0.374 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 109.401 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.47 146.95 76.17 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.235 1.29 . . . . 0.56999999999999995 110.29 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -67.78 -178.95 1.04 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.908 1.337 . . . . 0.56999999999999995 111.428 162.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 22.4 p-10 -117.4 -35.07 4.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 131.181 3.793 . . . . 0.66000000000000003 109.332 -172.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 -140.9 15.6 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.561 -1.133 . . . . 0.56999999999999995 110.689 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.96 87.06 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.894 3.73 . . . . 0.56999999999999995 112.575 -171.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.29 172.56 12.92 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.446 1.974 . . . . 0.56999999999999995 109.539 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 15.6 t30 48.7 -153.5 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 119.432 1.616 . . . . 0.56999999999999995 111.848 -174.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.3 m -48.64 126.52 11.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.716 2.406 . . . . 0.56999999999999995 112.908 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.02 -27.4 17.02 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.234 1.414 . . . . 0.56999999999999995 113.45 -173.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.93 161.83 40.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 108.344 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.96 163.34 37.16 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.029 -0.36 . . . . 0.65000000000000002 110.029 174.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.73 163.19 37.46 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.244 1.018 . . . . 0.56999999999999995 110.438 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.23 161.84 18.38 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.144 0.978 . . . . 0.56999999999999995 110.653 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.83 142.83 45.6 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-O 118.224 -0.893 . . . . 0.56999999999999995 109.383 -176.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.31 156.83 63.16 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.528 1.485 . . . . 0.56999999999999995 110.893 175.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.9 9.18 8.38 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.968 0.794 . . . . 0.56999999999999995 113.81 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.1 t -160.78 168.49 24.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.823 1.649 . . . . 0.56999999999999995 107.993 176.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.89 -57.78 16.56 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 125.591 1.567 . . . . 0.56999999999999995 113.079 -177.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 95' ' ' ASP . 5.9 tp -66.09 -17.61 64.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.395 1.078 . . . . 0.56999999999999995 110.997 173.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.0 147.79 33.5 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.793 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.32 -21.31 0.54 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.571 1.558 . . . . 0.56999999999999995 115.119 -176.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 63.4 m-20 -69.07 153.6 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.776 1.288 . . . . 0.66000000000000003 108.156 -175.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.09 144.87 29.38 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.56999999999999995 109.083 -171.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -131.84 159.23 39.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.371 -0.831 . . . . 0.65000000000000002 109.304 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 52.2 m-85 -137.65 147.19 44.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.821 1.648 . . . . 0.56999999999999995 109.002 -171.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.29 105.46 12.49 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 171.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.19 -27.66 64.07 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.468 1.107 . . . . 0.66000000000000003 111.069 171.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.62 -33.94 75.98 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.827 0.851 . . . . 0.66000000000000003 111.282 -178.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.84 120.55 20.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.767 -1.568 . . . . 0.66000000000000003 106.767 178.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 131.42 48.41 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.362 0.528 . . . . 1.2 110.699 -174.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.78 150.54 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.082 -1.081 . . . . 0.56999999999999995 108.082 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -145.06 145.72 31.57 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.92 -0.77 . . . . 0.56999999999999995 108.92 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.21 -39.73 93.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.164 0.986 . . . . 0.66000000000000003 112.052 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.05 173.42 27.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.934 1.254 . . . . 0.56999999999999995 110.034 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.13 30.29 5.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.681 1.192 . . . . 0.56999999999999995 114.174 176.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.04 168.63 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 109.315 -174.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.09 167.27 10.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 111.706 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.81 -160.97 22.64 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.434 -1.466 . . . . 0.56999999999999995 109.434 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.71 122.84 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.889 -1.152 . . . . 0.56999999999999995 107.889 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -55.53 105.23 0.16 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 109.999 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.75 -36.41 76.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 110.989 178.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.2 tp -71.12 -40.74 71.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.312 0.505 . . . . 0.56999999999999995 109.931 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.09 -44.31 96.93 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.473 0.709 . . . . 0.56999999999999995 109.375 173.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.23 -54.71 42.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.56999999999999995 110.043 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.75 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 117.891 -1.052 . . . . 0.56999999999999995 109.184 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.8 m -53.64 -43.99 69.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.116 1.325 . . . . 0.56999999999999995 111.452 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -64.32 -55.17 23.08 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.844 1.202 . . . . 0.65000000000000002 110.62 176.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.2 -39.66 86.38 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.412 -0.805 . . . . 0.66000000000000003 111.474 -172.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.65 -30.71 71.73 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.462 0.705 . . . . 0.56999999999999995 110.628 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.71 -43.96 60.17 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 119.194 0.906 . . . . 0.56999999999999995 111.411 170.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -74.86 -33.53 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.734 -0.65 . . . . 0.65000000000000002 112.452 176.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -33.58 75.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.837 0.744 . . . . 0.56999999999999995 111.428 174.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.13 -29.55 69.88 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.325 0.65 . . . . 0.56999999999999995 112.053 175.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 153.09 56.07 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.292 -1.282 . . . . 0.56999999999999995 113.202 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 mmt 48.99 -156.14 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.936 0.868 . . . . 0.56999999999999995 111.475 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.82 81.11 1.22 Allowed Glycine 0 C--O 1.219 -0.842 0 N-CA-C 108.703 -1.759 . . . . 0.56999999999999995 108.703 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.31 172.09 8.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.833 0.817 . . . . 0.65000000000000002 109.847 172.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.99 -177.3 6.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.853 2.061 . . . . 0.56999999999999995 107.946 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 99.24 3.04 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.188 -2.153 . . . . 0.56999999999999995 105.188 173.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.9 141.37 17.31 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 107.861 -1.163 . . . . 0.66000000000000003 107.861 170.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.59 -4.5 14.72 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.935 2.423 . . . . 0.56999999999999995 113.73 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.31 13.7 7.7 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.121 1.768 . . . . 0.56999999999999995 111.23 -174.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.82 40.73 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 109.866 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.98 -28.95 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.969 0.804 . . . . 0.56999999999999995 110.313 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 35.1 tpp -74.46 -11.37 60.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.404 1.082 . . . . 0.56999999999999995 113.33 -174.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.35 136.29 41.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.461 -0.57 . . . . 0.56999999999999995 109.461 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 -169.28 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.973 1.782 . . . . 0.56999999999999995 109.432 168.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.0 p 50.22 79.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.209 1.404 . . . . 0.56999999999999995 114.224 172.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.456 ' CE1' ' H47' ' A' ' 178' ' ' MDW . 7.5 t80 -56.18 93.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 113.832 -174.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.4 109.96 0.43 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.841 1.686 . . . . 0.56999999999999995 109.59 -177.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -170.14 -50.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 108.582 169.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.52 -122.57 3.16 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.084 -1.606 . . . . 0.56999999999999995 109.084 -177.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -147.01 124.1 5.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.65 -0.871 . . . . 0.66000000000000003 108.65 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -80.53 -8.17 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.948 3.098 . . . . 0.56999999999999995 114.166 177.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -67.15 -27.36 67.23 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.578 -1.326 . . . . 0.56999999999999995 110.738 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.83 80.47 1.38 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.11 1.364 . . . . 0.56999999999999995 111.199 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.47 148.0 38.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.578 1.551 . . . . 0.56999999999999995 109.629 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.2 47.54 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.47 1.108 . . . . 0.56999999999999995 111.213 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 61.85 79.27 0.26 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.968 1.307 . . . . 0.56999999999999995 111.581 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -64.46 -86.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.206 1.187 . . . . 0.56999999999999995 114.206 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -138.42 -46.04 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 110.058 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -45.81 64.28 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.654 172.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -53.71 55.05 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.708 0.63 . . . . 0.66000000000000003 109.955 177.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.12 -45.98 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.071 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -47.53 76.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.908 1.283 . . . . 0.56999999999999995 109.459 -178.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.71 97.19 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.924 -1.27 . . . . 0.56999999999999995 109.924 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -51.18 74.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.53 1.165 . . . . 0.56999999999999995 110.282 175.212 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.78 -37.81 77.12 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.902 0.481 . . . . 0.56999999999999995 110.204 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -39.01 73.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.101 -0.952 . . . . 0.56999999999999995 111.916 175.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -58.92 5.46 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.731 2.012 . . . . 0.56999999999999995 109.999 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.4 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.9 p90 -86.71 -16.77 35.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.264 -0.574 . . . . 0.56999999999999995 111.779 -176.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -85.02 -31.98 21.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.863 1.221 . . . . 0.56999999999999995 112.905 -175.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -70.66 0.08 Allowed 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.063 1.432 . . . . 0.56999999999999995 112.288 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.96 157.25 4.37 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.891 1.677 . . . . 1.2 109.87 -176.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 4.5 p -163.08 120.52 1.93 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.248 -1.76 . . . . 0.56999999999999995 106.248 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -177.64 161.46 1.68 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.343 1.857 . . . . 0.56999999999999995 110.496 173.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.3 p -152.51 72.03 0.96 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.465 0.65 . . . . 0.56999999999999995 112.169 175.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -73.87 74.54 1.62 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.311 -0.868 . . . . 1.2 111.981 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -147.51 67.73 1.13 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.028 1.331 . . . . 0.56999999999999995 110.09 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.342 0.254 0 C-N-CA 128.809 2.844 . . . . 0.5 . 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.456 ' H47' ' CE1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.202 0 CA-C-O 119.41 -0.328 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -164.86 -48.4 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.046 -1.835 . . . . 0.56999999999999995 106.046 -179.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -138.94 -52.09 0.56 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 117.599 -1.191 . . . . 0.56999999999999995 112.17 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 173.84 -52.4 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.413 1.885 . . . . 0.56999999999999995 112.046 -177.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.26 175.14 7.57 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.047 3.164 . . . . 0.56999999999999995 111.77 178.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -144.07 49.14 1.37 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.812 1.245 . . . . 0.56999999999999995 109.758 -173.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -157.44 66.74 3.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.076 1.35 . . . . 0.56999999999999995 108.364 174.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.32 175.68 10.25 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 120.668 0.912 . . . . 0.56999999999999995 110.97 172.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt 80.7 115.69 0.06 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.022 2.129 . . . . 0.56999999999999995 108.296 -177.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.416 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 79.7 m95 -58.54 163.53 3.12 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.243 1.021 . . . . 0.56999999999999995 111.939 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -69.31 -31.95 70.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.565 0.746 . . . . 0.56999999999999995 111.521 -174.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 t -123.65 150.49 44.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.39 2.276 . . . . 0.56999999999999995 107.264 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -71.97 3.02 4.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.283 -0.865 . . . . 0.56999999999999995 112.142 171.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -121.86 108.24 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.984 -1.488 . . . . 0.56999999999999995 106.984 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.71 143.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 107.964 -1.125 . . . . 0.56999999999999995 107.964 -172.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.1 p -97.32 152.6 18.74 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.644 -0.66 . . . . 0.56999999999999995 110.455 -176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -131.21 157.83 42.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.948 -1.095 . . . . 0.56999999999999995 110.681 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -144.73 119.11 9.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.425 0.69 . . . . 1.2 109.491 174.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.12 86.13 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 105.165 -2.161 . . . . 0.56999999999999995 105.165 176.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.07 -38.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.539 1.935 . . . . 0.56999999999999995 110.728 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -152.61 164.3 37.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.309 -2.108 . . . . 0.56999999999999995 105.309 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -132.1 169.09 16.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.812 1.645 . . . . 0.56999999999999995 106.82 -172.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.1 t -72.0 -168.07 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.56999999999999995 111.203 171.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -43.51 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 1.2 113.463 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -60.78 -41.78 96.23 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 -177.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.4 150.32 38.81 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 124.055 0.942 . . . . 0.56999999999999995 111.26 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -75.14 158.11 41.82 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.561 2.174 . . . . 0.56999999999999995 112.444 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -61.71 -38.62 88.53 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 112.536 -176.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.33 -40.96 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.77 -0.456 . . . . 0.56999999999999995 109.77 174.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -68.68 -38.9 80.71 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.237 -1.364 . . . . 0.56999999999999995 109.371 176.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.11 -53.55 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.875 1.671 . . . . 0.56999999999999995 110.053 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.0 -41.24 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.823 0.738 . . . . 0.66000000000000003 111.154 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -46.8 86.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 118.549 0.613 . . . . 1.2 111.719 178.042 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 mp -62.57 -44.81 95.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 116.598 -1.668 . . . . 0.56999999999999995 107.797 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.95 -47.04 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 121.049 1.749 . . . . 0.56999999999999995 110.698 174.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -48.6 76.44 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.949 0.795 . . . . 0.56999999999999995 109.303 -178.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -69.62 -36.88 76.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 112.104 -177.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.44 74.81 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 126.83 2.052 . . . . 0.56999999999999995 109.847 174.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.58 -33.42 75.64 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 118.505 -0.759 . . . . 0.56999999999999995 111.03 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -60.24 -33.87 72.89 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.383 -0.818 . . . . 0.56999999999999995 109.605 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.9 mtm -69.64 -23.5 63.49 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 115.925 -1.988 . . . . 0.56999999999999995 113.281 175.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -84.45 -34.51 23.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.529 1.513 . . . . 0.56999999999999995 111.157 169.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.95 83.0 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.839 -1.163 . . . . 0.56999999999999995 112.236 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.25 -25.98 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 111.13 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -100.35 -29.84 12.19 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.147 -0.93 . . . . 0.66000000000000003 111.468 176.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.7 131.23 24.4 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 119.364 0.984 . . . . 0.56999999999999995 111.255 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.11 43.39 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.694 2.93 . . . . 0.56999999999999995 112.234 178.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.73 145.33 29.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.146 1.378 . . . . 0.56999999999999995 108.593 175.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -126.78 162.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.315 1.046 . . . . 0.65000000000000002 108.208 -175.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 152.97 41.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.002 -1.481 . . . . 0.56999999999999995 107.002 -169.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 171.31 14.67 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.105 0.962 . . . . 1.2 109.083 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -115.04 163.93 14.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.976 -0.75 . . . . 0.56999999999999995 108.976 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.47 171.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.738 1.215 . . . . 0.56999999999999995 109.94 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -115.74 36.26 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 111.46 -171.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 92.02 107.5 0.03 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 128.739 2.816 . . . . 0.56999999999999995 108.99 -177.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.98 -124.41 1.43 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.078 -1.609 . . . . 0.56999999999999995 109.078 -173.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.9 p -138.0 143.17 40.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.39 0.676 . . . . 0.56999999999999995 109.803 -171.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.22 -177.33 4.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.056 1.743 . . . . 0.56999999999999995 109.357 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.416 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 35.9 m-20 -83.74 -39.78 19.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.544 0.738 . . . . 0.66000000000000003 110.88 -177.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.05 79.98 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.306 1.442 . . . . 0.56999999999999995 107.213 -175.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -78.86 126.62 30.94 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.695 -1.253 . . . . 0.56999999999999995 108.998 171.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.17 124.98 66.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.616 -1.994 . . . . 0.56999999999999995 105.616 173.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.97 162.94 27.45 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.221 -0.752 . . . . 0.56999999999999995 111.221 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.77 148.01 46.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.994 -1.113 . . . . 0.56999999999999995 107.994 -175.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.61 179.86 6.58 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 125.936 1.694 . . . . 0.56999999999999995 110.291 -175.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 71.2 1.4 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 122.487 1.137 . . . . 1.2 108.422 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.37 -65.14 0.78 Allowed Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.311 -1.115 . . . . 0.56999999999999995 110.311 -178.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.95 159.5 33.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.863 1.832 . . . . 0.56999999999999995 110.963 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -157.87 155.19 29.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.628 1.171 . . . . 0.65000000000000002 108.923 -178.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.98 52.13 3.94 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.733 1.635 . . . . 0.56999999999999995 112.752 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -109.68 -77.18 0.6 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.533 1.133 . . . . 0.66000000000000003 108.411 -176.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -177.93 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 110.107 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -130.43 99.13 19.43 Favored Pre-proline 0 C--N 1.344 0.357 0 N-CA-C 108.523 -0.917 . . . . 0.56999999999999995 108.523 -174.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 141.71 72.63 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 109.199 -1.116 . . . . 0.56999999999999995 109.199 174.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -61.85 177.3 0.45 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.192 1.472 . . . . 0.56999999999999995 111.041 167.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -99.34 -37.41 9.25 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.694 1.998 . . . . 0.66000000000000003 110.855 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.41 -150.11 18.19 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 120.461 1.482 . . . . 0.56999999999999995 112.422 -172.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.01 81.77 1.63 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.744 3.63 . . . . 0.56999999999999995 112.949 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.17 -168.29 37.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.756 1.646 . . . . 0.56999999999999995 110.705 176.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 41.72 -137.1 0.21 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.307 1.443 . . . . 0.56999999999999995 113.788 167.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -59.42 123.53 17.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.938 2.095 . . . . 0.56999999999999995 110.936 174.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.93 -28.81 13.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.7 1.2 . . . . 0.56999999999999995 113.21 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.72 159.09 36.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -143.7 156.57 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.65000000000000002 109.306 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.42 35.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.364 0.665 . . . . 0.56999999999999995 109.592 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -117.05 153.15 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.673 -0.862 . . . . 0.56999999999999995 108.673 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 158.89 50.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 110.835 176.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.79 161.46 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 112.175 177.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.06 -127.18 1.29 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.078 -2.009 . . . . 0.56999999999999995 108.078 -177.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.9 m -141.38 99.22 3.52 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 106.193 -1.78 . . . . 0.56999999999999995 106.193 -178.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.37 -125.62 6.34 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.177 -1.569 . . . . 0.56999999999999995 109.177 176.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 95' ' ' ASP . 1.3 tp -51.52 -35.43 40.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 111.842 178.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.17 136.97 8.32 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.574 -0.704 . . . . 0.56999999999999995 112.316 176.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.03 -22.15 8.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 126.384 1.945 . . . . 0.56999999999999995 114.464 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 68.3 m-20 -68.47 151.83 46.26 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.651 -1.24 . . . . 0.66000000000000003 107.651 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.05 147.7 32.88 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.374 1.069 . . . . 0.56999999999999995 108.973 -172.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -131.62 154.66 48.66 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.888 -1.051 . . . . 0.65000000000000002 108.523 -178.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.47 151.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.825 -1.176 . . . . 0.56999999999999995 107.825 -171.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.26 94.9 9.4 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.874 -1.158 . . . . 0.66000000000000003 107.874 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.81 -28.11 46.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.654 1.582 . . . . 0.66000000000000003 111.256 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.87 -36.27 81.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.181 0.593 . . . . 0.66000000000000003 110.79 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.71 130.55 43.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.918 -1.142 . . . . 0.66000000000000003 107.918 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -57.49 140.95 49.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.249 0.547 . . . . 1.2 110.66 178.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -123.68 150.15 44.61 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.927 -1.508 . . . . 0.56999999999999995 106.927 178.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -137.84 147.76 44.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 175.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.72 -54.0 48.51 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.343 0.974 . . . . 0.66000000000000003 108.684 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.81 72.73 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.437 -1.465 . . . . 0.56999999999999995 109.437 -169.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.3 p -159.44 151.22 20.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.218 0.607 . . . . 0.56999999999999995 109.668 173.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 m -67.66 87.2 0.22 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.007 0.923 . . . . 0.56999999999999995 110.604 174.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.33 -55.47 0.06 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 125.989 1.716 . . . . 0.56999999999999995 111.406 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.47 -147.87 7.41 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.211 -1.156 . . . . 0.56999999999999995 110.211 -176.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.61 124.7 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.437 -1.32 . . . . 0.56999999999999995 107.437 -177.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.86 107.63 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.822 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -60.28 -47.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.391 1.476 . . . . 0.56999999999999995 110.337 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.72 -44.76 81.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -72.92 -41.73 64.25 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.36 0.664 . . . . 0.56999999999999995 110.578 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.35 74.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.609 0.764 . . . . 0.56999999999999995 109.951 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.86 -56.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 118.289 -0.862 . . . . 0.56999999999999995 109.486 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.5 m -51.89 -36.57 49.15 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.686 1.13 . . . . 0.56999999999999995 112.522 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.4 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.7 t60 -64.12 -61.53 2.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.229 -0.656 . . . . 0.65000000000000002 109.229 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.95 -43.11 99.52 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.462 -0.773 . . . . 0.66000000000000003 111.036 -172.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.63 -32.76 72.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 112.027 177.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.84 -44.95 81.45 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.634 -0.986 . . . . 0.56999999999999995 110.634 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -67.02 -44.21 80.86 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 118.479 -0.772 . . . . 0.65000000000000002 111.885 175.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.3 m -53.7 -38.52 64.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 123.755 0.659 . . . . 0.56999999999999995 111.085 176.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -38.31 87.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 112.217 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 152.19 -21.95 0.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.262 -0.743 . . . . 0.56999999999999995 113.028 -175.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.6 158.79 4.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.689 1.244 . . . . 0.56999999999999995 110.927 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.03 -41.37 0.48 Allowed Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.73 -2.15 . . . . 0.56999999999999995 112.68 176.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 167.39 177.61 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 128.247 2.619 . . . . 0.65000000000000002 107.259 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 t -150.76 -175.73 5.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.992 -1.485 . . . . 0.56999999999999995 106.992 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.3 p -134.86 63.26 1.62 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.078 -174.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.06 147.65 65.75 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.66000000000000003 110.155 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.86 -27.11 21.66 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.842 2.362 . . . . 0.56999999999999995 112.158 -175.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -122.6 33.35 5.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.704 1.602 . . . . 0.56999999999999995 109.053 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.48 54.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.559 -0.713 . . . . 0.56999999999999995 110.567 176.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.74 -24.7 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 121.424 -0.797 . . . . 0.56999999999999995 110.336 168.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.4 ' CE ' ' HA ' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -96.6 11.84 33.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 112.157 177.117 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.55 137.11 9.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 119.764 1.166 . . . . 0.56999999999999995 112.48 174.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.04 -66.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.966 1.778 . . . . 0.56999999999999995 111.869 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -55.78 139.94 43.7 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 110.52 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -95.53 77.1 3.33 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.291 -0.633 . . . . 0.56999999999999995 109.291 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 96.75 0.12 Allowed Glycine 0 CA--C 1.536 1.374 0 N-CA-C 115.617 1.007 . . . . 0.56999999999999995 115.617 172.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -159.48 -46.68 0.05 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.399 1.1 . . . . 0.56999999999999995 113.105 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.76 -129.81 4.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.955 -2.058 . . . . 0.56999999999999995 107.955 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -147.57 114.2 4.08 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.537 -0.912 . . . . 0.66000000000000003 108.537 -178.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -12.6 23.04 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.198 1.932 . . . . 0.56999999999999995 112.706 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.03 -25.67 61.9 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.074 -1.016 . . . . 0.56999999999999995 111.167 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.88 93.28 4.3 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 108.735 174.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -52.43 -73.89 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.622 1.169 . . . . 0.56999999999999995 114.035 -177.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.36 67.04 0.2 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.504 2.321 . . . . 0.56999999999999995 110.979 176.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -40.13 121.97 1.43 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.866 1.666 . . . . 0.56999999999999995 109.121 -174.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.3 t -77.03 -101.63 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.626 0.771 . . . . 0.56999999999999995 109.272 -168.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -122.91 -8.26 8.37 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 125.102 1.361 . . . . 0.56999999999999995 110.838 172.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.22 -63.29 1.35 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 121.208 1.822 . . . . 0.66000000000000003 110.873 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.66 -50.84 61.61 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 117.616 -1.183 . . . . 0.66000000000000003 108.829 175.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.93 -48.83 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.199 0.909 . . . . 0.56999999999999995 110.314 -174.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -66.91 -49.82 64.37 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.057 -0.72 . . . . 0.56999999999999995 109.057 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.19 -58.84 11.91 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.682 -0.967 . . . . 0.56999999999999995 110.682 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.9 mm -50.39 -48.13 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 126.343 1.857 . . . . 0.56999999999999995 112.141 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.44 -33.6 75.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.438 0.563 . . . . 0.56999999999999995 111.714 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -76.05 -30.79 58.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.804 0.842 . . . . 0.56999999999999995 111.801 176.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.76 -53.19 12.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 110.065 178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -124.21 -53.88 1.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.778 -174.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.29 115.84 3.97 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 109.721 -1.352 . . . . 0.56999999999999995 109.721 -176.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 -75.74 0.36 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.777 -0.63 . . . . 0.56999999999999995 109.601 173.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.17 167.63 29.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.75 1.62 . . . . 1.2 108.65 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.4 t -142.0 126.46 17.76 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.697 -1.594 . . . . 0.56999999999999995 106.697 176.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -165.65 141.17 5.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.286 -1.746 . . . . 0.56999999999999995 106.286 171.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 151.19 10.9 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.048 -1.464 . . . . 0.56999999999999995 107.048 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.9 94.45 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.775 0.83 . . . . 1.2 109.279 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.56 175.58 8.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.783 0.833 . . . . 0.56999999999999995 109.055 175.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 C--N 1.33 -0.258 0 C-N-CA 127.225 2.21 . . . . 0.5 . 171.883 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 117.981 -1.009 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -70.79 -179.01 2.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.595 0.634 . . . . 0.56999999999999995 111.352 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.14 65.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.87 1.268 . . . . 0.56999999999999995 109.728 -172.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.97 -51.61 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 127.286 2.234 . . . . 0.56999999999999995 110.696 -176.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.67 162.99 24.17 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.86 2.373 . . . . 0.56999999999999995 112.128 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -126.04 -56.54 1.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.72 1.208 . . . . 0.56999999999999995 109.459 -176.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 p -127.64 61.93 52.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.938 1.295 . . . . 0.56999999999999995 109.958 178.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 166.22 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.875 1.717 . . . . 0.56999999999999995 110.946 176.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.2 99.26 0.07 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 126.243 1.817 . . . . 0.56999999999999995 108.912 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.3 m95 -53.86 154.06 4.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.511 0.672 . . . . 0.56999999999999995 111.651 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -72.76 -31.05 64.63 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.747 0.819 . . . . 0.56999999999999995 111.702 -176.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -92.44 155.62 17.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.137 2.175 . . . . 0.56999999999999995 111.162 174.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -79.68 -10.98 59.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 111.808 173.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.29 144.7 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.777 -1.194 . . . . 0.56999999999999995 107.777 175.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.76 150.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.7 p -102.52 148.78 25.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 119.015 -0.516 . . . . 0.56999999999999995 110.651 -174.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -127.38 158.19 37.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.865 1.211 . . . . 0.56999999999999995 111.915 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.74 116.56 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.988 0.423 . . . . 1.2 110.945 171.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.8 mt -79.19 96.63 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 N-CA-C 106.581 -1.637 . . . . 0.56999999999999995 106.581 176.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -33.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.878 2.071 . . . . 0.56999999999999995 112.007 -175.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 t -150.04 162.26 40.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.384 -2.821 . . . . 0.56999999999999995 103.384 -177.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.36 161.29 35.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.909 -1.515 . . . . 0.56999999999999995 106.909 -173.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -72.81 173.15 9.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.668 0.387 . . . . 0.56999999999999995 111.295 176.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -41.06 3.83 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.433 1.093 . . . . 1.2 111.221 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -35.1 74.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.057 0.389 . . . . 0.66000000000000003 110.81 -176.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.52 151.77 52.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.531 1.932 . . . . 0.56999999999999995 108.356 -176.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.23 155.92 46.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.198 1.265 . . . . 0.56999999999999995 112.422 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -59.33 -37.59 78.18 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.565 1.146 . . . . 0.65000000000000002 112.343 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 tt -63.6 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.28 -0.867 . . . . 0.56999999999999995 110.078 174.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -62.77 -42.81 99.86 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.63 -1.176 . . . . 0.56999999999999995 109.195 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.28 -53.51 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 120.607 1.549 . . . . 0.56999999999999995 111.667 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -59.79 -45.03 93.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.654 1.115 . . . . 0.66000000000000003 110.438 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.17 96.78 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 117.845 -1.074 . . . . 1.2 111.402 176.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mp -64.19 -46.24 84.8 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.518 1.054 . . . . 0.56999999999999995 108.472 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -49.75 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.244 0.929 . . . . 0.56999999999999995 109.709 172.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.26 -46.75 87.41 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.95 -1.024 . . . . 0.56999999999999995 111.887 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -65.62 -42.54 91.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.333 1.424 . . . . 0.56999999999999995 111.712 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.05 94.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 110.049 177.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.45 -32.39 73.73 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.934 -0.555 . . . . 0.56999999999999995 111.511 173.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -43.45 98.27 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.025 172.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 mtm -67.12 -37.44 83.87 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.483 -0.77 . . . . 0.56999999999999995 112.133 176.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.422 ' CZ3' ' HG3' ' A' ' 128' ' ' MET . 23.7 m95 -69.11 -43.92 73.47 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.862 1.21 . . . . 0.56999999999999995 112.004 173.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.04 -0.87 66.46 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.959 1.266 . . . . 0.56999999999999995 113.197 177.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -23.48 65.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.11 -1.23 . . . . 0.56999999999999995 110.953 171.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -105.47 -32.1 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.978 -1.01 . . . . 0.66000000000000003 112.331 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.2 pt -116.6 132.29 23.44 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 119.312 0.96 . . . . 0.56999999999999995 110.875 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.27 49.44 2.84 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.971 3.114 . . . . 0.56999999999999995 111.76 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -98.49 142.11 30.51 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.122 2.169 . . . . 0.56999999999999995 107.357 176.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -125.18 164.7 19.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.65000000000000002 109.329 -172.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.65 147.87 47.1 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.685 -1.228 . . . . 0.56999999999999995 107.685 -170.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.97 168.98 18.7 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.709 1.204 . . . . 1.2 109.048 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -110.77 150.39 29.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.793 -0.817 . . . . 0.56999999999999995 108.793 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.5 170.33 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.867 0.867 . . . . 0.56999999999999995 109.941 174.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.1 -48.71 7.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 109.17 177.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -146.58 139.61 25.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.106 1.362 . . . . 0.56999999999999995 107.387 173.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.43 166.4 22.79 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.571 0.605 . . . . 0.56999999999999995 111.808 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 164.54 21.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.914 0.387 . . . . 0.56999999999999995 110.369 174.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.51 173.71 8.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 110.8 -176.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -73.53 -35.89 65.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.09 -0.959 . . . . 0.66000000000000003 110.298 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.09 71.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.549 2.34 . . . . 0.56999999999999995 108.364 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.9 ttp -78.31 122.02 25.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.577 -1.327 . . . . 0.56999999999999995 108.229 173.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.93 135.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.473 -1.677 . . . . 0.56999999999999995 106.473 178.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.3 165.93 28.17 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 118.821 0.737 . . . . 0.56999999999999995 112.015 176.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 6.4 m-85 -139.12 137.54 36.24 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.172 -1.788 . . . . 0.56999999999999995 106.172 -175.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.8 175.85 9.27 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 109.318 -176.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -133.55 88.8 2.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.722 -1.214 . . . . 1.2 107.722 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.76 -40.89 2.27 Favored Glycine 0 C--N 1.343 0.933 0 C-N-CA 124.359 0.981 . . . . 0.56999999999999995 113.089 170.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.96 23.94 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.376 1.088 . . . . 0.56999999999999995 109.421 175.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 159.33 25.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.957 1.303 . . . . 0.65000000000000002 109.763 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.49 55.71 4.42 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 126.21 1.862 . . . . 0.56999999999999995 112.23 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -105.08 -78.39 0.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.176 1.39 . . . . 0.66000000000000003 109.094 -175.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.17 -50.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 106.52 -176.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -108.36 126.19 30.17 Favored Pre-proline 0 C--N 1.344 0.352 0 CA-C-O 118.798 -0.62 . . . . 0.56999999999999995 109.942 -174.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.08 133.37 26.66 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.272 1.315 . . . . 0.56999999999999995 108.836 170.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.64 -163.43 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.645 1.212 . . . . 0.56999999999999995 110.459 166.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.512 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 21.2 p-10 -132.53 -35.77 1.12 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.605 3.562 . . . . 0.66000000000000003 109.416 -162.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.37 -148.64 18.93 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.808 1.671 . . . . 0.56999999999999995 111.453 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.04 59.57 2.96 Favored 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.227 4.618 . . . . 0.56999999999999995 115.103 -169.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.0 40.55 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.552 1.549 . . . . 0.56999999999999995 110.053 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 33.8 t30 42.63 -139.76 0.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.229 1.812 . . . . 0.56999999999999995 113.593 173.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -49.57 112.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.436 2.694 . . . . 0.56999999999999995 111.989 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.23 -32.11 61.04 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.56999999999999995 114.352 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.12 166.37 28.09 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.84 -1.162 . . . . 0.56999999999999995 109.223 -178.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.509 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 1.9 p-80 -149.09 155.98 41.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.003 0.82 . . . . 0.65000000000000002 111.161 174.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.44 158.56 43.93 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.203 1.001 . . . . 0.56999999999999995 109.875 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.7 148.52 32.1 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.429 -0.582 . . . . 0.56999999999999995 109.429 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.42 96.5 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 110.242 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 21.9 Cg_endo -70.33 157.66 58.6 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.476 2.117 . . . . 0.56999999999999995 111.099 176.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.68 -53.52 0.6 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.414 1.007 . . . . 0.56999999999999995 111.141 173.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -96.64 177.67 5.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.704 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.96 -40.39 97.14 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.267 -1.296 . . . . 0.56999999999999995 112.488 -176.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.22 -29.38 66.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.881 1.34 . . . . 0.56999999999999995 110.875 168.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.13 152.19 14.69 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.85 -1.157 . . . . 0.56999999999999995 111.152 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.35 -20.55 4.89 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.436 1.017 . . . . 0.56999999999999995 113.391 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -75.39 157.22 34.52 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.483 1.141 . . . . 0.66000000000000003 108.867 -173.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.41 149.94 36.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.815 0.817 . . . . 0.56999999999999995 110.314 -172.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.83 151.56 48.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.602 -176.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 36.2 m-85 -138.07 150.01 46.51 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 108.034 -171.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -85.51 104.09 14.97 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.87 -0.789 . . . . 0.66000000000000003 108.87 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.86 -23.75 66.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.929 -1.107 . . . . 0.66000000000000003 111.671 175.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -56.72 -29.5 62.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.793 0.837 . . . . 0.66000000000000003 111.642 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -82.68 135.03 35.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.587 1.555 . . . . 0.66000000000000003 109.157 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.83 120.7 14.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.753 -0.592 . . . . 1.2 109.62 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -103.58 138.51 40.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -123.64 147.08 47.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.711 -1.218 . . . . 0.56999999999999995 107.711 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -88.26 21.23 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.396 0.998 . . . . 0.66000000000000003 112.081 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.86 25.6 37.52 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.252 1.406 . . . . 0.56999999999999995 112.834 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -64.76 -56.18 15.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.746 -172.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.1 m -151.68 -43.1 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.582 0.753 . . . . 0.56999999999999995 112.827 -176.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -167.84 166.4 13.54 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 108.078 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.84 -152.4 16.88 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.166 -1.574 . . . . 0.56999999999999995 109.166 -175.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.93 111.63 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.107 -1.442 . . . . 0.56999999999999995 107.107 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -66.28 111.65 3.58 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.074 -0.713 . . . . 0.56999999999999995 109.074 -177.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.43 -43.93 75.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.449 -0.796 . . . . 0.56999999999999995 111.464 177.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -59.7 -40.3 87.45 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -66.54 -44.61 81.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.569 0.748 . . . . 0.56999999999999995 109.662 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.098 0.559 . . . . 0.56999999999999995 110.327 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -50.95 72.09 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.861 -1.066 . . . . 0.56999999999999995 109.845 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 65.5 m -50.82 -46.33 59.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.175 1.352 . . . . 0.56999999999999995 111.714 175.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.91 -52.27 64.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.401 0.546 . . . . 0.65000000000000002 110.281 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HE2' ' N ' ' A' ' 84' ' ' HIS . 4.9 mm-40 -66.5 -43.37 85.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.195 0.998 . . . . 0.66000000000000003 110.9 -172.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -64.85 -28.68 69.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.202 1.401 . . . . 0.56999999999999995 111.282 176.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -46.33 80.46 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.127 -0.789 . . . . 0.56999999999999995 111.127 169.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -68.7 -40.46 80.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.537 -1.22 . . . . 0.65000000000000002 110.889 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.8 p -59.98 -26.44 66.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.136 0.88 . . . . 0.56999999999999995 112.838 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -41.59 78.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 111.773 173.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.73 25.91 1.2 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.478 1.037 . . . . 0.56999999999999995 113.621 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.422 ' HG3' ' CZ3' ' A' ' 42' ' ' TRP . 36.3 mmt -84.26 -176.94 6.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.855 0.836 . . . . 0.56999999999999995 111.052 -175.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.47 146.49 18.15 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.267 -0.879 . . . . 0.56999999999999995 111.44 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.23 164.33 1.81 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.036 0.922 . . . . 0.65000000000000002 111.25 166.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.26 179.97 7.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.515 1.926 . . . . 0.56999999999999995 107.538 -177.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.3 t -151.59 97.06 2.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.917 -1.883 . . . . 0.56999999999999995 105.917 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.1 137.62 31.09 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 105.587 -2.005 . . . . 0.66000000000000003 105.587 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.76 38.12 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.959 3.106 . . . . 0.56999999999999995 111.714 -176.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.46 32.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.9 1.68 . . . . 0.56999999999999995 111.291 170.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.64 142.91 49.0 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.98 -1.075 . . . . 0.56999999999999995 110.543 -170.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.47 -29.6 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 120.172 -0.611 . . . . 0.56999999999999995 109.514 177.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 tpp -61.39 -18.13 57.35 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 114.455 173.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -54.71 129.11 63.69 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.534 0.734 . . . . 0.56999999999999995 109.502 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.06 134.98 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.793 1.662 . . . . 0.56999999999999995 109.277 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.1 m 66.88 149.55 0.05 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.107 1.763 . . . . 0.56999999999999995 111.895 -173.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.84 131.48 48.93 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.017 -1.052 . . . . 0.56999999999999995 109.51 173.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.86 -104.72 0.18 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.161 -1.176 . . . . 0.56999999999999995 110.161 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -64.2 -33.61 76.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.923 0.712 . . . . 0.56999999999999995 112.923 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.59 142.93 36.08 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.613 -0.995 . . . . 0.56999999999999995 110.613 178.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -109.77 111.51 58.85 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.408 0.683 . . . . 0.66000000000000003 109.288 -169.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 -15.63 51.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.576 2.184 . . . . 0.56999999999999995 113.6 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.54 -1.24 28.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.024 0.93 . . . . 0.56999999999999995 110.675 177.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -142.51 77.42 1.58 Allowed 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 109.586 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.86 -63.15 1.2 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.67 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.11 72.96 0.03 OUTLIER 'General case' 0 C--N 1.346 0.436 0 O-C-N 126.369 2.293 . . . . 0.56999999999999995 111.364 -176.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp -33.16 116.07 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.965 2.106 . . . . 0.56999999999999995 108.55 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.4 p -93.7 -75.52 0.5 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.326 -0.55 . . . . 0.56999999999999995 110.382 -160.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -141.76 -49.51 0.39 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 109.351 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -51.84 -32.47 31.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.901 1.228 . . . . 0.66000000000000003 112.441 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -78.19 -82.94 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.902 1.681 . . . . 0.66000000000000003 110.404 168.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.62 -50.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.183 0.993 . . . . 0.56999999999999995 110.648 -169.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -69.05 -35.9 77.09 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 117.528 -1.225 . . . . 0.56999999999999995 109.684 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.71 95.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 120.416 1.462 . . . . 0.56999999999999995 111.049 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -60.03 -48.81 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.902 0.881 . . . . 0.56999999999999995 110.676 171.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -67.09 -16.86 64.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 112.89 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -82.57 -35.64 26.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.324 1.45 . . . . 0.56999999999999995 110.43 171.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -47.13 8.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.867 0.758 . . . . 0.56999999999999995 112.762 -175.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -104.48 -43.44 5.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.285 1.034 . . . . 0.56999999999999995 110.484 -175.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.41 -178.75 9.34 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.853 -0.899 . . . . 0.56999999999999995 110.853 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.02 -67.86 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.833 -0.803 . . . . 0.56999999999999995 108.833 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -150.26 165.97 31.36 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.699 -1.223 . . . . 1.2 107.699 178.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.6 t -155.37 -60.81 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.512 -1.292 . . . . 0.56999999999999995 107.512 172.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -164.82 178.04 7.49 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.914 1.685 . . . . 0.56999999999999995 110.356 175.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.1 p -149.37 146.07 27.31 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.089 1.355 . . . . 0.56999999999999995 109.889 171.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 73.51 114.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.962 2.905 . . . . 1.2 112.587 -177.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -151.36 177.2 10.51 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.282 0.633 . . . . 0.56999999999999995 111.287 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.8 tptt . . . . . 0 C--N 1.341 0.233 0 C-N-CA 129.099 2.96 . . . . 0.5 . 177.327 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.264 0 CA-C-O 117.126 -1.416 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.5 p -94.95 -0.25 54.07 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.468 1.486 . . . . 0.56999999999999995 112.855 -178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.43 -53.93 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.732 1.213 . . . . 0.56999999999999995 110.121 -175.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.2 171.11 8.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.615 1.966 . . . . 0.56999999999999995 110.672 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -71.08 -158.45 0.06 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.056 3.171 . . . . 0.56999999999999995 113.048 173.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -55.63 151.33 10.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.266 1.026 . . . . 0.56999999999999995 109.652 166.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 151.67 -53.51 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.437 0 C-N-CA 129.399 3.079 . . . . 0.56999999999999995 109.266 -172.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.9 168.97 21.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.404 1.402 . . . . 0.56999999999999995 111.856 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 pttt 86.81 133.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 129.406 3.082 . . . . 0.56999999999999995 108.548 -170.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -73.31 177.67 5.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.619 0.767 . . . . 0.56999999999999995 110.074 173.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -101.6 -14.77 17.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.728 -0.608 . . . . 0.56999999999999995 111.485 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -100.8 162.64 12.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.726 1.21 . . . . 0.56999999999999995 110.116 176.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -87.42 -4.08 59.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.13 1.372 . . . . 0.56999999999999995 112.549 171.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -133.1 140.93 46.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.868 -1.16 . . . . 0.56999999999999995 107.868 176.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.68 143.5 39.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.738 -1.578 . . . . 0.56999999999999995 106.738 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.94 140.43 33.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.69 -0.485 . . . . 0.56999999999999995 109.69 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.21 161.04 29.48 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.631 0.772 . . . . 0.56999999999999995 110.544 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.91 160.7 43.73 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.987 0.915 . . . . 1.2 109.599 172.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.25 85.92 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.239 -2.134 . . . . 0.56999999999999995 105.239 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.64 -56.27 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.021 0.529 . . . . 0.56999999999999995 109.985 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.5 111.82 22.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.733 -1.951 . . . . 0.56999999999999995 105.733 176.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.09 148.95 22.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.395 1.878 . . . . 0.56999999999999995 107.911 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -73.88 -170.05 0.84 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 109.799 -176.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.28 -14.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.869 1.433 . . . . 1.2 114.869 176.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -64.59 -29.87 70.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.085 1.354 . . . . 0.66000000000000003 110.846 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.28 150.82 73.48 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 126.55 1.94 . . . . 0.56999999999999995 108.488 175.13 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -70.81 157.3 58.72 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.537 2.825 . . . . 0.56999999999999995 112.736 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -65.59 -32.92 74.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.705 0.802 . . . . 0.65000000000000002 112.172 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -43.96 98.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.55 -0.907 . . . . 0.56999999999999995 108.55 174.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -64.95 -42.37 94.7 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.206 -1.378 . . . . 0.56999999999999995 109.839 172.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.3 -48.59 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 121.157 1.798 . . . . 0.56999999999999995 110.365 177.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.8 -42.19 90.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.19 0.904 . . . . 0.66000000000000003 109.672 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -67.34 -46.87 72.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.333 -0.855 . . . . 1.2 113.146 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -31.62 72.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.048 -0.977 . . . . 0.56999999999999995 109.676 177.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.15 -50.42 74.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.878 -1.156 . . . . 0.56999999999999995 107.878 173.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -38.88 91.55 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.244 -0.884 . . . . 0.56999999999999995 110.826 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.46 -47.71 69.31 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.473 1.488 . . . . 0.56999999999999995 111.105 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.96 86.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.075 0.95 . . . . 0.56999999999999995 111.726 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.21 -31.87 68.13 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.216 -0.897 . . . . 0.56999999999999995 111.156 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.63 -43.98 93.63 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 109.233 170.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.2 mtp -60.1 -35.34 75.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 112.86 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -70.55 -48.09 57.1 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.421 1.009 . . . . 0.56999999999999995 111.669 170.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -9.36 64.73 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.106 1.336 . . . . 0.56999999999999995 113.668 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -66.38 -20.16 66.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 110.499 170.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.89 -20.39 12.47 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.205 -0.902 . . . . 0.66000000000000003 112.691 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.8 pt -127.67 129.75 23.75 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.464 175.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.82 41.45 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.295 3.33 . . . . 0.56999999999999995 112.407 178.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.9 147.72 23.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.295 1.838 . . . . 0.56999999999999995 108.079 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -122.93 166.36 15.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.51 0.724 . . . . 0.65000000000000002 109.25 -172.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.84 39.5 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.111 -0.993 . . . . 0.56999999999999995 109.458 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 165.24 21.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.756 0.823 . . . . 1.2 109.217 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -130.3 114.1 15.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.812 -1.551 . . . . 0.56999999999999995 106.812 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.05 160.76 2.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.383 0.673 . . . . 0.56999999999999995 109.759 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.71 -14.76 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 112.227 -176.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -52.5 64.04 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.664 0.785 . . . . 0.56999999999999995 111.099 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.37 -152.81 6.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.965 1.745 . . . . 0.56999999999999995 109.431 -172.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -60.84 178.88 0.2 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.328 1.051 . . . . 0.56999999999999995 112.477 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.22 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.734 1.614 . . . . 0.56999999999999995 110.382 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.43 -31.62 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.494 -0.765 . . . . 0.66000000000000003 109.138 176.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 mt -125.45 79.13 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 126.641 1.976 . . . . 0.56999999999999995 108.471 -178.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -72.54 117.95 14.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.134 1.773 . . . . 0.56999999999999995 108.226 166.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.88 122.8 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.096 -2.187 . . . . 0.56999999999999995 105.096 177.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.55 138.73 8.06 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 118.149 0.431 . . . . 0.56999999999999995 112.024 -174.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.48 145.69 37.25 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.936 -1.135 . . . . 0.56999999999999995 107.936 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.94 151.7 51.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.685 1.194 . . . . 0.56999999999999995 108.34 -178.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -110.68 70.86 0.73 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.271 0.558 . . . . 1.2 109.608 -174.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.28 -53.79 0.66 Allowed Glycine 0 C--O 1.219 -0.805 0 N-CA-C 110.351 -1.099 . . . . 0.56999999999999995 110.351 174.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 171.66 19.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.328 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 159.56 22.17 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.429 1.892 . . . . 0.65000000000000002 108.537 -174.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.23 46.22 2.22 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.085 1.326 . . . . 0.56999999999999995 111.788 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.42 105.66 7.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.488 -1.301 . . . . 0.66000000000000003 107.488 -172.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.9 m 55.99 -71.72 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.113 2.165 . . . . 0.56999999999999995 113.034 -175.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.75 130.02 15.31 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.351 1.86 . . . . 0.56999999999999995 107.911 -173.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.7 137.75 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.833 175.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -66.48 -173.81 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.973 1.309 . . . . 0.56999999999999995 111.202 169.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.63 -33.52 6.75 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.136 2.574 . . . . 0.66000000000000003 111.962 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.02 -123.54 7.94 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 120.586 -1.321 . . . . 0.56999999999999995 111.965 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.67 95.72 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.83 2.315 . . . . 0.56999999999999995 112.327 -176.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.89 -160.45 25.73 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.966 0.793 . . . . 0.56999999999999995 112.232 173.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 43.57 -129.91 0.78 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 112.904 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -68.3 129.11 38.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.307 2.643 . . . . 0.56999999999999995 109.186 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.67 -30.44 12.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.104 1.361 . . . . 0.56999999999999995 112.049 -175.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.2 37.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.839 1.255 . . . . 0.56999999999999995 108.352 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.74 161.54 38.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.625 -0.88 . . . . 0.65000000000000002 108.625 173.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.36 159.91 43.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.966 0.506 . . . . 0.56999999999999995 109.651 175.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -114.32 152.62 31.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.49 -0.777 . . . . 0.56999999999999995 109.606 -173.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.25 146.57 83.44 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.203 -0.903 . . . . 0.56999999999999995 110.117 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.83 157.98 58.62 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.345 2.03 . . . . 0.56999999999999995 112.335 -176.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.36 -101.7 0.15 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.042 -1.223 . . . . 0.56999999999999995 110.042 176.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -147.05 -41.25 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.901 0.88 . . . . 0.56999999999999995 111.194 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.02 4.57 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.812 -1.315 . . . . 0.56999999999999995 109.812 -175.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -29.95 17.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.224 1.01 . . . . 0.56999999999999995 112.423 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.55 134.79 14.47 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 120.964 -1.085 . . . . 0.56999999999999995 112.865 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.58 9.26 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.217 1.865 . . . . 0.56999999999999995 112.203 -176.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.72 148.44 47.98 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.1 0.95 . . . . 0.66000000000000003 108.885 -166.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.38 137.85 46.02 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.691 0.796 . . . . 0.56999999999999995 109.13 -168.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -135.33 141.24 45.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.299 -1.0 . . . . 0.65000000000000002 108.299 -164.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.29 151.73 42.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.735 -0.839 . . . . 0.56999999999999995 108.735 -169.288 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.56 102.2 11.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.852 -0.796 . . . . 0.66000000000000003 108.852 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.85 -21.72 63.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.095 0.958 . . . . 0.66000000000000003 111.487 172.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.23 -38.83 88.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.611 0.642 . . . . 0.66000000000000003 110.436 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.68 126.37 29.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.345 -1.354 . . . . 0.66000000000000003 107.345 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.82 132.53 22.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.465 -0.939 . . . . 1.2 108.465 176.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -120.78 129.69 53.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.739 -1.948 . . . . 0.56999999999999995 105.739 -177.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -141.02 161.84 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.619 -0.882 . . . . 0.56999999999999995 108.619 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.78 -22.77 58.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.857 0.863 . . . . 0.66000000000000003 111.136 172.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 152.47 96.68 0.14 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.177 0.894 . . . . 0.56999999999999995 111.33 175.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.0 t -120.37 -68.54 0.9 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 118.658 -0.687 . . . . 0.56999999999999995 110.562 -178.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.79 -64.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.06 0.944 . . . . 0.56999999999999995 108.877 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 tt -94.56 -46.1 7.11 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 110.327 -170.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.67 145.58 32.22 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.077 -1.209 . . . . 0.56999999999999995 110.077 173.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.5 mm -77.62 138.26 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.594 -1.262 . . . . 0.56999999999999995 107.594 -171.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -74.16 105.57 5.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.684 -0.487 . . . . 0.56999999999999995 109.684 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.31 -33.73 76.51 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.288 0.635 . . . . 0.56999999999999995 110.887 178.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.51 -51.52 65.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.624 -1.25 . . . . 0.56999999999999995 107.624 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.82 -38.89 92.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.449 0.7 . . . . 0.56999999999999995 109.205 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.31 47.12 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.547 0.739 . . . . 0.56999999999999995 112.252 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.43 77.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.628 -0.879 . . . . 0.56999999999999995 108.628 179.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -60.88 -37.73 83.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 111.382 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.42 -58.8 6.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.17 0.441 . . . . 0.65000000000000002 109.871 172.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -68.63 -41.69 79.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.298 -0.876 . . . . 0.66000000000000003 111.635 -171.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.99 -24.85 66.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.943 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.89 93.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.56999999999999995 110.917 169.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -70.13 -32.96 71.22 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 117.729 -1.129 . . . . 0.65000000000000002 112.239 174.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 p -60.09 -38.1 81.93 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.657 1.117 . . . . 0.56999999999999995 110.894 174.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -33.07 73.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.014 0.435 . . . . 0.56999999999999995 111.181 176.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.48 -55.01 0.12 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 123.782 0.706 . . . . 0.56999999999999995 111.611 175.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 176.09 172.56 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 107.632 -166.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 161.24 75.22 0.02 OUTLIER Glycine 0 C--O 1.218 -0.847 0 N-CA-C 104.137 -3.585 . . . . 0.56999999999999995 104.137 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.14 45.13 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.314 -1.365 . . . . 0.65000000000000002 107.314 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.3 -177.13 0.99 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.966 2.106 . . . . 0.56999999999999995 106.469 -173.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -132.25 39.29 3.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.56999999999999995 109.696 -174.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -104.14 137.69 19.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.66000000000000003 111.197 -172.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.47 -9.49 25.96 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.837 2.358 . . . . 0.56999999999999995 113.573 -174.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -121.52 24.75 9.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 109.599 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.63 133.18 45.53 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.082 -1.011 . . . . 0.56999999999999995 110.115 172.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -22.26 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.069 0.548 . . . . 0.56999999999999995 110.442 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.2 24.75 12.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.43 1.892 . . . . 0.56999999999999995 110.622 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.453 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.12 142.89 92.87 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.137 -0.977 . . . . 0.56999999999999995 109.967 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.9 Cg_endo -69.53 -171.48 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.315 2.01 . . . . 0.56999999999999995 111.235 166.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 t 43.59 68.89 0.46 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.497 1.519 . . . . 0.56999999999999995 113.151 173.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -43.38 129.22 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.772 1.629 . . . . 0.56999999999999995 113.458 -173.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.42 113.86 3.51 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.28 -1.528 . . . . 0.56999999999999995 109.28 -178.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 168.4 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.063 2.145 . . . . 0.56999999999999995 108.48 175.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.96 -145.24 18.34 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.556 -1.017 . . . . 0.56999999999999995 110.556 177.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -128.06 102.25 21.85 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.833 -1.543 . . . . 0.66000000000000003 106.833 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.81 67.09 6.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.985 2.457 . . . . 0.56999999999999995 109.481 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -165.1 -48.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.326 1.85 . . . . 0.56999999999999995 108.961 178.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -77.4 43.11 0.37 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.9 1.444 . . . . 0.56999999999999995 114.9 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -14.4 -71.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 128.352 2.661 . . . . 0.56999999999999995 117.06 -177.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 17.81 79.03 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 128.324 2.649 . . . . 0.56999999999999995 112.309 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 mp -31.66 117.4 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.421 1.889 . . . . 0.56999999999999995 109.762 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -92.2 -87.85 0.21 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.101 -0.476 . . . . 0.56999999999999995 110.481 -163.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -139.57 -39.06 0.47 Allowed 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 117.644 -1.17 . . . . 0.56999999999999995 111.721 177.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -58.93 -37.2 76.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 120.174 1.352 . . . . 0.66000000000000003 110.87 174.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.42 -59.31 2.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 124.118 0.886 . . . . 0.66000000000000003 109.109 175.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.47 -46.0 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.574 1.149 . . . . 0.56999999999999995 110.237 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.37 -47.45 76.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.495 1.118 . . . . 0.56999999999999995 109.749 -177.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.53 58.14 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.995 -1.242 . . . . 0.56999999999999995 109.995 176.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -54.4 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.365 1.066 . . . . 0.56999999999999995 110.896 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -56.29 -43.5 78.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.546 1.139 . . . . 0.56999999999999995 109.569 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -65.14 -36.92 85.76 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.575 0.625 . . . . 0.56999999999999995 111.15 176.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.21 -46.57 79.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.813 1.645 . . . . 0.56999999999999995 112.153 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -104.88 8.06 34.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.406 0.683 . . . . 0.56999999999999995 112.636 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -101.11 -159.45 27.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.585 1.088 . . . . 0.56999999999999995 111.348 -167.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.7 -42.96 0.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.077 -1.062 . . . . 0.56999999999999995 111.227 -175.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.96 139.57 12.53 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.095 0.958 . . . . 1.2 108.863 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 p 167.72 63.68 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.221 2.208 . . . . 0.56999999999999995 110.193 -173.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -89.91 142.09 28.03 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.336 -0.852 . . . . 0.56999999999999995 109.238 170.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.7 t -172.48 149.7 2.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.617 . . . . 0.56999999999999995 106.944 169.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -142.48 133.99 26.53 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.237 -1.023 . . . . 1.2 108.237 176.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.46 148.91 43.81 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.127 1.371 . . . . 0.56999999999999995 108.334 -177.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 C-N-CA 124.77 1.228 . . . . 0.5 . 171.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 119.418 -0.325 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -96.04 -72.61 0.62 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.584 1.154 . . . . 0.56999999999999995 108.816 -177.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.96 -52.59 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.224 1.01 . . . . 0.56999999999999995 110.688 178.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.88 96.17 19.45 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.709 1.604 . . . . 0.56999999999999995 108.548 -175.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.0 119.71 6.36 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.474 1.449 . . . . 0.56999999999999995 108.743 173.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -144.73 -67.04 0.32 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.102 -1.444 . . . . 0.56999999999999995 107.102 170.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.39 70.13 0.95 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 126.63 1.972 . . . . 0.56999999999999995 109.019 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.46 134.04 31.98 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.559 1.506 . . . . 0.56999999999999995 109.328 177.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 71.47 115.84 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.043 1.737 . . . . 0.56999999999999995 109.48 -171.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -57.12 150.11 18.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.742 0.817 . . . . 0.56999999999999995 110.251 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -65.9 -23.89 66.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.841 0.857 . . . . 0.56999999999999995 111.392 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -94.16 152.63 18.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.99 0.916 . . . . 0.56999999999999995 110.364 173.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -85.62 -3.4 58.87 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.654 1.182 . . . . 0.56999999999999995 112.636 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.56 111.03 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.107 -1.072 . . . . 0.56999999999999995 108.107 177.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.15 124.78 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.551 -1.277 . . . . 0.56999999999999995 107.551 -170.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -92.6 152.23 19.7 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.599 -0.688 . . . . 0.56999999999999995 110.441 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -123.09 153.45 39.9 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.696 0.799 . . . . 0.56999999999999995 111.506 175.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.28 117.77 6.52 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.649 0.738 . . . . 1.2 110.549 174.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mt -87.74 89.46 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 105.05 -2.204 . . . . 0.56999999999999995 105.05 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.89 -31.78 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.135 0.974 . . . . 0.56999999999999995 112.097 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 t -136.2 157.65 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.589 -2.375 . . . . 0.56999999999999995 104.589 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -135.21 167.42 21.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 107.663 -173.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -68.49 -175.03 0.6 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 0.56999999999999995 111.459 172.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -41.49 2.56 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.544 1.138 . . . . 1.2 111.241 -176.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -41.43 77.48 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.875 1.27 . . . . 0.66000000000000003 111.739 178.137 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.41 142.56 29.66 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 108.015 -172.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.42 158.46 56.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.769 1.646 . . . . 0.56999999999999995 112.192 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -67.98 -36.83 80.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.374 -0.83 . . . . 0.65000000000000002 110.592 -171.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.3 tt -65.84 -40.72 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 110.814 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -62.5 -46.08 90.08 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 117.717 -1.135 . . . . 0.56999999999999995 108.272 173.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 t -54.86 -49.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.467 -1.254 . . . . 0.56999999999999995 110.701 175.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.24 -40.25 96.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.498 1.499 . . . . 0.66000000000000003 111.778 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -62.85 -46.21 88.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.487 1.04 . . . . 1.2 111.553 175.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.88 -42.79 89.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.483 1.113 . . . . 0.56999999999999995 109.531 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.44 -43.47 96.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.985 -1.007 . . . . 0.56999999999999995 110.637 170.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -53.5 57.7 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.071 1.305 . . . . 0.56999999999999995 110.692 177.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -63.98 -35.93 82.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.065 1.302 . . . . 0.56999999999999995 111.928 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -41.88 69.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.34 0.973 . . . . 0.56999999999999995 111.907 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -65.91 -35.17 79.88 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.519 -0.753 . . . . 0.56999999999999995 109.88 171.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -59.35 -43.22 92.83 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.113 0.87 . . . . 0.56999999999999995 109.851 171.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.8 mtp -62.16 -41.41 98.27 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.279 -0.867 . . . . 0.56999999999999995 110.971 176.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -61.03 -49.93 75.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.838 1.199 . . . . 0.56999999999999995 111.576 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.64 -5.63 79.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.45 1.024 . . . . 0.56999999999999995 113.88 -178.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -77.6 -21.25 52.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.831 1.315 . . . . 0.56999999999999995 110.741 170.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -97.1 -13.29 22.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.862 0.865 . . . . 0.66000000000000003 111.235 -177.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 164' ' ' TYR . 17.9 pt -142.33 150.66 55.79 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.708 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.51 12.64 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.219 2.613 . . . . 0.56999999999999995 113.452 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -79.67 137.67 37.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -119.18 165.68 13.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.571 0.701 . . . . 0.65000000000000002 109.636 -173.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.7 161.95 35.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.092 -0.707 . . . . 0.56999999999999995 109.092 -173.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -179.8 6.82 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.638 -0.875 . . . . 1.2 108.638 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -131.16 154.84 47.94 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.881 -1.155 . . . . 0.56999999999999995 107.881 177.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.46 164.6 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 124.301 1.041 . . . . 0.56999999999999995 109.256 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.79 -22.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.168 -176.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -64.81 0.81 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.381 -0.97 . . . . 0.56999999999999995 108.381 174.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.24 157.57 7.92 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.078 1.799 . . . . 0.56999999999999995 109.253 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.8 m 61.17 135.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 112.761 178.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.12 177.68 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 121.243 -0.911 . . . . 0.56999999999999995 110.586 -173.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.11 -53.89 32.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.275 -1.38 . . . . 0.66000000000000003 107.275 177.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -103.47 77.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.211 2.204 . . . . 0.56999999999999995 108.358 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.9 ttp -76.72 148.51 36.71 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 119.167 -2.208 . . . . 0.56999999999999995 109.564 173.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.2 140.34 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.736 -1.579 . . . . 0.56999999999999995 106.736 173.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.25 162.3 31.76 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.461 -0.656 . . . . 0.56999999999999995 111.461 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.8 m-85 -137.2 141.46 42.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.052 -1.462 . . . . 0.56999999999999995 107.052 -174.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.3 -174.34 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.713 1.605 . . . . 0.56999999999999995 109.305 -177.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 50.15 1.28 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.224 . . . . 1.2 112.461 -172.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.09 123.58 3.77 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.794 -1.322 . . . . 0.56999999999999995 109.794 -173.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 52.14 122.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.593 2.357 . . . . 0.56999999999999995 115.514 -172.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.14 159.37 44.3 Favored 'General case' 0 C--N 1.341 0.222 0 O-C-N 120.39 -1.444 . . . . 0.65000000000000002 112.193 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.9 80.86 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.522 1.534 . . . . 0.56999999999999995 110.195 175.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.57 -84.36 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.942 1.297 . . . . 0.66000000000000003 110.663 -174.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 t -171.05 -37.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.122 1.369 . . . . 0.56999999999999995 110.126 -177.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.76 142.0 38.16 Favored Pre-proline 0 C--N 1.343 0.284 0 C-N-CA 123.728 0.811 . . . . 0.56999999999999995 109.478 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 124.15 10.28 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.54 1.493 . . . . 0.56999999999999995 109.521 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 171.64 3.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.409 1.1 . . . . 0.56999999999999995 110.398 161.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.537 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 18.6 p-10 -108.81 -44.37 4.03 Favored 'General case' 0 CA--C 1.542 0.645 1 C-N-CA 131.763 4.025 . . . . 0.66000000000000003 109.979 -171.055 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.96 -145.21 17.61 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.226 -1.319 . . . . 0.56999999999999995 111.166 -174.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.94 74.66 2.32 Favored 'Trans proline' 0 C--N 1.354 0.818 1 C-N-CA 125.588 4.192 . . . . 0.56999999999999995 114.042 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.48 -177.76 36.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.183 -1.967 . . . . 0.56999999999999995 108.183 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 76' ' ' ASP . 9.1 t-20 45.01 -150.19 0.06 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 113.453 174.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -43.0 109.81 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.471 2.308 . . . . 0.56999999999999995 111.513 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.542 ' CG ' ' HE2' ' A' ' 102' ' ' GLU . 5.6 mp -79.25 -29.65 42.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.616 1.166 . . . . 0.56999999999999995 113.319 -172.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.67 157.8 27.74 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.79 1.236 . . . . 0.56999999999999995 108.337 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -142.53 160.44 40.28 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.427 -0.795 . . . . 0.65000000000000002 110.303 174.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.63 172.85 12.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.937 0.895 . . . . 0.56999999999999995 108.723 176.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.95 153.96 46.1 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.527 -0.916 . . . . 0.56999999999999995 108.527 -177.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.23 135.56 76.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.424 -0.798 . . . . 0.56999999999999995 110.111 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -71.16 169.74 19.9 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.394 2.729 . . . . 0.56999999999999995 113.456 -177.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.05 -8.97 27.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.52 1.533 . . . . 0.56999999999999995 113.632 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -136.81 45.41 2.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.246 1.023 . . . . 0.56999999999999995 111.255 -163.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -77.05 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.211 1.386 . . . . 0.56999999999999995 114.185 173.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.85 -21.12 63.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.56999999999999995 110.268 167.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.2 145.65 4.39 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.211 -0.931 . . . . 0.56999999999999995 111.087 170.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.44 -34.29 3.88 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 110.922 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.24 152.53 40.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.292 1.046 . . . . 0.66000000000000003 110.449 -164.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.83 146.01 50.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.824 0.821 . . . . 0.56999999999999995 109.506 -175.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -138.44 152.84 48.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.001 0.92 . . . . 0.65000000000000002 110.093 -177.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 51.3 m-85 -140.09 155.82 46.85 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.633 1.173 . . . . 0.56999999999999995 108.995 -168.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -87.32 102.58 14.65 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.187 -0.301 . . . . 0.66000000000000003 110.187 172.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -53.98 -30.71 48.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.772 1.629 . . . . 0.66000000000000003 111.733 171.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.56 -35.28 79.96 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.341 0.657 . . . . 0.66000000000000003 111.522 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.542 ' HE2' ' CG ' ' A' ' 82' ' ' LEU . 88.5 mt-10 -73.73 150.69 41.01 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.744 0.818 . . . . 0.66000000000000003 109.068 177.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -72.67 144.44 47.74 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.743 -0.598 . . . . 1.2 110.698 175.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.87 128.28 36.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.8 -1.556 . . . . 0.56999999999999995 106.8 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -124.04 144.69 49.69 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.547 -0.538 . . . . 0.56999999999999995 109.547 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.21 -33.51 75.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.66000000000000003 111.284 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.42 95.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.88 -0.888 . . . . 0.56999999999999995 110.88 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.04 138.24 8.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.45 0.7 . . . . 0.56999999999999995 109.276 172.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 t -76.25 54.49 0.89 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.383 2.273 . . . . 0.56999999999999995 110.786 -175.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -158.15 -44.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.486 0.714 . . . . 0.56999999999999995 112.164 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.65 -176.2 38.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.545 -1.022 . . . . 0.56999999999999995 110.545 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.25 118.27 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 105.782 -1.933 . . . . 0.56999999999999995 105.782 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.82 113.01 2.79 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.891 -0.781 . . . . 0.56999999999999995 108.891 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -54.14 -42.37 69.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.25 1.02 . . . . 0.56999999999999995 110.823 177.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.97 -34.06 57.6 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.451 0.569 . . . . 0.56999999999999995 111.469 -171.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -64.48 -48.55 74.79 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.569 -0.9 . . . . 0.56999999999999995 108.569 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.27 74.34 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.804 0.442 . . . . 0.56999999999999995 110.548 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.24 78.16 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.948 -176.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.7 m -61.89 -37.42 84.53 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 0.899 . . . . 0.56999999999999995 110.961 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.51 -53.8 53.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.63 0.772 . . . . 0.65000000000000002 109.817 172.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.8 -44.28 73.88 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.628 0.771 . . . . 0.66000000000000003 111.914 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.26 -28.93 70.06 Favored 'General case' 0 CA--C 1.526 0.036 0 C-N-CA 124.389 1.076 . . . . 0.56999999999999995 111.239 176.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.78 -46.56 93.3 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.623 -0.591 . . . . 0.56999999999999995 111.623 171.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -64.2 -38.41 90.96 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 117.161 0.48 . . . . 0.65000000000000002 111.243 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -34.38 69.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.707 0.632 . . . . 0.56999999999999995 112.707 174.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -22.69 65.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.343 -0.848 . . . . 0.56999999999999995 112.856 174.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.04 -13.61 4.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.709 1.147 . . . . 0.56999999999999995 113.464 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.3 tpp -65.15 144.59 57.11 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.817 1.309 . . . . 0.56999999999999995 110.862 -171.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -97.7 -38.96 4.01 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 117.762 -1.577 . . . . 0.56999999999999995 112.038 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 m80 156.52 -176.4 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.893 3.677 . . . . 0.65000000000000002 108.111 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.4 m -145.45 179.88 7.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 107.829 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.61 94.39 2.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.785 -1.561 . . . . 0.56999999999999995 106.785 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -154.24 138.02 10.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 107.211 -1.403 . . . . 0.66000000000000003 107.211 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.9 -19.57 46.21 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.978 1.785 . . . . 0.56999999999999995 113.37 -173.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -124.39 27.21 7.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.783 1.233 . . . . 0.56999999999999995 109.108 -177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.42 138.52 57.63 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.315 0.646 . . . . 0.56999999999999995 110.369 175.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.5 p -75.02 -26.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.815 -0.439 . . . . 0.56999999999999995 109.815 168.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 13.41 15.53 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.615 -0.678 . . . . 0.56999999999999995 112.148 174.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -70.46 146.35 93.98 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.552 1.524 . . . . 0.56999999999999995 111.528 -174.369 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 38.2 Cg_endo -78.81 -50.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.181 1.921 . . . . 0.56999999999999995 112.693 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.5 t -67.62 120.13 13.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.921 -0.77 . . . . 0.56999999999999995 108.921 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.52 112.77 9.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.899 -0.778 . . . . 0.56999999999999995 108.899 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.76 170.54 21.91 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.805 -1.318 . . . . 0.56999999999999995 109.805 172.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.28 -53.67 0.47 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.507 2.323 . . . . 0.56999999999999995 114.029 174.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.65 108.39 2.48 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 127.162 2.315 . . . . 0.56999999999999995 108.883 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.718 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 49.1 t0 -53.94 111.07 2.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.758 1.623 . . . . 0.66000000000000003 110.751 177.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.05 -10.07 13.99 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.804 2.336 . . . . 0.56999999999999995 112.733 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -96.43 -27.49 14.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.719 1.145 . . . . 0.56999999999999995 110.965 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.718 ' ND2' ' HD2' ' A' ' 146' ' ' ASP . 18.9 m-80 -116.15 71.1 0.77 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.069 -1.086 . . . . 0.56999999999999995 108.069 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -120.95 139.0 53.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.225 1.01 . . . . 0.56999999999999995 108.871 -178.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.96 42.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.36 1.064 . . . . 0.56999999999999995 110.592 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 64.44 92.89 0.06 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.213 1.805 . . . . 0.56999999999999995 110.638 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 75.3 m -75.23 -79.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.374 0.879 . . . . 0.56999999999999995 113.374 -169.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -149.1 -49.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.333 1.053 . . . . 0.56999999999999995 108.248 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -47.54 -46.48 27.76 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 126.151 1.78 . . . . 0.66000000000000003 111.749 167.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.79 -47.84 50.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.801 0.841 . . . . 0.66000000000000003 109.326 -174.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.16 -45.43 92.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 124.311 1.044 . . . . 0.56999999999999995 109.693 175.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -49.1 72.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.261 1.024 . . . . 0.56999999999999995 109.703 -178.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.74 72.79 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.705 -1.358 . . . . 0.56999999999999995 109.705 177.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.3 -53.99 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.178 -0.915 . . . . 0.56999999999999995 111.21 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.56 64.14 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.601 1.091 . . . . 0.56999999999999995 111.459 -178.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -77.33 -35.08 55.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.158 0.583 . . . . 0.56999999999999995 112.131 173.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.3 -40.85 98.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.992 1.717 . . . . 0.56999999999999995 112.749 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.443 ' CD1' HG21 ' A' ' 46' ' ' ILE . 16.8 p90 -106.65 7.14 30.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.363 0.665 . . . . 0.56999999999999995 112.503 178.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.46 -131.41 2.81 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.631 -1.788 . . . . 0.56999999999999995 108.631 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -148.22 -50.22 0.17 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.377 0.671 . . . . 0.56999999999999995 111.854 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.65 -179.89 0.06 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.937 0.895 . . . . 1.2 111.32 -169.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.18 111.76 20.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.56999999999999995 106.994 171.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.31 157.55 18.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.066 0.547 . . . . 0.56999999999999995 109.792 172.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.1 t -146.89 177.14 9.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.334 -1.358 . . . . 0.56999999999999995 107.334 168.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -63.13 145.0 56.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.429 1.092 . . . . 1.2 110.374 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.56 -42.11 17.16 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.439 0.903 . . . . 0.56999999999999995 113.439 -174.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 125.402 1.481 . . . . 0.5 . -177.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' MDW . . . . . 0.456 ' C24' HD12 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.452 -0.954 0 N-CA-C 109.174 -1.125 . . . . 0.57 109.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 pttt 101.19 138.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 130.174 3.389 . . . . 0.57 109.305 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.467 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 12.3 m95 -64.89 162.27 16.69 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.811 0.844 . . . . 0.57 110.69 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.9 p -91.46 6.42 45.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.697 -0.627 . . . . 0.57 112.42 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -109.7 147.7 32.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.881 1.272 . . . . 0.57 109.056 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -16.89 61.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.293 0.637 . . . . 0.57 111.943 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.55 143.49 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.009 -1.108 . . . . 0.57 108.009 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 172.24 13.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.893 -0.78 . . . . 0.57 108.893 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -116.56 153.33 32.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.389 0.276 . . . . 0.57 110.627 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -128.6 149.84 50.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.07 0.948 . . . . 0.57 111.128 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.64 106.23 3.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.821 0.849 . . . . 1.2 108.884 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.5 mt -84.47 84.2 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 106.716 -1.587 . . . . 0.57 106.716 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.38 -41.72 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 0.57 112.696 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -126.08 164.83 20.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.611 -2.366 . . . . 0.57 104.611 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -136.35 155.0 50.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.46 -1.311 . . . . 0.57 107.46 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -66.54 -172.02 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.906 0.883 . . . . 0.57 111.132 168.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -33.46 0.83 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.874 1.67 . . . . 1.2 112.763 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -39.3 78.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.016 0.926 . . . . 0.66 112.179 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 148.33 65.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.947 2.099 . . . . 0.57 108.088 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.8 163.49 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.84 2.36 . . . . 0.57 112.716 -171.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -62.48 -36.13 81.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.439 0.696 . . . . 0.65 112.265 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.78 -38.63 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.549 0.34 . . . . 0.57 110.744 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.9 m -69.65 -41.72 75.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.542 -1.218 . . . . 0.57 109.5 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.1 t -53.98 -54.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 120.341 1.428 . . . . 0.57 109.719 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -43.54 98.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.989 0.813 . . . . 0.66 110.834 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -42.08 98.2 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.28 0.945 . . . . 1.2 112.029 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.02 -40.64 68.3 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.682 -1.151 . . . . 0.57 109.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.24 -49.37 76.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 119.31 0.959 . . . . 0.57 109.183 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -65.03 -44.48 88.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.599 0.76 . . . . 0.57 110.437 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -66.3 -45.23 81.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.561 1.073 . . . . 0.57 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -47.26 86.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.033 0.833 . . . . 0.57 110.811 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 19.7 mt -67.8 -36.73 80.96 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.455 0.702 . . . . 0.57 111.514 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.36 -38.39 89.36 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 119.16 0.891 . . . . 0.57 109.651 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.28 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.032 0.933 . . . . 0.57 112.514 173.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 40.9 m95 -68.13 -51.05 50.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.845 1.202 . . . . 0.57 110.948 168.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.03 -11.65 58.86 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.563 1.077 . . . . 0.57 113.318 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -31.17 72.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.377 -1.072 . . . . 0.57 110.481 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -101.26 -21.17 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.016 0.825 . . . . 0.66 111.803 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.7 pt -133.15 135.5 25.76 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.493 1.117 . . . . 0.57 110.77 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.17 26.36 0.26 Allowed 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 123.814 3.009 . . . . 0.57 114.57 -174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.24 136.53 34.37 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.038 1.335 . . . . 0.57 108.239 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -117.24 165.15 13.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.664 0.785 . . . . 0.65 109.638 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -140.15 148.02 41.02 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.234 -1.024 . . . . 0.57 108.234 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -142.33 169.31 17.82 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.842 1.257 . . . . 1.2 109.661 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -103.75 149.39 25.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.571 -0.9 . . . . 0.57 108.571 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.78 167.49 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.399 1.08 . . . . 0.57 110.45 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.66 -40.83 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.514 0.726 . . . . 0.57 110.867 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -164.9 87.23 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.059 1.343 . . . . 0.57 107.392 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.41 160.5 11.56 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.219 -1.152 . . . . 0.57 110.219 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.1 m -66.38 136.11 55.29 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.258 1.029 . . . . 0.57 109.467 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.13 165.11 16.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.508 0.723 . . . . 0.57 111.494 175.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.37 -29.04 65.6 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.936 -1.029 . . . . 0.66 110.389 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.89 80.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.62 1.968 . . . . 0.57 108.731 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.7 ttm -69.37 128.27 35.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 120.653 -1.279 . . . . 0.57 107.684 163.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.18 127.1 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.163 -2.162 . . . . 0.57 105.163 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.42 158.63 26.55 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.505 -0.638 . . . . 0.57 111.505 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.8 m-85 -133.93 146.02 50.12 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 106.838 -1.542 . . . . 0.57 106.838 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.3 173.73 11.51 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.06 1.744 . . . . 0.57 108.537 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -134.12 66.77 1.53 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.461 1.028 . . . . 1.2 111.614 -169.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 105.37 0.49 Allowed Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.659 -0.976 . . . . 0.57 110.659 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 57.91 160.33 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.423 2.689 . . . . 0.57 114.474 -169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.11 170.24 10.46 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.998 1.319 . . . . 0.65 110.547 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.84 61.42 3.69 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.466 1.508 . . . . 0.57 112.37 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -131.47 -179.18 5.21 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.854 1.262 . . . . 0.66 109.909 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 p -58.23 -36.9 73.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.671 0.669 . . . . 0.57 111.25 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -135.57 112.12 10.74 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.447 0.699 . . . . 0.57 110.517 -172.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.95 130.32 18.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.918 1.745 . . . . 0.57 111.288 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -59.1 170.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.011 1.324 . . . . 0.57 113.585 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -115.41 -25.57 7.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.615 1.966 . . . . 0.66 112.168 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.81 -139.38 14.49 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 120.139 1.336 . . . . 0.57 111.408 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.19 98.28 1.19 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.361 2.707 . . . . 0.57 112.2 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.11 -176.4 23.4 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.706 1.146 . . . . 0.57 112.066 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 t30 52.27 -130.63 2.19 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 120.823 -1.398 . . . . 0.57 110.683 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.3 m -69.08 132.19 46.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.66 2.784 . . . . 0.57 110.828 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -102.27 -29.74 11.5 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.186 1.394 . . . . 0.57 112.741 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.7 32.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.076 1.35 . . . . 0.57 108.237 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -145.54 150.76 37.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.744 0.702 . . . . 0.65 110.113 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.52 165.35 28.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.806 0.842 . . . . 0.57 109.47 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -119.71 151.46 38.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.194 -1.039 . . . . 0.57 108.194 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.86 150.44 97.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.43 -0.795 . . . . 0.57 110.17 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 59.9 Cg_endo -72.8 154.41 53.85 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.216 1.944 . . . . 0.57 111.196 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.49 42.77 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.821 -0.989 . . . . 0.57 111.484 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.2 m 63.8 161.01 0.1 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.003 2.121 . . . . 0.57 112.491 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -140.39 28.65 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 121.06 -1.025 . . . . 0.57 110.852 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.71 -23.8 44.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.371 0.668 . . . . 0.57 111.525 171.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.77 139.61 31.84 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.002 -1.061 . . . . 0.57 110.907 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.13 -19.79 16.02 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.425 1.488 . . . . 0.57 113.286 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -71.92 155.92 39.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.954 1.377 . . . . 0.66 108.739 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.72 145.6 36.67 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.026 0.917 . . . . 0.57 109.598 -172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -138.07 147.1 43.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.002 -0.999 . . . . 0.65 108.465 -170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.443 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 41.4 m-85 -138.04 148.49 45.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.248 1.019 . . . . 0.57 108.434 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -95.04 100.64 12.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 106.634 -1.617 . . . . 0.66 106.634 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -59.61 -23.13 62.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.356 1.462 . . . . 0.66 111.495 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -60.48 -28.85 68.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.504 0.722 . . . . 0.66 111.088 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.4 129.68 34.73 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.177 -1.045 . . . . 0.66 108.177 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -64.04 112.41 2.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.394 0.677 . . . . 1.2 111.799 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.07 146.76 24.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.57 109.458 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -146.96 145.22 29.69 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.419 -0.956 . . . . 0.57 108.419 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.19 -39.79 93.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.077 0.551 . . . . 0.66 110.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.85 83.91 0.06 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.704 -1.758 . . . . 0.57 108.704 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.9 t -118.06 -62.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.677 0.738 . . . . 0.57 109.523 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -164.65 -45.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.85 1.26 . . . . 0.57 110.703 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.31 142.89 41.88 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.598 1.159 . . . . 0.57 109.441 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.3 -172.81 19.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.84 -1.704 . . . . 0.57 108.84 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.42 115.44 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.631 -1.618 . . . . 0.57 106.631 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.22 115.08 4.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.013 0.525 . . . . 0.57 110.05 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -66.13 -42.93 88.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.534 1.134 . . . . 0.57 111.693 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -42.65 90.66 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.078 0.951 . . . . 0.57 109.573 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -65.96 -49.61 67.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.857 0.863 . . . . 0.57 110.789 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -46.95 85.42 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.008 0.367 . . . . 0.57 111.737 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -50.0 75.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 117.97 -1.014 . . . . 0.57 108.588 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -53.72 -45.88 70.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.567 1.076 . . . . 0.57 111.307 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -58.09 -55.11 39.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.825 1.25 . . . . 0.65 109.708 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.73 -47.56 59.09 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.337 0.655 . . . . 0.66 111.194 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.52 -29.11 68.9 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.666 1.186 . . . . 0.57 110.799 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -61.1 -46.76 93.9 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 118.741 0.7 . . . . 0.57 112.373 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.15 -42.54 99.46 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.956 -1.021 . . . . 0.65 110.502 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.4 m -57.82 -32.67 67.81 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.086 0.866 . . . . 0.57 113.266 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -50.06 64.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.903 0.881 . . . . 0.57 109.928 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.21 32.34 0.03 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-O 117.862 -1.521 . . . . 0.57 114.995 -172.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.01 171.42 0.2 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.046 1.338 . . . . 0.57 111.713 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.26 43.6 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.53 -0.731 . . . . 0.57 113.601 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 166.94 18.39 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.909 1.355 . . . . 0.65 111.636 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -175.91 4.59 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.667 1.587 . . . . 0.57 109.388 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 35.69 1.28 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.529 1.532 . . . . 0.57 109.854 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.52 151.96 54.0 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.384 1.473 . . . . 0.66 109.376 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.16 -22.56 61.23 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.797 2.331 . . . . 0.57 113.219 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -130.44 27.48 5.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.544 1.537 . . . . 0.57 109.246 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 132.54 54.25 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 121.704 -0.623 . . . . 0.57 110.083 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.27 -23.45 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.554 0.742 . . . . 0.57 111.545 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.27 20.5 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.455 1.102 . . . . 0.57 111.381 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.01 133.32 80.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 119.511 1.05 . . . . 0.57 111.389 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.8 128.01 9.83 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.832 2.355 . . . . 0.57 110.753 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.5 m 70.78 115.15 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.094 2.158 . . . . 0.57 111.143 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.47 148.22 9.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.336 1.054 . . . . 0.57 112.939 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.91 -124.45 0.78 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.686 -0.966 . . . . 0.57 110.686 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.6 -37.21 83.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.569 1.148 . . . . 0.57 113.586 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.59 97.59 0.06 OUTLIER Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.817 1.198 . . . . 0.57 110.745 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -65.24 116.52 31.27 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.849 0.86 . . . . 0.66 108.885 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.4 -16.67 8.05 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 CA-C-O 117.53 -1.112 . . . . 0.57 112.964 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -61.18 -37.2 82.08 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.703 1.592 . . . . 0.57 109.279 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.14 122.35 14.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.566 1.146 . . . . 0.57 107.975 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -131.7 -55.64 1.0 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.653 1.181 . . . . 0.57 107.83 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 36.12 52.81 0.9 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.438 1.495 . . . . 0.57 111.005 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.01 90.89 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.021 2.128 . . . . 0.57 110.91 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -66.14 -83.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.829 1.418 . . . . 0.57 114.829 -168.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -143.84 -44.57 0.27 Allowed 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.863 1.665 . . . . 0.57 107.767 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.43 -51.69 33.74 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.81 1.244 . . . . 0.66 111.544 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -50.52 73.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.501 0.592 . . . . 0.66 111.598 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.81 -44.66 98.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 108.858 -0.793 . . . . 0.57 108.858 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -65.16 -44.81 87.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.698 -1.144 . . . . 0.57 108.971 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.47 -59.0 11.6 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.596 -1.002 . . . . 0.57 110.596 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 160' ' ' ILE . 6.1 mm -57.15 -48.65 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.361 1.08 . . . . 0.57 111.384 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -73.06 -15.46 61.5 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 120.02 1.282 . . . . 0.57 112.161 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -79.51 -32.11 42.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.678 1.126 . . . . 0.57 111.49 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.94 -43.64 11.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.283 1.433 . . . . 0.57 111.709 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 126.328 1.851 . . . . 0.57 110.928 -177.75 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.455 -0.747 0 N-CA-C 108.842 -1.253 . . . . 0.57 108.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 82.57 111.28 0.06 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.405 2.282 . . . . 0.57 109.104 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -56.37 147.7 20.74 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.107 0.563 . . . . 0.57 111.276 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -77.35 -28.22 52.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.489 0.715 . . . . 0.57 111.514 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -84.37 144.25 28.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.798 0.839 . . . . 0.57 109.902 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -81.49 -8.74 59.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.085 0.954 . . . . 0.57 111.866 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.25 119.57 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.924 -2.25 . . . . 0.57 104.924 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.21 142.98 36.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.122 -1.436 . . . . 0.57 107.122 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -96.32 152.68 18.36 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.001 -0.437 . . . . 0.57 111.028 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -128.2 155.04 45.15 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.809 0.844 . . . . 0.57 111.662 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 114.07 4.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 1.2 109.566 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.8 mt -85.43 86.11 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.222 -1.77 . . . . 0.57 106.222 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -68.25 -29.96 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.313 1.445 . . . . 0.57 113.846 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -136.57 160.26 39.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 130.714 3.606 . . . . 0.57 102.827 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -135.84 163.98 28.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.668 1.187 . . . . 0.57 108.345 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.416 HG22 HG21 ' A' ' 31' ' ' VAL . 5.7 t -74.02 -175.07 2.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.94 0.896 . . . . 0.57 111.409 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -44.2 1.86 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.667 1.187 . . . . 1.2 113.211 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -32.52 67.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.399 1.08 . . . . 0.66 110.791 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 105' ' ' THR . 46.0 mt -123.2 143.51 41.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.311 1.444 . . . . 0.57 109.243 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.35 152.09 38.73 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.765 1.643 . . . . 0.57 111.789 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -62.18 -37.24 84.52 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.07 1.348 . . . . 0.65 112.199 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.76 -42.86 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.819 . . . . 0.57 109.847 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.5 m -70.55 -38.73 74.19 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 117.209 -1.377 . . . . 0.57 110.042 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG21 HG22 ' A' ' 23' ' ' THR . 24.8 t -59.39 -45.66 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.434 1.47 . . . . 0.57 110.978 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.98 -41.09 78.37 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.93 0.786 . . . . 0.66 110.788 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.17 87.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.933 -1.104 . . . . 1.2 112.631 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -64.79 -39.56 93.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.615 -0.883 . . . . 0.57 108.615 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.66 -43.63 98.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 119.207 0.912 . . . . 0.57 110.415 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -59.1 -48.53 81.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.831 -1.08 . . . . 0.57 111.79 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -67.66 -34.45 76.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.583 1.538 . . . . 0.57 112.173 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.57 -40.7 76.6 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.105 1.321 . . . . 0.57 112.185 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.2 mt -72.98 -32.32 65.11 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 118.561 -0.733 . . . . 0.57 110.888 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.64 -47.38 86.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 119.138 0.881 . . . . 0.57 109.252 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.0 mtp -54.24 -36.59 63.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 117.226 -1.368 . . . . 0.57 112.442 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -72.5 -44.4 62.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.165 1.802 . . . . 0.57 112.352 171.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.93 59.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.17 0.89 . . . . 0.57 113.273 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -14.46 62.94 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.193 -1.18 . . . . 0.57 111.809 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -115.88 -29.11 6.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.53 1.132 . . . . 0.66 110.73 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 pt -123.66 132.72 24.3 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.524 1.13 . . . . 0.57 110.982 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.0 34.9 0.37 Allowed 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.235 3.29 . . . . 0.57 113.934 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.56 137.22 35.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.423 1.489 . . . . 0.57 107.782 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -121.12 159.56 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.04 1.336 . . . . 0.65 109.177 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 149.39 44.04 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.954 -1.091 . . . . 0.57 109.882 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.21 179.3 7.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.988 0.915 . . . . 1.2 110.68 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -118.71 161.3 20.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.407 1.083 . . . . 0.57 109.12 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.3 m -121.44 160.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.487 1.515 . . . . 0.57 108.88 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.97 29.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.32 1.048 . . . . 0.57 110.373 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -54.63 1.26 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.403 1.081 . . . . 0.57 110.394 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.27 -135.91 2.31 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.227 -1.149 . . . . 0.57 110.227 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 58' ' ' ALA . 5.0 m -83.65 176.94 8.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.561 1.145 . . . . 0.57 109.922 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 57' ' ' THR . . . -135.76 173.46 11.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.894 1.678 . . . . 0.57 110.285 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.19 -39.9 91.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.416 -0.802 . . . . 0.66 109.868 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.4 mt -117.93 75.33 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.204 2.202 . . . . 0.57 108.746 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.98 128.81 37.24 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.789 -1.194 . . . . 0.57 108.854 166.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.95 129.85 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 104.784 -2.302 . . . . 0.57 104.784 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.08 170.77 27.17 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.269 -0.733 . . . . 0.57 111.269 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.7 m-85 -144.59 151.16 38.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.782 -1.192 . . . . 0.57 107.782 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.3 171.01 18.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.822 1.326 . . . . 0.57 110.417 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 57.17 1.67 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.613 0.765 . . . . 1.2 111.019 -173.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -46.33 1.1 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.743 1.163 . . . . 0.57 111.482 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.69 157.45 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.558 1.179 . . . . 0.57 109.573 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -153.6 163.44 39.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.211 1.805 . . . . 0.65 108.336 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.21 85.59 1.53 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.88 -1.288 . . . . 0.57 109.88 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -130.92 -55.11 1.06 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.834 0.854 . . . . 0.66 110.998 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 157.76 -38.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.748 2.819 . . . . 0.57 110.156 -166.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -129.93 110.5 17.06 Favored Pre-proline 0 C--N 1.345 0.382 0 CA-C-N 119.794 1.179 . . . . 0.57 110.447 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.25 133.12 36.46 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 108.736 -1.294 . . . . 0.57 108.736 173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.55 -169.81 0.35 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.64 1.576 . . . . 0.57 110.217 172.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -119.63 -35.01 3.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.266 2.226 . . . . 0.66 109.815 -168.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.6 -146.37 18.18 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.925 1.25 . . . . 0.57 110.203 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.99 111.31 3.21 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.527 2.818 . . . . 0.57 112.22 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.31 160.09 13.92 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 128.099 2.762 . . . . 0.57 109.71 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.271 33.3 t30 70.57 -143.51 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.112 1.765 . . . . 0.57 112.528 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -49.92 138.79 14.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.324 1.85 . . . . 0.57 110.795 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 112' ' ' ILE . 38.2 mt -108.74 -28.96 8.93 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.72 -1.863 . . . . 0.57 112.303 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.22 165.41 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.573 1.149 . . . . 0.57 108.13 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -146.51 161.71 39.86 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.547 -0.538 . . . . 0.65 109.547 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.34 161.7 39.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.835 1.254 . . . . 0.57 109.106 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.52 150.7 34.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.393 -0.965 . . . . 0.57 108.393 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.9 91.17 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.562 -0.732 . . . . 0.57 109.856 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.4 161.21 45.81 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.29 1.994 . . . . 0.57 110.91 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.25 -83.48 0.18 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.835 -0.906 . . . . 0.57 110.835 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.7 p -78.15 -177.72 5.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.5 1.52 . . . . 0.57 111.272 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.81 -52.49 50.55 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.253 -1.304 . . . . 0.57 112.854 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -20.21 61.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.297 1.049 . . . . 0.57 110.967 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.51 148.74 11.29 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 120.756 -1.215 . . . . 0.57 111.18 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.11 1.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 117.259 -1.856 . . . . 0.57 114.924 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -68.22 156.18 38.15 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 125.306 1.239 . . . . 0.66 109.833 -160.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.78 144.48 31.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.57 110.956 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -131.19 157.79 42.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.024 -0.989 . . . . 0.65 109.437 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 69.1 m-85 -140.01 145.79 38.24 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.308 1.443 . . . . 0.57 108.516 -170.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.21 93.62 4.63 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.29 -0.633 . . . . 0.66 109.29 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -53.45 -28.04 28.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.799 1.24 . . . . 0.66 111.27 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.01 -33.62 76.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.758 0.281 . . . . 0.66 111.758 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.89 138.61 46.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.115 -1.439 . . . . 0.66 107.115 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -62.93 134.16 55.76 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.468 -0.77 . . . . 1.2 109.656 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -118.49 143.32 46.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.622 0.769 . . . . 0.57 109.444 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.442 ' HA ' HD21 ' A' ' 26' ' ' LEU . 3.6 t -138.89 151.75 47.21 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.339 0.656 . . . . 0.57 110.761 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.75 -38.19 83.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.467 0.707 . . . . 0.66 109.898 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.46 101.44 0.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.006 -1.638 . . . . 0.57 109.006 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.27 170.43 21.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.759 2.024 . . . . 0.57 108.647 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.74 72.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.247 1.419 . . . . 0.57 114.447 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.72 149.77 34.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.997 -0.742 . . . . 0.57 108.997 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.42 153.37 14.65 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.534 -1.426 . . . . 0.57 109.534 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.499 HG21 HD13 ' A' ' 82' ' ' LEU . 45.4 mm -78.36 130.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.78 -1.563 . . . . 0.57 106.78 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -65.53 109.04 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.428 -0.582 . . . . 0.57 109.428 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 34' ' ' LEU . 2.4 t80 -56.07 -43.57 78.09 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.24 1.416 . . . . 0.57 109.01 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 34' ' ' LEU . 12.7 tp -68.83 -38.54 79.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.589 0.631 . . . . 0.57 111.943 -173.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -65.01 -44.4 89.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.835 -0.802 . . . . 0.57 108.835 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -50.42 70.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.646 0.379 . . . . 0.57 111.23 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.09 75.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.109 -0.948 . . . . 0.57 109.86 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -60.52 -33.46 72.67 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.795 1.179 . . . . 0.57 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.3 -58.62 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.338 0.972 . . . . 0.65 109.978 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -64.3 -43.1 95.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.449 0.7 . . . . 0.66 111.272 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.09 -27.76 69.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.885 1.274 . . . . 0.57 110.971 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.33 -50.91 62.68 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.389 -0.684 . . . . 0.57 111.389 171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -59.18 -43.02 92.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.191 -0.909 . . . . 0.65 110.666 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -38.44 64.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.438 1.711 . . . . 0.57 114.035 174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -44.96 86.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.789 0.836 . . . . 0.57 110.949 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.67 43.32 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-O 118.688 -1.062 . . . . 0.57 114.338 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -121.77 150.77 41.37 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.926 1.363 . . . . 0.57 110.416 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -98.55 -43.32 2.74 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.455 -1.747 . . . . 0.57 113.191 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m170 163.75 179.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.95 2.9 . . . . 0.65 109.899 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 3.9 m -147.62 179.03 7.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.545 1.938 . . . . 0.57 109.508 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -146.52 81.83 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.437 1.095 . . . . 0.57 109.996 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -147.11 146.38 25.43 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.266 -1.012 . . . . 0.66 108.266 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.24 -32.25 42.56 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 CA-C-N 121.407 1.538 . . . . 0.57 111.882 -171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -116.84 23.86 11.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.031 1.332 . . . . 0.57 109.254 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -63.33 136.48 57.69 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.017 0.927 . . . . 0.57 109.266 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.43 -32.37 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 118.927 -1.109 . . . . 0.57 109.631 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.73 7.55 10.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.575 1.08 . . . . 0.57 113.17 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -69.03 145.8 96.8 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.895 1.679 . . . . 0.57 110.967 -176.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.04 166.21 30.65 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.08 1.853 . . . . 0.57 110.971 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 m 65.56 -67.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.662 1.985 . . . . 0.57 111.673 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 161.84 1.17 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.285 2.234 . . . . 0.57 107.366 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.1 136.22 12.81 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.061 -1.616 . . . . 0.57 109.061 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -71.89 -16.25 62.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.463 1.105 . . . . 0.57 112.394 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -78.29 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.573 -1.411 . . . . 0.57 109.573 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -174.85 144.74 0.87 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.955 1.302 . . . . 0.66 108.776 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.36 -23.24 8.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.275 1.983 . . . . 0.57 114.992 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -103.24 -39.31 6.88 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.456 1.48 . . . . 0.57 110.308 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.9 70.28 10.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.967 1.307 . . . . 0.57 109.563 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.5 150.77 40.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.289 0.636 . . . . 0.57 110.44 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.29 62.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.869 1.268 . . . . 0.57 110.052 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mp 62.69 87.45 0.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.224 1.41 . . . . 0.57 111.237 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.5 m -71.83 -97.51 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.802 1.241 . . . . 0.57 113.424 -171.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -122.99 -51.79 1.89 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 120.879 -1.138 . . . . 0.57 108.166 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 0.6 OUTLIER -51.06 -39.55 56.25 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.536 0.939 . . . . 0.66 113.536 177.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -69.07 -55.36 11.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.437 1.095 . . . . 0.66 110.748 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.58 -38.99 81.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-O 117.959 -1.02 . . . . 0.57 108.598 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.38 86.89 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 120.167 1.349 . . . . 0.57 109.51 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.33 31.47 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.247 -0.741 . . . . 0.57 111.247 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 160' ' ' ILE . 5.6 mm -64.3 -48.82 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.009 0.524 . . . . 0.57 111.803 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -17.56 64.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.426 1.09 . . . . 0.57 111.894 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -42.92 17.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.869 -1.062 . . . . 0.57 109.662 172.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.78 -49.23 60.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.559 1.144 . . . . 0.57 111.426 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 . . . . . 0 C--O 1.235 0.302 0 C-N-CA 124.941 1.296 . . . . 0.57 111.302 -175.051 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.449 -1.112 0 N-CA-C 110.821 -0.492 . . . . 0.57 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt 83.51 115.91 0.05 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 127.429 2.292 . . . . 0.57 108.997 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 4.2 m95 -64.93 163.03 15.27 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.096 0.558 . . . . 0.57 111.558 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.9 m -89.35 -24.46 21.97 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.418 1.087 . . . . 0.57 111.997 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -91.28 149.11 21.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.585 0.754 . . . . 0.57 109.797 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -5.84 52.98 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.961 0.726 . . . . 0.57 112.961 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.56 139.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.57 107.189 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.58 148.3 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.452 -1.314 . . . . 0.57 107.452 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.9 p -97.52 139.61 33.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.852 -0.795 . . . . 0.57 108.852 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -126.97 159.9 32.7 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.822 -0.549 . . . . 0.57 110.995 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -153.09 160.25 42.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.103 1.361 . . . . 1.2 108.301 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.56 94.24 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.086 -2.561 . . . . 0.57 104.086 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -40.69 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.112 0.965 . . . . 0.57 112.152 -170.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.12 153.4 41.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.146 -2.168 . . . . 0.57 105.146 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -134.98 143.19 46.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.058 0.943 . . . . 0.57 108.463 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -72.18 169.02 17.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.256 -1.338 . . . . 0.57 110.165 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -24.89 5.89 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.731 0.812 . . . . 1.2 112.881 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -35.43 80.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.942 0.877 . . . . 0.66 111.224 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.58 154.14 78.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.122 1.769 . . . . 0.57 109.629 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.19 161.15 29.4 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.702 1.602 . . . . 0.57 112.933 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.84 -35.45 80.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.65 111.342 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -64.84 -35.68 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.523 0.729 . . . . 0.57 110.55 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -64.73 -51.11 64.1 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.296 -1.335 . . . . 0.57 108.15 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.51 -49.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 120.398 1.454 . . . . 0.57 110.856 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.19 -39.86 90.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.519 1.054 . . . . 0.66 111.487 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -65.05 -42.98 93.74 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.642 1.11 . . . . 1.2 111.818 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.53 -43.64 89.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.402 0.681 . . . . 0.57 109.599 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.61 -45.12 99.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.017 -0.992 . . . . 0.57 110.035 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -60.96 -45.2 95.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.72 1.145 . . . . 0.57 111.504 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -36.95 73.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.66 1.118 . . . . 0.57 111.418 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.374 0.988 . . . . 0.57 111.519 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.4 -33.26 72.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.252 -0.88 . . . . 0.57 110.557 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.38 -42.36 91.48 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 119.439 1.018 . . . . 0.57 110.211 167.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.2 mtp -64.74 -33.38 75.83 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 119.912 1.233 . . . . 0.57 111.592 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -70.72 -44.47 66.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.2 1.364 . . . . 0.57 111.147 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.89 -8.1 77.08 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.205 -0.934 . . . . 0.57 113.734 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -65.92 -24.43 66.83 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.017 -1.284 . . . . 0.57 111.047 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.39 -41.29 7.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.958 -0.544 . . . . 0.66 110.789 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 164' ' ' TYR . 15.9 pt -117.25 139.21 25.71 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 124.02 0.928 . . . . 0.57 110.248 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.05 35.26 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.898 3.066 . . . . 0.57 114.13 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -90.87 132.0 36.17 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.695 1.598 . . . . 0.57 107.476 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -123.7 165.95 16.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.971 0.909 . . . . 0.65 109.411 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.26 144.86 33.5 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.343 -0.984 . . . . 0.57 108.343 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -143.05 165.33 27.67 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.861 0.865 . . . . 1.2 108.982 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -107.89 140.31 41.19 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.934 -1.135 . . . . 0.57 107.934 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -90.53 161.26 2.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.354 0.597 . . . . 0.57 110.112 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.31 -14.85 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.508 1.123 . . . . 0.57 111.602 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -58.96 2.98 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.829 0.852 . . . . 0.57 109.956 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.39 146.54 4.83 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.864 -1.295 . . . . 0.57 109.864 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.3 m 59.55 144.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.164 2.186 . . . . 0.57 112.709 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.2 170.32 15.97 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 120.857 -1.152 . . . . 0.57 110.119 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -58.68 -48.96 79.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.121 -1.066 . . . . 0.66 108.121 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.39 87.2 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.57 108.335 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 ttm -84.59 111.87 19.92 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.014 -1.106 . . . . 0.57 108.014 170.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.53 132.03 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 106.392 -1.707 . . . . 0.57 106.392 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -156.4 154.41 25.51 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 121.259 -0.901 . . . . 0.57 112.094 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -129.37 153.08 48.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.366 1.083 . . . . 0.57 110.672 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.95 178.14 7.31 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.044 1.337 . . . . 0.57 109.915 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -132.25 66.95 1.54 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.677 -1.231 . . . . 1.2 107.677 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.34 -40.99 2.3 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.11 -0.828 . . . . 0.57 112.759 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.36 164.84 12.92 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.261 1.53 . . . . 0.57 110.933 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 -109.71 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.508 2.323 . . . . 0.65 106.349 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.41 71.33 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.691 -1.764 . . . . 0.57 108.691 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.62 -56.68 2.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.716 1.206 . . . . 0.66 109.116 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.9 t 177.43 -39.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.795 2.038 . . . . 0.57 108.983 -169.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.84 102.13 44.65 Favored Pre-proline 0 C--N 1.345 0.395 0 CA-C-N 118.463 0.574 . . . . 0.57 109.455 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.67 144.39 84.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.943 1.015 . . . . 0.57 109.504 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -69.84 -168.02 0.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.061 . . . . 0.57 110.777 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.41 -31.68 4.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.485 3.114 . . . . 0.66 110.755 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -152.24 17.35 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 119.97 1.259 . . . . 0.57 111.816 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.18 61.94 4.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 125.168 3.912 . . . . 0.57 114.776 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.52 18.6 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.637 1.589 . . . . 0.57 112.521 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 31.4 -130.34 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.322 2.649 . . . . 0.57 114.225 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -61.43 119.54 8.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.651 1.981 . . . . 0.57 110.535 171.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.16 -34.6 22.07 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.961 1.304 . . . . 0.57 113.51 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.64 161.36 38.63 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.201 1.0 . . . . 0.57 108.644 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -149.11 151.73 34.91 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 122.955 0.502 . . . . 0.65 109.878 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.7 157.74 44.36 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.475 0.71 . . . . 0.57 109.502 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -109.95 145.06 37.56 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.734 -0.839 . . . . 0.57 108.734 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 151.11 92.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.57 109.887 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 48.9 Cg_endo -67.94 157.68 60.71 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.338 2.025 . . . . 0.57 111.887 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.34 21.43 0.02 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.226 1.251 . . . . 0.57 116.226 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.309 37.0 p 64.8 71.57 0.46 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.28 2.232 . . . . 0.57 113.743 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.39 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 120.783 -1.198 . . . . 0.57 112.38 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.54 -6.05 37.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.733 1.613 . . . . 0.57 111.211 164.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.93 129.75 13.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.115 -1.594 . . . . 0.57 109.115 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.3 -27.01 20.04 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.012 1.768 . . . . 0.57 112.758 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.07 147.26 53.8 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.795 -1.187 . . . . 0.66 107.795 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.58 141.15 35.23 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.058 0.943 . . . . 0.57 109.39 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 46.6 m170 -129.92 152.68 49.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.482 0.713 . . . . 0.65 110.411 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.08 154.75 42.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.036 0.934 . . . . 0.57 108.485 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.45 98.94 11.22 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.781 -0.822 . . . . 0.66 108.781 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -56.63 -25.77 54.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.651 1.981 . . . . 0.66 112.299 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -56.25 -40.63 74.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.594 1.157 . . . . 0.66 110.218 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.49 126.9 31.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.035 0.934 . . . . 0.66 108.575 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.97 98.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.617 1.167 . . . . 1.2 111.818 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.59 145.82 28.64 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.932 -1.136 . . . . 0.57 107.932 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -141.73 147.09 36.83 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.759 -1.2 . . . . 0.57 107.759 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.77 17.08 5.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.506 1.122 . . . . 0.66 112.365 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.39 -151.7 23.35 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.76 2.124 . . . . 0.57 108.006 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.81 -173.52 0.19 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.026 0.93 . . . . 0.57 110.934 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 p -109.23 179.52 4.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.037 1.335 . . . . 0.57 109.228 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.94 -58.87 0.57 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.499 2.32 . . . . 0.57 113.686 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 169.93 53.33 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.766 1.651 . . . . 0.57 110.36 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.1 120.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.976 -0.749 . . . . 0.57 108.976 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.05 112.73 3.11 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.822 0.701 . . . . 0.57 109.595 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.18 -40.13 64.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.22 1.008 . . . . 0.57 110.587 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.94 -42.98 84.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.168 0.44 . . . . 0.57 110.088 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.17 -45.12 95.94 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.663 -0.495 . . . . 0.57 109.663 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.97 66.29 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.393 0.677 . . . . 0.57 111.443 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -53.36 55.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.166 -0.921 . . . . 0.57 109.433 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 84.8 m -57.57 -37.76 73.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.684 1.129 . . . . 0.57 111.309 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -62.71 -54.36 40.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.935 0.789 . . . . 0.65 110.461 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.81 -43.15 84.58 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.149 0.979 . . . . 0.66 110.795 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.33 -30.36 71.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 0.57 111.226 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.05 -51.6 57.35 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.581 -1.008 . . . . 0.57 110.581 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.21 -46.08 89.41 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.243 -0.884 . . . . 0.65 111.016 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.8 p -61.94 -32.39 72.8 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 123.969 0.793 . . . . 0.57 112.364 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -46.38 89.82 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.561 0.744 . . . . 0.57 110.54 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.91 36.66 0.02 OUTLIER Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.796 -1.002 . . . . 0.57 114.372 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -124.99 163.59 21.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.141 1.47 . . . . 0.57 109.613 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.97 -47.0 0.17 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.61 -1.661 . . . . 0.57 111.788 -169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 167.38 -177.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.707 2.803 . . . . 0.65 107.964 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.6 p -152.07 -174.44 4.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.394 1.078 . . . . 0.57 108.478 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.7 m -137.04 67.61 1.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.525 1.53 . . . . 0.57 108.759 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -133.92 143.64 48.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.528 -0.916 . . . . 0.66 108.528 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.89 -14.91 21.29 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.818 2.345 . . . . 0.57 112.981 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 32.83 4.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.379 1.472 . . . . 0.57 109.462 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -92.59 143.18 26.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.57 109.875 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -67.46 -31.85 54.56 Favored 'Isoleucine or valine' 0 C--O 1.23 0.044 0 N-CA-C 109.401 -0.592 . . . . 0.57 109.401 166.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -19.2 64.85 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 117.057 -1.449 . . . . 0.57 112.236 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -49.9 109.81 1.4 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.266 1.394 . . . . 0.57 110.524 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.1 38.91 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.215 2.61 . . . . 0.57 113.331 -171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.2 m -150.28 132.58 15.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.666 1.586 . . . . 0.57 107.032 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -81.7 101.57 10.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.859 -1.163 . . . . 0.57 107.859 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.68 -108.66 0.31 Allowed Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.572 -0.571 . . . . 0.57 112.585 -171.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -38.03 87.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.714 0.806 . . . . 0.57 112.352 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.05 90.82 0.06 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 124.967 1.27 . . . . 0.57 110.767 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -52.68 115.53 7.34 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.758 2.023 . . . . 0.66 109.883 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.3 -23.58 5.06 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.44 2.093 . . . . 0.57 113.269 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -69.43 -39.59 77.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.863 1.211 . . . . 0.57 110.524 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -141.17 116.64 10.16 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.415 1.086 . . . . 0.57 108.902 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 15.0 p90 -147.2 -49.36 0.18 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.909 0.884 . . . . 0.57 111.207 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER 30.61 52.98 0.14 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 127.321 2.248 . . . . 0.57 113.113 -176.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp 63.32 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.006 1.722 . . . . 0.57 110.935 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -70.65 -82.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.051 0.94 . . . . 0.57 112.974 -165.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -144.63 -48.51 0.26 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 125.53 1.532 . . . . 0.57 108.566 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -47.3 51.93 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.473 1.909 . . . . 0.66 112.913 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.61 -54.42 47.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.756 0.822 . . . . 0.66 110.827 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.15 -45.73 92.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.329 1.052 . . . . 0.57 108.921 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -63.71 -41.91 98.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.812 1.245 . . . . 0.57 109.368 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.03 -49.03 69.93 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.743 -0.943 . . . . 0.57 110.743 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.65 -47.19 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 117.774 0.787 . . . . 0.57 110.995 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -66.79 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.904 -0.569 . . . . 0.57 112.063 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.45 43.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.292 0.951 . . . . 0.57 110.612 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mp -78.45 -41.94 31.34 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.959 0.8 . . . . 0.57 112.554 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 46' ' ' ILE . 70.1 m-85 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.202 0.815 . . . . 0.57 113.202 -169.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB2' ' HA ' ' A' ' 163' ' ' LEU . 35.7 Cg_endo . . . . . 0 N--CA 1.449 -1.107 0 N-CA-C 110.171 -0.742 . . . . 0.57 110.171 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.58 110.45 0.05 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.529 1.532 . . . . 0.57 108.25 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 53.6 m95 -48.38 150.81 1.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.441 0.696 . . . . 0.57 110.577 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.6 p -60.95 -24.23 65.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.57 111.807 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.0 t -99.88 152.29 20.32 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.752 1.621 . . . . 0.57 109.79 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -8.48 55.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.57 112.715 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.89 119.04 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.833 -2.284 . . . . 0.57 104.833 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.87 142.41 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.347 -1.353 . . . . 0.57 107.347 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -109.15 150.17 28.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.399 -0.813 . . . . 0.57 110.432 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -127.0 148.71 50.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.665 -0.698 . . . . 0.57 111.14 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.73 114.43 7.24 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.521 -0.918 . . . . 1.2 108.521 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.81 89.12 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 106.132 -1.803 . . . . 0.57 106.132 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.08 -30.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.856 1.262 . . . . 0.57 113.486 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.11 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.245 -2.502 . . . . 0.57 104.245 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' HIS . 88.4 m-85 -135.47 -178.88 5.32 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.547 1.139 . . . . 0.57 108.367 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 t -97.63 -162.69 0.98 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.57 109.817 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -136.54 -31.52 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.053 1.131 . . . . 1.2 114.053 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.15 -38.8 65.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.826 1.25 . . . . 0.66 109.957 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.64 153.28 81.05 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.267 2.227 . . . . 0.57 109.85 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.85 158.24 42.9 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.803 2.335 . . . . 0.57 113.475 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.404 ' HB2' ' CE1' ' A' ' 22' ' ' TYR . 12.8 p80 -62.38 -36.72 83.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.748 1.219 . . . . 0.65 113.193 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -65.79 -37.17 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.081 0.552 . . . . 0.57 110.52 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -63.27 -47.67 81.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 116.894 -1.527 . . . . 0.57 108.101 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.24 -50.19 48.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 CA-C-N 120.41 1.459 . . . . 0.57 110.762 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.36 -46.07 91.73 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.939 1.245 . . . . 0.66 111.989 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -45.43 94.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.728 -0.607 . . . . 1.2 111.55 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.88 -43.11 94.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.408 -1.282 . . . . 0.57 109.068 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -45.17 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 120.321 1.419 . . . . 0.57 109.918 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.1 91.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.063 0.847 . . . . 0.57 110.379 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -70.33 -37.08 74.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.972 0.909 . . . . 0.57 112.389 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -48.4 74.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.083 1.753 . . . . 0.57 110.908 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -67.57 -30.05 69.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.159 -0.924 . . . . 0.57 110.825 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.62 -36.94 77.32 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.342 0.974 . . . . 0.57 110.165 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.66 -38.22 88.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.406 -1.283 . . . . 0.57 111.69 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -73.76 -41.27 62.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.851 1.205 . . . . 0.57 111.677 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -5.46 55.66 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.915 -1.116 . . . . 0.57 112.362 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -19.56 64.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 118.552 1.176 . . . . 0.57 111.319 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.21 -35.55 5.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.313 1.045 . . . . 0.66 112.023 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.414 HG22 ' CD1' ' A' ' 164' ' ' TYR . 16.3 pt -106.2 129.55 24.37 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 119.616 1.098 . . . . 0.57 110.627 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.47 40.43 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.956 3.104 . . . . 0.57 112.332 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.47 143.78 28.35 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.0 1.32 . . . . 0.57 107.786 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -125.83 162.41 25.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.572 -0.899 . . . . 0.65 108.572 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 160.05 40.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.631 -0.877 . . . . 0.57 108.631 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -143.65 174.96 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -123.48 162.08 23.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.767 -1.197 . . . . 0.57 107.767 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.54 175.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.153 1.781 . . . . 0.57 108.494 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.3 -29.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.212 1.005 . . . . 0.57 111.901 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -63.39 -62.08 1.92 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.094 1.358 . . . . 0.57 112.512 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.39 38.14 0.15 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.354 0.502 . . . . 0.57 113.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.6 t -166.47 149.06 6.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.355 1.462 . . . . 0.57 107.316 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.19 -178.62 3.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.878 1.271 . . . . 0.57 109.983 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.31 -35.33 75.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.297 0.639 . . . . 0.66 109.915 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.27 69.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.595 1.958 . . . . 0.57 107.748 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.12 118.9 16.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.099 -1.626 . . . . 0.57 107.205 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.55 125.93 65.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.564 -2.013 . . . . 0.57 105.564 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.63 165.69 26.39 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 110.702 -0.959 . . . . 0.57 110.702 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.4 m-85 -133.2 148.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.042 -1.466 . . . . 0.57 107.042 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.86 -171.65 3.49 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.494 1.517 . . . . 0.57 108.767 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -122.59 179.92 4.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 1.2 108.953 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -39.84 106.41 0.06 OUTLIER Glycine 0 C--N 1.342 0.872 0 C-N-CA 126.084 1.802 . . . . 0.57 110.615 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 56.05 137.06 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.429 2.692 . . . . 0.57 115.169 -166.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -154.21 159.08 41.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.003 0.921 . . . . 0.65 109.99 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.62 55.04 1.99 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.706 1.146 . . . . 0.57 111.321 -170.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -108.58 -50.16 3.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.515 0.726 . . . . 0.66 110.511 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.13 -35.47 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.862 2.065 . . . . 0.57 110.874 -166.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.2 100.43 7.07 Favored Pre-proline 0 C--N 1.347 0.492 0 CA-C-N 119.975 1.262 . . . . 0.57 109.958 -170.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.97 120.27 7.47 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.076 1.184 . . . . 0.57 110.591 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -63.44 164.15 9.72 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 125.195 1.398 . . . . 0.57 110.594 167.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.28 -37.29 11.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.891 2.476 . . . . 0.66 112.017 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.41 -147.01 18.91 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 119.444 1.02 . . . . 0.57 112.018 -170.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.96 72.17 4.01 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.857 3.704 . . . . 0.57 115.04 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.87 37.15 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.49 -1.381 . . . . 0.57 111.815 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 38.6 -129.48 0.23 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.57 114.016 167.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -64.7 118.63 9.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.139 2.176 . . . . 0.57 111.154 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.71 -33.57 13.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.89 1.276 . . . . 0.57 112.795 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.83 29.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.928 1.291 . . . . 0.57 107.625 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -142.6 159.65 41.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.649 0.779 . . . . 0.65 108.938 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.71 167.12 30.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.263 0.625 . . . . 0.57 109.42 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -120.07 152.75 37.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.742 -0.663 . . . . 0.57 109.512 -171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.33 153.63 85.62 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.098 -0.953 . . . . 0.57 110.011 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 20.2 Cg_endo -65.33 162.98 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.889 1.726 . . . . 0.57 111.38 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 -100.02 0.15 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.168 -1.573 . . . . 0.57 109.168 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -157.24 120.14 3.99 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.262 -1.385 . . . . 0.57 107.262 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.96 -121.49 6.69 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.046 -1.419 . . . . 0.57 110.275 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.45 -27.9 58.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.637 1.175 . . . . 0.57 111.546 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.92 144.26 7.68 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.106 -0.996 . . . . 0.57 111.754 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.21 -26.72 2.89 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.48 1.514 . . . . 0.57 113.917 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.48 150.66 48.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.461 1.131 . . . . 0.66 108.936 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.1 146.22 48.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.611 1.196 . . . . 0.57 109.055 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 144.78 37.94 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.409 -1.269 . . . . 0.65 108.795 -169.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 50.9 m-85 -139.02 149.63 44.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.288 -1.375 . . . . 0.57 107.288 -166.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -94.69 99.05 11.23 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.091 -1.077 . . . . 0.66 108.091 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.24 -24.37 41.96 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.718 2.007 . . . . 0.66 111.785 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -59.21 -41.92 89.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.179 -0.304 . . . . 0.66 110.179 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.34 134.42 47.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.746 -0.835 . . . . 0.66 108.746 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -61.19 133.3 55.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.827 -0.434 . . . . 1.2 109.827 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -117.95 140.72 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.102 -1.444 . . . . 0.57 107.102 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -140.12 148.75 42.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.988 0.813 . . . . 0.57 109.431 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.79 -40.0 78.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.332 1.053 . . . . 0.66 111.338 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 155.69 58.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.394 0.997 . . . . 0.57 110.926 -170.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -153.1 170.81 19.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.926 0.863 . . . . 0.57 110.093 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -70.15 77.34 0.51 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.57 111.41 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -48.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.585 1.154 . . . . 0.57 112.995 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.53 -152.0 6.69 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.466 -1.454 . . . . 0.57 109.466 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.52 131.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.234 -0.654 . . . . 0.57 109.234 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -57.37 104.1 0.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.57 109.439 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.09 -41.69 79.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.543 1.537 . . . . 0.57 109.496 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.48 -46.17 89.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.7 -0.852 . . . . 0.57 108.7 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.09 -41.41 99.4 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.901 -0.777 . . . . 0.57 108.901 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.58 -53.08 60.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.294 0.638 . . . . 0.57 111.524 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.02 71.08 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.597 -0.716 . . . . 0.57 109.478 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.6 m -58.06 -40.05 80.01 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.872 0.76 . . . . 0.57 111.664 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -60.17 -54.47 45.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.665 0.666 . . . . 0.65 109.766 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.99 -45.21 82.46 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.555 -0.715 . . . . 0.66 111.671 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.1 -32.93 74.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.447 1.099 . . . . 0.57 111.341 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.4 -43.77 52.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.276 -0.73 . . . . 0.57 111.276 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -75.94 -35.62 59.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.698 -0.667 . . . . 0.65 112.26 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -37.49 70.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.763 0.825 . . . . 0.57 111.189 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 mm? -63.02 -41.15 99.48 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.934 -0.479 . . . . 0.57 111.77 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 165.7 45.12 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.681 -1.066 . . . . 0.57 114.431 -172.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.5 mmt 55.09 -168.28 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.587 1.193 . . . . 0.57 110.793 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.65 33.2 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.422 -0.799 . . . . 0.57 113.936 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 170.28 2.47 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.304 1.052 . . . . 0.65 113.686 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 p -151.35 -159.17 0.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.842 0.857 . . . . 0.57 110.935 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.2 t -168.93 80.14 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 104.03 -2.582 . . . . 0.57 104.03 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.67 147.56 55.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 108.315 -0.994 . . . . 0.66 108.315 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.21 -20.19 33.05 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.112 2.541 . . . . 0.57 112.951 -170.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -125.3 34.94 4.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.88 1.272 . . . . 0.57 108.614 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.02 30.34 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.563 0.745 . . . . 0.57 109.542 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.61 -31.22 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.876 -0.416 . . . . 0.57 109.876 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.7 mmt -69.25 -4.61 18.5 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.518 1.527 . . . . 0.57 112.402 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 31.1 t80 -60.94 145.14 89.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.781 1.173 . . . . 0.57 109.956 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 73.0 Cg_endo -79.82 162.78 23.84 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.459 2.106 . . . . 0.57 111.556 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.9 m 53.64 58.93 4.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.001 0.905 . . . . 0.57 109.72 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 71.51 -177.86 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.924 1.29 . . . . 0.57 110.173 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.31 137.0 11.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 107.493 -2.243 . . . . 0.57 107.493 166.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -39.81 94.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.447 0.624 . . . . 0.57 110.521 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.76 135.8 29.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.269 1.414 . . . . 0.57 110.811 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -41.12 111.91 0.88 Allowed Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 126.764 2.026 . . . . 0.66 111.819 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.77 -19.39 18.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.073 1.849 . . . . 0.57 112.226 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -46.67 25.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.995 -1.113 . . . . 0.57 107.995 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -91.99 71.99 5.56 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.012 0.925 . . . . 0.57 111.046 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -33.48 -72.42 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.74 2.016 . . . . 0.57 116.003 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 38.9 72.74 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.214 2.206 . . . . 0.57 112.543 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.564 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.9 mp -35.72 114.49 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.261 2.225 . . . . 0.57 110.091 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 p -82.93 -83.15 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.096 0.558 . . . . 0.57 110.711 -163.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -140.04 -44.52 0.42 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 117.425 -1.274 . . . . 0.57 111.711 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 -43.77 64.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.006 1.322 . . . . 0.66 111.654 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.11 -52.8 62.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.63 0.772 . . . . 0.66 110.198 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.98 -39.75 81.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 C-N-CA 123.359 0.664 . . . . 0.57 109.504 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.68 97.13 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.132 1.373 . . . . 0.57 109.071 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.18 -56.34 22.67 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.883 -1.287 . . . . 0.57 109.883 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -50.34 -56.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.979 1.712 . . . . 0.57 111.106 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -72.31 -11.5 60.73 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.196 -0.94 . . . . 0.57 112.035 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 -15.53 27.84 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 0.57 110.967 167.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -82.92 -52.86 6.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.929 1.692 . . . . 0.57 109.692 -178.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.414 ' CD1' HG22 ' A' ' 46' ' ' ILE . 3.8 p90 . . . . . 0 N--CA 1.468 0.463 0 C-N-CA 123.31 0.644 . . . . 0.57 110.999 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.402 -1.038 . . . . 0.57 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttt 86.79 138.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.449 2.7 . . . . 0.57 108.98 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 80.9 m95 -75.96 167.71 21.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.638 0.732 . . . . 0.57 110.689 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 p -73.66 -13.97 61.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.479 1.112 . . . . 0.57 112.507 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -134.34 150.58 50.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.975 1.31 . . . . 0.57 109.284 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.91 -3.12 37.06 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.557 1.543 . . . . 0.57 112.804 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.65 128.1 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.458 -1.682 . . . . 0.57 106.458 172.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.47 139.16 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.784 -1.932 . . . . 0.57 105.784 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -115.08 133.76 55.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.57 108.782 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -114.92 164.07 14.66 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.684 -0.689 . . . . 0.57 110.223 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.88 165.66 35.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.979 169.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.0 mt -126.61 78.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 104.272 -2.492 . . . . 0.57 104.272 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -65.57 -30.94 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.287 1.435 . . . . 0.57 112.134 -175.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -133.09 165.17 25.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.086 -2.19 . . . . 0.57 105.086 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.72 158.19 43.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.068 1.347 . . . . 0.57 109.423 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 t -77.41 -15.08 59.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.255 1.206 . . . . 0.57 114.255 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 66.63 -19.88 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.573 1.949 . . . . 1.2 115.03 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -66.88 -31.49 72.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.664 1.586 . . . . 0.66 111.951 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 148.05 62.24 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 125.962 1.705 . . . . 0.57 108.201 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.34 161.06 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.898 2.398 . . . . 0.57 112.128 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.02 -35.95 78.24 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.907 0.883 . . . . 0.65 111.831 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.44 -35.78 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.149 0.58 . . . . 0.57 110.194 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.7 m -78.97 -37.75 38.64 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 117.882 -1.056 . . . . 0.57 110.045 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.91 -44.32 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.202 1.365 . . . . 0.57 109.37 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -69.66 -42.39 74.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.78 0.718 . . . . 0.66 110.555 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -42.9 84.04 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.846 -1.159 . . . . 1.2 113.259 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.99 -40.82 97.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.57 108.338 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.11 -40.6 89.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 119.25 0.932 . . . . 0.57 110.604 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -56.89 -52.71 64.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.152 0.887 . . . . 0.57 109.119 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -69.76 -36.31 75.67 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.696 -1.145 . . . . 0.57 112.002 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.16 91.32 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.522 1.51 . . . . 0.57 111.917 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.35 -36.03 76.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.498 -0.763 . . . . 0.57 109.913 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.85 -39.1 90.66 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 119.009 0.822 . . . . 0.57 109.815 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.24 -38.06 89.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.14 1.337 . . . . 0.57 112.252 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' CE3' HD11 ' A' ' 160' ' ' ILE . 18.3 m95 -66.37 -54.76 20.71 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.404 1.002 . . . . 0.57 109.989 170.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.63 -8.91 49.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.054 1.312 . . . . 0.57 114.349 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -68.13 -18.3 64.59 Favored 'General case' 0 C--O 1.226 -0.134 0 O-C-N 120.928 -1.337 . . . . 0.57 111.454 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.12 -12.53 11.91 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.59 0.632 . . . . 0.66 111.052 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.62 127.54 19.6 Favored Pre-proline 0 C--N 1.347 0.483 0 C-N-CA 124.582 1.153 . . . . 0.57 108.763 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 41.18 0.65 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.141 3.228 . . . . 0.57 112.804 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 tt -92.75 146.62 23.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.685 1.994 . . . . 0.57 108.598 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -124.48 160.95 27.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.438 -0.949 . . . . 0.65 108.438 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 161.47 37.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.604 -0.517 . . . . 0.57 109.604 -171.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -144.52 177.4 8.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.2 1.4 . . . . 1.2 109.335 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.52 136.83 41.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.232 -1.396 . . . . 0.57 107.232 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.98 166.31 2.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.997 0.427 . . . . 0.57 110.044 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.89 25.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.57 111.515 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -55.0 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.243 1.017 . . . . 0.57 112.262 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.91 -153.1 5.79 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.825 -1.31 . . . . 0.57 109.825 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -68.94 175.28 3.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.316 0.579 . . . . 0.57 110.339 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.79 -178.29 5.19 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.528 1.531 . . . . 0.57 109.972 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.96 -32.85 74.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 117.554 -1.212 . . . . 0.66 110.834 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.31 73.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.893 1.277 . . . . 0.57 107.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.39 155.35 30.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.175 -1.578 . . . . 0.57 110.93 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.31 127.63 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.945 -2.613 . . . . 0.57 103.945 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.17 162.4 28.38 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.995 -0.842 . . . . 0.57 110.995 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -134.88 140.04 45.48 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.823 -1.917 . . . . 0.57 105.823 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.67 -178.0 5.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.444 1.498 . . . . 0.57 108.698 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 52.18 2.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.926 0.891 . . . . 1.2 110.295 -169.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.66 -141.0 16.64 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.768 -1.333 . . . . 0.57 109.768 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 131.43 8.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.367 1.067 . . . . 0.57 110.843 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.45 156.72 40.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 125.168 1.387 . . . . 0.65 109.493 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 93.4 0.38 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 109.237 -1.545 . . . . 0.57 109.237 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -149.63 -85.05 0.09 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.497 1.519 . . . . 0.66 108.034 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.22 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.392 1.477 . . . . 0.57 109.259 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.19 139.49 31.79 Favored Pre-proline 0 C--N 1.342 0.252 0 C-N-CA 124.07 0.948 . . . . 0.57 108.755 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -68.36 143.37 57.88 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.021 1.147 . . . . 0.57 109.264 167.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -73.84 -177.1 2.68 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.87 1.319 . . . . 0.57 109.759 163.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -108.88 -38.03 5.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.211 3.405 . . . . 0.66 111.341 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.4 -151.02 19.66 Favored Glycine 0 CA--C 1.54 1.603 0 CA-C-O 117.706 -1.608 . . . . 0.57 111.198 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.92 75.69 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.17 1 C-N-CA 125.549 4.166 . . . . 0.57 114.653 -168.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.66 172.32 25.63 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.561 2.505 . . . . 0.57 108.971 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.01 -143.56 0.65 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.715 1.606 . . . . 0.57 112.735 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -41.75 130.29 3.3 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 128.055 2.542 . . . . 0.57 110.856 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.77 -28.37 13.53 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.446 -1.409 . . . . 0.57 112.567 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.72 161.27 37.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.689 1.196 . . . . 0.57 108.851 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.03 151.11 36.39 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.545 0.688 . . . . 0.65 110.127 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.47 172.59 12.48 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.808 0.813 . . . . 0.57 109.189 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -124.18 139.26 54.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.568 -1.271 . . . . 0.57 107.568 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.93 159.11 11.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.963 0.905 . . . . 0.57 110.043 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 48.6 Cg_endo -66.99 158.64 55.77 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.552 1.501 . . . . 0.57 110.691 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.55 -138.49 5.15 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.573 -1.011 . . . . 0.57 110.573 -172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -138.58 96.68 3.2 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.444 -1.317 . . . . 0.57 107.444 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 125.33 -118.54 3.28 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 108.701 -1.759 . . . . 0.57 108.701 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -27.56 65.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.888 2.075 . . . . 0.57 112.473 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.66 145.09 10.64 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.208 -0.933 . . . . 0.57 111.433 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.34 -27.44 4.62 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 125.397 1.475 . . . . 0.57 114.117 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.61 156.06 39.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.66 108.97 -168.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.25 145.22 38.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.899 0.857 . . . . 0.57 110.061 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.11 146.65 39.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.396 1.078 . . . . 0.65 109.265 -171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 38.3 m-85 -139.55 146.91 40.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.833 -0.803 . . . . 0.57 108.833 -167.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -83.95 99.71 10.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.23 -0.656 . . . . 0.66 109.23 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -58.91 -24.6 62.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.292 1.437 . . . . 0.66 111.337 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.29 -43.62 98.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.515 1.526 . . . . 0.66 110.309 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.42 134.23 49.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.223 -1.769 . . . . 0.66 106.223 174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 149.55 41.39 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.226 -1.546 . . . . 1.2 109.434 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -129.98 168.22 17.02 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.273 1.029 . . . . 0.57 108.294 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.303 -0.999 . . . . 0.57 108.303 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.02 38.63 0.72 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.205 1.002 . . . . 0.66 110.683 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.02 60.32 2.06 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.985 1.279 . . . . 0.57 111.029 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 91.42 3.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.012 0.925 . . . . 0.57 110.236 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m 64.72 -71.53 0.07 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 127.835 2.454 . . . . 0.57 113.781 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.98 166.54 26.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.57 107.998 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.37 -156.71 21.02 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.093 -1.603 . . . . 0.57 109.093 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.06 112.15 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.283 -1.377 . . . . 0.57 107.283 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.39 101.94 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.35 0.66 . . . . 0.57 111.501 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -58.59 -38.44 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.41 1.084 . . . . 0.57 109.439 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -43.87 97.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.793 0.724 . . . . 0.57 110.667 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.17 -48.39 81.8 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.568 0.747 . . . . 0.57 109.528 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.27 76.96 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.545 0.338 . . . . 0.57 111.303 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.54 63.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.338 -0.839 . . . . 0.57 109.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.8 m -58.2 -37.81 75.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.282 0.946 . . . . 0.57 111.577 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.55 -57.14 13.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.652 1.181 . . . . 0.65 109.648 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.52 -45.43 90.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.331 0.653 . . . . 0.66 110.487 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.36 -28.67 69.39 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.621 1.169 . . . . 0.57 111.843 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.45 -45.71 95.72 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.638 0.654 . . . . 0.57 111.897 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -68.58 -37.32 79.75 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-O 118.292 -0.861 . . . . 0.65 110.93 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.6 m -59.85 -31.64 69.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.058 0.844 . . . . 0.57 112.361 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -34.56 66.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.515 1.052 . . . . 0.57 111.802 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.25 -56.68 0.13 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-O 119.198 -0.779 . . . . 0.57 111.45 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.99 178.04 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.855 2.062 . . . . 0.57 108.695 -169.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.12 22.68 0.02 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.028 -0.873 . . . . 0.57 112.812 172.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 161.05 30.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.871 1.335 . . . . 0.65 111.716 -174.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.44 -170.54 1.47 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.336 1.854 . . . . 0.57 108.777 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.71 48.56 1.81 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.442 1.097 . . . . 0.57 110.79 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.5 t70 -98.35 144.45 28.11 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 118.004 -0.998 . . . . 0.66 110.671 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 -20.58 68.21 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.08 1.853 . . . . 0.57 113.564 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -128.57 25.31 5.73 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.115 1.366 . . . . 0.57 110.776 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -62.97 134.09 55.64 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.138 0.97 . . . . 0.57 111.093 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.21 -24.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.287 1.035 . . . . 0.57 111.429 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -106.6 22.81 15.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.14 0.976 . . . . 0.57 111.38 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 3.6 t80 -60.67 131.28 90.98 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.488 1.495 . . . . 0.57 110.437 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 49.5 Cg_endo -79.58 -38.95 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.405 1.403 . . . . 0.57 112.625 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 139' ' ' TYR . 87.2 m -80.12 67.78 6.05 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.675 -1.266 . . . . 0.57 110.03 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -50.03 136.99 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.983 1.313 . . . . 0.57 112.054 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.71 107.74 2.99 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.024 0.821 . . . . 0.57 111.297 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -165.99 -56.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.608 1.563 . . . . 0.57 108.575 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -117.14 -100.84 2.14 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 108.852 -1.699 . . . . 0.57 108.852 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -156.52 111.89 2.03 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.66 109.463 -170.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.17 -9.14 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.4 2.733 . . . . 0.57 113.039 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.74 -18.37 61.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.138 1.335 . . . . 0.57 111.039 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -116.63 74.13 0.89 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.618 1.967 . . . . 0.57 109.494 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -128.8 122.66 30.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.492 1.517 . . . . 0.57 107.914 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 69.11 1.06 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.625 -1.25 . . . . 0.57 107.625 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp 52.59 79.77 0.11 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 0.57 110.798 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -78.36 0.05 OUTLIER 'General case' 0 C--N 1.342 0.261 0 N-CA-C 114.27 1.211 . . . . 0.57 114.27 -166.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -148.79 -49.23 0.15 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.861 1.264 . . . . 0.57 108.214 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -45.69 -42.64 11.92 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 128.294 2.638 . . . . 0.66 112.14 166.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -66.86 -58.36 5.17 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.8 0.84 . . . . 0.66 111.218 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.48 -37.04 67.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 119.014 -0.517 . . . . 0.57 109.694 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -59.82 -41.55 91.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.679 0.792 . . . . 0.57 108.9 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.26 -52.91 24.47 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.305 -1.118 . . . . 0.57 110.305 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.43 HD11 ' CE3' ' A' ' 42' ' ' TRP . 24.7 mm -56.2 -51.03 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.152 0.981 . . . . 0.57 111.641 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.63 -28.88 68.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.393 0.542 . . . . 0.57 110.783 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 162' ' ' LYS . 0.9 OUTLIER -75.67 -23.32 56.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.01 -0.519 . . . . 0.57 111.603 175.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.1 mt -85.92 -48.46 8.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.57 110.901 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.729 0.64 . . . . 0.57 112.729 -168.72 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.444 -1.395 0 N-CA-C 108.443 -1.406 . . . . 0.57 108.443 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.19 113.85 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.133 1.373 . . . . 0.57 108.672 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 40.0 m95 -46.88 147.42 1.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.537 0.735 . . . . 0.57 109.988 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -62.29 -27.91 69.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.572 0.749 . . . . 0.57 111.701 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.2 t -82.87 149.09 27.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.013 1.325 . . . . 0.57 110.963 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -74.55 -10.59 59.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.331 1.052 . . . . 0.57 112.868 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.45 144.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.71 1.204 . . . . 0.57 107.946 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.1 t -130.98 145.53 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.278 -1.378 . . . . 0.57 107.278 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -94.39 142.49 27.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.294 -0.632 . . . . 0.57 109.294 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -123.07 147.92 46.19 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.516 -0.74 . . . . 0.57 110.235 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 100.71 3.36 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.861 0.839 . . . . 1.2 109.586 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.18 101.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 105.122 -2.177 . . . . 0.57 105.122 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -48.89 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.458 1.503 . . . . 0.57 111.174 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.9 p -130.59 174.45 9.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.4 -1.704 . . . . 0.57 106.4 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -140.34 167.56 21.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.015 -1.476 . . . . 0.57 107.015 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -65.63 178.6 0.97 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.891 0.476 . . . . 0.57 111.03 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -34.45 2.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.393 1.077 . . . . 1.2 112.508 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -39.85 82.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.265 1.026 . . . . 0.66 110.305 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.3 mt -113.66 148.91 40.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.759 1.223 . . . . 0.57 108.646 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.21 150.82 33.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.103 1.868 . . . . 0.57 112.423 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -59.87 -40.14 87.64 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.698 1.199 . . . . 0.65 111.932 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.8 tt -62.95 -36.44 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.191 0.596 . . . . 0.57 111.048 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 m -69.05 -42.4 76.34 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.081 -1.438 . . . . 0.57 108.984 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -55.74 -47.59 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 121.154 1.797 . . . . 0.57 110.095 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.07 -48.73 80.5 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.876 0.87 . . . . 0.66 110.548 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.93 -46.29 88.34 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.509 -0.744 . . . . 1.2 112.48 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.86 -41.79 82.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.416 1.086 . . . . 0.57 109.346 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.87 -50.15 76.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 118.034 -0.984 . . . . 0.57 109.269 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -41.28 99.42 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.658 1.117 . . . . 0.57 111.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -65.03 -46.3 81.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.7 1.136 . . . . 0.57 110.864 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.74 92.06 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.889 1.276 . . . . 0.57 112.405 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.98 -37.34 75.73 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.512 0.725 . . . . 0.57 110.614 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.23 -41.14 87.98 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.828 0.74 . . . . 0.57 109.87 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.7 mtp -66.02 -33.1 75.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.677 0.791 . . . . 0.57 112.544 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -70.81 -49.34 47.5 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.369 0.986 . . . . 0.57 111.112 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.63 -10.78 71.92 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.0 1.286 . . . . 0.57 113.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -62.18 -26.63 68.45 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.667 -1.49 . . . . 0.57 111.022 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -97.94 -38.29 9.46 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.975 -0.535 . . . . 0.66 110.886 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.92 136.41 23.26 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 124.085 0.954 . . . . 0.57 110.576 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 38.32 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 124.195 3.264 . . . . 0.57 112.906 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.15 138.36 31.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.933 1.693 . . . . 0.57 107.601 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -120.59 170.82 9.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.65 108.662 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.51 153.92 45.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.396 -0.964 . . . . 0.57 108.396 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 161.04 37.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.14 0.576 . . . . 1.2 110.803 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -104.08 145.56 30.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.822 -0.807 . . . . 0.57 108.822 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.73 170.86 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.114 0.965 . . . . 0.57 110.32 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.93 37.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.852 1.261 . . . . 0.57 110.215 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -146.46 -72.58 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.028 0.931 . . . . 0.57 110.665 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.8 25.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.421 -1.211 . . . . 0.57 115.557 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -154.09 135.27 14.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.57 106.848 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.63 177.2 11.65 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.074 0.95 . . . . 0.57 110.598 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' HG12 ' A' ' 15' ' ' VAL . 49.2 m-20 -71.15 -37.09 72.25 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.297 -0.858 . . . . 0.66 110.516 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.99 77.76 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.182 2.193 . . . . 0.57 107.82 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -75.28 125.17 28.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.574 -1.269 . . . . 0.57 107.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.42 123.12 67.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.999 -2.223 . . . . 0.57 104.999 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.9 162.98 26.31 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.843 -0.503 . . . . 0.57 111.843 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 13.9 m-85 -137.32 126.8 25.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.546 -1.65 . . . . 0.57 106.546 -172.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.74 -174.41 4.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.425 1.49 . . . . 0.57 108.194 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.9 140.29 18.68 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.6 -0.889 . . . . 1.2 108.6 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.95 -90.4 0.41 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.251 0.453 . . . . 0.57 112.341 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.79 172.59 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.868 0.834 . . . . 0.57 110.049 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.75 142.87 21.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.65 109.466 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.72 45.73 1.58 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.024 1.297 . . . . 0.57 112.622 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.4 28.11 0.99 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.302 2.241 . . . . 0.66 110.139 -172.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.82 -38.86 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.174 1.79 . . . . 0.57 112.029 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -91.25 104.8 10.62 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.088 1.355 . . . . 0.57 109.604 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.43 143.01 74.55 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.16 1.24 . . . . 0.57 109.366 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -170.57 0.69 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.719 1.247 . . . . 0.57 109.776 170.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -124.65 -45.19 1.93 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.617 2.367 . . . . 0.66 108.617 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.29 -148.98 16.56 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.068 1.318 . . . . 0.57 110.953 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.74 68.76 2.95 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 125.969 4.446 . . . . 0.57 112.933 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.02 166.01 16.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 126.421 1.962 . . . . 0.57 108.933 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 49.73 -160.97 0.06 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.502 1.521 . . . . 0.57 112.924 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.2 m -31.8 104.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.913 2.885 . . . . 0.57 114.583 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.44 -29.74 57.09 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.104 -1.623 . . . . 0.57 114.0 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.7 161.99 40.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.371 1.069 . . . . 0.57 108.239 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.62 158.56 44.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.472 -0.566 . . . . 0.65 109.472 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.32 170.37 19.7 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.841 0.856 . . . . 0.57 108.824 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -124.09 149.22 46.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.212 -1.033 . . . . 0.57 108.212 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.72 154.54 80.12 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.593 -0.717 . . . . 0.57 110.137 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 37.4 Cg_endo -67.48 166.34 24.12 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.396 2.064 . . . . 0.57 111.784 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.45 -116.75 0.67 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.3 p -149.03 65.68 1.04 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.625 0.77 . . . . 0.57 111.046 -167.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.99 -121.67 1.4 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.5 -1.44 . . . . 0.57 109.5 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.91 -25.9 32.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.053 1.341 . . . . 0.57 112.024 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 140.33 11.79 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.852 -1.155 . . . . 0.57 111.089 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.4 -24.32 4.97 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.283 1.42 . . . . 0.57 113.776 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -68.63 153.24 44.15 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.987 0.893 . . . . 0.66 108.726 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.0 146.13 31.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.57 109.176 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -140.96 155.59 46.21 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.28 -0.873 . . . . 0.65 111.258 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 46.6 m-85 -137.25 141.9 42.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.877 -1.157 . . . . 0.57 107.877 -163.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -80.9 104.36 11.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.716 -1.216 . . . . 0.66 107.716 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.4 -23.74 67.39 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.33 -0.856 . . . . 0.66 110.844 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.29 -24.18 60.38 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.649 0.659 . . . . 0.66 110.117 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.92 132.48 39.1 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.16 -1.052 . . . . 0.66 108.16 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -65.98 143.36 57.43 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.352 -0.61 . . . . 1.2 109.352 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -126.36 137.38 53.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.609 -1.256 . . . . 0.57 107.609 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.3 t -113.53 147.41 37.99 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.869 -0.789 . . . . 0.57 108.869 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -74.52 21.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.166 1.786 . . . . 0.66 112.981 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.13 124.86 0.25 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.406 1.955 . . . . 0.57 109.998 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 t 74.74 58.49 0.07 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.987 1.715 . . . . 0.57 113.004 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 41.11 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.299 1.04 . . . . 0.57 112.538 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp 55.52 -178.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.184 1.394 . . . . 0.57 111.843 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.01 -168.33 52.06 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.011 -1.056 . . . . 0.57 111.653 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.9 121.16 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.847 -0.797 . . . . 0.57 108.847 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -56.8 106.72 0.33 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.872 1.269 . . . . 0.57 109.209 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.84 -38.29 75.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.481 0.712 . . . . 0.57 109.958 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.28 -51.42 66.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.596 -1.261 . . . . 0.57 107.596 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -54.92 -42.51 72.3 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.876 -0.583 . . . . 0.57 111.042 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.5 5.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.277 0.631 . . . . 0.57 110.275 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.79 -50.16 75.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 118.349 -0.834 . . . . 0.57 109.492 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 m -57.34 -36.45 71.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.557 1.071 . . . . 0.57 111.597 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.7 -55.39 17.65 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.405 1.082 . . . . 0.65 110.19 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.11 -40.74 90.96 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.61 -0.681 . . . . 0.66 110.749 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.81 -32.28 73.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.472 1.509 . . . . 0.57 111.692 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.25 94.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.466 -0.654 . . . . 0.57 111.466 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -69.33 -37.11 77.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 117.594 -1.193 . . . . 0.65 111.916 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.2 p -59.08 -33.19 70.53 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.18 0.925 . . . . 0.57 111.269 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.7 mm? -68.63 -33.97 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.525 -0.75 . . . . 0.57 112.023 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 151.78 53.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.605 1.093 . . . . 0.57 114.404 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 mmt 58.06 -177.17 0.07 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.489 0.661 . . . . 0.57 111.452 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.13 57.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.527 -1.429 . . . . 0.57 109.527 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.36 167.32 11.6 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.93 0.871 . . . . 0.65 110.467 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 t -160.69 -170.31 2.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.917 1.287 . . . . 0.57 109.74 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.23 30.36 1.14 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.571 1.948 . . . . 0.57 109.999 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.49 148.43 35.48 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.739 1.216 . . . . 0.66 109.974 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.94 -21.53 43.56 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.287 2.658 . . . . 0.57 113.279 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -132.59 29.05 4.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.376 1.871 . . . . 0.57 108.661 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.1 133.03 49.05 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.658 -1.276 . . . . 0.57 109.026 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 156' ' ' ASP . 4.3 p -55.8 -28.73 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.371 1.468 . . . . 0.57 112.68 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.49 27.9 9.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.099 . . . . 0.57 110.338 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -56.49 129.17 75.45 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.305 -0.872 . . . . 0.57 109.971 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.59 178.38 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.942 2.428 . . . . 0.57 110.573 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m 71.08 -40.99 0.49 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.504 1.522 . . . . 0.57 113.321 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.9 t80 55.39 92.21 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.275 2.23 . . . . 0.57 113.722 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.75 105.75 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.598 -1.001 . . . . 0.57 110.598 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -172.65 -50.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.093 1.357 . . . . 0.57 110.565 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.88 -113.1 2.94 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.25 -1.94 . . . . 0.57 108.25 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.68 134.59 9.19 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 106.529 -1.656 . . . . 0.66 106.529 174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.09 -8.43 6.63 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.023 3.149 . . . . 0.57 113.559 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -71.01 -28.16 64.21 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.151 -1.593 . . . . 0.57 111.368 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -106.96 61.79 0.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.57 110.916 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -126.44 141.26 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.575 1.15 . . . . 0.57 110.311 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.66 51.68 0.08 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.866 0.866 . . . . 0.57 110.956 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 69.27 76.64 0.23 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.787 1.235 . . . . 0.57 110.554 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.3 t -69.57 -94.42 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.918 0.887 . . . . 0.57 112.044 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -131.12 -44.69 1.03 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.986 0.914 . . . . 0.57 109.641 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -46.04 49.96 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.96 0.904 . . . . 0.66 110.615 166.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.597 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.2 t0 -60.23 -56.58 19.82 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.524 -0.75 . . . . 0.66 110.403 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.39 -43.84 87.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 N-CA-C 109.044 -0.724 . . . . 0.57 109.044 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -64.43 -38.66 91.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.675 0.79 . . . . 0.57 110.72 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.93 -49.73 39.75 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.689 -0.965 . . . . 0.57 110.689 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -56.54 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 C-N-CA 126.144 1.777 . . . . 0.57 110.254 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.6 -20.53 65.74 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.845 -0.534 . . . . 0.57 110.777 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -88.1 -29.83 20.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.455 0.702 . . . . 0.57 111.201 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.27 -58.02 8.51 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 125.717 1.607 . . . . 0.57 109.747 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 113.155 0.798 . . . . 0.57 113.155 -177.167 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.457 -0.622 0 N-CA-C 109.884 -0.852 . . . . 0.57 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 pttt 67.01 141.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.759 2.023 . . . . 0.57 110.881 -165.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -56.5 149.2 17.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.046 0.939 . . . . 0.57 110.371 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 p -62.63 -20.03 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.305 0.854 . . . . 0.57 113.305 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -96.7 140.98 30.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.412 1.885 . . . . 0.57 109.849 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -72.96 -14.09 61.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.617 0.767 . . . . 0.57 113.064 171.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 m -114.2 119.54 61.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.759 -1.941 . . . . 0.57 105.759 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.17 155.59 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.31 -1.367 . . . . 0.57 107.31 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -106.88 143.6 34.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.57 109.758 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -126.64 145.46 50.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.601 -0.518 . . . . 0.57 109.601 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.1 115.13 3.48 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.758 0.79 . . . . 1.2 111.921 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.0 95.17 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 105.718 -1.956 . . . . 0.57 105.718 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 m -67.0 -39.02 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.132 0.973 . . . . 0.57 112.067 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -130.0 152.49 49.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.089 -2.56 . . . . 0.57 104.089 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -127.41 167.34 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.977 1.311 . . . . 0.57 107.858 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 t -64.63 -179.99 0.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.808 0.813 . . . . 0.57 110.901 173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -40.13 3.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.83 0.852 . . . . 1.2 111.585 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -41.97 77.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.654 0.661 . . . . 0.66 111.583 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.69 152.86 38.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.57 108.587 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.42 149.53 39.79 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.897 1.731 . . . . 0.57 112.41 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -58.86 -37.42 76.47 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.59 1.156 . . . . 0.65 113.08 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -43.52 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.773 -0.455 . . . . 0.57 109.773 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 m -66.61 -39.99 88.62 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.945 -1.026 . . . . 0.57 109.577 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.5 -51.08 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.709 1.14 . . . . 0.57 110.704 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -63.35 -43.05 98.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.87 1.214 . . . . 0.66 110.482 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -46.75 87.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.216 -0.927 . . . . 1.2 111.207 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.79 -38.27 86.19 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.263 -1.351 . . . . 0.57 109.904 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -59.62 -46.55 93.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 120.245 1.384 . . . . 0.57 110.076 170.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.266 0.939 . . . . 0.57 109.502 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -68.47 -41.86 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.363 -0.827 . . . . 0.57 111.688 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.27 -46.62 87.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.735 1.152 . . . . 0.57 111.504 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.2 mt -67.91 -37.53 81.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.934 0.894 . . . . 0.57 110.162 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.39 -39.73 84.29 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.456 -0.783 . . . . 0.57 110.209 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -43.94 97.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.725 0.81 . . . . 0.57 111.349 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 33.9 m95 -61.76 -47.84 83.38 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.852 0.751 . . . . 0.57 111.285 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.21 -2.07 71.6 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.298 -0.876 . . . . 0.57 113.695 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -81.82 -11.59 58.9 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.347 1.573 . . . . 0.57 110.071 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -108.62 -21.8 12.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.356 0.526 . . . . 0.66 111.353 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 160' ' ' ILE . 8.4 pt -136.52 146.46 55.8 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.731 1.213 . . . . 0.57 110.302 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.99 58.43 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.624 3.549 . . . . 0.57 111.937 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.03 138.19 54.21 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.613 1.965 . . . . 0.57 106.631 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -123.23 160.46 26.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.291 -1.003 . . . . 0.65 108.291 -171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.43 149.98 38.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.829 -1.175 . . . . 0.57 107.829 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -134.2 157.34 46.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.149 0.979 . . . . 1.2 109.046 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -115.81 108.85 16.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.312 -0.996 . . . . 0.57 108.312 -174.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.46 133.76 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.555 -1.276 . . . . 0.57 107.555 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -37.18 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.179 -0.325 . . . . 0.57 110.208 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.63 162.17 39.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.312 1.045 . . . . 0.57 109.003 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.84 156.83 18.15 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.964 -1.255 . . . . 0.57 109.964 -164.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -64.32 168.53 5.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.517 0.675 . . . . 0.57 110.696 168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.2 17.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.766 1.226 . . . . 0.57 109.937 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -67.96 -44.04 77.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.987 -1.006 . . . . 0.66 109.341 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.4 mt -116.53 78.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.082 1.753 . . . . 0.57 107.74 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.0 ttm -76.3 153.66 35.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.848 -1.158 . . . . 0.57 109.612 171.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.75 134.83 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.73 -1.952 . . . . 0.57 105.73 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.56 166.54 30.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.779 -0.928 . . . . 0.57 110.779 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -138.6 149.99 45.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.42 175.92 11.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.969 1.308 . . . . 0.57 110.249 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -140.46 63.0 1.48 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.765 1.226 . . . . 1.2 109.812 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.79 -70.64 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.644 -0.583 . . . . 0.57 111.644 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.13 174.72 8.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.942 -1.328 . . . . 0.57 110.398 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -149.45 137.86 20.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.427 -0.583 . . . . 0.65 109.427 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.91 37.52 3.39 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.235 0.922 . . . . 0.57 112.021 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.78 -72.05 0.46 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.1 1.36 . . . . 0.66 108.574 -171.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -172.55 -36.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.979 -0.534 . . . . 0.57 111.677 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -102.76 101.64 21.96 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-O 118.286 -0.864 . . . . 0.57 108.732 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.79 129.27 28.46 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 108.26 -1.477 . . . . 0.57 108.26 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.5 OUTLIER -64.66 -167.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.769 1.747 . . . . 0.57 109.146 165.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.75 -46.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 129.773 3.229 . . . . 0.66 107.655 -163.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.01 -146.37 16.06 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.052 -1.416 . . . . 0.57 110.159 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 83.06 1.9 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.431 3.421 . . . . 0.57 112.437 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.87 169.24 17.86 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 127.749 2.595 . . . . 0.57 109.852 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 t30 54.5 -144.69 0.66 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.675 1.59 . . . . 0.57 112.604 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.5 m -47.33 135.81 10.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.578 2.351 . . . . 0.57 111.577 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.38 -33.18 10.11 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.411 -1.431 . . . . 0.57 112.519 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.9 158.47 28.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.57 108.812 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -141.56 164.75 29.39 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.023 0.829 . . . . 0.65 111.792 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.76 156.38 44.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.397 0.679 . . . . 0.57 110.433 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.08 152.87 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.925 -1.034 . . . . 0.57 108.894 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.05 95.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.701 -0.666 . . . . 0.57 110.186 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.47 149.7 69.08 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.077 2.518 . . . . 0.57 112.033 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.17 -70.65 0.32 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.406 0.527 . . . . 0.57 112.077 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -75.1 166.36 23.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.382 1.073 . . . . 0.57 109.796 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.46 45.35 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 117.554 -1.692 . . . . 0.57 114.797 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.78 -26.71 60.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.419 1.609 . . . . 0.57 111.049 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.15 149.11 6.21 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.231 -0.918 . . . . 0.57 110.925 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.75 -28.84 1.82 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.257 1.408 . . . . 0.57 113.624 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.97 152.95 44.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.242 1.021 . . . . 0.66 109.004 -170.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 149.7 52.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.57 109.608 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -140.39 151.34 44.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.836 -0.62 . . . . 0.65 110.957 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 40.6 m-85 -138.43 144.9 40.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.462 1.105 . . . . 0.57 109.007 -165.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.07 107.07 6.9 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.006 -1.109 . . . . 0.66 108.006 171.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.22 -19.11 62.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.524 1.511 . . . . 0.66 111.581 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.44 -44.96 81.41 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.398 1.479 . . . . 0.66 111.629 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.55 122.5 17.73 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 106.219 -1.771 . . . . 0.66 106.219 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 129.57 40.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.101 -0.952 . . . . 1.2 109.622 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -106.73 153.63 22.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.631 1.172 . . . . 0.57 109.465 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 141.85 51.46 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.558 -0.905 . . . . 0.57 108.558 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.23 42.27 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.824 1.65 . . . . 0.66 110.055 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.64 75.47 0.89 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.825 -0.91 . . . . 0.57 110.825 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.36 177.78 7.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.073 0.949 . . . . 0.57 108.967 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 m -57.17 122.65 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.836 0.855 . . . . 0.57 110.576 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.44 172.66 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.024 1.729 . . . . 0.57 112.577 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.08 169.69 42.09 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.561 -0.745 . . . . 0.57 111.447 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.25 123.59 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.747 -0.834 . . . . 0.57 108.747 -178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -64.58 120.36 12.21 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.482 -0.327 . . . . 0.57 110.729 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -52.65 -43.07 65.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.913 0.885 . . . . 0.57 111.869 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -64.77 -46.3 82.71 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.54 0.609 . . . . 0.57 109.839 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 137' ' ' VAL . 4.3 t80 -56.69 -48.62 77.25 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.801 -0.444 . . . . 0.57 109.801 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.76 85.32 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 122.8 0.44 . . . . 0.57 110.824 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -52.17 66.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 117.853 -1.07 . . . . 0.57 109.409 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.5 m -53.91 -40.25 66.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.174 1.352 . . . . 0.57 111.89 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -60.3 -56.37 22.32 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.206 0.602 . . . . 0.65 110.536 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.51 -44.51 78.24 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.931 0.892 . . . . 0.66 111.322 -172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.57 -25.91 68.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.584 1.554 . . . . 0.57 110.943 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.62 -51.72 57.21 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.713 -0.955 . . . . 0.57 110.713 169.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.07 -38.81 90.21 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 117.658 -1.163 . . . . 0.65 111.265 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.3 p -58.18 -31.3 67.15 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 118.559 0.618 . . . . 0.57 112.424 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -36.9 72.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.501 0.32 . . . . 0.57 111.815 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.16 43.24 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.691 -1.061 . . . . 0.57 113.342 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -116.58 149.59 39.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.594 1.197 . . . . 0.57 110.649 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.08 -45.62 4.09 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 117.786 -1.563 . . . . 0.57 111.928 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m80 156.24 174.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 129.739 3.216 . . . . 0.65 110.103 -171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 5.0 m -117.41 176.71 5.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.042 1.737 . . . . 0.57 110.807 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.27 58.99 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.625 1.17 . . . . 0.57 109.45 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.0 t70 -135.13 142.72 42.94 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 107.297 -1.372 . . . . 0.66 107.297 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.8 -34.58 30.49 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.696 1.597 . . . . 0.57 111.188 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -105.18 24.3 12.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.455 1.102 . . . . 0.57 110.071 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -58.54 130.64 47.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.97 -0.752 . . . . 0.57 108.97 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 150' ' ' PHE . 7.2 p -67.29 -24.39 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.411 -0.515 . . . . 0.57 109.815 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.4 16.54 14.93 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.483 -0.761 . . . . 0.57 112.318 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.486 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.1 t80 -72.18 144.46 87.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.857 1.662 . . . . 0.57 111.673 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 57.7 Cg_endo -74.25 163.52 36.27 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.48 2.12 . . . . 0.57 111.041 167.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.6 m 56.09 94.06 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.638 1.575 . . . . 0.57 112.034 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.37 105.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.491 1.516 . . . . 0.57 112.564 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.12 166.54 33.61 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.523 -1.831 . . . . 0.57 108.523 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.17 -47.89 0.22 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.88 2.472 . . . . 0.57 114.769 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.54 175.59 7.25 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.118 1.342 . . . . 0.57 112.142 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -121.0 101.15 45.3 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.939 -1.134 . . . . 0.66 107.939 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.79 40.29 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.527 2.818 . . . . 0.57 113.077 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.87 -54.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.638 -1.289 . . . . 0.57 107.994 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.07 88.22 2.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.637 1.575 . . . . 0.57 108.964 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 137' ' ' VAL . 45.7 p90 -121.45 -45.98 2.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.239 -0.891 . . . . 0.57 110.279 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 30.34 55.43 0.18 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.546 2.338 . . . . 0.57 113.574 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mp 63.46 100.22 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.617 1.967 . . . . 0.57 109.948 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.7 m -70.84 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.376 0.88 . . . . 0.57 113.376 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -143.94 -42.68 0.27 Allowed 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.938 0.895 . . . . 0.57 109.145 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 15.0 p-10 -59.95 -39.97 87.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.667 0.667 . . . . 0.66 112.172 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -54.56 29.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.7 1.2 . . . . 0.66 109.134 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.9 -46.25 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 124.826 1.251 . . . . 0.57 108.746 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -62.56 -47.71 82.69 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 117.971 -1.014 . . . . 0.57 108.761 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.55 -62.32 6.44 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.807 -1.717 . . . . 0.57 108.807 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 46' ' ' ILE . 5.3 mm -56.93 -43.61 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.242 1.021 . . . . 0.57 113.132 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -71.34 -27.75 63.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.58 -0.7 . . . . 0.57 111.662 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -36.01 68.13 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.964 0.906 . . . . 0.57 110.363 169.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -61.53 2.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.994 -1.003 . . . . 0.57 110.289 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 114.229 1.196 . . . . 0.57 114.229 -170.854 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 CA--C 1.552 1.377 0 N-CA-C 115.013 1.12 . . . . 0.57 115.013 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -162.06 31.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.944 1.698 . . . . 0.57 110.81 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.431 ' CH2' ' HA3' ' A' ' 94' ' ' GLY . 89.4 m95 51.93 -111.53 0.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.57 110.762 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -154.57 -40.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.613 1.565 . . . . 0.57 108.428 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -95.97 153.35 17.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.312 0.645 . . . . 0.57 109.506 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -9.93 20.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.988 0.915 . . . . 0.57 112.667 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.54 147.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.905 -1.517 . . . . 0.57 106.905 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.2 t -127.21 161.65 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.4 -1.333 . . . . 0.57 107.4 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -107.46 139.1 42.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.541 -1.281 . . . . 0.57 107.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -126.11 151.5 47.14 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.952 -1.093 . . . . 0.57 109.561 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -153.57 118.25 4.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.171 0.51 . . . . 1.2 109.803 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.3 mt -82.62 86.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.424 -1.695 . . . . 0.57 106.424 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.76 -49.59 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.548 1.139 . . . . 0.57 112.2 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.82 153.1 33.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.417 -2.438 . . . . 0.57 104.417 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -125.75 149.68 48.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.173 -1.788 . . . . 0.57 106.173 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -159.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 O-C-N 125.032 1.458 . . . . 0.57 111.084 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -148.04 -29.34 0.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 114.244 1.202 . . . . 1.2 114.244 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -52.61 -57.54 9.69 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.205 0.941 . . . . 0.66 110.915 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.31 164.41 14.99 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.641 1.576 . . . . 0.57 109.466 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -77.97 149.55 25.89 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.149 1.899 . . . . 0.57 112.618 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 11.7 m-70 -60.6 -35.65 76.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.398 1.079 . . . . 0.65 112.408 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.17 -38.98 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.011 0.524 . . . . 0.57 110.275 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -69.58 -41.32 75.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 117.222 -1.371 . . . . 0.57 109.069 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.54 -53.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 120.563 1.528 . . . . 0.57 109.96 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.21 -34.35 77.88 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 118.598 -0.715 . . . . 0.66 110.757 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -46.44 80.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.625 1.102 . . . . 1.2 111.717 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.1 mt -65.09 -45.22 86.14 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.223 1.009 . . . . 0.57 108.337 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.37 -44.86 99.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.94 -1.029 . . . . 0.57 110.565 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 m -60.27 -46.89 88.26 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 120.036 1.289 . . . . 0.57 109.895 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -36.89 69.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.508 -0.758 . . . . 0.57 111.501 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.69 91.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.296 1.038 . . . . 0.57 111.308 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 26.3 mt -72.11 -35.8 69.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.629 0.772 . . . . 0.57 110.493 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.52 -42.87 88.68 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.089 -0.958 . . . . 0.57 109.944 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.9 mtp -60.81 -36.93 80.32 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.928 0.891 . . . . 0.57 111.321 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -69.0 -47.04 66.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.975 1.261 . . . . 0.57 111.309 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.44 -3.86 59.08 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 123.94 0.781 . . . . 0.57 113.301 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -70.46 -19.81 62.93 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.984 -1.303 . . . . 0.57 111.043 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.6 mp0 -110.52 -34.8 6.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.503 1.521 . . . . 0.66 111.056 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 21.7 pt -114.07 143.06 28.96 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 119.596 1.089 . . . . 0.57 111.04 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.26 21.16 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.248 2.632 . . . . 0.57 112.488 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -86.96 126.38 34.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.188 -1.412 . . . . 0.57 107.188 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -126.68 -178.55 4.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.867 0.867 . . . . 0.65 109.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -147.83 147.53 29.9 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.704 -0.85 . . . . 0.57 108.704 -170.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.95 160.0 39.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.381 1.072 . . . . 1.2 109.722 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -110.05 116.08 30.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.286 -1.376 . . . . 0.57 107.286 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.58 161.21 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.585 -0.894 . . . . 0.57 108.585 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.79 39.44 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.208 1.003 . . . . 0.57 110.179 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -90.58 -65.57 1.0 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.045 0.538 . . . . 0.57 109.917 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.07 -70.55 0.02 OUTLIER Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.298 -1.521 . . . . 0.57 109.298 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -125.52 139.68 53.4 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.319 -1.363 . . . . 0.57 107.319 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.59 171.27 7.42 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.069 0.947 . . . . 0.57 110.012 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 15' ' ' VAL . 65.2 m-20 -62.48 -50.54 71.01 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.176 -1.046 . . . . 0.66 108.176 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.64 81.88 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.775 -1.565 . . . . 0.57 106.775 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -78.54 121.4 24.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.956 -1.127 . . . . 0.57 107.956 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.96 127.2 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 106.687 -1.597 . . . . 0.57 106.687 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.38 25.81 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 111.204 -0.758 . . . . 0.57 111.204 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 21.3 m-85 -132.62 137.32 46.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.948 -1.871 . . . . 0.57 105.948 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 160.22 36.59 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.826 1.65 . . . . 0.57 107.873 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -116.67 50.99 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.201 -0.937 . . . . 1.2 110.137 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.85 -127.35 6.31 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.254 -1.538 . . . . 0.57 109.254 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.94 139.46 0.46 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.14 1.376 . . . . 0.57 112.621 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -62.27 1.47 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.485 -0.78 . . . . 0.65 109.836 -173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.99 71.83 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.354 -0.692 . . . . 0.57 112.647 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.3 121.35 41.73 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.632 1.173 . . . . 0.66 108.485 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.82 -73.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.381 . . . . 0.57 111.689 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -148.23 144.12 18.38 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.426 1.49 . . . . 0.57 108.638 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.02 149.55 77.2 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.815 1.676 . . . . 0.57 110.405 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -70.44 -174.18 0.82 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.738 -1.119 . . . . 0.57 110.749 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.63 -32.16 4.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.688 2.395 . . . . 0.66 110.975 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.42 -139.94 15.83 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.364 0.983 . . . . 0.57 112.351 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.07 86.67 1.62 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.353 3.369 . . . . 0.57 112.036 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.04 -174.99 33.92 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.565 1.555 . . . . 0.57 111.226 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 m120 45.82 -134.71 0.82 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.829 1.314 . . . . 0.57 112.478 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -59.13 118.56 6.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.14 2.176 . . . . 0.57 111.449 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 112' ' ' ILE . 5.3 mp -94.68 -34.87 12.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.736 1.214 . . . . 0.57 112.195 -175.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.25 157.97 33.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.292 1.037 . . . . 0.57 108.826 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.68 161.93 37.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.341 -0.615 . . . . 0.65 109.341 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.46 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.696 -0.853 . . . . 0.57 108.696 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.58 153.82 32.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.317 -0.994 . . . . 0.57 108.317 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.38 149.56 96.94 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.072 -0.966 . . . . 0.57 109.63 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 29.3 Cg_endo -67.35 160.82 45.96 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.295 1.997 . . . . 0.57 111.47 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 -106.88 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.315 -1.914 . . . . 0.57 108.315 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.3 p -151.71 69.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.744 0.818 . . . . 0.57 110.948 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.36 -121.45 1.6 Allowed Glycine 0 C--N 1.342 0.904 0 N-CA-C 110.404 -1.079 . . . . 0.57 110.404 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.86 -21.76 61.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.797 1.239 . . . . 0.57 112.167 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.78 130.59 43.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.447 -1.196 . . . . 0.57 110.959 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' CH2' ' A' ' 10' ' ' TRP . . . 96.38 -36.86 3.65 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.084 2.278 . . . . 0.57 113.09 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.1 145.91 19.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.998 2.119 . . . . 0.66 107.092 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.29 146.61 36.99 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.871 -0.789 . . . . 0.57 108.871 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -139.56 160.6 39.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.381 -0.827 . . . . 0.65 110.236 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 57.5 m-85 -142.44 148.58 38.01 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.361 1.064 . . . . 0.57 108.323 -163.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.38 100.56 10.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.81 -1.552 . . . . 0.66 106.81 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.9 -25.73 31.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.463 -1.398 . . . . 0.66 111.43 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.18 -37.18 76.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.66 110.478 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.24 120.2 20.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.192 -1.41 . . . . 0.66 107.192 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -56.28 122.58 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.873 0.469 . . . . 1.2 110.254 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 114' ' ' PHE . 98.4 m95 -109.63 133.94 52.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 108.339 -0.985 . . . . 0.57 108.339 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.5 t -137.28 148.39 46.36 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.188 -0.671 . . . . 0.57 109.188 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.47 -26.04 67.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.844 0.857 . . . . 0.66 111.863 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.61 -141.19 11.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.088 1.327 . . . . 0.57 110.248 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -160.56 103.77 1.39 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.584 0.692 . . . . 0.57 109.566 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.51 -36.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.043 0.937 . . . . 0.57 112.231 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -104.04 -58.84 1.82 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.094 0.558 . . . . 0.57 109.516 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.9 -165.17 21.48 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.165 -1.174 . . . . 0.57 110.165 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.423 HD13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -85.58 143.96 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.887 1.275 . . . . 0.57 109.416 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.84 108.88 1.89 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.835 -1.075 . . . . 0.57 111.156 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -60.53 -34.42 74.09 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.581 0.752 . . . . 0.57 112.121 174.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.437 HD12 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -64.59 -51.33 63.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.7 -1.222 . . . . 0.57 107.7 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -57.55 -46.71 83.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.627 0.771 . . . . 0.57 110.147 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.65 19.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.515 0.509 . . . . 0.57 111.022 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.5 -55.52 34.03 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 117.933 -1.032 . . . . 0.57 109.907 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -58.18 -34.45 70.35 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.906 1.23 . . . . 0.57 111.841 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.01 -60.27 3.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.102 0.961 . . . . 0.65 109.79 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.88 -45.79 80.75 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.569 -0.707 . . . . 0.66 111.42 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.63 -30.8 71.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.524 1.13 . . . . 0.57 111.421 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.96 -42.51 80.67 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.156 -0.778 . . . . 0.57 111.156 170.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -74.52 -37.59 63.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 117.16 -1.4 . . . . 0.65 112.354 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 p -54.42 -38.65 66.5 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 124.453 1.096 . . . . 0.57 109.685 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.07 -43.38 95.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.7 0.8 . . . . 0.57 112.337 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.2 43.39 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.862 -0.966 . . . . 0.57 114.332 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.06 176.17 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.054 0.941 . . . . 0.57 111.45 -171.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.01 66.33 0.01 OUTLIER Glycine 0 C--N 1.342 0.882 0 O-C-N 121.473 -0.767 . . . . 0.57 111.735 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 174.24 7.11 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.626 1.171 . . . . 0.65 110.636 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 t -160.33 -177.16 6.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.36 -0.836 . . . . 0.57 110.773 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -146.8 56.37 1.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.306 2.642 . . . . 0.57 107.46 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.35 150.65 44.86 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 124.647 1.179 . . . . 0.66 108.278 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.0 -26.91 58.18 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.628 2.218 . . . . 0.57 111.607 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.94 30.29 5.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.27 -1.011 . . . . 0.57 108.27 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.42 131.04 46.05 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.294 -1.373 . . . . 0.57 107.294 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 150' ' ' PHE . 3.0 p -60.32 -32.26 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.57 110.68 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -99.21 25.86 6.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.827 0.451 . . . . 0.57 111.362 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.407 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 17.0 t80 -65.26 131.64 95.08 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 120.766 -1.209 . . . . 0.57 110.385 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.8 Cg_endo -75.28 171.79 17.6 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.662 2.241 . . . . 0.57 111.007 166.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 m 52.13 76.81 0.17 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.474 1.13 . . . . 0.57 110.657 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -46.92 125.52 7.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.234 1.014 . . . . 0.57 112.485 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.45 1.86 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.08 -1.208 . . . . 0.57 110.08 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.79 -44.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.55 0.74 . . . . 0.57 111.635 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -143.51 -137.14 3.23 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.208 -1.957 . . . . 0.57 108.208 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -126.03 112.0 24.31 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.589 -0.893 . . . . 0.66 108.589 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.41 -14.76 22.59 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.423 2.082 . . . . 0.57 112.035 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -64.65 -48.68 73.93 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 121.894 2.133 . . . . 0.57 109.87 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -92.5 69.91 4.98 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.643 1.177 . . . . 0.57 111.169 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.44 125.72 28.03 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.293 -0.632 . . . . 0.57 109.293 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 83.04 1.54 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.539 -1.282 . . . . 0.57 107.539 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 48.58 80.93 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.815 1.646 . . . . 0.57 111.629 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.6 t -67.95 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.128 0.571 . . . . 0.57 112.322 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.59 -57.37 0.69 Allowed 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.386 -0.968 . . . . 0.57 108.386 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -51.06 -39.43 55.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.277 1.431 . . . . 0.66 112.266 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -63.57 -53.83 45.61 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.64 -0.695 . . . . 0.66 109.366 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -48.92 86.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 118.752 -0.642 . . . . 0.57 109.843 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -32.76 74.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.12 1.768 . . . . 0.57 110.626 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.84 -60.45 3.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.98 -2.048 . . . . 0.57 107.98 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.55 -58.35 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 119.342 1.571 . . . . 0.57 111.151 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 10.6 pt20 -58.56 -22.56 56.16 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.705 0.684 . . . . 0.57 112.148 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -31.4 19.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.948 1.299 . . . . 0.57 110.777 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.14 -46.14 88.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.16 . . . . 0.57 110.157 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.1 p90 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 123.379 0.672 . . . . 0.57 112.674 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 CA--C 1.541 0.87 0 N-CA-C 111.011 -0.419 . . . . 0.57 111.011 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt 91.44 132.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 130.395 3.478 . . . . 0.57 109.9 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -64.41 159.46 21.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.513 0.725 . . . . 0.57 110.743 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -76.28 -25.33 54.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.715 0.635 . . . . 0.57 112.715 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -94.06 143.03 26.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.417 1.087 . . . . 0.57 109.9 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 pttm -76.48 -12.22 60.0 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.816 1.246 . . . . 0.57 112.963 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.85 109.49 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.735 -2.32 . . . . 0.57 104.735 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.11 163.86 3.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.67 -1.604 . . . . 0.57 106.67 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 p -114.37 147.45 39.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.694 -0.629 . . . . 0.57 111.351 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -123.77 155.42 37.96 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.474 0.71 . . . . 0.57 110.763 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 120.06 5.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.488 0.661 . . . . 1.2 110.052 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 22' ' ' TYR . 29.7 mt -87.02 113.8 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 105.842 -1.91 . . . . 0.57 105.842 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.48 -45.66 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.291 0.951 . . . . 0.57 111.237 -171.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.7 178.41 4.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.388 -1.708 . . . . 0.57 106.388 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 19' ' ' ILE . 49.2 m-85 -142.66 173.81 11.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.454 1.025 . . . . 0.57 109.306 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -90.28 -175.5 4.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.476 1.11 . . . . 0.57 111.251 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -123.96 -34.7 2.95 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.909 1.284 . . . . 1.2 113.491 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -61.86 -27.46 68.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.069 1.348 . . . . 0.66 111.648 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.47 144.31 20.65 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 126.957 2.103 . . . . 0.57 108.436 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 167.45 24.85 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.946 2.431 . . . . 0.57 112.863 -166.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.29 -36.24 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.859 0.864 . . . . 0.65 111.903 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.54 -36.87 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.724 0.81 . . . . 0.57 110.353 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -67.27 -49.84 62.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.846 -1.549 . . . . 0.57 108.39 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.97 -51.03 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 121.217 1.826 . . . . 0.57 110.66 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.8 -41.15 96.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.676 0.791 . . . . 0.66 111.986 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -62.98 -45.45 92.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.07 0.85 . . . . 1.2 111.772 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.14 -35.08 73.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.45 -0.786 . . . . 0.57 109.257 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.23 -49.45 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 117.886 -1.054 . . . . 0.57 110.204 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -60.17 -42.79 95.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.945 1.248 . . . . 0.57 111.076 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -65.05 -47.58 76.87 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.004 0.82 . . . . 0.57 111.234 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.99 99.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.127 0.971 . . . . 0.57 111.96 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 122' ' ' LEU . 42.8 mt -71.29 -35.54 71.33 Favored 'General case' 0 C--O 1.228 -0.044 0 O-C-N 121.531 -0.731 . . . . 0.57 111.427 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -61.96 -41.04 97.54 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 118.915 0.78 . . . . 0.57 110.092 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 36.0 mtp -60.71 -40.1 91.03 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.022 -0.99 . . . . 0.57 111.206 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.45 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 46.7 m95 -61.89 -50.24 73.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.45 1.477 . . . . 0.57 111.844 168.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.24 -8.97 53.22 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.424 1.012 . . . . 0.57 114.258 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -66.79 -24.2 66.15 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -1.225 . . . . 0.57 111.315 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -111.36 -11.34 14.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 118.445 -0.788 . . . . 0.66 111.023 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 pt -140.23 135.41 16.15 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 120.38 1.446 . . . . 0.57 110.96 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.87 48.36 2.2 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.52 3.48 . . . . 0.57 113.462 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tt -109.43 141.97 41.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.507 1.923 . . . . 0.57 107.842 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -133.0 163.77 28.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.785 0.834 . . . . 0.65 109.002 -168.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.75 145.49 32.43 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.573 -0.899 . . . . 0.57 108.573 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -145.33 175.23 10.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.331 1.052 . . . . 1.2 110.274 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -112.17 138.19 49.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.093 -0.706 . . . . 0.57 109.093 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.51 -28.96 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.097 0.959 . . . . 0.57 111.21 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.258 3.7 m 44.88 40.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.565 1.946 . . . . 0.57 112.72 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -156.47 -38.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.544 1.312 . . . . 0.57 114.544 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.83 -146.26 4.52 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.974 -1.25 . . . . 0.57 109.974 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -70.72 -173.64 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.0 0.9 . . . . 0.57 111.536 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.77 177.37 11.33 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.123 1.369 . . . . 0.57 110.403 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -63.66 -36.15 82.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.746 0.819 . . . . 0.66 110.097 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mt -120.33 76.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 126.769 2.027 . . . . 0.57 107.804 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -72.63 124.07 24.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.973 -1.121 . . . . 0.57 107.973 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.27 117.72 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 105.286 -2.116 . . . . 0.57 105.286 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.03 161.82 19.47 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.923 -0.871 . . . . 0.57 110.923 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -133.83 142.76 47.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.472 -2.048 . . . . 0.57 105.472 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.31 166.25 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.962 2.505 . . . . 0.57 107.535 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -130.0 93.96 3.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.06 -49.85 2.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.91 -0.939 . . . . 0.57 111.814 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.25 153.04 38.18 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.639 1.72 . . . . 0.57 110.897 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -152.04 159.69 43.64 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 125.568 1.547 . . . . 0.65 109.158 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.75 44.9 3.04 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.369 1.462 . . . . 0.57 112.872 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.67 -179.78 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.577 1.551 . . . . 0.66 110.409 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -39.82 -50.07 2.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.333 1.453 . . . . 0.57 111.791 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.89 132.06 13.7 Favored Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 124.611 1.164 . . . . 0.57 109.801 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.01 158.76 54.46 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.033 1.822 . . . . 0.57 111.204 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.33 -164.48 0.77 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.675 1.19 . . . . 0.57 111.061 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -121.73 -14.08 8.19 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.928 2.491 . . . . 0.66 112.408 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.71 -134.82 12.71 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.397 0.999 . . . . 0.57 110.678 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.51 100.51 1.16 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.471 2.114 . . . . 0.57 112.322 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.91 -163.85 25.55 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.516 1.055 . . . . 0.57 112.518 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 t30 45.42 -125.53 1.19 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.465 1.506 . . . . 0.57 114.346 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.6 m -74.48 131.91 41.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.635 2.374 . . . . 0.57 108.614 173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.76 -31.9 10.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.924 1.29 . . . . 0.57 112.194 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.34 37.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.945 1.298 . . . . 0.57 108.008 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -143.23 161.38 38.41 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.964 -0.46 . . . . 0.65 110.029 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.66 144.58 27.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.363 1.065 . . . . 0.57 109.167 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.04 146.4 27.96 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.849 -1.167 . . . . 0.57 107.849 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.86 155.15 12.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.502 -0.761 . . . . 0.57 110.891 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.48 166.07 26.92 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.121 1.881 . . . . 0.57 112.043 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.23 -101.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 108.984 -1.646 . . . . 0.57 108.984 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.3 p -151.36 -54.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.423 1.089 . . . . 0.57 110.599 -166.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.7 -108.56 3.24 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 125.086 1.327 . . . . 0.57 110.01 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -29.06 64.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.418 1.087 . . . . 0.57 111.754 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.33 141.75 6.95 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.201 -0.76 . . . . 0.57 111.201 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.99 4.61 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.664 -1.631 . . . . 0.57 114.504 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.25 159.47 33.38 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.043 1.921 . . . . 0.66 109.074 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.81 145.36 27.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.57 109.867 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -130.94 155.22 47.16 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.334 -0.617 . . . . 0.65 109.334 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -138.08 147.99 44.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.778 1.631 . . . . 0.57 108.631 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.39 93.99 8.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.795 0.838 . . . . 0.66 108.882 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.85 -22.36 14.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.77 1.628 . . . . 0.66 111.568 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.61 -28.81 68.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.115 0.416 . . . . 0.66 111.572 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -79.89 167.86 19.98 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 122.026 0.917 . . . . 0.66 111.502 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -79.55 156.39 27.76 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.69 -0.686 . . . . 1.2 110.157 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CZ3' HD11 ' A' ' 112' ' ' ILE . 96.9 m95 -151.28 121.7 7.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.817 -1.919 . . . . 0.57 105.817 -175.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -136.15 144.56 45.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.871 1.669 . . . . 0.57 109.342 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -68.07 -45.5 73.66 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.957 0.503 . . . . 0.66 110.596 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.95 39.27 0.02 OUTLIER Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.826 1.679 . . . . 0.57 111.43 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 -66.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.012 1.325 . . . . 0.57 110.199 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -84.44 168.23 15.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.461 0.704 . . . . 0.57 110.314 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.74 150.21 20.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.241 1.016 . . . . 0.57 111.371 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -145.88 15.29 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.709 -0.556 . . . . 0.57 111.709 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.401 HD11 ' CZ3' ' A' ' 104' ' ' TRP . 1.3 pp -122.83 142.66 38.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.453 1.101 . . . . 0.57 108.21 172.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.7 110.39 1.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.273 0.629 . . . . 0.57 111.615 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.04 -34.87 78.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.203 1.801 . . . . 0.57 113.104 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -39.97 84.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.434 0.561 . . . . 0.57 110.217 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.76 -45.72 81.49 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 124.038 0.836 . . . . 0.57 108.77 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.42 22.06 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 123.562 0.745 . . . . 0.57 111.114 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.9 74.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.749 -1.12 . . . . 0.57 109.866 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -51.89 -46.06 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.85 1.205 . . . . 0.57 111.029 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -61.76 -55.18 32.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.692 0.797 . . . . 0.65 109.773 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.43 -41.01 89.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.343 0.519 . . . . 0.66 110.96 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 HD21 ' A' ' 39' ' ' LEU . 4.5 mm? -63.14 -26.08 68.65 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.42 -0.8 . . . . 0.57 111.801 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.45 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -66.58 -44.59 89.54 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.893 1.224 . . . . 0.57 113.003 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -64.28 -38.56 91.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.042 -0.504 . . . . 0.65 110.025 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 t -59.4 -33.81 71.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.358 0.503 . . . . 0.57 112.358 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -38.43 65.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.992 0.917 . . . . 0.57 111.534 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.3 9.75 0.65 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.426 1.013 . . . . 0.57 115.224 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -93.99 157.96 15.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.681 1.24 . . . . 0.57 110.845 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.35 178.01 21.69 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.513 -1.035 . . . . 0.57 110.513 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -72.61 166.66 22.29 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.054 0.542 . . . . 0.65 111.439 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.0 t -123.55 -46.35 2.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.427 1.891 . . . . 0.57 112.299 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.72 43.71 0.32 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.366 1.467 . . . . 0.57 112.831 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -117.29 154.8 50.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.609 1.163 . . . . 0.66 109.48 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.71 -6.29 18.23 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.527 2.818 . . . . 0.57 114.353 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -137.5 17.62 2.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.039 1.336 . . . . 0.57 110.378 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.17 130.71 43.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.505 0.722 . . . . 0.57 111.077 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.79 -25.28 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.668 1.187 . . . . 0.57 111.752 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.95 21.55 11.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.453 1.501 . . . . 0.57 111.357 169.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -58.85 136.3 87.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 120.667 -1.271 . . . . 0.57 110.194 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.99 -163.76 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.729 2.953 . . . . 0.57 111.819 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t 36.29 77.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.524 1.929 . . . . 0.57 115.215 168.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -38.91 109.63 0.11 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.919 2.088 . . . . 0.57 113.341 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.34 111.34 1.2 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.747 1.165 . . . . 0.57 110.684 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -179.84 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.61 1.164 . . . . 0.57 112.279 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.0 -162.29 11.46 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.475 1.512 . . . . 0.57 110.024 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.04 108.88 56.55 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 106.846 -1.538 . . . . 0.66 106.846 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.44 -7.6 9.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.31 2.674 . . . . 0.57 112.922 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -69.48 -33.38 72.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 121.041 1.746 . . . . 0.57 109.684 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.74 86.8 2.26 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.288 1.035 . . . . 0.57 112.001 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.76 -50.75 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.623 1.569 . . . . 0.57 111.618 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.99 45.1 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.027 2.131 . . . . 0.57 114.85 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp 64.98 79.96 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.841 1.656 . . . . 0.57 109.893 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -58.82 -83.48 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.644 1.177 . . . . 0.57 113.448 -170.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -142.88 -49.45 0.34 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.738 1.615 . . . . 0.57 106.643 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.18 -53.4 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.66 112.953 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -51.67 69.08 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.874 0.469 . . . . 0.66 110.772 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.07 -38.58 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.341 1.056 . . . . 0.57 109.699 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -49.69 66.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.548 1.139 . . . . 0.57 108.046 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.6 -52.74 51.28 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.89 0.768 . . . . 0.57 111.311 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 mm -61.6 -50.74 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.438 -0.791 . . . . 0.57 111.052 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -70.81 -14.08 62.28 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.245 1.384 . . . . 0.57 112.143 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -83.26 -25.08 31.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.618 1.099 . . . . 0.57 111.829 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.27 -37.44 12.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.571 1.078 . . . . 0.57 111.9 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 126.148 1.779 . . . . 0.57 109.517 -173.448 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.444 -1.421 0 N-CA-C 110.042 -0.792 . . . . 0.57 110.042 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.23 132.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.425 2.29 . . . . 0.57 108.186 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG21 ' A' ' 15' ' ' VAL . 13.0 m95 -71.72 175.02 6.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.699 0.8 . . . . 0.57 110.422 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.0 p -97.38 -11.7 23.65 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.672 0.619 . . . . 0.57 112.672 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.0 t -104.49 151.25 23.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.85 1.66 . . . . 0.57 108.675 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -8.91 57.85 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.201 1.001 . . . . 0.57 112.449 172.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.66 144.62 37.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.568 1.547 . . . . 0.57 108.775 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 10' ' ' TRP . 96.2 t -130.37 153.73 39.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.856 1.262 . . . . 0.57 108.098 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 p -103.39 144.02 31.93 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.739 -0.467 . . . . 0.57 109.739 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -133.31 152.74 51.94 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.257 -1.527 . . . . 0.57 110.895 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.63 111.77 4.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.313 1.054 . . . . 1.2 109.626 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.28 101.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 104.152 -2.536 . . . . 0.57 104.152 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.45 -44.87 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.692 1.197 . . . . 0.57 111.651 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.44 174.86 6.12 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.362 1.865 . . . . 0.57 106.411 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -146.29 161.16 40.9 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.5 -0.926 . . . . 0.57 108.5 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.8 t -63.25 177.73 0.6 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.597 0.713 . . . . 0.57 110.913 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -117.67 -39.61 3.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.436 1.094 . . . . 1.2 112.836 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.07 -33.55 73.5 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.231 0.923 . . . . 0.66 110.084 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.35 149.7 44.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.57 109.811 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -76.73 164.81 29.69 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.918 2.412 . . . . 0.57 113.609 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 17.0 m-70 -62.38 -45.52 92.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.898 1.279 . . . . 0.65 112.06 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 tp -57.86 -42.21 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.653 0.781 . . . . 0.57 109.672 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -62.46 -48.35 80.04 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 117.759 -1.115 . . . . 0.57 109.251 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.43 -49.74 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 120.72 1.6 . . . . 0.57 110.679 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.59 -41.34 96.3 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.167 0.894 . . . . 0.66 111.404 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.275 -0.891 . . . . 1.2 112.307 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.11 -35.92 74.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.998 -1.001 . . . . 0.57 109.274 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.03 -51.56 60.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.05 -0.976 . . . . 0.57 108.773 166.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -43.61 88.76 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.08 1.309 . . . . 0.57 110.878 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -66.89 -38.51 86.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.565 1.075 . . . . 0.57 112.807 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.16 76.44 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.341 1.056 . . . . 0.57 111.554 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.5 -30.96 68.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.086 -0.959 . . . . 0.57 110.278 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.34 -31.76 72.44 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.859 1.209 . . . . 0.57 111.339 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.8 mtm -74.28 -37.55 63.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.328 -0.844 . . . . 0.57 111.66 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -64.9 -50.19 67.49 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.93 1.241 . . . . 0.57 110.681 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -4.91 55.24 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.511 1.529 . . . . 0.57 113.956 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -25.68 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.548 -0.972 . . . . 0.57 110.211 168.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -110.71 -19.06 12.99 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.695 -0.669 . . . . 0.66 112.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 160' ' ' ILE . 32.5 pt -126.35 126.3 24.64 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 123.951 0.9 . . . . 0.57 109.028 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.95 32.64 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.504 2.803 . . . . 0.57 113.557 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 15' ' ' VAL . 1.3 tt -80.89 145.9 31.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.147 1.379 . . . . 0.57 108.241 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.444 ' H ' HD23 ' A' ' 48' ' ' LEU . 9.3 m80 -126.54 165.92 18.25 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.65 108.47 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.06 157.33 46.56 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.723 -1.236 . . . . 0.57 108.511 -172.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.76 160.78 39.12 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.33 1.052 . . . . 1.2 108.857 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -106.9 146.7 30.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.438 -1.319 . . . . 0.57 107.438 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.1 169.01 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.927 0.491 . . . . 0.57 109.793 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.31 -13.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.57 111.504 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -93.23 -66.02 0.95 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.57 108.845 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.48 -27.38 0.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.843 0.292 . . . . 0.57 113.05 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -78.56 125.72 29.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.845 -1.169 . . . . 0.57 107.845 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.3 166.17 26.3 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.973 0.909 . . . . 0.57 109.321 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 74.1 m-20 -64.1 -47.19 81.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.11 0.964 . . . . 0.66 108.706 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.92 80.0 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.766 1.627 . . . . 0.57 107.282 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 ttm -75.48 134.26 40.87 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.77 -1.206 . . . . 0.57 107.841 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.59 119.63 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.963 -1.865 . . . . 0.57 105.963 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.94 163.92 23.35 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 111.841 -0.504 . . . . 0.57 111.841 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.31 134.01 33.74 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.467 -2.049 . . . . 0.57 105.467 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.03 -174.04 4.74 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.702 1.201 . . . . 0.57 109.27 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 3.04 8.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.893 0.77 . . . . 1.2 112.813 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.75 -130.67 2.12 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.175 -1.57 . . . . 0.57 109.175 -166.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.7 117.13 7.01 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.376 -0.485 . . . . 0.57 110.385 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -112.19 -46.8 3.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.558 0.743 . . . . 0.65 111.316 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.41 23.41 0.59 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.2 0.905 . . . . 0.57 113.893 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -53.18 4.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.515 1.926 . . . . 0.66 111.773 -170.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -178.38 -45.41 0.01 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.848 2.059 . . . . 0.57 107.646 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.56 139.5 35.48 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 123.852 0.861 . . . . 0.57 109.039 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.34 141.4 46.85 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.454 1.436 . . . . 0.57 109.965 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.75 -179.24 0.84 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.953 1.358 . . . . 0.57 111.121 163.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -115.52 -31.23 5.96 Favored 'General case' 0 CA--C 1.542 0.666 1 C-N-CA 131.92 4.088 . . . . 0.66 109.931 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.08 -138.03 15.65 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.668 -0.973 . . . . 0.57 110.668 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 104.1 1.69 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.803 3.002 . . . . 0.57 112.148 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -179.75 16.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 126.004 1.764 . . . . 0.57 108.891 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.74 -155.66 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.389 1.876 . . . . 0.57 112.86 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.7 m -44.87 120.39 2.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.365 2.266 . . . . 0.57 111.534 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.18 -25.13 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.888 1.275 . . . . 0.57 113.106 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.22 164.34 25.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.353 1.461 . . . . 0.57 108.367 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.03 158.74 44.42 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.998 -0.371 . . . . 0.65 109.998 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.0 155.74 39.68 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.725 1.21 . . . . 0.57 109.808 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.05 171.65 7.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.289 0.636 . . . . 0.57 110.596 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.55 139.08 26.48 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-O 118.245 -0.884 . . . . 0.57 109.363 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 50.3 Cg_endo -67.49 159.37 52.77 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.578 2.186 . . . . 0.57 112.166 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.28 12.72 21.09 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.351 -0.694 . . . . 0.57 113.752 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -153.47 43.73 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.55 1.675 . . . . 0.57 111.933 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.37 -71.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.168 1.842 . . . . 0.57 114.69 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.06 -5.05 39.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.372 1.869 . . . . 0.57 111.437 163.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 126.92 31.59 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.979 -1.075 . . . . 0.57 110.446 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.28 -44.33 1.5 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 126.046 1.784 . . . . 0.57 110.845 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.09 143.75 13.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.105 2.162 . . . . 0.66 109.199 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.07 150.36 42.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.633 0.73 . . . . 0.57 109.535 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.47 162.96 31.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.943 -0.762 . . . . 0.65 108.943 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -139.59 158.45 44.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.497 1.919 . . . . 0.57 109.344 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -84.45 102.35 12.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.655 0.382 . . . . 0.66 110.999 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -58.23 -28.44 64.87 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.605 -1.309 . . . . 0.66 111.116 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.46 -26.71 66.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.609 0.763 . . . . 0.66 111.581 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -72.37 138.93 47.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.203 1.002 . . . . 0.66 109.608 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.12 111.79 4.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -94.24 158.64 15.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.409 -0.96 . . . . 0.57 108.409 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.3 t -141.19 153.53 45.37 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.313 -0.995 . . . . 0.57 108.313 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.55 -36.43 70.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.331 0.652 . . . . 0.66 110.162 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.65 -97.36 1.47 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.102 -1.199 . . . . 0.57 110.102 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -158.17 139.31 13.29 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.728 -1.212 . . . . 0.57 107.728 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 t -163.82 -51.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.836 -0.602 . . . . 0.57 110.491 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -160.38 -44.12 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.001 1.72 . . . . 0.57 110.895 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.77 173.43 54.71 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.536 -1.026 . . . . 0.57 110.536 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -83.66 148.78 4.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.236 0.541 . . . . 0.57 109.816 177.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -65.39 114.58 4.91 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.67 -0.695 . . . . 0.57 109.488 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -60.92 -41.11 95.52 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.524 1.13 . . . . 0.57 111.573 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -47.44 84.61 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.555 1.142 . . . . 0.57 108.787 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -60.56 -39.25 87.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.061 0.944 . . . . 0.57 110.051 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.42 49.48 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.915 0.886 . . . . 0.57 112.765 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.76 68.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.219 -1.03 . . . . 0.57 108.219 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 m -56.1 -41.23 74.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.336 0.654 . . . . 0.57 111.758 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.08 -57.79 11.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.953 0.342 . . . . 0.65 110.109 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -68.11 -39.96 82.68 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.042 -1.036 . . . . 0.66 111.609 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.38 -32.72 74.51 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.586 1.154 . . . . 0.57 110.818 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.57 -47.35 57.67 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.166 -0.774 . . . . 0.57 111.166 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.48 -35.35 70.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.556 0.576 . . . . 0.65 112.556 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -35.85 73.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 0.57 111.02 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -46.5 89.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.562 0.745 . . . . 0.57 110.71 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.51 49.19 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.533 -0.593 . . . . 0.57 113.951 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.72 -160.1 0.17 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.029 1.414 . . . . 0.57 110.724 -173.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 132.65 35.22 0.32 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 121.427 -0.796 . . . . 0.57 113.659 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 167.8 7.2 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.219 1.009 . . . . 0.65 112.856 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.9 p -152.95 -173.33 4.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.584 1.153 . . . . 0.57 110.208 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.8 p -143.48 49.73 1.41 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.703 1.201 . . . . 0.57 110.949 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 143.87 27.91 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.08 1.352 . . . . 0.66 110.239 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.28 -12.27 29.7 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.455 2.103 . . . . 0.57 113.743 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -137.22 51.14 1.96 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.685 1.594 . . . . 0.57 107.909 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.21 43.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.637 1.575 . . . . 0.57 108.059 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.86 -27.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.57 109.381 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.2 mmt -78.14 -14.96 59.27 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.649 1.979 . . . . 0.57 114.154 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -58.8 128.25 83.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.009 1.277 . . . . 0.57 110.605 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.05 156.8 47.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.248 1.966 . . . . 0.57 110.642 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.5 m 61.14 99.35 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.207 1.403 . . . . 0.57 111.473 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.89 123.98 2.05 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.197 1.399 . . . . 0.57 111.883 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.68 -130.86 2.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.162 -1.575 . . . . 0.57 109.162 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -65.12 -61.55 2.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.537 0.668 . . . . 0.57 110.446 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 39.88 -150.45 0.11 Allowed Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.305 1.431 . . . . 0.57 113.409 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.24 75.36 4.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.266 -1.012 . . . . 0.66 108.266 167.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.0 39.8 0.3 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.962 3.108 . . . . 0.57 112.822 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -144.76 -54.51 0.32 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.129 1.772 . . . . 0.57 108.436 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.03 89.11 3.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.0 1.32 . . . . 0.57 108.43 -170.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -44.34 -63.24 0.92 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.479 1.511 . . . . 0.57 114.906 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt 31.49 63.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.915 2.486 . . . . 0.57 113.479 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -25.8 115.13 0.05 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 128.781 2.832 . . . . 0.57 110.874 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.3 t -82.66 -82.26 0.14 Allowed 'General case' 0 C--N 1.341 0.204 0 CA-C-O 119.051 -0.5 . . . . 0.57 111.022 -162.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -147.94 -44.12 0.16 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 118.531 0.605 . . . . 0.57 110.364 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.26 -49.22 9.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.903 2.081 . . . . 0.66 112.933 164.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.53 -54.76 23.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.808 0.843 . . . . 0.66 109.833 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.98 -41.68 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.349 1.06 . . . . 0.57 109.108 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -57.14 13.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.916 -1.142 . . . . 0.57 107.916 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.417 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -51.1 -53.9 25.32 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.523 -1.031 . . . . 0.57 110.523 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 46' ' ' ILE . 20.1 mm -50.86 -50.73 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.479 0.712 . . . . 0.57 111.294 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.37 -31.01 70.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.43 0.559 . . . . 0.57 112.241 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -24.41 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.653 -1.165 . . . . 0.57 110.814 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 159' ' ' GLY . 9.0 mp -93.01 -49.78 5.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.243 1.017 . . . . 0.57 110.667 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 123.841 0.856 . . . . 0.57 112.077 -173.837 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.448 -1.192 0 N-CA-C 109.115 -1.148 . . . . 0.57 109.115 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 80.38 128.5 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 129.05 2.94 . . . . 0.57 111.075 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -61.59 157.86 16.48 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.605 0.762 . . . . 0.57 110.491 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.1 p -78.28 -34.38 48.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.475 . . . . 0.57 111.508 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -82.93 139.12 33.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.958 0.903 . . . . 0.57 109.197 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -76.29 -2.79 33.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.5 0.72 . . . . 0.57 112.75 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.96 113.84 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.855 -2.276 . . . . 0.57 104.855 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.71 139.85 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.876 -1.527 . . . . 0.57 106.876 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 149.31 35.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.603 -0.686 . . . . 0.57 111.283 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.44 157.12 35.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.57 110.571 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 119.62 11.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.941 -0.763 . . . . 1.2 108.941 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -87.82 99.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 104.982 -2.229 . . . . 0.57 104.982 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -48.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.504 1.122 . . . . 0.57 111.712 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.84 175.46 5.57 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.151 1.78 . . . . 0.57 106.455 174.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -144.42 164.87 29.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.364 -0.976 . . . . 0.57 108.364 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.6 t -67.84 -175.32 0.54 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.57 0.748 . . . . 0.57 111.632 171.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.23 -38.16 1.8 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.704 1.202 . . . . 1.2 113.12 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.7 -43.9 93.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.345 0.658 . . . . 0.66 109.985 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.0 149.1 39.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.627 1.971 . . . . 0.57 108.606 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -75.11 160.31 39.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.311 2.007 . . . . 0.57 112.66 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.84 -38.99 83.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.353 1.061 . . . . 0.65 111.669 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.75 -39.58 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.341 0.656 . . . . 0.57 110.296 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.8 m -68.01 -43.62 78.42 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 116.442 -1.742 . . . . 0.57 109.013 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.97 -51.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 121.455 1.934 . . . . 0.57 110.736 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.33 -40.99 94.4 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.197 0.908 . . . . 0.66 111.352 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -42.74 97.65 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.852 1.206 . . . . 1.2 112.048 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 115' ' ' LEU . 7.8 mp -63.55 -48.65 76.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.598 1.559 . . . . 0.57 108.402 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -56.64 -41.61 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.977 0.808 . . . . 0.57 110.763 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -60.51 -53.25 59.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.499 1.045 . . . . 0.57 109.644 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -39.19 93.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.285 0.948 . . . . 0.57 111.624 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.96 93.74 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.943 1.297 . . . . 0.57 111.984 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 HD12 ' A' ' 122' ' ' LEU . 30.5 mt -70.42 -33.78 71.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.396 -0.812 . . . . 0.57 110.322 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.97 -37.3 76.48 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 118.808 0.731 . . . . 0.57 110.546 171.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.52 80.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.91 0.777 . . . . 0.57 112.268 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.427 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 17.7 m95 -73.03 -47.56 43.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.764 0.711 . . . . 0.57 110.823 171.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.87 63.54 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.562 1.077 . . . . 0.57 113.53 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.32 -17.47 64.78 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.113 -1.227 . . . . 0.57 111.863 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -106.41 -33.86 7.6 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.75 -0.643 . . . . 0.66 111.332 173.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 160' ' ' ILE . 21.4 pt -121.54 134.17 24.47 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 119.455 1.025 . . . . 0.57 110.39 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 37.27 0.38 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.9 3.067 . . . . 0.57 113.055 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.06 132.84 36.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.021 -1.474 . . . . 0.57 107.021 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -116.44 163.97 15.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.89 1.276 . . . . 0.65 108.915 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -139.6 153.47 47.37 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.231 -0.918 . . . . 0.57 108.962 -170.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -141.04 178.68 7.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.179 0.991 . . . . 1.2 109.461 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -125.35 156.07 39.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.538 -0.912 . . . . 0.57 108.538 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 m -108.19 169.53 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.998 1.319 . . . . 0.57 109.319 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.77 -29.37 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.71 -1.586 . . . . 0.57 110.948 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -62.69 -51.83 65.67 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.187 0.903 . . . . 0.57 111.719 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.64 -125.2 1.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.072 -1.611 . . . . 0.57 109.072 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -47.14 154.85 0.34 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.443 1.097 . . . . 0.57 113.744 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.87 -174.18 4.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.176 1.39 . . . . 0.57 110.943 -170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -60.51 -42.09 95.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.54 -0.743 . . . . 0.66 109.001 172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -124.19 82.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.57 108.375 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.3 ttp -79.89 117.32 20.65 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 120.294 -1.504 . . . . 0.57 107.116 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -108.62 129.09 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.25 -2.13 . . . . 0.57 105.25 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 164.77 27.64 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-O 121.962 0.756 . . . . 0.57 112.176 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.9 m-85 -132.43 141.4 48.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.026 -1.842 . . . . 0.57 106.026 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.38 164.69 30.08 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.874 1.669 . . . . 0.57 107.916 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 42.08 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.564 -0.71 . . . . 1.2 111.182 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.15 -46.29 0.61 Allowed Glycine 0 C--O 1.223 -0.586 0 CA-C-O 119.53 -0.594 . . . . 0.57 111.658 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.03 169.32 21.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.567 1.184 . . . . 0.57 110.245 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.76 159.92 33.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.969 1.708 . . . . 0.65 108.829 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.65 60.78 3.19 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.888 1.232 . . . . 0.57 111.412 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -105.78 -61.84 1.45 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.111 0.965 . . . . 0.66 110.406 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.5 t -179.74 -35.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.364 2.665 . . . . 0.57 110.003 -173.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.75 122.7 14.54 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 119.193 0.906 . . . . 0.57 108.992 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.99 133.13 34.56 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 N-CA-C 108.423 -1.414 . . . . 0.57 108.423 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -166.93 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 123.257 1.504 . . . . 0.57 110.809 166.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -134.01 -38.25 0.88 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.76 3.224 . . . . 0.66 109.172 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.74 -139.68 14.97 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.672 -1.071 . . . . 0.57 110.509 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.1 95.43 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 124.466 3.444 . . . . 0.57 111.281 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.64 170.85 12.33 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.849 1.69 . . . . 0.57 109.29 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 49.33 -159.6 0.06 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.485 1.514 . . . . 0.57 112.377 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -43.05 128.18 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.242 2.217 . . . . 0.57 112.848 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -95.53 -24.33 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.641 1.576 . . . . 0.57 113.062 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.09 162.0 33.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.629 -1.249 . . . . 0.57 107.629 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.3 167.83 22.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.321 -0.622 . . . . 0.65 109.321 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.39 160.28 42.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.285 -1.006 . . . . 0.57 108.285 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -111.45 147.07 36.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.688 -1.227 . . . . 0.57 107.688 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 151.4 53.22 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.268 -0.872 . . . . 0.57 110.249 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.13 164.85 23.72 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.95 1.767 . . . . 0.57 111.585 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.12 -93.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 109.357 -1.497 . . . . 0.57 109.357 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -158.92 -50.61 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.503 1.521 . . . . 0.57 109.709 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.52 -119.73 2.13 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.707 -0.957 . . . . 0.57 110.707 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -31.49 40.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.996 0.898 . . . . 0.57 111.879 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.2 142.44 7.97 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.509 -0.744 . . . . 0.57 112.135 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.4 -38.9 3.12 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.186 1.851 . . . . 0.57 112.625 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -60.36 149.78 32.71 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.759 -0.83 . . . . 0.66 108.759 -167.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.61 146.98 38.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.522 0.677 . . . . 0.57 109.25 -171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -135.39 156.2 49.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.265 -0.879 . . . . 0.65 109.975 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 47.0 m-85 -137.82 146.15 43.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.019 1.327 . . . . 0.57 108.081 -169.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.02 101.61 7.91 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.455 -0.942 . . . . 0.66 108.455 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -59.08 -24.34 62.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.66 111.885 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -69.12 -36.05 77.08 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.577 0.751 . . . . 0.66 111.215 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.86 131.26 44.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.441 -1.689 . . . . 0.66 106.441 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 139.69 48.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.635 0.774 . . . . 1.2 110.441 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -129.32 118.27 21.99 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.232 -1.395 . . . . 0.57 107.232 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -114.93 147.99 39.28 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.38 -0.97 . . . . 0.57 108.38 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.94 21.83 2.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.624 0.77 . . . . 0.66 111.981 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.03 68.95 1.29 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.399 -1.08 . . . . 0.57 110.399 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -40.04 4.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.984 -1.007 . . . . 0.57 113.697 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.0 -47.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.209 1.804 . . . . 0.57 110.621 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -139.09 155.2 48.09 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.354 1.462 . . . . 0.57 108.131 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.63 -161.47 12.85 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.236 -1.546 . . . . 0.57 109.236 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.2 mm -113.36 121.19 65.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.712 -1.959 . . . . 0.57 105.712 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.23 103.47 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.984 0.803 . . . . 0.57 109.072 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -53.27 -41.16 65.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.607 1.563 . . . . 0.57 110.399 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' A' ' 34' ' ' LEU . 13.3 tp -64.42 -50.36 67.9 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.694 -1.225 . . . . 0.57 107.694 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -60.35 -39.51 87.41 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.232 -0.655 . . . . 0.57 109.232 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.04 -61.69 2.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.425 1.09 . . . . 0.57 110.458 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.85 -51.49 65.74 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.235 0.614 . . . . 0.57 110.095 -175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.8 m -62.51 -37.71 87.09 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.438 0.695 . . . . 0.57 112.062 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -60.65 -53.95 51.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.196 0.598 . . . . 0.65 109.393 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.78 -40.43 96.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.258 0.481 . . . . 0.66 110.652 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 39' ' ' LEU . 2.9 mm? -61.26 -30.0 70.19 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.878 0.871 . . . . 0.57 111.37 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.427 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -56.29 -51.83 53.55 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 118.472 0.578 . . . . 0.57 112.083 170.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.01 -40.42 93.47 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.203 1.001 . . . . 0.65 110.635 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -33.36 65.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.115 0.966 . . . . 0.57 112.173 172.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.91 66.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.845 0.858 . . . . 0.57 111.648 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.82 63.88 0.88 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.446 -0.662 . . . . 0.57 111.446 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.6 176.84 8.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.32 1.448 . . . . 0.57 109.141 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -95.44 148.44 18.99 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.868 -0.605 . . . . 0.57 111.929 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 174.86 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.117 1.367 . . . . 0.65 113.045 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -133.74 178.31 7.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.599 1.16 . . . . 0.57 110.983 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -165.39 47.06 0.09 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.358 1.863 . . . . 0.57 108.212 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.7 t70 -121.63 143.23 37.56 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-O 118.269 -0.872 . . . . 0.66 109.708 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.7 2.49 2.92 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.696 2.931 . . . . 0.57 114.098 -171.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -146.98 20.57 1.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.432 1.093 . . . . 0.57 110.358 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -72.11 140.57 48.94 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.341 0.656 . . . . 0.57 110.463 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.56 -35.25 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.37 -0.974 . . . . 0.57 108.37 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -86.85 14.15 7.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.949 1.092 . . . . 0.57 113.949 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.07 128.26 93.61 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.496 -1.377 . . . . 0.57 111.137 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.62 -46.51 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.765 1.643 . . . . 0.57 111.551 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 p -81.32 52.05 1.75 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.141 1.377 . . . . 0.57 110.323 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -39.86 131.91 1.82 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.139 2.176 . . . . 0.57 112.902 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.7 114.9 2.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.212 1.387 . . . . 0.57 109.657 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 179.61 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.183 1.393 . . . . 0.57 109.349 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.38 -138.52 9.65 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.841 1.21 . . . . 0.57 110.343 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -127.38 111.29 21.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 0.66 108.853 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.33 -15.22 22.65 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.814 2.342 . . . . 0.57 113.015 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -62.57 -36.46 82.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.487 1.04 . . . . 0.57 110.252 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -90.53 70.0 6.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.947 1.299 . . . . 0.57 108.772 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -41.73 -68.45 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.773 1.629 . . . . 0.57 115.23 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 21.58 74.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.386 2.674 . . . . 0.57 112.633 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.4 mp -31.37 116.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 128.022 2.529 . . . . 0.57 109.742 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.6 t -82.2 -88.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.843 0.354 . . . . 0.57 110.998 -162.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -142.43 -30.51 0.55 Allowed 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 124.315 1.046 . . . . 0.57 110.774 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -51.54 -45.71 63.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 120.027 1.285 . . . . 0.66 110.795 167.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.406 ' CG ' HD23 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -72.76 -58.59 3.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.479 1.112 . . . . 0.66 111.023 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.56 -46.72 89.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.892 -0.781 . . . . 0.57 108.892 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -60.51 -49.8 76.12 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.046 -1.454 . . . . 0.57 108.864 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -54.18 -59.54 9.83 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.937 -1.265 . . . . 0.57 109.937 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 46' ' ' ILE . 6.6 mm -56.22 -50.22 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.933 1.293 . . . . 0.57 112.776 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -69.28 -19.75 63.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.476 0.71 . . . . 0.57 111.55 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -81.77 -25.96 34.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.13 0.972 . . . . 0.57 111.178 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 -50.59 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.348 0.976 . . . . 0.57 111.237 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 46' ' ' ILE . 39.4 m-85 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.548 1.139 . . . . 0.57 108.74 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.532 0.423 0 N-CA-C 110.988 -0.428 . . . . 0.57 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.78 95.52 0.04 OUTLIER 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.696 1.198 . . . . 0.57 110.384 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -46.21 142.71 2.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.571 1.148 . . . . 0.57 110.7 172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.9 m -62.06 -21.13 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.039 0.936 . . . . 0.57 112.456 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -94.94 143.7 26.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.886 1.275 . . . . 0.57 109.536 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -77.19 0.18 22.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.539 0.736 . . . . 0.57 112.533 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.34 144.05 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.113 -1.439 . . . . 0.57 107.113 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.07 145.8 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.412 -1.699 . . . . 0.57 106.412 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -109.11 139.07 44.5 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.431 1.014 . . . . 0.57 110.131 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -122.37 157.5 31.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.697 0.761 . . . . 0.57 111.088 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.552 1.141 . . . . 1.2 109.114 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.477 HG21 ' CE1' ' A' ' 22' ' ' TYR . 1.6 mm -122.22 97.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.472 -2.418 . . . . 0.57 104.472 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.19 -34.71 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.391 0.676 . . . . 0.57 111.954 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -130.44 141.31 50.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.357 -2.46 . . . . 0.57 104.357 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.477 ' CE1' HG21 ' A' ' 19' ' ' ILE . 23.2 m-85 -129.86 146.56 51.59 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.581 1.152 . . . . 0.57 108.931 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 t -75.9 -175.67 3.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.525 1.93 . . . . 0.57 111.063 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -128.25 -27.75 2.66 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.595 0.961 . . . . 1.2 113.595 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.82 -23.56 67.33 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.848 1.204 . . . . 0.66 111.519 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.36 146.95 24.15 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.097 1.759 . . . . 0.57 109.43 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -75.29 161.73 37.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.736 2.291 . . . . 0.57 112.96 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -70.42 -38.58 74.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.364 -0.835 . . . . 0.65 110.315 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.52 -37.13 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.192 0.997 . . . . 0.57 110.44 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 m -66.37 -46.33 77.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.419 -1.277 . . . . 0.57 109.057 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.5 t -55.59 -50.65 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 120.322 1.419 . . . . 0.57 110.121 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.36 -35.29 80.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.649 0.659 . . . . 0.66 111.736 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -44.28 74.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.426 1.012 . . . . 1.2 112.314 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.09 -46.88 82.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.57 108.112 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.86 -44.53 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 117.568 -1.206 . . . . 0.57 111.244 173.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -54.64 -49.97 69.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.48 1.491 . . . . 0.57 111.388 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -74.57 -33.36 62.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.155 0.889 . . . . 0.57 112.198 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.5 78.88 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.373 1.069 . . . . 0.57 110.949 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 122' ' ' LEU . 49.0 mt -66.76 -41.06 88.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.151 -0.928 . . . . 0.57 109.397 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -52.88 -43.19 65.97 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 119.402 1.001 . . . . 0.57 110.684 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.5 mtp -59.32 -39.03 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.062 1.301 . . . . 0.57 112.597 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -65.39 -43.44 90.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.861 1.209 . . . . 0.57 110.964 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.9 88.09 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.66 -1.275 . . . . 0.57 113.528 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -77.45 -12.89 60.01 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.671 1.188 . . . . 0.57 110.104 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -109.06 -21.04 12.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.828 1.251 . . . . 0.66 111.909 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 164' ' ' TYR . 7.9 pt -139.18 152.94 70.74 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 124.67 1.188 . . . . 0.57 110.137 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.06 13.55 1.25 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.11 2.54 . . . . 0.57 113.021 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tt -82.18 135.23 35.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.455 -1.313 . . . . 0.57 107.455 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -116.79 170.45 8.59 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.553 0.741 . . . . 0.65 109.516 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 157.76 41.92 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.472 -0.768 . . . . 0.57 109.203 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.16 164.57 26.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.366 1.466 . . . . 1.2 108.357 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -135.65 115.83 13.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.123 -2.177 . . . . 0.57 105.123 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.46 164.92 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.617 0.767 . . . . 0.57 109.023 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.02 -36.51 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.265 0.626 . . . . 0.57 111.084 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 153.31 19.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.148 0.579 . . . . 0.57 110.662 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.48 40.57 2.42 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.358 0.98 . . . . 0.57 113.076 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -163.8 143.13 8.03 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.687 -1.227 . . . . 0.57 107.687 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.54 6.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.669 1.188 . . . . 0.57 109.596 -174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -64.48 -32.29 73.86 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.18 -0.674 . . . . 0.66 109.18 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 122' ' ' LEU . 5.5 mt -124.43 97.12 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.724 2.01 . . . . 0.57 107.728 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 ttp -100.23 100.15 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.305 2.642 . . . . 0.57 106.341 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mt -92.77 128.08 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.005 -1.85 . . . . 0.57 106.005 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.47 145.11 11.61 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.424 -0.67 . . . . 0.57 111.424 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 142.21 47.45 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.351 -0.981 . . . . 0.57 108.351 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.23 165.59 26.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.565 1.546 . . . . 0.57 108.373 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.9 22.82 11.54 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.559 -0.713 . . . . 1.2 111.481 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 156.59 31.2 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.593 1.568 . . . . 0.57 109.81 -164.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 49.86 102.38 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.059 2.144 . . . . 0.57 114.201 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -147.33 157.44 43.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.476 1.111 . . . . 0.65 109.035 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.59 62.23 4.05 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.3 0.952 . . . . 0.57 111.192 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -106.83 -55.28 2.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.381 0.591 . . . . 0.66 111.105 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.86 -43.18 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.814 2.846 . . . . 0.57 109.594 -168.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -142.83 121.61 7.47 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 120.05 1.295 . . . . 0.57 111.019 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.53 140.25 35.92 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.972 1.781 . . . . 0.57 111.544 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -72.41 173.39 8.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.304 1.042 . . . . 0.57 111.797 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.78 -31.51 15.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.937 2.095 . . . . 0.66 112.41 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.04 -132.47 11.11 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 120.862 1.664 . . . . 0.57 111.516 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.48 103.86 1.43 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.45 2.767 . . . . 0.57 112.171 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.46 -167.06 25.65 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.682 2.087 . . . . 0.57 111.428 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.99 -140.43 0.71 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.025 -1.279 . . . . 0.57 114.152 164.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -51.18 137.2 22.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.042 2.137 . . . . 0.57 110.535 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.68 -30.54 10.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.618 1.567 . . . . 0.57 111.294 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.39 165.6 28.65 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.059 1.344 . . . . 0.57 108.987 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.85 159.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.565 0.62 . . . . 0.65 111.447 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.13 147.09 34.41 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.446 0.698 . . . . 0.57 110.011 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -98.67 150.86 21.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.005 -0.998 . . . . 0.57 109.414 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.49 150.23 86.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.543 -0.741 . . . . 0.57 110.298 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -69.29 162.53 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.234 1.956 . . . . 0.57 111.509 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.71 -93.35 0.1 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.258 -1.537 . . . . 0.57 109.258 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -160.61 123.0 3.22 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.653 0.726 . . . . 0.57 110.14 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.42 -123.32 7.47 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-O 118.187 -1.34 . . . . 0.57 110.23 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.04 -24.4 39.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.794 1.238 . . . . 0.57 112.364 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.25 143.14 12.75 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 120.939 -1.101 . . . . 0.57 111.468 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.99 -21.63 2.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.371 1.462 . . . . 0.57 114.13 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -70.51 159.47 34.23 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.02 1.91 . . . . 0.66 108.692 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.65 141.3 28.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.198 -0.668 . . . . 0.57 109.198 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -130.7 158.4 40.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.713 -0.477 . . . . 0.65 109.713 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.08 146.83 34.16 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.744 -1.206 . . . . 0.57 107.744 -169.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.96 98.35 3.57 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.823 -0.806 . . . . 0.66 108.823 174.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.12 -16.82 62.65 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.431 -1.418 . . . . 0.66 111.87 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.64 -33.74 76.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.564 1.546 . . . . 0.66 110.961 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.4 157.17 32.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.629 0.728 . . . . 0.66 109.82 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 135.73 38.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.282 -0.636 . . . . 1.2 109.282 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -126.98 151.87 47.96 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.147 -1.057 . . . . 0.57 108.147 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -154.1 167.94 28.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.801 0.728 . . . . 0.57 110.435 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.0 -32.1 45.04 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.396 1.079 . . . . 0.66 112.258 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.97 88.01 0.74 Allowed Glycine 0 C--N 1.343 0.92 0 C-N-CA 123.633 0.635 . . . . 0.57 112.614 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.3 m -120.47 -42.77 2.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.521 -0.752 . . . . 0.57 112.751 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 p -171.85 -43.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.23 0.923 . . . . 0.57 111.881 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.6 166.03 24.49 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.273 1.429 . . . . 0.57 109.313 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 179.09 35.59 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 110.694 -0.962 . . . . 0.57 110.694 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.6 mm -103.58 118.38 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.134 -1.062 . . . . 0.57 108.134 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -70.59 121.85 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 0.57 111.747 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -37.97 76.23 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.132 1.16 . . . . 0.57 114.132 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.37 -39.77 91.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.691 -0.855 . . . . 0.57 108.691 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 1.7 m-85 -75.63 -41.57 53.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.495 -0.928 . . . . 0.57 108.495 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.39 86.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.016 -0.516 . . . . 0.57 110.583 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.32 -55.84 29.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.863 -1.065 . . . . 0.57 109.789 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 m -53.67 -42.14 67.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.534 1.516 . . . . 0.57 112.335 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -62.01 -54.38 42.43 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.938 0.79 . . . . 0.65 110.088 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -68.41 -45.96 71.21 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.318 1.047 . . . . 0.66 111.528 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.22 -31.59 72.85 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.045 1.338 . . . . 0.57 110.959 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.59 -52.91 38.63 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.61 -0.996 . . . . 0.57 110.61 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -58.55 -45.49 88.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.569 0.684 . . . . 0.65 111.545 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.5 t -54.81 -38.6 67.55 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.15 0.906 . . . . 0.57 112.726 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -27.65 68.73 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.8 0.84 . . . . 0.57 111.777 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.24 44.44 0.13 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.839 1.209 . . . . 0.57 113.334 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.04 156.66 42.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.573 1.187 . . . . 0.57 111.013 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.44 -13.12 2.91 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 115.795 -2.67 . . . . 0.57 114.821 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 137.37 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 1 C-N-CA 131.836 4.054 . . . . 0.65 111.434 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.9 m -131.79 -173.09 3.04 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.833 2.853 . . . . 0.57 109.081 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.8 t -148.78 61.17 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.999 0.92 . . . . 0.57 110.17 -171.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 6.2 t0 -133.97 149.06 70.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.025 0.93 . . . . 0.66 108.798 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.03 -4.88 14.22 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.648 . . . . 0.57 112.972 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.52 28.93 4.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.57 109.101 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.09 130.18 34.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.645 1.578 . . . . 0.57 109.926 172.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.74 -19.65 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.052 0.387 . . . . 0.57 110.884 165.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.99 -14.56 63.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 117.66 -1.162 . . . . 0.57 112.962 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.11 133.09 87.53 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 121.246 1.839 . . . . 0.57 110.671 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.79 144.25 24.4 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.613 2.208 . . . . 0.57 110.301 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 52.6 m 66.67 116.03 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.197 1.799 . . . . 0.57 110.468 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -54.89 116.73 2.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.267 -0.896 . . . . 0.57 110.924 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.7 -121.03 2.19 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.213 1.863 . . . . 0.57 109.851 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.84 -26.59 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.455 1.502 . . . . 0.57 113.914 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.5 151.84 27.49 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.874 -0.891 . . . . 0.57 110.874 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.18 110.99 42.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.764 -1.939 . . . . 0.66 105.764 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 116' ' ' TYR . 27.2 Cg_endo -79.62 29.17 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.688 2.926 . . . . 0.57 115.499 174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -129.61 -28.11 2.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.085 1.354 . . . . 0.57 111.446 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -156.03 94.31 1.52 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.128 1.771 . . . . 0.57 109.327 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -138.41 169.04 18.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.828 1.251 . . . . 0.57 109.405 177.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.88 57.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.501 1.12 . . . . 0.57 111.127 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp 63.72 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.56 1.544 . . . . 0.57 110.254 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -68.7 -86.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.138 0.975 . . . . 0.57 112.234 -165.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -144.54 -35.8 0.34 Allowed 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.34 1.456 . . . . 0.57 108.817 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -55.61 -48.37 74.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.269 1.827 . . . . 0.66 111.378 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.54 -49.4 54.72 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.643 0.777 . . . . 0.66 109.424 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -46.49 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 123.581 0.752 . . . . 0.57 109.645 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -71.42 -40.48 70.41 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.73 -1.128 . . . . 0.57 109.306 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -50.0 -61.06 6.03 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.728 -1.349 . . . . 0.57 109.728 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 mm -57.08 -50.08 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 117.711 0.755 . . . . 0.57 111.5 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.86 -13.47 62.17 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.199 -0.938 . . . . 0.57 113.14 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -92.11 -25.31 18.8 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.961 1.304 . . . . 0.57 111.047 171.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.39 -35.95 65.98 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.554 1.142 . . . . 0.57 112.773 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 46' ' ' ILE . 33.8 m-85 . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.551 1.141 . . . . 0.57 109.969 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.453 -0.881 0 N-CA-C 108.659 -1.323 . . . . 0.57 108.659 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 83.58 134.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 128.111 2.565 . . . . 0.57 111.077 -172.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 63.9 m95 -66.24 169.2 7.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.963 0.887 . . . . 0.57 111.305 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -80.07 -33.84 38.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.478 0.711 . . . . 0.57 111.424 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.8 t -86.99 146.42 26.14 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.171 0.988 . . . . 0.57 109.379 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -75.3 -12.19 60.22 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.57 112.012 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -116.24 111.68 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.306 -1.738 . . . . 0.57 106.306 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.457 ' CG1' HD12 ' A' ' 60' ' ' ILE . 72.7 t -104.04 129.05 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.792 -1.188 . . . . 0.57 107.792 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -104.65 138.38 41.05 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.73 -0.606 . . . . 0.57 110.285 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -125.08 160.11 29.82 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.906 0.482 . . . . 0.57 110.869 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -152.14 166.4 31.78 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 122.758 0.423 . . . . 1.2 110.673 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.5 mt -130.26 94.67 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 103.806 -2.665 . . . . 0.57 103.806 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 t -76.8 -45.44 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.528 0.731 . . . . 0.57 109.597 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -112.63 156.19 23.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 104.651 -2.351 . . . . 0.57 104.651 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.38 154.48 50.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.788 -1.56 . . . . 0.57 106.788 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 31' ' ' VAL . 10.9 t -64.05 173.31 1.95 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.875 1.322 . . . . 0.57 111.827 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 -37.22 6.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.99 -1.459 . . . . 1.2 112.397 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.16 -35.76 76.68 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.357 0.526 . . . . 0.66 111.307 -172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 mt -114.12 151.93 45.38 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 126.884 2.074 . . . . 0.57 108.153 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -78.23 154.01 28.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.81 1.673 . . . . 0.57 111.974 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.81 -37.94 74.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.57 1.148 . . . . 0.65 113.174 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tp -59.36 -43.4 90.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.773 -0.454 . . . . 0.57 109.773 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -70.48 -41.08 73.2 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.895 -1.05 . . . . 0.57 108.988 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 23' ' ' THR . 47.4 t -54.5 -52.14 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 119.83 1.196 . . . . 0.57 109.698 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -65.96 -43.94 86.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.774 0.716 . . . . 0.66 111.096 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.71 92.64 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.368 -0.833 . . . . 1.2 112.099 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.94 -47.26 66.13 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.312 -0.996 . . . . 0.57 108.312 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.98 -44.49 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.393 1.451 . . . . 0.57 110.835 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -39.31 92.15 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 117.499 -1.239 . . . . 0.57 111.057 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -67.21 -44.37 79.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.48 1.112 . . . . 0.57 111.509 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.04 96.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.799 1.24 . . . . 0.57 111.023 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 122' ' ' LEU . 24.1 mt -68.8 -34.17 75.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.975 0.51 . . . . 0.57 111.039 174.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -46.97 81.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 118.679 -0.677 . . . . 0.57 109.319 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.422 ' HB3' HD11 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -56.38 -42.03 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.368 -0.825 . . . . 0.57 111.607 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.451 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 32.9 m95 -63.19 -46.77 85.49 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.441 1.019 . . . . 0.57 111.372 173.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.44 -10.81 63.86 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.337 -0.852 . . . . 0.57 114.317 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -80.96 -5.38 57.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.253 -1.145 . . . . 0.57 111.177 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 160' ' ' ILE . 9.3 mm-40 -113.06 -20.28 11.56 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.872 0.869 . . . . 0.66 111.636 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 160' ' ' ILE . 10.1 pt -136.42 150.22 69.94 Favored Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 124.57 1.148 . . . . 0.57 110.184 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.49 16.64 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.45 2.767 . . . . 0.57 113.113 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 126' ' ' LEU . 2.2 tt -82.04 142.69 32.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.018 1.327 . . . . 0.57 107.591 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -125.4 170.63 11.17 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.851 0.834 . . . . 0.65 109.487 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.02 162.09 36.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.912 -0.773 . . . . 0.57 108.912 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.75 -179.94 6.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.654 -1.157 . . . . 1.2 108.995 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -135.78 133.97 38.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.504 -1.665 . . . . 0.57 106.504 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.35 162.65 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 O-C-N 124.174 0.921 . . . . 0.57 109.526 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.9 m -110.72 -30.04 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.769 -1.105 . . . . 0.57 110.696 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -60.69 3.13 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.596 1.158 . . . . 0.57 110.695 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.87 -91.23 0.1 OUTLIER Glycine 0 C--O 1.219 -0.823 0 N-CA-C 109.896 -1.282 . . . . 0.57 109.896 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -62.22 153.76 29.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.379 1.589 . . . . 0.57 111.904 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.35 -170.55 3.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.161 1.384 . . . . 0.57 109.972 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.24 -38.5 71.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.286 -1.005 . . . . 0.66 108.286 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 15' ' ' VAL . 5.6 mt -127.66 90.8 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 125.32 1.448 . . . . 0.57 107.938 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 154.04 26.93 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.257 -0.883 . . . . 0.57 109.111 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.06 137.41 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.487 -2.042 . . . . 0.57 105.487 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.47 164.88 29.46 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.899 -0.88 . . . . 0.57 110.899 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 5.4 m-85 -138.29 133.91 33.66 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.235 -1.765 . . . . 0.57 106.235 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.69 178.89 8.1 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.57 109.512 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.71 85.69 2.39 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 107.123 -1.436 . . . . 1.2 107.123 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.56 -139.68 15.61 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.47 -0.652 . . . . 0.57 111.47 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.77 122.13 9.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.57 111.398 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -125.2 -39.86 2.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.65 112.2 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.71 44.85 0.8 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.886 -0.486 . . . . 0.57 111.886 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.79 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.173 1.389 . . . . 0.66 107.672 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -173.55 -34.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.616 1.966 . . . . 0.57 110.484 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -132.21 132.15 22.82 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 108.176 -1.046 . . . . 0.57 108.176 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.32 133.53 28.61 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 N-CA-C 108.857 -1.247 . . . . 0.57 108.857 171.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -64.41 178.36 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.917 1.342 . . . . 0.57 109.92 165.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -98.88 -43.36 6.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 131.436 3.894 . . . . 0.66 110.092 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.96 -139.28 14.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.832 -1.538 . . . . 0.57 110.363 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.18 96.48 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.624 3.549 . . . . 0.57 112.055 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 177.82 15.04 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 110.334 -1.106 . . . . 0.57 110.334 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.254 5.7 t-20 60.05 -142.69 0.56 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.907 1.283 . . . . 0.57 112.489 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.4 m -45.42 144.35 1.52 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 126.412 1.885 . . . . 0.57 109.628 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -107.62 -29.01 9.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.471 1.941 . . . . 0.57 112.462 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.26 166.08 25.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.522 1.129 . . . . 0.57 108.332 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.76 161.84 38.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.176 0.512 . . . . 0.65 109.715 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 160.82 43.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.981 0.912 . . . . 0.57 108.799 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -112.56 151.08 30.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.762 -0.829 . . . . 0.57 108.762 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.33 156.33 22.41 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.531 -0.747 . . . . 0.57 111.004 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.492 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 17.6 Cg_endo -68.52 148.26 72.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.888 1.725 . . . . 0.57 111.921 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.2 175.22 13.79 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.6 1.095 . . . . 0.57 110.84 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t 43.31 -148.54 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.603 1.561 . . . . 0.57 112.703 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.29 -56.62 1.45 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 117.182 -1.899 . . . . 0.57 110.482 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -44.37 74.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.44 1.62 . . . . 0.57 112.075 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 151.15 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.619 1.1 . . . . 0.57 112.659 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.89 -26.32 1.73 Allowed Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.853 -1.526 . . . . 0.57 114.641 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.05 150.11 49.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.971 -1.122 . . . . 0.66 107.971 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.14 148.51 35.16 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.424 -0.807 . . . . 0.57 109.341 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -132.47 159.69 38.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.659 -0.867 . . . . 0.65 108.659 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.2 m-85 -138.35 155.87 48.14 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.454 1.502 . . . . 0.57 108.868 -170.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.17 97.76 10.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.898 0.479 . . . . 0.66 109.952 172.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.25 -25.66 61.98 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.061 0.945 . . . . 0.66 111.676 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.01 -34.99 70.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.305 0.574 . . . . 0.66 111.075 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -82.48 150.26 27.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.636 1.175 . . . . 0.66 109.085 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -71.88 147.5 47.04 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.511 -0.743 . . . . 1.2 110.647 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -135.35 134.53 39.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.267 -1.383 . . . . 0.57 107.267 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -133.85 150.18 51.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 0.57 110.389 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.64 -29.45 64.65 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.191 0.997 . . . . 0.66 111.374 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.01 75.88 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.387 -1.085 . . . . 0.57 110.387 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.29 155.92 38.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.401 -1.333 . . . . 0.57 107.401 172.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -62.47 167.28 4.41 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.529 0.732 . . . . 0.57 110.509 170.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.35 -64.22 0.4 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.935 2.094 . . . . 0.57 111.016 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.28 147.76 49.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.052 -1.219 . . . . 0.57 110.052 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.32 129.82 36.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.004 -1.11 . . . . 0.57 108.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -66.62 113.19 4.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.388 -0.597 . . . . 0.57 109.388 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 9.6 t80 -58.5 -46.09 87.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.2 1.0 . . . . 0.57 111.372 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -63.43 -41.69 98.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.566 1.146 . . . . 0.57 109.745 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.36 -45.0 96.19 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.444 0.698 . . . . 0.57 109.934 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.66 72.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.035 0.534 . . . . 0.57 111.316 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.82 -55.37 33.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 117.366 -1.302 . . . . 0.57 109.086 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 m -52.35 -41.49 63.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.407 1.458 . . . . 0.57 111.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.15 -60.57 3.55 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.557 0.617 . . . . 0.65 110.058 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.47 -43.7 96.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.385 0.539 . . . . 0.66 110.9 -173.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.08 -26.98 68.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.681 1.193 . . . . 0.57 111.775 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.22 -45.95 92.16 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.009 -0.836 . . . . 0.57 111.009 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -68.71 -39.78 80.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.957 -1.02 . . . . 0.65 111.582 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.408 ' HB3' HG12 ' A' ' 60' ' ' ILE . 67.0 m -55.17 -30.69 60.38 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 124.159 0.912 . . . . 0.57 111.966 172.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.447 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.04 -34.32 66.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.338 0.972 . . . . 0.57 111.406 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.41 52.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.416 -1.214 . . . . 0.57 113.093 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 28.6 mmt 61.12 173.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.475 1.11 . . . . 0.57 112.106 -171.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.81 70.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.785 -1.008 . . . . 0.57 111.153 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.27 172.78 6.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.73 1.265 . . . . 0.65 110.175 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.57 -179.16 5.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.088 1.355 . . . . 0.57 109.35 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.5 m -138.14 54.7 1.78 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.015 1.726 . . . . 0.57 108.892 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.61 148.39 41.79 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.249 1.02 . . . . 0.66 109.233 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.68 -19.26 41.88 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.228 2.618 . . . . 0.57 113.004 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -130.76 28.22 4.87 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.839 1.656 . . . . 0.57 108.607 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.51 129.33 38.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.373 -0.973 . . . . 0.57 108.373 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.88 -26.78 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.635 0.374 . . . . 0.57 110.506 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -105.1 29.21 6.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.604 1.162 . . . . 0.57 111.811 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.29 128.62 87.98 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 120.606 -1.309 . . . . 0.57 110.554 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.21 177.76 8.2 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.421 2.747 . . . . 0.57 111.065 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m 48.59 77.57 0.1 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.225 1.41 . . . . 0.57 111.608 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -50.69 125.76 13.96 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.894 -1.048 . . . . 0.57 112.797 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.93 164.8 13.64 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 108.482 -1.847 . . . . 0.57 108.482 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.02 -51.37 0.47 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.867 2.467 . . . . 0.57 113.825 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.65 145.86 42.2 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.117 -1.193 . . . . 0.57 110.117 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -94.99 112.8 59.61 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.859 -1.904 . . . . 0.66 105.859 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -80.31 -31.39 1.68 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.803 1.669 . . . . 0.57 112.668 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -42.15 72.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.074 1.306 . . . . 0.57 110.322 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -122.98 89.82 3.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.193 -1.41 . . . . 0.57 107.193 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -120.96 159.74 24.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.97 0.89 . . . . 0.57 109.465 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.09 156.28 10.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.689 1.996 . . . . 0.57 105.996 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -56.07 108.31 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.141 1.376 . . . . 0.57 107.69 175.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.8 t -86.04 -101.41 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.77 -0.826 . . . . 0.57 108.77 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.3 -49.43 1.55 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-O 116.268 -1.825 . . . . 0.57 108.134 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -48.83 -38.95 23.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.911 1.687 . . . . 0.66 112.132 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -67.65 -58.89 3.88 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.354 0.661 . . . . 0.66 111.549 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.74 -40.26 84.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-O 117.811 -1.09 . . . . 0.57 108.369 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.48 74.91 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.671 1.588 . . . . 0.57 108.73 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.29 -56.79 22.57 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 46' ' ' ILE . 9.5 mm -58.72 -49.1 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.386 1.093 . . . . 0.57 112.949 -175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.59 -29.88 70.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.458 1.103 . . . . 0.57 110.115 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -29.21 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.57 110.17 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 3.2 mt -74.46 -48.7 25.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.14 -0.933 . . . . 0.57 111.585 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 163' ' ' LEU . 3.2 m-85 . . . . . 0 N--CA 1.48 1.041 0 CA-C-N 119.911 1.232 . . . . 0.57 113.887 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 N--CA 1.455 -0.752 0 N-CA-C 111.104 -0.383 . . . . 0.57 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 pttt 68.4 118.02 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.896 2.078 . . . . 0.57 110.073 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -62.17 150.35 39.01 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.57 109.704 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.1 p -88.43 28.66 1.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.471 0.708 . . . . 0.57 111.069 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -130.55 159.64 36.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.539 1.936 . . . . 0.57 108.851 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -90.54 -8.55 49.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.56 1.544 . . . . 0.57 112.748 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.46 145.76 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 0.57 106.747 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.506 HG23 HD21 ' A' ' 48' ' ' LEU . 29.0 t -131.06 134.48 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.075 -1.824 . . . . 0.57 106.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -100.4 147.86 25.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.651 -0.5 . . . . 0.57 109.651 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -125.15 153.73 42.57 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.424 0.689 . . . . 0.57 111.7 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.09 109.97 6.42 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.013 0.911 . . . . 1.2 110.59 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 22' ' ' TYR . 93.0 mt -76.03 95.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.674 -1.602 . . . . 0.57 106.674 169.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 m -75.23 -46.41 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.709 0.803 . . . . 0.57 111.365 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -115.96 160.31 20.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.263 -1.384 . . . . 0.57 107.263 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 19' ' ' ILE . 10.4 m-85 -127.6 179.9 5.27 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.17 0.988 . . . . 0.57 108.597 -172.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -119.95 -178.45 3.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.808 1.243 . . . . 0.57 109.711 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -131.42 -31.59 1.6 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.152 1.781 . . . . 1.2 111.713 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -31.4 71.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.374 1.07 . . . . 0.66 111.914 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.31 145.33 56.19 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 126.733 2.013 . . . . 0.57 106.733 -175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -72.97 153.76 52.71 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.587 1.525 . . . . 0.57 111.523 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.27 -34.73 74.15 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.245 1.018 . . . . 0.65 113.121 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.57 -39.56 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.624 0.37 . . . . 0.57 110.016 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -68.52 -42.49 78.44 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.332 -1.318 . . . . 0.57 110.152 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 t -57.23 -51.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 120.584 1.538 . . . . 0.57 109.398 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -43.56 98.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.145 0.578 . . . . 0.66 110.222 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.15 -46.6 88.27 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 117.957 -1.021 . . . . 1.2 112.139 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.8 mp -65.07 -41.87 94.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.783 1.174 . . . . 0.57 109.658 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.31 -48.82 79.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 108.792 -0.818 . . . . 0.57 108.792 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -39.06 81.42 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.537 0.608 . . . . 0.57 111.738 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -65.21 -46.22 81.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.821 1.191 . . . . 0.57 110.438 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.98 95.29 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.77 0.828 . . . . 0.57 111.245 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 122' ' ' LEU . 25.9 mt -68.22 -33.43 74.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.576 -0.726 . . . . 0.57 111.327 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -65.03 -33.33 75.79 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.424 1.011 . . . . 0.57 110.315 173.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.4 mtp -71.23 -28.83 64.47 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.857 0.753 . . . . 0.57 111.996 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.14 -48.83 40.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.195 0.907 . . . . 0.57 110.502 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.03 62.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.14 1.352 . . . . 0.57 113.65 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -64.58 -22.41 66.96 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.886 -1.361 . . . . 0.57 111.673 170.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -108.37 -21.3 12.81 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.796 0.725 . . . . 0.66 112.255 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.88 135.48 27.56 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 123.872 0.869 . . . . 0.57 110.761 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.12 61.26 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.821 3.014 . . . . 0.57 110.65 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -117.46 124.46 48.85 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.059 -1.83 . . . . 0.57 106.059 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -105.57 175.29 5.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.924 1.289 . . . . 0.65 108.623 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 1.2 m-85 -139.36 153.86 47.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.18 -0.95 . . . . 0.57 108.483 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.63 174.44 10.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.711 0.804 . . . . 1.2 109.009 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -124.29 155.69 38.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.05 -1.092 . . . . 0.57 108.05 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.06 -179.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.172 -0.922 . . . . 0.57 108.977 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.72 -38.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.795 -0.622 . . . . 0.57 110.34 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -175.65 92.95 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.291 1.436 . . . . 0.57 108.975 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.83 172.78 38.13 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.92 2.2 . . . . 0.57 108.122 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 p -67.92 167.05 14.43 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.583 0.692 . . . . 0.57 110.123 168.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.13 173.76 11.91 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.551 0.741 . . . . 0.57 110.145 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.93 -33.94 66.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 118.071 -0.966 . . . . 0.66 109.142 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.93 76.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.612 1.965 . . . . 0.57 108.586 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -70.03 133.58 47.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 119.522 -1.986 . . . . 0.57 107.959 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.73 105.89 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.037 -1.838 . . . . 0.57 106.037 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 73.92 0.26 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.775 1.655 . . . . 0.57 111.223 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -109.44 132.96 53.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.412 1.085 . . . . 0.57 110.157 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.33 172.0 17.33 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.57 108.449 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -91.74 113.48 25.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.286 -0.864 . . . . 1.2 110.222 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.66 71.2 0.86 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.376 -0.69 . . . . 0.57 111.376 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 81.21 147.58 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.009 2.924 . . . . 0.57 111.521 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.14 -11.52 4.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.944 1.297 . . . . 0.65 112.816 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.96 3.04 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 118.801 -1.0 . . . . 0.57 112.505 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.64 -55.89 1.61 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.718 0.759 . . . . 0.66 110.375 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.51 -44.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.536 1.934 . . . . 0.57 108.055 -177.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -97.42 121.24 59.02 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.397 0.679 . . . . 0.57 110.467 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.74 3.82 6.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.438 2.092 . . . . 0.57 113.204 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 56.17 -155.76 0.29 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.139 0.881 . . . . 0.57 110.651 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -143.18 -41.48 0.3 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.644 2.777 . . . . 0.66 108.524 -167.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.12 -149.78 16.66 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.213 1.387 . . . . 0.57 110.195 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.6 94.3 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.589 3.526 . . . . 0.57 111.414 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 167.95 11.45 Favored Glycine 0 C--O 1.22 -0.749 0 N-CA-C 109.411 -1.476 . . . . 0.57 109.411 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t30 48.31 -150.52 0.15 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 119.813 1.806 . . . . 0.57 112.241 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -47.09 111.06 0.35 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.12 2.168 . . . . 0.57 113.306 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.97 -31.96 34.6 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.796 -1.19 . . . . 0.57 112.497 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.49 39.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.57 109.737 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -146.57 144.96 29.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.982 0.913 . . . . 0.65 109.457 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.76 164.4 30.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.7 0.8 . . . . 0.57 109.521 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -115.21 156.95 24.39 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.961 -0.563 . . . . 0.57 109.515 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.65 98.73 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.358 -0.829 . . . . 0.57 109.359 176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -72.47 159.3 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.672 2.248 . . . . 0.57 111.178 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.32 -83.62 0.08 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.872 -1.691 . . . . 0.57 108.872 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -159.2 146.26 17.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.316 -0.994 . . . . 0.57 108.316 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -130.9 11.77 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 118.453 -1.193 . . . . 0.57 110.297 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.02 -25.34 58.42 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.342 1.071 . . . . 0.57 111.994 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.94 142.44 5.85 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.085 -1.009 . . . . 0.57 112.121 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.61 -26.79 3.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.526 2.012 . . . . 0.57 113.901 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -66.31 148.72 51.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.787 0.794 . . . . 0.66 109.399 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.57 140.77 49.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.107 0.963 . . . . 0.57 108.773 -168.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.78 139.68 29.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.234 -1.765 . . . . 0.65 106.234 -160.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.67 148.26 37.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.208 -1.034 . . . . 0.57 108.208 -166.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.69 105.99 12.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.199 -1.408 . . . . 0.66 107.199 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.52 -19.79 27.27 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.489 -0.757 . . . . 0.66 110.713 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -28.13 64.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.242 1.017 . . . . 0.66 111.141 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.28 110.72 9.86 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.289 -1.745 . . . . 0.66 106.289 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.95 110.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.151 0.887 . . . . 1.2 111.502 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.12 133.88 34.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.048 -1.093 . . . . 0.57 108.048 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -123.33 143.49 50.06 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.491 -1.299 . . . . 0.57 107.491 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.37 32.8 0.4 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.478 1.511 . . . . 0.66 111.599 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.66 69.56 1.37 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.625 -0.99 . . . . 0.57 110.625 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -57.31 2.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.478 0.639 . . . . 0.57 110.785 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.325 1.45 . . . . 0.57 108.617 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.93 159.22 16.43 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.57 109.075 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.2 -172.35 38.06 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.35 -1.1 . . . . 0.57 110.35 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.06 120.31 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.511 -1.292 . . . . 0.57 107.511 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -62.05 109.16 1.2 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.584 0.353 . . . . 0.57 110.237 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.81 -37.33 81.63 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.539 0.735 . . . . 0.57 110.686 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -65.95 -46.16 79.15 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 118.481 0.582 . . . . 0.57 110.256 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.44 -48.89 79.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.836 0.743 . . . . 0.57 109.18 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.33 90.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.114 0.566 . . . . 0.57 111.319 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.09 -54.56 43.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.892 -1.051 . . . . 0.57 109.517 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.5 m -57.17 -37.88 72.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.043 1.292 . . . . 0.57 111.33 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.45 -58.54 7.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.409 0.549 . . . . 0.65 109.935 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.3 -41.38 98.95 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.559 -0.713 . . . . 0.66 111.303 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 HD21 ' A' ' 39' ' ' LEU . 3.3 mm? -62.55 -26.2 68.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.57 111.666 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.81 99.35 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.73 1.15 . . . . 0.57 112.053 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -69.89 -39.89 75.97 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 118.279 -0.867 . . . . 0.65 110.067 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 t -57.23 -39.61 75.86 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.52 0.513 . . . . 0.57 111.859 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -39.56 82.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.536 -0.728 . . . . 0.57 110.476 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.2 51.1 0.52 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 123.877 0.751 . . . . 0.57 112.079 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 tpp -99.84 -55.82 2.55 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.069 0.935 . . . . 0.57 111.018 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.64 167.6 21.77 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.288 -1.125 . . . . 0.57 110.288 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -74.06 178.08 5.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.995 0.902 . . . . 0.65 111.465 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -145.26 -173.46 4.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.083 1.753 . . . . 0.57 108.531 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 82.26 1.64 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.162 -1.792 . . . . 0.57 106.162 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 5.8 t70 -151.36 145.26 17.78 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.456 -0.942 . . . . 0.66 108.456 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.77 -9.25 21.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.471 2.114 . . . . 0.57 113.269 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.01 9.51 13.69 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.555 1.142 . . . . 0.57 110.749 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -76.1 134.56 39.99 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.02 0.928 . . . . 0.57 109.171 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.07 -28.24 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.59 -0.444 . . . . 0.57 110.148 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 37.1 mmt -66.01 -12.2 53.43 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.681 1.593 . . . . 0.57 113.589 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -50.69 124.87 20.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.318 0.963 . . . . 0.57 110.589 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.58 175.21 9.09 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.018 2.479 . . . . 0.57 110.783 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER 52.13 -158.7 0.12 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.338 1.455 . . . . 0.57 111.864 -174.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 131.21 41.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.99 -1.485 . . . . 0.57 106.99 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -157.5 -120.9 0.64 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.125 -1.59 . . . . 0.57 109.125 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -64.75 0.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.318 1.047 . . . . 0.57 110.934 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 34.44 -140.6 0.12 Allowed Glycine 0 C--N 1.345 1.079 0 C-N-CA 126.277 1.894 . . . . 0.57 113.198 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 t0 178.71 77.13 0.15 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 128.134 2.573 . . . . 0.66 106.467 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.08 35.86 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.515 2.81 . . . . 0.57 113.554 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -132.0 -47.87 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.553 1.141 . . . . 0.57 109.89 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.99 43.5 0.17 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.063 0.945 . . . . 0.57 111.304 -171.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -40.3 -54.52 2.37 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.202 1.001 . . . . 0.57 111.972 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 55.53 156.03 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.966 1.306 . . . . 0.57 111.075 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp -65.88 116.74 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.907 -1.146 . . . . 0.57 107.907 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.8 m -82.2 -91.51 0.07 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.41 0.684 . . . . 0.57 112.226 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -134.49 -51.97 0.81 Allowed 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.853 -1.546 . . . . 0.57 107.465 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -45.4 -44.22 11.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.55 1.523 . . . . 0.66 113.823 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.55 -63.59 1.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.055 2.142 . . . . 0.66 110.9 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.06 -41.39 92.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 108.699 -0.852 . . . . 0.57 108.699 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -59.33 -44.84 92.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.287 1.435 . . . . 0.57 108.942 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.95 -56.16 26.65 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.972 -1.251 . . . . 0.57 109.972 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 mm -55.51 -51.15 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 117.88 0.84 . . . . 0.57 111.8 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.25 -18.72 64.62 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.475 1.11 . . . . 0.57 111.34 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -87.87 -20.84 25.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.93 1.241 . . . . 0.57 111.89 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.47 -43.84 9.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.918 . . . . 0.57 111.669 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 126.285 1.834 . . . . 0.57 111.333 -174.903 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 N--CA 1.453 -0.888 0 N-CA-C 110.729 -0.527 . . . . 0.57 110.729 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 76.21 107.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.378 1.871 . . . . 0.57 109.302 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 67.9 m95 -52.13 -70.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.49 . . . . 0.57 113.94 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m 173.88 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.406 2.282 . . . . 0.57 108.434 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t -102.5 161.98 13.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.213 1.005 . . . . 0.57 109.938 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -5.51 40.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.945 0.898 . . . . 0.57 113.36 168.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.35 143.56 39.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.241 -1.392 . . . . 0.57 107.241 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 48' ' ' LEU . 72.3 t -128.95 146.61 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.36 -1.348 . . . . 0.57 107.36 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 p -94.84 137.21 34.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.679 -0.86 . . . . 0.57 108.679 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -125.54 152.56 44.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.668 -0.645 . . . . 0.57 109.309 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -154.57 113.88 3.7 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.352 0.596 . . . . 1.2 110.011 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.03 82.61 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 107.161 -1.422 . . . . 0.57 107.161 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 m -56.11 -41.61 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.994 1.318 . . . . 0.57 112.922 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -124.39 153.97 41.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.37 -2.826 . . . . 0.57 103.37 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -131.23 158.05 41.59 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.338 1.455 . . . . 0.57 107.293 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -61.93 172.92 1.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.05 0.929 . . . . 0.57 111.624 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 -33.8 5.14 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.659 1.183 . . . . 1.2 112.262 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.41 -33.87 76.97 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.43 0.559 . . . . 0.66 109.997 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.32 154.78 62.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.971 1.709 . . . . 0.57 109.873 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.24 161.91 25.82 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.96 2.44 . . . . 0.57 113.049 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -40.25 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.307 1.043 . . . . 0.65 113.135 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.53 -33.85 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.342 0.257 . . . . 0.57 111.037 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.8 m -71.59 -43.96 65.31 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.402 -0.809 . . . . 0.57 109.359 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.69 -48.07 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 117.559 -1.21 . . . . 0.57 110.048 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.65 -35.07 79.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.896 1.225 . . . . 0.66 111.81 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -61.19 -51.06 70.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.557 1.071 . . . . 1.2 110.92 173.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.76 -45.36 93.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.447 -0.787 . . . . 0.57 109.111 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.66 -45.1 98.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-O 118.196 -0.907 . . . . 0.57 110.737 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 m -58.61 -47.74 83.34 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 120.249 1.386 . . . . 0.57 109.858 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.53 73.24 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.976 -0.535 . . . . 0.57 110.911 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.0 -47.55 84.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.99 1.316 . . . . 0.57 111.983 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 mp -69.78 -32.13 70.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 118.577 -0.725 . . . . 0.57 109.693 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -63.59 -33.37 75.45 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.089 0.859 . . . . 0.57 111.319 170.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.0 mtp -68.68 -42.73 77.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.649 1.113 . . . . 0.57 110.98 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.522 ' CE3' HD11 ' A' ' 160' ' ' ILE . 10.6 m95 -62.91 -51.75 65.72 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.503 1.047 . . . . 0.57 110.336 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.59 -10.92 61.53 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.654 1.597 . . . . 0.57 113.959 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -61.8 -30.87 71.1 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.449 1.125 . . . . 0.57 110.38 170.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -101.45 -31.04 11.1 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.69 0.796 . . . . 0.66 111.271 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.489 HG21 ' CD1' ' A' ' 164' ' ' TYR . 27.8 pt -115.66 126.08 28.09 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.662 0.785 . . . . 0.57 110.382 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.49 46.2 1.38 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.762 2.975 . . . . 0.57 112.941 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 49' ' ' HIS . 3.1 tt -103.3 141.96 35.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.672 1.989 . . . . 0.57 107.484 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.419 ' N ' HD23 ' A' ' 48' ' ' LEU . 10.1 m80 -123.85 169.33 11.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.913 0.885 . . . . 0.65 108.996 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.49 149.87 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.63 -1.294 . . . . 0.57 109.154 -173.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.93 36.72 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.43 1.092 . . . . 1.2 109.202 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.53 99.02 6.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.956 -1.127 . . . . 0.57 107.956 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.52 158.18 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.415 -0.587 . . . . 0.57 109.415 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.52 23.17 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.982 0.913 . . . . 0.57 110.953 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.21 75.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.93 1.292 . . . . 0.57 109.087 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.25 168.74 16.32 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.005 0.812 . . . . 0.57 111.575 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 p -64.72 171.89 3.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.806 1.242 . . . . 0.57 110.033 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.96 175.24 8.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.596 0.713 . . . . 0.57 109.626 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -68.95 -40.55 78.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.857 -0.61 . . . . 0.66 109.372 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -119.8 87.31 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.008 1.323 . . . . 0.57 108.0 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -83.91 120.66 26.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.814 1.246 . . . . 0.57 108.286 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.58 128.97 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 106.36 -1.719 . . . . 0.57 106.36 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.13 162.68 26.78 Favored Glycine 0 C--O 1.222 -0.6 0 N-CA-C 111.695 -0.562 . . . . 0.57 111.695 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 4.9 m-85 -134.54 141.63 46.75 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.009 -1.849 . . . . 0.57 106.009 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.47 -173.49 4.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.86 1.664 . . . . 0.57 109.635 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.42 52.52 2.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.173 0.989 . . . . 1.2 110.55 -175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.4 -120.97 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.117 -1.193 . . . . 0.57 110.117 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.45 138.28 55.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.273 -0.545 . . . . 0.57 110.569 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.59 -63.03 0.85 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.116 -0.945 . . . . 0.65 110.687 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.78 57.39 0.02 OUTLIER Glycine 0 C--N 1.341 0.834 0 CA-C-N 119.231 0.923 . . . . 0.57 112.474 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -126.33 -67.31 0.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.69 1.196 . . . . 0.66 109.094 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.67 -30.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.353 2.661 . . . . 0.57 110.156 -175.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.26 98.71 20.42 Favored Pre-proline 0 C--N 1.347 0.47 0 N-CA-C 108.51 -0.922 . . . . 0.57 108.51 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.14 139.42 55.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 120.881 1.054 . . . . 0.57 109.424 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.41 174.37 7.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.46 0.648 . . . . 0.57 110.584 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -95.27 -40.9 9.32 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.574 1.95 . . . . 0.66 111.898 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.62 -139.15 13.32 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 120.366 1.439 . . . . 0.57 111.969 -168.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -81.64 94.42 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.128 2.552 . . . . 0.57 110.567 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.65 174.46 22.43 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.132 1.825 . . . . 0.57 111.708 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.3 t30 47.39 -138.71 0.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 120.972 -1.31 . . . . 0.57 112.817 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -51.73 124.8 13.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.874 2.07 . . . . 0.57 111.207 173.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.81 -31.12 11.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.57 113.015 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.3 159.19 33.72 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.466 1.106 . . . . 0.57 108.091 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.1 154.93 43.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.29 0.567 . . . . 0.65 111.007 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.14 148.01 44.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.11 -1.07 . . . . 0.57 108.11 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.38 150.22 25.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.14 -1.059 . . . . 0.57 108.14 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.39 153.66 92.0 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.525 -0.75 . . . . 0.57 109.961 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 32.5 Cg_endo -68.73 165.09 30.78 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.579 1.52 . . . . 0.57 111.969 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 -70.8 0.15 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.652 -1.779 . . . . 0.57 108.652 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -173.52 144.02 1.09 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.257 -1.386 . . . . 0.57 107.257 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.15 -130.21 24.12 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.537 1.065 . . . . 0.57 111.615 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.89 -26.48 10.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.133 1.373 . . . . 0.57 112.345 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.17 143.67 8.74 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.191 -0.943 . . . . 0.57 111.633 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.1 -22.3 2.01 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.162 1.839 . . . . 0.57 114.553 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -70.49 157.69 37.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.787 1.294 . . . . 0.66 108.305 -176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.96 148.41 31.71 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.242 0.544 . . . . 0.57 109.63 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -132.02 160.5 35.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.65 109.282 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 23.9 m-85 -141.82 146.61 36.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.879 1.272 . . . . 0.57 108.155 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.78 103.83 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.922 -1.14 . . . . 0.66 107.922 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.77 -23.01 64.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.848 1.659 . . . . 0.66 111.395 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -65.38 -37.17 86.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.703 1.601 . . . . 0.66 110.157 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.0 133.39 48.96 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.327 -1.731 . . . . 0.66 106.327 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -54.94 151.89 8.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 118.905 -0.569 . . . . 1.2 109.72 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -133.93 135.88 43.87 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.749 -1.574 . . . . 0.57 106.749 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -132.52 140.77 48.47 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.494 -1.299 . . . . 0.57 107.494 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -57.16 -51.37 69.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.711 0.805 . . . . 0.66 109.396 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.45 56.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.889 -1.284 . . . . 0.57 109.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 t -154.71 164.31 38.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.656 -0.868 . . . . 0.57 108.656 173.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -76.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.502 2.321 . . . . 0.57 112.589 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -178.77 171.88 1.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.256 2.223 . . . . 0.57 107.348 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 123.85 -146.95 16.52 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.57 110.422 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 pt -116.65 119.55 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.322 1.449 . . . . 0.57 109.113 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -61.77 117.71 6.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.188 -0.914 . . . . 0.57 109.615 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.16 -40.05 96.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.319 1.448 . . . . 0.57 110.848 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -42.81 79.75 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.096 -1.076 . . . . 0.57 108.096 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -66.07 -47.61 73.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.021 0.828 . . . . 0.57 110.036 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.33 -50.09 70.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 123.531 0.52 . . . . 0.57 110.581 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.97 -57.88 10.0 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 117.908 -1.044 . . . . 0.57 109.74 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -55.82 -37.69 69.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.249 1.386 . . . . 0.57 111.333 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.97 -57.12 14.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.529 1.132 . . . . 0.65 110.518 173.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -72.72 -44.52 61.61 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.605 -0.684 . . . . 0.66 111.248 -171.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.2 -29.0 68.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.161 1.384 . . . . 0.57 111.036 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.34 -47.11 90.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.55 -1.02 . . . . 0.57 110.55 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.403 ' CE1' ' HG2' ' A' ' 138' ' ' MET . 70.9 m-70 -70.16 -36.29 74.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.255 -0.879 . . . . 0.65 112.191 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 p -57.74 -33.48 68.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.316 0.507 . . . . 0.57 111.251 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -36.34 79.81 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 112.493 0.553 . . . . 0.57 112.493 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 162.11 50.08 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 CA-C-O 117.993 -1.449 . . . . 0.57 113.271 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.73 -158.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.949 1.299 . . . . 0.57 112.024 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.08 62.6 0.22 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.091 -1.604 . . . . 0.57 109.091 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 169.62 17.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.675 0.75 . . . . 0.65 109.624 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -157.15 -179.99 8.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.701 1.2 . . . . 0.57 107.91 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t -144.17 78.16 1.57 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.771 -1.566 . . . . 0.57 106.771 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -131.08 145.91 59.81 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 106.545 -1.65 . . . . 0.66 106.545 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.71 -26.72 75.4 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.165 1.91 . . . . 0.57 112.427 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -125.11 29.37 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.572 1.549 . . . . 0.57 109.685 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.06 129.16 39.56 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 109.08 -0.711 . . . . 0.57 109.08 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.56 -17.5 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.619 1.168 . . . . 0.57 111.646 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.403 ' HG2' ' CE1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -113.72 22.5 13.98 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.307 1.843 . . . . 0.57 110.326 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.24 123.97 78.38 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 119.999 1.272 . . . . 0.57 110.292 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.7 48.3 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.728 2.952 . . . . 0.57 112.661 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -148.36 -45.48 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.57 110.373 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.3 t80 56.7 95.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.768 1.627 . . . . 0.57 112.305 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.41 -73.7 0.03 OUTLIER Glycine 0 C--N 1.346 1.101 0 O-C-N 120.751 -1.218 . . . . 0.57 115.706 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -35.52 61.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.503 1.151 . . . . 0.57 112.375 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.7 152.0 13.59 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.59 -1.004 . . . . 0.57 110.59 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.83 105.51 51.29 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 107.467 -1.309 . . . . 0.66 107.467 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.6 57.4 6.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.564 2.843 . . . . 0.57 109.92 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.5 -48.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.655 -0.653 . . . . 0.57 110.481 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -77.49 50.66 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.261 1.424 . . . . 0.57 110.886 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -41.86 -82.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.874 1.669 . . . . 0.57 112.917 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 43.91 22.82 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.16 2.584 . . . . 0.57 113.489 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 42.93 90.45 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.724 2.81 . . . . 0.57 111.222 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.9 t -56.12 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.088 1.355 . . . . 0.57 114.46 -170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -142.35 -46.24 0.33 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.424 1.09 . . . . 0.57 109.311 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.18 -51.56 10.4 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.886 1.274 . . . . 0.66 111.427 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -48.14 75.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.44 0.696 . . . . 0.66 111.964 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.4 mm -62.55 -46.57 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.886 0.874 . . . . 0.57 109.178 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -63.48 -44.1 95.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.049 1.339 . . . . 0.57 109.096 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.76 -62.59 6.14 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.1 -1.2 . . . . 0.57 110.1 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.522 HD11 ' CE3' ' A' ' 42' ' ' TRP . 8.0 mm -52.67 -48.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.394 1.077 . . . . 0.57 111.518 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -65.79 -28.53 69.07 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.436 -0.79 . . . . 0.57 111.875 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.2 -20.23 35.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.05 1.295 . . . . 0.57 111.959 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 6.5 mp -77.97 -45.39 24.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.064 0.946 . . . . 0.57 110.982 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.489 ' CD1' HG21 ' A' ' 46' ' ' ILE . 12.8 m-85 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 114.932 1.456 . . . . 0.57 114.932 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 CA-C-O 121.077 0.365 . . . . 0.57 111.263 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 77.92 -11.24 1.23 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.253 1.421 . . . . 0.57 112.252 -174.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 84.6 m95 60.92 19.2 9.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.813 1.188 . . . . 0.57 113.055 -168.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m 68.47 -43.07 0.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.23 1.812 . . . . 0.57 112.811 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 t -75.91 -178.15 4.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.598 2.359 . . . . 0.57 111.079 173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -10.29 20.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.541 1.137 . . . . 0.57 111.865 168.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -127.13 146.3 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.568 -1.271 . . . . 0.57 107.568 177.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.33 156.69 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 125.586 1.554 . . . . 0.57 107.06 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.7 p -108.46 138.12 45.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.275 -1.009 . . . . 0.57 108.275 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -126.59 143.21 51.29 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.075 -1.016 . . . . 0.57 108.725 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -150.66 110.94 4.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.755 0.788 . . . . 1.2 108.993 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 mt -80.6 95.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 105.874 -1.898 . . . . 0.57 105.874 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -69.82 -36.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.06 1.344 . . . . 0.57 112.557 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -130.04 158.38 39.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.129 -2.545 . . . . 0.57 104.129 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -133.45 175.99 8.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.188 1.395 . . . . 0.57 108.154 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -87.23 -154.68 0.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.847 0.859 . . . . 0.57 109.258 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -132.31 -28.8 1.65 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 116.412 -1.756 . . . . 1.2 115.074 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.82 -47.89 84.29 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.263 1.392 . . . . 0.66 110.696 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -109.52 158.11 35.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.344 1.458 . . . . 0.57 109.199 176.278 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -77.54 156.44 32.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.79 1.66 . . . . 0.57 112.672 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -59.87 -35.37 74.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.712 1.205 . . . . 0.65 113.514 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.69 -37.29 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.986 -0.446 . . . . 0.57 110.34 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -69.51 -39.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 116.965 -1.493 . . . . 0.57 109.313 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG13 ' CZ ' ' A' ' 114' ' ' PHE . 24.4 t -53.18 -56.84 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.761 1.619 . . . . 0.57 109.773 171.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.37 -41.4 97.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.959 -0.543 . . . . 0.66 111.323 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.65 -45.1 80.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.674 0.67 . . . . 1.2 111.904 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.24 -41.07 86.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.32 0.648 . . . . 0.57 109.413 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.1 -50.09 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 117.511 -1.233 . . . . 0.57 109.504 168.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -46.51 75.21 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 121.454 1.934 . . . . 0.57 110.946 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.58 -35.05 79.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.743 0.701 . . . . 0.57 112.335 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.71 -47.54 62.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.459 1.104 . . . . 0.57 112.605 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 122' ' ' LEU . 9.4 mp -68.52 -31.36 70.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.135 1.374 . . . . 0.57 109.514 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -59.77 -38.88 83.07 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.221 -0.895 . . . . 0.57 110.226 168.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 37.2 mtm -67.47 -33.98 76.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.265 1.393 . . . . 0.57 112.123 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 9.4 m95 -66.24 -54.58 23.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.07 0.85 . . . . 0.57 110.269 170.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.62 -4.01 43.99 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.806 1.193 . . . . 0.57 113.616 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -69.01 -25.92 64.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.685 1.242 . . . . 0.57 110.346 172.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.26 -15.4 13.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.218 1.007 . . . . 0.66 111.553 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 pt -131.5 140.66 39.09 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 119.466 1.03 . . . . 0.57 109.204 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.8 9.1 1.4 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.715 2.277 . . . . 0.57 112.963 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -71.48 135.03 46.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.043 1.337 . . . . 0.57 108.348 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -125.27 -179.76 4.73 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.25 1.02 . . . . 0.65 109.663 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.54 157.07 44.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.158 -0.682 . . . . 0.57 109.158 -171.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 154.46 49.15 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.346 1.458 . . . . 1.2 110.121 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -114.56 109.31 18.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.086 -1.079 . . . . 0.57 108.086 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.02 161.05 4.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.494 -0.558 . . . . 0.57 109.494 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.61 -53.14 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 118.767 -0.635 . . . . 0.57 110.524 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 165.88 58.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.292 2.237 . . . . 0.57 111.749 -172.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.09 38.85 1.7 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.752 -1.218 . . . . 0.57 113.588 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m 64.97 142.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.59 1.956 . . . . 0.57 110.28 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.18 168.03 20.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.773 0.796 . . . . 0.57 109.288 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 10' ' ' TRP . 58.0 m-20 -65.72 -45.02 84.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.582 -1.19 . . . . 0.66 108.545 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -112.34 81.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.051 1.74 . . . . 0.57 107.658 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -78.11 118.73 20.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.029 -1.1 . . . . 0.57 108.029 168.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.28 130.57 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.787 -1.931 . . . . 0.57 105.787 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.81 161.54 28.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.428 -0.669 . . . . 0.57 111.428 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.3 m-85 -132.02 143.35 50.01 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.881 -1.526 . . . . 0.57 106.881 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.02 179.98 6.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.433 1.493 . . . . 0.57 109.186 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -141.15 57.47 1.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.319 -0.623 . . . . 1.2 109.319 -171.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.04 -58.55 0.66 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.627 1.108 . . . . 0.57 111.889 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.86 155.01 45.91 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.684 0.794 . . . . 0.57 109.279 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -157.76 147.25 19.95 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.037 0.935 . . . . 0.65 109.127 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 74.63 1.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.371 -1.491 . . . . 0.57 109.371 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.74 -92.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.614 1.565 . . . . 0.66 107.169 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.9 p -158.92 -38.19 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.8 1.24 . . . . 0.57 110.024 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.88 131.42 23.99 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 109.541 -0.54 . . . . 0.57 109.541 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.0 137.08 43.36 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.036 -1.563 . . . . 0.57 108.036 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -158.22 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 123.622 1.677 . . . . 0.57 109.233 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -136.78 -22.64 1.22 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 130.205 3.402 . . . . 0.66 109.058 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 -141.43 26.42 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.079 -1.208 . . . . 0.57 110.079 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.06 95.21 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.965 3.11 . . . . 0.57 110.855 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.27 -176.15 21.89 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.622 -0.991 . . . . 0.57 110.622 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.25 31.8 t30 46.85 -135.72 0.88 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.451 1.5 . . . . 0.57 114.092 173.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -61.86 125.52 24.14 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.274 2.23 . . . . 0.57 110.909 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -82.48 -30.13 30.13 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.289 -1.507 . . . . 0.57 113.734 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.1 166.84 25.22 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.374 1.07 . . . . 0.57 109.377 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.08 163.93 32.13 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.799 -0.563 . . . . 0.65 109.783 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.44 155.24 40.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.958 1.303 . . . . 0.57 109.3 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.78 163.61 13.12 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.774 0.671 . . . . 0.57 110.11 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.4 153.92 83.96 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.7 -0.667 . . . . 0.57 109.946 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 36.3 Cg_endo -66.93 155.59 70.09 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.955 2.436 . . . . 0.57 112.176 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.81 -118.41 0.55 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.289 -1.925 . . . . 0.57 108.289 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 m -151.59 106.57 3.28 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 104.667 -2.345 . . . . 0.57 104.667 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.67 -132.57 10.51 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 117.483 -1.732 . . . . 0.57 109.301 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -31.13 12.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.662 1.585 . . . . 0.57 112.809 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -45.96 144.27 3.73 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.72 -0.552 . . . . 0.57 111.72 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CZ2' ' A' ' 10' ' ' TRP . . . 70.44 -18.81 0.71 Allowed Glycine 0 C--N 1.337 0.61 0 C-N-CA 126.546 2.022 . . . . 0.57 116.738 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -68.1 155.51 39.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.785 -1.191 . . . . 0.66 107.785 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.58 29.89 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.371 -0.832 . . . . 0.57 108.96 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.93 159.27 35.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.196 -0.911 . . . . 0.65 109.156 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.483 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 28.9 m-85 -144.56 154.74 43.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.566 1.546 . . . . 0.57 108.095 -170.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.06 99.15 12.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.672 0.389 . . . . 0.66 110.28 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.97 -28.14 49.31 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.741 -1.224 . . . . 0.66 111.977 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -54.67 -38.52 67.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.824 1.65 . . . . 0.66 110.592 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.79 151.14 37.6 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.881 1.272 . . . . 0.66 109.844 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -80.13 125.21 29.53 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.712 -1.243 . . . . 1.2 109.709 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -107.17 166.05 10.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.832 0.853 . . . . 0.57 109.118 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -158.8 164.4 35.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.815 0.846 . . . . 0.57 109.438 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -65.01 -48.03 75.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.326 0.65 . . . . 0.66 110.237 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.61 40.25 0.02 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.149 -0.806 . . . . 0.57 112.777 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -77.36 32.61 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.02 1.41 . . . . 0.57 113.827 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.1 m 53.51 35.09 19.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.667 1.587 . . . . 0.57 113.559 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -160.66 -175.16 4.81 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.551 1.54 . . . . 0.57 108.622 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.37 -144.76 24.32 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 124.237 0.922 . . . . 0.57 112.033 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -120.67 113.47 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.821 -1.548 . . . . 0.57 106.821 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -61.08 110.48 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.148 0.979 . . . . 0.57 111.304 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 10.0 t80 -63.21 -42.98 99.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.507 1.123 . . . . 0.57 111.355 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -55.11 22.77 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.86 -1.163 . . . . 0.57 107.86 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 147' ' ' PRO . 11.8 t80 -64.47 -43.25 94.81 Favored 'General case' 0 CA--C 1.526 0.02 0 C-N-CA 122.949 0.499 . . . . 0.57 111.004 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.2 70.82 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.085 0.554 . . . . 0.57 110.906 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.1 -55.66 31.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.191 -0.909 . . . . 0.57 109.607 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 m -53.93 -38.72 65.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.286 0.948 . . . . 0.57 111.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.429 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 4.0 t-160 -63.96 -59.29 4.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.252 0.621 . . . . 0.65 109.788 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -64.69 -46.71 81.19 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.232 0.469 . . . . 0.66 111.104 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.01 -31.48 71.86 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.4 1.08 . . . . 0.57 112.103 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -55.87 -41.89 84.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.219 -0.752 . . . . 0.57 111.219 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -72.33 -36.33 68.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.062 -0.971 . . . . 0.65 111.81 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -56.37 -36.33 68.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.283 0.947 . . . . 0.57 112.293 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 48' ' ' LEU . 2.5 mm? -65.87 -21.04 66.43 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.611 1.096 . . . . 0.57 112.942 176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.33 -54.59 0.28 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 124.343 0.973 . . . . 0.57 110.895 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.74 176.89 0.09 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.38 2.272 . . . . 0.57 107.7 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.4 70.65 0.02 OUTLIER Glycine 0 C--O 1.218 -0.874 0 N-CA-C 107.152 -2.379 . . . . 0.57 107.152 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 162.11 27.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.425 1.112 . . . . 0.65 108.651 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 t -157.95 -161.89 1.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.984 1.314 . . . . 0.57 108.388 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -152.74 58.43 0.8 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.119 1.768 . . . . 0.57 109.288 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -143.44 135.16 12.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 117.037 -1.458 . . . . 0.66 108.751 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.37 41.92 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.051 1 C-N-CA 125.981 4.454 . . . . 0.57 114.041 -174.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -154.02 -27.15 0.13 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 127.931 2.492 . . . . 0.57 111.566 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -50.7 133.35 25.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.7 -0.852 . . . . 0.57 108.7 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 156' ' ' ASP . 7.3 p -60.96 -25.44 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.852 -0.53 . . . . 0.57 110.745 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' HIS . 3.8 mpp? -109.63 28.61 8.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.41 1.084 . . . . 0.57 111.49 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -50.5 128.69 25.35 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 120.698 -1.251 . . . . 0.57 110.054 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.35 168.1 24.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.995 2.463 . . . . 0.57 110.542 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.4 m 62.0 70.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.871 0.759 . . . . 0.57 110.552 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -41.18 123.68 2.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.856 1.662 . . . . 0.57 112.115 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.1 -111.42 0.33 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.909 -1.277 . . . . 0.57 109.909 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -50.44 -39.97 49.16 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.667 0.988 . . . . 0.57 113.667 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.85 89.14 0.01 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.225 1.869 . . . . 0.57 112.115 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.99 107.91 1.06 Allowed Pre-proline 0 C--N 1.344 0.349 0 C-N-CA 124.635 1.174 . . . . 0.66 109.987 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.406 ' HA ' ' CD1' ' A' ' 116' ' ' TYR . 11.7 Cg_endo -72.19 -25.17 19.22 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.37 1.38 . . . . 0.57 112.145 -172.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.9 2.42 38.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.448 -0.787 . . . . 0.57 110.941 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.65 75.47 1.66 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.223 1.809 . . . . 0.57 108.418 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.11 -64.98 0.64 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.675 1.19 . . . . 0.57 113.291 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 22.61 77.55 0.02 OUTLIER 'General case' 0 C--N 1.343 0.296 0 C-N-CA 129.279 3.032 . . . . 0.57 112.657 174.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.7 mp -38.26 97.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.571 2.348 . . . . 0.57 109.97 -176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 m -74.13 -87.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.558 0.743 . . . . 0.57 112.546 -162.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -137.5 -28.02 0.92 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 116.779 -1.581 . . . . 0.57 110.248 168.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.17 -54.11 50.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.154 1.797 . . . . 0.66 111.299 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.598 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.5 t0 -62.68 -53.11 59.36 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 109.799 -0.445 . . . . 0.66 109.799 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.12 -40.62 83.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 123.865 0.866 . . . . 0.57 109.112 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -64.95 -43.03 94.02 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.823 -1.085 . . . . 0.57 110.653 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.48 -61.63 7.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.373 -1.491 . . . . 0.57 109.373 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.406 HD11 ' CE3' ' A' ' 42' ' ' TRP . 4.0 mm -53.47 -47.2 59.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.383 1.473 . . . . 0.57 112.748 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.14 -31.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.037 0.535 . . . . 0.57 111.017 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -29.61 64.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.702 0.683 . . . . 0.57 111.183 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.59 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.482 -0.77 . . . . 0.57 109.709 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.65 0.611 . . . . 0.57 112.65 -171.794 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.455 -0.738 0 N-CA-C 109.668 -0.935 . . . . 0.57 109.668 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 pttt 85.73 151.26 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.239 2.615 . . . . 0.57 108.937 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 64.6 m95 -65.76 170.11 5.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.265 1.026 . . . . 0.57 109.938 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 m -62.05 -29.66 70.45 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 120.94 -1.1 . . . . 0.57 111.252 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.6 t -97.62 156.87 16.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.57 112.163 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -75.1 -6.08 47.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.682 1.593 . . . . 0.57 112.754 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.63 151.94 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.523 -0.918 . . . . 0.57 108.523 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 150.16 33.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.047 -1.094 . . . . 0.57 108.047 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.8 p -104.54 136.78 43.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.605 -0.887 . . . . 0.57 108.605 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -118.79 163.2 17.23 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.801 0.84 . . . . 0.57 110.481 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.37 160.45 41.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.046 -1.094 . . . . 1.2 108.046 169.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.6 mt -123.2 94.25 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 103.663 -2.717 . . . . 0.57 103.663 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 m -73.29 -30.68 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.593 0.357 . . . . 0.57 111.263 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -142.63 147.27 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.161 -2.163 . . . . 0.57 105.161 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -131.9 159.19 39.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.357 1.063 . . . . 0.57 109.207 -166.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -91.74 -175.52 4.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.876 1.27 . . . . 0.57 109.437 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.61 -26.3 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.128 1.159 . . . . 1.2 114.128 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -59.19 -40.68 86.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.265 0.626 . . . . 0.66 110.305 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.65 152.57 80.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 128.767 2.827 . . . . 0.57 110.248 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.31 161.19 28.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.962 2.441 . . . . 0.57 114.453 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.82 -39.05 93.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.833 1.653 . . . . 0.65 112.027 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 tt -65.89 -35.96 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.424 0.69 . . . . 0.57 110.794 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -66.39 -46.62 76.03 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 116.703 -1.617 . . . . 0.57 108.723 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.56 -52.54 25.78 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.568 1.531 . . . . 0.57 110.043 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -63.04 -42.49 99.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.635 1.174 . . . . 0.66 110.955 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -63.32 -46.88 84.63 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.95 . . . . 1.2 112.062 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.15 -45.61 87.72 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.239 -0.886 . . . . 0.57 109.022 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -46.75 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 124.267 1.027 . . . . 0.57 109.574 172.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -46.06 89.47 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.047 0.839 . . . . 0.57 110.95 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -63.67 -42.95 98.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.912 1.285 . . . . 0.57 112.033 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.29 75.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.094 1.357 . . . . 0.57 111.447 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.92 -34.19 77.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.607 -0.711 . . . . 0.57 110.258 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -40.76 85.38 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.262 0.937 . . . . 0.57 110.613 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 39.4 mtm -63.85 -38.93 92.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.047 0.84 . . . . 0.57 111.293 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CH2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -64.29 -49.67 70.87 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.26 0.936 . . . . 0.57 111.405 172.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.16 -9.08 66.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.913 1.244 . . . . 0.57 113.174 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -23.77 63.08 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.506 1.653 . . . . 0.57 110.864 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -105.85 -14.03 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.258 1.023 . . . . 0.66 111.706 -171.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' CD1' ' A' ' 164' ' ' TYR . 12.8 pt -139.36 149.56 60.92 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.636 1.174 . . . . 0.57 111.445 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.37 10.32 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.313 2.675 . . . . 0.57 113.018 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.26 133.9 35.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.736 1.615 . . . . 0.57 107.513 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.12 170.88 10.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.002 0.921 . . . . 0.65 110.006 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.08 146.16 31.73 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.426 -0.953 . . . . 0.57 108.426 -172.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -143.6 166.53 24.58 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.875 1.27 . . . . 1.2 109.242 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -105.37 143.35 33.66 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.86 -0.793 . . . . 0.57 108.86 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.66 157.01 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.71 0.404 . . . . 0.57 110.98 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.86 -43.81 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.779 0.832 . . . . 0.57 111.509 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -176.64 146.98 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.97 2.908 . . . . 0.57 104.622 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.18 -116.87 3.07 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.523 -0.631 . . . . 0.57 111.523 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 43.9 p -132.88 164.64 26.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.635 1.974 . . . . 0.57 108.556 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.51 21.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.126 0.97 . . . . 0.57 110.121 -174.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -63.01 -33.08 74.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.611 0.764 . . . . 0.66 109.806 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.3 mt -123.53 76.94 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.068 2.147 . . . . 0.57 108.235 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -73.22 110.75 7.74 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.737 1.615 . . . . 0.57 108.519 167.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.91 128.13 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 104.568 -2.382 . . . . 0.57 104.568 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.62 148.9 19.07 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 110.111 -1.196 . . . . 0.57 110.111 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -113.38 167.28 10.7 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 118.299 1.05 . . . . 0.57 108.594 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.58 155.28 43.57 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.513 1.125 . . . . 0.57 108.162 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -105.13 110.03 22.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.521 -1.289 . . . . 1.2 107.521 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.73 -46.95 2.4 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.015 -1.436 . . . . 0.57 113.665 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.53 165.53 36.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.554 1.677 . . . . 0.57 111.56 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.13 162.51 33.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.411 1.085 . . . . 0.65 111.777 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.57 58.62 3.0 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.798 1.665 . . . . 0.57 112.307 -174.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.99 -52.71 2.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.561 0.745 . . . . 0.66 111.276 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 t 174.73 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.427 1.891 . . . . 0.57 110.65 -167.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -122.54 114.16 30.28 Favored Pre-proline 0 C--N 1.347 0.471 0 C-N-CA 123.388 0.675 . . . . 0.57 109.538 -170.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 28.88 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.941 2.427 . . . . 0.57 112.552 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 41.96 -136.3 0.27 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.128 1.771 . . . . 0.57 111.326 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -162.77 -40.46 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.779 2.432 . . . . 0.66 108.449 -163.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.39 -153.91 21.98 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.687 -1.365 . . . . 0.57 109.687 -170.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.77 101.98 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.096 3.198 . . . . 0.57 113.561 -167.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.88 -178.79 17.05 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 109.839 -1.304 . . . . 0.57 109.839 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t30 49.14 -145.01 0.42 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.195 0.997 . . . . 0.57 112.428 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.3 m -46.5 110.68 0.3 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.374 2.27 . . . . 0.57 112.577 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -83.83 -34.12 24.75 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.259 -0.9 . . . . 0.57 113.041 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.84 167.62 29.82 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.915 0.886 . . . . 0.57 109.382 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -150.98 150.44 30.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.876 -0.515 . . . . 0.65 110.053 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.95 163.2 32.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.1 0.96 . . . . 0.57 109.628 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.31 140.3 49.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.007 -1.109 . . . . 0.57 108.007 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.09 160.07 3.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.57 112.444 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.0 Cg_endo -68.6 152.87 74.46 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.538 2.158 . . . . 0.57 111.183 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.17 -78.57 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.045 -1.222 . . . . 0.57 110.045 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -172.21 -49.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.584 1.154 . . . . 0.57 109.497 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.69 -101.99 2.73 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.218 -1.153 . . . . 0.57 110.218 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -27.18 68.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.048 0.939 . . . . 0.57 111.828 175.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.54 146.77 15.67 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.148 -0.97 . . . . 0.57 111.411 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 -21.37 4.24 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.579 2.037 . . . . 0.57 114.506 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -74.76 160.14 31.1 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.975 1.388 . . . . 0.66 108.891 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.09 139.86 20.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.118 -0.492 . . . . 0.57 110.3 -169.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -132.77 149.52 52.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.437 0.695 . . . . 0.65 110.6 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -142.07 146.88 35.95 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.096 -1.446 . . . . 0.57 107.096 -166.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -86.55 103.89 15.48 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.02 0.914 . . . . 0.66 109.277 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.65 -15.54 62.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.316 1.446 . . . . 0.66 111.374 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -69.56 -20.58 63.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.436 1.016 . . . . 0.66 110.267 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -85.38 158.91 20.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.026 0.917 . . . . 0.66 110.325 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.27 138.66 35.73 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -131.47 144.84 51.45 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.269 -1.752 . . . . 0.57 106.269 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -138.48 153.07 48.79 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.46 0.648 . . . . 0.57 110.14 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -97.18 11.57 35.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.626 2.371 . . . . 0.66 110.741 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.74 -134.31 2.98 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.81 1.672 . . . . 0.57 111.674 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 t -143.33 171.5 14.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.309 1.444 . . . . 0.57 108.713 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 t 51.76 42.9 30.25 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.892 1.441 . . . . 0.57 114.892 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.56 -38.59 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 119.914 -1.741 . . . . 0.57 113.542 -172.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.35 -154.9 10.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 108.587 -1.805 . . . . 0.57 108.587 -172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.94 119.51 34.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 108.289 -1.004 . . . . 0.57 108.289 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -63.98 103.56 0.61 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.945 0.498 . . . . 0.57 109.675 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.24 -36.35 65.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.874 1.27 . . . . 0.57 110.645 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -65.44 -48.35 73.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.849 -0.797 . . . . 0.57 108.849 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.52 -39.07 93.47 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.558 -0.904 . . . . 0.57 108.558 -176.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.56 -56.3 22.97 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.58 0.752 . . . . 0.57 110.999 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.25 58.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.137 0.575 . . . . 0.57 109.71 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.7 m -58.73 -44.02 90.35 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.173 0.897 . . . . 0.57 111.732 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.66 -52.03 67.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.034 0.534 . . . . 0.65 109.723 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.23 -48.66 72.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.466 1.106 . . . . 0.66 110.393 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.14 -29.12 69.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 126.113 1.765 . . . . 0.57 111.534 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 42' ' ' TRP . . . -62.19 -45.32 96.27 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.691 -0.564 . . . . 0.57 111.691 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -62.32 -39.76 94.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 117.213 -1.375 . . . . 0.65 109.911 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -60.44 -29.1 68.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.825 1.193 . . . . 0.57 113.774 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -25.22 57.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.596 1.089 . . . . 0.57 112.71 172.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.89 -1.63 4.29 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.808 1.194 . . . . 0.57 114.5 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.43 164.68 20.5 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.951 1.375 . . . . 0.57 113.678 -166.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.38 166.49 12.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.227 1.394 . . . . 0.57 109.755 172.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -68.37 174.35 4.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.195 0.998 . . . . 0.65 112.558 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.08 179.83 7.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.735 1.614 . . . . 0.57 108.519 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.08 71.55 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.826 2.05 . . . . 0.57 107.51 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 12.3 t70 -136.72 140.49 32.13 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 107.668 -1.234 . . . . 0.66 107.668 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.34 -26.32 41.53 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.456 2.104 . . . . 0.57 112.317 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.2 22.87 14.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.981 1.313 . . . . 0.57 109.991 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -64.61 124.42 21.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.258 -1.016 . . . . 0.57 108.258 166.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.93 -31.03 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.986 -0.446 . . . . 0.57 109.871 166.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -84.51 8.54 16.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.94 1.089 . . . . 0.57 113.94 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -56.78 130.85 78.43 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.652 1.569 . . . . 0.57 110.565 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 150.01 26.53 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.197 1.931 . . . . 0.57 110.27 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.8 m 73.12 156.42 0.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.389 1.876 . . . . 0.57 111.545 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.79 132.73 53.88 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.252 1.021 . . . . 0.57 109.55 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 141.62 97.51 0.29 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.511 1.053 . . . . 0.57 110.53 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.25 -43.23 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.659 1.229 . . . . 0.57 113.443 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.66 -177.22 48.39 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.862 -1.695 . . . . 0.57 108.862 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -51.7 111.56 2.52 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.579 1.552 . . . . 0.66 110.969 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -3.86 12.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.21 1.94 . . . . 0.57 112.304 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -73.7 -9.99 59.23 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.706 1.139 . . . . 0.57 112.91 168.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -62.61 -6.58 3.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.721 1.749 . . . . 0.57 115.721 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 19.77 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.346 3.058 . . . . 0.57 116.83 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt 20.39 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.677 3.191 . . . . 0.57 112.859 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -26.11 106.09 0.03 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 127.876 2.471 . . . . 0.57 110.165 -175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.8 t -81.67 -87.54 0.09 Allowed 'General case' 0 C--N 1.343 0.316 0 O-C-N 123.853 0.721 . . . . 0.57 110.147 -160.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.75 -37.5 0.45 Allowed 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.252 -1.356 . . . . 0.57 109.376 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -47.85 -49.32 29.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.205 1.366 . . . . 0.66 110.571 171.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.428 ' CG ' HD23 ' A' ' 152' ' ' LEU . 12.1 t0 -77.57 -54.15 6.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.66 109.746 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mm -57.68 -45.64 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.76 0.709 . . . . 0.57 111.079 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -44.16 79.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 123.505 0.722 . . . . 0.57 109.565 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.43 -51.25 58.87 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.123 -1.191 . . . . 0.57 110.123 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -60.22 -51.97 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.456 1.102 . . . . 0.57 110.223 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.08 -25.28 61.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.877 0.762 . . . . 0.57 112.498 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -43.79 18.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.577 -1.201 . . . . 0.57 110.064 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.25 -56.67 6.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.666 2.386 . . . . 0.57 111.624 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.422 ' CD1' HG22 ' A' ' 46' ' ' ILE . 26.4 p90 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 119.02 -0.514 . . . . 0.57 112.143 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.45 -1.085 0 N-CA-C 110.187 -0.736 . . . . 0.57 110.187 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.5 111.55 0.07 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.48 1.912 . . . . 0.57 111.288 -174.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 19.9 m95 -58.02 152.29 16.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.996 0.918 . . . . 0.57 111.436 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.4 p -77.47 -20.69 54.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.57 112.764 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -94.19 142.41 27.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.236 1.415 . . . . 0.57 109.325 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -10.62 59.7 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.406 1.482 . . . . 0.57 112.577 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.87 109.91 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.614 -1.995 . . . . 0.57 105.614 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG23 HD21 ' A' ' 48' ' ' LEU . 59.9 t -102.02 159.0 4.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.607 -1.627 . . . . 0.57 106.607 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 p -106.96 139.8 40.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.277 -0.638 . . . . 0.57 109.277 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -128.08 157.37 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.409 -0.807 . . . . 0.57 110.092 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -158.48 115.88 2.88 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.057 0.456 . . . . 1.2 110.361 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.65 90.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 106.623 -1.621 . . . . 0.57 106.623 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.12 -25.46 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.408 -1.432 . . . . 0.57 113.901 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -147.6 154.72 41.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 103.241 -2.874 . . . . 0.57 103.241 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -135.78 43.95 2.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.756 0.707 . . . . 0.57 110.148 -164.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 64' ' ' PHE . 15.4 t 47.73 -153.98 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.779 1.232 . . . . 0.57 110.186 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -22.79 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.54 -0.743 . . . . 1.2 112.784 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -64.04 -39.72 94.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.04 0.836 . . . . 0.66 111.536 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.19 150.7 57.41 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.005 1.322 . . . . 0.57 109.062 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.28 159.67 40.09 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.82 2.347 . . . . 0.57 113.011 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -59.53 -36.78 76.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.98 1.312 . . . . 0.65 113.689 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -39.3 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.185 0.448 . . . . 0.57 110.039 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -69.74 -46.39 66.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.297 -1.335 . . . . 0.57 109.475 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.4 -48.14 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.985 1.721 . . . . 0.57 110.403 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.72 -45.67 91.65 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 119.019 0.827 . . . . 0.66 110.781 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -40.54 94.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.8 1.182 . . . . 1.2 113.189 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.23 -47.77 63.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.04 1.336 . . . . 0.57 109.235 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.2 -37.84 70.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.375 0.989 . . . . 0.57 110.809 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.0 t -61.49 -56.75 16.61 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.227 1.011 . . . . 0.57 109.95 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -62.34 -32.72 73.54 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.353 1.433 . . . . 0.57 112.338 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.95 62.0 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.451 1.1 . . . . 0.57 112.316 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.62 -31.16 70.99 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 118.228 -0.891 . . . . 0.57 110.165 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -59.85 -43.57 94.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.901 -1.047 . . . . 0.57 109.609 171.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.1 mtp -61.31 -45.26 95.18 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.893 1.224 . . . . 0.57 111.733 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -60.48 -47.75 84.77 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.085 1.311 . . . . 0.57 111.565 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.57 -17.01 68.37 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.64 1.114 . . . . 0.57 113.071 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -29.57 70.73 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.478 -1.013 . . . . 0.57 110.182 174.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.91 -32.26 13.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.72 -0.657 . . . . 0.66 111.808 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.89 132.87 24.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.757 0.823 . . . . 0.57 110.659 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.34 35.7 0.4 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 124.111 3.208 . . . . 0.57 113.991 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 49' ' ' HIS . 2.1 tt -78.81 146.26 33.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.718 1.607 . . . . 0.57 107.85 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.535 ' H ' HD23 ' A' ' 48' ' ' LEU . 68.8 m80 -130.59 160.17 34.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.02 1.328 . . . . 0.65 108.191 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 149.87 43.97 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 120.927 -1.108 . . . . 0.57 108.26 -173.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -137.18 170.33 16.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.926 0.89 . . . . 1.2 109.357 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -117.33 128.22 54.83 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.019 -1.104 . . . . 0.57 108.019 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.14 163.23 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.95 1.3 . . . . 0.57 110.444 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 55' ' ' TRP . 27.4 m -66.36 -60.21 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.845 0.858 . . . . 0.57 109.895 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.503 ' H ' HG23 ' A' ' 54' ' ' VAL . 19.7 p90 -164.57 154.12 13.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.415 2.686 . . . . 0.57 105.616 167.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.05 17.79 1.42 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.433 1.333 . . . . 0.57 116.433 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.6 m 68.0 159.04 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.944 1.698 . . . . 0.57 111.021 -168.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -131.82 177.26 7.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.623 1.569 . . . . 0.57 109.071 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.86 -34.97 79.36 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.921 0.488 . . . . 0.66 109.946 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mt -126.84 82.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.139 -1.8 . . . . 0.57 106.139 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.47 140.21 44.44 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.208 -0.932 . . . . 0.57 108.777 164.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.67 120.36 61.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 N-CA-C 105.705 -1.961 . . . . 0.57 105.705 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.74 161.12 24.74 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.697 -0.561 . . . . 0.57 111.697 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.5 m-85 -132.45 129.9 39.84 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 104.978 -2.23 . . . . 0.57 104.978 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.1 17.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.647 1.979 . . . . 0.57 108.223 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 ttp-105 -97.36 -14.15 21.43 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.69 0.996 . . . . 1.2 113.69 -168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.22 -44.07 0.03 OUTLIER Glycine 0 C--O 1.221 -0.669 0 CA-C-O 119.067 -0.852 . . . . 0.57 111.034 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.57 27.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.314 1.046 . . . . 0.57 109.143 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 -75.31 0.63 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.145 1.778 . . . . 0.65 109.096 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.44 46.52 0.02 OUTLIER Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.594 0.616 . . . . 0.57 112.371 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 -172.46 2.05 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.832 1.653 . . . . 0.66 108.098 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.1 -36.73 2.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.57 113.322 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.8 101.3 6.49 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.332 -0.988 . . . . 0.57 108.332 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.52 155.26 67.37 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.412 1.408 . . . . 0.57 111.155 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.03 177.23 3.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.53 1.157 . . . . 0.57 111.734 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.0 -26.6 8.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.828 3.251 . . . . 0.66 111.798 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.57 -146.0 18.06 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 120.89 1.677 . . . . 0.57 112.632 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.5 82.28 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 0.57 113.753 -172.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -165.02 35.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.984 1.754 . . . . 0.57 111.743 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 t30 38.41 -129.65 0.22 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.364 2.266 . . . . 0.57 115.755 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.2 m -65.67 131.26 45.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.153 2.181 . . . . 0.57 109.135 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.17 -27.15 13.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.767 1.227 . . . . 0.57 113.496 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.91 159.69 32.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.153 -1.425 . . . . 0.57 107.153 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.89 157.1 43.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.65 109.553 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.72 155.13 43.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.519 1.128 . . . . 0.57 108.709 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.97 143.73 42.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.522 -0.918 . . . . 0.57 108.522 -175.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.09 151.72 33.44 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 118.122 -0.942 . . . . 0.57 110.193 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 55.1 Cg_endo -70.15 155.52 64.44 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.678 1.585 . . . . 0.57 112.014 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.72 174.7 14.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.81 1.195 . . . . 0.57 110.733 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.257 7.1 t 43.52 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.049 1.74 . . . . 0.57 113.055 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.51 -53.06 2.69 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.945 -0.92 . . . . 0.57 111.178 172.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.16 -35.27 80.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.816 1.246 . . . . 0.57 112.089 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.0 153.62 30.15 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.889 -1.132 . . . . 0.57 111.007 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.61 -21.48 1.96 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.204 1.383 . . . . 0.57 114.091 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -74.72 155.07 38.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 120.138 1.969 . . . . 0.66 108.614 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.29 26.02 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.507 -0.769 . . . . 0.57 109.487 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -132.82 162.33 31.8 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.65 109.248 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.5 m-85 -143.03 155.44 44.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.732 1.613 . . . . 0.57 108.718 -171.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.63 96.29 7.85 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.552 -1.277 . . . . 0.66 107.552 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.13 -32.76 68.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.068 1.747 . . . . 0.66 111.74 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.74 -32.27 73.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.423 -0.584 . . . . 0.66 109.423 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.88 124.01 23.33 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.276 1.03 . . . . 0.66 109.471 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -54.48 131.06 41.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.301 1.04 . . . . 1.2 109.745 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.38 149.07 39.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.658 -1.238 . . . . 0.57 107.658 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -145.1 149.3 34.8 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.508 -0.745 . . . . 0.57 109.185 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.35 -39.25 75.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.385 0.538 . . . . 0.66 110.728 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.87 -35.47 0.1 OUTLIER Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.367 -0.685 . . . . 0.57 112.866 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.1 m -54.91 137.64 45.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.293 1.037 . . . . 0.57 111.633 174.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -56.12 110.44 0.75 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.689 1.196 . . . . 0.57 111.936 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -32.88 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.586 1.154 . . . . 0.57 111.804 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.98 -146.21 5.5 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 108.06 -2.016 . . . . 0.57 108.06 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.39 135.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.727 1.211 . . . . 0.57 109.523 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.71 103.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.896 0.878 . . . . 0.57 110.623 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.05 -41.39 74.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.085 2.154 . . . . 0.57 110.817 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 tp -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.088 -0.708 . . . . 0.57 109.088 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 137' ' ' VAL . 39.8 t80 -57.93 -48.86 78.68 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.719 0.807 . . . . 0.57 109.183 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.54 -57.05 14.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.811 0.844 . . . . 0.57 110.464 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -51.37 70.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.512 -0.756 . . . . 0.57 110.333 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.1 m -56.75 -41.21 77.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.551 1.069 . . . . 0.57 110.904 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -67.12 -52.89 36.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.348 0.659 . . . . 0.65 110.306 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.03 -41.92 94.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.9 0.773 . . . . 0.66 111.037 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.06 -27.91 66.06 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.275 0.63 . . . . 0.57 110.734 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.05 -44.01 88.28 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 118.855 0.752 . . . . 0.57 111.398 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -68.33 -39.56 81.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.18 -0.914 . . . . 0.65 112.067 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 p -65.05 -26.94 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 123.688 0.617 . . . . 0.57 111.955 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -44.18 85.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 0.57 111.08 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 168.84 41.64 0.03 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.411 -1.216 . . . . 0.57 115.128 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.7 mmt 54.39 -167.17 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.665 1.232 . . . . 0.57 111.072 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.8 24.44 0.34 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.17 -1.35 . . . . 0.57 114.917 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 163.69 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.402 1.601 . . . . 0.65 113.013 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.2 178.97 9.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.885 1.674 . . . . 0.57 109.235 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.5 m -147.52 75.7 1.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.165 1.786 . . . . 0.57 106.815 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -136.38 143.04 41.8 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.849 0.86 . . . . 0.66 108.703 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.72 3.73 3.05 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.257 2.638 . . . . 0.57 114.725 -169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -135.67 -1.53 2.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.432 1.493 . . . . 0.57 111.534 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.82 121.54 26.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.463 1.905 . . . . 0.57 108.851 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 116' ' ' TYR . 2.6 p -53.59 -29.06 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 120.948 1.703 . . . . 0.57 112.422 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 39.0 mmt -65.12 -15.37 62.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.308 -1.33 . . . . 0.57 113.854 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.34 126.55 82.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 120.726 1.603 . . . . 0.57 109.31 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.44 -165.33 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.543 2.162 . . . . 0.57 110.148 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m 79.92 -31.05 0.13 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.232 -1.543 . . . . 0.57 113.015 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.3 t80 45.21 80.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.668 1.587 . . . . 0.57 111.471 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.65 -92.04 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.587 1.565 . . . . 0.57 112.36 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -64.94 -49.18 71.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.172 1.389 . . . . 0.57 113.928 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.85 109.03 2.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 107.196 -2.362 . . . . 0.57 107.196 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.5 118.66 62.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.783 1.633 . . . . 0.66 112.218 -166.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.51 -1.47 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.97 3.113 . . . . 0.57 113.537 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.41 -30.03 53.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.55 1.068 . . . . 0.57 110.68 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -116.87 75.12 0.95 Allowed 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.532 -0.73 . . . . 0.57 109.305 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -126.31 145.88 50.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.284 0.634 . . . . 0.57 110.929 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 52.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.008 1.323 . . . . 0.57 111.157 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp 56.92 73.94 0.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.218 1.407 . . . . 0.57 111.458 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -61.5 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 C-N-CA 124.932 1.293 . . . . 0.57 113.645 -168.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -144.52 -50.85 0.28 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 116.621 -1.656 . . . . 0.57 108.429 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -42.73 -48.29 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.95 1.7 . . . . 0.66 112.994 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -49.52 62.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.953 0.901 . . . . 0.66 109.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.39 -40.83 82.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 118.23 -0.89 . . . . 0.57 108.95 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -40.25 97.04 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.989 1.315 . . . . 0.57 109.281 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.66 -55.55 29.89 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.235 -1.146 . . . . 0.57 110.235 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -62.3 -47.84 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.32 1.06 . . . . 0.57 112.481 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.25 -11.86 60.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.749 1.22 . . . . 0.57 111.92 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -80.46 -51.81 8.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.279 0.945 . . . . 0.57 108.666 164.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.42 -51.44 68.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.977 . . . . 0.57 112.301 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 124.153 0.981 . . . . 0.57 109.634 -176.676 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 CA-C-O 118.723 -0.615 . . . . 0.57 110.649 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.6 102.93 0.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.16 1.384 . . . . 0.57 108.958 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.8 m95 -51.2 148.15 4.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.476 0.711 . . . . 0.57 110.866 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -59.24 -33.14 70.65 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.982 0.913 . . . . 0.57 112.344 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 t -82.66 146.42 29.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.552 0.691 . . . . 0.57 109.326 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -19.01 61.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.387 0.675 . . . . 0.57 111.528 170.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 136.52 52.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.006 -1.109 . . . . 0.57 108.006 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.62 157.74 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.399 1.88 . . . . 0.57 108.417 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.7 p -113.18 138.4 50.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.071 -1.085 . . . . 0.57 108.071 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -126.06 153.56 44.28 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.756 0.423 . . . . 0.57 110.199 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -154.26 119.55 5.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.28 89.03 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 105.542 -2.021 . . . . 0.57 105.542 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -47.88 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.689 1.196 . . . . 0.57 112.428 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.49 145.37 41.99 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.522 -2.029 . . . . 0.57 105.522 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.42 143.55 51.14 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.371 1.069 . . . . 0.57 109.031 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -69.84 -172.64 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.696 1.599 . . . . 0.57 110.542 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -136.73 -29.37 0.94 Allowed 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.479 0.918 . . . . 1.2 113.479 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -53.96 -36.55 62.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.406 1.082 . . . . 0.66 110.702 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.29 154.57 73.91 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 128.111 2.565 . . . . 0.57 110.252 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 151.44 46.71 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.68 2.253 . . . . 0.57 112.925 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -60.58 -39.44 88.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.502 1.521 . . . . 0.65 113.324 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.2 tt -64.13 -36.38 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 119.202 -0.428 . . . . 0.57 110.597 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -67.55 -39.17 84.99 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 116.87 -1.538 . . . . 0.57 109.972 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.9 -52.98 51.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 120.069 1.304 . . . . 0.57 109.922 172.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -61.54 -39.54 91.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.343 0.52 . . . . 0.66 111.001 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -61.71 -47.1 86.78 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.399 -0.813 . . . . 1.2 112.402 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -38.2 78.52 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 123.959 0.903 . . . . 0.57 110.269 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.49 -44.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.117 -1.068 . . . . 0.57 108.117 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.87 -48.86 74.81 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.823 1.192 . . . . 0.57 110.903 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -40.59 75.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.943 1.247 . . . . 0.57 112.134 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.4 98.6 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.57 111.294 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 49.8 mt -72.4 -31.61 65.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.146 -0.93 . . . . 0.57 111.114 176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.87 -40.86 94.54 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.37 0.986 . . . . 0.57 109.602 169.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -64.09 -33.74 76.45 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.548 -0.72 . . . . 0.57 112.577 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.4 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 5.8 m95 -71.72 -47.3 54.8 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.275 0.943 . . . . 0.57 111.261 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.56 2.17 32.42 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.165 1.364 . . . . 0.57 113.62 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -22.68 61.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.346 -1.091 . . . . 0.57 111.242 172.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.7 -39.75 5.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.516 -0.754 . . . . 0.66 110.397 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 19.2 pt -101.94 135.27 19.73 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 119.427 1.012 . . . . 0.57 110.58 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.73 40.55 0.56 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.314 2.676 . . . . 0.57 112.628 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -101.66 134.49 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.651 1.58 . . . . 0.57 107.63 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -130.16 170.44 14.05 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.512 0.725 . . . . 0.65 109.652 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -137.59 158.37 44.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.843 -0.799 . . . . 0.57 108.843 -168.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -146.93 157.83 43.75 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.61 1.164 . . . . 1.2 110.36 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.3 105.81 14.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.192 0.997 . . . . 0.57 108.452 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.08 157.34 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.767 -1.106 . . . . 0.57 109.729 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 m -92.87 31.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.249 1.02 . . . . 0.57 110.913 -174.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.02 155.59 45.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.57 109.747 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.96 34.71 2.13 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.999 1.285 . . . . 0.57 114.091 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.1 m -150.65 132.63 15.18 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 106.101 -1.815 . . . . 0.57 106.101 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.61 174.09 13.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.561 1.145 . . . . 0.57 109.047 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 -31.46 66.16 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.863 -0.589 . . . . 0.66 110.391 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 mm -123.25 67.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.328 2.251 . . . . 0.57 107.847 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.87 116.9 10.79 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.615 -1.254 . . . . 0.57 107.615 169.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.59 129.97 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.482 -2.414 . . . . 0.57 104.482 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -152.88 150.45 22.23 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.222 -0.924 . . . . 0.57 111.543 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.18 143.9 51.15 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.27 -0.641 . . . . 0.57 109.27 -171.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.03 166.78 24.03 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 124.74 1.216 . . . . 0.57 109.658 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -94.19 -29.55 15.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.526 0.565 . . . . 1.2 112.526 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.5 -38.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.787 0 O-C-N 121.412 -0.805 . . . . 0.57 112.06 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.1 49.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.141 1.47 . . . . 0.57 108.797 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -156.98 155.18 30.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.347 1.059 . . . . 0.65 109.182 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.28 57.63 2.82 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.99 1.757 . . . . 0.57 112.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.24 -82.43 0.62 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.56 1.544 . . . . 0.66 109.079 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.76 -29.35 0.01 OUTLIER 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.506 1.122 . . . . 0.57 110.527 -171.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.46 120.92 11.67 Favored Pre-proline 0 C--N 1.343 0.305 0 N-CA-C 107.929 -1.137 . . . . 0.57 107.929 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.6 144.22 77.92 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.894 -1.233 . . . . 0.57 108.894 169.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.68 -171.11 0.09 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.393 1.477 . . . . 0.57 111.077 166.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -118.77 -33.21 4.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.693 2.797 . . . . 0.66 110.32 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.22 -150.91 19.66 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.556 1.071 . . . . 0.57 111.146 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.96 102.45 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 125.008 3.805 . . . . 0.57 111.968 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' H ' ' CD ' ' A' ' 102' ' ' GLU . . . 119.6 165.38 12.99 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.244 1.878 . . . . 0.57 109.329 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 t30 58.45 -156.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.734 1.214 . . . . 0.57 111.752 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 m -39.66 116.56 0.64 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.927 2.491 . . . . 0.57 113.337 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.07 -33.16 29.97 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.143 -1.598 . . . . 0.57 112.676 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.99 166.62 29.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.319 1.048 . . . . 0.57 109.438 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -144.47 163.31 34.21 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.992 0.517 . . . . 0.65 110.058 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.69 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.642 0.777 . . . . 0.57 109.804 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.93 152.12 32.88 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.732 -0.667 . . . . 0.57 109.33 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.36 151.61 90.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.657 -0.687 . . . . 0.57 109.761 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.2 Cg_endo -69.06 162.63 40.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.183 1.922 . . . . 0.57 111.452 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.42 -109.52 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.824 -2.111 . . . . 0.57 107.824 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -152.27 118.75 5.64 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.635 -1.617 . . . . 0.57 106.635 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 -131.74 10.76 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.4 -1.08 . . . . 0.57 110.4 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 tp -51.22 -28.25 11.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.126 1.37 . . . . 0.57 112.711 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.79 145.17 8.76 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.106 -0.996 . . . . 0.57 111.614 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.83 -24.27 3.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.032 1.301 . . . . 0.57 113.719 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.87 155.94 39.81 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.473 1.137 . . . . 0.66 108.45 -172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.09 140.74 34.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.934 -0.765 . . . . 0.57 108.934 -173.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 29.5 m170 -128.28 153.13 47.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.604 -0.725 . . . . 0.65 109.568 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.05 153.76 44.45 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.651 -1.24 . . . . 0.57 107.651 -173.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -92.37 100.64 13.17 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.608 -0.724 . . . . 0.66 109.31 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -21.89 66.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.138 0.975 . . . . 0.66 112.151 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.16 -23.49 63.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.38 0.991 . . . . 0.66 110.153 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 79' ' ' GLY . 2.9 mt-10 -80.93 130.13 34.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.654 -1.239 . . . . 0.66 107.654 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 147.6 4.35 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.335 1.054 . . . . 1.2 111.006 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -140.95 147.2 38.42 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.298 -1.001 . . . . 0.57 108.298 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -148.82 139.5 22.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.782 -0.821 . . . . 0.57 108.782 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.15 13.68 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.831 1.196 . . . . 0.66 111.553 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.03 -87.48 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 108.091 -2.004 . . . . 0.57 108.091 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.08 -67.12 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.301 2.24 . . . . 0.57 113.608 -176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -175.43 -48.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.855 1.662 . . . . 0.57 110.778 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -142.18 158.2 44.01 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.554 1.541 . . . . 0.57 108.993 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.53 178.66 15.86 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.299 1.428 . . . . 0.57 109.787 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.1 mm -80.45 102.89 6.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.241 -1.022 . . . . 0.57 108.241 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -50.97 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.925 1.69 . . . . 0.57 110.655 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -65.61 -29.18 69.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.985 1.714 . . . . 0.57 110.389 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -48.27 68.8 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.684 -1.598 . . . . 0.57 106.684 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.17 -47.49 84.27 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.483 0.713 . . . . 0.57 110.721 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.38 -49.45 76.15 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 122.745 0.418 . . . . 0.57 110.933 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.99 63.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 109.085 -0.709 . . . . 0.57 109.085 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -55.7 -39.28 70.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.022 0.828 . . . . 0.57 111.344 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -60.76 -59.88 4.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.324 0.65 . . . . 0.65 110.209 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.49 -42.37 95.9 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.177 0.898 . . . . 0.66 111.692 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.92 -26.96 67.11 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.136 1.375 . . . . 0.57 111.293 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.4 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.31 -41.88 93.27 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.29 -0.724 . . . . 0.57 111.29 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -73.01 -37.78 66.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.459 -1.258 . . . . 0.65 112.259 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 p -59.06 -31.58 69.0 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 124.101 0.875 . . . . 0.57 111.851 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -68.15 -39.89 82.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.328 0.651 . . . . 0.57 111.752 176.296 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 160.51 43.08 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.06 -0.856 . . . . 0.57 114.488 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 176.63 0.1 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 117.883 0.842 . . . . 0.57 111.925 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.09 46.12 0.01 OUTLIER Glycine 0 C--N 1.342 0.912 0 O-C-N 120.943 -1.098 . . . . 0.57 112.903 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.8 169.7 13.93 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.361 1.081 . . . . 0.65 110.4 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.6 t -161.65 -164.19 1.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.013 0.925 . . . . 0.57 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.07 57.26 0.59 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.897 1.279 . . . . 0.57 110.517 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -120.73 146.4 43.43 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.66 109.463 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -21.63 63.59 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.839 2.359 . . . . 0.57 113.056 -171.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -125.14 27.45 6.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.444 1.897 . . . . 0.57 109.602 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.89 124.61 24.18 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.145 -0.972 . . . . 0.57 108.916 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.05 -22.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 121.528 0.68 . . . . 0.57 110.461 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 19.08 18.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.098 1.759 . . . . 0.57 112.233 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.514 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.44 141.42 94.48 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.17 1.35 . . . . 0.57 111.288 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 70.8 Cg_endo -75.63 46.02 1.58 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 124.212 3.275 . . . . 0.57 113.007 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.29 153.14 7.71 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.77 2.428 . . . . 0.57 106.476 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -47.96 137.59 9.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.023 1.329 . . . . 0.57 111.265 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -47.14 99.75 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.705 1.621 . . . . 0.57 113.542 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.23 -37.41 77.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.063 1.345 . . . . 0.57 112.221 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.98 -85.87 0.95 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.27 0.938 . . . . 0.57 110.936 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.69 109.36 2.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.711 -0.848 . . . . 0.66 108.711 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.96 -16.4 18.18 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.807 2.338 . . . . 0.57 113.534 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -38.86 62.74 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.962 1.305 . . . . 0.57 109.125 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -77.57 74.08 4.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.79 0.836 . . . . 0.57 110.905 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -43.7 -70.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.791 1.637 . . . . 0.57 114.554 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 25.64 74.53 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.512 3.125 . . . . 0.57 112.071 177.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -30.93 111.78 0.08 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.529 2.331 . . . . 0.57 110.777 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 t -83.87 -99.71 0.05 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.181 0.301 . . . . 0.57 111.074 -166.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -127.75 -49.93 1.37 Allowed 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 117.216 -1.373 . . . . 0.57 109.443 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -44.07 -45.11 7.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.014 1.326 . . . . 0.66 112.116 169.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -66.43 -54.8 20.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 123.728 0.642 . . . . 0.66 109.995 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -37.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.418 0.687 . . . . 0.57 110.727 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -65.95 -45.41 81.89 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.664 1.586 . . . . 0.57 108.504 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.93 -51.02 61.21 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.204 -1.158 . . . . 0.57 110.204 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -56.46 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.488 1.115 . . . . 0.57 111.136 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.404 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 3.9 pt20 -62.74 -24.46 67.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.112 0.869 . . . . 0.57 111.517 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -37.02 36.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.25 -0.881 . . . . 0.57 110.889 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -54.7 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.661 1.585 . . . . 0.57 110.942 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.407 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 19.3 p90 . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 123.854 0.862 . . . . 0.57 113.159 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 111.021 -0.415 . . . . 0.57 111.021 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt 72.03 100.8 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.242 1.417 . . . . 0.57 109.715 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -53.08 157.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.045 0.938 . . . . 0.57 111.755 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.3 p -67.58 -19.54 65.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.875 1.27 . . . . 0.57 112.083 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -109.67 144.53 37.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.68 1.992 . . . . 0.57 108.75 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -12.39 61.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.304 1.442 . . . . 0.57 113.167 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.75 134.1 67.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.799 -1.926 . . . . 0.57 105.799 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.48 155.15 19.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.23 1.412 . . . . 0.57 108.621 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 p -106.54 141.22 38.18 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.912 -0.493 . . . . 0.57 109.774 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -132.75 158.24 42.91 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.596 -0.69 . . . . 0.57 111.0 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.42 163.15 40.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.687 0.795 . . . . 1.2 109.149 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.9 mt -127.93 105.08 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.199 -2.149 . . . . 0.57 105.199 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.85 -57.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.106 . . . . 0.57 112.385 -169.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -177.14 4.76 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.195 -1.409 . . . . 0.57 107.195 164.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -144.58 152.03 39.93 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.314 -0.995 . . . . 0.57 108.314 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -62.37 165.35 6.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.314 0.578 . . . . 0.57 110.938 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -100.25 -47.09 5.07 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.841 -0.618 . . . . 1.2 112.053 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.78 -32.61 73.81 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.031 0.532 . . . . 0.66 110.387 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.96 153.71 52.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.96 1.704 . . . . 0.57 109.652 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.57 161.29 37.3 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.145 1.897 . . . . 0.57 113.182 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.33 -40.6 94.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.659 1.184 . . . . 0.65 112.89 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.98 -35.95 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 119.181 -0.438 . . . . 0.57 111.155 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m -67.36 -45.65 75.69 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 117.688 -1.149 . . . . 0.57 109.264 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.25 -49.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 117.646 -1.169 . . . . 0.57 110.699 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.16 -35.93 82.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.1 1.318 . . . . 0.66 111.364 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -43.4 89.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.289 1.404 . . . . 1.2 112.524 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.95 -48.34 76.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.592 -0.892 . . . . 0.57 108.592 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.0 -41.63 89.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.719 -1.134 . . . . 0.57 111.021 173.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -58.48 -53.11 62.02 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.548 1.522 . . . . 0.57 110.056 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -36.06 78.52 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.679 1.127 . . . . 0.57 111.054 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.64 76.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.557 1.071 . . . . 0.57 111.76 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.38 -36.17 83.18 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 118.213 -0.898 . . . . 0.57 110.163 172.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -49.05 76.82 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 118.899 0.772 . . . . 0.57 109.153 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.442 ' HB3' HD11 ' A' ' 152' ' ' LEU . 50.4 mtp -61.73 -35.91 79.44 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.544 0.738 . . . . 0.57 111.498 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 10.5 m95 -68.61 -50.59 50.34 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.57 112.369 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.25 -8.09 69.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.885 1.231 . . . . 0.57 112.99 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -75.17 -8.31 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.214 -1.168 . . . . 0.57 111.765 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB3' HG21 ' A' ' 160' ' ' ILE . 55.4 mm-40 -109.54 -15.32 14.22 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.842 0.746 . . . . 0.66 112.259 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 160' ' ' ILE . 6.6 pt -142.58 148.75 48.03 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.52 1.128 . . . . 0.57 111.019 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.89 18.69 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.714 2.943 . . . . 0.57 113.286 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.91 138.22 35.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.16 1.784 . . . . 0.57 107.314 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.95 170.31 11.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.766 0.826 . . . . 0.65 109.217 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.35 150.85 45.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.271 -1.381 . . . . 0.57 107.271 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.85 149.42 46.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.866 -0.79 . . . . 1.2 108.866 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -107.24 129.26 54.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.031 -1.47 . . . . 0.57 107.031 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.43 171.84 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.533 1.133 . . . . 0.57 109.823 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.45 -38.77 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.769 0.828 . . . . 0.57 110.651 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -167.25 74.63 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.888 1.675 . . . . 0.57 107.694 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.35 163.06 36.84 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.511 -1.836 . . . . 0.57 108.511 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -68.63 144.98 54.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 117.987 0.893 . . . . 0.57 109.275 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.24 153.17 37.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.1 0.96 . . . . 0.57 108.96 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.64 -32.97 72.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.772 0.429 . . . . 0.66 110.069 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 125' ' ' SER . 7.3 mt -121.01 80.97 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 127.513 2.325 . . . . 0.57 107.871 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 ttm -78.02 111.85 14.33 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.805 1.242 . . . . 0.57 107.956 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 127.66 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.052 -1.832 . . . . 0.57 106.052 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.62 162.85 25.52 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.226 -0.75 . . . . 0.57 111.226 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -126.95 141.42 51.81 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.29 -1.744 . . . . 0.57 106.29 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.18 169.17 18.71 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.098 2.159 . . . . 0.57 106.8 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -111.02 -0.95 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.715 0.689 . . . . 1.2 112.652 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.32 -144.58 8.29 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.53 -1.828 . . . . 0.57 108.53 -165.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.49 142.64 13.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.746 0.784 . . . . 0.57 111.398 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -152.05 152.49 32.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.094 1.758 . . . . 0.65 106.562 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.35 80.48 1.82 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 110.155 -1.178 . . . . 0.57 110.155 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.6 -56.52 1.49 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.794 0.837 . . . . 0.66 111.343 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.95 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.959 2.503 . . . . 0.57 109.854 -167.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -147.57 123.1 5.28 Favored Pre-proline 0 C--N 1.349 0.545 0 CA-C-N 120.122 1.328 . . . . 0.57 110.437 -173.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.75 139.32 52.04 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.188 1.259 . . . . 0.57 110.367 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.83 -175.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.365 1.555 . . . . 0.57 111.161 167.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -115.12 -36.02 4.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 131.116 3.767 . . . . 0.66 109.75 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.11 -147.9 18.81 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 119.659 1.118 . . . . 0.57 110.841 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.65 70.3 6.45 Favored 'Trans proline' 0 CA--C 1.548 1.198 1 C-N-CA 125.645 4.23 . . . . 0.57 114.114 -171.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.41 167.07 20.43 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.409 2.909 . . . . 0.57 109.625 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.279 19.6 t30 64.81 -143.97 0.24 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.304 1.842 . . . . 0.57 113.503 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 m -47.03 153.23 0.45 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 127.767 2.427 . . . . 0.57 111.22 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.88 -27.47 6.18 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 118.572 -2.58 . . . . 0.57 112.759 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.61 158.48 26.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.01 1.324 . . . . 0.57 107.644 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -139.38 159.17 42.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.478 . . . . 0.65 109.711 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.87 36.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.741 1.216 . . . . 0.57 109.078 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.57 146.83 41.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.348 0.659 . . . . 0.57 109.495 -177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.84 157.89 64.84 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.795 0.838 . . . . 0.57 111.031 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.41 155.45 69.12 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.272 . . . . 0.57 112.188 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.07 -111.67 0.59 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.388 0.994 . . . . 0.57 110.891 174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.7 m -45.76 156.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.854 2.062 . . . . 0.57 111.542 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.93 -41.97 7.68 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.174 -1.348 . . . . 0.57 115.412 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -33.55 74.39 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.075 1.438 . . . . 0.57 112.247 174.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.26 145.5 12.21 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.873 -1.142 . . . . 0.57 111.498 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.86 -18.93 5.53 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 117.847 -1.529 . . . . 0.57 114.426 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.78 156.24 36.76 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.348 1.574 . . . . 0.66 108.045 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.06 146.05 27.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.787 -0.642 . . . . 0.57 109.818 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -129.81 152.28 49.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.575 -0.898 . . . . 0.65 108.575 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -137.91 145.37 42.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.16 1.384 . . . . 0.57 107.38 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -87.07 98.63 11.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.425 0.631 . . . . 0.66 109.608 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -60.84 -25.61 66.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.07 1.348 . . . . 0.66 111.85 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.39 -38.85 81.71 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.92 0.391 . . . . 0.66 110.406 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.16 126.7 29.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.771 -1.566 . . . . 0.66 106.771 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -59.01 147.16 35.61 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.702 -0.624 . . . . 1.2 109.473 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -124.03 158.21 32.68 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.359 -0.978 . . . . 0.57 108.359 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.2 t -133.54 142.34 48.14 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.635 0.652 . . . . 0.57 109.681 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.05 -46.89 72.99 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.046 1.339 . . . . 0.66 109.275 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.96 50.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.858 -0.897 . . . . 0.57 110.858 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -152.84 150.34 29.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.965 0.906 . . . . 0.57 109.854 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.17 108.37 0.78 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.615 0.766 . . . . 0.57 109.814 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -61.69 0.05 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.726 0.81 . . . . 0.57 110.213 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.98 -111.75 1.19 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.714 -1.354 . . . . 0.57 109.714 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.565 HG22 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -129.95 134.39 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 123.653 0.781 . . . . 0.57 110.271 -178.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.85 115.77 5.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.777 -1.102 . . . . 0.57 109.697 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.67 -37.32 83.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.047 -0.501 . . . . 0.57 110.895 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 -45.35 89.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.129 0.877 . . . . 0.57 109.673 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -64.03 -42.56 97.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.384 0.674 . . . . 0.57 110.791 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.86 67.99 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.215 0.606 . . . . 0.57 110.516 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.43 64.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.063 -0.97 . . . . 0.57 110.053 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.1 m -53.78 -41.74 67.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.512 1.051 . . . . 0.57 111.46 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -61.48 -56.36 21.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.819 0.448 . . . . 0.65 110.023 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.43 -48.08 74.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.734 0.814 . . . . 0.66 110.963 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.74 -30.77 70.99 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 125.312 1.445 . . . . 0.57 110.968 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.402 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.68 -46.81 73.66 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.913 -0.875 . . . . 0.57 110.913 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -66.27 -39.33 89.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.752 -0.642 . . . . 0.65 111.646 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.403 ' HB3' HG12 ' A' ' 60' ' ' ILE . 4.4 m -57.78 -37.37 73.59 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.524 0.565 . . . . 0.57 112.524 176.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.37 -27.22 68.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.737 1.153 . . . . 0.57 112.638 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.98 -13.97 2.37 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 118.529 -1.15 . . . . 0.57 114.285 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpp -61.79 152.25 31.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.168 1.484 . . . . 0.57 110.295 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.56 -23.6 3.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 115.58 -2.789 . . . . 0.57 114.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 m80 148.99 173.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 131.185 3.794 . . . . 0.65 110.151 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -145.33 -172.77 3.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.484 2.313 . . . . 0.57 109.607 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -147.12 67.33 1.15 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.43 1.492 . . . . 0.57 110.761 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 9.7 t70 -133.5 149.98 73.74 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 117.306 -1.33 . . . . 0.66 107.604 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.86 -35.96 42.01 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.927 1.752 . . . . 0.57 111.091 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -119.01 35.23 4.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.754 1.222 . . . . 0.57 108.394 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -63.62 131.98 49.71 Favored 'General case' 0 C--N 1.344 0.363 0 N-CA-C 108.156 -1.053 . . . . 0.57 108.156 171.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' A' ' 156' ' ' ASP . 8.5 p -58.7 -30.33 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.592 0.234 . . . . 0.57 110.986 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.683 ' SD ' HG13 ' A' ' 137' ' ' VAL . 4.2 mpp? -105.58 35.19 2.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.044 1.337 . . . . 0.57 110.075 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -74.46 130.3 82.26 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 120.433 -1.417 . . . . 0.57 110.875 173.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.34 168.64 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.962 1.775 . . . . 0.57 111.056 166.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m 58.03 72.93 0.49 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.113 0.965 . . . . 0.57 110.792 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.565 ' CE2' HG22 ' A' ' 112' ' ' ILE . 63.1 t80 -45.61 126.08 6.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.043 1.337 . . . . 0.57 113.175 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.01 96.43 0.89 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.095 0.855 . . . . 0.57 111.201 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -157.42 -49.88 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.022 0.911 . . . . 0.57 111.03 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.88 -171.33 13.05 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 125.595 1.569 . . . . 0.57 109.575 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.02 116.54 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 119.092 -0.48 . . . . 0.66 110.053 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.08 -18.03 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.853 2.369 . . . . 0.57 112.671 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.24 -36.63 83.52 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.002 0.819 . . . . 0.57 109.936 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.15 68.87 1.23 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.342 0.657 . . . . 0.57 109.507 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -60.04 -52.69 64.29 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.488 0.715 . . . . 0.57 110.323 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.94 158.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.991 2.517 . . . . 0.57 112.567 -159.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 41' ' ' MET . 5.4 mp -58.95 121.49 11.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.593 -1.262 . . . . 0.57 107.593 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -96.83 -94.25 0.21 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.787 1.235 . . . . 0.57 110.545 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -138.24 -46.44 0.51 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.08 -0.962 . . . . 0.57 110.273 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.38 -34.09 66.35 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.75 0.705 . . . . 0.66 111.02 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.71 ' CG ' HG11 ' A' ' 137' ' ' VAL . 0.7 OUTLIER -63.15 -60.18 3.77 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.571 1.148 . . . . 0.66 110.305 176.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.84 -50.47 80.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.57 107.756 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -59.3 -41.69 89.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.394 1.077 . . . . 0.57 111.476 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.69 50.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.456 -1.457 . . . . 0.57 109.456 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.459 HG21 ' HB3' ' A' ' 45' ' ' GLU . 1.7 mm -53.91 -52.99 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.259 1.023 . . . . 0.57 110.482 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -58.5 -28.63 65.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.086 -0.709 . . . . 0.57 109.086 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -80.64 -38.9 28.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 117.921 -1.038 . . . . 0.57 112.428 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.62 -52.06 61.08 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.322 1.419 . . . . 0.57 112.174 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.0 p90 . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 118.487 0.585 . . . . 0.57 112.38 179.716 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 110.751 -0.519 . . . . 0.57 110.751 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.89 10.88 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.216 2.206 . . . . 0.57 112.432 -173.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 56.5 m95 56.37 -166.01 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.656 1.183 . . . . 0.57 110.584 -169.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -101.53 -10.85 19.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.782 0.833 . . . . 0.57 110.97 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -118.8 149.58 41.26 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.423 1.489 . . . . 0.57 108.705 176.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -71.96 -11.83 60.96 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.448 0.699 . . . . 0.57 112.575 172.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.26 117.25 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.035 -1.839 . . . . 0.57 106.035 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.85 141.23 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.365 -0.976 . . . . 0.57 108.365 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -102.49 147.63 26.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.648 0.658 . . . . 0.57 111.238 -177.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -128.96 157.1 42.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.568 0.747 . . . . 0.57 111.884 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.88 112.13 4.95 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.597 0.713 . . . . 1.2 110.159 174.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 mt -77.68 82.69 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.233 -1.395 . . . . 0.57 107.233 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.05 -28.62 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.129 1.772 . . . . 0.57 113.458 -175.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -139.58 154.42 47.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 128.925 2.89 . . . . 0.57 103.604 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -132.16 174.67 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.703 1.601 . . . . 0.57 108.203 -173.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -90.82 -176.39 4.66 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.921 0.888 . . . . 0.57 111.399 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -129.62 -26.62 2.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.364 1.866 . . . . 1.2 113.651 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -24.0 67.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.725 0.81 . . . . 0.66 110.86 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.83 154.99 71.35 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 127.464 2.306 . . . . 0.57 108.582 177.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -75.58 158.51 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.189 2.592 . . . . 0.57 113.047 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -62.23 -34.6 76.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.953 1.301 . . . . 0.65 112.66 -176.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.46 -37.64 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.004 0.522 . . . . 0.57 110.251 175.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.4 m -67.59 -39.56 84.83 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 117.955 -1.021 . . . . 0.57 109.54 173.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.69 -56.1 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.769 1.168 . . . . 0.57 110.126 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.64 -34.95 78.1 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.631 1.105 . . . . 0.66 111.031 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.25 -48.89 63.87 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.087 0.858 . . . . 1.2 112.066 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -63.97 -43.67 95.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.815 -0.809 . . . . 0.57 108.815 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.3 -44.28 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 117.599 -1.191 . . . . 0.57 110.807 171.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -50.25 73.45 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 120.274 1.397 . . . . 0.57 110.894 178.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -34.86 73.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.167 0.894 . . . . 0.57 112.268 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.98 81.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.745 1.157 . . . . 0.57 111.153 177.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HD12 ' A' ' 122' ' ' LEU . 38.7 mt -67.83 -37.84 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.471 -0.776 . . . . 0.57 110.218 173.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.73 -37.41 84.11 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 119.009 0.822 . . . . 0.57 110.654 172.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 mtp -64.36 -36.93 85.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.077 0.853 . . . . 0.57 112.189 173.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -69.76 -49.36 53.83 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.251 0.932 . . . . 0.57 110.89 172.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.73 -5.1 63.41 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.983 1.278 . . . . 0.57 113.786 178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -67.99 -26.1 65.75 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.095 -1.238 . . . . 0.57 110.888 172.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -100.35 -36.72 9.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.541 0.737 . . . . 0.66 110.855 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 12.9 pt -114.05 136.81 22.21 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 118.569 0.622 . . . . 0.57 110.819 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 34.21 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.676 2.917 . . . . 0.57 111.912 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 126' ' ' LEU . 1.6 tt -85.42 131.95 34.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.311 -1.737 . . . . 0.57 106.311 176.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -116.0 171.08 8.01 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.803 1.241 . . . . 0.65 108.509 -173.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.85 156.1 45.54 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.747 -0.834 . . . . 0.57 108.747 -170.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -142.61 175.92 9.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.91 . . . . 1.2 109.273 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.6 16.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.57 108.23 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.76 158.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 124.671 1.188 . . . . 0.57 109.219 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.44 -41.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.353 0.661 . . . . 0.57 111.256 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -118.57 -66.34 1.08 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.939 0.876 . . . . 0.57 108.891 -172.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.38 -156.57 10.89 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.616 -1.793 . . . . 0.57 108.616 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 80.4 p 60.28 72.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.69 1.596 . . . . 0.57 111.826 173.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.67 172.37 7.16 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.351 1.06 . . . . 0.57 112.012 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -71.55 -39.44 70.65 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.274 -1.01 . . . . 0.66 108.274 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.14 84.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.58 1.952 . . . . 0.57 108.641 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.23 124.58 27.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.458 -1.401 . . . . 0.57 108.417 170.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.55 127.85 66.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 106.269 -1.752 . . . . 0.57 106.269 174.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.09 164.91 27.48 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.833 -0.507 . . . . 0.57 111.833 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.7 m-85 -136.03 150.65 49.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.609 -0.886 . . . . 0.57 108.609 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.29 157.67 44.15 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.754 1.221 . . . . 0.57 110.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -5.28 24.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.498 1.119 . . . . 1.2 113.443 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.47 106.85 0.49 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 108.341 -1.904 . . . . 0.57 108.341 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.12 126.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.062 2.945 . . . . 0.57 112.741 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 163.49 30.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.732 1.213 . . . . 0.65 110.909 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 76.68 0.9 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 173.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -135.15 177.58 7.7 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.66 110.157 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -44.47 12.61 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.296 1.038 . . . . 0.57 112.043 168.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -139.24 145.91 46.65 Favored Pre-proline 0 C--N 1.345 0.374 0 C-N-CA 124.026 0.93 . . . . 0.57 109.401 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.47 146.95 76.17 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.235 1.29 . . . . 0.57 110.29 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -178.95 1.04 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.908 1.337 . . . . 0.57 111.428 162.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -117.4 -35.07 4.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 131.181 3.793 . . . . 0.66 109.332 -172.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 -140.9 15.6 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.561 -1.133 . . . . 0.57 110.689 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.96 87.06 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.894 3.73 . . . . 0.57 112.575 -171.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.29 172.56 12.92 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.446 1.974 . . . . 0.57 109.539 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 48.7 -153.5 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 119.432 1.616 . . . . 0.57 111.848 -174.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.3 m -48.64 126.52 11.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.716 2.406 . . . . 0.57 112.908 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.02 -27.4 17.02 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.234 1.414 . . . . 0.57 113.45 -173.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.93 161.83 40.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.702 1.201 . . . . 0.57 108.344 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.96 163.34 37.16 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.029 -0.36 . . . . 0.65 110.029 174.202 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.73 163.19 37.46 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.244 1.018 . . . . 0.57 110.438 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.23 161.84 18.38 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.144 0.978 . . . . 0.57 110.653 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.83 142.83 45.6 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-O 118.224 -0.893 . . . . 0.57 109.383 -176.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.6 Cg_endo -66.31 156.83 63.16 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.528 1.485 . . . . 0.57 110.893 175.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.9 9.18 8.38 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.968 0.794 . . . . 0.57 113.81 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.1 t -160.78 168.49 24.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.823 1.649 . . . . 0.57 107.993 176.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.89 -57.78 16.56 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 125.591 1.567 . . . . 0.57 113.079 -177.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tp -66.09 -17.61 64.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.395 1.078 . . . . 0.57 110.997 173.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.0 147.79 33.5 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 120.776 -1.202 . . . . 0.57 110.793 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.32 -21.31 0.54 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.571 1.558 . . . . 0.57 115.119 -176.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.07 153.6 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.776 1.288 . . . . 0.66 108.156 -175.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.09 144.87 29.38 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.57 109.083 -171.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -131.84 159.23 39.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.371 -0.831 . . . . 0.65 109.304 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 52.2 m-85 -137.65 147.19 44.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.821 1.648 . . . . 0.57 109.002 -171.236 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.29 105.46 12.49 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.916 -0.772 . . . . 0.66 108.916 171.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.19 -27.66 64.07 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.468 1.107 . . . . 0.66 111.069 171.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.62 -33.94 75.98 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.827 0.851 . . . . 0.66 111.282 -178.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.84 120.55 20.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.767 -1.568 . . . . 0.66 106.767 178.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 131.42 48.41 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.362 0.528 . . . . 1.2 110.699 -174.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.78 150.54 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.082 -1.081 . . . . 0.57 108.082 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -145.06 145.72 31.57 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.92 -0.77 . . . . 0.57 108.92 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.21 -39.73 93.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.164 0.986 . . . . 0.66 112.052 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.05 173.42 27.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.934 1.254 . . . . 0.57 110.034 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.13 30.29 5.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.681 1.192 . . . . 0.57 114.174 176.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.04 168.63 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.828 1.651 . . . . 0.57 109.315 -174.44 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.09 167.27 10.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.005 1.322 . . . . 0.57 111.706 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.81 -160.97 22.64 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.434 -1.466 . . . . 0.57 109.434 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.71 122.84 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.889 -1.152 . . . . 0.57 107.889 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -55.53 105.23 0.16 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.184 1.394 . . . . 0.57 109.999 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.75 -36.41 76.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.628 1.971 . . . . 0.57 110.989 178.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.2 tp -71.12 -40.74 71.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.312 0.505 . . . . 0.57 109.931 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.09 -44.31 96.93 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.473 0.709 . . . . 0.57 109.375 173.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.23 -54.71 42.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.57 110.043 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.75 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 117.891 -1.052 . . . . 0.57 109.184 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.8 m -53.64 -43.99 69.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.116 1.325 . . . . 0.57 111.452 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -64.32 -55.17 23.08 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.844 1.202 . . . . 0.65 110.62 176.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.2 -39.66 86.38 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.412 -0.805 . . . . 0.66 111.474 -172.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.65 -30.71 71.73 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.462 0.705 . . . . 0.57 110.628 176.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.71 -43.96 60.17 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 119.194 0.906 . . . . 0.57 111.411 170.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -74.86 -33.53 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.734 -0.65 . . . . 0.65 112.452 176.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -33.58 75.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.837 0.744 . . . . 0.57 111.428 174.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 48' ' ' LEU . 1.6 mm? -66.13 -29.55 69.88 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.325 0.65 . . . . 0.57 112.053 175.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 153.09 56.07 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.292 -1.282 . . . . 0.57 113.202 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 mmt 48.99 -156.14 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.936 0.868 . . . . 0.57 111.475 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.82 81.11 1.22 Allowed Glycine 0 C--O 1.219 -0.842 0 N-CA-C 108.703 -1.759 . . . . 0.57 108.703 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.31 172.09 8.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.833 0.817 . . . . 0.65 109.847 172.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.99 -177.3 6.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.853 2.061 . . . . 0.57 107.946 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 99.24 3.04 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.188 -2.153 . . . . 0.57 105.188 173.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.9 141.37 17.31 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 107.861 -1.163 . . . . 0.66 107.861 170.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.59 -4.5 14.72 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.935 2.423 . . . . 0.57 113.73 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.31 13.7 7.7 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.121 1.768 . . . . 0.57 111.23 -174.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.82 40.73 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.327 1.851 . . . . 0.57 109.866 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.98 -28.95 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.969 0.804 . . . . 0.57 110.313 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 35.1 tpp -74.46 -11.37 60.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.404 1.082 . . . . 0.57 113.33 -174.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.35 136.29 41.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.461 -0.57 . . . . 0.57 109.461 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 -169.28 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.973 1.782 . . . . 0.57 109.432 168.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.0 p 50.22 79.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.209 1.404 . . . . 0.57 114.224 172.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -56.18 93.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.525 1.53 . . . . 0.57 113.832 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.4 109.96 0.43 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.841 1.686 . . . . 0.57 109.59 -177.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -170.14 -50.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.885 1.674 . . . . 0.57 108.582 169.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.52 -122.57 3.16 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.084 -1.606 . . . . 0.57 109.084 -177.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -147.01 124.1 5.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.65 -0.871 . . . . 0.66 108.65 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -80.53 -8.17 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.948 3.098 . . . . 0.57 114.166 177.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -67.15 -27.36 67.23 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.578 -1.326 . . . . 0.57 110.738 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.83 80.47 1.38 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.11 1.364 . . . . 0.57 111.199 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.47 148.0 38.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.578 1.551 . . . . 0.57 109.629 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.2 47.54 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.47 1.108 . . . . 0.57 111.213 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 61.85 79.27 0.26 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.968 1.307 . . . . 0.57 111.581 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -64.46 -86.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.206 1.187 . . . . 0.57 114.206 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -138.42 -46.04 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.57 110.058 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -45.81 64.28 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.265 1.026 . . . . 0.66 110.654 172.131 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -53.71 55.05 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.708 0.63 . . . . 0.66 109.955 177.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.12 -45.98 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.22 1.008 . . . . 0.57 110.071 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -47.53 76.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.908 1.283 . . . . 0.57 109.459 -178.029 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.71 97.19 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.924 -1.27 . . . . 0.57 109.924 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -51.18 74.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.53 1.165 . . . . 0.57 110.282 175.212 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.78 -37.81 77.12 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.902 0.481 . . . . 0.57 110.204 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -39.01 73.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.101 -0.952 . . . . 0.57 111.916 175.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -58.92 5.46 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.731 2.012 . . . . 0.57 109.999 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.4 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.9 p90 . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 120.264 -0.574 . . . . 0.57 111.779 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.448 -1.161 0 N-CA-C 110.97 -0.435 . . . . 0.57 110.97 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt 80.7 115.69 0.06 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.022 2.129 . . . . 0.57 108.296 -177.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 79.7 m95 -58.54 163.53 3.12 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.243 1.021 . . . . 0.57 111.939 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -69.31 -31.95 70.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.565 0.746 . . . . 0.57 111.521 -174.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 t -123.65 150.49 44.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.39 2.276 . . . . 0.57 107.264 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -71.97 3.02 4.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.283 -0.865 . . . . 0.57 112.142 171.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -121.86 108.24 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.984 -1.488 . . . . 0.57 106.984 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.71 143.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 107.964 -1.125 . . . . 0.57 107.964 -172.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.1 p -97.32 152.6 18.74 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.644 -0.66 . . . . 0.57 110.455 -176.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -131.21 157.83 42.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.948 -1.095 . . . . 0.57 110.681 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 14.9 ptt180 -144.73 119.11 9.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.425 0.69 . . . . 1.2 109.491 174.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.12 86.13 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 105.165 -2.161 . . . . 0.57 105.165 176.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.07 -38.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.539 1.935 . . . . 0.57 110.728 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -152.61 164.3 37.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.309 -2.108 . . . . 0.57 105.309 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -132.1 169.09 16.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.812 1.645 . . . . 0.57 106.82 -172.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.1 t -72.0 -168.07 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.57 111.203 171.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -43.51 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 1.2 113.463 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -60.78 -41.78 96.23 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.033 -0.729 . . . . 0.66 109.033 -177.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.4 150.32 38.81 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 124.055 0.942 . . . . 0.57 111.26 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -75.14 158.11 41.82 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.561 2.174 . . . . 0.57 112.444 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 30.9 m-70 -61.71 -38.62 88.53 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.59 1.156 . . . . 0.65 112.536 -176.296 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.33 -40.96 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.77 -0.456 . . . . 0.57 109.77 174.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -68.68 -38.9 80.71 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.237 -1.364 . . . . 0.57 109.371 176.16 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.11 -53.55 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.875 1.671 . . . . 0.57 110.053 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.0 -41.24 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.823 0.738 . . . . 0.66 111.154 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -46.8 86.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 118.549 0.613 . . . . 1.2 111.719 178.042 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.6 mp -62.57 -44.81 95.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 116.598 -1.668 . . . . 0.57 107.797 175.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.95 -47.04 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 121.049 1.749 . . . . 0.57 110.698 174.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -48.6 76.44 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.949 0.795 . . . . 0.57 109.303 -178.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -69.62 -36.88 76.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.842 0.857 . . . . 0.57 112.104 -177.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.44 74.81 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 126.83 2.052 . . . . 0.57 109.847 174.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 122' ' ' LEU . 21.9 mt -66.58 -33.42 75.64 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 118.505 -0.759 . . . . 0.57 111.03 174.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -60.24 -33.87 72.89 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.383 -0.818 . . . . 0.57 109.605 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.9 mtm -69.64 -23.5 63.49 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 115.925 -1.988 . . . . 0.57 113.281 175.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -84.45 -34.51 23.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.529 1.513 . . . . 0.57 111.157 169.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.95 83.0 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.839 -1.163 . . . . 0.57 112.236 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.25 -25.98 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 120.825 -1.397 . . . . 0.57 111.13 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -100.35 -29.84 12.19 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.147 -0.93 . . . . 0.66 111.468 176.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 160' ' ' ILE . 29.8 pt -122.7 131.23 24.4 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 119.364 0.984 . . . . 0.57 111.255 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.11 43.39 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.694 2.93 . . . . 0.57 112.234 178.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 126' ' ' LEU . 5.8 tt -82.73 145.33 29.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.146 1.378 . . . . 0.57 108.593 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -126.78 162.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.315 1.046 . . . . 0.65 108.208 -175.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 152.97 41.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.002 -1.481 . . . . 0.57 107.002 -169.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 171.31 14.67 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.105 0.962 . . . . 1.2 109.083 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -115.04 163.93 14.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.976 -0.75 . . . . 0.57 108.976 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.47 171.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.738 1.215 . . . . 0.57 109.94 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -115.74 36.26 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.077 0.951 . . . . 0.57 111.46 -171.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 92.02 107.5 0.03 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 128.739 2.816 . . . . 0.57 108.99 -177.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.98 -124.41 1.43 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.078 -1.609 . . . . 0.57 109.078 -173.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.9 p -138.0 143.17 40.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.39 0.676 . . . . 0.57 109.803 -171.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.647 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . . . -135.22 -177.33 4.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.056 1.743 . . . . 0.57 109.357 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 35.9 m-20 -83.74 -39.78 19.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.544 0.738 . . . . 0.66 110.88 -177.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 122' ' ' LEU . 12.9 mt -116.05 79.98 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.306 1.442 . . . . 0.57 107.213 -175.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -78.86 126.62 30.94 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.695 -1.253 . . . . 0.57 108.998 171.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.17 124.98 66.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.616 -1.994 . . . . 0.57 105.616 173.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.97 162.94 27.45 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.221 -0.752 . . . . 0.57 111.221 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.77 148.01 46.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.994 -1.113 . . . . 0.57 107.994 -175.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.61 179.86 6.58 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 125.936 1.694 . . . . 0.57 110.291 -175.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 71.2 1.4 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 122.487 1.137 . . . . 1.2 108.422 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.37 -65.14 0.78 Allowed Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.311 -1.115 . . . . 0.57 110.311 -178.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.95 159.5 33.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.863 1.832 . . . . 0.57 110.963 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -157.87 155.19 29.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.628 1.171 . . . . 0.65 108.923 -178.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.98 52.13 3.94 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.733 1.635 . . . . 0.57 112.752 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -109.68 -77.18 0.6 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.533 1.133 . . . . 0.66 108.411 -176.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -177.93 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.767 1.227 . . . . 0.57 110.107 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -130.43 99.13 19.43 Favored Pre-proline 0 C--N 1.344 0.357 0 N-CA-C 108.523 -0.917 . . . . 0.57 108.523 -174.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 141.71 72.63 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 109.199 -1.116 . . . . 0.57 109.199 174.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -61.85 177.3 0.45 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.192 1.472 . . . . 0.57 111.041 167.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -99.34 -37.41 9.25 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.694 1.998 . . . . 0.66 110.855 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.41 -150.11 18.19 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 120.461 1.482 . . . . 0.57 112.422 -172.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.01 81.77 1.63 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.744 3.63 . . . . 0.57 112.949 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.17 -168.29 37.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.756 1.646 . . . . 0.57 110.705 176.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 41.72 -137.1 0.21 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.307 1.443 . . . . 0.57 113.788 167.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -59.42 123.53 17.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.938 2.095 . . . . 0.57 110.936 174.004 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.93 -28.81 13.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.7 1.2 . . . . 0.57 113.21 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.72 159.09 36.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.817 -1.179 . . . . 0.57 107.817 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -143.7 156.57 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.65 109.306 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.42 35.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.364 0.665 . . . . 0.57 109.592 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -117.05 153.15 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.673 -0.862 . . . . 0.57 108.673 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 158.89 50.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.97 -1.014 . . . . 0.57 110.835 176.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 28.2 Cg_endo -69.79 161.46 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.438 2.092 . . . . 0.57 112.175 177.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.06 -127.18 1.29 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.078 -2.009 . . . . 0.57 108.078 -177.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.9 m -141.38 99.22 3.52 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 106.193 -1.78 . . . . 0.57 106.193 -178.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.37 -125.62 6.34 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.177 -1.569 . . . . 0.57 109.177 176.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -51.52 -35.43 40.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.425 1.09 . . . . 0.57 111.842 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.17 136.97 8.32 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.574 -0.704 . . . . 0.57 112.316 176.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.03 -22.15 8.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 126.384 1.945 . . . . 0.57 114.464 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -68.47 151.83 46.26 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.651 -1.24 . . . . 0.66 107.651 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.05 147.7 32.88 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.374 1.069 . . . . 0.57 108.973 -172.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -131.62 154.66 48.66 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.888 -1.051 . . . . 0.65 108.523 -178.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.47 151.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.825 -1.176 . . . . 0.57 107.825 -171.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.26 94.9 9.4 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.874 -1.158 . . . . 0.66 107.874 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.81 -28.11 46.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.654 1.582 . . . . 0.66 111.256 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.87 -36.27 81.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.181 0.593 . . . . 0.66 110.79 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.71 130.55 43.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.918 -1.142 . . . . 0.66 107.918 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -57.49 140.95 49.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.249 0.547 . . . . 1.2 110.66 178.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -123.68 150.15 44.61 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.927 -1.508 . . . . 0.57 106.927 178.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -137.84 147.76 44.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.019 -1.104 . . . . 0.57 108.019 175.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.72 -54.0 48.51 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.343 0.974 . . . . 0.66 108.684 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.81 72.73 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.437 -1.465 . . . . 0.57 109.437 -169.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.3 p -159.44 151.22 20.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.218 0.607 . . . . 0.57 109.668 173.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 m -67.66 87.2 0.22 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.007 0.923 . . . . 0.57 110.604 174.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.33 -55.47 0.06 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 125.989 1.716 . . . . 0.57 111.406 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.47 -147.87 7.41 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.211 -1.156 . . . . 0.57 110.211 -176.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.61 124.7 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.437 -1.32 . . . . 0.57 107.437 -177.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.86 107.63 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.319 1.048 . . . . 0.57 109.822 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -60.28 -47.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.391 1.476 . . . . 0.57 110.337 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD13 ' HG ' ' A' ' 34' ' ' LEU . 12.5 tp -56.72 -44.76 81.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.351 -0.981 . . . . 0.57 108.351 -177.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -72.92 -41.73 64.25 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.36 0.664 . . . . 0.57 110.578 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.35 74.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.609 0.764 . . . . 0.57 109.951 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.86 -56.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 118.289 -0.862 . . . . 0.57 109.486 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.5 m -51.89 -36.57 49.15 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.686 1.13 . . . . 0.57 112.522 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.7 t60 -64.12 -61.53 2.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.95 -43.11 99.52 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.462 -0.773 . . . . 0.66 111.036 -172.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 39' ' ' LEU . 4.1 mm? -61.63 -32.76 72.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.543 1.537 . . . . 0.57 112.027 177.319 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.84 -44.95 81.45 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.634 -0.986 . . . . 0.57 110.634 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -67.02 -44.21 80.86 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 118.479 -0.772 . . . . 0.65 111.885 175.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.3 m -53.7 -38.52 64.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 123.755 0.659 . . . . 0.57 111.085 176.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -61.77 -38.31 87.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.513 0.725 . . . . 0.57 112.217 177.528 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 152.19 -21.95 0.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.262 -0.743 . . . . 0.57 113.028 -175.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.6 158.79 4.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.689 1.244 . . . . 0.57 110.927 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.03 -41.37 0.48 Allowed Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.73 -2.15 . . . . 0.57 112.68 176.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 167.39 177.61 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 128.247 2.619 . . . . 0.65 107.259 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 t -150.76 -175.73 5.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.992 -1.485 . . . . 0.57 106.992 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.3 p -134.86 63.26 1.62 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.037 1.335 . . . . 0.57 109.078 -174.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.06 147.65 65.75 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.66 110.155 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.86 -27.11 21.66 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.842 2.362 . . . . 0.57 112.158 -175.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -122.6 33.35 5.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.704 1.602 . . . . 0.57 109.053 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.48 54.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.559 -0.713 . . . . 0.57 110.567 176.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 138' ' ' MET . 5.5 p -65.74 -24.7 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 121.424 -0.797 . . . . 0.57 110.336 168.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.47 ' HE3' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.6 11.84 33.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.57 112.157 177.117 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.55 137.11 9.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 119.764 1.166 . . . . 0.57 112.48 174.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.04 -66.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.966 1.778 . . . . 0.57 111.869 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -55.78 139.94 43.7 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.508 1.123 . . . . 0.57 110.52 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -95.53 77.1 3.33 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.291 -0.633 . . . . 0.57 109.291 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 96.75 0.12 Allowed Glycine 0 CA--C 1.536 1.374 0 N-CA-C 115.617 1.007 . . . . 0.57 115.617 172.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -159.48 -46.68 0.05 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.399 1.1 . . . . 0.57 113.105 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.76 -129.81 4.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.955 -2.058 . . . . 0.57 107.955 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -147.57 114.2 4.08 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.537 -0.912 . . . . 0.66 108.537 -178.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -12.6 23.04 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.198 1.932 . . . . 0.57 112.706 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.03 -25.67 61.9 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.074 -1.016 . . . . 0.57 111.167 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.88 93.28 4.3 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 125.322 1.449 . . . . 0.57 108.735 174.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -52.43 -73.89 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.622 1.169 . . . . 0.57 114.035 -177.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.36 67.04 0.2 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.504 2.321 . . . . 0.57 110.979 176.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -40.13 121.97 1.43 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.866 1.666 . . . . 0.57 109.121 -174.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.3 t -77.03 -101.63 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.626 0.771 . . . . 0.57 109.272 -168.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -122.91 -8.26 8.37 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 125.102 1.361 . . . . 0.57 110.838 172.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.22 -63.29 1.35 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 121.208 1.822 . . . . 0.66 110.873 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.66 -50.84 61.61 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 117.616 -1.183 . . . . 0.66 108.829 175.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.93 -48.83 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.199 0.909 . . . . 0.57 110.314 -174.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -66.91 -49.82 64.37 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.057 -0.72 . . . . 0.57 109.057 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.19 -58.84 11.91 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.682 -0.967 . . . . 0.57 110.682 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 46' ' ' ILE . 13.9 mm -50.39 -48.13 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 126.343 1.857 . . . . 0.57 112.141 174.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.44 -33.6 75.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.438 0.563 . . . . 0.57 111.714 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -76.05 -30.79 58.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.804 0.842 . . . . 0.57 111.801 176.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mm? -72.76 -53.19 12.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.907 1.283 . . . . 0.57 110.065 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' ILE . 19.6 m-85 . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 123.402 0.681 . . . . 0.57 109.778 -174.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 N-CA-C 110.946 -0.444 . . . . 0.57 110.946 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.2 99.26 0.07 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 126.243 1.817 . . . . 0.57 108.912 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.545 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.3 m95 -53.86 154.06 4.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.511 0.672 . . . . 0.57 111.651 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -72.76 -31.05 64.63 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.747 0.819 . . . . 0.57 111.702 -176.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -92.44 155.62 17.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.137 2.175 . . . . 0.57 111.162 174.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -79.68 -10.98 59.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.011 1.324 . . . . 0.57 111.808 173.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.29 144.7 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.777 -1.194 . . . . 0.57 107.777 175.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' ASP . 9.9 p -131.76 150.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.208 -1.034 . . . . 0.57 108.208 -178.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.7 p -102.52 148.78 25.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 119.015 -0.516 . . . . 0.57 110.651 -174.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -127.38 158.19 37.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.865 1.211 . . . . 0.57 111.915 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -152.74 116.56 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.988 0.423 . . . . 1.2 110.945 171.5 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 22' ' ' TYR . 34.8 mt -79.19 96.63 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 N-CA-C 106.581 -1.637 . . . . 0.57 106.581 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -33.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.878 2.071 . . . . 0.57 112.007 -175.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 t -150.04 162.26 40.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.384 -2.821 . . . . 0.57 103.384 -177.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 19' ' ' ILE . 72.1 m-85 -135.36 161.29 35.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.909 -1.515 . . . . 0.57 106.909 -173.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.431 HG22 HG21 ' A' ' 31' ' ' VAL . 6.4 t -72.81 173.15 9.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.668 0.387 . . . . 0.57 111.295 176.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -41.06 3.83 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.433 1.093 . . . . 1.2 111.221 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -35.1 74.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.057 0.389 . . . . 0.66 110.81 -176.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.52 151.77 52.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.531 1.932 . . . . 0.57 108.356 -176.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.23 155.92 46.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.198 1.265 . . . . 0.57 112.422 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -59.33 -37.59 78.18 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.565 1.146 . . . . 0.65 112.343 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 tt -63.6 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.28 -0.867 . . . . 0.57 110.078 174.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -62.77 -42.81 99.86 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.63 -1.176 . . . . 0.57 109.195 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 HG22 ' A' ' 23' ' ' THR . 46.3 t -61.28 -53.51 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 120.607 1.549 . . . . 0.57 111.667 175.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -59.79 -45.03 93.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.654 1.115 . . . . 0.66 110.438 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.17 96.78 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 117.845 -1.074 . . . . 1.2 111.402 176.426 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.0 mp -64.19 -46.24 84.8 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.518 1.054 . . . . 0.57 108.472 178.077 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -49.75 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.244 0.929 . . . . 0.57 109.709 172.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.26 -46.75 87.41 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.95 -1.024 . . . . 0.57 111.887 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -65.62 -42.54 91.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.333 1.424 . . . . 0.57 111.712 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.05 94.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.77 0.828 . . . . 0.57 110.049 177.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 122' ' ' LEU . 65.5 mt -66.45 -32.39 73.73 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.934 -0.555 . . . . 0.57 111.511 173.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -43.45 98.27 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.915 0.78 . . . . 0.57 110.025 172.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 mtm -67.12 -37.44 83.87 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.483 -0.77 . . . . 0.57 112.133 176.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 128' ' ' MET . 23.7 m95 -69.11 -43.92 73.47 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.862 1.21 . . . . 0.57 112.004 173.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.04 -0.87 66.46 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.959 1.266 . . . . 0.57 113.197 177.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -23.48 65.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.11 -1.23 . . . . 0.57 110.953 171.51 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -105.47 -32.1 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.978 -1.01 . . . . 0.66 112.331 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 160' ' ' ILE . 7.2 pt -116.6 132.29 23.44 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 119.312 0.96 . . . . 0.57 110.875 178.003 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.27 49.44 2.84 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.971 3.114 . . . . 0.57 111.76 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 126' ' ' LEU . 3.2 tt -98.49 142.11 30.51 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.122 2.169 . . . . 0.57 107.357 176.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -125.18 164.7 19.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.65 109.329 -172.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.65 147.87 47.1 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.685 -1.228 . . . . 0.57 107.685 -170.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.97 168.98 18.7 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.709 1.204 . . . . 1.2 109.048 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -110.77 150.39 29.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.793 -0.817 . . . . 0.57 108.793 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.5 170.33 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.867 0.867 . . . . 0.57 109.941 174.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.1 -48.71 7.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.077 0.951 . . . . 0.57 109.17 177.02 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -146.58 139.61 25.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.106 1.362 . . . . 0.57 107.387 173.082 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.43 166.4 22.79 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.571 0.605 . . . . 0.57 111.808 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 164.54 21.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.914 0.387 . . . . 0.57 110.369 174.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.51 173.71 8.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.835 1.254 . . . . 0.57 110.8 -176.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 15' ' ' VAL . 51.3 m-20 -73.53 -35.89 65.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.09 -0.959 . . . . 0.66 110.298 -177.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.09 71.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.549 2.34 . . . . 0.57 108.364 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 18.9 ttp -78.31 122.02 25.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.577 -1.327 . . . . 0.57 108.229 173.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.93 135.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.473 -1.677 . . . . 0.57 106.473 178.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.3 165.93 28.17 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 118.821 0.737 . . . . 0.57 112.015 176.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 6.4 m-85 -139.12 137.54 36.24 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.172 -1.788 . . . . 0.57 106.172 -175.208 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.8 175.85 9.27 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.018 1.327 . . . . 0.57 109.318 -176.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -133.55 88.8 2.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.722 -1.214 . . . . 1.2 107.722 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.76 -40.89 2.27 Favored Glycine 0 C--N 1.343 0.933 0 C-N-CA 124.359 0.981 . . . . 0.57 113.089 170.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.96 23.94 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.376 1.088 . . . . 0.57 109.421 175.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 159.33 25.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.957 1.303 . . . . 0.65 109.763 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.49 55.71 4.42 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 126.21 1.862 . . . . 0.57 112.23 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -105.08 -78.39 0.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.176 1.39 . . . . 0.66 109.094 -175.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.17 -50.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.545 1.938 . . . . 0.57 106.52 -176.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -108.36 126.19 30.17 Favored Pre-proline 0 C--N 1.344 0.352 0 CA-C-O 118.798 -0.62 . . . . 0.57 109.942 -174.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.08 133.37 26.66 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.272 1.315 . . . . 0.57 108.836 170.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.64 -163.43 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.645 1.212 . . . . 0.57 110.459 166.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -132.53 -35.77 1.12 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.605 3.562 . . . . 0.66 109.416 -162.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.37 -148.64 18.93 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.808 1.671 . . . . 0.57 111.453 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.04 59.57 2.96 Favored 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.227 4.618 . . . . 0.57 115.103 -169.639 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.0 40.55 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.552 1.549 . . . . 0.57 110.053 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 42.63 -139.76 0.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.229 1.812 . . . . 0.57 113.593 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -49.57 112.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.436 2.694 . . . . 0.57 111.989 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.23 -32.11 61.04 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.57 114.352 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.12 166.37 28.09 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.84 -1.162 . . . . 0.57 109.223 -178.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -149.09 155.98 41.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.003 0.82 . . . . 0.65 111.161 174.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.44 158.56 43.93 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.203 1.001 . . . . 0.57 109.875 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.7 148.52 32.1 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.429 -0.582 . . . . 0.57 109.429 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.42 96.5 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.801 -0.636 . . . . 0.57 110.242 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 21.9 Cg_endo -70.33 157.66 58.6 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.476 2.117 . . . . 0.57 111.099 176.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.68 -53.52 0.6 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.414 1.007 . . . . 0.57 111.141 173.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -96.64 177.67 5.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.57 110.704 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.96 -40.39 97.14 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.267 -1.296 . . . . 0.57 112.488 -176.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.22 -29.38 66.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.881 1.34 . . . . 0.57 110.875 168.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.13 152.19 14.69 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.85 -1.157 . . . . 0.57 111.152 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.35 -20.55 4.89 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.436 1.017 . . . . 0.57 113.391 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -75.39 157.22 34.52 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.483 1.141 . . . . 0.66 108.867 -173.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.41 149.94 36.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.815 0.817 . . . . 0.57 110.314 -172.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.83 151.56 48.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.982 0.913 . . . . 0.65 109.602 -176.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.502 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 36.2 m-85 -138.07 150.01 46.51 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.775 1.23 . . . . 0.57 108.034 -171.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -85.51 104.09 14.97 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.87 -0.789 . . . . 0.66 108.87 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.86 -23.75 66.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.929 -1.107 . . . . 0.66 111.671 175.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -56.72 -29.5 62.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.793 0.837 . . . . 0.66 111.642 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -82.68 135.03 35.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.587 1.555 . . . . 0.66 109.157 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.83 120.7 14.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.753 -0.592 . . . . 1.2 109.62 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -103.58 138.51 40.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.956 -1.127 . . . . 0.57 107.956 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -123.64 147.08 47.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.711 -1.218 . . . . 0.57 107.711 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -88.26 21.23 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.396 0.998 . . . . 0.66 112.081 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.86 25.6 37.52 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.252 1.406 . . . . 0.57 112.834 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -64.76 -56.18 15.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.797 1.239 . . . . 0.57 112.746 -172.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.1 m -151.68 -43.1 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.582 0.753 . . . . 0.57 112.827 -176.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -167.84 166.4 13.54 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.628 1.971 . . . . 0.57 108.078 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.84 -152.4 16.88 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.166 -1.574 . . . . 0.57 109.166 -175.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.93 111.63 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.107 -1.442 . . . . 0.57 107.107 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -66.28 111.65 3.58 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.074 -0.713 . . . . 0.57 109.074 -177.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.43 -43.93 75.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.449 -0.796 . . . . 0.57 111.464 177.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' HG ' ' A' ' 34' ' ' LEU . 20.5 tp -59.7 -40.3 87.45 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.555 -0.905 . . . . 0.57 108.555 -175.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -66.54 -44.61 81.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.569 0.748 . . . . 0.57 109.662 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.098 0.559 . . . . 0.57 110.327 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -50.95 72.09 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.861 -1.066 . . . . 0.57 109.845 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 65.5 m -50.82 -46.33 59.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.175 1.352 . . . . 0.57 111.714 175.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.91 -52.27 64.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.401 0.546 . . . . 0.65 110.281 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.5 -43.37 85.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.195 0.998 . . . . 0.66 110.9 -172.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 39' ' ' LEU . 60.0 mt -64.85 -28.68 69.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.202 1.401 . . . . 0.57 111.282 176.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -46.33 80.46 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.127 -0.789 . . . . 0.57 111.127 169.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -68.7 -40.46 80.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.537 -1.22 . . . . 0.65 110.889 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.8 p -59.98 -26.44 66.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.136 0.88 . . . . 0.57 112.838 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.74 -41.59 78.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.22 1.008 . . . . 0.57 111.773 173.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.73 25.91 1.2 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.478 1.037 . . . . 0.57 113.621 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 42' ' ' TRP . 36.3 mmt -84.26 -176.94 6.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.855 0.836 . . . . 0.57 111.052 -175.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.47 146.49 18.15 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.267 -0.879 . . . . 0.57 111.44 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.23 164.33 1.81 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.036 0.922 . . . . 0.65 111.25 166.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.26 179.97 7.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.515 1.926 . . . . 0.57 107.538 -177.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.3 t -151.59 97.06 2.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.917 -1.883 . . . . 0.57 105.917 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -131.1 137.62 31.09 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 105.587 -2.005 . . . . 0.66 105.587 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.76 38.12 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.959 3.106 . . . . 0.57 111.714 -176.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.46 32.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.9 1.68 . . . . 0.57 111.291 170.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -120.64 142.91 49.0 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.98 -1.075 . . . . 0.57 110.543 -170.04 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.47 -29.6 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 120.172 -0.611 . . . . 0.57 109.514 177.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 tpp -61.39 -18.13 57.35 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.129 1.772 . . . . 0.57 114.455 173.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -54.71 129.11 63.69 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.534 0.734 . . . . 0.57 109.502 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.06 134.98 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.793 1.662 . . . . 0.57 109.277 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.1 m 66.88 149.55 0.05 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.107 1.763 . . . . 0.57 111.895 -173.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.84 131.48 48.93 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.017 -1.052 . . . . 0.57 109.51 173.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.86 -104.72 0.18 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.161 -1.176 . . . . 0.57 110.161 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -64.2 -33.61 76.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.923 0.712 . . . . 0.57 112.923 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.59 142.93 36.08 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.613 -0.995 . . . . 0.57 110.613 178.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -109.77 111.51 58.85 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.408 0.683 . . . . 0.66 109.288 -169.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 -15.63 51.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.576 2.184 . . . . 0.57 113.6 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.54 -1.24 28.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.024 0.93 . . . . 0.57 110.675 177.227 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -142.51 77.42 1.58 Allowed 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.505 -1.372 . . . . 0.57 109.586 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.86 -63.15 1.2 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.871 0.868 . . . . 0.57 112.67 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.11 72.96 0.03 OUTLIER 'General case' 0 C--N 1.346 0.436 0 O-C-N 126.369 2.293 . . . . 0.57 111.364 -176.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -33.16 116.07 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.965 2.106 . . . . 0.57 108.55 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.4 p -93.7 -75.52 0.5 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.326 -0.55 . . . . 0.57 110.382 -160.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -141.76 -49.51 0.39 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.501 1.12 . . . . 0.57 109.351 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -51.84 -32.47 31.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.901 1.228 . . . . 0.66 112.441 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.458 ' HB3' HD23 ' A' ' 152' ' ' LEU . 71.7 m-20 -78.19 -82.94 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.902 1.681 . . . . 0.66 110.404 168.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.62 -50.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.183 0.993 . . . . 0.57 110.648 -169.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -69.05 -35.9 77.09 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 117.528 -1.225 . . . . 0.57 109.684 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.71 95.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 120.416 1.462 . . . . 0.57 111.049 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 46' ' ' ILE . 7.9 mm -60.03 -48.81 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.902 0.881 . . . . 0.57 110.676 171.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -67.09 -16.86 64.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.561 -0.733 . . . . 0.57 112.89 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -82.57 -35.64 26.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.324 1.45 . . . . 0.57 110.43 171.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -47.13 8.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.867 0.758 . . . . 0.57 112.762 -175.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 N--CA 1.465 0.323 0 C-N-CA 124.285 1.034 . . . . 0.57 110.484 -175.044 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 CA-C-O 120.676 0.198 . . . . 0.57 111.856 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 pttt 86.81 133.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 129.406 3.082 . . . . 0.57 108.548 -170.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.408 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 33.2 m95 -73.31 177.67 5.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.619 0.767 . . . . 0.57 110.074 173.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -101.6 -14.77 17.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.728 -0.608 . . . . 0.57 111.485 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -100.8 162.64 12.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.726 1.21 . . . . 0.57 110.116 176.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -87.42 -4.08 59.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.13 1.372 . . . . 0.57 112.549 171.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -133.1 140.93 46.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.868 -1.16 . . . . 0.57 107.868 176.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.68 143.5 39.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.738 -1.578 . . . . 0.57 106.738 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 59' ' ' ASP . 0.6 OUTLIER -98.94 140.43 33.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.69 -0.485 . . . . 0.57 109.69 -179.531 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.21 161.04 29.48 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.631 0.772 . . . . 0.57 110.544 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.91 160.7 43.73 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.987 0.915 . . . . 1.2 109.599 172.42 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.25 85.92 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.239 -2.134 . . . . 0.57 105.239 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.64 -56.27 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.021 0.529 . . . . 0.57 109.985 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.5 111.82 22.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.733 -1.951 . . . . 0.57 105.733 176.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.09 148.95 22.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.395 1.878 . . . . 0.57 107.911 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -73.88 -170.05 0.84 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.794 1.238 . . . . 0.57 109.799 -176.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.28 -14.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.869 1.433 . . . . 1.2 114.869 176.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -64.59 -29.87 70.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.085 1.354 . . . . 0.66 110.846 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.28 150.82 73.48 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 126.55 1.94 . . . . 0.57 108.488 175.13 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -70.81 157.3 58.72 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.537 2.825 . . . . 0.57 112.736 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -65.59 -32.92 74.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.705 0.802 . . . . 0.65 112.172 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -43.96 98.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.55 -0.907 . . . . 0.57 108.55 174.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -64.95 -42.37 94.7 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.206 -1.378 . . . . 0.57 109.839 172.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.3 t -58.3 -48.59 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 121.157 1.798 . . . . 0.57 110.365 177.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.8 -42.19 90.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.19 0.904 . . . . 0.66 109.672 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -67.34 -46.87 72.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.333 -0.855 . . . . 1.2 113.146 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.37 -31.62 72.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.048 -0.977 . . . . 0.57 109.676 177.325 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.15 -50.42 74.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.878 -1.156 . . . . 0.57 107.878 173.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -38.88 91.55 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.244 -0.884 . . . . 0.57 110.826 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.46 -47.71 69.31 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.473 1.488 . . . . 0.57 111.105 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.96 86.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.075 0.95 . . . . 0.57 111.726 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.21 -31.87 68.13 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.216 -0.897 . . . . 0.57 111.156 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.63 -43.98 93.63 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 119.286 0.948 . . . . 0.57 109.233 170.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.2 mtp -60.1 -35.34 75.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.551 1.069 . . . . 0.57 112.86 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 5.6 m95 -70.55 -48.09 57.1 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.421 1.009 . . . . 0.57 111.669 170.163 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -9.36 64.73 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.106 1.336 . . . . 0.57 113.668 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -66.38 -20.16 66.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.553 1.141 . . . . 0.57 110.499 170.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.89 -20.39 12.47 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.205 -0.902 . . . . 0.66 112.691 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.8 pt -127.67 129.75 23.75 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 119.195 0.907 . . . . 0.57 110.464 175.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.82 41.45 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.295 3.33 . . . . 0.57 112.407 178.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -89.9 147.72 23.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.295 1.838 . . . . 0.57 108.079 -179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -122.93 166.36 15.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.51 0.724 . . . . 0.65 109.25 -172.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.84 39.5 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.111 -0.993 . . . . 0.57 109.458 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 165.24 21.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.756 0.823 . . . . 1.2 109.217 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -130.3 114.1 15.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.812 -1.551 . . . . 0.57 106.812 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.05 160.76 2.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.383 0.673 . . . . 0.57 109.759 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.71 -14.76 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.192 0.997 . . . . 0.57 112.227 -176.21 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -52.5 64.04 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.664 0.785 . . . . 0.57 111.099 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.37 -152.81 6.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.965 1.745 . . . . 0.57 109.431 -172.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -60.84 178.88 0.2 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.328 1.051 . . . . 0.57 112.477 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.22 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.734 1.614 . . . . 0.57 110.382 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 16' ' ' THR . 79.8 m-20 -66.43 -31.62 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.494 -0.765 . . . . 0.66 109.138 176.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 mt -125.45 79.13 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 126.641 1.976 . . . . 0.57 108.471 -178.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -72.54 117.95 14.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.134 1.773 . . . . 0.57 108.226 166.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.88 122.8 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.096 -2.187 . . . . 0.57 105.096 177.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -144.55 138.73 8.06 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 118.149 0.431 . . . . 0.57 112.024 -174.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.48 145.69 37.25 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.936 -1.135 . . . . 0.57 107.936 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.94 151.7 51.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.685 1.194 . . . . 0.57 108.34 -178.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -110.68 70.86 0.73 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.271 0.558 . . . . 1.2 109.608 -174.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.28 -53.79 0.66 Allowed Glycine 0 C--O 1.219 -0.805 0 N-CA-C 110.351 -1.099 . . . . 0.57 110.351 174.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 171.66 19.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.958 0.903 . . . . 0.57 109.328 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 159.56 22.17 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.429 1.892 . . . . 0.65 108.537 -174.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.23 46.22 2.22 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.085 1.326 . . . . 0.57 111.788 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.42 105.66 7.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.488 -1.301 . . . . 0.66 107.488 -172.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.9 m 55.99 -71.72 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.113 2.165 . . . . 0.57 113.034 -175.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.75 130.02 15.31 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.351 1.86 . . . . 0.57 107.911 -173.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.7 137.75 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.543 1.495 . . . . 0.57 109.833 175.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -66.48 -173.81 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.973 1.309 . . . . 0.57 111.202 169.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.63 -33.52 6.75 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.136 2.574 . . . . 0.66 111.962 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.02 -123.54 7.94 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 120.586 -1.321 . . . . 0.57 111.965 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.67 95.72 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.83 2.315 . . . . 0.57 112.327 -176.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.89 -160.45 25.73 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.966 0.793 . . . . 0.57 112.232 173.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.57 -129.91 0.78 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.325 1.45 . . . . 0.57 112.904 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -68.3 129.11 38.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.307 2.643 . . . . 0.57 109.186 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.67 -30.44 12.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.104 1.361 . . . . 0.57 112.049 -175.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.2 37.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.839 1.255 . . . . 0.57 108.352 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.74 161.54 38.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.625 -0.88 . . . . 0.65 108.625 173.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.36 159.91 43.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.966 0.506 . . . . 0.57 109.651 175.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -114.32 152.62 31.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.49 -0.777 . . . . 0.57 109.606 -173.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.25 146.57 83.44 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.203 -0.903 . . . . 0.57 110.117 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.4 Cg_endo -66.83 157.98 58.62 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.345 2.03 . . . . 0.57 112.335 -176.229 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.36 -101.7 0.15 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.042 -1.223 . . . . 0.57 110.042 176.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -147.05 -41.25 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.901 0.88 . . . . 0.57 111.194 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.02 4.57 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.812 -1.315 . . . . 0.57 109.812 -175.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -29.95 17.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.224 1.01 . . . . 0.57 112.423 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.55 134.79 14.47 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 120.964 -1.085 . . . . 0.57 112.865 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.58 9.26 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.217 1.865 . . . . 0.57 112.203 -176.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.72 148.44 47.98 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.1 0.95 . . . . 0.66 108.885 -166.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.38 137.85 46.02 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.691 0.796 . . . . 0.57 109.13 -168.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 15.4 m-70 -135.33 141.24 45.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.299 -1.0 . . . . 0.65 108.299 -164.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.29 151.73 42.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.735 -0.839 . . . . 0.57 108.735 -169.288 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.56 102.2 11.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.852 -0.796 . . . . 0.66 108.852 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.85 -21.72 63.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.095 0.958 . . . . 0.66 111.487 172.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.23 -38.83 88.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.611 0.642 . . . . 0.66 110.436 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.68 126.37 29.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.345 -1.354 . . . . 0.66 107.345 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.82 132.53 22.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.465 -0.939 . . . . 1.2 108.465 176.108 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -120.78 129.69 53.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.739 -1.948 . . . . 0.57 105.739 -177.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -141.02 161.84 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.619 -0.882 . . . . 0.57 108.619 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.78 -22.77 58.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.857 0.863 . . . . 0.66 111.136 172.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 152.47 96.68 0.14 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.177 0.894 . . . . 0.57 111.33 175.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.0 t -120.37 -68.54 0.9 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 118.658 -0.687 . . . . 0.57 110.562 -178.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.79 -64.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.06 0.944 . . . . 0.57 108.877 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 tt -94.56 -46.1 7.11 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.815 0.846 . . . . 0.57 110.327 -170.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.67 145.58 32.22 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.077 -1.209 . . . . 0.57 110.077 173.048 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.5 mm -77.62 138.26 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.594 -1.262 . . . . 0.57 107.594 -171.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -74.16 105.57 5.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.684 -0.487 . . . . 0.57 109.684 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.31 -33.73 76.51 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.288 0.635 . . . . 0.57 110.887 178.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.51 -51.52 65.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.624 -1.25 . . . . 0.57 107.624 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.82 -38.89 92.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.449 0.7 . . . . 0.57 109.205 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.31 47.12 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.547 0.739 . . . . 0.57 112.252 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.43 77.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.628 -0.879 . . . . 0.57 108.628 179.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -60.88 -37.73 83.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.463 0.574 . . . . 0.57 111.382 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.42 -58.8 6.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.17 0.441 . . . . 0.65 109.871 172.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -68.63 -41.69 79.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.298 -0.876 . . . . 0.66 111.635 -171.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.99 -24.85 66.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.354 1.061 . . . . 0.57 110.943 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.54 -45.89 93.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.57 110.917 169.889 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -70.13 -32.96 71.22 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 117.729 -1.129 . . . . 0.65 112.239 174.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 p -60.09 -38.1 81.93 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.657 1.117 . . . . 0.57 110.894 174.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.55 -33.07 73.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.014 0.435 . . . . 0.57 111.181 176.901 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.48 -55.01 0.12 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 123.782 0.706 . . . . 0.57 111.611 175.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 176.09 172.56 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.432 1.493 . . . . 0.57 107.632 -166.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 161.24 75.22 0.02 OUTLIER Glycine 0 C--O 1.218 -0.847 0 N-CA-C 104.137 -3.585 . . . . 0.57 104.137 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.14 45.13 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.314 -1.365 . . . . 0.65 107.314 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.3 -177.13 0.99 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.966 2.106 . . . . 0.57 106.469 -173.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -132.25 39.29 3.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.57 109.696 -174.149 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -104.14 137.69 19.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.66 111.197 -172.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.47 -9.49 25.96 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.837 2.358 . . . . 0.57 113.573 -174.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -121.52 24.75 9.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.868 1.267 . . . . 0.57 109.599 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.63 133.18 45.53 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.082 -1.011 . . . . 0.57 110.115 172.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -22.26 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.069 0.548 . . . . 0.57 110.442 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.2 24.75 12.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.43 1.892 . . . . 0.57 110.622 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.12 142.89 92.87 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.137 -0.977 . . . . 0.57 109.967 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.9 Cg_endo -69.53 -171.48 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.315 2.01 . . . . 0.57 111.235 166.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 t 43.59 68.89 0.46 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.497 1.519 . . . . 0.57 113.151 173.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -43.38 129.22 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.772 1.629 . . . . 0.57 113.458 -173.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.42 113.86 3.51 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.28 -1.528 . . . . 0.57 109.28 -178.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 168.4 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.063 2.145 . . . . 0.57 108.48 175.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.96 -145.24 18.34 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.556 -1.017 . . . . 0.57 110.556 177.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -128.06 102.25 21.85 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.833 -1.543 . . . . 0.66 106.833 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.81 67.09 6.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.985 2.457 . . . . 0.57 109.481 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -165.1 -48.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.326 1.85 . . . . 0.57 108.961 178.45 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -77.4 43.11 0.37 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.9 1.444 . . . . 0.57 114.9 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -14.4 -71.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 128.352 2.661 . . . . 0.57 117.06 -177.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 17.81 79.03 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 128.324 2.649 . . . . 0.57 112.309 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -31.66 117.4 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.421 1.889 . . . . 0.57 109.762 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -92.2 -87.85 0.21 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.101 -0.476 . . . . 0.57 110.481 -163.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -139.57 -39.06 0.47 Allowed 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 117.644 -1.17 . . . . 0.57 111.721 177.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -58.93 -37.2 76.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 120.174 1.352 . . . . 0.66 110.87 174.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.42 -59.31 2.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 124.118 0.886 . . . . 0.66 109.109 175.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.47 -46.0 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.574 1.149 . . . . 0.57 110.237 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.37 -47.45 76.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.495 1.118 . . . . 0.57 109.749 -177.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.53 58.14 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.995 -1.242 . . . . 0.57 109.995 176.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -54.4 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.365 1.066 . . . . 0.57 110.896 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -56.29 -43.5 78.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.546 1.139 . . . . 0.57 109.569 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -65.14 -36.92 85.76 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.575 0.625 . . . . 0.57 111.15 176.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.21 -46.57 79.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.813 1.645 . . . . 0.57 112.153 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 20.4 p90 . . . . . 0 N--CA 1.473 0.694 0 C-N-CA 123.406 0.683 . . . . 0.57 112.636 -179.063 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 N-CA-C 109.328 -1.066 . . . . 0.57 109.328 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 71.47 115.84 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.043 1.737 . . . . 0.57 109.48 -171.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -57.12 150.11 18.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.742 0.817 . . . . 0.57 110.251 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -65.9 -23.89 66.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.841 0.857 . . . . 0.57 111.392 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -94.16 152.63 18.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.99 0.916 . . . . 0.57 110.364 173.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -85.62 -3.4 58.87 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.654 1.182 . . . . 0.57 112.636 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.56 111.03 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.107 -1.072 . . . . 0.57 108.107 177.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.15 124.78 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.551 -1.277 . . . . 0.57 107.551 -170.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -92.6 152.23 19.7 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.599 -0.688 . . . . 0.57 110.441 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -123.09 153.45 39.9 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.696 0.799 . . . . 0.57 111.506 175.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.28 117.77 6.52 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.649 0.738 . . . . 1.2 110.549 174.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mt -87.74 89.46 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 105.05 -2.204 . . . . 0.57 105.05 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.89 -31.78 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.135 0.974 . . . . 0.57 112.097 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 t -136.2 157.65 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.589 -2.375 . . . . 0.57 104.589 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -135.21 167.42 21.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.197 1.399 . . . . 0.57 107.663 -173.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -68.49 -175.03 0.6 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 0.57 111.459 172.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -41.49 2.56 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.544 1.138 . . . . 1.2 111.241 -176.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -41.43 77.48 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.875 1.27 . . . . 0.66 111.739 178.137 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.41 142.56 29.66 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 125.037 1.335 . . . . 0.57 108.015 -172.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.42 158.46 56.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.769 1.646 . . . . 0.57 112.192 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -67.98 -36.83 80.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.374 -0.83 . . . . 0.65 110.592 -171.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.3 tt -65.84 -40.72 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.909 0.884 . . . . 0.57 110.814 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -62.5 -46.08 90.08 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 117.717 -1.135 . . . . 0.57 108.272 173.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 t -54.86 -49.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.467 -1.254 . . . . 0.57 110.701 175.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.24 -40.25 96.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.498 1.499 . . . . 0.66 111.778 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -62.85 -46.21 88.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.487 1.04 . . . . 1.2 111.553 175.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.88 -42.79 89.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.483 1.113 . . . . 0.57 109.531 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.44 -43.47 96.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.985 -1.007 . . . . 0.57 110.637 170.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -53.5 57.7 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.071 1.305 . . . . 0.57 110.692 177.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -63.98 -35.93 82.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.065 1.302 . . . . 0.57 111.928 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -41.88 69.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.34 0.973 . . . . 0.57 111.907 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -65.91 -35.17 79.88 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.519 -0.753 . . . . 0.57 109.88 171.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -59.35 -43.22 92.83 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.113 0.87 . . . . 0.57 109.851 171.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.8 mtp -62.16 -41.41 98.27 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.279 -0.867 . . . . 0.57 110.971 176.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -61.03 -49.93 75.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.838 1.199 . . . . 0.57 111.576 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.64 -5.63 79.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.45 1.024 . . . . 0.57 113.88 -178.24 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -77.6 -21.25 52.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.831 1.315 . . . . 0.57 110.741 170.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -97.1 -13.29 22.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.862 0.865 . . . . 0.66 111.235 -177.212 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 164' ' ' TYR . 17.9 pt -142.33 150.66 55.79 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 119.859 1.209 . . . . 0.57 111.708 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.51 12.64 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.219 2.613 . . . . 0.57 113.452 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -79.67 137.67 37.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.817 -1.179 . . . . 0.57 107.817 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -119.18 165.68 13.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.571 0.701 . . . . 0.65 109.636 -173.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.7 161.95 35.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.092 -0.707 . . . . 0.57 109.092 -173.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -179.8 6.82 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.638 -0.875 . . . . 1.2 108.638 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -131.16 154.84 47.94 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.881 -1.155 . . . . 0.57 107.881 177.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.46 164.6 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 124.301 1.041 . . . . 0.57 109.256 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.79 -22.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.871 0.868 . . . . 0.57 112.168 -176.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -64.81 0.81 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.381 -0.97 . . . . 0.57 108.381 174.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.24 157.57 7.92 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.078 1.799 . . . . 0.57 109.253 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.8 m 61.17 135.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.598 2.359 . . . . 0.57 112.761 178.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.12 177.68 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 121.243 -0.911 . . . . 0.57 110.586 -173.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.11 -53.89 32.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.275 -1.38 . . . . 0.66 107.275 177.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -103.47 77.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.211 2.204 . . . . 0.57 108.358 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.9 ttp -76.72 148.51 36.71 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 119.167 -2.208 . . . . 0.57 109.564 173.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.2 140.34 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.736 -1.579 . . . . 0.57 106.736 173.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.25 162.3 31.76 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.461 -0.656 . . . . 0.57 111.461 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.8 m-85 -137.2 141.46 42.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.052 -1.462 . . . . 0.57 107.052 -174.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.3 -174.34 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.713 1.605 . . . . 0.57 109.305 -177.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 50.15 1.28 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.224 . . . . 1.2 112.461 -172.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.09 123.58 3.77 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.794 -1.322 . . . . 0.57 109.794 -173.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 52.14 122.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.593 2.357 . . . . 0.57 115.514 -172.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.14 159.37 44.3 Favored 'General case' 0 C--N 1.341 0.222 0 O-C-N 120.39 -1.444 . . . . 0.65 112.193 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.9 80.86 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.522 1.534 . . . . 0.57 110.195 175.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.57 -84.36 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.942 1.297 . . . . 0.66 110.663 -174.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 t -171.05 -37.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.122 1.369 . . . . 0.57 110.126 -177.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.76 142.0 38.16 Favored Pre-proline 0 C--N 1.343 0.284 0 C-N-CA 123.728 0.811 . . . . 0.57 109.478 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 124.15 10.28 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.54 1.493 . . . . 0.57 109.521 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 171.64 3.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.409 1.1 . . . . 0.57 110.398 161.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -108.81 -44.37 4.03 Favored 'General case' 0 CA--C 1.542 0.645 1 C-N-CA 131.763 4.025 . . . . 0.66 109.979 -171.055 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.96 -145.21 17.61 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.226 -1.319 . . . . 0.57 111.166 -174.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.94 74.66 2.32 Favored 'Trans proline' 0 C--N 1.354 0.818 1 C-N-CA 125.588 4.192 . . . . 0.57 114.042 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.48 -177.76 36.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.183 -1.967 . . . . 0.57 108.183 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 45.01 -150.19 0.06 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.425 1.49 . . . . 0.57 113.453 174.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -43.0 109.81 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.471 2.308 . . . . 0.57 111.513 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.25 -29.65 42.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.616 1.166 . . . . 0.57 113.319 -172.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.67 157.8 27.74 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.79 1.236 . . . . 0.57 108.337 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -142.53 160.44 40.28 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.427 -0.795 . . . . 0.65 110.303 174.021 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.63 172.85 12.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.937 0.895 . . . . 0.57 108.723 176.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.95 153.96 46.1 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.527 -0.916 . . . . 0.57 108.527 -177.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.23 135.56 76.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.424 -0.798 . . . . 0.57 110.111 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -71.16 169.74 19.9 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.394 2.729 . . . . 0.57 113.456 -177.239 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.05 -8.97 27.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.52 1.533 . . . . 0.57 113.632 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -136.81 45.41 2.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.246 1.023 . . . . 0.57 111.255 -163.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -77.05 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.211 1.386 . . . . 0.57 114.185 173.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.85 -21.12 63.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.57 110.268 167.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.2 145.65 4.39 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.211 -0.931 . . . . 0.57 111.087 170.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.44 -34.29 3.88 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 125.299 1.428 . . . . 0.57 110.922 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.24 152.53 40.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.292 1.046 . . . . 0.66 110.449 -164.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.83 146.01 50.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.824 0.821 . . . . 0.57 109.506 -175.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -138.44 152.84 48.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.001 0.92 . . . . 0.65 110.093 -177.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 51.3 m-85 -140.09 155.82 46.85 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.633 1.173 . . . . 0.57 108.995 -168.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -87.32 102.58 14.65 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.187 -0.301 . . . . 0.66 110.187 172.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -53.98 -30.71 48.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.772 1.629 . . . . 0.66 111.733 171.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.56 -35.28 79.96 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.341 0.657 . . . . 0.66 111.522 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -73.73 150.69 41.01 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.744 0.818 . . . . 0.66 109.068 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -72.67 144.44 47.74 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.743 -0.598 . . . . 1.2 110.698 175.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.87 128.28 36.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.8 -1.556 . . . . 0.57 106.8 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -124.04 144.69 49.69 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.547 -0.538 . . . . 0.57 109.547 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.21 -33.51 75.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.66 111.284 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.42 95.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.88 -0.888 . . . . 0.57 110.88 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.04 138.24 8.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.45 0.7 . . . . 0.57 109.276 172.143 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 t -76.25 54.49 0.89 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.383 2.273 . . . . 0.57 110.786 -175.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -158.15 -44.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.486 0.714 . . . . 0.57 112.164 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.65 -176.2 38.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.545 -1.022 . . . . 0.57 110.545 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.25 118.27 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 105.782 -1.933 . . . . 0.57 105.782 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.82 113.01 2.79 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.891 -0.781 . . . . 0.57 108.891 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -54.14 -42.37 69.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.25 1.02 . . . . 0.57 110.823 177.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.97 -34.06 57.6 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.451 0.569 . . . . 0.57 111.469 -171.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -64.48 -48.55 74.79 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.569 -0.9 . . . . 0.57 108.569 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.27 74.34 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.804 0.442 . . . . 0.57 110.548 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.24 78.16 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.456 -0.783 . . . . 0.57 110.948 -176.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.7 m -61.89 -37.42 84.53 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 0.899 . . . . 0.57 110.961 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.51 -53.8 53.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.63 0.772 . . . . 0.65 109.817 172.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.8 -44.28 73.88 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.628 0.771 . . . . 0.66 111.914 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.26 -28.93 70.06 Favored 'General case' 0 CA--C 1.526 0.036 0 C-N-CA 124.389 1.076 . . . . 0.57 111.239 176.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.78 -46.56 93.3 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.623 -0.591 . . . . 0.57 111.623 171.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -64.2 -38.41 90.96 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 117.161 0.48 . . . . 0.65 111.243 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -34.38 69.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.707 0.632 . . . . 0.57 112.707 174.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -22.69 65.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.343 -0.848 . . . . 0.57 112.856 174.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.04 -13.61 4.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.709 1.147 . . . . 0.57 113.464 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.3 tpp -65.15 144.59 57.11 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.817 1.309 . . . . 0.57 110.862 -171.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -97.7 -38.96 4.01 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 117.762 -1.577 . . . . 0.57 112.038 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 m80 156.52 -176.4 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.893 3.677 . . . . 0.65 108.111 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.4 m -145.45 179.88 7.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.327 1.851 . . . . 0.57 107.829 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.61 94.39 2.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.785 -1.561 . . . . 0.57 106.785 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 8.3 t70 -154.24 138.02 10.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 107.211 -1.403 . . . . 0.66 107.211 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.9 -19.57 46.21 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.978 1.785 . . . . 0.57 113.37 -173.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -124.39 27.21 7.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.783 1.233 . . . . 0.57 109.108 -177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -59.42 138.52 57.63 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.315 0.646 . . . . 0.57 110.369 175.385 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.5 p -75.02 -26.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.815 -0.439 . . . . 0.57 109.815 168.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 13.41 15.53 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.615 -0.678 . . . . 0.57 112.148 174.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -70.46 146.35 93.98 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.552 1.524 . . . . 0.57 111.528 -174.369 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 38.2 Cg_endo -78.81 -50.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.181 1.921 . . . . 0.57 112.693 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.5 t -67.62 120.13 13.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.921 -0.77 . . . . 0.57 108.921 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.52 112.77 9.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.899 -0.778 . . . . 0.57 108.899 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.76 170.54 21.91 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.805 -1.318 . . . . 0.57 109.805 172.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.28 -53.67 0.47 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.507 2.323 . . . . 0.57 114.029 174.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.65 108.39 2.48 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 127.162 2.315 . . . . 0.57 108.883 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -53.94 111.07 2.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.758 1.623 . . . . 0.66 110.751 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.05 -10.07 13.99 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.804 2.336 . . . . 0.57 112.733 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -96.43 -27.49 14.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.719 1.145 . . . . 0.57 110.965 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -116.15 71.1 0.77 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.069 -1.086 . . . . 0.57 108.069 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -120.95 139.0 53.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.225 1.01 . . . . 0.57 108.871 -178.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.96 42.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.36 1.064 . . . . 0.57 110.592 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 64.44 92.89 0.06 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.213 1.805 . . . . 0.57 110.638 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 75.3 m -75.23 -79.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.374 0.879 . . . . 0.57 113.374 -169.326 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -149.1 -49.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.333 1.053 . . . . 0.57 108.248 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -47.54 -46.48 27.76 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 126.151 1.78 . . . . 0.66 111.749 167.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.79 -47.84 50.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.801 0.841 . . . . 0.66 109.326 -174.43 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.16 -45.43 92.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 124.311 1.044 . . . . 0.57 109.693 175.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -49.1 72.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.261 1.024 . . . . 0.57 109.703 -178.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.74 72.79 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.705 -1.358 . . . . 0.57 109.705 177.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 160' ' ' ILE . 1.6 mm -59.3 -53.99 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.178 -0.915 . . . . 0.57 111.21 175.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.56 64.14 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.601 1.091 . . . . 0.57 111.459 -178.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -77.33 -35.08 55.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.158 0.583 . . . . 0.57 112.131 173.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.3 -40.85 98.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.992 1.717 . . . . 0.57 112.749 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' HG22 ' A' ' 46' ' ' ILE . 16.8 p90 . . . . . 0 N--CA 1.474 0.762 0 C-N-CA 123.363 0.665 . . . . 0.57 112.503 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.272 0 CA-C-O 117.248 -1.358 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m 49.92 75.49 0.17 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.815 1.246 . . . . 0.57 112.776 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.91 128.69 56.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.147 -1.427 . . . . 0.57 107.147 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -144.61 156.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.186 1.395 . . . . 0.57 108.774 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.31 33.91 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.286 3.324 . . . . 0.57 114.344 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -135.23 139.57 44.57 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 126.33 1.852 . . . . 0.57 106.994 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.5 m -56.27 106.78 0.72 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.648 1.179 . . . . 0.57 110.945 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.42 96.4 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.924 1.749 . . . . 0.57 109.174 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 pttt 101.19 138.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 130.174 3.389 . . . . 0.57 109.305 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.467 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 12.3 m95 -64.89 162.27 16.69 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.811 0.844 . . . . 0.57 110.69 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.9 p -91.46 6.42 45.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.697 -0.627 . . . . 0.57 112.42 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -109.7 147.7 32.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.881 1.272 . . . . 0.57 109.056 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -16.89 61.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.293 0.637 . . . . 0.57 111.943 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.55 143.49 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.009 -1.108 . . . . 0.57 108.009 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 172.24 13.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.893 -0.78 . . . . 0.57 108.893 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -116.56 153.33 32.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.389 0.276 . . . . 0.57 110.627 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -128.6 149.84 50.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.07 0.948 . . . . 0.57 111.128 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.64 106.23 3.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.821 0.849 . . . . 1.2 108.884 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.5 mt -84.47 84.2 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 106.716 -1.587 . . . . 0.57 106.716 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.38 -41.72 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 0.57 112.696 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -126.08 164.83 20.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.611 -2.366 . . . . 0.57 104.611 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -136.35 155.0 50.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.46 -1.311 . . . . 0.57 107.46 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -66.54 -172.02 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.906 0.883 . . . . 0.57 111.132 168.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -33.46 0.83 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.874 1.67 . . . . 1.2 112.763 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -39.3 78.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.016 0.926 . . . . 0.66 112.179 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 148.33 65.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.947 2.099 . . . . 0.57 108.088 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.8 163.49 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.84 2.36 . . . . 0.57 112.716 -171.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -62.48 -36.13 81.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.439 0.696 . . . . 0.65 112.265 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.78 -38.63 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.549 0.34 . . . . 0.57 110.744 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.9 m -69.65 -41.72 75.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.542 -1.218 . . . . 0.57 109.5 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.1 t -53.98 -54.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 120.341 1.428 . . . . 0.57 109.719 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -43.54 98.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.989 0.813 . . . . 0.66 110.834 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -42.08 98.2 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.28 0.945 . . . . 1.2 112.029 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.02 -40.64 68.3 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.682 -1.151 . . . . 0.57 109.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.24 -49.37 76.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 119.31 0.959 . . . . 0.57 109.183 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -65.03 -44.48 88.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.599 0.76 . . . . 0.57 110.437 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -66.3 -45.23 81.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.561 1.073 . . . . 0.57 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -47.26 86.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.033 0.833 . . . . 0.57 110.811 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 19.7 mt -67.8 -36.73 80.96 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.455 0.702 . . . . 0.57 111.514 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.36 -38.39 89.36 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 119.16 0.891 . . . . 0.57 109.651 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.28 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.032 0.933 . . . . 0.57 112.514 173.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 40.9 m95 -68.13 -51.05 50.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.845 1.202 . . . . 0.57 110.948 168.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.03 -11.65 58.86 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.563 1.077 . . . . 0.57 113.318 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -31.17 72.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.377 -1.072 . . . . 0.57 110.481 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -101.26 -21.17 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.016 0.825 . . . . 0.66 111.803 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.7 pt -133.15 135.5 25.76 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.493 1.117 . . . . 0.57 110.77 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.17 26.36 0.26 Allowed 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 123.814 3.009 . . . . 0.57 114.57 -174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.24 136.53 34.37 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.038 1.335 . . . . 0.57 108.239 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -117.24 165.15 13.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.664 0.785 . . . . 0.65 109.638 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -140.15 148.02 41.02 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.234 -1.024 . . . . 0.57 108.234 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -142.33 169.31 17.82 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.842 1.257 . . . . 1.2 109.661 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -103.75 149.39 25.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.571 -0.9 . . . . 0.57 108.571 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.78 167.49 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.399 1.08 . . . . 0.57 110.45 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.66 -40.83 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.514 0.726 . . . . 0.57 110.867 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -164.9 87.23 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.059 1.343 . . . . 0.57 107.392 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.41 160.5 11.56 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.219 -1.152 . . . . 0.57 110.219 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.1 m -66.38 136.11 55.29 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.258 1.029 . . . . 0.57 109.467 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.13 165.11 16.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.508 0.723 . . . . 0.57 111.494 175.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.37 -29.04 65.6 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.936 -1.029 . . . . 0.66 110.389 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.89 80.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.62 1.968 . . . . 0.57 108.731 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.7 ttm -69.37 128.27 35.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 120.653 -1.279 . . . . 0.57 107.684 163.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.18 127.1 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.163 -2.162 . . . . 0.57 105.163 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.42 158.63 26.55 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.505 -0.638 . . . . 0.57 111.505 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.8 m-85 -133.93 146.02 50.12 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 106.838 -1.542 . . . . 0.57 106.838 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.3 173.73 11.51 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.06 1.744 . . . . 0.57 108.537 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -134.12 66.77 1.53 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.461 1.028 . . . . 1.2 111.614 -169.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 105.37 0.49 Allowed Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.659 -0.976 . . . . 0.57 110.659 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 57.91 160.33 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.423 2.689 . . . . 0.57 114.474 -169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 170.24 10.46 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.998 1.319 . . . . 0.65 110.547 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.84 61.42 3.69 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.466 1.508 . . . . 0.57 112.37 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -131.47 -179.18 5.21 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.854 1.262 . . . . 0.66 109.909 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 p -58.23 -36.9 73.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.671 0.669 . . . . 0.57 111.25 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -135.57 112.12 10.74 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.447 0.699 . . . . 0.57 110.517 -172.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.95 130.32 18.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.918 1.745 . . . . 0.57 111.288 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -59.1 170.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.011 1.324 . . . . 0.57 113.585 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -115.41 -25.57 7.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.615 1.966 . . . . 0.66 112.168 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.81 -139.38 14.49 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 120.139 1.336 . . . . 0.57 111.408 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.19 98.28 1.19 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.361 2.707 . . . . 0.57 112.2 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.11 -176.4 23.4 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.706 1.146 . . . . 0.57 112.066 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 t30 52.27 -130.63 2.19 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 120.823 -1.398 . . . . 0.57 110.683 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.3 m -69.08 132.19 46.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.66 2.784 . . . . 0.57 110.828 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -102.27 -29.74 11.5 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.186 1.394 . . . . 0.57 112.741 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.7 32.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.076 1.35 . . . . 0.57 108.237 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -145.54 150.76 37.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.744 0.702 . . . . 0.65 110.113 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.52 165.35 28.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.806 0.842 . . . . 0.57 109.47 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -119.71 151.46 38.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.194 -1.039 . . . . 0.57 108.194 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.86 150.44 97.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.43 -0.795 . . . . 0.57 110.17 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 59.9 Cg_endo -72.8 154.41 53.85 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.216 1.944 . . . . 0.57 111.196 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.49 42.77 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.821 -0.989 . . . . 0.57 111.484 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.2 m 63.8 161.01 0.1 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.003 2.121 . . . . 0.57 112.491 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -140.39 28.65 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 121.06 -1.025 . . . . 0.57 110.852 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.71 -23.8 44.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.371 0.668 . . . . 0.57 111.525 171.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.77 139.61 31.84 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.002 -1.061 . . . . 0.57 110.907 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.13 -19.79 16.02 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.425 1.488 . . . . 0.57 113.286 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -71.92 155.92 39.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.954 1.377 . . . . 0.66 108.739 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.72 145.6 36.67 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.026 0.917 . . . . 0.57 109.598 -172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -138.07 147.1 43.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.002 -0.999 . . . . 0.65 108.465 -170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.443 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 41.4 m-85 -138.04 148.49 45.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.248 1.019 . . . . 0.57 108.434 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -95.04 100.64 12.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 106.634 -1.617 . . . . 0.66 106.634 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -59.61 -23.13 62.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.356 1.462 . . . . 0.66 111.495 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -60.48 -28.85 68.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.504 0.722 . . . . 0.66 111.088 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.4 129.68 34.73 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.177 -1.045 . . . . 0.66 108.177 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -64.04 112.41 2.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.394 0.677 . . . . 1.2 111.799 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.07 146.76 24.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.57 109.458 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -146.96 145.22 29.69 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.419 -0.956 . . . . 0.57 108.419 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.19 -39.79 93.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.077 0.551 . . . . 0.66 110.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.85 83.91 0.06 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.704 -1.758 . . . . 0.57 108.704 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.9 t -118.06 -62.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.677 0.738 . . . . 0.57 109.523 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -164.65 -45.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.85 1.26 . . . . 0.57 110.703 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.31 142.89 41.88 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.598 1.159 . . . . 0.57 109.441 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.3 -172.81 19.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.84 -1.704 . . . . 0.57 108.84 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.42 115.44 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.631 -1.618 . . . . 0.57 106.631 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.22 115.08 4.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.013 0.525 . . . . 0.57 110.05 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -66.13 -42.93 88.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.534 1.134 . . . . 0.57 111.693 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -42.65 90.66 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.078 0.951 . . . . 0.57 109.573 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -65.96 -49.61 67.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.857 0.863 . . . . 0.57 110.789 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -46.95 85.42 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.008 0.367 . . . . 0.57 111.737 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -50.0 75.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 117.97 -1.014 . . . . 0.57 108.588 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -53.72 -45.88 70.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.567 1.076 . . . . 0.57 111.307 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -58.09 -55.11 39.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.825 1.25 . . . . 0.65 109.708 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.73 -47.56 59.09 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.337 0.655 . . . . 0.66 111.194 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.52 -29.11 68.9 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.666 1.186 . . . . 0.57 110.799 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -61.1 -46.76 93.9 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 118.741 0.7 . . . . 0.57 112.373 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.15 -42.54 99.46 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.956 -1.021 . . . . 0.65 110.502 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.4 m -57.82 -32.67 67.81 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.086 0.866 . . . . 0.57 113.266 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -50.06 64.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.903 0.881 . . . . 0.57 109.928 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.21 32.34 0.03 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-O 117.862 -1.521 . . . . 0.57 114.995 -172.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.01 171.42 0.2 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.046 1.338 . . . . 0.57 111.713 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.26 43.6 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.53 -0.731 . . . . 0.57 113.601 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 166.94 18.39 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.909 1.355 . . . . 0.65 111.636 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -175.91 4.59 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.667 1.587 . . . . 0.57 109.388 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 35.69 1.28 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.529 1.532 . . . . 0.57 109.854 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.52 151.96 54.0 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.384 1.473 . . . . 0.66 109.376 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.16 -22.56 61.23 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.797 2.331 . . . . 0.57 113.219 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -130.44 27.48 5.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.544 1.537 . . . . 0.57 109.246 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 132.54 54.25 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 121.704 -0.623 . . . . 0.57 110.083 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.27 -23.45 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.554 0.742 . . . . 0.57 111.545 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.27 20.5 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.455 1.102 . . . . 0.57 111.381 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.01 133.32 80.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 119.511 1.05 . . . . 0.57 111.389 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.8 128.01 9.83 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.832 2.355 . . . . 0.57 110.753 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.5 m 70.78 115.15 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.094 2.158 . . . . 0.57 111.143 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.47 148.22 9.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.336 1.054 . . . . 0.57 112.939 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.91 -124.45 0.78 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.686 -0.966 . . . . 0.57 110.686 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.6 -37.21 83.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.569 1.148 . . . . 0.57 113.586 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.59 97.59 0.06 OUTLIER Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.817 1.198 . . . . 0.57 110.745 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -65.24 116.52 31.27 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.849 0.86 . . . . 0.66 108.885 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.4 -16.67 8.05 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 CA-C-O 117.53 -1.112 . . . . 0.57 112.964 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -61.18 -37.2 82.08 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.703 1.592 . . . . 0.57 109.279 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.14 122.35 14.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.566 1.146 . . . . 0.57 107.975 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -131.7 -55.64 1.0 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.653 1.181 . . . . 0.57 107.83 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 36.12 52.81 0.9 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.438 1.495 . . . . 0.57 111.005 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.01 90.89 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.021 2.128 . . . . 0.57 110.91 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -66.14 -83.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.829 1.418 . . . . 0.57 114.829 -168.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -143.84 -44.57 0.27 Allowed 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.863 1.665 . . . . 0.57 107.767 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.43 -51.69 33.74 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.81 1.244 . . . . 0.66 111.544 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -50.52 73.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.501 0.592 . . . . 0.66 111.598 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.81 -44.66 98.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 108.858 -0.793 . . . . 0.57 108.858 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -65.16 -44.81 87.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.698 -1.144 . . . . 0.57 108.971 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.47 -59.0 11.6 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.596 -1.002 . . . . 0.57 110.596 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 160' ' ' ILE . 6.1 mm -57.15 -48.65 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.361 1.08 . . . . 0.57 111.384 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -73.06 -15.46 61.5 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 120.02 1.282 . . . . 0.57 112.161 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -79.51 -32.11 42.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.678 1.126 . . . . 0.57 111.49 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.94 -43.64 11.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.283 1.433 . . . . 0.57 111.709 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -103.75 24.65 10.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.328 1.851 . . . . 0.57 110.928 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.0 -137.33 2.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 107.13 -2.388 . . . . 0.57 107.13 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -157.77 -54.78 0.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 117.956 0.878 . . . . 0.57 111.043 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? -46.33 137.7 6.15 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.167 1.787 . . . . 1.2 111.005 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 76.2 p -158.66 151.0 21.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.262 1.025 . . . . 0.57 109.072 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -84.2 156.08 22.21 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.264 0.555 . . . . 0.57 109.568 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.9 m -87.67 132.76 33.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.929 0.892 . . . . 0.57 108.875 170.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -158.7 160.63 36.63 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.106 -1.442 . . . . 1.2 107.106 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 134.39 24.82 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.127 -1.434 . . . . 0.57 107.127 168.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 125.63 1.572 . . . . 0.5 . 172.765 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.863 -0.113 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m -99.9 -68.12 0.82 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.301 -0.874 . . . . 0.57 109.46 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.5 tp -167.36 -61.12 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 CA-C-O 117.994 -1.003 . . . . 0.57 110.537 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 17.96 70.1 0.21 Allowed Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 128.472 2.709 . . . . 0.57 113.217 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.88 69.31 7.47 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.757 2.971 . . . . 0.57 109.3 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -131.16 -79.16 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.788 2.035 . . . . 0.57 107.825 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 p -167.15 60.67 0.55 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.509 1.124 . . . . 0.57 110.662 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.04 134.03 32.9 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.151 1.901 . . . . 0.57 108.842 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 82.57 111.28 0.06 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.405 2.282 . . . . 0.57 109.104 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -56.37 147.7 20.74 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.107 0.563 . . . . 0.57 111.276 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -77.35 -28.22 52.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.489 0.715 . . . . 0.57 111.514 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -84.37 144.25 28.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.798 0.839 . . . . 0.57 109.902 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -81.49 -8.74 59.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.085 0.954 . . . . 0.57 111.866 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.25 119.57 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.924 -2.25 . . . . 0.57 104.924 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.21 142.98 36.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.122 -1.436 . . . . 0.57 107.122 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -96.32 152.68 18.36 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.001 -0.437 . . . . 0.57 111.028 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -128.2 155.04 45.15 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.809 0.844 . . . . 0.57 111.662 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 114.07 4.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 1.2 109.566 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.8 mt -85.43 86.11 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.222 -1.77 . . . . 0.57 106.222 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -68.25 -29.96 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.313 1.445 . . . . 0.57 113.846 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -136.57 160.26 39.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 130.714 3.606 . . . . 0.57 102.827 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -135.84 163.98 28.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.668 1.187 . . . . 0.57 108.345 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.416 HG22 HG21 ' A' ' 31' ' ' VAL . 5.7 t -74.02 -175.07 2.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.94 0.896 . . . . 0.57 111.409 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -44.2 1.86 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.667 1.187 . . . . 1.2 113.211 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -32.52 67.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.399 1.08 . . . . 0.66 110.791 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 105' ' ' THR . 46.0 mt -123.2 143.51 41.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.311 1.444 . . . . 0.57 109.243 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.35 152.09 38.73 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.765 1.643 . . . . 0.57 111.789 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -62.18 -37.24 84.52 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.07 1.348 . . . . 0.65 112.199 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.76 -42.86 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.819 . . . . 0.57 109.847 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.5 m -70.55 -38.73 74.19 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 117.209 -1.377 . . . . 0.57 110.042 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG21 HG22 ' A' ' 23' ' ' THR . 24.8 t -59.39 -45.66 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.434 1.47 . . . . 0.57 110.978 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.98 -41.09 78.37 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.93 0.786 . . . . 0.66 110.788 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.17 87.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.933 -1.104 . . . . 1.2 112.631 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -64.79 -39.56 93.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.615 -0.883 . . . . 0.57 108.615 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.66 -43.63 98.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 119.207 0.912 . . . . 0.57 110.415 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -59.1 -48.53 81.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.831 -1.08 . . . . 0.57 111.79 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -67.66 -34.45 76.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.583 1.538 . . . . 0.57 112.173 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.57 -40.7 76.6 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.105 1.321 . . . . 0.57 112.185 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.2 mt -72.98 -32.32 65.11 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 118.561 -0.733 . . . . 0.57 110.888 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.64 -47.38 86.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 119.138 0.881 . . . . 0.57 109.252 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.0 mtp -54.24 -36.59 63.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 117.226 -1.368 . . . . 0.57 112.442 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -72.5 -44.4 62.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.165 1.802 . . . . 0.57 112.352 171.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.93 59.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.17 0.89 . . . . 0.57 113.273 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -14.46 62.94 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.193 -1.18 . . . . 0.57 111.809 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -115.88 -29.11 6.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.53 1.132 . . . . 0.66 110.73 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 pt -123.66 132.72 24.3 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.524 1.13 . . . . 0.57 110.982 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.0 34.9 0.37 Allowed 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.235 3.29 . . . . 0.57 113.934 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.56 137.22 35.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.423 1.489 . . . . 0.57 107.782 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -121.12 159.56 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.04 1.336 . . . . 0.65 109.177 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 149.39 44.04 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.954 -1.091 . . . . 0.57 109.882 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.21 179.3 7.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.988 0.915 . . . . 1.2 110.68 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -118.71 161.3 20.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.407 1.083 . . . . 0.57 109.12 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.3 m -121.44 160.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.487 1.515 . . . . 0.57 108.88 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.97 29.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.32 1.048 . . . . 0.57 110.373 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -54.63 1.26 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.403 1.081 . . . . 0.57 110.394 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.27 -135.91 2.31 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.227 -1.149 . . . . 0.57 110.227 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 58' ' ' ALA . 5.0 m -83.65 176.94 8.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.561 1.145 . . . . 0.57 109.922 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 57' ' ' THR . . . -135.76 173.46 11.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.894 1.678 . . . . 0.57 110.285 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.19 -39.9 91.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.416 -0.802 . . . . 0.66 109.868 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.4 mt -117.93 75.33 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.204 2.202 . . . . 0.57 108.746 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.98 128.81 37.24 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.789 -1.194 . . . . 0.57 108.854 166.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.95 129.85 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 104.784 -2.302 . . . . 0.57 104.784 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.08 170.77 27.17 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.269 -0.733 . . . . 0.57 111.269 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.7 m-85 -144.59 151.16 38.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.782 -1.192 . . . . 0.57 107.782 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.3 171.01 18.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.822 1.326 . . . . 0.57 110.417 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 57.17 1.67 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.613 0.765 . . . . 1.2 111.019 -173.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -46.33 1.1 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.743 1.163 . . . . 0.57 111.482 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.69 157.45 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.558 1.179 . . . . 0.57 109.573 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -153.6 163.44 39.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.211 1.805 . . . . 0.65 108.336 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.21 85.59 1.53 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.88 -1.288 . . . . 0.57 109.88 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -130.92 -55.11 1.06 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.834 0.854 . . . . 0.66 110.998 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 157.76 -38.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.748 2.819 . . . . 0.57 110.156 -166.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -129.93 110.5 17.06 Favored Pre-proline 0 C--N 1.345 0.382 0 CA-C-N 119.794 1.179 . . . . 0.57 110.447 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.25 133.12 36.46 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 108.736 -1.294 . . . . 0.57 108.736 173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.55 -169.81 0.35 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.64 1.576 . . . . 0.57 110.217 172.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -119.63 -35.01 3.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.266 2.226 . . . . 0.66 109.815 -168.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.6 -146.37 18.18 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.925 1.25 . . . . 0.57 110.203 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.99 111.31 3.21 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.527 2.818 . . . . 0.57 112.22 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.31 160.09 13.92 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 128.099 2.762 . . . . 0.57 109.71 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.271 33.3 t30 70.57 -143.51 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.112 1.765 . . . . 0.57 112.528 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -49.92 138.79 14.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.324 1.85 . . . . 0.57 110.795 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 112' ' ' ILE . 38.2 mt -108.74 -28.96 8.93 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.72 -1.863 . . . . 0.57 112.303 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.22 165.41 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.573 1.149 . . . . 0.57 108.13 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -146.51 161.71 39.86 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.547 -0.538 . . . . 0.65 109.547 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.34 161.7 39.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.835 1.254 . . . . 0.57 109.106 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.52 150.7 34.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.393 -0.965 . . . . 0.57 108.393 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.9 91.17 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.562 -0.732 . . . . 0.57 109.856 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.4 161.21 45.81 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.29 1.994 . . . . 0.57 110.91 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.25 -83.48 0.18 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.835 -0.906 . . . . 0.57 110.835 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.7 p -78.15 -177.72 5.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.5 1.52 . . . . 0.57 111.272 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.81 -52.49 50.55 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.253 -1.304 . . . . 0.57 112.854 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -20.21 61.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.297 1.049 . . . . 0.57 110.967 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.51 148.74 11.29 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 120.756 -1.215 . . . . 0.57 111.18 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.11 1.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 117.259 -1.856 . . . . 0.57 114.924 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -68.22 156.18 38.15 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 125.306 1.239 . . . . 0.66 109.833 -160.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.78 144.48 31.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.57 110.956 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -131.19 157.79 42.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.024 -0.989 . . . . 0.65 109.437 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 69.1 m-85 -140.01 145.79 38.24 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.308 1.443 . . . . 0.57 108.516 -170.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.21 93.62 4.63 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.29 -0.633 . . . . 0.66 109.29 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -53.45 -28.04 28.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.799 1.24 . . . . 0.66 111.27 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.01 -33.62 76.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.758 0.281 . . . . 0.66 111.758 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.89 138.61 46.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.115 -1.439 . . . . 0.66 107.115 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -62.93 134.16 55.76 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.468 -0.77 . . . . 1.2 109.656 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -118.49 143.32 46.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.622 0.769 . . . . 0.57 109.444 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.442 ' HA ' HD21 ' A' ' 26' ' ' LEU . 3.6 t -138.89 151.75 47.21 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.339 0.656 . . . . 0.57 110.761 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.75 -38.19 83.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.467 0.707 . . . . 0.66 109.898 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.46 101.44 0.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.006 -1.638 . . . . 0.57 109.006 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.27 170.43 21.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.759 2.024 . . . . 0.57 108.647 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.74 72.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.247 1.419 . . . . 0.57 114.447 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.72 149.77 34.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.997 -0.742 . . . . 0.57 108.997 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.42 153.37 14.65 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.534 -1.426 . . . . 0.57 109.534 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.499 HG21 HD13 ' A' ' 82' ' ' LEU . 45.4 mm -78.36 130.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.78 -1.563 . . . . 0.57 106.78 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -65.53 109.04 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.428 -0.582 . . . . 0.57 109.428 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 34' ' ' LEU . 2.4 t80 -56.07 -43.57 78.09 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.24 1.416 . . . . 0.57 109.01 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 34' ' ' LEU . 12.7 tp -68.83 -38.54 79.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.589 0.631 . . . . 0.57 111.943 -173.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -65.01 -44.4 89.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.835 -0.802 . . . . 0.57 108.835 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -50.42 70.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.646 0.379 . . . . 0.57 111.23 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.09 75.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.109 -0.948 . . . . 0.57 109.86 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -60.52 -33.46 72.67 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.795 1.179 . . . . 0.57 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.3 -58.62 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.338 0.972 . . . . 0.65 109.978 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -64.3 -43.1 95.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.449 0.7 . . . . 0.66 111.272 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.09 -27.76 69.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.885 1.274 . . . . 0.57 110.971 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.33 -50.91 62.68 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.389 -0.684 . . . . 0.57 111.389 171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -59.18 -43.02 92.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.191 -0.909 . . . . 0.65 110.666 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -38.44 64.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.438 1.711 . . . . 0.57 114.035 174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -44.96 86.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.789 0.836 . . . . 0.57 110.949 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.67 43.32 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-O 118.688 -1.062 . . . . 0.57 114.338 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -121.77 150.77 41.37 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.926 1.363 . . . . 0.57 110.416 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -98.55 -43.32 2.74 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.455 -1.747 . . . . 0.57 113.191 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m170 163.75 179.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.95 2.9 . . . . 0.65 109.899 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 3.9 m -147.62 179.03 7.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.545 1.938 . . . . 0.57 109.508 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -146.52 81.83 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.437 1.095 . . . . 0.57 109.996 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -147.11 146.38 25.43 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.266 -1.012 . . . . 0.66 108.266 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.24 -32.25 42.56 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 CA-C-N 121.407 1.538 . . . . 0.57 111.882 -171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -116.84 23.86 11.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.031 1.332 . . . . 0.57 109.254 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -63.33 136.48 57.69 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.017 0.927 . . . . 0.57 109.266 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.43 -32.37 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 118.927 -1.109 . . . . 0.57 109.631 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.73 7.55 10.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.575 1.08 . . . . 0.57 113.17 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -69.03 145.8 96.8 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.895 1.679 . . . . 0.57 110.967 -176.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.04 166.21 30.65 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.08 1.853 . . . . 0.57 110.971 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 m 65.56 -67.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.662 1.985 . . . . 0.57 111.673 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 161.84 1.17 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.285 2.234 . . . . 0.57 107.366 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.1 136.22 12.81 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.061 -1.616 . . . . 0.57 109.061 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -71.89 -16.25 62.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.463 1.105 . . . . 0.57 112.394 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -78.29 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.573 -1.411 . . . . 0.57 109.573 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -174.85 144.74 0.87 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.955 1.302 . . . . 0.66 108.776 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.36 -23.24 8.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.275 1.983 . . . . 0.57 114.992 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -103.24 -39.31 6.88 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.456 1.48 . . . . 0.57 110.308 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.9 70.28 10.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.967 1.307 . . . . 0.57 109.563 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.5 150.77 40.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.289 0.636 . . . . 0.57 110.44 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.29 62.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.869 1.268 . . . . 0.57 110.052 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mp 62.69 87.45 0.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.224 1.41 . . . . 0.57 111.237 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.5 m -71.83 -97.51 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.802 1.241 . . . . 0.57 113.424 -171.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -122.99 -51.79 1.89 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 120.879 -1.138 . . . . 0.57 108.166 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 0.6 OUTLIER -51.06 -39.55 56.25 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.536 0.939 . . . . 0.66 113.536 177.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -69.07 -55.36 11.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.437 1.095 . . . . 0.66 110.748 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.58 -38.99 81.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-O 117.959 -1.02 . . . . 0.57 108.598 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.38 86.89 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 120.167 1.349 . . . . 0.57 109.51 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.33 31.47 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.247 -0.741 . . . . 0.57 111.247 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 160' ' ' ILE . 5.6 mm -64.3 -48.82 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.009 0.524 . . . . 0.57 111.803 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -17.56 64.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.426 1.09 . . . . 0.57 111.894 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -42.92 17.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.869 -1.062 . . . . 0.57 109.662 172.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.78 -49.23 60.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.559 1.144 . . . . 0.57 111.426 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -97.54 3.88 50.49 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.941 1.296 . . . . 0.57 111.302 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.46 94.11 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.757 1.17 . . . . 0.57 113.868 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -152.02 -45.54 0.11 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.47 0.708 . . . . 0.57 112.256 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.6 128.24 10.81 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.228 -1.397 . . . . 1.2 107.228 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.8 t -86.25 160.11 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.57 107.497 167.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -67.17 164.19 18.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.888 -0.597 . . . . 0.57 110.557 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.6 t 70.71 -167.89 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.131 1.372 . . . . 0.57 110.691 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.0 126.76 29.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.409 -0.807 . . . . 1.2 109.29 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -76.02 168.98 19.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.916 1.687 . . . . 0.57 110.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 129.217 3.007 . . . . 0.5 . 172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 119.363 -0.351 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t -162.96 -78.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.437 -2.801 . . . . 0.57 103.437 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.87 72.41 0.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.959 0.904 . . . . 0.57 109.703 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 36.79 57.4 3.58 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.53 1.532 . . . . 0.57 114.074 -175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.94 175.34 11.35 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.979 2.453 . . . . 0.57 111.819 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -77.81 -71.12 0.44 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.102 0.561 . . . . 0.57 111.554 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -160.44 68.53 2.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.903 1.681 . . . . 0.57 106.82 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.23 167.61 21.57 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 120.888 1.059 . . . . 0.57 110.821 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt 83.51 115.91 0.05 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 127.429 2.292 . . . . 0.57 108.997 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 4.2 m95 -64.93 163.03 15.27 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.096 0.558 . . . . 0.57 111.558 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.9 m -89.35 -24.46 21.97 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.418 1.087 . . . . 0.57 111.997 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -91.28 149.11 21.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.585 0.754 . . . . 0.57 109.797 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -5.84 52.98 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.961 0.726 . . . . 0.57 112.961 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.56 139.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.57 107.189 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.58 148.3 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.452 -1.314 . . . . 0.57 107.452 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.9 p -97.52 139.61 33.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.852 -0.795 . . . . 0.57 108.852 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -126.97 159.9 32.7 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.822 -0.549 . . . . 0.57 110.995 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -153.09 160.25 42.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.103 1.361 . . . . 1.2 108.301 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.56 94.24 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.086 -2.561 . . . . 0.57 104.086 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -40.69 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.112 0.965 . . . . 0.57 112.152 -170.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.12 153.4 41.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.146 -2.168 . . . . 0.57 105.146 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -134.98 143.19 46.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.058 0.943 . . . . 0.57 108.463 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -72.18 169.02 17.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.256 -1.338 . . . . 0.57 110.165 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -24.89 5.89 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.731 0.812 . . . . 1.2 112.881 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -35.43 80.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.942 0.877 . . . . 0.66 111.224 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.58 154.14 78.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.122 1.769 . . . . 0.57 109.629 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.19 161.15 29.4 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.702 1.602 . . . . 0.57 112.933 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.84 -35.45 80.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.65 111.342 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -64.84 -35.68 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.523 0.729 . . . . 0.57 110.55 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -64.73 -51.11 64.1 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.296 -1.335 . . . . 0.57 108.15 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.51 -49.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 120.398 1.454 . . . . 0.57 110.856 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.19 -39.86 90.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.519 1.054 . . . . 0.66 111.487 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -65.05 -42.98 93.74 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.642 1.11 . . . . 1.2 111.818 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.53 -43.64 89.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.402 0.681 . . . . 0.57 109.599 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.61 -45.12 99.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.017 -0.992 . . . . 0.57 110.035 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -60.96 -45.2 95.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.72 1.145 . . . . 0.57 111.504 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -36.95 73.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.66 1.118 . . . . 0.57 111.418 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.374 0.988 . . . . 0.57 111.519 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.4 -33.26 72.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.252 -0.88 . . . . 0.57 110.557 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.38 -42.36 91.48 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 119.439 1.018 . . . . 0.57 110.211 167.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.2 mtp -64.74 -33.38 75.83 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 119.912 1.233 . . . . 0.57 111.592 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -70.72 -44.47 66.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.2 1.364 . . . . 0.57 111.147 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.89 -8.1 77.08 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.205 -0.934 . . . . 0.57 113.734 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -65.92 -24.43 66.83 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.017 -1.284 . . . . 0.57 111.047 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.39 -41.29 7.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.958 -0.544 . . . . 0.66 110.789 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 164' ' ' TYR . 15.9 pt -117.25 139.21 25.71 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 124.02 0.928 . . . . 0.57 110.248 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.05 35.26 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.898 3.066 . . . . 0.57 114.13 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -90.87 132.0 36.17 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.695 1.598 . . . . 0.57 107.476 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -123.7 165.95 16.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.971 0.909 . . . . 0.65 109.411 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.26 144.86 33.5 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.343 -0.984 . . . . 0.57 108.343 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -143.05 165.33 27.67 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.861 0.865 . . . . 1.2 108.982 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -107.89 140.31 41.19 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.934 -1.135 . . . . 0.57 107.934 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -90.53 161.26 2.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.354 0.597 . . . . 0.57 110.112 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.31 -14.85 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.508 1.123 . . . . 0.57 111.602 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -58.96 2.98 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.829 0.852 . . . . 0.57 109.956 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.39 146.54 4.83 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.864 -1.295 . . . . 0.57 109.864 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.3 m 59.55 144.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.164 2.186 . . . . 0.57 112.709 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.2 170.32 15.97 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 120.857 -1.152 . . . . 0.57 110.119 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -58.68 -48.96 79.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.121 -1.066 . . . . 0.66 108.121 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.39 87.2 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.57 108.335 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 ttm -84.59 111.87 19.92 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.014 -1.106 . . . . 0.57 108.014 170.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.53 132.03 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 106.392 -1.707 . . . . 0.57 106.392 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -156.4 154.41 25.51 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 121.259 -0.901 . . . . 0.57 112.094 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -129.37 153.08 48.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.366 1.083 . . . . 0.57 110.672 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.95 178.14 7.31 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.044 1.337 . . . . 0.57 109.915 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -132.25 66.95 1.54 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.677 -1.231 . . . . 1.2 107.677 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.34 -40.99 2.3 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.11 -0.828 . . . . 0.57 112.759 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.36 164.84 12.92 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.261 1.53 . . . . 0.57 110.933 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 -109.71 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.508 2.323 . . . . 0.65 106.349 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.41 71.33 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.691 -1.764 . . . . 0.57 108.691 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.62 -56.68 2.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.716 1.206 . . . . 0.66 109.116 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.9 t 177.43 -39.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.795 2.038 . . . . 0.57 108.983 -169.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.84 102.13 44.65 Favored Pre-proline 0 C--N 1.345 0.395 0 CA-C-N 118.463 0.574 . . . . 0.57 109.455 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.67 144.39 84.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.943 1.015 . . . . 0.57 109.504 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -69.84 -168.02 0.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.061 . . . . 0.57 110.777 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.41 -31.68 4.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.485 3.114 . . . . 0.66 110.755 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -152.24 17.35 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 119.97 1.259 . . . . 0.57 111.816 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.18 61.94 4.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 125.168 3.912 . . . . 0.57 114.776 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.52 18.6 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.637 1.589 . . . . 0.57 112.521 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 31.4 -130.34 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.322 2.649 . . . . 0.57 114.225 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -61.43 119.54 8.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.651 1.981 . . . . 0.57 110.535 171.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.16 -34.6 22.07 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.961 1.304 . . . . 0.57 113.51 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.64 161.36 38.63 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.201 1.0 . . . . 0.57 108.644 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -149.11 151.73 34.91 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 122.955 0.502 . . . . 0.65 109.878 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.7 157.74 44.36 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.475 0.71 . . . . 0.57 109.502 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -109.95 145.06 37.56 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.734 -0.839 . . . . 0.57 108.734 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 151.11 92.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.57 109.887 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 48.9 Cg_endo -67.94 157.68 60.71 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.338 2.025 . . . . 0.57 111.887 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.34 21.43 0.02 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.226 1.251 . . . . 0.57 116.226 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.309 37.0 p 64.8 71.57 0.46 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.28 2.232 . . . . 0.57 113.743 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.39 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 120.783 -1.198 . . . . 0.57 112.38 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.54 -6.05 37.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.733 1.613 . . . . 0.57 111.211 164.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.93 129.75 13.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.115 -1.594 . . . . 0.57 109.115 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.3 -27.01 20.04 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.012 1.768 . . . . 0.57 112.758 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.07 147.26 53.8 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.795 -1.187 . . . . 0.66 107.795 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.58 141.15 35.23 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.058 0.943 . . . . 0.57 109.39 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 46.6 m170 -129.92 152.68 49.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.482 0.713 . . . . 0.65 110.411 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.08 154.75 42.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.036 0.934 . . . . 0.57 108.485 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.45 98.94 11.22 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.781 -0.822 . . . . 0.66 108.781 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -56.63 -25.77 54.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.651 1.981 . . . . 0.66 112.299 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -56.25 -40.63 74.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.594 1.157 . . . . 0.66 110.218 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.49 126.9 31.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.035 0.934 . . . . 0.66 108.575 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.97 98.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.617 1.167 . . . . 1.2 111.818 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.59 145.82 28.64 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.932 -1.136 . . . . 0.57 107.932 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -141.73 147.09 36.83 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.759 -1.2 . . . . 0.57 107.759 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.77 17.08 5.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.506 1.122 . . . . 0.66 112.365 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.39 -151.7 23.35 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.76 2.124 . . . . 0.57 108.006 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.81 -173.52 0.19 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.026 0.93 . . . . 0.57 110.934 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 p -109.23 179.52 4.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.037 1.335 . . . . 0.57 109.228 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.94 -58.87 0.57 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.499 2.32 . . . . 0.57 113.686 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 169.93 53.33 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.766 1.651 . . . . 0.57 110.36 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.1 120.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.976 -0.749 . . . . 0.57 108.976 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.05 112.73 3.11 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.822 0.701 . . . . 0.57 109.595 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.18 -40.13 64.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.22 1.008 . . . . 0.57 110.587 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.94 -42.98 84.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.168 0.44 . . . . 0.57 110.088 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.17 -45.12 95.94 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.663 -0.495 . . . . 0.57 109.663 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.97 66.29 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.393 0.677 . . . . 0.57 111.443 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -53.36 55.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.166 -0.921 . . . . 0.57 109.433 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 84.8 m -57.57 -37.76 73.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.684 1.129 . . . . 0.57 111.309 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -62.71 -54.36 40.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.935 0.789 . . . . 0.65 110.461 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.81 -43.15 84.58 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.149 0.979 . . . . 0.66 110.795 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.33 -30.36 71.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 0.57 111.226 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.05 -51.6 57.35 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.581 -1.008 . . . . 0.57 110.581 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.21 -46.08 89.41 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.243 -0.884 . . . . 0.65 111.016 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.8 p -61.94 -32.39 72.8 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 123.969 0.793 . . . . 0.57 112.364 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -46.38 89.82 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.561 0.744 . . . . 0.57 110.54 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.91 36.66 0.02 OUTLIER Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.796 -1.002 . . . . 0.57 114.372 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -124.99 163.59 21.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.141 1.47 . . . . 0.57 109.613 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.97 -47.0 0.17 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.61 -1.661 . . . . 0.57 111.788 -169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m170 167.38 -177.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.707 2.803 . . . . 0.65 107.964 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.6 p -152.07 -174.44 4.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.394 1.078 . . . . 0.57 108.478 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.7 m -137.04 67.61 1.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.525 1.53 . . . . 0.57 108.759 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -133.92 143.64 48.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.528 -0.916 . . . . 0.66 108.528 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.89 -14.91 21.29 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.818 2.345 . . . . 0.57 112.981 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 32.83 4.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.379 1.472 . . . . 0.57 109.462 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -92.59 143.18 26.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.57 109.875 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -67.46 -31.85 54.56 Favored 'Isoleucine or valine' 0 C--O 1.23 0.044 0 N-CA-C 109.401 -0.592 . . . . 0.57 109.401 166.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -19.2 64.85 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 117.057 -1.449 . . . . 0.57 112.236 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -49.9 109.81 1.4 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.266 1.394 . . . . 0.57 110.524 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.1 38.91 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.215 2.61 . . . . 0.57 113.331 -171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.2 m -150.28 132.58 15.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.666 1.586 . . . . 0.57 107.032 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -81.7 101.57 10.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.859 -1.163 . . . . 0.57 107.859 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.68 -108.66 0.31 Allowed Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.572 -0.571 . . . . 0.57 112.585 -171.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -38.03 87.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.714 0.806 . . . . 0.57 112.352 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.05 90.82 0.06 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 124.967 1.27 . . . . 0.57 110.767 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -52.68 115.53 7.34 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.758 2.023 . . . . 0.66 109.883 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.3 -23.58 5.06 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.44 2.093 . . . . 0.57 113.269 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -69.43 -39.59 77.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.863 1.211 . . . . 0.57 110.524 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -141.17 116.64 10.16 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.415 1.086 . . . . 0.57 108.902 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 15.0 p90 -147.2 -49.36 0.18 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.909 0.884 . . . . 0.57 111.207 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER 30.61 52.98 0.14 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 127.321 2.248 . . . . 0.57 113.113 -176.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp 63.32 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.006 1.722 . . . . 0.57 110.935 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -70.65 -82.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.051 0.94 . . . . 0.57 112.974 -165.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -144.63 -48.51 0.26 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 125.53 1.532 . . . . 0.57 108.566 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -47.3 51.93 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.473 1.909 . . . . 0.66 112.913 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.61 -54.42 47.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.756 0.822 . . . . 0.66 110.827 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.15 -45.73 92.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.329 1.052 . . . . 0.57 108.921 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -63.71 -41.91 98.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.812 1.245 . . . . 0.57 109.368 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.03 -49.03 69.93 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.743 -0.943 . . . . 0.57 110.743 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.65 -47.19 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 117.774 0.787 . . . . 0.57 110.995 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -66.79 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.904 -0.569 . . . . 0.57 112.063 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.45 43.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.292 0.951 . . . . 0.57 110.612 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mp -78.45 -41.94 31.34 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.959 0.8 . . . . 0.57 112.554 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 46' ' ' ILE . 70.1 m-85 -131.13 -29.13 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.202 0.815 . . . . 0.57 113.202 -169.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.24 172.35 34.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.618 -1.393 . . . . 0.57 109.618 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -72.58 -49.49 31.94 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.096 -0.649 . . . . 0.57 110.898 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 11.3 ptt-85 177.68 160.63 0.5 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.773 2.029 . . . . 1.2 107.525 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 t -139.34 -52.53 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.013 0.525 . . . . 0.57 110.331 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.17 142.69 14.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.606 -1.627 . . . . 0.57 106.606 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.4 80.75 1.76 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.328 -0.99 . . . . 0.57 108.328 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -157.07 152.75 26.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.8 -0.815 . . . . 1.2 108.8 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.5 174.41 14.71 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.917 1.687 . . . . 0.57 108.635 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 C-N-CA 124.905 1.282 . . . . 0.5 . 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 117.511 -1.233 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -125.88 57.37 1.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.443 1.497 . . . . 0.57 108.221 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.55 129.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.909 2.084 . . . . 0.57 110.037 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 55.27 96.84 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.624 1.57 . . . . 0.57 113.069 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 89.2 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.178 2.585 . . . . 0.57 110.594 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -113.85 175.03 5.64 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.967 1.307 . . . . 0.57 109.677 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.27 116.76 66.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.795 -1.558 . . . . 0.57 106.795 168.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB2' ' HA ' ' A' ' 163' ' ' LEU . 35.7 Cg_endo -74.24 158.04 45.41 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.61 1.54 . . . . 0.57 110.171 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.58 110.45 0.05 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.529 1.532 . . . . 0.57 108.25 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 53.6 m95 -48.38 150.81 1.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.441 0.696 . . . . 0.57 110.577 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.6 p -60.95 -24.23 65.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.57 111.807 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.0 t -99.88 152.29 20.32 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.752 1.621 . . . . 0.57 109.79 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -8.48 55.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.57 112.715 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.89 119.04 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.833 -2.284 . . . . 0.57 104.833 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.87 142.41 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.347 -1.353 . . . . 0.57 107.347 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -109.15 150.17 28.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.399 -0.813 . . . . 0.57 110.432 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -127.0 148.71 50.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.665 -0.698 . . . . 0.57 111.14 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.73 114.43 7.24 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.521 -0.918 . . . . 1.2 108.521 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.81 89.12 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 106.132 -1.803 . . . . 0.57 106.132 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.08 -30.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.856 1.262 . . . . 0.57 113.486 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.11 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.245 -2.502 . . . . 0.57 104.245 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' HIS . 88.4 m-85 -135.47 -178.88 5.32 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.547 1.139 . . . . 0.57 108.367 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 t -97.63 -162.69 0.98 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.57 109.817 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -136.54 -31.52 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.053 1.131 . . . . 1.2 114.053 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.15 -38.8 65.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.826 1.25 . . . . 0.66 109.957 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.64 153.28 81.05 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.267 2.227 . . . . 0.57 109.85 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.85 158.24 42.9 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.803 2.335 . . . . 0.57 113.475 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' HB2' ' CE1' ' A' ' 22' ' ' TYR . 12.8 p80 -62.38 -36.72 83.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.748 1.219 . . . . 0.65 113.193 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -65.79 -37.17 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.081 0.552 . . . . 0.57 110.52 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -63.27 -47.67 81.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 116.894 -1.527 . . . . 0.57 108.101 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.24 -50.19 48.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 CA-C-N 120.41 1.459 . . . . 0.57 110.762 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.36 -46.07 91.73 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.939 1.245 . . . . 0.66 111.989 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -45.43 94.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.728 -0.607 . . . . 1.2 111.55 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.88 -43.11 94.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.408 -1.282 . . . . 0.57 109.068 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -45.17 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 120.321 1.419 . . . . 0.57 109.918 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.1 91.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.063 0.847 . . . . 0.57 110.379 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -70.33 -37.08 74.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.972 0.909 . . . . 0.57 112.389 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -48.4 74.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.083 1.753 . . . . 0.57 110.908 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -67.57 -30.05 69.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.159 -0.924 . . . . 0.57 110.825 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.62 -36.94 77.32 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.342 0.974 . . . . 0.57 110.165 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.66 -38.22 88.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.406 -1.283 . . . . 0.57 111.69 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -73.76 -41.27 62.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.851 1.205 . . . . 0.57 111.677 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -5.46 55.66 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.915 -1.116 . . . . 0.57 112.362 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -19.56 64.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 118.552 1.176 . . . . 0.57 111.319 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.21 -35.55 5.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.313 1.045 . . . . 0.66 112.023 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.414 HG22 ' CD1' ' A' ' 164' ' ' TYR . 16.3 pt -106.2 129.55 24.37 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 119.616 1.098 . . . . 0.57 110.627 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.47 40.43 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.956 3.104 . . . . 0.57 112.332 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.47 143.78 28.35 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.0 1.32 . . . . 0.57 107.786 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -125.83 162.41 25.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.572 -0.899 . . . . 0.65 108.572 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 160.05 40.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.631 -0.877 . . . . 0.57 108.631 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -143.65 174.96 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -123.48 162.08 23.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.767 -1.197 . . . . 0.57 107.767 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.54 175.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.153 1.781 . . . . 0.57 108.494 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.3 -29.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.212 1.005 . . . . 0.57 111.901 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -63.39 -62.08 1.92 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.094 1.358 . . . . 0.57 112.512 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.39 38.14 0.15 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.354 0.502 . . . . 0.57 113.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.6 t -166.47 149.06 6.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.355 1.462 . . . . 0.57 107.316 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.19 -178.62 3.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.878 1.271 . . . . 0.57 109.983 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.31 -35.33 75.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.297 0.639 . . . . 0.66 109.915 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.27 69.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.595 1.958 . . . . 0.57 107.748 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.12 118.9 16.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.099 -1.626 . . . . 0.57 107.205 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.55 125.93 65.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.564 -2.013 . . . . 0.57 105.564 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.63 165.69 26.39 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 110.702 -0.959 . . . . 0.57 110.702 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.4 m-85 -133.2 148.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.042 -1.466 . . . . 0.57 107.042 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.86 -171.65 3.49 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.494 1.517 . . . . 0.57 108.767 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -122.59 179.92 4.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 1.2 108.953 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -39.84 106.41 0.06 OUTLIER Glycine 0 C--N 1.342 0.872 0 C-N-CA 126.084 1.802 . . . . 0.57 110.615 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 56.05 137.06 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.429 2.692 . . . . 0.57 115.169 -166.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 11.8 p-80 -154.21 159.08 41.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.003 0.921 . . . . 0.65 109.99 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.62 55.04 1.99 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.706 1.146 . . . . 0.57 111.321 -170.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -108.58 -50.16 3.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.515 0.726 . . . . 0.66 110.511 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.13 -35.47 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.862 2.065 . . . . 0.57 110.874 -166.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.2 100.43 7.07 Favored Pre-proline 0 C--N 1.347 0.492 0 CA-C-N 119.975 1.262 . . . . 0.57 109.958 -170.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.97 120.27 7.47 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.076 1.184 . . . . 0.57 110.591 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 12.5 m-85 -63.44 164.15 9.72 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 125.195 1.398 . . . . 0.57 110.594 167.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.28 -37.29 11.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.891 2.476 . . . . 0.66 112.017 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.41 -147.01 18.91 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 119.444 1.02 . . . . 0.57 112.018 -170.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.96 72.17 4.01 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.857 3.704 . . . . 0.57 115.04 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.87 37.15 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.49 -1.381 . . . . 0.57 111.815 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 38.6 -129.48 0.23 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.57 114.016 167.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -64.7 118.63 9.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.139 2.176 . . . . 0.57 111.154 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.1 mp -93.71 -33.57 13.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.89 1.276 . . . . 0.57 112.795 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.83 29.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.928 1.291 . . . . 0.57 107.625 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -142.6 159.65 41.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.649 0.779 . . . . 0.65 108.938 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.71 167.12 30.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.263 0.625 . . . . 0.57 109.42 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -120.07 152.75 37.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.742 -0.663 . . . . 0.57 109.512 -171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.33 153.63 85.62 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.098 -0.953 . . . . 0.57 110.011 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 20.2 Cg_endo -65.33 162.98 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.889 1.726 . . . . 0.57 111.38 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 -100.02 0.15 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.168 -1.573 . . . . 0.57 109.168 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -157.24 120.14 3.99 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.262 -1.385 . . . . 0.57 107.262 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.96 -121.49 6.69 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.046 -1.419 . . . . 0.57 110.275 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.45 -27.9 58.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.637 1.175 . . . . 0.57 111.546 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.92 144.26 7.68 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.106 -0.996 . . . . 0.57 111.754 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.21 -26.72 2.89 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.48 1.514 . . . . 0.57 113.917 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.48 150.66 48.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.461 1.131 . . . . 0.66 108.936 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.1 146.22 48.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.611 1.196 . . . . 0.57 109.055 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 144.78 37.94 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.409 -1.269 . . . . 0.65 108.795 -169.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 50.9 m-85 -139.02 149.63 44.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.288 -1.375 . . . . 0.57 107.288 -166.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -94.69 99.05 11.23 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.091 -1.077 . . . . 0.66 108.091 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.24 -24.37 41.96 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.718 2.007 . . . . 0.66 111.785 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -59.21 -41.92 89.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.179 -0.304 . . . . 0.66 110.179 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.34 134.42 47.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.746 -0.835 . . . . 0.66 108.746 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -61.19 133.3 55.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.827 -0.434 . . . . 1.2 109.827 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -117.95 140.72 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.102 -1.444 . . . . 0.57 107.102 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -140.12 148.75 42.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.988 0.813 . . . . 0.57 109.431 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.79 -40.0 78.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.332 1.053 . . . . 0.66 111.338 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 155.69 58.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.394 0.997 . . . . 0.57 110.926 -170.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -153.1 170.81 19.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.926 0.863 . . . . 0.57 110.093 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -70.15 77.34 0.51 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.57 111.41 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -48.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.585 1.154 . . . . 0.57 112.995 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.53 -152.0 6.69 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.466 -1.454 . . . . 0.57 109.466 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.52 131.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.234 -0.654 . . . . 0.57 109.234 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -57.37 104.1 0.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.57 109.439 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.09 -41.69 79.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.543 1.537 . . . . 0.57 109.496 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.48 -46.17 89.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.7 -0.852 . . . . 0.57 108.7 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.09 -41.41 99.4 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.901 -0.777 . . . . 0.57 108.901 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.58 -53.08 60.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.294 0.638 . . . . 0.57 111.524 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.02 71.08 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.597 -0.716 . . . . 0.57 109.478 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.6 m -58.06 -40.05 80.01 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.872 0.76 . . . . 0.57 111.664 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -60.17 -54.47 45.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.665 0.666 . . . . 0.65 109.766 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.99 -45.21 82.46 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.555 -0.715 . . . . 0.66 111.671 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.1 -32.93 74.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.447 1.099 . . . . 0.57 111.341 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.4 -43.77 52.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.276 -0.73 . . . . 0.57 111.276 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -75.94 -35.62 59.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.698 -0.667 . . . . 0.65 112.26 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -37.49 70.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.763 0.825 . . . . 0.57 111.189 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 mm? -63.02 -41.15 99.48 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.934 -0.479 . . . . 0.57 111.77 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 165.7 45.12 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.681 -1.066 . . . . 0.57 114.431 -172.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.5 mmt 55.09 -168.28 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.587 1.193 . . . . 0.57 110.793 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.65 33.2 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.422 -0.799 . . . . 0.57 113.936 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 170.28 2.47 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.304 1.052 . . . . 0.65 113.686 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 p -151.35 -159.17 0.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.842 0.857 . . . . 0.57 110.935 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.2 t -168.93 80.14 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 104.03 -2.582 . . . . 0.57 104.03 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.67 147.56 55.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 108.315 -0.994 . . . . 0.66 108.315 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.21 -20.19 33.05 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.112 2.541 . . . . 0.57 112.951 -170.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -125.3 34.94 4.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.88 1.272 . . . . 0.57 108.614 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.02 30.34 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.563 0.745 . . . . 0.57 109.542 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.61 -31.22 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.876 -0.416 . . . . 0.57 109.876 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.7 mmt -69.25 -4.61 18.5 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.518 1.527 . . . . 0.57 112.402 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 31.1 t80 -60.94 145.14 89.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.781 1.173 . . . . 0.57 109.956 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 73.0 Cg_endo -79.82 162.78 23.84 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.459 2.106 . . . . 0.57 111.556 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.9 m 53.64 58.93 4.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.001 0.905 . . . . 0.57 109.72 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 71.51 -177.86 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.924 1.29 . . . . 0.57 110.173 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.31 137.0 11.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 107.493 -2.243 . . . . 0.57 107.493 166.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -39.81 94.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.447 0.624 . . . . 0.57 110.521 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.76 135.8 29.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.269 1.414 . . . . 0.57 110.811 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -41.12 111.91 0.88 Allowed Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 126.764 2.026 . . . . 0.66 111.819 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.77 -19.39 18.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.073 1.849 . . . . 0.57 112.226 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -46.67 25.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.995 -1.113 . . . . 0.57 107.995 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -91.99 71.99 5.56 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.012 0.925 . . . . 0.57 111.046 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -33.48 -72.42 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.74 2.016 . . . . 0.57 116.003 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 38.9 72.74 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.214 2.206 . . . . 0.57 112.543 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.564 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.9 mp -35.72 114.49 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.261 2.225 . . . . 0.57 110.091 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 p -82.93 -83.15 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.096 0.558 . . . . 0.57 110.711 -163.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -140.04 -44.52 0.42 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 117.425 -1.274 . . . . 0.57 111.711 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 -43.77 64.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.006 1.322 . . . . 0.66 111.654 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.11 -52.8 62.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.63 0.772 . . . . 0.66 110.198 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.98 -39.75 81.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 C-N-CA 123.359 0.664 . . . . 0.57 109.504 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.68 97.13 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.132 1.373 . . . . 0.57 109.071 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.18 -56.34 22.67 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.883 -1.287 . . . . 0.57 109.883 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -50.34 -56.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.979 1.712 . . . . 0.57 111.106 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -72.31 -11.5 60.73 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.196 -0.94 . . . . 0.57 112.035 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 -15.53 27.84 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 0.57 110.967 167.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -82.92 -52.86 6.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.929 1.692 . . . . 0.57 109.692 -178.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.414 ' CD1' HG22 ' A' ' 46' ' ' ILE . 3.8 p90 -113.35 -37.96 4.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.31 0.644 . . . . 0.57 110.999 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 146.09 50.1 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.047 -1.221 . . . . 0.57 110.047 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -81.0 -49.29 11.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 120.234 -0.587 . . . . 0.57 110.538 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 120.8 7.19 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 124.365 1.041 . . . . 1.2 108.727 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.0 p -105.13 125.59 51.14 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.916 -1.142 . . . . 0.57 107.916 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -151.02 102.92 3.0 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.493 1.917 . . . . 0.57 106.584 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -162.45 155.87 20.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.053 -1.091 . . . . 0.57 108.053 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.06 125.3 4.5 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 105.205 -2.146 . . . . 1.2 105.205 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -161.4 147.92 14.43 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.826 1.25 . . . . 0.57 109.32 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.194 0 C-N-CA 126.792 2.037 . . . . 0.5 . -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.485 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 118.858 -0.591 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -69.67 87.29 0.49 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.443 1.019 . . . . 0.57 111.116 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt 60.63 -174.15 0.12 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.053 1.341 . . . . 0.57 110.582 -171.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 51.22 84.93 0.2 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.846 1.659 . . . . 0.57 113.129 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.01 85.1 0.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.466 2.777 . . . . 0.57 110.896 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -135.02 133.2 39.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.841 -2.651 . . . . 0.57 103.841 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.05 103.49 0.36 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.532 1.133 . . . . 0.57 109.942 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.58 157.41 16.44 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.813 1.675 . . . . 0.57 109.402 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttt 86.79 138.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.449 2.7 . . . . 0.57 108.98 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 80.9 m95 -75.96 167.71 21.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.638 0.732 . . . . 0.57 110.689 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 p -73.66 -13.97 61.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.479 1.112 . . . . 0.57 112.507 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -134.34 150.58 50.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.975 1.31 . . . . 0.57 109.284 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.91 -3.12 37.06 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.557 1.543 . . . . 0.57 112.804 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.65 128.1 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.458 -1.682 . . . . 0.57 106.458 172.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.47 139.16 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.784 -1.932 . . . . 0.57 105.784 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -115.08 133.76 55.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.57 108.782 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -114.92 164.07 14.66 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.684 -0.689 . . . . 0.57 110.223 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.88 165.66 35.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.979 169.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.0 mt -126.61 78.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 104.272 -2.492 . . . . 0.57 104.272 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -65.57 -30.94 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.287 1.435 . . . . 0.57 112.134 -175.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -133.09 165.17 25.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.086 -2.19 . . . . 0.57 105.086 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.72 158.19 43.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.068 1.347 . . . . 0.57 109.423 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 t -77.41 -15.08 59.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.255 1.206 . . . . 0.57 114.255 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 66.63 -19.88 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.573 1.949 . . . . 1.2 115.03 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -66.88 -31.49 72.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.664 1.586 . . . . 0.66 111.951 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 148.05 62.24 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 125.962 1.705 . . . . 0.57 108.201 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.34 161.06 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.898 2.398 . . . . 0.57 112.128 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.02 -35.95 78.24 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.907 0.883 . . . . 0.65 111.831 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.44 -35.78 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.149 0.58 . . . . 0.57 110.194 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.7 m -78.97 -37.75 38.64 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 117.882 -1.056 . . . . 0.57 110.045 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.91 -44.32 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.202 1.365 . . . . 0.57 109.37 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -69.66 -42.39 74.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.78 0.718 . . . . 0.66 110.555 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -42.9 84.04 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.846 -1.159 . . . . 1.2 113.259 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.99 -40.82 97.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.57 108.338 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.11 -40.6 89.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 119.25 0.932 . . . . 0.57 110.604 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -56.89 -52.71 64.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.152 0.887 . . . . 0.57 109.119 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -69.76 -36.31 75.67 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.696 -1.145 . . . . 0.57 112.002 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.16 91.32 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.522 1.51 . . . . 0.57 111.917 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.35 -36.03 76.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.498 -0.763 . . . . 0.57 109.913 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.85 -39.1 90.66 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 119.009 0.822 . . . . 0.57 109.815 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.24 -38.06 89.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.14 1.337 . . . . 0.57 112.252 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' CE3' HD11 ' A' ' 160' ' ' ILE . 18.3 m95 -66.37 -54.76 20.71 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.404 1.002 . . . . 0.57 109.989 170.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.63 -8.91 49.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.054 1.312 . . . . 0.57 114.349 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -68.13 -18.3 64.59 Favored 'General case' 0 C--O 1.226 -0.134 0 O-C-N 120.928 -1.337 . . . . 0.57 111.454 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.12 -12.53 11.91 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.59 0.632 . . . . 0.66 111.052 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.62 127.54 19.6 Favored Pre-proline 0 C--N 1.347 0.483 0 C-N-CA 124.582 1.153 . . . . 0.57 108.763 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 41.18 0.65 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.141 3.228 . . . . 0.57 112.804 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 tt -92.75 146.62 23.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.685 1.994 . . . . 0.57 108.598 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -124.48 160.95 27.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.438 -0.949 . . . . 0.65 108.438 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 161.47 37.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.604 -0.517 . . . . 0.57 109.604 -171.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -144.52 177.4 8.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.2 1.4 . . . . 1.2 109.335 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.52 136.83 41.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.232 -1.396 . . . . 0.57 107.232 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.98 166.31 2.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.997 0.427 . . . . 0.57 110.044 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.89 25.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.57 111.515 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -55.0 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.243 1.017 . . . . 0.57 112.262 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.91 -153.1 5.79 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.825 -1.31 . . . . 0.57 109.825 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -68.94 175.28 3.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.316 0.579 . . . . 0.57 110.339 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.79 -178.29 5.19 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.528 1.531 . . . . 0.57 109.972 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.96 -32.85 74.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 117.554 -1.212 . . . . 0.66 110.834 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.31 73.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.893 1.277 . . . . 0.57 107.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.39 155.35 30.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.175 -1.578 . . . . 0.57 110.93 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.31 127.63 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.945 -2.613 . . . . 0.57 103.945 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.17 162.4 28.38 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.995 -0.842 . . . . 0.57 110.995 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -134.88 140.04 45.48 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.823 -1.917 . . . . 0.57 105.823 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.67 -178.0 5.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.444 1.498 . . . . 0.57 108.698 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 52.18 2.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.926 0.891 . . . . 1.2 110.295 -169.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.66 -141.0 16.64 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.768 -1.333 . . . . 0.57 109.768 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 131.43 8.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.367 1.067 . . . . 0.57 110.843 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.45 156.72 40.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 125.168 1.387 . . . . 0.65 109.493 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 93.4 0.38 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 109.237 -1.545 . . . . 0.57 109.237 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -149.63 -85.05 0.09 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.497 1.519 . . . . 0.66 108.034 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.22 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.392 1.477 . . . . 0.57 109.259 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.19 139.49 31.79 Favored Pre-proline 0 C--N 1.342 0.252 0 C-N-CA 124.07 0.948 . . . . 0.57 108.755 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -68.36 143.37 57.88 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.021 1.147 . . . . 0.57 109.264 167.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -73.84 -177.1 2.68 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.87 1.319 . . . . 0.57 109.759 163.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -108.88 -38.03 5.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.211 3.405 . . . . 0.66 111.341 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.4 -151.02 19.66 Favored Glycine 0 CA--C 1.54 1.603 0 CA-C-O 117.706 -1.608 . . . . 0.57 111.198 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.92 75.69 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.17 1 C-N-CA 125.549 4.166 . . . . 0.57 114.653 -168.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.66 172.32 25.63 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.561 2.505 . . . . 0.57 108.971 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.01 -143.56 0.65 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.715 1.606 . . . . 0.57 112.735 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -41.75 130.29 3.3 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 128.055 2.542 . . . . 0.57 110.856 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.77 -28.37 13.53 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.446 -1.409 . . . . 0.57 112.567 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.72 161.27 37.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.689 1.196 . . . . 0.57 108.851 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.03 151.11 36.39 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.545 0.688 . . . . 0.65 110.127 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.47 172.59 12.48 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.808 0.813 . . . . 0.57 109.189 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -124.18 139.26 54.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.568 -1.271 . . . . 0.57 107.568 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.93 159.11 11.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.963 0.905 . . . . 0.57 110.043 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 48.6 Cg_endo -66.99 158.64 55.77 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.552 1.501 . . . . 0.57 110.691 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.55 -138.49 5.15 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.573 -1.011 . . . . 0.57 110.573 -172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -138.58 96.68 3.2 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.444 -1.317 . . . . 0.57 107.444 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 125.33 -118.54 3.28 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 108.701 -1.759 . . . . 0.57 108.701 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -27.56 65.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.888 2.075 . . . . 0.57 112.473 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.66 145.09 10.64 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.208 -0.933 . . . . 0.57 111.433 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.34 -27.44 4.62 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 125.397 1.475 . . . . 0.57 114.117 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.61 156.06 39.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.66 108.97 -168.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.25 145.22 38.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.899 0.857 . . . . 0.57 110.061 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.11 146.65 39.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.396 1.078 . . . . 0.65 109.265 -171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 38.3 m-85 -139.55 146.91 40.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.833 -0.803 . . . . 0.57 108.833 -167.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -83.95 99.71 10.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.23 -0.656 . . . . 0.66 109.23 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -58.91 -24.6 62.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.292 1.437 . . . . 0.66 111.337 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.29 -43.62 98.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.515 1.526 . . . . 0.66 110.309 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.42 134.23 49.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.223 -1.769 . . . . 0.66 106.223 174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 149.55 41.39 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.226 -1.546 . . . . 1.2 109.434 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -129.98 168.22 17.02 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.273 1.029 . . . . 0.57 108.294 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.303 -0.999 . . . . 0.57 108.303 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.02 38.63 0.72 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.205 1.002 . . . . 0.66 110.683 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.02 60.32 2.06 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.985 1.279 . . . . 0.57 111.029 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 91.42 3.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.012 0.925 . . . . 0.57 110.236 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m 64.72 -71.53 0.07 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 127.835 2.454 . . . . 0.57 113.781 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.98 166.54 26.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.57 107.998 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.37 -156.71 21.02 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.093 -1.603 . . . . 0.57 109.093 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.06 112.15 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.283 -1.377 . . . . 0.57 107.283 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.39 101.94 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.35 0.66 . . . . 0.57 111.501 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -58.59 -38.44 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.41 1.084 . . . . 0.57 109.439 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -43.87 97.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.793 0.724 . . . . 0.57 110.667 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.17 -48.39 81.8 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.568 0.747 . . . . 0.57 109.528 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.27 76.96 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.545 0.338 . . . . 0.57 111.303 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.54 63.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.338 -0.839 . . . . 0.57 109.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.8 m -58.2 -37.81 75.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.282 0.946 . . . . 0.57 111.577 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.55 -57.14 13.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.652 1.181 . . . . 0.65 109.648 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.52 -45.43 90.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.331 0.653 . . . . 0.66 110.487 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.36 -28.67 69.39 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.621 1.169 . . . . 0.57 111.843 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.45 -45.71 95.72 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.638 0.654 . . . . 0.57 111.897 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -68.58 -37.32 79.75 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-O 118.292 -0.861 . . . . 0.65 110.93 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.6 m -59.85 -31.64 69.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.058 0.844 . . . . 0.57 112.361 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -34.56 66.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.515 1.052 . . . . 0.57 111.802 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.25 -56.68 0.13 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-O 119.198 -0.779 . . . . 0.57 111.45 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.99 178.04 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.855 2.062 . . . . 0.57 108.695 -169.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.12 22.68 0.02 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.028 -0.873 . . . . 0.57 112.812 172.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 161.05 30.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.871 1.335 . . . . 0.65 111.716 -174.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.44 -170.54 1.47 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.336 1.854 . . . . 0.57 108.777 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.71 48.56 1.81 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.442 1.097 . . . . 0.57 110.79 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.5 t70 -98.35 144.45 28.11 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 118.004 -0.998 . . . . 0.66 110.671 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 -20.58 68.21 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.08 1.853 . . . . 0.57 113.564 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -128.57 25.31 5.73 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.115 1.366 . . . . 0.57 110.776 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -62.97 134.09 55.64 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.138 0.97 . . . . 0.57 111.093 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.21 -24.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.287 1.035 . . . . 0.57 111.429 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -106.6 22.81 15.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.14 0.976 . . . . 0.57 111.38 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 3.6 t80 -60.67 131.28 90.98 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.488 1.495 . . . . 0.57 110.437 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 49.5 Cg_endo -79.58 -38.95 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.405 1.403 . . . . 0.57 112.625 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 139' ' ' TYR . 87.2 m -80.12 67.78 6.05 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.675 -1.266 . . . . 0.57 110.03 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -50.03 136.99 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.983 1.313 . . . . 0.57 112.054 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.71 107.74 2.99 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.024 0.821 . . . . 0.57 111.297 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -165.99 -56.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.608 1.563 . . . . 0.57 108.575 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -117.14 -100.84 2.14 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 108.852 -1.699 . . . . 0.57 108.852 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -156.52 111.89 2.03 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.66 109.463 -170.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.17 -9.14 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.4 2.733 . . . . 0.57 113.039 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.74 -18.37 61.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.138 1.335 . . . . 0.57 111.039 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -116.63 74.13 0.89 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.618 1.967 . . . . 0.57 109.494 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -128.8 122.66 30.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.492 1.517 . . . . 0.57 107.914 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 69.11 1.06 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.625 -1.25 . . . . 0.57 107.625 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp 52.59 79.77 0.11 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 0.57 110.798 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -78.36 0.05 OUTLIER 'General case' 0 C--N 1.342 0.261 0 N-CA-C 114.27 1.211 . . . . 0.57 114.27 -166.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -148.79 -49.23 0.15 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.861 1.264 . . . . 0.57 108.214 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -45.69 -42.64 11.92 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 128.294 2.638 . . . . 0.66 112.14 166.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -66.86 -58.36 5.17 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.8 0.84 . . . . 0.66 111.218 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.48 -37.04 67.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 119.014 -0.517 . . . . 0.57 109.694 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -59.82 -41.55 91.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.679 0.792 . . . . 0.57 108.9 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.26 -52.91 24.47 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.305 -1.118 . . . . 0.57 110.305 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.43 HD11 ' CE3' ' A' ' 42' ' ' TRP . 24.7 mm -56.2 -51.03 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.152 0.981 . . . . 0.57 111.641 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.63 -28.88 68.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.393 0.542 . . . . 0.57 110.783 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 162' ' ' LYS . 0.9 OUTLIER -75.67 -23.32 56.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.01 -0.519 . . . . 0.57 111.603 175.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.1 mt -85.92 -48.46 8.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.57 110.901 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -139.9 19.26 2.48 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.729 0.64 . . . . 0.57 112.729 -168.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.61 -142.69 12.48 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.832 1.206 . . . . 0.57 111.327 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -142.31 -30.54 0.55 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.144 1.164 . . . . 0.57 114.144 -161.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.49 164.81 35.01 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.418 1.887 . . . . 1.2 107.396 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 94.2 p -146.13 134.86 22.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.32 -0.622 . . . . 0.57 109.32 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -157.08 89.14 1.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 105.857 -1.905 . . . . 0.57 105.857 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 42.4 t -165.18 137.59 4.36 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.153 1.381 . . . . 0.57 107.304 171.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.52 173.03 8.99 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.144 1.778 . . . . 1.2 107.372 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.71 173.16 12.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.106 1.362 . . . . 0.57 108.715 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.6 tptt . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 125.582 1.553 . . . . 0.5 . -171.605 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.335 0 CA-C-O 118.716 -0.659 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -160.31 67.29 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.623 1.169 . . . . 0.57 108.447 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.8 77.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.002 1.721 . . . . 0.57 113.828 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 76.53 81.38 0.12 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 126.791 2.036 . . . . 0.57 110.765 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.46 145.85 54.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.779 1.652 . . . . 0.57 111.194 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.22 167.68 29.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.975 1.31 . . . . 0.57 107.717 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.19 103.77 0.39 Allowed Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 124.563 1.165 . . . . 0.57 108.893 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -78.66 138.3 15.06 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 108.443 -1.406 . . . . 0.57 108.443 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.19 113.85 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.133 1.373 . . . . 0.57 108.672 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 40.0 m95 -46.88 147.42 1.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.537 0.735 . . . . 0.57 109.988 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -62.29 -27.91 69.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.572 0.749 . . . . 0.57 111.701 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.2 t -82.87 149.09 27.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.013 1.325 . . . . 0.57 110.963 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -74.55 -10.59 59.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.331 1.052 . . . . 0.57 112.868 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.45 144.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.71 1.204 . . . . 0.57 107.946 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.1 t -130.98 145.53 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.278 -1.378 . . . . 0.57 107.278 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -94.39 142.49 27.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.294 -0.632 . . . . 0.57 109.294 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -123.07 147.92 46.19 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.516 -0.74 . . . . 0.57 110.235 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 100.71 3.36 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.861 0.839 . . . . 1.2 109.586 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.18 101.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 105.122 -2.177 . . . . 0.57 105.122 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -48.89 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.458 1.503 . . . . 0.57 111.174 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.9 p -130.59 174.45 9.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.4 -1.704 . . . . 0.57 106.4 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -140.34 167.56 21.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.015 -1.476 . . . . 0.57 107.015 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -65.63 178.6 0.97 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.891 0.476 . . . . 0.57 111.03 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -34.45 2.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.393 1.077 . . . . 1.2 112.508 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -39.85 82.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.265 1.026 . . . . 0.66 110.305 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.3 mt -113.66 148.91 40.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.759 1.223 . . . . 0.57 108.646 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.21 150.82 33.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.103 1.868 . . . . 0.57 112.423 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -59.87 -40.14 87.64 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.698 1.199 . . . . 0.65 111.932 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.8 tt -62.95 -36.44 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.191 0.596 . . . . 0.57 111.048 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 m -69.05 -42.4 76.34 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.081 -1.438 . . . . 0.57 108.984 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -55.74 -47.59 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 121.154 1.797 . . . . 0.57 110.095 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.07 -48.73 80.5 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.876 0.87 . . . . 0.66 110.548 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.93 -46.29 88.34 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.509 -0.744 . . . . 1.2 112.48 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.86 -41.79 82.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.416 1.086 . . . . 0.57 109.346 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.87 -50.15 76.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 118.034 -0.984 . . . . 0.57 109.269 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -41.28 99.42 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.658 1.117 . . . . 0.57 111.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -65.03 -46.3 81.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.7 1.136 . . . . 0.57 110.864 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.74 92.06 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.889 1.276 . . . . 0.57 112.405 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.98 -37.34 75.73 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.512 0.725 . . . . 0.57 110.614 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.23 -41.14 87.98 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.828 0.74 . . . . 0.57 109.87 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.7 mtp -66.02 -33.1 75.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.677 0.791 . . . . 0.57 112.544 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -70.81 -49.34 47.5 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.369 0.986 . . . . 0.57 111.112 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.63 -10.78 71.92 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.0 1.286 . . . . 0.57 113.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -62.18 -26.63 68.45 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.667 -1.49 . . . . 0.57 111.022 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -97.94 -38.29 9.46 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.975 -0.535 . . . . 0.66 110.886 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.92 136.41 23.26 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 124.085 0.954 . . . . 0.57 110.576 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 38.32 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 124.195 3.264 . . . . 0.57 112.906 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.15 138.36 31.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.933 1.693 . . . . 0.57 107.601 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -120.59 170.82 9.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.65 108.662 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.51 153.92 45.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.396 -0.964 . . . . 0.57 108.396 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 161.04 37.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.14 0.576 . . . . 1.2 110.803 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -104.08 145.56 30.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.822 -0.807 . . . . 0.57 108.822 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.73 170.86 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.114 0.965 . . . . 0.57 110.32 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.93 37.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.852 1.261 . . . . 0.57 110.215 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -146.46 -72.58 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.028 0.931 . . . . 0.57 110.665 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.8 25.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.421 -1.211 . . . . 0.57 115.557 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -154.09 135.27 14.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.57 106.848 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.63 177.2 11.65 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.074 0.95 . . . . 0.57 110.598 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' HG12 ' A' ' 15' ' ' VAL . 49.2 m-20 -71.15 -37.09 72.25 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.297 -0.858 . . . . 0.66 110.516 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.99 77.76 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.182 2.193 . . . . 0.57 107.82 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -75.28 125.17 28.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.574 -1.269 . . . . 0.57 107.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.42 123.12 67.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.999 -2.223 . . . . 0.57 104.999 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.9 162.98 26.31 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.843 -0.503 . . . . 0.57 111.843 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 13.9 m-85 -137.32 126.8 25.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.546 -1.65 . . . . 0.57 106.546 -172.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.74 -174.41 4.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.425 1.49 . . . . 0.57 108.194 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.9 140.29 18.68 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.6 -0.889 . . . . 1.2 108.6 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.95 -90.4 0.41 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.251 0.453 . . . . 0.57 112.341 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.79 172.59 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.868 0.834 . . . . 0.57 110.049 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.75 142.87 21.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.65 109.466 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.72 45.73 1.58 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.024 1.297 . . . . 0.57 112.622 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.4 28.11 0.99 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.302 2.241 . . . . 0.66 110.139 -172.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.82 -38.86 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.174 1.79 . . . . 0.57 112.029 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -91.25 104.8 10.62 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.088 1.355 . . . . 0.57 109.604 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.43 143.01 74.55 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.16 1.24 . . . . 0.57 109.366 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -170.57 0.69 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.719 1.247 . . . . 0.57 109.776 170.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -124.65 -45.19 1.93 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.617 2.367 . . . . 0.66 108.617 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.29 -148.98 16.56 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.068 1.318 . . . . 0.57 110.953 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.74 68.76 2.95 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 125.969 4.446 . . . . 0.57 112.933 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.02 166.01 16.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 126.421 1.962 . . . . 0.57 108.933 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 49.73 -160.97 0.06 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.502 1.521 . . . . 0.57 112.924 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.2 m -31.8 104.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.913 2.885 . . . . 0.57 114.583 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.44 -29.74 57.09 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.104 -1.623 . . . . 0.57 114.0 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.7 161.99 40.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.371 1.069 . . . . 0.57 108.239 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.62 158.56 44.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.472 -0.566 . . . . 0.65 109.472 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.32 170.37 19.7 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.841 0.856 . . . . 0.57 108.824 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -124.09 149.22 46.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.212 -1.033 . . . . 0.57 108.212 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.72 154.54 80.12 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.593 -0.717 . . . . 0.57 110.137 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 37.4 Cg_endo -67.48 166.34 24.12 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.396 2.064 . . . . 0.57 111.784 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.45 -116.75 0.67 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.3 p -149.03 65.68 1.04 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.625 0.77 . . . . 0.57 111.046 -167.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.99 -121.67 1.4 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.5 -1.44 . . . . 0.57 109.5 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.91 -25.9 32.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.053 1.341 . . . . 0.57 112.024 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 140.33 11.79 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.852 -1.155 . . . . 0.57 111.089 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.4 -24.32 4.97 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.283 1.42 . . . . 0.57 113.776 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -68.63 153.24 44.15 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.987 0.893 . . . . 0.66 108.726 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.0 146.13 31.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.57 109.176 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -140.96 155.59 46.21 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.28 -0.873 . . . . 0.65 111.258 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 46.6 m-85 -137.25 141.9 42.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.877 -1.157 . . . . 0.57 107.877 -163.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -80.9 104.36 11.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.716 -1.216 . . . . 0.66 107.716 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.4 -23.74 67.39 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.33 -0.856 . . . . 0.66 110.844 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.29 -24.18 60.38 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.649 0.659 . . . . 0.66 110.117 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.92 132.48 39.1 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.16 -1.052 . . . . 0.66 108.16 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -65.98 143.36 57.43 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.352 -0.61 . . . . 1.2 109.352 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -126.36 137.38 53.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.609 -1.256 . . . . 0.57 107.609 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.3 t -113.53 147.41 37.99 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.869 -0.789 . . . . 0.57 108.869 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -74.52 21.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.166 1.786 . . . . 0.66 112.981 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.13 124.86 0.25 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.406 1.955 . . . . 0.57 109.998 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 t 74.74 58.49 0.07 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.987 1.715 . . . . 0.57 113.004 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 41.11 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.299 1.04 . . . . 0.57 112.538 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp 55.52 -178.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.184 1.394 . . . . 0.57 111.843 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.01 -168.33 52.06 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.011 -1.056 . . . . 0.57 111.653 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.9 121.16 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.847 -0.797 . . . . 0.57 108.847 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -56.8 106.72 0.33 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.872 1.269 . . . . 0.57 109.209 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.84 -38.29 75.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.481 0.712 . . . . 0.57 109.958 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.28 -51.42 66.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.596 -1.261 . . . . 0.57 107.596 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -54.92 -42.51 72.3 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.876 -0.583 . . . . 0.57 111.042 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.5 5.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.277 0.631 . . . . 0.57 110.275 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.79 -50.16 75.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 118.349 -0.834 . . . . 0.57 109.492 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 m -57.34 -36.45 71.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.557 1.071 . . . . 0.57 111.597 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.7 -55.39 17.65 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.405 1.082 . . . . 0.65 110.19 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.11 -40.74 90.96 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.61 -0.681 . . . . 0.66 110.749 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.81 -32.28 73.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.472 1.509 . . . . 0.57 111.692 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.25 94.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.466 -0.654 . . . . 0.57 111.466 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -69.33 -37.11 77.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 117.594 -1.193 . . . . 0.65 111.916 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.2 p -59.08 -33.19 70.53 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.18 0.925 . . . . 0.57 111.269 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.7 mm? -68.63 -33.97 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.525 -0.75 . . . . 0.57 112.023 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 151.78 53.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.605 1.093 . . . . 0.57 114.404 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 mmt 58.06 -177.17 0.07 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.489 0.661 . . . . 0.57 111.452 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.13 57.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.527 -1.429 . . . . 0.57 109.527 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.36 167.32 11.6 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.93 0.871 . . . . 0.65 110.467 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 t -160.69 -170.31 2.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.917 1.287 . . . . 0.57 109.74 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.23 30.36 1.14 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.571 1.948 . . . . 0.57 109.999 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.49 148.43 35.48 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.739 1.216 . . . . 0.66 109.974 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.94 -21.53 43.56 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.287 2.658 . . . . 0.57 113.279 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -132.59 29.05 4.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.376 1.871 . . . . 0.57 108.661 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.1 133.03 49.05 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.658 -1.276 . . . . 0.57 109.026 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 156' ' ' ASP . 4.3 p -55.8 -28.73 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.371 1.468 . . . . 0.57 112.68 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.49 27.9 9.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.099 . . . . 0.57 110.338 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -56.49 129.17 75.45 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.305 -0.872 . . . . 0.57 109.971 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.59 178.38 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.942 2.428 . . . . 0.57 110.573 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m 71.08 -40.99 0.49 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.504 1.522 . . . . 0.57 113.321 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.47 ' CE1' ' H47' ' A' ' 178' ' ' MDW . 59.9 t80 55.39 92.21 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.275 2.23 . . . . 0.57 113.722 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.75 105.75 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.598 -1.001 . . . . 0.57 110.598 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -172.65 -50.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.093 1.357 . . . . 0.57 110.565 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.88 -113.1 2.94 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.25 -1.94 . . . . 0.57 108.25 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.68 134.59 9.19 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 106.529 -1.656 . . . . 0.66 106.529 174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.09 -8.43 6.63 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.023 3.149 . . . . 0.57 113.559 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -71.01 -28.16 64.21 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.151 -1.593 . . . . 0.57 111.368 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -106.96 61.79 0.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.57 110.916 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -126.44 141.26 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.575 1.15 . . . . 0.57 110.311 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.66 51.68 0.08 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.866 0.866 . . . . 0.57 110.956 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 69.27 76.64 0.23 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.787 1.235 . . . . 0.57 110.554 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.3 t -69.57 -94.42 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.918 0.887 . . . . 0.57 112.044 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -131.12 -44.69 1.03 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.986 0.914 . . . . 0.57 109.641 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -46.04 49.96 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.96 0.904 . . . . 0.66 110.615 166.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.597 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.2 t0 -60.23 -56.58 19.82 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.524 -0.75 . . . . 0.66 110.403 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.39 -43.84 87.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 N-CA-C 109.044 -0.724 . . . . 0.57 109.044 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -64.43 -38.66 91.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.675 0.79 . . . . 0.57 110.72 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.93 -49.73 39.75 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.689 -0.965 . . . . 0.57 110.689 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -56.54 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 C-N-CA 126.144 1.777 . . . . 0.57 110.254 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.6 -20.53 65.74 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.845 -0.534 . . . . 0.57 110.777 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -88.1 -29.83 20.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.455 0.702 . . . . 0.57 111.201 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.27 -58.02 8.51 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 125.717 1.607 . . . . 0.57 109.747 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -92.14 -0.11 57.45 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.155 0.798 . . . . 0.57 113.155 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.24 -82.37 0.63 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.637 -0.585 . . . . 0.57 111.637 -171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.19 -56.84 0.06 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.103 0.409 . . . . 0.57 112.103 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.57 177.98 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.526 1.53 . . . . 1.2 112.726 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 92.56 2.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.655 -1.98 . . . . 0.57 105.655 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -162.28 131.87 4.5 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 105.027 -2.212 . . . . 0.57 105.027 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.01 138.07 45.78 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.57 108.621 172.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -64.16 140.4 58.87 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.79 0.328 . . . . 1.2 110.485 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.7 142.34 26.61 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.717 1.207 . . . . 0.57 108.012 173.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 125.488 1.515 . . . . 0.5 . -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.47 ' H47' ' CE1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 118.127 -0.94 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m 55.91 38.28 29.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.302 0.955 . . . . 0.57 113.195 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 -68.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.38 -0.6 . . . . 0.57 109.38 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -157.2 83.15 3.05 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 126.009 1.723 . . . . 0.57 107.042 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.34 -171.42 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.324 2.682 . . . . 0.57 111.912 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -67.43 -58.25 5.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.032 0.933 . . . . 0.57 112.069 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.71 98.28 0.61 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 127.071 2.149 . . . . 0.57 105.235 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.52 170.83 19.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.935 2.423 . . . . 0.57 109.884 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 pttt 67.01 141.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.759 2.023 . . . . 0.57 110.881 -165.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -56.5 149.2 17.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.046 0.939 . . . . 0.57 110.371 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 p -62.63 -20.03 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.305 0.854 . . . . 0.57 113.305 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -96.7 140.98 30.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.412 1.885 . . . . 0.57 109.849 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -72.96 -14.09 61.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.617 0.767 . . . . 0.57 113.064 171.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 m -114.2 119.54 61.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.759 -1.941 . . . . 0.57 105.759 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.17 155.59 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.31 -1.367 . . . . 0.57 107.31 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -106.88 143.6 34.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.57 109.758 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -126.64 145.46 50.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.601 -0.518 . . . . 0.57 109.601 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.1 115.13 3.48 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.758 0.79 . . . . 1.2 111.921 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.0 95.17 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 105.718 -1.956 . . . . 0.57 105.718 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 m -67.0 -39.02 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.132 0.973 . . . . 0.57 112.067 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -130.0 152.49 49.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.089 -2.56 . . . . 0.57 104.089 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -127.41 167.34 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.977 1.311 . . . . 0.57 107.858 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 t -64.63 -179.99 0.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.808 0.813 . . . . 0.57 110.901 173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -40.13 3.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.83 0.852 . . . . 1.2 111.585 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -41.97 77.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.654 0.661 . . . . 0.66 111.583 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.69 152.86 38.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.57 108.587 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.42 149.53 39.79 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.897 1.731 . . . . 0.57 112.41 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -58.86 -37.42 76.47 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.59 1.156 . . . . 0.65 113.08 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -43.52 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.773 -0.455 . . . . 0.57 109.773 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 m -66.61 -39.99 88.62 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.945 -1.026 . . . . 0.57 109.577 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.5 -51.08 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.709 1.14 . . . . 0.57 110.704 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -63.35 -43.05 98.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.87 1.214 . . . . 0.66 110.482 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -46.75 87.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.216 -0.927 . . . . 1.2 111.207 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.79 -38.27 86.19 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.263 -1.351 . . . . 0.57 109.904 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -59.62 -46.55 93.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 120.245 1.384 . . . . 0.57 110.076 170.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.266 0.939 . . . . 0.57 109.502 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -68.47 -41.86 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.363 -0.827 . . . . 0.57 111.688 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.27 -46.62 87.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.735 1.152 . . . . 0.57 111.504 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.2 mt -67.91 -37.53 81.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.934 0.894 . . . . 0.57 110.162 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.39 -39.73 84.29 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.456 -0.783 . . . . 0.57 110.209 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -43.94 97.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.725 0.81 . . . . 0.57 111.349 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 33.9 m95 -61.76 -47.84 83.38 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.852 0.751 . . . . 0.57 111.285 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.21 -2.07 71.6 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.298 -0.876 . . . . 0.57 113.695 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -81.82 -11.59 58.9 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.347 1.573 . . . . 0.57 110.071 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -108.62 -21.8 12.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.356 0.526 . . . . 0.66 111.353 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 160' ' ' ILE . 8.4 pt -136.52 146.46 55.8 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.731 1.213 . . . . 0.57 110.302 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.99 58.43 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.624 3.549 . . . . 0.57 111.937 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.03 138.19 54.21 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.613 1.965 . . . . 0.57 106.631 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -123.23 160.46 26.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.291 -1.003 . . . . 0.65 108.291 -171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.43 149.98 38.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.829 -1.175 . . . . 0.57 107.829 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -134.2 157.34 46.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.149 0.979 . . . . 1.2 109.046 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -115.81 108.85 16.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.312 -0.996 . . . . 0.57 108.312 -174.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.46 133.76 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.555 -1.276 . . . . 0.57 107.555 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -37.18 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.179 -0.325 . . . . 0.57 110.208 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.63 162.17 39.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.312 1.045 . . . . 0.57 109.003 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.84 156.83 18.15 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.964 -1.255 . . . . 0.57 109.964 -164.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -64.32 168.53 5.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.517 0.675 . . . . 0.57 110.696 168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.2 17.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.766 1.226 . . . . 0.57 109.937 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -67.96 -44.04 77.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.987 -1.006 . . . . 0.66 109.341 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.4 mt -116.53 78.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.082 1.753 . . . . 0.57 107.74 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.0 ttm -76.3 153.66 35.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.848 -1.158 . . . . 0.57 109.612 171.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.75 134.83 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.73 -1.952 . . . . 0.57 105.73 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.56 166.54 30.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.779 -0.928 . . . . 0.57 110.779 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -138.6 149.99 45.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.42 175.92 11.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.969 1.308 . . . . 0.57 110.249 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -140.46 63.0 1.48 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.765 1.226 . . . . 1.2 109.812 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.79 -70.64 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.644 -0.583 . . . . 0.57 111.644 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.13 174.72 8.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.942 -1.328 . . . . 0.57 110.398 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -149.45 137.86 20.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.427 -0.583 . . . . 0.65 109.427 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.91 37.52 3.39 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.235 0.922 . . . . 0.57 112.021 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.78 -72.05 0.46 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.1 1.36 . . . . 0.66 108.574 -171.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -172.55 -36.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.979 -0.534 . . . . 0.57 111.677 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -102.76 101.64 21.96 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-O 118.286 -0.864 . . . . 0.57 108.732 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.79 129.27 28.46 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 108.26 -1.477 . . . . 0.57 108.26 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.5 OUTLIER -64.66 -167.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.769 1.747 . . . . 0.57 109.146 165.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.75 -46.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 129.773 3.229 . . . . 0.66 107.655 -163.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.01 -146.37 16.06 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.052 -1.416 . . . . 0.57 110.159 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 83.06 1.9 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.431 3.421 . . . . 0.57 112.437 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.87 169.24 17.86 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 127.749 2.595 . . . . 0.57 109.852 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 t30 54.5 -144.69 0.66 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.675 1.59 . . . . 0.57 112.604 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.5 m -47.33 135.81 10.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.578 2.351 . . . . 0.57 111.577 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.38 -33.18 10.11 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.411 -1.431 . . . . 0.57 112.519 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.9 158.47 28.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.57 108.812 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -141.56 164.75 29.39 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.023 0.829 . . . . 0.65 111.792 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.76 156.38 44.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.397 0.679 . . . . 0.57 110.433 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.08 152.87 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.925 -1.034 . . . . 0.57 108.894 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.05 95.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.701 -0.666 . . . . 0.57 110.186 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.47 149.7 69.08 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.077 2.518 . . . . 0.57 112.033 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.17 -70.65 0.32 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.406 0.527 . . . . 0.57 112.077 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -75.1 166.36 23.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.382 1.073 . . . . 0.57 109.796 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.46 45.35 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 117.554 -1.692 . . . . 0.57 114.797 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.78 -26.71 60.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.419 1.609 . . . . 0.57 111.049 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.15 149.11 6.21 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.231 -0.918 . . . . 0.57 110.925 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.75 -28.84 1.82 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.257 1.408 . . . . 0.57 113.624 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.97 152.95 44.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.242 1.021 . . . . 0.66 109.004 -170.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 149.7 52.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.57 109.608 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -140.39 151.34 44.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.836 -0.62 . . . . 0.65 110.957 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 40.6 m-85 -138.43 144.9 40.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.462 1.105 . . . . 0.57 109.007 -165.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.07 107.07 6.9 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.006 -1.109 . . . . 0.66 108.006 171.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.22 -19.11 62.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.524 1.511 . . . . 0.66 111.581 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.44 -44.96 81.41 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.398 1.479 . . . . 0.66 111.629 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.55 122.5 17.73 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 106.219 -1.771 . . . . 0.66 106.219 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 129.57 40.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.101 -0.952 . . . . 1.2 109.622 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -106.73 153.63 22.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.631 1.172 . . . . 0.57 109.465 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 141.85 51.46 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.558 -0.905 . . . . 0.57 108.558 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.23 42.27 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.824 1.65 . . . . 0.66 110.055 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.64 75.47 0.89 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.825 -0.91 . . . . 0.57 110.825 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.36 177.78 7.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.073 0.949 . . . . 0.57 108.967 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 m -57.17 122.65 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.836 0.855 . . . . 0.57 110.576 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.44 172.66 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.024 1.729 . . . . 0.57 112.577 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.08 169.69 42.09 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.561 -0.745 . . . . 0.57 111.447 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.25 123.59 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.747 -0.834 . . . . 0.57 108.747 -178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -64.58 120.36 12.21 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.482 -0.327 . . . . 0.57 110.729 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -52.65 -43.07 65.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.913 0.885 . . . . 0.57 111.869 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -64.77 -46.3 82.71 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.54 0.609 . . . . 0.57 109.839 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 137' ' ' VAL . 4.3 t80 -56.69 -48.62 77.25 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.801 -0.444 . . . . 0.57 109.801 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.76 85.32 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 122.8 0.44 . . . . 0.57 110.824 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -52.17 66.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 117.853 -1.07 . . . . 0.57 109.409 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.5 m -53.91 -40.25 66.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.174 1.352 . . . . 0.57 111.89 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -60.3 -56.37 22.32 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.206 0.602 . . . . 0.65 110.536 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.51 -44.51 78.24 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.931 0.892 . . . . 0.66 111.322 -172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.57 -25.91 68.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.584 1.554 . . . . 0.57 110.943 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.62 -51.72 57.21 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.713 -0.955 . . . . 0.57 110.713 169.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.07 -38.81 90.21 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 117.658 -1.163 . . . . 0.65 111.265 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.3 p -58.18 -31.3 67.15 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 118.559 0.618 . . . . 0.57 112.424 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -36.9 72.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.501 0.32 . . . . 0.57 111.815 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.16 43.24 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.691 -1.061 . . . . 0.57 113.342 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -116.58 149.59 39.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.594 1.197 . . . . 0.57 110.649 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.08 -45.62 4.09 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 117.786 -1.563 . . . . 0.57 111.928 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m80 156.24 174.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 129.739 3.216 . . . . 0.65 110.103 -171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 5.0 m -117.41 176.71 5.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.042 1.737 . . . . 0.57 110.807 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.27 58.99 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.625 1.17 . . . . 0.57 109.45 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.0 t70 -135.13 142.72 42.94 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 107.297 -1.372 . . . . 0.66 107.297 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.8 -34.58 30.49 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.696 1.597 . . . . 0.57 111.188 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -105.18 24.3 12.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.455 1.102 . . . . 0.57 110.071 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -58.54 130.64 47.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.97 -0.752 . . . . 0.57 108.97 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 150' ' ' PHE . 7.2 p -67.29 -24.39 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.411 -0.515 . . . . 0.57 109.815 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.4 16.54 14.93 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.483 -0.761 . . . . 0.57 112.318 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.486 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.1 t80 -72.18 144.46 87.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.857 1.662 . . . . 0.57 111.673 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 57.7 Cg_endo -74.25 163.52 36.27 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.48 2.12 . . . . 0.57 111.041 167.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.6 m 56.09 94.06 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.638 1.575 . . . . 0.57 112.034 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.5 ' CD1' ' H43' ' A' ' 178' ' ' MDW . 0.3 OUTLIER -50.37 105.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.491 1.516 . . . . 0.57 112.564 -176.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.12 166.54 33.61 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.523 -1.831 . . . . 0.57 108.523 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.17 -47.89 0.22 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.88 2.472 . . . . 0.57 114.769 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.54 175.59 7.25 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.118 1.342 . . . . 0.57 112.142 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -121.0 101.15 45.3 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.939 -1.134 . . . . 0.66 107.939 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.79 40.29 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.527 2.818 . . . . 0.57 113.077 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.87 -54.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.638 -1.289 . . . . 0.57 107.994 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.07 88.22 2.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.637 1.575 . . . . 0.57 108.964 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 137' ' ' VAL . 45.7 p90 -121.45 -45.98 2.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.239 -0.891 . . . . 0.57 110.279 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 30.34 55.43 0.18 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.546 2.338 . . . . 0.57 113.574 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mp 63.46 100.22 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.617 1.967 . . . . 0.57 109.948 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.7 m -70.84 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.376 0.88 . . . . 0.57 113.376 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -143.94 -42.68 0.27 Allowed 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.938 0.895 . . . . 0.57 109.145 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 15.0 p-10 -59.95 -39.97 87.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.667 0.667 . . . . 0.66 112.172 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -54.56 29.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.7 1.2 . . . . 0.66 109.134 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.9 -46.25 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 124.826 1.251 . . . . 0.57 108.746 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -62.56 -47.71 82.69 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 117.971 -1.014 . . . . 0.57 108.761 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.55 -62.32 6.44 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.807 -1.717 . . . . 0.57 108.807 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 46' ' ' ILE . 5.3 mm -56.93 -43.61 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.242 1.021 . . . . 0.57 113.132 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -71.34 -27.75 63.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.58 -0.7 . . . . 0.57 111.662 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -36.01 68.13 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.964 0.906 . . . . 0.57 110.363 169.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -61.53 2.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.994 -1.003 . . . . 0.57 110.289 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -142.38 18.24 2.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.229 1.196 . . . . 0.57 114.229 -170.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -93.64 -87.01 1.62 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.385 -0.686 . . . . 0.57 111.385 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -158.83 -69.73 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.719 0.807 . . . . 0.57 110.665 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.22 154.1 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.393 1.477 . . . . 1.2 108.318 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.1 t -165.08 176.72 8.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.563 -1.644 . . . . 0.57 106.563 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.21 164.79 26.28 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.649 -1.612 . . . . 0.57 106.649 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 p -125.31 168.4 13.57 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.804 0.841 . . . . 0.57 108.792 171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.81 147.45 26.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.501 -1.666 . . . . 1.2 106.501 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.38 170.86 7.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.288 -0.634 . . . . 0.57 109.288 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.346 0.428 0 C-N-CA 122.88 0.472 . . . . 0.5 . 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.5 ' H43' ' CD1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 118.572 -0.728 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -104.78 -58.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.297 1.439 . . . . 0.57 108.643 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -173.76 122.85 0.34 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 104.284 -2.487 . . . . 0.57 104.284 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.24 80.58 0.29 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 114.141 1.163 . . . . 0.57 114.141 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.72 109.55 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.929 1.753 . . . . 0.57 110.276 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -145.2 105.24 4.04 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 107.6 -1.259 . . . . 0.57 107.6 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.5 m 36.7 70.52 1.08 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.08 1.352 . . . . 0.57 113.349 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -67.77 31.21 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.123 3.215 . . . . 0.57 115.013 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -162.06 31.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.944 1.698 . . . . 0.57 110.81 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.431 ' CH2' ' HA3' ' A' ' 94' ' ' GLY . 89.4 m95 51.93 -111.53 0.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.57 110.762 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -154.57 -40.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.613 1.565 . . . . 0.57 108.428 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -95.97 153.35 17.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.312 0.645 . . . . 0.57 109.506 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -9.93 20.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.988 0.915 . . . . 0.57 112.667 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.54 147.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.905 -1.517 . . . . 0.57 106.905 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.2 t -127.21 161.65 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.4 -1.333 . . . . 0.57 107.4 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -107.46 139.1 42.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.541 -1.281 . . . . 0.57 107.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -126.11 151.5 47.14 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.952 -1.093 . . . . 0.57 109.561 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -153.57 118.25 4.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.171 0.51 . . . . 1.2 109.803 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.3 mt -82.62 86.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.424 -1.695 . . . . 0.57 106.424 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.76 -49.59 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.548 1.139 . . . . 0.57 112.2 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.82 153.1 33.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.417 -2.438 . . . . 0.57 104.417 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -125.75 149.68 48.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.173 -1.788 . . . . 0.57 106.173 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -159.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 O-C-N 125.032 1.458 . . . . 0.57 111.084 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -148.04 -29.34 0.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 114.244 1.202 . . . . 1.2 114.244 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -52.61 -57.54 9.69 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.205 0.941 . . . . 0.66 110.915 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.31 164.41 14.99 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.641 1.576 . . . . 0.57 109.466 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -77.97 149.55 25.89 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.149 1.899 . . . . 0.57 112.618 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 11.7 m-70 -60.6 -35.65 76.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.398 1.079 . . . . 0.65 112.408 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.17 -38.98 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.011 0.524 . . . . 0.57 110.275 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -69.58 -41.32 75.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 117.222 -1.371 . . . . 0.57 109.069 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.54 -53.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 120.563 1.528 . . . . 0.57 109.96 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.21 -34.35 77.88 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 118.598 -0.715 . . . . 0.66 110.757 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -46.44 80.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.625 1.102 . . . . 1.2 111.717 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.1 mt -65.09 -45.22 86.14 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.223 1.009 . . . . 0.57 108.337 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.37 -44.86 99.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.94 -1.029 . . . . 0.57 110.565 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 m -60.27 -46.89 88.26 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 120.036 1.289 . . . . 0.57 109.895 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -36.89 69.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.508 -0.758 . . . . 0.57 111.501 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.69 91.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.296 1.038 . . . . 0.57 111.308 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 26.3 mt -72.11 -35.8 69.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.629 0.772 . . . . 0.57 110.493 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.52 -42.87 88.68 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.089 -0.958 . . . . 0.57 109.944 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.9 mtp -60.81 -36.93 80.32 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.928 0.891 . . . . 0.57 111.321 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -69.0 -47.04 66.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.975 1.261 . . . . 0.57 111.309 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.44 -3.86 59.08 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 123.94 0.781 . . . . 0.57 113.301 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -70.46 -19.81 62.93 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.984 -1.303 . . . . 0.57 111.043 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.6 mp0 -110.52 -34.8 6.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.503 1.521 . . . . 0.66 111.056 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 21.7 pt -114.07 143.06 28.96 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 119.596 1.089 . . . . 0.57 111.04 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.26 21.16 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.248 2.632 . . . . 0.57 112.488 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -86.96 126.38 34.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.188 -1.412 . . . . 0.57 107.188 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -126.68 -178.55 4.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.867 0.867 . . . . 0.65 109.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -147.83 147.53 29.9 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.704 -0.85 . . . . 0.57 108.704 -170.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.95 160.0 39.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.381 1.072 . . . . 1.2 109.722 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -110.05 116.08 30.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.286 -1.376 . . . . 0.57 107.286 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.58 161.21 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.585 -0.894 . . . . 0.57 108.585 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.79 39.44 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.208 1.003 . . . . 0.57 110.179 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -90.58 -65.57 1.0 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.045 0.538 . . . . 0.57 109.917 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.07 -70.55 0.02 OUTLIER Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.298 -1.521 . . . . 0.57 109.298 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -125.52 139.68 53.4 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.319 -1.363 . . . . 0.57 107.319 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.59 171.27 7.42 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.069 0.947 . . . . 0.57 110.012 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 15' ' ' VAL . 65.2 m-20 -62.48 -50.54 71.01 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.176 -1.046 . . . . 0.66 108.176 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.64 81.88 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.775 -1.565 . . . . 0.57 106.775 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -78.54 121.4 24.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.956 -1.127 . . . . 0.57 107.956 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.96 127.2 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 106.687 -1.597 . . . . 0.57 106.687 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.38 25.81 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 111.204 -0.758 . . . . 0.57 111.204 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 21.3 m-85 -132.62 137.32 46.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.948 -1.871 . . . . 0.57 105.948 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 160.22 36.59 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.826 1.65 . . . . 0.57 107.873 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -116.67 50.99 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.201 -0.937 . . . . 1.2 110.137 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.85 -127.35 6.31 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.254 -1.538 . . . . 0.57 109.254 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.94 139.46 0.46 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.14 1.376 . . . . 0.57 112.621 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -120.9 -62.27 1.47 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.485 -0.78 . . . . 0.65 109.836 -173.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.99 71.83 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.354 -0.692 . . . . 0.57 112.647 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.3 121.35 41.73 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.632 1.173 . . . . 0.66 108.485 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.82 -73.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.381 . . . . 0.57 111.689 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -148.23 144.12 18.38 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.426 1.49 . . . . 0.57 108.638 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.02 149.55 77.2 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.815 1.676 . . . . 0.57 110.405 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 1.4 m-85 -70.44 -174.18 0.82 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.738 -1.119 . . . . 0.57 110.749 170.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.63 -32.16 4.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.688 2.395 . . . . 0.66 110.975 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.42 -139.94 15.83 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.364 0.983 . . . . 0.57 112.351 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.07 86.67 1.62 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.353 3.369 . . . . 0.57 112.036 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.04 -174.99 33.92 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.565 1.555 . . . . 0.57 111.226 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 m120 45.82 -134.71 0.82 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.829 1.314 . . . . 0.57 112.478 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -59.13 118.56 6.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.14 2.176 . . . . 0.57 111.449 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.522 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.3 mp -94.68 -34.87 12.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.736 1.214 . . . . 0.57 112.195 -175.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.25 157.97 33.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.292 1.037 . . . . 0.57 108.826 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.68 161.93 37.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.341 -0.615 . . . . 0.65 109.341 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.46 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.696 -0.853 . . . . 0.57 108.696 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.58 153.82 32.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.317 -0.994 . . . . 0.57 108.317 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.38 149.56 96.94 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.072 -0.966 . . . . 0.57 109.63 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 29.3 Cg_endo -67.35 160.82 45.96 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.295 1.997 . . . . 0.57 111.47 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 -106.88 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.315 -1.914 . . . . 0.57 108.315 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.3 p -151.71 69.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.744 0.818 . . . . 0.57 110.948 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.36 -121.45 1.6 Allowed Glycine 0 C--N 1.342 0.904 0 N-CA-C 110.404 -1.079 . . . . 0.57 110.404 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.86 -21.76 61.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.797 1.239 . . . . 0.57 112.167 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.78 130.59 43.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.447 -1.196 . . . . 0.57 110.959 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' CH2' ' A' ' 10' ' ' TRP . . . 96.38 -36.86 3.65 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.084 2.278 . . . . 0.57 113.09 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.1 145.91 19.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.998 2.119 . . . . 0.66 107.092 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.29 146.61 36.99 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.871 -0.789 . . . . 0.57 108.871 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -139.56 160.6 39.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.381 -0.827 . . . . 0.65 110.236 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 57.5 m-85 -142.44 148.58 38.01 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.361 1.064 . . . . 0.57 108.323 -163.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.38 100.56 10.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.81 -1.552 . . . . 0.66 106.81 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.9 -25.73 31.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.463 -1.398 . . . . 0.66 111.43 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.18 -37.18 76.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.66 110.478 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.24 120.2 20.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.192 -1.41 . . . . 0.66 107.192 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -56.28 122.58 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.873 0.469 . . . . 1.2 110.254 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 114' ' ' PHE . 98.4 m95 -109.63 133.94 52.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 108.339 -0.985 . . . . 0.57 108.339 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.5 t -137.28 148.39 46.36 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.188 -0.671 . . . . 0.57 109.188 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.47 -26.04 67.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.844 0.857 . . . . 0.66 111.863 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.61 -141.19 11.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.088 1.327 . . . . 0.57 110.248 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -160.56 103.77 1.39 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.584 0.692 . . . . 0.57 109.566 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.51 -36.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.043 0.937 . . . . 0.57 112.231 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -104.04 -58.84 1.82 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.094 0.558 . . . . 0.57 109.516 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.9 -165.17 21.48 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.165 -1.174 . . . . 0.57 110.165 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.423 HD13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -85.58 143.96 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.887 1.275 . . . . 0.57 109.416 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.84 108.88 1.89 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.835 -1.075 . . . . 0.57 111.156 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -60.53 -34.42 74.09 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.581 0.752 . . . . 0.57 112.121 174.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.437 HD12 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -64.59 -51.33 63.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.7 -1.222 . . . . 0.57 107.7 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -57.55 -46.71 83.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.627 0.771 . . . . 0.57 110.147 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.65 19.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.515 0.509 . . . . 0.57 111.022 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.5 -55.52 34.03 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 117.933 -1.032 . . . . 0.57 109.907 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -58.18 -34.45 70.35 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.906 1.23 . . . . 0.57 111.841 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.01 -60.27 3.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.102 0.961 . . . . 0.65 109.79 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.88 -45.79 80.75 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.569 -0.707 . . . . 0.66 111.42 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.63 -30.8 71.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.524 1.13 . . . . 0.57 111.421 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.96 -42.51 80.67 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.156 -0.778 . . . . 0.57 111.156 170.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -74.52 -37.59 63.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 117.16 -1.4 . . . . 0.65 112.354 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 p -54.42 -38.65 66.5 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 124.453 1.096 . . . . 0.57 109.685 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.07 -43.38 95.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.7 0.8 . . . . 0.57 112.337 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.2 43.39 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.862 -0.966 . . . . 0.57 114.332 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.06 176.17 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.054 0.941 . . . . 0.57 111.45 -171.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.01 66.33 0.01 OUTLIER Glycine 0 C--N 1.342 0.882 0 O-C-N 121.473 -0.767 . . . . 0.57 111.735 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 174.24 7.11 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.626 1.171 . . . . 0.65 110.636 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 t -160.33 -177.16 6.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.36 -0.836 . . . . 0.57 110.773 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -146.8 56.37 1.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.306 2.642 . . . . 0.57 107.46 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.35 150.65 44.86 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 124.647 1.179 . . . . 0.66 108.278 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.0 -26.91 58.18 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.628 2.218 . . . . 0.57 111.607 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.94 30.29 5.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.27 -1.011 . . . . 0.57 108.27 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.42 131.04 46.05 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.294 -1.373 . . . . 0.57 107.294 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 150' ' ' PHE . 3.0 p -60.32 -32.26 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.57 110.68 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -99.21 25.86 6.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.827 0.451 . . . . 0.57 111.362 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.407 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 17.0 t80 -65.26 131.64 95.08 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 120.766 -1.209 . . . . 0.57 110.385 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.8 Cg_endo -75.28 171.79 17.6 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.662 2.241 . . . . 0.57 111.007 166.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 m 52.13 76.81 0.17 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.474 1.13 . . . . 0.57 110.657 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -46.92 125.52 7.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.234 1.014 . . . . 0.57 112.485 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.45 1.86 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.08 -1.208 . . . . 0.57 110.08 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.79 -44.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.55 0.74 . . . . 0.57 111.635 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -143.51 -137.14 3.23 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.208 -1.957 . . . . 0.57 108.208 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -126.03 112.0 24.31 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.589 -0.893 . . . . 0.66 108.589 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.41 -14.76 22.59 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.423 2.082 . . . . 0.57 112.035 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -64.65 -48.68 73.93 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 121.894 2.133 . . . . 0.57 109.87 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -92.5 69.91 4.98 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.643 1.177 . . . . 0.57 111.169 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.44 125.72 28.03 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.293 -0.632 . . . . 0.57 109.293 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 83.04 1.54 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.539 -1.282 . . . . 0.57 107.539 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 48.58 80.93 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.815 1.646 . . . . 0.57 111.629 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.6 t -67.95 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.128 0.571 . . . . 0.57 112.322 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.59 -57.37 0.69 Allowed 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.386 -0.968 . . . . 0.57 108.386 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -51.06 -39.43 55.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.277 1.431 . . . . 0.66 112.266 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -63.57 -53.83 45.61 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.64 -0.695 . . . . 0.66 109.366 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -48.92 86.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 118.752 -0.642 . . . . 0.57 109.843 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -32.76 74.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.12 1.768 . . . . 0.57 110.626 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.84 -60.45 3.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.98 -2.048 . . . . 0.57 107.98 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.55 -58.35 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 119.342 1.571 . . . . 0.57 111.151 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 10.6 pt20 -58.56 -22.56 56.16 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.705 0.684 . . . . 0.57 112.148 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -31.4 19.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.948 1.299 . . . . 0.57 110.777 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.14 -46.14 88.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.16 . . . . 0.57 110.157 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.1 p90 -104.88 12.73 32.18 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.379 0.672 . . . . 0.57 112.674 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.85 -141.85 12.36 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 122.163 0.868 . . . . 0.57 112.039 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -143.9 -60.51 0.4 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.039 -1.08 . . . . 0.57 110.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 160.61 39.05 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.863 0.865 . . . . 1.2 108.834 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -164.0 160.58 21.98 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.103 -1.814 . . . . 0.57 106.103 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -47.34 14.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.655 -0.498 . . . . 0.57 109.655 172.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.3 t 56.61 171.89 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.013 1.387 . . . . 0.57 112.641 -170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.06 159.52 41.82 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.922 -1.14 . . . . 1.2 107.922 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.65 171.04 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.943 1.697 . . . . 0.57 107.28 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.164 0 C-N-CA 127.124 2.17 . . . . 0.5 . -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.522 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 117.386 -1.293 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 t -138.34 -51.24 0.58 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.991 1.269 . . . . 0.57 109.31 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 tp -164.34 173.56 12.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.519 1.528 . . . . 0.57 107.258 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -31.36 96.99 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.393 2.277 . . . . 0.57 113.404 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.5 84.01 2.03 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.275 2.65 . . . . 0.57 110.416 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.14 97.97 7.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.888 -1.051 . . . . 0.57 108.988 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 m 44.43 69.76 2.3 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.76 1.624 . . . . 0.57 113.727 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 108.13 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.53 2.153 . . . . 0.57 111.011 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt 91.44 132.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 130.395 3.478 . . . . 0.57 109.9 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -64.41 159.46 21.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.513 0.725 . . . . 0.57 110.743 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -76.28 -25.33 54.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.715 0.635 . . . . 0.57 112.715 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -94.06 143.03 26.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.417 1.087 . . . . 0.57 109.9 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 pttm -76.48 -12.22 60.0 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.816 1.246 . . . . 0.57 112.963 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.85 109.49 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.735 -2.32 . . . . 0.57 104.735 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.11 163.86 3.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.67 -1.604 . . . . 0.57 106.67 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 p -114.37 147.45 39.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.694 -0.629 . . . . 0.57 111.351 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -123.77 155.42 37.96 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.474 0.71 . . . . 0.57 110.763 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 120.06 5.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.488 0.661 . . . . 1.2 110.052 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 22' ' ' TYR . 29.7 mt -87.02 113.8 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 105.842 -1.91 . . . . 0.57 105.842 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.48 -45.66 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.291 0.951 . . . . 0.57 111.237 -171.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.7 178.41 4.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.388 -1.708 . . . . 0.57 106.388 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 19' ' ' ILE . 49.2 m-85 -142.66 173.81 11.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.454 1.025 . . . . 0.57 109.306 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -90.28 -175.5 4.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.476 1.11 . . . . 0.57 111.251 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -123.96 -34.7 2.95 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.909 1.284 . . . . 1.2 113.491 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -61.86 -27.46 68.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.069 1.348 . . . . 0.66 111.648 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.47 144.31 20.65 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 126.957 2.103 . . . . 0.57 108.436 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 167.45 24.85 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.946 2.431 . . . . 0.57 112.863 -166.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.29 -36.24 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.859 0.864 . . . . 0.65 111.903 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.54 -36.87 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.724 0.81 . . . . 0.57 110.353 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -67.27 -49.84 62.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.846 -1.549 . . . . 0.57 108.39 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.97 -51.03 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 121.217 1.826 . . . . 0.57 110.66 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.8 -41.15 96.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.676 0.791 . . . . 0.66 111.986 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -62.98 -45.45 92.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.07 0.85 . . . . 1.2 111.772 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.14 -35.08 73.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.45 -0.786 . . . . 0.57 109.257 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.23 -49.45 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 117.886 -1.054 . . . . 0.57 110.204 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -60.17 -42.79 95.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.945 1.248 . . . . 0.57 111.076 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -65.05 -47.58 76.87 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.004 0.82 . . . . 0.57 111.234 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.99 99.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.127 0.971 . . . . 0.57 111.96 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 122' ' ' LEU . 42.8 mt -71.29 -35.54 71.33 Favored 'General case' 0 C--O 1.228 -0.044 0 O-C-N 121.531 -0.731 . . . . 0.57 111.427 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -61.96 -41.04 97.54 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 118.915 0.78 . . . . 0.57 110.092 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 36.0 mtp -60.71 -40.1 91.03 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.022 -0.99 . . . . 0.57 111.206 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.45 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 46.7 m95 -61.89 -50.24 73.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.45 1.477 . . . . 0.57 111.844 168.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.24 -8.97 53.22 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.424 1.012 . . . . 0.57 114.258 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -66.79 -24.2 66.15 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -1.225 . . . . 0.57 111.315 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -111.36 -11.34 14.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 118.445 -0.788 . . . . 0.66 111.023 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 pt -140.23 135.41 16.15 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 120.38 1.446 . . . . 0.57 110.96 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.87 48.36 2.2 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.52 3.48 . . . . 0.57 113.462 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tt -109.43 141.97 41.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.507 1.923 . . . . 0.57 107.842 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -133.0 163.77 28.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.785 0.834 . . . . 0.65 109.002 -168.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.75 145.49 32.43 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.573 -0.899 . . . . 0.57 108.573 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -145.33 175.23 10.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.331 1.052 . . . . 1.2 110.274 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -112.17 138.19 49.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.093 -0.706 . . . . 0.57 109.093 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.51 -28.96 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.097 0.959 . . . . 0.57 111.21 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.258 3.7 m 44.88 40.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.565 1.946 . . . . 0.57 112.72 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -156.47 -38.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.544 1.312 . . . . 0.57 114.544 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.83 -146.26 4.52 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.974 -1.25 . . . . 0.57 109.974 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -70.72 -173.64 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.0 0.9 . . . . 0.57 111.536 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.77 177.37 11.33 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.123 1.369 . . . . 0.57 110.403 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -63.66 -36.15 82.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.746 0.819 . . . . 0.66 110.097 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mt -120.33 76.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 126.769 2.027 . . . . 0.57 107.804 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -72.63 124.07 24.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.973 -1.121 . . . . 0.57 107.973 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.27 117.72 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 105.286 -2.116 . . . . 0.57 105.286 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.03 161.82 19.47 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.923 -0.871 . . . . 0.57 110.923 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -133.83 142.76 47.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.472 -2.048 . . . . 0.57 105.472 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.31 166.25 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.962 2.505 . . . . 0.57 107.535 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -130.0 93.96 3.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.06 -49.85 2.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.91 -0.939 . . . . 0.57 111.814 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.25 153.04 38.18 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.639 1.72 . . . . 0.57 110.897 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -152.04 159.69 43.64 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 125.568 1.547 . . . . 0.65 109.158 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.75 44.9 3.04 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.369 1.462 . . . . 0.57 112.872 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.67 -179.78 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.577 1.551 . . . . 0.66 110.409 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -39.82 -50.07 2.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.333 1.453 . . . . 0.57 111.791 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.89 132.06 13.7 Favored Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 124.611 1.164 . . . . 0.57 109.801 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.01 158.76 54.46 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.033 1.822 . . . . 0.57 111.204 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.33 -164.48 0.77 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.675 1.19 . . . . 0.57 111.061 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -121.73 -14.08 8.19 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.928 2.491 . . . . 0.66 112.408 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.71 -134.82 12.71 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.397 0.999 . . . . 0.57 110.678 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.51 100.51 1.16 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.471 2.114 . . . . 0.57 112.322 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.91 -163.85 25.55 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.516 1.055 . . . . 0.57 112.518 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 t30 45.42 -125.53 1.19 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.465 1.506 . . . . 0.57 114.346 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.6 m -74.48 131.91 41.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.635 2.374 . . . . 0.57 108.614 173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -100.76 -31.9 10.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.924 1.29 . . . . 0.57 112.194 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.34 37.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.945 1.298 . . . . 0.57 108.008 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -143.23 161.38 38.41 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.964 -0.46 . . . . 0.65 110.029 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.66 144.58 27.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.363 1.065 . . . . 0.57 109.167 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.04 146.4 27.96 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.849 -1.167 . . . . 0.57 107.849 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.86 155.15 12.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.502 -0.761 . . . . 0.57 110.891 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.48 166.07 26.92 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.121 1.881 . . . . 0.57 112.043 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.23 -101.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 108.984 -1.646 . . . . 0.57 108.984 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.3 p -151.36 -54.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.423 1.089 . . . . 0.57 110.599 -166.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.7 -108.56 3.24 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 125.086 1.327 . . . . 0.57 110.01 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -29.06 64.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.418 1.087 . . . . 0.57 111.754 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.33 141.75 6.95 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.201 -0.76 . . . . 0.57 111.201 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.99 4.61 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.664 -1.631 . . . . 0.57 114.504 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.25 159.47 33.38 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.043 1.921 . . . . 0.66 109.074 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.81 145.36 27.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.57 109.867 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -130.94 155.22 47.16 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.334 -0.617 . . . . 0.65 109.334 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -138.08 147.99 44.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.778 1.631 . . . . 0.57 108.631 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.39 93.99 8.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.795 0.838 . . . . 0.66 108.882 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.85 -22.36 14.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.77 1.628 . . . . 0.66 111.568 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.61 -28.81 68.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.115 0.416 . . . . 0.66 111.572 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -79.89 167.86 19.98 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 122.026 0.917 . . . . 0.66 111.502 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -79.55 156.39 27.76 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.69 -0.686 . . . . 1.2 110.157 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CZ3' HD11 ' A' ' 112' ' ' ILE . 96.9 m95 -151.28 121.7 7.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.817 -1.919 . . . . 0.57 105.817 -175.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -136.15 144.56 45.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.871 1.669 . . . . 0.57 109.342 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -68.07 -45.5 73.66 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.957 0.503 . . . . 0.66 110.596 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.95 39.27 0.02 OUTLIER Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.826 1.679 . . . . 0.57 111.43 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 -66.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.012 1.325 . . . . 0.57 110.199 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -84.44 168.23 15.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.461 0.704 . . . . 0.57 110.314 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.74 150.21 20.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.241 1.016 . . . . 0.57 111.371 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -145.88 15.29 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.709 -0.556 . . . . 0.57 111.709 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.401 HD11 ' CZ3' ' A' ' 104' ' ' TRP . 1.3 pp -122.83 142.66 38.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.453 1.101 . . . . 0.57 108.21 172.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.7 110.39 1.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.273 0.629 . . . . 0.57 111.615 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.04 -34.87 78.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.203 1.801 . . . . 0.57 113.104 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -39.97 84.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.434 0.561 . . . . 0.57 110.217 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.76 -45.72 81.49 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 124.038 0.836 . . . . 0.57 108.77 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.42 22.06 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 123.562 0.745 . . . . 0.57 111.114 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.9 74.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.749 -1.12 . . . . 0.57 109.866 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -51.89 -46.06 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.85 1.205 . . . . 0.57 111.029 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -61.76 -55.18 32.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.692 0.797 . . . . 0.65 109.773 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.43 -41.01 89.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.343 0.519 . . . . 0.66 110.96 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 HD21 ' A' ' 39' ' ' LEU . 4.5 mm? -63.14 -26.08 68.65 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.42 -0.8 . . . . 0.57 111.801 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.45 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -66.58 -44.59 89.54 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.893 1.224 . . . . 0.57 113.003 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -64.28 -38.56 91.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.042 -0.504 . . . . 0.65 110.025 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 t -59.4 -33.81 71.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.358 0.503 . . . . 0.57 112.358 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -38.43 65.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.992 0.917 . . . . 0.57 111.534 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.3 9.75 0.65 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.426 1.013 . . . . 0.57 115.224 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -93.99 157.96 15.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.681 1.24 . . . . 0.57 110.845 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.35 178.01 21.69 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.513 -1.035 . . . . 0.57 110.513 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -72.61 166.66 22.29 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.054 0.542 . . . . 0.65 111.439 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.0 t -123.55 -46.35 2.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.427 1.891 . . . . 0.57 112.299 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.72 43.71 0.32 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.366 1.467 . . . . 0.57 112.831 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -117.29 154.8 50.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.609 1.163 . . . . 0.66 109.48 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.71 -6.29 18.23 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.527 2.818 . . . . 0.57 114.353 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -137.5 17.62 2.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.039 1.336 . . . . 0.57 110.378 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.17 130.71 43.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.505 0.722 . . . . 0.57 111.077 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.79 -25.28 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.668 1.187 . . . . 0.57 111.752 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.95 21.55 11.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.453 1.501 . . . . 0.57 111.357 169.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -58.85 136.3 87.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 120.667 -1.271 . . . . 0.57 110.194 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.99 -163.76 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.729 2.953 . . . . 0.57 111.819 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t 36.29 77.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.524 1.929 . . . . 0.57 115.215 168.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -38.91 109.63 0.11 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.919 2.088 . . . . 0.57 113.341 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.34 111.34 1.2 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.747 1.165 . . . . 0.57 110.684 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -179.84 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.61 1.164 . . . . 0.57 112.279 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.0 -162.29 11.46 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.475 1.512 . . . . 0.57 110.024 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.04 108.88 56.55 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 106.846 -1.538 . . . . 0.66 106.846 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.44 -7.6 9.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.31 2.674 . . . . 0.57 112.922 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -69.48 -33.38 72.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 121.041 1.746 . . . . 0.57 109.684 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.74 86.8 2.26 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.288 1.035 . . . . 0.57 112.001 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.76 -50.75 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.623 1.569 . . . . 0.57 111.618 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.99 45.1 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.027 2.131 . . . . 0.57 114.85 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp 64.98 79.96 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.841 1.656 . . . . 0.57 109.893 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -58.82 -83.48 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.644 1.177 . . . . 0.57 113.448 -170.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -142.88 -49.45 0.34 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.738 1.615 . . . . 0.57 106.643 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.18 -53.4 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.66 112.953 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -51.67 69.08 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.874 0.469 . . . . 0.66 110.772 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.07 -38.58 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.341 1.056 . . . . 0.57 109.699 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -49.69 66.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.548 1.139 . . . . 0.57 108.046 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.6 -52.74 51.28 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.89 0.768 . . . . 0.57 111.311 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 mm -61.6 -50.74 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.438 -0.791 . . . . 0.57 111.052 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -70.81 -14.08 62.28 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.245 1.384 . . . . 0.57 112.143 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -83.26 -25.08 31.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.618 1.099 . . . . 0.57 111.829 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.27 -37.44 12.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.571 1.078 . . . . 0.57 111.9 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -113.06 28.67 8.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.148 1.779 . . . . 0.57 109.517 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.73 -137.24 2.66 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.997 2.237 . . . . 0.57 108.163 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -135.3 -52.04 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 0.57 112.097 -164.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -145.65 142.12 28.76 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.354 1.062 . . . . 1.2 109.124 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.71 125.13 2.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.393 -2.077 . . . . 0.57 105.393 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.94 -174.94 0.15 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.941 1.296 . . . . 0.57 113.333 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.4 t -130.94 177.81 7.15 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.734 1.614 . . . . 0.57 108.689 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -83.19 131.19 35.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.79 -1.189 . . . . 1.2 107.79 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -159.52 128.44 5.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.143 0.883 . . . . 0.57 109.322 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? . . . . . 0 N--CA 1.468 0.444 0 C-N-CA 123.618 0.767 . . . . 0.5 . -169.701 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.414 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 119.469 -0.301 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -142.71 -36.39 0.39 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.019 0.928 . . . . 0.57 110.82 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -60.86 99.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.618 1.199 . . . . 0.57 110.111 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -45.59 1.25 Allowed Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.361 1.864 . . . . 0.57 112.289 172.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.44 -169.03 0.63 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.75 2.3 . . . . 0.57 111.973 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -55.06 166.82 0.48 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.675 0.79 . . . . 0.57 110.823 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -45.31 113.79 2.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.115 0.966 . . . . 0.57 110.499 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.77 176.41 8.28 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.205 1.27 . . . . 0.57 110.042 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.23 132.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.425 2.29 . . . . 0.57 108.186 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG21 ' A' ' 15' ' ' VAL . 13.0 m95 -71.72 175.02 6.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.699 0.8 . . . . 0.57 110.422 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.0 p -97.38 -11.7 23.65 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.672 0.619 . . . . 0.57 112.672 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.0 t -104.49 151.25 23.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.85 1.66 . . . . 0.57 108.675 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -8.91 57.85 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.201 1.001 . . . . 0.57 112.449 172.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.66 144.62 37.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.568 1.547 . . . . 0.57 108.775 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 10' ' ' TRP . 96.2 t -130.37 153.73 39.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.856 1.262 . . . . 0.57 108.098 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 p -103.39 144.02 31.93 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.739 -0.467 . . . . 0.57 109.739 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -133.31 152.74 51.94 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.257 -1.527 . . . . 0.57 110.895 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.63 111.77 4.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.313 1.054 . . . . 1.2 109.626 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.28 101.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 104.152 -2.536 . . . . 0.57 104.152 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.45 -44.87 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.692 1.197 . . . . 0.57 111.651 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.44 174.86 6.12 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.362 1.865 . . . . 0.57 106.411 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -146.29 161.16 40.9 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.5 -0.926 . . . . 0.57 108.5 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.8 t -63.25 177.73 0.6 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.597 0.713 . . . . 0.57 110.913 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -117.67 -39.61 3.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.436 1.094 . . . . 1.2 112.836 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.07 -33.55 73.5 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.231 0.923 . . . . 0.66 110.084 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.35 149.7 44.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.57 109.811 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -76.73 164.81 29.69 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.918 2.412 . . . . 0.57 113.609 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 17.0 m-70 -62.38 -45.52 92.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.898 1.279 . . . . 0.65 112.06 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 tp -57.86 -42.21 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.653 0.781 . . . . 0.57 109.672 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -62.46 -48.35 80.04 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 117.759 -1.115 . . . . 0.57 109.251 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.43 -49.74 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 120.72 1.6 . . . . 0.57 110.679 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.59 -41.34 96.3 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.167 0.894 . . . . 0.66 111.404 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.275 -0.891 . . . . 1.2 112.307 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.11 -35.92 74.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.998 -1.001 . . . . 0.57 109.274 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.03 -51.56 60.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.05 -0.976 . . . . 0.57 108.773 166.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -43.61 88.76 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.08 1.309 . . . . 0.57 110.878 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -66.89 -38.51 86.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.565 1.075 . . . . 0.57 112.807 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.16 76.44 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.341 1.056 . . . . 0.57 111.554 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.5 -30.96 68.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.086 -0.959 . . . . 0.57 110.278 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.34 -31.76 72.44 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.859 1.209 . . . . 0.57 111.339 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.8 mtm -74.28 -37.55 63.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.328 -0.844 . . . . 0.57 111.66 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -64.9 -50.19 67.49 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.93 1.241 . . . . 0.57 110.681 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -4.91 55.24 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.511 1.529 . . . . 0.57 113.956 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -25.68 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.548 -0.972 . . . . 0.57 110.211 168.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -110.71 -19.06 12.99 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.695 -0.669 . . . . 0.66 112.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 160' ' ' ILE . 32.5 pt -126.35 126.3 24.64 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 123.951 0.9 . . . . 0.57 109.028 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.95 32.64 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.504 2.803 . . . . 0.57 113.557 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 15' ' ' VAL . 1.3 tt -80.89 145.9 31.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.147 1.379 . . . . 0.57 108.241 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.444 ' H ' HD23 ' A' ' 48' ' ' LEU . 9.3 m80 -126.54 165.92 18.25 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.65 108.47 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.06 157.33 46.56 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.723 -1.236 . . . . 0.57 108.511 -172.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.76 160.78 39.12 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.33 1.052 . . . . 1.2 108.857 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -106.9 146.7 30.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.438 -1.319 . . . . 0.57 107.438 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.1 169.01 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.927 0.491 . . . . 0.57 109.793 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.31 -13.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.57 111.504 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -93.23 -66.02 0.95 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.57 108.845 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.48 -27.38 0.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.843 0.292 . . . . 0.57 113.05 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -78.56 125.72 29.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.845 -1.169 . . . . 0.57 107.845 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.3 166.17 26.3 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.973 0.909 . . . . 0.57 109.321 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 74.1 m-20 -64.1 -47.19 81.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.11 0.964 . . . . 0.66 108.706 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.92 80.0 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.766 1.627 . . . . 0.57 107.282 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 ttm -75.48 134.26 40.87 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.77 -1.206 . . . . 0.57 107.841 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.59 119.63 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.963 -1.865 . . . . 0.57 105.963 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.94 163.92 23.35 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 111.841 -0.504 . . . . 0.57 111.841 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.31 134.01 33.74 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.467 -2.049 . . . . 0.57 105.467 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.03 -174.04 4.74 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.702 1.201 . . . . 0.57 109.27 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 3.04 8.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.893 0.77 . . . . 1.2 112.813 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.75 -130.67 2.12 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.175 -1.57 . . . . 0.57 109.175 -166.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.7 117.13 7.01 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.376 -0.485 . . . . 0.57 110.385 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -112.19 -46.8 3.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.558 0.743 . . . . 0.65 111.316 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.41 23.41 0.59 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.2 0.905 . . . . 0.57 113.893 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -53.18 4.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.515 1.926 . . . . 0.66 111.773 -170.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -178.38 -45.41 0.01 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.848 2.059 . . . . 0.57 107.646 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.56 139.5 35.48 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 123.852 0.861 . . . . 0.57 109.039 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.34 141.4 46.85 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.454 1.436 . . . . 0.57 109.965 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.75 -179.24 0.84 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.953 1.358 . . . . 0.57 111.121 163.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -115.52 -31.23 5.96 Favored 'General case' 0 CA--C 1.542 0.666 1 C-N-CA 131.92 4.088 . . . . 0.66 109.931 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.08 -138.03 15.65 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.668 -0.973 . . . . 0.57 110.668 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 104.1 1.69 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.803 3.002 . . . . 0.57 112.148 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -179.75 16.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 126.004 1.764 . . . . 0.57 108.891 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.74 -155.66 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.389 1.876 . . . . 0.57 112.86 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.7 m -44.87 120.39 2.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.365 2.266 . . . . 0.57 111.534 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.18 -25.13 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.888 1.275 . . . . 0.57 113.106 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.22 164.34 25.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.353 1.461 . . . . 0.57 108.367 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.03 158.74 44.42 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.998 -0.371 . . . . 0.65 109.998 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.0 155.74 39.68 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.725 1.21 . . . . 0.57 109.808 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.05 171.65 7.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.289 0.636 . . . . 0.57 110.596 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.55 139.08 26.48 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-O 118.245 -0.884 . . . . 0.57 109.363 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 50.3 Cg_endo -67.49 159.37 52.77 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.578 2.186 . . . . 0.57 112.166 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.28 12.72 21.09 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.351 -0.694 . . . . 0.57 113.752 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -153.47 43.73 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.55 1.675 . . . . 0.57 111.933 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.37 -71.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.168 1.842 . . . . 0.57 114.69 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.06 -5.05 39.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.372 1.869 . . . . 0.57 111.437 163.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 126.92 31.59 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.979 -1.075 . . . . 0.57 110.446 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.28 -44.33 1.5 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 126.046 1.784 . . . . 0.57 110.845 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.09 143.75 13.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.105 2.162 . . . . 0.66 109.199 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.07 150.36 42.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.633 0.73 . . . . 0.57 109.535 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.47 162.96 31.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.943 -0.762 . . . . 0.65 108.943 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -139.59 158.45 44.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.497 1.919 . . . . 0.57 109.344 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -84.45 102.35 12.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.655 0.382 . . . . 0.66 110.999 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -58.23 -28.44 64.87 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.605 -1.309 . . . . 0.66 111.116 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.46 -26.71 66.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.609 0.763 . . . . 0.66 111.581 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -72.37 138.93 47.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.203 1.002 . . . . 0.66 109.608 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.12 111.79 4.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -94.24 158.64 15.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.409 -0.96 . . . . 0.57 108.409 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.3 t -141.19 153.53 45.37 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.313 -0.995 . . . . 0.57 108.313 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.55 -36.43 70.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.331 0.652 . . . . 0.66 110.162 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.65 -97.36 1.47 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.102 -1.199 . . . . 0.57 110.102 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -158.17 139.31 13.29 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.728 -1.212 . . . . 0.57 107.728 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 t -163.82 -51.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.836 -0.602 . . . . 0.57 110.491 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -160.38 -44.12 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.001 1.72 . . . . 0.57 110.895 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.77 173.43 54.71 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.536 -1.026 . . . . 0.57 110.536 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -83.66 148.78 4.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.236 0.541 . . . . 0.57 109.816 177.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -65.39 114.58 4.91 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.67 -0.695 . . . . 0.57 109.488 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -60.92 -41.11 95.52 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.524 1.13 . . . . 0.57 111.573 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -47.44 84.61 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.555 1.142 . . . . 0.57 108.787 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -60.56 -39.25 87.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.061 0.944 . . . . 0.57 110.051 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.42 49.48 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.915 0.886 . . . . 0.57 112.765 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.76 68.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.219 -1.03 . . . . 0.57 108.219 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 m -56.1 -41.23 74.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.336 0.654 . . . . 0.57 111.758 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.08 -57.79 11.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.953 0.342 . . . . 0.65 110.109 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -68.11 -39.96 82.68 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.042 -1.036 . . . . 0.66 111.609 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.38 -32.72 74.51 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.586 1.154 . . . . 0.57 110.818 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.57 -47.35 57.67 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.166 -0.774 . . . . 0.57 111.166 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.48 -35.35 70.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.556 0.576 . . . . 0.65 112.556 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -35.85 73.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 0.57 111.02 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -46.5 89.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.562 0.745 . . . . 0.57 110.71 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.51 49.19 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.533 -0.593 . . . . 0.57 113.951 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.72 -160.1 0.17 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.029 1.414 . . . . 0.57 110.724 -173.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 132.65 35.22 0.32 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 121.427 -0.796 . . . . 0.57 113.659 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 167.8 7.2 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.219 1.009 . . . . 0.65 112.856 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.9 p -152.95 -173.33 4.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.584 1.153 . . . . 0.57 110.208 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.8 p -143.48 49.73 1.41 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.703 1.201 . . . . 0.57 110.949 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 143.87 27.91 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.08 1.352 . . . . 0.66 110.239 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.28 -12.27 29.7 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.455 2.103 . . . . 0.57 113.743 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -137.22 51.14 1.96 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.685 1.594 . . . . 0.57 107.909 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.21 43.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.637 1.575 . . . . 0.57 108.059 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.86 -27.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.57 109.381 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.2 mmt -78.14 -14.96 59.27 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.649 1.979 . . . . 0.57 114.154 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -58.8 128.25 83.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.009 1.277 . . . . 0.57 110.605 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.05 156.8 47.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.248 1.966 . . . . 0.57 110.642 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.5 m 61.14 99.35 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.207 1.403 . . . . 0.57 111.473 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.89 123.98 2.05 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.197 1.399 . . . . 0.57 111.883 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.68 -130.86 2.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.162 -1.575 . . . . 0.57 109.162 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -65.12 -61.55 2.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.537 0.668 . . . . 0.57 110.446 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 39.88 -150.45 0.11 Allowed Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.305 1.431 . . . . 0.57 113.409 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.24 75.36 4.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.266 -1.012 . . . . 0.66 108.266 167.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.0 39.8 0.3 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.962 3.108 . . . . 0.57 112.822 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -144.76 -54.51 0.32 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.129 1.772 . . . . 0.57 108.436 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.03 89.11 3.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.0 1.32 . . . . 0.57 108.43 -170.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -44.34 -63.24 0.92 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.479 1.511 . . . . 0.57 114.906 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt 31.49 63.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.915 2.486 . . . . 0.57 113.479 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -25.8 115.13 0.05 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 128.781 2.832 . . . . 0.57 110.874 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.3 t -82.66 -82.26 0.14 Allowed 'General case' 0 C--N 1.341 0.204 0 CA-C-O 119.051 -0.5 . . . . 0.57 111.022 -162.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -147.94 -44.12 0.16 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 118.531 0.605 . . . . 0.57 110.364 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.26 -49.22 9.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.903 2.081 . . . . 0.66 112.933 164.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.53 -54.76 23.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.808 0.843 . . . . 0.66 109.833 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.98 -41.68 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.349 1.06 . . . . 0.57 109.108 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -57.14 13.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.916 -1.142 . . . . 0.57 107.916 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.417 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -51.1 -53.9 25.32 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.523 -1.031 . . . . 0.57 110.523 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 46' ' ' ILE . 20.1 mm -50.86 -50.73 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.479 0.712 . . . . 0.57 111.294 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.37 -31.01 70.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.43 0.559 . . . . 0.57 112.241 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -24.41 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.653 -1.165 . . . . 0.57 110.814 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 159' ' ' GLY . 9.0 mp -93.01 -49.78 5.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.243 1.017 . . . . 0.57 110.667 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -144.43 30.07 1.25 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.841 0.856 . . . . 0.57 112.077 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.54 -124.04 1.64 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.253 -1.139 . . . . 0.57 110.253 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.79 -58.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.595 . . . . 0.57 111.06 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.01 131.34 15.6 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 107.255 -1.387 . . . . 1.2 107.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.19 81.34 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.96 -1.867 . . . . 0.57 105.96 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -161.16 141.1 10.77 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.488 -1.301 . . . . 0.57 107.488 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.0 t -169.95 -57.34 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.036 0.935 . . . . 0.57 108.846 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 57.15 171.76 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.809 2.044 . . . . 1.2 111.806 -170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.58 56.9 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.868 -1.145 . . . . 0.57 110.578 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.47 0.566 0 C-N-CA 125.392 1.477 . . . . 0.5 . -175.454 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.249 0.071 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 t -76.21 -91.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.107 0.963 . . . . 0.57 108.42 169.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.46 24.13 0.41 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.619 1.1 . . . . 0.57 113.613 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -139.85 66.84 34.38 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.412 1.085 . . . . 0.57 110.632 -175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 64.15 5.12 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.539 2.826 . . . . 0.57 111.507 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.81 73.15 1.52 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 125.299 1.44 . . . . 0.57 108.559 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m 42.36 75.13 0.66 Allowed Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.828 1.651 . . . . 0.57 112.385 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.89 123.8 11.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.363 2.042 . . . . 0.57 109.115 -173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 80.38 128.5 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 129.05 2.94 . . . . 0.57 111.075 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -61.59 157.86 16.48 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.605 0.762 . . . . 0.57 110.491 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.1 p -78.28 -34.38 48.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.475 . . . . 0.57 111.508 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -82.93 139.12 33.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.958 0.903 . . . . 0.57 109.197 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -76.29 -2.79 33.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.5 0.72 . . . . 0.57 112.75 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.96 113.84 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.855 -2.276 . . . . 0.57 104.855 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.71 139.85 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.876 -1.527 . . . . 0.57 106.876 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 149.31 35.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.603 -0.686 . . . . 0.57 111.283 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.44 157.12 35.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.57 110.571 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 119.62 11.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.941 -0.763 . . . . 1.2 108.941 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -87.82 99.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 104.982 -2.229 . . . . 0.57 104.982 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -48.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.504 1.122 . . . . 0.57 111.712 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.84 175.46 5.57 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.151 1.78 . . . . 0.57 106.455 174.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -144.42 164.87 29.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.364 -0.976 . . . . 0.57 108.364 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.6 t -67.84 -175.32 0.54 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.57 0.748 . . . . 0.57 111.632 171.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.23 -38.16 1.8 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.704 1.202 . . . . 1.2 113.12 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.7 -43.9 93.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.345 0.658 . . . . 0.66 109.985 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.0 149.1 39.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.627 1.971 . . . . 0.57 108.606 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -75.11 160.31 39.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.311 2.007 . . . . 0.57 112.66 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.84 -38.99 83.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.353 1.061 . . . . 0.65 111.669 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.75 -39.58 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.341 0.656 . . . . 0.57 110.296 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.8 m -68.01 -43.62 78.42 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 116.442 -1.742 . . . . 0.57 109.013 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.97 -51.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 121.455 1.934 . . . . 0.57 110.736 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.33 -40.99 94.4 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.197 0.908 . . . . 0.66 111.352 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -42.74 97.65 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.852 1.206 . . . . 1.2 112.048 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 115' ' ' LEU . 7.8 mp -63.55 -48.65 76.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.598 1.559 . . . . 0.57 108.402 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -56.64 -41.61 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.977 0.808 . . . . 0.57 110.763 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -60.51 -53.25 59.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.499 1.045 . . . . 0.57 109.644 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -39.19 93.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.285 0.948 . . . . 0.57 111.624 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.96 93.74 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.943 1.297 . . . . 0.57 111.984 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 HD12 ' A' ' 122' ' ' LEU . 30.5 mt -70.42 -33.78 71.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.396 -0.812 . . . . 0.57 110.322 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.97 -37.3 76.48 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 118.808 0.731 . . . . 0.57 110.546 171.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.52 80.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.91 0.777 . . . . 0.57 112.268 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.427 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 17.7 m95 -73.03 -47.56 43.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.764 0.711 . . . . 0.57 110.823 171.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.87 63.54 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.562 1.077 . . . . 0.57 113.53 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.32 -17.47 64.78 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.113 -1.227 . . . . 0.57 111.863 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -106.41 -33.86 7.6 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.75 -0.643 . . . . 0.66 111.332 173.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 160' ' ' ILE . 21.4 pt -121.54 134.17 24.47 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 119.455 1.025 . . . . 0.57 110.39 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 37.27 0.38 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.9 3.067 . . . . 0.57 113.055 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.06 132.84 36.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.021 -1.474 . . . . 0.57 107.021 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -116.44 163.97 15.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.89 1.276 . . . . 0.65 108.915 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -139.6 153.47 47.37 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.231 -0.918 . . . . 0.57 108.962 -170.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -141.04 178.68 7.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.179 0.991 . . . . 1.2 109.461 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -125.35 156.07 39.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.538 -0.912 . . . . 0.57 108.538 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 m -108.19 169.53 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.998 1.319 . . . . 0.57 109.319 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.77 -29.37 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.71 -1.586 . . . . 0.57 110.948 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -62.69 -51.83 65.67 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.187 0.903 . . . . 0.57 111.719 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.64 -125.2 1.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.072 -1.611 . . . . 0.57 109.072 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -47.14 154.85 0.34 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.443 1.097 . . . . 0.57 113.744 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.87 -174.18 4.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.176 1.39 . . . . 0.57 110.943 -170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -60.51 -42.09 95.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.54 -0.743 . . . . 0.66 109.001 172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -124.19 82.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.57 108.375 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.3 ttp -79.89 117.32 20.65 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 120.294 -1.504 . . . . 0.57 107.116 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -108.62 129.09 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.25 -2.13 . . . . 0.57 105.25 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 164.77 27.64 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-O 121.962 0.756 . . . . 0.57 112.176 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.9 m-85 -132.43 141.4 48.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.026 -1.842 . . . . 0.57 106.026 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.38 164.69 30.08 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.874 1.669 . . . . 0.57 107.916 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 42.08 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.564 -0.71 . . . . 1.2 111.182 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.15 -46.29 0.61 Allowed Glycine 0 C--O 1.223 -0.586 0 CA-C-O 119.53 -0.594 . . . . 0.57 111.658 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.03 169.32 21.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.567 1.184 . . . . 0.57 110.245 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.76 159.92 33.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.969 1.708 . . . . 0.65 108.829 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.65 60.78 3.19 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.888 1.232 . . . . 0.57 111.412 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -105.78 -61.84 1.45 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.111 0.965 . . . . 0.66 110.406 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.5 t -179.74 -35.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.364 2.665 . . . . 0.57 110.003 -173.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.75 122.7 14.54 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 119.193 0.906 . . . . 0.57 108.992 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.99 133.13 34.56 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 N-CA-C 108.423 -1.414 . . . . 0.57 108.423 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -166.93 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 123.257 1.504 . . . . 0.57 110.809 166.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -134.01 -38.25 0.88 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.76 3.224 . . . . 0.66 109.172 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.74 -139.68 14.97 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.672 -1.071 . . . . 0.57 110.509 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.1 95.43 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 124.466 3.444 . . . . 0.57 111.281 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.64 170.85 12.33 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.849 1.69 . . . . 0.57 109.29 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 49.33 -159.6 0.06 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.485 1.514 . . . . 0.57 112.377 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -43.05 128.18 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.242 2.217 . . . . 0.57 112.848 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -95.53 -24.33 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.641 1.576 . . . . 0.57 113.062 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.09 162.0 33.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.629 -1.249 . . . . 0.57 107.629 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.3 167.83 22.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.321 -0.622 . . . . 0.65 109.321 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.39 160.28 42.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.285 -1.006 . . . . 0.57 108.285 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -111.45 147.07 36.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.688 -1.227 . . . . 0.57 107.688 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 151.4 53.22 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.268 -0.872 . . . . 0.57 110.249 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.13 164.85 23.72 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.95 1.767 . . . . 0.57 111.585 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.12 -93.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 109.357 -1.497 . . . . 0.57 109.357 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -158.92 -50.61 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.503 1.521 . . . . 0.57 109.709 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.52 -119.73 2.13 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.707 -0.957 . . . . 0.57 110.707 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -31.49 40.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.996 0.898 . . . . 0.57 111.879 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.2 142.44 7.97 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.509 -0.744 . . . . 0.57 112.135 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.4 -38.9 3.12 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.186 1.851 . . . . 0.57 112.625 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -60.36 149.78 32.71 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.759 -0.83 . . . . 0.66 108.759 -167.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.61 146.98 38.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.522 0.677 . . . . 0.57 109.25 -171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -135.39 156.2 49.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.265 -0.879 . . . . 0.65 109.975 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 47.0 m-85 -137.82 146.15 43.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.019 1.327 . . . . 0.57 108.081 -169.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.02 101.61 7.91 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.455 -0.942 . . . . 0.66 108.455 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -59.08 -24.34 62.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.66 111.885 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -69.12 -36.05 77.08 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.577 0.751 . . . . 0.66 111.215 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.86 131.26 44.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.441 -1.689 . . . . 0.66 106.441 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 139.69 48.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.635 0.774 . . . . 1.2 110.441 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -129.32 118.27 21.99 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.232 -1.395 . . . . 0.57 107.232 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -114.93 147.99 39.28 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.38 -0.97 . . . . 0.57 108.38 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.94 21.83 2.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.624 0.77 . . . . 0.66 111.981 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.03 68.95 1.29 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.399 -1.08 . . . . 0.57 110.399 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -40.04 4.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.984 -1.007 . . . . 0.57 113.697 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.0 -47.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.209 1.804 . . . . 0.57 110.621 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -139.09 155.2 48.09 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.354 1.462 . . . . 0.57 108.131 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.63 -161.47 12.85 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.236 -1.546 . . . . 0.57 109.236 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.2 mm -113.36 121.19 65.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.712 -1.959 . . . . 0.57 105.712 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.23 103.47 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.984 0.803 . . . . 0.57 109.072 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -53.27 -41.16 65.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.607 1.563 . . . . 0.57 110.399 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' A' ' 34' ' ' LEU . 13.3 tp -64.42 -50.36 67.9 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.694 -1.225 . . . . 0.57 107.694 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -60.35 -39.51 87.41 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.232 -0.655 . . . . 0.57 109.232 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.04 -61.69 2.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.425 1.09 . . . . 0.57 110.458 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.85 -51.49 65.74 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.235 0.614 . . . . 0.57 110.095 -175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.8 m -62.51 -37.71 87.09 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.438 0.695 . . . . 0.57 112.062 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -60.65 -53.95 51.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.196 0.598 . . . . 0.65 109.393 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.78 -40.43 96.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.258 0.481 . . . . 0.66 110.652 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 39' ' ' LEU . 2.9 mm? -61.26 -30.0 70.19 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.878 0.871 . . . . 0.57 111.37 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.427 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -56.29 -51.83 53.55 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 118.472 0.578 . . . . 0.57 112.083 170.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.01 -40.42 93.47 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.203 1.001 . . . . 0.65 110.635 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -33.36 65.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.115 0.966 . . . . 0.57 112.173 172.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.91 66.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.845 0.858 . . . . 0.57 111.648 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.82 63.88 0.88 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.446 -0.662 . . . . 0.57 111.446 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.6 176.84 8.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.32 1.448 . . . . 0.57 109.141 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -95.44 148.44 18.99 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.868 -0.605 . . . . 0.57 111.929 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 174.86 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.117 1.367 . . . . 0.65 113.045 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -133.74 178.31 7.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.599 1.16 . . . . 0.57 110.983 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.486 ' HB3' ' HE3' ' A' ' 172' ' ' LYS . 1.3 t -165.39 47.06 0.09 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.358 1.863 . . . . 0.57 108.212 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.7 t70 -121.63 143.23 37.56 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-O 118.269 -0.872 . . . . 0.66 109.708 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.7 2.49 2.92 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.696 2.931 . . . . 0.57 114.098 -171.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -146.98 20.57 1.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.432 1.093 . . . . 0.57 110.358 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -72.11 140.57 48.94 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.341 0.656 . . . . 0.57 110.463 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.56 -35.25 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.37 -0.974 . . . . 0.57 108.37 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -86.85 14.15 7.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.949 1.092 . . . . 0.57 113.949 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.07 128.26 93.61 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.496 -1.377 . . . . 0.57 111.137 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.62 -46.51 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.765 1.643 . . . . 0.57 111.551 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 p -81.32 52.05 1.75 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.141 1.377 . . . . 0.57 110.323 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -39.86 131.91 1.82 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.139 2.176 . . . . 0.57 112.902 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.7 114.9 2.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.212 1.387 . . . . 0.57 109.657 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 179.61 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.183 1.393 . . . . 0.57 109.349 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.38 -138.52 9.65 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.841 1.21 . . . . 0.57 110.343 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -127.38 111.29 21.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 0.66 108.853 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.33 -15.22 22.65 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.814 2.342 . . . . 0.57 113.015 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -62.57 -36.46 82.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.487 1.04 . . . . 0.57 110.252 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -90.53 70.0 6.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.947 1.299 . . . . 0.57 108.772 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -41.73 -68.45 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.773 1.629 . . . . 0.57 115.23 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 21.58 74.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.386 2.674 . . . . 0.57 112.633 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.4 mp -31.37 116.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 128.022 2.529 . . . . 0.57 109.742 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.6 t -82.2 -88.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.843 0.354 . . . . 0.57 110.998 -162.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -142.43 -30.51 0.55 Allowed 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 124.315 1.046 . . . . 0.57 110.774 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -51.54 -45.71 63.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 120.027 1.285 . . . . 0.66 110.795 167.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.406 ' CG ' HD23 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -72.76 -58.59 3.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.479 1.112 . . . . 0.66 111.023 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.56 -46.72 89.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.892 -0.781 . . . . 0.57 108.892 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -60.51 -49.8 76.12 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.046 -1.454 . . . . 0.57 108.864 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -54.18 -59.54 9.83 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.937 -1.265 . . . . 0.57 109.937 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 46' ' ' ILE . 6.6 mm -56.22 -50.22 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.933 1.293 . . . . 0.57 112.776 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -69.28 -19.75 63.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.476 0.71 . . . . 0.57 111.55 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -81.77 -25.96 34.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.13 0.972 . . . . 0.57 111.178 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 -50.59 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.348 0.976 . . . . 0.57 111.237 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 46' ' ' ILE . 39.4 m-85 -105.0 41.63 1.32 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.548 1.139 . . . . 0.57 108.74 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.26 0.15 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 109.52 -1.432 . . . . 0.57 109.52 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.904 1.075 . . . . 0.57 113.904 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -178.41 164.27 1.67 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.325 2.25 . . . . 1.2 108.054 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -160.71 136.84 8.43 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.266 -1.383 . . . . 0.57 107.266 168.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.13 162.68 0.07 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.574 1.549 . . . . 0.57 112.951 -173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.0 p -162.81 89.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.843 0.83 . . . . 0.57 109.082 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.39 157.98 43.12 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.579 -0.897 . . . . 1.2 108.579 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 132' ' ' SER . 0.2 OUTLIER -157.83 139.35 13.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.62 -1.622 . . . . 0.57 106.62 173.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 125.575 1.55 . . . . 0.5 . 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 119.982 -0.056 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 3' ' ' LEU . 5.9 m -69.87 -51.61 31.8 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 121.032 -1.043 . . . . 0.57 111.662 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 2' ' ' SER . 1.2 mp -146.44 -61.68 0.31 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.848 0.859 . . . . 0.57 109.585 -176.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -69.08 120.71 78.33 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.188 -0.911 . . . . 0.57 109.461 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.07 -25.66 7.16 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.58 2.187 . . . . 0.57 112.412 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -117.35 126.07 52.09 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 105.171 -2.159 . . . . 0.57 105.171 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m 135.35 -56.58 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 1 C-N-CA 132.181 4.192 . . . . 0.57 111.21 -170.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 163.37 33.98 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.974 1.741 . . . . 0.57 110.988 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.78 95.52 0.04 OUTLIER 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.696 1.198 . . . . 0.57 110.384 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -46.21 142.71 2.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.571 1.148 . . . . 0.57 110.7 172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.9 m -62.06 -21.13 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.039 0.936 . . . . 0.57 112.456 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -94.94 143.7 26.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.886 1.275 . . . . 0.57 109.536 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -77.19 0.18 22.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.539 0.736 . . . . 0.57 112.533 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.34 144.05 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.113 -1.439 . . . . 0.57 107.113 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.07 145.8 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.412 -1.699 . . . . 0.57 106.412 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -109.11 139.07 44.5 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.431 1.014 . . . . 0.57 110.131 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -122.37 157.5 31.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.697 0.761 . . . . 0.57 111.088 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.552 1.141 . . . . 1.2 109.114 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.477 HG21 ' CE1' ' A' ' 22' ' ' TYR . 1.6 mm -122.22 97.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.472 -2.418 . . . . 0.57 104.472 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.19 -34.71 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.391 0.676 . . . . 0.57 111.954 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -130.44 141.31 50.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.357 -2.46 . . . . 0.57 104.357 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.477 ' CE1' HG21 ' A' ' 19' ' ' ILE . 23.2 m-85 -129.86 146.56 51.59 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.581 1.152 . . . . 0.57 108.931 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 t -75.9 -175.67 3.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.525 1.93 . . . . 0.57 111.063 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -128.25 -27.75 2.66 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.595 0.961 . . . . 1.2 113.595 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.82 -23.56 67.33 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.848 1.204 . . . . 0.66 111.519 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.36 146.95 24.15 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.097 1.759 . . . . 0.57 109.43 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -75.29 161.73 37.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.736 2.291 . . . . 0.57 112.96 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -70.42 -38.58 74.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.364 -0.835 . . . . 0.65 110.315 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.52 -37.13 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.192 0.997 . . . . 0.57 110.44 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 m -66.37 -46.33 77.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.419 -1.277 . . . . 0.57 109.057 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.5 t -55.59 -50.65 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 120.322 1.419 . . . . 0.57 110.121 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.36 -35.29 80.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.649 0.659 . . . . 0.66 111.736 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -44.28 74.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.426 1.012 . . . . 1.2 112.314 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.09 -46.88 82.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.57 108.112 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.86 -44.53 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 117.568 -1.206 . . . . 0.57 111.244 173.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -54.64 -49.97 69.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.48 1.491 . . . . 0.57 111.388 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -74.57 -33.36 62.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.155 0.889 . . . . 0.57 112.198 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.5 78.88 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.373 1.069 . . . . 0.57 110.949 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 122' ' ' LEU . 49.0 mt -66.76 -41.06 88.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.151 -0.928 . . . . 0.57 109.397 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -52.88 -43.19 65.97 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 119.402 1.001 . . . . 0.57 110.684 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.5 mtp -59.32 -39.03 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.062 1.301 . . . . 0.57 112.597 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -65.39 -43.44 90.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.861 1.209 . . . . 0.57 110.964 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.9 88.09 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.66 -1.275 . . . . 0.57 113.528 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -77.45 -12.89 60.01 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.671 1.188 . . . . 0.57 110.104 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -109.06 -21.04 12.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.828 1.251 . . . . 0.66 111.909 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 164' ' ' TYR . 7.9 pt -139.18 152.94 70.74 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 124.67 1.188 . . . . 0.57 110.137 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.06 13.55 1.25 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.11 2.54 . . . . 0.57 113.021 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tt -82.18 135.23 35.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.455 -1.313 . . . . 0.57 107.455 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -116.79 170.45 8.59 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.553 0.741 . . . . 0.65 109.516 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 157.76 41.92 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.472 -0.768 . . . . 0.57 109.203 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.16 164.57 26.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.366 1.466 . . . . 1.2 108.357 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -135.65 115.83 13.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.123 -2.177 . . . . 0.57 105.123 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.46 164.92 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.617 0.767 . . . . 0.57 109.023 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.02 -36.51 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.265 0.626 . . . . 0.57 111.084 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 153.31 19.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.148 0.579 . . . . 0.57 110.662 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.48 40.57 2.42 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.358 0.98 . . . . 0.57 113.076 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -163.8 143.13 8.03 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.687 -1.227 . . . . 0.57 107.687 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.54 6.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.669 1.188 . . . . 0.57 109.596 -174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -64.48 -32.29 73.86 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.18 -0.674 . . . . 0.66 109.18 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 122' ' ' LEU . 5.5 mt -124.43 97.12 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.724 2.01 . . . . 0.57 107.728 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 ttp -100.23 100.15 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.305 2.642 . . . . 0.57 106.341 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mt -92.77 128.08 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.005 -1.85 . . . . 0.57 106.005 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.47 145.11 11.61 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.424 -0.67 . . . . 0.57 111.424 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 142.21 47.45 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.351 -0.981 . . . . 0.57 108.351 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.23 165.59 26.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.565 1.546 . . . . 0.57 108.373 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.9 22.82 11.54 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.559 -0.713 . . . . 1.2 111.481 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 156.59 31.2 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.593 1.568 . . . . 0.57 109.81 -164.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 49.86 102.38 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.059 2.144 . . . . 0.57 114.201 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -147.33 157.44 43.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.476 1.111 . . . . 0.65 109.035 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.59 62.23 4.05 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.3 0.952 . . . . 0.57 111.192 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -106.83 -55.28 2.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.381 0.591 . . . . 0.66 111.105 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.86 -43.18 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.814 2.846 . . . . 0.57 109.594 -168.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -142.83 121.61 7.47 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 120.05 1.295 . . . . 0.57 111.019 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.53 140.25 35.92 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.972 1.781 . . . . 0.57 111.544 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -72.41 173.39 8.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.304 1.042 . . . . 0.57 111.797 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.78 -31.51 15.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.937 2.095 . . . . 0.66 112.41 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.04 -132.47 11.11 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 120.862 1.664 . . . . 0.57 111.516 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.48 103.86 1.43 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.45 2.767 . . . . 0.57 112.171 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.46 -167.06 25.65 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.682 2.087 . . . . 0.57 111.428 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.99 -140.43 0.71 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.025 -1.279 . . . . 0.57 114.152 164.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -51.18 137.2 22.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.042 2.137 . . . . 0.57 110.535 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.68 -30.54 10.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.618 1.567 . . . . 0.57 111.294 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.39 165.6 28.65 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.059 1.344 . . . . 0.57 108.987 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.85 159.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.565 0.62 . . . . 0.65 111.447 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.13 147.09 34.41 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.446 0.698 . . . . 0.57 110.011 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -98.67 150.86 21.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.005 -0.998 . . . . 0.57 109.414 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.49 150.23 86.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.543 -0.741 . . . . 0.57 110.298 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -69.29 162.53 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.234 1.956 . . . . 0.57 111.509 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.71 -93.35 0.1 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.258 -1.537 . . . . 0.57 109.258 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -160.61 123.0 3.22 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.653 0.726 . . . . 0.57 110.14 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.42 -123.32 7.47 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-O 118.187 -1.34 . . . . 0.57 110.23 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.04 -24.4 39.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.794 1.238 . . . . 0.57 112.364 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.25 143.14 12.75 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 120.939 -1.101 . . . . 0.57 111.468 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.99 -21.63 2.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.371 1.462 . . . . 0.57 114.13 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -70.51 159.47 34.23 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.02 1.91 . . . . 0.66 108.692 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.65 141.3 28.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.198 -0.668 . . . . 0.57 109.198 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -130.7 158.4 40.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.713 -0.477 . . . . 0.65 109.713 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.08 146.83 34.16 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.744 -1.206 . . . . 0.57 107.744 -169.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.96 98.35 3.57 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.823 -0.806 . . . . 0.66 108.823 174.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.12 -16.82 62.65 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.431 -1.418 . . . . 0.66 111.87 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.64 -33.74 76.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.564 1.546 . . . . 0.66 110.961 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.4 157.17 32.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.629 0.728 . . . . 0.66 109.82 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 135.73 38.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.282 -0.636 . . . . 1.2 109.282 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -126.98 151.87 47.96 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.147 -1.057 . . . . 0.57 108.147 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -154.1 167.94 28.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.801 0.728 . . . . 0.57 110.435 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.0 -32.1 45.04 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.396 1.079 . . . . 0.66 112.258 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.97 88.01 0.74 Allowed Glycine 0 C--N 1.343 0.92 0 C-N-CA 123.633 0.635 . . . . 0.57 112.614 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.3 m -120.47 -42.77 2.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.521 -0.752 . . . . 0.57 112.751 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 p -171.85 -43.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.23 0.923 . . . . 0.57 111.881 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.6 166.03 24.49 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.273 1.429 . . . . 0.57 109.313 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 179.09 35.59 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 110.694 -0.962 . . . . 0.57 110.694 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.6 mm -103.58 118.38 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.134 -1.062 . . . . 0.57 108.134 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -70.59 121.85 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 0.57 111.747 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -37.97 76.23 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.132 1.16 . . . . 0.57 114.132 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.37 -39.77 91.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.691 -0.855 . . . . 0.57 108.691 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 1.7 m-85 -75.63 -41.57 53.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.495 -0.928 . . . . 0.57 108.495 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.39 86.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.016 -0.516 . . . . 0.57 110.583 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.32 -55.84 29.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.863 -1.065 . . . . 0.57 109.789 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 m -53.67 -42.14 67.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.534 1.516 . . . . 0.57 112.335 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -62.01 -54.38 42.43 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.938 0.79 . . . . 0.65 110.088 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -68.41 -45.96 71.21 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.318 1.047 . . . . 0.66 111.528 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.22 -31.59 72.85 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.045 1.338 . . . . 0.57 110.959 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.59 -52.91 38.63 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.61 -0.996 . . . . 0.57 110.61 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -58.55 -45.49 88.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.569 0.684 . . . . 0.65 111.545 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.5 t -54.81 -38.6 67.55 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.15 0.906 . . . . 0.57 112.726 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -27.65 68.73 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.8 0.84 . . . . 0.57 111.777 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.24 44.44 0.13 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.839 1.209 . . . . 0.57 113.334 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.04 156.66 42.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.573 1.187 . . . . 0.57 111.013 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.44 -13.12 2.91 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 115.795 -2.67 . . . . 0.57 114.821 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.6 m170 137.37 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 1 C-N-CA 131.836 4.054 . . . . 0.65 111.434 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.9 m -131.79 -173.09 3.04 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.833 2.853 . . . . 0.57 109.081 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.8 t -148.78 61.17 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.999 0.92 . . . . 0.57 110.17 -171.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 6.2 t0 -133.97 149.06 70.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.025 0.93 . . . . 0.66 108.798 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.03 -4.88 14.22 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.648 . . . . 0.57 112.972 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.52 28.93 4.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.57 109.101 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.09 130.18 34.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.645 1.578 . . . . 0.57 109.926 172.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.74 -19.65 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.052 0.387 . . . . 0.57 110.884 165.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.99 -14.56 63.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 117.66 -1.162 . . . . 0.57 112.962 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.11 133.09 87.53 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 121.246 1.839 . . . . 0.57 110.671 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.79 144.25 24.4 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.613 2.208 . . . . 0.57 110.301 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 52.6 m 66.67 116.03 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.197 1.799 . . . . 0.57 110.468 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -54.89 116.73 2.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.267 -0.896 . . . . 0.57 110.924 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.7 -121.03 2.19 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.213 1.863 . . . . 0.57 109.851 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.84 -26.59 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.455 1.502 . . . . 0.57 113.914 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.5 151.84 27.49 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.874 -0.891 . . . . 0.57 110.874 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.18 110.99 42.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.764 -1.939 . . . . 0.66 105.764 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 116' ' ' TYR . 27.2 Cg_endo -79.62 29.17 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.688 2.926 . . . . 0.57 115.499 174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -129.61 -28.11 2.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.085 1.354 . . . . 0.57 111.446 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -156.03 94.31 1.52 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.128 1.771 . . . . 0.57 109.327 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -138.41 169.04 18.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.828 1.251 . . . . 0.57 109.405 177.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.88 57.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.501 1.12 . . . . 0.57 111.127 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp 63.72 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.56 1.544 . . . . 0.57 110.254 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -68.7 -86.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.138 0.975 . . . . 0.57 112.234 -165.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -144.54 -35.8 0.34 Allowed 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.34 1.456 . . . . 0.57 108.817 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -55.61 -48.37 74.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.269 1.827 . . . . 0.66 111.378 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.54 -49.4 54.72 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.643 0.777 . . . . 0.66 109.424 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -46.49 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 123.581 0.752 . . . . 0.57 109.645 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -71.42 -40.48 70.41 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.73 -1.128 . . . . 0.57 109.306 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -50.0 -61.06 6.03 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.728 -1.349 . . . . 0.57 109.728 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 mm -57.08 -50.08 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 117.711 0.755 . . . . 0.57 111.5 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.86 -13.47 62.17 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.199 -0.938 . . . . 0.57 113.14 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -92.11 -25.31 18.8 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.961 1.304 . . . . 0.57 111.047 171.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.39 -35.95 65.98 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.554 1.142 . . . . 0.57 112.773 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 46' ' ' ILE . 33.8 m-85 -126.52 29.2 5.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.551 1.141 . . . . 0.57 109.969 -173.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.31 -124.78 0.75 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.573 -1.411 . . . . 0.57 109.573 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -148.66 -57.31 0.22 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.067 1.506 . . . . 0.57 115.067 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 39.29 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.616 2.367 . . . . 1.2 113.871 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.3 p -59.5 114.59 2.78 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.95 -0.469 . . . . 0.57 110.228 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.62 153.3 14.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.741 1.616 . . . . 0.57 107.074 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 p -70.03 -179.16 1.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.738 0.78 . . . . 0.57 110.743 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -138.31 165.46 26.68 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.064 1.345 . . . . 1.2 107.436 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 -62.98 0.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.311 -0.852 . . . . 0.57 109.886 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 C-N-CA 128.162 2.585 . . . . 0.5 . 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.213 0 CA-C-O 118.84 -0.6 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -67.35 -63.23 1.1 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.046 -0.502 . . . . 0.57 110.218 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -169.64 -57.1 0.02 OUTLIER 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.86 2.064 . . . . 0.57 109.851 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.54 139.81 12.11 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.61 0.764 . . . . 0.57 109.512 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.88 60.99 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.431 3.421 . . . . 0.57 110.423 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.86 90.25 1.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.617 -0.882 . . . . 0.57 108.617 177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 41.96 61.72 8.15 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 126.055 1.742 . . . . 0.57 112.661 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 117.88 5.04 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.257 1.972 . . . . 0.57 108.659 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 83.58 134.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 128.111 2.565 . . . . 0.57 111.077 -172.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 63.9 m95 -66.24 169.2 7.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.963 0.887 . . . . 0.57 111.305 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -80.07 -33.84 38.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.478 0.711 . . . . 0.57 111.424 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.8 t -86.99 146.42 26.14 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.171 0.988 . . . . 0.57 109.379 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -75.3 -12.19 60.22 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.57 112.012 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -116.24 111.68 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.306 -1.738 . . . . 0.57 106.306 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.457 ' CG1' HD12 ' A' ' 60' ' ' ILE . 72.7 t -104.04 129.05 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.792 -1.188 . . . . 0.57 107.792 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -104.65 138.38 41.05 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.73 -0.606 . . . . 0.57 110.285 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -125.08 160.11 29.82 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.906 0.482 . . . . 0.57 110.869 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -152.14 166.4 31.78 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 122.758 0.423 . . . . 1.2 110.673 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.5 mt -130.26 94.67 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 103.806 -2.665 . . . . 0.57 103.806 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 t -76.8 -45.44 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.528 0.731 . . . . 0.57 109.597 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -112.63 156.19 23.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 104.651 -2.351 . . . . 0.57 104.651 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.38 154.48 50.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.788 -1.56 . . . . 0.57 106.788 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 31' ' ' VAL . 10.9 t -64.05 173.31 1.95 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.875 1.322 . . . . 0.57 111.827 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 -37.22 6.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.99 -1.459 . . . . 1.2 112.397 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.16 -35.76 76.68 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.357 0.526 . . . . 0.66 111.307 -172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 mt -114.12 151.93 45.38 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 126.884 2.074 . . . . 0.57 108.153 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -78.23 154.01 28.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.81 1.673 . . . . 0.57 111.974 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.81 -37.94 74.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.57 1.148 . . . . 0.65 113.174 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tp -59.36 -43.4 90.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.773 -0.454 . . . . 0.57 109.773 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -70.48 -41.08 73.2 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.895 -1.05 . . . . 0.57 108.988 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 23' ' ' THR . 47.4 t -54.5 -52.14 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 119.83 1.196 . . . . 0.57 109.698 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -65.96 -43.94 86.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.774 0.716 . . . . 0.66 111.096 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.71 92.64 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.368 -0.833 . . . . 1.2 112.099 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.94 -47.26 66.13 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.312 -0.996 . . . . 0.57 108.312 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.98 -44.49 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.393 1.451 . . . . 0.57 110.835 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -39.31 92.15 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 117.499 -1.239 . . . . 0.57 111.057 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -67.21 -44.37 79.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.48 1.112 . . . . 0.57 111.509 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.04 96.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.799 1.24 . . . . 0.57 111.023 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 122' ' ' LEU . 24.1 mt -68.8 -34.17 75.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.975 0.51 . . . . 0.57 111.039 174.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -46.97 81.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 118.679 -0.677 . . . . 0.57 109.319 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.422 ' HB3' HD11 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -56.38 -42.03 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.368 -0.825 . . . . 0.57 111.607 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.451 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 32.9 m95 -63.19 -46.77 85.49 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.441 1.019 . . . . 0.57 111.372 173.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.44 -10.81 63.86 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.337 -0.852 . . . . 0.57 114.317 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -80.96 -5.38 57.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.253 -1.145 . . . . 0.57 111.177 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 160' ' ' ILE . 9.3 mm-40 -113.06 -20.28 11.56 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.872 0.869 . . . . 0.66 111.636 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 160' ' ' ILE . 10.1 pt -136.42 150.22 69.94 Favored Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 124.57 1.148 . . . . 0.57 110.184 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.49 16.64 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.45 2.767 . . . . 0.57 113.113 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 126' ' ' LEU . 2.2 tt -82.04 142.69 32.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.018 1.327 . . . . 0.57 107.591 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -125.4 170.63 11.17 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.851 0.834 . . . . 0.65 109.487 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.02 162.09 36.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.912 -0.773 . . . . 0.57 108.912 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.75 -179.94 6.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.654 -1.157 . . . . 1.2 108.995 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -135.78 133.97 38.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.504 -1.665 . . . . 0.57 106.504 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.35 162.65 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 O-C-N 124.174 0.921 . . . . 0.57 109.526 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.9 m -110.72 -30.04 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.769 -1.105 . . . . 0.57 110.696 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -60.69 3.13 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.596 1.158 . . . . 0.57 110.695 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.87 -91.23 0.1 OUTLIER Glycine 0 C--O 1.219 -0.823 0 N-CA-C 109.896 -1.282 . . . . 0.57 109.896 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -62.22 153.76 29.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.379 1.589 . . . . 0.57 111.904 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.35 -170.55 3.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.161 1.384 . . . . 0.57 109.972 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.24 -38.5 71.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.286 -1.005 . . . . 0.66 108.286 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 15' ' ' VAL . 5.6 mt -127.66 90.8 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 125.32 1.448 . . . . 0.57 107.938 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 154.04 26.93 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.257 -0.883 . . . . 0.57 109.111 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.06 137.41 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.487 -2.042 . . . . 0.57 105.487 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.47 164.88 29.46 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.899 -0.88 . . . . 0.57 110.899 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 5.4 m-85 -138.29 133.91 33.66 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.235 -1.765 . . . . 0.57 106.235 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.69 178.89 8.1 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.57 109.512 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.71 85.69 2.39 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 107.123 -1.436 . . . . 1.2 107.123 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.56 -139.68 15.61 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.47 -0.652 . . . . 0.57 111.47 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.77 122.13 9.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.57 111.398 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -125.2 -39.86 2.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.65 112.2 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.71 44.85 0.8 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.886 -0.486 . . . . 0.57 111.886 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.79 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.173 1.389 . . . . 0.66 107.672 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -173.55 -34.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.616 1.966 . . . . 0.57 110.484 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -132.21 132.15 22.82 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 108.176 -1.046 . . . . 0.57 108.176 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.32 133.53 28.61 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 N-CA-C 108.857 -1.247 . . . . 0.57 108.857 171.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -64.41 178.36 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.917 1.342 . . . . 0.57 109.92 165.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -98.88 -43.36 6.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 131.436 3.894 . . . . 0.66 110.092 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.96 -139.28 14.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.832 -1.538 . . . . 0.57 110.363 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.18 96.48 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.624 3.549 . . . . 0.57 112.055 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 177.82 15.04 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 110.334 -1.106 . . . . 0.57 110.334 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.254 5.7 t-20 60.05 -142.69 0.56 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.907 1.283 . . . . 0.57 112.489 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.4 m -45.42 144.35 1.52 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 126.412 1.885 . . . . 0.57 109.628 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -107.62 -29.01 9.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.471 1.941 . . . . 0.57 112.462 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.26 166.08 25.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.522 1.129 . . . . 0.57 108.332 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.76 161.84 38.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.176 0.512 . . . . 0.65 109.715 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 160.82 43.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.981 0.912 . . . . 0.57 108.799 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -112.56 151.08 30.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.762 -0.829 . . . . 0.57 108.762 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.33 156.33 22.41 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.531 -0.747 . . . . 0.57 111.004 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.492 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 17.6 Cg_endo -68.52 148.26 72.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.888 1.725 . . . . 0.57 111.921 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.2 175.22 13.79 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.6 1.095 . . . . 0.57 110.84 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t 43.31 -148.54 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.603 1.561 . . . . 0.57 112.703 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.29 -56.62 1.45 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 117.182 -1.899 . . . . 0.57 110.482 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -44.37 74.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.44 1.62 . . . . 0.57 112.075 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 151.15 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.619 1.1 . . . . 0.57 112.659 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.89 -26.32 1.73 Allowed Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.853 -1.526 . . . . 0.57 114.641 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.05 150.11 49.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.971 -1.122 . . . . 0.66 107.971 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.14 148.51 35.16 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.424 -0.807 . . . . 0.57 109.341 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -132.47 159.69 38.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.659 -0.867 . . . . 0.65 108.659 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.2 m-85 -138.35 155.87 48.14 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.454 1.502 . . . . 0.57 108.868 -170.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.17 97.76 10.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.898 0.479 . . . . 0.66 109.952 172.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.25 -25.66 61.98 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.061 0.945 . . . . 0.66 111.676 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.01 -34.99 70.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.305 0.574 . . . . 0.66 111.075 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -82.48 150.26 27.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.636 1.175 . . . . 0.66 109.085 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -71.88 147.5 47.04 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.511 -0.743 . . . . 1.2 110.647 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -135.35 134.53 39.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.267 -1.383 . . . . 0.57 107.267 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -133.85 150.18 51.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 0.57 110.389 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.64 -29.45 64.65 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.191 0.997 . . . . 0.66 111.374 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.01 75.88 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.387 -1.085 . . . . 0.57 110.387 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.29 155.92 38.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.401 -1.333 . . . . 0.57 107.401 172.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -62.47 167.28 4.41 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.529 0.732 . . . . 0.57 110.509 170.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.35 -64.22 0.4 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.935 2.094 . . . . 0.57 111.016 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.28 147.76 49.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.052 -1.219 . . . . 0.57 110.052 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.32 129.82 36.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.004 -1.11 . . . . 0.57 108.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -66.62 113.19 4.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.388 -0.597 . . . . 0.57 109.388 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 9.6 t80 -58.5 -46.09 87.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.2 1.0 . . . . 0.57 111.372 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -63.43 -41.69 98.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.566 1.146 . . . . 0.57 109.745 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.36 -45.0 96.19 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.444 0.698 . . . . 0.57 109.934 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.66 72.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.035 0.534 . . . . 0.57 111.316 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.82 -55.37 33.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 117.366 -1.302 . . . . 0.57 109.086 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 m -52.35 -41.49 63.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.407 1.458 . . . . 0.57 111.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.15 -60.57 3.55 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.557 0.617 . . . . 0.65 110.058 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.47 -43.7 96.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.385 0.539 . . . . 0.66 110.9 -173.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.08 -26.98 68.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.681 1.193 . . . . 0.57 111.775 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.22 -45.95 92.16 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.009 -0.836 . . . . 0.57 111.009 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -68.71 -39.78 80.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.957 -1.02 . . . . 0.65 111.582 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.408 ' HB3' HG12 ' A' ' 60' ' ' ILE . 67.0 m -55.17 -30.69 60.38 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 124.159 0.912 . . . . 0.57 111.966 172.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.447 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.04 -34.32 66.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.338 0.972 . . . . 0.57 111.406 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.41 52.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.416 -1.214 . . . . 0.57 113.093 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 28.6 mmt 61.12 173.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.475 1.11 . . . . 0.57 112.106 -171.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.81 70.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.785 -1.008 . . . . 0.57 111.153 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.27 172.78 6.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.73 1.265 . . . . 0.65 110.175 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.57 -179.16 5.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.088 1.355 . . . . 0.57 109.35 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.5 m -138.14 54.7 1.78 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.015 1.726 . . . . 0.57 108.892 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.61 148.39 41.79 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.249 1.02 . . . . 0.66 109.233 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.68 -19.26 41.88 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.228 2.618 . . . . 0.57 113.004 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -130.76 28.22 4.87 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.839 1.656 . . . . 0.57 108.607 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.51 129.33 38.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.373 -0.973 . . . . 0.57 108.373 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.88 -26.78 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.635 0.374 . . . . 0.57 110.506 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -105.1 29.21 6.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.604 1.162 . . . . 0.57 111.811 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.29 128.62 87.98 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 120.606 -1.309 . . . . 0.57 110.554 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.21 177.76 8.2 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.421 2.747 . . . . 0.57 111.065 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m 48.59 77.57 0.1 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.225 1.41 . . . . 0.57 111.608 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.426 ' CD1' ' H43' ' A' ' 178' ' ' MDW . 4.8 t80 -50.69 125.76 13.96 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.894 -1.048 . . . . 0.57 112.797 -174.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.93 164.8 13.64 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 108.482 -1.847 . . . . 0.57 108.482 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.02 -51.37 0.47 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.867 2.467 . . . . 0.57 113.825 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.65 145.86 42.2 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.117 -1.193 . . . . 0.57 110.117 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -94.99 112.8 59.61 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.859 -1.904 . . . . 0.66 105.859 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -80.31 -31.39 1.68 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.803 1.669 . . . . 0.57 112.668 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -42.15 72.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.074 1.306 . . . . 0.57 110.322 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -122.98 89.82 3.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.193 -1.41 . . . . 0.57 107.193 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -120.96 159.74 24.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.97 0.89 . . . . 0.57 109.465 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.09 156.28 10.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.689 1.996 . . . . 0.57 105.996 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -56.07 108.31 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.141 1.376 . . . . 0.57 107.69 175.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.8 t -86.04 -101.41 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.77 -0.826 . . . . 0.57 108.77 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.3 -49.43 1.55 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-O 116.268 -1.825 . . . . 0.57 108.134 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -48.83 -38.95 23.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.911 1.687 . . . . 0.66 112.132 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -67.65 -58.89 3.88 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.354 0.661 . . . . 0.66 111.549 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.74 -40.26 84.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-O 117.811 -1.09 . . . . 0.57 108.369 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.48 74.91 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.671 1.588 . . . . 0.57 108.73 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.29 -56.79 22.57 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.25 -1.14 . . . . 0.57 110.25 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 46' ' ' ILE . 9.5 mm -58.72 -49.1 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.386 1.093 . . . . 0.57 112.949 -175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.59 -29.88 70.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.458 1.103 . . . . 0.57 110.115 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -29.21 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.57 110.17 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 3.2 mt -74.46 -48.7 25.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.14 -0.933 . . . . 0.57 111.585 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 163' ' ' LEU . 3.2 m-85 -144.44 24.38 1.58 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.911 1.232 . . . . 0.57 113.887 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.91 -155.55 7.87 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.682 -1.367 . . . . 0.57 109.682 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.63 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.478 0.711 . . . . 0.57 111.4 173.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.7 162.55 28.61 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.376 -0.972 . . . . 1.2 108.376 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.4 p -135.85 163.13 30.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.583 -1.265 . . . . 0.57 107.583 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -178.07 162.36 1.61 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.524 1.93 . . . . 0.57 106.5 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t 62.41 99.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.095 1.758 . . . . 0.57 112.148 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -155.85 94.88 1.59 Allowed 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.456 -1.313 . . . . 1.2 107.456 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.62 -63.55 1.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.699 -0.852 . . . . 0.57 108.699 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.2 tttt . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 127.972 2.509 . . . . 0.5 . -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.426 ' H43' ' CD1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 118.244 -0.884 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p -78.25 65.56 3.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.309 0.959 . . . . 0.57 111.633 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.51 168.26 21.01 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.871 0.869 . . . . 0.57 111.468 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -95.92 153.72 39.17 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.953 1.301 . . . . 0.57 110.743 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -76.05 -7.66 18.34 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.678 2.919 . . . . 0.57 113.598 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.05 108.28 1.48 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.919 -2.622 . . . . 0.57 103.919 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.88 -63.54 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 129.308 3.043 . . . . 0.57 108.909 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.8 163.81 34.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 0.57 111.104 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 pttt 68.4 118.02 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.896 2.078 . . . . 0.57 110.073 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -62.17 150.35 39.01 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.57 109.704 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.1 p -88.43 28.66 1.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.471 0.708 . . . . 0.57 111.069 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -130.55 159.64 36.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.539 1.936 . . . . 0.57 108.851 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -90.54 -8.55 49.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.56 1.544 . . . . 0.57 112.748 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.46 145.76 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 0.57 106.747 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.506 HG23 HD21 ' A' ' 48' ' ' LEU . 29.0 t -131.06 134.48 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.075 -1.824 . . . . 0.57 106.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -100.4 147.86 25.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.651 -0.5 . . . . 0.57 109.651 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -125.15 153.73 42.57 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.424 0.689 . . . . 0.57 111.7 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.09 109.97 6.42 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.013 0.911 . . . . 1.2 110.59 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 22' ' ' TYR . 93.0 mt -76.03 95.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.674 -1.602 . . . . 0.57 106.674 169.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 m -75.23 -46.41 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.709 0.803 . . . . 0.57 111.365 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -115.96 160.31 20.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.263 -1.384 . . . . 0.57 107.263 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 19' ' ' ILE . 10.4 m-85 -127.6 179.9 5.27 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.17 0.988 . . . . 0.57 108.597 -172.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -119.95 -178.45 3.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.808 1.243 . . . . 0.57 109.711 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -131.42 -31.59 1.6 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.152 1.781 . . . . 1.2 111.713 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -31.4 71.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.374 1.07 . . . . 0.66 111.914 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.31 145.33 56.19 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 126.733 2.013 . . . . 0.57 106.733 -175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -72.97 153.76 52.71 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.587 1.525 . . . . 0.57 111.523 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.27 -34.73 74.15 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.245 1.018 . . . . 0.65 113.121 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.57 -39.56 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.624 0.37 . . . . 0.57 110.016 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -68.52 -42.49 78.44 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.332 -1.318 . . . . 0.57 110.152 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 t -57.23 -51.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 120.584 1.538 . . . . 0.57 109.398 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -43.56 98.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.145 0.578 . . . . 0.66 110.222 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.15 -46.6 88.27 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 117.957 -1.021 . . . . 1.2 112.139 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.8 mp -65.07 -41.87 94.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.783 1.174 . . . . 0.57 109.658 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.31 -48.82 79.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 108.792 -0.818 . . . . 0.57 108.792 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -39.06 81.42 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.537 0.608 . . . . 0.57 111.738 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -65.21 -46.22 81.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.821 1.191 . . . . 0.57 110.438 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.98 95.29 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.77 0.828 . . . . 0.57 111.245 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 122' ' ' LEU . 25.9 mt -68.22 -33.43 74.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.576 -0.726 . . . . 0.57 111.327 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -65.03 -33.33 75.79 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.424 1.011 . . . . 0.57 110.315 173.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.4 mtp -71.23 -28.83 64.47 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.857 0.753 . . . . 0.57 111.996 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.14 -48.83 40.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.195 0.907 . . . . 0.57 110.502 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.03 62.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.14 1.352 . . . . 0.57 113.65 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -64.58 -22.41 66.96 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.886 -1.361 . . . . 0.57 111.673 170.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -108.37 -21.3 12.81 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.796 0.725 . . . . 0.66 112.255 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.88 135.48 27.56 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 123.872 0.869 . . . . 0.57 110.761 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.12 61.26 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.821 3.014 . . . . 0.57 110.65 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -117.46 124.46 48.85 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.059 -1.83 . . . . 0.57 106.059 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -105.57 175.29 5.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.924 1.289 . . . . 0.65 108.623 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 1.2 m-85 -139.36 153.86 47.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.18 -0.95 . . . . 0.57 108.483 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.63 174.44 10.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.711 0.804 . . . . 1.2 109.009 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -124.29 155.69 38.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.05 -1.092 . . . . 0.57 108.05 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.06 -179.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.172 -0.922 . . . . 0.57 108.977 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.72 -38.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.795 -0.622 . . . . 0.57 110.34 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -175.65 92.95 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.291 1.436 . . . . 0.57 108.975 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.83 172.78 38.13 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.92 2.2 . . . . 0.57 108.122 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 p -67.92 167.05 14.43 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.583 0.692 . . . . 0.57 110.123 168.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.13 173.76 11.91 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.551 0.741 . . . . 0.57 110.145 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.93 -33.94 66.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 118.071 -0.966 . . . . 0.66 109.142 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.93 76.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.612 1.965 . . . . 0.57 108.586 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -70.03 133.58 47.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 119.522 -1.986 . . . . 0.57 107.959 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.73 105.89 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.037 -1.838 . . . . 0.57 106.037 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 73.92 0.26 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.775 1.655 . . . . 0.57 111.223 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -109.44 132.96 53.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.412 1.085 . . . . 0.57 110.157 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.33 172.0 17.33 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.57 108.449 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -91.74 113.48 25.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.286 -0.864 . . . . 1.2 110.222 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.66 71.2 0.86 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.376 -0.69 . . . . 0.57 111.376 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 81.21 147.58 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.009 2.924 . . . . 0.57 111.521 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.14 -11.52 4.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.944 1.297 . . . . 0.65 112.816 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.96 3.04 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 118.801 -1.0 . . . . 0.57 112.505 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.64 -55.89 1.61 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.718 0.759 . . . . 0.66 110.375 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.51 -44.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.536 1.934 . . . . 0.57 108.055 -177.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -97.42 121.24 59.02 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.397 0.679 . . . . 0.57 110.467 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.74 3.82 6.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.438 2.092 . . . . 0.57 113.204 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 56.17 -155.76 0.29 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.139 0.881 . . . . 0.57 110.651 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -143.18 -41.48 0.3 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.644 2.777 . . . . 0.66 108.524 -167.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.12 -149.78 16.66 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.213 1.387 . . . . 0.57 110.195 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.6 94.3 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.589 3.526 . . . . 0.57 111.414 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 167.95 11.45 Favored Glycine 0 C--O 1.22 -0.749 0 N-CA-C 109.411 -1.476 . . . . 0.57 109.411 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t30 48.31 -150.52 0.15 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 119.813 1.806 . . . . 0.57 112.241 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -47.09 111.06 0.35 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.12 2.168 . . . . 0.57 113.306 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -80.97 -31.96 34.6 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.796 -1.19 . . . . 0.57 112.497 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.49 39.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.57 109.737 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -146.57 144.96 29.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.982 0.913 . . . . 0.65 109.457 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.76 164.4 30.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.7 0.8 . . . . 0.57 109.521 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -115.21 156.95 24.39 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.961 -0.563 . . . . 0.57 109.515 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.65 98.73 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.358 -0.829 . . . . 0.57 109.359 176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -72.47 159.3 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.672 2.248 . . . . 0.57 111.178 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.32 -83.62 0.08 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.872 -1.691 . . . . 0.57 108.872 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -159.2 146.26 17.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.316 -0.994 . . . . 0.57 108.316 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -130.9 11.77 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 118.453 -1.193 . . . . 0.57 110.297 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.02 -25.34 58.42 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.342 1.071 . . . . 0.57 111.994 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.94 142.44 5.85 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.085 -1.009 . . . . 0.57 112.121 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.61 -26.79 3.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.526 2.012 . . . . 0.57 113.901 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -66.31 148.72 51.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.787 0.794 . . . . 0.66 109.399 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.57 140.77 49.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.107 0.963 . . . . 0.57 108.773 -168.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.78 139.68 29.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.234 -1.765 . . . . 0.65 106.234 -160.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.67 148.26 37.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.208 -1.034 . . . . 0.57 108.208 -166.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.69 105.99 12.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.199 -1.408 . . . . 0.66 107.199 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.52 -19.79 27.27 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.489 -0.757 . . . . 0.66 110.713 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -28.13 64.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.242 1.017 . . . . 0.66 111.141 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.28 110.72 9.86 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.289 -1.745 . . . . 0.66 106.289 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.95 110.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.151 0.887 . . . . 1.2 111.502 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.12 133.88 34.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.048 -1.093 . . . . 0.57 108.048 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -123.33 143.49 50.06 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.491 -1.299 . . . . 0.57 107.491 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.37 32.8 0.4 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.478 1.511 . . . . 0.66 111.599 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.66 69.56 1.37 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.625 -0.99 . . . . 0.57 110.625 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -57.31 2.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.478 0.639 . . . . 0.57 110.785 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.325 1.45 . . . . 0.57 108.617 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.93 159.22 16.43 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.57 109.075 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.2 -172.35 38.06 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.35 -1.1 . . . . 0.57 110.35 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.06 120.31 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.511 -1.292 . . . . 0.57 107.511 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -62.05 109.16 1.2 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.584 0.353 . . . . 0.57 110.237 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.81 -37.33 81.63 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.539 0.735 . . . . 0.57 110.686 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -65.95 -46.16 79.15 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 118.481 0.582 . . . . 0.57 110.256 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.44 -48.89 79.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.836 0.743 . . . . 0.57 109.18 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.33 90.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.114 0.566 . . . . 0.57 111.319 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.09 -54.56 43.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.892 -1.051 . . . . 0.57 109.517 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.5 m -57.17 -37.88 72.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.043 1.292 . . . . 0.57 111.33 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.45 -58.54 7.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.409 0.549 . . . . 0.65 109.935 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.3 -41.38 98.95 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.559 -0.713 . . . . 0.66 111.303 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 HD21 ' A' ' 39' ' ' LEU . 3.3 mm? -62.55 -26.2 68.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.57 111.666 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.81 99.35 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.73 1.15 . . . . 0.57 112.053 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -69.89 -39.89 75.97 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 118.279 -0.867 . . . . 0.65 110.067 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 t -57.23 -39.61 75.86 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.52 0.513 . . . . 0.57 111.859 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -39.56 82.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.536 -0.728 . . . . 0.57 110.476 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.2 51.1 0.52 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 123.877 0.751 . . . . 0.57 112.079 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 tpp -99.84 -55.82 2.55 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.069 0.935 . . . . 0.57 111.018 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.64 167.6 21.77 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.288 -1.125 . . . . 0.57 110.288 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -74.06 178.08 5.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.995 0.902 . . . . 0.65 111.465 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -145.26 -173.46 4.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.083 1.753 . . . . 0.57 108.531 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 82.26 1.64 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.162 -1.792 . . . . 0.57 106.162 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 5.8 t70 -151.36 145.26 17.78 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.456 -0.942 . . . . 0.66 108.456 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.77 -9.25 21.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.471 2.114 . . . . 0.57 113.269 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.01 9.51 13.69 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.555 1.142 . . . . 0.57 110.749 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -76.1 134.56 39.99 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.02 0.928 . . . . 0.57 109.171 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.07 -28.24 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.59 -0.444 . . . . 0.57 110.148 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 37.1 mmt -66.01 -12.2 53.43 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.681 1.593 . . . . 0.57 113.589 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -50.69 124.87 20.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.318 0.963 . . . . 0.57 110.589 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.58 175.21 9.09 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.018 2.479 . . . . 0.57 110.783 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER 52.13 -158.7 0.12 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.338 1.455 . . . . 0.57 111.864 -174.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 131.21 41.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.99 -1.485 . . . . 0.57 106.99 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -157.5 -120.9 0.64 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.125 -1.59 . . . . 0.57 109.125 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -64.75 0.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.318 1.047 . . . . 0.57 110.934 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 34.44 -140.6 0.12 Allowed Glycine 0 C--N 1.345 1.079 0 C-N-CA 126.277 1.894 . . . . 0.57 113.198 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 t0 178.71 77.13 0.15 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 128.134 2.573 . . . . 0.66 106.467 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.08 35.86 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.515 2.81 . . . . 0.57 113.554 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -132.0 -47.87 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.553 1.141 . . . . 0.57 109.89 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.99 43.5 0.17 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.063 0.945 . . . . 0.57 111.304 -171.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -40.3 -54.52 2.37 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.202 1.001 . . . . 0.57 111.972 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 55.53 156.03 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.966 1.306 . . . . 0.57 111.075 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp -65.88 116.74 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.907 -1.146 . . . . 0.57 107.907 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.8 m -82.2 -91.51 0.07 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.41 0.684 . . . . 0.57 112.226 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -134.49 -51.97 0.81 Allowed 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.853 -1.546 . . . . 0.57 107.465 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -45.4 -44.22 11.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.55 1.523 . . . . 0.66 113.823 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.55 -63.59 1.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.055 2.142 . . . . 0.66 110.9 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.06 -41.39 92.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 108.699 -0.852 . . . . 0.57 108.699 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -59.33 -44.84 92.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.287 1.435 . . . . 0.57 108.942 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.95 -56.16 26.65 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.972 -1.251 . . . . 0.57 109.972 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 mm -55.51 -51.15 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 117.88 0.84 . . . . 0.57 111.8 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.25 -18.72 64.62 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.475 1.11 . . . . 0.57 111.34 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -87.87 -20.84 25.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.93 1.241 . . . . 0.57 111.89 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.47 -43.84 9.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.918 . . . . 0.57 111.669 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.41 9.53 31.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.285 1.834 . . . . 0.57 111.333 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.22 -135.92 2.24 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.893 2.187 . . . . 0.57 107.869 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -44.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.456 1.502 . . . . 0.57 111.657 167.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 140.19 55.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.022 0.929 . . . . 1.2 110.354 -171.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 p -142.25 166.85 23.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.534 1.133 . . . . 0.57 110.583 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.23 136.21 35.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.191 -1.411 . . . . 0.57 107.191 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.17 162.09 17.81 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.206 0.527 . . . . 0.57 111.708 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.36 159.62 40.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.088 1.355 . . . . 1.2 109.42 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 129.06 53.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.492 -0.559 . . . . 0.57 109.492 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.754 1.621 . . . . 0.5 . -175.523 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.428 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 119.38 -0.343 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 t -112.82 -53.36 2.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.539 0.736 . . . . 0.57 109.292 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 4' ' ' PHE . 6.9 tt -162.63 -104.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.57 107.45 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -73.68 -56.13 3.08 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 126.347 1.859 . . . . 0.57 110.07 174.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.56 163.87 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.251 1.301 . . . . 0.57 111.888 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -166.0 84.49 0.32 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.839 1.656 . . . . 0.57 107.443 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.43 65.9 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 128.022 2.529 . . . . 0.57 108.76 171.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.28 161.95 44.13 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.108 1.206 . . . . 0.57 110.729 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 76.21 107.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.378 1.871 . . . . 0.57 109.302 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 67.9 m95 -52.13 -70.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.49 . . . . 0.57 113.94 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m 173.88 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.406 2.282 . . . . 0.57 108.434 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t -102.5 161.98 13.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.213 1.005 . . . . 0.57 109.938 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -5.51 40.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.945 0.898 . . . . 0.57 113.36 168.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.35 143.56 39.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.241 -1.392 . . . . 0.57 107.241 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 48' ' ' LEU . 72.3 t -128.95 146.61 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.36 -1.348 . . . . 0.57 107.36 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 p -94.84 137.21 34.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.679 -0.86 . . . . 0.57 108.679 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -125.54 152.56 44.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.668 -0.645 . . . . 0.57 109.309 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -154.57 113.88 3.7 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.352 0.596 . . . . 1.2 110.011 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.03 82.61 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 107.161 -1.422 . . . . 0.57 107.161 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 m -56.11 -41.61 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.994 1.318 . . . . 0.57 112.922 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -124.39 153.97 41.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.37 -2.826 . . . . 0.57 103.37 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -131.23 158.05 41.59 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.338 1.455 . . . . 0.57 107.293 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -61.93 172.92 1.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.05 0.929 . . . . 0.57 111.624 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 -33.8 5.14 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.659 1.183 . . . . 1.2 112.262 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.41 -33.87 76.97 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.43 0.559 . . . . 0.66 109.997 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.32 154.78 62.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.971 1.709 . . . . 0.57 109.873 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.24 161.91 25.82 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.96 2.44 . . . . 0.57 113.049 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -40.25 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.307 1.043 . . . . 0.65 113.135 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.53 -33.85 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.342 0.257 . . . . 0.57 111.037 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.8 m -71.59 -43.96 65.31 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.402 -0.809 . . . . 0.57 109.359 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.69 -48.07 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 117.559 -1.21 . . . . 0.57 110.048 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.65 -35.07 79.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.896 1.225 . . . . 0.66 111.81 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -61.19 -51.06 70.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.557 1.071 . . . . 1.2 110.92 173.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.76 -45.36 93.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.447 -0.787 . . . . 0.57 109.111 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.66 -45.1 98.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-O 118.196 -0.907 . . . . 0.57 110.737 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 m -58.61 -47.74 83.34 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 120.249 1.386 . . . . 0.57 109.858 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.53 73.24 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.976 -0.535 . . . . 0.57 110.911 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.0 -47.55 84.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.99 1.316 . . . . 0.57 111.983 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 mp -69.78 -32.13 70.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 118.577 -0.725 . . . . 0.57 109.693 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -63.59 -33.37 75.45 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.089 0.859 . . . . 0.57 111.319 170.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.0 mtp -68.68 -42.73 77.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.649 1.113 . . . . 0.57 110.98 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.522 ' CE3' HD11 ' A' ' 160' ' ' ILE . 10.6 m95 -62.91 -51.75 65.72 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.503 1.047 . . . . 0.57 110.336 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.59 -10.92 61.53 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.654 1.597 . . . . 0.57 113.959 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -61.8 -30.87 71.1 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.449 1.125 . . . . 0.57 110.38 170.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -101.45 -31.04 11.1 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.69 0.796 . . . . 0.66 111.271 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.489 HG21 ' CD1' ' A' ' 164' ' ' TYR . 27.8 pt -115.66 126.08 28.09 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.662 0.785 . . . . 0.57 110.382 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.49 46.2 1.38 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.762 2.975 . . . . 0.57 112.941 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 49' ' ' HIS . 3.1 tt -103.3 141.96 35.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.672 1.989 . . . . 0.57 107.484 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.419 ' N ' HD23 ' A' ' 48' ' ' LEU . 10.1 m80 -123.85 169.33 11.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.913 0.885 . . . . 0.65 108.996 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.49 149.87 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.63 -1.294 . . . . 0.57 109.154 -173.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.93 36.72 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.43 1.092 . . . . 1.2 109.202 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.53 99.02 6.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.956 -1.127 . . . . 0.57 107.956 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.52 158.18 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.415 -0.587 . . . . 0.57 109.415 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.52 23.17 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.982 0.913 . . . . 0.57 110.953 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.21 75.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.93 1.292 . . . . 0.57 109.087 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.25 168.74 16.32 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.005 0.812 . . . . 0.57 111.575 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 p -64.72 171.89 3.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.806 1.242 . . . . 0.57 110.033 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.96 175.24 8.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.596 0.713 . . . . 0.57 109.626 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -68.95 -40.55 78.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.857 -0.61 . . . . 0.66 109.372 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -119.8 87.31 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.008 1.323 . . . . 0.57 108.0 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -83.91 120.66 26.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.814 1.246 . . . . 0.57 108.286 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.58 128.97 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 106.36 -1.719 . . . . 0.57 106.36 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.13 162.68 26.78 Favored Glycine 0 C--O 1.222 -0.6 0 N-CA-C 111.695 -0.562 . . . . 0.57 111.695 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 4.9 m-85 -134.54 141.63 46.75 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.009 -1.849 . . . . 0.57 106.009 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.47 -173.49 4.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.86 1.664 . . . . 0.57 109.635 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.42 52.52 2.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.173 0.989 . . . . 1.2 110.55 -175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.4 -120.97 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.117 -1.193 . . . . 0.57 110.117 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.45 138.28 55.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.273 -0.545 . . . . 0.57 110.569 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.59 -63.03 0.85 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.116 -0.945 . . . . 0.65 110.687 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.78 57.39 0.02 OUTLIER Glycine 0 C--N 1.341 0.834 0 CA-C-N 119.231 0.923 . . . . 0.57 112.474 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -126.33 -67.31 0.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.69 1.196 . . . . 0.66 109.094 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.67 -30.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.353 2.661 . . . . 0.57 110.156 -175.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.26 98.71 20.42 Favored Pre-proline 0 C--N 1.347 0.47 0 N-CA-C 108.51 -0.922 . . . . 0.57 108.51 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.14 139.42 55.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 120.881 1.054 . . . . 0.57 109.424 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.41 174.37 7.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.46 0.648 . . . . 0.57 110.584 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -95.27 -40.9 9.32 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.574 1.95 . . . . 0.66 111.898 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.62 -139.15 13.32 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 120.366 1.439 . . . . 0.57 111.969 -168.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -81.64 94.42 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.128 2.552 . . . . 0.57 110.567 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.65 174.46 22.43 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.132 1.825 . . . . 0.57 111.708 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.3 t30 47.39 -138.71 0.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 120.972 -1.31 . . . . 0.57 112.817 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -51.73 124.8 13.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.874 2.07 . . . . 0.57 111.207 173.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.81 -31.12 11.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.57 113.015 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.3 159.19 33.72 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.466 1.106 . . . . 0.57 108.091 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.1 154.93 43.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.29 0.567 . . . . 0.65 111.007 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.14 148.01 44.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.11 -1.07 . . . . 0.57 108.11 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.38 150.22 25.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.14 -1.059 . . . . 0.57 108.14 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.39 153.66 92.0 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.525 -0.75 . . . . 0.57 109.961 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 32.5 Cg_endo -68.73 165.09 30.78 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.579 1.52 . . . . 0.57 111.969 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 -70.8 0.15 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.652 -1.779 . . . . 0.57 108.652 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -173.52 144.02 1.09 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.257 -1.386 . . . . 0.57 107.257 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.15 -130.21 24.12 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.537 1.065 . . . . 0.57 111.615 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.89 -26.48 10.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.133 1.373 . . . . 0.57 112.345 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.17 143.67 8.74 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.191 -0.943 . . . . 0.57 111.633 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.1 -22.3 2.01 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.162 1.839 . . . . 0.57 114.553 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -70.49 157.69 37.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.787 1.294 . . . . 0.66 108.305 -176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.96 148.41 31.71 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.242 0.544 . . . . 0.57 109.63 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -132.02 160.5 35.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.65 109.282 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 23.9 m-85 -141.82 146.61 36.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.879 1.272 . . . . 0.57 108.155 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.78 103.83 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.922 -1.14 . . . . 0.66 107.922 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.77 -23.01 64.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.848 1.659 . . . . 0.66 111.395 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -65.38 -37.17 86.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.703 1.601 . . . . 0.66 110.157 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.0 133.39 48.96 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.327 -1.731 . . . . 0.66 106.327 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -54.94 151.89 8.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 118.905 -0.569 . . . . 1.2 109.72 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -133.93 135.88 43.87 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.749 -1.574 . . . . 0.57 106.749 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -132.52 140.77 48.47 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.494 -1.299 . . . . 0.57 107.494 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -57.16 -51.37 69.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.711 0.805 . . . . 0.66 109.396 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.45 56.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.889 -1.284 . . . . 0.57 109.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 t -154.71 164.31 38.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.656 -0.868 . . . . 0.57 108.656 173.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -76.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.502 2.321 . . . . 0.57 112.589 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -178.77 171.88 1.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.256 2.223 . . . . 0.57 107.348 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 123.85 -146.95 16.52 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.57 110.422 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 pt -116.65 119.55 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.322 1.449 . . . . 0.57 109.113 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -61.77 117.71 6.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.188 -0.914 . . . . 0.57 109.615 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.16 -40.05 96.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.319 1.448 . . . . 0.57 110.848 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -42.81 79.75 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.096 -1.076 . . . . 0.57 108.096 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -66.07 -47.61 73.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.021 0.828 . . . . 0.57 110.036 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.33 -50.09 70.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 123.531 0.52 . . . . 0.57 110.581 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.97 -57.88 10.0 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 117.908 -1.044 . . . . 0.57 109.74 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -55.82 -37.69 69.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.249 1.386 . . . . 0.57 111.333 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.97 -57.12 14.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.529 1.132 . . . . 0.65 110.518 173.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -72.72 -44.52 61.61 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.605 -0.684 . . . . 0.66 111.248 -171.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.2 -29.0 68.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.161 1.384 . . . . 0.57 111.036 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.34 -47.11 90.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.55 -1.02 . . . . 0.57 110.55 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.403 ' CE1' ' HG2' ' A' ' 138' ' ' MET . 70.9 m-70 -70.16 -36.29 74.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.255 -0.879 . . . . 0.65 112.191 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 p -57.74 -33.48 68.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.316 0.507 . . . . 0.57 111.251 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -36.34 79.81 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 112.493 0.553 . . . . 0.57 112.493 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 162.11 50.08 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 CA-C-O 117.993 -1.449 . . . . 0.57 113.271 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.73 -158.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.949 1.299 . . . . 0.57 112.024 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.08 62.6 0.22 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.091 -1.604 . . . . 0.57 109.091 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 169.62 17.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.675 0.75 . . . . 0.65 109.624 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -157.15 -179.99 8.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.701 1.2 . . . . 0.57 107.91 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t -144.17 78.16 1.57 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.771 -1.566 . . . . 0.57 106.771 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -131.08 145.91 59.81 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 106.545 -1.65 . . . . 0.66 106.545 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.71 -26.72 75.4 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.165 1.91 . . . . 0.57 112.427 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -125.11 29.37 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.572 1.549 . . . . 0.57 109.685 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.06 129.16 39.56 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 109.08 -0.711 . . . . 0.57 109.08 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.56 -17.5 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.619 1.168 . . . . 0.57 111.646 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.403 ' HG2' ' CE1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -113.72 22.5 13.98 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.307 1.843 . . . . 0.57 110.326 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.24 123.97 78.38 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 119.999 1.272 . . . . 0.57 110.292 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.7 48.3 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.728 2.952 . . . . 0.57 112.661 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -148.36 -45.48 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.57 110.373 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.3 t80 56.7 95.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.768 1.627 . . . . 0.57 112.305 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.41 -73.7 0.03 OUTLIER Glycine 0 C--N 1.346 1.101 0 O-C-N 120.751 -1.218 . . . . 0.57 115.706 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -35.52 61.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.503 1.151 . . . . 0.57 112.375 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.7 152.0 13.59 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.59 -1.004 . . . . 0.57 110.59 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.83 105.51 51.29 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 107.467 -1.309 . . . . 0.66 107.467 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.6 57.4 6.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.564 2.843 . . . . 0.57 109.92 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.5 -48.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.655 -0.653 . . . . 0.57 110.481 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -77.49 50.66 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.261 1.424 . . . . 0.57 110.886 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -41.86 -82.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.874 1.669 . . . . 0.57 112.917 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 43.91 22.82 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.16 2.584 . . . . 0.57 113.489 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 42.93 90.45 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.724 2.81 . . . . 0.57 111.222 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.9 t -56.12 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.088 1.355 . . . . 0.57 114.46 -170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -142.35 -46.24 0.33 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.424 1.09 . . . . 0.57 109.311 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.18 -51.56 10.4 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.886 1.274 . . . . 0.66 111.427 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -48.14 75.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.44 0.696 . . . . 0.66 111.964 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.4 mm -62.55 -46.57 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.886 0.874 . . . . 0.57 109.178 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -63.48 -44.1 95.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.049 1.339 . . . . 0.57 109.096 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.76 -62.59 6.14 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.1 -1.2 . . . . 0.57 110.1 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.522 HD11 ' CE3' ' A' ' 42' ' ' TRP . 8.0 mm -52.67 -48.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.394 1.077 . . . . 0.57 111.518 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -65.79 -28.53 69.07 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.436 -0.79 . . . . 0.57 111.875 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.2 -20.23 35.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.05 1.295 . . . . 0.57 111.959 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 6.5 mp -77.97 -45.39 24.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.064 0.946 . . . . 0.57 110.982 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.489 ' CD1' HG21 ' A' ' 46' ' ' ILE . 12.8 m-85 -138.17 -22.86 1.03 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.932 1.456 . . . . 0.57 114.932 -171.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.78 -81.97 0.13 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.556 -1.417 . . . . 0.57 109.556 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -154.78 -70.44 0.13 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.14 1.376 . . . . 0.57 112.14 173.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.46 -178.99 2.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.639 1.176 . . . . 1.2 110.047 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -142.44 130.7 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.859 0.837 . . . . 0.57 109.686 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.11 91.53 8.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.806 1.242 . . . . 0.57 108.032 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.26 149.44 21.76 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.656 -0.868 . . . . 0.57 108.656 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -136.59 155.82 49.4 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.561 1.145 . . . . 1.2 108.446 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 173' ' ' LYS . 25.8 tttt 64.71 -172.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.745 1.618 . . . . 0.57 111.614 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 172' ' ' LYS . 2.9 mtmp? . . . . . 0 N--CA 1.457 -0.104 0 C-N-CA 127.137 2.175 . . . . 0.5 . 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 117.853 -1.07 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.542 ' H ' ' HG3' ' A' ' 128' ' ' MET . 6.6 p -93.49 -33.03 13.95 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.827 0.739 . . . . 0.57 111.69 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.28 87.98 1.14 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.884 -1.154 . . . . 0.57 107.884 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 t80 61.77 90.58 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.112 1.365 . . . . 0.57 113.383 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.72 171.95 8.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.572 2.181 . . . . 0.57 112.252 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -154.3 -62.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.049 -0.5 . . . . 0.57 110.827 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.03 63.53 1.55 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.962 1.705 . . . . 0.57 109.068 176.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.08 165.86 15.81 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.959 1.773 . . . . 0.57 111.263 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 77.92 -11.24 1.23 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.253 1.421 . . . . 0.57 112.252 -174.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 84.6 m95 60.92 19.2 9.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.813 1.188 . . . . 0.57 113.055 -168.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m 68.47 -43.07 0.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.23 1.812 . . . . 0.57 112.811 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 t -75.91 -178.15 4.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.598 2.359 . . . . 0.57 111.079 173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -10.29 20.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.541 1.137 . . . . 0.57 111.865 168.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -127.13 146.3 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.568 -1.271 . . . . 0.57 107.568 177.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.33 156.69 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 125.586 1.554 . . . . 0.57 107.06 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.7 p -108.46 138.12 45.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.275 -1.009 . . . . 0.57 108.275 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -126.59 143.21 51.29 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.075 -1.016 . . . . 0.57 108.725 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -150.66 110.94 4.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.755 0.788 . . . . 1.2 108.993 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 mt -80.6 95.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 105.874 -1.898 . . . . 0.57 105.874 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -69.82 -36.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.06 1.344 . . . . 0.57 112.557 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -130.04 158.38 39.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.129 -2.545 . . . . 0.57 104.129 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -133.45 175.99 8.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.188 1.395 . . . . 0.57 108.154 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -87.23 -154.68 0.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.847 0.859 . . . . 0.57 109.258 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -132.31 -28.8 1.65 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 116.412 -1.756 . . . . 1.2 115.074 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.82 -47.89 84.29 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.263 1.392 . . . . 0.66 110.696 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -109.52 158.11 35.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.344 1.458 . . . . 0.57 109.199 176.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -77.54 156.44 32.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.79 1.66 . . . . 0.57 112.672 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -59.87 -35.37 74.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.712 1.205 . . . . 0.65 113.514 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.69 -37.29 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.986 -0.446 . . . . 0.57 110.34 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -69.51 -39.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 116.965 -1.493 . . . . 0.57 109.313 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG13 ' CZ ' ' A' ' 114' ' ' PHE . 24.4 t -53.18 -56.84 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.761 1.619 . . . . 0.57 109.773 171.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.37 -41.4 97.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.959 -0.543 . . . . 0.66 111.323 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.65 -45.1 80.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.674 0.67 . . . . 1.2 111.904 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.24 -41.07 86.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.32 0.648 . . . . 0.57 109.413 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.1 -50.09 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 117.511 -1.233 . . . . 0.57 109.504 168.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -46.51 75.21 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 121.454 1.934 . . . . 0.57 110.946 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.58 -35.05 79.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.743 0.701 . . . . 0.57 112.335 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.71 -47.54 62.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.459 1.104 . . . . 0.57 112.605 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 122' ' ' LEU . 9.4 mp -68.52 -31.36 70.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.135 1.374 . . . . 0.57 109.514 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -59.77 -38.88 83.07 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.221 -0.895 . . . . 0.57 110.226 168.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 37.2 mtm -67.47 -33.98 76.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.265 1.393 . . . . 0.57 112.123 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 9.4 m95 -66.24 -54.58 23.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.07 0.85 . . . . 0.57 110.269 170.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.62 -4.01 43.99 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.806 1.193 . . . . 0.57 113.616 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -69.01 -25.92 64.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.685 1.242 . . . . 0.57 110.346 172.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.26 -15.4 13.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.218 1.007 . . . . 0.66 111.553 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 pt -131.5 140.66 39.09 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 119.466 1.03 . . . . 0.57 109.204 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.8 9.1 1.4 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.715 2.277 . . . . 0.57 112.963 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -71.48 135.03 46.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.043 1.337 . . . . 0.57 108.348 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -125.27 -179.76 4.73 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.25 1.02 . . . . 0.65 109.663 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.54 157.07 44.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.158 -0.682 . . . . 0.57 109.158 -171.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 154.46 49.15 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.346 1.458 . . . . 1.2 110.121 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -114.56 109.31 18.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.086 -1.079 . . . . 0.57 108.086 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.02 161.05 4.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.494 -0.558 . . . . 0.57 109.494 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.61 -53.14 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 118.767 -0.635 . . . . 0.57 110.524 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 165.88 58.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.292 2.237 . . . . 0.57 111.749 -172.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.09 38.85 1.7 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.752 -1.218 . . . . 0.57 113.588 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m 64.97 142.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.59 1.956 . . . . 0.57 110.28 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.18 168.03 20.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.773 0.796 . . . . 0.57 109.288 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 10' ' ' TRP . 58.0 m-20 -65.72 -45.02 84.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.582 -1.19 . . . . 0.66 108.545 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -112.34 81.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.051 1.74 . . . . 0.57 107.658 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -78.11 118.73 20.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.029 -1.1 . . . . 0.57 108.029 168.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.28 130.57 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.787 -1.931 . . . . 0.57 105.787 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.81 161.54 28.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.428 -0.669 . . . . 0.57 111.428 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.3 m-85 -132.02 143.35 50.01 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.881 -1.526 . . . . 0.57 106.881 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.02 179.98 6.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.433 1.493 . . . . 0.57 109.186 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -141.15 57.47 1.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.319 -0.623 . . . . 1.2 109.319 -171.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.04 -58.55 0.66 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.627 1.108 . . . . 0.57 111.889 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.86 155.01 45.91 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.684 0.794 . . . . 0.57 109.279 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -157.76 147.25 19.95 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.037 0.935 . . . . 0.65 109.127 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 74.63 1.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.371 -1.491 . . . . 0.57 109.371 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.74 -92.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.614 1.565 . . . . 0.66 107.169 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.9 p -158.92 -38.19 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.8 1.24 . . . . 0.57 110.024 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.88 131.42 23.99 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 109.541 -0.54 . . . . 0.57 109.541 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.0 137.08 43.36 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.036 -1.563 . . . . 0.57 108.036 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -158.22 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 123.622 1.677 . . . . 0.57 109.233 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -136.78 -22.64 1.22 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 130.205 3.402 . . . . 0.66 109.058 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 -141.43 26.42 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.079 -1.208 . . . . 0.57 110.079 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.06 95.21 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.965 3.11 . . . . 0.57 110.855 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.27 -176.15 21.89 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.622 -0.991 . . . . 0.57 110.622 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.25 31.8 t30 46.85 -135.72 0.88 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.451 1.5 . . . . 0.57 114.092 173.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -61.86 125.52 24.14 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.274 2.23 . . . . 0.57 110.909 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -82.48 -30.13 30.13 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.289 -1.507 . . . . 0.57 113.734 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.1 166.84 25.22 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.374 1.07 . . . . 0.57 109.377 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.08 163.93 32.13 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.799 -0.563 . . . . 0.65 109.783 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.44 155.24 40.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.958 1.303 . . . . 0.57 109.3 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.78 163.61 13.12 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.774 0.671 . . . . 0.57 110.11 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.4 153.92 83.96 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.7 -0.667 . . . . 0.57 109.946 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 36.3 Cg_endo -66.93 155.59 70.09 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.955 2.436 . . . . 0.57 112.176 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.81 -118.41 0.55 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.289 -1.925 . . . . 0.57 108.289 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 m -151.59 106.57 3.28 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 104.667 -2.345 . . . . 0.57 104.667 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.67 -132.57 10.51 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 117.483 -1.732 . . . . 0.57 109.301 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -31.13 12.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.662 1.585 . . . . 0.57 112.809 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -45.96 144.27 3.73 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.72 -0.552 . . . . 0.57 111.72 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CZ2' ' A' ' 10' ' ' TRP . . . 70.44 -18.81 0.71 Allowed Glycine 0 C--N 1.337 0.61 0 C-N-CA 126.546 2.022 . . . . 0.57 116.738 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -68.1 155.51 39.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.785 -1.191 . . . . 0.66 107.785 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.58 29.89 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.371 -0.832 . . . . 0.57 108.96 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.93 159.27 35.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.196 -0.911 . . . . 0.65 109.156 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.483 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 28.9 m-85 -144.56 154.74 43.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.566 1.546 . . . . 0.57 108.095 -170.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.06 99.15 12.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.672 0.389 . . . . 0.66 110.28 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.97 -28.14 49.31 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.741 -1.224 . . . . 0.66 111.977 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -54.67 -38.52 67.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.824 1.65 . . . . 0.66 110.592 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.79 151.14 37.6 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.881 1.272 . . . . 0.66 109.844 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -80.13 125.21 29.53 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.712 -1.243 . . . . 1.2 109.709 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -107.17 166.05 10.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.832 0.853 . . . . 0.57 109.118 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -158.8 164.4 35.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.815 0.846 . . . . 0.57 109.438 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -65.01 -48.03 75.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.326 0.65 . . . . 0.66 110.237 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.61 40.25 0.02 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.149 -0.806 . . . . 0.57 112.777 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -77.36 32.61 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.02 1.41 . . . . 0.57 113.827 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.1 m 53.51 35.09 19.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.667 1.587 . . . . 0.57 113.559 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -160.66 -175.16 4.81 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.551 1.54 . . . . 0.57 108.622 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.37 -144.76 24.32 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 124.237 0.922 . . . . 0.57 112.033 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -120.67 113.47 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.821 -1.548 . . . . 0.57 106.821 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -61.08 110.48 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.148 0.979 . . . . 0.57 111.304 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 10.0 t80 -63.21 -42.98 99.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.507 1.123 . . . . 0.57 111.355 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -55.11 22.77 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.86 -1.163 . . . . 0.57 107.86 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 147' ' ' PRO . 11.8 t80 -64.47 -43.25 94.81 Favored 'General case' 0 CA--C 1.526 0.02 0 C-N-CA 122.949 0.499 . . . . 0.57 111.004 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.2 70.82 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.085 0.554 . . . . 0.57 110.906 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.1 -55.66 31.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.191 -0.909 . . . . 0.57 109.607 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 m -53.93 -38.72 65.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.286 0.948 . . . . 0.57 111.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 4.0 t-160 -63.96 -59.29 4.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.252 0.621 . . . . 0.65 109.788 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -64.69 -46.71 81.19 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.232 0.469 . . . . 0.66 111.104 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.01 -31.48 71.86 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.4 1.08 . . . . 0.57 112.103 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -55.87 -41.89 84.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.219 -0.752 . . . . 0.57 111.219 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -72.33 -36.33 68.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.062 -0.971 . . . . 0.65 111.81 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -56.37 -36.33 68.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.283 0.947 . . . . 0.57 112.293 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 48' ' ' LEU . 2.5 mm? -65.87 -21.04 66.43 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.611 1.096 . . . . 0.57 112.942 176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.33 -54.59 0.28 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 124.343 0.973 . . . . 0.57 110.895 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.542 ' HG3' ' H ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 172.74 176.89 0.09 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.38 2.272 . . . . 0.57 107.7 -173.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.4 70.65 0.02 OUTLIER Glycine 0 C--O 1.218 -0.874 0 N-CA-C 107.152 -2.379 . . . . 0.57 107.152 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 162.11 27.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.425 1.112 . . . . 0.65 108.651 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 t -157.95 -161.89 1.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.984 1.314 . . . . 0.57 108.388 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -152.74 58.43 0.8 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.119 1.768 . . . . 0.57 109.288 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -143.44 135.16 12.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 117.037 -1.458 . . . . 0.66 108.751 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.37 41.92 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.051 1 C-N-CA 125.981 4.454 . . . . 0.57 114.041 -174.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -154.02 -27.15 0.13 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 127.931 2.492 . . . . 0.57 111.566 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -50.7 133.35 25.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.7 -0.852 . . . . 0.57 108.7 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 156' ' ' ASP . 7.3 p -60.96 -25.44 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.852 -0.53 . . . . 0.57 110.745 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' HIS . 3.8 mpp? -109.63 28.61 8.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.41 1.084 . . . . 0.57 111.49 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -50.5 128.69 25.35 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 120.698 -1.251 . . . . 0.57 110.054 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.35 168.1 24.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.995 2.463 . . . . 0.57 110.542 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.4 m 62.0 70.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.871 0.759 . . . . 0.57 110.552 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -41.18 123.68 2.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.856 1.662 . . . . 0.57 112.115 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.1 -111.42 0.33 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.909 -1.277 . . . . 0.57 109.909 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -50.44 -39.97 49.16 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.667 0.988 . . . . 0.57 113.667 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.85 89.14 0.01 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.225 1.869 . . . . 0.57 112.115 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.99 107.91 1.06 Allowed Pre-proline 0 C--N 1.344 0.349 0 C-N-CA 124.635 1.174 . . . . 0.66 109.987 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.406 ' HA ' ' CD1' ' A' ' 116' ' ' TYR . 11.7 Cg_endo -72.19 -25.17 19.22 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.37 1.38 . . . . 0.57 112.145 -172.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.9 2.42 38.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.448 -0.787 . . . . 0.57 110.941 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.65 75.47 1.66 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.223 1.809 . . . . 0.57 108.418 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.11 -64.98 0.64 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.675 1.19 . . . . 0.57 113.291 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 22.61 77.55 0.02 OUTLIER 'General case' 0 C--N 1.343 0.296 0 C-N-CA 129.279 3.032 . . . . 0.57 112.657 174.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.7 mp -38.26 97.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.571 2.348 . . . . 0.57 109.97 -176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 m -74.13 -87.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.558 0.743 . . . . 0.57 112.546 -162.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -137.5 -28.02 0.92 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 116.779 -1.581 . . . . 0.57 110.248 168.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.17 -54.11 50.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.154 1.797 . . . . 0.66 111.299 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.598 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.5 t0 -62.68 -53.11 59.36 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 109.799 -0.445 . . . . 0.66 109.799 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.12 -40.62 83.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 123.865 0.866 . . . . 0.57 109.112 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -64.95 -43.03 94.02 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.823 -1.085 . . . . 0.57 110.653 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.48 -61.63 7.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.373 -1.491 . . . . 0.57 109.373 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.406 HD11 ' CE3' ' A' ' 42' ' ' TRP . 4.0 mm -53.47 -47.2 59.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.383 1.473 . . . . 0.57 112.748 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.14 -31.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.037 0.535 . . . . 0.57 111.017 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -29.61 64.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.702 0.683 . . . . 0.57 111.183 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.59 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.482 -0.77 . . . . 0.57 109.709 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -143.31 22.64 1.86 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.65 0.611 . . . . 0.57 112.65 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.14 -153.99 12.96 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.139 0.876 . . . . 0.57 113.04 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -120.83 -43.89 2.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.355 1.462 . . . . 0.57 112.942 -171.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -73.73 123.68 24.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.625 -0.88 . . . . 1.2 108.625 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.9 p -126.0 74.64 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.22 1.408 . . . . 0.57 109.056 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.13 100.74 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.604 1.162 . . . . 0.57 108.051 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.07 110.02 0.69 Allowed 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.28 -1.007 . . . . 0.57 108.28 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -123.11 113.14 18.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.556 -1.275 . . . . 1.2 107.556 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.46 -179.34 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.379 1.049 . . . . 0.57 108.798 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tttp . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 125.429 1.492 . . . . 0.5 . -179.551 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.14 -0.457 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 m -70.72 -63.59 1.06 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 119.939 -1.725 . . . . 0.57 112.132 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -176.0 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.174 1.789 . . . . 0.57 106.559 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 165.63 -52.8 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 127.889 2.476 . . . . 0.57 110.502 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.67 150.5 5.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.405 1.403 . . . . 0.57 112.625 -171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -150.41 76.66 1.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.407 0.683 . . . . 0.57 110.514 -169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.88 84.51 3.37 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 108.601 -0.889 . . . . 0.57 108.601 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.24 85.24 1.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.114 2.543 . . . . 0.57 109.668 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 pttt 85.73 151.26 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.239 2.615 . . . . 0.57 108.937 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 64.6 m95 -65.76 170.11 5.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.265 1.026 . . . . 0.57 109.938 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 m -62.05 -29.66 70.45 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 120.94 -1.1 . . . . 0.57 111.252 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.6 t -97.62 156.87 16.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.57 112.163 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -75.1 -6.08 47.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.682 1.593 . . . . 0.57 112.754 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.63 151.94 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.523 -0.918 . . . . 0.57 108.523 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 150.16 33.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.047 -1.094 . . . . 0.57 108.047 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.8 p -104.54 136.78 43.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.605 -0.887 . . . . 0.57 108.605 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -118.79 163.2 17.23 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.801 0.84 . . . . 0.57 110.481 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.37 160.45 41.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.046 -1.094 . . . . 1.2 108.046 169.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.6 mt -123.2 94.25 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 103.663 -2.717 . . . . 0.57 103.663 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 m -73.29 -30.68 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.593 0.357 . . . . 0.57 111.263 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -142.63 147.27 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.161 -2.163 . . . . 0.57 105.161 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -131.9 159.19 39.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.357 1.063 . . . . 0.57 109.207 -166.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -91.74 -175.52 4.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.876 1.27 . . . . 0.57 109.437 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.61 -26.3 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.128 1.159 . . . . 1.2 114.128 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -59.19 -40.68 86.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.265 0.626 . . . . 0.66 110.305 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.65 152.57 80.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 128.767 2.827 . . . . 0.57 110.248 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.31 161.19 28.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.962 2.441 . . . . 0.57 114.453 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.82 -39.05 93.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.833 1.653 . . . . 0.65 112.027 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 tt -65.89 -35.96 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.424 0.69 . . . . 0.57 110.794 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -66.39 -46.62 76.03 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 116.703 -1.617 . . . . 0.57 108.723 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.56 -52.54 25.78 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.568 1.531 . . . . 0.57 110.043 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -63.04 -42.49 99.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.635 1.174 . . . . 0.66 110.955 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -63.32 -46.88 84.63 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.95 . . . . 1.2 112.062 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.15 -45.61 87.72 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.239 -0.886 . . . . 0.57 109.022 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -46.75 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 124.267 1.027 . . . . 0.57 109.574 172.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -46.06 89.47 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.047 0.839 . . . . 0.57 110.95 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -63.67 -42.95 98.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.912 1.285 . . . . 0.57 112.033 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.29 75.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.094 1.357 . . . . 0.57 111.447 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.92 -34.19 77.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.607 -0.711 . . . . 0.57 110.258 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -40.76 85.38 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.262 0.937 . . . . 0.57 110.613 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 39.4 mtm -63.85 -38.93 92.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.047 0.84 . . . . 0.57 111.293 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CH2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -64.29 -49.67 70.87 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.26 0.936 . . . . 0.57 111.405 172.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.16 -9.08 66.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.913 1.244 . . . . 0.57 113.174 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -23.77 63.08 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.506 1.653 . . . . 0.57 110.864 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -105.85 -14.03 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.258 1.023 . . . . 0.66 111.706 -171.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' CD1' ' A' ' 164' ' ' TYR . 12.8 pt -139.36 149.56 60.92 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.636 1.174 . . . . 0.57 111.445 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.37 10.32 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.313 2.675 . . . . 0.57 113.018 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.26 133.9 35.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.736 1.615 . . . . 0.57 107.513 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.12 170.88 10.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.002 0.921 . . . . 0.65 110.006 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.08 146.16 31.73 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.426 -0.953 . . . . 0.57 108.426 -172.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -143.6 166.53 24.58 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.875 1.27 . . . . 1.2 109.242 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -105.37 143.35 33.66 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.86 -0.793 . . . . 0.57 108.86 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.66 157.01 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.71 0.404 . . . . 0.57 110.98 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.86 -43.81 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.779 0.832 . . . . 0.57 111.509 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -176.64 146.98 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.97 2.908 . . . . 0.57 104.622 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.18 -116.87 3.07 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.523 -0.631 . . . . 0.57 111.523 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 43.9 p -132.88 164.64 26.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.635 1.974 . . . . 0.57 108.556 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.51 21.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.126 0.97 . . . . 0.57 110.121 -174.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -63.01 -33.08 74.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.611 0.764 . . . . 0.66 109.806 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.3 mt -123.53 76.94 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.068 2.147 . . . . 0.57 108.235 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -73.22 110.75 7.74 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.737 1.615 . . . . 0.57 108.519 167.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.91 128.13 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 104.568 -2.382 . . . . 0.57 104.568 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.62 148.9 19.07 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 110.111 -1.196 . . . . 0.57 110.111 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -113.38 167.28 10.7 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 118.299 1.05 . . . . 0.57 108.594 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.58 155.28 43.57 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.513 1.125 . . . . 0.57 108.162 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -105.13 110.03 22.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.521 -1.289 . . . . 1.2 107.521 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.73 -46.95 2.4 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.015 -1.436 . . . . 0.57 113.665 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.53 165.53 36.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.554 1.677 . . . . 0.57 111.56 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.13 162.51 33.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.411 1.085 . . . . 0.65 111.777 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.57 58.62 3.0 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.798 1.665 . . . . 0.57 112.307 -174.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.99 -52.71 2.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.561 0.745 . . . . 0.66 111.276 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 t 174.73 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.427 1.891 . . . . 0.57 110.65 -167.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -122.54 114.16 30.28 Favored Pre-proline 0 C--N 1.347 0.471 0 C-N-CA 123.388 0.675 . . . . 0.57 109.538 -170.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 28.88 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.941 2.427 . . . . 0.57 112.552 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 41.96 -136.3 0.27 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.128 1.771 . . . . 0.57 111.326 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -162.77 -40.46 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.779 2.432 . . . . 0.66 108.449 -163.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.39 -153.91 21.98 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.687 -1.365 . . . . 0.57 109.687 -170.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.77 101.98 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.096 3.198 . . . . 0.57 113.561 -167.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.88 -178.79 17.05 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 109.839 -1.304 . . . . 0.57 109.839 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t30 49.14 -145.01 0.42 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.195 0.997 . . . . 0.57 112.428 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.3 m -46.5 110.68 0.3 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.374 2.27 . . . . 0.57 112.577 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -83.83 -34.12 24.75 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.259 -0.9 . . . . 0.57 113.041 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.84 167.62 29.82 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.915 0.886 . . . . 0.57 109.382 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -150.98 150.44 30.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.876 -0.515 . . . . 0.65 110.053 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.95 163.2 32.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.1 0.96 . . . . 0.57 109.628 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.31 140.3 49.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.007 -1.109 . . . . 0.57 108.007 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.09 160.07 3.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.57 112.444 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.0 Cg_endo -68.6 152.87 74.46 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.538 2.158 . . . . 0.57 111.183 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.17 -78.57 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.045 -1.222 . . . . 0.57 110.045 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -172.21 -49.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.584 1.154 . . . . 0.57 109.497 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.69 -101.99 2.73 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.218 -1.153 . . . . 0.57 110.218 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -27.18 68.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.048 0.939 . . . . 0.57 111.828 175.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.54 146.77 15.67 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.148 -0.97 . . . . 0.57 111.411 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 -21.37 4.24 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.579 2.037 . . . . 0.57 114.506 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -74.76 160.14 31.1 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.975 1.388 . . . . 0.66 108.891 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.09 139.86 20.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.118 -0.492 . . . . 0.57 110.3 -169.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -132.77 149.52 52.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.437 0.695 . . . . 0.65 110.6 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -142.07 146.88 35.95 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.096 -1.446 . . . . 0.57 107.096 -166.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -86.55 103.89 15.48 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.02 0.914 . . . . 0.66 109.277 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.65 -15.54 62.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.316 1.446 . . . . 0.66 111.374 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -69.56 -20.58 63.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.436 1.016 . . . . 0.66 110.267 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -85.38 158.91 20.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.026 0.917 . . . . 0.66 110.325 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.27 138.66 35.73 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -131.47 144.84 51.45 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.269 -1.752 . . . . 0.57 106.269 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -138.48 153.07 48.79 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.46 0.648 . . . . 0.57 110.14 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -97.18 11.57 35.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.626 2.371 . . . . 0.66 110.741 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.74 -134.31 2.98 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.81 1.672 . . . . 0.57 111.674 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 t -143.33 171.5 14.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.309 1.444 . . . . 0.57 108.713 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 t 51.76 42.9 30.25 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.892 1.441 . . . . 0.57 114.892 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.56 -38.59 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 119.914 -1.741 . . . . 0.57 113.542 -172.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.35 -154.9 10.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 108.587 -1.805 . . . . 0.57 108.587 -172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.94 119.51 34.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 108.289 -1.004 . . . . 0.57 108.289 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -63.98 103.56 0.61 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.945 0.498 . . . . 0.57 109.675 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.24 -36.35 65.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.874 1.27 . . . . 0.57 110.645 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -65.44 -48.35 73.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.849 -0.797 . . . . 0.57 108.849 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.52 -39.07 93.47 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.558 -0.904 . . . . 0.57 108.558 -176.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.56 -56.3 22.97 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.58 0.752 . . . . 0.57 110.999 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.25 58.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.137 0.575 . . . . 0.57 109.71 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.7 m -58.73 -44.02 90.35 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.173 0.897 . . . . 0.57 111.732 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.66 -52.03 67.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.034 0.534 . . . . 0.65 109.723 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.23 -48.66 72.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.466 1.106 . . . . 0.66 110.393 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.14 -29.12 69.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 126.113 1.765 . . . . 0.57 111.534 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 42' ' ' TRP . . . -62.19 -45.32 96.27 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.691 -0.564 . . . . 0.57 111.691 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -62.32 -39.76 94.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 117.213 -1.375 . . . . 0.65 109.911 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -60.44 -29.1 68.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.825 1.193 . . . . 0.57 113.774 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -25.22 57.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.596 1.089 . . . . 0.57 112.71 172.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.89 -1.63 4.29 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.808 1.194 . . . . 0.57 114.5 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.43 164.68 20.5 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.951 1.375 . . . . 0.57 113.678 -166.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.38 166.49 12.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.227 1.394 . . . . 0.57 109.755 172.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -68.37 174.35 4.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.195 0.998 . . . . 0.65 112.558 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.08 179.83 7.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.735 1.614 . . . . 0.57 108.519 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.08 71.55 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.826 2.05 . . . . 0.57 107.51 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 12.3 t70 -136.72 140.49 32.13 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 107.668 -1.234 . . . . 0.66 107.668 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.34 -26.32 41.53 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.456 2.104 . . . . 0.57 112.317 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.2 22.87 14.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.981 1.313 . . . . 0.57 109.991 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -64.61 124.42 21.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.258 -1.016 . . . . 0.57 108.258 166.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.93 -31.03 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.986 -0.446 . . . . 0.57 109.871 166.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -84.51 8.54 16.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.94 1.089 . . . . 0.57 113.94 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -56.78 130.85 78.43 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.652 1.569 . . . . 0.57 110.565 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 150.01 26.53 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.197 1.931 . . . . 0.57 110.27 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.8 m 73.12 156.42 0.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.389 1.876 . . . . 0.57 111.545 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.79 132.73 53.88 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.252 1.021 . . . . 0.57 109.55 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 141.62 97.51 0.29 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.511 1.053 . . . . 0.57 110.53 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.25 -43.23 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.659 1.229 . . . . 0.57 113.443 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.66 -177.22 48.39 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.862 -1.695 . . . . 0.57 108.862 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -51.7 111.56 2.52 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.579 1.552 . . . . 0.66 110.969 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -3.86 12.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.21 1.94 . . . . 0.57 112.304 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -73.7 -9.99 59.23 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.706 1.139 . . . . 0.57 112.91 168.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -62.61 -6.58 3.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.721 1.749 . . . . 0.57 115.721 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 19.77 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.346 3.058 . . . . 0.57 116.83 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt 20.39 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.677 3.191 . . . . 0.57 112.859 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -26.11 106.09 0.03 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 127.876 2.471 . . . . 0.57 110.165 -175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.8 t -81.67 -87.54 0.09 Allowed 'General case' 0 C--N 1.343 0.316 0 O-C-N 123.853 0.721 . . . . 0.57 110.147 -160.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.75 -37.5 0.45 Allowed 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.252 -1.356 . . . . 0.57 109.376 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -47.85 -49.32 29.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.205 1.366 . . . . 0.66 110.571 171.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.428 ' CG ' HD23 ' A' ' 152' ' ' LEU . 12.1 t0 -77.57 -54.15 6.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.66 109.746 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mm -57.68 -45.64 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.76 0.709 . . . . 0.57 111.079 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -44.16 79.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 123.505 0.722 . . . . 0.57 109.565 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.43 -51.25 58.87 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.123 -1.191 . . . . 0.57 110.123 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -60.22 -51.97 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.456 1.102 . . . . 0.57 110.223 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.08 -25.28 61.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.877 0.762 . . . . 0.57 112.498 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -43.79 18.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.577 -1.201 . . . . 0.57 110.064 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.25 -56.67 6.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.666 2.386 . . . . 0.57 111.624 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.422 ' CD1' HG22 ' A' ' 46' ' ' ILE . 26.4 p90 -93.6 1.15 56.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 119.02 -0.514 . . . . 0.57 112.143 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.21 -115.38 4.07 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.718 -1.753 . . . . 0.57 108.718 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -61.62 -63.07 1.39 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.22 -0.895 . . . . 0.57 111.741 -172.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -169.18 -79.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.012 2.125 . . . . 1.2 107.382 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 158.69 8.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.825 0.85 . . . . 0.57 109.489 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 159.15 39.56 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.607 1.163 . . . . 0.57 108.77 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.0 t -163.7 178.81 7.61 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.547 1.139 . . . . 0.57 108.519 168.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.64 129.39 55.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.323 -2.102 . . . . 1.2 105.323 167.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -47.82 140.85 6.15 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.163 0.985 . . . . 0.57 110.788 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 126.365 1.866 . . . . 0.5 . -179.32 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 120.409 0.147 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.4 t -62.89 -54.07 44.27 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.263 1.025 . . . . 0.57 111.241 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.85 173.13 15.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.884 2.073 . . . . 0.57 109.043 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -45.0 138.78 4.13 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.05 2.14 . . . . 0.57 113.069 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.09 -4.45 15.44 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.827 2.351 . . . . 0.57 113.518 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -134.73 101.17 4.84 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.014 1.326 . . . . 0.57 108.048 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.68 -61.48 0.0 OUTLIER Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 129.259 3.024 . . . . 0.57 107.622 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.01 158.17 58.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.57 110.187 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.5 111.55 0.07 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.48 1.912 . . . . 0.57 111.288 -174.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 19.9 m95 -58.02 152.29 16.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.996 0.918 . . . . 0.57 111.436 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.4 p -77.47 -20.69 54.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.57 112.764 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -94.19 142.41 27.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.236 1.415 . . . . 0.57 109.325 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -10.62 59.7 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.406 1.482 . . . . 0.57 112.577 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.87 109.91 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.614 -1.995 . . . . 0.57 105.614 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG23 HD21 ' A' ' 48' ' ' LEU . 59.9 t -102.02 159.0 4.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.607 -1.627 . . . . 0.57 106.607 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 p -106.96 139.8 40.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.277 -0.638 . . . . 0.57 109.277 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -128.08 157.37 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.409 -0.807 . . . . 0.57 110.092 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -158.48 115.88 2.88 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.057 0.456 . . . . 1.2 110.361 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.65 90.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 106.623 -1.621 . . . . 0.57 106.623 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.12 -25.46 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.408 -1.432 . . . . 0.57 113.901 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -147.6 154.72 41.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 103.241 -2.874 . . . . 0.57 103.241 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -135.78 43.95 2.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.756 0.707 . . . . 0.57 110.148 -164.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 64' ' ' PHE . 15.4 t 47.73 -153.98 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.779 1.232 . . . . 0.57 110.186 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -22.79 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.54 -0.743 . . . . 1.2 112.784 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -64.04 -39.72 94.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.04 0.836 . . . . 0.66 111.536 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.19 150.7 57.41 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.005 1.322 . . . . 0.57 109.062 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.28 159.67 40.09 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.82 2.347 . . . . 0.57 113.011 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -59.53 -36.78 76.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.98 1.312 . . . . 0.65 113.689 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -39.3 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.185 0.448 . . . . 0.57 110.039 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -69.74 -46.39 66.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.297 -1.335 . . . . 0.57 109.475 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.4 -48.14 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.985 1.721 . . . . 0.57 110.403 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.72 -45.67 91.65 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 119.019 0.827 . . . . 0.66 110.781 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -40.54 94.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.8 1.182 . . . . 1.2 113.189 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.23 -47.77 63.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.04 1.336 . . . . 0.57 109.235 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.2 -37.84 70.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.375 0.989 . . . . 0.57 110.809 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.0 t -61.49 -56.75 16.61 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.227 1.011 . . . . 0.57 109.95 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -62.34 -32.72 73.54 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.353 1.433 . . . . 0.57 112.338 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.95 62.0 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.451 1.1 . . . . 0.57 112.316 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.62 -31.16 70.99 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 118.228 -0.891 . . . . 0.57 110.165 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -59.85 -43.57 94.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.901 -1.047 . . . . 0.57 109.609 171.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.1 mtp -61.31 -45.26 95.18 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.893 1.224 . . . . 0.57 111.733 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -60.48 -47.75 84.77 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.085 1.311 . . . . 0.57 111.565 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.57 -17.01 68.37 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.64 1.114 . . . . 0.57 113.071 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -29.57 70.73 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.478 -1.013 . . . . 0.57 110.182 174.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.91 -32.26 13.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.72 -0.657 . . . . 0.66 111.808 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.89 132.87 24.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.757 0.823 . . . . 0.57 110.659 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.34 35.7 0.4 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 124.111 3.208 . . . . 0.57 113.991 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 49' ' ' HIS . 2.1 tt -78.81 146.26 33.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.718 1.607 . . . . 0.57 107.85 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.535 ' H ' HD23 ' A' ' 48' ' ' LEU . 68.8 m80 -130.59 160.17 34.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.02 1.328 . . . . 0.65 108.191 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 149.87 43.97 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 120.927 -1.108 . . . . 0.57 108.26 -173.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -137.18 170.33 16.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.926 0.89 . . . . 1.2 109.357 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -117.33 128.22 54.83 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.019 -1.104 . . . . 0.57 108.019 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.14 163.23 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.95 1.3 . . . . 0.57 110.444 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 55' ' ' TRP . 27.4 m -66.36 -60.21 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.845 0.858 . . . . 0.57 109.895 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.503 ' H ' HG23 ' A' ' 54' ' ' VAL . 19.7 p90 -164.57 154.12 13.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.415 2.686 . . . . 0.57 105.616 167.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.05 17.79 1.42 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.433 1.333 . . . . 0.57 116.433 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.6 m 68.0 159.04 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.944 1.698 . . . . 0.57 111.021 -168.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -131.82 177.26 7.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.623 1.569 . . . . 0.57 109.071 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.86 -34.97 79.36 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.921 0.488 . . . . 0.66 109.946 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mt -126.84 82.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.139 -1.8 . . . . 0.57 106.139 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.47 140.21 44.44 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.208 -0.932 . . . . 0.57 108.777 164.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.67 120.36 61.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 N-CA-C 105.705 -1.961 . . . . 0.57 105.705 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.74 161.12 24.74 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.697 -0.561 . . . . 0.57 111.697 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.5 m-85 -132.45 129.9 39.84 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 104.978 -2.23 . . . . 0.57 104.978 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.1 17.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.647 1.979 . . . . 0.57 108.223 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 ttp-105 -97.36 -14.15 21.43 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.69 0.996 . . . . 1.2 113.69 -168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.22 -44.07 0.03 OUTLIER Glycine 0 C--O 1.221 -0.669 0 CA-C-O 119.067 -0.852 . . . . 0.57 111.034 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.57 27.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.314 1.046 . . . . 0.57 109.143 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 -75.31 0.63 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.145 1.778 . . . . 0.65 109.096 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.44 46.52 0.02 OUTLIER Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.594 0.616 . . . . 0.57 112.371 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 -172.46 2.05 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.832 1.653 . . . . 0.66 108.098 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.1 -36.73 2.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.57 113.322 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.8 101.3 6.49 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.332 -0.988 . . . . 0.57 108.332 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.52 155.26 67.37 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.412 1.408 . . . . 0.57 111.155 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.03 177.23 3.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.53 1.157 . . . . 0.57 111.734 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.0 -26.6 8.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.828 3.251 . . . . 0.66 111.798 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.57 -146.0 18.06 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 120.89 1.677 . . . . 0.57 112.632 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.5 82.28 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 0.57 113.753 -172.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -165.02 35.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.984 1.754 . . . . 0.57 111.743 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 t30 38.41 -129.65 0.22 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.364 2.266 . . . . 0.57 115.755 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.2 m -65.67 131.26 45.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.153 2.181 . . . . 0.57 109.135 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.5 mp -101.17 -27.15 13.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.767 1.227 . . . . 0.57 113.496 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.91 159.69 32.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.153 -1.425 . . . . 0.57 107.153 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.89 157.1 43.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.65 109.553 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.72 155.13 43.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.519 1.128 . . . . 0.57 108.709 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.97 143.73 42.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.522 -0.918 . . . . 0.57 108.522 -175.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.09 151.72 33.44 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 118.122 -0.942 . . . . 0.57 110.193 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 55.1 Cg_endo -70.15 155.52 64.44 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.678 1.585 . . . . 0.57 112.014 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.72 174.7 14.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.81 1.195 . . . . 0.57 110.733 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.257 7.1 t 43.52 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.049 1.74 . . . . 0.57 113.055 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.51 -53.06 2.69 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.945 -0.92 . . . . 0.57 111.178 172.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.16 -35.27 80.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.816 1.246 . . . . 0.57 112.089 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.0 153.62 30.15 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.889 -1.132 . . . . 0.57 111.007 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.61 -21.48 1.96 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.204 1.383 . . . . 0.57 114.091 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -74.72 155.07 38.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 120.138 1.969 . . . . 0.66 108.614 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.29 26.02 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.507 -0.769 . . . . 0.57 109.487 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -132.82 162.33 31.8 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.65 109.248 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.5 m-85 -143.03 155.44 44.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.732 1.613 . . . . 0.57 108.718 -171.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.63 96.29 7.85 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.552 -1.277 . . . . 0.66 107.552 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.13 -32.76 68.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.068 1.747 . . . . 0.66 111.74 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.74 -32.27 73.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.423 -0.584 . . . . 0.66 109.423 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.88 124.01 23.33 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.276 1.03 . . . . 0.66 109.471 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -54.48 131.06 41.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.301 1.04 . . . . 1.2 109.745 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.38 149.07 39.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.658 -1.238 . . . . 0.57 107.658 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -145.1 149.3 34.8 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.508 -0.745 . . . . 0.57 109.185 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.35 -39.25 75.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.385 0.538 . . . . 0.66 110.728 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.87 -35.47 0.1 OUTLIER Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.367 -0.685 . . . . 0.57 112.866 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.1 m -54.91 137.64 45.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.293 1.037 . . . . 0.57 111.633 174.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -56.12 110.44 0.75 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.689 1.196 . . . . 0.57 111.936 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -32.88 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.586 1.154 . . . . 0.57 111.804 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.98 -146.21 5.5 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 108.06 -2.016 . . . . 0.57 108.06 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.39 135.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.727 1.211 . . . . 0.57 109.523 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.71 103.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.896 0.878 . . . . 0.57 110.623 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.05 -41.39 74.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.085 2.154 . . . . 0.57 110.817 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 tp -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.088 -0.708 . . . . 0.57 109.088 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 137' ' ' VAL . 39.8 t80 -57.93 -48.86 78.68 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.719 0.807 . . . . 0.57 109.183 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.54 -57.05 14.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.811 0.844 . . . . 0.57 110.464 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -51.37 70.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.512 -0.756 . . . . 0.57 110.333 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.1 m -56.75 -41.21 77.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.551 1.069 . . . . 0.57 110.904 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -67.12 -52.89 36.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.348 0.659 . . . . 0.65 110.306 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.03 -41.92 94.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.9 0.773 . . . . 0.66 111.037 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.06 -27.91 66.06 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.275 0.63 . . . . 0.57 110.734 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.05 -44.01 88.28 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 118.855 0.752 . . . . 0.57 111.398 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -68.33 -39.56 81.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.18 -0.914 . . . . 0.65 112.067 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 p -65.05 -26.94 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 123.688 0.617 . . . . 0.57 111.955 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -44.18 85.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 0.57 111.08 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 168.84 41.64 0.03 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.411 -1.216 . . . . 0.57 115.128 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.7 mmt 54.39 -167.17 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.665 1.232 . . . . 0.57 111.072 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.8 24.44 0.34 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.17 -1.35 . . . . 0.57 114.917 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 163.69 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.402 1.601 . . . . 0.65 113.013 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.2 178.97 9.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.885 1.674 . . . . 0.57 109.235 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.5 m -147.52 75.7 1.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.165 1.786 . . . . 0.57 106.815 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -136.38 143.04 41.8 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.849 0.86 . . . . 0.66 108.703 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.72 3.73 3.05 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.257 2.638 . . . . 0.57 114.725 -169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -135.67 -1.53 2.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.432 1.493 . . . . 0.57 111.534 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.82 121.54 26.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.463 1.905 . . . . 0.57 108.851 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 116' ' ' TYR . 2.6 p -53.59 -29.06 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 120.948 1.703 . . . . 0.57 112.422 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 39.0 mmt -65.12 -15.37 62.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.308 -1.33 . . . . 0.57 113.854 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.34 126.55 82.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 120.726 1.603 . . . . 0.57 109.31 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.44 -165.33 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.543 2.162 . . . . 0.57 110.148 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m 79.92 -31.05 0.13 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.232 -1.543 . . . . 0.57 113.015 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.3 t80 45.21 80.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.668 1.587 . . . . 0.57 111.471 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.65 -92.04 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.587 1.565 . . . . 0.57 112.36 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -64.94 -49.18 71.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.172 1.389 . . . . 0.57 113.928 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.85 109.03 2.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 107.196 -2.362 . . . . 0.57 107.196 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.5 118.66 62.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.783 1.633 . . . . 0.66 112.218 -166.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.51 -1.47 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.97 3.113 . . . . 0.57 113.537 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.41 -30.03 53.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.55 1.068 . . . . 0.57 110.68 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -116.87 75.12 0.95 Allowed 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.532 -0.73 . . . . 0.57 109.305 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -126.31 145.88 50.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.284 0.634 . . . . 0.57 110.929 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 52.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.008 1.323 . . . . 0.57 111.157 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp 56.92 73.94 0.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.218 1.407 . . . . 0.57 111.458 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -61.5 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 C-N-CA 124.932 1.293 . . . . 0.57 113.645 -168.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -144.52 -50.85 0.28 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 116.621 -1.656 . . . . 0.57 108.429 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -42.73 -48.29 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.95 1.7 . . . . 0.66 112.994 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -49.52 62.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.953 0.901 . . . . 0.66 109.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.39 -40.83 82.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 118.23 -0.89 . . . . 0.57 108.95 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -40.25 97.04 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.989 1.315 . . . . 0.57 109.281 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.66 -55.55 29.89 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.235 -1.146 . . . . 0.57 110.235 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -62.3 -47.84 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.32 1.06 . . . . 0.57 112.481 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.25 -11.86 60.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.749 1.22 . . . . 0.57 111.92 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -80.46 -51.81 8.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.279 0.945 . . . . 0.57 108.666 164.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.42 -51.44 68.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.977 . . . . 0.57 112.301 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -106.29 27.81 8.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.153 0.981 . . . . 0.57 109.634 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 -68.73 1.43 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.37 -0.692 . . . . 0.57 111.37 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -137.84 -67.65 0.48 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.345 1.058 . . . . 0.57 109.168 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -176.08 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.092 1.145 . . . . 1.2 114.092 -175.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -173.81 146.03 1.21 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.946 2.099 . . . . 0.57 105.608 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -171.03 86.34 0.1 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.841 1.656 . . . . 0.57 108.561 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -162.43 174.85 12.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.925 1.69 . . . . 0.57 107.491 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.33 142.15 25.71 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.201 -1.407 . . . . 1.2 107.201 171.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.52 -178.28 0.12 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.026 1.331 . . . . 0.57 112.249 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 126.522 1.929 . . . . 0.5 . -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.476 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.015 0.436 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -68.75 -57.09 6.12 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.239 0.616 . . . . 0.57 111.685 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 tp -174.89 108.64 0.11 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.363 2.265 . . . . 0.57 106.029 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 49.91 80.76 0.28 Allowed Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.378 1.471 . . . . 0.57 114.473 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.13 102.54 0.67 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.985 2.456 . . . . 0.57 110.901 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.26 -49.84 31.82 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.415 0.524 . . . . 0.57 112.415 -171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 t -174.41 66.07 0.28 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 127.55 2.34 . . . . 0.57 108.379 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.75 141.83 50.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.629 2.219 . . . . 0.57 110.649 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.6 102.93 0.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.16 1.384 . . . . 0.57 108.958 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.8 m95 -51.2 148.15 4.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.476 0.711 . . . . 0.57 110.866 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -59.24 -33.14 70.65 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.982 0.913 . . . . 0.57 112.344 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 t -82.66 146.42 29.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.552 0.691 . . . . 0.57 109.326 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -19.01 61.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.387 0.675 . . . . 0.57 111.528 170.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 136.52 52.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.006 -1.109 . . . . 0.57 108.006 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.62 157.74 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.399 1.88 . . . . 0.57 108.417 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.7 p -113.18 138.4 50.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.071 -1.085 . . . . 0.57 108.071 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -126.06 153.56 44.28 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.756 0.423 . . . . 0.57 110.199 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -154.26 119.55 5.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.28 89.03 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 105.542 -2.021 . . . . 0.57 105.542 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -47.88 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.689 1.196 . . . . 0.57 112.428 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.49 145.37 41.99 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.522 -2.029 . . . . 0.57 105.522 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.42 143.55 51.14 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.371 1.069 . . . . 0.57 109.031 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -69.84 -172.64 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.696 1.599 . . . . 0.57 110.542 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -136.73 -29.37 0.94 Allowed 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.479 0.918 . . . . 1.2 113.479 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -53.96 -36.55 62.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.406 1.082 . . . . 0.66 110.702 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.29 154.57 73.91 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 128.111 2.565 . . . . 0.57 110.252 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 151.44 46.71 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.68 2.253 . . . . 0.57 112.925 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -60.58 -39.44 88.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.502 1.521 . . . . 0.65 113.324 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.2 tt -64.13 -36.38 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 119.202 -0.428 . . . . 0.57 110.597 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -67.55 -39.17 84.99 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 116.87 -1.538 . . . . 0.57 109.972 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.9 -52.98 51.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 120.069 1.304 . . . . 0.57 109.922 172.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -61.54 -39.54 91.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.343 0.52 . . . . 0.66 111.001 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -61.71 -47.1 86.78 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.399 -0.813 . . . . 1.2 112.402 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -38.2 78.52 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 123.959 0.903 . . . . 0.57 110.269 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.49 -44.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.117 -1.068 . . . . 0.57 108.117 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.87 -48.86 74.81 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.823 1.192 . . . . 0.57 110.903 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -40.59 75.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.943 1.247 . . . . 0.57 112.134 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.4 98.6 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.57 111.294 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 49.8 mt -72.4 -31.61 65.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.146 -0.93 . . . . 0.57 111.114 176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.87 -40.86 94.54 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.37 0.986 . . . . 0.57 109.602 169.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -64.09 -33.74 76.45 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.548 -0.72 . . . . 0.57 112.577 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.4 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 5.8 m95 -71.72 -47.3 54.8 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.275 0.943 . . . . 0.57 111.261 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.56 2.17 32.42 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.165 1.364 . . . . 0.57 113.62 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -22.68 61.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.346 -1.091 . . . . 0.57 111.242 172.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.7 -39.75 5.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.516 -0.754 . . . . 0.66 110.397 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 19.2 pt -101.94 135.27 19.73 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 119.427 1.012 . . . . 0.57 110.58 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.73 40.55 0.56 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.314 2.676 . . . . 0.57 112.628 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -101.66 134.49 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.651 1.58 . . . . 0.57 107.63 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -130.16 170.44 14.05 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.512 0.725 . . . . 0.65 109.652 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -137.59 158.37 44.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.843 -0.799 . . . . 0.57 108.843 -168.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -146.93 157.83 43.75 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.61 1.164 . . . . 1.2 110.36 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.3 105.81 14.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.192 0.997 . . . . 0.57 108.452 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.08 157.34 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.767 -1.106 . . . . 0.57 109.729 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 m -92.87 31.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.249 1.02 . . . . 0.57 110.913 -174.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.02 155.59 45.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.57 109.747 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.96 34.71 2.13 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.999 1.285 . . . . 0.57 114.091 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.1 m -150.65 132.63 15.18 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 106.101 -1.815 . . . . 0.57 106.101 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.61 174.09 13.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.561 1.145 . . . . 0.57 109.047 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 -31.46 66.16 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.863 -0.589 . . . . 0.66 110.391 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 mm -123.25 67.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.328 2.251 . . . . 0.57 107.847 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.87 116.9 10.79 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.615 -1.254 . . . . 0.57 107.615 169.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.59 129.97 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.482 -2.414 . . . . 0.57 104.482 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -152.88 150.45 22.23 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.222 -0.924 . . . . 0.57 111.543 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.18 143.9 51.15 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.27 -0.641 . . . . 0.57 109.27 -171.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.03 166.78 24.03 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 124.74 1.216 . . . . 0.57 109.658 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -94.19 -29.55 15.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.526 0.565 . . . . 1.2 112.526 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.5 -38.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.787 0 O-C-N 121.412 -0.805 . . . . 0.57 112.06 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.1 49.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.141 1.47 . . . . 0.57 108.797 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -156.98 155.18 30.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.347 1.059 . . . . 0.65 109.182 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.28 57.63 2.82 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.99 1.757 . . . . 0.57 112.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.24 -82.43 0.62 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.56 1.544 . . . . 0.66 109.079 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.76 -29.35 0.01 OUTLIER 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.506 1.122 . . . . 0.57 110.527 -171.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.46 120.92 11.67 Favored Pre-proline 0 C--N 1.343 0.305 0 N-CA-C 107.929 -1.137 . . . . 0.57 107.929 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.6 144.22 77.92 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.894 -1.233 . . . . 0.57 108.894 169.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.68 -171.11 0.09 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.393 1.477 . . . . 0.57 111.077 166.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -118.77 -33.21 4.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.693 2.797 . . . . 0.66 110.32 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.22 -150.91 19.66 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.556 1.071 . . . . 0.57 111.146 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.96 102.45 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 125.008 3.805 . . . . 0.57 111.968 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' H ' ' CD ' ' A' ' 102' ' ' GLU . . . 119.6 165.38 12.99 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.244 1.878 . . . . 0.57 109.329 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 t30 58.45 -156.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.734 1.214 . . . . 0.57 111.752 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 m -39.66 116.56 0.64 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.927 2.491 . . . . 0.57 113.337 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.07 -33.16 29.97 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.143 -1.598 . . . . 0.57 112.676 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.99 166.62 29.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.319 1.048 . . . . 0.57 109.438 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -144.47 163.31 34.21 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.992 0.517 . . . . 0.65 110.058 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.69 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.642 0.777 . . . . 0.57 109.804 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.93 152.12 32.88 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.732 -0.667 . . . . 0.57 109.33 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.36 151.61 90.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.657 -0.687 . . . . 0.57 109.761 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.2 Cg_endo -69.06 162.63 40.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.183 1.922 . . . . 0.57 111.452 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.42 -109.52 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.824 -2.111 . . . . 0.57 107.824 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -152.27 118.75 5.64 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.635 -1.617 . . . . 0.57 106.635 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 -131.74 10.76 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.4 -1.08 . . . . 0.57 110.4 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 tp -51.22 -28.25 11.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.126 1.37 . . . . 0.57 112.711 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.79 145.17 8.76 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.106 -0.996 . . . . 0.57 111.614 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.83 -24.27 3.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.032 1.301 . . . . 0.57 113.719 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.87 155.94 39.81 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.473 1.137 . . . . 0.66 108.45 -172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.09 140.74 34.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.934 -0.765 . . . . 0.57 108.934 -173.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 29.5 m170 -128.28 153.13 47.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.604 -0.725 . . . . 0.65 109.568 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.05 153.76 44.45 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.651 -1.24 . . . . 0.57 107.651 -173.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -92.37 100.64 13.17 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.608 -0.724 . . . . 0.66 109.31 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -21.89 66.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.138 0.975 . . . . 0.66 112.151 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.16 -23.49 63.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.38 0.991 . . . . 0.66 110.153 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 79' ' ' GLY . 2.9 mt-10 -80.93 130.13 34.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.654 -1.239 . . . . 0.66 107.654 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 147.6 4.35 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.335 1.054 . . . . 1.2 111.006 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -140.95 147.2 38.42 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.298 -1.001 . . . . 0.57 108.298 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -148.82 139.5 22.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.782 -0.821 . . . . 0.57 108.782 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.15 13.68 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.831 1.196 . . . . 0.66 111.553 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.03 -87.48 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 108.091 -2.004 . . . . 0.57 108.091 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.08 -67.12 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.301 2.24 . . . . 0.57 113.608 -176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -175.43 -48.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.855 1.662 . . . . 0.57 110.778 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -142.18 158.2 44.01 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.554 1.541 . . . . 0.57 108.993 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.53 178.66 15.86 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.299 1.428 . . . . 0.57 109.787 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.1 mm -80.45 102.89 6.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.241 -1.022 . . . . 0.57 108.241 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -50.97 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.925 1.69 . . . . 0.57 110.655 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -65.61 -29.18 69.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.985 1.714 . . . . 0.57 110.389 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -48.27 68.8 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.684 -1.598 . . . . 0.57 106.684 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.17 -47.49 84.27 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.483 0.713 . . . . 0.57 110.721 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.38 -49.45 76.15 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 122.745 0.418 . . . . 0.57 110.933 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.99 63.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 109.085 -0.709 . . . . 0.57 109.085 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -55.7 -39.28 70.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.022 0.828 . . . . 0.57 111.344 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -60.76 -59.88 4.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.324 0.65 . . . . 0.65 110.209 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.49 -42.37 95.9 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.177 0.898 . . . . 0.66 111.692 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.92 -26.96 67.11 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.136 1.375 . . . . 0.57 111.293 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.4 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.31 -41.88 93.27 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.29 -0.724 . . . . 0.57 111.29 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -73.01 -37.78 66.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.459 -1.258 . . . . 0.65 112.259 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 p -59.06 -31.58 69.0 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 124.101 0.875 . . . . 0.57 111.851 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -68.15 -39.89 82.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.328 0.651 . . . . 0.57 111.752 176.296 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 160.51 43.08 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.06 -0.856 . . . . 0.57 114.488 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 176.63 0.1 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 117.883 0.842 . . . . 0.57 111.925 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.09 46.12 0.01 OUTLIER Glycine 0 C--N 1.342 0.912 0 O-C-N 120.943 -1.098 . . . . 0.57 112.903 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.8 169.7 13.93 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.361 1.081 . . . . 0.65 110.4 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.6 t -161.65 -164.19 1.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.013 0.925 . . . . 0.57 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.07 57.26 0.59 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.897 1.279 . . . . 0.57 110.517 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -120.73 146.4 43.43 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.66 109.463 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -21.63 63.59 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.839 2.359 . . . . 0.57 113.056 -171.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -125.14 27.45 6.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.444 1.897 . . . . 0.57 109.602 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.89 124.61 24.18 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.145 -0.972 . . . . 0.57 108.916 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.05 -22.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 121.528 0.68 . . . . 0.57 110.461 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 19.08 18.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.098 1.759 . . . . 0.57 112.233 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.514 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.44 141.42 94.48 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.17 1.35 . . . . 0.57 111.288 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 70.8 Cg_endo -75.63 46.02 1.58 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 124.212 3.275 . . . . 0.57 113.007 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.29 153.14 7.71 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.77 2.428 . . . . 0.57 106.476 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -47.96 137.59 9.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.023 1.329 . . . . 0.57 111.265 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -47.14 99.75 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.705 1.621 . . . . 0.57 113.542 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.23 -37.41 77.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.063 1.345 . . . . 0.57 112.221 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.98 -85.87 0.95 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.27 0.938 . . . . 0.57 110.936 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.69 109.36 2.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.711 -0.848 . . . . 0.66 108.711 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.96 -16.4 18.18 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.807 2.338 . . . . 0.57 113.534 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -38.86 62.74 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.962 1.305 . . . . 0.57 109.125 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -77.57 74.08 4.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.79 0.836 . . . . 0.57 110.905 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -43.7 -70.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.791 1.637 . . . . 0.57 114.554 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 25.64 74.53 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.512 3.125 . . . . 0.57 112.071 177.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -30.93 111.78 0.08 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.529 2.331 . . . . 0.57 110.777 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 t -83.87 -99.71 0.05 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.181 0.301 . . . . 0.57 111.074 -166.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -127.75 -49.93 1.37 Allowed 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 117.216 -1.373 . . . . 0.57 109.443 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -44.07 -45.11 7.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.014 1.326 . . . . 0.66 112.116 169.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -66.43 -54.8 20.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 123.728 0.642 . . . . 0.66 109.995 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -37.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.418 0.687 . . . . 0.57 110.727 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -65.95 -45.41 81.89 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.664 1.586 . . . . 0.57 108.504 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.93 -51.02 61.21 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.204 -1.158 . . . . 0.57 110.204 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -56.46 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.488 1.115 . . . . 0.57 111.136 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.404 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 3.9 pt20 -62.74 -24.46 67.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.112 0.869 . . . . 0.57 111.517 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -37.02 36.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.25 -0.881 . . . . 0.57 110.889 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -54.7 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.661 1.585 . . . . 0.57 110.942 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.407 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 19.3 p90 -98.29 5.85 47.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.854 0.862 . . . . 0.57 113.159 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -113.19 -145.37 9.32 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.532 1.063 . . . . 0.57 111.083 -172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -137.99 -62.32 0.59 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.41 0.684 . . . . 0.57 112.306 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.47 153.68 19.82 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.841 1.657 . . . . 1.2 107.902 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.78 129.7 0.15 Allowed 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.827 -1.916 . . . . 0.57 105.827 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.65 165.4 0.08 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.286 1.835 . . . . 0.57 113.511 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.8 t -169.67 107.61 0.39 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.211 1.404 . . . . 0.57 107.519 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 155.66 30.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.101 0.96 . . . . 1.2 108.884 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.78 56.76 0.09 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.271 1.028 . . . . 0.57 112.141 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tttt . . . . . 0 C--N 1.338 0.072 0 C-N-CA 123.948 0.899 . . . . 0.5 . -177.649 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.374 0 CA-C-O 118.647 -0.692 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -30.82 52.06 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.726 1.21 . . . . 0.57 113.818 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 tt -144.55 -78.19 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.036 -1.468 . . . . 0.57 107.036 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.15 -53.36 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.52 1.928 . . . . 0.57 111.318 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -77.51 49.72 2.98 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.227 3.285 . . . . 0.57 111.963 -175.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -148.11 149.43 32.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.643 1.577 . . . . 0.57 106.816 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -117.85 80.13 14.07 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 107.99 -1.115 . . . . 0.57 107.99 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.65 152.12 79.78 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.365 2.043 . . . . 0.57 111.021 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt 72.03 100.8 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.242 1.417 . . . . 0.57 109.715 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -53.08 157.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.045 0.938 . . . . 0.57 111.755 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.3 p -67.58 -19.54 65.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.875 1.27 . . . . 0.57 112.083 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -109.67 144.53 37.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.68 1.992 . . . . 0.57 108.75 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -12.39 61.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.304 1.442 . . . . 0.57 113.167 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.75 134.1 67.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.799 -1.926 . . . . 0.57 105.799 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.48 155.15 19.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.23 1.412 . . . . 0.57 108.621 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 p -106.54 141.22 38.18 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.912 -0.493 . . . . 0.57 109.774 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -132.75 158.24 42.91 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.596 -0.69 . . . . 0.57 111.0 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.42 163.15 40.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.687 0.795 . . . . 1.2 109.149 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.9 mt -127.93 105.08 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.199 -2.149 . . . . 0.57 105.199 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.85 -57.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.106 . . . . 0.57 112.385 -169.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -177.14 4.76 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.195 -1.409 . . . . 0.57 107.195 164.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -144.58 152.03 39.93 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.314 -0.995 . . . . 0.57 108.314 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -62.37 165.35 6.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.314 0.578 . . . . 0.57 110.938 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -100.25 -47.09 5.07 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.841 -0.618 . . . . 1.2 112.053 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.78 -32.61 73.81 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.031 0.532 . . . . 0.66 110.387 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.96 153.71 52.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.96 1.704 . . . . 0.57 109.652 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.57 161.29 37.3 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.145 1.897 . . . . 0.57 113.182 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.33 -40.6 94.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.659 1.184 . . . . 0.65 112.89 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.98 -35.95 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 119.181 -0.438 . . . . 0.57 111.155 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m -67.36 -45.65 75.69 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 117.688 -1.149 . . . . 0.57 109.264 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.25 -49.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 117.646 -1.169 . . . . 0.57 110.699 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.16 -35.93 82.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.1 1.318 . . . . 0.66 111.364 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -43.4 89.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.289 1.404 . . . . 1.2 112.524 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.95 -48.34 76.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.592 -0.892 . . . . 0.57 108.592 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.0 -41.63 89.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.719 -1.134 . . . . 0.57 111.021 173.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -58.48 -53.11 62.02 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.548 1.522 . . . . 0.57 110.056 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -36.06 78.52 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.679 1.127 . . . . 0.57 111.054 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.64 76.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.557 1.071 . . . . 0.57 111.76 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.38 -36.17 83.18 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 118.213 -0.898 . . . . 0.57 110.163 172.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -49.05 76.82 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 118.899 0.772 . . . . 0.57 109.153 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.442 ' HB3' HD11 ' A' ' 152' ' ' LEU . 50.4 mtp -61.73 -35.91 79.44 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.544 0.738 . . . . 0.57 111.498 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 10.5 m95 -68.61 -50.59 50.34 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.57 112.369 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.25 -8.09 69.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.885 1.231 . . . . 0.57 112.99 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -75.17 -8.31 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.214 -1.168 . . . . 0.57 111.765 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB3' HG21 ' A' ' 160' ' ' ILE . 55.4 mm-40 -109.54 -15.32 14.22 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.842 0.746 . . . . 0.66 112.259 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 160' ' ' ILE . 6.6 pt -142.58 148.75 48.03 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.52 1.128 . . . . 0.57 111.019 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.89 18.69 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.714 2.943 . . . . 0.57 113.286 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.91 138.22 35.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.16 1.784 . . . . 0.57 107.314 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.95 170.31 11.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.766 0.826 . . . . 0.65 109.217 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.35 150.85 45.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.271 -1.381 . . . . 0.57 107.271 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.85 149.42 46.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.866 -0.79 . . . . 1.2 108.866 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -107.24 129.26 54.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.031 -1.47 . . . . 0.57 107.031 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.43 171.84 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.533 1.133 . . . . 0.57 109.823 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.45 -38.77 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.769 0.828 . . . . 0.57 110.651 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -167.25 74.63 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.888 1.675 . . . . 0.57 107.694 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.35 163.06 36.84 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.511 -1.836 . . . . 0.57 108.511 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -68.63 144.98 54.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 117.987 0.893 . . . . 0.57 109.275 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.24 153.17 37.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.1 0.96 . . . . 0.57 108.96 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.64 -32.97 72.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.772 0.429 . . . . 0.66 110.069 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 125' ' ' SER . 7.3 mt -121.01 80.97 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 127.513 2.325 . . . . 0.57 107.871 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 ttm -78.02 111.85 14.33 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.805 1.242 . . . . 0.57 107.956 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 127.66 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.052 -1.832 . . . . 0.57 106.052 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.62 162.85 25.52 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.226 -0.75 . . . . 0.57 111.226 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -126.95 141.42 51.81 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.29 -1.744 . . . . 0.57 106.29 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.18 169.17 18.71 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.098 2.159 . . . . 0.57 106.8 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -111.02 -0.95 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.715 0.689 . . . . 1.2 112.652 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.32 -144.58 8.29 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.53 -1.828 . . . . 0.57 108.53 -165.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.49 142.64 13.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.746 0.784 . . . . 0.57 111.398 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -152.05 152.49 32.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.094 1.758 . . . . 0.65 106.562 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.35 80.48 1.82 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 110.155 -1.178 . . . . 0.57 110.155 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.6 -56.52 1.49 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.794 0.837 . . . . 0.66 111.343 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.95 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.959 2.503 . . . . 0.57 109.854 -167.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -147.57 123.1 5.28 Favored Pre-proline 0 C--N 1.349 0.545 0 CA-C-N 120.122 1.328 . . . . 0.57 110.437 -173.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.75 139.32 52.04 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.188 1.259 . . . . 0.57 110.367 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.83 -175.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.365 1.555 . . . . 0.57 111.161 167.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -115.12 -36.02 4.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 131.116 3.767 . . . . 0.66 109.75 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.11 -147.9 18.81 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 119.659 1.118 . . . . 0.57 110.841 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.65 70.3 6.45 Favored 'Trans proline' 0 CA--C 1.548 1.198 1 C-N-CA 125.645 4.23 . . . . 0.57 114.114 -171.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.41 167.07 20.43 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.409 2.909 . . . . 0.57 109.625 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.279 19.6 t30 64.81 -143.97 0.24 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.304 1.842 . . . . 0.57 113.503 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 m -47.03 153.23 0.45 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 127.767 2.427 . . . . 0.57 111.22 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.88 -27.47 6.18 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 118.572 -2.58 . . . . 0.57 112.759 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.61 158.48 26.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.01 1.324 . . . . 0.57 107.644 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -139.38 159.17 42.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.478 . . . . 0.65 109.711 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.87 36.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.741 1.216 . . . . 0.57 109.078 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.57 146.83 41.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.348 0.659 . . . . 0.57 109.495 -177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.84 157.89 64.84 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.795 0.838 . . . . 0.57 111.031 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.41 155.45 69.12 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.272 . . . . 0.57 112.188 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.07 -111.67 0.59 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.388 0.994 . . . . 0.57 110.891 174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.7 m -45.76 156.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.854 2.062 . . . . 0.57 111.542 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.93 -41.97 7.68 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.174 -1.348 . . . . 0.57 115.412 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -33.55 74.39 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.075 1.438 . . . . 0.57 112.247 174.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.26 145.5 12.21 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.873 -1.142 . . . . 0.57 111.498 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.86 -18.93 5.53 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 117.847 -1.529 . . . . 0.57 114.426 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.78 156.24 36.76 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.348 1.574 . . . . 0.66 108.045 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.06 146.05 27.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.787 -0.642 . . . . 0.57 109.818 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -129.81 152.28 49.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.575 -0.898 . . . . 0.65 108.575 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -137.91 145.37 42.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.16 1.384 . . . . 0.57 107.38 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -87.07 98.63 11.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.425 0.631 . . . . 0.66 109.608 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -60.84 -25.61 66.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.07 1.348 . . . . 0.66 111.85 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.39 -38.85 81.71 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.92 0.391 . . . . 0.66 110.406 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.16 126.7 29.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.771 -1.566 . . . . 0.66 106.771 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -59.01 147.16 35.61 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.702 -0.624 . . . . 1.2 109.473 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -124.03 158.21 32.68 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.359 -0.978 . . . . 0.57 108.359 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.2 t -133.54 142.34 48.14 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.635 0.652 . . . . 0.57 109.681 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.05 -46.89 72.99 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.046 1.339 . . . . 0.66 109.275 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.96 50.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.858 -0.897 . . . . 0.57 110.858 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -152.84 150.34 29.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.965 0.906 . . . . 0.57 109.854 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.17 108.37 0.78 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.615 0.766 . . . . 0.57 109.814 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -61.69 0.05 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.726 0.81 . . . . 0.57 110.213 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.98 -111.75 1.19 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.714 -1.354 . . . . 0.57 109.714 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.565 HG22 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -129.95 134.39 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 123.653 0.781 . . . . 0.57 110.271 -178.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.85 115.77 5.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.777 -1.102 . . . . 0.57 109.697 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.67 -37.32 83.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.047 -0.501 . . . . 0.57 110.895 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 -45.35 89.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.129 0.877 . . . . 0.57 109.673 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -64.03 -42.56 97.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.384 0.674 . . . . 0.57 110.791 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.86 67.99 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.215 0.606 . . . . 0.57 110.516 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.43 64.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.063 -0.97 . . . . 0.57 110.053 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.1 m -53.78 -41.74 67.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.512 1.051 . . . . 0.57 111.46 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -61.48 -56.36 21.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.819 0.448 . . . . 0.65 110.023 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.43 -48.08 74.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.734 0.814 . . . . 0.66 110.963 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.74 -30.77 70.99 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 125.312 1.445 . . . . 0.57 110.968 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.402 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.68 -46.81 73.66 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.913 -0.875 . . . . 0.57 110.913 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -66.27 -39.33 89.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.752 -0.642 . . . . 0.65 111.646 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.403 ' HB3' HG12 ' A' ' 60' ' ' ILE . 4.4 m -57.78 -37.37 73.59 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.524 0.565 . . . . 0.57 112.524 176.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.37 -27.22 68.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.737 1.153 . . . . 0.57 112.638 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.98 -13.97 2.37 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 118.529 -1.15 . . . . 0.57 114.285 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpp -61.79 152.25 31.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.168 1.484 . . . . 0.57 110.295 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.56 -23.6 3.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 115.58 -2.789 . . . . 0.57 114.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 m80 148.99 173.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 131.185 3.794 . . . . 0.65 110.151 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -145.33 -172.77 3.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.484 2.313 . . . . 0.57 109.607 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -147.12 67.33 1.15 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.43 1.492 . . . . 0.57 110.761 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 9.7 t70 -133.5 149.98 73.74 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 117.306 -1.33 . . . . 0.66 107.604 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.86 -35.96 42.01 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.927 1.752 . . . . 0.57 111.091 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -119.01 35.23 4.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.754 1.222 . . . . 0.57 108.394 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -63.62 131.98 49.71 Favored 'General case' 0 C--N 1.344 0.363 0 N-CA-C 108.156 -1.053 . . . . 0.57 108.156 171.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' A' ' 156' ' ' ASP . 8.5 p -58.7 -30.33 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.592 0.234 . . . . 0.57 110.986 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.683 ' SD ' HG13 ' A' ' 137' ' ' VAL . 4.2 mpp? -105.58 35.19 2.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.044 1.337 . . . . 0.57 110.075 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -74.46 130.3 82.26 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 120.433 -1.417 . . . . 0.57 110.875 173.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.42 ' HA ' ' H33' ' A' ' 178' ' ' MDW . 48.7 Cg_endo -71.34 168.64 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.962 1.775 . . . . 0.57 111.056 166.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m 58.03 72.93 0.49 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.113 0.965 . . . . 0.57 110.792 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.565 ' CE2' HG22 ' A' ' 112' ' ' ILE . 63.1 t80 -45.61 126.08 6.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.043 1.337 . . . . 0.57 113.175 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.01 96.43 0.89 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.095 0.855 . . . . 0.57 111.201 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -157.42 -49.88 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.022 0.911 . . . . 0.57 111.03 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.88 -171.33 13.05 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 125.595 1.569 . . . . 0.57 109.575 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.02 116.54 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 119.092 -0.48 . . . . 0.66 110.053 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.08 -18.03 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.853 2.369 . . . . 0.57 112.671 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.24 -36.63 83.52 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.002 0.819 . . . . 0.57 109.936 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.15 68.87 1.23 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.342 0.657 . . . . 0.57 109.507 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -60.04 -52.69 64.29 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.488 0.715 . . . . 0.57 110.323 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.94 158.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.991 2.517 . . . . 0.57 112.567 -159.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 41' ' ' MET . 5.4 mp -58.95 121.49 11.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.593 -1.262 . . . . 0.57 107.593 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -96.83 -94.25 0.21 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.787 1.235 . . . . 0.57 110.545 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -138.24 -46.44 0.51 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.08 -0.962 . . . . 0.57 110.273 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.38 -34.09 66.35 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.75 0.705 . . . . 0.66 111.02 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.71 ' CG ' HG11 ' A' ' 137' ' ' VAL . 0.7 OUTLIER -63.15 -60.18 3.77 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.571 1.148 . . . . 0.66 110.305 176.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.84 -50.47 80.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.57 107.756 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -59.3 -41.69 89.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.394 1.077 . . . . 0.57 111.476 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.69 50.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.456 -1.457 . . . . 0.57 109.456 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.459 HG21 ' HB3' ' A' ' 45' ' ' GLU . 1.7 mm -53.91 -52.99 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.259 1.023 . . . . 0.57 110.482 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -58.5 -28.63 65.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.086 -0.709 . . . . 0.57 109.086 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -80.64 -38.9 28.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 117.921 -1.038 . . . . 0.57 112.428 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.62 -52.06 61.08 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.322 1.419 . . . . 0.57 112.174 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -90.84 3.83 53.42 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.487 0.585 . . . . 0.57 112.38 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.0 155.85 0.7 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.931 1.253 . . . . 0.57 111.639 -169.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -129.86 -69.55 0.67 Allowed 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.41 -1.053 . . . . 0.57 109.737 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -155.57 -54.22 0.09 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.713 1.205 . . . . 1.2 109.315 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.01 158.99 38.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.107 0.963 . . . . 0.57 109.414 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.09 172.32 4.71 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.533 -1.212 . . . . 0.57 110.01 173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -55.93 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.675 -1.602 . . . . 0.57 106.675 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.4 -179.01 0.08 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 1.2 110.414 -170.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.9 tptp 68.11 149.15 0.06 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.99 2.116 . . . . 0.57 112.566 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.557 1.543 . . . . 0.5 . 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.42 ' H33' ' HA ' ' A' ' 140' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.981 0.419 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -60.12 72.63 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.951 2.5 . . . . 0.57 111.082 168.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -118.25 -71.0 0.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.984 1.714 . . . . 0.57 111.873 177.766 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 46.76 164.42 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.286 2.634 . . . . 0.57 115.62 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -75.61 137.45 20.41 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 O-C-N 117.656 -1.813 . . . . 0.57 109.488 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -176.24 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.532 1.933 . . . . 0.57 111.175 174.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.2 m 57.67 82.0 0.24 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.921 1.288 . . . . 0.57 110.864 -172.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.86 174.98 6.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.183 2.589 . . . . 0.57 110.751 174.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.89 10.88 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.216 2.206 . . . . 0.57 112.432 -173.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 56.5 m95 56.37 -166.01 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.656 1.183 . . . . 0.57 110.584 -169.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -101.53 -10.85 19.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.782 0.833 . . . . 0.57 110.97 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -118.8 149.58 41.26 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.423 1.489 . . . . 0.57 108.705 176.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -71.96 -11.83 60.96 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.448 0.699 . . . . 0.57 112.575 172.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.26 117.25 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.035 -1.839 . . . . 0.57 106.035 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.85 141.23 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.365 -0.976 . . . . 0.57 108.365 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -102.49 147.63 26.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.648 0.658 . . . . 0.57 111.238 -177.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -128.96 157.1 42.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.568 0.747 . . . . 0.57 111.884 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.88 112.13 4.95 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.597 0.713 . . . . 1.2 110.159 174.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 mt -77.68 82.69 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.233 -1.395 . . . . 0.57 107.233 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.05 -28.62 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.129 1.772 . . . . 0.57 113.458 -175.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -139.58 154.42 47.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 128.925 2.89 . . . . 0.57 103.604 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -132.16 174.67 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.703 1.601 . . . . 0.57 108.203 -173.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -90.82 -176.39 4.66 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.921 0.888 . . . . 0.57 111.399 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -129.62 -26.62 2.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.364 1.866 . . . . 1.2 113.651 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -24.0 67.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.725 0.81 . . . . 0.66 110.86 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.83 154.99 71.35 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 127.464 2.306 . . . . 0.57 108.582 177.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -75.58 158.51 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.189 2.592 . . . . 0.57 113.047 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -62.23 -34.6 76.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.953 1.301 . . . . 0.65 112.66 -176.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.46 -37.64 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.004 0.522 . . . . 0.57 110.251 175.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.4 m -67.59 -39.56 84.83 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 117.955 -1.021 . . . . 0.57 109.54 173.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.69 -56.1 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.769 1.168 . . . . 0.57 110.126 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.64 -34.95 78.1 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.631 1.105 . . . . 0.66 111.031 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.25 -48.89 63.87 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.087 0.858 . . . . 1.2 112.066 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -63.97 -43.67 95.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.815 -0.809 . . . . 0.57 108.815 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.3 -44.28 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 117.599 -1.191 . . . . 0.57 110.807 171.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -50.25 73.45 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 120.274 1.397 . . . . 0.57 110.894 178.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -34.86 73.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.167 0.894 . . . . 0.57 112.268 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.98 81.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.745 1.157 . . . . 0.57 111.153 177.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HD12 ' A' ' 122' ' ' LEU . 38.7 mt -67.83 -37.84 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.471 -0.776 . . . . 0.57 110.218 173.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.73 -37.41 84.11 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 119.009 0.822 . . . . 0.57 110.654 172.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 mtp -64.36 -36.93 85.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.077 0.853 . . . . 0.57 112.189 173.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -69.76 -49.36 53.83 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.251 0.932 . . . . 0.57 110.89 172.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.73 -5.1 63.41 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.983 1.278 . . . . 0.57 113.786 178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -67.99 -26.1 65.75 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.095 -1.238 . . . . 0.57 110.888 172.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -100.35 -36.72 9.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.541 0.737 . . . . 0.66 110.855 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 12.9 pt -114.05 136.81 22.21 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 118.569 0.622 . . . . 0.57 110.819 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 34.21 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.676 2.917 . . . . 0.57 111.912 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 126' ' ' LEU . 1.6 tt -85.42 131.95 34.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.311 -1.737 . . . . 0.57 106.311 176.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -116.0 171.08 8.01 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.803 1.241 . . . . 0.65 108.509 -173.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.85 156.1 45.54 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.747 -0.834 . . . . 0.57 108.747 -170.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -142.61 175.92 9.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.91 . . . . 1.2 109.273 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.6 16.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.57 108.23 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.76 158.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 124.671 1.188 . . . . 0.57 109.219 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.44 -41.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.353 0.661 . . . . 0.57 111.256 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -118.57 -66.34 1.08 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.939 0.876 . . . . 0.57 108.891 -172.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.38 -156.57 10.89 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.616 -1.793 . . . . 0.57 108.616 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 80.4 p 60.28 72.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.69 1.596 . . . . 0.57 111.826 173.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.67 172.37 7.16 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.351 1.06 . . . . 0.57 112.012 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -71.55 -39.44 70.65 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.274 -1.01 . . . . 0.66 108.274 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.14 84.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.58 1.952 . . . . 0.57 108.641 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.23 124.58 27.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.458 -1.401 . . . . 0.57 108.417 170.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.55 127.85 66.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 106.269 -1.752 . . . . 0.57 106.269 174.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.09 164.91 27.48 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.833 -0.507 . . . . 0.57 111.833 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.7 m-85 -136.03 150.65 49.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.609 -0.886 . . . . 0.57 108.609 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.29 157.67 44.15 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.754 1.221 . . . . 0.57 110.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -5.28 24.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.498 1.119 . . . . 1.2 113.443 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.47 106.85 0.49 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 108.341 -1.904 . . . . 0.57 108.341 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.12 126.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.062 2.945 . . . . 0.57 112.741 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 163.49 30.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.732 1.213 . . . . 0.65 110.909 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 76.68 0.9 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.269 -1.132 . . . . 0.57 110.269 173.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -135.15 177.58 7.7 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.66 110.157 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -44.47 12.61 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.296 1.038 . . . . 0.57 112.043 168.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -139.24 145.91 46.65 Favored Pre-proline 0 C--N 1.345 0.374 0 C-N-CA 124.026 0.93 . . . . 0.57 109.401 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.47 146.95 76.17 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.235 1.29 . . . . 0.57 110.29 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.78 -178.95 1.04 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.908 1.337 . . . . 0.57 111.428 162.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -117.4 -35.07 4.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 131.181 3.793 . . . . 0.66 109.332 -172.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 -140.9 15.6 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.561 -1.133 . . . . 0.57 110.689 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.96 87.06 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.894 3.73 . . . . 0.57 112.575 -171.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.29 172.56 12.92 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.446 1.974 . . . . 0.57 109.539 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 48.7 -153.5 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 119.432 1.616 . . . . 0.57 111.848 -174.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.3 m -48.64 126.52 11.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.716 2.406 . . . . 0.57 112.908 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.02 -27.4 17.02 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.234 1.414 . . . . 0.57 113.45 -173.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.93 161.83 40.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.702 1.201 . . . . 0.57 108.344 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.96 163.34 37.16 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.029 -0.36 . . . . 0.65 110.029 174.202 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.73 163.19 37.46 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.244 1.018 . . . . 0.57 110.438 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.23 161.84 18.38 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.144 0.978 . . . . 0.57 110.653 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.83 142.83 45.6 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-O 118.224 -0.893 . . . . 0.57 109.383 -176.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.6 Cg_endo -66.31 156.83 63.16 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.528 1.485 . . . . 0.57 110.893 175.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.9 9.18 8.38 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.968 0.794 . . . . 0.57 113.81 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.1 t -160.78 168.49 24.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.823 1.649 . . . . 0.57 107.993 176.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.89 -57.78 16.56 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 125.591 1.567 . . . . 0.57 113.079 -177.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tp -66.09 -17.61 64.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.395 1.078 . . . . 0.57 110.997 173.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.0 147.79 33.5 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 120.776 -1.202 . . . . 0.57 110.793 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.32 -21.31 0.54 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.571 1.558 . . . . 0.57 115.119 -176.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.07 153.6 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.776 1.288 . . . . 0.66 108.156 -175.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.09 144.87 29.38 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.57 109.083 -171.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -131.84 159.23 39.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.371 -0.831 . . . . 0.65 109.304 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 52.2 m-85 -137.65 147.19 44.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.821 1.648 . . . . 0.57 109.002 -171.236 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.29 105.46 12.49 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.916 -0.772 . . . . 0.66 108.916 171.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.19 -27.66 64.07 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.468 1.107 . . . . 0.66 111.069 171.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.62 -33.94 75.98 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.827 0.851 . . . . 0.66 111.282 -178.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.84 120.55 20.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.767 -1.568 . . . . 0.66 106.767 178.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 131.42 48.41 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.362 0.528 . . . . 1.2 110.699 -174.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.78 150.54 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.082 -1.081 . . . . 0.57 108.082 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -145.06 145.72 31.57 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.92 -0.77 . . . . 0.57 108.92 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.21 -39.73 93.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.164 0.986 . . . . 0.66 112.052 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.05 173.42 27.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.934 1.254 . . . . 0.57 110.034 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.13 30.29 5.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.681 1.192 . . . . 0.57 114.174 176.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.04 168.63 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.828 1.651 . . . . 0.57 109.315 -174.44 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.09 167.27 10.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.005 1.322 . . . . 0.57 111.706 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.81 -160.97 22.64 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.434 -1.466 . . . . 0.57 109.434 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.71 122.84 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.889 -1.152 . . . . 0.57 107.889 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -55.53 105.23 0.16 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.184 1.394 . . . . 0.57 109.999 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.75 -36.41 76.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.628 1.971 . . . . 0.57 110.989 178.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.2 tp -71.12 -40.74 71.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.312 0.505 . . . . 0.57 109.931 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.09 -44.31 96.93 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.473 0.709 . . . . 0.57 109.375 173.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.23 -54.71 42.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.57 110.043 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.75 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 117.891 -1.052 . . . . 0.57 109.184 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.8 m -53.64 -43.99 69.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.116 1.325 . . . . 0.57 111.452 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -64.32 -55.17 23.08 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.844 1.202 . . . . 0.65 110.62 176.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.2 -39.66 86.38 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.412 -0.805 . . . . 0.66 111.474 -172.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.65 -30.71 71.73 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.462 0.705 . . . . 0.57 110.628 176.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.71 -43.96 60.17 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 119.194 0.906 . . . . 0.57 111.411 170.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -74.86 -33.53 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.734 -0.65 . . . . 0.65 112.452 176.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -33.58 75.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.837 0.744 . . . . 0.57 111.428 174.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 48' ' ' LEU . 1.6 mm? -66.13 -29.55 69.88 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.325 0.65 . . . . 0.57 112.053 175.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 153.09 56.07 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.292 -1.282 . . . . 0.57 113.202 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 mmt 48.99 -156.14 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.936 0.868 . . . . 0.57 111.475 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.82 81.11 1.22 Allowed Glycine 0 C--O 1.219 -0.842 0 N-CA-C 108.703 -1.759 . . . . 0.57 108.703 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.31 172.09 8.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.833 0.817 . . . . 0.65 109.847 172.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.99 -177.3 6.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.853 2.061 . . . . 0.57 107.946 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 99.24 3.04 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.188 -2.153 . . . . 0.57 105.188 173.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.9 141.37 17.31 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 107.861 -1.163 . . . . 0.66 107.861 170.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.59 -4.5 14.72 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.935 2.423 . . . . 0.57 113.73 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.31 13.7 7.7 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.121 1.768 . . . . 0.57 111.23 -174.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.82 40.73 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.327 1.851 . . . . 0.57 109.866 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.98 -28.95 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.969 0.804 . . . . 0.57 110.313 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 35.1 tpp -74.46 -11.37 60.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.404 1.082 . . . . 0.57 113.33 -174.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.35 136.29 41.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.461 -0.57 . . . . 0.57 109.461 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 -169.28 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.973 1.782 . . . . 0.57 109.432 168.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.0 p 50.22 79.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.209 1.404 . . . . 0.57 114.224 172.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.493 ' CE1' ' H47' ' A' ' 178' ' ' MDW . 7.5 t80 -56.18 93.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.525 1.53 . . . . 0.57 113.832 -174.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.4 109.96 0.43 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.841 1.686 . . . . 0.57 109.59 -177.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -170.14 -50.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.885 1.674 . . . . 0.57 108.582 169.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.52 -122.57 3.16 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.084 -1.606 . . . . 0.57 109.084 -177.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -147.01 124.1 5.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.65 -0.871 . . . . 0.66 108.65 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -80.53 -8.17 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.948 3.098 . . . . 0.57 114.166 177.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -67.15 -27.36 67.23 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.578 -1.326 . . . . 0.57 110.738 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.83 80.47 1.38 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.11 1.364 . . . . 0.57 111.199 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.47 148.0 38.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.578 1.551 . . . . 0.57 109.629 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.2 47.54 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.47 1.108 . . . . 0.57 111.213 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 61.85 79.27 0.26 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.968 1.307 . . . . 0.57 111.581 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -64.46 -86.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.206 1.187 . . . . 0.57 114.206 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -138.42 -46.04 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.57 110.058 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -45.81 64.28 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.265 1.026 . . . . 0.66 110.654 172.131 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -53.71 55.05 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.708 0.63 . . . . 0.66 109.955 177.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.12 -45.98 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.22 1.008 . . . . 0.57 110.071 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -47.53 76.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.908 1.283 . . . . 0.57 109.459 -178.029 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.71 97.19 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.924 -1.27 . . . . 0.57 109.924 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -51.18 74.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.53 1.165 . . . . 0.57 110.282 175.212 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.78 -37.81 77.12 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.902 0.481 . . . . 0.57 110.204 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -39.01 73.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.101 -0.952 . . . . 0.57 111.916 175.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -58.92 5.46 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.731 2.012 . . . . 0.57 109.999 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.4 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.9 p90 -86.71 -16.77 35.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.264 -0.574 . . . . 0.57 111.779 -176.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -85.02 -31.98 21.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.863 1.221 . . . . 0.57 112.905 -175.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -70.66 0.08 Allowed 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.063 1.432 . . . . 0.57 112.288 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.96 157.25 4.37 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.891 1.677 . . . . 1.2 109.87 -176.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 4.5 p -163.08 120.52 1.93 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.248 -1.76 . . . . 0.57 106.248 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -177.64 161.46 1.68 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.343 1.857 . . . . 0.57 110.496 173.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.3 p -152.51 72.03 0.96 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.465 0.65 . . . . 0.57 112.169 175.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -73.87 74.54 1.62 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.311 -0.868 . . . . 1.2 111.981 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -147.51 67.73 1.13 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.028 1.331 . . . . 0.57 110.09 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.342 0.254 0 C-N-CA 128.809 2.844 . . . . 0.5 . 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.493 ' H47' ' CE1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.202 0 CA-C-O 119.41 -0.328 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -164.86 -48.4 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.046 -1.835 . . . . 0.57 106.046 -179.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -138.94 -52.09 0.56 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 117.599 -1.191 . . . . 0.57 112.17 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 173.84 -52.4 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.413 1.885 . . . . 0.57 112.046 -177.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.26 175.14 7.57 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.047 3.164 . . . . 0.57 111.77 178.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -144.07 49.14 1.37 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.812 1.245 . . . . 0.57 109.758 -173.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -157.44 66.74 3.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.076 1.35 . . . . 0.57 108.364 174.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.32 175.68 10.25 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 120.668 0.912 . . . . 0.57 110.97 172.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt 80.7 115.69 0.06 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.022 2.129 . . . . 0.57 108.296 -177.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 79.7 m95 -58.54 163.53 3.12 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.243 1.021 . . . . 0.57 111.939 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -69.31 -31.95 70.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.565 0.746 . . . . 0.57 111.521 -174.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 t -123.65 150.49 44.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.39 2.276 . . . . 0.57 107.264 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -71.97 3.02 4.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.283 -0.865 . . . . 0.57 112.142 171.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -121.86 108.24 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.984 -1.488 . . . . 0.57 106.984 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.71 143.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 107.964 -1.125 . . . . 0.57 107.964 -172.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.1 p -97.32 152.6 18.74 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.644 -0.66 . . . . 0.57 110.455 -176.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -131.21 157.83 42.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.948 -1.095 . . . . 0.57 110.681 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 14.9 ptt180 -144.73 119.11 9.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.425 0.69 . . . . 1.2 109.491 174.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.12 86.13 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 105.165 -2.161 . . . . 0.57 105.165 176.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.07 -38.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.539 1.935 . . . . 0.57 110.728 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -152.61 164.3 37.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.309 -2.108 . . . . 0.57 105.309 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -132.1 169.09 16.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.812 1.645 . . . . 0.57 106.82 -172.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.1 t -72.0 -168.07 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.57 111.203 171.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -43.51 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 1.2 113.463 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -60.78 -41.78 96.23 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.033 -0.729 . . . . 0.66 109.033 -177.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.4 150.32 38.81 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 124.055 0.942 . . . . 0.57 111.26 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -75.14 158.11 41.82 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.561 2.174 . . . . 0.57 112.444 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 30.9 m-70 -61.71 -38.62 88.53 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.59 1.156 . . . . 0.65 112.536 -176.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.33 -40.96 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.77 -0.456 . . . . 0.57 109.77 174.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -68.68 -38.9 80.71 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.237 -1.364 . . . . 0.57 109.371 176.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.11 -53.55 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.875 1.671 . . . . 0.57 110.053 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.0 -41.24 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.823 0.738 . . . . 0.66 111.154 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -46.8 86.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 118.549 0.613 . . . . 1.2 111.719 178.042 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.6 mp -62.57 -44.81 95.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 116.598 -1.668 . . . . 0.57 107.797 175.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.95 -47.04 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 121.049 1.749 . . . . 0.57 110.698 174.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -48.6 76.44 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.949 0.795 . . . . 0.57 109.303 -178.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -69.62 -36.88 76.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.842 0.857 . . . . 0.57 112.104 -177.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.44 74.81 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 126.83 2.052 . . . . 0.57 109.847 174.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 122' ' ' LEU . 21.9 mt -66.58 -33.42 75.64 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 118.505 -0.759 . . . . 0.57 111.03 174.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -60.24 -33.87 72.89 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.383 -0.818 . . . . 0.57 109.605 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.9 mtm -69.64 -23.5 63.49 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 115.925 -1.988 . . . . 0.57 113.281 175.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -84.45 -34.51 23.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.529 1.513 . . . . 0.57 111.157 169.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.95 83.0 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.839 -1.163 . . . . 0.57 112.236 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.25 -25.98 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 120.825 -1.397 . . . . 0.57 111.13 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -100.35 -29.84 12.19 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.147 -0.93 . . . . 0.66 111.468 176.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 160' ' ' ILE . 29.8 pt -122.7 131.23 24.4 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 119.364 0.984 . . . . 0.57 111.255 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.11 43.39 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.694 2.93 . . . . 0.57 112.234 178.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 126' ' ' LEU . 5.8 tt -82.73 145.33 29.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.146 1.378 . . . . 0.57 108.593 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -126.78 162.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.315 1.046 . . . . 0.65 108.208 -175.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 152.97 41.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.002 -1.481 . . . . 0.57 107.002 -169.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 171.31 14.67 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.105 0.962 . . . . 1.2 109.083 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -115.04 163.93 14.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.976 -0.75 . . . . 0.57 108.976 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.47 171.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.738 1.215 . . . . 0.57 109.94 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -115.74 36.26 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.077 0.951 . . . . 0.57 111.46 -171.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 92.02 107.5 0.03 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 128.739 2.816 . . . . 0.57 108.99 -177.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.98 -124.41 1.43 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.078 -1.609 . . . . 0.57 109.078 -173.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.9 p -138.0 143.17 40.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.39 0.676 . . . . 0.57 109.803 -171.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.647 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . . . -135.22 -177.33 4.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.056 1.743 . . . . 0.57 109.357 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 35.9 m-20 -83.74 -39.78 19.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.544 0.738 . . . . 0.66 110.88 -177.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 122' ' ' LEU . 12.9 mt -116.05 79.98 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.306 1.442 . . . . 0.57 107.213 -175.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -78.86 126.62 30.94 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.695 -1.253 . . . . 0.57 108.998 171.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.17 124.98 66.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.616 -1.994 . . . . 0.57 105.616 173.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.97 162.94 27.45 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.221 -0.752 . . . . 0.57 111.221 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.77 148.01 46.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.994 -1.113 . . . . 0.57 107.994 -175.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.61 179.86 6.58 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 125.936 1.694 . . . . 0.57 110.291 -175.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 71.2 1.4 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 122.487 1.137 . . . . 1.2 108.422 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.37 -65.14 0.78 Allowed Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.311 -1.115 . . . . 0.57 110.311 -178.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.95 159.5 33.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.863 1.832 . . . . 0.57 110.963 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -157.87 155.19 29.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.628 1.171 . . . . 0.65 108.923 -178.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.98 52.13 3.94 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.733 1.635 . . . . 0.57 112.752 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -109.68 -77.18 0.6 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.533 1.133 . . . . 0.66 108.411 -176.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -177.93 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.767 1.227 . . . . 0.57 110.107 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -130.43 99.13 19.43 Favored Pre-proline 0 C--N 1.344 0.357 0 N-CA-C 108.523 -0.917 . . . . 0.57 108.523 -174.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 141.71 72.63 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 109.199 -1.116 . . . . 0.57 109.199 174.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -61.85 177.3 0.45 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.192 1.472 . . . . 0.57 111.041 167.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -99.34 -37.41 9.25 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.694 1.998 . . . . 0.66 110.855 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.41 -150.11 18.19 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 120.461 1.482 . . . . 0.57 112.422 -172.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.01 81.77 1.63 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.744 3.63 . . . . 0.57 112.949 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.17 -168.29 37.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.756 1.646 . . . . 0.57 110.705 176.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 41.72 -137.1 0.21 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.307 1.443 . . . . 0.57 113.788 167.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -59.42 123.53 17.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.938 2.095 . . . . 0.57 110.936 174.004 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD13 ' C24' ' A' ' 178' ' ' MDW . 4.7 mp -98.93 -28.81 13.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.7 1.2 . . . . 0.57 113.21 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.72 159.09 36.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.817 -1.179 . . . . 0.57 107.817 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -143.7 156.57 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.65 109.306 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.42 35.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.364 0.665 . . . . 0.57 109.592 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -117.05 153.15 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.673 -0.862 . . . . 0.57 108.673 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 158.89 50.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.97 -1.014 . . . . 0.57 110.835 176.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 28.2 Cg_endo -69.79 161.46 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.438 2.092 . . . . 0.57 112.175 177.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.06 -127.18 1.29 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.078 -2.009 . . . . 0.57 108.078 -177.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.9 m -141.38 99.22 3.52 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 106.193 -1.78 . . . . 0.57 106.193 -178.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.37 -125.62 6.34 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.177 -1.569 . . . . 0.57 109.177 176.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -51.52 -35.43 40.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.425 1.09 . . . . 0.57 111.842 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.17 136.97 8.32 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.574 -0.704 . . . . 0.57 112.316 176.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.03 -22.15 8.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 126.384 1.945 . . . . 0.57 114.464 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -68.47 151.83 46.26 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.651 -1.24 . . . . 0.66 107.651 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.05 147.7 32.88 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.374 1.069 . . . . 0.57 108.973 -172.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -131.62 154.66 48.66 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.888 -1.051 . . . . 0.65 108.523 -178.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.47 151.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.825 -1.176 . . . . 0.57 107.825 -171.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.26 94.9 9.4 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.874 -1.158 . . . . 0.66 107.874 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.81 -28.11 46.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.654 1.582 . . . . 0.66 111.256 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.87 -36.27 81.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.181 0.593 . . . . 0.66 110.79 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.71 130.55 43.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.918 -1.142 . . . . 0.66 107.918 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -57.49 140.95 49.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.249 0.547 . . . . 1.2 110.66 178.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -123.68 150.15 44.61 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.927 -1.508 . . . . 0.57 106.927 178.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -137.84 147.76 44.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.019 -1.104 . . . . 0.57 108.019 175.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.72 -54.0 48.51 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.343 0.974 . . . . 0.66 108.684 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.81 72.73 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.437 -1.465 . . . . 0.57 109.437 -169.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.3 p -159.44 151.22 20.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.218 0.607 . . . . 0.57 109.668 173.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 m -67.66 87.2 0.22 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.007 0.923 . . . . 0.57 110.604 174.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.33 -55.47 0.06 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 125.989 1.716 . . . . 0.57 111.406 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.47 -147.87 7.41 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.211 -1.156 . . . . 0.57 110.211 -176.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.61 124.7 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.437 -1.32 . . . . 0.57 107.437 -177.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.86 107.63 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.319 1.048 . . . . 0.57 109.822 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -60.28 -47.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.391 1.476 . . . . 0.57 110.337 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD13 ' HG ' ' A' ' 34' ' ' LEU . 12.5 tp -56.72 -44.76 81.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.351 -0.981 . . . . 0.57 108.351 -177.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -72.92 -41.73 64.25 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.36 0.664 . . . . 0.57 110.578 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.35 74.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.609 0.764 . . . . 0.57 109.951 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.86 -56.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 118.289 -0.862 . . . . 0.57 109.486 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.5 m -51.89 -36.57 49.15 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.686 1.13 . . . . 0.57 112.522 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.7 t60 -64.12 -61.53 2.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.95 -43.11 99.52 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.462 -0.773 . . . . 0.66 111.036 -172.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 39' ' ' LEU . 4.1 mm? -61.63 -32.76 72.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.543 1.537 . . . . 0.57 112.027 177.319 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.84 -44.95 81.45 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.634 -0.986 . . . . 0.57 110.634 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -67.02 -44.21 80.86 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 118.479 -0.772 . . . . 0.65 111.885 175.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.3 m -53.7 -38.52 64.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 123.755 0.659 . . . . 0.57 111.085 176.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -61.77 -38.31 87.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.513 0.725 . . . . 0.57 112.217 177.528 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 152.19 -21.95 0.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.262 -0.743 . . . . 0.57 113.028 -175.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.6 158.79 4.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.689 1.244 . . . . 0.57 110.927 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.03 -41.37 0.48 Allowed Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.73 -2.15 . . . . 0.57 112.68 176.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 167.39 177.61 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 128.247 2.619 . . . . 0.65 107.259 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 t -150.76 -175.73 5.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.992 -1.485 . . . . 0.57 106.992 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.3 p -134.86 63.26 1.62 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.037 1.335 . . . . 0.57 109.078 -174.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.06 147.65 65.75 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.66 110.155 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.86 -27.11 21.66 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.842 2.362 . . . . 0.57 112.158 -175.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -122.6 33.35 5.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.704 1.602 . . . . 0.57 109.053 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.48 54.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.559 -0.713 . . . . 0.57 110.567 176.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 138' ' ' MET . 5.5 p -65.74 -24.7 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 121.424 -0.797 . . . . 0.57 110.336 168.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.47 ' HE3' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.6 11.84 33.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.57 112.157 177.117 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.55 137.11 9.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 119.764 1.166 . . . . 0.57 112.48 174.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.04 -66.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.966 1.778 . . . . 0.57 111.869 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -55.78 139.94 43.7 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.508 1.123 . . . . 0.57 110.52 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -95.53 77.1 3.33 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.291 -0.633 . . . . 0.57 109.291 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 96.75 0.12 Allowed Glycine 0 CA--C 1.536 1.374 0 N-CA-C 115.617 1.007 . . . . 0.57 115.617 172.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -159.48 -46.68 0.05 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.399 1.1 . . . . 0.57 113.105 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.76 -129.81 4.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.955 -2.058 . . . . 0.57 107.955 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -147.57 114.2 4.08 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.537 -0.912 . . . . 0.66 108.537 -178.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -12.6 23.04 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.198 1.932 . . . . 0.57 112.706 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.03 -25.67 61.9 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.074 -1.016 . . . . 0.57 111.167 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.88 93.28 4.3 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 125.322 1.449 . . . . 0.57 108.735 174.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -52.43 -73.89 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.622 1.169 . . . . 0.57 114.035 -177.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.36 67.04 0.2 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.504 2.321 . . . . 0.57 110.979 176.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -40.13 121.97 1.43 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.866 1.666 . . . . 0.57 109.121 -174.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.3 t -77.03 -101.63 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.626 0.771 . . . . 0.57 109.272 -168.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -122.91 -8.26 8.37 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 125.102 1.361 . . . . 0.57 110.838 172.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.22 -63.29 1.35 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 121.208 1.822 . . . . 0.66 110.873 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.66 -50.84 61.61 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 117.616 -1.183 . . . . 0.66 108.829 175.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.93 -48.83 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.199 0.909 . . . . 0.57 110.314 -174.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -66.91 -49.82 64.37 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.057 -0.72 . . . . 0.57 109.057 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.19 -58.84 11.91 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.682 -0.967 . . . . 0.57 110.682 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 46' ' ' ILE . 13.9 mm -50.39 -48.13 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 126.343 1.857 . . . . 0.57 112.141 174.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.44 -33.6 75.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.438 0.563 . . . . 0.57 111.714 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -76.05 -30.79 58.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.804 0.842 . . . . 0.57 111.801 176.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mm? -72.76 -53.19 12.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.907 1.283 . . . . 0.57 110.065 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' ILE . 19.6 m-85 -124.21 -53.88 1.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.402 0.681 . . . . 0.57 109.778 -174.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.29 115.84 3.97 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 109.721 -1.352 . . . . 0.57 109.721 -176.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 -75.74 0.36 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.777 -0.63 . . . . 0.57 109.601 173.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.17 167.63 29.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.75 1.62 . . . . 1.2 108.65 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.4 t -142.0 126.46 17.76 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.697 -1.594 . . . . 0.57 106.697 176.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -165.65 141.17 5.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.286 -1.746 . . . . 0.57 106.286 171.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 151.19 10.9 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.048 -1.464 . . . . 0.57 107.048 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.9 94.45 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.775 0.83 . . . . 1.2 109.279 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.56 175.58 8.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.783 0.833 . . . . 0.57 109.055 175.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 C--N 1.33 -0.258 0 C-N-CA 127.225 2.21 . . . . 0.5 . 171.883 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.425 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 117.981 -1.009 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -70.79 -179.01 2.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.595 0.634 . . . . 0.57 111.352 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.14 65.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.87 1.268 . . . . 0.57 109.728 -172.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.97 -51.61 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 127.286 2.234 . . . . 0.57 110.696 -176.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.67 162.99 24.17 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.86 2.373 . . . . 0.57 112.128 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -126.04 -56.54 1.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.72 1.208 . . . . 0.57 109.459 -176.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 p -127.64 61.93 52.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.938 1.295 . . . . 0.57 109.958 178.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 166.22 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.875 1.717 . . . . 0.57 110.946 176.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.2 99.26 0.07 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 126.243 1.817 . . . . 0.57 108.912 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.545 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.3 m95 -53.86 154.06 4.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.511 0.672 . . . . 0.57 111.651 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -72.76 -31.05 64.63 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.747 0.819 . . . . 0.57 111.702 -176.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -92.44 155.62 17.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.137 2.175 . . . . 0.57 111.162 174.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -79.68 -10.98 59.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.011 1.324 . . . . 0.57 111.808 173.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.29 144.7 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.777 -1.194 . . . . 0.57 107.777 175.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' ASP . 9.9 p -131.76 150.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.208 -1.034 . . . . 0.57 108.208 -178.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.7 p -102.52 148.78 25.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 119.015 -0.516 . . . . 0.57 110.651 -174.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -127.38 158.19 37.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.865 1.211 . . . . 0.57 111.915 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -152.74 116.56 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.988 0.423 . . . . 1.2 110.945 171.5 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 22' ' ' TYR . 34.8 mt -79.19 96.63 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 N-CA-C 106.581 -1.637 . . . . 0.57 106.581 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -33.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.878 2.071 . . . . 0.57 112.007 -175.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 t -150.04 162.26 40.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.384 -2.821 . . . . 0.57 103.384 -177.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 19' ' ' ILE . 72.1 m-85 -135.36 161.29 35.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.909 -1.515 . . . . 0.57 106.909 -173.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.431 HG22 HG21 ' A' ' 31' ' ' VAL . 6.4 t -72.81 173.15 9.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.668 0.387 . . . . 0.57 111.295 176.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -41.06 3.83 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.433 1.093 . . . . 1.2 111.221 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -35.1 74.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.057 0.389 . . . . 0.66 110.81 -176.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.52 151.77 52.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.531 1.932 . . . . 0.57 108.356 -176.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.23 155.92 46.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.198 1.265 . . . . 0.57 112.422 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -59.33 -37.59 78.18 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.565 1.146 . . . . 0.65 112.343 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 tt -63.6 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.28 -0.867 . . . . 0.57 110.078 174.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -62.77 -42.81 99.86 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.63 -1.176 . . . . 0.57 109.195 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 HG22 ' A' ' 23' ' ' THR . 46.3 t -61.28 -53.51 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 120.607 1.549 . . . . 0.57 111.667 175.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -59.79 -45.03 93.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.654 1.115 . . . . 0.66 110.438 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.17 96.78 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 117.845 -1.074 . . . . 1.2 111.402 176.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.0 mp -64.19 -46.24 84.8 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.518 1.054 . . . . 0.57 108.472 178.077 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -49.75 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.244 0.929 . . . . 0.57 109.709 172.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.26 -46.75 87.41 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.95 -1.024 . . . . 0.57 111.887 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -65.62 -42.54 91.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.333 1.424 . . . . 0.57 111.712 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.05 94.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.77 0.828 . . . . 0.57 110.049 177.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 122' ' ' LEU . 65.5 mt -66.45 -32.39 73.73 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.934 -0.555 . . . . 0.57 111.511 173.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -43.45 98.27 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.915 0.78 . . . . 0.57 110.025 172.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 mtm -67.12 -37.44 83.87 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.483 -0.77 . . . . 0.57 112.133 176.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 128' ' ' MET . 23.7 m95 -69.11 -43.92 73.47 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.862 1.21 . . . . 0.57 112.004 173.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.04 -0.87 66.46 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.959 1.266 . . . . 0.57 113.197 177.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -23.48 65.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.11 -1.23 . . . . 0.57 110.953 171.51 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -105.47 -32.1 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.978 -1.01 . . . . 0.66 112.331 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 160' ' ' ILE . 7.2 pt -116.6 132.29 23.44 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 119.312 0.96 . . . . 0.57 110.875 178.003 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.27 49.44 2.84 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.971 3.114 . . . . 0.57 111.76 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 126' ' ' LEU . 3.2 tt -98.49 142.11 30.51 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.122 2.169 . . . . 0.57 107.357 176.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -125.18 164.7 19.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.65 109.329 -172.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.65 147.87 47.1 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.685 -1.228 . . . . 0.57 107.685 -170.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.97 168.98 18.7 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.709 1.204 . . . . 1.2 109.048 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -110.77 150.39 29.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.793 -0.817 . . . . 0.57 108.793 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.5 170.33 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.867 0.867 . . . . 0.57 109.941 174.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.1 -48.71 7.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.077 0.951 . . . . 0.57 109.17 177.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -146.58 139.61 25.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.106 1.362 . . . . 0.57 107.387 173.082 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.43 166.4 22.79 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.571 0.605 . . . . 0.57 111.808 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 164.54 21.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.914 0.387 . . . . 0.57 110.369 174.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.51 173.71 8.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.835 1.254 . . . . 0.57 110.8 -176.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 15' ' ' VAL . 51.3 m-20 -73.53 -35.89 65.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.09 -0.959 . . . . 0.66 110.298 -177.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.09 71.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.549 2.34 . . . . 0.57 108.364 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 18.9 ttp -78.31 122.02 25.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.577 -1.327 . . . . 0.57 108.229 173.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.93 135.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.473 -1.677 . . . . 0.57 106.473 178.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.3 165.93 28.17 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 118.821 0.737 . . . . 0.57 112.015 176.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 6.4 m-85 -139.12 137.54 36.24 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.172 -1.788 . . . . 0.57 106.172 -175.208 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.8 175.85 9.27 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.018 1.327 . . . . 0.57 109.318 -176.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -133.55 88.8 2.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.722 -1.214 . . . . 1.2 107.722 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.76 -40.89 2.27 Favored Glycine 0 C--N 1.343 0.933 0 C-N-CA 124.359 0.981 . . . . 0.57 113.089 170.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.96 23.94 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.376 1.088 . . . . 0.57 109.421 175.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 159.33 25.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.957 1.303 . . . . 0.65 109.763 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.49 55.71 4.42 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 126.21 1.862 . . . . 0.57 112.23 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -105.08 -78.39 0.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.176 1.39 . . . . 0.66 109.094 -175.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.17 -50.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.545 1.938 . . . . 0.57 106.52 -176.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -108.36 126.19 30.17 Favored Pre-proline 0 C--N 1.344 0.352 0 CA-C-O 118.798 -0.62 . . . . 0.57 109.942 -174.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.08 133.37 26.66 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.272 1.315 . . . . 0.57 108.836 170.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.64 -163.43 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.645 1.212 . . . . 0.57 110.459 166.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -132.53 -35.77 1.12 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.605 3.562 . . . . 0.66 109.416 -162.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.37 -148.64 18.93 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.808 1.671 . . . . 0.57 111.453 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.04 59.57 2.96 Favored 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.227 4.618 . . . . 0.57 115.103 -169.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.0 40.55 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.552 1.549 . . . . 0.57 110.053 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 42.63 -139.76 0.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.229 1.812 . . . . 0.57 113.593 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -49.57 112.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.436 2.694 . . . . 0.57 111.989 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.23 -32.11 61.04 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.57 114.352 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.12 166.37 28.09 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.84 -1.162 . . . . 0.57 109.223 -178.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -149.09 155.98 41.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.003 0.82 . . . . 0.65 111.161 174.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.44 158.56 43.93 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.203 1.001 . . . . 0.57 109.875 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.7 148.52 32.1 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.429 -0.582 . . . . 0.57 109.429 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.42 96.5 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.801 -0.636 . . . . 0.57 110.242 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 21.9 Cg_endo -70.33 157.66 58.6 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.476 2.117 . . . . 0.57 111.099 176.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.68 -53.52 0.6 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.414 1.007 . . . . 0.57 111.141 173.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -96.64 177.67 5.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.57 110.704 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.96 -40.39 97.14 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.267 -1.296 . . . . 0.57 112.488 -176.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.22 -29.38 66.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.881 1.34 . . . . 0.57 110.875 168.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.13 152.19 14.69 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.85 -1.157 . . . . 0.57 111.152 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.35 -20.55 4.89 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.436 1.017 . . . . 0.57 113.391 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -75.39 157.22 34.52 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.483 1.141 . . . . 0.66 108.867 -173.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.41 149.94 36.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.815 0.817 . . . . 0.57 110.314 -172.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.83 151.56 48.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.982 0.913 . . . . 0.65 109.602 -176.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.502 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 36.2 m-85 -138.07 150.01 46.51 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.775 1.23 . . . . 0.57 108.034 -171.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -85.51 104.09 14.97 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.87 -0.789 . . . . 0.66 108.87 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.86 -23.75 66.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.929 -1.107 . . . . 0.66 111.671 175.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -56.72 -29.5 62.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.793 0.837 . . . . 0.66 111.642 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -82.68 135.03 35.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.587 1.555 . . . . 0.66 109.157 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.83 120.7 14.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.753 -0.592 . . . . 1.2 109.62 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -103.58 138.51 40.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.956 -1.127 . . . . 0.57 107.956 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -123.64 147.08 47.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.711 -1.218 . . . . 0.57 107.711 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -88.26 21.23 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.396 0.998 . . . . 0.66 112.081 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.86 25.6 37.52 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.252 1.406 . . . . 0.57 112.834 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -64.76 -56.18 15.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.797 1.239 . . . . 0.57 112.746 -172.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.1 m -151.68 -43.1 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.582 0.753 . . . . 0.57 112.827 -176.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -167.84 166.4 13.54 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.628 1.971 . . . . 0.57 108.078 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.84 -152.4 16.88 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.166 -1.574 . . . . 0.57 109.166 -175.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.93 111.63 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.107 -1.442 . . . . 0.57 107.107 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -66.28 111.65 3.58 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.074 -0.713 . . . . 0.57 109.074 -177.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.43 -43.93 75.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.449 -0.796 . . . . 0.57 111.464 177.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' HG ' ' A' ' 34' ' ' LEU . 20.5 tp -59.7 -40.3 87.45 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.555 -0.905 . . . . 0.57 108.555 -175.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -66.54 -44.61 81.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.569 0.748 . . . . 0.57 109.662 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.425 ' HB2' ' C26' ' A' ' 178' ' ' MDW . . . -58.65 -49.95 75.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.098 0.559 . . . . 0.57 110.327 176.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -50.95 72.09 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.861 -1.066 . . . . 0.57 109.845 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 65.5 m -50.82 -46.33 59.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.175 1.352 . . . . 0.57 111.714 175.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.91 -52.27 64.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.401 0.546 . . . . 0.65 110.281 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.5 -43.37 85.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.195 0.998 . . . . 0.66 110.9 -172.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 39' ' ' LEU . 60.0 mt -64.85 -28.68 69.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.202 1.401 . . . . 0.57 111.282 176.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -46.33 80.46 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.127 -0.789 . . . . 0.57 111.127 169.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -68.7 -40.46 80.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.537 -1.22 . . . . 0.65 110.889 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.8 p -59.98 -26.44 66.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.136 0.88 . . . . 0.57 112.838 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.74 -41.59 78.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.22 1.008 . . . . 0.57 111.773 173.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.73 25.91 1.2 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.478 1.037 . . . . 0.57 113.621 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 42' ' ' TRP . 36.3 mmt -84.26 -176.94 6.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.855 0.836 . . . . 0.57 111.052 -175.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.47 146.49 18.15 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.267 -0.879 . . . . 0.57 111.44 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.23 164.33 1.81 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.036 0.922 . . . . 0.65 111.25 166.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.26 179.97 7.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.515 1.926 . . . . 0.57 107.538 -177.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.3 t -151.59 97.06 2.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.917 -1.883 . . . . 0.57 105.917 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -131.1 137.62 31.09 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 105.587 -2.005 . . . . 0.66 105.587 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.76 38.12 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.959 3.106 . . . . 0.57 111.714 -176.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.46 32.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.9 1.68 . . . . 0.57 111.291 170.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -120.64 142.91 49.0 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.98 -1.075 . . . . 0.57 110.543 -170.04 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.47 -29.6 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 120.172 -0.611 . . . . 0.57 109.514 177.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 tpp -61.39 -18.13 57.35 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.129 1.772 . . . . 0.57 114.455 173.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -54.71 129.11 63.69 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.534 0.734 . . . . 0.57 109.502 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.06 134.98 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.793 1.662 . . . . 0.57 109.277 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.1 m 66.88 149.55 0.05 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.107 1.763 . . . . 0.57 111.895 -173.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.84 131.48 48.93 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.017 -1.052 . . . . 0.57 109.51 173.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.86 -104.72 0.18 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.161 -1.176 . . . . 0.57 110.161 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -64.2 -33.61 76.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.923 0.712 . . . . 0.57 112.923 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.59 142.93 36.08 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.613 -0.995 . . . . 0.57 110.613 178.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -109.77 111.51 58.85 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.408 0.683 . . . . 0.66 109.288 -169.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 -15.63 51.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.576 2.184 . . . . 0.57 113.6 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.54 -1.24 28.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.024 0.93 . . . . 0.57 110.675 177.227 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -142.51 77.42 1.58 Allowed 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.505 -1.372 . . . . 0.57 109.586 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.86 -63.15 1.2 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.871 0.868 . . . . 0.57 112.67 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.11 72.96 0.03 OUTLIER 'General case' 0 C--N 1.346 0.436 0 O-C-N 126.369 2.293 . . . . 0.57 111.364 -176.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -33.16 116.07 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.965 2.106 . . . . 0.57 108.55 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.4 p -93.7 -75.52 0.5 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.326 -0.55 . . . . 0.57 110.382 -160.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -141.76 -49.51 0.39 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.501 1.12 . . . . 0.57 109.351 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -51.84 -32.47 31.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.901 1.228 . . . . 0.66 112.441 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.458 ' HB3' HD23 ' A' ' 152' ' ' LEU . 71.7 m-20 -78.19 -82.94 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.902 1.681 . . . . 0.66 110.404 168.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.62 -50.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.183 0.993 . . . . 0.57 110.648 -169.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -69.05 -35.9 77.09 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 117.528 -1.225 . . . . 0.57 109.684 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.71 95.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 120.416 1.462 . . . . 0.57 111.049 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 46' ' ' ILE . 7.9 mm -60.03 -48.81 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.902 0.881 . . . . 0.57 110.676 171.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -67.09 -16.86 64.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.561 -0.733 . . . . 0.57 112.89 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -82.57 -35.64 26.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.324 1.45 . . . . 0.57 110.43 171.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -47.13 8.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.867 0.758 . . . . 0.57 112.762 -175.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -104.48 -43.44 5.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.285 1.034 . . . . 0.57 110.484 -175.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.41 -178.75 9.34 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.853 -0.899 . . . . 0.57 110.853 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.02 -67.86 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.833 -0.803 . . . . 0.57 108.833 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -150.26 165.97 31.36 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.699 -1.223 . . . . 1.2 107.699 178.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.6 t -155.37 -60.81 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.512 -1.292 . . . . 0.57 107.512 172.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -164.82 178.04 7.49 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.914 1.685 . . . . 0.57 110.356 175.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.1 p -149.37 146.07 27.31 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.089 1.355 . . . . 0.57 109.889 171.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 73.51 114.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.962 2.905 . . . . 1.2 112.587 -177.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -151.36 177.2 10.51 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.282 0.633 . . . . 0.57 111.287 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.8 tptt . . . . . 0 C--N 1.341 0.233 0 C-N-CA 129.099 2.96 . . . . 0.5 . 177.327 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.425 ' C26' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.264 0 CA-C-O 117.126 -1.416 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.5 p -94.95 -0.25 54.07 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.468 1.486 . . . . 0.57 112.855 -178.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.43 -53.93 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.732 1.213 . . . . 0.57 110.121 -175.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.2 171.11 8.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.615 1.966 . . . . 0.57 110.672 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -71.08 -158.45 0.06 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.056 3.171 . . . . 0.57 113.048 173.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -55.63 151.33 10.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.266 1.026 . . . . 0.57 109.652 166.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 151.67 -53.51 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.437 0 C-N-CA 129.399 3.079 . . . . 0.57 109.266 -172.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.9 168.97 21.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.404 1.402 . . . . 0.57 111.856 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 pttt 86.81 133.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 129.406 3.082 . . . . 0.57 108.548 -170.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.408 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 33.2 m95 -73.31 177.67 5.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.619 0.767 . . . . 0.57 110.074 173.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -101.6 -14.77 17.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.728 -0.608 . . . . 0.57 111.485 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -100.8 162.64 12.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.726 1.21 . . . . 0.57 110.116 176.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -87.42 -4.08 59.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.13 1.372 . . . . 0.57 112.549 171.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -133.1 140.93 46.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.868 -1.16 . . . . 0.57 107.868 176.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.68 143.5 39.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.738 -1.578 . . . . 0.57 106.738 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 59' ' ' ASP . 0.6 OUTLIER -98.94 140.43 33.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.69 -0.485 . . . . 0.57 109.69 -179.531 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.21 161.04 29.48 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.631 0.772 . . . . 0.57 110.544 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.91 160.7 43.73 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.987 0.915 . . . . 1.2 109.599 172.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.25 85.92 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.239 -2.134 . . . . 0.57 105.239 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.64 -56.27 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.021 0.529 . . . . 0.57 109.985 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.5 111.82 22.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.733 -1.951 . . . . 0.57 105.733 176.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.09 148.95 22.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.395 1.878 . . . . 0.57 107.911 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -73.88 -170.05 0.84 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.794 1.238 . . . . 0.57 109.799 -176.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.28 -14.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.869 1.433 . . . . 1.2 114.869 176.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -64.59 -29.87 70.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.085 1.354 . . . . 0.66 110.846 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.28 150.82 73.48 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 126.55 1.94 . . . . 0.57 108.488 175.13 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -70.81 157.3 58.72 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.537 2.825 . . . . 0.57 112.736 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -65.59 -32.92 74.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.705 0.802 . . . . 0.65 112.172 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -43.96 98.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.55 -0.907 . . . . 0.57 108.55 174.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -64.95 -42.37 94.7 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.206 -1.378 . . . . 0.57 109.839 172.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.3 t -58.3 -48.59 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 121.157 1.798 . . . . 0.57 110.365 177.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.8 -42.19 90.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.19 0.904 . . . . 0.66 109.672 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -67.34 -46.87 72.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.333 -0.855 . . . . 1.2 113.146 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.37 -31.62 72.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.048 -0.977 . . . . 0.57 109.676 177.325 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.15 -50.42 74.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.878 -1.156 . . . . 0.57 107.878 173.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -38.88 91.55 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.244 -0.884 . . . . 0.57 110.826 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.46 -47.71 69.31 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.473 1.488 . . . . 0.57 111.105 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.96 86.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.075 0.95 . . . . 0.57 111.726 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.21 -31.87 68.13 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.216 -0.897 . . . . 0.57 111.156 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.63 -43.98 93.63 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 119.286 0.948 . . . . 0.57 109.233 170.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.2 mtp -60.1 -35.34 75.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.551 1.069 . . . . 0.57 112.86 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 5.6 m95 -70.55 -48.09 57.1 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.421 1.009 . . . . 0.57 111.669 170.163 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -9.36 64.73 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.106 1.336 . . . . 0.57 113.668 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -66.38 -20.16 66.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.553 1.141 . . . . 0.57 110.499 170.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.89 -20.39 12.47 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.205 -0.902 . . . . 0.66 112.691 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.8 pt -127.67 129.75 23.75 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 119.195 0.907 . . . . 0.57 110.464 175.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.82 41.45 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.295 3.33 . . . . 0.57 112.407 178.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -89.9 147.72 23.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.295 1.838 . . . . 0.57 108.079 -179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -122.93 166.36 15.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.51 0.724 . . . . 0.65 109.25 -172.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.84 39.5 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.111 -0.993 . . . . 0.57 109.458 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 165.24 21.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.756 0.823 . . . . 1.2 109.217 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -130.3 114.1 15.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.812 -1.551 . . . . 0.57 106.812 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.05 160.76 2.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.383 0.673 . . . . 0.57 109.759 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.71 -14.76 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.192 0.997 . . . . 0.57 112.227 -176.21 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -52.5 64.04 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.664 0.785 . . . . 0.57 111.099 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.37 -152.81 6.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.965 1.745 . . . . 0.57 109.431 -172.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -60.84 178.88 0.2 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.328 1.051 . . . . 0.57 112.477 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.22 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.734 1.614 . . . . 0.57 110.382 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 16' ' ' THR . 79.8 m-20 -66.43 -31.62 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.494 -0.765 . . . . 0.66 109.138 176.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 mt -125.45 79.13 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 126.641 1.976 . . . . 0.57 108.471 -178.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -72.54 117.95 14.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.134 1.773 . . . . 0.57 108.226 166.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.88 122.8 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.096 -2.187 . . . . 0.57 105.096 177.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -144.55 138.73 8.06 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 118.149 0.431 . . . . 0.57 112.024 -174.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.48 145.69 37.25 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.936 -1.135 . . . . 0.57 107.936 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.94 151.7 51.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.685 1.194 . . . . 0.57 108.34 -178.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -110.68 70.86 0.73 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.271 0.558 . . . . 1.2 109.608 -174.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.28 -53.79 0.66 Allowed Glycine 0 C--O 1.219 -0.805 0 N-CA-C 110.351 -1.099 . . . . 0.57 110.351 174.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 171.66 19.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.958 0.903 . . . . 0.57 109.328 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 159.56 22.17 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.429 1.892 . . . . 0.65 108.537 -174.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.23 46.22 2.22 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.085 1.326 . . . . 0.57 111.788 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.42 105.66 7.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.488 -1.301 . . . . 0.66 107.488 -172.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.9 m 55.99 -71.72 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.113 2.165 . . . . 0.57 113.034 -175.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.75 130.02 15.31 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.351 1.86 . . . . 0.57 107.911 -173.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.7 137.75 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.543 1.495 . . . . 0.57 109.833 175.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -66.48 -173.81 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.973 1.309 . . . . 0.57 111.202 169.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.63 -33.52 6.75 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.136 2.574 . . . . 0.66 111.962 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.02 -123.54 7.94 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 120.586 -1.321 . . . . 0.57 111.965 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.67 95.72 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.83 2.315 . . . . 0.57 112.327 -176.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.89 -160.45 25.73 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.966 0.793 . . . . 0.57 112.232 173.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.57 -129.91 0.78 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.325 1.45 . . . . 0.57 112.904 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -68.3 129.11 38.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.307 2.643 . . . . 0.57 109.186 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.67 -30.44 12.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.104 1.361 . . . . 0.57 112.049 -175.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.2 37.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.839 1.255 . . . . 0.57 108.352 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.74 161.54 38.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.625 -0.88 . . . . 0.65 108.625 173.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.36 159.91 43.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.966 0.506 . . . . 0.57 109.651 175.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -114.32 152.62 31.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.49 -0.777 . . . . 0.57 109.606 -173.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.25 146.57 83.44 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.203 -0.903 . . . . 0.57 110.117 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.4 Cg_endo -66.83 157.98 58.62 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.345 2.03 . . . . 0.57 112.335 -176.229 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.36 -101.7 0.15 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.042 -1.223 . . . . 0.57 110.042 176.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -147.05 -41.25 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.901 0.88 . . . . 0.57 111.194 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.02 4.57 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.812 -1.315 . . . . 0.57 109.812 -175.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -29.95 17.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.224 1.01 . . . . 0.57 112.423 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.55 134.79 14.47 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 120.964 -1.085 . . . . 0.57 112.865 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.58 9.26 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.217 1.865 . . . . 0.57 112.203 -176.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.72 148.44 47.98 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.1 0.95 . . . . 0.66 108.885 -166.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.38 137.85 46.02 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.691 0.796 . . . . 0.57 109.13 -168.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 15.4 m-70 -135.33 141.24 45.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.299 -1.0 . . . . 0.65 108.299 -164.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.29 151.73 42.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.735 -0.839 . . . . 0.57 108.735 -169.288 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.56 102.2 11.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.852 -0.796 . . . . 0.66 108.852 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.85 -21.72 63.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.095 0.958 . . . . 0.66 111.487 172.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.23 -38.83 88.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.611 0.642 . . . . 0.66 110.436 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.68 126.37 29.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.345 -1.354 . . . . 0.66 107.345 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.82 132.53 22.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.465 -0.939 . . . . 1.2 108.465 176.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -120.78 129.69 53.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.739 -1.948 . . . . 0.57 105.739 -177.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -141.02 161.84 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.619 -0.882 . . . . 0.57 108.619 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.78 -22.77 58.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.857 0.863 . . . . 0.66 111.136 172.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 152.47 96.68 0.14 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.177 0.894 . . . . 0.57 111.33 175.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.0 t -120.37 -68.54 0.9 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 118.658 -0.687 . . . . 0.57 110.562 -178.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.79 -64.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.06 0.944 . . . . 0.57 108.877 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 tt -94.56 -46.1 7.11 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.815 0.846 . . . . 0.57 110.327 -170.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.67 145.58 32.22 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.077 -1.209 . . . . 0.57 110.077 173.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.5 mm -77.62 138.26 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.594 -1.262 . . . . 0.57 107.594 -171.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -74.16 105.57 5.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.684 -0.487 . . . . 0.57 109.684 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.31 -33.73 76.51 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.288 0.635 . . . . 0.57 110.887 178.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.51 -51.52 65.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.624 -1.25 . . . . 0.57 107.624 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.82 -38.89 92.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.449 0.7 . . . . 0.57 109.205 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.31 47.12 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.547 0.739 . . . . 0.57 112.252 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.43 77.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.628 -0.879 . . . . 0.57 108.628 179.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -60.88 -37.73 83.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.463 0.574 . . . . 0.57 111.382 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.42 -58.8 6.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.17 0.441 . . . . 0.65 109.871 172.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -68.63 -41.69 79.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.298 -0.876 . . . . 0.66 111.635 -171.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.99 -24.85 66.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.354 1.061 . . . . 0.57 110.943 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.54 -45.89 93.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.57 110.917 169.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -70.13 -32.96 71.22 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 117.729 -1.129 . . . . 0.65 112.239 174.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 p -60.09 -38.1 81.93 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.657 1.117 . . . . 0.57 110.894 174.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.55 -33.07 73.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.014 0.435 . . . . 0.57 111.181 176.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.48 -55.01 0.12 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 123.782 0.706 . . . . 0.57 111.611 175.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 176.09 172.56 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.432 1.493 . . . . 0.57 107.632 -166.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 161.24 75.22 0.02 OUTLIER Glycine 0 C--O 1.218 -0.847 0 N-CA-C 104.137 -3.585 . . . . 0.57 104.137 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.14 45.13 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.314 -1.365 . . . . 0.65 107.314 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.3 -177.13 0.99 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.966 2.106 . . . . 0.57 106.469 -173.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -132.25 39.29 3.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.57 109.696 -174.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -104.14 137.69 19.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.66 111.197 -172.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.47 -9.49 25.96 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.837 2.358 . . . . 0.57 113.573 -174.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -121.52 24.75 9.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.868 1.267 . . . . 0.57 109.599 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.63 133.18 45.53 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.082 -1.011 . . . . 0.57 110.115 172.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -22.26 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.069 0.548 . . . . 0.57 110.442 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.2 24.75 12.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.43 1.892 . . . . 0.57 110.622 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.12 142.89 92.87 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.137 -0.977 . . . . 0.57 109.967 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.9 Cg_endo -69.53 -171.48 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.315 2.01 . . . . 0.57 111.235 166.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 t 43.59 68.89 0.46 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.497 1.519 . . . . 0.57 113.151 173.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -43.38 129.22 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.772 1.629 . . . . 0.57 113.458 -173.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.42 113.86 3.51 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.28 -1.528 . . . . 0.57 109.28 -178.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 168.4 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.063 2.145 . . . . 0.57 108.48 175.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.96 -145.24 18.34 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.556 -1.017 . . . . 0.57 110.556 177.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -128.06 102.25 21.85 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.833 -1.543 . . . . 0.66 106.833 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.81 67.09 6.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.985 2.457 . . . . 0.57 109.481 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -165.1 -48.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.326 1.85 . . . . 0.57 108.961 178.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -77.4 43.11 0.37 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.9 1.444 . . . . 0.57 114.9 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -14.4 -71.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 128.352 2.661 . . . . 0.57 117.06 -177.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 17.81 79.03 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 128.324 2.649 . . . . 0.57 112.309 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -31.66 117.4 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.421 1.889 . . . . 0.57 109.762 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -92.2 -87.85 0.21 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.101 -0.476 . . . . 0.57 110.481 -163.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -139.57 -39.06 0.47 Allowed 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 117.644 -1.17 . . . . 0.57 111.721 177.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -58.93 -37.2 76.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 120.174 1.352 . . . . 0.66 110.87 174.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.42 -59.31 2.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 124.118 0.886 . . . . 0.66 109.109 175.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.47 -46.0 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.574 1.149 . . . . 0.57 110.237 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.37 -47.45 76.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.495 1.118 . . . . 0.57 109.749 -177.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.53 58.14 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.995 -1.242 . . . . 0.57 109.995 176.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -54.4 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.365 1.066 . . . . 0.57 110.896 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -56.29 -43.5 78.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.546 1.139 . . . . 0.57 109.569 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -65.14 -36.92 85.76 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.575 0.625 . . . . 0.57 111.15 176.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.21 -46.57 79.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.813 1.645 . . . . 0.57 112.153 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -104.88 8.06 34.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.406 0.683 . . . . 0.57 112.636 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -101.11 -159.45 27.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.585 1.088 . . . . 0.57 111.348 -167.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.7 -42.96 0.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.077 -1.062 . . . . 0.57 111.227 -175.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.96 139.57 12.53 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.095 0.958 . . . . 1.2 108.863 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 p 167.72 63.68 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.221 2.208 . . . . 0.57 110.193 -173.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -89.91 142.09 28.03 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.336 -0.852 . . . . 0.57 109.238 170.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.7 t -172.48 149.7 2.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.617 . . . . 0.57 106.944 169.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -142.48 133.99 26.53 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.237 -1.023 . . . . 1.2 108.237 176.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.46 148.91 43.81 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.127 1.371 . . . . 0.57 108.334 -177.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 C-N-CA 124.77 1.228 . . . . 0.5 . 171.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 119.418 -0.325 . . . . 0.57 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -96.04 -72.61 0.62 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.584 1.154 . . . . 0.57 108.816 -177.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.96 -52.59 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.224 1.01 . . . . 0.57 110.688 178.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.88 96.17 19.45 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.709 1.604 . . . . 0.57 108.548 -175.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.0 119.71 6.36 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.474 1.449 . . . . 0.57 108.743 173.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -144.73 -67.04 0.32 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.102 -1.444 . . . . 0.57 107.102 170.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.39 70.13 0.95 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 126.63 1.972 . . . . 0.57 109.019 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.46 134.04 31.98 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.559 1.506 . . . . 0.57 109.328 177.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 71.47 115.84 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.043 1.737 . . . . 0.57 109.48 -171.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -57.12 150.11 18.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.742 0.817 . . . . 0.57 110.251 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -65.9 -23.89 66.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.841 0.857 . . . . 0.57 111.392 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -94.16 152.63 18.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.99 0.916 . . . . 0.57 110.364 173.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -85.62 -3.4 58.87 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.654 1.182 . . . . 0.57 112.636 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.56 111.03 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.107 -1.072 . . . . 0.57 108.107 177.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.15 124.78 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.551 -1.277 . . . . 0.57 107.551 -170.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -92.6 152.23 19.7 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.599 -0.688 . . . . 0.57 110.441 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -123.09 153.45 39.9 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.696 0.799 . . . . 0.57 111.506 175.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.28 117.77 6.52 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.649 0.738 . . . . 1.2 110.549 174.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mt -87.74 89.46 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 105.05 -2.204 . . . . 0.57 105.05 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.89 -31.78 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.135 0.974 . . . . 0.57 112.097 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 t -136.2 157.65 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.589 -2.375 . . . . 0.57 104.589 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -135.21 167.42 21.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.197 1.399 . . . . 0.57 107.663 -173.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -68.49 -175.03 0.6 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 0.57 111.459 172.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -41.49 2.56 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.544 1.138 . . . . 1.2 111.241 -176.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -41.43 77.48 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.875 1.27 . . . . 0.66 111.739 178.137 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.41 142.56 29.66 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 125.037 1.335 . . . . 0.57 108.015 -172.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.42 158.46 56.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.769 1.646 . . . . 0.57 112.192 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -67.98 -36.83 80.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.374 -0.83 . . . . 0.65 110.592 -171.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.3 tt -65.84 -40.72 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.909 0.884 . . . . 0.57 110.814 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -62.5 -46.08 90.08 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 117.717 -1.135 . . . . 0.57 108.272 173.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 t -54.86 -49.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.467 -1.254 . . . . 0.57 110.701 175.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.24 -40.25 96.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.498 1.499 . . . . 0.66 111.778 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -62.85 -46.21 88.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.487 1.04 . . . . 1.2 111.553 175.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.88 -42.79 89.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.483 1.113 . . . . 0.57 109.531 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.44 -43.47 96.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.985 -1.007 . . . . 0.57 110.637 170.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -53.5 57.7 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.071 1.305 . . . . 0.57 110.692 177.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -63.98 -35.93 82.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.065 1.302 . . . . 0.57 111.928 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -41.88 69.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.34 0.973 . . . . 0.57 111.907 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -65.91 -35.17 79.88 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.519 -0.753 . . . . 0.57 109.88 171.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -59.35 -43.22 92.83 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.113 0.87 . . . . 0.57 109.851 171.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.8 mtp -62.16 -41.41 98.27 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.279 -0.867 . . . . 0.57 110.971 176.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -61.03 -49.93 75.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.838 1.199 . . . . 0.57 111.576 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.64 -5.63 79.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.45 1.024 . . . . 0.57 113.88 -178.24 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -77.6 -21.25 52.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.831 1.315 . . . . 0.57 110.741 170.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -97.1 -13.29 22.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.862 0.865 . . . . 0.66 111.235 -177.212 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 164' ' ' TYR . 17.9 pt -142.33 150.66 55.79 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 119.859 1.209 . . . . 0.57 111.708 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.51 12.64 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.219 2.613 . . . . 0.57 113.452 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -79.67 137.67 37.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.817 -1.179 . . . . 0.57 107.817 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -119.18 165.68 13.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.571 0.701 . . . . 0.65 109.636 -173.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.7 161.95 35.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.092 -0.707 . . . . 0.57 109.092 -173.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -179.8 6.82 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.638 -0.875 . . . . 1.2 108.638 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -131.16 154.84 47.94 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.881 -1.155 . . . . 0.57 107.881 177.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.46 164.6 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 124.301 1.041 . . . . 0.57 109.256 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.79 -22.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.871 0.868 . . . . 0.57 112.168 -176.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -64.81 0.81 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.381 -0.97 . . . . 0.57 108.381 174.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.24 157.57 7.92 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.078 1.799 . . . . 0.57 109.253 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.8 m 61.17 135.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.598 2.359 . . . . 0.57 112.761 178.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.12 177.68 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 121.243 -0.911 . . . . 0.57 110.586 -173.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.11 -53.89 32.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.275 -1.38 . . . . 0.66 107.275 177.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -103.47 77.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.211 2.204 . . . . 0.57 108.358 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.9 ttp -76.72 148.51 36.71 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 119.167 -2.208 . . . . 0.57 109.564 173.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.2 140.34 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.736 -1.579 . . . . 0.57 106.736 173.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.25 162.3 31.76 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.461 -0.656 . . . . 0.57 111.461 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.8 m-85 -137.2 141.46 42.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.052 -1.462 . . . . 0.57 107.052 -174.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.3 -174.34 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.713 1.605 . . . . 0.57 109.305 -177.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 50.15 1.28 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.224 . . . . 1.2 112.461 -172.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.09 123.58 3.77 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.794 -1.322 . . . . 0.57 109.794 -173.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 52.14 122.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.593 2.357 . . . . 0.57 115.514 -172.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.14 159.37 44.3 Favored 'General case' 0 C--N 1.341 0.222 0 O-C-N 120.39 -1.444 . . . . 0.65 112.193 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.9 80.86 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.522 1.534 . . . . 0.57 110.195 175.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.57 -84.36 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.942 1.297 . . . . 0.66 110.663 -174.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 t -171.05 -37.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.122 1.369 . . . . 0.57 110.126 -177.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.76 142.0 38.16 Favored Pre-proline 0 C--N 1.343 0.284 0 C-N-CA 123.728 0.811 . . . . 0.57 109.478 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 124.15 10.28 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.54 1.493 . . . . 0.57 109.521 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 171.64 3.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.409 1.1 . . . . 0.57 110.398 161.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -108.81 -44.37 4.03 Favored 'General case' 0 CA--C 1.542 0.645 1 C-N-CA 131.763 4.025 . . . . 0.66 109.979 -171.055 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.96 -145.21 17.61 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.226 -1.319 . . . . 0.57 111.166 -174.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.94 74.66 2.32 Favored 'Trans proline' 0 C--N 1.354 0.818 1 C-N-CA 125.588 4.192 . . . . 0.57 114.042 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.48 -177.76 36.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.183 -1.967 . . . . 0.57 108.183 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 45.01 -150.19 0.06 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.425 1.49 . . . . 0.57 113.453 174.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -43.0 109.81 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.471 2.308 . . . . 0.57 111.513 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -79.25 -29.65 42.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.616 1.166 . . . . 0.57 113.319 -172.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.67 157.8 27.74 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.79 1.236 . . . . 0.57 108.337 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -142.53 160.44 40.28 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.427 -0.795 . . . . 0.65 110.303 174.021 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.63 172.85 12.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.937 0.895 . . . . 0.57 108.723 176.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.95 153.96 46.1 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.527 -0.916 . . . . 0.57 108.527 -177.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.23 135.56 76.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.424 -0.798 . . . . 0.57 110.111 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -71.16 169.74 19.9 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.394 2.729 . . . . 0.57 113.456 -177.239 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.05 -8.97 27.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.52 1.533 . . . . 0.57 113.632 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -136.81 45.41 2.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.246 1.023 . . . . 0.57 111.255 -163.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -77.05 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.211 1.386 . . . . 0.57 114.185 173.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.85 -21.12 63.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.57 110.268 167.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.2 145.65 4.39 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.211 -0.931 . . . . 0.57 111.087 170.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.44 -34.29 3.88 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 125.299 1.428 . . . . 0.57 110.922 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.24 152.53 40.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.292 1.046 . . . . 0.66 110.449 -164.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.83 146.01 50.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.824 0.821 . . . . 0.57 109.506 -175.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -138.44 152.84 48.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.001 0.92 . . . . 0.65 110.093 -177.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 51.3 m-85 -140.09 155.82 46.85 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.633 1.173 . . . . 0.57 108.995 -168.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -87.32 102.58 14.65 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.187 -0.301 . . . . 0.66 110.187 172.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -53.98 -30.71 48.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.772 1.629 . . . . 0.66 111.733 171.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.56 -35.28 79.96 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.341 0.657 . . . . 0.66 111.522 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -73.73 150.69 41.01 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.744 0.818 . . . . 0.66 109.068 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -72.67 144.44 47.74 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.743 -0.598 . . . . 1.2 110.698 175.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.87 128.28 36.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.8 -1.556 . . . . 0.57 106.8 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -124.04 144.69 49.69 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.547 -0.538 . . . . 0.57 109.547 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.21 -33.51 75.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.66 111.284 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.42 95.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.88 -0.888 . . . . 0.57 110.88 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.04 138.24 8.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.45 0.7 . . . . 0.57 109.276 172.143 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 t -76.25 54.49 0.89 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.383 2.273 . . . . 0.57 110.786 -175.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -158.15 -44.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.486 0.714 . . . . 0.57 112.164 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.65 -176.2 38.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.545 -1.022 . . . . 0.57 110.545 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.25 118.27 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 105.782 -1.933 . . . . 0.57 105.782 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.82 113.01 2.79 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.891 -0.781 . . . . 0.57 108.891 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -54.14 -42.37 69.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.25 1.02 . . . . 0.57 110.823 177.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.97 -34.06 57.6 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.451 0.569 . . . . 0.57 111.469 -171.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -64.48 -48.55 74.79 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.569 -0.9 . . . . 0.57 108.569 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.27 74.34 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.804 0.442 . . . . 0.57 110.548 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.24 78.16 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.456 -0.783 . . . . 0.57 110.948 -176.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.7 m -61.89 -37.42 84.53 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 0.899 . . . . 0.57 110.961 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.51 -53.8 53.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.63 0.772 . . . . 0.65 109.817 172.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.8 -44.28 73.88 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.628 0.771 . . . . 0.66 111.914 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.26 -28.93 70.06 Favored 'General case' 0 CA--C 1.526 0.036 0 C-N-CA 124.389 1.076 . . . . 0.57 111.239 176.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.78 -46.56 93.3 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.623 -0.591 . . . . 0.57 111.623 171.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -64.2 -38.41 90.96 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 117.161 0.48 . . . . 0.65 111.243 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -34.38 69.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.707 0.632 . . . . 0.57 112.707 174.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -22.69 65.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.343 -0.848 . . . . 0.57 112.856 174.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.04 -13.61 4.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.709 1.147 . . . . 0.57 113.464 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.3 tpp -65.15 144.59 57.11 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.817 1.309 . . . . 0.57 110.862 -171.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -97.7 -38.96 4.01 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 117.762 -1.577 . . . . 0.57 112.038 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 m80 156.52 -176.4 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.893 3.677 . . . . 0.65 108.111 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.4 m -145.45 179.88 7.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.327 1.851 . . . . 0.57 107.829 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.61 94.39 2.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.785 -1.561 . . . . 0.57 106.785 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 8.3 t70 -154.24 138.02 10.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 107.211 -1.403 . . . . 0.66 107.211 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.9 -19.57 46.21 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.978 1.785 . . . . 0.57 113.37 -173.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -124.39 27.21 7.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.783 1.233 . . . . 0.57 109.108 -177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -59.42 138.52 57.63 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.315 0.646 . . . . 0.57 110.369 175.385 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.5 p -75.02 -26.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.815 -0.439 . . . . 0.57 109.815 168.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 13.41 15.53 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.615 -0.678 . . . . 0.57 112.148 174.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -70.46 146.35 93.98 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.552 1.524 . . . . 0.57 111.528 -174.369 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 38.2 Cg_endo -78.81 -50.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.181 1.921 . . . . 0.57 112.693 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.5 t -67.62 120.13 13.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.921 -0.77 . . . . 0.57 108.921 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.52 112.77 9.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.899 -0.778 . . . . 0.57 108.899 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.76 170.54 21.91 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.805 -1.318 . . . . 0.57 109.805 172.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.28 -53.67 0.47 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.507 2.323 . . . . 0.57 114.029 174.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.65 108.39 2.48 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 127.162 2.315 . . . . 0.57 108.883 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -53.94 111.07 2.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.758 1.623 . . . . 0.66 110.751 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.05 -10.07 13.99 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.804 2.336 . . . . 0.57 112.733 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -96.43 -27.49 14.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.719 1.145 . . . . 0.57 110.965 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -116.15 71.1 0.77 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.069 -1.086 . . . . 0.57 108.069 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -120.95 139.0 53.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.225 1.01 . . . . 0.57 108.871 -178.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.96 42.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.36 1.064 . . . . 0.57 110.592 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 64.44 92.89 0.06 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.213 1.805 . . . . 0.57 110.638 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 75.3 m -75.23 -79.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.374 0.879 . . . . 0.57 113.374 -169.326 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -149.1 -49.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.333 1.053 . . . . 0.57 108.248 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -47.54 -46.48 27.76 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 126.151 1.78 . . . . 0.66 111.749 167.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.79 -47.84 50.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.801 0.841 . . . . 0.66 109.326 -174.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.16 -45.43 92.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 124.311 1.044 . . . . 0.57 109.693 175.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -49.1 72.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.261 1.024 . . . . 0.57 109.703 -178.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.74 72.79 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.705 -1.358 . . . . 0.57 109.705 177.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 160' ' ' ILE . 1.6 mm -59.3 -53.99 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.178 -0.915 . . . . 0.57 111.21 175.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.56 64.14 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.601 1.091 . . . . 0.57 111.459 -178.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -77.33 -35.08 55.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.158 0.583 . . . . 0.57 112.131 173.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.3 -40.85 98.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.992 1.717 . . . . 0.57 112.749 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' HG22 ' A' ' 46' ' ' ILE . 16.8 p90 -106.65 7.14 30.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.363 0.665 . . . . 0.57 112.503 178.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.46 -131.41 2.81 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.631 -1.788 . . . . 0.57 108.631 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -148.22 -50.22 0.17 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.377 0.671 . . . . 0.57 111.854 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.65 -179.89 0.06 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.937 0.895 . . . . 1.2 111.32 -169.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.18 111.76 20.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.57 106.994 171.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.31 157.55 18.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.066 0.547 . . . . 0.57 109.792 172.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.1 t -146.89 177.14 9.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.334 -1.358 . . . . 0.57 107.334 168.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -63.13 145.0 56.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.429 1.092 . . . . 1.2 110.374 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.56 -42.11 17.16 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.439 0.903 . . . . 0.57 113.439 -174.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 125.402 1.481 . . . . 0.5 . -177.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 178' ' ' MDW . . . . . 0.451 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.452 -0.954 0 N-CA-C 109.174 -1.125 . . . . 0.56999999999999995 109.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 pttt 101.19 138.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 130.174 3.389 . . . . 0.56999999999999995 109.305 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.467 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 12.3 m95 -64.89 162.27 16.69 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.69 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.9 p -91.46 6.42 45.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.697 -0.627 . . . . 0.56999999999999995 112.42 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -109.7 147.7 32.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.881 1.272 . . . . 0.56999999999999995 109.056 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -16.89 61.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.293 0.637 . . . . 0.56999999999999995 111.943 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.55 143.49 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.009 -1.108 . . . . 0.56999999999999995 108.009 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 172.24 13.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.893 -0.78 . . . . 0.56999999999999995 108.893 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -116.56 153.33 32.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.389 0.276 . . . . 0.56999999999999995 110.627 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -128.6 149.84 50.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 111.128 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.64 106.23 3.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.821 0.849 . . . . 1.2 108.884 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.5 mt -84.47 84.2 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 106.716 -1.587 . . . . 0.56999999999999995 106.716 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.38 -41.72 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 112.696 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -126.08 164.83 20.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.611 -2.366 . . . . 0.56999999999999995 104.611 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -136.35 155.0 50.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.46 -1.311 . . . . 0.56999999999999995 107.46 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -66.54 -172.02 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.906 0.883 . . . . 0.56999999999999995 111.132 168.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -33.46 0.83 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.874 1.67 . . . . 1.2 112.763 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -39.3 78.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.016 0.926 . . . . 0.66000000000000003 112.179 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 148.33 65.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.947 2.099 . . . . 0.56999999999999995 108.088 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.8 163.49 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.84 2.36 . . . . 0.56999999999999995 112.716 -171.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -62.48 -36.13 81.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.439 0.696 . . . . 0.65000000000000002 112.265 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.78 -38.63 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.549 0.34 . . . . 0.56999999999999995 110.744 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.9 m -69.65 -41.72 75.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.542 -1.218 . . . . 0.56999999999999995 109.5 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.1 t -53.98 -54.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 120.341 1.428 . . . . 0.56999999999999995 109.719 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -43.54 98.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.989 0.813 . . . . 0.66000000000000003 110.834 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -42.08 98.2 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.28 0.945 . . . . 1.2 112.029 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.02 -40.64 68.3 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.682 -1.151 . . . . 0.56999999999999995 109.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.24 -49.37 76.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 119.31 0.959 . . . . 0.56999999999999995 109.183 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -65.03 -44.48 88.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.599 0.76 . . . . 0.56999999999999995 110.437 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -66.3 -45.23 81.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.561 1.073 . . . . 0.56999999999999995 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -47.26 86.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.033 0.833 . . . . 0.56999999999999995 110.811 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 19.7 mt -67.8 -36.73 80.96 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.514 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.36 -38.39 89.36 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 119.16 0.891 . . . . 0.56999999999999995 109.651 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.28 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.032 0.933 . . . . 0.56999999999999995 112.514 173.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 40.9 m95 -68.13 -51.05 50.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.845 1.202 . . . . 0.56999999999999995 110.948 168.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.03 -11.65 58.86 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.563 1.077 . . . . 0.56999999999999995 113.318 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -31.17 72.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.377 -1.072 . . . . 0.56999999999999995 110.481 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -101.26 -21.17 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.016 0.825 . . . . 0.66000000000000003 111.803 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.7 pt -133.15 135.5 25.76 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.493 1.117 . . . . 0.56999999999999995 110.77 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.17 26.36 0.26 Allowed 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 123.814 3.009 . . . . 0.56999999999999995 114.57 -174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.24 136.53 34.37 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.038 1.335 . . . . 0.56999999999999995 108.239 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -117.24 165.15 13.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.664 0.785 . . . . 0.65000000000000002 109.638 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -140.15 148.02 41.02 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.234 -1.024 . . . . 0.56999999999999995 108.234 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -142.33 169.31 17.82 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.842 1.257 . . . . 1.2 109.661 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -103.75 149.39 25.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.571 -0.9 . . . . 0.56999999999999995 108.571 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.78 167.49 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.399 1.08 . . . . 0.56999999999999995 110.45 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.66 -40.83 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.514 0.726 . . . . 0.56999999999999995 110.867 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -164.9 87.23 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.059 1.343 . . . . 0.56999999999999995 107.392 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.41 160.5 11.56 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.219 -1.152 . . . . 0.56999999999999995 110.219 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.1 m -66.38 136.11 55.29 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.258 1.029 . . . . 0.56999999999999995 109.467 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.13 165.11 16.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.508 0.723 . . . . 0.56999999999999995 111.494 175.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.37 -29.04 65.6 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.936 -1.029 . . . . 0.66000000000000003 110.389 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.89 80.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.62 1.968 . . . . 0.56999999999999995 108.731 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.7 ttm -69.37 128.27 35.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 120.653 -1.279 . . . . 0.56999999999999995 107.684 163.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.18 127.1 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.163 -2.162 . . . . 0.56999999999999995 105.163 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.42 158.63 26.55 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.505 -0.638 . . . . 0.56999999999999995 111.505 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.8 m-85 -133.93 146.02 50.12 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 106.838 -1.542 . . . . 0.56999999999999995 106.838 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.3 173.73 11.51 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.06 1.744 . . . . 0.56999999999999995 108.537 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -134.12 66.77 1.53 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.461 1.028 . . . . 1.2 111.614 -169.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 105.37 0.49 Allowed Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.659 -0.976 . . . . 0.56999999999999995 110.659 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 57.91 160.33 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.423 2.689 . . . . 0.56999999999999995 114.474 -169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 170.24 10.46 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.998 1.319 . . . . 0.65000000000000002 110.547 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.84 61.42 3.69 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.466 1.508 . . . . 0.56999999999999995 112.37 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -131.47 -179.18 5.21 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.854 1.262 . . . . 0.66000000000000003 109.909 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 p -58.23 -36.9 73.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.671 0.669 . . . . 0.56999999999999995 111.25 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -135.57 112.12 10.74 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.447 0.699 . . . . 0.56999999999999995 110.517 -172.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.95 130.32 18.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.918 1.745 . . . . 0.56999999999999995 111.288 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -59.1 170.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 113.585 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -115.41 -25.57 7.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.615 1.966 . . . . 0.66000000000000003 112.168 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.81 -139.38 14.49 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 120.139 1.336 . . . . 0.56999999999999995 111.408 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.19 98.28 1.19 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.361 2.707 . . . . 0.56999999999999995 112.2 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.11 -176.4 23.4 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 112.066 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 t30 52.27 -130.63 2.19 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 120.823 -1.398 . . . . 0.56999999999999995 110.683 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.3 m -69.08 132.19 46.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.66 2.784 . . . . 0.56999999999999995 110.828 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -102.27 -29.74 11.5 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.186 1.394 . . . . 0.56999999999999995 112.741 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.7 32.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.076 1.35 . . . . 0.56999999999999995 108.237 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -145.54 150.76 37.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.744 0.702 . . . . 0.65000000000000002 110.113 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.52 165.35 28.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.806 0.842 . . . . 0.56999999999999995 109.47 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -119.71 151.46 38.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.194 -1.039 . . . . 0.56999999999999995 108.194 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.86 150.44 97.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.43 -0.795 . . . . 0.56999999999999995 110.17 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 59.9 Cg_endo -72.8 154.41 53.85 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.216 1.944 . . . . 0.56999999999999995 111.196 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.49 42.77 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.821 -0.989 . . . . 0.56999999999999995 111.484 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.2 m 63.8 161.01 0.1 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.003 2.121 . . . . 0.56999999999999995 112.491 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -140.39 28.65 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 121.06 -1.025 . . . . 0.56999999999999995 110.852 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.71 -23.8 44.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.371 0.668 . . . . 0.56999999999999995 111.525 171.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.77 139.61 31.84 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.002 -1.061 . . . . 0.56999999999999995 110.907 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.13 -19.79 16.02 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.425 1.488 . . . . 0.56999999999999995 113.286 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -71.92 155.92 39.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.954 1.377 . . . . 0.66000000000000003 108.739 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.72 145.6 36.67 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.026 0.917 . . . . 0.56999999999999995 109.598 -172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -138.07 147.1 43.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.002 -0.999 . . . . 0.65000000000000002 108.465 -170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.443 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 41.4 m-85 -138.04 148.49 45.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.248 1.019 . . . . 0.56999999999999995 108.434 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -95.04 100.64 12.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 106.634 -1.617 . . . . 0.66000000000000003 106.634 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -59.61 -23.13 62.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.356 1.462 . . . . 0.66000000000000003 111.495 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -60.48 -28.85 68.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.504 0.722 . . . . 0.66000000000000003 111.088 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.4 129.68 34.73 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.177 -1.045 . . . . 0.66000000000000003 108.177 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -64.04 112.41 2.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.394 0.677 . . . . 1.2 111.799 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.07 146.76 24.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.56999999999999995 109.458 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -146.96 145.22 29.69 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.419 -0.956 . . . . 0.56999999999999995 108.419 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.19 -39.79 93.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.077 0.551 . . . . 0.66000000000000003 110.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.85 83.91 0.06 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.704 -1.758 . . . . 0.56999999999999995 108.704 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.9 t -118.06 -62.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.677 0.738 . . . . 0.56999999999999995 109.523 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -164.65 -45.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.85 1.26 . . . . 0.56999999999999995 110.703 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.31 142.89 41.88 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.598 1.159 . . . . 0.56999999999999995 109.441 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.3 -172.81 19.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.84 -1.704 . . . . 0.56999999999999995 108.84 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.42 115.44 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.631 -1.618 . . . . 0.56999999999999995 106.631 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.22 115.08 4.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.013 0.525 . . . . 0.56999999999999995 110.05 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -66.13 -42.93 88.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.534 1.134 . . . . 0.56999999999999995 111.693 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -42.65 90.66 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.078 0.951 . . . . 0.56999999999999995 109.573 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -65.96 -49.61 67.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.857 0.863 . . . . 0.56999999999999995 110.789 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -46.95 85.42 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.008 0.367 . . . . 0.56999999999999995 111.737 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -50.0 75.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 108.588 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -53.72 -45.88 70.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.567 1.076 . . . . 0.56999999999999995 111.307 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -58.09 -55.11 39.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.825 1.25 . . . . 0.65000000000000002 109.708 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.73 -47.56 59.09 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.337 0.655 . . . . 0.66000000000000003 111.194 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.52 -29.11 68.9 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.666 1.186 . . . . 0.56999999999999995 110.799 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -61.1 -46.76 93.9 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 118.741 0.7 . . . . 0.56999999999999995 112.373 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.15 -42.54 99.46 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.956 -1.021 . . . . 0.65000000000000002 110.502 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.4 m -57.82 -32.67 67.81 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.086 0.866 . . . . 0.56999999999999995 113.266 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -50.06 64.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.903 0.881 . . . . 0.56999999999999995 109.928 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.21 32.34 0.03 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-O 117.862 -1.521 . . . . 0.56999999999999995 114.995 -172.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.01 171.42 0.2 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.046 1.338 . . . . 0.56999999999999995 111.713 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.26 43.6 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.53 -0.731 . . . . 0.56999999999999995 113.601 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 166.94 18.39 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.909 1.355 . . . . 0.65000000000000002 111.636 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -175.91 4.59 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 109.388 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 35.69 1.28 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 109.854 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.52 151.96 54.0 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.384 1.473 . . . . 0.66000000000000003 109.376 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.16 -22.56 61.23 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.797 2.331 . . . . 0.56999999999999995 113.219 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -130.44 27.48 5.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 109.246 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 132.54 54.25 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 121.704 -0.623 . . . . 0.56999999999999995 110.083 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.27 -23.45 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.554 0.742 . . . . 0.56999999999999995 111.545 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.27 20.5 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 111.381 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.01 133.32 80.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 119.511 1.05 . . . . 0.56999999999999995 111.389 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.8 128.01 9.83 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.832 2.355 . . . . 0.56999999999999995 110.753 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.5 m 70.78 115.15 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.094 2.158 . . . . 0.56999999999999995 111.143 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.47 148.22 9.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.336 1.054 . . . . 0.56999999999999995 112.939 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.91 -124.45 0.78 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.686 -0.966 . . . . 0.56999999999999995 110.686 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.6 -37.21 83.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.569 1.148 . . . . 0.56999999999999995 113.586 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.59 97.59 0.06 OUTLIER Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.817 1.198 . . . . 0.56999999999999995 110.745 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -65.24 116.52 31.27 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.885 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.4 -16.67 8.05 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 CA-C-O 117.53 -1.112 . . . . 0.56999999999999995 112.964 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -61.18 -37.2 82.08 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.703 1.592 . . . . 0.56999999999999995 109.279 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.14 122.35 14.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 107.975 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -131.7 -55.64 1.0 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.653 1.181 . . . . 0.56999999999999995 107.83 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 36.12 52.81 0.9 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.438 1.495 . . . . 0.56999999999999995 111.005 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.01 90.89 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.021 2.128 . . . . 0.56999999999999995 110.91 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -66.14 -83.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.829 1.418 . . . . 0.56999999999999995 114.829 -168.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -143.84 -44.57 0.27 Allowed 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.863 1.665 . . . . 0.56999999999999995 107.767 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.43 -51.69 33.74 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.81 1.244 . . . . 0.66000000000000003 111.544 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -50.52 73.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.501 0.592 . . . . 0.66000000000000003 111.598 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.81 -44.66 98.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 108.858 -0.793 . . . . 0.56999999999999995 108.858 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -65.16 -44.81 87.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.698 -1.144 . . . . 0.56999999999999995 108.971 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.47 -59.0 11.6 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.596 -1.002 . . . . 0.56999999999999995 110.596 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 160' ' ' ILE . 6.1 mm -57.15 -48.65 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.361 1.08 . . . . 0.56999999999999995 111.384 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -73.06 -15.46 61.5 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 120.02 1.282 . . . . 0.56999999999999995 112.161 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -79.51 -32.11 42.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.678 1.126 . . . . 0.56999999999999995 111.49 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.94 -43.64 11.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.283 1.433 . . . . 0.56999999999999995 111.709 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 126.328 1.851 . . . . 0.56999999999999995 110.928 -177.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.455 -0.747 0 N-CA-C 108.842 -1.253 . . . . 0.56999999999999995 108.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 82.57 111.28 0.06 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.405 2.282 . . . . 0.56999999999999995 109.104 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -56.37 147.7 20.74 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.107 0.563 . . . . 0.56999999999999995 111.276 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -77.35 -28.22 52.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.489 0.715 . . . . 0.56999999999999995 111.514 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -84.37 144.25 28.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.798 0.839 . . . . 0.56999999999999995 109.902 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -81.49 -8.74 59.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 111.866 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.25 119.57 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.924 -2.25 . . . . 0.56999999999999995 104.924 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.21 142.98 36.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.122 -1.436 . . . . 0.56999999999999995 107.122 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -96.32 152.68 18.36 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.001 -0.437 . . . . 0.56999999999999995 111.028 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -128.2 155.04 45.15 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.809 0.844 . . . . 0.56999999999999995 111.662 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 114.07 4.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 1.2 109.566 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.8 mt -85.43 86.11 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.222 -1.77 . . . . 0.56999999999999995 106.222 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -68.25 -29.96 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.313 1.445 . . . . 0.56999999999999995 113.846 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -136.57 160.26 39.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 130.714 3.606 . . . . 0.56999999999999995 102.827 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -135.84 163.98 28.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 108.345 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.416 HG22 HG21 ' A' ' 31' ' ' VAL . 5.7 t -74.02 -175.07 2.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.94 0.896 . . . . 0.56999999999999995 111.409 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -44.2 1.86 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.667 1.187 . . . . 1.2 113.211 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -32.52 67.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.399 1.08 . . . . 0.66000000000000003 110.791 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 105' ' ' THR . 46.0 mt -123.2 143.51 41.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.311 1.444 . . . . 0.56999999999999995 109.243 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.35 152.09 38.73 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.789 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -62.18 -37.24 84.52 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 112.199 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.76 -42.86 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.819 . . . . 0.56999999999999995 109.847 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.5 m -70.55 -38.73 74.19 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 117.209 -1.377 . . . . 0.56999999999999995 110.042 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG21 HG22 ' A' ' 23' ' ' THR . 24.8 t -59.39 -45.66 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.434 1.47 . . . . 0.56999999999999995 110.978 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.98 -41.09 78.37 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.93 0.786 . . . . 0.66000000000000003 110.788 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.17 87.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.933 -1.104 . . . . 1.2 112.631 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -64.79 -39.56 93.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.615 -0.883 . . . . 0.56999999999999995 108.615 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.66 -43.63 98.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 119.207 0.912 . . . . 0.56999999999999995 110.415 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -59.1 -48.53 81.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.831 -1.08 . . . . 0.56999999999999995 111.79 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -67.66 -34.45 76.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.583 1.538 . . . . 0.56999999999999995 112.173 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.57 -40.7 76.6 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.105 1.321 . . . . 0.56999999999999995 112.185 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.2 mt -72.98 -32.32 65.11 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 110.888 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.64 -47.38 86.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 119.138 0.881 . . . . 0.56999999999999995 109.252 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.0 mtp -54.24 -36.59 63.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 117.226 -1.368 . . . . 0.56999999999999995 112.442 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -72.5 -44.4 62.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.165 1.802 . . . . 0.56999999999999995 112.352 171.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.93 59.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.17 0.89 . . . . 0.56999999999999995 113.273 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -14.46 62.94 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.193 -1.18 . . . . 0.56999999999999995 111.809 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -115.88 -29.11 6.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.53 1.132 . . . . 0.66000000000000003 110.73 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 pt -123.66 132.72 24.3 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 110.982 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.0 34.9 0.37 Allowed 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.235 3.29 . . . . 0.56999999999999995 113.934 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.56 137.22 35.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 107.782 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -121.12 159.56 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.04 1.336 . . . . 0.65000000000000002 109.177 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 149.39 44.04 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.954 -1.091 . . . . 0.56999999999999995 109.882 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.21 179.3 7.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.988 0.915 . . . . 1.2 110.68 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -118.71 161.3 20.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.407 1.083 . . . . 0.56999999999999995 109.12 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.3 m -121.44 160.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.487 1.515 . . . . 0.56999999999999995 108.88 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.97 29.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.32 1.048 . . . . 0.56999999999999995 110.373 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -54.63 1.26 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.403 1.081 . . . . 0.56999999999999995 110.394 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.27 -135.91 2.31 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.227 -1.149 . . . . 0.56999999999999995 110.227 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 58' ' ' ALA . 5.0 m -83.65 176.94 8.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.922 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 57' ' ' THR . . . -135.76 173.46 11.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.894 1.678 . . . . 0.56999999999999995 110.285 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.19 -39.9 91.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.416 -0.802 . . . . 0.66000000000000003 109.868 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.4 mt -117.93 75.33 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.204 2.202 . . . . 0.56999999999999995 108.746 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.98 128.81 37.24 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.789 -1.194 . . . . 0.56999999999999995 108.854 166.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.95 129.85 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 104.784 -2.302 . . . . 0.56999999999999995 104.784 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.08 170.77 27.17 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.269 -0.733 . . . . 0.56999999999999995 111.269 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.7 m-85 -144.59 151.16 38.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.782 -1.192 . . . . 0.56999999999999995 107.782 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.3 171.01 18.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.822 1.326 . . . . 0.56999999999999995 110.417 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 57.17 1.67 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.613 0.765 . . . . 1.2 111.019 -173.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -46.33 1.1 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.743 1.163 . . . . 0.56999999999999995 111.482 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.69 157.45 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.558 1.179 . . . . 0.56999999999999995 109.573 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -153.6 163.44 39.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.211 1.805 . . . . 0.65000000000000002 108.336 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.21 85.59 1.53 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.88 -1.288 . . . . 0.56999999999999995 109.88 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -130.92 -55.11 1.06 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.834 0.854 . . . . 0.66000000000000003 110.998 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 157.76 -38.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.748 2.819 . . . . 0.56999999999999995 110.156 -166.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -129.93 110.5 17.06 Favored Pre-proline 0 C--N 1.345 0.382 0 CA-C-N 119.794 1.179 . . . . 0.56999999999999995 110.447 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.25 133.12 36.46 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 108.736 -1.294 . . . . 0.56999999999999995 108.736 173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.55 -169.81 0.35 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.64 1.576 . . . . 0.56999999999999995 110.217 172.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -119.63 -35.01 3.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.266 2.226 . . . . 0.66000000000000003 109.815 -168.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.6 -146.37 18.18 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.925 1.25 . . . . 0.56999999999999995 110.203 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.99 111.31 3.21 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 112.22 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.31 160.09 13.92 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 128.099 2.762 . . . . 0.56999999999999995 109.71 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.271 33.3 t30 70.57 -143.51 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.112 1.765 . . . . 0.56999999999999995 112.528 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -49.92 138.79 14.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.324 1.85 . . . . 0.56999999999999995 110.795 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 112' ' ' ILE . 38.2 mt -108.74 -28.96 8.93 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.72 -1.863 . . . . 0.56999999999999995 112.303 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.22 165.41 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.573 1.149 . . . . 0.56999999999999995 108.13 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -146.51 161.71 39.86 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.547 -0.538 . . . . 0.65000000000000002 109.547 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.34 161.7 39.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 109.106 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.52 150.7 34.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.393 -0.965 . . . . 0.56999999999999995 108.393 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.9 91.17 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.562 -0.732 . . . . 0.56999999999999995 109.856 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.4 161.21 45.81 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.29 1.994 . . . . 0.56999999999999995 110.91 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.25 -83.48 0.18 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.835 -0.906 . . . . 0.56999999999999995 110.835 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.7 p -78.15 -177.72 5.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.5 1.52 . . . . 0.56999999999999995 111.272 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.81 -52.49 50.55 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.253 -1.304 . . . . 0.56999999999999995 112.854 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -20.21 61.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.297 1.049 . . . . 0.56999999999999995 110.967 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.51 148.74 11.29 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 111.18 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.11 1.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 117.259 -1.856 . . . . 0.56999999999999995 114.924 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -68.22 156.18 38.15 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 125.306 1.239 . . . . 0.66000000000000003 109.833 -160.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.78 144.48 31.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.56999999999999995 110.956 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -131.19 157.79 42.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.024 -0.989 . . . . 0.65000000000000002 109.437 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 69.1 m-85 -140.01 145.79 38.24 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.308 1.443 . . . . 0.56999999999999995 108.516 -170.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.21 93.62 4.63 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.29 -0.633 . . . . 0.66000000000000003 109.29 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -53.45 -28.04 28.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.799 1.24 . . . . 0.66000000000000003 111.27 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.01 -33.62 76.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.758 0.281 . . . . 0.66000000000000003 111.758 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.89 138.61 46.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.115 -1.439 . . . . 0.66000000000000003 107.115 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -62.93 134.16 55.76 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.468 -0.77 . . . . 1.2 109.656 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -118.49 143.32 46.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.622 0.769 . . . . 0.56999999999999995 109.444 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.442 ' HA ' HD21 ' A' ' 26' ' ' LEU . 3.6 t -138.89 151.75 47.21 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.339 0.656 . . . . 0.56999999999999995 110.761 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.75 -38.19 83.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.467 0.707 . . . . 0.66000000000000003 109.898 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.46 101.44 0.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.006 -1.638 . . . . 0.56999999999999995 109.006 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.27 170.43 21.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.759 2.024 . . . . 0.56999999999999995 108.647 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.74 72.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.247 1.419 . . . . 0.56999999999999995 114.447 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.72 149.77 34.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.997 -0.742 . . . . 0.56999999999999995 108.997 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.42 153.37 14.65 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.534 -1.426 . . . . 0.56999999999999995 109.534 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.499 HG21 HD13 ' A' ' 82' ' ' LEU . 45.4 mm -78.36 130.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.78 -1.563 . . . . 0.56999999999999995 106.78 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -65.53 109.04 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.428 -0.582 . . . . 0.56999999999999995 109.428 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 34' ' ' LEU . 2.4 t80 -56.07 -43.57 78.09 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.24 1.416 . . . . 0.56999999999999995 109.01 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 34' ' ' LEU . 12.7 tp -68.83 -38.54 79.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.589 0.631 . . . . 0.56999999999999995 111.943 -173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -65.01 -44.4 89.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.835 -0.802 . . . . 0.56999999999999995 108.835 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -50.42 70.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.646 0.379 . . . . 0.56999999999999995 111.23 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.09 75.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.109 -0.948 . . . . 0.56999999999999995 109.86 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -60.52 -33.46 72.67 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.795 1.179 . . . . 0.56999999999999995 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.3 -58.62 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.338 0.972 . . . . 0.65000000000000002 109.978 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -64.3 -43.1 95.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.449 0.7 . . . . 0.66000000000000003 111.272 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.09 -27.76 69.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.885 1.274 . . . . 0.56999999999999995 110.971 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.33 -50.91 62.68 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.389 -0.684 . . . . 0.56999999999999995 111.389 171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -59.18 -43.02 92.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.191 -0.909 . . . . 0.65000000000000002 110.666 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -38.44 64.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.438 1.711 . . . . 0.56999999999999995 114.035 174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -44.96 86.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.789 0.836 . . . . 0.56999999999999995 110.949 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.67 43.32 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-O 118.688 -1.062 . . . . 0.56999999999999995 114.338 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -121.77 150.77 41.37 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.926 1.363 . . . . 0.56999999999999995 110.416 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -98.55 -43.32 2.74 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.455 -1.747 . . . . 0.56999999999999995 113.191 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m170 163.75 179.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.95 2.9 . . . . 0.65000000000000002 109.899 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 3.9 m -147.62 179.03 7.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 109.508 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -146.52 81.83 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.437 1.095 . . . . 0.56999999999999995 109.996 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -147.11 146.38 25.43 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.24 -32.25 42.56 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 CA-C-N 121.407 1.538 . . . . 0.56999999999999995 111.882 -171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -116.84 23.86 11.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.031 1.332 . . . . 0.56999999999999995 109.254 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -63.33 136.48 57.69 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.017 0.927 . . . . 0.56999999999999995 109.266 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.43 -32.37 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 118.927 -1.109 . . . . 0.56999999999999995 109.631 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.73 7.55 10.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.575 1.08 . . . . 0.56999999999999995 113.17 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -69.03 145.8 96.8 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.895 1.679 . . . . 0.56999999999999995 110.967 -176.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.04 166.21 30.65 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 110.971 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 m 65.56 -67.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.662 1.985 . . . . 0.56999999999999995 111.673 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 161.84 1.17 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.285 2.234 . . . . 0.56999999999999995 107.366 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.1 136.22 12.81 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.061 -1.616 . . . . 0.56999999999999995 109.061 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -71.89 -16.25 62.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.463 1.105 . . . . 0.56999999999999995 112.394 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -78.29 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.573 -1.411 . . . . 0.56999999999999995 109.573 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -174.85 144.74 0.87 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.955 1.302 . . . . 0.66000000000000003 108.776 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.36 -23.24 8.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.275 1.983 . . . . 0.56999999999999995 114.992 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -103.24 -39.31 6.88 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.456 1.48 . . . . 0.56999999999999995 110.308 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.9 70.28 10.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.967 1.307 . . . . 0.56999999999999995 109.563 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.5 150.77 40.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.44 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.29 62.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.869 1.268 . . . . 0.56999999999999995 110.052 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mp 62.69 87.45 0.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.224 1.41 . . . . 0.56999999999999995 111.237 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.5 m -71.83 -97.51 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.802 1.241 . . . . 0.56999999999999995 113.424 -171.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -122.99 -51.79 1.89 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 120.879 -1.138 . . . . 0.56999999999999995 108.166 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 0.6 OUTLIER -51.06 -39.55 56.25 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.536 0.939 . . . . 0.66000000000000003 113.536 177.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -69.07 -55.36 11.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.437 1.095 . . . . 0.66000000000000003 110.748 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.58 -38.99 81.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-O 117.959 -1.02 . . . . 0.56999999999999995 108.598 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.38 86.89 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 120.167 1.349 . . . . 0.56999999999999995 109.51 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.33 31.47 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.247 -0.741 . . . . 0.56999999999999995 111.247 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 160' ' ' ILE . 5.6 mm -64.3 -48.82 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.009 0.524 . . . . 0.56999999999999995 111.803 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -17.56 64.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.426 1.09 . . . . 0.56999999999999995 111.894 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -42.92 17.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.869 -1.062 . . . . 0.56999999999999995 109.662 172.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.78 -49.23 60.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.559 1.144 . . . . 0.56999999999999995 111.426 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 . . . . . 0 C--O 1.235 0.302 0 C-N-CA 124.941 1.296 . . . . 0.56999999999999995 111.302 -175.051 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.449 -1.112 0 N-CA-C 110.821 -0.492 . . . . 0.56999999999999995 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt 83.51 115.91 0.05 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 127.429 2.292 . . . . 0.56999999999999995 108.997 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 4.2 m95 -64.93 163.03 15.27 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 111.558 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.9 m -89.35 -24.46 21.97 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.997 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -91.28 149.11 21.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.585 0.754 . . . . 0.56999999999999995 109.797 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -5.84 52.98 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.961 0.726 . . . . 0.56999999999999995 112.961 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.56 139.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.56999999999999995 107.189 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.58 148.3 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.452 -1.314 . . . . 0.56999999999999995 107.452 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.9 p -97.52 139.61 33.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.852 -0.795 . . . . 0.56999999999999995 108.852 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -126.97 159.9 32.7 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.822 -0.549 . . . . 0.56999999999999995 110.995 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -153.09 160.25 42.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.103 1.361 . . . . 1.2 108.301 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.56 94.24 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.086 -2.561 . . . . 0.56999999999999995 104.086 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -40.69 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.112 0.965 . . . . 0.56999999999999995 112.152 -170.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.12 153.4 41.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.146 -2.168 . . . . 0.56999999999999995 105.146 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -134.98 143.19 46.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 108.463 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -72.18 169.02 17.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.256 -1.338 . . . . 0.56999999999999995 110.165 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -24.89 5.89 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.731 0.812 . . . . 1.2 112.881 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -35.43 80.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.942 0.877 . . . . 0.66000000000000003 111.224 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.58 154.14 78.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.122 1.769 . . . . 0.56999999999999995 109.629 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.19 161.15 29.4 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.702 1.602 . . . . 0.56999999999999995 112.933 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.84 -35.45 80.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.65000000000000002 111.342 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -64.84 -35.68 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.523 0.729 . . . . 0.56999999999999995 110.55 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -64.73 -51.11 64.1 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.296 -1.335 . . . . 0.56999999999999995 108.15 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.51 -49.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 120.398 1.454 . . . . 0.56999999999999995 110.856 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.19 -39.86 90.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.519 1.054 . . . . 0.66000000000000003 111.487 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -65.05 -42.98 93.74 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.642 1.11 . . . . 1.2 111.818 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.53 -43.64 89.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.599 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.61 -45.12 99.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.017 -0.992 . . . . 0.56999999999999995 110.035 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -60.96 -45.2 95.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.72 1.145 . . . . 0.56999999999999995 111.504 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -36.95 73.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.66 1.118 . . . . 0.56999999999999995 111.418 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.374 0.988 . . . . 0.56999999999999995 111.519 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.4 -33.26 72.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.252 -0.88 . . . . 0.56999999999999995 110.557 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.38 -42.36 91.48 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 119.439 1.018 . . . . 0.56999999999999995 110.211 167.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.2 mtp -64.74 -33.38 75.83 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 119.912 1.233 . . . . 0.56999999999999995 111.592 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -70.72 -44.47 66.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.2 1.364 . . . . 0.56999999999999995 111.147 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.89 -8.1 77.08 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.205 -0.934 . . . . 0.56999999999999995 113.734 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -65.92 -24.43 66.83 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.017 -1.284 . . . . 0.56999999999999995 111.047 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.39 -41.29 7.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.958 -0.544 . . . . 0.66000000000000003 110.789 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 164' ' ' TYR . 15.9 pt -117.25 139.21 25.71 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 110.248 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.05 35.26 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.898 3.066 . . . . 0.56999999999999995 114.13 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -90.87 132.0 36.17 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.695 1.598 . . . . 0.56999999999999995 107.476 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -123.7 165.95 16.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.971 0.909 . . . . 0.65000000000000002 109.411 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.26 144.86 33.5 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.343 -0.984 . . . . 0.56999999999999995 108.343 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -143.05 165.33 27.67 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.861 0.865 . . . . 1.2 108.982 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -107.89 140.31 41.19 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.934 -1.135 . . . . 0.56999999999999995 107.934 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -90.53 161.26 2.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.354 0.597 . . . . 0.56999999999999995 110.112 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.31 -14.85 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 111.602 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -58.96 2.98 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.829 0.852 . . . . 0.56999999999999995 109.956 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.39 146.54 4.83 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.864 -1.295 . . . . 0.56999999999999995 109.864 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.3 m 59.55 144.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.164 2.186 . . . . 0.56999999999999995 112.709 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.2 170.32 15.97 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 120.857 -1.152 . . . . 0.56999999999999995 110.119 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -58.68 -48.96 79.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.121 -1.066 . . . . 0.66000000000000003 108.121 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.39 87.2 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.56999999999999995 108.335 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 ttm -84.59 111.87 19.92 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.014 -1.106 . . . . 0.56999999999999995 108.014 170.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.53 132.03 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 106.392 -1.707 . . . . 0.56999999999999995 106.392 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -156.4 154.41 25.51 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 112.094 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -129.37 153.08 48.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.366 1.083 . . . . 0.56999999999999995 110.672 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.95 178.14 7.31 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 109.915 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -132.25 66.95 1.54 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.677 -1.231 . . . . 1.2 107.677 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.34 -40.99 2.3 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.11 -0.828 . . . . 0.56999999999999995 112.759 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.36 164.84 12.92 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.261 1.53 . . . . 0.56999999999999995 110.933 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 -109.71 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.508 2.323 . . . . 0.65000000000000002 106.349 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.41 71.33 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.691 -1.764 . . . . 0.56999999999999995 108.691 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.62 -56.68 2.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.716 1.206 . . . . 0.66000000000000003 109.116 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.9 t 177.43 -39.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.795 2.038 . . . . 0.56999999999999995 108.983 -169.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.84 102.13 44.65 Favored Pre-proline 0 C--N 1.345 0.395 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 109.455 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.67 144.39 84.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.943 1.015 . . . . 0.56999999999999995 109.504 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -69.84 -168.02 0.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.777 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.41 -31.68 4.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.485 3.114 . . . . 0.66000000000000003 110.755 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -152.24 17.35 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 119.97 1.259 . . . . 0.56999999999999995 111.816 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.18 61.94 4.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 125.168 3.912 . . . . 0.56999999999999995 114.776 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.52 18.6 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.637 1.589 . . . . 0.56999999999999995 112.521 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 31.4 -130.34 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.322 2.649 . . . . 0.56999999999999995 114.225 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -61.43 119.54 8.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.651 1.981 . . . . 0.56999999999999995 110.535 171.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.16 -34.6 22.07 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 113.51 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.64 161.36 38.63 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.201 1.0 . . . . 0.56999999999999995 108.644 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -149.11 151.73 34.91 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 122.955 0.502 . . . . 0.65000000000000002 109.878 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.7 157.74 44.36 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.475 0.71 . . . . 0.56999999999999995 109.502 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -109.95 145.06 37.56 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.734 -0.839 . . . . 0.56999999999999995 108.734 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 151.11 92.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.56999999999999995 109.887 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 48.9 Cg_endo -67.94 157.68 60.71 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.338 2.025 . . . . 0.56999999999999995 111.887 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.34 21.43 0.02 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.226 1.251 . . . . 0.56999999999999995 116.226 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.309 37.0 p 64.8 71.57 0.46 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.28 2.232 . . . . 0.56999999999999995 113.743 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.39 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 120.783 -1.198 . . . . 0.56999999999999995 112.38 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.54 -6.05 37.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.733 1.613 . . . . 0.56999999999999995 111.211 164.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.93 129.75 13.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.115 -1.594 . . . . 0.56999999999999995 109.115 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.3 -27.01 20.04 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.012 1.768 . . . . 0.56999999999999995 112.758 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.07 147.26 53.8 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.795 -1.187 . . . . 0.66000000000000003 107.795 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.58 141.15 35.23 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 109.39 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 46.6 m170 -129.92 152.68 49.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 110.411 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.08 154.75 42.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.036 0.934 . . . . 0.56999999999999995 108.485 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.45 98.94 11.22 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.781 -0.822 . . . . 0.66000000000000003 108.781 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -56.63 -25.77 54.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.651 1.981 . . . . 0.66000000000000003 112.299 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -56.25 -40.63 74.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.594 1.157 . . . . 0.66000000000000003 110.218 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.49 126.9 31.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.035 0.934 . . . . 0.66000000000000003 108.575 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.97 98.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.617 1.167 . . . . 1.2 111.818 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.59 145.82 28.64 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.932 -1.136 . . . . 0.56999999999999995 107.932 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -141.73 147.09 36.83 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.759 -1.2 . . . . 0.56999999999999995 107.759 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.77 17.08 5.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.506 1.122 . . . . 0.66000000000000003 112.365 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.39 -151.7 23.35 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.76 2.124 . . . . 0.56999999999999995 108.006 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.81 -173.52 0.19 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 110.934 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 p -109.23 179.52 4.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.228 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.94 -58.87 0.57 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.499 2.32 . . . . 0.56999999999999995 113.686 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 169.93 53.33 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.766 1.651 . . . . 0.56999999999999995 110.36 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.1 120.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.976 -0.749 . . . . 0.56999999999999995 108.976 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.05 112.73 3.11 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.822 0.701 . . . . 0.56999999999999995 109.595 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.18 -40.13 64.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.587 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.94 -42.98 84.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.168 0.44 . . . . 0.56999999999999995 110.088 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.17 -45.12 95.94 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.97 66.29 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.393 0.677 . . . . 0.56999999999999995 111.443 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -53.36 55.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.166 -0.921 . . . . 0.56999999999999995 109.433 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 84.8 m -57.57 -37.76 73.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.684 1.129 . . . . 0.56999999999999995 111.309 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -62.71 -54.36 40.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.935 0.789 . . . . 0.65000000000000002 110.461 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.81 -43.15 84.58 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.149 0.979 . . . . 0.66000000000000003 110.795 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.33 -30.36 71.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 0.56999999999999995 111.226 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.05 -51.6 57.35 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.581 -1.008 . . . . 0.56999999999999995 110.581 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.21 -46.08 89.41 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.243 -0.884 . . . . 0.65000000000000002 111.016 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.8 p -61.94 -32.39 72.8 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 123.969 0.793 . . . . 0.56999999999999995 112.364 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -46.38 89.82 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.561 0.744 . . . . 0.56999999999999995 110.54 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.91 36.66 0.02 OUTLIER Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.796 -1.002 . . . . 0.56999999999999995 114.372 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -124.99 163.59 21.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 109.613 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.97 -47.0 0.17 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.61 -1.661 . . . . 0.56999999999999995 111.788 -169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m170 167.38 -177.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.707 2.803 . . . . 0.65000000000000002 107.964 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.6 p -152.07 -174.44 4.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.394 1.078 . . . . 0.56999999999999995 108.478 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.7 m -137.04 67.61 1.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 108.759 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -133.92 143.64 48.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.528 -0.916 . . . . 0.66000000000000003 108.528 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.89 -14.91 21.29 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 112.981 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 32.83 4.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.379 1.472 . . . . 0.56999999999999995 109.462 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -92.59 143.18 26.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.56999999999999995 109.875 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -67.46 -31.85 54.56 Favored 'Isoleucine or valine' 0 C--O 1.23 0.044 0 N-CA-C 109.401 -0.592 . . . . 0.56999999999999995 109.401 166.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -19.2 64.85 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 117.057 -1.449 . . . . 0.56999999999999995 112.236 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -49.9 109.81 1.4 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.266 1.394 . . . . 0.56999999999999995 110.524 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.1 38.91 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.215 2.61 . . . . 0.56999999999999995 113.331 -171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.2 m -150.28 132.58 15.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.666 1.586 . . . . 0.56999999999999995 107.032 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -81.7 101.57 10.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.68 -108.66 0.31 Allowed Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.572 -0.571 . . . . 0.56999999999999995 112.585 -171.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -38.03 87.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.714 0.806 . . . . 0.56999999999999995 112.352 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.05 90.82 0.06 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 124.967 1.27 . . . . 0.56999999999999995 110.767 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -52.68 115.53 7.34 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.758 2.023 . . . . 0.66000000000000003 109.883 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.3 -23.58 5.06 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.44 2.093 . . . . 0.56999999999999995 113.269 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -69.43 -39.59 77.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.863 1.211 . . . . 0.56999999999999995 110.524 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -141.17 116.64 10.16 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.415 1.086 . . . . 0.56999999999999995 108.902 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 15.0 p90 -147.2 -49.36 0.18 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 111.207 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER 30.61 52.98 0.14 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 127.321 2.248 . . . . 0.56999999999999995 113.113 -176.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp 63.32 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.006 1.722 . . . . 0.56999999999999995 110.935 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -70.65 -82.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.051 0.94 . . . . 0.56999999999999995 112.974 -165.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -144.63 -48.51 0.26 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 108.566 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -47.3 51.93 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.473 1.909 . . . . 0.66000000000000003 112.913 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.61 -54.42 47.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.756 0.822 . . . . 0.66000000000000003 110.827 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.15 -45.73 92.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.329 1.052 . . . . 0.56999999999999995 108.921 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -63.71 -41.91 98.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.812 1.245 . . . . 0.56999999999999995 109.368 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.03 -49.03 69.93 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.743 -0.943 . . . . 0.56999999999999995 110.743 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.65 -47.19 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 117.774 0.787 . . . . 0.56999999999999995 110.995 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -66.79 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.904 -0.569 . . . . 0.56999999999999995 112.063 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.45 43.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.292 0.951 . . . . 0.56999999999999995 110.612 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mp -78.45 -41.94 31.34 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.959 0.8 . . . . 0.56999999999999995 112.554 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 46' ' ' ILE . 70.1 m-85 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.202 0.815 . . . . 0.56999999999999995 113.202 -169.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB2' ' HA ' ' A' ' 163' ' ' LEU . 35.7 Cg_endo . . . . . 0 N--CA 1.449 -1.107 0 N-CA-C 110.171 -0.742 . . . . 0.56999999999999995 110.171 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.58 110.45 0.05 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 108.25 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 53.6 m95 -48.38 150.81 1.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.441 0.696 . . . . 0.56999999999999995 110.577 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.6 p -60.95 -24.23 65.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.56999999999999995 111.807 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.0 t -99.88 152.29 20.32 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.752 1.621 . . . . 0.56999999999999995 109.79 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -8.48 55.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 112.715 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.89 119.04 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.833 -2.284 . . . . 0.56999999999999995 104.833 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.87 142.41 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.347 -1.353 . . . . 0.56999999999999995 107.347 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -109.15 150.17 28.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.399 -0.813 . . . . 0.56999999999999995 110.432 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -127.0 148.71 50.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.665 -0.698 . . . . 0.56999999999999995 111.14 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.73 114.43 7.24 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.521 -0.918 . . . . 1.2 108.521 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.81 89.12 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 106.132 -1.803 . . . . 0.56999999999999995 106.132 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.08 -30.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 113.486 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.11 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.245 -2.502 . . . . 0.56999999999999995 104.245 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' HIS . 88.4 m-85 -135.47 -178.88 5.32 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.547 1.139 . . . . 0.56999999999999995 108.367 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 t -97.63 -162.69 0.98 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.56999999999999995 109.817 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -136.54 -31.52 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.053 1.131 . . . . 1.2 114.053 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.15 -38.8 65.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.826 1.25 . . . . 0.66000000000000003 109.957 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.64 153.28 81.05 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.267 2.227 . . . . 0.56999999999999995 109.85 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.85 158.24 42.9 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.803 2.335 . . . . 0.56999999999999995 113.475 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.404 ' HB2' ' CE1' ' A' ' 22' ' ' TYR . 12.8 p80 -62.38 -36.72 83.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.748 1.219 . . . . 0.65000000000000002 113.193 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -65.79 -37.17 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.081 0.552 . . . . 0.56999999999999995 110.52 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -63.27 -47.67 81.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 116.894 -1.527 . . . . 0.56999999999999995 108.101 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.24 -50.19 48.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 CA-C-N 120.41 1.459 . . . . 0.56999999999999995 110.762 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.36 -46.07 91.73 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.939 1.245 . . . . 0.66000000000000003 111.989 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -45.43 94.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.728 -0.607 . . . . 1.2 111.55 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.88 -43.11 94.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.408 -1.282 . . . . 0.56999999999999995 109.068 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -45.17 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 120.321 1.419 . . . . 0.56999999999999995 109.918 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.1 91.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.063 0.847 . . . . 0.56999999999999995 110.379 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -70.33 -37.08 74.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.972 0.909 . . . . 0.56999999999999995 112.389 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -48.4 74.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 110.908 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -67.57 -30.05 69.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.159 -0.924 . . . . 0.56999999999999995 110.825 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.62 -36.94 77.32 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.342 0.974 . . . . 0.56999999999999995 110.165 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.66 -38.22 88.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.406 -1.283 . . . . 0.56999999999999995 111.69 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -73.76 -41.27 62.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.851 1.205 . . . . 0.56999999999999995 111.677 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -5.46 55.66 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.915 -1.116 . . . . 0.56999999999999995 112.362 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -19.56 64.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 118.552 1.176 . . . . 0.56999999999999995 111.319 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.21 -35.55 5.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.313 1.045 . . . . 0.66000000000000003 112.023 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.414 HG22 ' CD1' ' A' ' 164' ' ' TYR . 16.3 pt -106.2 129.55 24.37 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 119.616 1.098 . . . . 0.56999999999999995 110.627 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.47 40.43 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.956 3.104 . . . . 0.56999999999999995 112.332 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.47 143.78 28.35 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 107.786 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -125.83 162.41 25.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.572 -0.899 . . . . 0.65000000000000002 108.572 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 160.05 40.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.631 -0.877 . . . . 0.56999999999999995 108.631 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -143.65 174.96 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -123.48 162.08 23.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.767 -1.197 . . . . 0.56999999999999995 107.767 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.54 175.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.153 1.781 . . . . 0.56999999999999995 108.494 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.3 -29.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.212 1.005 . . . . 0.56999999999999995 111.901 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -63.39 -62.08 1.92 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.094 1.358 . . . . 0.56999999999999995 112.512 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.39 38.14 0.15 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.354 0.502 . . . . 0.56999999999999995 113.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.6 t -166.47 149.06 6.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.355 1.462 . . . . 0.56999999999999995 107.316 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.19 -178.62 3.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.878 1.271 . . . . 0.56999999999999995 109.983 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.31 -35.33 75.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.297 0.639 . . . . 0.66000000000000003 109.915 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.27 69.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.595 1.958 . . . . 0.56999999999999995 107.748 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.12 118.9 16.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.099 -1.626 . . . . 0.56999999999999995 107.205 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.55 125.93 65.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.564 -2.013 . . . . 0.56999999999999995 105.564 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.63 165.69 26.39 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 110.702 -0.959 . . . . 0.56999999999999995 110.702 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.4 m-85 -133.2 148.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.042 -1.466 . . . . 0.56999999999999995 107.042 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.86 -171.65 3.49 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.494 1.517 . . . . 0.56999999999999995 108.767 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -122.59 179.92 4.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 1.2 108.953 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -39.84 106.41 0.06 OUTLIER Glycine 0 C--N 1.342 0.872 0 C-N-CA 126.084 1.802 . . . . 0.56999999999999995 110.615 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 56.05 137.06 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.429 2.692 . . . . 0.56999999999999995 115.169 -166.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 11.8 p-80 -154.21 159.08 41.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.003 0.921 . . . . 0.65000000000000002 109.99 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.62 55.04 1.99 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 111.321 -170.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -108.58 -50.16 3.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.515 0.726 . . . . 0.66000000000000003 110.511 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.13 -35.47 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.862 2.065 . . . . 0.56999999999999995 110.874 -166.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.2 100.43 7.07 Favored Pre-proline 0 C--N 1.347 0.492 0 CA-C-N 119.975 1.262 . . . . 0.56999999999999995 109.958 -170.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.97 120.27 7.47 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.076 1.184 . . . . 0.56999999999999995 110.591 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 12.5 m-85 -63.44 164.15 9.72 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 125.195 1.398 . . . . 0.56999999999999995 110.594 167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.28 -37.29 11.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.891 2.476 . . . . 0.66000000000000003 112.017 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.41 -147.01 18.91 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 119.444 1.02 . . . . 0.56999999999999995 112.018 -170.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.96 72.17 4.01 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.857 3.704 . . . . 0.56999999999999995 115.04 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.87 37.15 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.49 -1.381 . . . . 0.56999999999999995 111.815 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 38.6 -129.48 0.23 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.56999999999999995 114.016 167.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -64.7 118.63 9.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 111.154 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.71 -33.57 13.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 112.795 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.83 29.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.928 1.291 . . . . 0.56999999999999995 107.625 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -142.6 159.65 41.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.649 0.779 . . . . 0.65000000000000002 108.938 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.71 167.12 30.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.263 0.625 . . . . 0.56999999999999995 109.42 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -120.07 152.75 37.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.742 -0.663 . . . . 0.56999999999999995 109.512 -171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.33 153.63 85.62 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.098 -0.953 . . . . 0.56999999999999995 110.011 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 20.2 Cg_endo -65.33 162.98 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.889 1.726 . . . . 0.56999999999999995 111.38 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 -100.02 0.15 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.168 -1.573 . . . . 0.56999999999999995 109.168 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -157.24 120.14 3.99 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.262 -1.385 . . . . 0.56999999999999995 107.262 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.96 -121.49 6.69 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.046 -1.419 . . . . 0.56999999999999995 110.275 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.45 -27.9 58.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.637 1.175 . . . . 0.56999999999999995 111.546 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.92 144.26 7.68 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.754 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.21 -26.72 2.89 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.48 1.514 . . . . 0.56999999999999995 113.917 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.48 150.66 48.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.461 1.131 . . . . 0.66000000000000003 108.936 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.1 146.22 48.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.611 1.196 . . . . 0.56999999999999995 109.055 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 144.78 37.94 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.409 -1.269 . . . . 0.65000000000000002 108.795 -169.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 50.9 m-85 -139.02 149.63 44.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.288 -1.375 . . . . 0.56999999999999995 107.288 -166.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -94.69 99.05 11.23 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.091 -1.077 . . . . 0.66000000000000003 108.091 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.24 -24.37 41.96 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.718 2.007 . . . . 0.66000000000000003 111.785 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -59.21 -41.92 89.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.179 -0.304 . . . . 0.66000000000000003 110.179 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.34 134.42 47.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.746 -0.835 . . . . 0.66000000000000003 108.746 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -61.19 133.3 55.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.827 -0.434 . . . . 1.2 109.827 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -117.95 140.72 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.102 -1.444 . . . . 0.56999999999999995 107.102 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -140.12 148.75 42.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.988 0.813 . . . . 0.56999999999999995 109.431 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.79 -40.0 78.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.332 1.053 . . . . 0.66000000000000003 111.338 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 155.69 58.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.394 0.997 . . . . 0.56999999999999995 110.926 -170.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -153.1 170.81 19.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.926 0.863 . . . . 0.56999999999999995 110.093 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -70.15 77.34 0.51 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.56999999999999995 111.41 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -48.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.585 1.154 . . . . 0.56999999999999995 112.995 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.53 -152.0 6.69 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.466 -1.454 . . . . 0.56999999999999995 109.466 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.52 131.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.234 -0.654 . . . . 0.56999999999999995 109.234 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -57.37 104.1 0.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.56999999999999995 109.439 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.09 -41.69 79.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 109.496 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.48 -46.17 89.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.09 -41.41 99.4 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.901 -0.777 . . . . 0.56999999999999995 108.901 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.58 -53.08 60.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.294 0.638 . . . . 0.56999999999999995 111.524 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.02 71.08 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.597 -0.716 . . . . 0.56999999999999995 109.478 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.6 m -58.06 -40.05 80.01 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.872 0.76 . . . . 0.56999999999999995 111.664 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -60.17 -54.47 45.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.665 0.666 . . . . 0.65000000000000002 109.766 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.99 -45.21 82.46 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.555 -0.715 . . . . 0.66000000000000003 111.671 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.1 -32.93 74.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.447 1.099 . . . . 0.56999999999999995 111.341 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.4 -43.77 52.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.276 -0.73 . . . . 0.56999999999999995 111.276 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -75.94 -35.62 59.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.698 -0.667 . . . . 0.65000000000000002 112.26 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -37.49 70.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.763 0.825 . . . . 0.56999999999999995 111.189 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 mm? -63.02 -41.15 99.48 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.934 -0.479 . . . . 0.56999999999999995 111.77 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 165.7 45.12 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.681 -1.066 . . . . 0.56999999999999995 114.431 -172.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.5 mmt 55.09 -168.28 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.587 1.193 . . . . 0.56999999999999995 110.793 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.65 33.2 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.422 -0.799 . . . . 0.56999999999999995 113.936 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 170.28 2.47 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.304 1.052 . . . . 0.65000000000000002 113.686 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 p -151.35 -159.17 0.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 110.935 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.2 t -168.93 80.14 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 104.03 -2.582 . . . . 0.56999999999999995 104.03 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.67 147.56 55.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 108.315 -0.994 . . . . 0.66000000000000003 108.315 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.21 -20.19 33.05 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.112 2.541 . . . . 0.56999999999999995 112.951 -170.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -125.3 34.94 4.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.88 1.272 . . . . 0.56999999999999995 108.614 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.02 30.34 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.563 0.745 . . . . 0.56999999999999995 109.542 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.61 -31.22 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.876 -0.416 . . . . 0.56999999999999995 109.876 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.7 mmt -69.25 -4.61 18.5 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 112.402 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 31.1 t80 -60.94 145.14 89.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.781 1.173 . . . . 0.56999999999999995 109.956 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 73.0 Cg_endo -79.82 162.78 23.84 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.459 2.106 . . . . 0.56999999999999995 111.556 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.9 m 53.64 58.93 4.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.001 0.905 . . . . 0.56999999999999995 109.72 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 71.51 -177.86 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 110.173 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.31 137.0 11.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 107.493 -2.243 . . . . 0.56999999999999995 107.493 166.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -39.81 94.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.447 0.624 . . . . 0.56999999999999995 110.521 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.76 135.8 29.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.269 1.414 . . . . 0.56999999999999995 110.811 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -41.12 111.91 0.88 Allowed Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 126.764 2.026 . . . . 0.66000000000000003 111.819 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.77 -19.39 18.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.073 1.849 . . . . 0.56999999999999995 112.226 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -46.67 25.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.995 -1.113 . . . . 0.56999999999999995 107.995 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -91.99 71.99 5.56 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 111.046 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -33.48 -72.42 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.74 2.016 . . . . 0.56999999999999995 116.003 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 38.9 72.74 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.214 2.206 . . . . 0.56999999999999995 112.543 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.564 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.9 mp -35.72 114.49 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.261 2.225 . . . . 0.56999999999999995 110.091 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 p -82.93 -83.15 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 110.711 -163.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -140.04 -44.52 0.42 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 117.425 -1.274 . . . . 0.56999999999999995 111.711 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 -43.77 64.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 111.654 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.11 -52.8 62.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.63 0.772 . . . . 0.66000000000000003 110.198 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.98 -39.75 81.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 C-N-CA 123.359 0.664 . . . . 0.56999999999999995 109.504 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.68 97.13 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.132 1.373 . . . . 0.56999999999999995 109.071 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.18 -56.34 22.67 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.883 -1.287 . . . . 0.56999999999999995 109.883 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -50.34 -56.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.979 1.712 . . . . 0.56999999999999995 111.106 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -72.31 -11.5 60.73 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.196 -0.94 . . . . 0.56999999999999995 112.035 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 -15.53 27.84 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 0.56999999999999995 110.967 167.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -82.92 -52.86 6.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.929 1.692 . . . . 0.56999999999999995 109.692 -178.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.414 ' CD1' HG22 ' A' ' 46' ' ' ILE . 3.8 p90 . . . . . 0 N--CA 1.468 0.463 0 C-N-CA 123.31 0.644 . . . . 0.56999999999999995 110.999 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.402 -1.038 . . . . 0.56999999999999995 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttt 86.79 138.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.449 2.7 . . . . 0.56999999999999995 108.98 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 80.9 m95 -75.96 167.71 21.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.638 0.732 . . . . 0.56999999999999995 110.689 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 p -73.66 -13.97 61.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.479 1.112 . . . . 0.56999999999999995 112.507 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -134.34 150.58 50.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.975 1.31 . . . . 0.56999999999999995 109.284 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.91 -3.12 37.06 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.557 1.543 . . . . 0.56999999999999995 112.804 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.65 128.1 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.458 -1.682 . . . . 0.56999999999999995 106.458 172.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.47 139.16 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.784 -1.932 . . . . 0.56999999999999995 105.784 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -115.08 133.76 55.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -114.92 164.07 14.66 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.684 -0.689 . . . . 0.56999999999999995 110.223 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.88 165.66 35.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.979 169.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.0 mt -126.61 78.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 104.272 -2.492 . . . . 0.56999999999999995 104.272 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -65.57 -30.94 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 112.134 -175.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -133.09 165.17 25.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.086 -2.19 . . . . 0.56999999999999995 105.086 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.72 158.19 43.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.068 1.347 . . . . 0.56999999999999995 109.423 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 t -77.41 -15.08 59.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.255 1.206 . . . . 0.56999999999999995 114.255 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 66.63 -19.88 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.573 1.949 . . . . 1.2 115.03 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -66.88 -31.49 72.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.664 1.586 . . . . 0.66000000000000003 111.951 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 148.05 62.24 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 125.962 1.705 . . . . 0.56999999999999995 108.201 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.34 161.06 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.898 2.398 . . . . 0.56999999999999995 112.128 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.02 -35.95 78.24 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.907 0.883 . . . . 0.65000000000000002 111.831 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.44 -35.78 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.149 0.58 . . . . 0.56999999999999995 110.194 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.7 m -78.97 -37.75 38.64 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 117.882 -1.056 . . . . 0.56999999999999995 110.045 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.91 -44.32 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.202 1.365 . . . . 0.56999999999999995 109.37 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -69.66 -42.39 74.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.78 0.718 . . . . 0.66000000000000003 110.555 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -42.9 84.04 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.846 -1.159 . . . . 1.2 113.259 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.99 -40.82 97.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.56999999999999995 108.338 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.11 -40.6 89.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 119.25 0.932 . . . . 0.56999999999999995 110.604 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -56.89 -52.71 64.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.152 0.887 . . . . 0.56999999999999995 109.119 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -69.76 -36.31 75.67 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.696 -1.145 . . . . 0.56999999999999995 112.002 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.16 91.32 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.522 1.51 . . . . 0.56999999999999995 111.917 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.35 -36.03 76.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.498 -0.763 . . . . 0.56999999999999995 109.913 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.85 -39.1 90.66 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 109.815 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.24 -38.06 89.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.14 1.337 . . . . 0.56999999999999995 112.252 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' CE3' HD11 ' A' ' 160' ' ' ILE . 18.3 m95 -66.37 -54.76 20.71 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.404 1.002 . . . . 0.56999999999999995 109.989 170.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.63 -8.91 49.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.054 1.312 . . . . 0.56999999999999995 114.349 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -68.13 -18.3 64.59 Favored 'General case' 0 C--O 1.226 -0.134 0 O-C-N 120.928 -1.337 . . . . 0.56999999999999995 111.454 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.12 -12.53 11.91 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.59 0.632 . . . . 0.66000000000000003 111.052 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.62 127.54 19.6 Favored Pre-proline 0 C--N 1.347 0.483 0 C-N-CA 124.582 1.153 . . . . 0.56999999999999995 108.763 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 41.18 0.65 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.141 3.228 . . . . 0.56999999999999995 112.804 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 tt -92.75 146.62 23.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.685 1.994 . . . . 0.56999999999999995 108.598 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -124.48 160.95 27.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.438 -0.949 . . . . 0.65000000000000002 108.438 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 161.47 37.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.604 -0.517 . . . . 0.56999999999999995 109.604 -171.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -144.52 177.4 8.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.2 1.4 . . . . 1.2 109.335 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.52 136.83 41.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.232 -1.396 . . . . 0.56999999999999995 107.232 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.98 166.31 2.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.997 0.427 . . . . 0.56999999999999995 110.044 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.89 25.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 111.515 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -55.0 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 112.262 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.91 -153.1 5.79 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.825 -1.31 . . . . 0.56999999999999995 109.825 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -68.94 175.28 3.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.316 0.579 . . . . 0.56999999999999995 110.339 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.79 -178.29 5.19 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.528 1.531 . . . . 0.56999999999999995 109.972 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.96 -32.85 74.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 117.554 -1.212 . . . . 0.66000000000000003 110.834 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.31 73.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.893 1.277 . . . . 0.56999999999999995 107.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.39 155.35 30.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.175 -1.578 . . . . 0.56999999999999995 110.93 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.31 127.63 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.945 -2.613 . . . . 0.56999999999999995 103.945 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.17 162.4 28.38 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.995 -0.842 . . . . 0.56999999999999995 110.995 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -134.88 140.04 45.48 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.823 -1.917 . . . . 0.56999999999999995 105.823 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.67 -178.0 5.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.444 1.498 . . . . 0.56999999999999995 108.698 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 52.18 2.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.926 0.891 . . . . 1.2 110.295 -169.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.66 -141.0 16.64 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.768 -1.333 . . . . 0.56999999999999995 109.768 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 131.43 8.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.367 1.067 . . . . 0.56999999999999995 110.843 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.45 156.72 40.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 125.168 1.387 . . . . 0.65000000000000002 109.493 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 93.4 0.38 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 109.237 -1.545 . . . . 0.56999999999999995 109.237 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -149.63 -85.05 0.09 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.497 1.519 . . . . 0.66000000000000003 108.034 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.22 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.392 1.477 . . . . 0.56999999999999995 109.259 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.19 139.49 31.79 Favored Pre-proline 0 C--N 1.342 0.252 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 108.755 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -68.36 143.37 57.88 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.021 1.147 . . . . 0.56999999999999995 109.264 167.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -73.84 -177.1 2.68 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.87 1.319 . . . . 0.56999999999999995 109.759 163.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -108.88 -38.03 5.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.211 3.405 . . . . 0.66000000000000003 111.341 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.4 -151.02 19.66 Favored Glycine 0 CA--C 1.54 1.603 0 CA-C-O 117.706 -1.608 . . . . 0.56999999999999995 111.198 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.92 75.69 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.17 1 C-N-CA 125.549 4.166 . . . . 0.56999999999999995 114.653 -168.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.66 172.32 25.63 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.561 2.505 . . . . 0.56999999999999995 108.971 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.01 -143.56 0.65 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.715 1.606 . . . . 0.56999999999999995 112.735 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -41.75 130.29 3.3 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 128.055 2.542 . . . . 0.56999999999999995 110.856 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.77 -28.37 13.53 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.446 -1.409 . . . . 0.56999999999999995 112.567 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.72 161.27 37.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 108.851 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.03 151.11 36.39 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.545 0.688 . . . . 0.65000000000000002 110.127 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.47 172.59 12.48 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 109.189 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -124.18 139.26 54.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.93 159.11 11.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.963 0.905 . . . . 0.56999999999999995 110.043 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 48.6 Cg_endo -66.99 158.64 55.77 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.552 1.501 . . . . 0.56999999999999995 110.691 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.55 -138.49 5.15 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.573 -1.011 . . . . 0.56999999999999995 110.573 -172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -138.58 96.68 3.2 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.444 -1.317 . . . . 0.56999999999999995 107.444 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 125.33 -118.54 3.28 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 108.701 -1.759 . . . . 0.56999999999999995 108.701 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -27.56 65.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.888 2.075 . . . . 0.56999999999999995 112.473 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.66 145.09 10.64 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.208 -0.933 . . . . 0.56999999999999995 111.433 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.34 -27.44 4.62 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 125.397 1.475 . . . . 0.56999999999999995 114.117 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.61 156.06 39.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.66000000000000003 108.97 -168.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.25 145.22 38.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.899 0.857 . . . . 0.56999999999999995 110.061 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.11 146.65 39.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.396 1.078 . . . . 0.65000000000000002 109.265 -171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 38.3 m-85 -139.55 146.91 40.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.833 -0.803 . . . . 0.56999999999999995 108.833 -167.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -83.95 99.71 10.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.23 -0.656 . . . . 0.66000000000000003 109.23 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -58.91 -24.6 62.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.292 1.437 . . . . 0.66000000000000003 111.337 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.29 -43.62 98.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.515 1.526 . . . . 0.66000000000000003 110.309 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.42 134.23 49.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.223 -1.769 . . . . 0.66000000000000003 106.223 174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 149.55 41.39 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.226 -1.546 . . . . 1.2 109.434 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -129.98 168.22 17.02 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.273 1.029 . . . . 0.56999999999999995 108.294 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.303 -0.999 . . . . 0.56999999999999995 108.303 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.02 38.63 0.72 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.205 1.002 . . . . 0.66000000000000003 110.683 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.02 60.32 2.06 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.985 1.279 . . . . 0.56999999999999995 111.029 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 91.42 3.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 110.236 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m 64.72 -71.53 0.07 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 127.835 2.454 . . . . 0.56999999999999995 113.781 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.98 166.54 26.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.56999999999999995 107.998 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.37 -156.71 21.02 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.093 -1.603 . . . . 0.56999999999999995 109.093 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.06 112.15 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.283 -1.377 . . . . 0.56999999999999995 107.283 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.39 101.94 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.35 0.66 . . . . 0.56999999999999995 111.501 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -58.59 -38.44 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 109.439 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -43.87 97.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.793 0.724 . . . . 0.56999999999999995 110.667 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.17 -48.39 81.8 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 109.528 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.27 76.96 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.545 0.338 . . . . 0.56999999999999995 111.303 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.54 63.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.338 -0.839 . . . . 0.56999999999999995 109.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.8 m -58.2 -37.81 75.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.282 0.946 . . . . 0.56999999999999995 111.577 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.55 -57.14 13.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.652 1.181 . . . . 0.65000000000000002 109.648 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.52 -45.43 90.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.331 0.653 . . . . 0.66000000000000003 110.487 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.36 -28.67 69.39 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.621 1.169 . . . . 0.56999999999999995 111.843 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.45 -45.71 95.72 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.638 0.654 . . . . 0.56999999999999995 111.897 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -68.58 -37.32 79.75 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-O 118.292 -0.861 . . . . 0.65000000000000002 110.93 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.6 m -59.85 -31.64 69.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.058 0.844 . . . . 0.56999999999999995 112.361 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -34.56 66.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.515 1.052 . . . . 0.56999999999999995 111.802 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.25 -56.68 0.13 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-O 119.198 -0.779 . . . . 0.56999999999999995 111.45 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.99 178.04 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.855 2.062 . . . . 0.56999999999999995 108.695 -169.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.12 22.68 0.02 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.028 -0.873 . . . . 0.56999999999999995 112.812 172.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 161.05 30.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.871 1.335 . . . . 0.65000000000000002 111.716 -174.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.44 -170.54 1.47 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.336 1.854 . . . . 0.56999999999999995 108.777 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.71 48.56 1.81 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.442 1.097 . . . . 0.56999999999999995 110.79 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.5 t70 -98.35 144.45 28.11 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 118.004 -0.998 . . . . 0.66000000000000003 110.671 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 -20.58 68.21 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 113.564 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -128.57 25.31 5.73 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.115 1.366 . . . . 0.56999999999999995 110.776 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -62.97 134.09 55.64 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.138 0.97 . . . . 0.56999999999999995 111.093 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.21 -24.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 111.429 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -106.6 22.81 15.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.14 0.976 . . . . 0.56999999999999995 111.38 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 3.6 t80 -60.67 131.28 90.98 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.488 1.495 . . . . 0.56999999999999995 110.437 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 49.5 Cg_endo -79.58 -38.95 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.405 1.403 . . . . 0.56999999999999995 112.625 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 139' ' ' TYR . 87.2 m -80.12 67.78 6.05 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.675 -1.266 . . . . 0.56999999999999995 110.03 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -50.03 136.99 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.983 1.313 . . . . 0.56999999999999995 112.054 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.71 107.74 2.99 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.024 0.821 . . . . 0.56999999999999995 111.297 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -165.99 -56.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.608 1.563 . . . . 0.56999999999999995 108.575 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -117.14 -100.84 2.14 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 108.852 -1.699 . . . . 0.56999999999999995 108.852 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -156.52 111.89 2.03 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.66000000000000003 109.463 -170.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.17 -9.14 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.4 2.733 . . . . 0.56999999999999995 113.039 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.74 -18.37 61.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.138 1.335 . . . . 0.56999999999999995 111.039 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -116.63 74.13 0.89 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.618 1.967 . . . . 0.56999999999999995 109.494 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -128.8 122.66 30.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.492 1.517 . . . . 0.56999999999999995 107.914 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 69.11 1.06 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.625 -1.25 . . . . 0.56999999999999995 107.625 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp 52.59 79.77 0.11 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 0.56999999999999995 110.798 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -78.36 0.05 OUTLIER 'General case' 0 C--N 1.342 0.261 0 N-CA-C 114.27 1.211 . . . . 0.56999999999999995 114.27 -166.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -148.79 -49.23 0.15 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.861 1.264 . . . . 0.56999999999999995 108.214 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -45.69 -42.64 11.92 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 128.294 2.638 . . . . 0.66000000000000003 112.14 166.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -66.86 -58.36 5.17 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.8 0.84 . . . . 0.66000000000000003 111.218 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.48 -37.04 67.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 119.014 -0.517 . . . . 0.56999999999999995 109.694 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -59.82 -41.55 91.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.679 0.792 . . . . 0.56999999999999995 108.9 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.26 -52.91 24.47 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.305 -1.118 . . . . 0.56999999999999995 110.305 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.43 HD11 ' CE3' ' A' ' 42' ' ' TRP . 24.7 mm -56.2 -51.03 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.152 0.981 . . . . 0.56999999999999995 111.641 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.63 -28.88 68.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.393 0.542 . . . . 0.56999999999999995 110.783 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 162' ' ' LYS . 0.9 OUTLIER -75.67 -23.32 56.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.01 -0.519 . . . . 0.56999999999999995 111.603 175.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.1 mt -85.92 -48.46 8.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.56999999999999995 110.901 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.729 0.64 . . . . 0.56999999999999995 112.729 -168.72 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.444 -1.395 0 N-CA-C 108.443 -1.406 . . . . 0.56999999999999995 108.443 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.19 113.85 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 108.672 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 40.0 m95 -46.88 147.42 1.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.537 0.735 . . . . 0.56999999999999995 109.988 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -62.29 -27.91 69.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.572 0.749 . . . . 0.56999999999999995 111.701 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.2 t -82.87 149.09 27.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.013 1.325 . . . . 0.56999999999999995 110.963 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -74.55 -10.59 59.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.331 1.052 . . . . 0.56999999999999995 112.868 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.45 144.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.71 1.204 . . . . 0.56999999999999995 107.946 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.1 t -130.98 145.53 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.278 -1.378 . . . . 0.56999999999999995 107.278 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -94.39 142.49 27.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.294 -0.632 . . . . 0.56999999999999995 109.294 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -123.07 147.92 46.19 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.235 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 100.71 3.36 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.861 0.839 . . . . 1.2 109.586 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.18 101.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 105.122 -2.177 . . . . 0.56999999999999995 105.122 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -48.89 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.458 1.503 . . . . 0.56999999999999995 111.174 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.9 p -130.59 174.45 9.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.4 -1.704 . . . . 0.56999999999999995 106.4 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -140.34 167.56 21.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.015 -1.476 . . . . 0.56999999999999995 107.015 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -65.63 178.6 0.97 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.891 0.476 . . . . 0.56999999999999995 111.03 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -34.45 2.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.393 1.077 . . . . 1.2 112.508 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -39.85 82.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.305 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.3 mt -113.66 148.91 40.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.759 1.223 . . . . 0.56999999999999995 108.646 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.21 150.82 33.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.103 1.868 . . . . 0.56999999999999995 112.423 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -59.87 -40.14 87.64 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.698 1.199 . . . . 0.65000000000000002 111.932 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.8 tt -62.95 -36.44 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.191 0.596 . . . . 0.56999999999999995 111.048 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 m -69.05 -42.4 76.34 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.081 -1.438 . . . . 0.56999999999999995 108.984 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -55.74 -47.59 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 121.154 1.797 . . . . 0.56999999999999995 110.095 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.07 -48.73 80.5 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.876 0.87 . . . . 0.66000000000000003 110.548 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.93 -46.29 88.34 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.509 -0.744 . . . . 1.2 112.48 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.86 -41.79 82.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.416 1.086 . . . . 0.56999999999999995 109.346 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.87 -50.15 76.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 118.034 -0.984 . . . . 0.56999999999999995 109.269 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -41.28 99.42 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 111.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -65.03 -46.3 81.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.7 1.136 . . . . 0.56999999999999995 110.864 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.74 92.06 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.889 1.276 . . . . 0.56999999999999995 112.405 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.98 -37.34 75.73 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.512 0.725 . . . . 0.56999999999999995 110.614 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.23 -41.14 87.98 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.828 0.74 . . . . 0.56999999999999995 109.87 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.7 mtp -66.02 -33.1 75.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.677 0.791 . . . . 0.56999999999999995 112.544 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -70.81 -49.34 47.5 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.369 0.986 . . . . 0.56999999999999995 111.112 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.63 -10.78 71.92 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.0 1.286 . . . . 0.56999999999999995 113.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -62.18 -26.63 68.45 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.667 -1.49 . . . . 0.56999999999999995 111.022 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -97.94 -38.29 9.46 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.975 -0.535 . . . . 0.66000000000000003 110.886 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.92 136.41 23.26 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 110.576 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 38.32 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 124.195 3.264 . . . . 0.56999999999999995 112.906 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.15 138.36 31.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.933 1.693 . . . . 0.56999999999999995 107.601 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -120.59 170.82 9.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.65000000000000002 108.662 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.51 153.92 45.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.396 -0.964 . . . . 0.56999999999999995 108.396 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 161.04 37.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.14 0.576 . . . . 1.2 110.803 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -104.08 145.56 30.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.822 -0.807 . . . . 0.56999999999999995 108.822 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.73 170.86 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.114 0.965 . . . . 0.56999999999999995 110.32 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.93 37.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.852 1.261 . . . . 0.56999999999999995 110.215 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -146.46 -72.58 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.028 0.931 . . . . 0.56999999999999995 110.665 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.8 25.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.421 -1.211 . . . . 0.56999999999999995 115.557 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -154.09 135.27 14.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.56999999999999995 106.848 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.63 177.2 11.65 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.074 0.95 . . . . 0.56999999999999995 110.598 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' HG12 ' A' ' 15' ' ' VAL . 49.2 m-20 -71.15 -37.09 72.25 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.297 -0.858 . . . . 0.66000000000000003 110.516 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.99 77.76 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.182 2.193 . . . . 0.56999999999999995 107.82 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -75.28 125.17 28.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.574 -1.269 . . . . 0.56999999999999995 107.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.42 123.12 67.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.999 -2.223 . . . . 0.56999999999999995 104.999 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.9 162.98 26.31 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.843 -0.503 . . . . 0.56999999999999995 111.843 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 13.9 m-85 -137.32 126.8 25.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.546 -1.65 . . . . 0.56999999999999995 106.546 -172.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.74 -174.41 4.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 108.194 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.9 140.29 18.68 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.6 -0.889 . . . . 1.2 108.6 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.95 -90.4 0.41 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.251 0.453 . . . . 0.56999999999999995 112.341 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.79 172.59 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.868 0.834 . . . . 0.56999999999999995 110.049 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -153.75 142.87 21.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.65000000000000002 109.466 175.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.72 45.73 1.58 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.024 1.297 . . . . 0.56999999999999995 112.622 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.4 28.11 0.99 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.302 2.241 . . . . 0.66000000000000003 110.139 -172.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.82 -38.86 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.174 1.79 . . . . 0.56999999999999995 112.029 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -91.25 104.8 10.62 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.604 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.43 143.01 74.55 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.16 1.24 . . . . 0.56999999999999995 109.366 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -72.61 -170.57 0.69 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.719 1.247 . . . . 0.56999999999999995 109.776 170.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -124.65 -45.19 1.93 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.617 2.367 . . . . 0.66000000000000003 108.617 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.29 -148.98 16.56 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.068 1.318 . . . . 0.56999999999999995 110.953 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.74 68.76 2.95 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 125.969 4.446 . . . . 0.56999999999999995 112.933 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.02 166.01 16.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 126.421 1.962 . . . . 0.56999999999999995 108.933 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 49.73 -160.97 0.06 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.502 1.521 . . . . 0.56999999999999995 112.924 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.2 m -31.8 104.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.913 2.885 . . . . 0.56999999999999995 114.583 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.44 -29.74 57.09 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.104 -1.623 . . . . 0.56999999999999995 114.0 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.7 161.99 40.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 108.239 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.62 158.56 44.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.472 -0.566 . . . . 0.65000000000000002 109.472 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.32 170.37 19.7 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 108.824 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -124.09 149.22 46.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.212 -1.033 . . . . 0.56999999999999995 108.212 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.72 154.54 80.12 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.593 -0.717 . . . . 0.56999999999999995 110.137 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 37.4 Cg_endo -67.48 166.34 24.12 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.396 2.064 . . . . 0.56999999999999995 111.784 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.45 -116.75 0.67 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.3 p -149.03 65.68 1.04 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.625 0.77 . . . . 0.56999999999999995 111.046 -167.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.99 -121.67 1.4 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.5 -1.44 . . . . 0.56999999999999995 109.5 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.91 -25.9 32.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.053 1.341 . . . . 0.56999999999999995 112.024 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 140.33 11.79 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.852 -1.155 . . . . 0.56999999999999995 111.089 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.4 -24.32 4.97 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.283 1.42 . . . . 0.56999999999999995 113.776 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -68.63 153.24 44.15 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.987 0.893 . . . . 0.66000000000000003 108.726 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.0 146.13 31.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.56999999999999995 109.176 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -140.96 155.59 46.21 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.28 -0.873 . . . . 0.65000000000000002 111.258 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 46.6 m-85 -137.25 141.9 42.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.877 -1.157 . . . . 0.56999999999999995 107.877 -163.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -80.9 104.36 11.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.716 -1.216 . . . . 0.66000000000000003 107.716 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.4 -23.74 67.39 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.33 -0.856 . . . . 0.66000000000000003 110.844 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.29 -24.18 60.38 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 110.117 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.92 132.48 39.1 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.16 -1.052 . . . . 0.66000000000000003 108.16 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -65.98 143.36 57.43 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.352 -0.61 . . . . 1.2 109.352 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -126.36 137.38 53.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.609 -1.256 . . . . 0.56999999999999995 107.609 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.3 t -113.53 147.41 37.99 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.869 -0.789 . . . . 0.56999999999999995 108.869 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -74.52 21.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.166 1.786 . . . . 0.66000000000000003 112.981 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.13 124.86 0.25 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.406 1.955 . . . . 0.56999999999999995 109.998 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 t 74.74 58.49 0.07 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.987 1.715 . . . . 0.56999999999999995 113.004 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 41.11 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.299 1.04 . . . . 0.56999999999999995 112.538 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp 55.52 -178.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 111.843 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.01 -168.33 52.06 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.011 -1.056 . . . . 0.56999999999999995 111.653 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.9 121.16 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.847 -0.797 . . . . 0.56999999999999995 108.847 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -56.8 106.72 0.33 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.872 1.269 . . . . 0.56999999999999995 109.209 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.84 -38.29 75.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.481 0.712 . . . . 0.56999999999999995 109.958 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.28 -51.42 66.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.596 -1.261 . . . . 0.56999999999999995 107.596 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -54.92 -42.51 72.3 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.876 -0.583 . . . . 0.56999999999999995 111.042 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.5 5.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.277 0.631 . . . . 0.56999999999999995 110.275 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.79 -50.16 75.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 118.349 -0.834 . . . . 0.56999999999999995 109.492 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 m -57.34 -36.45 71.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.597 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.7 -55.39 17.65 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.19 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.11 -40.74 90.96 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.61 -0.681 . . . . 0.66000000000000003 110.749 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.81 -32.28 73.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.472 1.509 . . . . 0.56999999999999995 111.692 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.25 94.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.466 -0.654 . . . . 0.56999999999999995 111.466 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -69.33 -37.11 77.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 117.594 -1.193 . . . . 0.65000000000000002 111.916 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.2 p -59.08 -33.19 70.53 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.18 0.925 . . . . 0.56999999999999995 111.269 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.7 mm? -68.63 -33.97 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 112.023 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 151.78 53.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.605 1.093 . . . . 0.56999999999999995 114.404 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 mmt 58.06 -177.17 0.07 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.489 0.661 . . . . 0.56999999999999995 111.452 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.13 57.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.527 -1.429 . . . . 0.56999999999999995 109.527 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.36 167.32 11.6 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.93 0.871 . . . . 0.65000000000000002 110.467 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 t -160.69 -170.31 2.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.917 1.287 . . . . 0.56999999999999995 109.74 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.23 30.36 1.14 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.571 1.948 . . . . 0.56999999999999995 109.999 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.49 148.43 35.48 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.739 1.216 . . . . 0.66000000000000003 109.974 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.94 -21.53 43.56 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.287 2.658 . . . . 0.56999999999999995 113.279 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -132.59 29.05 4.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.376 1.871 . . . . 0.56999999999999995 108.661 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.1 133.03 49.05 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.658 -1.276 . . . . 0.56999999999999995 109.026 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 156' ' ' ASP . 4.3 p -55.8 -28.73 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.371 1.468 . . . . 0.56999999999999995 112.68 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.49 27.9 9.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.099 . . . . 0.56999999999999995 110.338 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -56.49 129.17 75.45 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 109.971 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.59 178.38 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.942 2.428 . . . . 0.56999999999999995 110.573 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m 71.08 -40.99 0.49 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.504 1.522 . . . . 0.56999999999999995 113.321 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.9 t80 55.39 92.21 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.275 2.23 . . . . 0.56999999999999995 113.722 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.75 105.75 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.598 -1.001 . . . . 0.56999999999999995 110.598 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -172.65 -50.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.093 1.357 . . . . 0.56999999999999995 110.565 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.88 -113.1 2.94 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.25 -1.94 . . . . 0.56999999999999995 108.25 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.68 134.59 9.19 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 106.529 -1.656 . . . . 0.66000000000000003 106.529 174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.09 -8.43 6.63 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.023 3.149 . . . . 0.56999999999999995 113.559 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -71.01 -28.16 64.21 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.151 -1.593 . . . . 0.56999999999999995 111.368 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -106.96 61.79 0.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.56999999999999995 110.916 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -126.44 141.26 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.575 1.15 . . . . 0.56999999999999995 110.311 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.66 51.68 0.08 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.866 0.866 . . . . 0.56999999999999995 110.956 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 69.27 76.64 0.23 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.554 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.3 t -69.57 -94.42 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.918 0.887 . . . . 0.56999999999999995 112.044 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -131.12 -44.69 1.03 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.986 0.914 . . . . 0.56999999999999995 109.641 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -46.04 49.96 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.96 0.904 . . . . 0.66000000000000003 110.615 166.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.597 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.2 t0 -60.23 -56.58 19.82 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.524 -0.75 . . . . 0.66000000000000003 110.403 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.39 -43.84 87.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 N-CA-C 109.044 -0.724 . . . . 0.56999999999999995 109.044 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -64.43 -38.66 91.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.675 0.79 . . . . 0.56999999999999995 110.72 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.93 -49.73 39.75 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.689 -0.965 . . . . 0.56999999999999995 110.689 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -56.54 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 C-N-CA 126.144 1.777 . . . . 0.56999999999999995 110.254 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.6 -20.53 65.74 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.845 -0.534 . . . . 0.56999999999999995 110.777 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -88.1 -29.83 20.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.201 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.27 -58.02 8.51 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 125.717 1.607 . . . . 0.56999999999999995 109.747 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 113.155 0.798 . . . . 0.56999999999999995 113.155 -177.167 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.457 -0.622 0 N-CA-C 109.884 -0.852 . . . . 0.56999999999999995 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 pttt 67.01 141.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.759 2.023 . . . . 0.56999999999999995 110.881 -165.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -56.5 149.2 17.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.046 0.939 . . . . 0.56999999999999995 110.371 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 p -62.63 -20.03 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.305 0.854 . . . . 0.56999999999999995 113.305 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -96.7 140.98 30.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.849 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -72.96 -14.09 61.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 113.064 171.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 m -114.2 119.54 61.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.759 -1.941 . . . . 0.56999999999999995 105.759 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.17 155.59 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.31 -1.367 . . . . 0.56999999999999995 107.31 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -106.88 143.6 34.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.56999999999999995 109.758 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -126.64 145.46 50.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.601 -0.518 . . . . 0.56999999999999995 109.601 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.1 115.13 3.48 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.758 0.79 . . . . 1.2 111.921 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.0 95.17 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 105.718 -1.956 . . . . 0.56999999999999995 105.718 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 m -67.0 -39.02 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.132 0.973 . . . . 0.56999999999999995 112.067 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -130.0 152.49 49.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.089 -2.56 . . . . 0.56999999999999995 104.089 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -127.41 167.34 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.977 1.311 . . . . 0.56999999999999995 107.858 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 t -64.63 -179.99 0.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 110.901 173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -40.13 3.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.83 0.852 . . . . 1.2 111.585 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -41.97 77.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.654 0.661 . . . . 0.66000000000000003 111.583 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.69 152.86 38.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.56999999999999995 108.587 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.42 149.53 39.79 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.897 1.731 . . . . 0.56999999999999995 112.41 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -58.86 -37.42 76.47 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 113.08 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -43.52 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.773 -0.455 . . . . 0.56999999999999995 109.773 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 m -66.61 -39.99 88.62 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.945 -1.026 . . . . 0.56999999999999995 109.577 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.5 -51.08 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.709 1.14 . . . . 0.56999999999999995 110.704 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -63.35 -43.05 98.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.87 1.214 . . . . 0.66000000000000003 110.482 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -46.75 87.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.216 -0.927 . . . . 1.2 111.207 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.79 -38.27 86.19 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.263 -1.351 . . . . 0.56999999999999995 109.904 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -59.62 -46.55 93.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 110.076 170.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.266 0.939 . . . . 0.56999999999999995 109.502 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -68.47 -41.86 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.363 -0.827 . . . . 0.56999999999999995 111.688 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.27 -46.62 87.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.735 1.152 . . . . 0.56999999999999995 111.504 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.2 mt -67.91 -37.53 81.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.934 0.894 . . . . 0.56999999999999995 110.162 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.39 -39.73 84.29 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.209 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -43.94 97.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.725 0.81 . . . . 0.56999999999999995 111.349 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 33.9 m95 -61.76 -47.84 83.38 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.852 0.751 . . . . 0.56999999999999995 111.285 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.21 -2.07 71.6 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.298 -0.876 . . . . 0.56999999999999995 113.695 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -81.82 -11.59 58.9 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.347 1.573 . . . . 0.56999999999999995 110.071 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -108.62 -21.8 12.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.356 0.526 . . . . 0.66000000000000003 111.353 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 160' ' ' ILE . 8.4 pt -136.52 146.46 55.8 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.731 1.213 . . . . 0.56999999999999995 110.302 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.99 58.43 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 111.937 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.03 138.19 54.21 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.613 1.965 . . . . 0.56999999999999995 106.631 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -123.23 160.46 26.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.291 -1.003 . . . . 0.65000000000000002 108.291 -171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.43 149.98 38.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.829 -1.175 . . . . 0.56999999999999995 107.829 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -134.2 157.34 46.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.149 0.979 . . . . 1.2 109.046 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -115.81 108.85 16.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 -174.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.46 133.76 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.555 -1.276 . . . . 0.56999999999999995 107.555 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -37.18 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.179 -0.325 . . . . 0.56999999999999995 110.208 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.63 162.17 39.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.312 1.045 . . . . 0.56999999999999995 109.003 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.84 156.83 18.15 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.964 -1.255 . . . . 0.56999999999999995 109.964 -164.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -64.32 168.53 5.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.517 0.675 . . . . 0.56999999999999995 110.696 168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.2 17.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.766 1.226 . . . . 0.56999999999999995 109.937 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -67.96 -44.04 77.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.987 -1.006 . . . . 0.66000000000000003 109.341 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.4 mt -116.53 78.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.082 1.753 . . . . 0.56999999999999995 107.74 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.0 ttm -76.3 153.66 35.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.848 -1.158 . . . . 0.56999999999999995 109.612 171.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.75 134.83 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.73 -1.952 . . . . 0.56999999999999995 105.73 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.56 166.54 30.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.779 -0.928 . . . . 0.56999999999999995 110.779 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -138.6 149.99 45.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.661 -0.866 . . . . 0.56999999999999995 108.661 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.42 175.92 11.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.969 1.308 . . . . 0.56999999999999995 110.249 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -140.46 63.0 1.48 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.765 1.226 . . . . 1.2 109.812 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.79 -70.64 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.644 -0.583 . . . . 0.56999999999999995 111.644 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.13 174.72 8.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.942 -1.328 . . . . 0.56999999999999995 110.398 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -149.45 137.86 20.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.427 -0.583 . . . . 0.65000000000000002 109.427 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.91 37.52 3.39 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.235 0.922 . . . . 0.56999999999999995 112.021 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.78 -72.05 0.46 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.1 1.36 . . . . 0.66000000000000003 108.574 -171.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -172.55 -36.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.979 -0.534 . . . . 0.56999999999999995 111.677 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -102.76 101.64 21.96 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-O 118.286 -0.864 . . . . 0.56999999999999995 108.732 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.79 129.27 28.46 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 108.26 -1.477 . . . . 0.56999999999999995 108.26 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.5 OUTLIER -64.66 -167.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.769 1.747 . . . . 0.56999999999999995 109.146 165.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.75 -46.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 129.773 3.229 . . . . 0.66000000000000003 107.655 -163.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.01 -146.37 16.06 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.052 -1.416 . . . . 0.56999999999999995 110.159 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 83.06 1.9 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.431 3.421 . . . . 0.56999999999999995 112.437 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.87 169.24 17.86 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 127.749 2.595 . . . . 0.56999999999999995 109.852 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 t30 54.5 -144.69 0.66 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.675 1.59 . . . . 0.56999999999999995 112.604 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.5 m -47.33 135.81 10.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.578 2.351 . . . . 0.56999999999999995 111.577 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.38 -33.18 10.11 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 112.519 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.9 158.47 28.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.56999999999999995 108.812 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -141.56 164.75 29.39 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.023 0.829 . . . . 0.65000000000000002 111.792 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.76 156.38 44.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.433 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.08 152.87 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.925 -1.034 . . . . 0.56999999999999995 108.894 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.05 95.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.701 -0.666 . . . . 0.56999999999999995 110.186 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.47 149.7 69.08 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.077 2.518 . . . . 0.56999999999999995 112.033 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.17 -70.65 0.32 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.406 0.527 . . . . 0.56999999999999995 112.077 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -75.1 166.36 23.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.382 1.073 . . . . 0.56999999999999995 109.796 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.46 45.35 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 117.554 -1.692 . . . . 0.56999999999999995 114.797 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.78 -26.71 60.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.419 1.609 . . . . 0.56999999999999995 111.049 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.15 149.11 6.21 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 110.925 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.75 -28.84 1.82 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.257 1.408 . . . . 0.56999999999999995 113.624 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.97 152.95 44.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.242 1.021 . . . . 0.66000000000000003 109.004 -170.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 149.7 52.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.608 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -140.39 151.34 44.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.836 -0.62 . . . . 0.65000000000000002 110.957 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 40.6 m-85 -138.43 144.9 40.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.462 1.105 . . . . 0.56999999999999995 109.007 -165.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.07 107.07 6.9 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.006 -1.109 . . . . 0.66000000000000003 108.006 171.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.22 -19.11 62.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.524 1.511 . . . . 0.66000000000000003 111.581 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.44 -44.96 81.41 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.398 1.479 . . . . 0.66000000000000003 111.629 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.55 122.5 17.73 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 106.219 -1.771 . . . . 0.66000000000000003 106.219 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 129.57 40.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.101 -0.952 . . . . 1.2 109.622 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -106.73 153.63 22.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.631 1.172 . . . . 0.56999999999999995 109.465 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 141.85 51.46 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.558 -0.905 . . . . 0.56999999999999995 108.558 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.23 42.27 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.055 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.64 75.47 0.89 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.825 -0.91 . . . . 0.56999999999999995 110.825 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.36 177.78 7.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.073 0.949 . . . . 0.56999999999999995 108.967 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 m -57.17 122.65 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.836 0.855 . . . . 0.56999999999999995 110.576 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.44 172.66 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.024 1.729 . . . . 0.56999999999999995 112.577 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.08 169.69 42.09 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.561 -0.745 . . . . 0.56999999999999995 111.447 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.25 123.59 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -64.58 120.36 12.21 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.482 -0.327 . . . . 0.56999999999999995 110.729 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -52.65 -43.07 65.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.913 0.885 . . . . 0.56999999999999995 111.869 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -64.77 -46.3 82.71 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.54 0.609 . . . . 0.56999999999999995 109.839 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 137' ' ' VAL . 4.3 t80 -56.69 -48.62 77.25 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.801 -0.444 . . . . 0.56999999999999995 109.801 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.76 85.32 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 122.8 0.44 . . . . 0.56999999999999995 110.824 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -52.17 66.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 117.853 -1.07 . . . . 0.56999999999999995 109.409 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.5 m -53.91 -40.25 66.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.174 1.352 . . . . 0.56999999999999995 111.89 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -60.3 -56.37 22.32 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.206 0.602 . . . . 0.65000000000000002 110.536 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.51 -44.51 78.24 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.931 0.892 . . . . 0.66000000000000003 111.322 -172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.57 -25.91 68.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.584 1.554 . . . . 0.56999999999999995 110.943 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.62 -51.72 57.21 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.713 -0.955 . . . . 0.56999999999999995 110.713 169.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.07 -38.81 90.21 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 117.658 -1.163 . . . . 0.65000000000000002 111.265 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.3 p -58.18 -31.3 67.15 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 118.559 0.618 . . . . 0.56999999999999995 112.424 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -36.9 72.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.501 0.32 . . . . 0.56999999999999995 111.815 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.16 43.24 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.691 -1.061 . . . . 0.56999999999999995 113.342 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -116.58 149.59 39.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.594 1.197 . . . . 0.56999999999999995 110.649 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.08 -45.62 4.09 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 117.786 -1.563 . . . . 0.56999999999999995 111.928 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m80 156.24 174.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 129.739 3.216 . . . . 0.65000000000000002 110.103 -171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 5.0 m -117.41 176.71 5.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.042 1.737 . . . . 0.56999999999999995 110.807 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.27 58.99 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.625 1.17 . . . . 0.56999999999999995 109.45 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.0 t70 -135.13 142.72 42.94 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 107.297 -1.372 . . . . 0.66000000000000003 107.297 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.8 -34.58 30.49 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.696 1.597 . . . . 0.56999999999999995 111.188 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -105.18 24.3 12.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 110.071 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -58.54 130.64 47.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.97 -0.752 . . . . 0.56999999999999995 108.97 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 150' ' ' PHE . 7.2 p -67.29 -24.39 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.411 -0.515 . . . . 0.56999999999999995 109.815 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.4 16.54 14.93 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.483 -0.761 . . . . 0.56999999999999995 112.318 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.486 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.1 t80 -72.18 144.46 87.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.857 1.662 . . . . 0.56999999999999995 111.673 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 57.7 Cg_endo -74.25 163.52 36.27 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.48 2.12 . . . . 0.56999999999999995 111.041 167.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.6 m 56.09 94.06 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.638 1.575 . . . . 0.56999999999999995 112.034 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.37 105.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.491 1.516 . . . . 0.56999999999999995 112.564 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.12 166.54 33.61 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.523 -1.831 . . . . 0.56999999999999995 108.523 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.17 -47.89 0.22 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.88 2.472 . . . . 0.56999999999999995 114.769 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.54 175.59 7.25 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.118 1.342 . . . . 0.56999999999999995 112.142 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -121.0 101.15 45.3 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.939 -1.134 . . . . 0.66000000000000003 107.939 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.79 40.29 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 113.077 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.87 -54.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.638 -1.289 . . . . 0.56999999999999995 107.994 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.07 88.22 2.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.964 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 137' ' ' VAL . 45.7 p90 -121.45 -45.98 2.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 110.279 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 30.34 55.43 0.18 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.546 2.338 . . . . 0.56999999999999995 113.574 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mp 63.46 100.22 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.617 1.967 . . . . 0.56999999999999995 109.948 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.7 m -70.84 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.376 0.88 . . . . 0.56999999999999995 113.376 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -143.94 -42.68 0.27 Allowed 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.938 0.895 . . . . 0.56999999999999995 109.145 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 15.0 p-10 -59.95 -39.97 87.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.667 0.667 . . . . 0.66000000000000003 112.172 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -54.56 29.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.7 1.2 . . . . 0.66000000000000003 109.134 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.9 -46.25 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 124.826 1.251 . . . . 0.56999999999999995 108.746 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -62.56 -47.71 82.69 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 117.971 -1.014 . . . . 0.56999999999999995 108.761 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.55 -62.32 6.44 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.807 -1.717 . . . . 0.56999999999999995 108.807 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 46' ' ' ILE . 5.3 mm -56.93 -43.61 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.242 1.021 . . . . 0.56999999999999995 113.132 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -71.34 -27.75 63.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.58 -0.7 . . . . 0.56999999999999995 111.662 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -36.01 68.13 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.964 0.906 . . . . 0.56999999999999995 110.363 169.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -61.53 2.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.994 -1.003 . . . . 0.56999999999999995 110.289 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 114.229 1.196 . . . . 0.56999999999999995 114.229 -170.854 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 CA--C 1.552 1.377 0 N-CA-C 115.013 1.12 . . . . 0.56999999999999995 115.013 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -162.06 31.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 110.81 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.431 ' CH2' ' HA3' ' A' ' 94' ' ' GLY . 89.4 m95 51.93 -111.53 0.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.762 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -154.57 -40.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.613 1.565 . . . . 0.56999999999999995 108.428 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -95.97 153.35 17.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.312 0.645 . . . . 0.56999999999999995 109.506 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -9.93 20.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.988 0.915 . . . . 0.56999999999999995 112.667 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.54 147.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.905 -1.517 . . . . 0.56999999999999995 106.905 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.2 t -127.21 161.65 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.4 -1.333 . . . . 0.56999999999999995 107.4 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -107.46 139.1 42.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.541 -1.281 . . . . 0.56999999999999995 107.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -126.11 151.5 47.14 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 109.561 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -153.57 118.25 4.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.171 0.51 . . . . 1.2 109.803 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.3 mt -82.62 86.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.424 -1.695 . . . . 0.56999999999999995 106.424 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.76 -49.59 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 112.2 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.82 153.1 33.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.417 -2.438 . . . . 0.56999999999999995 104.417 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -125.75 149.68 48.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.173 -1.788 . . . . 0.56999999999999995 106.173 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -159.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 O-C-N 125.032 1.458 . . . . 0.56999999999999995 111.084 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -148.04 -29.34 0.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 114.244 1.202 . . . . 1.2 114.244 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -52.61 -57.54 9.69 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.205 0.941 . . . . 0.66000000000000003 110.915 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.31 164.41 14.99 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 109.466 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -77.97 149.55 25.89 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.149 1.899 . . . . 0.56999999999999995 112.618 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 11.7 m-70 -60.6 -35.65 76.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.398 1.079 . . . . 0.65000000000000002 112.408 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.17 -38.98 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.011 0.524 . . . . 0.56999999999999995 110.275 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -69.58 -41.32 75.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 117.222 -1.371 . . . . 0.56999999999999995 109.069 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.54 -53.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 120.563 1.528 . . . . 0.56999999999999995 109.96 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.21 -34.35 77.88 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 118.598 -0.715 . . . . 0.66000000000000003 110.757 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -46.44 80.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.625 1.102 . . . . 1.2 111.717 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.1 mt -65.09 -45.22 86.14 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.223 1.009 . . . . 0.56999999999999995 108.337 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.37 -44.86 99.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.94 -1.029 . . . . 0.56999999999999995 110.565 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 m -60.27 -46.89 88.26 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 120.036 1.289 . . . . 0.56999999999999995 109.895 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -36.89 69.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.508 -0.758 . . . . 0.56999999999999995 111.501 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.69 91.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 111.308 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 26.3 mt -72.11 -35.8 69.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.629 0.772 . . . . 0.56999999999999995 110.493 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.52 -42.87 88.68 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.089 -0.958 . . . . 0.56999999999999995 109.944 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.9 mtp -60.81 -36.93 80.32 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.928 0.891 . . . . 0.56999999999999995 111.321 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -69.0 -47.04 66.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.975 1.261 . . . . 0.56999999999999995 111.309 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.44 -3.86 59.08 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 123.94 0.781 . . . . 0.56999999999999995 113.301 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -70.46 -19.81 62.93 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.984 -1.303 . . . . 0.56999999999999995 111.043 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.6 mp0 -110.52 -34.8 6.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.503 1.521 . . . . 0.66000000000000003 111.056 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 21.7 pt -114.07 143.06 28.96 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 111.04 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.26 21.16 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.248 2.632 . . . . 0.56999999999999995 112.488 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -86.96 126.38 34.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.188 -1.412 . . . . 0.56999999999999995 107.188 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -126.68 -178.55 4.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.867 0.867 . . . . 0.65000000000000002 109.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -147.83 147.53 29.9 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.704 -0.85 . . . . 0.56999999999999995 108.704 -170.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.95 160.0 39.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.381 1.072 . . . . 1.2 109.722 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -110.05 116.08 30.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.286 -1.376 . . . . 0.56999999999999995 107.286 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.58 161.21 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.585 -0.894 . . . . 0.56999999999999995 108.585 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.79 39.44 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.208 1.003 . . . . 0.56999999999999995 110.179 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -90.58 -65.57 1.0 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.045 0.538 . . . . 0.56999999999999995 109.917 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.07 -70.55 0.02 OUTLIER Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.298 -1.521 . . . . 0.56999999999999995 109.298 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -125.52 139.68 53.4 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.319 -1.363 . . . . 0.56999999999999995 107.319 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.59 171.27 7.42 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.069 0.947 . . . . 0.56999999999999995 110.012 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 15' ' ' VAL . 65.2 m-20 -62.48 -50.54 71.01 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.176 -1.046 . . . . 0.66000000000000003 108.176 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.64 81.88 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.775 -1.565 . . . . 0.56999999999999995 106.775 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -78.54 121.4 24.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.96 127.2 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 106.687 -1.597 . . . . 0.56999999999999995 106.687 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.38 25.81 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 111.204 -0.758 . . . . 0.56999999999999995 111.204 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 21.3 m-85 -132.62 137.32 46.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.948 -1.871 . . . . 0.56999999999999995 105.948 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 160.22 36.59 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.826 1.65 . . . . 0.56999999999999995 107.873 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -116.67 50.99 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.201 -0.937 . . . . 1.2 110.137 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.85 -127.35 6.31 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.254 -1.538 . . . . 0.56999999999999995 109.254 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.94 139.46 0.46 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.14 1.376 . . . . 0.56999999999999995 112.621 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -120.9 -62.27 1.47 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.485 -0.78 . . . . 0.65000000000000002 109.836 -173.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.99 71.83 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.354 -0.692 . . . . 0.56999999999999995 112.647 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.3 121.35 41.73 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.632 1.173 . . . . 0.66000000000000003 108.485 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.82 -73.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.381 . . . . 0.56999999999999995 111.689 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -148.23 144.12 18.38 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 108.638 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.02 149.55 77.2 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.815 1.676 . . . . 0.56999999999999995 110.405 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 1.4 m-85 -70.44 -174.18 0.82 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.738 -1.119 . . . . 0.56999999999999995 110.749 170.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.63 -32.16 4.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.688 2.395 . . . . 0.66000000000000003 110.975 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.42 -139.94 15.83 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 112.351 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.07 86.67 1.62 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.353 3.369 . . . . 0.56999999999999995 112.036 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.04 -174.99 33.92 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.565 1.555 . . . . 0.56999999999999995 111.226 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 m120 45.82 -134.71 0.82 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.829 1.314 . . . . 0.56999999999999995 112.478 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -59.13 118.56 6.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.14 2.176 . . . . 0.56999999999999995 111.449 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 112' ' ' ILE . 5.3 mp -94.68 -34.87 12.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.736 1.214 . . . . 0.56999999999999995 112.195 -175.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.25 157.97 33.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.292 1.037 . . . . 0.56999999999999995 108.826 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.68 161.93 37.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.341 -0.615 . . . . 0.65000000000000002 109.341 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.46 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.696 -0.853 . . . . 0.56999999999999995 108.696 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.58 153.82 32.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.317 -0.994 . . . . 0.56999999999999995 108.317 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.38 149.56 96.94 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.072 -0.966 . . . . 0.56999999999999995 109.63 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 29.3 Cg_endo -67.35 160.82 45.96 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.295 1.997 . . . . 0.56999999999999995 111.47 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 -106.88 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.315 -1.914 . . . . 0.56999999999999995 108.315 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.3 p -151.71 69.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.744 0.818 . . . . 0.56999999999999995 110.948 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.36 -121.45 1.6 Allowed Glycine 0 C--N 1.342 0.904 0 N-CA-C 110.404 -1.079 . . . . 0.56999999999999995 110.404 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.86 -21.76 61.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.167 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.78 130.59 43.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.447 -1.196 . . . . 0.56999999999999995 110.959 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' CH2' ' A' ' 10' ' ' TRP . . . 96.38 -36.86 3.65 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.084 2.278 . . . . 0.56999999999999995 113.09 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.1 145.91 19.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.998 2.119 . . . . 0.66000000000000003 107.092 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.29 146.61 36.99 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.871 -0.789 . . . . 0.56999999999999995 108.871 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -139.56 160.6 39.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 110.236 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 57.5 m-85 -142.44 148.58 38.01 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.361 1.064 . . . . 0.56999999999999995 108.323 -163.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.38 100.56 10.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.81 -1.552 . . . . 0.66000000000000003 106.81 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.9 -25.73 31.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.463 -1.398 . . . . 0.66000000000000003 111.43 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.18 -37.18 76.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.66000000000000003 110.478 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.24 120.2 20.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.192 -1.41 . . . . 0.66000000000000003 107.192 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -56.28 122.58 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.873 0.469 . . . . 1.2 110.254 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 114' ' ' PHE . 98.4 m95 -109.63 133.94 52.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 108.339 -0.985 . . . . 0.56999999999999995 108.339 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.5 t -137.28 148.39 46.36 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.188 -0.671 . . . . 0.56999999999999995 109.188 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.47 -26.04 67.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.844 0.857 . . . . 0.66000000000000003 111.863 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.61 -141.19 11.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.088 1.327 . . . . 0.56999999999999995 110.248 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -160.56 103.77 1.39 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.584 0.692 . . . . 0.56999999999999995 109.566 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.51 -36.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.043 0.937 . . . . 0.56999999999999995 112.231 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -104.04 -58.84 1.82 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.094 0.558 . . . . 0.56999999999999995 109.516 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.9 -165.17 21.48 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.165 -1.174 . . . . 0.56999999999999995 110.165 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.423 HD13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -85.58 143.96 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 109.416 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.84 108.88 1.89 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.156 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -60.53 -34.42 74.09 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 112.121 174.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.437 HD12 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -64.59 -51.33 63.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.7 -1.222 . . . . 0.56999999999999995 107.7 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -57.55 -46.71 83.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.627 0.771 . . . . 0.56999999999999995 110.147 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.65 19.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.515 0.509 . . . . 0.56999999999999995 111.022 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.5 -55.52 34.03 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 117.933 -1.032 . . . . 0.56999999999999995 109.907 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -58.18 -34.45 70.35 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.906 1.23 . . . . 0.56999999999999995 111.841 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.01 -60.27 3.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.102 0.961 . . . . 0.65000000000000002 109.79 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.88 -45.79 80.75 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.569 -0.707 . . . . 0.66000000000000003 111.42 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.63 -30.8 71.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.421 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.96 -42.51 80.67 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.156 -0.778 . . . . 0.56999999999999995 111.156 170.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -74.52 -37.59 63.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 117.16 -1.4 . . . . 0.65000000000000002 112.354 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 p -54.42 -38.65 66.5 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 124.453 1.096 . . . . 0.56999999999999995 109.685 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.07 -43.38 95.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 112.337 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.2 43.39 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.862 -0.966 . . . . 0.56999999999999995 114.332 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.06 176.17 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.054 0.941 . . . . 0.56999999999999995 111.45 -171.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.01 66.33 0.01 OUTLIER Glycine 0 C--N 1.342 0.882 0 O-C-N 121.473 -0.767 . . . . 0.56999999999999995 111.735 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 174.24 7.11 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.626 1.171 . . . . 0.65000000000000002 110.636 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 t -160.33 -177.16 6.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.36 -0.836 . . . . 0.56999999999999995 110.773 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -146.8 56.37 1.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.306 2.642 . . . . 0.56999999999999995 107.46 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.35 150.65 44.86 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 124.647 1.179 . . . . 0.66000000000000003 108.278 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.0 -26.91 58.18 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.628 2.218 . . . . 0.56999999999999995 111.607 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.94 30.29 5.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.27 -1.011 . . . . 0.56999999999999995 108.27 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.42 131.04 46.05 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.294 -1.373 . . . . 0.56999999999999995 107.294 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 150' ' ' PHE . 3.0 p -60.32 -32.26 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 110.68 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -99.21 25.86 6.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.827 0.451 . . . . 0.56999999999999995 111.362 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.407 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 17.0 t80 -65.26 131.64 95.08 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 120.766 -1.209 . . . . 0.56999999999999995 110.385 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.8 Cg_endo -75.28 171.79 17.6 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.662 2.241 . . . . 0.56999999999999995 111.007 166.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 m 52.13 76.81 0.17 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.474 1.13 . . . . 0.56999999999999995 110.657 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -46.92 125.52 7.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.234 1.014 . . . . 0.56999999999999995 112.485 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.45 1.86 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.08 -1.208 . . . . 0.56999999999999995 110.08 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.79 -44.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.55 0.74 . . . . 0.56999999999999995 111.635 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -143.51 -137.14 3.23 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.208 -1.957 . . . . 0.56999999999999995 108.208 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -126.03 112.0 24.31 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.589 -0.893 . . . . 0.66000000000000003 108.589 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.41 -14.76 22.59 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.423 2.082 . . . . 0.56999999999999995 112.035 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -64.65 -48.68 73.93 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 121.894 2.133 . . . . 0.56999999999999995 109.87 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -92.5 69.91 4.98 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.643 1.177 . . . . 0.56999999999999995 111.169 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.44 125.72 28.03 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.293 -0.632 . . . . 0.56999999999999995 109.293 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 83.04 1.54 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.539 -1.282 . . . . 0.56999999999999995 107.539 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 48.58 80.93 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.815 1.646 . . . . 0.56999999999999995 111.629 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.6 t -67.95 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.128 0.571 . . . . 0.56999999999999995 112.322 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.59 -57.37 0.69 Allowed 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.386 -0.968 . . . . 0.56999999999999995 108.386 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -51.06 -39.43 55.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.277 1.431 . . . . 0.66000000000000003 112.266 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -63.57 -53.83 45.61 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.64 -0.695 . . . . 0.66000000000000003 109.366 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -48.92 86.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 118.752 -0.642 . . . . 0.56999999999999995 109.843 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -32.76 74.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.12 1.768 . . . . 0.56999999999999995 110.626 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.84 -60.45 3.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.98 -2.048 . . . . 0.56999999999999995 107.98 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.55 -58.35 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 119.342 1.571 . . . . 0.56999999999999995 111.151 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 10.6 pt20 -58.56 -22.56 56.16 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.705 0.684 . . . . 0.56999999999999995 112.148 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -31.4 19.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.948 1.299 . . . . 0.56999999999999995 110.777 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.14 -46.14 88.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.157 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.1 p90 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 123.379 0.672 . . . . 0.56999999999999995 112.674 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 CA--C 1.541 0.87 0 N-CA-C 111.011 -0.419 . . . . 0.56999999999999995 111.011 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt 91.44 132.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 130.395 3.478 . . . . 0.56999999999999995 109.9 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -64.41 159.46 21.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 110.743 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -76.28 -25.33 54.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.715 0.635 . . . . 0.56999999999999995 112.715 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -94.06 143.03 26.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.9 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 pttm -76.48 -12.22 60.0 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.963 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.85 109.49 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.735 -2.32 . . . . 0.56999999999999995 104.735 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.11 163.86 3.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.67 -1.604 . . . . 0.56999999999999995 106.67 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 p -114.37 147.45 39.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.694 -0.629 . . . . 0.56999999999999995 111.351 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -123.77 155.42 37.96 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.474 0.71 . . . . 0.56999999999999995 110.763 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 120.06 5.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.488 0.661 . . . . 1.2 110.052 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 22' ' ' TYR . 29.7 mt -87.02 113.8 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 105.842 -1.91 . . . . 0.56999999999999995 105.842 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.48 -45.66 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.291 0.951 . . . . 0.56999999999999995 111.237 -171.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.7 178.41 4.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.388 -1.708 . . . . 0.56999999999999995 106.388 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 19' ' ' ILE . 49.2 m-85 -142.66 173.81 11.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.454 1.025 . . . . 0.56999999999999995 109.306 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -90.28 -175.5 4.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.476 1.11 . . . . 0.56999999999999995 111.251 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -123.96 -34.7 2.95 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.909 1.284 . . . . 1.2 113.491 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -61.86 -27.46 68.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.069 1.348 . . . . 0.66000000000000003 111.648 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.47 144.31 20.65 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 126.957 2.103 . . . . 0.56999999999999995 108.436 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 167.45 24.85 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.946 2.431 . . . . 0.56999999999999995 112.863 -166.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.29 -36.24 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.859 0.864 . . . . 0.65000000000000002 111.903 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.54 -36.87 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.724 0.81 . . . . 0.56999999999999995 110.353 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -67.27 -49.84 62.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.846 -1.549 . . . . 0.56999999999999995 108.39 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.97 -51.03 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 121.217 1.826 . . . . 0.56999999999999995 110.66 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.8 -41.15 96.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.676 0.791 . . . . 0.66000000000000003 111.986 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -62.98 -45.45 92.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.07 0.85 . . . . 1.2 111.772 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.14 -35.08 73.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.45 -0.786 . . . . 0.56999999999999995 109.257 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.23 -49.45 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 117.886 -1.054 . . . . 0.56999999999999995 110.204 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -60.17 -42.79 95.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.945 1.248 . . . . 0.56999999999999995 111.076 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -65.05 -47.58 76.87 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.004 0.82 . . . . 0.56999999999999995 111.234 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.99 99.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.127 0.971 . . . . 0.56999999999999995 111.96 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 122' ' ' LEU . 42.8 mt -71.29 -35.54 71.33 Favored 'General case' 0 C--O 1.228 -0.044 0 O-C-N 121.531 -0.731 . . . . 0.56999999999999995 111.427 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -61.96 -41.04 97.54 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.092 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 36.0 mtp -60.71 -40.1 91.03 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.022 -0.99 . . . . 0.56999999999999995 111.206 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.45 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 46.7 m95 -61.89 -50.24 73.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.45 1.477 . . . . 0.56999999999999995 111.844 168.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.24 -8.97 53.22 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.424 1.012 . . . . 0.56999999999999995 114.258 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -66.79 -24.2 66.15 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -1.225 . . . . 0.56999999999999995 111.315 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -111.36 -11.34 14.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 118.445 -0.788 . . . . 0.66000000000000003 111.023 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 pt -140.23 135.41 16.15 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 120.38 1.446 . . . . 0.56999999999999995 110.96 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.87 48.36 2.2 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.52 3.48 . . . . 0.56999999999999995 113.462 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tt -109.43 141.97 41.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.507 1.923 . . . . 0.56999999999999995 107.842 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -133.0 163.77 28.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.785 0.834 . . . . 0.65000000000000002 109.002 -168.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.75 145.49 32.43 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.573 -0.899 . . . . 0.56999999999999995 108.573 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -145.33 175.23 10.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.331 1.052 . . . . 1.2 110.274 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -112.17 138.19 49.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.093 -0.706 . . . . 0.56999999999999995 109.093 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.51 -28.96 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.097 0.959 . . . . 0.56999999999999995 111.21 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.258 3.7 m 44.88 40.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.565 1.946 . . . . 0.56999999999999995 112.72 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -156.47 -38.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.544 1.312 . . . . 0.56999999999999995 114.544 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.83 -146.26 4.52 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.974 -1.25 . . . . 0.56999999999999995 109.974 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -70.72 -173.64 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.0 0.9 . . . . 0.56999999999999995 111.536 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.77 177.37 11.33 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.123 1.369 . . . . 0.56999999999999995 110.403 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -63.66 -36.15 82.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.746 0.819 . . . . 0.66000000000000003 110.097 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mt -120.33 76.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 126.769 2.027 . . . . 0.56999999999999995 107.804 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -72.63 124.07 24.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.973 -1.121 . . . . 0.56999999999999995 107.973 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.27 117.72 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 105.286 -2.116 . . . . 0.56999999999999995 105.286 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.03 161.82 19.47 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.923 -0.871 . . . . 0.56999999999999995 110.923 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -133.83 142.76 47.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.472 -2.048 . . . . 0.56999999999999995 105.472 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.31 166.25 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.962 2.505 . . . . 0.56999999999999995 107.535 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -130.0 93.96 3.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.06 -49.85 2.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.91 -0.939 . . . . 0.56999999999999995 111.814 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.25 153.04 38.18 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.639 1.72 . . . . 0.56999999999999995 110.897 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -152.04 159.69 43.64 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 125.568 1.547 . . . . 0.65000000000000002 109.158 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.75 44.9 3.04 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.369 1.462 . . . . 0.56999999999999995 112.872 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.67 -179.78 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.577 1.551 . . . . 0.66000000000000003 110.409 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -39.82 -50.07 2.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.333 1.453 . . . . 0.56999999999999995 111.791 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.89 132.06 13.7 Favored Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 124.611 1.164 . . . . 0.56999999999999995 109.801 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.01 158.76 54.46 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.033 1.822 . . . . 0.56999999999999995 111.204 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.33 -164.48 0.77 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 111.061 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -121.73 -14.08 8.19 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.928 2.491 . . . . 0.66000000000000003 112.408 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.71 -134.82 12.71 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.397 0.999 . . . . 0.56999999999999995 110.678 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.51 100.51 1.16 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 112.322 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.91 -163.85 25.55 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.516 1.055 . . . . 0.56999999999999995 112.518 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 t30 45.42 -125.53 1.19 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.465 1.506 . . . . 0.56999999999999995 114.346 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.6 m -74.48 131.91 41.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.635 2.374 . . . . 0.56999999999999995 108.614 173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.76 -31.9 10.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 112.194 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.34 37.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.945 1.298 . . . . 0.56999999999999995 108.008 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -143.23 161.38 38.41 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.964 -0.46 . . . . 0.65000000000000002 110.029 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.66 144.58 27.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.363 1.065 . . . . 0.56999999999999995 109.167 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.04 146.4 27.96 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.849 -1.167 . . . . 0.56999999999999995 107.849 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.86 155.15 12.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.502 -0.761 . . . . 0.56999999999999995 110.891 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.48 166.07 26.92 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.121 1.881 . . . . 0.56999999999999995 112.043 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.23 -101.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.3 p -151.36 -54.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.423 1.089 . . . . 0.56999999999999995 110.599 -166.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.7 -108.56 3.24 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 125.086 1.327 . . . . 0.56999999999999995 110.01 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -29.06 64.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.754 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.33 141.75 6.95 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.201 -0.76 . . . . 0.56999999999999995 111.201 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.99 4.61 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.664 -1.631 . . . . 0.56999999999999995 114.504 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.25 159.47 33.38 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.043 1.921 . . . . 0.66000000000000003 109.074 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.81 145.36 27.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 109.867 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -130.94 155.22 47.16 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.334 -0.617 . . . . 0.65000000000000002 109.334 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -138.08 147.99 44.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.778 1.631 . . . . 0.56999999999999995 108.631 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.39 93.99 8.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.795 0.838 . . . . 0.66000000000000003 108.882 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.85 -22.36 14.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.77 1.628 . . . . 0.66000000000000003 111.568 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.61 -28.81 68.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.115 0.416 . . . . 0.66000000000000003 111.572 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -79.89 167.86 19.98 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 111.502 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -79.55 156.39 27.76 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.69 -0.686 . . . . 1.2 110.157 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CZ3' HD11 ' A' ' 112' ' ' ILE . 96.9 m95 -151.28 121.7 7.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.817 -1.919 . . . . 0.56999999999999995 105.817 -175.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -136.15 144.56 45.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.871 1.669 . . . . 0.56999999999999995 109.342 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -68.07 -45.5 73.66 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.957 0.503 . . . . 0.66000000000000003 110.596 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.95 39.27 0.02 OUTLIER Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.826 1.679 . . . . 0.56999999999999995 111.43 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 -66.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.012 1.325 . . . . 0.56999999999999995 110.199 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -84.44 168.23 15.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.461 0.704 . . . . 0.56999999999999995 110.314 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.74 150.21 20.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.241 1.016 . . . . 0.56999999999999995 111.371 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -145.88 15.29 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.709 -0.556 . . . . 0.56999999999999995 111.709 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.401 HD11 ' CZ3' ' A' ' 104' ' ' TRP . 1.3 pp -122.83 142.66 38.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.453 1.101 . . . . 0.56999999999999995 108.21 172.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.7 110.39 1.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.273 0.629 . . . . 0.56999999999999995 111.615 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.04 -34.87 78.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.203 1.801 . . . . 0.56999999999999995 113.104 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -39.97 84.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.434 0.561 . . . . 0.56999999999999995 110.217 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.76 -45.72 81.49 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 124.038 0.836 . . . . 0.56999999999999995 108.77 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.42 22.06 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 111.114 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.9 74.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.749 -1.12 . . . . 0.56999999999999995 109.866 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -51.89 -46.06 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.85 1.205 . . . . 0.56999999999999995 111.029 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -61.76 -55.18 32.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.692 0.797 . . . . 0.65000000000000002 109.773 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.43 -41.01 89.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.343 0.519 . . . . 0.66000000000000003 110.96 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 HD21 ' A' ' 39' ' ' LEU . 4.5 mm? -63.14 -26.08 68.65 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.42 -0.8 . . . . 0.56999999999999995 111.801 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.45 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -66.58 -44.59 89.54 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 113.003 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -64.28 -38.56 91.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.042 -0.504 . . . . 0.65000000000000002 110.025 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 t -59.4 -33.81 71.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.358 0.503 . . . . 0.56999999999999995 112.358 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -38.43 65.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.992 0.917 . . . . 0.56999999999999995 111.534 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.3 9.75 0.65 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.426 1.013 . . . . 0.56999999999999995 115.224 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -93.99 157.96 15.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.681 1.24 . . . . 0.56999999999999995 110.845 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.35 178.01 21.69 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.513 -1.035 . . . . 0.56999999999999995 110.513 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -72.61 166.66 22.29 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.054 0.542 . . . . 0.65000000000000002 111.439 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.0 t -123.55 -46.35 2.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 112.299 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.72 43.71 0.32 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.366 1.467 . . . . 0.56999999999999995 112.831 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -117.29 154.8 50.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.609 1.163 . . . . 0.66000000000000003 109.48 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.71 -6.29 18.23 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 114.353 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -137.5 17.62 2.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.039 1.336 . . . . 0.56999999999999995 110.378 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.17 130.71 43.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 111.077 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.79 -25.28 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 111.752 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.95 21.55 11.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.453 1.501 . . . . 0.56999999999999995 111.357 169.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -58.85 136.3 87.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 120.667 -1.271 . . . . 0.56999999999999995 110.194 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.99 -163.76 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.729 2.953 . . . . 0.56999999999999995 111.819 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t 36.29 77.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.524 1.929 . . . . 0.56999999999999995 115.215 168.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -38.91 109.63 0.11 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.919 2.088 . . . . 0.56999999999999995 113.341 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.34 111.34 1.2 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.747 1.165 . . . . 0.56999999999999995 110.684 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -179.84 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.61 1.164 . . . . 0.56999999999999995 112.279 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.0 -162.29 11.46 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.475 1.512 . . . . 0.56999999999999995 110.024 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.04 108.88 56.55 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 106.846 -1.538 . . . . 0.66000000000000003 106.846 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.44 -7.6 9.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.31 2.674 . . . . 0.56999999999999995 112.922 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -69.48 -33.38 72.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 121.041 1.746 . . . . 0.56999999999999995 109.684 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.74 86.8 2.26 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.288 1.035 . . . . 0.56999999999999995 112.001 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.76 -50.75 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 111.618 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.99 45.1 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.027 2.131 . . . . 0.56999999999999995 114.85 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp 64.98 79.96 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.841 1.656 . . . . 0.56999999999999995 109.893 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -58.82 -83.48 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.644 1.177 . . . . 0.56999999999999995 113.448 -170.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -142.88 -49.45 0.34 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.738 1.615 . . . . 0.56999999999999995 106.643 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.18 -53.4 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.66000000000000003 112.953 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -51.67 69.08 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.874 0.469 . . . . 0.66000000000000003 110.772 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.07 -38.58 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 109.699 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -49.69 66.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.046 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.6 -52.74 51.28 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.89 0.768 . . . . 0.56999999999999995 111.311 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 mm -61.6 -50.74 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.438 -0.791 . . . . 0.56999999999999995 111.052 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -70.81 -14.08 62.28 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 112.143 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -83.26 -25.08 31.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.618 1.099 . . . . 0.56999999999999995 111.829 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.27 -37.44 12.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.571 1.078 . . . . 0.56999999999999995 111.9 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 126.148 1.779 . . . . 0.56999999999999995 109.517 -173.448 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.444 -1.421 0 N-CA-C 110.042 -0.792 . . . . 0.56999999999999995 110.042 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.23 132.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.425 2.29 . . . . 0.56999999999999995 108.186 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG21 ' A' ' 15' ' ' VAL . 13.0 m95 -71.72 175.02 6.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.699 0.8 . . . . 0.56999999999999995 110.422 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.0 p -97.38 -11.7 23.65 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.672 0.619 . . . . 0.56999999999999995 112.672 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.0 t -104.49 151.25 23.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.85 1.66 . . . . 0.56999999999999995 108.675 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -8.91 57.85 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.201 1.001 . . . . 0.56999999999999995 112.449 172.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.66 144.62 37.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.568 1.547 . . . . 0.56999999999999995 108.775 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 10' ' ' TRP . 96.2 t -130.37 153.73 39.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 108.098 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 p -103.39 144.02 31.93 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.739 -0.467 . . . . 0.56999999999999995 109.739 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -133.31 152.74 51.94 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.257 -1.527 . . . . 0.56999999999999995 110.895 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.63 111.77 4.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.313 1.054 . . . . 1.2 109.626 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.28 101.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 104.152 -2.536 . . . . 0.56999999999999995 104.152 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.45 -44.87 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.692 1.197 . . . . 0.56999999999999995 111.651 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.44 174.86 6.12 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.362 1.865 . . . . 0.56999999999999995 106.411 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -146.29 161.16 40.9 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.5 -0.926 . . . . 0.56999999999999995 108.5 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.8 t -63.25 177.73 0.6 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.597 0.713 . . . . 0.56999999999999995 110.913 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -117.67 -39.61 3.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.436 1.094 . . . . 1.2 112.836 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.07 -33.55 73.5 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.231 0.923 . . . . 0.66000000000000003 110.084 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.35 149.7 44.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.56999999999999995 109.811 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -76.73 164.81 29.69 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.918 2.412 . . . . 0.56999999999999995 113.609 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 17.0 m-70 -62.38 -45.52 92.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.898 1.279 . . . . 0.65000000000000002 112.06 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 tp -57.86 -42.21 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 109.672 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -62.46 -48.35 80.04 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 117.759 -1.115 . . . . 0.56999999999999995 109.251 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.43 -49.74 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 120.72 1.6 . . . . 0.56999999999999995 110.679 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.59 -41.34 96.3 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.167 0.894 . . . . 0.66000000000000003 111.404 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.275 -0.891 . . . . 1.2 112.307 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.11 -35.92 74.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.998 -1.001 . . . . 0.56999999999999995 109.274 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.03 -51.56 60.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.05 -0.976 . . . . 0.56999999999999995 108.773 166.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -43.61 88.76 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.08 1.309 . . . . 0.56999999999999995 110.878 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -66.89 -38.51 86.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.565 1.075 . . . . 0.56999999999999995 112.807 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.16 76.44 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 111.554 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.5 -30.96 68.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.086 -0.959 . . . . 0.56999999999999995 110.278 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.34 -31.76 72.44 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.339 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.8 mtm -74.28 -37.55 63.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.328 -0.844 . . . . 0.56999999999999995 111.66 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -64.9 -50.19 67.49 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 110.681 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -4.91 55.24 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.511 1.529 . . . . 0.56999999999999995 113.956 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -25.68 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.548 -0.972 . . . . 0.56999999999999995 110.211 168.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -110.71 -19.06 12.99 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.695 -0.669 . . . . 0.66000000000000003 112.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 160' ' ' ILE . 32.5 pt -126.35 126.3 24.64 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 123.951 0.9 . . . . 0.56999999999999995 109.028 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.95 32.64 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.504 2.803 . . . . 0.56999999999999995 113.557 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 15' ' ' VAL . 1.3 tt -80.89 145.9 31.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.147 1.379 . . . . 0.56999999999999995 108.241 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.444 ' H ' HD23 ' A' ' 48' ' ' LEU . 9.3 m80 -126.54 165.92 18.25 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.65000000000000002 108.47 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.06 157.33 46.56 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.723 -1.236 . . . . 0.56999999999999995 108.511 -172.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.76 160.78 39.12 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.33 1.052 . . . . 1.2 108.857 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -106.9 146.7 30.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.438 -1.319 . . . . 0.56999999999999995 107.438 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.1 169.01 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.927 0.491 . . . . 0.56999999999999995 109.793 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.31 -13.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.56999999999999995 111.504 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -93.23 -66.02 0.95 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.56999999999999995 108.845 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.48 -27.38 0.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.843 0.292 . . . . 0.56999999999999995 113.05 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -78.56 125.72 29.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.845 -1.169 . . . . 0.56999999999999995 107.845 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.3 166.17 26.3 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.973 0.909 . . . . 0.56999999999999995 109.321 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 74.1 m-20 -64.1 -47.19 81.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.11 0.964 . . . . 0.66000000000000003 108.706 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.92 80.0 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.766 1.627 . . . . 0.56999999999999995 107.282 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 ttm -75.48 134.26 40.87 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.77 -1.206 . . . . 0.56999999999999995 107.841 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.59 119.63 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.963 -1.865 . . . . 0.56999999999999995 105.963 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.94 163.92 23.35 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 111.841 -0.504 . . . . 0.56999999999999995 111.841 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.31 134.01 33.74 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.467 -2.049 . . . . 0.56999999999999995 105.467 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.03 -174.04 4.74 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 109.27 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 3.04 8.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.893 0.77 . . . . 1.2 112.813 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.75 -130.67 2.12 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.175 -1.57 . . . . 0.56999999999999995 109.175 -166.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.7 117.13 7.01 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.376 -0.485 . . . . 0.56999999999999995 110.385 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -112.19 -46.8 3.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.558 0.743 . . . . 0.65000000000000002 111.316 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.41 23.41 0.59 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.2 0.905 . . . . 0.56999999999999995 113.893 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -53.18 4.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.515 1.926 . . . . 0.66000000000000003 111.773 -170.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -178.38 -45.41 0.01 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.848 2.059 . . . . 0.56999999999999995 107.646 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.56 139.5 35.48 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 123.852 0.861 . . . . 0.56999999999999995 109.039 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.34 141.4 46.85 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.454 1.436 . . . . 0.56999999999999995 109.965 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.75 -179.24 0.84 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.953 1.358 . . . . 0.56999999999999995 111.121 163.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -115.52 -31.23 5.96 Favored 'General case' 0 CA--C 1.542 0.666 1 C-N-CA 131.92 4.088 . . . . 0.66000000000000003 109.931 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.08 -138.03 15.65 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.668 -0.973 . . . . 0.56999999999999995 110.668 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 104.1 1.69 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.803 3.002 . . . . 0.56999999999999995 112.148 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -179.75 16.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 126.004 1.764 . . . . 0.56999999999999995 108.891 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.74 -155.66 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 112.86 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.7 m -44.87 120.39 2.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.365 2.266 . . . . 0.56999999999999995 111.534 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.18 -25.13 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.888 1.275 . . . . 0.56999999999999995 113.106 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.22 164.34 25.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.353 1.461 . . . . 0.56999999999999995 108.367 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.03 158.74 44.42 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.998 -0.371 . . . . 0.65000000000000002 109.998 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.0 155.74 39.68 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.725 1.21 . . . . 0.56999999999999995 109.808 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.05 171.65 7.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.596 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.55 139.08 26.48 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-O 118.245 -0.884 . . . . 0.56999999999999995 109.363 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 50.3 Cg_endo -67.49 159.37 52.77 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.578 2.186 . . . . 0.56999999999999995 112.166 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.28 12.72 21.09 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.351 -0.694 . . . . 0.56999999999999995 113.752 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -153.47 43.73 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.55 1.675 . . . . 0.56999999999999995 111.933 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.37 -71.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.168 1.842 . . . . 0.56999999999999995 114.69 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.06 -5.05 39.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.372 1.869 . . . . 0.56999999999999995 111.437 163.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 126.92 31.59 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.979 -1.075 . . . . 0.56999999999999995 110.446 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.28 -44.33 1.5 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 126.046 1.784 . . . . 0.56999999999999995 110.845 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.09 143.75 13.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.105 2.162 . . . . 0.66000000000000003 109.199 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.07 150.36 42.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.633 0.73 . . . . 0.56999999999999995 109.535 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.47 162.96 31.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.943 -0.762 . . . . 0.65000000000000002 108.943 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -139.59 158.45 44.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.497 1.919 . . . . 0.56999999999999995 109.344 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -84.45 102.35 12.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.655 0.382 . . . . 0.66000000000000003 110.999 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -58.23 -28.44 64.87 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.605 -1.309 . . . . 0.66000000000000003 111.116 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.46 -26.71 66.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.609 0.763 . . . . 0.66000000000000003 111.581 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -72.37 138.93 47.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.203 1.002 . . . . 0.66000000000000003 109.608 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.12 111.79 4.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -94.24 158.64 15.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.409 -0.96 . . . . 0.56999999999999995 108.409 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.3 t -141.19 153.53 45.37 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.313 -0.995 . . . . 0.56999999999999995 108.313 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.55 -36.43 70.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.331 0.652 . . . . 0.66000000000000003 110.162 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.65 -97.36 1.47 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.102 -1.199 . . . . 0.56999999999999995 110.102 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -158.17 139.31 13.29 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.728 -1.212 . . . . 0.56999999999999995 107.728 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 t -163.82 -51.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.836 -0.602 . . . . 0.56999999999999995 110.491 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -160.38 -44.12 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.001 1.72 . . . . 0.56999999999999995 110.895 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.77 173.43 54.71 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.536 -1.026 . . . . 0.56999999999999995 110.536 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.422 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -83.66 148.78 4.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.236 0.541 . . . . 0.56999999999999995 109.816 177.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -65.39 114.58 4.91 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.67 -0.695 . . . . 0.56999999999999995 109.488 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -60.92 -41.11 95.52 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.573 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -47.44 84.61 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 108.787 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -60.56 -39.25 87.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.061 0.944 . . . . 0.56999999999999995 110.051 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.42 49.48 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 112.765 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.76 68.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.219 -1.03 . . . . 0.56999999999999995 108.219 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 m -56.1 -41.23 74.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.336 0.654 . . . . 0.56999999999999995 111.758 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.08 -57.79 11.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.953 0.342 . . . . 0.65000000000000002 110.109 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -68.11 -39.96 82.68 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.042 -1.036 . . . . 0.66000000000000003 111.609 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.38 -32.72 74.51 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 110.818 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.57 -47.35 57.67 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.166 -0.774 . . . . 0.56999999999999995 111.166 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.48 -35.35 70.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.556 0.576 . . . . 0.65000000000000002 112.556 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -35.85 73.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 0.56999999999999995 111.02 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -46.5 89.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 110.71 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.51 49.19 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.533 -0.593 . . . . 0.56999999999999995 113.951 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.72 -160.1 0.17 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.029 1.414 . . . . 0.56999999999999995 110.724 -173.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 132.65 35.22 0.32 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 121.427 -0.796 . . . . 0.56999999999999995 113.659 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 167.8 7.2 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.219 1.009 . . . . 0.65000000000000002 112.856 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.9 p -152.95 -173.33 4.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.584 1.153 . . . . 0.56999999999999995 110.208 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.8 p -143.48 49.73 1.41 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.703 1.201 . . . . 0.56999999999999995 110.949 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 143.87 27.91 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.08 1.352 . . . . 0.66000000000000003 110.239 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.28 -12.27 29.7 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.455 2.103 . . . . 0.56999999999999995 113.743 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -137.22 51.14 1.96 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.685 1.594 . . . . 0.56999999999999995 107.909 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.21 43.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.059 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.86 -27.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.56999999999999995 109.381 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.2 mmt -78.14 -14.96 59.27 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.649 1.979 . . . . 0.56999999999999995 114.154 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -58.8 128.25 83.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.009 1.277 . . . . 0.56999999999999995 110.605 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.05 156.8 47.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.248 1.966 . . . . 0.56999999999999995 110.642 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.5 m 61.14 99.35 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.207 1.403 . . . . 0.56999999999999995 111.473 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.89 123.98 2.05 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 111.883 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.68 -130.86 2.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.162 -1.575 . . . . 0.56999999999999995 109.162 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -65.12 -61.55 2.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.537 0.668 . . . . 0.56999999999999995 110.446 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 39.88 -150.45 0.11 Allowed Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.305 1.431 . . . . 0.56999999999999995 113.409 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.24 75.36 4.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 167.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.0 39.8 0.3 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.962 3.108 . . . . 0.56999999999999995 112.822 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -144.76 -54.51 0.32 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 108.436 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.03 89.11 3.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 108.43 -170.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -44.34 -63.24 0.92 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.479 1.511 . . . . 0.56999999999999995 114.906 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt 31.49 63.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.915 2.486 . . . . 0.56999999999999995 113.479 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -25.8 115.13 0.05 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 128.781 2.832 . . . . 0.56999999999999995 110.874 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.3 t -82.66 -82.26 0.14 Allowed 'General case' 0 C--N 1.341 0.204 0 CA-C-O 119.051 -0.5 . . . . 0.56999999999999995 111.022 -162.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -147.94 -44.12 0.16 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 118.531 0.605 . . . . 0.56999999999999995 110.364 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.26 -49.22 9.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.903 2.081 . . . . 0.66000000000000003 112.933 164.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.53 -54.76 23.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.808 0.843 . . . . 0.66000000000000003 109.833 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.98 -41.68 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.349 1.06 . . . . 0.56999999999999995 109.108 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -57.14 13.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.916 -1.142 . . . . 0.56999999999999995 107.916 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.417 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -51.1 -53.9 25.32 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.523 -1.031 . . . . 0.56999999999999995 110.523 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 46' ' ' ILE . 20.1 mm -50.86 -50.73 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.479 0.712 . . . . 0.56999999999999995 111.294 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.37 -31.01 70.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.43 0.559 . . . . 0.56999999999999995 112.241 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -24.41 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.653 -1.165 . . . . 0.56999999999999995 110.814 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 159' ' ' GLY . 9.0 mp -93.01 -49.78 5.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 110.667 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 112.077 -173.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.448 -1.192 0 N-CA-C 109.115 -1.148 . . . . 0.56999999999999995 109.115 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 80.38 128.5 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 129.05 2.94 . . . . 0.56999999999999995 111.075 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -61.59 157.86 16.48 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.605 0.762 . . . . 0.56999999999999995 110.491 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.1 p -78.28 -34.38 48.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.475 . . . . 0.56999999999999995 111.508 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -82.93 139.12 33.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.197 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -76.29 -2.79 33.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.5 0.72 . . . . 0.56999999999999995 112.75 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.96 113.84 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.855 -2.276 . . . . 0.56999999999999995 104.855 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.71 139.85 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.876 -1.527 . . . . 0.56999999999999995 106.876 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 149.31 35.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.603 -0.686 . . . . 0.56999999999999995 111.283 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.44 157.12 35.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.56999999999999995 110.571 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 119.62 11.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.941 -0.763 . . . . 1.2 108.941 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -87.82 99.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 104.982 -2.229 . . . . 0.56999999999999995 104.982 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -48.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.504 1.122 . . . . 0.56999999999999995 111.712 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.84 175.46 5.57 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.151 1.78 . . . . 0.56999999999999995 106.455 174.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -144.42 164.87 29.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.6 t -67.84 -175.32 0.54 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.57 0.748 . . . . 0.56999999999999995 111.632 171.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.23 -38.16 1.8 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.704 1.202 . . . . 1.2 113.12 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.7 -43.9 93.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.345 0.658 . . . . 0.66000000000000003 109.985 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.0 149.1 39.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.627 1.971 . . . . 0.56999999999999995 108.606 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -75.11 160.31 39.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.311 2.007 . . . . 0.56999999999999995 112.66 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.84 -38.99 83.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.353 1.061 . . . . 0.65000000000000002 111.669 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.75 -39.58 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.296 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.8 m -68.01 -43.62 78.42 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 116.442 -1.742 . . . . 0.56999999999999995 109.013 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.97 -51.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 121.455 1.934 . . . . 0.56999999999999995 110.736 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.33 -40.99 94.4 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.197 0.908 . . . . 0.66000000000000003 111.352 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -42.74 97.65 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.852 1.206 . . . . 1.2 112.048 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 115' ' ' LEU . 7.8 mp -63.55 -48.65 76.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.598 1.559 . . . . 0.56999999999999995 108.402 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -56.64 -41.61 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.977 0.808 . . . . 0.56999999999999995 110.763 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -60.51 -53.25 59.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.499 1.045 . . . . 0.56999999999999995 109.644 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -39.19 93.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.285 0.948 . . . . 0.56999999999999995 111.624 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.96 93.74 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.943 1.297 . . . . 0.56999999999999995 111.984 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 HD12 ' A' ' 122' ' ' LEU . 30.5 mt -70.42 -33.78 71.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.396 -0.812 . . . . 0.56999999999999995 110.322 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.97 -37.3 76.48 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 118.808 0.731 . . . . 0.56999999999999995 110.546 171.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.52 80.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.91 0.777 . . . . 0.56999999999999995 112.268 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.427 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 17.7 m95 -73.03 -47.56 43.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.764 0.711 . . . . 0.56999999999999995 110.823 171.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.87 63.54 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.562 1.077 . . . . 0.56999999999999995 113.53 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.32 -17.47 64.78 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.113 -1.227 . . . . 0.56999999999999995 111.863 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -106.41 -33.86 7.6 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.75 -0.643 . . . . 0.66000000000000003 111.332 173.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 160' ' ' ILE . 21.4 pt -121.54 134.17 24.47 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 119.455 1.025 . . . . 0.56999999999999995 110.39 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 37.27 0.38 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.9 3.067 . . . . 0.56999999999999995 113.055 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.06 132.84 36.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.021 -1.474 . . . . 0.56999999999999995 107.021 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -116.44 163.97 15.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.89 1.276 . . . . 0.65000000000000002 108.915 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -139.6 153.47 47.37 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 108.962 -170.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -141.04 178.68 7.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.179 0.991 . . . . 1.2 109.461 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -125.35 156.07 39.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.538 -0.912 . . . . 0.56999999999999995 108.538 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 m -108.19 169.53 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.998 1.319 . . . . 0.56999999999999995 109.319 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.77 -29.37 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.71 -1.586 . . . . 0.56999999999999995 110.948 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -62.69 -51.83 65.67 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.187 0.903 . . . . 0.56999999999999995 111.719 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.64 -125.2 1.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.072 -1.611 . . . . 0.56999999999999995 109.072 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -47.14 154.85 0.34 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.443 1.097 . . . . 0.56999999999999995 113.744 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.87 -174.18 4.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.176 1.39 . . . . 0.56999999999999995 110.943 -170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -60.51 -42.09 95.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.54 -0.743 . . . . 0.66000000000000003 109.001 172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -124.19 82.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.56999999999999995 108.375 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.3 ttp -79.89 117.32 20.65 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 120.294 -1.504 . . . . 0.56999999999999995 107.116 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -108.62 129.09 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.25 -2.13 . . . . 0.56999999999999995 105.25 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 164.77 27.64 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-O 121.962 0.756 . . . . 0.56999999999999995 112.176 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.9 m-85 -132.43 141.4 48.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.026 -1.842 . . . . 0.56999999999999995 106.026 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.38 164.69 30.08 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 107.916 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 42.08 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.564 -0.71 . . . . 1.2 111.182 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.15 -46.29 0.61 Allowed Glycine 0 C--O 1.223 -0.586 0 CA-C-O 119.53 -0.594 . . . . 0.56999999999999995 111.658 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.03 169.32 21.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.567 1.184 . . . . 0.56999999999999995 110.245 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.76 159.92 33.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.969 1.708 . . . . 0.65000000000000002 108.829 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.65 60.78 3.19 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.888 1.232 . . . . 0.56999999999999995 111.412 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -105.78 -61.84 1.45 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.111 0.965 . . . . 0.66000000000000003 110.406 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.5 t -179.74 -35.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.364 2.665 . . . . 0.56999999999999995 110.003 -173.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.75 122.7 14.54 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 119.193 0.906 . . . . 0.56999999999999995 108.992 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.99 133.13 34.56 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 N-CA-C 108.423 -1.414 . . . . 0.56999999999999995 108.423 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -166.93 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 123.257 1.504 . . . . 0.56999999999999995 110.809 166.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -134.01 -38.25 0.88 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.76 3.224 . . . . 0.66000000000000003 109.172 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.74 -139.68 14.97 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.672 -1.071 . . . . 0.56999999999999995 110.509 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.1 95.43 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 124.466 3.444 . . . . 0.56999999999999995 111.281 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.64 170.85 12.33 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.849 1.69 . . . . 0.56999999999999995 109.29 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 49.33 -159.6 0.06 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.485 1.514 . . . . 0.56999999999999995 112.377 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -43.05 128.18 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.242 2.217 . . . . 0.56999999999999995 112.848 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -95.53 -24.33 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 113.062 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.09 162.0 33.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.629 -1.249 . . . . 0.56999999999999995 107.629 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.3 167.83 22.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.321 -0.622 . . . . 0.65000000000000002 109.321 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.39 160.28 42.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.285 -1.006 . . . . 0.56999999999999995 108.285 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -111.45 147.07 36.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.688 -1.227 . . . . 0.56999999999999995 107.688 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 151.4 53.22 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.268 -0.872 . . . . 0.56999999999999995 110.249 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.13 164.85 23.72 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.95 1.767 . . . . 0.56999999999999995 111.585 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.12 -93.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 109.357 -1.497 . . . . 0.56999999999999995 109.357 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -158.92 -50.61 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.503 1.521 . . . . 0.56999999999999995 109.709 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.52 -119.73 2.13 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.707 -0.957 . . . . 0.56999999999999995 110.707 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -31.49 40.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.996 0.898 . . . . 0.56999999999999995 111.879 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.2 142.44 7.97 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.509 -0.744 . . . . 0.56999999999999995 112.135 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.4 -38.9 3.12 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.186 1.851 . . . . 0.56999999999999995 112.625 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -60.36 149.78 32.71 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.759 -0.83 . . . . 0.66000000000000003 108.759 -167.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.61 146.98 38.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.522 0.677 . . . . 0.56999999999999995 109.25 -171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -135.39 156.2 49.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.265 -0.879 . . . . 0.65000000000000002 109.975 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 47.0 m-85 -137.82 146.15 43.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.019 1.327 . . . . 0.56999999999999995 108.081 -169.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.02 101.61 7.91 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.455 -0.942 . . . . 0.66000000000000003 108.455 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -59.08 -24.34 62.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.66000000000000003 111.885 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -69.12 -36.05 77.08 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.577 0.751 . . . . 0.66000000000000003 111.215 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.86 131.26 44.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.441 -1.689 . . . . 0.66000000000000003 106.441 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 139.69 48.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.635 0.774 . . . . 1.2 110.441 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -129.32 118.27 21.99 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.232 -1.395 . . . . 0.56999999999999995 107.232 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -114.93 147.99 39.28 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.38 -0.97 . . . . 0.56999999999999995 108.38 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.94 21.83 2.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.624 0.77 . . . . 0.66000000000000003 111.981 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.03 68.95 1.29 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.399 -1.08 . . . . 0.56999999999999995 110.399 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -40.04 4.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.984 -1.007 . . . . 0.56999999999999995 113.697 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.0 -47.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.209 1.804 . . . . 0.56999999999999995 110.621 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -139.09 155.2 48.09 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.354 1.462 . . . . 0.56999999999999995 108.131 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.63 -161.47 12.85 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.236 -1.546 . . . . 0.56999999999999995 109.236 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.2 mm -113.36 121.19 65.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.712 -1.959 . . . . 0.56999999999999995 105.712 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.23 103.47 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.984 0.803 . . . . 0.56999999999999995 109.072 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -53.27 -41.16 65.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.607 1.563 . . . . 0.56999999999999995 110.399 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' A' ' 34' ' ' LEU . 13.3 tp -64.42 -50.36 67.9 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.694 -1.225 . . . . 0.56999999999999995 107.694 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -60.35 -39.51 87.41 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.232 -0.655 . . . . 0.56999999999999995 109.232 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.04 -61.69 2.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 110.458 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.85 -51.49 65.74 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.235 0.614 . . . . 0.56999999999999995 110.095 -175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.8 m -62.51 -37.71 87.09 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.438 0.695 . . . . 0.56999999999999995 112.062 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -60.65 -53.95 51.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.196 0.598 . . . . 0.65000000000000002 109.393 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.78 -40.43 96.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.258 0.481 . . . . 0.66000000000000003 110.652 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 39' ' ' LEU . 2.9 mm? -61.26 -30.0 70.19 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.878 0.871 . . . . 0.56999999999999995 111.37 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.427 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -56.29 -51.83 53.55 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 118.472 0.578 . . . . 0.56999999999999995 112.083 170.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.01 -40.42 93.47 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.203 1.001 . . . . 0.65000000000000002 110.635 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -33.36 65.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.115 0.966 . . . . 0.56999999999999995 112.173 172.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.91 66.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 111.648 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.82 63.88 0.88 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.446 -0.662 . . . . 0.56999999999999995 111.446 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.6 176.84 8.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 109.141 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -95.44 148.44 18.99 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.868 -0.605 . . . . 0.56999999999999995 111.929 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 174.86 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.117 1.367 . . . . 0.65000000000000002 113.045 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -133.74 178.31 7.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.983 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -165.39 47.06 0.09 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.358 1.863 . . . . 0.56999999999999995 108.212 -173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.7 t70 -121.63 143.23 37.56 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-O 118.269 -0.872 . . . . 0.66000000000000003 109.708 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.7 2.49 2.92 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.696 2.931 . . . . 0.56999999999999995 114.098 -171.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -146.98 20.57 1.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.432 1.093 . . . . 0.56999999999999995 110.358 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -72.11 140.57 48.94 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.463 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.56 -35.25 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.37 -0.974 . . . . 0.56999999999999995 108.37 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -86.85 14.15 7.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.949 1.092 . . . . 0.56999999999999995 113.949 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.07 128.26 93.61 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.496 -1.377 . . . . 0.56999999999999995 111.137 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.62 -46.51 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.551 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 p -81.32 52.05 1.75 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.141 1.377 . . . . 0.56999999999999995 110.323 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -39.86 131.91 1.82 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 112.902 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.7 114.9 2.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.212 1.387 . . . . 0.56999999999999995 109.657 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 179.61 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.183 1.393 . . . . 0.56999999999999995 109.349 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.38 -138.52 9.65 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.841 1.21 . . . . 0.56999999999999995 110.343 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -127.38 111.29 21.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 0.66000000000000003 108.853 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.33 -15.22 22.65 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.814 2.342 . . . . 0.56999999999999995 113.015 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -62.57 -36.46 82.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.487 1.04 . . . . 0.56999999999999995 110.252 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -90.53 70.0 6.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.947 1.299 . . . . 0.56999999999999995 108.772 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -41.73 -68.45 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.773 1.629 . . . . 0.56999999999999995 115.23 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 21.58 74.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.386 2.674 . . . . 0.56999999999999995 112.633 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.4 mp -31.37 116.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 128.022 2.529 . . . . 0.56999999999999995 109.742 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.6 t -82.2 -88.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.843 0.354 . . . . 0.56999999999999995 110.998 -162.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -142.43 -30.51 0.55 Allowed 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 124.315 1.046 . . . . 0.56999999999999995 110.774 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -51.54 -45.71 63.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 120.027 1.285 . . . . 0.66000000000000003 110.795 167.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.406 ' CG ' HD23 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -72.76 -58.59 3.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.479 1.112 . . . . 0.66000000000000003 111.023 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.56 -46.72 89.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.892 -0.781 . . . . 0.56999999999999995 108.892 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -60.51 -49.8 76.12 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.046 -1.454 . . . . 0.56999999999999995 108.864 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -54.18 -59.54 9.83 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.937 -1.265 . . . . 0.56999999999999995 109.937 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 46' ' ' ILE . 6.6 mm -56.22 -50.22 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.933 1.293 . . . . 0.56999999999999995 112.776 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -69.28 -19.75 63.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.476 0.71 . . . . 0.56999999999999995 111.55 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -81.77 -25.96 34.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.13 0.972 . . . . 0.56999999999999995 111.178 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 -50.59 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.348 0.976 . . . . 0.56999999999999995 111.237 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 46' ' ' ILE . 39.4 m-85 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.74 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.532 0.423 0 N-CA-C 110.988 -0.428 . . . . 0.56999999999999995 110.988 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.78 95.52 0.04 OUTLIER 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.696 1.198 . . . . 0.56999999999999995 110.384 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -46.21 142.71 2.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.571 1.148 . . . . 0.56999999999999995 110.7 172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.9 m -62.06 -21.13 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.039 0.936 . . . . 0.56999999999999995 112.456 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -94.94 143.7 26.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.886 1.275 . . . . 0.56999999999999995 109.536 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -77.19 0.18 22.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.539 0.736 . . . . 0.56999999999999995 112.533 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.34 144.05 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.113 -1.439 . . . . 0.56999999999999995 107.113 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.07 145.8 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.412 -1.699 . . . . 0.56999999999999995 106.412 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -109.11 139.07 44.5 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.431 1.014 . . . . 0.56999999999999995 110.131 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -122.37 157.5 31.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.697 0.761 . . . . 0.56999999999999995 111.088 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.552 1.141 . . . . 1.2 109.114 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.477 HG21 ' CE1' ' A' ' 22' ' ' TYR . 1.6 mm -122.22 97.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.472 -2.418 . . . . 0.56999999999999995 104.472 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.19 -34.71 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.391 0.676 . . . . 0.56999999999999995 111.954 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -130.44 141.31 50.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.357 -2.46 . . . . 0.56999999999999995 104.357 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.477 ' CE1' HG21 ' A' ' 19' ' ' ILE . 23.2 m-85 -129.86 146.56 51.59 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.581 1.152 . . . . 0.56999999999999995 108.931 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 t -75.9 -175.67 3.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.525 1.93 . . . . 0.56999999999999995 111.063 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -128.25 -27.75 2.66 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.595 0.961 . . . . 1.2 113.595 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.82 -23.56 67.33 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.848 1.204 . . . . 0.66000000000000003 111.519 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.36 146.95 24.15 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.097 1.759 . . . . 0.56999999999999995 109.43 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -75.29 161.73 37.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.736 2.291 . . . . 0.56999999999999995 112.96 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -70.42 -38.58 74.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.364 -0.835 . . . . 0.65000000000000002 110.315 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.52 -37.13 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 110.44 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 m -66.37 -46.33 77.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.419 -1.277 . . . . 0.56999999999999995 109.057 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.5 t -55.59 -50.65 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 110.121 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.36 -35.29 80.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 111.736 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -44.28 74.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.426 1.012 . . . . 1.2 112.314 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.09 -46.88 82.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.56999999999999995 108.112 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.86 -44.53 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 117.568 -1.206 . . . . 0.56999999999999995 111.244 173.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -54.64 -49.97 69.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.48 1.491 . . . . 0.56999999999999995 111.388 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -74.57 -33.36 62.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.155 0.889 . . . . 0.56999999999999995 112.198 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.5 78.88 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.373 1.069 . . . . 0.56999999999999995 110.949 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 122' ' ' LEU . 49.0 mt -66.76 -41.06 88.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.151 -0.928 . . . . 0.56999999999999995 109.397 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -52.88 -43.19 65.97 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 119.402 1.001 . . . . 0.56999999999999995 110.684 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.5 mtp -59.32 -39.03 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.062 1.301 . . . . 0.56999999999999995 112.597 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -65.39 -43.44 90.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.861 1.209 . . . . 0.56999999999999995 110.964 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.9 88.09 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.66 -1.275 . . . . 0.56999999999999995 113.528 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -77.45 -12.89 60.01 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 110.104 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -109.06 -21.04 12.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.828 1.251 . . . . 0.66000000000000003 111.909 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 164' ' ' TYR . 7.9 pt -139.18 152.94 70.74 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 110.137 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.06 13.55 1.25 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.11 2.54 . . . . 0.56999999999999995 113.021 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tt -82.18 135.23 35.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.455 -1.313 . . . . 0.56999999999999995 107.455 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -116.79 170.45 8.59 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.553 0.741 . . . . 0.65000000000000002 109.516 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 157.76 41.92 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.472 -0.768 . . . . 0.56999999999999995 109.203 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.16 164.57 26.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.366 1.466 . . . . 1.2 108.357 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -135.65 115.83 13.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.123 -2.177 . . . . 0.56999999999999995 105.123 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.46 164.92 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 109.023 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.02 -36.51 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.265 0.626 . . . . 0.56999999999999995 111.084 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 153.31 19.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.148 0.579 . . . . 0.56999999999999995 110.662 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.48 40.57 2.42 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.358 0.98 . . . . 0.56999999999999995 113.076 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -163.8 143.13 8.03 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.687 -1.227 . . . . 0.56999999999999995 107.687 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.54 6.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.669 1.188 . . . . 0.56999999999999995 109.596 -174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -64.48 -32.29 73.86 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.18 -0.674 . . . . 0.66000000000000003 109.18 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 122' ' ' LEU . 5.5 mt -124.43 97.12 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.724 2.01 . . . . 0.56999999999999995 107.728 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 ttp -100.23 100.15 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.305 2.642 . . . . 0.56999999999999995 106.341 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mt -92.77 128.08 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.005 -1.85 . . . . 0.56999999999999995 106.005 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.47 145.11 11.61 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.424 -0.67 . . . . 0.56999999999999995 111.424 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 142.21 47.45 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.23 165.59 26.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.565 1.546 . . . . 0.56999999999999995 108.373 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.9 22.82 11.54 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.559 -0.713 . . . . 1.2 111.481 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 156.59 31.2 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.593 1.568 . . . . 0.56999999999999995 109.81 -164.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 49.86 102.38 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.059 2.144 . . . . 0.56999999999999995 114.201 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -147.33 157.44 43.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.476 1.111 . . . . 0.65000000000000002 109.035 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.59 62.23 4.05 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.3 0.952 . . . . 0.56999999999999995 111.192 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -106.83 -55.28 2.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.381 0.591 . . . . 0.66000000000000003 111.105 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.86 -43.18 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.814 2.846 . . . . 0.56999999999999995 109.594 -168.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -142.83 121.61 7.47 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.019 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.53 140.25 35.92 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.972 1.781 . . . . 0.56999999999999995 111.544 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -72.41 173.39 8.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.304 1.042 . . . . 0.56999999999999995 111.797 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.78 -31.51 15.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.937 2.095 . . . . 0.66000000000000003 112.41 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.04 -132.47 11.11 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 120.862 1.664 . . . . 0.56999999999999995 111.516 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.48 103.86 1.43 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 112.171 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.46 -167.06 25.65 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.682 2.087 . . . . 0.56999999999999995 111.428 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.99 -140.43 0.71 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.025 -1.279 . . . . 0.56999999999999995 114.152 164.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -51.18 137.2 22.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.042 2.137 . . . . 0.56999999999999995 110.535 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.68 -30.54 10.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.618 1.567 . . . . 0.56999999999999995 111.294 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.39 165.6 28.65 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.059 1.344 . . . . 0.56999999999999995 108.987 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.85 159.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.565 0.62 . . . . 0.65000000000000002 111.447 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.13 147.09 34.41 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.446 0.698 . . . . 0.56999999999999995 110.011 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -98.67 150.86 21.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.005 -0.998 . . . . 0.56999999999999995 109.414 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.49 150.23 86.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.543 -0.741 . . . . 0.56999999999999995 110.298 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -69.29 162.53 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.234 1.956 . . . . 0.56999999999999995 111.509 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.71 -93.35 0.1 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.258 -1.537 . . . . 0.56999999999999995 109.258 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -160.61 123.0 3.22 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.653 0.726 . . . . 0.56999999999999995 110.14 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.42 -123.32 7.47 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-O 118.187 -1.34 . . . . 0.56999999999999995 110.23 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.04 -24.4 39.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 112.364 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.25 143.14 12.75 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 120.939 -1.101 . . . . 0.56999999999999995 111.468 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.99 -21.63 2.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.371 1.462 . . . . 0.56999999999999995 114.13 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -70.51 159.47 34.23 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.02 1.91 . . . . 0.66000000000000003 108.692 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.65 141.3 28.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.198 -0.668 . . . . 0.56999999999999995 109.198 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -130.7 158.4 40.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.713 -0.477 . . . . 0.65000000000000002 109.713 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.08 146.83 34.16 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.744 -1.206 . . . . 0.56999999999999995 107.744 -169.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.96 98.35 3.57 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.823 -0.806 . . . . 0.66000000000000003 108.823 174.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.12 -16.82 62.65 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.431 -1.418 . . . . 0.66000000000000003 111.87 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.64 -33.74 76.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.564 1.546 . . . . 0.66000000000000003 110.961 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.4 157.17 32.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.629 0.728 . . . . 0.66000000000000003 109.82 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 135.73 38.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.282 -0.636 . . . . 1.2 109.282 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -126.98 151.87 47.96 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.147 -1.057 . . . . 0.56999999999999995 108.147 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -154.1 167.94 28.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.801 0.728 . . . . 0.56999999999999995 110.435 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.0 -32.1 45.04 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.396 1.079 . . . . 0.66000000000000003 112.258 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.97 88.01 0.74 Allowed Glycine 0 C--N 1.343 0.92 0 C-N-CA 123.633 0.635 . . . . 0.56999999999999995 112.614 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.3 m -120.47 -42.77 2.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.521 -0.752 . . . . 0.56999999999999995 112.751 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 p -171.85 -43.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.23 0.923 . . . . 0.56999999999999995 111.881 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.6 166.03 24.49 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.273 1.429 . . . . 0.56999999999999995 109.313 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 179.09 35.59 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 110.694 -0.962 . . . . 0.56999999999999995 110.694 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.6 mm -103.58 118.38 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.134 -1.062 . . . . 0.56999999999999995 108.134 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -70.59 121.85 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.747 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -37.97 76.23 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.132 1.16 . . . . 0.56999999999999995 114.132 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.37 -39.77 91.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.691 -0.855 . . . . 0.56999999999999995 108.691 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 1.7 m-85 -75.63 -41.57 53.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.495 -0.928 . . . . 0.56999999999999995 108.495 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.39 86.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.016 -0.516 . . . . 0.56999999999999995 110.583 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.32 -55.84 29.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.863 -1.065 . . . . 0.56999999999999995 109.789 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 m -53.67 -42.14 67.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.534 1.516 . . . . 0.56999999999999995 112.335 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -62.01 -54.38 42.43 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.938 0.79 . . . . 0.65000000000000002 110.088 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -68.41 -45.96 71.21 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.318 1.047 . . . . 0.66000000000000003 111.528 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.22 -31.59 72.85 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.045 1.338 . . . . 0.56999999999999995 110.959 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.59 -52.91 38.63 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.61 -0.996 . . . . 0.56999999999999995 110.61 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -58.55 -45.49 88.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.569 0.684 . . . . 0.65000000000000002 111.545 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.5 t -54.81 -38.6 67.55 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.15 0.906 . . . . 0.56999999999999995 112.726 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -27.65 68.73 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.8 0.84 . . . . 0.56999999999999995 111.777 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.24 44.44 0.13 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.839 1.209 . . . . 0.56999999999999995 113.334 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.04 156.66 42.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.573 1.187 . . . . 0.56999999999999995 111.013 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.44 -13.12 2.91 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 115.795 -2.67 . . . . 0.56999999999999995 114.821 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.6 m170 137.37 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 1 C-N-CA 131.836 4.054 . . . . 0.65000000000000002 111.434 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.9 m -131.79 -173.09 3.04 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.833 2.853 . . . . 0.56999999999999995 109.081 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.8 t -148.78 61.17 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.999 0.92 . . . . 0.56999999999999995 110.17 -171.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 6.2 t0 -133.97 149.06 70.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 108.798 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.03 -4.88 14.22 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.648 . . . . 0.56999999999999995 112.972 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.52 28.93 4.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.56999999999999995 109.101 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.09 130.18 34.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.645 1.578 . . . . 0.56999999999999995 109.926 172.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.74 -19.65 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.052 0.387 . . . . 0.56999999999999995 110.884 165.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.99 -14.56 63.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 117.66 -1.162 . . . . 0.56999999999999995 112.962 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.11 133.09 87.53 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 121.246 1.839 . . . . 0.56999999999999995 110.671 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.79 144.25 24.4 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.613 2.208 . . . . 0.56999999999999995 110.301 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 52.6 m 66.67 116.03 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.197 1.799 . . . . 0.56999999999999995 110.468 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -54.89 116.73 2.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.267 -0.896 . . . . 0.56999999999999995 110.924 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.7 -121.03 2.19 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.213 1.863 . . . . 0.56999999999999995 109.851 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.84 -26.59 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.455 1.502 . . . . 0.56999999999999995 113.914 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.5 151.84 27.49 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.874 -0.891 . . . . 0.56999999999999995 110.874 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.18 110.99 42.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.764 -1.939 . . . . 0.66000000000000003 105.764 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 116' ' ' TYR . 27.2 Cg_endo -79.62 29.17 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.688 2.926 . . . . 0.56999999999999995 115.499 174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -129.61 -28.11 2.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.085 1.354 . . . . 0.56999999999999995 111.446 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.03 94.31 1.52 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 109.327 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -138.41 169.04 18.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.828 1.251 . . . . 0.56999999999999995 109.405 177.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.88 57.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 111.127 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp 63.72 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 110.254 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -68.7 -86.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.138 0.975 . . . . 0.56999999999999995 112.234 -165.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -144.54 -35.8 0.34 Allowed 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.34 1.456 . . . . 0.56999999999999995 108.817 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -55.61 -48.37 74.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.269 1.827 . . . . 0.66000000000000003 111.378 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.54 -49.4 54.72 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.643 0.777 . . . . 0.66000000000000003 109.424 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -46.49 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 109.645 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -71.42 -40.48 70.41 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.73 -1.128 . . . . 0.56999999999999995 109.306 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -50.0 -61.06 6.03 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 mm -57.08 -50.08 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 117.711 0.755 . . . . 0.56999999999999995 111.5 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.86 -13.47 62.17 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.199 -0.938 . . . . 0.56999999999999995 113.14 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -92.11 -25.31 18.8 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 111.047 171.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.39 -35.95 65.98 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.554 1.142 . . . . 0.56999999999999995 112.773 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 46' ' ' ILE . 33.8 m-85 . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 124.551 1.141 . . . . 0.56999999999999995 109.969 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.453 -0.881 0 N-CA-C 108.659 -1.323 . . . . 0.56999999999999995 108.659 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 83.58 134.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 111.077 -172.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 63.9 m95 -66.24 169.2 7.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.963 0.887 . . . . 0.56999999999999995 111.305 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -80.07 -33.84 38.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.478 0.711 . . . . 0.56999999999999995 111.424 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.8 t -86.99 146.42 26.14 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.171 0.988 . . . . 0.56999999999999995 109.379 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -75.3 -12.19 60.22 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.56999999999999995 112.012 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -116.24 111.68 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.306 -1.738 . . . . 0.56999999999999995 106.306 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.457 ' CG1' HD12 ' A' ' 60' ' ' ILE . 72.7 t -104.04 129.05 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.792 -1.188 . . . . 0.56999999999999995 107.792 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -104.65 138.38 41.05 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.73 -0.606 . . . . 0.56999999999999995 110.285 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -125.08 160.11 29.82 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.906 0.482 . . . . 0.56999999999999995 110.869 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -152.14 166.4 31.78 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 122.758 0.423 . . . . 1.2 110.673 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.5 mt -130.26 94.67 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 103.806 -2.665 . . . . 0.56999999999999995 103.806 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 t -76.8 -45.44 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.528 0.731 . . . . 0.56999999999999995 109.597 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -112.63 156.19 23.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 104.651 -2.351 . . . . 0.56999999999999995 104.651 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.38 154.48 50.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.788 -1.56 . . . . 0.56999999999999995 106.788 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 31' ' ' VAL . 10.9 t -64.05 173.31 1.95 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.875 1.322 . . . . 0.56999999999999995 111.827 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 -37.22 6.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.99 -1.459 . . . . 1.2 112.397 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.16 -35.76 76.68 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.357 0.526 . . . . 0.66000000000000003 111.307 -172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 mt -114.12 151.93 45.38 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 126.884 2.074 . . . . 0.56999999999999995 108.153 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -78.23 154.01 28.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 111.974 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.81 -37.94 74.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.57 1.148 . . . . 0.65000000000000002 113.174 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tp -59.36 -43.4 90.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.773 -0.454 . . . . 0.56999999999999995 109.773 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -70.48 -41.08 73.2 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.895 -1.05 . . . . 0.56999999999999995 108.988 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 23' ' ' THR . 47.4 t -54.5 -52.14 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 119.83 1.196 . . . . 0.56999999999999995 109.698 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -65.96 -43.94 86.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.774 0.716 . . . . 0.66000000000000003 111.096 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.71 92.64 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.368 -0.833 . . . . 1.2 112.099 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.94 -47.26 66.13 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.98 -44.49 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.393 1.451 . . . . 0.56999999999999995 110.835 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -39.31 92.15 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 117.499 -1.239 . . . . 0.56999999999999995 111.057 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -67.21 -44.37 79.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.48 1.112 . . . . 0.56999999999999995 111.509 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.04 96.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.799 1.24 . . . . 0.56999999999999995 111.023 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 122' ' ' LEU . 24.1 mt -68.8 -34.17 75.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.975 0.51 . . . . 0.56999999999999995 111.039 174.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -46.97 81.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 118.679 -0.677 . . . . 0.56999999999999995 109.319 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.422 ' HB3' HD11 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -56.38 -42.03 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.368 -0.825 . . . . 0.56999999999999995 111.607 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.451 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 32.9 m95 -63.19 -46.77 85.49 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.441 1.019 . . . . 0.56999999999999995 111.372 173.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.44 -10.81 63.86 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.337 -0.852 . . . . 0.56999999999999995 114.317 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -80.96 -5.38 57.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.253 -1.145 . . . . 0.56999999999999995 111.177 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 160' ' ' ILE . 9.3 mm-40 -113.06 -20.28 11.56 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.872 0.869 . . . . 0.66000000000000003 111.636 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 160' ' ' ILE . 10.1 pt -136.42 150.22 69.94 Favored Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 124.57 1.148 . . . . 0.56999999999999995 110.184 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.49 16.64 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 113.113 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 126' ' ' LEU . 2.2 tt -82.04 142.69 32.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 107.591 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -125.4 170.63 11.17 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.851 0.834 . . . . 0.65000000000000002 109.487 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.02 162.09 36.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.912 -0.773 . . . . 0.56999999999999995 108.912 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.75 -179.94 6.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.654 -1.157 . . . . 1.2 108.995 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -135.78 133.97 38.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.504 -1.665 . . . . 0.56999999999999995 106.504 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.35 162.65 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 O-C-N 124.174 0.921 . . . . 0.56999999999999995 109.526 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.9 m -110.72 -30.04 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.769 -1.105 . . . . 0.56999999999999995 110.696 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -60.69 3.13 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.596 1.158 . . . . 0.56999999999999995 110.695 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.87 -91.23 0.1 OUTLIER Glycine 0 C--O 1.219 -0.823 0 N-CA-C 109.896 -1.282 . . . . 0.56999999999999995 109.896 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -62.22 153.76 29.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.379 1.589 . . . . 0.56999999999999995 111.904 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.35 -170.55 3.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 109.972 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.24 -38.5 71.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.286 -1.005 . . . . 0.66000000000000003 108.286 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 15' ' ' VAL . 5.6 mt -127.66 90.8 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 107.938 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 154.04 26.93 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 109.111 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.06 137.41 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.487 -2.042 . . . . 0.56999999999999995 105.487 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.47 164.88 29.46 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.899 -0.88 . . . . 0.56999999999999995 110.899 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 5.4 m-85 -138.29 133.91 33.66 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.235 -1.765 . . . . 0.56999999999999995 106.235 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.69 178.89 8.1 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.56999999999999995 109.512 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.71 85.69 2.39 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 107.123 -1.436 . . . . 1.2 107.123 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.56 -139.68 15.61 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.47 -0.652 . . . . 0.56999999999999995 111.47 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.77 122.13 9.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.56999999999999995 111.398 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -125.2 -39.86 2.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.65000000000000002 112.2 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.71 44.85 0.8 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.886 -0.486 . . . . 0.56999999999999995 111.886 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.79 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.173 1.389 . . . . 0.66000000000000003 107.672 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -173.55 -34.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.616 1.966 . . . . 0.56999999999999995 110.484 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -132.21 132.15 22.82 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 108.176 -1.046 . . . . 0.56999999999999995 108.176 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.32 133.53 28.61 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 N-CA-C 108.857 -1.247 . . . . 0.56999999999999995 108.857 171.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -64.41 178.36 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.917 1.342 . . . . 0.56999999999999995 109.92 165.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -98.88 -43.36 6.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 131.436 3.894 . . . . 0.66000000000000003 110.092 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.96 -139.28 14.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.832 -1.538 . . . . 0.56999999999999995 110.363 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.18 96.48 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 112.055 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 177.82 15.04 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 110.334 -1.106 . . . . 0.56999999999999995 110.334 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.254 15.3 t30 60.05 -142.69 0.56 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 112.489 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.4 m -45.42 144.35 1.52 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.628 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -107.62 -29.01 9.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.471 1.941 . . . . 0.56999999999999995 112.462 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.26 166.08 25.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.522 1.129 . . . . 0.56999999999999995 108.332 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.76 161.84 38.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.176 0.512 . . . . 0.65000000000000002 109.715 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 160.82 43.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.981 0.912 . . . . 0.56999999999999995 108.799 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -112.56 151.08 30.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.762 -0.829 . . . . 0.56999999999999995 108.762 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.33 156.33 22.41 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.531 -0.747 . . . . 0.56999999999999995 111.004 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.492 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 17.6 Cg_endo -68.52 148.26 72.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.888 1.725 . . . . 0.56999999999999995 111.921 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.2 175.22 13.79 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.6 1.095 . . . . 0.56999999999999995 110.84 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t 43.31 -148.54 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.603 1.561 . . . . 0.56999999999999995 112.703 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.29 -56.62 1.45 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 117.182 -1.899 . . . . 0.56999999999999995 110.482 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -44.37 74.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.44 1.62 . . . . 0.56999999999999995 112.075 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 151.15 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.619 1.1 . . . . 0.56999999999999995 112.659 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.89 -26.32 1.73 Allowed Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.853 -1.526 . . . . 0.56999999999999995 114.641 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.05 150.11 49.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.971 -1.122 . . . . 0.66000000000000003 107.971 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.14 148.51 35.16 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.424 -0.807 . . . . 0.56999999999999995 109.341 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -132.47 159.69 38.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.659 -0.867 . . . . 0.65000000000000002 108.659 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.2 m-85 -138.35 155.87 48.14 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.454 1.502 . . . . 0.56999999999999995 108.868 -170.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.17 97.76 10.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.898 0.479 . . . . 0.66000000000000003 109.952 172.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.25 -25.66 61.98 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.061 0.945 . . . . 0.66000000000000003 111.676 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.01 -34.99 70.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.305 0.574 . . . . 0.66000000000000003 111.075 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -82.48 150.26 27.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.636 1.175 . . . . 0.66000000000000003 109.085 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -71.88 147.5 47.04 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.511 -0.743 . . . . 1.2 110.647 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -135.35 134.53 39.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.267 -1.383 . . . . 0.56999999999999995 107.267 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -133.85 150.18 51.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 0.56999999999999995 110.389 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.64 -29.45 64.65 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.191 0.997 . . . . 0.66000000000000003 111.374 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.01 75.88 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.387 -1.085 . . . . 0.56999999999999995 110.387 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.29 155.92 38.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.401 -1.333 . . . . 0.56999999999999995 107.401 172.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -62.47 167.28 4.41 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.529 0.732 . . . . 0.56999999999999995 110.509 170.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.35 -64.22 0.4 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.935 2.094 . . . . 0.56999999999999995 111.016 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.28 147.76 49.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.052 -1.219 . . . . 0.56999999999999995 110.052 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.32 129.82 36.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.004 -1.11 . . . . 0.56999999999999995 108.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -66.62 113.19 4.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.388 -0.597 . . . . 0.56999999999999995 109.388 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 9.6 t80 -58.5 -46.09 87.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.2 1.0 . . . . 0.56999999999999995 111.372 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -63.43 -41.69 98.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 109.745 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.36 -45.0 96.19 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.444 0.698 . . . . 0.56999999999999995 109.934 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.66 72.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.035 0.534 . . . . 0.56999999999999995 111.316 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.82 -55.37 33.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 117.366 -1.302 . . . . 0.56999999999999995 109.086 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 m -52.35 -41.49 63.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.407 1.458 . . . . 0.56999999999999995 111.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.15 -60.57 3.55 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.557 0.617 . . . . 0.65000000000000002 110.058 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.47 -43.7 96.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.385 0.539 . . . . 0.66000000000000003 110.9 -173.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.08 -26.98 68.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.681 1.193 . . . . 0.56999999999999995 111.775 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.22 -45.95 92.16 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.009 -0.836 . . . . 0.56999999999999995 111.009 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -68.71 -39.78 80.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.957 -1.02 . . . . 0.65000000000000002 111.582 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.408 ' HB3' HG12 ' A' ' 60' ' ' ILE . 67.0 m -55.17 -30.69 60.38 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 124.159 0.912 . . . . 0.56999999999999995 111.966 172.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.447 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.04 -34.32 66.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.338 0.972 . . . . 0.56999999999999995 111.406 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.41 52.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.416 -1.214 . . . . 0.56999999999999995 113.093 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 28.6 mmt 61.12 173.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 112.106 -171.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.81 70.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.785 -1.008 . . . . 0.56999999999999995 111.153 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.27 172.78 6.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.73 1.265 . . . . 0.65000000000000002 110.175 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.57 -179.16 5.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.35 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.5 m -138.14 54.7 1.78 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.015 1.726 . . . . 0.56999999999999995 108.892 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.61 148.39 41.79 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.249 1.02 . . . . 0.66000000000000003 109.233 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.68 -19.26 41.88 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.228 2.618 . . . . 0.56999999999999995 113.004 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -130.76 28.22 4.87 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.839 1.656 . . . . 0.56999999999999995 108.607 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.51 129.33 38.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.373 -0.973 . . . . 0.56999999999999995 108.373 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.88 -26.78 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.635 0.374 . . . . 0.56999999999999995 110.506 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -105.1 29.21 6.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.604 1.162 . . . . 0.56999999999999995 111.811 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.29 128.62 87.98 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 120.606 -1.309 . . . . 0.56999999999999995 110.554 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.21 177.76 8.2 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.421 2.747 . . . . 0.56999999999999995 111.065 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m 48.59 77.57 0.1 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.225 1.41 . . . . 0.56999999999999995 111.608 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -50.69 125.76 13.96 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.797 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.93 164.8 13.64 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 108.482 -1.847 . . . . 0.56999999999999995 108.482 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.02 -51.37 0.47 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.867 2.467 . . . . 0.56999999999999995 113.825 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.65 145.86 42.2 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -94.99 112.8 59.61 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.859 -1.904 . . . . 0.66000000000000003 105.859 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -80.31 -31.39 1.68 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.803 1.669 . . . . 0.56999999999999995 112.668 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -42.15 72.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.074 1.306 . . . . 0.56999999999999995 110.322 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -122.98 89.82 3.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.193 -1.41 . . . . 0.56999999999999995 107.193 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -120.96 159.74 24.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.97 0.89 . . . . 0.56999999999999995 109.465 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.09 156.28 10.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.689 1.996 . . . . 0.56999999999999995 105.996 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -56.07 108.31 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.141 1.376 . . . . 0.56999999999999995 107.69 175.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.8 t -86.04 -101.41 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.77 -0.826 . . . . 0.56999999999999995 108.77 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.3 -49.43 1.55 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-O 116.268 -1.825 . . . . 0.56999999999999995 108.134 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -48.83 -38.95 23.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.911 1.687 . . . . 0.66000000000000003 112.132 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -67.65 -58.89 3.88 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.354 0.661 . . . . 0.66000000000000003 111.549 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.74 -40.26 84.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-O 117.811 -1.09 . . . . 0.56999999999999995 108.369 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.48 74.91 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.671 1.588 . . . . 0.56999999999999995 108.73 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.29 -56.79 22.57 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 46' ' ' ILE . 9.5 mm -58.72 -49.1 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.386 1.093 . . . . 0.56999999999999995 112.949 -175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.59 -29.88 70.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.458 1.103 . . . . 0.56999999999999995 110.115 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -29.21 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.56999999999999995 110.17 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 3.2 mt -74.46 -48.7 25.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.14 -0.933 . . . . 0.56999999999999995 111.585 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 163' ' ' LEU . 3.2 m-85 . . . . . 0 N--CA 1.48 1.041 0 CA-C-N 119.911 1.232 . . . . 0.56999999999999995 113.887 -171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 N--CA 1.455 -0.752 0 N-CA-C 111.104 -0.383 . . . . 0.56999999999999995 111.104 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 pttt 68.4 118.02 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.896 2.078 . . . . 0.56999999999999995 110.073 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -62.17 150.35 39.01 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.56999999999999995 109.704 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.1 p -88.43 28.66 1.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.471 0.708 . . . . 0.56999999999999995 111.069 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -130.55 159.64 36.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.539 1.936 . . . . 0.56999999999999995 108.851 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -90.54 -8.55 49.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 112.748 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.46 145.76 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 0.56999999999999995 106.747 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.506 HG23 HD21 ' A' ' 48' ' ' LEU . 29.0 t -131.06 134.48 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.075 -1.824 . . . . 0.56999999999999995 106.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -100.4 147.86 25.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.651 -0.5 . . . . 0.56999999999999995 109.651 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -125.15 153.73 42.57 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.424 0.689 . . . . 0.56999999999999995 111.7 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.09 109.97 6.42 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.013 0.911 . . . . 1.2 110.59 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 22' ' ' TYR . 93.0 mt -76.03 95.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.674 -1.602 . . . . 0.56999999999999995 106.674 169.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 m -75.23 -46.41 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.709 0.803 . . . . 0.56999999999999995 111.365 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -115.96 160.31 20.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.263 -1.384 . . . . 0.56999999999999995 107.263 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 19' ' ' ILE . 10.4 m-85 -127.6 179.9 5.27 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.17 0.988 . . . . 0.56999999999999995 108.597 -172.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -119.95 -178.45 3.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.808 1.243 . . . . 0.56999999999999995 109.711 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -131.42 -31.59 1.6 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.152 1.781 . . . . 1.2 111.713 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -31.4 71.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.374 1.07 . . . . 0.66000000000000003 111.914 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.31 145.33 56.19 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 126.733 2.013 . . . . 0.56999999999999995 106.733 -175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -72.97 153.76 52.71 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.587 1.525 . . . . 0.56999999999999995 111.523 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.27 -34.73 74.15 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.245 1.018 . . . . 0.65000000000000002 113.121 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.57 -39.56 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.624 0.37 . . . . 0.56999999999999995 110.016 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -68.52 -42.49 78.44 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.332 -1.318 . . . . 0.56999999999999995 110.152 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 t -57.23 -51.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 120.584 1.538 . . . . 0.56999999999999995 109.398 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -43.56 98.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.145 0.578 . . . . 0.66000000000000003 110.222 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.15 -46.6 88.27 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 117.957 -1.021 . . . . 1.2 112.139 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.8 mp -65.07 -41.87 94.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.783 1.174 . . . . 0.56999999999999995 109.658 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.31 -48.82 79.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 108.792 -0.818 . . . . 0.56999999999999995 108.792 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -39.06 81.42 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.537 0.608 . . . . 0.56999999999999995 111.738 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -65.21 -46.22 81.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.821 1.191 . . . . 0.56999999999999995 110.438 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.98 95.29 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 111.245 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 122' ' ' LEU . 25.9 mt -68.22 -33.43 74.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.576 -0.726 . . . . 0.56999999999999995 111.327 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -65.03 -33.33 75.79 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.424 1.011 . . . . 0.56999999999999995 110.315 173.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.4 mtp -71.23 -28.83 64.47 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.857 0.753 . . . . 0.56999999999999995 111.996 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.14 -48.83 40.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.502 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.03 62.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.14 1.352 . . . . 0.56999999999999995 113.65 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -64.58 -22.41 66.96 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.886 -1.361 . . . . 0.56999999999999995 111.673 170.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -108.37 -21.3 12.81 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.796 0.725 . . . . 0.66000000000000003 112.255 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.88 135.48 27.56 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 123.872 0.869 . . . . 0.56999999999999995 110.761 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.12 61.26 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.821 3.014 . . . . 0.56999999999999995 110.65 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -117.46 124.46 48.85 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.059 -1.83 . . . . 0.56999999999999995 106.059 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -105.57 175.29 5.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.924 1.289 . . . . 0.65000000000000002 108.623 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 1.2 m-85 -139.36 153.86 47.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.18 -0.95 . . . . 0.56999999999999995 108.483 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.63 174.44 10.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.711 0.804 . . . . 1.2 109.009 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -124.29 155.69 38.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.05 -1.092 . . . . 0.56999999999999995 108.05 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.06 -179.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.172 -0.922 . . . . 0.56999999999999995 108.977 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.72 -38.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.795 -0.622 . . . . 0.56999999999999995 110.34 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -175.65 92.95 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.291 1.436 . . . . 0.56999999999999995 108.975 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.83 172.78 38.13 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.92 2.2 . . . . 0.56999999999999995 108.122 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 p -67.92 167.05 14.43 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.583 0.692 . . . . 0.56999999999999995 110.123 168.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.13 173.76 11.91 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.551 0.741 . . . . 0.56999999999999995 110.145 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.93 -33.94 66.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 118.071 -0.966 . . . . 0.66000000000000003 109.142 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.93 76.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.612 1.965 . . . . 0.56999999999999995 108.586 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -70.03 133.58 47.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 119.522 -1.986 . . . . 0.56999999999999995 107.959 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.73 105.89 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.037 -1.838 . . . . 0.56999999999999995 106.037 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 73.92 0.26 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.775 1.655 . . . . 0.56999999999999995 111.223 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -109.44 132.96 53.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 110.157 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.33 172.0 17.33 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.56999999999999995 108.449 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -91.74 113.48 25.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.286 -0.864 . . . . 1.2 110.222 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.66 71.2 0.86 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.376 -0.69 . . . . 0.56999999999999995 111.376 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 81.21 147.58 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.009 2.924 . . . . 0.56999999999999995 111.521 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.14 -11.52 4.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.944 1.297 . . . . 0.65000000000000002 112.816 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.96 3.04 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 118.801 -1.0 . . . . 0.56999999999999995 112.505 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.64 -55.89 1.61 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.718 0.759 . . . . 0.66000000000000003 110.375 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.51 -44.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.536 1.934 . . . . 0.56999999999999995 108.055 -177.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -97.42 121.24 59.02 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.467 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.74 3.82 6.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 113.204 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 56.17 -155.76 0.29 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.139 0.881 . . . . 0.56999999999999995 110.651 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -143.18 -41.48 0.3 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.644 2.777 . . . . 0.66000000000000003 108.524 -167.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.12 -149.78 16.66 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.213 1.387 . . . . 0.56999999999999995 110.195 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.6 94.3 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.589 3.526 . . . . 0.56999999999999995 111.414 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 167.95 11.45 Favored Glycine 0 C--O 1.22 -0.749 0 N-CA-C 109.411 -1.476 . . . . 0.56999999999999995 109.411 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t30 48.31 -150.52 0.15 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 119.813 1.806 . . . . 0.56999999999999995 112.241 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -47.09 111.06 0.35 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.12 2.168 . . . . 0.56999999999999995 113.306 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.97 -31.96 34.6 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.796 -1.19 . . . . 0.56999999999999995 112.497 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.49 39.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.56999999999999995 109.737 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -146.57 144.96 29.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.457 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.76 164.4 30.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 109.521 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -115.21 156.95 24.39 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.961 -0.563 . . . . 0.56999999999999995 109.515 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.65 98.73 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.358 -0.829 . . . . 0.56999999999999995 109.359 176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -72.47 159.3 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.672 2.248 . . . . 0.56999999999999995 111.178 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.32 -83.62 0.08 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.872 -1.691 . . . . 0.56999999999999995 108.872 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -159.2 146.26 17.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.316 -0.994 . . . . 0.56999999999999995 108.316 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -130.9 11.77 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 118.453 -1.193 . . . . 0.56999999999999995 110.297 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.02 -25.34 58.42 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.342 1.071 . . . . 0.56999999999999995 111.994 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.94 142.44 5.85 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.085 -1.009 . . . . 0.56999999999999995 112.121 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.61 -26.79 3.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.526 2.012 . . . . 0.56999999999999995 113.901 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -66.31 148.72 51.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.787 0.794 . . . . 0.66000000000000003 109.399 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.57 140.77 49.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 108.773 -168.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.78 139.68 29.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.234 -1.765 . . . . 0.65000000000000002 106.234 -160.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.67 148.26 37.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -166.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.69 105.99 12.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.199 -1.408 . . . . 0.66000000000000003 107.199 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.52 -19.79 27.27 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.489 -0.757 . . . . 0.66000000000000003 110.713 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -28.13 64.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.242 1.017 . . . . 0.66000000000000003 111.141 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.28 110.72 9.86 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.289 -1.745 . . . . 0.66000000000000003 106.289 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.95 110.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.151 0.887 . . . . 1.2 111.502 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.12 133.88 34.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.048 -1.093 . . . . 0.56999999999999995 108.048 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -123.33 143.49 50.06 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.491 -1.299 . . . . 0.56999999999999995 107.491 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.37 32.8 0.4 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.478 1.511 . . . . 0.66000000000000003 111.599 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.66 69.56 1.37 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.625 -0.99 . . . . 0.56999999999999995 110.625 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -57.31 2.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.478 0.639 . . . . 0.56999999999999995 110.785 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 108.617 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.93 159.22 16.43 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.56999999999999995 109.075 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.2 -172.35 38.06 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.35 -1.1 . . . . 0.56999999999999995 110.35 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.06 120.31 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.511 -1.292 . . . . 0.56999999999999995 107.511 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -62.05 109.16 1.2 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.584 0.353 . . . . 0.56999999999999995 110.237 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.81 -37.33 81.63 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.539 0.735 . . . . 0.56999999999999995 110.686 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -65.95 -46.16 79.15 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 118.481 0.582 . . . . 0.56999999999999995 110.256 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.44 -48.89 79.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.836 0.743 . . . . 0.56999999999999995 109.18 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.33 90.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.114 0.566 . . . . 0.56999999999999995 111.319 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.09 -54.56 43.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.892 -1.051 . . . . 0.56999999999999995 109.517 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.5 m -57.17 -37.88 72.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.043 1.292 . . . . 0.56999999999999995 111.33 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.45 -58.54 7.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.409 0.549 . . . . 0.65000000000000002 109.935 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.3 -41.38 98.95 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.559 -0.713 . . . . 0.66000000000000003 111.303 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 HD21 ' A' ' 39' ' ' LEU . 3.3 mm? -62.55 -26.2 68.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.56999999999999995 111.666 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.81 99.35 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.73 1.15 . . . . 0.56999999999999995 112.053 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -69.89 -39.89 75.97 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 118.279 -0.867 . . . . 0.65000000000000002 110.067 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 t -57.23 -39.61 75.86 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.52 0.513 . . . . 0.56999999999999995 111.859 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -39.56 82.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.536 -0.728 . . . . 0.56999999999999995 110.476 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.2 51.1 0.52 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 123.877 0.751 . . . . 0.56999999999999995 112.079 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 tpp -99.84 -55.82 2.55 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.069 0.935 . . . . 0.56999999999999995 111.018 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.64 167.6 21.77 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.288 -1.125 . . . . 0.56999999999999995 110.288 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -74.06 178.08 5.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.995 0.902 . . . . 0.65000000000000002 111.465 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -145.26 -173.46 4.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 108.531 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 82.26 1.64 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.162 -1.792 . . . . 0.56999999999999995 106.162 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 5.8 t70 -151.36 145.26 17.78 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.456 -0.942 . . . . 0.66000000000000003 108.456 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.77 -9.25 21.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 113.269 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.01 9.51 13.69 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 110.749 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -76.1 134.56 39.99 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 109.171 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.07 -28.24 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.59 -0.444 . . . . 0.56999999999999995 110.148 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 37.1 mmt -66.01 -12.2 53.43 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.681 1.593 . . . . 0.56999999999999995 113.589 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -50.69 124.87 20.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.318 0.963 . . . . 0.56999999999999995 110.589 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.58 175.21 9.09 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.018 2.479 . . . . 0.56999999999999995 110.783 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER 52.13 -158.7 0.12 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 111.864 -174.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 131.21 41.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.99 -1.485 . . . . 0.56999999999999995 106.99 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -157.5 -120.9 0.64 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.125 -1.59 . . . . 0.56999999999999995 109.125 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -64.75 0.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.318 1.047 . . . . 0.56999999999999995 110.934 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 34.44 -140.6 0.12 Allowed Glycine 0 C--N 1.345 1.079 0 C-N-CA 126.277 1.894 . . . . 0.56999999999999995 113.198 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 t0 178.71 77.13 0.15 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 128.134 2.573 . . . . 0.66000000000000003 106.467 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.08 35.86 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.515 2.81 . . . . 0.56999999999999995 113.554 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -132.0 -47.87 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 109.89 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.99 43.5 0.17 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.063 0.945 . . . . 0.56999999999999995 111.304 -171.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -40.3 -54.52 2.37 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.202 1.001 . . . . 0.56999999999999995 111.972 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 55.53 156.03 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.966 1.306 . . . . 0.56999999999999995 111.075 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp -65.88 116.74 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.907 -1.146 . . . . 0.56999999999999995 107.907 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.8 m -82.2 -91.51 0.07 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.41 0.684 . . . . 0.56999999999999995 112.226 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -134.49 -51.97 0.81 Allowed 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.853 -1.546 . . . . 0.56999999999999995 107.465 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -45.4 -44.22 11.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.55 1.523 . . . . 0.66000000000000003 113.823 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.55 -63.59 1.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.055 2.142 . . . . 0.66000000000000003 110.9 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.06 -41.39 92.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 108.699 -0.852 . . . . 0.56999999999999995 108.699 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -59.33 -44.84 92.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 108.942 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.95 -56.16 26.65 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.972 -1.251 . . . . 0.56999999999999995 109.972 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 mm -55.51 -51.15 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 117.88 0.84 . . . . 0.56999999999999995 111.8 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.25 -18.72 64.62 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 111.34 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -87.87 -20.84 25.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 111.89 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.47 -43.84 9.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.918 . . . . 0.56999999999999995 111.669 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 126.285 1.834 . . . . 0.56999999999999995 111.333 -174.903 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 N--CA 1.453 -0.888 0 N-CA-C 110.729 -0.527 . . . . 0.56999999999999995 110.729 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 76.21 107.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.378 1.871 . . . . 0.56999999999999995 109.302 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 67.9 m95 -52.13 -70.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 113.94 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m 173.88 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.406 2.282 . . . . 0.56999999999999995 108.434 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t -102.5 161.98 13.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.213 1.005 . . . . 0.56999999999999995 109.938 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -5.51 40.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.945 0.898 . . . . 0.56999999999999995 113.36 168.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.35 143.56 39.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.241 -1.392 . . . . 0.56999999999999995 107.241 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 48' ' ' LEU . 72.3 t -128.95 146.61 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.36 -1.348 . . . . 0.56999999999999995 107.36 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 p -94.84 137.21 34.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.679 -0.86 . . . . 0.56999999999999995 108.679 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -125.54 152.56 44.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.668 -0.645 . . . . 0.56999999999999995 109.309 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -154.57 113.88 3.7 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.352 0.596 . . . . 1.2 110.011 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.03 82.61 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 107.161 -1.422 . . . . 0.56999999999999995 107.161 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 m -56.11 -41.61 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.994 1.318 . . . . 0.56999999999999995 112.922 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -124.39 153.97 41.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.37 -2.826 . . . . 0.56999999999999995 103.37 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -131.23 158.05 41.59 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 107.293 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -61.93 172.92 1.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.05 0.929 . . . . 0.56999999999999995 111.624 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 -33.8 5.14 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.659 1.183 . . . . 1.2 112.262 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.41 -33.87 76.97 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.43 0.559 . . . . 0.66000000000000003 109.997 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.32 154.78 62.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.971 1.709 . . . . 0.56999999999999995 109.873 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.24 161.91 25.82 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.96 2.44 . . . . 0.56999999999999995 113.049 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -40.25 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.307 1.043 . . . . 0.65000000000000002 113.135 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.53 -33.85 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.342 0.257 . . . . 0.56999999999999995 111.037 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.8 m -71.59 -43.96 65.31 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.402 -0.809 . . . . 0.56999999999999995 109.359 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.69 -48.07 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 117.559 -1.21 . . . . 0.56999999999999995 110.048 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.65 -35.07 79.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.896 1.225 . . . . 0.66000000000000003 111.81 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -61.19 -51.06 70.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.557 1.071 . . . . 1.2 110.92 173.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.76 -45.36 93.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.447 -0.787 . . . . 0.56999999999999995 109.111 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.66 -45.1 98.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-O 118.196 -0.907 . . . . 0.56999999999999995 110.737 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 m -58.61 -47.74 83.34 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 109.858 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.53 73.24 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.976 -0.535 . . . . 0.56999999999999995 110.911 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.0 -47.55 84.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.99 1.316 . . . . 0.56999999999999995 111.983 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 mp -69.78 -32.13 70.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 118.577 -0.725 . . . . 0.56999999999999995 109.693 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -63.59 -33.37 75.45 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.089 0.859 . . . . 0.56999999999999995 111.319 170.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.0 mtp -68.68 -42.73 77.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.649 1.113 . . . . 0.56999999999999995 110.98 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.522 ' CE3' HD11 ' A' ' 160' ' ' ILE . 10.6 m95 -62.91 -51.75 65.72 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.503 1.047 . . . . 0.56999999999999995 110.336 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.59 -10.92 61.53 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.654 1.597 . . . . 0.56999999999999995 113.959 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -61.8 -30.87 71.1 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.449 1.125 . . . . 0.56999999999999995 110.38 170.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -101.45 -31.04 11.1 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.69 0.796 . . . . 0.66000000000000003 111.271 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.489 HG21 ' CD1' ' A' ' 164' ' ' TYR . 27.8 pt -115.66 126.08 28.09 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.662 0.785 . . . . 0.56999999999999995 110.382 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.49 46.2 1.38 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.762 2.975 . . . . 0.56999999999999995 112.941 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 49' ' ' HIS . 3.1 tt -103.3 141.96 35.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.672 1.989 . . . . 0.56999999999999995 107.484 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.419 ' N ' HD23 ' A' ' 48' ' ' LEU . 10.1 m80 -123.85 169.33 11.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.913 0.885 . . . . 0.65000000000000002 108.996 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.49 149.87 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.63 -1.294 . . . . 0.56999999999999995 109.154 -173.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.93 36.72 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.43 1.092 . . . . 1.2 109.202 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.53 99.02 6.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.52 158.18 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.415 -0.587 . . . . 0.56999999999999995 109.415 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.52 23.17 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 110.953 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.21 75.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.93 1.292 . . . . 0.56999999999999995 109.087 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.25 168.74 16.32 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.005 0.812 . . . . 0.56999999999999995 111.575 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 p -64.72 171.89 3.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.806 1.242 . . . . 0.56999999999999995 110.033 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.96 175.24 8.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.596 0.713 . . . . 0.56999999999999995 109.626 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -68.95 -40.55 78.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.857 -0.61 . . . . 0.66000000000000003 109.372 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -119.8 87.31 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 108.0 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -83.91 120.66 26.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.814 1.246 . . . . 0.56999999999999995 108.286 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.58 128.97 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 106.36 -1.719 . . . . 0.56999999999999995 106.36 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.13 162.68 26.78 Favored Glycine 0 C--O 1.222 -0.6 0 N-CA-C 111.695 -0.562 . . . . 0.56999999999999995 111.695 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 4.9 m-85 -134.54 141.63 46.75 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.009 -1.849 . . . . 0.56999999999999995 106.009 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.47 -173.49 4.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.86 1.664 . . . . 0.56999999999999995 109.635 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.42 52.52 2.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.173 0.989 . . . . 1.2 110.55 -175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.4 -120.97 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.45 138.28 55.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.273 -0.545 . . . . 0.56999999999999995 110.569 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.59 -63.03 0.85 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.116 -0.945 . . . . 0.65000000000000002 110.687 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.78 57.39 0.02 OUTLIER Glycine 0 C--N 1.341 0.834 0 CA-C-N 119.231 0.923 . . . . 0.56999999999999995 112.474 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -126.33 -67.31 0.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.69 1.196 . . . . 0.66000000000000003 109.094 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.67 -30.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.353 2.661 . . . . 0.56999999999999995 110.156 -175.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.26 98.71 20.42 Favored Pre-proline 0 C--N 1.347 0.47 0 N-CA-C 108.51 -0.922 . . . . 0.56999999999999995 108.51 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.14 139.42 55.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 120.881 1.054 . . . . 0.56999999999999995 109.424 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.41 174.37 7.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.584 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -95.27 -40.9 9.32 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.574 1.95 . . . . 0.66000000000000003 111.898 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.62 -139.15 13.32 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 120.366 1.439 . . . . 0.56999999999999995 111.969 -168.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -81.64 94.42 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.128 2.552 . . . . 0.56999999999999995 110.567 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.65 174.46 22.43 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.132 1.825 . . . . 0.56999999999999995 111.708 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.3 t30 47.39 -138.71 0.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 120.972 -1.31 . . . . 0.56999999999999995 112.817 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -51.73 124.8 13.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.874 2.07 . . . . 0.56999999999999995 111.207 173.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.81 -31.12 11.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.56999999999999995 113.015 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.3 159.19 33.72 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.466 1.106 . . . . 0.56999999999999995 108.091 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.1 154.93 43.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.29 0.567 . . . . 0.65000000000000002 111.007 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.14 148.01 44.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.11 -1.07 . . . . 0.56999999999999995 108.11 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.38 150.22 25.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.14 -1.059 . . . . 0.56999999999999995 108.14 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.39 153.66 92.0 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 109.961 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 32.5 Cg_endo -68.73 165.09 30.78 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.579 1.52 . . . . 0.56999999999999995 111.969 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 -70.8 0.15 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.652 -1.779 . . . . 0.56999999999999995 108.652 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -173.52 144.02 1.09 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.257 -1.386 . . . . 0.56999999999999995 107.257 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.15 -130.21 24.12 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.537 1.065 . . . . 0.56999999999999995 111.615 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.89 -26.48 10.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 112.345 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.17 143.67 8.74 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.191 -0.943 . . . . 0.56999999999999995 111.633 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.1 -22.3 2.01 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.162 1.839 . . . . 0.56999999999999995 114.553 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -70.49 157.69 37.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.787 1.294 . . . . 0.66000000000000003 108.305 -176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.96 148.41 31.71 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.242 0.544 . . . . 0.56999999999999995 109.63 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -132.02 160.5 35.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.65000000000000002 109.282 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 23.9 m-85 -141.82 146.61 36.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.879 1.272 . . . . 0.56999999999999995 108.155 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.78 103.83 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.922 -1.14 . . . . 0.66000000000000003 107.922 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.77 -23.01 64.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.848 1.659 . . . . 0.66000000000000003 111.395 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -65.38 -37.17 86.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.703 1.601 . . . . 0.66000000000000003 110.157 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.0 133.39 48.96 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.327 -1.731 . . . . 0.66000000000000003 106.327 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -54.94 151.89 8.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 118.905 -0.569 . . . . 1.2 109.72 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -133.93 135.88 43.87 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.749 -1.574 . . . . 0.56999999999999995 106.749 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -132.52 140.77 48.47 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.494 -1.299 . . . . 0.56999999999999995 107.494 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -57.16 -51.37 69.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.711 0.805 . . . . 0.66000000000000003 109.396 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.45 56.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.889 -1.284 . . . . 0.56999999999999995 109.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 t -154.71 164.31 38.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.656 -0.868 . . . . 0.56999999999999995 108.656 173.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -76.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.502 2.321 . . . . 0.56999999999999995 112.589 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -178.77 171.88 1.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.256 2.223 . . . . 0.56999999999999995 107.348 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 123.85 -146.95 16.52 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.56999999999999995 110.422 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 pt -116.65 119.55 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 109.113 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -61.77 117.71 6.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.188 -0.914 . . . . 0.56999999999999995 109.615 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.16 -40.05 96.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.319 1.448 . . . . 0.56999999999999995 110.848 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -42.81 79.75 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.096 -1.076 . . . . 0.56999999999999995 108.096 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -66.07 -47.61 73.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.021 0.828 . . . . 0.56999999999999995 110.036 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.33 -50.09 70.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 123.531 0.52 . . . . 0.56999999999999995 110.581 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.97 -57.88 10.0 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 117.908 -1.044 . . . . 0.56999999999999995 109.74 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -55.82 -37.69 69.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 111.333 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.97 -57.12 14.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.529 1.132 . . . . 0.65000000000000002 110.518 173.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -72.72 -44.52 61.61 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.605 -0.684 . . . . 0.66000000000000003 111.248 -171.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.2 -29.0 68.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 111.036 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.34 -47.11 90.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.55 -1.02 . . . . 0.56999999999999995 110.55 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.403 ' CE1' ' HG2' ' A' ' 138' ' ' MET . 70.9 m-70 -70.16 -36.29 74.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.255 -0.879 . . . . 0.65000000000000002 112.191 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 p -57.74 -33.48 68.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.316 0.507 . . . . 0.56999999999999995 111.251 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -36.34 79.81 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 112.493 0.553 . . . . 0.56999999999999995 112.493 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 162.11 50.08 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 CA-C-O 117.993 -1.449 . . . . 0.56999999999999995 113.271 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.73 -158.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.949 1.299 . . . . 0.56999999999999995 112.024 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.08 62.6 0.22 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.091 -1.604 . . . . 0.56999999999999995 109.091 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 169.62 17.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.675 0.75 . . . . 0.65000000000000002 109.624 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -157.15 -179.99 8.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.701 1.2 . . . . 0.56999999999999995 107.91 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t -144.17 78.16 1.57 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.771 -1.566 . . . . 0.56999999999999995 106.771 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -131.08 145.91 59.81 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 106.545 -1.65 . . . . 0.66000000000000003 106.545 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.71 -26.72 75.4 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.165 1.91 . . . . 0.56999999999999995 112.427 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -125.11 29.37 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.572 1.549 . . . . 0.56999999999999995 109.685 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.06 129.16 39.56 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 109.08 -0.711 . . . . 0.56999999999999995 109.08 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.56 -17.5 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 111.646 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.403 ' HG2' ' CE1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -113.72 22.5 13.98 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.307 1.843 . . . . 0.56999999999999995 110.326 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.24 123.97 78.38 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 119.999 1.272 . . . . 0.56999999999999995 110.292 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.7 48.3 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.728 2.952 . . . . 0.56999999999999995 112.661 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -148.36 -45.48 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 110.373 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.3 t80 56.7 95.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.768 1.627 . . . . 0.56999999999999995 112.305 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.41 -73.7 0.03 OUTLIER Glycine 0 C--N 1.346 1.101 0 O-C-N 120.751 -1.218 . . . . 0.56999999999999995 115.706 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -35.52 61.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.503 1.151 . . . . 0.56999999999999995 112.375 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.7 152.0 13.59 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.59 -1.004 . . . . 0.56999999999999995 110.59 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.83 105.51 51.29 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 107.467 -1.309 . . . . 0.66000000000000003 107.467 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.6 57.4 6.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.564 2.843 . . . . 0.56999999999999995 109.92 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.5 -48.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.655 -0.653 . . . . 0.56999999999999995 110.481 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -77.49 50.66 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.261 1.424 . . . . 0.56999999999999995 110.886 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -41.86 -82.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 112.917 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 43.91 22.82 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.16 2.584 . . . . 0.56999999999999995 113.489 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 42.93 90.45 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.724 2.81 . . . . 0.56999999999999995 111.222 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.9 t -56.12 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 114.46 -170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -142.35 -46.24 0.33 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.424 1.09 . . . . 0.56999999999999995 109.311 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.18 -51.56 10.4 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.886 1.274 . . . . 0.66000000000000003 111.427 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -48.14 75.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.44 0.696 . . . . 0.66000000000000003 111.964 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.4 mm -62.55 -46.57 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.886 0.874 . . . . 0.56999999999999995 109.178 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -63.48 -44.1 95.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.049 1.339 . . . . 0.56999999999999995 109.096 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.76 -62.59 6.14 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.1 -1.2 . . . . 0.56999999999999995 110.1 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.522 HD11 ' CE3' ' A' ' 42' ' ' TRP . 8.0 mm -52.67 -48.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.518 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -65.79 -28.53 69.07 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.436 -0.79 . . . . 0.56999999999999995 111.875 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.2 -20.23 35.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.959 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 6.5 mp -77.97 -45.39 24.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.064 0.946 . . . . 0.56999999999999995 110.982 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.489 ' CD1' HG21 ' A' ' 46' ' ' ILE . 12.8 m-85 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 CA-C-O 121.077 0.365 . . . . 0.56999999999999995 111.263 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 77.92 -11.24 1.23 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.253 1.421 . . . . 0.56999999999999995 112.252 -174.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 84.6 m95 60.92 19.2 9.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.813 1.188 . . . . 0.56999999999999995 113.055 -168.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m 68.47 -43.07 0.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.23 1.812 . . . . 0.56999999999999995 112.811 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 t -75.91 -178.15 4.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 111.079 173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -10.29 20.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.541 1.137 . . . . 0.56999999999999995 111.865 168.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -127.13 146.3 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 177.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.33 156.69 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 125.586 1.554 . . . . 0.56999999999999995 107.06 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.7 p -108.46 138.12 45.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.275 -1.009 . . . . 0.56999999999999995 108.275 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -126.59 143.21 51.29 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.075 -1.016 . . . . 0.56999999999999995 108.725 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -150.66 110.94 4.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.755 0.788 . . . . 1.2 108.993 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 mt -80.6 95.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 105.874 -1.898 . . . . 0.56999999999999995 105.874 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -69.82 -36.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.06 1.344 . . . . 0.56999999999999995 112.557 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -130.04 158.38 39.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.129 -2.545 . . . . 0.56999999999999995 104.129 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -133.45 175.99 8.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.188 1.395 . . . . 0.56999999999999995 108.154 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -87.23 -154.68 0.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.847 0.859 . . . . 0.56999999999999995 109.258 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -132.31 -28.8 1.65 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 116.412 -1.756 . . . . 1.2 115.074 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.82 -47.89 84.29 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.263 1.392 . . . . 0.66000000000000003 110.696 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -109.52 158.11 35.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.344 1.458 . . . . 0.56999999999999995 109.199 176.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -77.54 156.44 32.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.79 1.66 . . . . 0.56999999999999995 112.672 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -59.87 -35.37 74.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.712 1.205 . . . . 0.65000000000000002 113.514 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.69 -37.29 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 110.34 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -69.51 -39.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 116.965 -1.493 . . . . 0.56999999999999995 109.313 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG13 ' CZ ' ' A' ' 114' ' ' PHE . 24.4 t -53.18 -56.84 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.761 1.619 . . . . 0.56999999999999995 109.773 171.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.37 -41.4 97.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.959 -0.543 . . . . 0.66000000000000003 111.323 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.65 -45.1 80.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.674 0.67 . . . . 1.2 111.904 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.24 -41.07 86.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.32 0.648 . . . . 0.56999999999999995 109.413 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.1 -50.09 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 117.511 -1.233 . . . . 0.56999999999999995 109.504 168.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -46.51 75.21 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 121.454 1.934 . . . . 0.56999999999999995 110.946 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.58 -35.05 79.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.743 0.701 . . . . 0.56999999999999995 112.335 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.71 -47.54 62.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.459 1.104 . . . . 0.56999999999999995 112.605 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 122' ' ' LEU . 9.4 mp -68.52 -31.36 70.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.135 1.374 . . . . 0.56999999999999995 109.514 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -59.77 -38.88 83.07 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.221 -0.895 . . . . 0.56999999999999995 110.226 168.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 37.2 mtm -67.47 -33.98 76.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.265 1.393 . . . . 0.56999999999999995 112.123 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 9.4 m95 -66.24 -54.58 23.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.07 0.85 . . . . 0.56999999999999995 110.269 170.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.62 -4.01 43.99 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.806 1.193 . . . . 0.56999999999999995 113.616 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -69.01 -25.92 64.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.685 1.242 . . . . 0.56999999999999995 110.346 172.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.26 -15.4 13.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.218 1.007 . . . . 0.66000000000000003 111.553 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 pt -131.5 140.66 39.09 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 119.466 1.03 . . . . 0.56999999999999995 109.204 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.8 9.1 1.4 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.715 2.277 . . . . 0.56999999999999995 112.963 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -71.48 135.03 46.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 108.348 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -125.27 -179.76 4.73 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.25 1.02 . . . . 0.65000000000000002 109.663 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.54 157.07 44.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.158 -0.682 . . . . 0.56999999999999995 109.158 -171.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 154.46 49.15 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.346 1.458 . . . . 1.2 110.121 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -114.56 109.31 18.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.086 -1.079 . . . . 0.56999999999999995 108.086 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.02 161.05 4.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.494 -0.558 . . . . 0.56999999999999995 109.494 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.61 -53.14 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 118.767 -0.635 . . . . 0.56999999999999995 110.524 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 165.88 58.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.292 2.237 . . . . 0.56999999999999995 111.749 -172.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.09 38.85 1.7 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.752 -1.218 . . . . 0.56999999999999995 113.588 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m 64.97 142.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.59 1.956 . . . . 0.56999999999999995 110.28 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.18 168.03 20.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.773 0.796 . . . . 0.56999999999999995 109.288 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 10' ' ' TRP . 58.0 m-20 -65.72 -45.02 84.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.582 -1.19 . . . . 0.66000000000000003 108.545 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -112.34 81.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.051 1.74 . . . . 0.56999999999999995 107.658 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -78.11 118.73 20.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.029 -1.1 . . . . 0.56999999999999995 108.029 168.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.28 130.57 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.787 -1.931 . . . . 0.56999999999999995 105.787 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.81 161.54 28.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.428 -0.669 . . . . 0.56999999999999995 111.428 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.3 m-85 -132.02 143.35 50.01 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.881 -1.526 . . . . 0.56999999999999995 106.881 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.02 179.98 6.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.433 1.493 . . . . 0.56999999999999995 109.186 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -141.15 57.47 1.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.319 -0.623 . . . . 1.2 109.319 -171.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.04 -58.55 0.66 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.627 1.108 . . . . 0.56999999999999995 111.889 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.86 155.01 45.91 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.684 0.794 . . . . 0.56999999999999995 109.279 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -157.76 147.25 19.95 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.037 0.935 . . . . 0.65000000000000002 109.127 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 74.63 1.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.371 -1.491 . . . . 0.56999999999999995 109.371 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.74 -92.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.614 1.565 . . . . 0.66000000000000003 107.169 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.9 p -158.92 -38.19 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.8 1.24 . . . . 0.56999999999999995 110.024 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.88 131.42 23.99 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 109.541 -0.54 . . . . 0.56999999999999995 109.541 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.0 137.08 43.36 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.036 -1.563 . . . . 0.56999999999999995 108.036 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -158.22 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 123.622 1.677 . . . . 0.56999999999999995 109.233 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -136.78 -22.64 1.22 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 130.205 3.402 . . . . 0.66000000000000003 109.058 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 -141.43 26.42 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.079 -1.208 . . . . 0.56999999999999995 110.079 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.06 95.21 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.965 3.11 . . . . 0.56999999999999995 110.855 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.27 -176.15 21.89 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.622 -0.991 . . . . 0.56999999999999995 110.622 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.25 31.8 t30 46.85 -135.72 0.88 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.451 1.5 . . . . 0.56999999999999995 114.092 173.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -61.86 125.52 24.14 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.274 2.23 . . . . 0.56999999999999995 110.909 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -82.48 -30.13 30.13 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.289 -1.507 . . . . 0.56999999999999995 113.734 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.1 166.84 25.22 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.374 1.07 . . . . 0.56999999999999995 109.377 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.08 163.93 32.13 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.799 -0.563 . . . . 0.65000000000000002 109.783 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.44 155.24 40.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.958 1.303 . . . . 0.56999999999999995 109.3 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.78 163.61 13.12 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.774 0.671 . . . . 0.56999999999999995 110.11 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.4 153.92 83.96 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.7 -0.667 . . . . 0.56999999999999995 109.946 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 36.3 Cg_endo -66.93 155.59 70.09 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.955 2.436 . . . . 0.56999999999999995 112.176 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.81 -118.41 0.55 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.289 -1.925 . . . . 0.56999999999999995 108.289 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 m -151.59 106.57 3.28 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 104.667 -2.345 . . . . 0.56999999999999995 104.667 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.67 -132.57 10.51 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 117.483 -1.732 . . . . 0.56999999999999995 109.301 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -31.13 12.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.662 1.585 . . . . 0.56999999999999995 112.809 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -45.96 144.27 3.73 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.72 -0.552 . . . . 0.56999999999999995 111.72 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CZ2' ' A' ' 10' ' ' TRP . . . 70.44 -18.81 0.71 Allowed Glycine 0 C--N 1.337 0.61 0 C-N-CA 126.546 2.022 . . . . 0.56999999999999995 116.738 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -68.1 155.51 39.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.785 -1.191 . . . . 0.66000000000000003 107.785 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.58 29.89 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.371 -0.832 . . . . 0.56999999999999995 108.96 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.93 159.27 35.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.196 -0.911 . . . . 0.65000000000000002 109.156 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.483 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 28.9 m-85 -144.56 154.74 43.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.566 1.546 . . . . 0.56999999999999995 108.095 -170.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.06 99.15 12.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.672 0.389 . . . . 0.66000000000000003 110.28 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.97 -28.14 49.31 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.741 -1.224 . . . . 0.66000000000000003 111.977 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -54.67 -38.52 67.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.592 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.79 151.14 37.6 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.881 1.272 . . . . 0.66000000000000003 109.844 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -80.13 125.21 29.53 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.712 -1.243 . . . . 1.2 109.709 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -107.17 166.05 10.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.832 0.853 . . . . 0.56999999999999995 109.118 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -158.8 164.4 35.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 109.438 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -65.01 -48.03 75.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.326 0.65 . . . . 0.66000000000000003 110.237 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.61 40.25 0.02 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.149 -0.806 . . . . 0.56999999999999995 112.777 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -77.36 32.61 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.02 1.41 . . . . 0.56999999999999995 113.827 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.1 m 53.51 35.09 19.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 113.559 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -160.66 -175.16 4.81 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.551 1.54 . . . . 0.56999999999999995 108.622 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.37 -144.76 24.32 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 124.237 0.922 . . . . 0.56999999999999995 112.033 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -120.67 113.47 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.821 -1.548 . . . . 0.56999999999999995 106.821 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -61.08 110.48 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.148 0.979 . . . . 0.56999999999999995 111.304 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 10.0 t80 -63.21 -42.98 99.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.507 1.123 . . . . 0.56999999999999995 111.355 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -55.11 22.77 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.86 -1.163 . . . . 0.56999999999999995 107.86 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 147' ' ' PRO . 11.8 t80 -64.47 -43.25 94.81 Favored 'General case' 0 CA--C 1.526 0.02 0 C-N-CA 122.949 0.499 . . . . 0.56999999999999995 111.004 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.2 70.82 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.085 0.554 . . . . 0.56999999999999995 110.906 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.1 -55.66 31.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.191 -0.909 . . . . 0.56999999999999995 109.607 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 m -53.93 -38.72 65.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 111.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.429 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 4.0 t-160 -63.96 -59.29 4.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.252 0.621 . . . . 0.65000000000000002 109.788 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -64.69 -46.71 81.19 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.232 0.469 . . . . 0.66000000000000003 111.104 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.01 -31.48 71.86 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.4 1.08 . . . . 0.56999999999999995 112.103 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -55.87 -41.89 84.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.219 -0.752 . . . . 0.56999999999999995 111.219 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -72.33 -36.33 68.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.062 -0.971 . . . . 0.65000000000000002 111.81 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -56.37 -36.33 68.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.283 0.947 . . . . 0.56999999999999995 112.293 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 48' ' ' LEU . 2.5 mm? -65.87 -21.04 66.43 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.611 1.096 . . . . 0.56999999999999995 112.942 176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.33 -54.59 0.28 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 124.343 0.973 . . . . 0.56999999999999995 110.895 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.74 176.89 0.09 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.38 2.272 . . . . 0.56999999999999995 107.7 -173.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.4 70.65 0.02 OUTLIER Glycine 0 C--O 1.218 -0.874 0 N-CA-C 107.152 -2.379 . . . . 0.56999999999999995 107.152 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 162.11 27.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.425 1.112 . . . . 0.65000000000000002 108.651 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 t -157.95 -161.89 1.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.984 1.314 . . . . 0.56999999999999995 108.388 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -152.74 58.43 0.8 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.119 1.768 . . . . 0.56999999999999995 109.288 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -143.44 135.16 12.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 117.037 -1.458 . . . . 0.66000000000000003 108.751 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.37 41.92 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.051 1 C-N-CA 125.981 4.454 . . . . 0.56999999999999995 114.041 -174.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -154.02 -27.15 0.13 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 127.931 2.492 . . . . 0.56999999999999995 111.566 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -50.7 133.35 25.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 156' ' ' ASP . 7.3 p -60.96 -25.44 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.852 -0.53 . . . . 0.56999999999999995 110.745 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' HIS . 3.8 mpp? -109.63 28.61 8.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 111.49 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -50.5 128.69 25.35 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 120.698 -1.251 . . . . 0.56999999999999995 110.054 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.35 168.1 24.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.995 2.463 . . . . 0.56999999999999995 110.542 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.4 m 62.0 70.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.871 0.759 . . . . 0.56999999999999995 110.552 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -41.18 123.68 2.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.856 1.662 . . . . 0.56999999999999995 112.115 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.1 -111.42 0.33 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.909 -1.277 . . . . 0.56999999999999995 109.909 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -50.44 -39.97 49.16 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.667 0.988 . . . . 0.56999999999999995 113.667 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.85 89.14 0.01 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.225 1.869 . . . . 0.56999999999999995 112.115 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.99 107.91 1.06 Allowed Pre-proline 0 C--N 1.344 0.349 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 109.987 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.406 ' HA ' ' CD1' ' A' ' 116' ' ' TYR . 11.7 Cg_endo -72.19 -25.17 19.22 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.37 1.38 . . . . 0.56999999999999995 112.145 -172.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.9 2.42 38.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.448 -0.787 . . . . 0.56999999999999995 110.941 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.65 75.47 1.66 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.223 1.809 . . . . 0.56999999999999995 108.418 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.11 -64.98 0.64 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 113.291 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 22.61 77.55 0.02 OUTLIER 'General case' 0 C--N 1.343 0.296 0 C-N-CA 129.279 3.032 . . . . 0.56999999999999995 112.657 174.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.7 mp -38.26 97.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.571 2.348 . . . . 0.56999999999999995 109.97 -176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 m -74.13 -87.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.558 0.743 . . . . 0.56999999999999995 112.546 -162.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -137.5 -28.02 0.92 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 116.779 -1.581 . . . . 0.56999999999999995 110.248 168.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.17 -54.11 50.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.154 1.797 . . . . 0.66000000000000003 111.299 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.598 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.5 t0 -62.68 -53.11 59.36 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 109.799 -0.445 . . . . 0.66000000000000003 109.799 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.12 -40.62 83.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 123.865 0.866 . . . . 0.56999999999999995 109.112 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -64.95 -43.03 94.02 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.823 -1.085 . . . . 0.56999999999999995 110.653 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.48 -61.63 7.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.373 -1.491 . . . . 0.56999999999999995 109.373 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.406 HD11 ' CE3' ' A' ' 42' ' ' TRP . 4.0 mm -53.47 -47.2 59.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.383 1.473 . . . . 0.56999999999999995 112.748 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.14 -31.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.037 0.535 . . . . 0.56999999999999995 111.017 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -29.61 64.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.702 0.683 . . . . 0.56999999999999995 111.183 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.59 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.482 -0.77 . . . . 0.56999999999999995 109.709 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.65 0.611 . . . . 0.56999999999999995 112.65 -171.794 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.455 -0.738 0 N-CA-C 109.668 -0.935 . . . . 0.56999999999999995 109.668 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 pttt 85.73 151.26 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.239 2.615 . . . . 0.56999999999999995 108.937 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 64.6 m95 -65.76 170.11 5.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.265 1.026 . . . . 0.56999999999999995 109.938 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 m -62.05 -29.66 70.45 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 120.94 -1.1 . . . . 0.56999999999999995 111.252 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.6 t -97.62 156.87 16.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 112.163 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -75.1 -6.08 47.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.682 1.593 . . . . 0.56999999999999995 112.754 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.63 151.94 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.523 -0.918 . . . . 0.56999999999999995 108.523 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 150.16 33.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.047 -1.094 . . . . 0.56999999999999995 108.047 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.8 p -104.54 136.78 43.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.605 -0.887 . . . . 0.56999999999999995 108.605 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -118.79 163.2 17.23 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.801 0.84 . . . . 0.56999999999999995 110.481 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.37 160.45 41.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.046 -1.094 . . . . 1.2 108.046 169.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.6 mt -123.2 94.25 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 103.663 -2.717 . . . . 0.56999999999999995 103.663 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 m -73.29 -30.68 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.593 0.357 . . . . 0.56999999999999995 111.263 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -142.63 147.27 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.161 -2.163 . . . . 0.56999999999999995 105.161 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -131.9 159.19 39.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.357 1.063 . . . . 0.56999999999999995 109.207 -166.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -91.74 -175.52 4.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.876 1.27 . . . . 0.56999999999999995 109.437 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.61 -26.3 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.128 1.159 . . . . 1.2 114.128 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -59.19 -40.68 86.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.265 0.626 . . . . 0.66000000000000003 110.305 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.65 152.57 80.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 128.767 2.827 . . . . 0.56999999999999995 110.248 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.31 161.19 28.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.962 2.441 . . . . 0.56999999999999995 114.453 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.82 -39.05 93.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.833 1.653 . . . . 0.65000000000000002 112.027 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 tt -65.89 -35.96 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.424 0.69 . . . . 0.56999999999999995 110.794 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -66.39 -46.62 76.03 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 116.703 -1.617 . . . . 0.56999999999999995 108.723 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.56 -52.54 25.78 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.568 1.531 . . . . 0.56999999999999995 110.043 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -63.04 -42.49 99.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 110.955 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -63.32 -46.88 84.63 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.95 . . . . 1.2 112.062 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.15 -45.61 87.72 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.239 -0.886 . . . . 0.56999999999999995 109.022 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -46.75 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 124.267 1.027 . . . . 0.56999999999999995 109.574 172.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -46.06 89.47 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.047 0.839 . . . . 0.56999999999999995 110.95 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -63.67 -42.95 98.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.912 1.285 . . . . 0.56999999999999995 112.033 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.29 75.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.094 1.357 . . . . 0.56999999999999995 111.447 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.92 -34.19 77.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.607 -0.711 . . . . 0.56999999999999995 110.258 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -40.76 85.38 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.262 0.937 . . . . 0.56999999999999995 110.613 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 39.4 mtm -63.85 -38.93 92.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.047 0.84 . . . . 0.56999999999999995 111.293 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CH2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -64.29 -49.67 70.87 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.26 0.936 . . . . 0.56999999999999995 111.405 172.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.16 -9.08 66.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.913 1.244 . . . . 0.56999999999999995 113.174 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -23.77 63.08 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.506 1.653 . . . . 0.56999999999999995 110.864 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -105.85 -14.03 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.258 1.023 . . . . 0.66000000000000003 111.706 -171.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' CD1' ' A' ' 164' ' ' TYR . 12.8 pt -139.36 149.56 60.92 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.636 1.174 . . . . 0.56999999999999995 111.445 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.37 10.32 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.313 2.675 . . . . 0.56999999999999995 113.018 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.26 133.9 35.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.736 1.615 . . . . 0.56999999999999995 107.513 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.12 170.88 10.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.002 0.921 . . . . 0.65000000000000002 110.006 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.08 146.16 31.73 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.426 -0.953 . . . . 0.56999999999999995 108.426 -172.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -143.6 166.53 24.58 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.875 1.27 . . . . 1.2 109.242 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -105.37 143.35 33.66 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.86 -0.793 . . . . 0.56999999999999995 108.86 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.66 157.01 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.71 0.404 . . . . 0.56999999999999995 110.98 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.86 -43.81 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.779 0.832 . . . . 0.56999999999999995 111.509 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -176.64 146.98 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.97 2.908 . . . . 0.56999999999999995 104.622 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.18 -116.87 3.07 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.523 -0.631 . . . . 0.56999999999999995 111.523 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 43.9 p -132.88 164.64 26.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.635 1.974 . . . . 0.56999999999999995 108.556 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.51 21.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.126 0.97 . . . . 0.56999999999999995 110.121 -174.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -63.01 -33.08 74.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.611 0.764 . . . . 0.66000000000000003 109.806 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.3 mt -123.53 76.94 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.068 2.147 . . . . 0.56999999999999995 108.235 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -73.22 110.75 7.74 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.737 1.615 . . . . 0.56999999999999995 108.519 167.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.91 128.13 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 104.568 -2.382 . . . . 0.56999999999999995 104.568 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.62 148.9 19.07 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 110.111 -1.196 . . . . 0.56999999999999995 110.111 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -113.38 167.28 10.7 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 118.299 1.05 . . . . 0.56999999999999995 108.594 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.58 155.28 43.57 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.513 1.125 . . . . 0.56999999999999995 108.162 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -105.13 110.03 22.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.521 -1.289 . . . . 1.2 107.521 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.73 -46.95 2.4 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.015 -1.436 . . . . 0.56999999999999995 113.665 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.53 165.53 36.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.554 1.677 . . . . 0.56999999999999995 111.56 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.13 162.51 33.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.411 1.085 . . . . 0.65000000000000002 111.777 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.57 58.62 3.0 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.798 1.665 . . . . 0.56999999999999995 112.307 -174.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.99 -52.71 2.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.561 0.745 . . . . 0.66000000000000003 111.276 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 t 174.73 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 110.65 -167.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -122.54 114.16 30.28 Favored Pre-proline 0 C--N 1.347 0.471 0 C-N-CA 123.388 0.675 . . . . 0.56999999999999995 109.538 -170.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 28.88 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.941 2.427 . . . . 0.56999999999999995 112.552 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 41.96 -136.3 0.27 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 111.326 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -162.77 -40.46 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.779 2.432 . . . . 0.66000000000000003 108.449 -163.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.39 -153.91 21.98 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.687 -1.365 . . . . 0.56999999999999995 109.687 -170.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.77 101.98 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.096 3.198 . . . . 0.56999999999999995 113.561 -167.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.88 -178.79 17.05 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 109.839 -1.304 . . . . 0.56999999999999995 109.839 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t30 49.14 -145.01 0.42 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.195 0.997 . . . . 0.56999999999999995 112.428 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.3 m -46.5 110.68 0.3 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.374 2.27 . . . . 0.56999999999999995 112.577 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -83.83 -34.12 24.75 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.259 -0.9 . . . . 0.56999999999999995 113.041 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.84 167.62 29.82 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 109.382 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -150.98 150.44 30.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.876 -0.515 . . . . 0.65000000000000002 110.053 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.95 163.2 32.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 109.628 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.31 140.3 49.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.007 -1.109 . . . . 0.56999999999999995 108.007 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.09 160.07 3.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.56999999999999995 112.444 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.0 Cg_endo -68.6 152.87 74.46 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.538 2.158 . . . . 0.56999999999999995 111.183 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.17 -78.57 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -172.21 -49.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.584 1.154 . . . . 0.56999999999999995 109.497 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.69 -101.99 2.73 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.218 -1.153 . . . . 0.56999999999999995 110.218 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -27.18 68.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.048 0.939 . . . . 0.56999999999999995 111.828 175.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.54 146.77 15.67 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.148 -0.97 . . . . 0.56999999999999995 111.411 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 -21.37 4.24 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.579 2.037 . . . . 0.56999999999999995 114.506 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -74.76 160.14 31.1 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.975 1.388 . . . . 0.66000000000000003 108.891 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.09 139.86 20.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.3 -169.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -132.77 149.52 52.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.437 0.695 . . . . 0.65000000000000002 110.6 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -142.07 146.88 35.95 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 -166.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -86.55 103.89 15.48 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.02 0.914 . . . . 0.66000000000000003 109.277 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.65 -15.54 62.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.316 1.446 . . . . 0.66000000000000003 111.374 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -69.56 -20.58 63.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.436 1.016 . . . . 0.66000000000000003 110.267 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -85.38 158.91 20.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 110.325 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.27 138.66 35.73 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -131.47 144.84 51.45 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -138.48 153.07 48.79 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.14 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -97.18 11.57 35.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.626 2.371 . . . . 0.66000000000000003 110.741 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.74 -134.31 2.98 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.81 1.672 . . . . 0.56999999999999995 111.674 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 t -143.33 171.5 14.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.309 1.444 . . . . 0.56999999999999995 108.713 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 t 51.76 42.9 30.25 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.892 1.441 . . . . 0.56999999999999995 114.892 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.56 -38.59 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 119.914 -1.741 . . . . 0.56999999999999995 113.542 -172.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.35 -154.9 10.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 108.587 -1.805 . . . . 0.56999999999999995 108.587 -172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.94 119.51 34.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 108.289 -1.004 . . . . 0.56999999999999995 108.289 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -63.98 103.56 0.61 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.945 0.498 . . . . 0.56999999999999995 109.675 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.24 -36.35 65.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.874 1.27 . . . . 0.56999999999999995 110.645 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -65.44 -48.35 73.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.849 -0.797 . . . . 0.56999999999999995 108.849 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.52 -39.07 93.47 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.558 -0.904 . . . . 0.56999999999999995 108.558 -176.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.56 -56.3 22.97 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.58 0.752 . . . . 0.56999999999999995 110.999 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.25 58.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.137 0.575 . . . . 0.56999999999999995 109.71 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.7 m -58.73 -44.02 90.35 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.173 0.897 . . . . 0.56999999999999995 111.732 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.66 -52.03 67.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.034 0.534 . . . . 0.65000000000000002 109.723 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.23 -48.66 72.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.466 1.106 . . . . 0.66000000000000003 110.393 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.14 -29.12 69.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 126.113 1.765 . . . . 0.56999999999999995 111.534 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 42' ' ' TRP . . . -62.19 -45.32 96.27 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.691 -0.564 . . . . 0.56999999999999995 111.691 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -62.32 -39.76 94.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 117.213 -1.375 . . . . 0.65000000000000002 109.911 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -60.44 -29.1 68.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.825 1.193 . . . . 0.56999999999999995 113.774 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -25.22 57.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 112.71 172.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.89 -1.63 4.29 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.808 1.194 . . . . 0.56999999999999995 114.5 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.43 164.68 20.5 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.951 1.375 . . . . 0.56999999999999995 113.678 -166.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.38 166.49 12.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.227 1.394 . . . . 0.56999999999999995 109.755 172.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -68.37 174.35 4.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.195 0.998 . . . . 0.65000000000000002 112.558 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.08 179.83 7.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.735 1.614 . . . . 0.56999999999999995 108.519 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.08 71.55 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.826 2.05 . . . . 0.56999999999999995 107.51 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 12.3 t70 -136.72 140.49 32.13 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 107.668 -1.234 . . . . 0.66000000000000003 107.668 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.34 -26.32 41.53 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.456 2.104 . . . . 0.56999999999999995 112.317 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.2 22.87 14.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.981 1.313 . . . . 0.56999999999999995 109.991 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -64.61 124.42 21.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.258 -1.016 . . . . 0.56999999999999995 108.258 166.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.93 -31.03 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 109.871 166.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -84.51 8.54 16.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.94 1.089 . . . . 0.56999999999999995 113.94 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -56.78 130.85 78.43 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.652 1.569 . . . . 0.56999999999999995 110.565 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 150.01 26.53 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.197 1.931 . . . . 0.56999999999999995 110.27 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.8 m 73.12 156.42 0.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 111.545 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.79 132.73 53.88 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.252 1.021 . . . . 0.56999999999999995 109.55 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 141.62 97.51 0.29 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.511 1.053 . . . . 0.56999999999999995 110.53 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.25 -43.23 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.659 1.229 . . . . 0.56999999999999995 113.443 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.66 -177.22 48.39 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.862 -1.695 . . . . 0.56999999999999995 108.862 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -51.7 111.56 2.52 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.579 1.552 . . . . 0.66000000000000003 110.969 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -3.86 12.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.21 1.94 . . . . 0.56999999999999995 112.304 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -73.7 -9.99 59.23 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.706 1.139 . . . . 0.56999999999999995 112.91 168.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -62.61 -6.58 3.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.721 1.749 . . . . 0.56999999999999995 115.721 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 19.77 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.346 3.058 . . . . 0.56999999999999995 116.83 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt 20.39 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.677 3.191 . . . . 0.56999999999999995 112.859 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -26.11 106.09 0.03 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 127.876 2.471 . . . . 0.56999999999999995 110.165 -175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.8 t -81.67 -87.54 0.09 Allowed 'General case' 0 C--N 1.343 0.316 0 O-C-N 123.853 0.721 . . . . 0.56999999999999995 110.147 -160.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.75 -37.5 0.45 Allowed 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.252 -1.356 . . . . 0.56999999999999995 109.376 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -47.85 -49.32 29.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.205 1.366 . . . . 0.66000000000000003 110.571 171.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.428 ' CG ' HD23 ' A' ' 152' ' ' LEU . 12.1 t0 -77.57 -54.15 6.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.66000000000000003 109.746 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mm -57.68 -45.64 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.76 0.709 . . . . 0.56999999999999995 111.079 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -44.16 79.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 109.565 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.43 -51.25 58.87 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.123 -1.191 . . . . 0.56999999999999995 110.123 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -60.22 -51.97 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.456 1.102 . . . . 0.56999999999999995 110.223 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.08 -25.28 61.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.877 0.762 . . . . 0.56999999999999995 112.498 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -43.79 18.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.577 -1.201 . . . . 0.56999999999999995 110.064 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.25 -56.67 6.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.666 2.386 . . . . 0.56999999999999995 111.624 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.422 ' CD1' HG22 ' A' ' 46' ' ' ILE . 26.4 p90 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 119.02 -0.514 . . . . 0.56999999999999995 112.143 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.45 -1.085 0 N-CA-C 110.187 -0.736 . . . . 0.56999999999999995 110.187 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.5 111.55 0.07 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.48 1.912 . . . . 0.56999999999999995 111.288 -174.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 19.9 m95 -58.02 152.29 16.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.996 0.918 . . . . 0.56999999999999995 111.436 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.4 p -77.47 -20.69 54.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.56999999999999995 112.764 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -94.19 142.41 27.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.236 1.415 . . . . 0.56999999999999995 109.325 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -10.62 59.7 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.406 1.482 . . . . 0.56999999999999995 112.577 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.87 109.91 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.614 -1.995 . . . . 0.56999999999999995 105.614 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG23 HD21 ' A' ' 48' ' ' LEU . 59.9 t -102.02 159.0 4.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.607 -1.627 . . . . 0.56999999999999995 106.607 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 p -106.96 139.8 40.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.277 -0.638 . . . . 0.56999999999999995 109.277 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -128.08 157.37 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.409 -0.807 . . . . 0.56999999999999995 110.092 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -158.48 115.88 2.88 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.057 0.456 . . . . 1.2 110.361 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.65 90.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 106.623 -1.621 . . . . 0.56999999999999995 106.623 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.12 -25.46 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.408 -1.432 . . . . 0.56999999999999995 113.901 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -147.6 154.72 41.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 103.241 -2.874 . . . . 0.56999999999999995 103.241 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -135.78 43.95 2.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.756 0.707 . . . . 0.56999999999999995 110.148 -164.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 64' ' ' PHE . 15.4 t 47.73 -153.98 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.779 1.232 . . . . 0.56999999999999995 110.186 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -22.79 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.54 -0.743 . . . . 1.2 112.784 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -64.04 -39.72 94.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.04 0.836 . . . . 0.66000000000000003 111.536 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.19 150.7 57.41 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 109.062 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.28 159.67 40.09 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.82 2.347 . . . . 0.56999999999999995 113.011 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -59.53 -36.78 76.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.98 1.312 . . . . 0.65000000000000002 113.689 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -39.3 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.185 0.448 . . . . 0.56999999999999995 110.039 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -69.74 -46.39 66.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.297 -1.335 . . . . 0.56999999999999995 109.475 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.4 -48.14 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.985 1.721 . . . . 0.56999999999999995 110.403 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.72 -45.67 91.65 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 119.019 0.827 . . . . 0.66000000000000003 110.781 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -40.54 94.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.8 1.182 . . . . 1.2 113.189 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.23 -47.77 63.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.04 1.336 . . . . 0.56999999999999995 109.235 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.2 -37.84 70.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.375 0.989 . . . . 0.56999999999999995 110.809 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.0 t -61.49 -56.75 16.61 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.227 1.011 . . . . 0.56999999999999995 109.95 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -62.34 -32.72 73.54 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.353 1.433 . . . . 0.56999999999999995 112.338 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.95 62.0 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.451 1.1 . . . . 0.56999999999999995 112.316 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.62 -31.16 70.99 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 118.228 -0.891 . . . . 0.56999999999999995 110.165 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -59.85 -43.57 94.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.901 -1.047 . . . . 0.56999999999999995 109.609 171.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.1 mtp -61.31 -45.26 95.18 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 111.733 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -60.48 -47.75 84.77 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.085 1.311 . . . . 0.56999999999999995 111.565 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.57 -17.01 68.37 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.64 1.114 . . . . 0.56999999999999995 113.071 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -29.57 70.73 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.478 -1.013 . . . . 0.56999999999999995 110.182 174.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.91 -32.26 13.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.72 -0.657 . . . . 0.66000000000000003 111.808 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.89 132.87 24.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.757 0.823 . . . . 0.56999999999999995 110.659 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.34 35.7 0.4 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 124.111 3.208 . . . . 0.56999999999999995 113.991 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 49' ' ' HIS . 2.1 tt -78.81 146.26 33.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.718 1.607 . . . . 0.56999999999999995 107.85 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.535 ' H ' HD23 ' A' ' 48' ' ' LEU . 68.8 m80 -130.59 160.17 34.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.02 1.328 . . . . 0.65000000000000002 108.191 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 149.87 43.97 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 120.927 -1.108 . . . . 0.56999999999999995 108.26 -173.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -137.18 170.33 16.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.926 0.89 . . . . 1.2 109.357 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -117.33 128.22 54.83 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.14 163.23 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.95 1.3 . . . . 0.56999999999999995 110.444 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 55' ' ' TRP . 27.4 m -66.36 -60.21 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 109.895 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.503 ' H ' HG23 ' A' ' 54' ' ' VAL . 19.7 p90 -164.57 154.12 13.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.415 2.686 . . . . 0.56999999999999995 105.616 167.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.05 17.79 1.42 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.433 1.333 . . . . 0.56999999999999995 116.433 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.6 m 68.0 159.04 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 111.021 -168.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -131.82 177.26 7.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 109.071 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.86 -34.97 79.36 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.921 0.488 . . . . 0.66000000000000003 109.946 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mt -126.84 82.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.139 -1.8 . . . . 0.56999999999999995 106.139 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.47 140.21 44.44 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.208 -0.932 . . . . 0.56999999999999995 108.777 164.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.67 120.36 61.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 N-CA-C 105.705 -1.961 . . . . 0.56999999999999995 105.705 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.74 161.12 24.74 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.697 -0.561 . . . . 0.56999999999999995 111.697 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.5 m-85 -132.45 129.9 39.84 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 104.978 -2.23 . . . . 0.56999999999999995 104.978 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.1 17.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.647 1.979 . . . . 0.56999999999999995 108.223 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 ttp-105 -97.36 -14.15 21.43 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.69 0.996 . . . . 1.2 113.69 -168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.22 -44.07 0.03 OUTLIER Glycine 0 C--O 1.221 -0.669 0 CA-C-O 119.067 -0.852 . . . . 0.56999999999999995 111.034 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.57 27.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.314 1.046 . . . . 0.56999999999999995 109.143 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 -75.31 0.63 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.145 1.778 . . . . 0.65000000000000002 109.096 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.44 46.52 0.02 OUTLIER Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.594 0.616 . . . . 0.56999999999999995 112.371 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 -172.46 2.05 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.832 1.653 . . . . 0.66000000000000003 108.098 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.1 -36.73 2.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.56999999999999995 113.322 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.8 101.3 6.49 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.332 -0.988 . . . . 0.56999999999999995 108.332 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.52 155.26 67.37 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.412 1.408 . . . . 0.56999999999999995 111.155 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.03 177.23 3.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.53 1.157 . . . . 0.56999999999999995 111.734 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.0 -26.6 8.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.828 3.251 . . . . 0.66000000000000003 111.798 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.57 -146.0 18.06 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 120.89 1.677 . . . . 0.56999999999999995 112.632 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.5 82.28 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 0.56999999999999995 113.753 -172.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -165.02 35.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.984 1.754 . . . . 0.56999999999999995 111.743 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 t30 38.41 -129.65 0.22 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.364 2.266 . . . . 0.56999999999999995 115.755 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.2 m -65.67 131.26 45.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.153 2.181 . . . . 0.56999999999999995 109.135 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.17 -27.15 13.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 113.496 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.91 159.69 32.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.153 -1.425 . . . . 0.56999999999999995 107.153 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.89 157.1 43.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.65000000000000002 109.553 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.72 155.13 43.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.519 1.128 . . . . 0.56999999999999995 108.709 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.97 143.73 42.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.522 -0.918 . . . . 0.56999999999999995 108.522 -175.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.09 151.72 33.44 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 118.122 -0.942 . . . . 0.56999999999999995 110.193 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 55.1 Cg_endo -70.15 155.52 64.44 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.678 1.585 . . . . 0.56999999999999995 112.014 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.72 174.7 14.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.81 1.195 . . . . 0.56999999999999995 110.733 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.257 7.1 t 43.52 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.049 1.74 . . . . 0.56999999999999995 113.055 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.51 -53.06 2.69 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.945 -0.92 . . . . 0.56999999999999995 111.178 172.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.16 -35.27 80.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.089 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.0 153.62 30.15 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.889 -1.132 . . . . 0.56999999999999995 111.007 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.61 -21.48 1.96 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.204 1.383 . . . . 0.56999999999999995 114.091 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -74.72 155.07 38.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 120.138 1.969 . . . . 0.66000000000000003 108.614 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.29 26.02 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.507 -0.769 . . . . 0.56999999999999995 109.487 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -132.82 162.33 31.8 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.65000000000000002 109.248 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.5 m-85 -143.03 155.44 44.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.732 1.613 . . . . 0.56999999999999995 108.718 -171.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.63 96.29 7.85 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.552 -1.277 . . . . 0.66000000000000003 107.552 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.13 -32.76 68.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.068 1.747 . . . . 0.66000000000000003 111.74 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.74 -32.27 73.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.423 -0.584 . . . . 0.66000000000000003 109.423 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.88 124.01 23.33 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.276 1.03 . . . . 0.66000000000000003 109.471 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -54.48 131.06 41.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.301 1.04 . . . . 1.2 109.745 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.38 149.07 39.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.658 -1.238 . . . . 0.56999999999999995 107.658 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -145.1 149.3 34.8 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.508 -0.745 . . . . 0.56999999999999995 109.185 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.35 -39.25 75.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.385 0.538 . . . . 0.66000000000000003 110.728 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.87 -35.47 0.1 OUTLIER Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.367 -0.685 . . . . 0.56999999999999995 112.866 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.1 m -54.91 137.64 45.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.293 1.037 . . . . 0.56999999999999995 111.633 174.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -56.12 110.44 0.75 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 111.936 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -32.88 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 111.804 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.98 -146.21 5.5 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 108.06 -2.016 . . . . 0.56999999999999995 108.06 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.39 135.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.727 1.211 . . . . 0.56999999999999995 109.523 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.71 103.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.896 0.878 . . . . 0.56999999999999995 110.623 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.05 -41.39 74.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.085 2.154 . . . . 0.56999999999999995 110.817 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 tp -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.088 -0.708 . . . . 0.56999999999999995 109.088 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 137' ' ' VAL . 39.8 t80 -57.93 -48.86 78.68 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.719 0.807 . . . . 0.56999999999999995 109.183 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.54 -57.05 14.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.464 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -51.37 70.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.512 -0.756 . . . . 0.56999999999999995 110.333 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.1 m -56.75 -41.21 77.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 110.904 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -67.12 -52.89 36.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.348 0.659 . . . . 0.65000000000000002 110.306 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.03 -41.92 94.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.9 0.773 . . . . 0.66000000000000003 111.037 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.06 -27.91 66.06 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.275 0.63 . . . . 0.56999999999999995 110.734 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.05 -44.01 88.28 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 118.855 0.752 . . . . 0.56999999999999995 111.398 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -68.33 -39.56 81.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.18 -0.914 . . . . 0.65000000000000002 112.067 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 p -65.05 -26.94 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 123.688 0.617 . . . . 0.56999999999999995 111.955 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -44.18 85.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 0.56999999999999995 111.08 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 168.84 41.64 0.03 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.411 -1.216 . . . . 0.56999999999999995 115.128 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.7 mmt 54.39 -167.17 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.665 1.232 . . . . 0.56999999999999995 111.072 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.8 24.44 0.34 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.17 -1.35 . . . . 0.56999999999999995 114.917 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 163.69 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.402 1.601 . . . . 0.65000000000000002 113.013 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.2 178.97 9.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 109.235 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.5 m -147.52 75.7 1.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.165 1.786 . . . . 0.56999999999999995 106.815 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -136.38 143.04 41.8 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.703 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.72 3.73 3.05 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.257 2.638 . . . . 0.56999999999999995 114.725 -169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -135.67 -1.53 2.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 111.534 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.82 121.54 26.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.463 1.905 . . . . 0.56999999999999995 108.851 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 116' ' ' TYR . 2.6 p -53.59 -29.06 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 120.948 1.703 . . . . 0.56999999999999995 112.422 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 39.0 mmt -65.12 -15.37 62.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.308 -1.33 . . . . 0.56999999999999995 113.854 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.34 126.55 82.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 120.726 1.603 . . . . 0.56999999999999995 109.31 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.44 -165.33 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.543 2.162 . . . . 0.56999999999999995 110.148 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m 79.92 -31.05 0.13 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.232 -1.543 . . . . 0.56999999999999995 113.015 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.3 t80 45.21 80.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.668 1.587 . . . . 0.56999999999999995 111.471 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.65 -92.04 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.587 1.565 . . . . 0.56999999999999995 112.36 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -64.94 -49.18 71.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.172 1.389 . . . . 0.56999999999999995 113.928 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.85 109.03 2.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 107.196 -2.362 . . . . 0.56999999999999995 107.196 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.5 118.66 62.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.783 1.633 . . . . 0.66000000000000003 112.218 -166.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.51 -1.47 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.97 3.113 . . . . 0.56999999999999995 113.537 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.41 -30.03 53.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.55 1.068 . . . . 0.56999999999999995 110.68 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -116.87 75.12 0.95 Allowed 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.532 -0.73 . . . . 0.56999999999999995 109.305 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -126.31 145.88 50.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.284 0.634 . . . . 0.56999999999999995 110.929 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 52.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 111.157 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp 56.92 73.94 0.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.218 1.407 . . . . 0.56999999999999995 111.458 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -61.5 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 C-N-CA 124.932 1.293 . . . . 0.56999999999999995 113.645 -168.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -144.52 -50.85 0.28 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 116.621 -1.656 . . . . 0.56999999999999995 108.429 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -42.73 -48.29 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.95 1.7 . . . . 0.66000000000000003 112.994 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -49.52 62.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.953 0.901 . . . . 0.66000000000000003 109.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.39 -40.83 82.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 118.23 -0.89 . . . . 0.56999999999999995 108.95 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -40.25 97.04 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.989 1.315 . . . . 0.56999999999999995 109.281 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.66 -55.55 29.89 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.235 -1.146 . . . . 0.56999999999999995 110.235 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -62.3 -47.84 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.32 1.06 . . . . 0.56999999999999995 112.481 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.25 -11.86 60.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.749 1.22 . . . . 0.56999999999999995 111.92 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -80.46 -51.81 8.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.279 0.945 . . . . 0.56999999999999995 108.666 164.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.42 -51.44 68.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.977 . . . . 0.56999999999999995 112.301 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 124.153 0.981 . . . . 0.56999999999999995 109.634 -176.676 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 CA-C-O 118.723 -0.615 . . . . 0.56999999999999995 110.649 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.6 102.93 0.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 108.958 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.8 m95 -51.2 148.15 4.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.476 0.711 . . . . 0.56999999999999995 110.866 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -59.24 -33.14 70.65 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 112.344 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 t -82.66 146.42 29.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.552 0.691 . . . . 0.56999999999999995 109.326 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -19.01 61.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.387 0.675 . . . . 0.56999999999999995 111.528 170.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 136.52 52.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.006 -1.109 . . . . 0.56999999999999995 108.006 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.62 157.74 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.399 1.88 . . . . 0.56999999999999995 108.417 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.7 p -113.18 138.4 50.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.071 -1.085 . . . . 0.56999999999999995 108.071 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -126.06 153.56 44.28 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.756 0.423 . . . . 0.56999999999999995 110.199 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -154.26 119.55 5.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.28 89.03 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 105.542 -2.021 . . . . 0.56999999999999995 105.542 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -47.88 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 112.428 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.49 145.37 41.99 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.522 -2.029 . . . . 0.56999999999999995 105.522 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.42 143.55 51.14 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 109.031 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -69.84 -172.64 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.696 1.599 . . . . 0.56999999999999995 110.542 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -136.73 -29.37 0.94 Allowed 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.479 0.918 . . . . 1.2 113.479 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -53.96 -36.55 62.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.406 1.082 . . . . 0.66000000000000003 110.702 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.29 154.57 73.91 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 110.252 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 151.44 46.71 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.68 2.253 . . . . 0.56999999999999995 112.925 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -60.58 -39.44 88.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.502 1.521 . . . . 0.65000000000000002 113.324 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.2 tt -64.13 -36.38 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 119.202 -0.428 . . . . 0.56999999999999995 110.597 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -67.55 -39.17 84.99 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 116.87 -1.538 . . . . 0.56999999999999995 109.972 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.9 -52.98 51.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 120.069 1.304 . . . . 0.56999999999999995 109.922 172.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -61.54 -39.54 91.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.343 0.52 . . . . 0.66000000000000003 111.001 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -61.71 -47.1 86.78 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.399 -0.813 . . . . 1.2 112.402 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -38.2 78.52 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 123.959 0.903 . . . . 0.56999999999999995 110.269 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.49 -44.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.117 -1.068 . . . . 0.56999999999999995 108.117 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.87 -48.86 74.81 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.823 1.192 . . . . 0.56999999999999995 110.903 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -40.59 75.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.943 1.247 . . . . 0.56999999999999995 112.134 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.4 98.6 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.56999999999999995 111.294 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 49.8 mt -72.4 -31.61 65.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.146 -0.93 . . . . 0.56999999999999995 111.114 176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.87 -40.86 94.54 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.37 0.986 . . . . 0.56999999999999995 109.602 169.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -64.09 -33.74 76.45 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.548 -0.72 . . . . 0.56999999999999995 112.577 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.4 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 5.8 m95 -71.72 -47.3 54.8 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.275 0.943 . . . . 0.56999999999999995 111.261 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.56 2.17 32.42 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.165 1.364 . . . . 0.56999999999999995 113.62 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -22.68 61.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.346 -1.091 . . . . 0.56999999999999995 111.242 172.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.7 -39.75 5.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.516 -0.754 . . . . 0.66000000000000003 110.397 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 19.2 pt -101.94 135.27 19.73 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 119.427 1.012 . . . . 0.56999999999999995 110.58 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.73 40.55 0.56 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.314 2.676 . . . . 0.56999999999999995 112.628 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -101.66 134.49 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.651 1.58 . . . . 0.56999999999999995 107.63 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -130.16 170.44 14.05 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.512 0.725 . . . . 0.65000000000000002 109.652 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -137.59 158.37 44.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.843 -0.799 . . . . 0.56999999999999995 108.843 -168.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -146.93 157.83 43.75 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.61 1.164 . . . . 1.2 110.36 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.3 105.81 14.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 108.452 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.08 157.34 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.767 -1.106 . . . . 0.56999999999999995 109.729 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 m -92.87 31.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 110.913 -174.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.02 155.59 45.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 109.747 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.96 34.71 2.13 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.999 1.285 . . . . 0.56999999999999995 114.091 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.1 m -150.65 132.63 15.18 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 106.101 -1.815 . . . . 0.56999999999999995 106.101 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.61 174.09 13.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.047 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 -31.46 66.16 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.863 -0.589 . . . . 0.66000000000000003 110.391 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 mm -123.25 67.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.328 2.251 . . . . 0.56999999999999995 107.847 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.87 116.9 10.79 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.615 -1.254 . . . . 0.56999999999999995 107.615 169.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.59 129.97 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.482 -2.414 . . . . 0.56999999999999995 104.482 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -152.88 150.45 22.23 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.222 -0.924 . . . . 0.56999999999999995 111.543 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.18 143.9 51.15 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.27 -0.641 . . . . 0.56999999999999995 109.27 -171.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.03 166.78 24.03 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 124.74 1.216 . . . . 0.56999999999999995 109.658 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -94.19 -29.55 15.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.526 0.565 . . . . 1.2 112.526 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.5 -38.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.787 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 112.06 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.1 49.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 108.797 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -156.98 155.18 30.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.347 1.059 . . . . 0.65000000000000002 109.182 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.28 57.63 2.82 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.99 1.757 . . . . 0.56999999999999995 112.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.24 -82.43 0.62 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.56 1.544 . . . . 0.66000000000000003 109.079 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.76 -29.35 0.01 OUTLIER 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.506 1.122 . . . . 0.56999999999999995 110.527 -171.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.46 120.92 11.67 Favored Pre-proline 0 C--N 1.343 0.305 0 N-CA-C 107.929 -1.137 . . . . 0.56999999999999995 107.929 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.6 144.22 77.92 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.894 -1.233 . . . . 0.56999999999999995 108.894 169.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.68 -171.11 0.09 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.393 1.477 . . . . 0.56999999999999995 111.077 166.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -118.77 -33.21 4.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.693 2.797 . . . . 0.66000000000000003 110.32 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.22 -150.91 19.66 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.556 1.071 . . . . 0.56999999999999995 111.146 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.96 102.45 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 125.008 3.805 . . . . 0.56999999999999995 111.968 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' H ' ' CD ' ' A' ' 102' ' ' GLU . . . 119.6 165.38 12.99 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.244 1.878 . . . . 0.56999999999999995 109.329 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 t30 58.45 -156.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.734 1.214 . . . . 0.56999999999999995 111.752 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 m -39.66 116.56 0.64 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.927 2.491 . . . . 0.56999999999999995 113.337 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.07 -33.16 29.97 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.143 -1.598 . . . . 0.56999999999999995 112.676 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.99 166.62 29.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.438 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -144.47 163.31 34.21 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.992 0.517 . . . . 0.65000000000000002 110.058 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.69 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.642 0.777 . . . . 0.56999999999999995 109.804 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.93 152.12 32.88 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.732 -0.667 . . . . 0.56999999999999995 109.33 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.36 151.61 90.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.657 -0.687 . . . . 0.56999999999999995 109.761 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.2 Cg_endo -69.06 162.63 40.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.183 1.922 . . . . 0.56999999999999995 111.452 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.42 -109.52 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.824 -2.111 . . . . 0.56999999999999995 107.824 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -152.27 118.75 5.64 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.635 -1.617 . . . . 0.56999999999999995 106.635 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 -131.74 10.76 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.4 -1.08 . . . . 0.56999999999999995 110.4 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 tp -51.22 -28.25 11.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.126 1.37 . . . . 0.56999999999999995 112.711 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.79 145.17 8.76 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.614 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.83 -24.27 3.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.032 1.301 . . . . 0.56999999999999995 113.719 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.87 155.94 39.81 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.473 1.137 . . . . 0.66000000000000003 108.45 -172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.09 140.74 34.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.934 -0.765 . . . . 0.56999999999999995 108.934 -173.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 29.5 m170 -128.28 153.13 47.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.604 -0.725 . . . . 0.65000000000000002 109.568 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.05 153.76 44.45 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.651 -1.24 . . . . 0.56999999999999995 107.651 -173.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -92.37 100.64 13.17 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.608 -0.724 . . . . 0.66000000000000003 109.31 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -21.89 66.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.138 0.975 . . . . 0.66000000000000003 112.151 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.16 -23.49 63.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.38 0.991 . . . . 0.66000000000000003 110.153 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 79' ' ' GLY . 2.9 mt-10 -80.93 130.13 34.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.654 -1.239 . . . . 0.66000000000000003 107.654 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 147.6 4.35 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.335 1.054 . . . . 1.2 111.006 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -140.95 147.2 38.42 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.298 -1.001 . . . . 0.56999999999999995 108.298 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -148.82 139.5 22.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.15 13.68 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.831 1.196 . . . . 0.66000000000000003 111.553 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.03 -87.48 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 108.091 -2.004 . . . . 0.56999999999999995 108.091 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.08 -67.12 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.301 2.24 . . . . 0.56999999999999995 113.608 -176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -175.43 -48.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.855 1.662 . . . . 0.56999999999999995 110.778 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -142.18 158.2 44.01 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.554 1.541 . . . . 0.56999999999999995 108.993 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.53 178.66 15.86 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 109.787 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.1 mm -80.45 102.89 6.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.241 -1.022 . . . . 0.56999999999999995 108.241 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -50.97 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.925 1.69 . . . . 0.56999999999999995 110.655 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -65.61 -29.18 69.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.985 1.714 . . . . 0.56999999999999995 110.389 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -48.27 68.8 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.684 -1.598 . . . . 0.56999999999999995 106.684 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.17 -47.49 84.27 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.483 0.713 . . . . 0.56999999999999995 110.721 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.38 -49.45 76.15 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 122.745 0.418 . . . . 0.56999999999999995 110.933 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.99 63.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 109.085 -0.709 . . . . 0.56999999999999995 109.085 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -55.7 -39.28 70.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.022 0.828 . . . . 0.56999999999999995 111.344 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -60.76 -59.88 4.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.324 0.65 . . . . 0.65000000000000002 110.209 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.49 -42.37 95.9 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.177 0.898 . . . . 0.66000000000000003 111.692 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.92 -26.96 67.11 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.136 1.375 . . . . 0.56999999999999995 111.293 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.4 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.31 -41.88 93.27 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.29 -0.724 . . . . 0.56999999999999995 111.29 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -73.01 -37.78 66.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.459 -1.258 . . . . 0.65000000000000002 112.259 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 p -59.06 -31.58 69.0 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 124.101 0.875 . . . . 0.56999999999999995 111.851 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -68.15 -39.89 82.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.328 0.651 . . . . 0.56999999999999995 111.752 176.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 160.51 43.08 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.06 -0.856 . . . . 0.56999999999999995 114.488 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 176.63 0.1 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 117.883 0.842 . . . . 0.56999999999999995 111.925 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.09 46.12 0.01 OUTLIER Glycine 0 C--N 1.342 0.912 0 O-C-N 120.943 -1.098 . . . . 0.56999999999999995 112.903 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.8 169.7 13.93 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.361 1.081 . . . . 0.65000000000000002 110.4 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.6 t -161.65 -164.19 1.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.013 0.925 . . . . 0.56999999999999995 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.07 57.26 0.59 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.897 1.279 . . . . 0.56999999999999995 110.517 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -120.73 146.4 43.43 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.66000000000000003 109.463 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -21.63 63.59 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.839 2.359 . . . . 0.56999999999999995 113.056 -171.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -125.14 27.45 6.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.444 1.897 . . . . 0.56999999999999995 109.602 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.89 124.61 24.18 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.145 -0.972 . . . . 0.56999999999999995 108.916 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.05 -22.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 121.528 0.68 . . . . 0.56999999999999995 110.461 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 19.08 18.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.098 1.759 . . . . 0.56999999999999995 112.233 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.514 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.44 141.42 94.48 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.17 1.35 . . . . 0.56999999999999995 111.288 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 70.8 Cg_endo -75.63 46.02 1.58 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 124.212 3.275 . . . . 0.56999999999999995 113.007 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.29 153.14 7.71 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.77 2.428 . . . . 0.56999999999999995 106.476 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -47.96 137.59 9.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.023 1.329 . . . . 0.56999999999999995 111.265 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -47.14 99.75 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.705 1.621 . . . . 0.56999999999999995 113.542 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.23 -37.41 77.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.063 1.345 . . . . 0.56999999999999995 112.221 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.98 -85.87 0.95 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.27 0.938 . . . . 0.56999999999999995 110.936 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.69 109.36 2.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.711 -0.848 . . . . 0.66000000000000003 108.711 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.96 -16.4 18.18 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.807 2.338 . . . . 0.56999999999999995 113.534 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -38.86 62.74 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.962 1.305 . . . . 0.56999999999999995 109.125 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -77.57 74.08 4.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.79 0.836 . . . . 0.56999999999999995 110.905 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -43.7 -70.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.791 1.637 . . . . 0.56999999999999995 114.554 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 25.64 74.53 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.512 3.125 . . . . 0.56999999999999995 112.071 177.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -30.93 111.78 0.08 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.529 2.331 . . . . 0.56999999999999995 110.777 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 t -83.87 -99.71 0.05 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.181 0.301 . . . . 0.56999999999999995 111.074 -166.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -127.75 -49.93 1.37 Allowed 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 117.216 -1.373 . . . . 0.56999999999999995 109.443 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -44.07 -45.11 7.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.014 1.326 . . . . 0.66000000000000003 112.116 169.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -66.43 -54.8 20.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 123.728 0.642 . . . . 0.66000000000000003 109.995 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -37.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.418 0.687 . . . . 0.56999999999999995 110.727 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -65.95 -45.41 81.89 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.664 1.586 . . . . 0.56999999999999995 108.504 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.93 -51.02 61.21 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.204 -1.158 . . . . 0.56999999999999995 110.204 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -56.46 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.488 1.115 . . . . 0.56999999999999995 111.136 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.404 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 3.9 pt20 -62.74 -24.46 67.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.112 0.869 . . . . 0.56999999999999995 111.517 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -37.02 36.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.25 -0.881 . . . . 0.56999999999999995 110.889 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -54.7 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.661 1.585 . . . . 0.56999999999999995 110.942 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.407 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 19.3 p90 . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 123.854 0.862 . . . . 0.56999999999999995 113.159 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.451 -1.0 0 N-CA-C 111.021 -0.415 . . . . 0.56999999999999995 111.021 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt 72.03 100.8 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.242 1.417 . . . . 0.56999999999999995 109.715 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -53.08 157.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.045 0.938 . . . . 0.56999999999999995 111.755 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.3 p -67.58 -19.54 65.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.875 1.27 . . . . 0.56999999999999995 112.083 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -109.67 144.53 37.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.68 1.992 . . . . 0.56999999999999995 108.75 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -12.39 61.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.304 1.442 . . . . 0.56999999999999995 113.167 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.75 134.1 67.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.799 -1.926 . . . . 0.56999999999999995 105.799 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.48 155.15 19.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.23 1.412 . . . . 0.56999999999999995 108.621 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 p -106.54 141.22 38.18 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.912 -0.493 . . . . 0.56999999999999995 109.774 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -132.75 158.24 42.91 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.596 -0.69 . . . . 0.56999999999999995 111.0 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.42 163.15 40.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.687 0.795 . . . . 1.2 109.149 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.9 mt -127.93 105.08 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.199 -2.149 . . . . 0.56999999999999995 105.199 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.85 -57.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.106 . . . . 0.56999999999999995 112.385 -169.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -177.14 4.76 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.195 -1.409 . . . . 0.56999999999999995 107.195 164.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -144.58 152.03 39.93 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.314 -0.995 . . . . 0.56999999999999995 108.314 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -62.37 165.35 6.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.314 0.578 . . . . 0.56999999999999995 110.938 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -100.25 -47.09 5.07 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.841 -0.618 . . . . 1.2 112.053 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.78 -32.61 73.81 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.031 0.532 . . . . 0.66000000000000003 110.387 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.96 153.71 52.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.96 1.704 . . . . 0.56999999999999995 109.652 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.57 161.29 37.3 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.145 1.897 . . . . 0.56999999999999995 113.182 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.33 -40.6 94.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.659 1.184 . . . . 0.65000000000000002 112.89 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.98 -35.95 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 119.181 -0.438 . . . . 0.56999999999999995 111.155 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m -67.36 -45.65 75.69 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 117.688 -1.149 . . . . 0.56999999999999995 109.264 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.25 -49.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 117.646 -1.169 . . . . 0.56999999999999995 110.699 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.16 -35.93 82.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.1 1.318 . . . . 0.66000000000000003 111.364 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -43.4 89.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.289 1.404 . . . . 1.2 112.524 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.95 -48.34 76.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.592 -0.892 . . . . 0.56999999999999995 108.592 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.0 -41.63 89.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.719 -1.134 . . . . 0.56999999999999995 111.021 173.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -58.48 -53.11 62.02 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.548 1.522 . . . . 0.56999999999999995 110.056 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -36.06 78.52 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.679 1.127 . . . . 0.56999999999999995 111.054 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.64 76.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.76 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.38 -36.17 83.18 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 118.213 -0.898 . . . . 0.56999999999999995 110.163 172.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -49.05 76.82 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 118.899 0.772 . . . . 0.56999999999999995 109.153 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.442 ' HB3' HD11 ' A' ' 152' ' ' LEU . 50.4 mtp -61.73 -35.91 79.44 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.544 0.738 . . . . 0.56999999999999995 111.498 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 10.5 m95 -68.61 -50.59 50.34 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.56999999999999995 112.369 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.25 -8.09 69.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.885 1.231 . . . . 0.56999999999999995 112.99 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -75.17 -8.31 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.214 -1.168 . . . . 0.56999999999999995 111.765 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB3' HG21 ' A' ' 160' ' ' ILE . 55.4 mm-40 -109.54 -15.32 14.22 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.842 0.746 . . . . 0.66000000000000003 112.259 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 160' ' ' ILE . 6.6 pt -142.58 148.75 48.03 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.52 1.128 . . . . 0.56999999999999995 111.019 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.89 18.69 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.714 2.943 . . . . 0.56999999999999995 113.286 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.91 138.22 35.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.16 1.784 . . . . 0.56999999999999995 107.314 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.95 170.31 11.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.766 0.826 . . . . 0.65000000000000002 109.217 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.35 150.85 45.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.271 -1.381 . . . . 0.56999999999999995 107.271 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.85 149.42 46.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.866 -0.79 . . . . 1.2 108.866 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -107.24 129.26 54.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.031 -1.47 . . . . 0.56999999999999995 107.031 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.43 171.84 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.533 1.133 . . . . 0.56999999999999995 109.823 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.45 -38.77 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.769 0.828 . . . . 0.56999999999999995 110.651 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -167.25 74.63 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.888 1.675 . . . . 0.56999999999999995 107.694 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.35 163.06 36.84 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.511 -1.836 . . . . 0.56999999999999995 108.511 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -68.63 144.98 54.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 117.987 0.893 . . . . 0.56999999999999995 109.275 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.24 153.17 37.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 108.96 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.64 -32.97 72.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.772 0.429 . . . . 0.66000000000000003 110.069 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 125' ' ' SER . 7.3 mt -121.01 80.97 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 127.513 2.325 . . . . 0.56999999999999995 107.871 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 ttm -78.02 111.85 14.33 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.805 1.242 . . . . 0.56999999999999995 107.956 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 127.66 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.052 -1.832 . . . . 0.56999999999999995 106.052 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.62 162.85 25.52 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.226 -0.75 . . . . 0.56999999999999995 111.226 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -126.95 141.42 51.81 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.29 -1.744 . . . . 0.56999999999999995 106.29 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.18 169.17 18.71 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.098 2.159 . . . . 0.56999999999999995 106.8 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -111.02 -0.95 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.715 0.689 . . . . 1.2 112.652 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.32 -144.58 8.29 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.53 -1.828 . . . . 0.56999999999999995 108.53 -165.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.49 142.64 13.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.746 0.784 . . . . 0.56999999999999995 111.398 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -152.05 152.49 32.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.094 1.758 . . . . 0.65000000000000002 106.562 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.35 80.48 1.82 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 110.155 -1.178 . . . . 0.56999999999999995 110.155 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.6 -56.52 1.49 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.794 0.837 . . . . 0.66000000000000003 111.343 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.95 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.959 2.503 . . . . 0.56999999999999995 109.854 -167.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -147.57 123.1 5.28 Favored Pre-proline 0 C--N 1.349 0.545 0 CA-C-N 120.122 1.328 . . . . 0.56999999999999995 110.437 -173.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.75 139.32 52.04 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.188 1.259 . . . . 0.56999999999999995 110.367 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.83 -175.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.365 1.555 . . . . 0.56999999999999995 111.161 167.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -115.12 -36.02 4.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 131.116 3.767 . . . . 0.66000000000000003 109.75 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.11 -147.9 18.81 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 119.659 1.118 . . . . 0.56999999999999995 110.841 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.65 70.3 6.45 Favored 'Trans proline' 0 CA--C 1.548 1.198 1 C-N-CA 125.645 4.23 . . . . 0.56999999999999995 114.114 -171.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.41 167.07 20.43 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.409 2.909 . . . . 0.56999999999999995 109.625 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.279 19.6 t30 64.81 -143.97 0.24 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.304 1.842 . . . . 0.56999999999999995 113.503 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 m -47.03 153.23 0.45 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 127.767 2.427 . . . . 0.56999999999999995 111.22 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.88 -27.47 6.18 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 112.759 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.61 158.48 26.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.01 1.324 . . . . 0.56999999999999995 107.644 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -139.38 159.17 42.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.478 . . . . 0.65000000000000002 109.711 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.87 36.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.741 1.216 . . . . 0.56999999999999995 109.078 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.57 146.83 41.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.348 0.659 . . . . 0.56999999999999995 109.495 -177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.84 157.89 64.84 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.795 0.838 . . . . 0.56999999999999995 111.031 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.41 155.45 69.12 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.188 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.07 -111.67 0.59 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.388 0.994 . . . . 0.56999999999999995 110.891 174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.7 m -45.76 156.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.854 2.062 . . . . 0.56999999999999995 111.542 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.93 -41.97 7.68 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.174 -1.348 . . . . 0.56999999999999995 115.412 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -33.55 74.39 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.075 1.438 . . . . 0.56999999999999995 112.247 174.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.26 145.5 12.21 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.873 -1.142 . . . . 0.56999999999999995 111.498 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.86 -18.93 5.53 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 117.847 -1.529 . . . . 0.56999999999999995 114.426 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.78 156.24 36.76 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.348 1.574 . . . . 0.66000000000000003 108.045 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.06 146.05 27.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.818 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -129.81 152.28 49.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.575 -0.898 . . . . 0.65000000000000002 108.575 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -137.91 145.37 42.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 107.38 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -87.07 98.63 11.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.425 0.631 . . . . 0.66000000000000003 109.608 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -60.84 -25.61 66.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.07 1.348 . . . . 0.66000000000000003 111.85 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.39 -38.85 81.71 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.92 0.391 . . . . 0.66000000000000003 110.406 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.16 126.7 29.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.771 -1.566 . . . . 0.66000000000000003 106.771 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -59.01 147.16 35.61 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.702 -0.624 . . . . 1.2 109.473 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -124.03 158.21 32.68 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.359 -0.978 . . . . 0.56999999999999995 108.359 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.2 t -133.54 142.34 48.14 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.635 0.652 . . . . 0.56999999999999995 109.681 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.05 -46.89 72.99 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.046 1.339 . . . . 0.66000000000000003 109.275 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.96 50.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.858 -0.897 . . . . 0.56999999999999995 110.858 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -152.84 150.34 29.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.965 0.906 . . . . 0.56999999999999995 109.854 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.17 108.37 0.78 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.615 0.766 . . . . 0.56999999999999995 109.814 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -61.69 0.05 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.726 0.81 . . . . 0.56999999999999995 110.213 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.98 -111.75 1.19 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.714 -1.354 . . . . 0.56999999999999995 109.714 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.565 HG22 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -129.95 134.39 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 110.271 -178.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.85 115.77 5.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.777 -1.102 . . . . 0.56999999999999995 109.697 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.67 -37.32 83.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.047 -0.501 . . . . 0.56999999999999995 110.895 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 -45.35 89.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.129 0.877 . . . . 0.56999999999999995 109.673 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -64.03 -42.56 97.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.384 0.674 . . . . 0.56999999999999995 110.791 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.86 67.99 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.215 0.606 . . . . 0.56999999999999995 110.516 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.43 64.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.063 -0.97 . . . . 0.56999999999999995 110.053 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.1 m -53.78 -41.74 67.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.512 1.051 . . . . 0.56999999999999995 111.46 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -61.48 -56.36 21.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.819 0.448 . . . . 0.65000000000000002 110.023 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.43 -48.08 74.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.734 0.814 . . . . 0.66000000000000003 110.963 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.74 -30.77 70.99 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 125.312 1.445 . . . . 0.56999999999999995 110.968 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.402 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.68 -46.81 73.66 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.913 -0.875 . . . . 0.56999999999999995 110.913 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -66.27 -39.33 89.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.752 -0.642 . . . . 0.65000000000000002 111.646 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.403 ' HB3' HG12 ' A' ' 60' ' ' ILE . 4.4 m -57.78 -37.37 73.59 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.524 0.565 . . . . 0.56999999999999995 112.524 176.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.37 -27.22 68.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.737 1.153 . . . . 0.56999999999999995 112.638 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.98 -13.97 2.37 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 118.529 -1.15 . . . . 0.56999999999999995 114.285 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpp -61.79 152.25 31.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.168 1.484 . . . . 0.56999999999999995 110.295 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.56 -23.6 3.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 115.58 -2.789 . . . . 0.56999999999999995 114.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 m80 148.99 173.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 131.185 3.794 . . . . 0.65000000000000002 110.151 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -145.33 -172.77 3.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.484 2.313 . . . . 0.56999999999999995 109.607 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -147.12 67.33 1.15 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.43 1.492 . . . . 0.56999999999999995 110.761 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 9.7 t70 -133.5 149.98 73.74 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 117.306 -1.33 . . . . 0.66000000000000003 107.604 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.86 -35.96 42.01 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.927 1.752 . . . . 0.56999999999999995 111.091 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -119.01 35.23 4.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.754 1.222 . . . . 0.56999999999999995 108.394 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -63.62 131.98 49.71 Favored 'General case' 0 C--N 1.344 0.363 0 N-CA-C 108.156 -1.053 . . . . 0.56999999999999995 108.156 171.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' A' ' 156' ' ' ASP . 8.5 p -58.7 -30.33 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.592 0.234 . . . . 0.56999999999999995 110.986 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.683 ' SD ' HG13 ' A' ' 137' ' ' VAL . 4.2 mpp? -105.58 35.19 2.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 110.075 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -74.46 130.3 82.26 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 120.433 -1.417 . . . . 0.56999999999999995 110.875 173.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.34 168.64 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.962 1.775 . . . . 0.56999999999999995 111.056 166.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m 58.03 72.93 0.49 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.113 0.965 . . . . 0.56999999999999995 110.792 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.565 ' CE2' HG22 ' A' ' 112' ' ' ILE . 63.1 t80 -45.61 126.08 6.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 113.175 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.01 96.43 0.89 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.095 0.855 . . . . 0.56999999999999995 111.201 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -157.42 -49.88 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.022 0.911 . . . . 0.56999999999999995 111.03 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.88 -171.33 13.05 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 125.595 1.569 . . . . 0.56999999999999995 109.575 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.02 116.54 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 119.092 -0.48 . . . . 0.66000000000000003 110.053 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.08 -18.03 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.853 2.369 . . . . 0.56999999999999995 112.671 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.24 -36.63 83.52 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.002 0.819 . . . . 0.56999999999999995 109.936 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.15 68.87 1.23 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.342 0.657 . . . . 0.56999999999999995 109.507 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -60.04 -52.69 64.29 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.488 0.715 . . . . 0.56999999999999995 110.323 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.94 158.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.991 2.517 . . . . 0.56999999999999995 112.567 -159.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 41' ' ' MET . 5.4 mp -58.95 121.49 11.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.593 -1.262 . . . . 0.56999999999999995 107.593 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -96.83 -94.25 0.21 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.545 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -138.24 -46.44 0.51 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.08 -0.962 . . . . 0.56999999999999995 110.273 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.38 -34.09 66.35 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.75 0.705 . . . . 0.66000000000000003 111.02 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.71 ' CG ' HG11 ' A' ' 137' ' ' VAL . 0.7 OUTLIER -63.15 -60.18 3.77 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.571 1.148 . . . . 0.66000000000000003 110.305 176.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.84 -50.47 80.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.56999999999999995 107.756 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -59.3 -41.69 89.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.476 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.69 50.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.456 -1.457 . . . . 0.56999999999999995 109.456 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.459 HG21 ' HB3' ' A' ' 45' ' ' GLU . 1.7 mm -53.91 -52.99 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.259 1.023 . . . . 0.56999999999999995 110.482 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -58.5 -28.63 65.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.086 -0.709 . . . . 0.56999999999999995 109.086 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -80.64 -38.9 28.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 117.921 -1.038 . . . . 0.56999999999999995 112.428 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.62 -52.06 61.08 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 112.174 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.0 p90 . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 118.487 0.585 . . . . 0.56999999999999995 112.38 179.716 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 110.751 -0.519 . . . . 0.56999999999999995 110.751 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.89 10.88 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.216 2.206 . . . . 0.56999999999999995 112.432 -173.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 56.5 m95 56.37 -166.01 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.656 1.183 . . . . 0.56999999999999995 110.584 -169.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -101.53 -10.85 19.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.782 0.833 . . . . 0.56999999999999995 110.97 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -118.8 149.58 41.26 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 108.705 176.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -71.96 -11.83 60.96 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.448 0.699 . . . . 0.56999999999999995 112.575 172.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.26 117.25 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.035 -1.839 . . . . 0.56999999999999995 106.035 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.85 141.23 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.365 -0.976 . . . . 0.56999999999999995 108.365 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -102.49 147.63 26.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.648 0.658 . . . . 0.56999999999999995 111.238 -177.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -128.96 157.1 42.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 111.884 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.88 112.13 4.95 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.597 0.713 . . . . 1.2 110.159 174.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 mt -77.68 82.69 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.233 -1.395 . . . . 0.56999999999999995 107.233 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.05 -28.62 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 113.458 -175.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -139.58 154.42 47.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 128.925 2.89 . . . . 0.56999999999999995 103.604 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -132.16 174.67 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.703 1.601 . . . . 0.56999999999999995 108.203 -173.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -90.82 -176.39 4.66 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.921 0.888 . . . . 0.56999999999999995 111.399 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -129.62 -26.62 2.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.364 1.866 . . . . 1.2 113.651 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -24.0 67.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.725 0.81 . . . . 0.66000000000000003 110.86 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.83 154.99 71.35 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 127.464 2.306 . . . . 0.56999999999999995 108.582 177.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -75.58 158.51 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.189 2.592 . . . . 0.56999999999999995 113.047 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -62.23 -34.6 76.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.953 1.301 . . . . 0.65000000000000002 112.66 -176.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.46 -37.64 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.004 0.522 . . . . 0.56999999999999995 110.251 175.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.4 m -67.59 -39.56 84.83 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 117.955 -1.021 . . . . 0.56999999999999995 109.54 173.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.69 -56.1 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.769 1.168 . . . . 0.56999999999999995 110.126 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.64 -34.95 78.1 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.631 1.105 . . . . 0.66000000000000003 111.031 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.25 -48.89 63.87 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.087 0.858 . . . . 1.2 112.066 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -63.97 -43.67 95.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.815 -0.809 . . . . 0.56999999999999995 108.815 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.3 -44.28 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 117.599 -1.191 . . . . 0.56999999999999995 110.807 171.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -50.25 73.45 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 120.274 1.397 . . . . 0.56999999999999995 110.894 178.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -34.86 73.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.167 0.894 . . . . 0.56999999999999995 112.268 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.98 81.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.745 1.157 . . . . 0.56999999999999995 111.153 177.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HD12 ' A' ' 122' ' ' LEU . 38.7 mt -67.83 -37.84 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.471 -0.776 . . . . 0.56999999999999995 110.218 173.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.73 -37.41 84.11 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 110.654 172.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 mtp -64.36 -36.93 85.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.077 0.853 . . . . 0.56999999999999995 112.189 173.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -69.76 -49.36 53.83 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.251 0.932 . . . . 0.56999999999999995 110.89 172.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.73 -5.1 63.41 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.983 1.278 . . . . 0.56999999999999995 113.786 178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -67.99 -26.1 65.75 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.095 -1.238 . . . . 0.56999999999999995 110.888 172.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -100.35 -36.72 9.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.541 0.737 . . . . 0.66000000000000003 110.855 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 12.9 pt -114.05 136.81 22.21 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 118.569 0.622 . . . . 0.56999999999999995 110.819 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 34.21 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.676 2.917 . . . . 0.56999999999999995 111.912 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 126' ' ' LEU . 1.6 tt -85.42 131.95 34.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.311 -1.737 . . . . 0.56999999999999995 106.311 176.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -116.0 171.08 8.01 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.803 1.241 . . . . 0.65000000000000002 108.509 -173.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.85 156.1 45.54 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -170.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -142.61 175.92 9.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.91 . . . . 1.2 109.273 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.6 16.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.56999999999999995 108.23 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.76 158.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 109.219 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.44 -41.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.256 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -118.57 -66.34 1.08 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.939 0.876 . . . . 0.56999999999999995 108.891 -172.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.38 -156.57 10.89 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.616 -1.793 . . . . 0.56999999999999995 108.616 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 80.4 p 60.28 72.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.69 1.596 . . . . 0.56999999999999995 111.826 173.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.67 172.37 7.16 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.351 1.06 . . . . 0.56999999999999995 112.012 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -71.55 -39.44 70.65 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.274 -1.01 . . . . 0.66000000000000003 108.274 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.14 84.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.58 1.952 . . . . 0.56999999999999995 108.641 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.23 124.58 27.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.458 -1.401 . . . . 0.56999999999999995 108.417 170.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.55 127.85 66.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 174.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.09 164.91 27.48 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.833 -0.507 . . . . 0.56999999999999995 111.833 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.7 m-85 -136.03 150.65 49.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.609 -0.886 . . . . 0.56999999999999995 108.609 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.29 157.67 44.15 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.754 1.221 . . . . 0.56999999999999995 110.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -5.28 24.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.498 1.119 . . . . 1.2 113.443 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.47 106.85 0.49 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 108.341 -1.904 . . . . 0.56999999999999995 108.341 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.12 126.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.062 2.945 . . . . 0.56999999999999995 112.741 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.1 163.49 30.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.732 1.213 . . . . 0.65000000000000002 110.909 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 76.68 0.9 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.269 -1.132 . . . . 0.56999999999999995 110.269 173.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -135.15 177.58 7.7 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.66000000000000003 110.157 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -44.47 12.61 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 112.043 168.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -139.24 145.91 46.65 Favored Pre-proline 0 C--N 1.345 0.374 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 109.401 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.47 146.95 76.17 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.235 1.29 . . . . 0.56999999999999995 110.29 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -67.78 -178.95 1.04 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.908 1.337 . . . . 0.56999999999999995 111.428 162.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -117.4 -35.07 4.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 131.181 3.793 . . . . 0.66000000000000003 109.332 -172.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 -140.9 15.6 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.561 -1.133 . . . . 0.56999999999999995 110.689 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.96 87.06 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.894 3.73 . . . . 0.56999999999999995 112.575 -171.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.29 172.56 12.92 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.446 1.974 . . . . 0.56999999999999995 109.539 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.6 t30 48.7 -153.5 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 119.432 1.616 . . . . 0.56999999999999995 111.848 -174.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.3 m -48.64 126.52 11.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.716 2.406 . . . . 0.56999999999999995 112.908 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.02 -27.4 17.02 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.234 1.414 . . . . 0.56999999999999995 113.45 -173.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.93 161.83 40.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 108.344 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.96 163.34 37.16 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.029 -0.36 . . . . 0.65000000000000002 110.029 174.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.73 163.19 37.46 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.244 1.018 . . . . 0.56999999999999995 110.438 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.23 161.84 18.38 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.144 0.978 . . . . 0.56999999999999995 110.653 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.83 142.83 45.6 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-O 118.224 -0.893 . . . . 0.56999999999999995 109.383 -176.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.6 Cg_endo -66.31 156.83 63.16 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.528 1.485 . . . . 0.56999999999999995 110.893 175.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.9 9.18 8.38 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.968 0.794 . . . . 0.56999999999999995 113.81 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.1 t -160.78 168.49 24.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.823 1.649 . . . . 0.56999999999999995 107.993 176.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.89 -57.78 16.56 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 125.591 1.567 . . . . 0.56999999999999995 113.079 -177.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tp -66.09 -17.61 64.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.395 1.078 . . . . 0.56999999999999995 110.997 173.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.0 147.79 33.5 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.793 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.32 -21.31 0.54 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.571 1.558 . . . . 0.56999999999999995 115.119 -176.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.07 153.6 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.776 1.288 . . . . 0.66000000000000003 108.156 -175.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.09 144.87 29.38 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.56999999999999995 109.083 -171.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -131.84 159.23 39.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.371 -0.831 . . . . 0.65000000000000002 109.304 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 52.2 m-85 -137.65 147.19 44.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.821 1.648 . . . . 0.56999999999999995 109.002 -171.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.29 105.46 12.49 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 171.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.19 -27.66 64.07 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.468 1.107 . . . . 0.66000000000000003 111.069 171.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.62 -33.94 75.98 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.827 0.851 . . . . 0.66000000000000003 111.282 -178.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.84 120.55 20.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.767 -1.568 . . . . 0.66000000000000003 106.767 178.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 131.42 48.41 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.362 0.528 . . . . 1.2 110.699 -174.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.78 150.54 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.082 -1.081 . . . . 0.56999999999999995 108.082 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -145.06 145.72 31.57 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.92 -0.77 . . . . 0.56999999999999995 108.92 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.21 -39.73 93.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.164 0.986 . . . . 0.66000000000000003 112.052 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.05 173.42 27.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.934 1.254 . . . . 0.56999999999999995 110.034 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.13 30.29 5.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.681 1.192 . . . . 0.56999999999999995 114.174 176.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.04 168.63 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 109.315 -174.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.09 167.27 10.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 111.706 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.81 -160.97 22.64 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.434 -1.466 . . . . 0.56999999999999995 109.434 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.71 122.84 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.889 -1.152 . . . . 0.56999999999999995 107.889 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -55.53 105.23 0.16 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 109.999 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.75 -36.41 76.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 110.989 178.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.2 tp -71.12 -40.74 71.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.312 0.505 . . . . 0.56999999999999995 109.931 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.09 -44.31 96.93 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.473 0.709 . . . . 0.56999999999999995 109.375 173.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.23 -54.71 42.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.56999999999999995 110.043 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.75 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 117.891 -1.052 . . . . 0.56999999999999995 109.184 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.8 m -53.64 -43.99 69.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.116 1.325 . . . . 0.56999999999999995 111.452 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -64.32 -55.17 23.08 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.844 1.202 . . . . 0.65000000000000002 110.62 176.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.2 -39.66 86.38 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.412 -0.805 . . . . 0.66000000000000003 111.474 -172.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.65 -30.71 71.73 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.462 0.705 . . . . 0.56999999999999995 110.628 176.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.71 -43.96 60.17 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 119.194 0.906 . . . . 0.56999999999999995 111.411 170.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -74.86 -33.53 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.734 -0.65 . . . . 0.65000000000000002 112.452 176.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -33.58 75.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.837 0.744 . . . . 0.56999999999999995 111.428 174.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 48' ' ' LEU . 1.6 mm? -66.13 -29.55 69.88 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.325 0.65 . . . . 0.56999999999999995 112.053 175.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 153.09 56.07 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.292 -1.282 . . . . 0.56999999999999995 113.202 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 mmt 48.99 -156.14 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.936 0.868 . . . . 0.56999999999999995 111.475 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.82 81.11 1.22 Allowed Glycine 0 C--O 1.219 -0.842 0 N-CA-C 108.703 -1.759 . . . . 0.56999999999999995 108.703 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.31 172.09 8.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.833 0.817 . . . . 0.65000000000000002 109.847 172.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.99 -177.3 6.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.853 2.061 . . . . 0.56999999999999995 107.946 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 99.24 3.04 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.188 -2.153 . . . . 0.56999999999999995 105.188 173.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.9 141.37 17.31 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 107.861 -1.163 . . . . 0.66000000000000003 107.861 170.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.59 -4.5 14.72 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.935 2.423 . . . . 0.56999999999999995 113.73 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.31 13.7 7.7 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.121 1.768 . . . . 0.56999999999999995 111.23 -174.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.82 40.73 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 109.866 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.98 -28.95 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.969 0.804 . . . . 0.56999999999999995 110.313 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 35.1 tpp -74.46 -11.37 60.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.404 1.082 . . . . 0.56999999999999995 113.33 -174.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.35 136.29 41.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.461 -0.57 . . . . 0.56999999999999995 109.461 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 -169.28 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.973 1.782 . . . . 0.56999999999999995 109.432 168.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.0 p 50.22 79.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.209 1.404 . . . . 0.56999999999999995 114.224 172.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -56.18 93.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 113.832 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.4 109.96 0.43 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.841 1.686 . . . . 0.56999999999999995 109.59 -177.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -170.14 -50.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 108.582 169.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.52 -122.57 3.16 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.084 -1.606 . . . . 0.56999999999999995 109.084 -177.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -147.01 124.1 5.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.65 -0.871 . . . . 0.66000000000000003 108.65 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -80.53 -8.17 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.948 3.098 . . . . 0.56999999999999995 114.166 177.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -67.15 -27.36 67.23 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.578 -1.326 . . . . 0.56999999999999995 110.738 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.83 80.47 1.38 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.11 1.364 . . . . 0.56999999999999995 111.199 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.47 148.0 38.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.578 1.551 . . . . 0.56999999999999995 109.629 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.2 47.54 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.47 1.108 . . . . 0.56999999999999995 111.213 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 61.85 79.27 0.26 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.968 1.307 . . . . 0.56999999999999995 111.581 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -64.46 -86.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.206 1.187 . . . . 0.56999999999999995 114.206 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -138.42 -46.04 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 110.058 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -45.81 64.28 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.654 172.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -53.71 55.05 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.708 0.63 . . . . 0.66000000000000003 109.955 177.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.12 -45.98 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.071 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -47.53 76.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.908 1.283 . . . . 0.56999999999999995 109.459 -178.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.71 97.19 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.924 -1.27 . . . . 0.56999999999999995 109.924 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -51.18 74.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.53 1.165 . . . . 0.56999999999999995 110.282 175.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.78 -37.81 77.12 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.902 0.481 . . . . 0.56999999999999995 110.204 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -39.01 73.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.101 -0.952 . . . . 0.56999999999999995 111.916 175.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -58.92 5.46 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.731 2.012 . . . . 0.56999999999999995 109.999 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.4 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.9 p90 . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 120.264 -0.574 . . . . 0.56999999999999995 111.779 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.448 -1.161 0 N-CA-C 110.97 -0.435 . . . . 0.56999999999999995 110.97 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt 80.7 115.69 0.06 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.022 2.129 . . . . 0.56999999999999995 108.296 -177.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 79.7 m95 -58.54 163.53 3.12 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.243 1.021 . . . . 0.56999999999999995 111.939 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -69.31 -31.95 70.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.565 0.746 . . . . 0.56999999999999995 111.521 -174.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 t -123.65 150.49 44.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.39 2.276 . . . . 0.56999999999999995 107.264 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -71.97 3.02 4.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.283 -0.865 . . . . 0.56999999999999995 112.142 171.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -121.86 108.24 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.984 -1.488 . . . . 0.56999999999999995 106.984 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.71 143.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 107.964 -1.125 . . . . 0.56999999999999995 107.964 -172.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.1 p -97.32 152.6 18.74 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.644 -0.66 . . . . 0.56999999999999995 110.455 -176.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -131.21 157.83 42.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.948 -1.095 . . . . 0.56999999999999995 110.681 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 14.9 ptt180 -144.73 119.11 9.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.425 0.69 . . . . 1.2 109.491 174.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.12 86.13 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 105.165 -2.161 . . . . 0.56999999999999995 105.165 176.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.07 -38.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.539 1.935 . . . . 0.56999999999999995 110.728 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -152.61 164.3 37.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.309 -2.108 . . . . 0.56999999999999995 105.309 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -132.1 169.09 16.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.812 1.645 . . . . 0.56999999999999995 106.82 -172.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.1 t -72.0 -168.07 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.56999999999999995 111.203 171.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -43.51 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 1.2 113.463 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -60.78 -41.78 96.23 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 -177.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.4 150.32 38.81 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 124.055 0.942 . . . . 0.56999999999999995 111.26 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -75.14 158.11 41.82 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.561 2.174 . . . . 0.56999999999999995 112.444 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 30.9 m-70 -61.71 -38.62 88.53 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 112.536 -176.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.33 -40.96 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.77 -0.456 . . . . 0.56999999999999995 109.77 174.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -68.68 -38.9 80.71 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.237 -1.364 . . . . 0.56999999999999995 109.371 176.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.11 -53.55 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.875 1.671 . . . . 0.56999999999999995 110.053 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.0 -41.24 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.823 0.738 . . . . 0.66000000000000003 111.154 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -46.8 86.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 118.549 0.613 . . . . 1.2 111.719 178.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.6 mp -62.57 -44.81 95.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 116.598 -1.668 . . . . 0.56999999999999995 107.797 175.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.95 -47.04 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 121.049 1.749 . . . . 0.56999999999999995 110.698 174.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -48.6 76.44 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.949 0.795 . . . . 0.56999999999999995 109.303 -178.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -69.62 -36.88 76.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 112.104 -177.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.44 74.81 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 126.83 2.052 . . . . 0.56999999999999995 109.847 174.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 122' ' ' LEU . 21.9 mt -66.58 -33.42 75.64 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 118.505 -0.759 . . . . 0.56999999999999995 111.03 174.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -60.24 -33.87 72.89 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.383 -0.818 . . . . 0.56999999999999995 109.605 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.9 mtm -69.64 -23.5 63.49 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 115.925 -1.988 . . . . 0.56999999999999995 113.281 175.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -84.45 -34.51 23.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.529 1.513 . . . . 0.56999999999999995 111.157 169.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.95 83.0 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.839 -1.163 . . . . 0.56999999999999995 112.236 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.25 -25.98 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 111.13 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -100.35 -29.84 12.19 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.147 -0.93 . . . . 0.66000000000000003 111.468 176.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 160' ' ' ILE . 29.8 pt -122.7 131.23 24.4 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 119.364 0.984 . . . . 0.56999999999999995 111.255 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.11 43.39 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.694 2.93 . . . . 0.56999999999999995 112.234 178.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 126' ' ' LEU . 5.8 tt -82.73 145.33 29.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.146 1.378 . . . . 0.56999999999999995 108.593 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -126.78 162.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.315 1.046 . . . . 0.65000000000000002 108.208 -175.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 152.97 41.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.002 -1.481 . . . . 0.56999999999999995 107.002 -169.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 171.31 14.67 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.105 0.962 . . . . 1.2 109.083 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -115.04 163.93 14.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.976 -0.75 . . . . 0.56999999999999995 108.976 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.47 171.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.738 1.215 . . . . 0.56999999999999995 109.94 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -115.74 36.26 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 111.46 -171.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 92.02 107.5 0.03 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 128.739 2.816 . . . . 0.56999999999999995 108.99 -177.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.98 -124.41 1.43 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.078 -1.609 . . . . 0.56999999999999995 109.078 -173.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.9 p -138.0 143.17 40.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.39 0.676 . . . . 0.56999999999999995 109.803 -171.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.647 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . . . -135.22 -177.33 4.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.056 1.743 . . . . 0.56999999999999995 109.357 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 35.9 m-20 -83.74 -39.78 19.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.544 0.738 . . . . 0.66000000000000003 110.88 -177.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 122' ' ' LEU . 12.9 mt -116.05 79.98 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.306 1.442 . . . . 0.56999999999999995 107.213 -175.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -78.86 126.62 30.94 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.695 -1.253 . . . . 0.56999999999999995 108.998 171.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.17 124.98 66.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.616 -1.994 . . . . 0.56999999999999995 105.616 173.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.97 162.94 27.45 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.221 -0.752 . . . . 0.56999999999999995 111.221 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.77 148.01 46.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.994 -1.113 . . . . 0.56999999999999995 107.994 -175.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.61 179.86 6.58 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 125.936 1.694 . . . . 0.56999999999999995 110.291 -175.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 71.2 1.4 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 122.487 1.137 . . . . 1.2 108.422 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.37 -65.14 0.78 Allowed Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.311 -1.115 . . . . 0.56999999999999995 110.311 -178.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.95 159.5 33.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.863 1.832 . . . . 0.56999999999999995 110.963 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -157.87 155.19 29.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.628 1.171 . . . . 0.65000000000000002 108.923 -178.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.98 52.13 3.94 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.733 1.635 . . . . 0.56999999999999995 112.752 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -109.68 -77.18 0.6 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.533 1.133 . . . . 0.66000000000000003 108.411 -176.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -177.93 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 110.107 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -130.43 99.13 19.43 Favored Pre-proline 0 C--N 1.344 0.357 0 N-CA-C 108.523 -0.917 . . . . 0.56999999999999995 108.523 -174.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 141.71 72.63 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 109.199 -1.116 . . . . 0.56999999999999995 109.199 174.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -61.85 177.3 0.45 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.192 1.472 . . . . 0.56999999999999995 111.041 167.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -99.34 -37.41 9.25 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.694 1.998 . . . . 0.66000000000000003 110.855 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.41 -150.11 18.19 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 120.461 1.482 . . . . 0.56999999999999995 112.422 -172.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.01 81.77 1.63 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.744 3.63 . . . . 0.56999999999999995 112.949 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.17 -168.29 37.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.756 1.646 . . . . 0.56999999999999995 110.705 176.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 41.72 -137.1 0.21 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.307 1.443 . . . . 0.56999999999999995 113.788 167.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -59.42 123.53 17.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.938 2.095 . . . . 0.56999999999999995 110.936 174.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.93 -28.81 13.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.7 1.2 . . . . 0.56999999999999995 113.21 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.72 159.09 36.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -143.7 156.57 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.65000000000000002 109.306 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.42 35.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.364 0.665 . . . . 0.56999999999999995 109.592 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -117.05 153.15 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.673 -0.862 . . . . 0.56999999999999995 108.673 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 158.89 50.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 110.835 176.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 28.2 Cg_endo -69.79 161.46 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 112.175 177.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.06 -127.18 1.29 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.078 -2.009 . . . . 0.56999999999999995 108.078 -177.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.9 m -141.38 99.22 3.52 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 106.193 -1.78 . . . . 0.56999999999999995 106.193 -178.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.37 -125.62 6.34 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.177 -1.569 . . . . 0.56999999999999995 109.177 176.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -51.52 -35.43 40.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 111.842 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.17 136.97 8.32 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.574 -0.704 . . . . 0.56999999999999995 112.316 176.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.03 -22.15 8.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 126.384 1.945 . . . . 0.56999999999999995 114.464 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -68.47 151.83 46.26 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.651 -1.24 . . . . 0.66000000000000003 107.651 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.05 147.7 32.88 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.374 1.069 . . . . 0.56999999999999995 108.973 -172.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -131.62 154.66 48.66 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.888 -1.051 . . . . 0.65000000000000002 108.523 -178.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.47 151.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.825 -1.176 . . . . 0.56999999999999995 107.825 -171.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.26 94.9 9.4 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.874 -1.158 . . . . 0.66000000000000003 107.874 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.81 -28.11 46.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.654 1.582 . . . . 0.66000000000000003 111.256 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.87 -36.27 81.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.181 0.593 . . . . 0.66000000000000003 110.79 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.71 130.55 43.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.918 -1.142 . . . . 0.66000000000000003 107.918 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -57.49 140.95 49.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.249 0.547 . . . . 1.2 110.66 178.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -123.68 150.15 44.61 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.927 -1.508 . . . . 0.56999999999999995 106.927 178.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -137.84 147.76 44.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 175.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.72 -54.0 48.51 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.343 0.974 . . . . 0.66000000000000003 108.684 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.81 72.73 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.437 -1.465 . . . . 0.56999999999999995 109.437 -169.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.3 p -159.44 151.22 20.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.218 0.607 . . . . 0.56999999999999995 109.668 173.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 m -67.66 87.2 0.22 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.007 0.923 . . . . 0.56999999999999995 110.604 174.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.33 -55.47 0.06 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 125.989 1.716 . . . . 0.56999999999999995 111.406 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.47 -147.87 7.41 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.211 -1.156 . . . . 0.56999999999999995 110.211 -176.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.61 124.7 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.437 -1.32 . . . . 0.56999999999999995 107.437 -177.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.86 107.63 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.822 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -60.28 -47.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.391 1.476 . . . . 0.56999999999999995 110.337 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD13 ' HG ' ' A' ' 34' ' ' LEU . 12.5 tp -56.72 -44.76 81.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -177.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -72.92 -41.73 64.25 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.36 0.664 . . . . 0.56999999999999995 110.578 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.35 74.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.609 0.764 . . . . 0.56999999999999995 109.951 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.86 -56.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 118.289 -0.862 . . . . 0.56999999999999995 109.486 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.5 m -51.89 -36.57 49.15 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.686 1.13 . . . . 0.56999999999999995 112.522 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.7 t60 -64.12 -61.53 2.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.229 -0.656 . . . . 0.65000000000000002 109.229 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.95 -43.11 99.52 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.462 -0.773 . . . . 0.66000000000000003 111.036 -172.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 39' ' ' LEU . 4.1 mm? -61.63 -32.76 72.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 112.027 177.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.84 -44.95 81.45 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.634 -0.986 . . . . 0.56999999999999995 110.634 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -67.02 -44.21 80.86 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 118.479 -0.772 . . . . 0.65000000000000002 111.885 175.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.3 m -53.7 -38.52 64.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 123.755 0.659 . . . . 0.56999999999999995 111.085 176.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -61.77 -38.31 87.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 112.217 177.528 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 152.19 -21.95 0.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.262 -0.743 . . . . 0.56999999999999995 113.028 -175.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.6 158.79 4.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.689 1.244 . . . . 0.56999999999999995 110.927 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.03 -41.37 0.48 Allowed Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.73 -2.15 . . . . 0.56999999999999995 112.68 176.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 167.39 177.61 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 128.247 2.619 . . . . 0.65000000000000002 107.259 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 t -150.76 -175.73 5.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.992 -1.485 . . . . 0.56999999999999995 106.992 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.3 p -134.86 63.26 1.62 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.078 -174.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.06 147.65 65.75 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.66000000000000003 110.155 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.86 -27.11 21.66 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.842 2.362 . . . . 0.56999999999999995 112.158 -175.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -122.6 33.35 5.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.704 1.602 . . . . 0.56999999999999995 109.053 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.48 54.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.559 -0.713 . . . . 0.56999999999999995 110.567 176.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 138' ' ' MET . 5.5 p -65.74 -24.7 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 121.424 -0.797 . . . . 0.56999999999999995 110.336 168.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.47 ' HE3' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.6 11.84 33.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 112.157 177.117 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.55 137.11 9.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 119.764 1.166 . . . . 0.56999999999999995 112.48 174.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.04 -66.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.966 1.778 . . . . 0.56999999999999995 111.869 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -55.78 139.94 43.7 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 110.52 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -95.53 77.1 3.33 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.291 -0.633 . . . . 0.56999999999999995 109.291 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 96.75 0.12 Allowed Glycine 0 CA--C 1.536 1.374 0 N-CA-C 115.617 1.007 . . . . 0.56999999999999995 115.617 172.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -159.48 -46.68 0.05 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.399 1.1 . . . . 0.56999999999999995 113.105 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.76 -129.81 4.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.955 -2.058 . . . . 0.56999999999999995 107.955 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -147.57 114.2 4.08 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.537 -0.912 . . . . 0.66000000000000003 108.537 -178.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -12.6 23.04 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.198 1.932 . . . . 0.56999999999999995 112.706 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.03 -25.67 61.9 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.074 -1.016 . . . . 0.56999999999999995 111.167 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.88 93.28 4.3 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 108.735 174.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -52.43 -73.89 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.622 1.169 . . . . 0.56999999999999995 114.035 -177.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.36 67.04 0.2 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.504 2.321 . . . . 0.56999999999999995 110.979 176.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -40.13 121.97 1.43 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.866 1.666 . . . . 0.56999999999999995 109.121 -174.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.3 t -77.03 -101.63 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.626 0.771 . . . . 0.56999999999999995 109.272 -168.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -122.91 -8.26 8.37 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 125.102 1.361 . . . . 0.56999999999999995 110.838 172.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.22 -63.29 1.35 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 121.208 1.822 . . . . 0.66000000000000003 110.873 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.66 -50.84 61.61 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 117.616 -1.183 . . . . 0.66000000000000003 108.829 175.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.93 -48.83 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.199 0.909 . . . . 0.56999999999999995 110.314 -174.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -66.91 -49.82 64.37 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.057 -0.72 . . . . 0.56999999999999995 109.057 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.19 -58.84 11.91 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.682 -0.967 . . . . 0.56999999999999995 110.682 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 46' ' ' ILE . 13.9 mm -50.39 -48.13 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 126.343 1.857 . . . . 0.56999999999999995 112.141 174.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.44 -33.6 75.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.438 0.563 . . . . 0.56999999999999995 111.714 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -76.05 -30.79 58.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.804 0.842 . . . . 0.56999999999999995 111.801 176.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mm? -72.76 -53.19 12.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 110.065 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' ILE . 19.6 m-85 . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.778 -174.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 N-CA-C 110.946 -0.444 . . . . 0.56999999999999995 110.946 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.2 99.26 0.07 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 126.243 1.817 . . . . 0.56999999999999995 108.912 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.545 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.3 m95 -53.86 154.06 4.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.511 0.672 . . . . 0.56999999999999995 111.651 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -72.76 -31.05 64.63 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.747 0.819 . . . . 0.56999999999999995 111.702 -176.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -92.44 155.62 17.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.137 2.175 . . . . 0.56999999999999995 111.162 174.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -79.68 -10.98 59.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 111.808 173.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.29 144.7 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.777 -1.194 . . . . 0.56999999999999995 107.777 175.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' ASP . 9.9 p -131.76 150.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -178.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.7 p -102.52 148.78 25.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 119.015 -0.516 . . . . 0.56999999999999995 110.651 -174.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -127.38 158.19 37.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.865 1.211 . . . . 0.56999999999999995 111.915 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -152.74 116.56 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.988 0.423 . . . . 1.2 110.945 171.5 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 22' ' ' TYR . 34.8 mt -79.19 96.63 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 N-CA-C 106.581 -1.637 . . . . 0.56999999999999995 106.581 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -33.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.878 2.071 . . . . 0.56999999999999995 112.007 -175.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 t -150.04 162.26 40.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.384 -2.821 . . . . 0.56999999999999995 103.384 -177.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 19' ' ' ILE . 72.1 m-85 -135.36 161.29 35.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.909 -1.515 . . . . 0.56999999999999995 106.909 -173.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.431 HG22 HG21 ' A' ' 31' ' ' VAL . 6.4 t -72.81 173.15 9.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.668 0.387 . . . . 0.56999999999999995 111.295 176.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -41.06 3.83 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.433 1.093 . . . . 1.2 111.221 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -35.1 74.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.057 0.389 . . . . 0.66000000000000003 110.81 -176.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.52 151.77 52.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.531 1.932 . . . . 0.56999999999999995 108.356 -176.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.23 155.92 46.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.198 1.265 . . . . 0.56999999999999995 112.422 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -59.33 -37.59 78.18 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.565 1.146 . . . . 0.65000000000000002 112.343 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 tt -63.6 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.28 -0.867 . . . . 0.56999999999999995 110.078 174.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -62.77 -42.81 99.86 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.63 -1.176 . . . . 0.56999999999999995 109.195 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 HG22 ' A' ' 23' ' ' THR . 46.3 t -61.28 -53.51 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 120.607 1.549 . . . . 0.56999999999999995 111.667 175.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -59.79 -45.03 93.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.654 1.115 . . . . 0.66000000000000003 110.438 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.17 96.78 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 117.845 -1.074 . . . . 1.2 111.402 176.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.0 mp -64.19 -46.24 84.8 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.518 1.054 . . . . 0.56999999999999995 108.472 178.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -49.75 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.244 0.929 . . . . 0.56999999999999995 109.709 172.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.26 -46.75 87.41 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.95 -1.024 . . . . 0.56999999999999995 111.887 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -65.62 -42.54 91.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.333 1.424 . . . . 0.56999999999999995 111.712 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.05 94.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 110.049 177.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 122' ' ' LEU . 65.5 mt -66.45 -32.39 73.73 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.934 -0.555 . . . . 0.56999999999999995 111.511 173.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -43.45 98.27 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.025 172.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 mtm -67.12 -37.44 83.87 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.483 -0.77 . . . . 0.56999999999999995 112.133 176.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 128' ' ' MET . 23.7 m95 -69.11 -43.92 73.47 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.862 1.21 . . . . 0.56999999999999995 112.004 173.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.04 -0.87 66.46 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.959 1.266 . . . . 0.56999999999999995 113.197 177.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -23.48 65.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.11 -1.23 . . . . 0.56999999999999995 110.953 171.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -105.47 -32.1 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.978 -1.01 . . . . 0.66000000000000003 112.331 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 160' ' ' ILE . 7.2 pt -116.6 132.29 23.44 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 119.312 0.96 . . . . 0.56999999999999995 110.875 178.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.27 49.44 2.84 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.971 3.114 . . . . 0.56999999999999995 111.76 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 126' ' ' LEU . 3.2 tt -98.49 142.11 30.51 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.122 2.169 . . . . 0.56999999999999995 107.357 176.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -125.18 164.7 19.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.65000000000000002 109.329 -172.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.65 147.87 47.1 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.685 -1.228 . . . . 0.56999999999999995 107.685 -170.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.97 168.98 18.7 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.709 1.204 . . . . 1.2 109.048 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -110.77 150.39 29.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.793 -0.817 . . . . 0.56999999999999995 108.793 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.5 170.33 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.867 0.867 . . . . 0.56999999999999995 109.941 174.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.1 -48.71 7.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 109.17 177.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -146.58 139.61 25.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.106 1.362 . . . . 0.56999999999999995 107.387 173.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.43 166.4 22.79 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.571 0.605 . . . . 0.56999999999999995 111.808 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 164.54 21.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.914 0.387 . . . . 0.56999999999999995 110.369 174.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.51 173.71 8.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 110.8 -176.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 15' ' ' VAL . 51.3 m-20 -73.53 -35.89 65.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.09 -0.959 . . . . 0.66000000000000003 110.298 -177.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.09 71.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.549 2.34 . . . . 0.56999999999999995 108.364 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 18.9 ttp -78.31 122.02 25.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.577 -1.327 . . . . 0.56999999999999995 108.229 173.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.93 135.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.473 -1.677 . . . . 0.56999999999999995 106.473 178.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.3 165.93 28.17 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 118.821 0.737 . . . . 0.56999999999999995 112.015 176.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 6.4 m-85 -139.12 137.54 36.24 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.172 -1.788 . . . . 0.56999999999999995 106.172 -175.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.8 175.85 9.27 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 109.318 -176.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -133.55 88.8 2.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.722 -1.214 . . . . 1.2 107.722 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.76 -40.89 2.27 Favored Glycine 0 C--N 1.343 0.933 0 C-N-CA 124.359 0.981 . . . . 0.56999999999999995 113.089 170.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.96 23.94 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.376 1.088 . . . . 0.56999999999999995 109.421 175.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 159.33 25.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.957 1.303 . . . . 0.65000000000000002 109.763 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.49 55.71 4.42 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 126.21 1.862 . . . . 0.56999999999999995 112.23 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -105.08 -78.39 0.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.176 1.39 . . . . 0.66000000000000003 109.094 -175.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.17 -50.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 106.52 -176.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -108.36 126.19 30.17 Favored Pre-proline 0 C--N 1.344 0.352 0 CA-C-O 118.798 -0.62 . . . . 0.56999999999999995 109.942 -174.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.08 133.37 26.66 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.272 1.315 . . . . 0.56999999999999995 108.836 170.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.64 -163.43 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.645 1.212 . . . . 0.56999999999999995 110.459 166.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -132.53 -35.77 1.12 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.605 3.562 . . . . 0.66000000000000003 109.416 -162.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.37 -148.64 18.93 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.808 1.671 . . . . 0.56999999999999995 111.453 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.04 59.57 2.96 Favored 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.227 4.618 . . . . 0.56999999999999995 115.103 -169.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.0 40.55 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.552 1.549 . . . . 0.56999999999999995 110.053 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 42.63 -139.76 0.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.229 1.812 . . . . 0.56999999999999995 113.593 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -49.57 112.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.436 2.694 . . . . 0.56999999999999995 111.989 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.23 -32.11 61.04 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.56999999999999995 114.352 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.12 166.37 28.09 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.84 -1.162 . . . . 0.56999999999999995 109.223 -178.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -149.09 155.98 41.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.003 0.82 . . . . 0.65000000000000002 111.161 174.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.44 158.56 43.93 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.203 1.001 . . . . 0.56999999999999995 109.875 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.7 148.52 32.1 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.429 -0.582 . . . . 0.56999999999999995 109.429 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.42 96.5 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 110.242 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 21.9 Cg_endo -70.33 157.66 58.6 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.476 2.117 . . . . 0.56999999999999995 111.099 176.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.68 -53.52 0.6 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.414 1.007 . . . . 0.56999999999999995 111.141 173.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -96.64 177.67 5.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.704 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.96 -40.39 97.14 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.267 -1.296 . . . . 0.56999999999999995 112.488 -176.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.22 -29.38 66.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.881 1.34 . . . . 0.56999999999999995 110.875 168.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.13 152.19 14.69 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.85 -1.157 . . . . 0.56999999999999995 111.152 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.35 -20.55 4.89 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.436 1.017 . . . . 0.56999999999999995 113.391 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -75.39 157.22 34.52 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.483 1.141 . . . . 0.66000000000000003 108.867 -173.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.41 149.94 36.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.815 0.817 . . . . 0.56999999999999995 110.314 -172.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.83 151.56 48.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.602 -176.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.502 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 36.2 m-85 -138.07 150.01 46.51 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 108.034 -171.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -85.51 104.09 14.97 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.87 -0.789 . . . . 0.66000000000000003 108.87 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.86 -23.75 66.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.929 -1.107 . . . . 0.66000000000000003 111.671 175.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -56.72 -29.5 62.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.793 0.837 . . . . 0.66000000000000003 111.642 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -82.68 135.03 35.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.587 1.555 . . . . 0.66000000000000003 109.157 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.83 120.7 14.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.753 -0.592 . . . . 1.2 109.62 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -103.58 138.51 40.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -123.64 147.08 47.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.711 -1.218 . . . . 0.56999999999999995 107.711 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -88.26 21.23 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.396 0.998 . . . . 0.66000000000000003 112.081 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.86 25.6 37.52 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.252 1.406 . . . . 0.56999999999999995 112.834 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -64.76 -56.18 15.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.746 -172.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.1 m -151.68 -43.1 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.582 0.753 . . . . 0.56999999999999995 112.827 -176.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -167.84 166.4 13.54 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 108.078 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.84 -152.4 16.88 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.166 -1.574 . . . . 0.56999999999999995 109.166 -175.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.93 111.63 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.107 -1.442 . . . . 0.56999999999999995 107.107 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -66.28 111.65 3.58 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.074 -0.713 . . . . 0.56999999999999995 109.074 -177.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.43 -43.93 75.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.449 -0.796 . . . . 0.56999999999999995 111.464 177.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' HG ' ' A' ' 34' ' ' LEU . 20.5 tp -59.7 -40.3 87.45 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -175.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -66.54 -44.61 81.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.569 0.748 . . . . 0.56999999999999995 109.662 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.098 0.559 . . . . 0.56999999999999995 110.327 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -50.95 72.09 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.861 -1.066 . . . . 0.56999999999999995 109.845 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 65.5 m -50.82 -46.33 59.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.175 1.352 . . . . 0.56999999999999995 111.714 175.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.91 -52.27 64.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.401 0.546 . . . . 0.65000000000000002 110.281 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.5 -43.37 85.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.195 0.998 . . . . 0.66000000000000003 110.9 -172.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 39' ' ' LEU . 60.0 mt -64.85 -28.68 69.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.202 1.401 . . . . 0.56999999999999995 111.282 176.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -46.33 80.46 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.127 -0.789 . . . . 0.56999999999999995 111.127 169.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -68.7 -40.46 80.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.537 -1.22 . . . . 0.65000000000000002 110.889 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.8 p -59.98 -26.44 66.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.136 0.88 . . . . 0.56999999999999995 112.838 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.74 -41.59 78.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 111.773 173.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.73 25.91 1.2 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.478 1.037 . . . . 0.56999999999999995 113.621 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 42' ' ' TRP . 36.3 mmt -84.26 -176.94 6.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.855 0.836 . . . . 0.56999999999999995 111.052 -175.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.47 146.49 18.15 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.267 -0.879 . . . . 0.56999999999999995 111.44 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.23 164.33 1.81 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.036 0.922 . . . . 0.65000000000000002 111.25 166.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.26 179.97 7.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.515 1.926 . . . . 0.56999999999999995 107.538 -177.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.3 t -151.59 97.06 2.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.917 -1.883 . . . . 0.56999999999999995 105.917 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -131.1 137.62 31.09 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 105.587 -2.005 . . . . 0.66000000000000003 105.587 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.76 38.12 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.959 3.106 . . . . 0.56999999999999995 111.714 -176.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.46 32.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.9 1.68 . . . . 0.56999999999999995 111.291 170.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -120.64 142.91 49.0 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.98 -1.075 . . . . 0.56999999999999995 110.543 -170.04 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.47 -29.6 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 120.172 -0.611 . . . . 0.56999999999999995 109.514 177.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 tpp -61.39 -18.13 57.35 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 114.455 173.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -54.71 129.11 63.69 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.534 0.734 . . . . 0.56999999999999995 109.502 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.06 134.98 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.793 1.662 . . . . 0.56999999999999995 109.277 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.1 m 66.88 149.55 0.05 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.107 1.763 . . . . 0.56999999999999995 111.895 -173.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.84 131.48 48.93 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.017 -1.052 . . . . 0.56999999999999995 109.51 173.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.86 -104.72 0.18 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.161 -1.176 . . . . 0.56999999999999995 110.161 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -64.2 -33.61 76.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.923 0.712 . . . . 0.56999999999999995 112.923 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.59 142.93 36.08 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.613 -0.995 . . . . 0.56999999999999995 110.613 178.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -109.77 111.51 58.85 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.408 0.683 . . . . 0.66000000000000003 109.288 -169.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 -15.63 51.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.576 2.184 . . . . 0.56999999999999995 113.6 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.54 -1.24 28.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.024 0.93 . . . . 0.56999999999999995 110.675 177.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -142.51 77.42 1.58 Allowed 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 109.586 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.86 -63.15 1.2 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.67 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.11 72.96 0.03 OUTLIER 'General case' 0 C--N 1.346 0.436 0 O-C-N 126.369 2.293 . . . . 0.56999999999999995 111.364 -176.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -33.16 116.07 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.965 2.106 . . . . 0.56999999999999995 108.55 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.4 p -93.7 -75.52 0.5 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.326 -0.55 . . . . 0.56999999999999995 110.382 -160.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -141.76 -49.51 0.39 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 109.351 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -51.84 -32.47 31.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.901 1.228 . . . . 0.66000000000000003 112.441 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.458 ' HB3' HD23 ' A' ' 152' ' ' LEU . 71.7 m-20 -78.19 -82.94 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.902 1.681 . . . . 0.66000000000000003 110.404 168.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.62 -50.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.183 0.993 . . . . 0.56999999999999995 110.648 -169.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -69.05 -35.9 77.09 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 117.528 -1.225 . . . . 0.56999999999999995 109.684 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.71 95.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 120.416 1.462 . . . . 0.56999999999999995 111.049 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 46' ' ' ILE . 7.9 mm -60.03 -48.81 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.902 0.881 . . . . 0.56999999999999995 110.676 171.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -67.09 -16.86 64.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 112.89 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -82.57 -35.64 26.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.324 1.45 . . . . 0.56999999999999995 110.43 171.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -47.13 8.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.867 0.758 . . . . 0.56999999999999995 112.762 -175.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 N--CA 1.465 0.323 0 C-N-CA 124.285 1.034 . . . . 0.56999999999999995 110.484 -175.044 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 CA-C-O 120.676 0.198 . . . . 0.56999999999999995 111.856 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 pttt 86.81 133.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 129.406 3.082 . . . . 0.56999999999999995 108.548 -170.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.408 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 33.2 m95 -73.31 177.67 5.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.619 0.767 . . . . 0.56999999999999995 110.074 173.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -101.6 -14.77 17.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.728 -0.608 . . . . 0.56999999999999995 111.485 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -100.8 162.64 12.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.726 1.21 . . . . 0.56999999999999995 110.116 176.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -87.42 -4.08 59.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.13 1.372 . . . . 0.56999999999999995 112.549 171.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -133.1 140.93 46.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.868 -1.16 . . . . 0.56999999999999995 107.868 176.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.68 143.5 39.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.738 -1.578 . . . . 0.56999999999999995 106.738 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 59' ' ' ASP . 0.6 OUTLIER -98.94 140.43 33.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.69 -0.485 . . . . 0.56999999999999995 109.69 -179.531 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.21 161.04 29.48 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.631 0.772 . . . . 0.56999999999999995 110.544 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.91 160.7 43.73 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.987 0.915 . . . . 1.2 109.599 172.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.25 85.92 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.239 -2.134 . . . . 0.56999999999999995 105.239 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.64 -56.27 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.021 0.529 . . . . 0.56999999999999995 109.985 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.5 111.82 22.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.733 -1.951 . . . . 0.56999999999999995 105.733 176.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.09 148.95 22.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.395 1.878 . . . . 0.56999999999999995 107.911 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -73.88 -170.05 0.84 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 109.799 -176.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.28 -14.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.869 1.433 . . . . 1.2 114.869 176.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -64.59 -29.87 70.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.085 1.354 . . . . 0.66000000000000003 110.846 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.28 150.82 73.48 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 126.55 1.94 . . . . 0.56999999999999995 108.488 175.13 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -70.81 157.3 58.72 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.537 2.825 . . . . 0.56999999999999995 112.736 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -65.59 -32.92 74.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.705 0.802 . . . . 0.65000000000000002 112.172 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -43.96 98.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.55 -0.907 . . . . 0.56999999999999995 108.55 174.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -64.95 -42.37 94.7 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.206 -1.378 . . . . 0.56999999999999995 109.839 172.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.3 t -58.3 -48.59 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 121.157 1.798 . . . . 0.56999999999999995 110.365 177.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.8 -42.19 90.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.19 0.904 . . . . 0.66000000000000003 109.672 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -67.34 -46.87 72.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.333 -0.855 . . . . 1.2 113.146 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.37 -31.62 72.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.048 -0.977 . . . . 0.56999999999999995 109.676 177.325 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.15 -50.42 74.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.878 -1.156 . . . . 0.56999999999999995 107.878 173.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -38.88 91.55 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.244 -0.884 . . . . 0.56999999999999995 110.826 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.46 -47.71 69.31 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.473 1.488 . . . . 0.56999999999999995 111.105 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.96 86.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.075 0.95 . . . . 0.56999999999999995 111.726 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.21 -31.87 68.13 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.216 -0.897 . . . . 0.56999999999999995 111.156 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.63 -43.98 93.63 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 109.233 170.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.2 mtp -60.1 -35.34 75.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 112.86 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 5.6 m95 -70.55 -48.09 57.1 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.421 1.009 . . . . 0.56999999999999995 111.669 170.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -9.36 64.73 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.106 1.336 . . . . 0.56999999999999995 113.668 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -66.38 -20.16 66.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 110.499 170.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.89 -20.39 12.47 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.205 -0.902 . . . . 0.66000000000000003 112.691 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.8 pt -127.67 129.75 23.75 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.464 175.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.82 41.45 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.295 3.33 . . . . 0.56999999999999995 112.407 178.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -89.9 147.72 23.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.295 1.838 . . . . 0.56999999999999995 108.079 -179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -122.93 166.36 15.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.51 0.724 . . . . 0.65000000000000002 109.25 -172.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.84 39.5 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.111 -0.993 . . . . 0.56999999999999995 109.458 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 165.24 21.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.756 0.823 . . . . 1.2 109.217 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -130.3 114.1 15.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.812 -1.551 . . . . 0.56999999999999995 106.812 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.05 160.76 2.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.383 0.673 . . . . 0.56999999999999995 109.759 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.71 -14.76 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 112.227 -176.21 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -52.5 64.04 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.664 0.785 . . . . 0.56999999999999995 111.099 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.37 -152.81 6.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.965 1.745 . . . . 0.56999999999999995 109.431 -172.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -60.84 178.88 0.2 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.328 1.051 . . . . 0.56999999999999995 112.477 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.22 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.734 1.614 . . . . 0.56999999999999995 110.382 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 16' ' ' THR . 79.8 m-20 -66.43 -31.62 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.494 -0.765 . . . . 0.66000000000000003 109.138 176.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 mt -125.45 79.13 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 126.641 1.976 . . . . 0.56999999999999995 108.471 -178.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -72.54 117.95 14.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.134 1.773 . . . . 0.56999999999999995 108.226 166.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.88 122.8 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.096 -2.187 . . . . 0.56999999999999995 105.096 177.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -144.55 138.73 8.06 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 118.149 0.431 . . . . 0.56999999999999995 112.024 -174.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.48 145.69 37.25 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.936 -1.135 . . . . 0.56999999999999995 107.936 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.94 151.7 51.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.685 1.194 . . . . 0.56999999999999995 108.34 -178.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -110.68 70.86 0.73 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.271 0.558 . . . . 1.2 109.608 -174.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.28 -53.79 0.66 Allowed Glycine 0 C--O 1.219 -0.805 0 N-CA-C 110.351 -1.099 . . . . 0.56999999999999995 110.351 174.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 171.66 19.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.328 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 159.56 22.17 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.429 1.892 . . . . 0.65000000000000002 108.537 -174.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.23 46.22 2.22 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.085 1.326 . . . . 0.56999999999999995 111.788 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.42 105.66 7.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.488 -1.301 . . . . 0.66000000000000003 107.488 -172.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.9 m 55.99 -71.72 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.113 2.165 . . . . 0.56999999999999995 113.034 -175.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.75 130.02 15.31 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.351 1.86 . . . . 0.56999999999999995 107.911 -173.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.7 137.75 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.833 175.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -66.48 -173.81 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.973 1.309 . . . . 0.56999999999999995 111.202 169.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.63 -33.52 6.75 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.136 2.574 . . . . 0.66000000000000003 111.962 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.02 -123.54 7.94 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 120.586 -1.321 . . . . 0.56999999999999995 111.965 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.67 95.72 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.83 2.315 . . . . 0.56999999999999995 112.327 -176.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.89 -160.45 25.73 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.966 0.793 . . . . 0.56999999999999995 112.232 173.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 43.57 -129.91 0.78 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 112.904 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -68.3 129.11 38.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.307 2.643 . . . . 0.56999999999999995 109.186 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.67 -30.44 12.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.104 1.361 . . . . 0.56999999999999995 112.049 -175.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.2 37.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.839 1.255 . . . . 0.56999999999999995 108.352 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.74 161.54 38.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.625 -0.88 . . . . 0.65000000000000002 108.625 173.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.36 159.91 43.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.966 0.506 . . . . 0.56999999999999995 109.651 175.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -114.32 152.62 31.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.49 -0.777 . . . . 0.56999999999999995 109.606 -173.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.25 146.57 83.44 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.203 -0.903 . . . . 0.56999999999999995 110.117 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.4 Cg_endo -66.83 157.98 58.62 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.345 2.03 . . . . 0.56999999999999995 112.335 -176.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.36 -101.7 0.15 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.042 -1.223 . . . . 0.56999999999999995 110.042 176.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -147.05 -41.25 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.901 0.88 . . . . 0.56999999999999995 111.194 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.02 4.57 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.812 -1.315 . . . . 0.56999999999999995 109.812 -175.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -29.95 17.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.224 1.01 . . . . 0.56999999999999995 112.423 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.55 134.79 14.47 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 120.964 -1.085 . . . . 0.56999999999999995 112.865 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.58 9.26 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.217 1.865 . . . . 0.56999999999999995 112.203 -176.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.72 148.44 47.98 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.1 0.95 . . . . 0.66000000000000003 108.885 -166.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.38 137.85 46.02 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.691 0.796 . . . . 0.56999999999999995 109.13 -168.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 15.4 m-70 -135.33 141.24 45.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.299 -1.0 . . . . 0.65000000000000002 108.299 -164.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.29 151.73 42.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.735 -0.839 . . . . 0.56999999999999995 108.735 -169.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.56 102.2 11.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.852 -0.796 . . . . 0.66000000000000003 108.852 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.85 -21.72 63.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.095 0.958 . . . . 0.66000000000000003 111.487 172.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.23 -38.83 88.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.611 0.642 . . . . 0.66000000000000003 110.436 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.68 126.37 29.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.345 -1.354 . . . . 0.66000000000000003 107.345 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.82 132.53 22.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.465 -0.939 . . . . 1.2 108.465 176.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -120.78 129.69 53.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.739 -1.948 . . . . 0.56999999999999995 105.739 -177.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -141.02 161.84 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.619 -0.882 . . . . 0.56999999999999995 108.619 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.78 -22.77 58.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.857 0.863 . . . . 0.66000000000000003 111.136 172.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 152.47 96.68 0.14 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.177 0.894 . . . . 0.56999999999999995 111.33 175.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.0 t -120.37 -68.54 0.9 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 118.658 -0.687 . . . . 0.56999999999999995 110.562 -178.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.79 -64.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.06 0.944 . . . . 0.56999999999999995 108.877 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 tt -94.56 -46.1 7.11 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 110.327 -170.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.67 145.58 32.22 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.077 -1.209 . . . . 0.56999999999999995 110.077 173.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.5 mm -77.62 138.26 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.594 -1.262 . . . . 0.56999999999999995 107.594 -171.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -74.16 105.57 5.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.684 -0.487 . . . . 0.56999999999999995 109.684 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.31 -33.73 76.51 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.288 0.635 . . . . 0.56999999999999995 110.887 178.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.51 -51.52 65.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.624 -1.25 . . . . 0.56999999999999995 107.624 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.82 -38.89 92.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.449 0.7 . . . . 0.56999999999999995 109.205 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.31 47.12 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.547 0.739 . . . . 0.56999999999999995 112.252 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.43 77.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.628 -0.879 . . . . 0.56999999999999995 108.628 179.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -60.88 -37.73 83.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 111.382 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.42 -58.8 6.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.17 0.441 . . . . 0.65000000000000002 109.871 172.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -68.63 -41.69 79.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.298 -0.876 . . . . 0.66000000000000003 111.635 -171.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.99 -24.85 66.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.943 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.54 -45.89 93.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.56999999999999995 110.917 169.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -70.13 -32.96 71.22 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 117.729 -1.129 . . . . 0.65000000000000002 112.239 174.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 p -60.09 -38.1 81.93 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.657 1.117 . . . . 0.56999999999999995 110.894 174.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.55 -33.07 73.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.014 0.435 . . . . 0.56999999999999995 111.181 176.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.48 -55.01 0.12 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 123.782 0.706 . . . . 0.56999999999999995 111.611 175.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 176.09 172.56 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 107.632 -166.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 161.24 75.22 0.02 OUTLIER Glycine 0 C--O 1.218 -0.847 0 N-CA-C 104.137 -3.585 . . . . 0.56999999999999995 104.137 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.14 45.13 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.314 -1.365 . . . . 0.65000000000000002 107.314 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.3 -177.13 0.99 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.966 2.106 . . . . 0.56999999999999995 106.469 -173.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -132.25 39.29 3.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.56999999999999995 109.696 -174.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -104.14 137.69 19.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.66000000000000003 111.197 -172.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.47 -9.49 25.96 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.837 2.358 . . . . 0.56999999999999995 113.573 -174.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -121.52 24.75 9.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 109.599 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.63 133.18 45.53 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.082 -1.011 . . . . 0.56999999999999995 110.115 172.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -22.26 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.069 0.548 . . . . 0.56999999999999995 110.442 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.2 24.75 12.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.43 1.892 . . . . 0.56999999999999995 110.622 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.12 142.89 92.87 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.137 -0.977 . . . . 0.56999999999999995 109.967 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.9 Cg_endo -69.53 -171.48 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.315 2.01 . . . . 0.56999999999999995 111.235 166.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 t 43.59 68.89 0.46 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.497 1.519 . . . . 0.56999999999999995 113.151 173.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -43.38 129.22 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.772 1.629 . . . . 0.56999999999999995 113.458 -173.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.42 113.86 3.51 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.28 -1.528 . . . . 0.56999999999999995 109.28 -178.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 168.4 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.063 2.145 . . . . 0.56999999999999995 108.48 175.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.96 -145.24 18.34 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.556 -1.017 . . . . 0.56999999999999995 110.556 177.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -128.06 102.25 21.85 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.833 -1.543 . . . . 0.66000000000000003 106.833 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.81 67.09 6.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.985 2.457 . . . . 0.56999999999999995 109.481 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -165.1 -48.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.326 1.85 . . . . 0.56999999999999995 108.961 178.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -77.4 43.11 0.37 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.9 1.444 . . . . 0.56999999999999995 114.9 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -14.4 -71.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 128.352 2.661 . . . . 0.56999999999999995 117.06 -177.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 17.81 79.03 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 128.324 2.649 . . . . 0.56999999999999995 112.309 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -31.66 117.4 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.421 1.889 . . . . 0.56999999999999995 109.762 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -92.2 -87.85 0.21 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.101 -0.476 . . . . 0.56999999999999995 110.481 -163.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -139.57 -39.06 0.47 Allowed 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 117.644 -1.17 . . . . 0.56999999999999995 111.721 177.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -58.93 -37.2 76.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 120.174 1.352 . . . . 0.66000000000000003 110.87 174.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.42 -59.31 2.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 124.118 0.886 . . . . 0.66000000000000003 109.109 175.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.47 -46.0 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.574 1.149 . . . . 0.56999999999999995 110.237 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.37 -47.45 76.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.495 1.118 . . . . 0.56999999999999995 109.749 -177.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.53 58.14 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.995 -1.242 . . . . 0.56999999999999995 109.995 176.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -54.4 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.365 1.066 . . . . 0.56999999999999995 110.896 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -56.29 -43.5 78.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.546 1.139 . . . . 0.56999999999999995 109.569 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -65.14 -36.92 85.76 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.575 0.625 . . . . 0.56999999999999995 111.15 176.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.21 -46.57 79.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.813 1.645 . . . . 0.56999999999999995 112.153 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 20.4 p90 . . . . . 0 N--CA 1.473 0.694 0 C-N-CA 123.406 0.683 . . . . 0.56999999999999995 112.636 -179.063 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 N-CA-C 109.328 -1.066 . . . . 0.56999999999999995 109.328 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 71.47 115.84 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.043 1.737 . . . . 0.56999999999999995 109.48 -171.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -57.12 150.11 18.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.742 0.817 . . . . 0.56999999999999995 110.251 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -65.9 -23.89 66.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.841 0.857 . . . . 0.56999999999999995 111.392 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -94.16 152.63 18.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.99 0.916 . . . . 0.56999999999999995 110.364 173.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -85.62 -3.4 58.87 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.654 1.182 . . . . 0.56999999999999995 112.636 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.56 111.03 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.107 -1.072 . . . . 0.56999999999999995 108.107 177.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.15 124.78 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.551 -1.277 . . . . 0.56999999999999995 107.551 -170.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -92.6 152.23 19.7 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.599 -0.688 . . . . 0.56999999999999995 110.441 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -123.09 153.45 39.9 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.696 0.799 . . . . 0.56999999999999995 111.506 175.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.28 117.77 6.52 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.649 0.738 . . . . 1.2 110.549 174.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mt -87.74 89.46 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 105.05 -2.204 . . . . 0.56999999999999995 105.05 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.89 -31.78 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.135 0.974 . . . . 0.56999999999999995 112.097 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 t -136.2 157.65 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.589 -2.375 . . . . 0.56999999999999995 104.589 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -135.21 167.42 21.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 107.663 -173.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -68.49 -175.03 0.6 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 0.56999999999999995 111.459 172.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -41.49 2.56 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.544 1.138 . . . . 1.2 111.241 -176.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -41.43 77.48 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.875 1.27 . . . . 0.66000000000000003 111.739 178.137 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.41 142.56 29.66 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 108.015 -172.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.42 158.46 56.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.769 1.646 . . . . 0.56999999999999995 112.192 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -67.98 -36.83 80.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.374 -0.83 . . . . 0.65000000000000002 110.592 -171.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.3 tt -65.84 -40.72 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 110.814 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -62.5 -46.08 90.08 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 117.717 -1.135 . . . . 0.56999999999999995 108.272 173.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 t -54.86 -49.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.467 -1.254 . . . . 0.56999999999999995 110.701 175.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.24 -40.25 96.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.498 1.499 . . . . 0.66000000000000003 111.778 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -62.85 -46.21 88.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.487 1.04 . . . . 1.2 111.553 175.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.88 -42.79 89.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.483 1.113 . . . . 0.56999999999999995 109.531 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.44 -43.47 96.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.985 -1.007 . . . . 0.56999999999999995 110.637 170.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -53.5 57.7 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.071 1.305 . . . . 0.56999999999999995 110.692 177.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -63.98 -35.93 82.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.065 1.302 . . . . 0.56999999999999995 111.928 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -41.88 69.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.34 0.973 . . . . 0.56999999999999995 111.907 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -65.91 -35.17 79.88 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.519 -0.753 . . . . 0.56999999999999995 109.88 171.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -59.35 -43.22 92.83 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.113 0.87 . . . . 0.56999999999999995 109.851 171.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.8 mtp -62.16 -41.41 98.27 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.279 -0.867 . . . . 0.56999999999999995 110.971 176.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -61.03 -49.93 75.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.838 1.199 . . . . 0.56999999999999995 111.576 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.64 -5.63 79.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.45 1.024 . . . . 0.56999999999999995 113.88 -178.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -77.6 -21.25 52.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.831 1.315 . . . . 0.56999999999999995 110.741 170.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -97.1 -13.29 22.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.862 0.865 . . . . 0.66000000000000003 111.235 -177.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 164' ' ' TYR . 17.9 pt -142.33 150.66 55.79 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.708 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.51 12.64 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.219 2.613 . . . . 0.56999999999999995 113.452 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -79.67 137.67 37.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -119.18 165.68 13.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.571 0.701 . . . . 0.65000000000000002 109.636 -173.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.7 161.95 35.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.092 -0.707 . . . . 0.56999999999999995 109.092 -173.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -179.8 6.82 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.638 -0.875 . . . . 1.2 108.638 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -131.16 154.84 47.94 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.881 -1.155 . . . . 0.56999999999999995 107.881 177.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.46 164.6 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 124.301 1.041 . . . . 0.56999999999999995 109.256 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.79 -22.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.168 -176.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -64.81 0.81 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.381 -0.97 . . . . 0.56999999999999995 108.381 174.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.24 157.57 7.92 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.078 1.799 . . . . 0.56999999999999995 109.253 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.8 m 61.17 135.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 112.761 178.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.12 177.68 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 121.243 -0.911 . . . . 0.56999999999999995 110.586 -173.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.11 -53.89 32.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.275 -1.38 . . . . 0.66000000000000003 107.275 177.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -103.47 77.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.211 2.204 . . . . 0.56999999999999995 108.358 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.9 ttp -76.72 148.51 36.71 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 119.167 -2.208 . . . . 0.56999999999999995 109.564 173.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.2 140.34 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.736 -1.579 . . . . 0.56999999999999995 106.736 173.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.25 162.3 31.76 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.461 -0.656 . . . . 0.56999999999999995 111.461 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.8 m-85 -137.2 141.46 42.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.052 -1.462 . . . . 0.56999999999999995 107.052 -174.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.3 -174.34 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.713 1.605 . . . . 0.56999999999999995 109.305 -177.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 50.15 1.28 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.224 . . . . 1.2 112.461 -172.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.09 123.58 3.77 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.794 -1.322 . . . . 0.56999999999999995 109.794 -173.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 52.14 122.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.593 2.357 . . . . 0.56999999999999995 115.514 -172.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.14 159.37 44.3 Favored 'General case' 0 C--N 1.341 0.222 0 O-C-N 120.39 -1.444 . . . . 0.65000000000000002 112.193 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.9 80.86 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.522 1.534 . . . . 0.56999999999999995 110.195 175.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.57 -84.36 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.942 1.297 . . . . 0.66000000000000003 110.663 -174.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 t -171.05 -37.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.122 1.369 . . . . 0.56999999999999995 110.126 -177.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.76 142.0 38.16 Favored Pre-proline 0 C--N 1.343 0.284 0 C-N-CA 123.728 0.811 . . . . 0.56999999999999995 109.478 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 124.15 10.28 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.54 1.493 . . . . 0.56999999999999995 109.521 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 171.64 3.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.409 1.1 . . . . 0.56999999999999995 110.398 161.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -108.81 -44.37 4.03 Favored 'General case' 0 CA--C 1.542 0.645 1 C-N-CA 131.763 4.025 . . . . 0.66000000000000003 109.979 -171.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.96 -145.21 17.61 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.226 -1.319 . . . . 0.56999999999999995 111.166 -174.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.94 74.66 2.32 Favored 'Trans proline' 0 C--N 1.354 0.818 1 C-N-CA 125.588 4.192 . . . . 0.56999999999999995 114.042 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.48 -177.76 36.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.183 -1.967 . . . . 0.56999999999999995 108.183 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 45.01 -150.19 0.06 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 113.453 174.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -43.0 109.81 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.471 2.308 . . . . 0.56999999999999995 111.513 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.25 -29.65 42.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.616 1.166 . . . . 0.56999999999999995 113.319 -172.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.67 157.8 27.74 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.79 1.236 . . . . 0.56999999999999995 108.337 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -142.53 160.44 40.28 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.427 -0.795 . . . . 0.65000000000000002 110.303 174.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.63 172.85 12.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.937 0.895 . . . . 0.56999999999999995 108.723 176.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.95 153.96 46.1 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.527 -0.916 . . . . 0.56999999999999995 108.527 -177.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.23 135.56 76.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.424 -0.798 . . . . 0.56999999999999995 110.111 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -71.16 169.74 19.9 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.394 2.729 . . . . 0.56999999999999995 113.456 -177.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.05 -8.97 27.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.52 1.533 . . . . 0.56999999999999995 113.632 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -136.81 45.41 2.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.246 1.023 . . . . 0.56999999999999995 111.255 -163.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -77.05 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.211 1.386 . . . . 0.56999999999999995 114.185 173.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.85 -21.12 63.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.56999999999999995 110.268 167.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.2 145.65 4.39 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.211 -0.931 . . . . 0.56999999999999995 111.087 170.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.44 -34.29 3.88 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 110.922 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.24 152.53 40.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.292 1.046 . . . . 0.66000000000000003 110.449 -164.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.83 146.01 50.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.824 0.821 . . . . 0.56999999999999995 109.506 -175.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -138.44 152.84 48.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.001 0.92 . . . . 0.65000000000000002 110.093 -177.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 51.3 m-85 -140.09 155.82 46.85 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.633 1.173 . . . . 0.56999999999999995 108.995 -168.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -87.32 102.58 14.65 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.187 -0.301 . . . . 0.66000000000000003 110.187 172.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -53.98 -30.71 48.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.772 1.629 . . . . 0.66000000000000003 111.733 171.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.56 -35.28 79.96 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.341 0.657 . . . . 0.66000000000000003 111.522 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -73.73 150.69 41.01 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.744 0.818 . . . . 0.66000000000000003 109.068 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -72.67 144.44 47.74 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.743 -0.598 . . . . 1.2 110.698 175.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.87 128.28 36.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.8 -1.556 . . . . 0.56999999999999995 106.8 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -124.04 144.69 49.69 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.547 -0.538 . . . . 0.56999999999999995 109.547 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.21 -33.51 75.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.66000000000000003 111.284 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.42 95.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.88 -0.888 . . . . 0.56999999999999995 110.88 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.04 138.24 8.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.45 0.7 . . . . 0.56999999999999995 109.276 172.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 t -76.25 54.49 0.89 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.383 2.273 . . . . 0.56999999999999995 110.786 -175.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -158.15 -44.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.486 0.714 . . . . 0.56999999999999995 112.164 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.65 -176.2 38.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.545 -1.022 . . . . 0.56999999999999995 110.545 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.25 118.27 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 105.782 -1.933 . . . . 0.56999999999999995 105.782 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.82 113.01 2.79 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.891 -0.781 . . . . 0.56999999999999995 108.891 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -54.14 -42.37 69.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.25 1.02 . . . . 0.56999999999999995 110.823 177.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.97 -34.06 57.6 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.451 0.569 . . . . 0.56999999999999995 111.469 -171.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -64.48 -48.55 74.79 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.569 -0.9 . . . . 0.56999999999999995 108.569 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.27 74.34 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.804 0.442 . . . . 0.56999999999999995 110.548 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.24 78.16 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.948 -176.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.7 m -61.89 -37.42 84.53 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 0.899 . . . . 0.56999999999999995 110.961 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.51 -53.8 53.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.63 0.772 . . . . 0.65000000000000002 109.817 172.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.8 -44.28 73.88 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.628 0.771 . . . . 0.66000000000000003 111.914 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.26 -28.93 70.06 Favored 'General case' 0 CA--C 1.526 0.036 0 C-N-CA 124.389 1.076 . . . . 0.56999999999999995 111.239 176.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.78 -46.56 93.3 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.623 -0.591 . . . . 0.56999999999999995 111.623 171.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -64.2 -38.41 90.96 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 117.161 0.48 . . . . 0.65000000000000002 111.243 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -34.38 69.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.707 0.632 . . . . 0.56999999999999995 112.707 174.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -22.69 65.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.343 -0.848 . . . . 0.56999999999999995 112.856 174.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.04 -13.61 4.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.709 1.147 . . . . 0.56999999999999995 113.464 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.3 tpp -65.15 144.59 57.11 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.817 1.309 . . . . 0.56999999999999995 110.862 -171.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -97.7 -38.96 4.01 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 117.762 -1.577 . . . . 0.56999999999999995 112.038 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 m80 156.52 -176.4 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.893 3.677 . . . . 0.65000000000000002 108.111 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.4 m -145.45 179.88 7.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 107.829 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.61 94.39 2.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.785 -1.561 . . . . 0.56999999999999995 106.785 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 8.3 t70 -154.24 138.02 10.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 107.211 -1.403 . . . . 0.66000000000000003 107.211 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.9 -19.57 46.21 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.978 1.785 . . . . 0.56999999999999995 113.37 -173.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -124.39 27.21 7.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.783 1.233 . . . . 0.56999999999999995 109.108 -177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -59.42 138.52 57.63 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.315 0.646 . . . . 0.56999999999999995 110.369 175.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.5 p -75.02 -26.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.815 -0.439 . . . . 0.56999999999999995 109.815 168.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 13.41 15.53 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.615 -0.678 . . . . 0.56999999999999995 112.148 174.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -70.46 146.35 93.98 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.552 1.524 . . . . 0.56999999999999995 111.528 -174.369 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 38.2 Cg_endo -78.81 -50.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.181 1.921 . . . . 0.56999999999999995 112.693 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.5 t -67.62 120.13 13.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.921 -0.77 . . . . 0.56999999999999995 108.921 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.52 112.77 9.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.899 -0.778 . . . . 0.56999999999999995 108.899 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.76 170.54 21.91 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.805 -1.318 . . . . 0.56999999999999995 109.805 172.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.28 -53.67 0.47 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.507 2.323 . . . . 0.56999999999999995 114.029 174.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.65 108.39 2.48 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 127.162 2.315 . . . . 0.56999999999999995 108.883 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -53.94 111.07 2.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.758 1.623 . . . . 0.66000000000000003 110.751 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.05 -10.07 13.99 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.804 2.336 . . . . 0.56999999999999995 112.733 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -96.43 -27.49 14.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.719 1.145 . . . . 0.56999999999999995 110.965 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -116.15 71.1 0.77 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.069 -1.086 . . . . 0.56999999999999995 108.069 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -120.95 139.0 53.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.225 1.01 . . . . 0.56999999999999995 108.871 -178.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.96 42.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.36 1.064 . . . . 0.56999999999999995 110.592 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 64.44 92.89 0.06 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.213 1.805 . . . . 0.56999999999999995 110.638 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 75.3 m -75.23 -79.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.374 0.879 . . . . 0.56999999999999995 113.374 -169.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -149.1 -49.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.333 1.053 . . . . 0.56999999999999995 108.248 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -47.54 -46.48 27.76 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 126.151 1.78 . . . . 0.66000000000000003 111.749 167.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.79 -47.84 50.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.801 0.841 . . . . 0.66000000000000003 109.326 -174.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.16 -45.43 92.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 124.311 1.044 . . . . 0.56999999999999995 109.693 175.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -49.1 72.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.261 1.024 . . . . 0.56999999999999995 109.703 -178.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.74 72.79 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.705 -1.358 . . . . 0.56999999999999995 109.705 177.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 160' ' ' ILE . 1.6 mm -59.3 -53.99 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.178 -0.915 . . . . 0.56999999999999995 111.21 175.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.56 64.14 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.601 1.091 . . . . 0.56999999999999995 111.459 -178.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -77.33 -35.08 55.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.158 0.583 . . . . 0.56999999999999995 112.131 173.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.3 -40.85 98.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.992 1.717 . . . . 0.56999999999999995 112.749 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' HG22 ' A' ' 46' ' ' ILE . 16.8 p90 . . . . . 0 N--CA 1.474 0.762 0 C-N-CA 123.363 0.665 . . . . 0.56999999999999995 112.503 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.272 0 CA-C-O 117.248 -1.358 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m 49.92 75.49 0.17 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.815 1.246 . . . . 0.56999999999999995 112.776 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.91 128.69 56.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.147 -1.427 . . . . 0.56999999999999995 107.147 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -144.61 156.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.186 1.395 . . . . 0.56999999999999995 108.774 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.31 33.91 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.286 3.324 . . . . 0.56999999999999995 114.344 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -135.23 139.57 44.57 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 126.33 1.852 . . . . 0.56999999999999995 106.994 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.5 m -56.27 106.78 0.72 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.648 1.179 . . . . 0.56999999999999995 110.945 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.42 96.4 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.924 1.749 . . . . 0.56999999999999995 109.174 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 pttt 101.19 138.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 130.174 3.389 . . . . 0.56999999999999995 109.305 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.467 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 12.3 m95 -64.89 162.27 16.69 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.69 174.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.9 p -91.46 6.42 45.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.697 -0.627 . . . . 0.56999999999999995 112.42 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -109.7 147.7 32.69 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.881 1.272 . . . . 0.56999999999999995 109.056 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -16.89 61.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.293 0.637 . . . . 0.56999999999999995 111.943 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.55 143.49 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.009 -1.108 . . . . 0.56999999999999995 108.009 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 172.24 13.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.893 -0.78 . . . . 0.56999999999999995 108.893 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -116.56 153.33 32.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.389 0.276 . . . . 0.56999999999999995 110.627 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -128.6 149.84 50.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 111.128 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.64 106.23 3.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.821 0.849 . . . . 1.2 108.884 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.5 mt -84.47 84.2 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 106.716 -1.587 . . . . 0.56999999999999995 106.716 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.38 -41.72 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 112.696 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -126.08 164.83 20.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.611 -2.366 . . . . 0.56999999999999995 104.611 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -136.35 155.0 50.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.46 -1.311 . . . . 0.56999999999999995 107.46 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -66.54 -172.02 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.906 0.883 . . . . 0.56999999999999995 111.132 168.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -33.46 0.83 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.874 1.67 . . . . 1.2 112.763 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -39.3 78.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.016 0.926 . . . . 0.66000000000000003 112.179 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 148.33 65.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.947 2.099 . . . . 0.56999999999999995 108.088 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.8 163.49 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.84 2.36 . . . . 0.56999999999999995 112.716 -171.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -62.48 -36.13 81.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.439 0.696 . . . . 0.65000000000000002 112.265 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tt -61.78 -38.63 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.549 0.34 . . . . 0.56999999999999995 110.744 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.9 m -69.65 -41.72 75.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.542 -1.218 . . . . 0.56999999999999995 109.5 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.1 t -53.98 -54.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 120.341 1.428 . . . . 0.56999999999999995 109.719 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.28 -43.54 98.6 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.989 0.813 . . . . 0.66000000000000003 110.834 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -42.08 98.2 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.28 0.945 . . . . 1.2 112.029 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.02 -40.64 68.3 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.682 -1.151 . . . . 0.56999999999999995 109.838 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.24 -49.37 76.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 119.31 0.959 . . . . 0.56999999999999995 109.183 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -65.03 -44.48 88.96 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.599 0.76 . . . . 0.56999999999999995 110.437 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -66.3 -45.23 81.11 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.561 1.073 . . . . 0.56999999999999995 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -47.26 86.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.033 0.833 . . . . 0.56999999999999995 110.811 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 19.7 mt -67.8 -36.73 80.96 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.514 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.36 -38.39 89.36 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 119.16 0.891 . . . . 0.56999999999999995 109.651 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -33.28 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.032 0.933 . . . . 0.56999999999999995 112.514 173.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.479 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 40.9 m95 -68.13 -51.05 50.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.845 1.202 . . . . 0.56999999999999995 110.948 168.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.03 -11.65 58.86 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.563 1.077 . . . . 0.56999999999999995 113.318 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -31.17 72.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.377 -1.072 . . . . 0.56999999999999995 110.481 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -101.26 -21.17 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.016 0.825 . . . . 0.66000000000000003 111.803 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.7 pt -133.15 135.5 25.76 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.493 1.117 . . . . 0.56999999999999995 110.77 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.17 26.36 0.26 Allowed 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 123.814 3.009 . . . . 0.56999999999999995 114.57 -174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.24 136.53 34.37 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.038 1.335 . . . . 0.56999999999999995 108.239 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -117.24 165.15 13.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.664 0.785 . . . . 0.65000000000000002 109.638 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -140.15 148.02 41.02 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.234 -1.024 . . . . 0.56999999999999995 108.234 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -142.33 169.31 17.82 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.842 1.257 . . . . 1.2 109.661 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -103.75 149.39 25.04 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.571 -0.9 . . . . 0.56999999999999995 108.571 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.78 167.49 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.399 1.08 . . . . 0.56999999999999995 110.45 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.66 -40.83 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.514 0.726 . . . . 0.56999999999999995 110.867 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -164.9 87.23 0.44 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.059 1.343 . . . . 0.56999999999999995 107.392 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.41 160.5 11.56 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.219 -1.152 . . . . 0.56999999999999995 110.219 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.1 m -66.38 136.11 55.29 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.258 1.029 . . . . 0.56999999999999995 109.467 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.13 165.11 16.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.508 0.723 . . . . 0.56999999999999995 111.494 175.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.37 -29.04 65.6 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.936 -1.029 . . . . 0.66000000000000003 110.389 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.89 80.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.62 1.968 . . . . 0.56999999999999995 108.731 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.7 ttm -69.37 128.27 35.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 120.653 -1.279 . . . . 0.56999999999999995 107.684 163.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -116.18 127.1 73.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.163 -2.162 . . . . 0.56999999999999995 105.163 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.42 158.63 26.55 Favored Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.505 -0.638 . . . . 0.56999999999999995 111.505 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.8 m-85 -133.93 146.02 50.12 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 106.838 -1.542 . . . . 0.56999999999999995 106.838 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.3 173.73 11.51 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.06 1.744 . . . . 0.56999999999999995 108.537 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -134.12 66.77 1.53 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.461 1.028 . . . . 1.2 111.614 -169.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.98 105.37 0.49 Allowed Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.659 -0.976 . . . . 0.56999999999999995 110.659 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 57.91 160.33 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.423 2.689 . . . . 0.56999999999999995 114.474 -169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 170.24 10.46 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.998 1.319 . . . . 0.65000000000000002 110.547 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.84 61.42 3.69 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.466 1.508 . . . . 0.56999999999999995 112.37 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -131.47 -179.18 5.21 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.854 1.262 . . . . 0.66000000000000003 109.909 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 p -58.23 -36.9 73.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.671 0.669 . . . . 0.56999999999999995 111.25 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -135.57 112.12 10.74 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.447 0.699 . . . . 0.56999999999999995 110.517 -172.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.95 130.32 18.9 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.918 1.745 . . . . 0.56999999999999995 111.288 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -59.1 170.2 0.94 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 113.585 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -115.41 -25.57 7.9 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.615 1.966 . . . . 0.66000000000000003 112.168 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.81 -139.38 14.49 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 120.139 1.336 . . . . 0.56999999999999995 111.408 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.19 98.28 1.19 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.361 2.707 . . . . 0.56999999999999995 112.2 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.11 -176.4 23.4 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 112.066 174.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 t30 52.27 -130.63 2.19 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 120.823 -1.398 . . . . 0.56999999999999995 110.683 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.3 m -69.08 132.19 46.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.66 2.784 . . . . 0.56999999999999995 110.828 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -102.27 -29.74 11.5 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.186 1.394 . . . . 0.56999999999999995 112.741 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.7 32.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.076 1.35 . . . . 0.56999999999999995 108.237 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -145.54 150.76 37.01 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.744 0.702 . . . . 0.65000000000000002 110.113 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.52 165.35 28.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.806 0.842 . . . . 0.56999999999999995 109.47 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -119.71 151.46 38.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.194 -1.039 . . . . 0.56999999999999995 108.194 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.86 150.44 97.62 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.43 -0.795 . . . . 0.56999999999999995 110.17 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 59.9 Cg_endo -72.8 154.41 53.85 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.216 1.944 . . . . 0.56999999999999995 111.196 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.49 42.77 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.821 -0.989 . . . . 0.56999999999999995 111.484 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.2 m 63.8 161.01 0.1 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.003 2.121 . . . . 0.56999999999999995 112.491 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -140.39 28.65 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 121.06 -1.025 . . . . 0.56999999999999995 110.852 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.71 -23.8 44.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.371 0.668 . . . . 0.56999999999999995 111.525 171.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.77 139.61 31.84 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.002 -1.061 . . . . 0.56999999999999995 110.907 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.13 -19.79 16.02 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.425 1.488 . . . . 0.56999999999999995 113.286 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -71.92 155.92 39.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.954 1.377 . . . . 0.66000000000000003 108.739 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.72 145.6 36.67 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.026 0.917 . . . . 0.56999999999999995 109.598 -172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -138.07 147.1 43.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.002 -0.999 . . . . 0.65000000000000002 108.465 -170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.443 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 41.4 m-85 -138.04 148.49 45.14 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.248 1.019 . . . . 0.56999999999999995 108.434 -170.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -95.04 100.64 12.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 106.634 -1.617 . . . . 0.66000000000000003 106.634 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -59.61 -23.13 62.72 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.356 1.462 . . . . 0.66000000000000003 111.495 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -60.48 -28.85 68.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.504 0.722 . . . . 0.66000000000000003 111.088 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.4 129.68 34.73 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.177 -1.045 . . . . 0.66000000000000003 108.177 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -64.04 112.41 2.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.394 0.677 . . . . 1.2 111.799 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -96.07 146.76 24.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.56999999999999995 109.458 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -146.96 145.22 29.69 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.419 -0.956 . . . . 0.56999999999999995 108.419 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.19 -39.79 93.34 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.077 0.551 . . . . 0.66000000000000003 110.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.85 83.91 0.06 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.704 -1.758 . . . . 0.56999999999999995 108.704 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.9 t -118.06 -62.56 1.53 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.677 0.738 . . . . 0.56999999999999995 109.523 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -164.65 -45.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.85 1.26 . . . . 0.56999999999999995 110.703 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.31 142.89 41.88 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.598 1.159 . . . . 0.56999999999999995 109.441 -172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.3 -172.81 19.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.84 -1.704 . . . . 0.56999999999999995 108.84 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 mm -100.42 115.44 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.631 -1.618 . . . . 0.56999999999999995 106.631 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.22 115.08 4.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.013 0.525 . . . . 0.56999999999999995 110.05 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -66.13 -42.93 88.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.534 1.134 . . . . 0.56999999999999995 111.693 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -42.65 90.66 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.078 0.951 . . . . 0.56999999999999995 109.573 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -65.96 -49.61 67.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.857 0.863 . . . . 0.56999999999999995 110.789 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -46.95 85.42 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.008 0.367 . . . . 0.56999999999999995 111.737 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.09 -50.0 75.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 108.588 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -53.72 -45.88 70.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.567 1.076 . . . . 0.56999999999999995 111.307 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -58.09 -55.11 39.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.825 1.25 . . . . 0.65000000000000002 109.708 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.73 -47.56 59.09 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.337 0.655 . . . . 0.66000000000000003 111.194 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.52 -29.11 68.9 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.666 1.186 . . . . 0.56999999999999995 110.799 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -61.1 -46.76 93.9 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 118.741 0.7 . . . . 0.56999999999999995 112.373 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.15 -42.54 99.46 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.956 -1.021 . . . . 0.65000000000000002 110.502 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.4 m -57.82 -32.67 67.81 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.086 0.866 . . . . 0.56999999999999995 113.266 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -50.06 64.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.903 0.881 . . . . 0.56999999999999995 109.928 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.21 32.34 0.03 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-O 117.862 -1.521 . . . . 0.56999999999999995 114.995 -172.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.9 mmt 65.01 171.42 0.2 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.046 1.338 . . . . 0.56999999999999995 111.713 -168.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.26 43.6 0.02 OUTLIER Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.53 -0.731 . . . . 0.56999999999999995 113.601 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 166.94 18.39 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.909 1.355 . . . . 0.65000000000000002 111.636 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.07 -175.91 4.59 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 109.388 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 35.69 1.28 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 109.854 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.52 151.96 54.0 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.384 1.473 . . . . 0.66000000000000003 109.376 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.16 -22.56 61.23 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.797 2.331 . . . . 0.56999999999999995 113.219 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -130.44 27.48 5.02 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 109.246 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 132.54 54.25 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 121.704 -0.623 . . . . 0.56999999999999995 110.083 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.27 -23.45 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.554 0.742 . . . . 0.56999999999999995 111.545 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.27 20.5 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 111.381 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.01 133.32 80.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 119.511 1.05 . . . . 0.56999999999999995 111.389 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.8 128.01 9.83 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.832 2.355 . . . . 0.56999999999999995 110.753 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.5 m 70.78 115.15 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.094 2.158 . . . . 0.56999999999999995 111.143 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.47 148.22 9.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.336 1.054 . . . . 0.56999999999999995 112.939 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.91 -124.45 0.78 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.686 -0.966 . . . . 0.56999999999999995 110.686 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.6 -37.21 83.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.569 1.148 . . . . 0.56999999999999995 113.586 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.59 97.59 0.06 OUTLIER Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.817 1.198 . . . . 0.56999999999999995 110.745 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -65.24 116.52 31.27 Favored Pre-proline 0 N--CA 1.456 -0.156 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.885 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.4 -16.67 8.05 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 CA-C-O 117.53 -1.112 . . . . 0.56999999999999995 112.964 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -61.18 -37.2 82.08 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.703 1.592 . . . . 0.56999999999999995 109.279 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -141.14 122.35 14.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 107.975 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -131.7 -55.64 1.0 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.653 1.181 . . . . 0.56999999999999995 107.83 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 36.12 52.81 0.9 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.438 1.495 . . . . 0.56999999999999995 111.005 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.01 90.89 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.021 2.128 . . . . 0.56999999999999995 110.91 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.5 m -66.14 -83.03 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.829 1.418 . . . . 0.56999999999999995 114.829 -168.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -143.84 -44.57 0.27 Allowed 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 125.863 1.665 . . . . 0.56999999999999995 107.767 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.43 -51.69 33.74 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.81 1.244 . . . . 0.66000000000000003 111.544 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -50.52 73.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.501 0.592 . . . . 0.66000000000000003 111.598 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.81 -44.66 98.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 108.858 -0.793 . . . . 0.56999999999999995 108.858 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -65.16 -44.81 87.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.698 -1.144 . . . . 0.56999999999999995 108.971 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.47 -59.0 11.6 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.596 -1.002 . . . . 0.56999999999999995 110.596 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 160' ' ' ILE . 6.1 mm -57.15 -48.65 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.361 1.08 . . . . 0.56999999999999995 111.384 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -73.06 -15.46 61.5 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 120.02 1.282 . . . . 0.56999999999999995 112.161 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -79.51 -32.11 42.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.678 1.126 . . . . 0.56999999999999995 111.49 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.94 -43.64 11.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.283 1.433 . . . . 0.56999999999999995 111.709 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -103.75 24.65 10.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.328 1.851 . . . . 0.56999999999999995 110.928 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.0 -137.33 2.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 107.13 -2.388 . . . . 0.56999999999999995 107.13 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -157.77 -54.78 0.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 117.956 0.878 . . . . 0.56999999999999995 111.043 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? -46.33 137.7 6.15 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.167 1.787 . . . . 1.2 111.005 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 76.2 p -158.66 151.0 21.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.262 1.025 . . . . 0.56999999999999995 109.072 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -84.2 156.08 22.21 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.264 0.555 . . . . 0.56999999999999995 109.568 167.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.9 m -87.67 132.76 33.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.929 0.892 . . . . 0.56999999999999995 108.875 170.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -158.7 160.63 36.63 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.106 -1.442 . . . . 1.2 107.106 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 134.39 24.82 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.127 -1.434 . . . . 0.56999999999999995 107.127 168.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 125.63 1.572 . . . . 0.5 . 172.765 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.863 -0.113 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m -99.9 -68.12 0.82 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.301 -0.874 . . . . 0.56999999999999995 109.46 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.5 tp -167.36 -61.12 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 CA-C-O 117.994 -1.003 . . . . 0.56999999999999995 110.537 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 17.96 70.1 0.21 Allowed Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 128.472 2.709 . . . . 0.56999999999999995 113.217 -171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.88 69.31 7.47 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.757 2.971 . . . . 0.56999999999999995 109.3 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -131.16 -79.16 0.53 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.788 2.035 . . . . 0.56999999999999995 107.825 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 p -167.15 60.67 0.55 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.509 1.124 . . . . 0.56999999999999995 110.662 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.04 134.03 32.9 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.151 1.901 . . . . 0.56999999999999995 108.842 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 82.57 111.28 0.06 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 127.405 2.282 . . . . 0.56999999999999995 109.104 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -56.37 147.7 20.74 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.107 0.563 . . . . 0.56999999999999995 111.276 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.7 p -77.35 -28.22 52.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.489 0.715 . . . . 0.56999999999999995 111.514 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -84.37 144.25 28.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.798 0.839 . . . . 0.56999999999999995 109.902 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -81.49 -8.74 59.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 111.866 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.25 119.57 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.924 -2.25 . . . . 0.56999999999999995 104.924 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.21 142.98 36.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.122 -1.436 . . . . 0.56999999999999995 107.122 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -96.32 152.68 18.36 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.001 -0.437 . . . . 0.56999999999999995 111.028 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -128.2 155.04 45.15 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.809 0.844 . . . . 0.56999999999999995 111.662 172.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 114.07 4.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 1.2 109.566 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.8 mt -85.43 86.11 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.222 -1.77 . . . . 0.56999999999999995 106.222 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -68.25 -29.96 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.313 1.445 . . . . 0.56999999999999995 113.846 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 t -136.57 160.26 39.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 130.714 3.606 . . . . 0.56999999999999995 102.827 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -135.84 163.98 28.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 108.345 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.416 HG22 HG21 ' A' ' 31' ' ' VAL . 5.7 t -74.02 -175.07 2.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.94 0.896 . . . . 0.56999999999999995 111.409 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -44.2 1.86 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.667 1.187 . . . . 1.2 113.211 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -32.52 67.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.399 1.08 . . . . 0.66000000000000003 110.791 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 105' ' ' THR . 46.0 mt -123.2 143.51 41.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.311 1.444 . . . . 0.56999999999999995 109.243 -174.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.35 152.09 38.73 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.789 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -62.18 -37.24 84.52 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 112.199 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.76 -42.86 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.819 . . . . 0.56999999999999995 109.847 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.5 m -70.55 -38.73 74.19 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 117.209 -1.377 . . . . 0.56999999999999995 110.042 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG21 HG22 ' A' ' 23' ' ' THR . 24.8 t -59.39 -45.66 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.434 1.47 . . . . 0.56999999999999995 110.978 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.98 -41.09 78.37 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.93 0.786 . . . . 0.66000000000000003 110.788 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.17 87.22 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.933 -1.104 . . . . 1.2 112.631 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -64.79 -39.56 93.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.615 -0.883 . . . . 0.56999999999999995 108.615 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.66 -43.63 98.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 CA-C-N 119.207 0.912 . . . . 0.56999999999999995 110.415 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -59.1 -48.53 81.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.831 -1.08 . . . . 0.56999999999999995 111.79 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -67.66 -34.45 76.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.583 1.538 . . . . 0.56999999999999995 112.173 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.57 -40.7 76.6 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.105 1.321 . . . . 0.56999999999999995 112.185 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.2 mt -72.98 -32.32 65.11 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 110.888 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.64 -47.38 86.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 119.138 0.881 . . . . 0.56999999999999995 109.252 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.0 mtp -54.24 -36.59 63.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 117.226 -1.368 . . . . 0.56999999999999995 112.442 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -72.5 -44.4 62.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 121.165 1.802 . . . . 0.56999999999999995 112.352 171.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.8 -7.93 59.73 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.17 0.89 . . . . 0.56999999999999995 113.273 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -14.46 62.94 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.193 -1.18 . . . . 0.56999999999999995 111.809 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -115.88 -29.11 6.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.53 1.132 . . . . 0.66000000000000003 110.73 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 pt -123.66 132.72 24.3 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 110.982 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.0 34.9 0.37 Allowed 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 124.235 3.29 . . . . 0.56999999999999995 113.934 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.56 137.22 35.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 107.782 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -121.12 159.56 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.04 1.336 . . . . 0.65000000000000002 109.177 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 149.39 44.04 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.954 -1.091 . . . . 0.56999999999999995 109.882 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.21 179.3 7.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.988 0.915 . . . . 1.2 110.68 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -118.71 161.3 20.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.407 1.083 . . . . 0.56999999999999995 109.12 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.3 m -121.44 160.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.487 1.515 . . . . 0.56999999999999995 108.88 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.97 29.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.32 1.048 . . . . 0.56999999999999995 110.373 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -54.63 1.26 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.403 1.081 . . . . 0.56999999999999995 110.394 -172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.27 -135.91 2.31 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.227 -1.149 . . . . 0.56999999999999995 110.227 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 58' ' ' ALA . 5.0 m -83.65 176.94 8.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.922 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 57' ' ' THR . . . -135.76 173.46 11.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.894 1.678 . . . . 0.56999999999999995 110.285 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.19 -39.9 91.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.416 -0.802 . . . . 0.66000000000000003 109.868 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.4 mt -117.93 75.33 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.204 2.202 . . . . 0.56999999999999995 108.746 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -70.98 128.81 37.24 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.789 -1.194 . . . . 0.56999999999999995 108.854 166.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.95 129.85 72.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 104.784 -2.302 . . . . 0.56999999999999995 104.784 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.08 170.77 27.17 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.269 -0.733 . . . . 0.56999999999999995 111.269 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.7 m-85 -144.59 151.16 38.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.782 -1.192 . . . . 0.56999999999999995 107.782 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.3 171.01 18.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 124.822 1.326 . . . . 0.56999999999999995 110.417 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 57.17 1.67 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.613 0.765 . . . . 1.2 111.019 -173.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.01 -46.33 1.1 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.743 1.163 . . . . 0.56999999999999995 111.482 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.69 157.45 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.558 1.179 . . . . 0.56999999999999995 109.573 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -153.6 163.44 39.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.211 1.805 . . . . 0.65000000000000002 108.336 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.21 85.59 1.53 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.88 -1.288 . . . . 0.56999999999999995 109.88 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -130.92 -55.11 1.06 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.834 0.854 . . . . 0.66000000000000003 110.998 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 157.76 -38.45 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.748 2.819 . . . . 0.56999999999999995 110.156 -166.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -129.93 110.5 17.06 Favored Pre-proline 0 C--N 1.345 0.382 0 CA-C-N 119.794 1.179 . . . . 0.56999999999999995 110.447 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.25 133.12 36.46 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 108.736 -1.294 . . . . 0.56999999999999995 108.736 173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.55 -169.81 0.35 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.64 1.576 . . . . 0.56999999999999995 110.217 172.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -119.63 -35.01 3.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.266 2.226 . . . . 0.66000000000000003 109.815 -168.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.6 -146.37 18.18 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.925 1.25 . . . . 0.56999999999999995 110.203 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.99 111.31 3.21 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 112.22 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.31 160.09 13.92 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 128.099 2.762 . . . . 0.56999999999999995 109.71 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.271 33.3 t30 70.57 -143.51 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.112 1.765 . . . . 0.56999999999999995 112.528 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -49.92 138.79 14.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.324 1.85 . . . . 0.56999999999999995 110.795 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 112' ' ' ILE . 38.2 mt -108.74 -28.96 8.93 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.72 -1.863 . . . . 0.56999999999999995 112.303 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.22 165.41 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.573 1.149 . . . . 0.56999999999999995 108.13 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -146.51 161.71 39.86 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.547 -0.538 . . . . 0.65000000000000002 109.547 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.34 161.7 39.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 109.106 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.52 150.7 34.5 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.393 -0.965 . . . . 0.56999999999999995 108.393 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 149.9 91.17 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.562 -0.732 . . . . 0.56999999999999995 109.856 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.4 161.21 45.81 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.29 1.994 . . . . 0.56999999999999995 110.91 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.25 -83.48 0.18 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.835 -0.906 . . . . 0.56999999999999995 110.835 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.7 p -78.15 -177.72 5.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.5 1.52 . . . . 0.56999999999999995 111.272 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.81 -52.49 50.55 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.253 -1.304 . . . . 0.56999999999999995 112.854 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -20.21 61.8 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.297 1.049 . . . . 0.56999999999999995 110.967 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.51 148.74 11.29 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 111.18 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.11 1.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 117.259 -1.856 . . . . 0.56999999999999995 114.924 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -68.22 156.18 38.15 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 125.306 1.239 . . . . 0.66000000000000003 109.833 -160.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.78 144.48 31.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.56999999999999995 110.956 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -131.19 157.79 42.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.024 -0.989 . . . . 0.65000000000000002 109.437 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 69.1 m-85 -140.01 145.79 38.24 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.308 1.443 . . . . 0.56999999999999995 108.516 -170.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.21 93.62 4.63 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.29 -0.633 . . . . 0.66000000000000003 109.29 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -53.45 -28.04 28.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.799 1.24 . . . . 0.66000000000000003 111.27 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.01 -33.62 76.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.758 0.281 . . . . 0.66000000000000003 111.758 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.89 138.61 46.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.115 -1.439 . . . . 0.66000000000000003 107.115 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -62.93 134.16 55.76 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.468 -0.77 . . . . 1.2 109.656 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -118.49 143.32 46.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.622 0.769 . . . . 0.56999999999999995 109.444 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.442 ' HA ' HD21 ' A' ' 26' ' ' LEU . 3.6 t -138.89 151.75 47.21 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.339 0.656 . . . . 0.56999999999999995 110.761 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.75 -38.19 83.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.467 0.707 . . . . 0.66000000000000003 109.898 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.46 101.44 0.15 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.006 -1.638 . . . . 0.56999999999999995 109.006 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.27 170.43 21.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.759 2.024 . . . . 0.56999999999999995 108.647 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -33.74 72.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.247 1.419 . . . . 0.56999999999999995 114.447 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -113.72 149.77 34.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.997 -0.742 . . . . 0.56999999999999995 108.997 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.42 153.37 14.65 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.534 -1.426 . . . . 0.56999999999999995 109.534 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.499 HG21 HD13 ' A' ' 82' ' ' LEU . 45.4 mm -78.36 130.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.78 -1.563 . . . . 0.56999999999999995 106.78 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -65.53 109.04 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.428 -0.582 . . . . 0.56999999999999995 109.428 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.474 ' CE1' HD11 ' A' ' 34' ' ' LEU . 2.4 t80 -56.07 -43.57 78.09 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.24 1.416 . . . . 0.56999999999999995 109.01 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 34' ' ' LEU . 12.7 tp -68.83 -38.54 79.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.589 0.631 . . . . 0.56999999999999995 111.943 -173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -65.01 -44.4 89.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.835 -0.802 . . . . 0.56999999999999995 108.835 176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -50.42 70.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.646 0.379 . . . . 0.56999999999999995 111.23 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.09 75.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.109 -0.948 . . . . 0.56999999999999995 109.86 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -60.52 -33.46 72.67 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.795 1.179 . . . . 0.56999999999999995 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -64.3 -58.62 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.338 0.972 . . . . 0.65000000000000002 109.978 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -64.3 -43.1 95.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.449 0.7 . . . . 0.66000000000000003 111.272 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.09 -27.76 69.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.885 1.274 . . . . 0.56999999999999995 110.971 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.33 -50.91 62.68 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.389 -0.684 . . . . 0.56999999999999995 111.389 171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -59.18 -43.02 92.16 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.191 -0.909 . . . . 0.65000000000000002 110.666 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -38.44 64.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.438 1.711 . . . . 0.56999999999999995 114.035 174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -44.96 86.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.789 0.836 . . . . 0.56999999999999995 110.949 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.67 43.32 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-O 118.688 -1.062 . . . . 0.56999999999999995 114.338 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -121.77 150.77 41.37 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.926 1.363 . . . . 0.56999999999999995 110.416 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -98.55 -43.32 2.74 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.455 -1.747 . . . . 0.56999999999999995 113.191 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m170 163.75 179.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.95 2.9 . . . . 0.65000000000000002 109.899 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 3.9 m -147.62 179.03 7.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 109.508 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -146.52 81.83 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.437 1.095 . . . . 0.56999999999999995 109.996 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -147.11 146.38 25.43 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.24 -32.25 42.56 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 CA-C-N 121.407 1.538 . . . . 0.56999999999999995 111.882 -171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -116.84 23.86 11.64 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.031 1.332 . . . . 0.56999999999999995 109.254 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -63.33 136.48 57.69 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.017 0.927 . . . . 0.56999999999999995 109.266 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.43 -32.37 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 118.927 -1.109 . . . . 0.56999999999999995 109.631 168.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.73 7.55 10.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.575 1.08 . . . . 0.56999999999999995 113.17 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -69.03 145.8 96.8 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.895 1.679 . . . . 0.56999999999999995 110.967 -176.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.04 166.21 30.65 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 110.971 170.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 m 65.56 -67.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.662 1.985 . . . . 0.56999999999999995 111.673 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 161.84 1.17 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.285 2.234 . . . . 0.56999999999999995 107.366 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.1 136.22 12.81 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.061 -1.616 . . . . 0.56999999999999995 109.061 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -71.89 -16.25 62.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.463 1.105 . . . . 0.56999999999999995 112.394 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.94 -78.29 0.2 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.573 -1.411 . . . . 0.56999999999999995 109.573 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -174.85 144.74 0.87 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.955 1.302 . . . . 0.66000000000000003 108.776 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.36 -23.24 8.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.275 1.983 . . . . 0.56999999999999995 114.992 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -103.24 -39.31 6.88 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.456 1.48 . . . . 0.56999999999999995 110.308 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -86.9 70.28 10.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.967 1.307 . . . . 0.56999999999999995 109.563 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.5 150.77 40.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.44 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.29 62.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.869 1.268 . . . . 0.56999999999999995 110.052 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mp 62.69 87.45 0.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.224 1.41 . . . . 0.56999999999999995 111.237 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.5 m -71.83 -97.51 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.802 1.241 . . . . 0.56999999999999995 113.424 -171.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -122.99 -51.79 1.89 Allowed 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 120.879 -1.138 . . . . 0.56999999999999995 108.166 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 0.6 OUTLIER -51.06 -39.55 56.25 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.536 0.939 . . . . 0.66000000000000003 113.536 177.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -69.07 -55.36 11.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.437 1.095 . . . . 0.66000000000000003 110.748 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.58 -38.99 81.51 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-O 117.959 -1.02 . . . . 0.56999999999999995 108.598 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.38 86.89 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 120.167 1.349 . . . . 0.56999999999999995 109.51 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.33 31.47 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.247 -0.741 . . . . 0.56999999999999995 111.247 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 160' ' ' ILE . 5.6 mm -64.3 -48.82 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.009 0.524 . . . . 0.56999999999999995 111.803 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -17.56 64.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.426 1.09 . . . . 0.56999999999999995 111.894 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -42.92 17.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.869 -1.062 . . . . 0.56999999999999995 109.662 172.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.78 -49.23 60.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.559 1.144 . . . . 0.56999999999999995 111.426 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -97.54 3.88 50.49 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.941 1.296 . . . . 0.56999999999999995 111.302 -175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.46 94.11 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.757 1.17 . . . . 0.56999999999999995 113.868 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -152.02 -45.54 0.11 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.47 0.708 . . . . 0.56999999999999995 112.256 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.6 128.24 10.81 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.228 -1.397 . . . . 1.2 107.228 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.8 t -86.25 160.11 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.56999999999999995 107.497 167.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -67.17 164.19 18.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.888 -0.597 . . . . 0.56999999999999995 110.557 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.6 t 70.71 -167.89 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.131 1.372 . . . . 0.56999999999999995 110.691 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.0 126.76 29.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.409 -0.807 . . . . 1.2 109.29 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -76.02 168.98 19.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.916 1.687 . . . . 0.56999999999999995 110.724 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 129.217 3.007 . . . . 0.5 . 172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.162 0 CA-C-O 119.363 -0.351 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t -162.96 -78.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.437 -2.801 . . . . 0.56999999999999995 103.437 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.87 72.41 0.38 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.959 0.904 . . . . 0.56999999999999995 109.703 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 36.79 57.4 3.58 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 114.074 -175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.94 175.34 11.35 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.979 2.453 . . . . 0.56999999999999995 111.819 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -77.81 -71.12 0.44 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.102 0.561 . . . . 0.56999999999999995 111.554 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -160.44 68.53 2.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.903 1.681 . . . . 0.56999999999999995 106.82 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.23 167.61 21.57 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 120.888 1.059 . . . . 0.56999999999999995 110.821 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt 83.51 115.91 0.05 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 127.429 2.292 . . . . 0.56999999999999995 108.997 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 4.2 m95 -64.93 163.03 15.27 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 111.558 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.9 m -89.35 -24.46 21.97 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.997 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -91.28 149.11 21.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.585 0.754 . . . . 0.56999999999999995 109.797 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -5.84 52.98 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.961 0.726 . . . . 0.56999999999999995 112.961 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.56 139.55 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.56999999999999995 107.189 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.58 148.3 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.452 -1.314 . . . . 0.56999999999999995 107.452 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.9 p -97.52 139.61 33.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.852 -0.795 . . . . 0.56999999999999995 108.852 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -126.97 159.9 32.7 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.822 -0.549 . . . . 0.56999999999999995 110.995 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -153.09 160.25 42.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.103 1.361 . . . . 1.2 108.301 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.56 94.24 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 104.086 -2.561 . . . . 0.56999999999999995 104.086 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -40.69 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.112 0.965 . . . . 0.56999999999999995 112.152 -170.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.12 153.4 41.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.146 -2.168 . . . . 0.56999999999999995 105.146 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -134.98 143.19 46.7 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 108.463 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -72.18 169.02 17.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.256 -1.338 . . . . 0.56999999999999995 110.165 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -24.89 5.89 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.731 0.812 . . . . 1.2 112.881 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -35.43 80.86 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.942 0.877 . . . . 0.66000000000000003 111.224 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.58 154.14 78.06 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.122 1.769 . . . . 0.56999999999999995 109.629 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.19 161.15 29.4 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.702 1.602 . . . . 0.56999999999999995 112.933 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.84 -35.45 80.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.773 -1.103 . . . . 0.65000000000000002 111.342 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -64.84 -35.68 75.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.523 0.729 . . . . 0.56999999999999995 110.55 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -64.73 -51.11 64.1 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 117.296 -1.335 . . . . 0.56999999999999995 108.15 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.51 -49.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 120.398 1.454 . . . . 0.56999999999999995 110.856 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.19 -39.86 90.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.519 1.054 . . . . 0.66000000000000003 111.487 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -65.05 -42.98 93.74 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.642 1.11 . . . . 1.2 111.818 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.53 -43.64 89.36 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.599 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.61 -45.12 99.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.017 -0.992 . . . . 0.56999999999999995 110.035 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -60.96 -45.2 95.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.72 1.145 . . . . 0.56999999999999995 111.504 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -36.95 73.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.66 1.118 . . . . 0.56999999999999995 111.418 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.374 0.988 . . . . 0.56999999999999995 111.519 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.4 -33.26 72.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.252 -0.88 . . . . 0.56999999999999995 110.557 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -59.38 -42.36 91.48 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 119.439 1.018 . . . . 0.56999999999999995 110.211 167.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.2 mtp -64.74 -33.38 75.83 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 119.912 1.233 . . . . 0.56999999999999995 111.592 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -70.72 -44.47 66.81 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.2 1.364 . . . . 0.56999999999999995 111.147 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.89 -8.1 77.08 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.205 -0.934 . . . . 0.56999999999999995 113.734 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -65.92 -24.43 66.83 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.017 -1.284 . . . . 0.56999999999999995 111.047 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.39 -41.29 7.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.958 -0.544 . . . . 0.66000000000000003 110.789 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 164' ' ' TYR . 15.9 pt -117.25 139.21 25.71 Favored Pre-proline 0 N--CA 1.466 0.369 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 110.248 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.05 35.26 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.898 3.066 . . . . 0.56999999999999995 114.13 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -90.87 132.0 36.17 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.695 1.598 . . . . 0.56999999999999995 107.476 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -123.7 165.95 16.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.971 0.909 . . . . 0.65000000000000002 109.411 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.26 144.86 33.5 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.343 -0.984 . . . . 0.56999999999999995 108.343 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -143.05 165.33 27.67 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.861 0.865 . . . . 1.2 108.982 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -107.89 140.31 41.19 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.934 -1.135 . . . . 0.56999999999999995 107.934 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -90.53 161.26 2.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.354 0.597 . . . . 0.56999999999999995 110.112 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.31 -14.85 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 111.602 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -58.96 2.98 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.829 0.852 . . . . 0.56999999999999995 109.956 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.39 146.54 4.83 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.864 -1.295 . . . . 0.56999999999999995 109.864 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.3 m 59.55 144.13 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.164 2.186 . . . . 0.56999999999999995 112.709 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.2 170.32 15.97 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 120.857 -1.152 . . . . 0.56999999999999995 110.119 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -58.68 -48.96 79.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.121 -1.066 . . . . 0.66000000000000003 108.121 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.39 87.2 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.56999999999999995 108.335 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 ttm -84.59 111.87 19.92 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.014 -1.106 . . . . 0.56999999999999995 108.014 170.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.53 132.03 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 106.392 -1.707 . . . . 0.56999999999999995 106.392 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -156.4 154.41 25.51 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 112.094 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -129.37 153.08 48.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.366 1.083 . . . . 0.56999999999999995 110.672 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.95 178.14 7.31 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 109.915 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -132.25 66.95 1.54 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.677 -1.231 . . . . 1.2 107.677 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.34 -40.99 2.3 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.11 -0.828 . . . . 0.56999999999999995 112.759 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.36 164.84 12.92 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.261 1.53 . . . . 0.56999999999999995 110.933 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 -109.71 0.24 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.508 2.323 . . . . 0.65000000000000002 106.349 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.41 71.33 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.691 -1.764 . . . . 0.56999999999999995 108.691 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.62 -56.68 2.38 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.716 1.206 . . . . 0.66000000000000003 109.116 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.9 t 177.43 -39.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.795 2.038 . . . . 0.56999999999999995 108.983 -169.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.84 102.13 44.65 Favored Pre-proline 0 C--N 1.345 0.395 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 109.455 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.67 144.39 84.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.943 1.015 . . . . 0.56999999999999995 109.504 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -69.84 -168.02 0.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.777 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.41 -31.68 4.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.485 3.114 . . . . 0.66000000000000003 110.755 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.24 -152.24 17.35 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-N 119.97 1.259 . . . . 0.56999999999999995 111.816 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.18 61.94 4.12 Favored 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 125.168 3.912 . . . . 0.56999999999999995 114.776 -170.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.52 18.6 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.637 1.589 . . . . 0.56999999999999995 112.521 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 31.4 -130.34 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.322 2.649 . . . . 0.56999999999999995 114.225 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.7 m -61.43 119.54 8.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.651 1.981 . . . . 0.56999999999999995 110.535 171.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.16 -34.6 22.07 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 113.51 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.64 161.36 38.63 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.201 1.0 . . . . 0.56999999999999995 108.644 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -149.11 151.73 34.91 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 122.955 0.502 . . . . 0.65000000000000002 109.878 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.7 157.74 44.36 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.475 0.71 . . . . 0.56999999999999995 109.502 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -109.95 145.06 37.56 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.734 -0.839 . . . . 0.56999999999999995 108.734 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 151.11 92.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.56999999999999995 109.887 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 48.9 Cg_endo -67.94 157.68 60.71 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.338 2.025 . . . . 0.56999999999999995 111.887 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.34 21.43 0.02 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.226 1.251 . . . . 0.56999999999999995 116.226 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.309 37.0 p 64.8 71.57 0.46 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.28 2.232 . . . . 0.56999999999999995 113.743 -173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.39 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 120.783 -1.198 . . . . 0.56999999999999995 112.38 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.54 -6.05 37.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.733 1.613 . . . . 0.56999999999999995 111.211 164.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.93 129.75 13.34 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.115 -1.594 . . . . 0.56999999999999995 109.115 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.3 -27.01 20.04 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 126.012 1.768 . . . . 0.56999999999999995 112.758 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.07 147.26 53.8 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.795 -1.187 . . . . 0.66000000000000003 107.795 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.58 141.15 35.23 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.058 0.943 . . . . 0.56999999999999995 109.39 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 46.6 m170 -129.92 152.68 49.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 110.411 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -145.08 154.75 42.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.036 0.934 . . . . 0.56999999999999995 108.485 -172.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.45 98.94 11.22 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.781 -0.822 . . . . 0.66000000000000003 108.781 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -56.63 -25.77 54.09 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.651 1.981 . . . . 0.66000000000000003 112.299 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -56.25 -40.63 74.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.594 1.157 . . . . 0.66000000000000003 110.218 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.49 126.9 31.11 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.035 0.934 . . . . 0.66000000000000003 108.575 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.97 98.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.617 1.167 . . . . 1.2 111.818 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.59 145.82 28.64 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.932 -1.136 . . . . 0.56999999999999995 107.932 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -141.73 147.09 36.83 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.759 -1.2 . . . . 0.56999999999999995 107.759 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.77 17.08 5.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.506 1.122 . . . . 0.66000000000000003 112.365 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.39 -151.7 23.35 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.76 2.124 . . . . 0.56999999999999995 108.006 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.81 -173.52 0.19 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 110.934 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 p -109.23 179.52 4.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.228 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.94 -58.87 0.57 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.499 2.32 . . . . 0.56999999999999995 113.686 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 169.93 53.33 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.766 1.651 . . . . 0.56999999999999995 110.36 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.1 120.99 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.976 -0.749 . . . . 0.56999999999999995 108.976 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.05 112.73 3.11 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.822 0.701 . . . . 0.56999999999999995 109.595 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.18 -40.13 64.16 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.587 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.3 tp -66.94 -42.98 84.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.168 0.44 . . . . 0.56999999999999995 110.088 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.17 -45.12 95.94 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.97 66.29 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.393 0.677 . . . . 0.56999999999999995 111.443 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.8 -53.36 55.41 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.166 -0.921 . . . . 0.56999999999999995 109.433 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 84.8 m -57.57 -37.76 73.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.684 1.129 . . . . 0.56999999999999995 111.309 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -62.71 -54.36 40.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.935 0.789 . . . . 0.65000000000000002 110.461 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.81 -43.15 84.58 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.149 0.979 . . . . 0.66000000000000003 110.795 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.33 -30.36 71.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 0.56999999999999995 111.226 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.05 -51.6 57.35 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.581 -1.008 . . . . 0.56999999999999995 110.581 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -59.21 -46.08 89.41 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 118.243 -0.884 . . . . 0.65000000000000002 111.016 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.8 p -61.94 -32.39 72.8 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 123.969 0.793 . . . . 0.56999999999999995 112.364 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -46.38 89.82 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.561 0.744 . . . . 0.56999999999999995 110.54 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.91 36.66 0.02 OUTLIER Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.796 -1.002 . . . . 0.56999999999999995 114.372 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -124.99 163.59 21.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 109.613 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.97 -47.0 0.17 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.61 -1.661 . . . . 0.56999999999999995 111.788 -169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m170 167.38 -177.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.707 2.803 . . . . 0.65000000000000002 107.964 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.6 p -152.07 -174.44 4.87 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.394 1.078 . . . . 0.56999999999999995 108.478 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.7 m -137.04 67.61 1.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 108.759 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -133.92 143.64 48.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.528 -0.916 . . . . 0.66000000000000003 108.528 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.89 -14.91 21.29 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 112.981 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 32.83 4.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.379 1.472 . . . . 0.56999999999999995 109.462 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -92.59 143.18 26.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.459 1.904 . . . . 0.56999999999999995 109.875 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -67.46 -31.85 54.56 Favored 'Isoleucine or valine' 0 C--O 1.23 0.044 0 N-CA-C 109.401 -0.592 . . . . 0.56999999999999995 109.401 166.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -19.2 64.85 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 117.057 -1.449 . . . . 0.56999999999999995 112.236 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -49.9 109.81 1.4 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.266 1.394 . . . . 0.56999999999999995 110.524 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.1 38.91 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.215 2.61 . . . . 0.56999999999999995 113.331 -171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.2 m -150.28 132.58 15.5 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.666 1.586 . . . . 0.56999999999999995 107.032 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -81.7 101.57 10.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.68 -108.66 0.31 Allowed Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.572 -0.571 . . . . 0.56999999999999995 112.585 -171.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.02 -38.03 87.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.714 0.806 . . . . 0.56999999999999995 112.352 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.05 90.82 0.06 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 124.967 1.27 . . . . 0.56999999999999995 110.767 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -52.68 115.53 7.34 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.758 2.023 . . . . 0.66000000000000003 109.883 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.3 -23.58 5.06 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.44 2.093 . . . . 0.56999999999999995 113.269 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -69.43 -39.59 77.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.863 1.211 . . . . 0.56999999999999995 110.524 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -141.17 116.64 10.16 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.415 1.086 . . . . 0.56999999999999995 108.902 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 15.0 p90 -147.2 -49.36 0.18 Allowed 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 111.207 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER 30.61 52.98 0.14 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 127.321 2.248 . . . . 0.56999999999999995 113.113 -176.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.9 mp 63.32 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.006 1.722 . . . . 0.56999999999999995 110.935 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -70.65 -82.07 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.051 0.94 . . . . 0.56999999999999995 112.974 -165.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -144.63 -48.51 0.26 Allowed 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 108.566 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -47.3 51.93 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.473 1.909 . . . . 0.66000000000000003 112.913 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.61 -54.42 47.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.756 0.822 . . . . 0.66000000000000003 110.827 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.15 -45.73 92.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.329 1.052 . . . . 0.56999999999999995 108.921 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -63.71 -41.91 98.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.812 1.245 . . . . 0.56999999999999995 109.368 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.03 -49.03 69.93 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.743 -0.943 . . . . 0.56999999999999995 110.743 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.65 -47.19 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 117.774 0.787 . . . . 0.56999999999999995 110.995 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -66.79 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.904 -0.569 . . . . 0.56999999999999995 112.063 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.45 43.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.292 0.951 . . . . 0.56999999999999995 110.612 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mp -78.45 -41.94 31.34 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.959 0.8 . . . . 0.56999999999999995 112.554 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.412 ' CD1' HG21 ' A' ' 46' ' ' ILE . 70.1 m-85 -131.13 -29.13 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.202 0.815 . . . . 0.56999999999999995 113.202 -169.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.24 172.35 34.42 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.618 -1.393 . . . . 0.56999999999999995 109.618 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -72.58 -49.49 31.94 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.096 -0.649 . . . . 0.56999999999999995 110.898 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 11.3 ptt-85 177.68 160.63 0.5 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.773 2.029 . . . . 1.2 107.525 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 t -139.34 -52.53 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.013 0.525 . . . . 0.56999999999999995 110.331 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.17 142.69 14.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.606 -1.627 . . . . 0.56999999999999995 106.606 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.4 80.75 1.76 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.328 -0.99 . . . . 0.56999999999999995 108.328 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -157.07 152.75 26.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.8 -0.815 . . . . 1.2 108.8 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.5 174.41 14.71 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.917 1.687 . . . . 0.56999999999999995 108.635 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.132 0 C-N-CA 124.905 1.282 . . . . 0.5 . 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 117.511 -1.233 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -125.88 57.37 1.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.443 1.497 . . . . 0.56999999999999995 108.221 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.55 129.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.909 2.084 . . . . 0.56999999999999995 110.037 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 55.27 96.84 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.624 1.57 . . . . 0.56999999999999995 113.069 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 89.2 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.178 2.585 . . . . 0.56999999999999995 110.594 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -113.85 175.03 5.64 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.967 1.307 . . . . 0.56999999999999995 109.677 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.27 116.76 66.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 106.795 -1.558 . . . . 0.56999999999999995 106.795 168.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB2' ' HA ' ' A' ' 163' ' ' LEU . 35.7 Cg_endo -74.24 158.04 45.41 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.61 1.54 . . . . 0.56999999999999995 110.171 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.58 110.45 0.05 OUTLIER 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.529 1.532 . . . . 0.56999999999999995 108.25 -177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 53.6 m95 -48.38 150.81 1.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.441 0.696 . . . . 0.56999999999999995 110.577 175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.6 p -60.95 -24.23 65.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.56999999999999995 111.807 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.0 t -99.88 152.29 20.32 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.752 1.621 . . . . 0.56999999999999995 109.79 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -8.48 55.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 112.715 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.89 119.04 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.833 -2.284 . . . . 0.56999999999999995 104.833 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.87 142.41 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.347 -1.353 . . . . 0.56999999999999995 107.347 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -109.15 150.17 28.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.399 -0.813 . . . . 0.56999999999999995 110.432 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -127.0 148.71 50.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.665 -0.698 . . . . 0.56999999999999995 111.14 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.73 114.43 7.24 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.521 -0.918 . . . . 1.2 108.521 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.81 89.12 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 106.132 -1.803 . . . . 0.56999999999999995 106.132 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.08 -30.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 113.486 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.11 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.245 -2.502 . . . . 0.56999999999999995 104.245 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' HIS . 88.4 m-85 -135.47 -178.88 5.32 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.547 1.139 . . . . 0.56999999999999995 108.367 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 t -97.63 -162.69 0.98 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.01 0.924 . . . . 0.56999999999999995 109.817 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -136.54 -31.52 0.87 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.053 1.131 . . . . 1.2 114.053 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.15 -38.8 65.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.826 1.25 . . . . 0.66000000000000003 109.957 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.64 153.28 81.05 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.267 2.227 . . . . 0.56999999999999995 109.85 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.85 158.24 42.9 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.803 2.335 . . . . 0.56999999999999995 113.475 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' HB2' ' CE1' ' A' ' 22' ' ' TYR . 12.8 p80 -62.38 -36.72 83.17 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.748 1.219 . . . . 0.65000000000000002 113.193 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -65.79 -37.17 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.081 0.552 . . . . 0.56999999999999995 110.52 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -63.27 -47.67 81.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 116.894 -1.527 . . . . 0.56999999999999995 108.101 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -53.24 -50.19 48.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 CA-C-N 120.41 1.459 . . . . 0.56999999999999995 110.762 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.36 -46.07 91.73 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.939 1.245 . . . . 0.66000000000000003 111.989 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -45.43 94.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.728 -0.607 . . . . 1.2 111.55 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.88 -43.11 94.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.408 -1.282 . . . . 0.56999999999999995 109.068 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -45.17 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 120.321 1.419 . . . . 0.56999999999999995 109.918 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.1 91.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.063 0.847 . . . . 0.56999999999999995 110.379 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -70.33 -37.08 74.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.972 0.909 . . . . 0.56999999999999995 112.389 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -48.4 74.49 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 110.908 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -67.57 -30.05 69.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.159 -0.924 . . . . 0.56999999999999995 110.825 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.62 -36.94 77.32 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.342 0.974 . . . . 0.56999999999999995 110.165 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.66 -38.22 88.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.406 -1.283 . . . . 0.56999999999999995 111.69 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -73.76 -41.27 62.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.851 1.205 . . . . 0.56999999999999995 111.677 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -5.46 55.66 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.915 -1.116 . . . . 0.56999999999999995 112.362 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -19.56 64.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 118.552 1.176 . . . . 0.56999999999999995 111.319 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -112.21 -35.55 5.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.313 1.045 . . . . 0.66000000000000003 112.023 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.414 HG22 ' CD1' ' A' ' 164' ' ' TYR . 16.3 pt -106.2 129.55 24.37 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 119.616 1.098 . . . . 0.56999999999999995 110.627 177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.47 40.43 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.956 3.104 . . . . 0.56999999999999995 112.332 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.47 143.78 28.35 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 107.786 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -125.83 162.41 25.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.572 -0.899 . . . . 0.65000000000000002 108.572 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 160.05 40.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.631 -0.877 . . . . 0.56999999999999995 108.631 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -143.65 174.96 10.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -123.48 162.08 23.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.767 -1.197 . . . . 0.56999999999999995 107.767 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.54 175.48 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.153 1.781 . . . . 0.56999999999999995 108.494 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.3 -29.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.212 1.005 . . . . 0.56999999999999995 111.901 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -63.39 -62.08 1.92 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.094 1.358 . . . . 0.56999999999999995 112.512 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.39 38.14 0.15 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.354 0.502 . . . . 0.56999999999999995 113.218 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.6 t -166.47 149.06 6.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.355 1.462 . . . . 0.56999999999999995 107.316 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.19 -178.62 3.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.878 1.271 . . . . 0.56999999999999995 109.983 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.31 -35.33 75.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.297 0.639 . . . . 0.66000000000000003 109.915 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.27 69.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.595 1.958 . . . . 0.56999999999999995 107.748 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.12 118.9 16.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.099 -1.626 . . . . 0.56999999999999995 107.205 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.55 125.93 65.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.564 -2.013 . . . . 0.56999999999999995 105.564 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.63 165.69 26.39 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 110.702 -0.959 . . . . 0.56999999999999995 110.702 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.4 m-85 -133.2 148.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.042 -1.466 . . . . 0.56999999999999995 107.042 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.86 -171.65 3.49 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.494 1.517 . . . . 0.56999999999999995 108.767 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 -122.59 179.92 4.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 1.2 108.953 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -39.84 106.41 0.06 OUTLIER Glycine 0 C--N 1.342 0.872 0 C-N-CA 126.084 1.802 . . . . 0.56999999999999995 110.615 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 56.05 137.06 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.429 2.692 . . . . 0.56999999999999995 115.169 -166.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 11.8 p-80 -154.21 159.08 41.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.003 0.921 . . . . 0.65000000000000002 109.99 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.62 55.04 1.99 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.706 1.146 . . . . 0.56999999999999995 111.321 -170.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -108.58 -50.16 3.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.515 0.726 . . . . 0.66000000000000003 110.511 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.13 -35.47 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.862 2.065 . . . . 0.56999999999999995 110.874 -166.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.2 100.43 7.07 Favored Pre-proline 0 C--N 1.347 0.492 0 CA-C-N 119.975 1.262 . . . . 0.56999999999999995 109.958 -170.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.97 120.27 7.47 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.076 1.184 . . . . 0.56999999999999995 110.591 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 12.5 m-85 -63.44 164.15 9.72 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 125.195 1.398 . . . . 0.56999999999999995 110.594 167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.28 -37.29 11.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.891 2.476 . . . . 0.66000000000000003 112.017 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 115.41 -147.01 18.91 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 119.444 1.02 . . . . 0.56999999999999995 112.018 -170.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.96 72.17 4.01 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.857 3.704 . . . . 0.56999999999999995 115.04 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.87 37.15 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.49 -1.381 . . . . 0.56999999999999995 111.815 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 38.6 -129.48 0.23 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.56999999999999995 114.016 167.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -64.7 118.63 9.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 111.154 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.1 mp -93.71 -33.57 13.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 112.795 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.83 29.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.928 1.291 . . . . 0.56999999999999995 107.625 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -142.6 159.65 41.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.649 0.779 . . . . 0.65000000000000002 108.938 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.71 167.12 30.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.263 0.625 . . . . 0.56999999999999995 109.42 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -120.07 152.75 37.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.742 -0.663 . . . . 0.56999999999999995 109.512 -171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.33 153.63 85.62 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.098 -0.953 . . . . 0.56999999999999995 110.011 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 20.2 Cg_endo -65.33 162.98 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.889 1.726 . . . . 0.56999999999999995 111.38 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.04 -100.02 0.15 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 109.168 -1.573 . . . . 0.56999999999999995 109.168 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -157.24 120.14 3.99 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.262 -1.385 . . . . 0.56999999999999995 107.262 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.96 -121.49 6.69 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.046 -1.419 . . . . 0.56999999999999995 110.275 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.45 -27.9 58.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.637 1.175 . . . . 0.56999999999999995 111.546 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.92 144.26 7.68 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.754 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.21 -26.72 2.89 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.48 1.514 . . . . 0.56999999999999995 113.917 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.48 150.66 48.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.461 1.131 . . . . 0.66000000000000003 108.936 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.1 146.22 48.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.611 1.196 . . . . 0.56999999999999995 109.055 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.58 144.78 37.94 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.409 -1.269 . . . . 0.65000000000000002 108.795 -169.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 50.9 m-85 -139.02 149.63 44.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.288 -1.375 . . . . 0.56999999999999995 107.288 -166.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -94.69 99.05 11.23 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.091 -1.077 . . . . 0.66000000000000003 108.091 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.24 -24.37 41.96 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.718 2.007 . . . . 0.66000000000000003 111.785 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -59.21 -41.92 89.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.179 -0.304 . . . . 0.66000000000000003 110.179 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.34 134.42 47.89 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.746 -0.835 . . . . 0.66000000000000003 108.746 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -61.19 133.3 55.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.827 -0.434 . . . . 1.2 109.827 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -117.95 140.72 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.102 -1.444 . . . . 0.56999999999999995 107.102 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -140.12 148.75 42.14 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.988 0.813 . . . . 0.56999999999999995 109.431 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.79 -40.0 78.84 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.332 1.053 . . . . 0.66000000000000003 111.338 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 155.69 58.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.394 0.997 . . . . 0.56999999999999995 110.926 -170.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -153.1 170.81 19.56 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.926 0.863 . . . . 0.56999999999999995 110.093 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -70.15 77.34 0.51 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.56999999999999995 111.41 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -48.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.585 1.154 . . . . 0.56999999999999995 112.995 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.53 -152.0 6.69 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.466 -1.454 . . . . 0.56999999999999995 109.466 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.52 131.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.234 -0.654 . . . . 0.56999999999999995 109.234 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -57.37 104.1 0.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.56999999999999995 109.439 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.09 -41.69 79.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 109.496 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.48 -46.17 89.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.09 -41.41 99.4 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.901 -0.777 . . . . 0.56999999999999995 108.901 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.58 -53.08 60.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.294 0.638 . . . . 0.56999999999999995 111.524 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.02 71.08 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.597 -0.716 . . . . 0.56999999999999995 109.478 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.6 m -58.06 -40.05 80.01 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.872 0.76 . . . . 0.56999999999999995 111.664 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -60.17 -54.47 45.46 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.665 0.666 . . . . 0.65000000000000002 109.766 175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.99 -45.21 82.46 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.555 -0.715 . . . . 0.66000000000000003 111.671 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.1 -32.93 74.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.447 1.099 . . . . 0.56999999999999995 111.341 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.4 -43.77 52.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.276 -0.73 . . . . 0.56999999999999995 111.276 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -75.94 -35.62 59.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.698 -0.667 . . . . 0.65000000000000002 112.26 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -37.49 70.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.763 0.825 . . . . 0.56999999999999995 111.189 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 mm? -63.02 -41.15 99.48 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.934 -0.479 . . . . 0.56999999999999995 111.77 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 165.7 45.12 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.681 -1.066 . . . . 0.56999999999999995 114.431 -172.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.5 mmt 55.09 -168.28 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.587 1.193 . . . . 0.56999999999999995 110.793 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.65 33.2 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.422 -0.799 . . . . 0.56999999999999995 113.936 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 170.28 2.47 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.304 1.052 . . . . 0.65000000000000002 113.686 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 p -151.35 -159.17 0.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 110.935 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.2 t -168.93 80.14 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 104.03 -2.582 . . . . 0.56999999999999995 104.03 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.67 147.56 55.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 108.315 -0.994 . . . . 0.66000000000000003 108.315 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.21 -20.19 33.05 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.112 2.541 . . . . 0.56999999999999995 112.951 -170.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -125.3 34.94 4.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.88 1.272 . . . . 0.56999999999999995 108.614 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.02 30.34 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.563 0.745 . . . . 0.56999999999999995 109.542 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.61 -31.22 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.876 -0.416 . . . . 0.56999999999999995 109.876 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.7 mmt -69.25 -4.61 18.5 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 112.402 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 31.1 t80 -60.94 145.14 89.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.781 1.173 . . . . 0.56999999999999995 109.956 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 73.0 Cg_endo -79.82 162.78 23.84 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.459 2.106 . . . . 0.56999999999999995 111.556 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.9 m 53.64 58.93 4.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.001 0.905 . . . . 0.56999999999999995 109.72 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 71.51 -177.86 0.21 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 110.173 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.31 137.0 11.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 107.493 -2.243 . . . . 0.56999999999999995 107.493 166.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -39.81 94.11 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.447 0.624 . . . . 0.56999999999999995 110.521 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.76 135.8 29.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.269 1.414 . . . . 0.56999999999999995 110.811 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -41.12 111.91 0.88 Allowed Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 126.764 2.026 . . . . 0.66000000000000003 111.819 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.77 -19.39 18.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.073 1.849 . . . . 0.56999999999999995 112.226 -175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -46.67 25.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.995 -1.113 . . . . 0.56999999999999995 107.995 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -91.99 71.99 5.56 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 111.046 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -33.48 -72.42 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.74 2.016 . . . . 0.56999999999999995 116.003 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 38.9 72.74 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.214 2.206 . . . . 0.56999999999999995 112.543 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.564 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.9 mp -35.72 114.49 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.261 2.225 . . . . 0.56999999999999995 110.091 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 p -82.93 -83.15 0.14 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.096 0.558 . . . . 0.56999999999999995 110.711 -163.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -140.04 -44.52 0.42 Allowed 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 117.425 -1.274 . . . . 0.56999999999999995 111.711 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -52.24 -43.77 64.5 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 111.654 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.11 -52.8 62.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.63 0.772 . . . . 0.66000000000000003 110.198 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.98 -39.75 81.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 C-N-CA 123.359 0.664 . . . . 0.56999999999999995 109.504 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.68 97.13 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.132 1.373 . . . . 0.56999999999999995 109.071 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.18 -56.34 22.67 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.883 -1.287 . . . . 0.56999999999999995 109.883 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -50.34 -56.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.979 1.712 . . . . 0.56999999999999995 111.106 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -72.31 -11.5 60.73 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.196 -0.94 . . . . 0.56999999999999995 112.035 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 -15.53 27.84 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 0.56999999999999995 110.967 167.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -82.92 -52.86 6.31 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.929 1.692 . . . . 0.56999999999999995 109.692 -178.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.414 ' CD1' HG22 ' A' ' 46' ' ' ILE . 3.8 p90 -113.35 -37.96 4.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.31 0.644 . . . . 0.56999999999999995 110.999 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 146.09 50.1 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.047 -1.221 . . . . 0.56999999999999995 110.047 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -81.0 -49.29 11.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 120.234 -0.587 . . . . 0.56999999999999995 110.538 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 120.8 7.19 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 124.365 1.041 . . . . 1.2 108.727 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.0 p -105.13 125.59 51.14 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.916 -1.142 . . . . 0.56999999999999995 107.916 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -151.02 102.92 3.0 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.493 1.917 . . . . 0.56999999999999995 106.584 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -162.45 155.87 20.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.053 -1.091 . . . . 0.56999999999999995 108.053 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.06 125.3 4.5 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 105.205 -2.146 . . . . 1.2 105.205 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -161.4 147.92 14.43 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.826 1.25 . . . . 0.56999999999999995 109.32 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.194 0 C-N-CA 126.792 2.037 . . . . 0.5 . -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.485 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 118.858 -0.591 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -69.67 87.29 0.49 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.443 1.019 . . . . 0.56999999999999995 111.116 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt 60.63 -174.15 0.12 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.053 1.341 . . . . 0.56999999999999995 110.582 -171.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 51.22 84.93 0.2 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.846 1.659 . . . . 0.56999999999999995 113.129 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.01 85.1 0.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.466 2.777 . . . . 0.56999999999999995 110.896 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -135.02 133.2 39.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.841 -2.651 . . . . 0.56999999999999995 103.841 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.05 103.49 0.36 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.532 1.133 . . . . 0.56999999999999995 109.942 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.58 157.41 16.44 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.813 1.675 . . . . 0.56999999999999995 109.402 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttt 86.79 138.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.449 2.7 . . . . 0.56999999999999995 108.98 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 80.9 m95 -75.96 167.71 21.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.638 0.732 . . . . 0.56999999999999995 110.689 175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 p -73.66 -13.97 61.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.479 1.112 . . . . 0.56999999999999995 112.507 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -134.34 150.58 50.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.975 1.31 . . . . 0.56999999999999995 109.284 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.91 -3.12 37.06 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.557 1.543 . . . . 0.56999999999999995 112.804 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.65 128.1 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.458 -1.682 . . . . 0.56999999999999995 106.458 172.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.47 139.16 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.784 -1.932 . . . . 0.56999999999999995 105.784 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -115.08 133.76 55.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -114.92 164.07 14.66 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.684 -0.689 . . . . 0.56999999999999995 110.223 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.88 165.66 35.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.979 169.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.0 mt -126.61 78.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 104.272 -2.492 . . . . 0.56999999999999995 104.272 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -65.57 -30.94 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 112.134 -175.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -133.09 165.17 25.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.086 -2.19 . . . . 0.56999999999999995 105.086 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.72 158.19 43.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.068 1.347 . . . . 0.56999999999999995 109.423 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 t -77.41 -15.08 59.54 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.255 1.206 . . . . 0.56999999999999995 114.255 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 66.63 -19.88 0.11 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.573 1.949 . . . . 1.2 115.03 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -66.88 -31.49 72.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.664 1.586 . . . . 0.66000000000000003 111.951 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 148.05 62.24 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 125.962 1.705 . . . . 0.56999999999999995 108.201 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.34 161.06 43.63 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.898 2.398 . . . . 0.56999999999999995 112.128 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.02 -35.95 78.24 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.907 0.883 . . . . 0.65000000000000002 111.831 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.44 -35.78 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.149 0.58 . . . . 0.56999999999999995 110.194 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.7 m -78.97 -37.75 38.64 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 117.882 -1.056 . . . . 0.56999999999999995 110.045 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.91 -44.32 98.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.202 1.365 . . . . 0.56999999999999995 109.37 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -69.66 -42.39 74.27 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.78 0.718 . . . . 0.66000000000000003 110.555 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -42.9 84.04 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 120.846 -1.159 . . . . 1.2 113.259 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.99 -40.82 97.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.56999999999999995 108.338 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.11 -40.6 89.65 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-N 119.25 0.932 . . . . 0.56999999999999995 110.604 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -56.89 -52.71 64.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.152 0.887 . . . . 0.56999999999999995 109.119 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -69.76 -36.31 75.67 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.696 -1.145 . . . . 0.56999999999999995 112.002 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.16 91.32 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.522 1.51 . . . . 0.56999999999999995 111.917 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.35 -36.03 76.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.498 -0.763 . . . . 0.56999999999999995 109.913 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -61.85 -39.1 90.66 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 109.815 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.24 -38.06 89.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.14 1.337 . . . . 0.56999999999999995 112.252 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' CE3' HD11 ' A' ' 160' ' ' ILE . 18.3 m95 -66.37 -54.76 20.71 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.404 1.002 . . . . 0.56999999999999995 109.989 170.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.63 -8.91 49.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.054 1.312 . . . . 0.56999999999999995 114.349 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -68.13 -18.3 64.59 Favored 'General case' 0 C--O 1.226 -0.134 0 O-C-N 120.928 -1.337 . . . . 0.56999999999999995 111.454 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.12 -12.53 11.91 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.59 0.632 . . . . 0.66000000000000003 111.052 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.62 127.54 19.6 Favored Pre-proline 0 C--N 1.347 0.483 0 C-N-CA 124.582 1.153 . . . . 0.56999999999999995 108.763 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.27 41.18 0.65 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.141 3.228 . . . . 0.56999999999999995 112.804 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 tt -92.75 146.62 23.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.685 1.994 . . . . 0.56999999999999995 108.598 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -124.48 160.95 27.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.438 -0.949 . . . . 0.65000000000000002 108.438 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 161.47 37.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.604 -0.517 . . . . 0.56999999999999995 109.604 -171.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -144.52 177.4 8.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.2 1.4 . . . . 1.2 109.335 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.52 136.83 41.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.232 -1.396 . . . . 0.56999999999999995 107.232 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.98 166.31 2.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.997 0.427 . . . . 0.56999999999999995 110.044 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.89 25.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 111.515 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.78 -55.0 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 112.262 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.91 -153.1 5.79 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.825 -1.31 . . . . 0.56999999999999995 109.825 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -68.94 175.28 3.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.316 0.579 . . . . 0.56999999999999995 110.339 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.79 -178.29 5.19 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.528 1.531 . . . . 0.56999999999999995 109.972 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.96 -32.85 74.37 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 117.554 -1.212 . . . . 0.66000000000000003 110.834 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.31 73.58 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.893 1.277 . . . . 0.56999999999999995 107.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.39 155.35 30.05 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.175 -1.578 . . . . 0.56999999999999995 110.93 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mt -130.31 127.63 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 103.945 -2.613 . . . . 0.56999999999999995 103.945 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.17 162.4 28.38 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.995 -0.842 . . . . 0.56999999999999995 110.995 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -134.88 140.04 45.48 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.823 -1.917 . . . . 0.56999999999999995 105.823 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.67 -178.0 5.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.444 1.498 . . . . 0.56999999999999995 108.698 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 52.18 2.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.926 0.891 . . . . 1.2 110.295 -169.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.66 -141.0 16.64 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.768 -1.333 . . . . 0.56999999999999995 109.768 -174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 131.43 8.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.367 1.067 . . . . 0.56999999999999995 110.843 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.45 156.72 40.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 125.168 1.387 . . . . 0.65000000000000002 109.493 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 93.4 0.38 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 109.237 -1.545 . . . . 0.56999999999999995 109.237 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -149.63 -85.05 0.09 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.497 1.519 . . . . 0.66000000000000003 108.034 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.22 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.392 1.477 . . . . 0.56999999999999995 109.259 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.19 139.49 31.79 Favored Pre-proline 0 C--N 1.342 0.252 0 C-N-CA 124.07 0.948 . . . . 0.56999999999999995 108.755 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -68.36 143.37 57.88 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.021 1.147 . . . . 0.56999999999999995 109.264 167.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -73.84 -177.1 2.68 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.87 1.319 . . . . 0.56999999999999995 109.759 163.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -108.88 -38.03 5.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.211 3.405 . . . . 0.66000000000000003 111.341 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.4 -151.02 19.66 Favored Glycine 0 CA--C 1.54 1.603 0 CA-C-O 117.706 -1.608 . . . . 0.56999999999999995 111.198 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.92 75.69 4.01 Favored 'Trans proline' 0 CA--C 1.547 1.17 1 C-N-CA 125.549 4.166 . . . . 0.56999999999999995 114.653 -168.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.66 172.32 25.63 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.561 2.505 . . . . 0.56999999999999995 108.971 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.01 -143.56 0.65 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.715 1.606 . . . . 0.56999999999999995 112.735 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -41.75 130.29 3.3 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 128.055 2.542 . . . . 0.56999999999999995 110.856 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.77 -28.37 13.53 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.446 -1.409 . . . . 0.56999999999999995 112.567 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.72 161.27 37.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 108.851 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.03 151.11 36.39 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.545 0.688 . . . . 0.65000000000000002 110.127 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.47 172.59 12.48 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 109.189 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -124.18 139.26 54.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.93 159.11 11.06 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 123.963 0.905 . . . . 0.56999999999999995 110.043 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 48.6 Cg_endo -66.99 158.64 55.77 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.552 1.501 . . . . 0.56999999999999995 110.691 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.55 -138.49 5.15 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.573 -1.011 . . . . 0.56999999999999995 110.573 -172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -138.58 96.68 3.2 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.444 -1.317 . . . . 0.56999999999999995 107.444 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 125.33 -118.54 3.28 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 108.701 -1.759 . . . . 0.56999999999999995 108.701 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -27.56 65.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.888 2.075 . . . . 0.56999999999999995 112.473 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.66 145.09 10.64 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.208 -0.933 . . . . 0.56999999999999995 111.433 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.34 -27.44 4.62 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 125.397 1.475 . . . . 0.56999999999999995 114.117 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -72.61 156.06 39.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.97 -0.752 . . . . 0.66000000000000003 108.97 -168.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.25 145.22 38.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.899 0.857 . . . . 0.56999999999999995 110.061 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.11 146.65 39.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.396 1.078 . . . . 0.65000000000000002 109.265 -171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.469 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 38.3 m-85 -139.55 146.91 40.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.833 -0.803 . . . . 0.56999999999999995 108.833 -167.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -83.95 99.71 10.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.23 -0.656 . . . . 0.66000000000000003 109.23 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -58.91 -24.6 62.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.292 1.437 . . . . 0.66000000000000003 111.337 171.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.29 -43.62 98.57 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.515 1.526 . . . . 0.66000000000000003 110.309 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.42 134.23 49.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.223 -1.769 . . . . 0.66000000000000003 106.223 174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 149.55 41.39 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.226 -1.546 . . . . 1.2 109.434 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -129.98 168.22 17.02 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.273 1.029 . . . . 0.56999999999999995 108.294 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -161.87 141.68 10.1 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.303 -0.999 . . . . 0.56999999999999995 108.303 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.02 38.63 0.72 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.205 1.002 . . . . 0.66000000000000003 110.683 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.02 60.32 2.06 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.985 1.279 . . . . 0.56999999999999995 111.029 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 91.42 3.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.012 0.925 . . . . 0.56999999999999995 110.236 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m 64.72 -71.53 0.07 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 127.835 2.454 . . . . 0.56999999999999995 113.781 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.98 166.54 26.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.56999999999999995 107.998 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.37 -156.71 21.02 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.093 -1.603 . . . . 0.56999999999999995 109.093 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.06 112.15 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.283 -1.377 . . . . 0.56999999999999995 107.283 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -57.39 101.94 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.35 0.66 . . . . 0.56999999999999995 111.501 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -58.59 -38.44 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 109.439 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -43.87 97.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.793 0.724 . . . . 0.56999999999999995 110.667 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.17 -48.39 81.8 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 109.528 171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.27 76.96 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.545 0.338 . . . . 0.56999999999999995 111.303 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.54 63.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.338 -0.839 . . . . 0.56999999999999995 109.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.8 m -58.2 -37.81 75.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.282 0.946 . . . . 0.56999999999999995 111.577 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.55 -57.14 13.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.652 1.181 . . . . 0.65000000000000002 109.648 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.52 -45.43 90.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.331 0.653 . . . . 0.66000000000000003 110.487 -175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.36 -28.67 69.39 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.621 1.169 . . . . 0.56999999999999995 111.843 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.45 -45.71 95.72 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.638 0.654 . . . . 0.56999999999999995 111.897 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -68.58 -37.32 79.75 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-O 118.292 -0.861 . . . . 0.65000000000000002 110.93 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.6 m -59.85 -31.64 69.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.058 0.844 . . . . 0.56999999999999995 112.361 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -34.56 66.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.515 1.052 . . . . 0.56999999999999995 111.802 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 174.25 -56.68 0.13 Allowed Glycine 0 C--N 1.336 0.548 0 CA-C-O 119.198 -0.779 . . . . 0.56999999999999995 111.45 -175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.99 178.04 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.855 2.062 . . . . 0.56999999999999995 108.695 -169.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.12 22.68 0.02 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.028 -0.873 . . . . 0.56999999999999995 112.812 172.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 161.05 30.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.871 1.335 . . . . 0.65000000000000002 111.716 -174.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.44 -170.54 1.47 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.336 1.854 . . . . 0.56999999999999995 108.777 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.71 48.56 1.81 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.442 1.097 . . . . 0.56999999999999995 110.79 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.5 t70 -98.35 144.45 28.11 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 118.004 -0.998 . . . . 0.66000000000000003 110.671 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.95 -20.58 68.21 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.08 1.853 . . . . 0.56999999999999995 113.564 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -128.57 25.31 5.73 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.115 1.366 . . . . 0.56999999999999995 110.776 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -62.97 134.09 55.64 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.138 0.97 . . . . 0.56999999999999995 111.093 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.21 -24.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 111.429 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -106.6 22.81 15.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.14 0.976 . . . . 0.56999999999999995 111.38 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 3.6 t80 -60.67 131.28 90.98 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.488 1.495 . . . . 0.56999999999999995 110.437 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 49.5 Cg_endo -79.58 -38.95 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.405 1.403 . . . . 0.56999999999999995 112.625 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 139' ' ' TYR . 87.2 m -80.12 67.78 6.05 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.675 -1.266 . . . . 0.56999999999999995 110.03 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -50.03 136.99 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.983 1.313 . . . . 0.56999999999999995 112.054 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.71 107.74 2.99 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.024 0.821 . . . . 0.56999999999999995 111.297 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -165.99 -56.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.608 1.563 . . . . 0.56999999999999995 108.575 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -117.14 -100.84 2.14 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 108.852 -1.699 . . . . 0.56999999999999995 108.852 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -156.52 111.89 2.03 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.023 0.929 . . . . 0.66000000000000003 109.463 -170.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.17 -9.14 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.4 2.733 . . . . 0.56999999999999995 113.039 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.74 -18.37 61.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.138 1.335 . . . . 0.56999999999999995 111.039 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -116.63 74.13 0.89 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.618 1.967 . . . . 0.56999999999999995 109.494 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -128.8 122.66 30.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.492 1.517 . . . . 0.56999999999999995 107.914 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 69.11 1.06 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.625 -1.25 . . . . 0.56999999999999995 107.625 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 mp 52.59 79.77 0.11 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 0.56999999999999995 110.798 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.72 -78.36 0.05 OUTLIER 'General case' 0 C--N 1.342 0.261 0 N-CA-C 114.27 1.211 . . . . 0.56999999999999995 114.27 -166.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -148.79 -49.23 0.15 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.861 1.264 . . . . 0.56999999999999995 108.214 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -45.69 -42.64 11.92 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 128.294 2.638 . . . . 0.66000000000000003 112.14 166.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -66.86 -58.36 5.17 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.8 0.84 . . . . 0.66000000000000003 111.218 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.48 -37.04 67.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 119.014 -0.517 . . . . 0.56999999999999995 109.694 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -59.82 -41.55 91.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.679 0.792 . . . . 0.56999999999999995 108.9 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.26 -52.91 24.47 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.305 -1.118 . . . . 0.56999999999999995 110.305 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.43 HD11 ' CE3' ' A' ' 42' ' ' TRP . 24.7 mm -56.2 -51.03 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.152 0.981 . . . . 0.56999999999999995 111.641 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.63 -28.88 68.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.393 0.542 . . . . 0.56999999999999995 110.783 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 162' ' ' LYS . 0.9 OUTLIER -75.67 -23.32 56.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 119.01 -0.519 . . . . 0.56999999999999995 111.603 175.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.1 mt -85.92 -48.46 8.7 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.56999999999999995 110.901 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -139.9 19.26 2.48 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.729 0.64 . . . . 0.56999999999999995 112.729 -168.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.61 -142.69 12.48 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.832 1.206 . . . . 0.56999999999999995 111.327 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -142.31 -30.54 0.55 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.144 1.164 . . . . 0.56999999999999995 114.144 -161.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.49 164.81 35.01 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.418 1.887 . . . . 1.2 107.396 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 94.2 p -146.13 134.86 22.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.32 -0.622 . . . . 0.56999999999999995 109.32 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -157.08 89.14 1.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 105.857 -1.905 . . . . 0.56999999999999995 105.857 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 42.4 t -165.18 137.59 4.36 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.153 1.381 . . . . 0.56999999999999995 107.304 171.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.52 173.03 8.99 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.144 1.778 . . . . 1.2 107.372 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.71 173.16 12.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.106 1.362 . . . . 0.56999999999999995 108.715 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.6 tptt . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 125.582 1.553 . . . . 0.5 . -171.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.335 0 CA-C-O 118.716 -0.659 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -160.31 67.29 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.623 1.169 . . . . 0.56999999999999995 108.447 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.8 77.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.002 1.721 . . . . 0.56999999999999995 113.828 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 76.53 81.38 0.12 Allowed Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 126.791 2.036 . . . . 0.56999999999999995 110.765 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.46 145.85 54.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.779 1.652 . . . . 0.56999999999999995 111.194 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.22 167.68 29.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.975 1.31 . . . . 0.56999999999999995 107.717 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.19 103.77 0.39 Allowed Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 124.563 1.165 . . . . 0.56999999999999995 108.893 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -78.66 138.3 15.06 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 108.443 -1.406 . . . . 0.56999999999999995 108.443 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.19 113.85 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 108.672 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 40.0 m95 -46.88 147.42 1.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.537 0.735 . . . . 0.56999999999999995 109.988 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 p -62.29 -27.91 69.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.572 0.749 . . . . 0.56999999999999995 111.701 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.2 t -82.87 149.09 27.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.013 1.325 . . . . 0.56999999999999995 110.963 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -74.55 -10.59 59.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.331 1.052 . . . . 0.56999999999999995 112.868 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.45 144.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 124.71 1.204 . . . . 0.56999999999999995 107.946 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.1 t -130.98 145.53 35.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.278 -1.378 . . . . 0.56999999999999995 107.278 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -94.39 142.49 27.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.294 -0.632 . . . . 0.56999999999999995 109.294 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -123.07 147.92 46.19 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.516 -0.74 . . . . 0.56999999999999995 110.235 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 100.71 3.36 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.861 0.839 . . . . 1.2 109.586 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.18 101.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 105.122 -2.177 . . . . 0.56999999999999995 105.122 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -48.89 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.458 1.503 . . . . 0.56999999999999995 111.174 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.9 p -130.59 174.45 9.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.4 -1.704 . . . . 0.56999999999999995 106.4 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -140.34 167.56 21.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.015 -1.476 . . . . 0.56999999999999995 107.015 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -65.63 178.6 0.97 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.891 0.476 . . . . 0.56999999999999995 111.03 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -34.45 2.93 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.393 1.077 . . . . 1.2 112.508 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -39.85 82.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.305 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.3 mt -113.66 148.91 40.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.759 1.223 . . . . 0.56999999999999995 108.646 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.21 150.82 33.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.103 1.868 . . . . 0.56999999999999995 112.423 -177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -59.87 -40.14 87.64 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.698 1.199 . . . . 0.65000000000000002 111.932 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.8 tt -62.95 -36.44 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.191 0.596 . . . . 0.56999999999999995 111.048 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 m -69.05 -42.4 76.34 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.081 -1.438 . . . . 0.56999999999999995 108.984 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -55.74 -47.59 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 121.154 1.797 . . . . 0.56999999999999995 110.095 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.07 -48.73 80.5 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.876 0.87 . . . . 0.66000000000000003 110.548 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.93 -46.29 88.34 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.509 -0.744 . . . . 1.2 112.48 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.86 -41.79 82.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.416 1.086 . . . . 0.56999999999999995 109.346 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.87 -50.15 76.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 118.034 -0.984 . . . . 0.56999999999999995 109.269 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -41.28 99.42 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.658 1.117 . . . . 0.56999999999999995 111.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -65.03 -46.3 81.86 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.7 1.136 . . . . 0.56999999999999995 110.864 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.74 92.06 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.889 1.276 . . . . 0.56999999999999995 112.405 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.98 -37.34 75.73 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.512 0.725 . . . . 0.56999999999999995 110.614 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.23 -41.14 87.98 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 118.828 0.74 . . . . 0.56999999999999995 109.87 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.7 mtp -66.02 -33.1 75.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.677 0.791 . . . . 0.56999999999999995 112.544 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -70.81 -49.34 47.5 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.369 0.986 . . . . 0.56999999999999995 111.112 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.63 -10.78 71.92 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.0 1.286 . . . . 0.56999999999999995 113.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -62.18 -26.63 68.45 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.667 -1.49 . . . . 0.56999999999999995 111.022 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -97.94 -38.29 9.46 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.975 -0.535 . . . . 0.66000000000000003 110.886 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.92 136.41 23.26 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 124.085 0.954 . . . . 0.56999999999999995 110.576 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 38.32 0.44 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 124.195 3.264 . . . . 0.56999999999999995 112.906 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.15 138.36 31.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.933 1.693 . . . . 0.56999999999999995 107.601 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -120.59 170.82 9.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.65000000000000002 108.662 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.51 153.92 45.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.396 -0.964 . . . . 0.56999999999999995 108.396 -175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.36 161.04 37.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.14 0.576 . . . . 1.2 110.803 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -104.08 145.56 30.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.822 -0.807 . . . . 0.56999999999999995 108.822 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.73 170.86 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.114 0.965 . . . . 0.56999999999999995 110.32 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.93 37.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.852 1.261 . . . . 0.56999999999999995 110.215 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -146.46 -72.58 0.23 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.028 0.931 . . . . 0.56999999999999995 110.665 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.8 25.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.421 -1.211 . . . . 0.56999999999999995 115.557 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -154.09 135.27 14.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.56999999999999995 106.848 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.63 177.2 11.65 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.074 0.95 . . . . 0.56999999999999995 110.598 -177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' HG12 ' A' ' 15' ' ' VAL . 49.2 m-20 -71.15 -37.09 72.25 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.297 -0.858 . . . . 0.66000000000000003 110.516 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 mt -118.99 77.76 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.182 2.193 . . . . 0.56999999999999995 107.82 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -75.28 125.17 28.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.574 -1.269 . . . . 0.56999999999999995 107.574 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.42 123.12 67.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 104.999 -2.223 . . . . 0.56999999999999995 104.999 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.9 162.98 26.31 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.843 -0.503 . . . . 0.56999999999999995 111.843 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 13.9 m-85 -137.32 126.8 25.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.546 -1.65 . . . . 0.56999999999999995 106.546 -172.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.74 -174.41 4.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 108.194 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.9 140.29 18.68 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.6 -0.889 . . . . 1.2 108.6 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.95 -90.4 0.41 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.251 0.453 . . . . 0.56999999999999995 112.341 174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.79 172.59 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.868 0.834 . . . . 0.56999999999999995 110.049 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -153.75 142.87 21.34 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.65000000000000002 109.466 175.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.72 45.73 1.58 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.024 1.297 . . . . 0.56999999999999995 112.622 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.4 28.11 0.99 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.302 2.241 . . . . 0.66000000000000003 110.139 -172.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.82 -38.86 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.174 1.79 . . . . 0.56999999999999995 112.029 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -91.25 104.8 10.62 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.604 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.43 143.01 74.55 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.16 1.24 . . . . 0.56999999999999995 109.366 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -72.61 -170.57 0.69 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.719 1.247 . . . . 0.56999999999999995 109.776 170.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -124.65 -45.19 1.93 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.617 2.367 . . . . 0.66000000000000003 108.617 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.29 -148.98 16.56 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.068 1.318 . . . . 0.56999999999999995 110.953 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.74 68.76 2.95 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 125.969 4.446 . . . . 0.56999999999999995 112.933 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.02 166.01 16.54 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 126.421 1.962 . . . . 0.56999999999999995 108.933 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 49.73 -160.97 0.06 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.502 1.521 . . . . 0.56999999999999995 112.924 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.2 m -31.8 104.87 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.913 2.885 . . . . 0.56999999999999995 114.583 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 mp -76.44 -29.74 57.09 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.104 -1.623 . . . . 0.56999999999999995 114.0 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.7 161.99 40.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 108.239 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.62 158.56 44.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.472 -0.566 . . . . 0.65000000000000002 109.472 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.32 170.37 19.7 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 108.824 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -124.09 149.22 46.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.212 -1.033 . . . . 0.56999999999999995 108.212 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.72 154.54 80.12 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 118.593 -0.717 . . . . 0.56999999999999995 110.137 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 37.4 Cg_endo -67.48 166.34 24.12 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.396 2.064 . . . . 0.56999999999999995 111.784 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.45 -116.75 0.67 Allowed Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.3 p -149.03 65.68 1.04 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.625 0.77 . . . . 0.56999999999999995 111.046 -167.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.99 -121.67 1.4 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.5 -1.44 . . . . 0.56999999999999995 109.5 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.91 -25.9 32.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.053 1.341 . . . . 0.56999999999999995 112.024 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 140.33 11.79 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 120.852 -1.155 . . . . 0.56999999999999995 111.089 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.4 -24.32 4.97 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.283 1.42 . . . . 0.56999999999999995 113.776 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -68.63 153.24 44.15 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.987 0.893 . . . . 0.66000000000000003 108.726 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.0 146.13 31.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.56999999999999995 109.176 -170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -140.96 155.59 46.21 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.28 -0.873 . . . . 0.65000000000000002 111.258 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 46.6 m-85 -137.25 141.9 42.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.877 -1.157 . . . . 0.56999999999999995 107.877 -163.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -80.9 104.36 11.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.716 -1.216 . . . . 0.66000000000000003 107.716 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.4 -23.74 67.39 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.33 -0.856 . . . . 0.66000000000000003 110.844 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -73.29 -24.18 60.38 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 110.117 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.92 132.48 39.1 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.16 -1.052 . . . . 0.66000000000000003 108.16 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -65.98 143.36 57.43 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.352 -0.61 . . . . 1.2 109.352 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -126.36 137.38 53.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.609 -1.256 . . . . 0.56999999999999995 107.609 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.3 t -113.53 147.41 37.99 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.869 -0.789 . . . . 0.56999999999999995 108.869 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -74.52 21.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.166 1.786 . . . . 0.66000000000000003 112.981 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.13 124.86 0.25 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.406 1.955 . . . . 0.56999999999999995 109.998 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 t 74.74 58.49 0.07 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.987 1.715 . . . . 0.56999999999999995 113.004 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 41.11 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.299 1.04 . . . . 0.56999999999999995 112.538 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp 55.52 -178.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 111.843 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.01 -168.33 52.06 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.011 -1.056 . . . . 0.56999999999999995 111.653 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.9 121.16 44.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.847 -0.797 . . . . 0.56999999999999995 108.847 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -56.8 106.72 0.33 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.872 1.269 . . . . 0.56999999999999995 109.209 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.84 -38.29 75.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.481 0.712 . . . . 0.56999999999999995 109.958 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.28 -51.42 66.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.596 -1.261 . . . . 0.56999999999999995 107.596 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -54.92 -42.51 72.3 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.876 -0.583 . . . . 0.56999999999999995 111.042 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.5 5.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.277 0.631 . . . . 0.56999999999999995 110.275 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.79 -50.16 75.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 118.349 -0.834 . . . . 0.56999999999999995 109.492 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 m -57.34 -36.45 71.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.597 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.7 -55.39 17.65 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.19 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -66.11 -40.74 90.96 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.61 -0.681 . . . . 0.66000000000000003 110.749 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.5 mt -62.81 -32.28 73.44 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.472 1.509 . . . . 0.56999999999999995 111.692 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.25 94.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.466 -0.654 . . . . 0.56999999999999995 111.466 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -69.33 -37.11 77.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 117.594 -1.193 . . . . 0.65000000000000002 111.916 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.2 p -59.08 -33.19 70.53 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.18 0.925 . . . . 0.56999999999999995 111.269 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.7 mm? -68.63 -33.97 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 112.023 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 151.78 53.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.605 1.093 . . . . 0.56999999999999995 114.404 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.0 mmt 58.06 -177.17 0.07 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.489 0.661 . . . . 0.56999999999999995 111.452 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.13 57.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.527 -1.429 . . . . 0.56999999999999995 109.527 -174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.36 167.32 11.6 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.93 0.871 . . . . 0.65000000000000002 110.467 173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 t -160.69 -170.31 2.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.917 1.287 . . . . 0.56999999999999995 109.74 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.23 30.36 1.14 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.571 1.948 . . . . 0.56999999999999995 109.999 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.49 148.43 35.48 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.739 1.216 . . . . 0.66000000000000003 109.974 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.94 -21.53 43.56 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.287 2.658 . . . . 0.56999999999999995 113.279 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -132.59 29.05 4.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.376 1.871 . . . . 0.56999999999999995 108.661 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.1 133.03 49.05 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.658 -1.276 . . . . 0.56999999999999995 109.026 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 156' ' ' ASP . 4.3 p -55.8 -28.73 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.371 1.468 . . . . 0.56999999999999995 112.68 171.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.49 27.9 9.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.099 . . . . 0.56999999999999995 110.338 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -56.49 129.17 75.45 Favored Pre-proline 0 CA--C 1.545 0.777 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 109.971 171.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.59 178.38 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.942 2.428 . . . . 0.56999999999999995 110.573 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m 71.08 -40.99 0.49 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.504 1.522 . . . . 0.56999999999999995 113.321 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.47 ' CE1' ' H47' ' A' ' 178' ' ' MDW . 59.9 t80 55.39 92.21 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.275 2.23 . . . . 0.56999999999999995 113.722 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.75 105.75 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.598 -1.001 . . . . 0.56999999999999995 110.598 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -172.65 -50.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.093 1.357 . . . . 0.56999999999999995 110.565 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.88 -113.1 2.94 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.25 -1.94 . . . . 0.56999999999999995 108.25 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.68 134.59 9.19 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 106.529 -1.656 . . . . 0.66000000000000003 106.529 174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.09 -8.43 6.63 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.023 3.149 . . . . 0.56999999999999995 113.559 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -71.01 -28.16 64.21 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.151 -1.593 . . . . 0.56999999999999995 111.368 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -106.96 61.79 0.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.56999999999999995 110.916 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -126.44 141.26 51.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.575 1.15 . . . . 0.56999999999999995 110.311 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.66 51.68 0.08 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.866 0.866 . . . . 0.56999999999999995 110.956 -176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 69.27 76.64 0.23 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.554 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.3 t -69.57 -94.42 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.918 0.887 . . . . 0.56999999999999995 112.044 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -131.12 -44.69 1.03 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.986 0.914 . . . . 0.56999999999999995 109.641 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -46.04 49.96 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.96 0.904 . . . . 0.66000000000000003 110.615 166.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.597 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.2 t0 -60.23 -56.58 19.82 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.524 -0.75 . . . . 0.66000000000000003 110.403 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.39 -43.84 87.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 N-CA-C 109.044 -0.724 . . . . 0.56999999999999995 109.044 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -64.43 -38.66 91.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.675 0.79 . . . . 0.56999999999999995 110.72 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.93 -49.73 39.75 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.689 -0.965 . . . . 0.56999999999999995 110.689 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -56.54 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 C-N-CA 126.144 1.777 . . . . 0.56999999999999995 110.254 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.6 -20.53 65.74 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.845 -0.534 . . . . 0.56999999999999995 110.777 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -88.1 -29.83 20.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.455 0.702 . . . . 0.56999999999999995 111.201 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.27 -58.02 8.51 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 125.717 1.607 . . . . 0.56999999999999995 109.747 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -92.14 -0.11 57.45 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.155 0.798 . . . . 0.56999999999999995 113.155 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.24 -82.37 0.63 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.637 -0.585 . . . . 0.56999999999999995 111.637 -171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.19 -56.84 0.06 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.103 0.409 . . . . 0.56999999999999995 112.103 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.57 177.98 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.526 1.53 . . . . 1.2 112.726 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 92.56 2.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.655 -1.98 . . . . 0.56999999999999995 105.655 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -162.28 131.87 4.5 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 105.027 -2.212 . . . . 0.56999999999999995 105.027 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.01 138.07 45.78 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.56999999999999995 108.621 172.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -64.16 140.4 58.87 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.79 0.328 . . . . 1.2 110.485 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.7 142.34 26.61 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.717 1.207 . . . . 0.56999999999999995 108.012 173.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 125.488 1.515 . . . . 0.5 . -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.47 ' H47' ' CE1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.285 0 CA-C-O 118.127 -0.94 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m 55.91 38.28 29.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.302 0.955 . . . . 0.56999999999999995 113.195 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 -68.64 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.38 -0.6 . . . . 0.56999999999999995 109.38 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -157.2 83.15 3.05 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 126.009 1.723 . . . . 0.56999999999999995 107.042 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -73.34 -171.42 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.324 2.682 . . . . 0.56999999999999995 111.912 168.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -67.43 -58.25 5.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.032 0.933 . . . . 0.56999999999999995 112.069 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.71 98.28 0.61 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 127.071 2.149 . . . . 0.56999999999999995 105.235 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.52 170.83 19.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.935 2.423 . . . . 0.56999999999999995 109.884 169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 pttt 67.01 141.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.759 2.023 . . . . 0.56999999999999995 110.881 -165.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -56.5 149.2 17.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.046 0.939 . . . . 0.56999999999999995 110.371 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 p -62.63 -20.03 64.37 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.305 0.854 . . . . 0.56999999999999995 113.305 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -96.7 140.98 30.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.849 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -72.96 -14.09 61.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 113.064 171.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 m -114.2 119.54 61.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.759 -1.941 . . . . 0.56999999999999995 105.759 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.17 155.59 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.31 -1.367 . . . . 0.56999999999999995 107.31 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.0 p -106.88 143.6 34.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.758 -0.46 . . . . 0.56999999999999995 109.758 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -126.64 145.46 50.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.601 -0.518 . . . . 0.56999999999999995 109.601 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.1 115.13 3.48 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.758 0.79 . . . . 1.2 111.921 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.0 95.17 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 105.718 -1.956 . . . . 0.56999999999999995 105.718 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 m -67.0 -39.02 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.132 0.973 . . . . 0.56999999999999995 112.067 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -130.0 152.49 49.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.089 -2.56 . . . . 0.56999999999999995 104.089 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -127.41 167.34 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.977 1.311 . . . . 0.56999999999999995 107.858 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 t -64.63 -179.99 0.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.808 0.813 . . . . 0.56999999999999995 110.901 173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.28 -40.13 3.3 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.83 0.852 . . . . 1.2 111.585 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -41.97 77.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.654 0.661 . . . . 0.66000000000000003 111.583 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.69 152.86 38.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.56999999999999995 108.587 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.42 149.53 39.79 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.897 1.731 . . . . 0.56999999999999995 112.41 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -58.86 -37.42 76.47 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 113.08 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -43.52 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.773 -0.455 . . . . 0.56999999999999995 109.773 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.9 m -66.61 -39.99 88.62 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.945 -1.026 . . . . 0.56999999999999995 109.577 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.5 -51.08 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.709 1.14 . . . . 0.56999999999999995 110.704 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -63.35 -43.05 98.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.87 1.214 . . . . 0.66000000000000003 110.482 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -46.75 87.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.216 -0.927 . . . . 1.2 111.207 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.79 -38.27 86.19 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 117.263 -1.351 . . . . 0.56999999999999995 109.904 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -59.62 -46.55 93.09 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 110.076 170.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.266 0.939 . . . . 0.56999999999999995 109.502 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -68.47 -41.86 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.363 -0.827 . . . . 0.56999999999999995 111.688 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.27 -46.62 87.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.735 1.152 . . . . 0.56999999999999995 111.504 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.2 mt -67.91 -37.53 81.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.934 0.894 . . . . 0.56999999999999995 110.162 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.39 -39.73 84.29 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.209 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -43.94 97.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.725 0.81 . . . . 0.56999999999999995 111.349 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 33.9 m95 -61.76 -47.84 83.38 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.852 0.751 . . . . 0.56999999999999995 111.285 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.21 -2.07 71.6 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.298 -0.876 . . . . 0.56999999999999995 113.695 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -81.82 -11.59 58.9 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.347 1.573 . . . . 0.56999999999999995 110.071 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -108.62 -21.8 12.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.356 0.526 . . . . 0.66000000000000003 111.353 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 160' ' ' ILE . 8.4 pt -136.52 146.46 55.8 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.731 1.213 . . . . 0.56999999999999995 110.302 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.99 58.43 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 111.937 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.03 138.19 54.21 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.613 1.965 . . . . 0.56999999999999995 106.631 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -123.23 160.46 26.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.291 -1.003 . . . . 0.65000000000000002 108.291 -171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.43 149.98 38.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.829 -1.175 . . . . 0.56999999999999995 107.829 -172.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -134.2 157.34 46.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.149 0.979 . . . . 1.2 109.046 -175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -115.81 108.85 16.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 -174.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.46 133.76 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.555 -1.276 . . . . 0.56999999999999995 107.555 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -37.18 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.179 -0.325 . . . . 0.56999999999999995 110.208 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -147.63 162.17 39.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.312 1.045 . . . . 0.56999999999999995 109.003 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.84 156.83 18.15 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.964 -1.255 . . . . 0.56999999999999995 109.964 -164.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -64.32 168.53 5.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.517 0.675 . . . . 0.56999999999999995 110.696 168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.99 169.2 17.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.766 1.226 . . . . 0.56999999999999995 109.937 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -67.96 -44.04 77.64 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.987 -1.006 . . . . 0.66000000000000003 109.341 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.4 mt -116.53 78.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.082 1.753 . . . . 0.56999999999999995 107.74 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.0 ttm -76.3 153.66 35.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.848 -1.158 . . . . 0.56999999999999995 109.612 171.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.75 134.83 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.73 -1.952 . . . . 0.56999999999999995 105.73 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.56 166.54 30.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.779 -0.928 . . . . 0.56999999999999995 110.779 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 3.7 m-85 -138.6 149.99 45.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.661 -0.866 . . . . 0.56999999999999995 108.661 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.42 175.92 11.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.969 1.308 . . . . 0.56999999999999995 110.249 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 ptt85 -140.46 63.0 1.48 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.765 1.226 . . . . 1.2 109.812 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.79 -70.64 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.644 -0.583 . . . . 0.56999999999999995 111.644 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.13 174.72 8.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.942 -1.328 . . . . 0.56999999999999995 110.398 172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -149.45 137.86 20.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.427 -0.583 . . . . 0.65000000000000002 109.427 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.91 37.52 3.39 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.235 0.922 . . . . 0.56999999999999995 112.021 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.78 -72.05 0.46 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.1 1.36 . . . . 0.66000000000000003 108.574 -171.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -172.55 -36.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 118.979 -0.534 . . . . 0.56999999999999995 111.677 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -102.76 101.64 21.96 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-O 118.286 -0.864 . . . . 0.56999999999999995 108.732 -171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.79 129.27 28.46 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 108.26 -1.477 . . . . 0.56999999999999995 108.26 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 0.5 OUTLIER -64.66 -167.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.769 1.747 . . . . 0.56999999999999995 109.146 165.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.75 -46.28 0.74 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 129.773 3.229 . . . . 0.66000000000000003 107.655 -163.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.01 -146.37 16.06 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.052 -1.416 . . . . 0.56999999999999995 110.159 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.11 83.06 1.9 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.431 3.421 . . . . 0.56999999999999995 112.437 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.87 169.24 17.86 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 127.749 2.595 . . . . 0.56999999999999995 109.852 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 t30 54.5 -144.69 0.66 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.675 1.59 . . . . 0.56999999999999995 112.604 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.5 m -47.33 135.81 10.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.578 2.351 . . . . 0.56999999999999995 111.577 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.38 -33.18 10.11 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 112.519 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.9 158.47 28.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.56999999999999995 108.812 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -141.56 164.75 29.39 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 119.023 0.829 . . . . 0.65000000000000002 111.792 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.76 156.38 44.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.433 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.08 152.87 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.925 -1.034 . . . . 0.56999999999999995 108.894 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.05 95.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.701 -0.666 . . . . 0.56999999999999995 110.186 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.47 149.7 69.08 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.077 2.518 . . . . 0.56999999999999995 112.033 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.17 -70.65 0.32 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.406 0.527 . . . . 0.56999999999999995 112.077 169.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -75.1 166.36 23.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.382 1.073 . . . . 0.56999999999999995 109.796 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -50.94 -48.46 45.35 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 117.554 -1.692 . . . . 0.56999999999999995 114.797 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.78 -26.71 60.78 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.419 1.609 . . . . 0.56999999999999995 111.049 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.15 149.11 6.21 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 110.925 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.75 -28.84 1.82 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.257 1.408 . . . . 0.56999999999999995 113.624 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -66.97 152.95 44.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.242 1.021 . . . . 0.66000000000000003 109.004 -170.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 149.7 52.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.608 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -140.39 151.34 44.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.836 -0.62 . . . . 0.65000000000000002 110.957 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 40.6 m-85 -138.43 144.9 40.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.462 1.105 . . . . 0.56999999999999995 109.007 -165.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.07 107.07 6.9 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.006 -1.109 . . . . 0.66000000000000003 108.006 171.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.22 -19.11 62.82 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.524 1.511 . . . . 0.66000000000000003 111.581 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.44 -44.96 81.41 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.398 1.479 . . . . 0.66000000000000003 111.629 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -66.55 122.5 17.73 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 106.219 -1.771 . . . . 0.66000000000000003 106.219 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 129.57 40.51 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.101 -0.952 . . . . 1.2 109.622 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -106.73 153.63 22.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.631 1.172 . . . . 0.56999999999999995 109.465 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.81 141.85 51.46 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.558 -0.905 . . . . 0.56999999999999995 108.558 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.23 42.27 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.055 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.64 75.47 0.89 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.825 -0.91 . . . . 0.56999999999999995 110.825 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.36 177.78 7.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.073 0.949 . . . . 0.56999999999999995 108.967 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 m -57.17 122.65 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.836 0.855 . . . . 0.56999999999999995 110.576 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.44 172.66 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.024 1.729 . . . . 0.56999999999999995 112.577 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.08 169.69 42.09 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.561 -0.745 . . . . 0.56999999999999995 111.447 -173.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.25 123.59 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -64.58 120.36 12.21 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.482 -0.327 . . . . 0.56999999999999995 110.729 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -52.65 -43.07 65.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.913 0.885 . . . . 0.56999999999999995 111.869 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 tp -64.77 -46.3 82.71 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.54 0.609 . . . . 0.56999999999999995 109.839 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 137' ' ' VAL . 4.3 t80 -56.69 -48.62 77.25 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.801 -0.444 . . . . 0.56999999999999995 109.801 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.76 85.32 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 122.8 0.44 . . . . 0.56999999999999995 110.824 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -52.17 66.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 117.853 -1.07 . . . . 0.56999999999999995 109.409 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.5 m -53.91 -40.25 66.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.174 1.352 . . . . 0.56999999999999995 111.89 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -60.3 -56.37 22.32 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.206 0.602 . . . . 0.65000000000000002 110.536 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.51 -44.51 78.24 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.931 0.892 . . . . 0.66000000000000003 111.322 -172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.57 -25.91 68.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.584 1.554 . . . . 0.56999999999999995 110.943 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.62 -51.72 57.21 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.713 -0.955 . . . . 0.56999999999999995 110.713 169.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -62.07 -38.81 90.21 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 117.658 -1.163 . . . . 0.65000000000000002 111.265 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.3 p -58.18 -31.3 67.15 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 118.559 0.618 . . . . 0.56999999999999995 112.424 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -36.9 72.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.501 0.32 . . . . 0.56999999999999995 111.815 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.16 43.24 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.691 -1.061 . . . . 0.56999999999999995 113.342 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -116.58 149.59 39.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.594 1.197 . . . . 0.56999999999999995 110.649 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -91.08 -45.62 4.09 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 117.786 -1.563 . . . . 0.56999999999999995 111.928 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 m80 156.24 174.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 129.739 3.216 . . . . 0.65000000000000002 110.103 -171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 155' ' ' ASP . 5.0 m -117.41 176.71 5.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.042 1.737 . . . . 0.56999999999999995 110.807 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.27 58.99 1.52 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.625 1.17 . . . . 0.56999999999999995 109.45 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 2.0 t70 -135.13 142.72 42.94 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 107.297 -1.372 . . . . 0.66000000000000003 107.297 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.8 -34.58 30.49 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.696 1.597 . . . . 0.56999999999999995 111.188 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -105.18 24.3 12.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.455 1.102 . . . . 0.56999999999999995 110.071 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -58.54 130.64 47.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.97 -0.752 . . . . 0.56999999999999995 108.97 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 150' ' ' PHE . 7.2 p -67.29 -24.39 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.411 -0.515 . . . . 0.56999999999999995 109.815 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.4 16.54 14.93 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.483 -0.761 . . . . 0.56999999999999995 112.318 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.486 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.1 t80 -72.18 144.46 87.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.857 1.662 . . . . 0.56999999999999995 111.673 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 57.7 Cg_endo -74.25 163.52 36.27 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.48 2.12 . . . . 0.56999999999999995 111.041 167.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.6 m 56.09 94.06 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.638 1.575 . . . . 0.56999999999999995 112.034 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.5 ' CD1' ' H43' ' A' ' 178' ' ' MDW . 0.3 OUTLIER -50.37 105.96 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.491 1.516 . . . . 0.56999999999999995 112.564 -176.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.12 166.54 33.61 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.523 -1.831 . . . . 0.56999999999999995 108.523 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.17 -47.89 0.22 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.88 2.472 . . . . 0.56999999999999995 114.769 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.54 175.59 7.25 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.118 1.342 . . . . 0.56999999999999995 112.142 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -121.0 101.15 45.3 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.939 -1.134 . . . . 0.66000000000000003 107.939 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.79 40.29 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 113.077 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.87 -54.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.638 -1.289 . . . . 0.56999999999999995 107.994 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.07 88.22 2.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.964 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 137' ' ' VAL . 45.7 p90 -121.45 -45.98 2.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 110.279 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 30.34 55.43 0.18 Allowed 'General case' 0 C--N 1.348 0.516 0 C-N-CA 127.546 2.338 . . . . 0.56999999999999995 113.574 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mp 63.46 100.22 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.617 1.967 . . . . 0.56999999999999995 109.948 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.7 m -70.84 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.376 0.88 . . . . 0.56999999999999995 113.376 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -143.94 -42.68 0.27 Allowed 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.938 0.895 . . . . 0.56999999999999995 109.145 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 131' ' ' SER . 15.0 p-10 -59.95 -39.97 87.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.667 0.667 . . . . 0.66000000000000003 112.172 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -54.56 29.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.7 1.2 . . . . 0.66000000000000003 109.134 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.9 -46.25 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 124.826 1.251 . . . . 0.56999999999999995 108.746 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -62.56 -47.71 82.69 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 117.971 -1.014 . . . . 0.56999999999999995 108.761 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.55 -62.32 6.44 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.807 -1.717 . . . . 0.56999999999999995 108.807 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.558 HG23 HG23 ' A' ' 46' ' ' ILE . 5.3 mm -56.93 -43.61 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.242 1.021 . . . . 0.56999999999999995 113.132 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -71.34 -27.75 63.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.58 -0.7 . . . . 0.56999999999999995 111.662 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -36.01 68.13 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.964 0.906 . . . . 0.56999999999999995 110.363 169.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -61.53 2.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.994 -1.003 . . . . 0.56999999999999995 110.289 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -142.38 18.24 2.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.229 1.196 . . . . 0.56999999999999995 114.229 -170.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -93.64 -87.01 1.62 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.385 -0.686 . . . . 0.56999999999999995 111.385 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -158.83 -69.73 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.719 0.807 . . . . 0.56999999999999995 110.665 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.22 154.1 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.393 1.477 . . . . 1.2 108.318 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.1 t -165.08 176.72 8.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.563 -1.644 . . . . 0.56999999999999995 106.563 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.21 164.79 26.28 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.649 -1.612 . . . . 0.56999999999999995 106.649 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.6 p -125.31 168.4 13.57 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.804 0.841 . . . . 0.56999999999999995 108.792 171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.81 147.45 26.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.501 -1.666 . . . . 1.2 106.501 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.38 170.86 7.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.288 -0.634 . . . . 0.56999999999999995 109.288 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.346 0.428 0 C-N-CA 122.88 0.472 . . . . 0.5 . 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.5 ' H43' ' CD1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 118.572 -0.728 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -104.78 -58.5 1.88 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.297 1.439 . . . . 0.56999999999999995 108.643 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -173.76 122.85 0.34 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 104.284 -2.487 . . . . 0.56999999999999995 104.284 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.24 80.58 0.29 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 114.141 1.163 . . . . 0.56999999999999995 114.141 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.72 109.55 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.929 1.753 . . . . 0.56999999999999995 110.276 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -145.2 105.24 4.04 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 107.6 -1.259 . . . . 0.56999999999999995 107.6 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.5 m 36.7 70.52 1.08 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.08 1.352 . . . . 0.56999999999999995 113.349 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -67.77 31.21 0.14 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.123 3.215 . . . . 0.56999999999999995 115.013 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -162.06 31.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 110.81 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.431 ' CH2' ' HA3' ' A' ' 94' ' ' GLY . 89.4 m95 51.93 -111.53 0.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.762 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -154.57 -40.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.613 1.565 . . . . 0.56999999999999995 108.428 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.0 t -95.97 153.35 17.81 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.312 0.645 . . . . 0.56999999999999995 109.506 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.23 -9.93 20.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.988 0.915 . . . . 0.56999999999999995 112.667 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.54 147.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.905 -1.517 . . . . 0.56999999999999995 106.905 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 59' ' ' ASP . 9.2 t -127.21 161.65 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.4 -1.333 . . . . 0.56999999999999995 107.4 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -107.46 139.1 42.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.541 -1.281 . . . . 0.56999999999999995 107.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -126.11 151.5 47.14 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 109.561 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -153.57 118.25 4.98 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.171 0.51 . . . . 1.2 109.803 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.3 mt -82.62 86.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.424 -1.695 . . . . 0.56999999999999995 106.424 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -56.76 -49.59 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 112.2 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.82 153.1 33.07 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.417 -2.438 . . . . 0.56999999999999995 104.417 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -125.75 149.68 48.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.173 -1.788 . . . . 0.56999999999999995 106.173 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -159.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 O-C-N 125.032 1.458 . . . . 0.56999999999999995 111.084 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -148.04 -29.34 0.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 114.244 1.202 . . . . 1.2 114.244 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -52.61 -57.54 9.69 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.205 0.941 . . . . 0.66000000000000003 110.915 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.31 164.41 14.99 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 109.466 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -77.97 149.55 25.89 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.149 1.899 . . . . 0.56999999999999995 112.618 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 11.7 m-70 -60.6 -35.65 76.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.398 1.079 . . . . 0.65000000000000002 112.408 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.17 -38.98 82.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.011 0.524 . . . . 0.56999999999999995 110.275 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -69.58 -41.32 75.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 117.222 -1.371 . . . . 0.56999999999999995 109.069 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.1 t -54.54 -53.37 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 120.563 1.528 . . . . 0.56999999999999995 109.96 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.21 -34.35 77.88 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 118.598 -0.715 . . . . 0.66000000000000003 110.757 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -46.44 80.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.625 1.102 . . . . 1.2 111.717 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.1 mt -65.09 -45.22 86.14 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.223 1.009 . . . . 0.56999999999999995 108.337 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.37 -44.86 99.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.94 -1.029 . . . . 0.56999999999999995 110.565 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 m -60.27 -46.89 88.26 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 120.036 1.289 . . . . 0.56999999999999995 109.895 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -36.89 69.85 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.508 -0.758 . . . . 0.56999999999999995 111.501 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.69 91.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 111.308 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 26.3 mt -72.11 -35.8 69.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.629 0.772 . . . . 0.56999999999999995 110.493 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.52 -42.87 88.68 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.089 -0.958 . . . . 0.56999999999999995 109.944 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.9 mtp -60.81 -36.93 80.32 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.928 0.891 . . . . 0.56999999999999995 111.321 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -69.0 -47.04 66.51 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.975 1.261 . . . . 0.56999999999999995 111.309 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.44 -3.86 59.08 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 123.94 0.781 . . . . 0.56999999999999995 113.301 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -70.46 -19.81 62.93 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.984 -1.303 . . . . 0.56999999999999995 111.043 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.6 mp0 -110.52 -34.8 6.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.503 1.521 . . . . 0.66000000000000003 111.056 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 21.7 pt -114.07 143.06 28.96 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 111.04 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.26 21.16 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.248 2.632 . . . . 0.56999999999999995 112.488 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -86.96 126.38 34.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.188 -1.412 . . . . 0.56999999999999995 107.188 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -126.68 -178.55 4.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.867 0.867 . . . . 0.65000000000000002 109.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -147.83 147.53 29.9 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.704 -0.85 . . . . 0.56999999999999995 108.704 -170.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.95 160.0 39.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.381 1.072 . . . . 1.2 109.722 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -110.05 116.08 30.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.286 -1.376 . . . . 0.56999999999999995 107.286 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.2 m -103.58 161.21 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.585 -0.894 . . . . 0.56999999999999995 108.585 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.79 39.44 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.208 1.003 . . . . 0.56999999999999995 110.179 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -90.58 -65.57 1.0 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.045 0.538 . . . . 0.56999999999999995 109.917 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.07 -70.55 0.02 OUTLIER Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.298 -1.521 . . . . 0.56999999999999995 109.298 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -125.52 139.68 53.4 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.319 -1.363 . . . . 0.56999999999999995 107.319 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.59 171.27 7.42 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.069 0.947 . . . . 0.56999999999999995 110.012 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 15' ' ' VAL . 65.2 m-20 -62.48 -50.54 71.01 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.176 -1.046 . . . . 0.66000000000000003 108.176 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.64 81.88 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 106.775 -1.565 . . . . 0.56999999999999995 106.775 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -78.54 121.4 24.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.96 127.2 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 106.687 -1.597 . . . . 0.56999999999999995 106.687 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.38 25.81 Favored Glycine 0 C--O 1.226 -0.362 0 N-CA-C 111.204 -0.758 . . . . 0.56999999999999995 111.204 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 21.3 m-85 -132.62 137.32 46.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.948 -1.871 . . . . 0.56999999999999995 105.948 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 160.22 36.59 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.826 1.65 . . . . 0.56999999999999995 107.873 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -116.67 50.99 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.201 -0.937 . . . . 1.2 110.137 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.85 -127.35 6.31 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.254 -1.538 . . . . 0.56999999999999995 109.254 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.94 139.46 0.46 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.14 1.376 . . . . 0.56999999999999995 112.621 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -120.9 -62.27 1.47 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.485 -0.78 . . . . 0.65000000000000002 109.836 -173.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.99 71.83 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.354 -0.692 . . . . 0.56999999999999995 112.647 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.3 121.35 41.73 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.632 1.173 . . . . 0.66000000000000003 108.485 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.82 -73.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.381 . . . . 0.56999999999999995 111.689 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -148.23 144.12 18.38 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 108.638 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.02 149.55 77.2 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.815 1.676 . . . . 0.56999999999999995 110.405 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 1.4 m-85 -70.44 -174.18 0.82 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.738 -1.119 . . . . 0.56999999999999995 110.749 170.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -118.63 -32.16 4.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.688 2.395 . . . . 0.66000000000000003 110.975 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.42 -139.94 15.83 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 112.351 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.07 86.67 1.62 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.353 3.369 . . . . 0.56999999999999995 112.036 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.04 -174.99 33.92 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.565 1.555 . . . . 0.56999999999999995 111.226 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 m120 45.82 -134.71 0.82 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.829 1.314 . . . . 0.56999999999999995 112.478 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -59.13 118.56 6.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.14 2.176 . . . . 0.56999999999999995 111.449 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.522 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.3 mp -94.68 -34.87 12.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.736 1.214 . . . . 0.56999999999999995 112.195 -175.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.25 157.97 33.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.292 1.037 . . . . 0.56999999999999995 108.826 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.68 161.93 37.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.341 -0.615 . . . . 0.65000000000000002 109.341 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.46 34.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.696 -0.853 . . . . 0.56999999999999995 108.696 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.58 153.82 32.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.317 -0.994 . . . . 0.56999999999999995 108.317 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.38 149.56 96.94 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.072 -0.966 . . . . 0.56999999999999995 109.63 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 29.3 Cg_endo -67.35 160.82 45.96 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.295 1.997 . . . . 0.56999999999999995 111.47 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.09 -106.88 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.315 -1.914 . . . . 0.56999999999999995 108.315 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.3 p -151.71 69.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.744 0.818 . . . . 0.56999999999999995 110.948 -165.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.36 -121.45 1.6 Allowed Glycine 0 C--N 1.342 0.904 0 N-CA-C 110.404 -1.079 . . . . 0.56999999999999995 110.404 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.86 -21.76 61.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.167 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.78 130.59 43.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.447 -1.196 . . . . 0.56999999999999995 110.959 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' CH2' ' A' ' 10' ' ' TRP . . . 96.38 -36.86 3.65 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.084 2.278 . . . . 0.56999999999999995 113.09 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.1 145.91 19.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.998 2.119 . . . . 0.66000000000000003 107.092 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.29 146.61 36.99 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.871 -0.789 . . . . 0.56999999999999995 108.871 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -139.56 160.6 39.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 110.236 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 57.5 m-85 -142.44 148.58 38.01 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.361 1.064 . . . . 0.56999999999999995 108.323 -163.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.38 100.56 10.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.81 -1.552 . . . . 0.66000000000000003 106.81 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.9 -25.73 31.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.463 -1.398 . . . . 0.66000000000000003 111.43 171.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.18 -37.18 76.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.66000000000000003 110.478 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.24 120.2 20.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.192 -1.41 . . . . 0.66000000000000003 107.192 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -56.28 122.58 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.873 0.469 . . . . 1.2 110.254 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 114' ' ' PHE . 98.4 m95 -109.63 133.94 52.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 108.339 -0.985 . . . . 0.56999999999999995 108.339 -175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.5 t -137.28 148.39 46.36 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.188 -0.671 . . . . 0.56999999999999995 109.188 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.47 -26.04 67.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.844 0.857 . . . . 0.66000000000000003 111.863 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.61 -141.19 11.12 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.088 1.327 . . . . 0.56999999999999995 110.248 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -160.56 103.77 1.39 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.584 0.692 . . . . 0.56999999999999995 109.566 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.51 -36.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.043 0.937 . . . . 0.56999999999999995 112.231 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -104.04 -58.84 1.82 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.094 0.558 . . . . 0.56999999999999995 109.516 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.9 -165.17 21.48 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.165 -1.174 . . . . 0.56999999999999995 110.165 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.423 HD13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -85.58 143.96 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 109.416 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.84 108.88 1.89 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.156 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -60.53 -34.42 74.09 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 112.121 174.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.437 HD12 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -64.59 -51.33 63.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.7 -1.222 . . . . 0.56999999999999995 107.7 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -57.55 -46.71 83.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.627 0.771 . . . . 0.56999999999999995 110.147 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.65 19.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 123.515 0.509 . . . . 0.56999999999999995 111.022 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.5 -55.52 34.03 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 117.933 -1.032 . . . . 0.56999999999999995 109.907 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -58.18 -34.45 70.35 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.906 1.23 . . . . 0.56999999999999995 111.841 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -66.01 -60.27 3.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.102 0.961 . . . . 0.65000000000000002 109.79 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.88 -45.79 80.75 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.569 -0.707 . . . . 0.66000000000000003 111.42 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.63 -30.8 71.63 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.421 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.96 -42.51 80.67 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.156 -0.778 . . . . 0.56999999999999995 111.156 170.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -74.52 -37.59 63.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 117.16 -1.4 . . . . 0.65000000000000002 112.354 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 p -54.42 -38.65 66.5 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 124.453 1.096 . . . . 0.56999999999999995 109.685 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.07 -43.38 95.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 112.337 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.2 43.39 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.862 -0.966 . . . . 0.56999999999999995 114.332 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.06 176.17 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.054 0.941 . . . . 0.56999999999999995 111.45 -171.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.01 66.33 0.01 OUTLIER Glycine 0 C--N 1.342 0.882 0 O-C-N 121.473 -0.767 . . . . 0.56999999999999995 111.735 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 174.24 7.11 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.626 1.171 . . . . 0.65000000000000002 110.636 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 t -160.33 -177.16 6.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.36 -0.836 . . . . 0.56999999999999995 110.773 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -146.8 56.37 1.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.306 2.642 . . . . 0.56999999999999995 107.46 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.35 150.65 44.86 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 124.647 1.179 . . . . 0.66000000000000003 108.278 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.0 -26.91 58.18 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.628 2.218 . . . . 0.56999999999999995 111.607 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.94 30.29 5.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.27 -1.011 . . . . 0.56999999999999995 108.27 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.42 131.04 46.05 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.294 -1.373 . . . . 0.56999999999999995 107.294 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 150' ' ' PHE . 3.0 p -60.32 -32.26 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 110.68 169.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -99.21 25.86 6.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.827 0.451 . . . . 0.56999999999999995 111.362 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.407 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 17.0 t80 -65.26 131.64 95.08 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 120.766 -1.209 . . . . 0.56999999999999995 110.385 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.8 Cg_endo -75.28 171.79 17.6 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.662 2.241 . . . . 0.56999999999999995 111.007 166.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.3 m 52.13 76.81 0.17 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.474 1.13 . . . . 0.56999999999999995 110.657 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -46.92 125.52 7.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.234 1.014 . . . . 0.56999999999999995 112.485 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.45 1.86 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.08 -1.208 . . . . 0.56999999999999995 110.08 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.79 -44.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.55 0.74 . . . . 0.56999999999999995 111.635 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -143.51 -137.14 3.23 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.208 -1.957 . . . . 0.56999999999999995 108.208 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -126.03 112.0 24.31 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.589 -0.893 . . . . 0.66000000000000003 108.589 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.41 -14.76 22.59 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.423 2.082 . . . . 0.56999999999999995 112.035 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -64.65 -48.68 73.93 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 121.894 2.133 . . . . 0.56999999999999995 109.87 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -92.5 69.91 4.98 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.643 1.177 . . . . 0.56999999999999995 111.169 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.44 125.72 28.03 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.293 -0.632 . . . . 0.56999999999999995 109.293 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 83.04 1.54 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.539 -1.282 . . . . 0.56999999999999995 107.539 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 48.58 80.93 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.815 1.646 . . . . 0.56999999999999995 111.629 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.6 t -67.95 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.128 0.571 . . . . 0.56999999999999995 112.322 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -137.59 -57.37 0.69 Allowed 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.386 -0.968 . . . . 0.56999999999999995 108.386 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -51.06 -39.43 55.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 125.277 1.431 . . . . 0.66000000000000003 112.266 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -63.57 -53.83 45.61 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.64 -0.695 . . . . 0.66000000000000003 109.366 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.92 -48.92 86.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-O 118.752 -0.642 . . . . 0.56999999999999995 109.843 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -32.76 74.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.12 1.768 . . . . 0.56999999999999995 110.626 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.84 -60.45 3.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.98 -2.048 . . . . 0.56999999999999995 107.98 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.55 -58.35 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 119.342 1.571 . . . . 0.56999999999999995 111.151 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 10.6 pt20 -58.56 -22.56 56.16 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.705 0.684 . . . . 0.56999999999999995 112.148 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -31.4 19.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.948 1.299 . . . . 0.56999999999999995 110.777 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.14 -46.14 88.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.157 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.1 p90 -104.88 12.73 32.18 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.379 0.672 . . . . 0.56999999999999995 112.674 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -95.85 -141.85 12.36 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 122.163 0.868 . . . . 0.56999999999999995 112.039 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -143.9 -60.51 0.4 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.039 -1.08 . . . . 0.56999999999999995 110.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 160.61 39.05 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.863 0.865 . . . . 1.2 108.834 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.7 t -164.0 160.58 21.98 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.103 -1.814 . . . . 0.56999999999999995 106.103 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -47.34 14.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.655 -0.498 . . . . 0.56999999999999995 109.655 172.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.3 t 56.61 171.89 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.013 1.387 . . . . 0.56999999999999995 112.641 -170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.06 159.52 41.82 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.922 -1.14 . . . . 1.2 107.922 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.65 171.04 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.943 1.697 . . . . 0.56999999999999995 107.28 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.164 0 C-N-CA 127.124 2.17 . . . . 0.5 . -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.522 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 117.386 -1.293 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 t -138.34 -51.24 0.58 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.991 1.269 . . . . 0.56999999999999995 109.31 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 tp -164.34 173.56 12.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.519 1.528 . . . . 0.56999999999999995 107.258 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -31.36 96.99 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.393 2.277 . . . . 0.56999999999999995 113.404 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.5 84.01 2.03 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.275 2.65 . . . . 0.56999999999999995 110.416 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.14 97.97 7.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.888 -1.051 . . . . 0.56999999999999995 108.988 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 m 44.43 69.76 2.3 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.76 1.624 . . . . 0.56999999999999995 113.727 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.77 108.13 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.53 2.153 . . . . 0.56999999999999995 111.011 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt 91.44 132.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 130.395 3.478 . . . . 0.56999999999999995 109.9 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -64.41 159.46 21.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 110.743 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -76.28 -25.33 54.79 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.715 0.635 . . . . 0.56999999999999995 112.715 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.8 t -94.06 143.03 26.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.9 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 pttm -76.48 -12.22 60.0 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.963 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.85 109.49 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.735 -2.32 . . . . 0.56999999999999995 104.735 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.11 163.86 3.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.67 -1.604 . . . . 0.56999999999999995 106.67 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 p -114.37 147.45 39.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.694 -0.629 . . . . 0.56999999999999995 111.351 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -123.77 155.42 37.96 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.474 0.71 . . . . 0.56999999999999995 110.763 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 120.06 5.8 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.488 0.661 . . . . 1.2 110.052 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 22' ' ' TYR . 29.7 mt -87.02 113.8 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 105.842 -1.91 . . . . 0.56999999999999995 105.842 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.48 -45.66 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.291 0.951 . . . . 0.56999999999999995 111.237 -171.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.7 178.41 4.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.388 -1.708 . . . . 0.56999999999999995 106.388 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 19' ' ' ILE . 49.2 m-85 -142.66 173.81 11.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.454 1.025 . . . . 0.56999999999999995 109.306 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -90.28 -175.5 4.52 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.476 1.11 . . . . 0.56999999999999995 111.251 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -123.96 -34.7 2.95 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.909 1.284 . . . . 1.2 113.491 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -61.86 -27.46 68.8 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.069 1.348 . . . . 0.66000000000000003 111.648 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.47 144.31 20.65 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 126.957 2.103 . . . . 0.56999999999999995 108.436 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 167.45 24.85 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.946 2.431 . . . . 0.56999999999999995 112.863 -166.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.29 -36.24 83.45 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.859 0.864 . . . . 0.65000000000000002 111.903 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.54 -36.87 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.724 0.81 . . . . 0.56999999999999995 110.353 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -67.27 -49.84 62.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.846 -1.549 . . . . 0.56999999999999995 108.39 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.97 -51.03 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 121.217 1.826 . . . . 0.56999999999999995 110.66 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.8 -41.15 96.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.676 0.791 . . . . 0.66000000000000003 111.986 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -62.98 -45.45 92.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.07 0.85 . . . . 1.2 111.772 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.14 -35.08 73.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.45 -0.786 . . . . 0.56999999999999995 109.257 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.23 -49.45 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 117.886 -1.054 . . . . 0.56999999999999995 110.204 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -60.17 -42.79 95.74 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.945 1.248 . . . . 0.56999999999999995 111.076 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -65.05 -47.58 76.87 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.004 0.82 . . . . 0.56999999999999995 111.234 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.99 99.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.127 0.971 . . . . 0.56999999999999995 111.96 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 122' ' ' LEU . 42.8 mt -71.29 -35.54 71.33 Favored 'General case' 0 C--O 1.228 -0.044 0 O-C-N 121.531 -0.731 . . . . 0.56999999999999995 111.427 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -61.96 -41.04 97.54 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.092 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 36.0 mtp -60.71 -40.1 91.03 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.022 -0.99 . . . . 0.56999999999999995 111.206 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.45 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 46.7 m95 -61.89 -50.24 73.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.45 1.477 . . . . 0.56999999999999995 111.844 168.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.24 -8.97 53.22 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.424 1.012 . . . . 0.56999999999999995 114.258 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -66.79 -24.2 66.15 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.117 -1.225 . . . . 0.56999999999999995 111.315 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -111.36 -11.34 14.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 118.445 -0.788 . . . . 0.66000000000000003 111.023 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 pt -140.23 135.41 16.15 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 120.38 1.446 . . . . 0.56999999999999995 110.96 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.87 48.36 2.2 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.52 3.48 . . . . 0.56999999999999995 113.462 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tt -109.43 141.97 41.08 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.507 1.923 . . . . 0.56999999999999995 107.842 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -133.0 163.77 28.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.785 0.834 . . . . 0.65000000000000002 109.002 -168.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.75 145.49 32.43 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.573 -0.899 . . . . 0.56999999999999995 108.573 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -145.33 175.23 10.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.331 1.052 . . . . 1.2 110.274 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -112.17 138.19 49.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.093 -0.706 . . . . 0.56999999999999995 109.093 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.51 -28.96 43.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.097 0.959 . . . . 0.56999999999999995 111.21 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.258 3.7 m 44.88 40.78 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.565 1.946 . . . . 0.56999999999999995 112.72 -176.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -156.47 -38.06 0.08 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.544 1.312 . . . . 0.56999999999999995 114.544 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.83 -146.26 4.52 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.974 -1.25 . . . . 0.56999999999999995 109.974 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -70.72 -173.64 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.0 0.9 . . . . 0.56999999999999995 111.536 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.77 177.37 11.33 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.123 1.369 . . . . 0.56999999999999995 110.403 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -63.66 -36.15 82.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.746 0.819 . . . . 0.66000000000000003 110.097 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mt -120.33 76.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 126.769 2.027 . . . . 0.56999999999999995 107.804 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -72.63 124.07 24.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.973 -1.121 . . . . 0.56999999999999995 107.973 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.27 117.72 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 105.286 -2.116 . . . . 0.56999999999999995 105.286 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.03 161.82 19.47 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.923 -0.871 . . . . 0.56999999999999995 110.923 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -133.83 142.76 47.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.472 -2.048 . . . . 0.56999999999999995 105.472 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.31 166.25 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.962 2.505 . . . . 0.56999999999999995 107.535 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -130.0 93.96 3.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.704 -1.221 . . . . 1.2 107.704 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.06 -49.85 2.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.91 -0.939 . . . . 0.56999999999999995 111.814 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.25 153.04 38.18 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.639 1.72 . . . . 0.56999999999999995 110.897 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -152.04 159.69 43.64 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 125.568 1.547 . . . . 0.65000000000000002 109.158 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.75 44.9 3.04 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.369 1.462 . . . . 0.56999999999999995 112.872 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.67 -179.78 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.577 1.551 . . . . 0.66000000000000003 110.409 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -39.82 -50.07 2.39 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.333 1.453 . . . . 0.56999999999999995 111.791 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -140.89 132.06 13.7 Favored Pre-proline 0 C--N 1.35 0.613 0 C-N-CA 124.611 1.164 . . . . 0.56999999999999995 109.801 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.01 158.76 54.46 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.033 1.822 . . . . 0.56999999999999995 111.204 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.33 -164.48 0.77 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 111.061 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -121.73 -14.08 8.19 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.928 2.491 . . . . 0.66000000000000003 112.408 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.71 -134.82 12.71 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 119.397 0.999 . . . . 0.56999999999999995 110.678 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.51 100.51 1.16 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 112.322 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.91 -163.85 25.55 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.516 1.055 . . . . 0.56999999999999995 112.518 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 t30 45.42 -125.53 1.19 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.465 1.506 . . . . 0.56999999999999995 114.346 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.6 m -74.48 131.91 41.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.635 2.374 . . . . 0.56999999999999995 108.614 173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -100.76 -31.9 10.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.924 1.29 . . . . 0.56999999999999995 112.194 -175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.34 161.34 37.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.945 1.298 . . . . 0.56999999999999995 108.008 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -143.23 161.38 38.41 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.964 -0.46 . . . . 0.65000000000000002 110.029 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.66 144.58 27.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.363 1.065 . . . . 0.56999999999999995 109.167 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.04 146.4 27.96 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.849 -1.167 . . . . 0.56999999999999995 107.849 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.86 155.15 12.07 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 118.502 -0.761 . . . . 0.56999999999999995 110.891 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.48 166.07 26.92 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.121 1.881 . . . . 0.56999999999999995 112.043 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.23 -101.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.3 p -151.36 -54.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.423 1.089 . . . . 0.56999999999999995 110.599 -166.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.7 -108.56 3.24 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 125.086 1.327 . . . . 0.56999999999999995 110.01 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -29.06 64.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.418 1.087 . . . . 0.56999999999999995 111.754 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.33 141.75 6.95 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.201 -0.76 . . . . 0.56999999999999995 111.201 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.99 4.61 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.664 -1.631 . . . . 0.56999999999999995 114.504 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.25 159.47 33.38 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.043 1.921 . . . . 0.66000000000000003 109.074 -171.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.81 145.36 27.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 109.867 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -130.94 155.22 47.16 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.334 -0.617 . . . . 0.65000000000000002 109.334 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -138.08 147.99 44.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.778 1.631 . . . . 0.56999999999999995 108.631 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.39 93.99 8.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.795 0.838 . . . . 0.66000000000000003 108.882 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.85 -22.36 14.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.77 1.628 . . . . 0.66000000000000003 111.568 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.61 -28.81 68.79 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.115 0.416 . . . . 0.66000000000000003 111.572 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -79.89 167.86 19.98 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 111.502 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -79.55 156.39 27.76 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.69 -0.686 . . . . 1.2 110.157 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CZ3' HD11 ' A' ' 112' ' ' ILE . 96.9 m95 -151.28 121.7 7.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.817 -1.919 . . . . 0.56999999999999995 105.817 -175.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -136.15 144.56 45.09 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.871 1.669 . . . . 0.56999999999999995 109.342 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -68.07 -45.5 73.66 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.957 0.503 . . . . 0.66000000000000003 110.596 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.95 39.27 0.02 OUTLIER Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.826 1.679 . . . . 0.56999999999999995 111.43 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 -66.7 0.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.012 1.325 . . . . 0.56999999999999995 110.199 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m -84.44 168.23 15.7 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.461 0.704 . . . . 0.56999999999999995 110.314 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.74 150.21 20.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.241 1.016 . . . . 0.56999999999999995 111.371 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.41 -145.88 15.29 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.709 -0.556 . . . . 0.56999999999999995 111.709 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.401 HD11 ' CZ3' ' A' ' 104' ' ' TRP . 1.3 pp -122.83 142.66 38.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.453 1.101 . . . . 0.56999999999999995 108.21 172.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.7 110.39 1.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.273 0.629 . . . . 0.56999999999999995 111.615 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -67.04 -34.87 78.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.203 1.801 . . . . 0.56999999999999995 113.104 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -39.97 84.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.434 0.561 . . . . 0.56999999999999995 110.217 176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.76 -45.72 81.49 Favored 'General case' 0 C--N 1.342 0.252 0 O-C-N 124.038 0.836 . . . . 0.56999999999999995 108.77 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.42 22.06 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 111.114 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.9 74.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.749 -1.12 . . . . 0.56999999999999995 109.866 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.9 m -51.89 -46.06 64.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.85 1.205 . . . . 0.56999999999999995 111.029 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -61.76 -55.18 32.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.692 0.797 . . . . 0.65000000000000002 109.773 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.43 -41.01 89.83 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.343 0.519 . . . . 0.66000000000000003 110.96 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 HD21 ' A' ' 39' ' ' LEU . 4.5 mm? -63.14 -26.08 68.65 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.42 -0.8 . . . . 0.56999999999999995 111.801 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.45 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -66.58 -44.59 89.54 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 113.003 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -64.28 -38.56 91.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.042 -0.504 . . . . 0.65000000000000002 110.025 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 t -59.4 -33.81 71.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.358 0.503 . . . . 0.56999999999999995 112.358 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -38.43 65.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.992 0.917 . . . . 0.56999999999999995 111.534 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.3 9.75 0.65 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.426 1.013 . . . . 0.56999999999999995 115.224 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -93.99 157.96 15.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.681 1.24 . . . . 0.56999999999999995 110.845 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.35 178.01 21.69 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.513 -1.035 . . . . 0.56999999999999995 110.513 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -72.61 166.66 22.29 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.054 0.542 . . . . 0.65000000000000002 111.439 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.0 t -123.55 -46.35 2.02 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 112.299 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.72 43.71 0.32 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.366 1.467 . . . . 0.56999999999999995 112.831 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -117.29 154.8 50.31 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.609 1.163 . . . . 0.66000000000000003 109.48 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.71 -6.29 18.23 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.527 2.818 . . . . 0.56999999999999995 114.353 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -137.5 17.62 2.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.039 1.336 . . . . 0.56999999999999995 110.378 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.17 130.71 43.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 111.077 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.79 -25.28 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.668 1.187 . . . . 0.56999999999999995 111.752 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.95 21.55 11.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.453 1.501 . . . . 0.56999999999999995 111.357 169.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -58.85 136.3 87.12 Favored Pre-proline 0 CA--C 1.548 0.883 0 O-C-N 120.667 -1.271 . . . . 0.56999999999999995 110.194 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.99 -163.76 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.729 2.953 . . . . 0.56999999999999995 111.819 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t 36.29 77.21 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.524 1.929 . . . . 0.56999999999999995 115.215 168.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -38.91 109.63 0.11 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.919 2.088 . . . . 0.56999999999999995 113.341 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.34 111.34 1.2 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 124.747 1.165 . . . . 0.56999999999999995 110.684 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -179.84 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.61 1.164 . . . . 0.56999999999999995 112.279 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.0 -162.29 11.46 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.475 1.512 . . . . 0.56999999999999995 110.024 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.04 108.88 56.55 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 106.846 -1.538 . . . . 0.66000000000000003 106.846 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.44 -7.6 9.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.31 2.674 . . . . 0.56999999999999995 112.922 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -69.48 -33.38 72.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 121.041 1.746 . . . . 0.56999999999999995 109.684 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.74 86.8 2.26 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.288 1.035 . . . . 0.56999999999999995 112.001 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.76 -50.75 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 111.618 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.99 45.1 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.027 2.131 . . . . 0.56999999999999995 114.85 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp 64.98 79.96 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.841 1.656 . . . . 0.56999999999999995 109.893 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -58.82 -83.48 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.644 1.177 . . . . 0.56999999999999995 113.448 -170.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -142.88 -49.45 0.34 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 125.738 1.615 . . . . 0.56999999999999995 106.643 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.18 -53.4 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.859 2.064 . . . . 0.66000000000000003 112.953 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -51.67 69.08 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.874 0.469 . . . . 0.66000000000000003 110.772 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.07 -38.58 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 109.699 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -49.69 66.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.046 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.6 -52.74 51.28 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.89 0.768 . . . . 0.56999999999999995 111.311 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 mm -61.6 -50.74 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.438 -0.791 . . . . 0.56999999999999995 111.052 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -70.81 -14.08 62.28 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.245 1.384 . . . . 0.56999999999999995 112.143 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -83.26 -25.08 31.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.618 1.099 . . . . 0.56999999999999995 111.829 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.27 -37.44 12.65 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.571 1.078 . . . . 0.56999999999999995 111.9 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -113.06 28.67 8.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.148 1.779 . . . . 0.56999999999999995 109.517 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.73 -137.24 2.66 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.997 2.237 . . . . 0.56999999999999995 108.163 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -135.3 -52.04 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 0.56999999999999995 112.097 -164.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -145.65 142.12 28.76 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.354 1.062 . . . . 1.2 109.124 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.71 125.13 2.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.393 -2.077 . . . . 0.56999999999999995 105.393 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 62.94 -174.94 0.15 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.941 1.296 . . . . 0.56999999999999995 113.333 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.4 t -130.94 177.81 7.15 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.734 1.614 . . . . 0.56999999999999995 108.689 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -83.19 131.19 35.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.79 -1.189 . . . . 1.2 107.79 169.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -159.52 128.44 5.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.143 0.883 . . . . 0.56999999999999995 109.322 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? . . . . . 0 N--CA 1.468 0.444 0 C-N-CA 123.618 0.767 . . . . 0.5 . -169.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.414 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 119.469 -0.301 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -142.71 -36.39 0.39 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.019 0.928 . . . . 0.56999999999999995 110.82 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -60.86 99.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.618 1.199 . . . . 0.56999999999999995 110.111 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -45.59 1.25 Allowed Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.361 1.864 . . . . 0.56999999999999995 112.289 172.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.44 -169.03 0.63 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.75 2.3 . . . . 0.56999999999999995 111.973 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -55.06 166.82 0.48 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.675 0.79 . . . . 0.56999999999999995 110.823 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -45.31 113.79 2.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 124.115 0.966 . . . . 0.56999999999999995 110.499 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.77 176.41 8.28 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.205 1.27 . . . . 0.56999999999999995 110.042 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.23 132.69 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.425 2.29 . . . . 0.56999999999999995 108.186 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG21 ' A' ' 15' ' ' VAL . 13.0 m95 -71.72 175.02 6.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.699 0.8 . . . . 0.56999999999999995 110.422 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.0 p -97.38 -11.7 23.65 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.672 0.619 . . . . 0.56999999999999995 112.672 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.0 t -104.49 151.25 23.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.85 1.66 . . . . 0.56999999999999995 108.675 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -8.91 57.85 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.201 1.001 . . . . 0.56999999999999995 112.449 172.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.66 144.62 37.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.568 1.547 . . . . 0.56999999999999995 108.775 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 10' ' ' TRP . 96.2 t -130.37 153.73 39.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.856 1.262 . . . . 0.56999999999999995 108.098 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 p -103.39 144.02 31.93 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.739 -0.467 . . . . 0.56999999999999995 109.739 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -133.31 152.74 51.94 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.257 -1.527 . . . . 0.56999999999999995 110.895 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.63 111.77 4.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 122.313 1.054 . . . . 1.2 109.626 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.28 101.94 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 104.152 -2.536 . . . . 0.56999999999999995 104.152 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.45 -44.87 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.692 1.197 . . . . 0.56999999999999995 111.651 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.44 174.86 6.12 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.362 1.865 . . . . 0.56999999999999995 106.411 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -146.29 161.16 40.9 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.5 -0.926 . . . . 0.56999999999999995 108.5 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.8 t -63.25 177.73 0.6 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.597 0.713 . . . . 0.56999999999999995 110.913 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -117.67 -39.61 3.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.436 1.094 . . . . 1.2 112.836 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.07 -33.55 73.5 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.231 0.923 . . . . 0.66000000000000003 110.084 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.35 149.7 44.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.56999999999999995 109.811 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -76.73 164.81 29.69 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.918 2.412 . . . . 0.56999999999999995 113.609 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 17.0 m-70 -62.38 -45.52 92.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.898 1.279 . . . . 0.65000000000000002 112.06 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 tp -57.86 -42.21 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 109.672 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -62.46 -48.35 80.04 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 117.759 -1.115 . . . . 0.56999999999999995 109.251 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.43 -49.74 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 120.72 1.6 . . . . 0.56999999999999995 110.679 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.59 -41.34 96.3 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.167 0.894 . . . . 0.66000000000000003 111.404 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.275 -0.891 . . . . 1.2 112.307 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.11 -35.92 74.47 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.998 -1.001 . . . . 0.56999999999999995 109.274 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.03 -51.56 60.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.05 -0.976 . . . . 0.56999999999999995 108.773 166.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -43.61 88.76 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.08 1.309 . . . . 0.56999999999999995 110.878 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -66.89 -38.51 86.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.565 1.075 . . . . 0.56999999999999995 112.807 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.16 76.44 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.341 1.056 . . . . 0.56999999999999995 111.554 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.5 -30.96 68.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.086 -0.959 . . . . 0.56999999999999995 110.278 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.34 -31.76 72.44 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.339 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.8 mtm -74.28 -37.55 63.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.328 -0.844 . . . . 0.56999999999999995 111.66 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -64.9 -50.19 67.49 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 110.681 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -4.91 55.24 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.511 1.529 . . . . 0.56999999999999995 113.956 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -25.68 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.548 -0.972 . . . . 0.56999999999999995 110.211 168.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -110.71 -19.06 12.99 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.695 -0.669 . . . . 0.66000000000000003 112.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 160' ' ' ILE . 32.5 pt -126.35 126.3 24.64 Favored Pre-proline 0 N--CA 1.466 0.348 0 C-N-CA 123.951 0.9 . . . . 0.56999999999999995 109.028 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.95 32.64 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.504 2.803 . . . . 0.56999999999999995 113.557 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 15' ' ' VAL . 1.3 tt -80.89 145.9 31.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.147 1.379 . . . . 0.56999999999999995 108.241 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.444 ' H ' HD23 ' A' ' 48' ' ' LEU . 9.3 m80 -126.54 165.92 18.25 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.65000000000000002 108.47 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.06 157.33 46.56 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.723 -1.236 . . . . 0.56999999999999995 108.511 -172.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.76 160.78 39.12 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.33 1.052 . . . . 1.2 108.857 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -106.9 146.7 30.69 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.438 -1.319 . . . . 0.56999999999999995 107.438 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.1 169.01 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.927 0.491 . . . . 0.56999999999999995 109.793 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.31 -13.79 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.56999999999999995 111.504 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -93.23 -66.02 0.95 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.56999999999999995 108.845 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.48 -27.38 0.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.843 0.292 . . . . 0.56999999999999995 113.05 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 p -78.56 125.72 29.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.845 -1.169 . . . . 0.56999999999999995 107.845 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.3 166.17 26.3 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.973 0.909 . . . . 0.56999999999999995 109.321 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 74.1 m-20 -64.1 -47.19 81.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.11 0.964 . . . . 0.66000000000000003 108.706 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.92 80.0 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.766 1.627 . . . . 0.56999999999999995 107.282 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 ttm -75.48 134.26 40.87 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.77 -1.206 . . . . 0.56999999999999995 107.841 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mt -121.59 119.63 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 105.963 -1.865 . . . . 0.56999999999999995 105.963 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.94 163.92 23.35 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 111.841 -0.504 . . . . 0.56999999999999995 111.841 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.31 134.01 33.74 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.467 -2.049 . . . . 0.56999999999999995 105.467 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.03 -174.04 4.74 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 109.27 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 3.04 8.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.893 0.77 . . . . 1.2 112.813 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.75 -130.67 2.12 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.175 -1.57 . . . . 0.56999999999999995 109.175 -166.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.7 117.13 7.01 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.376 -0.485 . . . . 0.56999999999999995 110.385 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -112.19 -46.8 3.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.558 0.743 . . . . 0.65000000000000002 111.316 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.41 23.41 0.59 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.2 0.905 . . . . 0.56999999999999995 113.893 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -53.18 4.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.515 1.926 . . . . 0.66000000000000003 111.773 -170.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -178.38 -45.41 0.01 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.848 2.059 . . . . 0.56999999999999995 107.646 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.56 139.5 35.48 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 123.852 0.861 . . . . 0.56999999999999995 109.039 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.34 141.4 46.85 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 121.454 1.436 . . . . 0.56999999999999995 109.965 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.75 -179.24 0.84 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.953 1.358 . . . . 0.56999999999999995 111.121 163.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -115.52 -31.23 5.96 Favored 'General case' 0 CA--C 1.542 0.666 1 C-N-CA 131.92 4.088 . . . . 0.66000000000000003 109.931 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.08 -138.03 15.65 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 110.668 -0.973 . . . . 0.56999999999999995 110.668 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 104.1 1.69 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.803 3.002 . . . . 0.56999999999999995 112.148 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -179.75 16.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 126.004 1.764 . . . . 0.56999999999999995 108.891 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.74 -155.66 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 112.86 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.7 m -44.87 120.39 2.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.365 2.266 . . . . 0.56999999999999995 111.534 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.18 -25.13 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.888 1.275 . . . . 0.56999999999999995 113.106 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.22 164.34 25.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.353 1.461 . . . . 0.56999999999999995 108.367 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.03 158.74 44.42 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.998 -0.371 . . . . 0.65000000000000002 109.998 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.0 155.74 39.68 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.725 1.21 . . . . 0.56999999999999995 109.808 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.05 171.65 7.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.289 0.636 . . . . 0.56999999999999995 110.596 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.55 139.08 26.48 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-O 118.245 -0.884 . . . . 0.56999999999999995 109.363 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 50.3 Cg_endo -67.49 159.37 52.77 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.578 2.186 . . . . 0.56999999999999995 112.166 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.28 12.72 21.09 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.351 -0.694 . . . . 0.56999999999999995 113.752 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -153.47 43.73 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.55 1.675 . . . . 0.56999999999999995 111.933 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.37 -71.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.168 1.842 . . . . 0.56999999999999995 114.69 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.06 -5.05 39.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.372 1.869 . . . . 0.56999999999999995 111.437 163.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 126.92 31.59 Favored Glycine 0 N--CA 1.445 -0.754 0 O-C-N 120.979 -1.075 . . . . 0.56999999999999995 110.446 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.28 -44.33 1.5 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 126.046 1.784 . . . . 0.56999999999999995 110.845 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.09 143.75 13.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.105 2.162 . . . . 0.66000000000000003 109.199 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.07 150.36 42.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.633 0.73 . . . . 0.56999999999999995 109.535 -169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.47 162.96 31.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.943 -0.762 . . . . 0.65000000000000002 108.943 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -139.59 158.45 44.1 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.497 1.919 . . . . 0.56999999999999995 109.344 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -84.45 102.35 12.73 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.655 0.382 . . . . 0.66000000000000003 110.999 171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -58.23 -28.44 64.87 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.605 -1.309 . . . . 0.66000000000000003 111.116 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.46 -26.71 66.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.609 0.763 . . . . 0.66000000000000003 111.581 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -72.37 138.93 47.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.203 1.002 . . . . 0.66000000000000003 109.608 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.12 111.79 4.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -94.24 158.64 15.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.409 -0.96 . . . . 0.56999999999999995 108.409 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.3 t -141.19 153.53 45.37 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.313 -0.995 . . . . 0.56999999999999995 108.313 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.55 -36.43 70.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.331 0.652 . . . . 0.66000000000000003 110.162 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.65 -97.36 1.47 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.102 -1.199 . . . . 0.56999999999999995 110.102 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t -158.17 139.31 13.29 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.728 -1.212 . . . . 0.56999999999999995 107.728 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 t -163.82 -51.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.836 -0.602 . . . . 0.56999999999999995 110.491 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -160.38 -44.12 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.001 1.72 . . . . 0.56999999999999995 110.895 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.77 173.43 54.71 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.536 -1.026 . . . . 0.56999999999999995 110.536 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.422 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -83.66 148.78 4.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.236 0.541 . . . . 0.56999999999999995 109.816 177.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -65.39 114.58 4.91 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.67 -0.695 . . . . 0.56999999999999995 109.488 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -60.92 -41.11 95.52 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.524 1.13 . . . . 0.56999999999999995 111.573 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.73 -47.44 84.61 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 108.787 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -60.56 -39.25 87.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.061 0.944 . . . . 0.56999999999999995 110.051 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.42 49.48 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 112.765 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.76 68.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.219 -1.03 . . . . 0.56999999999999995 108.219 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 m -56.1 -41.23 74.88 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.336 0.654 . . . . 0.56999999999999995 111.758 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.08 -57.79 11.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.953 0.342 . . . . 0.65000000000000002 110.109 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -68.11 -39.96 82.68 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.042 -1.036 . . . . 0.66000000000000003 111.609 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.38 -32.72 74.51 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 110.818 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.57 -47.35 57.67 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.166 -0.774 . . . . 0.56999999999999995 111.166 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.48 -35.35 70.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.556 0.576 . . . . 0.65000000000000002 112.556 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -35.85 73.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 0.56999999999999995 111.02 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.37 -46.5 89.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.562 0.745 . . . . 0.56999999999999995 110.71 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.51 49.19 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.533 -0.593 . . . . 0.56999999999999995 113.951 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.72 -160.1 0.17 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 119.029 1.414 . . . . 0.56999999999999995 110.724 -173.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 132.65 35.22 0.32 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 121.427 -0.796 . . . . 0.56999999999999995 113.659 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 167.8 7.2 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.219 1.009 . . . . 0.65000000000000002 112.856 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.9 p -152.95 -173.33 4.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.584 1.153 . . . . 0.56999999999999995 110.208 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.8 p -143.48 49.73 1.41 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.703 1.201 . . . . 0.56999999999999995 110.949 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 143.87 27.91 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.08 1.352 . . . . 0.66000000000000003 110.239 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.28 -12.27 29.7 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.455 2.103 . . . . 0.56999999999999995 113.743 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -137.22 51.14 1.96 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.685 1.594 . . . . 0.56999999999999995 107.909 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.21 43.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.637 1.575 . . . . 0.56999999999999995 108.059 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.86 -27.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.56999999999999995 109.381 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.2 mmt -78.14 -14.96 59.27 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.649 1.979 . . . . 0.56999999999999995 114.154 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -58.8 128.25 83.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 120.009 1.277 . . . . 0.56999999999999995 110.605 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.05 156.8 47.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.248 1.966 . . . . 0.56999999999999995 110.642 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.5 m 61.14 99.35 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.207 1.403 . . . . 0.56999999999999995 111.473 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -40.89 123.98 2.05 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 111.883 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.68 -130.86 2.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.162 -1.575 . . . . 0.56999999999999995 109.162 -173.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -65.12 -61.55 2.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.537 0.668 . . . . 0.56999999999999995 110.446 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 39.88 -150.45 0.11 Allowed Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.305 1.431 . . . . 0.56999999999999995 113.409 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -156.24 75.36 4.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.266 -1.012 . . . . 0.66000000000000003 108.266 167.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.0 39.8 0.3 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.962 3.108 . . . . 0.56999999999999995 112.822 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -144.76 -54.51 0.32 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 108.436 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.03 89.11 3.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.0 1.32 . . . . 0.56999999999999995 108.43 -170.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -44.34 -63.24 0.92 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.479 1.511 . . . . 0.56999999999999995 114.906 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt 31.49 63.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.915 2.486 . . . . 0.56999999999999995 113.479 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -25.8 115.13 0.05 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 128.781 2.832 . . . . 0.56999999999999995 110.874 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.3 t -82.66 -82.26 0.14 Allowed 'General case' 0 C--N 1.341 0.204 0 CA-C-O 119.051 -0.5 . . . . 0.56999999999999995 111.022 -162.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -147.94 -44.12 0.16 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 118.531 0.605 . . . . 0.56999999999999995 110.364 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.26 -49.22 9.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.903 2.081 . . . . 0.66000000000000003 112.933 164.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.53 -54.76 23.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.808 0.843 . . . . 0.66000000000000003 109.833 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.98 -41.68 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.349 1.06 . . . . 0.56999999999999995 109.108 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -57.14 13.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.916 -1.142 . . . . 0.56999999999999995 107.916 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.417 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -51.1 -53.9 25.32 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.523 -1.031 . . . . 0.56999999999999995 110.523 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 46' ' ' ILE . 20.1 mm -50.86 -50.73 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.479 0.712 . . . . 0.56999999999999995 111.294 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.37 -31.01 70.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.43 0.559 . . . . 0.56999999999999995 112.241 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -24.41 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.653 -1.165 . . . . 0.56999999999999995 110.814 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 159' ' ' GLY . 9.0 mp -93.01 -49.78 5.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.243 1.017 . . . . 0.56999999999999995 110.667 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -144.43 30.07 1.25 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.841 0.856 . . . . 0.56999999999999995 112.077 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.54 -124.04 1.64 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.253 -1.139 . . . . 0.56999999999999995 110.253 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.79 -58.71 0.4 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.189 0.595 . . . . 0.56999999999999995 111.06 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.01 131.34 15.6 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 107.255 -1.387 . . . . 1.2 107.255 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.19 81.34 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.96 -1.867 . . . . 0.56999999999999995 105.96 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -161.16 141.1 10.77 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.488 -1.301 . . . . 0.56999999999999995 107.488 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.0 t -169.95 -57.34 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.036 0.935 . . . . 0.56999999999999995 108.846 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 57.15 171.76 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.809 2.044 . . . . 1.2 111.806 -170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.58 56.9 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.868 -1.145 . . . . 0.56999999999999995 110.578 172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.47 0.566 0 C-N-CA 125.392 1.477 . . . . 0.5 . -175.454 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.249 0.071 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 t -76.21 -91.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 108.42 169.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.46 24.13 0.41 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.619 1.1 . . . . 0.56999999999999995 113.613 -173.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -139.85 66.84 34.38 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 110.632 -175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 64.15 5.12 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.539 2.826 . . . . 0.56999999999999995 111.507 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.81 73.15 1.52 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 125.299 1.44 . . . . 0.56999999999999995 108.559 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m 42.36 75.13 0.66 Allowed Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 112.385 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.89 123.8 11.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.363 2.042 . . . . 0.56999999999999995 109.115 -173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 80.38 128.5 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 129.05 2.94 . . . . 0.56999999999999995 111.075 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -61.59 157.86 16.48 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.605 0.762 . . . . 0.56999999999999995 110.491 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.1 p -78.28 -34.38 48.94 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.475 . . . . 0.56999999999999995 111.508 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 t -82.93 139.12 33.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.197 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -76.29 -2.79 33.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.5 0.72 . . . . 0.56999999999999995 112.75 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.96 113.84 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.855 -2.276 . . . . 0.56999999999999995 104.855 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 p -114.71 139.85 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.876 -1.527 . . . . 0.56999999999999995 106.876 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 149.31 35.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.603 -0.686 . . . . 0.56999999999999995 111.283 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.44 157.12 35.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.56999999999999995 110.571 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 119.62 11.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.941 -0.763 . . . . 1.2 108.941 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -87.82 99.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 104.982 -2.229 . . . . 0.56999999999999995 104.982 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -48.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.504 1.122 . . . . 0.56999999999999995 111.712 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.84 175.46 5.57 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.151 1.78 . . . . 0.56999999999999995 106.455 174.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -144.42 164.87 29.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.6 t -67.84 -175.32 0.54 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.57 0.748 . . . . 0.56999999999999995 111.632 171.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.23 -38.16 1.8 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.704 1.202 . . . . 1.2 113.12 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.7 -43.9 93.88 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.345 0.658 . . . . 0.66000000000000003 109.985 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.0 149.1 39.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.627 1.971 . . . . 0.56999999999999995 108.606 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -75.11 160.31 39.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.311 2.007 . . . . 0.56999999999999995 112.66 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.84 -38.99 83.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.353 1.061 . . . . 0.65000000000000002 111.669 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.75 -39.58 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.296 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.8 m -68.01 -43.62 78.42 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 116.442 -1.742 . . . . 0.56999999999999995 109.013 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.97 -51.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 121.455 1.934 . . . . 0.56999999999999995 110.736 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.33 -40.99 94.4 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.197 0.908 . . . . 0.66000000000000003 111.352 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -42.74 97.65 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.852 1.206 . . . . 1.2 112.048 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' A' ' 115' ' ' LEU . 7.8 mp -63.55 -48.65 76.6 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.598 1.559 . . . . 0.56999999999999995 108.402 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.9 t -56.64 -41.61 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.977 0.808 . . . . 0.56999999999999995 110.763 171.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -60.51 -53.25 59.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.499 1.045 . . . . 0.56999999999999995 109.644 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -39.19 93.22 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.285 0.948 . . . . 0.56999999999999995 111.624 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.96 93.74 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.943 1.297 . . . . 0.56999999999999995 111.984 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 HD12 ' A' ' 122' ' ' LEU . 30.5 mt -70.42 -33.78 71.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.396 -0.812 . . . . 0.56999999999999995 110.322 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.97 -37.3 76.48 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 118.808 0.731 . . . . 0.56999999999999995 110.546 171.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -35.52 80.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.91 0.777 . . . . 0.56999999999999995 112.268 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.427 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 17.7 m95 -73.03 -47.56 43.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.764 0.711 . . . . 0.56999999999999995 110.823 171.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.07 -12.87 63.54 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.562 1.077 . . . . 0.56999999999999995 113.53 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -66.32 -17.47 64.78 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 121.113 -1.227 . . . . 0.56999999999999995 111.863 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.2 mm-40 -106.41 -33.86 7.6 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.75 -0.643 . . . . 0.66000000000000003 111.332 173.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 160' ' ' ILE . 21.4 pt -121.54 134.17 24.47 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 119.455 1.025 . . . . 0.56999999999999995 110.39 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 37.27 0.38 Allowed 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.9 3.067 . . . . 0.56999999999999995 113.055 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.06 132.84 36.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.021 -1.474 . . . . 0.56999999999999995 107.021 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -116.44 163.97 15.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.89 1.276 . . . . 0.65000000000000002 108.915 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -139.6 153.47 47.37 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.231 -0.918 . . . . 0.56999999999999995 108.962 -170.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -141.04 178.68 7.21 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.179 0.991 . . . . 1.2 109.461 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -125.35 156.07 39.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.538 -0.912 . . . . 0.56999999999999995 108.538 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 m -108.19 169.53 3.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.998 1.319 . . . . 0.56999999999999995 109.319 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.77 -29.37 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.71 -1.586 . . . . 0.56999999999999995 110.948 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -62.69 -51.83 65.67 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.187 0.903 . . . . 0.56999999999999995 111.719 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.64 -125.2 1.32 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.072 -1.611 . . . . 0.56999999999999995 109.072 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -47.14 154.85 0.34 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.443 1.097 . . . . 0.56999999999999995 113.744 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.87 -174.18 4.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.176 1.39 . . . . 0.56999999999999995 110.943 -170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -60.51 -42.09 95.7 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.54 -0.743 . . . . 0.66000000000000003 109.001 172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -124.19 82.0 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.56999999999999995 108.375 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.3 ttp -79.89 117.32 20.65 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 120.294 -1.504 . . . . 0.56999999999999995 107.116 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.0 mt -108.62 129.09 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.25 -2.13 . . . . 0.56999999999999995 105.25 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 164.77 27.64 Favored Glycine 0 C--O 1.226 -0.365 0 CA-C-O 121.962 0.756 . . . . 0.56999999999999995 112.176 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.9 m-85 -132.43 141.4 48.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.026 -1.842 . . . . 0.56999999999999995 106.026 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.38 164.69 30.08 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 107.916 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.03 42.08 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.564 -0.71 . . . . 1.2 111.182 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.15 -46.29 0.61 Allowed Glycine 0 C--O 1.223 -0.586 0 CA-C-O 119.53 -0.594 . . . . 0.56999999999999995 111.658 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.03 169.32 21.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.567 1.184 . . . . 0.56999999999999995 110.245 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.76 159.92 33.33 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.969 1.708 . . . . 0.65000000000000002 108.829 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.65 60.78 3.19 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.888 1.232 . . . . 0.56999999999999995 111.412 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -105.78 -61.84 1.45 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.111 0.965 . . . . 0.66000000000000003 110.406 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.5 t -179.74 -35.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.364 2.665 . . . . 0.56999999999999995 110.003 -173.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.75 122.7 14.54 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 119.193 0.906 . . . . 0.56999999999999995 108.992 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.99 133.13 34.56 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 N-CA-C 108.423 -1.414 . . . . 0.56999999999999995 108.423 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -166.93 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 123.257 1.504 . . . . 0.56999999999999995 110.809 166.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -134.01 -38.25 0.88 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.76 3.224 . . . . 0.66000000000000003 109.172 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.74 -139.68 14.97 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.672 -1.071 . . . . 0.56999999999999995 110.509 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.1 95.43 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 124.466 3.444 . . . . 0.56999999999999995 111.281 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.64 170.85 12.33 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.849 1.69 . . . . 0.56999999999999995 109.29 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 49.33 -159.6 0.06 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.485 1.514 . . . . 0.56999999999999995 112.377 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -43.05 128.18 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.242 2.217 . . . . 0.56999999999999995 112.848 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.1 mp -95.53 -24.33 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.641 1.576 . . . . 0.56999999999999995 113.062 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.09 162.0 33.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.629 -1.249 . . . . 0.56999999999999995 107.629 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.3 167.83 22.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.321 -0.622 . . . . 0.65000000000000002 109.321 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.39 160.28 42.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.285 -1.006 . . . . 0.56999999999999995 108.285 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -111.45 147.07 36.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.688 -1.227 . . . . 0.56999999999999995 107.688 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.73 151.4 53.22 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.268 -0.872 . . . . 0.56999999999999995 110.249 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.13 164.85 23.72 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.95 1.767 . . . . 0.56999999999999995 111.585 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.12 -93.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 109.357 -1.497 . . . . 0.56999999999999995 109.357 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -158.92 -50.61 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.503 1.521 . . . . 0.56999999999999995 109.709 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.52 -119.73 2.13 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.707 -0.957 . . . . 0.56999999999999995 110.707 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.96 -31.49 40.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.996 0.898 . . . . 0.56999999999999995 111.879 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.2 142.44 7.97 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.509 -0.744 . . . . 0.56999999999999995 112.135 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.4 -38.9 3.12 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.186 1.851 . . . . 0.56999999999999995 112.625 -175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -60.36 149.78 32.71 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.759 -0.83 . . . . 0.66000000000000003 108.759 -167.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.61 146.98 38.68 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.522 0.677 . . . . 0.56999999999999995 109.25 -171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -135.39 156.2 49.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.265 -0.879 . . . . 0.65000000000000002 109.975 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 47.0 m-85 -137.82 146.15 43.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.019 1.327 . . . . 0.56999999999999995 108.081 -169.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -79.02 101.61 7.91 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.455 -0.942 . . . . 0.66000000000000003 108.455 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -59.08 -24.34 62.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.375 1.07 . . . . 0.66000000000000003 111.885 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -69.12 -36.05 77.08 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.577 0.751 . . . . 0.66000000000000003 111.215 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.86 131.26 44.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.441 -1.689 . . . . 0.66000000000000003 106.441 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 139.69 48.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.635 0.774 . . . . 1.2 110.441 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -129.32 118.27 21.99 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.232 -1.395 . . . . 0.56999999999999995 107.232 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -114.93 147.99 39.28 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.38 -0.97 . . . . 0.56999999999999995 108.38 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.94 21.83 2.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.624 0.77 . . . . 0.66000000000000003 111.981 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.03 68.95 1.29 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.399 -1.08 . . . . 0.56999999999999995 110.399 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.48 -40.04 4.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.984 -1.007 . . . . 0.56999999999999995 113.697 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.0 -47.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.209 1.804 . . . . 0.56999999999999995 110.621 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -139.09 155.2 48.09 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.354 1.462 . . . . 0.56999999999999995 108.131 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.63 -161.47 12.85 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.236 -1.546 . . . . 0.56999999999999995 109.236 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.2 mm -113.36 121.19 65.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 105.712 -1.959 . . . . 0.56999999999999995 105.712 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -61.23 103.47 0.3 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.984 0.803 . . . . 0.56999999999999995 109.072 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -53.27 -41.16 65.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.607 1.563 . . . . 0.56999999999999995 110.399 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' A' ' 34' ' ' LEU . 13.3 tp -64.42 -50.36 67.9 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.694 -1.225 . . . . 0.56999999999999995 107.694 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -60.35 -39.51 87.41 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.232 -0.655 . . . . 0.56999999999999995 109.232 -176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.04 -61.69 2.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 110.458 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.85 -51.49 65.74 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.235 0.614 . . . . 0.56999999999999995 110.095 -175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.8 m -62.51 -37.71 87.09 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.438 0.695 . . . . 0.56999999999999995 112.062 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -60.65 -53.95 51.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.196 0.598 . . . . 0.65000000000000002 109.393 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.78 -40.43 96.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.258 0.481 . . . . 0.66000000000000003 110.652 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 39' ' ' LEU . 2.9 mm? -61.26 -30.0 70.19 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.878 0.871 . . . . 0.56999999999999995 111.37 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.427 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -56.29 -51.83 53.55 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 118.472 0.578 . . . . 0.56999999999999995 112.083 170.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.01 -40.42 93.47 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.203 1.001 . . . . 0.65000000000000002 110.635 177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -33.36 65.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.115 0.966 . . . . 0.56999999999999995 112.173 172.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.91 66.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 111.648 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.82 63.88 0.88 Allowed Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.446 -0.662 . . . . 0.56999999999999995 111.446 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.6 176.84 8.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 109.141 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -95.44 148.44 18.99 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.868 -0.605 . . . . 0.56999999999999995 111.929 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 174.86 0.06 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.117 1.367 . . . . 0.65000000000000002 113.045 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -133.74 178.31 7.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.599 1.16 . . . . 0.56999999999999995 110.983 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.486 ' HB3' ' HE3' ' A' ' 172' ' ' LYS . 1.3 t -165.39 47.06 0.09 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.358 1.863 . . . . 0.56999999999999995 108.212 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.7 t70 -121.63 143.23 37.56 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-O 118.269 -0.872 . . . . 0.66000000000000003 109.708 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.7 2.49 2.92 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.696 2.931 . . . . 0.56999999999999995 114.098 -171.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -146.98 20.57 1.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.432 1.093 . . . . 0.56999999999999995 110.358 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -72.11 140.57 48.94 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.341 0.656 . . . . 0.56999999999999995 110.463 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.56 -35.25 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.37 -0.974 . . . . 0.56999999999999995 108.37 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -86.85 14.15 7.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.949 1.092 . . . . 0.56999999999999995 113.949 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.07 128.26 93.61 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.496 -1.377 . . . . 0.56999999999999995 111.137 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.62 -46.51 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.765 1.643 . . . . 0.56999999999999995 111.551 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 p -81.32 52.05 1.75 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.141 1.377 . . . . 0.56999999999999995 110.323 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -39.86 131.91 1.82 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.139 2.176 . . . . 0.56999999999999995 112.902 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.7 114.9 2.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.212 1.387 . . . . 0.56999999999999995 109.657 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 179.61 -58.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.183 1.393 . . . . 0.56999999999999995 109.349 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.38 -138.52 9.65 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.841 1.21 . . . . 0.56999999999999995 110.343 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -127.38 111.29 21.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 108.853 -0.795 . . . . 0.66000000000000003 108.853 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.33 -15.22 22.65 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.814 2.342 . . . . 0.56999999999999995 113.015 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -62.57 -36.46 82.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.487 1.04 . . . . 0.56999999999999995 110.252 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -90.53 70.0 6.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.947 1.299 . . . . 0.56999999999999995 108.772 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -41.73 -68.45 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.773 1.629 . . . . 0.56999999999999995 115.23 -176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 21.58 74.59 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.386 2.674 . . . . 0.56999999999999995 112.633 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.4 mp -31.37 116.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 128.022 2.529 . . . . 0.56999999999999995 109.742 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.6 t -82.2 -88.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.843 0.354 . . . . 0.56999999999999995 110.998 -162.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -142.43 -30.51 0.55 Allowed 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 124.315 1.046 . . . . 0.56999999999999995 110.774 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -51.54 -45.71 63.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 120.027 1.285 . . . . 0.66000000000000003 110.795 167.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.406 ' CG ' HD23 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -72.76 -58.59 3.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 124.479 1.112 . . . . 0.66000000000000003 111.023 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.56 -46.72 89.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.892 -0.781 . . . . 0.56999999999999995 108.892 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -60.51 -49.8 76.12 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 117.046 -1.454 . . . . 0.56999999999999995 108.864 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -54.18 -59.54 9.83 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.937 -1.265 . . . . 0.56999999999999995 109.937 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 46' ' ' ILE . 6.6 mm -56.22 -50.22 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.933 1.293 . . . . 0.56999999999999995 112.776 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -69.28 -19.75 63.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.476 0.71 . . . . 0.56999999999999995 111.55 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -81.77 -25.96 34.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.13 0.972 . . . . 0.56999999999999995 111.178 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 -50.59 10.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.348 0.976 . . . . 0.56999999999999995 111.237 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' A' ' 46' ' ' ILE . 39.4 m-85 -105.0 41.63 1.32 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.548 1.139 . . . . 0.56999999999999995 108.74 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.46 -101.26 0.15 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 109.52 -1.432 . . . . 0.56999999999999995 109.52 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.34 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.904 1.075 . . . . 0.56999999999999995 113.904 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -178.41 164.27 1.67 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.325 2.25 . . . . 1.2 108.054 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -160.71 136.84 8.43 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.266 -1.383 . . . . 0.56999999999999995 107.266 168.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.13 162.68 0.07 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.574 1.549 . . . . 0.56999999999999995 112.951 -173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.0 p -162.81 89.9 0.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.843 0.83 . . . . 0.56999999999999995 109.082 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.39 157.98 43.12 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.579 -0.897 . . . . 1.2 108.579 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 132' ' ' SER . 0.2 OUTLIER -157.83 139.35 13.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.62 -1.622 . . . . 0.56999999999999995 106.62 173.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 125.575 1.55 . . . . 0.5 . 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 119.982 -0.056 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 3' ' ' LEU . 5.9 m -69.87 -51.61 31.8 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 121.032 -1.043 . . . . 0.56999999999999995 111.662 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 2' ' ' SER . 1.2 mp -146.44 -61.68 0.31 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.848 0.859 . . . . 0.56999999999999995 109.585 -176.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -69.08 120.71 78.33 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.188 -0.911 . . . . 0.56999999999999995 109.461 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.07 -25.66 7.16 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.58 2.187 . . . . 0.56999999999999995 112.412 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -117.35 126.07 52.09 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 105.171 -2.159 . . . . 0.56999999999999995 105.171 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m 135.35 -56.58 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 1 C-N-CA 132.181 4.192 . . . . 0.56999999999999995 111.21 -170.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 163.37 33.98 Favored 'Trans proline' 0 C--N 1.353 0.786 0 CA-C-N 121.974 1.741 . . . . 0.56999999999999995 110.988 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? 62.78 95.52 0.04 OUTLIER 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.696 1.198 . . . . 0.56999999999999995 110.384 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -46.21 142.71 2.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.571 1.148 . . . . 0.56999999999999995 110.7 172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.9 m -62.06 -21.13 64.69 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.039 0.936 . . . . 0.56999999999999995 112.456 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 t -94.94 143.7 26.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.886 1.275 . . . . 0.56999999999999995 109.536 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -77.19 0.18 22.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.539 0.736 . . . . 0.56999999999999995 112.533 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.34 144.05 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.113 -1.439 . . . . 0.56999999999999995 107.113 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.07 145.8 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.412 -1.699 . . . . 0.56999999999999995 106.412 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -109.11 139.07 44.5 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.431 1.014 . . . . 0.56999999999999995 110.131 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -122.37 157.5 31.69 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.697 0.761 . . . . 0.56999999999999995 111.088 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.552 1.141 . . . . 1.2 109.114 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.477 HG21 ' CE1' ' A' ' 22' ' ' TYR . 1.6 mm -122.22 97.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 104.472 -2.418 . . . . 0.56999999999999995 104.472 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.19 -34.71 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.391 0.676 . . . . 0.56999999999999995 111.954 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -130.44 141.31 50.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.357 -2.46 . . . . 0.56999999999999995 104.357 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.477 ' CE1' HG21 ' A' ' 19' ' ' ILE . 23.2 m-85 -129.86 146.56 51.59 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.581 1.152 . . . . 0.56999999999999995 108.931 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 t -75.9 -175.67 3.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.525 1.93 . . . . 0.56999999999999995 111.063 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -128.25 -27.75 2.66 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.595 0.961 . . . . 1.2 113.595 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.82 -23.56 67.33 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.848 1.204 . . . . 0.66000000000000003 111.519 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.36 146.95 24.15 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.097 1.759 . . . . 0.56999999999999995 109.43 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -75.29 161.73 37.45 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.736 2.291 . . . . 0.56999999999999995 112.96 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -70.42 -38.58 74.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.364 -0.835 . . . . 0.65000000000000002 110.315 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.52 -37.13 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 110.44 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 m -66.37 -46.33 77.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.419 -1.277 . . . . 0.56999999999999995 109.057 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.5 t -55.59 -50.65 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 110.121 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.36 -35.29 80.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 111.736 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -44.28 74.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.426 1.012 . . . . 1.2 112.314 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.09 -46.88 82.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.56999999999999995 108.112 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.86 -44.53 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 117.568 -1.206 . . . . 0.56999999999999995 111.244 173.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -54.64 -49.97 69.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.48 1.491 . . . . 0.56999999999999995 111.388 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -74.57 -33.36 62.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.155 0.889 . . . . 0.56999999999999995 112.198 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.5 78.88 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.373 1.069 . . . . 0.56999999999999995 110.949 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 122' ' ' LEU . 49.0 mt -66.76 -41.06 88.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.151 -0.928 . . . . 0.56999999999999995 109.397 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -52.88 -43.19 65.97 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 119.402 1.001 . . . . 0.56999999999999995 110.684 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.5 mtp -59.32 -39.03 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.062 1.301 . . . . 0.56999999999999995 112.597 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -65.39 -43.44 90.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.861 1.209 . . . . 0.56999999999999995 110.964 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.9 88.09 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.66 -1.275 . . . . 0.56999999999999995 113.528 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -77.45 -12.89 60.01 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 110.104 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -109.06 -21.04 12.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.828 1.251 . . . . 0.66000000000000003 111.909 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 164' ' ' TYR . 7.9 pt -139.18 152.94 70.74 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 110.137 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.06 13.55 1.25 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.11 2.54 . . . . 0.56999999999999995 113.021 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tt -82.18 135.23 35.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.455 -1.313 . . . . 0.56999999999999995 107.455 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -116.79 170.45 8.59 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.553 0.741 . . . . 0.65000000000000002 109.516 -172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 157.76 41.92 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.472 -0.768 . . . . 0.56999999999999995 109.203 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.16 164.57 26.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.366 1.466 . . . . 1.2 108.357 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -135.65 115.83 13.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.123 -2.177 . . . . 0.56999999999999995 105.123 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.46 164.92 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.617 0.767 . . . . 0.56999999999999995 109.023 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.02 -36.51 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.265 0.626 . . . . 0.56999999999999995 111.084 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 153.31 19.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.148 0.579 . . . . 0.56999999999999995 110.662 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.48 40.57 2.42 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.358 0.98 . . . . 0.56999999999999995 113.076 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -163.8 143.13 8.03 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.687 -1.227 . . . . 0.56999999999999995 107.687 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.54 6.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.669 1.188 . . . . 0.56999999999999995 109.596 -174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -64.48 -32.29 73.86 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.18 -0.674 . . . . 0.66000000000000003 109.18 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 122' ' ' LEU . 5.5 mt -124.43 97.12 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.724 2.01 . . . . 0.56999999999999995 107.728 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 ttp -100.23 100.15 10.93 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.305 2.642 . . . . 0.56999999999999995 106.341 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mt -92.77 128.08 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.005 -1.85 . . . . 0.56999999999999995 106.005 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.47 145.11 11.61 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.424 -0.67 . . . . 0.56999999999999995 111.424 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 142.21 47.45 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.23 165.59 26.31 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.565 1.546 . . . . 0.56999999999999995 108.373 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.9 22.82 11.54 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.559 -0.713 . . . . 1.2 111.481 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 156.59 31.2 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.593 1.568 . . . . 0.56999999999999995 109.81 -164.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 49.86 102.38 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.059 2.144 . . . . 0.56999999999999995 114.201 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -147.33 157.44 43.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.476 1.111 . . . . 0.65000000000000002 109.035 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.59 62.23 4.05 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.3 0.952 . . . . 0.56999999999999995 111.192 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -106.83 -55.28 2.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 117.381 0.591 . . . . 0.66000000000000003 111.105 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.86 -43.18 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.814 2.846 . . . . 0.56999999999999995 109.594 -168.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -142.83 121.61 7.47 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.019 -172.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.53 140.25 35.92 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.972 1.781 . . . . 0.56999999999999995 111.544 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -72.41 173.39 8.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.304 1.042 . . . . 0.56999999999999995 111.797 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.78 -31.51 15.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.937 2.095 . . . . 0.66000000000000003 112.41 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.04 -132.47 11.11 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 120.862 1.664 . . . . 0.56999999999999995 111.516 -171.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.48 103.86 1.43 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 112.171 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.46 -167.06 25.65 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.682 2.087 . . . . 0.56999999999999995 111.428 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.99 -140.43 0.71 Allowed 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.025 -1.279 . . . . 0.56999999999999995 114.152 164.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -51.18 137.2 22.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.042 2.137 . . . . 0.56999999999999995 110.535 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.68 -30.54 10.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.618 1.567 . . . . 0.56999999999999995 111.294 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.39 165.6 28.65 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.059 1.344 . . . . 0.56999999999999995 108.987 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.85 159.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.565 0.62 . . . . 0.65000000000000002 111.447 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.13 147.09 34.41 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.446 0.698 . . . . 0.56999999999999995 110.011 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -98.67 150.86 21.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.005 -0.998 . . . . 0.56999999999999995 109.414 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.49 150.23 86.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.543 -0.741 . . . . 0.56999999999999995 110.298 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -69.29 162.53 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.234 1.956 . . . . 0.56999999999999995 111.509 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.71 -93.35 0.1 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.258 -1.537 . . . . 0.56999999999999995 109.258 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -160.61 123.0 3.22 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.653 0.726 . . . . 0.56999999999999995 110.14 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.42 -123.32 7.47 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-O 118.187 -1.34 . . . . 0.56999999999999995 110.23 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.04 -24.4 39.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 112.364 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.25 143.14 12.75 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 120.939 -1.101 . . . . 0.56999999999999995 111.468 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.99 -21.63 2.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.371 1.462 . . . . 0.56999999999999995 114.13 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -70.51 159.47 34.23 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.02 1.91 . . . . 0.66000000000000003 108.692 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.65 141.3 28.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.198 -0.668 . . . . 0.56999999999999995 109.198 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -130.7 158.4 40.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.713 -0.477 . . . . 0.65000000000000002 109.713 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.08 146.83 34.16 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.744 -1.206 . . . . 0.56999999999999995 107.744 -169.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.96 98.35 3.57 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.823 -0.806 . . . . 0.66000000000000003 108.823 174.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.12 -16.82 62.65 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.431 -1.418 . . . . 0.66000000000000003 111.87 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.64 -33.74 76.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.564 1.546 . . . . 0.66000000000000003 110.961 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -76.4 157.17 32.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.629 0.728 . . . . 0.66000000000000003 109.82 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 135.73 38.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.282 -0.636 . . . . 1.2 109.282 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -126.98 151.87 47.96 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.147 -1.057 . . . . 0.56999999999999995 108.147 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -154.1 167.94 28.13 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.801 0.728 . . . . 0.56999999999999995 110.435 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.0 -32.1 45.04 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.396 1.079 . . . . 0.66000000000000003 112.258 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.97 88.01 0.74 Allowed Glycine 0 C--N 1.343 0.92 0 C-N-CA 123.633 0.635 . . . . 0.56999999999999995 112.614 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.3 m -120.47 -42.77 2.53 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.521 -0.752 . . . . 0.56999999999999995 112.751 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 p -171.85 -43.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.23 0.923 . . . . 0.56999999999999995 111.881 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.6 166.03 24.49 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.273 1.429 . . . . 0.56999999999999995 109.313 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 179.09 35.59 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 110.694 -0.962 . . . . 0.56999999999999995 110.694 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.6 mm -103.58 118.38 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.134 -1.062 . . . . 0.56999999999999995 108.134 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -70.59 121.85 18.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.747 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -37.97 76.23 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.132 1.16 . . . . 0.56999999999999995 114.132 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.37 -39.77 91.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.691 -0.855 . . . . 0.56999999999999995 108.691 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 1.7 m-85 -75.63 -41.57 53.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.495 -0.928 . . . . 0.56999999999999995 108.495 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -47.39 86.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.016 -0.516 . . . . 0.56999999999999995 110.583 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.32 -55.84 29.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.863 -1.065 . . . . 0.56999999999999995 109.789 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.1 m -53.67 -42.14 67.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.534 1.516 . . . . 0.56999999999999995 112.335 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -62.01 -54.38 42.43 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.938 0.79 . . . . 0.65000000000000002 110.088 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -68.41 -45.96 71.21 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.318 1.047 . . . . 0.66000000000000003 111.528 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.22 -31.59 72.85 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.045 1.338 . . . . 0.56999999999999995 110.959 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.59 -52.91 38.63 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.61 -0.996 . . . . 0.56999999999999995 110.61 170.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -58.55 -45.49 88.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.569 0.684 . . . . 0.65000000000000002 111.545 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.5 t -54.81 -38.6 67.55 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.15 0.906 . . . . 0.56999999999999995 112.726 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -27.65 68.73 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.8 0.84 . . . . 0.56999999999999995 111.777 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.24 44.44 0.13 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.839 1.209 . . . . 0.56999999999999995 113.334 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -128.04 156.66 42.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.573 1.187 . . . . 0.56999999999999995 111.013 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.44 -13.12 2.91 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 115.795 -2.67 . . . . 0.56999999999999995 114.821 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.6 m170 137.37 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 1 C-N-CA 131.836 4.054 . . . . 0.65000000000000002 111.434 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.9 m -131.79 -173.09 3.04 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.833 2.853 . . . . 0.56999999999999995 109.081 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.8 t -148.78 61.17 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.999 0.92 . . . . 0.56999999999999995 110.17 -171.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 6.2 t0 -133.97 149.06 70.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 108.798 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.03 -4.88 14.22 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.271 2.648 . . . . 0.56999999999999995 112.972 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.52 28.93 4.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.56999999999999995 109.101 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.09 130.18 34.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.645 1.578 . . . . 0.56999999999999995 109.926 172.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.74 -19.65 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.052 0.387 . . . . 0.56999999999999995 110.884 165.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.99 -14.56 63.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 117.66 -1.162 . . . . 0.56999999999999995 112.962 169.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.11 133.09 87.53 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 121.246 1.839 . . . . 0.56999999999999995 110.671 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.79 144.25 24.4 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.613 2.208 . . . . 0.56999999999999995 110.301 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 52.6 m 66.67 116.03 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.197 1.799 . . . . 0.56999999999999995 110.468 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -54.89 116.73 2.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.267 -0.896 . . . . 0.56999999999999995 110.924 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.7 -121.03 2.19 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.213 1.863 . . . . 0.56999999999999995 109.851 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.84 -26.59 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.455 1.502 . . . . 0.56999999999999995 113.914 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.5 151.84 27.49 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.874 -0.891 . . . . 0.56999999999999995 110.874 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.18 110.99 42.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.764 -1.939 . . . . 0.66000000000000003 105.764 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 116' ' ' TYR . 27.2 Cg_endo -79.62 29.17 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.688 2.926 . . . . 0.56999999999999995 115.499 174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -129.61 -28.11 2.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.085 1.354 . . . . 0.56999999999999995 111.446 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.03 94.31 1.52 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 109.327 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -138.41 169.04 18.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.828 1.251 . . . . 0.56999999999999995 109.405 177.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.88 57.2 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 111.127 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp 63.72 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 110.254 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 40.5 t -68.7 -86.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.138 0.975 . . . . 0.56999999999999995 112.234 -165.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -144.54 -35.8 0.34 Allowed 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.34 1.456 . . . . 0.56999999999999995 108.817 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -55.61 -48.37 74.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.269 1.827 . . . . 0.66000000000000003 111.378 170.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.54 -49.4 54.72 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.643 0.777 . . . . 0.66000000000000003 109.424 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -46.49 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 123.581 0.752 . . . . 0.56999999999999995 109.645 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -71.42 -40.48 70.41 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.73 -1.128 . . . . 0.56999999999999995 109.306 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -50.0 -61.06 6.03 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 170.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 mm -57.08 -50.08 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 117.711 0.755 . . . . 0.56999999999999995 111.5 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.86 -13.47 62.17 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.199 -0.938 . . . . 0.56999999999999995 113.14 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -92.11 -25.31 18.8 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.961 1.304 . . . . 0.56999999999999995 111.047 171.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.39 -35.95 65.98 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.554 1.142 . . . . 0.56999999999999995 112.773 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 46' ' ' ILE . 33.8 m-85 -126.52 29.2 5.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.551 1.141 . . . . 0.56999999999999995 109.969 -173.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.31 -124.78 0.75 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.573 -1.411 . . . . 0.56999999999999995 109.573 -174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -148.66 -57.31 0.22 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.067 1.506 . . . . 0.56999999999999995 115.067 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 39.29 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.616 2.367 . . . . 1.2 113.871 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.3 p -59.5 114.59 2.78 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.95 -0.469 . . . . 0.56999999999999995 110.228 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.62 153.3 14.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.741 1.616 . . . . 0.56999999999999995 107.074 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 p -70.03 -179.16 1.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.738 0.78 . . . . 0.56999999999999995 110.743 172.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -138.31 165.46 26.68 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.064 1.345 . . . . 1.2 107.436 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 -62.98 0.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.311 -0.852 . . . . 0.56999999999999995 109.886 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 C-N-CA 128.162 2.585 . . . . 0.5 . 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.213 0 CA-C-O 118.84 -0.6 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -67.35 -63.23 1.1 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.046 -0.502 . . . . 0.56999999999999995 110.218 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -169.64 -57.1 0.02 OUTLIER 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.86 2.064 . . . . 0.56999999999999995 109.851 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.54 139.81 12.11 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.61 0.764 . . . . 0.56999999999999995 109.512 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.88 60.99 6.97 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.431 3.421 . . . . 0.56999999999999995 110.423 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.86 90.25 1.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.617 -0.882 . . . . 0.56999999999999995 108.617 177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 41.96 61.72 8.15 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 126.055 1.742 . . . . 0.56999999999999995 112.661 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 117.88 5.04 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.257 1.972 . . . . 0.56999999999999995 108.659 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 83.58 134.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 111.077 -172.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 63.9 m95 -66.24 169.2 7.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.963 0.887 . . . . 0.56999999999999995 111.305 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -80.07 -33.84 38.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.478 0.711 . . . . 0.56999999999999995 111.424 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.8 t -86.99 146.42 26.14 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.171 0.988 . . . . 0.56999999999999995 109.379 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -75.3 -12.19 60.22 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.862 0.865 . . . . 0.56999999999999995 112.012 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -116.24 111.68 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.306 -1.738 . . . . 0.56999999999999995 106.306 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.457 ' CG1' HD12 ' A' ' 60' ' ' ILE . 72.7 t -104.04 129.05 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.792 -1.188 . . . . 0.56999999999999995 107.792 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -104.65 138.38 41.05 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.73 -0.606 . . . . 0.56999999999999995 110.285 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -125.08 160.11 29.82 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 122.906 0.482 . . . . 0.56999999999999995 110.869 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -152.14 166.4 31.78 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 122.758 0.423 . . . . 1.2 110.673 172.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.5 mt -130.26 94.67 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 103.806 -2.665 . . . . 0.56999999999999995 103.806 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 t -76.8 -45.44 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.528 0.731 . . . . 0.56999999999999995 109.597 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 t -112.63 156.19 23.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 104.651 -2.351 . . . . 0.56999999999999995 104.651 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.38 154.48 50.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.788 -1.56 . . . . 0.56999999999999995 106.788 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 31' ' ' VAL . 10.9 t -64.05 173.31 1.95 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.875 1.322 . . . . 0.56999999999999995 111.827 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 -37.22 6.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 113.99 -1.459 . . . . 1.2 112.397 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.16 -35.76 76.68 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.357 0.526 . . . . 0.66000000000000003 111.307 -172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 mt -114.12 151.93 45.38 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 126.884 2.074 . . . . 0.56999999999999995 108.153 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -78.23 154.01 28.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 111.974 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.81 -37.94 74.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.57 1.148 . . . . 0.65000000000000002 113.174 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 tp -59.36 -43.4 90.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.773 -0.454 . . . . 0.56999999999999995 109.773 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -70.48 -41.08 73.2 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.895 -1.05 . . . . 0.56999999999999995 108.988 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 23' ' ' THR . 47.4 t -54.5 -52.14 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 119.83 1.196 . . . . 0.56999999999999995 109.698 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -65.96 -43.94 86.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.774 0.716 . . . . 0.66000000000000003 111.096 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.71 92.64 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.368 -0.833 . . . . 1.2 112.099 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.94 -47.26 66.13 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.312 -0.996 . . . . 0.56999999999999995 108.312 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.98 -44.49 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 120.393 1.451 . . . . 0.56999999999999995 110.835 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -39.31 92.15 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 117.499 -1.239 . . . . 0.56999999999999995 111.057 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -67.21 -44.37 79.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.48 1.112 . . . . 0.56999999999999995 111.509 174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.04 96.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.799 1.24 . . . . 0.56999999999999995 111.023 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 122' ' ' LEU . 24.1 mt -68.8 -34.17 75.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.975 0.51 . . . . 0.56999999999999995 111.039 174.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -46.97 81.9 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 118.679 -0.677 . . . . 0.56999999999999995 109.319 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.422 ' HB3' HD11 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -56.38 -42.03 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.368 -0.825 . . . . 0.56999999999999995 111.607 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.451 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 32.9 m95 -63.19 -46.77 85.49 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.441 1.019 . . . . 0.56999999999999995 111.372 173.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.44 -10.81 63.86 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 121.337 -0.852 . . . . 0.56999999999999995 114.317 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -80.96 -5.38 57.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.253 -1.145 . . . . 0.56999999999999995 111.177 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 160' ' ' ILE . 9.3 mm-40 -113.06 -20.28 11.56 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.872 0.869 . . . . 0.66000000000000003 111.636 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 160' ' ' ILE . 10.1 pt -136.42 150.22 69.94 Favored Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 124.57 1.148 . . . . 0.56999999999999995 110.184 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.49 16.64 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.45 2.767 . . . . 0.56999999999999995 113.113 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 126' ' ' LEU . 2.2 tt -82.04 142.69 32.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 107.591 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -125.4 170.63 11.17 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.851 0.834 . . . . 0.65000000000000002 109.487 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.02 162.09 36.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.912 -0.773 . . . . 0.56999999999999995 108.912 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.75 -179.94 6.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.654 -1.157 . . . . 1.2 108.995 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -135.78 133.97 38.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.504 -1.665 . . . . 0.56999999999999995 106.504 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 m -81.35 162.65 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 O-C-N 124.174 0.921 . . . . 0.56999999999999995 109.526 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.9 m -110.72 -30.04 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.769 -1.105 . . . . 0.56999999999999995 110.696 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -60.69 3.13 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 124.596 1.158 . . . . 0.56999999999999995 110.695 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.87 -91.23 0.1 OUTLIER Glycine 0 C--O 1.219 -0.823 0 N-CA-C 109.896 -1.282 . . . . 0.56999999999999995 109.896 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -62.22 153.76 29.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.379 1.589 . . . . 0.56999999999999995 111.904 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.35 -170.55 3.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 109.972 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.24 -38.5 71.93 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.286 -1.005 . . . . 0.66000000000000003 108.286 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 15' ' ' VAL . 5.6 mt -127.66 90.8 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 C-N-CA 125.32 1.448 . . . . 0.56999999999999995 107.938 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 154.04 26.93 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.257 -0.883 . . . . 0.56999999999999995 109.111 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.06 137.41 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.487 -2.042 . . . . 0.56999999999999995 105.487 172.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.47 164.88 29.46 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.899 -0.88 . . . . 0.56999999999999995 110.899 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 5.4 m-85 -138.29 133.91 33.66 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.235 -1.765 . . . . 0.56999999999999995 106.235 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.69 178.89 8.1 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.56999999999999995 109.512 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.71 85.69 2.39 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 107.123 -1.436 . . . . 1.2 107.123 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.56 -139.68 15.61 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.47 -0.652 . . . . 0.56999999999999995 111.47 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.77 122.13 9.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.56999999999999995 111.398 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -125.2 -39.86 2.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.65000000000000002 112.2 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.71 44.85 0.8 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.886 -0.486 . . . . 0.56999999999999995 111.886 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.79 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.173 1.389 . . . . 0.66000000000000003 107.672 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 m -173.55 -34.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.616 1.966 . . . . 0.56999999999999995 110.484 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -132.21 132.15 22.82 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 108.176 -1.046 . . . . 0.56999999999999995 108.176 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.32 133.53 28.61 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 N-CA-C 108.857 -1.247 . . . . 0.56999999999999995 108.857 171.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -64.41 178.36 0.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 122.917 1.342 . . . . 0.56999999999999995 109.92 165.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -98.88 -43.36 6.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 131.436 3.894 . . . . 0.66000000000000003 110.092 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.96 -139.28 14.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.832 -1.538 . . . . 0.56999999999999995 110.363 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.18 96.48 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.624 3.549 . . . . 0.56999999999999995 112.055 -172.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 177.82 15.04 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 110.334 -1.106 . . . . 0.56999999999999995 110.334 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.254 15.3 t30 60.05 -142.69 0.56 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 112.489 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.4 m -45.42 144.35 1.52 Allowed 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 126.412 1.885 . . . . 0.56999999999999995 109.628 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -107.62 -29.01 9.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.471 1.941 . . . . 0.56999999999999995 112.462 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.26 166.08 25.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.522 1.129 . . . . 0.56999999999999995 108.332 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.76 161.84 38.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.176 0.512 . . . . 0.65000000000000002 109.715 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 160.82 43.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.981 0.912 . . . . 0.56999999999999995 108.799 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -112.56 151.08 30.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.762 -0.829 . . . . 0.56999999999999995 108.762 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.33 156.33 22.41 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.531 -0.747 . . . . 0.56999999999999995 111.004 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.492 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 17.6 Cg_endo -68.52 148.26 72.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.888 1.725 . . . . 0.56999999999999995 111.921 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.2 175.22 13.79 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.6 1.095 . . . . 0.56999999999999995 110.84 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t 43.31 -148.54 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.603 1.561 . . . . 0.56999999999999995 112.703 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.29 -56.62 1.45 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-O 117.182 -1.899 . . . . 0.56999999999999995 110.482 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 -44.37 74.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.44 1.62 . . . . 0.56999999999999995 112.075 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.99 151.15 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.619 1.1 . . . . 0.56999999999999995 112.659 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.89 -26.32 1.73 Allowed Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.853 -1.526 . . . . 0.56999999999999995 114.641 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -66.05 150.11 49.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.971 -1.122 . . . . 0.66000000000000003 107.971 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.14 148.51 35.16 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.424 -0.807 . . . . 0.56999999999999995 109.341 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -132.47 159.69 38.61 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.659 -0.867 . . . . 0.65000000000000002 108.659 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.2 m-85 -138.35 155.87 48.14 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.454 1.502 . . . . 0.56999999999999995 108.868 -170.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.17 97.76 10.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.898 0.479 . . . . 0.66000000000000003 109.952 172.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.25 -25.66 61.98 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.061 0.945 . . . . 0.66000000000000003 111.676 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.01 -34.99 70.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.305 0.574 . . . . 0.66000000000000003 111.075 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -82.48 150.26 27.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.636 1.175 . . . . 0.66000000000000003 109.085 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -71.88 147.5 47.04 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.511 -0.743 . . . . 1.2 110.647 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -135.35 134.53 39.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.267 -1.383 . . . . 0.56999999999999995 107.267 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -133.85 150.18 51.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.123 0.569 . . . . 0.56999999999999995 110.389 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.64 -29.45 64.65 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.191 0.997 . . . . 0.66000000000000003 111.374 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.01 75.88 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.387 -1.085 . . . . 0.56999999999999995 110.387 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.29 155.92 38.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.401 -1.333 . . . . 0.56999999999999995 107.401 172.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -62.47 167.28 4.41 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.529 0.732 . . . . 0.56999999999999995 110.509 170.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 72.35 -64.22 0.4 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.935 2.094 . . . . 0.56999999999999995 111.016 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.28 147.76 49.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.052 -1.219 . . . . 0.56999999999999995 110.052 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.32 129.82 36.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.004 -1.11 . . . . 0.56999999999999995 108.004 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -66.62 113.19 4.59 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.388 -0.597 . . . . 0.56999999999999995 109.388 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 9.6 t80 -58.5 -46.09 87.41 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.2 1.0 . . . . 0.56999999999999995 111.372 176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -63.43 -41.69 98.68 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.566 1.146 . . . . 0.56999999999999995 109.745 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.36 -45.0 96.19 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.444 0.698 . . . . 0.56999999999999995 109.934 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.66 72.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 123.035 0.534 . . . . 0.56999999999999995 111.316 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.82 -55.37 33.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 117.366 -1.302 . . . . 0.56999999999999995 109.086 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.8 m -52.35 -41.49 63.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.407 1.458 . . . . 0.56999999999999995 111.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -61.15 -60.57 3.55 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.557 0.617 . . . . 0.65000000000000002 110.058 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.47 -43.7 96.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.385 0.539 . . . . 0.66000000000000003 110.9 -173.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.08 -26.98 68.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.681 1.193 . . . . 0.56999999999999995 111.775 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.22 -45.95 92.16 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.009 -0.836 . . . . 0.56999999999999995 111.009 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -68.71 -39.78 80.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.957 -1.02 . . . . 0.65000000000000002 111.582 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.408 ' HB3' HG12 ' A' ' 60' ' ' ILE . 67.0 m -55.17 -30.69 60.38 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 124.159 0.912 . . . . 0.56999999999999995 111.966 172.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.447 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.04 -34.32 66.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.338 0.972 . . . . 0.56999999999999995 111.406 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.41 52.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.416 -1.214 . . . . 0.56999999999999995 113.093 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 28.6 mmt 61.12 173.07 0.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 112.106 -171.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.81 70.16 0.01 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.785 -1.008 . . . . 0.56999999999999995 111.153 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.27 172.78 6.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.73 1.265 . . . . 0.65000000000000002 110.175 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.57 -179.16 5.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 109.35 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.5 m -138.14 54.7 1.78 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.015 1.726 . . . . 0.56999999999999995 108.892 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.61 148.39 41.79 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.249 1.02 . . . . 0.66000000000000003 109.233 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.68 -19.26 41.88 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.228 2.618 . . . . 0.56999999999999995 113.004 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -130.76 28.22 4.87 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.839 1.656 . . . . 0.56999999999999995 108.607 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.51 129.33 38.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.373 -0.973 . . . . 0.56999999999999995 108.373 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.88 -26.78 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 122.635 0.374 . . . . 0.56999999999999995 110.506 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -105.1 29.21 6.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.604 1.162 . . . . 0.56999999999999995 111.811 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.29 128.62 87.98 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 120.606 -1.309 . . . . 0.56999999999999995 110.554 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.21 177.76 8.2 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.421 2.747 . . . . 0.56999999999999995 111.065 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m 48.59 77.57 0.1 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.225 1.41 . . . . 0.56999999999999995 111.608 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.426 ' CD1' ' H43' ' A' ' 178' ' ' MDW . 4.8 t80 -50.69 125.76 13.96 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.797 -174.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.93 164.8 13.64 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 108.482 -1.847 . . . . 0.56999999999999995 108.482 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.02 -51.37 0.47 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.867 2.467 . . . . 0.56999999999999995 113.825 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.65 145.86 42.2 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -94.99 112.8 59.61 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 105.859 -1.904 . . . . 0.66000000000000003 105.859 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -80.31 -31.39 1.68 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.803 1.669 . . . . 0.56999999999999995 112.668 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -42.15 72.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.074 1.306 . . . . 0.56999999999999995 110.322 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -122.98 89.82 3.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.193 -1.41 . . . . 0.56999999999999995 107.193 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -120.96 159.74 24.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.97 0.89 . . . . 0.56999999999999995 109.465 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.09 156.28 10.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.689 1.996 . . . . 0.56999999999999995 105.996 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -56.07 108.31 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.141 1.376 . . . . 0.56999999999999995 107.69 175.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.8 t -86.04 -101.41 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.77 -0.826 . . . . 0.56999999999999995 108.77 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.3 -49.43 1.55 Allowed 'General case' 0 C--O 1.208 -1.088 0 CA-C-O 116.268 -1.825 . . . . 0.56999999999999995 108.134 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -48.83 -38.95 23.73 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.911 1.687 . . . . 0.66000000000000003 112.132 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -67.65 -58.89 3.88 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.354 0.661 . . . . 0.66000000000000003 111.549 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.74 -40.26 84.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-O 117.811 -1.09 . . . . 0.56999999999999995 108.369 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.48 74.91 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.671 1.588 . . . . 0.56999999999999995 108.73 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.29 -56.79 22.57 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.25 -1.14 . . . . 0.56999999999999995 110.25 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 46' ' ' ILE . 9.5 mm -58.72 -49.1 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.386 1.093 . . . . 0.56999999999999995 112.949 -175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.59 -29.88 70.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.458 1.103 . . . . 0.56999999999999995 110.115 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -29.21 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.56999999999999995 110.17 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 3.2 mt -74.46 -48.7 25.84 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.14 -0.933 . . . . 0.56999999999999995 111.585 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 163' ' ' LEU . 3.2 m-85 -144.44 24.38 1.58 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.911 1.232 . . . . 0.56999999999999995 113.887 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -132.91 -155.55 7.87 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.682 -1.367 . . . . 0.56999999999999995 109.682 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.63 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.478 0.711 . . . . 0.56999999999999995 111.4 173.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.7 162.55 28.61 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.376 -0.972 . . . . 1.2 108.376 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.4 p -135.85 163.13 30.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.583 -1.265 . . . . 0.56999999999999995 107.583 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -178.07 162.36 1.61 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.524 1.93 . . . . 0.56999999999999995 106.5 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.8 t 62.41 99.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.095 1.758 . . . . 0.56999999999999995 112.148 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -155.85 94.88 1.59 Allowed 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.456 -1.313 . . . . 1.2 107.456 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.62 -63.55 1.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.699 -0.852 . . . . 0.56999999999999995 108.699 176.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.2 tttt . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 127.972 2.509 . . . . 0.5 . -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.426 ' H43' ' CD1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 118.244 -0.884 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p -78.25 65.56 3.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.309 0.959 . . . . 0.56999999999999995 111.633 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.51 168.26 21.01 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.871 0.869 . . . . 0.56999999999999995 111.468 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -95.92 153.72 39.17 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.953 1.301 . . . . 0.56999999999999995 110.743 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -76.05 -7.66 18.34 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.678 2.919 . . . . 0.56999999999999995 113.598 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.05 108.28 1.48 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 103.919 -2.622 . . . . 0.56999999999999995 103.919 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.88 -63.54 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 129.308 3.043 . . . . 0.56999999999999995 108.909 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.8 163.81 34.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 0.56999999999999995 111.104 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 pttt 68.4 118.02 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.896 2.078 . . . . 0.56999999999999995 110.073 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -62.17 150.35 39.01 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.56999999999999995 109.704 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.1 p -88.43 28.66 1.07 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.471 0.708 . . . . 0.56999999999999995 111.069 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -130.55 159.64 36.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.539 1.936 . . . . 0.56999999999999995 108.851 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -90.54 -8.55 49.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.56 1.544 . . . . 0.56999999999999995 112.748 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.46 145.76 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 0.56999999999999995 106.747 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.506 HG23 HD21 ' A' ' 48' ' ' LEU . 29.0 t -131.06 134.48 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.075 -1.824 . . . . 0.56999999999999995 106.075 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 t -100.4 147.86 25.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.651 -0.5 . . . . 0.56999999999999995 109.651 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -125.15 153.73 42.57 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.424 0.689 . . . . 0.56999999999999995 111.7 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.09 109.97 6.42 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.013 0.911 . . . . 1.2 110.59 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.564 HG21 ' CE1' ' A' ' 22' ' ' TYR . 93.0 mt -76.03 95.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.674 -1.602 . . . . 0.56999999999999995 106.674 169.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 m -75.23 -46.41 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.709 0.803 . . . . 0.56999999999999995 111.365 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -115.96 160.31 20.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.263 -1.384 . . . . 0.56999999999999995 107.263 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 19' ' ' ILE . 10.4 m-85 -127.6 179.9 5.27 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.17 0.988 . . . . 0.56999999999999995 108.597 -172.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -119.95 -178.45 3.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.808 1.243 . . . . 0.56999999999999995 109.711 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -131.42 -31.59 1.6 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.152 1.781 . . . . 1.2 111.713 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.12 -31.4 71.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.374 1.07 . . . . 0.66000000000000003 111.914 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.31 145.33 56.19 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 126.733 2.013 . . . . 0.56999999999999995 106.733 -175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -72.97 153.76 52.71 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.587 1.525 . . . . 0.56999999999999995 111.523 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.27 -34.73 74.15 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.245 1.018 . . . . 0.65000000000000002 113.121 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.57 -39.56 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.624 0.37 . . . . 0.56999999999999995 110.016 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -68.52 -42.49 78.44 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.332 -1.318 . . . . 0.56999999999999995 110.152 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 t -57.23 -51.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 120.584 1.538 . . . . 0.56999999999999995 109.398 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -61.37 -43.56 98.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.145 0.578 . . . . 0.66000000000000003 110.222 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -62.15 -46.6 88.27 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 117.957 -1.021 . . . . 1.2 112.139 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.8 mp -65.07 -41.87 94.68 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.783 1.174 . . . . 0.56999999999999995 109.658 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.31 -48.82 79.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 108.792 -0.818 . . . . 0.56999999999999995 108.792 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -39.06 81.42 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 118.537 0.608 . . . . 0.56999999999999995 111.738 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -65.21 -46.22 81.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.821 1.191 . . . . 0.56999999999999995 110.438 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.98 95.29 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 111.245 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 122' ' ' LEU . 25.9 mt -68.22 -33.43 74.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.576 -0.726 . . . . 0.56999999999999995 111.327 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -65.03 -33.33 75.79 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.424 1.011 . . . . 0.56999999999999995 110.315 173.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.4 mtp -71.23 -28.83 64.47 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.857 0.753 . . . . 0.56999999999999995 111.996 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -72.14 -48.83 40.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.502 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.03 62.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.14 1.352 . . . . 0.56999999999999995 113.65 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -64.58 -22.41 66.96 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.886 -1.361 . . . . 0.56999999999999995 111.673 170.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -108.37 -21.3 12.81 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.796 0.725 . . . . 0.66000000000000003 112.255 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.88 135.48 27.56 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 123.872 0.869 . . . . 0.56999999999999995 110.761 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.12 61.26 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.821 3.014 . . . . 0.56999999999999995 110.65 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -117.46 124.46 48.85 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.059 -1.83 . . . . 0.56999999999999995 106.059 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -105.57 175.29 5.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.924 1.289 . . . . 0.65000000000000002 108.623 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 39' ' ' LEU . 1.2 m-85 -139.36 153.86 47.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 121.18 -0.95 . . . . 0.56999999999999995 108.483 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.63 174.44 10.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.711 0.804 . . . . 1.2 109.009 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -124.29 155.69 38.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.05 -1.092 . . . . 0.56999999999999995 108.05 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.06 -179.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.172 -0.922 . . . . 0.56999999999999995 108.977 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.72 -38.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.795 -0.622 . . . . 0.56999999999999995 110.34 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -175.65 92.95 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.291 1.436 . . . . 0.56999999999999995 108.975 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.83 172.78 38.13 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.92 2.2 . . . . 0.56999999999999995 108.122 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 p -67.92 167.05 14.43 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.583 0.692 . . . . 0.56999999999999995 110.123 168.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.13 173.76 11.91 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.551 0.741 . . . . 0.56999999999999995 110.145 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.93 -33.94 66.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 118.071 -0.966 . . . . 0.66000000000000003 109.142 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.93 76.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.612 1.965 . . . . 0.56999999999999995 108.586 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -70.03 133.58 47.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 119.522 -1.986 . . . . 0.56999999999999995 107.959 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.73 105.89 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.037 -1.838 . . . . 0.56999999999999995 106.037 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 73.92 0.26 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.775 1.655 . . . . 0.56999999999999995 111.223 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -109.44 132.96 53.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 110.157 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.33 172.0 17.33 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.56999999999999995 108.449 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -91.74 113.48 25.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 118.286 -0.864 . . . . 1.2 110.222 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.66 71.2 0.86 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.376 -0.69 . . . . 0.56999999999999995 111.376 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 81.21 147.58 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.009 2.924 . . . . 0.56999999999999995 111.521 -172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.14 -11.52 4.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.944 1.297 . . . . 0.65000000000000002 112.816 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.96 3.04 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 118.801 -1.0 . . . . 0.56999999999999995 112.505 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.64 -55.89 1.61 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.718 0.759 . . . . 0.66000000000000003 110.375 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.51 -44.23 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.536 1.934 . . . . 0.56999999999999995 108.055 -177.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -97.42 121.24 59.02 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.397 0.679 . . . . 0.56999999999999995 110.467 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.74 3.82 6.59 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 113.204 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 56.17 -155.76 0.29 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.139 0.881 . . . . 0.56999999999999995 110.651 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -143.18 -41.48 0.3 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.644 2.777 . . . . 0.66000000000000003 108.524 -167.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.12 -149.78 16.66 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.213 1.387 . . . . 0.56999999999999995 110.195 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.6 94.3 0.85 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.589 3.526 . . . . 0.56999999999999995 111.414 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 167.95 11.45 Favored Glycine 0 C--O 1.22 -0.749 0 N-CA-C 109.411 -1.476 . . . . 0.56999999999999995 109.411 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t30 48.31 -150.52 0.15 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 119.813 1.806 . . . . 0.56999999999999995 112.241 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -47.09 111.06 0.35 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.12 2.168 . . . . 0.56999999999999995 113.306 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -80.97 -31.96 34.6 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.796 -1.19 . . . . 0.56999999999999995 112.497 -176.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.49 39.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.491 1.116 . . . . 0.56999999999999995 109.737 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -146.57 144.96 29.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.457 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.76 164.4 30.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.7 0.8 . . . . 0.56999999999999995 109.521 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -115.21 156.95 24.39 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.961 -0.563 . . . . 0.56999999999999995 109.515 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.65 98.73 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.358 -0.829 . . . . 0.56999999999999995 109.359 176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -72.47 159.3 49.47 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.672 2.248 . . . . 0.56999999999999995 111.178 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.32 -83.62 0.08 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.872 -1.691 . . . . 0.56999999999999995 108.872 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -159.2 146.26 17.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.316 -0.994 . . . . 0.56999999999999995 108.316 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -130.9 11.77 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 118.453 -1.193 . . . . 0.56999999999999995 110.297 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.02 -25.34 58.42 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.342 1.071 . . . . 0.56999999999999995 111.994 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.94 142.44 5.85 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.085 -1.009 . . . . 0.56999999999999995 112.121 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.61 -26.79 3.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 126.526 2.012 . . . . 0.56999999999999995 113.901 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -66.31 148.72 51.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.787 0.794 . . . . 0.66000000000000003 109.399 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.57 140.77 49.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 108.773 -168.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.78 139.68 29.51 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.234 -1.765 . . . . 0.65000000000000002 106.234 -160.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.67 148.26 37.06 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -166.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.69 105.99 12.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.199 -1.408 . . . . 0.66000000000000003 107.199 171.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.52 -19.79 27.27 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.489 -0.757 . . . . 0.66000000000000003 110.713 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -28.13 64.78 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.242 1.017 . . . . 0.66000000000000003 111.141 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.28 110.72 9.86 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.289 -1.745 . . . . 0.66000000000000003 106.289 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -45.95 110.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.151 0.887 . . . . 1.2 111.502 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.12 133.88 34.6 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.048 -1.093 . . . . 0.56999999999999995 108.048 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -123.33 143.49 50.06 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.491 -1.299 . . . . 0.56999999999999995 107.491 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.37 32.8 0.4 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.478 1.511 . . . . 0.66000000000000003 111.599 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.66 69.56 1.37 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.625 -0.99 . . . . 0.56999999999999995 110.625 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -57.31 2.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.478 0.639 . . . . 0.56999999999999995 110.785 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.47 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 108.617 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.93 159.22 16.43 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.56999999999999995 109.075 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.2 -172.35 38.06 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.35 -1.1 . . . . 0.56999999999999995 110.35 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.06 120.31 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.511 -1.292 . . . . 0.56999999999999995 107.511 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -62.05 109.16 1.2 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.584 0.353 . . . . 0.56999999999999995 110.237 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.81 -37.33 81.63 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.539 0.735 . . . . 0.56999999999999995 110.686 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -65.95 -46.16 79.15 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 118.481 0.582 . . . . 0.56999999999999995 110.256 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -59.44 -48.89 79.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.836 0.743 . . . . 0.56999999999999995 109.18 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.33 90.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.114 0.566 . . . . 0.56999999999999995 111.319 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.09 -54.56 43.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.892 -1.051 . . . . 0.56999999999999995 109.517 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.5 m -57.17 -37.88 72.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.043 1.292 . . . . 0.56999999999999995 111.33 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.45 -58.54 7.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.409 0.549 . . . . 0.65000000000000002 109.935 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.3 -41.38 98.95 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.559 -0.713 . . . . 0.66000000000000003 111.303 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 HD21 ' A' ' 39' ' ' LEU . 3.3 mm? -62.55 -26.2 68.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.56999999999999995 111.666 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.81 99.35 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.73 1.15 . . . . 0.56999999999999995 112.053 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -69.89 -39.89 75.97 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-O 118.279 -0.867 . . . . 0.65000000000000002 110.067 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 t -57.23 -39.61 75.86 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.52 0.513 . . . . 0.56999999999999995 111.859 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -39.56 82.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.536 -0.728 . . . . 0.56999999999999995 110.476 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.2 51.1 0.52 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 123.877 0.751 . . . . 0.56999999999999995 112.079 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 tpp -99.84 -55.82 2.55 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.069 0.935 . . . . 0.56999999999999995 111.018 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.64 167.6 21.77 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.288 -1.125 . . . . 0.56999999999999995 110.288 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -74.06 178.08 5.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.995 0.902 . . . . 0.65000000000000002 111.465 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -145.26 -173.46 4.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.083 1.753 . . . . 0.56999999999999995 108.531 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.0 t -145.45 82.26 1.64 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.162 -1.792 . . . . 0.56999999999999995 106.162 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 5.8 t70 -151.36 145.26 17.78 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.456 -0.942 . . . . 0.66000000000000003 108.456 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.77 -9.25 21.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.471 2.114 . . . . 0.56999999999999995 113.269 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.01 9.51 13.69 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.555 1.142 . . . . 0.56999999999999995 110.749 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -76.1 134.56 39.99 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.02 0.928 . . . . 0.56999999999999995 109.171 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.07 -28.24 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.59 -0.444 . . . . 0.56999999999999995 110.148 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 37.1 mmt -66.01 -12.2 53.43 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.681 1.593 . . . . 0.56999999999999995 113.589 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -50.69 124.87 20.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.318 0.963 . . . . 0.56999999999999995 110.589 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.58 175.21 9.09 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.018 2.479 . . . . 0.56999999999999995 110.783 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER 52.13 -158.7 0.12 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 111.864 -174.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 131.21 41.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.99 -1.485 . . . . 0.56999999999999995 106.99 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -157.5 -120.9 0.64 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.125 -1.59 . . . . 0.56999999999999995 109.125 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -64.75 0.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.318 1.047 . . . . 0.56999999999999995 110.934 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 34.44 -140.6 0.12 Allowed Glycine 0 C--N 1.345 1.079 0 C-N-CA 126.277 1.894 . . . . 0.56999999999999995 113.198 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 t0 178.71 77.13 0.15 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 128.134 2.573 . . . . 0.66000000000000003 106.467 168.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.08 35.86 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.515 2.81 . . . . 0.56999999999999995 113.554 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -132.0 -47.87 0.94 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 109.89 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.99 43.5 0.17 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.063 0.945 . . . . 0.56999999999999995 111.304 -171.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -40.3 -54.52 2.37 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.202 1.001 . . . . 0.56999999999999995 111.972 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 55.53 156.03 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.966 1.306 . . . . 0.56999999999999995 111.075 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 mp -65.88 116.74 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.907 -1.146 . . . . 0.56999999999999995 107.907 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.8 m -82.2 -91.51 0.07 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.41 0.684 . . . . 0.56999999999999995 112.226 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -134.49 -51.97 0.81 Allowed 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.853 -1.546 . . . . 0.56999999999999995 107.465 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -45.4 -44.22 11.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.55 1.523 . . . . 0.66000000000000003 113.823 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.55 -63.59 1.18 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.055 2.142 . . . . 0.66000000000000003 110.9 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.06 -41.39 92.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 108.699 -0.852 . . . . 0.56999999999999995 108.699 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -59.33 -44.84 92.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.287 1.435 . . . . 0.56999999999999995 108.942 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.95 -56.16 26.65 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.972 -1.251 . . . . 0.56999999999999995 109.972 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 mm -55.51 -51.15 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 117.88 0.84 . . . . 0.56999999999999995 111.8 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -68.25 -18.72 64.62 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.475 1.11 . . . . 0.56999999999999995 111.34 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -87.87 -20.84 25.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.93 1.241 . . . . 0.56999999999999995 111.89 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.47 -43.84 9.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.918 . . . . 0.56999999999999995 111.669 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.41 9.53 31.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.285 1.834 . . . . 0.56999999999999995 111.333 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.22 -135.92 2.24 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.893 2.187 . . . . 0.56999999999999995 107.869 -175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -44.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.456 1.502 . . . . 0.56999999999999995 111.657 167.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.71 140.19 55.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.022 0.929 . . . . 1.2 110.354 -171.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 p -142.25 166.85 23.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.534 1.133 . . . . 0.56999999999999995 110.583 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.23 136.21 35.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.191 -1.411 . . . . 0.56999999999999995 107.191 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.17 162.09 17.81 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.206 0.527 . . . . 0.56999999999999995 111.708 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.36 159.62 40.98 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.088 1.355 . . . . 1.2 109.42 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.22 129.06 53.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.492 -0.559 . . . . 0.56999999999999995 109.492 175.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.754 1.621 . . . . 0.5 . -175.523 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.428 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 119.38 -0.343 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 t -112.82 -53.36 2.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.539 0.736 . . . . 0.56999999999999995 109.292 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 4' ' ' PHE . 6.9 tt -162.63 -104.79 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.45 -1.315 . . . . 0.56999999999999995 107.45 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -73.68 -56.13 3.08 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 126.347 1.859 . . . . 0.56999999999999995 110.07 174.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.56 163.87 16.55 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.251 1.301 . . . . 0.56999999999999995 111.888 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -166.0 84.49 0.32 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.839 1.656 . . . . 0.56999999999999995 107.443 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 174.43 65.9 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 128.022 2.529 . . . . 0.56999999999999995 108.76 171.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.28 161.95 44.13 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.108 1.206 . . . . 0.56999999999999995 110.729 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 76.21 107.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.378 1.871 . . . . 0.56999999999999995 109.302 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 67.9 m95 -52.13 -70.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.49 . . . . 0.56999999999999995 113.94 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m 173.88 -43.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.406 2.282 . . . . 0.56999999999999995 108.434 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t -102.5 161.98 13.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.213 1.005 . . . . 0.56999999999999995 109.938 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -5.51 40.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.945 0.898 . . . . 0.56999999999999995 113.36 168.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.35 143.56 39.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.241 -1.392 . . . . 0.56999999999999995 107.241 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 48' ' ' LEU . 72.3 t -128.95 146.61 33.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.36 -1.348 . . . . 0.56999999999999995 107.36 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 p -94.84 137.21 34.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.679 -0.86 . . . . 0.56999999999999995 108.679 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -125.54 152.56 44.87 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.668 -0.645 . . . . 0.56999999999999995 109.309 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -154.57 113.88 3.7 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.352 0.596 . . . . 1.2 110.011 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.03 82.61 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 107.161 -1.422 . . . . 0.56999999999999995 107.161 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 m -56.11 -41.61 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.994 1.318 . . . . 0.56999999999999995 112.922 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 t -124.39 153.97 41.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.37 -2.826 . . . . 0.56999999999999995 103.37 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -131.23 158.05 41.59 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.338 1.455 . . . . 0.56999999999999995 107.293 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -61.93 172.92 1.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.05 0.929 . . . . 0.56999999999999995 111.624 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 -33.8 5.14 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.659 1.183 . . . . 1.2 112.262 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.41 -33.87 76.97 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.43 0.559 . . . . 0.66000000000000003 109.997 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.32 154.78 62.41 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.971 1.709 . . . . 0.56999999999999995 109.873 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.24 161.91 25.82 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.96 2.44 . . . . 0.56999999999999995 113.049 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.35 -40.25 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.307 1.043 . . . . 0.65000000000000002 113.135 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.9 tt -62.53 -33.85 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.342 0.257 . . . . 0.56999999999999995 111.037 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.8 m -71.59 -43.96 65.31 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.402 -0.809 . . . . 0.56999999999999995 109.359 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.69 -48.07 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 117.559 -1.21 . . . . 0.56999999999999995 110.048 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -65.65 -35.07 79.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.896 1.225 . . . . 0.66000000000000003 111.81 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -61.19 -51.06 70.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.557 1.071 . . . . 1.2 110.92 173.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.76 -45.36 93.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.447 -0.787 . . . . 0.56999999999999995 109.111 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.66 -45.1 98.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-O 118.196 -0.907 . . . . 0.56999999999999995 110.737 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.0 m -58.61 -47.74 83.34 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 109.858 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.53 73.24 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.976 -0.535 . . . . 0.56999999999999995 110.911 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.0 -47.55 84.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.99 1.316 . . . . 0.56999999999999995 111.983 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 mp -69.78 -32.13 70.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 118.577 -0.725 . . . . 0.56999999999999995 109.693 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -63.59 -33.37 75.45 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.089 0.859 . . . . 0.56999999999999995 111.319 170.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 17.0 mtp -68.68 -42.73 77.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.649 1.113 . . . . 0.56999999999999995 110.98 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.522 ' CE3' HD11 ' A' ' 160' ' ' ILE . 10.6 m95 -62.91 -51.75 65.72 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.503 1.047 . . . . 0.56999999999999995 110.336 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.59 -10.92 61.53 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.654 1.597 . . . . 0.56999999999999995 113.959 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -61.8 -30.87 71.1 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.449 1.125 . . . . 0.56999999999999995 110.38 170.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -101.45 -31.04 11.1 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.69 0.796 . . . . 0.66000000000000003 111.271 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.489 HG21 ' CD1' ' A' ' 164' ' ' TYR . 27.8 pt -115.66 126.08 28.09 Favored Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.662 0.785 . . . . 0.56999999999999995 110.382 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.49 46.2 1.38 Allowed 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.762 2.975 . . . . 0.56999999999999995 112.941 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 49' ' ' HIS . 3.1 tt -103.3 141.96 35.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.672 1.989 . . . . 0.56999999999999995 107.484 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.419 ' N ' HD23 ' A' ' 48' ' ' LEU . 10.1 m80 -123.85 169.33 11.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.913 0.885 . . . . 0.65000000000000002 108.996 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.49 149.87 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.63 -1.294 . . . . 0.56999999999999995 109.154 -173.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.93 36.72 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.43 1.092 . . . . 1.2 109.202 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.53 99.02 6.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.52 158.18 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.415 -0.587 . . . . 0.56999999999999995 109.415 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.52 23.17 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 110.953 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.21 75.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.93 1.292 . . . . 0.56999999999999995 109.087 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.25 168.74 16.32 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.005 0.812 . . . . 0.56999999999999995 111.575 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 p -64.72 171.89 3.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.806 1.242 . . . . 0.56999999999999995 110.033 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.96 175.24 8.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.596 0.713 . . . . 0.56999999999999995 109.626 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -68.95 -40.55 78.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.857 -0.61 . . . . 0.66000000000000003 109.372 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -119.8 87.31 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 108.0 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -83.91 120.66 26.35 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.814 1.246 . . . . 0.56999999999999995 108.286 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.58 128.97 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 106.36 -1.719 . . . . 0.56999999999999995 106.36 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.13 162.68 26.78 Favored Glycine 0 C--O 1.222 -0.6 0 N-CA-C 111.695 -0.562 . . . . 0.56999999999999995 111.695 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 4.9 m-85 -134.54 141.63 46.75 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.009 -1.849 . . . . 0.56999999999999995 106.009 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.47 -173.49 4.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.86 1.664 . . . . 0.56999999999999995 109.635 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.42 52.52 2.05 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.173 0.989 . . . . 1.2 110.55 -175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.4 -120.97 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.117 -1.193 . . . . 0.56999999999999995 110.117 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.45 138.28 55.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.273 -0.545 . . . . 0.56999999999999995 110.569 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -131.59 -63.03 0.85 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.116 -0.945 . . . . 0.65000000000000002 110.687 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.78 57.39 0.02 OUTLIER Glycine 0 C--N 1.341 0.834 0 CA-C-N 119.231 0.923 . . . . 0.56999999999999995 112.474 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -126.33 -67.31 0.87 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.69 1.196 . . . . 0.66000000000000003 109.094 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.67 -30.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.353 2.661 . . . . 0.56999999999999995 110.156 -175.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.26 98.71 20.42 Favored Pre-proline 0 C--N 1.347 0.47 0 N-CA-C 108.51 -0.922 . . . . 0.56999999999999995 108.51 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.14 139.42 55.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 120.881 1.054 . . . . 0.56999999999999995 109.424 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -72.41 174.37 7.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.584 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -95.27 -40.9 9.32 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.574 1.95 . . . . 0.66000000000000003 111.898 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.62 -139.15 13.32 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-N 120.366 1.439 . . . . 0.56999999999999995 111.969 -168.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -81.64 94.42 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.128 2.552 . . . . 0.56999999999999995 110.567 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.65 174.46 22.43 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.132 1.825 . . . . 0.56999999999999995 111.708 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.3 t30 47.39 -138.71 0.68 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 120.972 -1.31 . . . . 0.56999999999999995 112.817 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -51.73 124.8 13.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.874 2.07 . . . . 0.56999999999999995 111.207 173.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.81 -31.12 11.68 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.56999999999999995 113.015 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.3 159.19 33.72 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.466 1.106 . . . . 0.56999999999999995 108.091 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.1 154.93 43.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.29 0.567 . . . . 0.65000000000000002 111.007 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.14 148.01 44.49 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.11 -1.07 . . . . 0.56999999999999995 108.11 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.38 150.22 25.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.14 -1.059 . . . . 0.56999999999999995 108.14 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.39 153.66 92.0 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.525 -0.75 . . . . 0.56999999999999995 109.961 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 32.5 Cg_endo -68.73 165.09 30.78 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.579 1.52 . . . . 0.56999999999999995 111.969 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 -70.8 0.15 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.652 -1.779 . . . . 0.56999999999999995 108.652 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -173.52 144.02 1.09 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.257 -1.386 . . . . 0.56999999999999995 107.257 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.15 -130.21 24.12 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.537 1.065 . . . . 0.56999999999999995 111.615 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 tp -51.89 -26.48 10.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.133 1.373 . . . . 0.56999999999999995 112.345 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.17 143.67 8.74 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.191 -0.943 . . . . 0.56999999999999995 111.633 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.1 -22.3 2.01 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.162 1.839 . . . . 0.56999999999999995 114.553 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -70.49 157.69 37.4 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.787 1.294 . . . . 0.66000000000000003 108.305 -176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.96 148.41 31.71 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.242 0.544 . . . . 0.56999999999999995 109.63 -175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -132.02 160.5 35.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.65000000000000002 109.282 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 23.9 m-85 -141.82 146.61 36.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.879 1.272 . . . . 0.56999999999999995 108.155 -171.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.78 103.83 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.922 -1.14 . . . . 0.66000000000000003 107.922 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.77 -23.01 64.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.848 1.659 . . . . 0.66000000000000003 111.395 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -65.38 -37.17 86.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.703 1.601 . . . . 0.66000000000000003 110.157 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.0 133.39 48.96 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.327 -1.731 . . . . 0.66000000000000003 106.327 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -54.94 151.89 8.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 118.905 -0.569 . . . . 1.2 109.72 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -133.93 135.88 43.87 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.749 -1.574 . . . . 0.56999999999999995 106.749 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -132.52 140.77 48.47 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.494 -1.299 . . . . 0.56999999999999995 107.494 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -57.16 -51.37 69.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.711 0.805 . . . . 0.66000000000000003 109.396 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.45 56.63 0.01 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.889 -1.284 . . . . 0.56999999999999995 109.889 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 t -154.71 164.31 38.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.656 -0.868 . . . . 0.56999999999999995 108.656 173.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -76.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.502 2.321 . . . . 0.56999999999999995 112.589 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mt -178.77 171.88 1.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.256 2.223 . . . . 0.56999999999999995 107.348 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 123.85 -146.95 16.52 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.56999999999999995 110.422 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.4 pt -116.65 119.55 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 109.113 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -61.77 117.71 6.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.188 -0.914 . . . . 0.56999999999999995 109.615 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.16 -40.05 96.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.319 1.448 . . . . 0.56999999999999995 110.848 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -42.81 79.75 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.096 -1.076 . . . . 0.56999999999999995 108.096 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -66.07 -47.61 73.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.021 0.828 . . . . 0.56999999999999995 110.036 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.33 -50.09 70.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 123.531 0.52 . . . . 0.56999999999999995 110.581 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.97 -57.88 10.0 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 117.908 -1.044 . . . . 0.56999999999999995 109.74 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -55.82 -37.69 69.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.249 1.386 . . . . 0.56999999999999995 111.333 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.97 -57.12 14.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.529 1.132 . . . . 0.65000000000000002 110.518 173.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -72.72 -44.52 61.61 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.605 -0.684 . . . . 0.66000000000000003 111.248 -171.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.2 -29.0 68.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.161 1.384 . . . . 0.56999999999999995 111.036 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.34 -47.11 90.35 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.55 -1.02 . . . . 0.56999999999999995 110.55 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.403 ' CE1' ' HG2' ' A' ' 138' ' ' MET . 70.9 m-70 -70.16 -36.29 74.6 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.255 -0.879 . . . . 0.65000000000000002 112.191 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 p -57.74 -33.48 68.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.316 0.507 . . . . 0.56999999999999995 111.251 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -36.34 79.81 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 112.493 0.553 . . . . 0.56999999999999995 112.493 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 162.11 50.08 0.02 OUTLIER Glycine 0 C--N 1.339 0.708 0 CA-C-O 117.993 -1.449 . . . . 0.56999999999999995 113.271 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.73 -158.78 0.06 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.949 1.299 . . . . 0.56999999999999995 112.024 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.08 62.6 0.22 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.091 -1.604 . . . . 0.56999999999999995 109.091 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 169.62 17.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.675 0.75 . . . . 0.65000000000000002 109.624 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -157.15 -179.99 8.73 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.701 1.2 . . . . 0.56999999999999995 107.91 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t -144.17 78.16 1.57 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.771 -1.566 . . . . 0.56999999999999995 106.771 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -131.08 145.91 59.81 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 106.545 -1.65 . . . . 0.66000000000000003 106.545 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.71 -26.72 75.4 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.165 1.91 . . . . 0.56999999999999995 112.427 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -125.11 29.37 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.572 1.549 . . . . 0.56999999999999995 109.685 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.06 129.16 39.56 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 109.08 -0.711 . . . . 0.56999999999999995 109.08 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.56 -17.5 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.619 1.168 . . . . 0.56999999999999995 111.646 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.403 ' HG2' ' CE1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -113.72 22.5 13.98 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.307 1.843 . . . . 0.56999999999999995 110.326 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.24 123.97 78.38 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 119.999 1.272 . . . . 0.56999999999999995 110.292 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.7 48.3 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.728 2.952 . . . . 0.56999999999999995 112.661 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -148.36 -45.48 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.56999999999999995 110.373 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.3 t80 56.7 95.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.768 1.627 . . . . 0.56999999999999995 112.305 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.41 -73.7 0.03 OUTLIER Glycine 0 C--N 1.346 1.101 0 O-C-N 120.751 -1.218 . . . . 0.56999999999999995 115.706 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -35.52 61.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.503 1.151 . . . . 0.56999999999999995 112.375 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.7 152.0 13.59 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.59 -1.004 . . . . 0.56999999999999995 110.59 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -104.83 105.51 51.29 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 107.467 -1.309 . . . . 0.66000000000000003 107.467 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.6 57.4 6.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.564 2.843 . . . . 0.56999999999999995 109.92 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.5 -48.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.655 -0.653 . . . . 0.56999999999999995 110.481 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -77.49 50.66 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.261 1.424 . . . . 0.56999999999999995 110.886 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -41.86 -82.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.874 1.669 . . . . 0.56999999999999995 112.917 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 43.91 22.82 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.16 2.584 . . . . 0.56999999999999995 113.489 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 42.93 90.45 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.724 2.81 . . . . 0.56999999999999995 111.222 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.9 t -56.12 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.088 1.355 . . . . 0.56999999999999995 114.46 -170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -142.35 -46.24 0.33 Allowed 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.424 1.09 . . . . 0.56999999999999995 109.311 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.18 -51.56 10.4 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.886 1.274 . . . . 0.66000000000000003 111.427 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -48.14 75.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.44 0.696 . . . . 0.66000000000000003 111.964 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.4 mm -62.55 -46.57 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.886 0.874 . . . . 0.56999999999999995 109.178 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -63.48 -44.1 95.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.049 1.339 . . . . 0.56999999999999995 109.096 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.76 -62.59 6.14 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.1 -1.2 . . . . 0.56999999999999995 110.1 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.522 HD11 ' CE3' ' A' ' 42' ' ' TRP . 8.0 mm -52.67 -48.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.518 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -65.79 -28.53 69.07 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.436 -0.79 . . . . 0.56999999999999995 111.875 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.2 -20.23 35.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.05 1.295 . . . . 0.56999999999999995 111.959 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 6.5 mp -77.97 -45.39 24.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.064 0.946 . . . . 0.56999999999999995 110.982 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.489 ' CD1' HG21 ' A' ' 46' ' ' ILE . 12.8 m-85 -138.17 -22.86 1.03 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -171.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.78 -81.97 0.13 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.556 -1.417 . . . . 0.56999999999999995 109.556 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -154.78 -70.44 0.13 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.14 1.376 . . . . 0.56999999999999995 112.14 173.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -172.46 -178.99 2.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.639 1.176 . . . . 1.2 110.047 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -142.44 130.7 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.859 0.837 . . . . 0.56999999999999995 109.686 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.11 91.53 8.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.806 1.242 . . . . 0.56999999999999995 108.032 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.26 149.44 21.76 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.656 -0.868 . . . . 0.56999999999999995 108.656 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -136.59 155.82 49.4 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.561 1.145 . . . . 1.2 108.446 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 173' ' ' LYS . 25.8 tttt 64.71 -172.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.745 1.618 . . . . 0.56999999999999995 111.614 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 172' ' ' LYS . 2.9 mtmp? . . . . . 0 N--CA 1.457 -0.104 0 C-N-CA 127.137 2.175 . . . . 0.5 . 174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 117.853 -1.07 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.542 ' H ' ' HG3' ' A' ' 128' ' ' MET . 6.6 p -93.49 -33.03 13.95 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.827 0.739 . . . . 0.56999999999999995 111.69 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.28 87.98 1.14 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.884 -1.154 . . . . 0.56999999999999995 107.884 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 t80 61.77 90.58 0.09 OUTLIER Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.112 1.365 . . . . 0.56999999999999995 113.383 176.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.72 171.95 8.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.572 2.181 . . . . 0.56999999999999995 112.252 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -154.3 -62.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.049 -0.5 . . . . 0.56999999999999995 110.827 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.03 63.53 1.55 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.962 1.705 . . . . 0.56999999999999995 109.068 176.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.08 165.86 15.81 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.959 1.773 . . . . 0.56999999999999995 111.263 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 77.92 -11.24 1.23 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.253 1.421 . . . . 0.56999999999999995 112.252 -174.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 84.6 m95 60.92 19.2 9.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.813 1.188 . . . . 0.56999999999999995 113.055 -168.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 m 68.47 -43.07 0.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.23 1.812 . . . . 0.56999999999999995 112.811 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 t -75.91 -178.15 4.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 111.079 173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -10.29 20.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.541 1.137 . . . . 0.56999999999999995 111.865 168.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -127.13 146.3 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.568 -1.271 . . . . 0.56999999999999995 107.568 177.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.33 156.69 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 125.586 1.554 . . . . 0.56999999999999995 107.06 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.7 p -108.46 138.12 45.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.275 -1.009 . . . . 0.56999999999999995 108.275 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -126.59 143.21 51.29 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.075 -1.016 . . . . 0.56999999999999995 108.725 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -150.66 110.94 4.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.755 0.788 . . . . 1.2 108.993 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 mt -80.6 95.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 105.874 -1.898 . . . . 0.56999999999999995 105.874 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -69.82 -36.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.06 1.344 . . . . 0.56999999999999995 112.557 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -130.04 158.38 39.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.129 -2.545 . . . . 0.56999999999999995 104.129 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -133.45 175.99 8.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.188 1.395 . . . . 0.56999999999999995 108.154 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -87.23 -154.68 0.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.847 0.859 . . . . 0.56999999999999995 109.258 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -132.31 -28.8 1.65 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 116.412 -1.756 . . . . 1.2 115.074 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.82 -47.89 84.29 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.263 1.392 . . . . 0.66000000000000003 110.696 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -109.52 158.11 35.57 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.344 1.458 . . . . 0.56999999999999995 109.199 176.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -77.54 156.44 32.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.79 1.66 . . . . 0.56999999999999995 112.672 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -59.87 -35.37 74.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.712 1.205 . . . . 0.65000000000000002 113.514 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.69 -37.29 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 110.34 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -69.51 -39.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 116.965 -1.493 . . . . 0.56999999999999995 109.313 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG13 ' CZ ' ' A' ' 114' ' ' PHE . 24.4 t -53.18 -56.84 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.761 1.619 . . . . 0.56999999999999995 109.773 171.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.37 -41.4 97.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.959 -0.543 . . . . 0.66000000000000003 111.323 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.65 -45.1 80.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.674 0.67 . . . . 1.2 111.904 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.24 -41.07 86.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.32 0.648 . . . . 0.56999999999999995 109.413 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.1 -50.09 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 117.511 -1.233 . . . . 0.56999999999999995 109.504 168.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -46.51 75.21 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 121.454 1.934 . . . . 0.56999999999999995 110.946 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.58 -35.05 79.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.743 0.701 . . . . 0.56999999999999995 112.335 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.71 -47.54 62.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.459 1.104 . . . . 0.56999999999999995 112.605 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 122' ' ' LEU . 9.4 mp -68.52 -31.36 70.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.135 1.374 . . . . 0.56999999999999995 109.514 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -59.77 -38.88 83.07 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.221 -0.895 . . . . 0.56999999999999995 110.226 168.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 37.2 mtm -67.47 -33.98 76.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.265 1.393 . . . . 0.56999999999999995 112.123 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 9.4 m95 -66.24 -54.58 23.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.07 0.85 . . . . 0.56999999999999995 110.269 170.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.62 -4.01 43.99 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.806 1.193 . . . . 0.56999999999999995 113.616 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -69.01 -25.92 64.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.685 1.242 . . . . 0.56999999999999995 110.346 172.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.26 -15.4 13.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.218 1.007 . . . . 0.66000000000000003 111.553 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 pt -131.5 140.66 39.09 Favored Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 119.466 1.03 . . . . 0.56999999999999995 109.204 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.8 9.1 1.4 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.715 2.277 . . . . 0.56999999999999995 112.963 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 126' ' ' LEU . 0.8 OUTLIER -71.48 135.03 46.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 108.348 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -125.27 -179.76 4.73 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.25 1.02 . . . . 0.65000000000000002 109.663 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.54 157.07 44.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.158 -0.682 . . . . 0.56999999999999995 109.158 -171.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 154.46 49.15 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.346 1.458 . . . . 1.2 110.121 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -114.56 109.31 18.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.086 -1.079 . . . . 0.56999999999999995 108.086 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.3 m -75.02 161.05 4.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.494 -0.558 . . . . 0.56999999999999995 109.494 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -61.61 -53.14 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 118.767 -0.635 . . . . 0.56999999999999995 110.524 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 165.88 58.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.292 2.237 . . . . 0.56999999999999995 111.749 -172.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.09 38.85 1.7 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.752 -1.218 . . . . 0.56999999999999995 113.588 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m 64.97 142.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.59 1.956 . . . . 0.56999999999999995 110.28 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.18 168.03 20.41 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.773 0.796 . . . . 0.56999999999999995 109.288 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 10' ' ' TRP . 58.0 m-20 -65.72 -45.02 84.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.582 -1.19 . . . . 0.66000000000000003 108.545 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -112.34 81.92 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.051 1.74 . . . . 0.56999999999999995 107.658 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -78.11 118.73 20.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.029 -1.1 . . . . 0.56999999999999995 108.029 168.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.28 130.57 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 105.787 -1.931 . . . . 0.56999999999999995 105.787 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.81 161.54 28.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.428 -0.669 . . . . 0.56999999999999995 111.428 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.3 m-85 -132.02 143.35 50.01 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.881 -1.526 . . . . 0.56999999999999995 106.881 -175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.02 179.98 6.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.433 1.493 . . . . 0.56999999999999995 109.186 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.4 ptt85 -141.15 57.47 1.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.319 -0.623 . . . . 1.2 109.319 -171.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.04 -58.55 0.66 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.627 1.108 . . . . 0.56999999999999995 111.889 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.86 155.01 45.91 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.684 0.794 . . . . 0.56999999999999995 109.279 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -157.76 147.25 19.95 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.037 0.935 . . . . 0.65000000000000002 109.127 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 74.63 1.5 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.371 -1.491 . . . . 0.56999999999999995 109.371 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.74 -92.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.614 1.565 . . . . 0.66000000000000003 107.169 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.9 p -158.92 -38.19 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.8 1.24 . . . . 0.56999999999999995 110.024 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -125.88 131.42 23.99 Favored Pre-proline 0 C--N 1.342 0.24 0 N-CA-C 109.541 -0.54 . . . . 0.56999999999999995 109.541 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.0 137.08 43.36 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.036 -1.563 . . . . 0.56999999999999995 108.036 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 -158.22 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 123.622 1.677 . . . . 0.56999999999999995 109.233 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -136.78 -22.64 1.22 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 130.205 3.402 . . . . 0.66000000000000003 109.058 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 -141.43 26.42 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.079 -1.208 . . . . 0.56999999999999995 110.079 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.06 95.21 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.965 3.11 . . . . 0.56999999999999995 110.855 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.27 -176.15 21.89 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.622 -0.991 . . . . 0.56999999999999995 110.622 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.25 31.8 t30 46.85 -135.72 0.88 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.451 1.5 . . . . 0.56999999999999995 114.092 173.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -61.86 125.52 24.14 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.274 2.23 . . . . 0.56999999999999995 110.909 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -82.48 -30.13 30.13 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.289 -1.507 . . . . 0.56999999999999995 113.734 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.1 166.84 25.22 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.374 1.07 . . . . 0.56999999999999995 109.377 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -144.08 163.93 32.13 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.799 -0.563 . . . . 0.65000000000000002 109.783 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.44 155.24 40.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.958 1.303 . . . . 0.56999999999999995 109.3 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.78 163.61 13.12 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 123.774 0.671 . . . . 0.56999999999999995 110.11 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.4 153.92 83.96 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.7 -0.667 . . . . 0.56999999999999995 109.946 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 36.3 Cg_endo -66.93 155.59 70.09 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.955 2.436 . . . . 0.56999999999999995 112.176 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.81 -118.41 0.55 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.289 -1.925 . . . . 0.56999999999999995 108.289 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.7 m -151.59 106.57 3.28 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 104.667 -2.345 . . . . 0.56999999999999995 104.667 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.67 -132.57 10.51 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 117.483 -1.732 . . . . 0.56999999999999995 109.301 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -31.13 12.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.662 1.585 . . . . 0.56999999999999995 112.809 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -45.96 144.27 3.73 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.72 -0.552 . . . . 0.56999999999999995 111.72 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CZ2' ' A' ' 10' ' ' TRP . . . 70.44 -18.81 0.71 Allowed Glycine 0 C--N 1.337 0.61 0 C-N-CA 126.546 2.022 . . . . 0.56999999999999995 116.738 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -68.1 155.51 39.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.785 -1.191 . . . . 0.66000000000000003 107.785 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.58 29.89 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.371 -0.832 . . . . 0.56999999999999995 108.96 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -127.93 159.27 35.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.196 -0.911 . . . . 0.65000000000000002 109.156 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.483 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 28.9 m-85 -144.56 154.74 43.18 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.566 1.546 . . . . 0.56999999999999995 108.095 -170.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -90.06 99.15 12.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.672 0.389 . . . . 0.66000000000000003 110.28 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.97 -28.14 49.31 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.741 -1.224 . . . . 0.66000000000000003 111.977 172.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -54.67 -38.52 67.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.824 1.65 . . . . 0.66000000000000003 110.592 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -75.79 151.14 37.6 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.881 1.272 . . . . 0.66000000000000003 109.844 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -80.13 125.21 29.53 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.712 -1.243 . . . . 1.2 109.709 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -107.17 166.05 10.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.832 0.853 . . . . 0.56999999999999995 109.118 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -158.8 164.4 35.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 109.438 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -65.01 -48.03 75.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.326 0.65 . . . . 0.66000000000000003 110.237 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.61 40.25 0.02 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.149 -0.806 . . . . 0.56999999999999995 112.777 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -77.36 32.61 0.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.02 1.41 . . . . 0.56999999999999995 113.827 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.1 m 53.51 35.09 19.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.667 1.587 . . . . 0.56999999999999995 113.559 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -160.66 -175.16 4.81 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.551 1.54 . . . . 0.56999999999999995 108.622 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.37 -144.76 24.32 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 124.237 0.922 . . . . 0.56999999999999995 112.033 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -120.67 113.47 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.821 -1.548 . . . . 0.56999999999999995 106.821 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -61.08 110.48 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.148 0.979 . . . . 0.56999999999999995 111.304 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 31' ' ' VAL . 10.0 t80 -63.21 -42.98 99.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.507 1.123 . . . . 0.56999999999999995 111.355 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -55.11 22.77 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.86 -1.163 . . . . 0.56999999999999995 107.86 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 147' ' ' PRO . 11.8 t80 -64.47 -43.25 94.81 Favored 'General case' 0 CA--C 1.526 0.02 0 C-N-CA 122.949 0.499 . . . . 0.56999999999999995 111.004 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.2 70.82 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.085 0.554 . . . . 0.56999999999999995 110.906 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.1 -55.66 31.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.191 -0.909 . . . . 0.56999999999999995 109.607 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 m -53.93 -38.72 65.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 111.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 4.0 t-160 -63.96 -59.29 4.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.252 0.621 . . . . 0.65000000000000002 109.788 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -64.69 -46.71 81.19 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.232 0.469 . . . . 0.66000000000000003 111.104 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.01 -31.48 71.86 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.4 1.08 . . . . 0.56999999999999995 112.103 177.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -55.87 -41.89 84.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.219 -0.752 . . . . 0.56999999999999995 111.219 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -72.33 -36.33 68.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.062 -0.971 . . . . 0.65000000000000002 111.81 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -56.37 -36.33 68.72 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.283 0.947 . . . . 0.56999999999999995 112.293 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 48' ' ' LEU . 2.5 mm? -65.87 -21.04 66.43 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.611 1.096 . . . . 0.56999999999999995 112.942 176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.33 -54.59 0.28 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 124.343 0.973 . . . . 0.56999999999999995 110.895 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.542 ' HG3' ' H ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 172.74 176.89 0.09 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.38 2.272 . . . . 0.56999999999999995 107.7 -173.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.4 70.65 0.02 OUTLIER Glycine 0 C--O 1.218 -0.874 0 N-CA-C 107.152 -2.379 . . . . 0.56999999999999995 107.152 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 162.11 27.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.425 1.112 . . . . 0.65000000000000002 108.651 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 t -157.95 -161.89 1.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.984 1.314 . . . . 0.56999999999999995 108.388 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -152.74 58.43 0.8 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.119 1.768 . . . . 0.56999999999999995 109.288 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -143.44 135.16 12.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 117.037 -1.458 . . . . 0.66000000000000003 108.751 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.37 41.92 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.051 1 C-N-CA 125.981 4.454 . . . . 0.56999999999999995 114.041 -174.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -154.02 -27.15 0.13 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 127.931 2.492 . . . . 0.56999999999999995 111.566 -173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -50.7 133.35 25.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.7 -0.852 . . . . 0.56999999999999995 108.7 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 156' ' ' ASP . 7.3 p -60.96 -25.44 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.852 -0.53 . . . . 0.56999999999999995 110.745 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' HIS . 3.8 mpp? -109.63 28.61 8.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.41 1.084 . . . . 0.56999999999999995 111.49 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -50.5 128.69 25.35 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 120.698 -1.251 . . . . 0.56999999999999995 110.054 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.35 168.1 24.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.995 2.463 . . . . 0.56999999999999995 110.542 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.4 m 62.0 70.43 0.58 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.871 0.759 . . . . 0.56999999999999995 110.552 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -41.18 123.68 2.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.856 1.662 . . . . 0.56999999999999995 112.115 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.1 -111.42 0.33 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.909 -1.277 . . . . 0.56999999999999995 109.909 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -50.44 -39.97 49.16 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.667 0.988 . . . . 0.56999999999999995 113.667 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.85 89.14 0.01 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.225 1.869 . . . . 0.56999999999999995 112.115 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.99 107.91 1.06 Allowed Pre-proline 0 C--N 1.344 0.349 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 109.987 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.406 ' HA ' ' CD1' ' A' ' 116' ' ' TYR . 11.7 Cg_endo -72.19 -25.17 19.22 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.37 1.38 . . . . 0.56999999999999995 112.145 -172.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.9 2.42 38.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.448 -0.787 . . . . 0.56999999999999995 110.941 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.65 75.47 1.66 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.223 1.809 . . . . 0.56999999999999995 108.418 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.11 -64.98 0.64 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.675 1.19 . . . . 0.56999999999999995 113.291 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 22.61 77.55 0.02 OUTLIER 'General case' 0 C--N 1.343 0.296 0 C-N-CA 129.279 3.032 . . . . 0.56999999999999995 112.657 174.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.7 mp -38.26 97.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.571 2.348 . . . . 0.56999999999999995 109.97 -176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 m -74.13 -87.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.558 0.743 . . . . 0.56999999999999995 112.546 -162.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -137.5 -28.02 0.92 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 116.779 -1.581 . . . . 0.56999999999999995 110.248 168.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.17 -54.11 50.47 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.154 1.797 . . . . 0.66000000000000003 111.299 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.598 ' HB2' HG11 ' A' ' 137' ' ' VAL . 1.5 t0 -62.68 -53.11 59.36 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 109.799 -0.445 . . . . 0.66000000000000003 109.799 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.12 -40.62 83.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 C-N-CA 123.865 0.866 . . . . 0.56999999999999995 109.112 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -64.95 -43.03 94.02 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.823 -1.085 . . . . 0.56999999999999995 110.653 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.48 -61.63 7.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.373 -1.491 . . . . 0.56999999999999995 109.373 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.406 HD11 ' CE3' ' A' ' 42' ' ' TRP . 4.0 mm -53.47 -47.2 59.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.383 1.473 . . . . 0.56999999999999995 112.748 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.14 -31.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.037 0.535 . . . . 0.56999999999999995 111.017 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -29.61 64.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.702 0.683 . . . . 0.56999999999999995 111.183 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.59 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.482 -0.77 . . . . 0.56999999999999995 109.709 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -143.31 22.64 1.86 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.65 0.611 . . . . 0.56999999999999995 112.65 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.14 -153.99 12.96 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.139 0.876 . . . . 0.56999999999999995 113.04 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -120.83 -43.89 2.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.355 1.462 . . . . 0.56999999999999995 112.942 -171.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -73.73 123.68 24.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.625 -0.88 . . . . 1.2 108.625 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.9 p -126.0 74.64 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.22 1.408 . . . . 0.56999999999999995 109.056 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.13 100.74 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.604 1.162 . . . . 0.56999999999999995 108.051 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.07 110.02 0.69 Allowed 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.28 -1.007 . . . . 0.56999999999999995 108.28 174.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -123.11 113.14 18.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.556 -1.275 . . . . 1.2 107.556 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.46 -179.34 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.379 1.049 . . . . 0.56999999999999995 108.798 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tttp . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 125.429 1.492 . . . . 0.5 . -179.551 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.14 -0.457 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 m -70.72 -63.59 1.06 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 119.939 -1.725 . . . . 0.56999999999999995 112.132 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -176.0 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.174 1.789 . . . . 0.56999999999999995 106.559 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 165.63 -52.8 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 127.889 2.476 . . . . 0.56999999999999995 110.502 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.67 150.5 5.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.405 1.403 . . . . 0.56999999999999995 112.625 -171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -150.41 76.66 1.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.407 0.683 . . . . 0.56999999999999995 110.514 -169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.88 84.51 3.37 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 108.601 -0.889 . . . . 0.56999999999999995 108.601 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.24 85.24 1.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.114 2.543 . . . . 0.56999999999999995 109.668 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 pttt 85.73 151.26 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.239 2.615 . . . . 0.56999999999999995 108.937 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 64.6 m95 -65.76 170.11 5.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.265 1.026 . . . . 0.56999999999999995 109.938 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 m -62.05 -29.66 70.45 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 120.94 -1.1 . . . . 0.56999999999999995 111.252 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.6 t -97.62 156.87 16.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.56999999999999995 112.163 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -75.1 -6.08 47.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.682 1.593 . . . . 0.56999999999999995 112.754 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.63 151.94 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.523 -0.918 . . . . 0.56999999999999995 108.523 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 150.16 33.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.047 -1.094 . . . . 0.56999999999999995 108.047 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.8 p -104.54 136.78 43.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.605 -0.887 . . . . 0.56999999999999995 108.605 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -118.79 163.2 17.23 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.801 0.84 . . . . 0.56999999999999995 110.481 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.37 160.45 41.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.046 -1.094 . . . . 1.2 108.046 169.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.6 mt -123.2 94.25 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 103.663 -2.717 . . . . 0.56999999999999995 103.663 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 m -73.29 -30.68 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.593 0.357 . . . . 0.56999999999999995 111.263 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -142.63 147.27 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.161 -2.163 . . . . 0.56999999999999995 105.161 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -131.9 159.19 39.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.357 1.063 . . . . 0.56999999999999995 109.207 -166.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -91.74 -175.52 4.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.876 1.27 . . . . 0.56999999999999995 109.437 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.61 -26.3 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.128 1.159 . . . . 1.2 114.128 -174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -59.19 -40.68 86.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.265 0.626 . . . . 0.66000000000000003 110.305 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.65 152.57 80.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 128.767 2.827 . . . . 0.56999999999999995 110.248 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.31 161.19 28.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.962 2.441 . . . . 0.56999999999999995 114.453 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -63.82 -39.05 93.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.833 1.653 . . . . 0.65000000000000002 112.027 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 tt -65.89 -35.96 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.424 0.69 . . . . 0.56999999999999995 110.794 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -66.39 -46.62 76.03 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 116.703 -1.617 . . . . 0.56999999999999995 108.723 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.56 -52.54 25.78 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.568 1.531 . . . . 0.56999999999999995 110.043 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -63.04 -42.49 99.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.635 1.174 . . . . 0.66000000000000003 110.955 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -63.32 -46.88 84.63 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.95 . . . . 1.2 112.062 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.15 -45.61 87.72 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.239 -0.886 . . . . 0.56999999999999995 109.022 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -46.75 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 124.267 1.027 . . . . 0.56999999999999995 109.574 172.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -46.06 89.47 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 119.047 0.839 . . . . 0.56999999999999995 110.95 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -63.67 -42.95 98.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.912 1.285 . . . . 0.56999999999999995 112.033 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -49.29 75.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.094 1.357 . . . . 0.56999999999999995 111.447 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.5 mt -64.92 -34.19 77.82 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.607 -0.711 . . . . 0.56999999999999995 110.258 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -40.76 85.38 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.262 0.937 . . . . 0.56999999999999995 110.613 172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 39.4 mtm -63.85 -38.93 92.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.047 0.84 . . . . 0.56999999999999995 111.293 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CH2' ' HA2' ' A' ' 123' ' ' GLY . 12.1 m95 -64.29 -49.67 70.87 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.26 0.936 . . . . 0.56999999999999995 111.405 172.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.16 -9.08 66.6 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.913 1.244 . . . . 0.56999999999999995 113.174 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -23.77 63.08 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.506 1.653 . . . . 0.56999999999999995 110.864 170.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -105.85 -14.03 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.258 1.023 . . . . 0.66000000000000003 111.706 -171.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' CD1' ' A' ' 164' ' ' TYR . 12.8 pt -139.36 149.56 60.92 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.636 1.174 . . . . 0.56999999999999995 111.445 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.37 10.32 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.313 2.675 . . . . 0.56999999999999995 113.018 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.26 133.9 35.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.736 1.615 . . . . 0.56999999999999995 107.513 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.12 170.88 10.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.002 0.921 . . . . 0.65000000000000002 110.006 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.08 146.16 31.73 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.426 -0.953 . . . . 0.56999999999999995 108.426 -172.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -143.6 166.53 24.58 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.875 1.27 . . . . 1.2 109.242 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -105.37 143.35 33.66 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.86 -0.793 . . . . 0.56999999999999995 108.86 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.66 157.01 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.71 0.404 . . . . 0.56999999999999995 110.98 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.86 -43.81 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.779 0.832 . . . . 0.56999999999999995 111.509 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -176.64 146.98 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.97 2.908 . . . . 0.56999999999999995 104.622 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.18 -116.87 3.07 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.523 -0.631 . . . . 0.56999999999999995 111.523 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 43.9 p -132.88 164.64 26.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.635 1.974 . . . . 0.56999999999999995 108.556 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.57 168.51 21.78 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.126 0.97 . . . . 0.56999999999999995 110.121 -174.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -63.01 -33.08 74.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.611 0.764 . . . . 0.66000000000000003 109.806 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.3 mt -123.53 76.94 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.068 2.147 . . . . 0.56999999999999995 108.235 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -73.22 110.75 7.74 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.737 1.615 . . . . 0.56999999999999995 108.519 167.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -97.91 128.13 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 104.568 -2.382 . . . . 0.56999999999999995 104.568 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.62 148.9 19.07 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 110.111 -1.196 . . . . 0.56999999999999995 110.111 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -113.38 167.28 10.7 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 118.299 1.05 . . . . 0.56999999999999995 108.594 -171.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.58 155.28 43.57 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.513 1.125 . . . . 0.56999999999999995 108.162 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -105.13 110.03 22.25 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 107.521 -1.289 . . . . 1.2 107.521 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.73 -46.95 2.4 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.015 -1.436 . . . . 0.56999999999999995 113.665 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.53 165.53 36.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.554 1.677 . . . . 0.56999999999999995 111.56 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.13 162.51 33.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.411 1.085 . . . . 0.65000000000000002 111.777 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.57 58.62 3.0 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.798 1.665 . . . . 0.56999999999999995 112.307 -174.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -116.99 -52.71 2.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.561 0.745 . . . . 0.66000000000000003 111.276 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 t 174.73 -38.38 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.427 1.891 . . . . 0.56999999999999995 110.65 -167.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -122.54 114.16 30.28 Favored Pre-proline 0 C--N 1.347 0.471 0 C-N-CA 123.388 0.675 . . . . 0.56999999999999995 109.538 -170.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.07 28.88 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.941 2.427 . . . . 0.56999999999999995 112.552 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 41.96 -136.3 0.27 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.128 1.771 . . . . 0.56999999999999995 111.326 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -162.77 -40.46 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.779 2.432 . . . . 0.66000000000000003 108.449 -163.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.39 -153.91 21.98 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.687 -1.365 . . . . 0.56999999999999995 109.687 -170.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.77 101.98 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.096 3.198 . . . . 0.56999999999999995 113.561 -167.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.88 -178.79 17.05 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 109.839 -1.304 . . . . 0.56999999999999995 109.839 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t30 49.14 -145.01 0.42 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.195 0.997 . . . . 0.56999999999999995 112.428 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.3 m -46.5 110.68 0.3 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.374 2.27 . . . . 0.56999999999999995 112.577 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -83.83 -34.12 24.75 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.259 -0.9 . . . . 0.56999999999999995 113.041 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.84 167.62 29.82 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.915 0.886 . . . . 0.56999999999999995 109.382 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -150.98 150.44 30.79 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.876 -0.515 . . . . 0.65000000000000002 110.053 172.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.95 163.2 32.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 109.628 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -117.31 140.3 49.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.007 -1.109 . . . . 0.56999999999999995 108.007 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.09 160.07 3.47 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.56999999999999995 112.444 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.0 Cg_endo -68.6 152.87 74.46 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.538 2.158 . . . . 0.56999999999999995 111.183 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.17 -78.57 0.03 OUTLIER Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -172.21 -49.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.584 1.154 . . . . 0.56999999999999995 109.497 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.69 -101.99 2.73 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.218 -1.153 . . . . 0.56999999999999995 110.218 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -27.18 68.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.048 0.939 . . . . 0.56999999999999995 111.828 175.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.54 146.77 15.67 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.148 -0.97 . . . . 0.56999999999999995 111.411 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 -21.37 4.24 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.579 2.037 . . . . 0.56999999999999995 114.506 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -74.76 160.14 31.1 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.975 1.388 . . . . 0.66000000000000003 108.891 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.09 139.86 20.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.3 -169.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -132.77 149.52 52.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.437 0.695 . . . . 0.65000000000000002 110.6 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -142.07 146.88 35.95 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.096 -1.446 . . . . 0.56999999999999995 107.096 -166.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -86.55 103.89 15.48 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.02 0.914 . . . . 0.66000000000000003 109.277 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.65 -15.54 62.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.316 1.446 . . . . 0.66000000000000003 111.374 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -69.56 -20.58 63.66 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.436 1.016 . . . . 0.66000000000000003 110.267 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -85.38 158.91 20.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.026 0.917 . . . . 0.66000000000000003 110.325 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.27 138.66 35.73 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -131.47 144.84 51.45 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -138.48 153.07 48.79 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.46 0.648 . . . . 0.56999999999999995 110.14 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -97.18 11.57 35.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.626 2.371 . . . . 0.66000000000000003 110.741 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.74 -134.31 2.98 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.81 1.672 . . . . 0.56999999999999995 111.674 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.5 t -143.33 171.5 14.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.309 1.444 . . . . 0.56999999999999995 108.713 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 t 51.76 42.9 30.25 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.892 1.441 . . . . 0.56999999999999995 114.892 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.56 -38.59 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 119.914 -1.741 . . . . 0.56999999999999995 113.542 -172.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.35 -154.9 10.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 108.587 -1.805 . . . . 0.56999999999999995 108.587 -172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.94 119.51 34.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 108.289 -1.004 . . . . 0.56999999999999995 108.289 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -63.98 103.56 0.61 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.945 0.498 . . . . 0.56999999999999995 109.675 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -55.24 -36.35 65.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.874 1.27 . . . . 0.56999999999999995 110.645 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.6 tp -65.44 -48.35 73.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.849 -0.797 . . . . 0.56999999999999995 108.849 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.52 -39.07 93.47 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.558 -0.904 . . . . 0.56999999999999995 108.558 -176.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.56 -56.3 22.97 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.58 0.752 . . . . 0.56999999999999995 110.999 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.25 58.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.137 0.575 . . . . 0.56999999999999995 109.71 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.7 m -58.73 -44.02 90.35 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.173 0.897 . . . . 0.56999999999999995 111.732 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.66 -52.03 67.1 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.034 0.534 . . . . 0.65000000000000002 109.723 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.23 -48.66 72.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.466 1.106 . . . . 0.66000000000000003 110.393 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -61.14 -29.12 69.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 126.113 1.765 . . . . 0.56999999999999995 111.534 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 42' ' ' TRP . . . -62.19 -45.32 96.27 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.691 -0.564 . . . . 0.56999999999999995 111.691 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -62.32 -39.76 94.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 117.213 -1.375 . . . . 0.65000000000000002 109.911 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -60.44 -29.1 68.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.825 1.193 . . . . 0.56999999999999995 113.774 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -25.22 57.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.596 1.089 . . . . 0.56999999999999995 112.71 172.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.89 -1.63 4.29 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.808 1.194 . . . . 0.56999999999999995 114.5 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.43 164.68 20.5 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.951 1.375 . . . . 0.56999999999999995 113.678 -166.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.38 166.49 12.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.227 1.394 . . . . 0.56999999999999995 109.755 172.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -68.37 174.35 4.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.195 0.998 . . . . 0.65000000000000002 112.558 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.08 179.83 7.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.735 1.614 . . . . 0.56999999999999995 108.519 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.08 71.55 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.826 2.05 . . . . 0.56999999999999995 107.51 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 12.3 t70 -136.72 140.49 32.13 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 107.668 -1.234 . . . . 0.66000000000000003 107.668 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.34 -26.32 41.53 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.456 2.104 . . . . 0.56999999999999995 112.317 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.2 22.87 14.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.981 1.313 . . . . 0.56999999999999995 109.991 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -64.61 124.42 21.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.258 -1.016 . . . . 0.56999999999999995 108.258 166.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.93 -31.03 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.986 -0.446 . . . . 0.56999999999999995 109.871 166.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -84.51 8.54 16.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.94 1.089 . . . . 0.56999999999999995 113.94 171.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -56.78 130.85 78.43 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.652 1.569 . . . . 0.56999999999999995 110.565 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 150.01 26.53 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.197 1.931 . . . . 0.56999999999999995 110.27 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.8 m 73.12 156.42 0.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.389 1.876 . . . . 0.56999999999999995 111.545 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.79 132.73 53.88 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.252 1.021 . . . . 0.56999999999999995 109.55 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 141.62 97.51 0.29 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.511 1.053 . . . . 0.56999999999999995 110.53 170.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.25 -43.23 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.659 1.229 . . . . 0.56999999999999995 113.443 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.66 -177.22 48.39 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.862 -1.695 . . . . 0.56999999999999995 108.862 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -51.7 111.56 2.52 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.579 1.552 . . . . 0.66000000000000003 110.969 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -3.86 12.39 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.21 1.94 . . . . 0.56999999999999995 112.304 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -73.7 -9.99 59.23 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.706 1.139 . . . . 0.56999999999999995 112.91 168.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -62.61 -6.58 3.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.721 1.749 . . . . 0.56999999999999995 115.721 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 19.77 -88.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.346 3.058 . . . . 0.56999999999999995 116.83 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt 20.39 73.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 129.677 3.191 . . . . 0.56999999999999995 112.859 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -26.11 106.09 0.03 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 127.876 2.471 . . . . 0.56999999999999995 110.165 -175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.8 t -81.67 -87.54 0.09 Allowed 'General case' 0 C--N 1.343 0.316 0 O-C-N 123.853 0.721 . . . . 0.56999999999999995 110.147 -160.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.75 -37.5 0.45 Allowed 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.252 -1.356 . . . . 0.56999999999999995 109.376 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -47.85 -49.32 29.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.205 1.366 . . . . 0.66000000000000003 110.571 171.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.428 ' CG ' HD23 ' A' ' 152' ' ' LEU . 12.1 t0 -77.57 -54.15 6.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.66000000000000003 109.746 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mm -57.68 -45.64 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.76 0.709 . . . . 0.56999999999999995 111.079 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -44.16 79.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 123.505 0.722 . . . . 0.56999999999999995 109.565 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.43 -51.25 58.87 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.123 -1.191 . . . . 0.56999999999999995 110.123 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.7 mm -60.22 -51.97 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.456 1.102 . . . . 0.56999999999999995 110.223 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.08 -25.28 61.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.877 0.762 . . . . 0.56999999999999995 112.498 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -43.79 18.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.577 -1.201 . . . . 0.56999999999999995 110.064 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.25 -56.67 6.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.666 2.386 . . . . 0.56999999999999995 111.624 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.422 ' CD1' HG22 ' A' ' 46' ' ' ILE . 26.4 p90 -93.6 1.15 56.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 119.02 -0.514 . . . . 0.56999999999999995 112.143 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -104.21 -115.38 4.07 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.718 -1.753 . . . . 0.56999999999999995 108.718 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -61.62 -63.07 1.39 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.22 -0.895 . . . . 0.56999999999999995 111.741 -172.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -169.18 -79.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.012 2.125 . . . . 1.2 107.382 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 158.69 8.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.825 0.85 . . . . 0.56999999999999995 109.489 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 159.15 39.56 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.607 1.163 . . . . 0.56999999999999995 108.77 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.0 t -163.7 178.81 7.61 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.547 1.139 . . . . 0.56999999999999995 108.519 168.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.64 129.39 55.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.323 -2.102 . . . . 1.2 105.323 167.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -47.82 140.85 6.15 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.163 0.985 . . . . 0.56999999999999995 110.788 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 126.365 1.866 . . . . 0.5 . -179.32 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 120.409 0.147 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.4 t -62.89 -54.07 44.27 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.263 1.025 . . . . 0.56999999999999995 111.241 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.85 173.13 15.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.884 2.073 . . . . 0.56999999999999995 109.043 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -45.0 138.78 4.13 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.05 2.14 . . . . 0.56999999999999995 113.069 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.09 -4.45 15.44 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.827 2.351 . . . . 0.56999999999999995 113.518 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -134.73 101.17 4.84 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.014 1.326 . . . . 0.56999999999999995 108.048 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.68 -61.48 0.0 OUTLIER Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 129.259 3.024 . . . . 0.56999999999999995 107.622 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.01 158.17 58.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.627 1.551 . . . . 0.56999999999999995 110.187 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.5 111.55 0.07 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.48 1.912 . . . . 0.56999999999999995 111.288 -174.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 19.9 m95 -58.02 152.29 16.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.996 0.918 . . . . 0.56999999999999995 111.436 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.4 p -77.47 -20.69 54.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 0.56999999999999995 112.764 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -94.19 142.41 27.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.236 1.415 . . . . 0.56999999999999995 109.325 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -10.62 59.7 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.406 1.482 . . . . 0.56999999999999995 112.577 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.87 109.91 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.614 -1.995 . . . . 0.56999999999999995 105.614 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG23 HD21 ' A' ' 48' ' ' LEU . 59.9 t -102.02 159.0 4.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.607 -1.627 . . . . 0.56999999999999995 106.607 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 p -106.96 139.8 40.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.277 -0.638 . . . . 0.56999999999999995 109.277 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -128.08 157.37 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.409 -0.807 . . . . 0.56999999999999995 110.092 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -158.48 115.88 2.88 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.057 0.456 . . . . 1.2 110.361 169.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.65 90.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 106.623 -1.621 . . . . 0.56999999999999995 106.623 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 m -64.12 -25.46 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.408 -1.432 . . . . 0.56999999999999995 113.901 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -147.6 154.72 41.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 103.241 -2.874 . . . . 0.56999999999999995 103.241 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -135.78 43.95 2.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.756 0.707 . . . . 0.56999999999999995 110.148 -164.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 64' ' ' PHE . 15.4 t 47.73 -153.98 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.779 1.232 . . . . 0.56999999999999995 110.186 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -22.79 0.55 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.54 -0.743 . . . . 1.2 112.784 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -64.04 -39.72 94.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.04 0.836 . . . . 0.66000000000000003 111.536 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.19 150.7 57.41 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 109.062 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.28 159.67 40.09 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.82 2.347 . . . . 0.56999999999999995 113.011 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -59.53 -36.78 76.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.98 1.312 . . . . 0.65000000000000002 113.689 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -39.3 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.185 0.448 . . . . 0.56999999999999995 110.039 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -69.74 -46.39 66.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.297 -1.335 . . . . 0.56999999999999995 109.475 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.4 -48.14 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.985 1.721 . . . . 0.56999999999999995 110.403 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.72 -45.67 91.65 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 119.019 0.827 . . . . 0.66000000000000003 110.781 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -40.54 94.83 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.8 1.182 . . . . 1.2 113.189 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.23 -47.77 63.83 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.04 1.336 . . . . 0.56999999999999995 109.235 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.2 -37.84 70.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 119.375 0.989 . . . . 0.56999999999999995 110.809 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.0 t -61.49 -56.75 16.61 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.227 1.011 . . . . 0.56999999999999995 109.95 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -62.34 -32.72 73.54 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.353 1.433 . . . . 0.56999999999999995 112.338 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.95 62.0 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.451 1.1 . . . . 0.56999999999999995 112.316 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.62 -31.16 70.99 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 118.228 -0.891 . . . . 0.56999999999999995 110.165 172.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -59.85 -43.57 94.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.901 -1.047 . . . . 0.56999999999999995 109.609 171.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.1 mtp -61.31 -45.26 95.18 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.893 1.224 . . . . 0.56999999999999995 111.733 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -60.48 -47.75 84.77 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.085 1.311 . . . . 0.56999999999999995 111.565 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.57 -17.01 68.37 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.64 1.114 . . . . 0.56999999999999995 113.071 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -29.57 70.73 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.478 -1.013 . . . . 0.56999999999999995 110.182 174.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -94.91 -32.26 13.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.72 -0.657 . . . . 0.66000000000000003 111.808 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.89 132.87 24.57 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.757 0.823 . . . . 0.56999999999999995 110.659 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.34 35.7 0.4 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 124.111 3.208 . . . . 0.56999999999999995 113.991 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 49' ' ' HIS . 2.1 tt -78.81 146.26 33.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.718 1.607 . . . . 0.56999999999999995 107.85 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.535 ' H ' HD23 ' A' ' 48' ' ' LEU . 68.8 m80 -130.59 160.17 34.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.02 1.328 . . . . 0.65000000000000002 108.191 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 149.87 43.97 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 120.927 -1.108 . . . . 0.56999999999999995 108.26 -173.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -137.18 170.33 16.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.926 0.89 . . . . 1.2 109.357 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -117.33 128.22 54.83 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.14 163.23 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.95 1.3 . . . . 0.56999999999999995 110.444 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 55' ' ' TRP . 27.4 m -66.36 -60.21 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.845 0.858 . . . . 0.56999999999999995 109.895 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.503 ' H ' HG23 ' A' ' 54' ' ' VAL . 19.7 p90 -164.57 154.12 13.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.415 2.686 . . . . 0.56999999999999995 105.616 167.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.05 17.79 1.42 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.433 1.333 . . . . 0.56999999999999995 116.433 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.6 m 68.0 159.04 0.15 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 111.021 -168.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -131.82 177.26 7.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.623 1.569 . . . . 0.56999999999999995 109.071 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.86 -34.97 79.36 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.921 0.488 . . . . 0.66000000000000003 109.946 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mt -126.84 82.25 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.139 -1.8 . . . . 0.56999999999999995 106.139 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.47 140.21 44.44 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.208 -0.932 . . . . 0.56999999999999995 108.777 164.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.67 120.36 61.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 N-CA-C 105.705 -1.961 . . . . 0.56999999999999995 105.705 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.74 161.12 24.74 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.697 -0.561 . . . . 0.56999999999999995 111.697 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.5 m-85 -132.45 129.9 39.84 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 104.978 -2.23 . . . . 0.56999999999999995 104.978 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.24 165.1 17.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 126.647 1.979 . . . . 0.56999999999999995 108.223 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 ttp-105 -97.36 -14.15 21.43 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.69 0.996 . . . . 1.2 113.69 -168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.22 -44.07 0.03 OUTLIER Glycine 0 C--O 1.221 -0.669 0 CA-C-O 119.067 -0.852 . . . . 0.56999999999999995 111.034 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.57 27.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.314 1.046 . . . . 0.56999999999999995 109.143 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 -75.31 0.63 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.145 1.778 . . . . 0.65000000000000002 109.096 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.44 46.52 0.02 OUTLIER Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.594 0.616 . . . . 0.56999999999999995 112.371 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.38 -172.46 2.05 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.832 1.653 . . . . 0.66000000000000003 108.098 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.1 -36.73 2.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.02 1.328 . . . . 0.56999999999999995 113.322 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.8 101.3 6.49 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 108.332 -0.988 . . . . 0.56999999999999995 108.332 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.52 155.26 67.37 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.412 1.408 . . . . 0.56999999999999995 111.155 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.03 177.23 3.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.53 1.157 . . . . 0.56999999999999995 111.734 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.0 -26.6 8.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.828 3.251 . . . . 0.66000000000000003 111.798 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.57 -146.0 18.06 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 120.89 1.677 . . . . 0.56999999999999995 112.632 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.5 82.28 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.133 2.555 . . . . 0.56999999999999995 113.753 -172.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -165.02 35.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.984 1.754 . . . . 0.56999999999999995 111.743 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 t30 38.41 -129.65 0.22 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.364 2.266 . . . . 0.56999999999999995 115.755 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.2 m -65.67 131.26 45.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.153 2.181 . . . . 0.56999999999999995 109.135 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.5 mp -101.17 -27.15 13.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 113.496 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.91 159.69 32.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.153 -1.425 . . . . 0.56999999999999995 107.153 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.89 157.1 43.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.65000000000000002 109.553 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.72 155.13 43.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.519 1.128 . . . . 0.56999999999999995 108.709 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -111.97 143.73 42.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.522 -0.918 . . . . 0.56999999999999995 108.522 -175.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.09 151.72 33.44 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 118.122 -0.942 . . . . 0.56999999999999995 110.193 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 55.1 Cg_endo -70.15 155.52 64.44 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.678 1.585 . . . . 0.56999999999999995 112.014 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.72 174.7 14.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.81 1.195 . . . . 0.56999999999999995 110.733 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.257 7.1 t 43.52 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.049 1.74 . . . . 0.56999999999999995 113.055 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.51 -53.06 2.69 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.945 -0.92 . . . . 0.56999999999999995 111.178 172.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.16 -35.27 80.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.816 1.246 . . . . 0.56999999999999995 112.089 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.0 153.62 30.15 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.889 -1.132 . . . . 0.56999999999999995 111.007 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.61 -21.48 1.96 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.204 1.383 . . . . 0.56999999999999995 114.091 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -74.72 155.07 38.09 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 120.138 1.969 . . . . 0.66000000000000003 108.614 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.29 26.02 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.507 -0.769 . . . . 0.56999999999999995 109.487 -173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -132.82 162.33 31.8 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.65000000000000002 109.248 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 37.5 m-85 -143.03 155.44 44.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.732 1.613 . . . . 0.56999999999999995 108.718 -171.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.63 96.29 7.85 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.552 -1.277 . . . . 0.66000000000000003 107.552 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.13 -32.76 68.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.068 1.747 . . . . 0.66000000000000003 111.74 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.74 -32.27 73.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.423 -0.584 . . . . 0.66000000000000003 109.423 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.88 124.01 23.33 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.276 1.03 . . . . 0.66000000000000003 109.471 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -54.48 131.06 41.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.301 1.04 . . . . 1.2 109.745 -175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.38 149.07 39.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.658 -1.238 . . . . 0.56999999999999995 107.658 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -145.1 149.3 34.8 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.508 -0.745 . . . . 0.56999999999999995 109.185 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.35 -39.25 75.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.385 0.538 . . . . 0.66000000000000003 110.728 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.87 -35.47 0.1 OUTLIER Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.367 -0.685 . . . . 0.56999999999999995 112.866 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.1 m -54.91 137.64 45.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.293 1.037 . . . . 0.56999999999999995 111.633 174.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -56.12 110.44 0.75 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 111.936 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.6 -32.88 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.586 1.154 . . . . 0.56999999999999995 111.804 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.98 -146.21 5.5 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 108.06 -2.016 . . . . 0.56999999999999995 108.06 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -90.39 135.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.727 1.211 . . . . 0.56999999999999995 109.523 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.71 103.66 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.896 0.878 . . . . 0.56999999999999995 110.623 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -56.05 -41.39 74.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.085 2.154 . . . . 0.56999999999999995 110.817 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 tp -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.088 -0.708 . . . . 0.56999999999999995 109.088 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 137' ' ' VAL . 39.8 t80 -57.93 -48.86 78.68 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.719 0.807 . . . . 0.56999999999999995 109.183 173.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.54 -57.05 14.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.811 0.844 . . . . 0.56999999999999995 110.464 177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.9 -51.37 70.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.512 -0.756 . . . . 0.56999999999999995 110.333 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.1 m -56.75 -41.21 77.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 110.904 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -67.12 -52.89 36.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.348 0.659 . . . . 0.65000000000000002 110.306 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -65.03 -41.92 94.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.9 0.773 . . . . 0.66000000000000003 111.037 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.06 -27.91 66.06 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.275 0.63 . . . . 0.56999999999999995 110.734 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.05 -44.01 88.28 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 118.855 0.752 . . . . 0.56999999999999995 111.398 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -68.33 -39.56 81.91 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.18 -0.914 . . . . 0.65000000000000002 112.067 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.3 p -65.05 -26.94 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 123.688 0.617 . . . . 0.56999999999999995 111.955 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -44.18 85.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 0.56999999999999995 111.08 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 168.84 41.64 0.03 OUTLIER Glycine 0 C--N 1.34 0.8 0 CA-C-O 118.411 -1.216 . . . . 0.56999999999999995 115.128 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.7 mmt 54.39 -167.17 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.665 1.232 . . . . 0.56999999999999995 111.072 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.8 24.44 0.34 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.17 -1.35 . . . . 0.56999999999999995 114.917 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 163.69 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.402 1.601 . . . . 0.65000000000000002 113.013 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.2 178.97 9.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 109.235 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.5 m -147.52 75.7 1.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.165 1.786 . . . . 0.56999999999999995 106.815 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.2 t70 -136.38 143.04 41.8 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.849 0.86 . . . . 0.66000000000000003 108.703 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.72 3.73 3.05 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.257 2.638 . . . . 0.56999999999999995 114.725 -169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -135.67 -1.53 2.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 111.534 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -81.82 121.54 26.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.463 1.905 . . . . 0.56999999999999995 108.851 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 116' ' ' TYR . 2.6 p -53.59 -29.06 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 120.948 1.703 . . . . 0.56999999999999995 112.422 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 39.0 mmt -65.12 -15.37 62.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.308 -1.33 . . . . 0.56999999999999995 113.854 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.34 126.55 82.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 120.726 1.603 . . . . 0.56999999999999995 109.31 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.44 -165.33 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.543 2.162 . . . . 0.56999999999999995 110.148 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m 79.92 -31.05 0.13 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.232 -1.543 . . . . 0.56999999999999995 113.015 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.3 t80 45.21 80.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.668 1.587 . . . . 0.56999999999999995 111.471 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.65 -92.04 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.587 1.565 . . . . 0.56999999999999995 112.36 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -64.94 -49.18 71.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.172 1.389 . . . . 0.56999999999999995 113.928 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.85 109.03 2.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 107.196 -2.362 . . . . 0.56999999999999995 107.196 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -68.5 118.66 62.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.783 1.633 . . . . 0.66000000000000003 112.218 -166.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.51 -1.47 11.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.97 3.113 . . . . 0.56999999999999995 113.537 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -77.41 -30.03 53.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.55 1.068 . . . . 0.56999999999999995 110.68 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -116.87 75.12 0.95 Allowed 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.532 -0.73 . . . . 0.56999999999999995 109.305 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -126.31 145.88 50.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.284 0.634 . . . . 0.56999999999999995 110.929 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.66 52.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.008 1.323 . . . . 0.56999999999999995 111.157 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp 56.92 73.94 0.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.218 1.407 . . . . 0.56999999999999995 111.458 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 67.8 m -61.5 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 C-N-CA 124.932 1.293 . . . . 0.56999999999999995 113.645 -168.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -144.52 -50.85 0.28 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 116.621 -1.656 . . . . 0.56999999999999995 108.429 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -42.73 -48.29 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.95 1.7 . . . . 0.66000000000000003 112.994 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -49.52 62.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.953 0.901 . . . . 0.66000000000000003 109.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.39 -40.83 82.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 118.23 -0.89 . . . . 0.56999999999999995 108.95 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -40.25 97.04 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.989 1.315 . . . . 0.56999999999999995 109.281 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.66 -55.55 29.89 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.235 -1.146 . . . . 0.56999999999999995 110.235 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -62.3 -47.84 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.32 1.06 . . . . 0.56999999999999995 112.481 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.25 -11.86 60.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.749 1.22 . . . . 0.56999999999999995 111.92 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -80.46 -51.81 8.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.279 0.945 . . . . 0.56999999999999995 108.666 164.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.42 -51.44 68.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.977 . . . . 0.56999999999999995 112.301 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -106.29 27.81 8.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.153 0.981 . . . . 0.56999999999999995 109.634 -176.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 -68.73 1.43 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.37 -0.692 . . . . 0.56999999999999995 111.37 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -137.84 -67.65 0.48 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.345 1.058 . . . . 0.56999999999999995 109.168 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -176.08 -46.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.092 1.145 . . . . 1.2 114.092 -175.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.8 t -173.81 146.03 1.21 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.946 2.099 . . . . 0.56999999999999995 105.608 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -171.03 86.34 0.1 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.841 1.656 . . . . 0.56999999999999995 108.561 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.4 t -162.43 174.85 12.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.925 1.69 . . . . 0.56999999999999995 107.491 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.33 142.15 25.71 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.201 -1.407 . . . . 1.2 107.201 171.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.52 -178.28 0.12 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.026 1.331 . . . . 0.56999999999999995 112.249 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 126.522 1.929 . . . . 0.5 . -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.476 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.015 0.436 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -68.75 -57.09 6.12 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.239 0.616 . . . . 0.56999999999999995 111.685 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 tp -174.89 108.64 0.11 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.363 2.265 . . . . 0.56999999999999995 106.029 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 49.91 80.76 0.28 Allowed Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.378 1.471 . . . . 0.56999999999999995 114.473 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.13 102.54 0.67 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.985 2.456 . . . . 0.56999999999999995 110.901 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.26 -49.84 31.82 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.415 0.524 . . . . 0.56999999999999995 112.415 -171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 t -174.41 66.07 0.28 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 127.55 2.34 . . . . 0.56999999999999995 108.379 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.75 141.83 50.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.629 2.219 . . . . 0.56999999999999995 110.649 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.6 102.93 0.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 108.958 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.8 m95 -51.2 148.15 4.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.476 0.711 . . . . 0.56999999999999995 110.866 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.3 m -59.24 -33.14 70.65 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.982 0.913 . . . . 0.56999999999999995 112.344 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.0 t -82.66 146.42 29.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.552 0.691 . . . . 0.56999999999999995 109.326 174.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -19.01 61.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.387 0.675 . . . . 0.56999999999999995 111.528 170.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 136.52 52.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.006 -1.109 . . . . 0.56999999999999995 108.006 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.62 157.74 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.399 1.88 . . . . 0.56999999999999995 108.417 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.7 p -113.18 138.4 50.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.071 -1.085 . . . . 0.56999999999999995 108.071 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -126.06 153.56 44.28 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.756 0.423 . . . . 0.56999999999999995 110.199 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -154.26 119.55 5.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.4 mt -91.28 89.03 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 105.542 -2.021 . . . . 0.56999999999999995 105.542 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -47.88 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.689 1.196 . . . . 0.56999999999999995 112.428 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.49 145.37 41.99 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 105.522 -2.029 . . . . 0.56999999999999995 105.522 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.42 143.55 51.14 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.371 1.069 . . . . 0.56999999999999995 109.031 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.4 t -69.84 -172.64 0.53 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.696 1.599 . . . . 0.56999999999999995 110.542 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -136.73 -29.37 0.94 Allowed 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.479 0.918 . . . . 1.2 113.479 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -53.96 -36.55 62.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.406 1.082 . . . . 0.66000000000000003 110.702 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.29 154.57 73.91 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 128.111 2.565 . . . . 0.56999999999999995 110.252 -177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 151.44 46.71 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.68 2.253 . . . . 0.56999999999999995 112.925 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -60.58 -39.44 88.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.502 1.521 . . . . 0.65000000000000002 113.324 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.2 tt -64.13 -36.38 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 119.202 -0.428 . . . . 0.56999999999999995 110.597 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -67.55 -39.17 84.99 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 116.87 -1.538 . . . . 0.56999999999999995 109.972 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.9 -52.98 51.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 120.069 1.304 . . . . 0.56999999999999995 109.922 172.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -61.54 -39.54 91.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.343 0.52 . . . . 0.66000000000000003 111.001 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -61.71 -47.1 86.78 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.399 -0.813 . . . . 1.2 112.402 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -38.2 78.52 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 123.959 0.903 . . . . 0.56999999999999995 110.269 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.49 -44.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 108.117 -1.068 . . . . 0.56999999999999995 108.117 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.87 -48.86 74.81 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.823 1.192 . . . . 0.56999999999999995 110.903 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.98 -40.59 75.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.943 1.247 . . . . 0.56999999999999995 112.134 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.4 98.6 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.56999999999999995 111.294 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 49.8 mt -72.4 -31.61 65.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.146 -0.93 . . . . 0.56999999999999995 111.114 176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.87 -40.86 94.54 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.37 0.986 . . . . 0.56999999999999995 109.602 169.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -64.09 -33.74 76.45 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.548 -0.72 . . . . 0.56999999999999995 112.577 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.4 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 5.8 m95 -71.72 -47.3 54.8 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.275 0.943 . . . . 0.56999999999999995 111.261 170.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.56 2.17 32.42 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.165 1.364 . . . . 0.56999999999999995 113.62 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -22.68 61.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.346 -1.091 . . . . 0.56999999999999995 111.242 172.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.7 -39.75 5.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.516 -0.754 . . . . 0.66000000000000003 110.397 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 19.2 pt -101.94 135.27 19.73 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 119.427 1.012 . . . . 0.56999999999999995 110.58 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.73 40.55 0.56 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.314 2.676 . . . . 0.56999999999999995 112.628 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tt -101.66 134.49 44.73 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.651 1.58 . . . . 0.56999999999999995 107.63 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -130.16 170.44 14.05 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.512 0.725 . . . . 0.65000000000000002 109.652 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -137.59 158.37 44.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.843 -0.799 . . . . 0.56999999999999995 108.843 -168.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -146.93 157.83 43.75 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.61 1.164 . . . . 1.2 110.36 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.3 105.81 14.2 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 108.452 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -76.08 157.34 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.767 -1.106 . . . . 0.56999999999999995 109.729 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 m -92.87 31.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 110.913 -174.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.02 155.59 45.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.56999999999999995 109.747 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.96 34.71 2.13 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.999 1.285 . . . . 0.56999999999999995 114.091 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.1 m -150.65 132.63 15.18 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 106.101 -1.815 . . . . 0.56999999999999995 106.101 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -161.61 174.09 13.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.561 1.145 . . . . 0.56999999999999995 109.047 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 -31.46 66.16 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.863 -0.589 . . . . 0.66000000000000003 110.391 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.8 mm -123.25 67.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.328 2.251 . . . . 0.56999999999999995 107.847 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.87 116.9 10.79 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.615 -1.254 . . . . 0.56999999999999995 107.615 169.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.59 129.97 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.482 -2.414 . . . . 0.56999999999999995 104.482 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -152.88 150.45 22.23 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.222 -0.924 . . . . 0.56999999999999995 111.543 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.18 143.9 51.15 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.27 -0.641 . . . . 0.56999999999999995 109.27 -171.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.03 166.78 24.03 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 124.74 1.216 . . . . 0.56999999999999995 109.658 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -94.19 -29.55 15.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.526 0.565 . . . . 1.2 112.526 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.5 -38.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.787 0 O-C-N 121.412 -0.805 . . . . 0.56999999999999995 112.06 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.1 49.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.141 1.47 . . . . 0.56999999999999995 108.797 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -156.98 155.18 30.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.347 1.059 . . . . 0.65000000000000002 109.182 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.28 57.63 2.82 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.99 1.757 . . . . 0.56999999999999995 112.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -116.24 -82.43 0.62 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.56 1.544 . . . . 0.66000000000000003 109.079 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.76 -29.35 0.01 OUTLIER 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.506 1.122 . . . . 0.56999999999999995 110.527 -171.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.46 120.92 11.67 Favored Pre-proline 0 C--N 1.343 0.305 0 N-CA-C 107.929 -1.137 . . . . 0.56999999999999995 107.929 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.6 144.22 77.92 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.894 -1.233 . . . . 0.56999999999999995 108.894 169.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.68 -171.11 0.09 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.393 1.477 . . . . 0.56999999999999995 111.077 166.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -118.77 -33.21 4.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.693 2.797 . . . . 0.66000000000000003 110.32 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.22 -150.91 19.66 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.556 1.071 . . . . 0.56999999999999995 111.146 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.96 102.45 1.06 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 125.008 3.805 . . . . 0.56999999999999995 111.968 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' H ' ' CD ' ' A' ' 102' ' ' GLU . . . 119.6 165.38 12.99 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.244 1.878 . . . . 0.56999999999999995 109.329 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 t30 58.45 -156.09 0.33 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.734 1.214 . . . . 0.56999999999999995 111.752 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 m -39.66 116.56 0.64 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.927 2.491 . . . . 0.56999999999999995 113.337 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.07 -33.16 29.97 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.143 -1.598 . . . . 0.56999999999999995 112.676 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.99 166.62 29.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.438 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -144.47 163.31 34.21 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.992 0.517 . . . . 0.65000000000000002 110.058 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.69 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.642 0.777 . . . . 0.56999999999999995 109.804 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.93 152.12 32.88 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.732 -0.667 . . . . 0.56999999999999995 109.33 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.36 151.61 90.7 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.657 -0.687 . . . . 0.56999999999999995 109.761 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.2 Cg_endo -69.06 162.63 40.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.183 1.922 . . . . 0.56999999999999995 111.452 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.42 -109.52 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.824 -2.111 . . . . 0.56999999999999995 107.824 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -152.27 118.75 5.64 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.635 -1.617 . . . . 0.56999999999999995 106.635 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.08 -131.74 10.76 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.4 -1.08 . . . . 0.56999999999999995 110.4 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 tp -51.22 -28.25 11.01 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.126 1.37 . . . . 0.56999999999999995 112.711 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.79 145.17 8.76 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 111.614 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.83 -24.27 3.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.032 1.301 . . . . 0.56999999999999995 113.719 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.87 155.94 39.81 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.473 1.137 . . . . 0.66000000000000003 108.45 -172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.09 140.74 34.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.934 -0.765 . . . . 0.56999999999999995 108.934 -173.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 29.5 m170 -128.28 153.13 47.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.604 -0.725 . . . . 0.65000000000000002 109.568 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.05 153.76 44.45 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.651 -1.24 . . . . 0.56999999999999995 107.651 -173.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -92.37 100.64 13.17 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.608 -0.724 . . . . 0.66000000000000003 109.31 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -21.89 66.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.138 0.975 . . . . 0.66000000000000003 112.151 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.16 -23.49 63.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.38 0.991 . . . . 0.66000000000000003 110.153 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 79' ' ' GLY . 2.9 mt-10 -80.93 130.13 34.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.654 -1.239 . . . . 0.66000000000000003 107.654 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 147.6 4.35 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.335 1.054 . . . . 1.2 111.006 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -140.95 147.2 38.42 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.298 -1.001 . . . . 0.56999999999999995 108.298 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -148.82 139.5 22.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.782 -0.821 . . . . 0.56999999999999995 108.782 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.15 13.68 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.831 1.196 . . . . 0.66000000000000003 111.553 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.03 -87.48 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 108.091 -2.004 . . . . 0.56999999999999995 108.091 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.08 -67.12 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.301 2.24 . . . . 0.56999999999999995 113.608 -176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -175.43 -48.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.855 1.662 . . . . 0.56999999999999995 110.778 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mp -142.18 158.2 44.01 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.554 1.541 . . . . 0.56999999999999995 108.993 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.53 178.66 15.86 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 109.787 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.1 mm -80.45 102.89 6.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.241 -1.022 . . . . 0.56999999999999995 108.241 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -50.97 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.925 1.69 . . . . 0.56999999999999995 110.655 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -65.61 -29.18 69.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.985 1.714 . . . . 0.56999999999999995 110.389 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -48.27 68.8 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.684 -1.598 . . . . 0.56999999999999995 106.684 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.17 -47.49 84.27 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.483 0.713 . . . . 0.56999999999999995 110.721 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.38 -49.45 76.15 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 122.745 0.418 . . . . 0.56999999999999995 110.933 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.99 63.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 109.085 -0.709 . . . . 0.56999999999999995 109.085 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -55.7 -39.28 70.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.022 0.828 . . . . 0.56999999999999995 111.344 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -60.76 -59.88 4.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.324 0.65 . . . . 0.65000000000000002 110.209 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.49 -42.37 95.9 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.177 0.898 . . . . 0.66000000000000003 111.692 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.92 -26.96 67.11 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.136 1.375 . . . . 0.56999999999999995 111.293 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.4 ' CA ' ' CZ2' ' A' ' 42' ' ' TRP . . . -57.31 -41.88 93.27 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.29 -0.724 . . . . 0.56999999999999995 111.29 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -73.01 -37.78 66.83 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.459 -1.258 . . . . 0.65000000000000002 112.259 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 p -59.06 -31.58 69.0 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 124.101 0.875 . . . . 0.56999999999999995 111.851 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -68.15 -39.89 82.53 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.328 0.651 . . . . 0.56999999999999995 111.752 176.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 160.51 43.08 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 CA-C-O 119.06 -0.856 . . . . 0.56999999999999995 114.488 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.66 176.63 0.1 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 117.883 0.842 . . . . 0.56999999999999995 111.925 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.09 46.12 0.01 OUTLIER Glycine 0 C--N 1.342 0.912 0 O-C-N 120.943 -1.098 . . . . 0.56999999999999995 112.903 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.8 169.7 13.93 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.361 1.081 . . . . 0.65000000000000002 110.4 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.6 t -161.65 -164.19 1.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.013 0.925 . . . . 0.56999999999999995 110.225 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.07 57.26 0.59 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.897 1.279 . . . . 0.56999999999999995 110.517 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -120.73 146.4 43.43 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.66000000000000003 109.463 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.96 -21.63 63.59 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.839 2.359 . . . . 0.56999999999999995 113.056 -171.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -125.14 27.45 6.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.444 1.897 . . . . 0.56999999999999995 109.602 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.89 124.61 24.18 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.145 -0.972 . . . . 0.56999999999999995 108.916 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.05 -22.85 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 121.528 0.68 . . . . 0.56999999999999995 110.461 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.28 19.08 18.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.098 1.759 . . . . 0.56999999999999995 112.233 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.514 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.44 141.42 94.48 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.17 1.35 . . . . 0.56999999999999995 111.288 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 70.8 Cg_endo -75.63 46.02 1.58 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 124.212 3.275 . . . . 0.56999999999999995 113.007 175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.29 153.14 7.71 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.77 2.428 . . . . 0.56999999999999995 106.476 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -47.96 137.59 9.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.023 1.329 . . . . 0.56999999999999995 111.265 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -47.14 99.75 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.705 1.621 . . . . 0.56999999999999995 113.542 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.23 -37.41 77.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.063 1.345 . . . . 0.56999999999999995 112.221 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.98 -85.87 0.95 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.27 0.938 . . . . 0.56999999999999995 110.936 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.69 109.36 2.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.711 -0.848 . . . . 0.66000000000000003 108.711 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.96 -16.4 18.18 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.807 2.338 . . . . 0.56999999999999995 113.534 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -38.86 62.74 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.962 1.305 . . . . 0.56999999999999995 109.125 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -77.57 74.08 4.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.79 0.836 . . . . 0.56999999999999995 110.905 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -43.7 -70.57 0.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.791 1.637 . . . . 0.56999999999999995 114.554 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 25.64 74.53 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 129.512 3.125 . . . . 0.56999999999999995 112.071 177.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -30.93 111.78 0.08 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.529 2.331 . . . . 0.56999999999999995 110.777 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 t -83.87 -99.71 0.05 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.181 0.301 . . . . 0.56999999999999995 111.074 -166.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -127.75 -49.93 1.37 Allowed 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 117.216 -1.373 . . . . 0.56999999999999995 109.443 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -44.07 -45.11 7.9 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.014 1.326 . . . . 0.66000000000000003 112.116 169.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -66.43 -54.8 20.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 123.728 0.642 . . . . 0.66000000000000003 109.995 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.78 -37.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.418 0.687 . . . . 0.56999999999999995 110.727 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -65.95 -45.41 81.89 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.664 1.586 . . . . 0.56999999999999995 108.504 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.93 -51.02 61.21 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.204 -1.158 . . . . 0.56999999999999995 110.204 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -56.46 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.488 1.115 . . . . 0.56999999999999995 111.136 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.404 ' HA ' ' CE1' ' A' ' 164' ' ' TYR . 3.9 pt20 -62.74 -24.46 67.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.112 0.869 . . . . 0.56999999999999995 111.517 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -37.02 36.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.25 -0.881 . . . . 0.56999999999999995 110.889 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -54.7 34.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.661 1.585 . . . . 0.56999999999999995 110.942 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.407 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 19.3 p90 -98.29 5.85 47.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.854 0.862 . . . . 0.56999999999999995 113.159 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -113.19 -145.37 9.32 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.532 1.063 . . . . 0.56999999999999995 111.083 -172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -137.99 -62.32 0.59 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.41 0.684 . . . . 0.56999999999999995 112.306 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.47 153.68 19.82 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.841 1.657 . . . . 1.2 107.902 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.78 129.7 0.15 Allowed 'General case' 0 C--O 1.234 0.238 0 N-CA-C 105.827 -1.916 . . . . 0.56999999999999995 105.827 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.65 165.4 0.08 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.286 1.835 . . . . 0.56999999999999995 113.511 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.8 t -169.67 107.61 0.39 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.211 1.404 . . . . 0.56999999999999995 107.519 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 155.66 30.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.101 0.96 . . . . 1.2 108.884 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.78 56.76 0.09 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.271 1.028 . . . . 0.56999999999999995 112.141 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tttt . . . . . 0 C--N 1.338 0.072 0 C-N-CA 123.948 0.899 . . . . 0.5 . -177.649 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.374 0 CA-C-O 118.647 -0.692 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -30.82 52.06 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.726 1.21 . . . . 0.56999999999999995 113.818 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 tt -144.55 -78.19 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.036 -1.468 . . . . 0.56999999999999995 107.036 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.15 -53.36 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.52 1.928 . . . . 0.56999999999999995 111.318 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -77.51 49.72 2.98 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.227 3.285 . . . . 0.56999999999999995 111.963 -175.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -148.11 149.43 32.03 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.643 1.577 . . . . 0.56999999999999995 106.816 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -117.85 80.13 14.07 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 107.99 -1.115 . . . . 0.56999999999999995 107.99 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.65 152.12 79.78 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.365 2.043 . . . . 0.56999999999999995 111.021 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt 72.03 100.8 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.242 1.417 . . . . 0.56999999999999995 109.715 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -53.08 157.15 1.88 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.045 0.938 . . . . 0.56999999999999995 111.755 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.3 p -67.58 -19.54 65.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.875 1.27 . . . . 0.56999999999999995 112.083 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -109.67 144.53 37.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.68 1.992 . . . . 0.56999999999999995 108.75 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -12.39 61.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.304 1.442 . . . . 0.56999999999999995 113.167 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.75 134.1 67.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.799 -1.926 . . . . 0.56999999999999995 105.799 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.48 155.15 19.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.23 1.412 . . . . 0.56999999999999995 108.621 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 p -106.54 141.22 38.18 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.912 -0.493 . . . . 0.56999999999999995 109.774 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -132.75 158.24 42.91 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.596 -0.69 . . . . 0.56999999999999995 111.0 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.42 163.15 40.44 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 123.687 0.795 . . . . 1.2 109.149 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.9 mt -127.93 105.08 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.199 -2.149 . . . . 0.56999999999999995 105.199 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.85 -57.06 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.106 . . . . 0.56999999999999995 112.385 -169.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -177.14 4.76 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.195 -1.409 . . . . 0.56999999999999995 107.195 164.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -144.58 152.03 39.93 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.314 -0.995 . . . . 0.56999999999999995 108.314 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 t -62.37 165.35 6.13 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.314 0.578 . . . . 0.56999999999999995 110.938 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -100.25 -47.09 5.07 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.841 -0.618 . . . . 1.2 112.053 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.78 -32.61 73.81 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.031 0.532 . . . . 0.66000000000000003 110.387 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.96 153.71 52.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.96 1.704 . . . . 0.56999999999999995 109.652 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.57 161.29 37.3 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.145 1.897 . . . . 0.56999999999999995 113.182 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.33 -40.6 94.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.659 1.184 . . . . 0.65000000000000002 112.89 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.98 -35.95 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 119.181 -0.438 . . . . 0.56999999999999995 111.155 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m -67.36 -45.65 75.69 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 117.688 -1.149 . . . . 0.56999999999999995 109.264 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.25 -49.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 117.646 -1.169 . . . . 0.56999999999999995 110.699 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.16 -35.93 82.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.1 1.318 . . . . 0.66000000000000003 111.364 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.72 -43.4 89.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.289 1.404 . . . . 1.2 112.524 174.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.95 -48.34 76.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.592 -0.892 . . . . 0.56999999999999995 108.592 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.0 -41.63 89.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.719 -1.134 . . . . 0.56999999999999995 111.021 173.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -58.48 -53.11 62.02 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.548 1.522 . . . . 0.56999999999999995 110.056 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -36.06 78.52 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.679 1.127 . . . . 0.56999999999999995 111.054 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.64 76.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.557 1.071 . . . . 0.56999999999999995 111.76 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.9 mt -65.38 -36.17 83.18 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 118.213 -0.898 . . . . 0.56999999999999995 110.163 172.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.93 -49.05 76.82 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 118.899 0.772 . . . . 0.56999999999999995 109.153 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.442 ' HB3' HD11 ' A' ' 152' ' ' LEU . 50.4 mtp -61.73 -35.91 79.44 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.544 0.738 . . . . 0.56999999999999995 111.498 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 10.5 m95 -68.61 -50.59 50.34 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.56999999999999995 112.369 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.25 -8.09 69.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.885 1.231 . . . . 0.56999999999999995 112.99 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -75.17 -8.31 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.214 -1.168 . . . . 0.56999999999999995 111.765 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB3' HG21 ' A' ' 160' ' ' ILE . 55.4 mm-40 -109.54 -15.32 14.22 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.842 0.746 . . . . 0.66000000000000003 112.259 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 160' ' ' ILE . 6.6 pt -142.58 148.75 48.03 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.52 1.128 . . . . 0.56999999999999995 111.019 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.89 18.69 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.714 2.943 . . . . 0.56999999999999995 113.286 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.91 138.22 35.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.16 1.784 . . . . 0.56999999999999995 107.314 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.95 170.31 11.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.766 0.826 . . . . 0.65000000000000002 109.217 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.35 150.85 45.83 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.271 -1.381 . . . . 0.56999999999999995 107.271 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.85 149.42 46.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.866 -0.79 . . . . 1.2 108.866 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -107.24 129.26 54.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.031 -1.47 . . . . 0.56999999999999995 107.031 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.43 171.84 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.533 1.133 . . . . 0.56999999999999995 109.823 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.45 -38.77 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.769 0.828 . . . . 0.56999999999999995 110.651 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -167.25 74.63 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.888 1.675 . . . . 0.56999999999999995 107.694 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.35 163.06 36.84 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.511 -1.836 . . . . 0.56999999999999995 108.511 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -68.63 144.98 54.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 117.987 0.893 . . . . 0.56999999999999995 109.275 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.24 153.17 37.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.1 0.96 . . . . 0.56999999999999995 108.96 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.64 -32.97 72.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.772 0.429 . . . . 0.66000000000000003 110.069 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 125' ' ' SER . 7.3 mt -121.01 80.97 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 127.513 2.325 . . . . 0.56999999999999995 107.871 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 ttm -78.02 111.85 14.33 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.805 1.242 . . . . 0.56999999999999995 107.956 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 127.66 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.052 -1.832 . . . . 0.56999999999999995 106.052 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.62 162.85 25.52 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.226 -0.75 . . . . 0.56999999999999995 111.226 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -126.95 141.42 51.81 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.29 -1.744 . . . . 0.56999999999999995 106.29 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.18 169.17 18.71 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.098 2.159 . . . . 0.56999999999999995 106.8 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -111.02 -0.95 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.715 0.689 . . . . 1.2 112.652 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.32 -144.58 8.29 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.53 -1.828 . . . . 0.56999999999999995 108.53 -165.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.49 142.64 13.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.746 0.784 . . . . 0.56999999999999995 111.398 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -152.05 152.49 32.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.094 1.758 . . . . 0.65000000000000002 106.562 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.35 80.48 1.82 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 110.155 -1.178 . . . . 0.56999999999999995 110.155 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.6 -56.52 1.49 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.794 0.837 . . . . 0.66000000000000003 111.343 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.95 -37.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.959 2.503 . . . . 0.56999999999999995 109.854 -167.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -147.57 123.1 5.28 Favored Pre-proline 0 C--N 1.349 0.545 0 CA-C-N 120.122 1.328 . . . . 0.56999999999999995 110.437 -173.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.75 139.32 52.04 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.188 1.259 . . . . 0.56999999999999995 110.367 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.83 -175.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 123.365 1.555 . . . . 0.56999999999999995 111.161 167.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -115.12 -36.02 4.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 131.116 3.767 . . . . 0.66000000000000003 109.75 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.11 -147.9 18.81 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 119.659 1.118 . . . . 0.56999999999999995 110.841 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.65 70.3 6.45 Favored 'Trans proline' 0 CA--C 1.548 1.198 1 C-N-CA 125.645 4.23 . . . . 0.56999999999999995 114.114 -171.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.41 167.07 20.43 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 128.409 2.909 . . . . 0.56999999999999995 109.625 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.279 19.6 t30 64.81 -143.97 0.24 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.304 1.842 . . . . 0.56999999999999995 113.503 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 m -47.03 153.23 0.45 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 127.767 2.427 . . . . 0.56999999999999995 111.22 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.88 -27.47 6.18 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 112.759 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.61 158.48 26.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.01 1.324 . . . . 0.56999999999999995 107.644 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -139.38 159.17 42.77 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.478 . . . . 0.65000000000000002 109.711 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.87 36.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.741 1.216 . . . . 0.56999999999999995 109.078 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.57 146.83 41.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.348 0.659 . . . . 0.56999999999999995 109.495 -177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.84 157.89 64.84 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.795 0.838 . . . . 0.56999999999999995 111.031 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.41 155.45 69.12 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.188 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.07 -111.67 0.59 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.388 0.994 . . . . 0.56999999999999995 110.891 174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.7 m -45.76 156.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.854 2.062 . . . . 0.56999999999999995 111.542 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.93 -41.97 7.68 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.174 -1.348 . . . . 0.56999999999999995 115.412 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.45 -33.55 74.39 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.075 1.438 . . . . 0.56999999999999995 112.247 174.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.26 145.5 12.21 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.873 -1.142 . . . . 0.56999999999999995 111.498 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.86 -18.93 5.53 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 117.847 -1.529 . . . . 0.56999999999999995 114.426 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.78 156.24 36.76 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.348 1.574 . . . . 0.66000000000000003 108.045 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.06 146.05 27.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.787 -0.642 . . . . 0.56999999999999995 109.818 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -129.81 152.28 49.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.575 -0.898 . . . . 0.65000000000000002 108.575 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -137.91 145.37 42.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.16 1.384 . . . . 0.56999999999999995 107.38 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -87.07 98.63 11.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.425 0.631 . . . . 0.66000000000000003 109.608 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -60.84 -25.61 66.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.07 1.348 . . . . 0.66000000000000003 111.85 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.39 -38.85 81.71 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.92 0.391 . . . . 0.66000000000000003 110.406 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.16 126.7 29.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.771 -1.566 . . . . 0.66000000000000003 106.771 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -59.01 147.16 35.61 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.702 -0.624 . . . . 1.2 109.473 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -124.03 158.21 32.68 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.359 -0.978 . . . . 0.56999999999999995 108.359 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.2 t -133.54 142.34 48.14 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.635 0.652 . . . . 0.56999999999999995 109.681 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.05 -46.89 72.99 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.046 1.339 . . . . 0.66000000000000003 109.275 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.96 50.73 0.04 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.858 -0.897 . . . . 0.56999999999999995 110.858 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 t -152.84 150.34 29.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.965 0.906 . . . . 0.56999999999999995 109.854 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.17 108.37 0.78 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.615 0.766 . . . . 0.56999999999999995 109.814 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -61.69 0.05 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.726 0.81 . . . . 0.56999999999999995 110.213 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.98 -111.75 1.19 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.714 -1.354 . . . . 0.56999999999999995 109.714 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.565 HG22 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -129.95 134.39 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 123.653 0.781 . . . . 0.56999999999999995 110.271 -178.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.85 115.77 5.67 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.777 -1.102 . . . . 0.56999999999999995 109.697 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.67 -37.32 83.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.047 -0.501 . . . . 0.56999999999999995 110.895 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 -45.35 89.2 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.129 0.877 . . . . 0.56999999999999995 109.673 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -64.03 -42.56 97.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.384 0.674 . . . . 0.56999999999999995 110.791 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.86 67.99 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.215 0.606 . . . . 0.56999999999999995 110.516 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.43 64.3 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.063 -0.97 . . . . 0.56999999999999995 110.053 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.1 m -53.78 -41.74 67.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.512 1.051 . . . . 0.56999999999999995 111.46 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -61.48 -56.36 21.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.819 0.448 . . . . 0.65000000000000002 110.023 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.43 -48.08 74.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.734 0.814 . . . . 0.66000000000000003 110.963 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.74 -30.77 70.99 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 125.312 1.445 . . . . 0.56999999999999995 110.968 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.402 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -54.68 -46.81 73.66 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.913 -0.875 . . . . 0.56999999999999995 110.913 170.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -66.27 -39.33 89.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.752 -0.642 . . . . 0.65000000000000002 111.646 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.403 ' HB3' HG12 ' A' ' 60' ' ' ILE . 4.4 m -57.78 -37.37 73.59 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.524 0.565 . . . . 0.56999999999999995 112.524 176.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.37 -27.22 68.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.737 1.153 . . . . 0.56999999999999995 112.638 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.98 -13.97 2.37 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 118.529 -1.15 . . . . 0.56999999999999995 114.285 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.0 tpp -61.79 152.25 31.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.168 1.484 . . . . 0.56999999999999995 110.295 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.56 -23.6 3.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 115.58 -2.789 . . . . 0.56999999999999995 114.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.3 m80 148.99 173.23 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 131.185 3.794 . . . . 0.65000000000000002 110.151 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -145.33 -172.77 3.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.484 2.313 . . . . 0.56999999999999995 109.607 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -147.12 67.33 1.15 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.43 1.492 . . . . 0.56999999999999995 110.761 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 9.7 t70 -133.5 149.98 73.74 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 117.306 -1.33 . . . . 0.66000000000000003 107.604 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.86 -35.96 42.01 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.927 1.752 . . . . 0.56999999999999995 111.091 -174.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -119.01 35.23 4.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.754 1.222 . . . . 0.56999999999999995 108.394 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -63.62 131.98 49.71 Favored 'General case' 0 C--N 1.344 0.363 0 N-CA-C 108.156 -1.053 . . . . 0.56999999999999995 108.156 171.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' A' ' 156' ' ' ASP . 8.5 p -58.7 -30.33 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.592 0.234 . . . . 0.56999999999999995 110.986 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.683 ' SD ' HG13 ' A' ' 137' ' ' VAL . 4.2 mpp? -105.58 35.19 2.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.044 1.337 . . . . 0.56999999999999995 110.075 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -74.46 130.3 82.26 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 120.433 -1.417 . . . . 0.56999999999999995 110.875 173.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.42 ' HA ' ' H33' ' A' ' 178' ' ' MDW . 48.7 Cg_endo -71.34 168.64 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.962 1.775 . . . . 0.56999999999999995 111.056 166.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m 58.03 72.93 0.49 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.113 0.965 . . . . 0.56999999999999995 110.792 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.565 ' CE2' HG22 ' A' ' 112' ' ' ILE . 63.1 t80 -45.61 126.08 6.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.043 1.337 . . . . 0.56999999999999995 113.175 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.01 96.43 0.89 Allowed Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.095 0.855 . . . . 0.56999999999999995 111.201 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -157.42 -49.88 0.07 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.022 0.911 . . . . 0.56999999999999995 111.03 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.88 -171.33 13.05 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 125.595 1.569 . . . . 0.56999999999999995 109.575 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.02 116.54 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 119.092 -0.48 . . . . 0.66000000000000003 110.053 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.08 -18.03 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.853 2.369 . . . . 0.56999999999999995 112.671 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.24 -36.63 83.52 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.002 0.819 . . . . 0.56999999999999995 109.936 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.15 68.87 1.23 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.342 0.657 . . . . 0.56999999999999995 109.507 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -60.04 -52.69 64.29 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.488 0.715 . . . . 0.56999999999999995 110.323 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.94 158.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.991 2.517 . . . . 0.56999999999999995 112.567 -159.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 41' ' ' MET . 5.4 mp -58.95 121.49 11.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.593 -1.262 . . . . 0.56999999999999995 107.593 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.0 m -96.83 -94.25 0.21 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.787 1.235 . . . . 0.56999999999999995 110.545 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -138.24 -46.44 0.51 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.08 -0.962 . . . . 0.56999999999999995 110.273 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.38 -34.09 66.35 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.75 0.705 . . . . 0.66000000000000003 111.02 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.71 ' CG ' HG11 ' A' ' 137' ' ' VAL . 0.7 OUTLIER -63.15 -60.18 3.77 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.571 1.148 . . . . 0.66000000000000003 110.305 176.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.84 -50.47 80.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.756 -1.201 . . . . 0.56999999999999995 107.756 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -59.3 -41.69 89.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.394 1.077 . . . . 0.56999999999999995 111.476 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.69 50.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.456 -1.457 . . . . 0.56999999999999995 109.456 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.459 HG21 ' HB3' ' A' ' 45' ' ' GLU . 1.7 mm -53.91 -52.99 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.259 1.023 . . . . 0.56999999999999995 110.482 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -58.5 -28.63 65.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.086 -0.709 . . . . 0.56999999999999995 109.086 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -80.64 -38.9 28.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 117.921 -1.038 . . . . 0.56999999999999995 112.428 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.62 -52.06 61.08 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.322 1.419 . . . . 0.56999999999999995 112.174 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -90.84 3.83 53.42 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.487 0.585 . . . . 0.56999999999999995 112.38 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.0 155.85 0.7 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.931 1.253 . . . . 0.56999999999999995 111.639 -169.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -129.86 -69.55 0.67 Allowed 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.41 -1.053 . . . . 0.56999999999999995 109.737 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -155.57 -54.22 0.09 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.713 1.205 . . . . 1.2 109.315 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.01 158.99 38.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.107 0.963 . . . . 0.56999999999999995 109.414 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.09 172.32 4.71 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.533 -1.212 . . . . 0.56999999999999995 110.01 173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -55.93 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.675 -1.602 . . . . 0.56999999999999995 106.675 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.4 -179.01 0.08 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 1.2 110.414 -170.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.9 tptp 68.11 149.15 0.06 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.99 2.116 . . . . 0.56999999999999995 112.566 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.557 1.543 . . . . 0.5 . 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.42 ' H33' ' HA ' ' A' ' 140' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.981 0.419 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -60.12 72.63 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.951 2.5 . . . . 0.56999999999999995 111.082 168.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -118.25 -71.0 0.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.984 1.714 . . . . 0.56999999999999995 111.873 177.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 46.76 164.42 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.286 2.634 . . . . 0.56999999999999995 115.62 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -75.61 137.45 20.41 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 O-C-N 117.656 -1.813 . . . . 0.56999999999999995 109.488 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -176.24 -29.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.532 1.933 . . . . 0.56999999999999995 111.175 174.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.2 m 57.67 82.0 0.24 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.921 1.288 . . . . 0.56999999999999995 110.864 -172.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.86 174.98 6.92 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.183 2.589 . . . . 0.56999999999999995 110.751 174.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.89 10.88 0.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.216 2.206 . . . . 0.56999999999999995 112.432 -173.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 88' ' ' PRO . 56.5 m95 56.37 -166.01 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.656 1.183 . . . . 0.56999999999999995 110.584 -169.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -101.53 -10.85 19.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.782 0.833 . . . . 0.56999999999999995 110.97 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -118.8 149.58 41.26 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.423 1.489 . . . . 0.56999999999999995 108.705 176.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -71.96 -11.83 60.96 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.448 0.699 . . . . 0.56999999999999995 112.575 172.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.26 117.25 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.035 -1.839 . . . . 0.56999999999999995 106.035 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.85 141.23 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.365 -0.976 . . . . 0.56999999999999995 108.365 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -102.49 147.63 26.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.648 0.658 . . . . 0.56999999999999995 111.238 -177.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -128.96 157.1 42.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 111.884 -178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.88 112.13 4.95 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.597 0.713 . . . . 1.2 110.159 174.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 mt -77.68 82.69 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 107.233 -1.395 . . . . 0.56999999999999995 107.233 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 m -66.05 -28.62 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 113.458 -175.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -139.58 154.42 47.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 128.925 2.89 . . . . 0.56999999999999995 103.604 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -132.16 174.67 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.703 1.601 . . . . 0.56999999999999995 108.203 -173.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -90.82 -176.39 4.66 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.921 0.888 . . . . 0.56999999999999995 111.399 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -129.62 -26.62 2.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.364 1.866 . . . . 1.2 113.651 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -24.0 67.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.725 0.81 . . . . 0.66000000000000003 110.86 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.83 154.99 71.35 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 127.464 2.306 . . . . 0.56999999999999995 108.582 177.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -75.58 158.51 39.88 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.189 2.592 . . . . 0.56999999999999995 113.047 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -62.23 -34.6 76.82 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.953 1.301 . . . . 0.65000000000000002 112.66 -176.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 tt -67.46 -37.64 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.004 0.522 . . . . 0.56999999999999995 110.251 175.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.4 m -67.59 -39.56 84.83 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 117.955 -1.021 . . . . 0.56999999999999995 109.54 173.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.69 -56.1 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.769 1.168 . . . . 0.56999999999999995 110.126 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.64 -34.95 78.1 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.631 1.105 . . . . 0.66000000000000003 111.031 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.25 -48.89 63.87 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.087 0.858 . . . . 1.2 112.066 177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 mp -63.97 -43.67 95.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.815 -0.809 . . . . 0.56999999999999995 108.815 178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.3 -44.28 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 117.599 -1.191 . . . . 0.56999999999999995 110.807 171.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -50.25 73.45 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 120.274 1.397 . . . . 0.56999999999999995 110.894 178.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -34.86 73.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.167 0.894 . . . . 0.56999999999999995 112.268 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.98 81.84 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.745 1.157 . . . . 0.56999999999999995 111.153 177.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HD12 ' A' ' 122' ' ' LEU . 38.7 mt -67.83 -37.84 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.471 -0.776 . . . . 0.56999999999999995 110.218 173.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.73 -37.41 84.11 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 119.009 0.822 . . . . 0.56999999999999995 110.654 172.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 mtp -64.36 -36.93 85.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.077 0.853 . . . . 0.56999999999999995 112.189 173.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -69.76 -49.36 53.83 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.251 0.932 . . . . 0.56999999999999995 110.89 172.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.73 -5.1 63.41 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.983 1.278 . . . . 0.56999999999999995 113.786 178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -67.99 -26.1 65.75 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.095 -1.238 . . . . 0.56999999999999995 110.888 172.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -100.35 -36.72 9.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.541 0.737 . . . . 0.66000000000000003 110.855 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' CG2' ' CD1' ' A' ' 164' ' ' TYR . 12.9 pt -114.05 136.81 22.21 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 118.569 0.622 . . . . 0.56999999999999995 110.819 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 34.21 0.37 Allowed 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.676 2.917 . . . . 0.56999999999999995 111.912 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 126' ' ' LEU . 1.6 tt -85.42 131.95 34.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.311 -1.737 . . . . 0.56999999999999995 106.311 176.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -116.0 171.08 8.01 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.803 1.241 . . . . 0.65000000000000002 108.509 -173.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.85 156.1 45.54 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.747 -0.834 . . . . 0.56999999999999995 108.747 -170.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -142.61 175.92 9.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.91 . . . . 1.2 109.273 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.6 16.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.23 -1.026 . . . . 0.56999999999999995 108.23 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.76 158.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 124.671 1.188 . . . . 0.56999999999999995 109.219 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -70.44 -41.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.353 0.661 . . . . 0.56999999999999995 111.256 174.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -118.57 -66.34 1.08 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.939 0.876 . . . . 0.56999999999999995 108.891 -172.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -169.38 -156.57 10.89 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.616 -1.793 . . . . 0.56999999999999995 108.616 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 80.4 p 60.28 72.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.69 1.596 . . . . 0.56999999999999995 111.826 173.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.67 172.37 7.16 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.351 1.06 . . . . 0.56999999999999995 112.012 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -71.55 -39.44 70.65 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.274 -1.01 . . . . 0.66000000000000003 108.274 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.14 84.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 126.58 1.952 . . . . 0.56999999999999995 108.641 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.23 124.58 27.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.458 -1.401 . . . . 0.56999999999999995 108.417 170.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.55 127.85 66.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 106.269 -1.752 . . . . 0.56999999999999995 106.269 174.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.09 164.91 27.48 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.833 -0.507 . . . . 0.56999999999999995 111.833 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 9.7 m-85 -136.03 150.65 49.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.609 -0.886 . . . . 0.56999999999999995 108.609 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.29 157.67 44.15 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.754 1.221 . . . . 0.56999999999999995 110.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -5.28 24.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.498 1.119 . . . . 1.2 113.443 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.47 106.85 0.49 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 108.341 -1.904 . . . . 0.56999999999999995 108.341 -176.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.12 126.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.062 2.945 . . . . 0.56999999999999995 112.741 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' CE1' ' CD2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.1 163.49 30.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.732 1.213 . . . . 0.65000000000000002 110.909 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 76.68 0.9 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.269 -1.132 . . . . 0.56999999999999995 110.269 173.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -135.15 177.58 7.7 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.66000000000000003 110.157 179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.51 -44.47 12.61 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.296 1.038 . . . . 0.56999999999999995 112.043 168.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -139.24 145.91 46.65 Favored Pre-proline 0 C--N 1.345 0.374 0 C-N-CA 124.026 0.93 . . . . 0.56999999999999995 109.401 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.47 146.95 76.17 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.235 1.29 . . . . 0.56999999999999995 110.29 173.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -67.78 -178.95 1.04 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.908 1.337 . . . . 0.56999999999999995 111.428 162.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -117.4 -35.07 4.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 131.181 3.793 . . . . 0.66000000000000003 109.332 -172.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 -140.9 15.6 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.561 -1.133 . . . . 0.56999999999999995 110.689 -177.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.96 87.06 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.894 3.73 . . . . 0.56999999999999995 112.575 -171.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.29 172.56 12.92 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.446 1.974 . . . . 0.56999999999999995 109.539 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.6 t30 48.7 -153.5 0.1 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 119.432 1.616 . . . . 0.56999999999999995 111.848 -174.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.3 m -48.64 126.52 11.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.716 2.406 . . . . 0.56999999999999995 112.908 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.02 -27.4 17.02 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.234 1.414 . . . . 0.56999999999999995 113.45 -173.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.93 161.83 40.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.702 1.201 . . . . 0.56999999999999995 108.344 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.96 163.34 37.16 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.029 -0.36 . . . . 0.65000000000000002 110.029 174.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.73 163.19 37.46 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.244 1.018 . . . . 0.56999999999999995 110.438 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.23 161.84 18.38 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.144 0.978 . . . . 0.56999999999999995 110.653 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.83 142.83 45.6 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-O 118.224 -0.893 . . . . 0.56999999999999995 109.383 -176.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 34.6 Cg_endo -66.31 156.83 63.16 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.528 1.485 . . . . 0.56999999999999995 110.893 175.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.9 9.18 8.38 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 123.968 0.794 . . . . 0.56999999999999995 113.81 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.1 t -160.78 168.49 24.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.823 1.649 . . . . 0.56999999999999995 107.993 176.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.89 -57.78 16.56 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 125.591 1.567 . . . . 0.56999999999999995 113.079 -177.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.9 tp -66.09 -17.61 64.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.395 1.078 . . . . 0.56999999999999995 110.997 173.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.0 147.79 33.5 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 120.776 -1.202 . . . . 0.56999999999999995 110.793 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.32 -21.31 0.54 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.571 1.558 . . . . 0.56999999999999995 115.119 -176.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -69.07 153.6 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.776 1.288 . . . . 0.66000000000000003 108.156 -175.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.09 144.87 29.38 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.264 -0.88 . . . . 0.56999999999999995 109.083 -171.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -131.84 159.23 39.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.371 -0.831 . . . . 0.65000000000000002 109.304 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 52.2 m-85 -137.65 147.19 44.72 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.821 1.648 . . . . 0.56999999999999995 109.002 -171.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.29 105.46 12.49 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.916 -0.772 . . . . 0.66000000000000003 108.916 171.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -58.19 -27.66 64.07 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.468 1.107 . . . . 0.66000000000000003 111.069 171.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.62 -33.94 75.98 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.827 0.851 . . . . 0.66000000000000003 111.282 -178.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.84 120.55 20.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.767 -1.568 . . . . 0.66000000000000003 106.767 178.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 131.42 48.41 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.362 0.528 . . . . 1.2 110.699 -174.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.78 150.54 28.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.082 -1.081 . . . . 0.56999999999999995 108.082 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -145.06 145.72 31.57 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.92 -0.77 . . . . 0.56999999999999995 108.92 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.21 -39.73 93.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.164 0.986 . . . . 0.66000000000000003 112.052 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.05 173.42 27.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.934 1.254 . . . . 0.56999999999999995 110.034 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.13 30.29 5.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.681 1.192 . . . . 0.56999999999999995 114.174 176.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.04 168.63 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 109.315 -174.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.09 167.27 10.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.005 1.322 . . . . 0.56999999999999995 111.706 172.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.81 -160.97 22.64 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.434 -1.466 . . . . 0.56999999999999995 109.434 -174.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.71 122.84 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.889 -1.152 . . . . 0.56999999999999995 107.889 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -55.53 105.23 0.16 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.184 1.394 . . . . 0.56999999999999995 109.999 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.75 -36.41 76.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 110.989 178.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.2 tp -71.12 -40.74 71.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.312 0.505 . . . . 0.56999999999999995 109.931 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.09 -44.31 96.93 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.473 0.709 . . . . 0.56999999999999995 109.375 173.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.23 -54.71 42.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.56999999999999995 110.043 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.2 -52.75 64.25 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 117.891 -1.052 . . . . 0.56999999999999995 109.184 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.8 m -53.64 -43.99 69.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.116 1.325 . . . . 0.56999999999999995 111.452 177.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -64.32 -55.17 23.08 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.844 1.202 . . . . 0.65000000000000002 110.62 176.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.2 -39.66 86.38 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.412 -0.805 . . . . 0.66000000000000003 111.474 -172.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 HD21 ' A' ' 39' ' ' LEU . 4.3 mm? -64.65 -30.71 71.73 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.462 0.705 . . . . 0.56999999999999995 110.628 176.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.71 -43.96 60.17 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 119.194 0.906 . . . . 0.56999999999999995 111.411 170.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -74.86 -33.53 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.734 -0.65 . . . . 0.65000000000000002 112.452 176.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -33.58 75.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.837 0.744 . . . . 0.56999999999999995 111.428 174.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 48' ' ' LEU . 1.6 mm? -66.13 -29.55 69.88 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.325 0.65 . . . . 0.56999999999999995 112.053 175.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 153.09 56.07 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.292 -1.282 . . . . 0.56999999999999995 113.202 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 mmt 48.99 -156.14 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.936 0.868 . . . . 0.56999999999999995 111.475 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.82 81.11 1.22 Allowed Glycine 0 C--O 1.219 -0.842 0 N-CA-C 108.703 -1.759 . . . . 0.56999999999999995 108.703 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.31 172.09 8.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.833 0.817 . . . . 0.65000000000000002 109.847 172.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.99 -177.3 6.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.853 2.061 . . . . 0.56999999999999995 107.946 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.01 99.24 3.04 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.188 -2.153 . . . . 0.56999999999999995 105.188 173.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.9 141.37 17.31 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 107.861 -1.163 . . . . 0.66000000000000003 107.861 170.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.59 -4.5 14.72 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.935 2.423 . . . . 0.56999999999999995 113.73 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.31 13.7 7.7 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.121 1.768 . . . . 0.56999999999999995 111.23 -174.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.1 140.82 40.73 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 109.866 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.98 -28.95 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.969 0.804 . . . . 0.56999999999999995 110.313 171.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 35.1 tpp -74.46 -11.37 60.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.404 1.082 . . . . 0.56999999999999995 113.33 -174.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.35 136.29 41.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.461 -0.57 . . . . 0.56999999999999995 109.461 176.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 -169.28 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.973 1.782 . . . . 0.56999999999999995 109.432 168.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.0 p 50.22 79.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.209 1.404 . . . . 0.56999999999999995 114.224 172.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.493 ' CE1' ' H47' ' A' ' 178' ' ' MDW . 7.5 t80 -56.18 93.1 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.525 1.53 . . . . 0.56999999999999995 113.832 -174.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.4 109.96 0.43 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.841 1.686 . . . . 0.56999999999999995 109.59 -177.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -170.14 -50.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.885 1.674 . . . . 0.56999999999999995 108.582 169.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -118.52 -122.57 3.16 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 109.084 -1.606 . . . . 0.56999999999999995 109.084 -177.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -147.01 124.1 5.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.65 -0.871 . . . . 0.66000000000000003 108.65 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -80.53 -8.17 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.948 3.098 . . . . 0.56999999999999995 114.166 177.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -67.15 -27.36 67.23 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.578 -1.326 . . . . 0.56999999999999995 110.738 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.83 80.47 1.38 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.11 1.364 . . . . 0.56999999999999995 111.199 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.47 148.0 38.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.578 1.551 . . . . 0.56999999999999995 109.629 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.2 47.54 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.47 1.108 . . . . 0.56999999999999995 111.213 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp 61.85 79.27 0.26 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.968 1.307 . . . . 0.56999999999999995 111.581 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -64.46 -86.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.206 1.187 . . . . 0.56999999999999995 114.206 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -138.42 -46.04 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.56999999999999995 110.058 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -45.81 64.28 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.265 1.026 . . . . 0.66000000000000003 110.654 172.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -53.71 55.05 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.708 0.63 . . . . 0.66000000000000003 109.955 177.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.12 -45.98 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 110.071 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -47.53 76.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.908 1.283 . . . . 0.56999999999999995 109.459 -178.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.71 97.19 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.924 -1.27 . . . . 0.56999999999999995 109.924 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -51.18 74.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.53 1.165 . . . . 0.56999999999999995 110.282 175.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.78 -37.81 77.12 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.902 0.481 . . . . 0.56999999999999995 110.204 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -39.01 73.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.101 -0.952 . . . . 0.56999999999999995 111.916 175.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -58.92 5.46 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.731 2.012 . . . . 0.56999999999999995 109.999 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.4 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 14.9 p90 -86.71 -16.77 35.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.264 -0.574 . . . . 0.56999999999999995 111.779 -176.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -85.02 -31.98 21.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.863 1.221 . . . . 0.56999999999999995 112.905 -175.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.45 -70.66 0.08 Allowed 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.063 1.432 . . . . 0.56999999999999995 112.288 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.96 157.25 4.37 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.891 1.677 . . . . 1.2 109.87 -176.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 4.5 p -163.08 120.52 1.93 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.248 -1.76 . . . . 0.56999999999999995 106.248 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -177.64 161.46 1.68 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.343 1.857 . . . . 0.56999999999999995 110.496 173.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.3 p -152.51 72.03 0.96 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.465 0.65 . . . . 0.56999999999999995 112.169 175.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -73.87 74.54 1.62 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.311 -0.868 . . . . 1.2 111.981 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -147.51 67.73 1.13 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.028 1.331 . . . . 0.56999999999999995 110.09 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.342 0.254 0 C-N-CA 128.809 2.844 . . . . 0.5 . 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.493 ' H47' ' CE1' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.202 0 CA-C-O 119.41 -0.328 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -164.86 -48.4 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.046 -1.835 . . . . 0.56999999999999995 106.046 -179.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.8 tp -138.94 -52.09 0.56 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 117.599 -1.191 . . . . 0.56999999999999995 112.17 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 173.84 -52.4 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.413 1.885 . . . . 0.56999999999999995 112.046 -177.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.26 175.14 7.57 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.047 3.164 . . . . 0.56999999999999995 111.77 178.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -144.07 49.14 1.37 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.812 1.245 . . . . 0.56999999999999995 109.758 -173.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -157.44 66.74 3.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.076 1.35 . . . . 0.56999999999999995 108.364 174.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.32 175.68 10.25 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 120.668 0.912 . . . . 0.56999999999999995 110.97 172.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt 80.7 115.69 0.06 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.022 2.129 . . . . 0.56999999999999995 108.296 -177.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' A' ' 59' ' ' ASP . 79.7 m95 -58.54 163.53 3.12 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.243 1.021 . . . . 0.56999999999999995 111.939 175.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -69.31 -31.95 70.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.565 0.746 . . . . 0.56999999999999995 111.521 -174.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 t -123.65 150.49 44.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.39 2.276 . . . . 0.56999999999999995 107.264 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -71.97 3.02 4.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.283 -0.865 . . . . 0.56999999999999995 112.142 171.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -121.86 108.24 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.984 -1.488 . . . . 0.56999999999999995 106.984 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.71 143.73 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 107.964 -1.125 . . . . 0.56999999999999995 107.964 -172.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.1 p -97.32 152.6 18.74 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.644 -0.66 . . . . 0.56999999999999995 110.455 -176.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -131.21 157.83 42.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.948 -1.095 . . . . 0.56999999999999995 110.681 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 14.9 ptt180 -144.73 119.11 9.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.425 0.69 . . . . 1.2 109.491 174.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.12 86.13 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 105.165 -2.161 . . . . 0.56999999999999995 105.165 176.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.07 -38.0 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.539 1.935 . . . . 0.56999999999999995 110.728 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -152.61 164.3 37.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.309 -2.108 . . . . 0.56999999999999995 105.309 -178.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -132.1 169.09 16.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.812 1.645 . . . . 0.56999999999999995 106.82 -172.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.1 t -72.0 -168.07 0.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.56999999999999995 111.203 171.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -43.51 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.826 1.25 . . . . 1.2 113.463 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -60.78 -41.78 96.23 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.033 -0.729 . . . . 0.66000000000000003 109.033 -177.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.4 150.32 38.81 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 124.055 0.942 . . . . 0.56999999999999995 111.26 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -75.14 158.11 41.82 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.561 2.174 . . . . 0.56999999999999995 112.444 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 30.9 m-70 -61.71 -38.62 88.53 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.59 1.156 . . . . 0.65000000000000002 112.536 -176.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.33 -40.96 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.77 -0.456 . . . . 0.56999999999999995 109.77 174.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -68.68 -38.9 80.71 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.237 -1.364 . . . . 0.56999999999999995 109.371 176.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.11 -53.55 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.875 1.671 . . . . 0.56999999999999995 110.053 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.0 -41.24 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.823 0.738 . . . . 0.66000000000000003 111.154 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -46.8 86.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 118.549 0.613 . . . . 1.2 111.719 178.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.6 mp -62.57 -44.81 95.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 116.598 -1.668 . . . . 0.56999999999999995 107.797 175.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 t -55.95 -47.04 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 121.049 1.749 . . . . 0.56999999999999995 110.698 174.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -48.6 76.44 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 118.949 0.795 . . . . 0.56999999999999995 109.303 -178.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -69.62 -36.88 76.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.842 0.857 . . . . 0.56999999999999995 112.104 -177.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.44 74.81 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 126.83 2.052 . . . . 0.56999999999999995 109.847 174.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.476 HD21 HD12 ' A' ' 122' ' ' LEU . 21.9 mt -66.58 -33.42 75.64 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 118.505 -0.759 . . . . 0.56999999999999995 111.03 174.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -60.24 -33.87 72.89 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.383 -0.818 . . . . 0.56999999999999995 109.605 173.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.9 mtm -69.64 -23.5 63.49 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 115.925 -1.988 . . . . 0.56999999999999995 113.281 175.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -84.45 -34.51 23.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.529 1.513 . . . . 0.56999999999999995 111.157 169.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.67 -13.95 83.0 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.839 -1.163 . . . . 0.56999999999999995 112.236 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.25 -25.98 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 111.13 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -100.35 -29.84 12.19 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.147 -0.93 . . . . 0.66000000000000003 111.468 176.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 160' ' ' ILE . 29.8 pt -122.7 131.23 24.4 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 119.364 0.984 . . . . 0.56999999999999995 111.255 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.11 43.39 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.694 2.93 . . . . 0.56999999999999995 112.234 178.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 126' ' ' LEU . 5.8 tt -82.73 145.33 29.63 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.146 1.378 . . . . 0.56999999999999995 108.593 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -126.78 162.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.315 1.046 . . . . 0.65000000000000002 108.208 -175.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 152.97 41.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.002 -1.481 . . . . 0.56999999999999995 107.002 -169.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 171.31 14.67 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.105 0.962 . . . . 1.2 109.083 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -115.04 163.93 14.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.976 -0.75 . . . . 0.56999999999999995 108.976 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.47 171.46 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 124.738 1.215 . . . . 0.56999999999999995 109.94 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -115.74 36.26 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 111.46 -171.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 92.02 107.5 0.03 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 128.739 2.816 . . . . 0.56999999999999995 108.99 -177.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.98 -124.41 1.43 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.078 -1.609 . . . . 0.56999999999999995 109.078 -173.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.9 p -138.0 143.17 40.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.39 0.676 . . . . 0.56999999999999995 109.803 -171.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.647 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . . . -135.22 -177.33 4.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.056 1.743 . . . . 0.56999999999999995 109.357 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 35.9 m-20 -83.74 -39.78 19.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.544 0.738 . . . . 0.66000000000000003 110.88 -177.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 122' ' ' LEU . 12.9 mt -116.05 79.98 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.306 1.442 . . . . 0.56999999999999995 107.213 -175.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -78.86 126.62 30.94 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.695 -1.253 . . . . 0.56999999999999995 108.998 171.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.17 124.98 66.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.616 -1.994 . . . . 0.56999999999999995 105.616 173.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.97 162.94 27.45 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.221 -0.752 . . . . 0.56999999999999995 111.221 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.77 148.01 46.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.994 -1.113 . . . . 0.56999999999999995 107.994 -175.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.61 179.86 6.58 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 125.936 1.694 . . . . 0.56999999999999995 110.291 -175.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 71.2 1.4 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 122.487 1.137 . . . . 1.2 108.422 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.37 -65.14 0.78 Allowed Glycine 0 C--O 1.218 -0.869 0 N-CA-C 110.311 -1.115 . . . . 0.56999999999999995 110.311 -178.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.95 159.5 33.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.863 1.832 . . . . 0.56999999999999995 110.963 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -157.87 155.19 29.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.628 1.171 . . . . 0.65000000000000002 108.923 -178.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.98 52.13 3.94 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.733 1.635 . . . . 0.56999999999999995 112.752 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -109.68 -77.18 0.6 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.533 1.133 . . . . 0.66000000000000003 108.411 -176.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -177.93 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.767 1.227 . . . . 0.56999999999999995 110.107 -175.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -130.43 99.13 19.43 Favored Pre-proline 0 C--N 1.344 0.357 0 N-CA-C 108.523 -0.917 . . . . 0.56999999999999995 108.523 -174.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 141.71 72.63 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 109.199 -1.116 . . . . 0.56999999999999995 109.199 174.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -61.85 177.3 0.45 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.192 1.472 . . . . 0.56999999999999995 111.041 167.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -99.34 -37.41 9.25 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.694 1.998 . . . . 0.66000000000000003 110.855 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.41 -150.11 18.19 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-N 120.461 1.482 . . . . 0.56999999999999995 112.422 -172.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.01 81.77 1.63 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.744 3.63 . . . . 0.56999999999999995 112.949 -176.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.17 -168.29 37.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.756 1.646 . . . . 0.56999999999999995 110.705 176.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 41.72 -137.1 0.21 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.307 1.443 . . . . 0.56999999999999995 113.788 167.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -59.42 123.53 17.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.938 2.095 . . . . 0.56999999999999995 110.936 174.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD13 ' C24' ' A' ' 178' ' ' MDW . 4.7 mp -98.93 -28.81 13.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.7 1.2 . . . . 0.56999999999999995 113.21 -176.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.72 159.09 36.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -143.7 156.57 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.65000000000000002 109.306 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.42 35.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.364 0.665 . . . . 0.56999999999999995 109.592 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -117.05 153.15 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.673 -0.862 . . . . 0.56999999999999995 108.673 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 158.89 50.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.97 -1.014 . . . . 0.56999999999999995 110.835 176.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 28.2 Cg_endo -69.79 161.46 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.438 2.092 . . . . 0.56999999999999995 112.175 177.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.06 -127.18 1.29 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.078 -2.009 . . . . 0.56999999999999995 108.078 -177.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.9 m -141.38 99.22 3.52 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 106.193 -1.78 . . . . 0.56999999999999995 106.193 -178.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.37 -125.62 6.34 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.177 -1.569 . . . . 0.56999999999999995 109.177 176.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tp -51.52 -35.43 40.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.425 1.09 . . . . 0.56999999999999995 111.842 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -46.17 136.97 8.32 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 121.574 -0.704 . . . . 0.56999999999999995 112.316 176.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.03 -22.15 8.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 126.384 1.945 . . . . 0.56999999999999995 114.464 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -68.47 151.83 46.26 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.651 -1.24 . . . . 0.66000000000000003 107.651 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.05 147.7 32.88 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.374 1.069 . . . . 0.56999999999999995 108.973 -172.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -131.62 154.66 48.66 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.888 -1.051 . . . . 0.65000000000000002 108.523 -178.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.47 151.84 48.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.825 -1.176 . . . . 0.56999999999999995 107.825 -171.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.26 94.9 9.4 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.874 -1.158 . . . . 0.66000000000000003 107.874 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.81 -28.11 46.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.654 1.582 . . . . 0.66000000000000003 111.256 175.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.87 -36.27 81.93 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.181 0.593 . . . . 0.66000000000000003 110.79 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.71 130.55 43.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.918 -1.142 . . . . 0.66000000000000003 107.918 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -57.49 140.95 49.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.249 0.547 . . . . 1.2 110.66 178.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -123.68 150.15 44.61 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.927 -1.508 . . . . 0.56999999999999995 106.927 178.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.5 t -137.84 147.76 44.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.019 -1.104 . . . . 0.56999999999999995 108.019 175.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.72 -54.0 48.51 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.343 0.974 . . . . 0.66000000000000003 108.684 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.81 72.73 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.437 -1.465 . . . . 0.56999999999999995 109.437 -169.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.3 p -159.44 151.22 20.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.218 0.607 . . . . 0.56999999999999995 109.668 173.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 m -67.66 87.2 0.22 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.007 0.923 . . . . 0.56999999999999995 110.604 174.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.33 -55.47 0.06 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 125.989 1.716 . . . . 0.56999999999999995 111.406 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.47 -147.87 7.41 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.211 -1.156 . . . . 0.56999999999999995 110.211 -176.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.61 124.7 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.437 -1.32 . . . . 0.56999999999999995 107.437 -177.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.86 107.63 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.319 1.048 . . . . 0.56999999999999995 109.822 -175.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -60.28 -47.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.391 1.476 . . . . 0.56999999999999995 110.337 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD13 ' HG ' ' A' ' 34' ' ' LEU . 12.5 tp -56.72 -44.76 81.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.351 -0.981 . . . . 0.56999999999999995 108.351 -177.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -72.92 -41.73 64.25 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.36 0.664 . . . . 0.56999999999999995 110.578 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.35 74.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.609 0.764 . . . . 0.56999999999999995 109.951 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.86 -56.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 118.289 -0.862 . . . . 0.56999999999999995 109.486 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.5 m -51.89 -36.57 49.15 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.686 1.13 . . . . 0.56999999999999995 112.522 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 138' ' ' MET . 4.7 t60 -64.12 -61.53 2.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.229 -0.656 . . . . 0.65000000000000002 109.229 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.95 -43.11 99.52 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.462 -0.773 . . . . 0.66000000000000003 111.036 -172.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 39' ' ' LEU . 4.1 mm? -61.63 -32.76 72.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 112.027 177.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.84 -44.95 81.45 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.634 -0.986 . . . . 0.56999999999999995 110.634 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -67.02 -44.21 80.86 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 118.479 -0.772 . . . . 0.65000000000000002 111.885 175.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.3 m -53.7 -38.52 64.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 123.755 0.659 . . . . 0.56999999999999995 111.085 176.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -61.77 -38.31 87.53 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.513 0.725 . . . . 0.56999999999999995 112.217 177.528 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 152.19 -21.95 0.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 119.262 -0.743 . . . . 0.56999999999999995 113.028 -175.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.6 158.79 4.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.689 1.244 . . . . 0.56999999999999995 110.927 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.03 -41.37 0.48 Allowed Glycine 0 C--O 1.219 -0.796 0 CA-C-O 116.73 -2.15 . . . . 0.56999999999999995 112.68 176.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 167.39 177.61 0.03 OUTLIER 'General case' 0 C--O 1.235 0.339 0 C-N-CA 128.247 2.619 . . . . 0.65000000000000002 107.259 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 t -150.76 -175.73 5.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.992 -1.485 . . . . 0.56999999999999995 106.992 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.3 p -134.86 63.26 1.62 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 109.078 -174.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.06 147.65 65.75 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.878 0.471 . . . . 0.66000000000000003 110.155 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -70.86 -27.11 21.66 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.842 2.362 . . . . 0.56999999999999995 112.158 -175.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -122.6 33.35 5.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.704 1.602 . . . . 0.56999999999999995 109.053 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.48 54.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.559 -0.713 . . . . 0.56999999999999995 110.567 176.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 138' ' ' MET . 5.5 p -65.74 -24.7 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 121.424 -0.797 . . . . 0.56999999999999995 110.336 168.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.47 ' HE3' HG13 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.6 11.84 33.82 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 112.157 177.117 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.55 137.11 9.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 119.764 1.166 . . . . 0.56999999999999995 112.48 174.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.04 -66.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.966 1.778 . . . . 0.56999999999999995 111.869 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -55.78 139.94 43.7 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.508 1.123 . . . . 0.56999999999999995 110.52 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -95.53 77.1 3.33 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.291 -0.633 . . . . 0.56999999999999995 109.291 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 96.75 0.12 Allowed Glycine 0 CA--C 1.536 1.374 0 N-CA-C 115.617 1.007 . . . . 0.56999999999999995 115.617 172.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -159.48 -46.68 0.05 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.399 1.1 . . . . 0.56999999999999995 113.105 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.76 -129.81 4.57 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.955 -2.058 . . . . 0.56999999999999995 107.955 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -147.57 114.2 4.08 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.537 -0.912 . . . . 0.66000000000000003 108.537 -178.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.33 -12.6 23.04 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.198 1.932 . . . . 0.56999999999999995 112.706 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.03 -25.67 61.9 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.074 -1.016 . . . . 0.56999999999999995 111.167 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.88 93.28 4.3 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 125.322 1.449 . . . . 0.56999999999999995 108.735 174.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -52.43 -73.89 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.622 1.169 . . . . 0.56999999999999995 114.035 -177.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 33.36 67.04 0.2 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.504 2.321 . . . . 0.56999999999999995 110.979 176.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.1 mp -40.13 121.97 1.43 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.866 1.666 . . . . 0.56999999999999995 109.121 -174.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 27.3 t -77.03 -101.63 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.626 0.771 . . . . 0.56999999999999995 109.272 -168.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -122.91 -8.26 8.37 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 125.102 1.361 . . . . 0.56999999999999995 110.838 172.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -59.22 -63.29 1.35 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 121.208 1.822 . . . . 0.66000000000000003 110.873 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.66 -50.84 61.61 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 117.616 -1.183 . . . . 0.66000000000000003 108.829 175.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.93 -48.83 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.199 0.909 . . . . 0.56999999999999995 110.314 -174.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -66.91 -49.82 64.37 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.057 -0.72 . . . . 0.56999999999999995 109.057 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.19 -58.84 11.91 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.682 -0.967 . . . . 0.56999999999999995 110.682 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.494 HG23 HG23 ' A' ' 46' ' ' ILE . 13.9 mm -50.39 -48.13 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 126.343 1.857 . . . . 0.56999999999999995 112.141 174.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.44 -33.6 75.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.438 0.563 . . . . 0.56999999999999995 111.714 177.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -76.05 -30.79 58.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.804 0.842 . . . . 0.56999999999999995 111.801 176.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 164' ' ' TYR . 3.6 mm? -72.76 -53.19 12.25 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.907 1.283 . . . . 0.56999999999999995 110.065 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' ILE . 19.6 m-85 -124.21 -53.88 1.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.402 0.681 . . . . 0.56999999999999995 109.778 -174.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.29 115.84 3.97 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 109.721 -1.352 . . . . 0.56999999999999995 109.721 -176.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.21 -75.74 0.36 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.777 -0.63 . . . . 0.56999999999999995 109.601 173.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.17 167.63 29.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.75 1.62 . . . . 1.2 108.65 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.4 t -142.0 126.46 17.76 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.697 -1.594 . . . . 0.56999999999999995 106.697 176.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -165.65 141.17 5.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.286 -1.746 . . . . 0.56999999999999995 106.286 171.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.59 151.19 10.9 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.048 -1.464 . . . . 0.56999999999999995 107.048 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.9 94.45 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.775 0.83 . . . . 1.2 109.279 176.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.56 175.58 8.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.783 0.833 . . . . 0.56999999999999995 109.055 175.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 C--N 1.33 -0.258 0 C-N-CA 127.225 2.21 . . . . 0.5 . 171.883 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.425 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 117.981 -1.009 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -70.79 -179.01 2.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.595 0.634 . . . . 0.56999999999999995 111.352 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.14 65.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.87 1.268 . . . . 0.56999999999999995 109.728 -172.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.97 -51.61 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 127.286 2.234 . . . . 0.56999999999999995 110.696 -176.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.67 162.99 24.17 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.86 2.373 . . . . 0.56999999999999995 112.128 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -126.04 -56.54 1.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.72 1.208 . . . . 0.56999999999999995 109.459 -176.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 p -127.64 61.93 52.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.938 1.295 . . . . 0.56999999999999995 109.958 178.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.52 166.22 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.875 1.717 . . . . 0.56999999999999995 110.946 176.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.2 99.26 0.07 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 126.243 1.817 . . . . 0.56999999999999995 108.912 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.545 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 20.3 m95 -53.86 154.06 4.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.511 0.672 . . . . 0.56999999999999995 111.651 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -72.76 -31.05 64.63 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.747 0.819 . . . . 0.56999999999999995 111.702 -176.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -92.44 155.62 17.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.137 2.175 . . . . 0.56999999999999995 111.162 174.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -79.68 -10.98 59.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.011 1.324 . . . . 0.56999999999999995 111.808 173.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.29 144.7 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.777 -1.194 . . . . 0.56999999999999995 107.777 175.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' ASP . 9.9 p -131.76 150.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.208 -1.034 . . . . 0.56999999999999995 108.208 -178.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.7 p -102.52 148.78 25.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 119.015 -0.516 . . . . 0.56999999999999995 110.651 -174.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -127.38 158.19 37.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.865 1.211 . . . . 0.56999999999999995 111.915 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -152.74 116.56 4.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.988 0.423 . . . . 1.2 110.945 171.5 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 22' ' ' TYR . 34.8 mt -79.19 96.63 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 N-CA-C 106.581 -1.637 . . . . 0.56999999999999995 106.581 176.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -33.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.878 2.071 . . . . 0.56999999999999995 112.007 -175.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 t -150.04 162.26 40.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 103.384 -2.821 . . . . 0.56999999999999995 103.384 -177.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 19' ' ' ILE . 72.1 m-85 -135.36 161.29 35.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.909 -1.515 . . . . 0.56999999999999995 106.909 -173.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.431 HG22 HG21 ' A' ' 31' ' ' VAL . 6.4 t -72.81 173.15 9.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.668 0.387 . . . . 0.56999999999999995 111.295 176.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -41.06 3.83 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.433 1.093 . . . . 1.2 111.221 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.32 -35.1 74.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.057 0.389 . . . . 0.66000000000000003 110.81 -176.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.52 151.77 52.11 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 126.531 1.932 . . . . 0.56999999999999995 108.356 -176.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -74.23 155.92 46.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.198 1.265 . . . . 0.56999999999999995 112.422 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -59.33 -37.59 78.18 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.565 1.146 . . . . 0.65000000000000002 112.343 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 tt -63.6 -39.82 86.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.28 -0.867 . . . . 0.56999999999999995 110.078 174.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -62.77 -42.81 99.86 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.63 -1.176 . . . . 0.56999999999999995 109.195 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 HG22 ' A' ' 23' ' ' THR . 46.3 t -61.28 -53.51 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 120.607 1.549 . . . . 0.56999999999999995 111.667 175.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -59.79 -45.03 93.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.654 1.115 . . . . 0.66000000000000003 110.438 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.17 96.78 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 117.845 -1.074 . . . . 1.2 111.402 176.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 115' ' ' LEU . 4.0 mp -64.19 -46.24 84.8 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.518 1.054 . . . . 0.56999999999999995 108.472 178.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -53.08 -49.75 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.244 0.929 . . . . 0.56999999999999995 109.709 172.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.26 -46.75 87.41 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.95 -1.024 . . . . 0.56999999999999995 111.887 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -65.62 -42.54 91.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.333 1.424 . . . . 0.56999999999999995 111.712 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.05 94.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.77 0.828 . . . . 0.56999999999999995 110.049 177.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 122' ' ' LEU . 65.5 mt -66.45 -32.39 73.73 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.934 -0.555 . . . . 0.56999999999999995 111.511 173.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.84 -43.45 98.27 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.915 0.78 . . . . 0.56999999999999995 110.025 172.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 mtm -67.12 -37.44 83.87 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.483 -0.77 . . . . 0.56999999999999995 112.133 176.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.47 ' CZ3' ' HG3' ' A' ' 128' ' ' MET . 23.7 m95 -69.11 -43.92 73.47 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.862 1.21 . . . . 0.56999999999999995 112.004 173.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.04 -0.87 66.46 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.959 1.266 . . . . 0.56999999999999995 113.197 177.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -23.48 65.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.11 -1.23 . . . . 0.56999999999999995 110.953 171.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -105.47 -32.1 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.978 -1.01 . . . . 0.66000000000000003 112.331 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 160' ' ' ILE . 7.2 pt -116.6 132.29 23.44 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 119.312 0.96 . . . . 0.56999999999999995 110.875 178.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.27 49.44 2.84 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.971 3.114 . . . . 0.56999999999999995 111.76 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 126' ' ' LEU . 3.2 tt -98.49 142.11 30.51 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.122 2.169 . . . . 0.56999999999999995 107.357 176.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -125.18 164.7 19.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.65000000000000002 109.329 -172.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.65 147.87 47.1 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.685 -1.228 . . . . 0.56999999999999995 107.685 -170.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.97 168.98 18.7 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.709 1.204 . . . . 1.2 109.048 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -110.77 150.39 29.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.793 -0.817 . . . . 0.56999999999999995 108.793 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.5 170.33 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.867 0.867 . . . . 0.56999999999999995 109.941 174.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.1 -48.71 7.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.077 0.951 . . . . 0.56999999999999995 109.17 177.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -146.58 139.61 25.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.106 1.362 . . . . 0.56999999999999995 107.387 173.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.43 166.4 22.79 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.571 0.605 . . . . 0.56999999999999995 111.808 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 164.54 21.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.914 0.387 . . . . 0.56999999999999995 110.369 174.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.51 173.71 8.28 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.835 1.254 . . . . 0.56999999999999995 110.8 -176.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 15' ' ' VAL . 51.3 m-20 -73.53 -35.89 65.6 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.09 -0.959 . . . . 0.66000000000000003 110.298 -177.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.09 71.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.549 2.34 . . . . 0.56999999999999995 108.364 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 18.9 ttp -78.31 122.02 25.2 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 120.577 -1.327 . . . . 0.56999999999999995 108.229 173.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.93 135.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.473 -1.677 . . . . 0.56999999999999995 106.473 178.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.3 165.93 28.17 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 118.821 0.737 . . . . 0.56999999999999995 112.015 176.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 6.4 m-85 -139.12 137.54 36.24 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.172 -1.788 . . . . 0.56999999999999995 106.172 -175.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.8 175.85 9.27 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.018 1.327 . . . . 0.56999999999999995 109.318 -176.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -133.55 88.8 2.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.722 -1.214 . . . . 1.2 107.722 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.76 -40.89 2.27 Favored Glycine 0 C--N 1.343 0.933 0 C-N-CA 124.359 0.981 . . . . 0.56999999999999995 113.089 170.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.96 23.94 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.376 1.088 . . . . 0.56999999999999995 109.421 175.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.3 159.33 25.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.957 1.303 . . . . 0.65000000000000002 109.763 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.49 55.71 4.42 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 126.21 1.862 . . . . 0.56999999999999995 112.23 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -105.08 -78.39 0.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.176 1.39 . . . . 0.66000000000000003 109.094 -175.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.17 -50.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.545 1.938 . . . . 0.56999999999999995 106.52 -176.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -108.36 126.19 30.17 Favored Pre-proline 0 C--N 1.344 0.352 0 CA-C-O 118.798 -0.62 . . . . 0.56999999999999995 109.942 -174.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.08 133.37 26.66 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.272 1.315 . . . . 0.56999999999999995 108.836 170.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.64 -163.43 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 122.645 1.212 . . . . 0.56999999999999995 110.459 166.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -132.53 -35.77 1.12 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.605 3.562 . . . . 0.66000000000000003 109.416 -162.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.37 -148.64 18.93 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.808 1.671 . . . . 0.56999999999999995 111.453 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.04 59.57 2.96 Favored 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.227 4.618 . . . . 0.56999999999999995 115.103 -169.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.0 40.55 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.552 1.549 . . . . 0.56999999999999995 110.053 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 42.63 -139.76 0.17 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.229 1.812 . . . . 0.56999999999999995 113.593 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -49.57 112.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.436 2.694 . . . . 0.56999999999999995 111.989 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.23 -32.11 61.04 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.352 1.242 . . . . 0.56999999999999995 114.352 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.12 166.37 28.09 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.84 -1.162 . . . . 0.56999999999999995 109.223 -178.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -149.09 155.98 41.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.003 0.82 . . . . 0.65000000000000002 111.161 174.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.44 158.56 43.93 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.203 1.001 . . . . 0.56999999999999995 109.875 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.7 148.52 32.1 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.429 -0.582 . . . . 0.56999999999999995 109.429 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.42 96.5 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.801 -0.636 . . . . 0.56999999999999995 110.242 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 21.9 Cg_endo -70.33 157.66 58.6 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.476 2.117 . . . . 0.56999999999999995 111.099 176.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.68 -53.52 0.6 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.414 1.007 . . . . 0.56999999999999995 111.141 173.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 t -96.64 177.67 5.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.56999999999999995 110.704 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.96 -40.39 97.14 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.267 -1.296 . . . . 0.56999999999999995 112.488 -176.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.22 -29.38 66.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.881 1.34 . . . . 0.56999999999999995 110.875 168.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.13 152.19 14.69 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 120.85 -1.157 . . . . 0.56999999999999995 111.152 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.35 -20.55 4.89 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.436 1.017 . . . . 0.56999999999999995 113.391 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -75.39 157.22 34.52 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.483 1.141 . . . . 0.66000000000000003 108.867 -173.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.41 149.94 36.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.815 0.817 . . . . 0.56999999999999995 110.314 -172.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -137.83 151.56 48.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.982 0.913 . . . . 0.65000000000000002 109.602 -176.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.502 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 36.2 m-85 -138.07 150.01 46.51 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.775 1.23 . . . . 0.56999999999999995 108.034 -171.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -85.51 104.09 14.97 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.87 -0.789 . . . . 0.66000000000000003 108.87 172.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.86 -23.75 66.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.929 -1.107 . . . . 0.66000000000000003 111.671 175.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -56.72 -29.5 62.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.793 0.837 . . . . 0.66000000000000003 111.642 179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -82.68 135.03 35.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.587 1.555 . . . . 0.66000000000000003 109.157 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.83 120.7 14.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.753 -0.592 . . . . 1.2 109.62 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -103.58 138.51 40.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.956 -1.127 . . . . 0.56999999999999995 107.956 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -123.64 147.08 47.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.711 -1.218 . . . . 0.56999999999999995 107.711 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -88.26 21.23 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.396 0.998 . . . . 0.66000000000000003 112.081 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.86 25.6 37.52 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.252 1.406 . . . . 0.56999999999999995 112.834 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.9 t -64.76 -56.18 15.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.797 1.239 . . . . 0.56999999999999995 112.746 -172.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.1 m -151.68 -43.1 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.582 0.753 . . . . 0.56999999999999995 112.827 -176.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 pp -167.84 166.4 13.54 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.628 1.971 . . . . 0.56999999999999995 108.078 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.84 -152.4 16.88 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.166 -1.574 . . . . 0.56999999999999995 109.166 -175.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.93 111.63 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.107 -1.442 . . . . 0.56999999999999995 107.107 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -66.28 111.65 3.58 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.074 -0.713 . . . . 0.56999999999999995 109.074 -177.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.43 -43.93 75.8 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.449 -0.796 . . . . 0.56999999999999995 111.464 177.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' HG ' ' A' ' 34' ' ' LEU . 20.5 tp -59.7 -40.3 87.45 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -175.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -66.54 -44.61 81.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.569 0.748 . . . . 0.56999999999999995 109.662 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.425 ' HB2' ' C26' ' A' ' 178' ' ' MDW . . . -58.65 -49.95 75.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.098 0.559 . . . . 0.56999999999999995 110.327 176.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.16 -50.95 72.09 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 117.861 -1.066 . . . . 0.56999999999999995 109.845 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 65.5 m -50.82 -46.33 59.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.175 1.352 . . . . 0.56999999999999995 111.714 175.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -61.91 -52.27 64.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.401 0.546 . . . . 0.65000000000000002 110.281 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.5 -43.37 85.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.195 0.998 . . . . 0.66000000000000003 110.9 -172.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 39' ' ' LEU . 60.0 mt -64.85 -28.68 69.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.202 1.401 . . . . 0.56999999999999995 111.282 176.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -46.33 80.46 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.127 -0.789 . . . . 0.56999999999999995 111.127 169.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -68.7 -40.46 80.01 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 117.537 -1.22 . . . . 0.65000000000000002 110.889 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.8 p -59.98 -26.44 66.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.136 0.88 . . . . 0.56999999999999995 112.838 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.74 -41.59 78.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.22 1.008 . . . . 0.56999999999999995 111.773 173.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.73 25.91 1.2 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 124.478 1.037 . . . . 0.56999999999999995 113.621 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.47 ' HG3' ' CZ3' ' A' ' 42' ' ' TRP . 36.3 mmt -84.26 -176.94 6.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.855 0.836 . . . . 0.56999999999999995 111.052 -175.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.47 146.49 18.15 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.267 -0.879 . . . . 0.56999999999999995 111.44 178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.23 164.33 1.81 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.036 0.922 . . . . 0.65000000000000002 111.25 166.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.26 179.97 7.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.515 1.926 . . . . 0.56999999999999995 107.538 -177.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.3 t -151.59 97.06 2.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.917 -1.883 . . . . 0.56999999999999995 105.917 174.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -131.1 137.62 31.09 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 105.587 -2.005 . . . . 0.66000000000000003 105.587 -179.679 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.76 38.12 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.959 3.106 . . . . 0.56999999999999995 111.714 -176.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.46 32.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.9 1.68 . . . . 0.56999999999999995 111.291 170.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -120.64 142.91 49.0 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.98 -1.075 . . . . 0.56999999999999995 110.543 -170.04 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -67.47 -29.6 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 120.172 -0.611 . . . . 0.56999999999999995 109.514 177.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 tpp -61.39 -18.13 57.35 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.129 1.772 . . . . 0.56999999999999995 114.455 173.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -54.71 129.11 63.69 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.534 0.734 . . . . 0.56999999999999995 109.502 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.06 134.98 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.793 1.662 . . . . 0.56999999999999995 109.277 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.1 m 66.88 149.55 0.05 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.107 1.763 . . . . 0.56999999999999995 111.895 -173.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.84 131.48 48.93 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.017 -1.052 . . . . 0.56999999999999995 109.51 173.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.86 -104.72 0.18 Allowed Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.161 -1.176 . . . . 0.56999999999999995 110.161 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -64.2 -33.61 76.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.923 0.712 . . . . 0.56999999999999995 112.923 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.59 142.93 36.08 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.613 -0.995 . . . . 0.56999999999999995 110.613 178.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -109.77 111.51 58.85 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.408 0.683 . . . . 0.66000000000000003 109.288 -169.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 -15.63 51.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.576 2.184 . . . . 0.56999999999999995 113.6 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.54 -1.24 28.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.024 0.93 . . . . 0.56999999999999995 110.675 177.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -142.51 77.42 1.58 Allowed 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 109.586 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.86 -63.15 1.2 Allowed 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.67 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 25.11 72.96 0.03 OUTLIER 'General case' 0 C--N 1.346 0.436 0 O-C-N 126.369 2.293 . . . . 0.56999999999999995 111.364 -176.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.2 mp -33.16 116.07 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.965 2.106 . . . . 0.56999999999999995 108.55 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.4 p -93.7 -75.52 0.5 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.326 -0.55 . . . . 0.56999999999999995 110.382 -160.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -141.76 -49.51 0.39 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.501 1.12 . . . . 0.56999999999999995 109.351 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -51.84 -32.47 31.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.901 1.228 . . . . 0.66000000000000003 112.441 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.458 ' HB3' HD23 ' A' ' 152' ' ' LEU . 71.7 m-20 -78.19 -82.94 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.902 1.681 . . . . 0.66000000000000003 110.404 168.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.3 mt -60.62 -50.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.183 0.993 . . . . 0.56999999999999995 110.648 -169.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -69.05 -35.9 77.09 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 117.528 -1.225 . . . . 0.56999999999999995 109.684 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.71 95.25 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 120.416 1.462 . . . . 0.56999999999999995 111.049 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 46' ' ' ILE . 7.9 mm -60.03 -48.81 86.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.902 0.881 . . . . 0.56999999999999995 110.676 171.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -67.09 -16.86 64.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.561 -0.733 . . . . 0.56999999999999995 112.89 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -82.57 -35.64 26.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.324 1.45 . . . . 0.56999999999999995 110.43 171.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -47.13 8.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.867 0.758 . . . . 0.56999999999999995 112.762 -175.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -104.48 -43.44 5.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.285 1.034 . . . . 0.56999999999999995 110.484 -175.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.41 -178.75 9.34 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.853 -0.899 . . . . 0.56999999999999995 110.853 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.02 -67.86 0.94 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.833 -0.803 . . . . 0.56999999999999995 108.833 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -150.26 165.97 31.36 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.699 -1.223 . . . . 1.2 107.699 178.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 33.6 t -155.37 -60.81 0.11 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.512 -1.292 . . . . 0.56999999999999995 107.512 172.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -164.82 178.04 7.49 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.914 1.685 . . . . 0.56999999999999995 110.356 175.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.1 p -149.37 146.07 27.31 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.089 1.355 . . . . 0.56999999999999995 109.889 171.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 73.51 114.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.962 2.905 . . . . 1.2 112.587 -177.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -151.36 177.2 10.51 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.282 0.633 . . . . 0.56999999999999995 111.287 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.8 tptt . . . . . 0 C--N 1.341 0.233 0 C-N-CA 129.099 2.96 . . . . 0.5 . 177.327 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.425 ' C26' ' HB2' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.264 0 CA-C-O 117.126 -1.416 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.5 p -94.95 -0.25 54.07 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.468 1.486 . . . . 0.56999999999999995 112.855 -178.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.43 -53.93 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.732 1.213 . . . . 0.56999999999999995 110.121 -175.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.2 171.11 8.56 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.615 1.966 . . . . 0.56999999999999995 110.672 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -71.08 -158.45 0.06 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.056 3.171 . . . . 0.56999999999999995 113.048 173.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -55.63 151.33 10.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.266 1.026 . . . . 0.56999999999999995 109.652 166.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 151.67 -53.51 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.437 0 C-N-CA 129.399 3.079 . . . . 0.56999999999999995 109.266 -172.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.9 168.97 21.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.404 1.402 . . . . 0.56999999999999995 111.856 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 pttt 86.81 133.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 129.406 3.082 . . . . 0.56999999999999995 108.548 -170.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.408 ' CZ2' ' HB3' ' A' ' 88' ' ' PRO . 33.2 m95 -73.31 177.67 5.02 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.619 0.767 . . . . 0.56999999999999995 110.074 173.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.7 m -101.6 -14.77 17.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.728 -0.608 . . . . 0.56999999999999995 111.485 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -100.8 162.64 12.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.726 1.21 . . . . 0.56999999999999995 110.116 176.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -87.42 -4.08 59.02 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.13 1.372 . . . . 0.56999999999999995 112.549 171.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -133.1 140.93 46.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.868 -1.16 . . . . 0.56999999999999995 107.868 176.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.68 143.5 39.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 106.738 -1.578 . . . . 0.56999999999999995 106.738 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 59' ' ' ASP . 0.6 OUTLIER -98.94 140.43 33.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.69 -0.485 . . . . 0.56999999999999995 109.69 -179.531 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.21 161.04 29.48 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.631 0.772 . . . . 0.56999999999999995 110.544 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.91 160.7 43.73 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.987 0.915 . . . . 1.2 109.599 172.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.7 mt -122.25 85.92 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.239 -2.134 . . . . 0.56999999999999995 105.239 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.64 -56.27 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.021 0.529 . . . . 0.56999999999999995 109.985 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.5 111.82 22.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.733 -1.951 . . . . 0.56999999999999995 105.733 176.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.09 148.95 22.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.395 1.878 . . . . 0.56999999999999995 107.911 177.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 t -73.88 -170.05 0.84 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.794 1.238 . . . . 0.56999999999999995 109.799 -176.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.28 -14.43 0.88 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.869 1.433 . . . . 1.2 114.869 176.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -64.59 -29.87 70.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.085 1.354 . . . . 0.66000000000000003 110.846 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.28 150.82 73.48 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 126.55 1.94 . . . . 0.56999999999999995 108.488 175.13 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -70.81 157.3 58.72 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.537 2.825 . . . . 0.56999999999999995 112.736 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -65.59 -32.92 74.76 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.705 0.802 . . . . 0.65000000000000002 112.172 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.3 -43.96 98.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.55 -0.907 . . . . 0.56999999999999995 108.55 174.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -64.95 -42.37 94.7 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.206 -1.378 . . . . 0.56999999999999995 109.839 172.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.3 t -58.3 -48.59 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 121.157 1.798 . . . . 0.56999999999999995 110.365 177.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -65.8 -42.19 90.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.19 0.904 . . . . 0.66000000000000003 109.672 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -67.34 -46.87 72.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.333 -0.855 . . . . 1.2 113.146 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.37 -31.62 72.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.048 -0.977 . . . . 0.56999999999999995 109.676 177.325 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.15 -50.42 74.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 107.878 -1.156 . . . . 0.56999999999999995 107.878 173.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -38.88 91.55 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 118.244 -0.884 . . . . 0.56999999999999995 110.826 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.46 -47.71 69.31 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.473 1.488 . . . . 0.56999999999999995 111.105 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.96 86.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.075 0.95 . . . . 0.56999999999999995 111.726 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.21 -31.87 68.13 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.216 -0.897 . . . . 0.56999999999999995 111.156 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.63 -43.98 93.63 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 119.286 0.948 . . . . 0.56999999999999995 109.233 170.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.2 mtp -60.1 -35.34 75.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.551 1.069 . . . . 0.56999999999999995 112.86 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' CZ2' ' HA2' ' A' ' 123' ' ' GLY . 5.6 m95 -70.55 -48.09 57.1 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.421 1.009 . . . . 0.56999999999999995 111.669 170.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.51 -9.36 64.73 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.106 1.336 . . . . 0.56999999999999995 113.668 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -66.38 -20.16 66.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.553 1.141 . . . . 0.56999999999999995 110.499 170.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.89 -20.39 12.47 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.205 -0.902 . . . . 0.66000000000000003 112.691 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.8 pt -127.67 129.75 23.75 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 119.195 0.907 . . . . 0.56999999999999995 110.464 175.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.82 41.45 0.63 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.295 3.33 . . . . 0.56999999999999995 112.407 178.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -89.9 147.72 23.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.295 1.838 . . . . 0.56999999999999995 108.079 -179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -122.93 166.36 15.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.51 0.724 . . . . 0.65000000000000002 109.25 -172.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.84 39.5 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.111 -0.993 . . . . 0.56999999999999995 109.458 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 165.24 21.54 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.756 0.823 . . . . 1.2 109.217 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -130.3 114.1 15.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.812 -1.551 . . . . 0.56999999999999995 106.812 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.05 160.76 2.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.383 0.673 . . . . 0.56999999999999995 109.759 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.71 -14.76 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.192 0.997 . . . . 0.56999999999999995 112.227 -176.21 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -52.5 64.04 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.664 0.785 . . . . 0.56999999999999995 111.099 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.37 -152.81 6.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.965 1.745 . . . . 0.56999999999999995 109.431 -172.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -60.84 178.88 0.2 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.328 1.051 . . . . 0.56999999999999995 112.477 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.22 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.734 1.614 . . . . 0.56999999999999995 110.382 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 16' ' ' THR . 79.8 m-20 -66.43 -31.62 72.49 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.494 -0.765 . . . . 0.66000000000000003 109.138 176.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.1 mt -125.45 79.13 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 126.641 1.976 . . . . 0.56999999999999995 108.471 -178.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -72.54 117.95 14.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.134 1.773 . . . . 0.56999999999999995 108.226 166.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.88 122.8 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 105.096 -2.187 . . . . 0.56999999999999995 105.096 177.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 97' ' ' HIS . . . -144.55 138.73 8.06 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 118.149 0.431 . . . . 0.56999999999999995 112.024 -174.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.48 145.69 37.25 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.936 -1.135 . . . . 0.56999999999999995 107.936 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.94 151.7 51.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.685 1.194 . . . . 0.56999999999999995 108.34 -178.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -110.68 70.86 0.73 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.271 0.558 . . . . 1.2 109.608 -174.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.28 -53.79 0.66 Allowed Glycine 0 C--O 1.219 -0.805 0 N-CA-C 110.351 -1.099 . . . . 0.56999999999999995 110.351 174.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.58 171.66 19.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.958 0.903 . . . . 0.56999999999999995 109.328 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.51 159.56 22.17 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.429 1.892 . . . . 0.65000000000000002 108.537 -174.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.23 46.22 2.22 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.085 1.326 . . . . 0.56999999999999995 111.788 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.42 105.66 7.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.488 -1.301 . . . . 0.66000000000000003 107.488 -172.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.9 m 55.99 -71.72 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.113 2.165 . . . . 0.56999999999999995 113.034 -175.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.75 130.02 15.31 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.351 1.86 . . . . 0.56999999999999995 107.911 -173.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.7 137.75 43.07 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.833 175.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -66.48 -173.81 0.24 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.973 1.309 . . . . 0.56999999999999995 111.202 169.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.63 -33.52 6.75 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.136 2.574 . . . . 0.66000000000000003 111.962 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.02 -123.54 7.94 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 120.586 -1.321 . . . . 0.56999999999999995 111.965 -173.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.67 95.72 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.83 2.315 . . . . 0.56999999999999995 112.327 -176.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.89 -160.45 25.73 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.966 0.793 . . . . 0.56999999999999995 112.232 173.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 43.57 -129.91 0.78 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.325 1.45 . . . . 0.56999999999999995 112.904 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -68.3 129.11 38.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.307 2.643 . . . . 0.56999999999999995 109.186 170.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.67 -30.44 12.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.104 1.361 . . . . 0.56999999999999995 112.049 -175.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.2 37.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.839 1.255 . . . . 0.56999999999999995 108.352 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.74 161.54 38.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.625 -0.88 . . . . 0.65000000000000002 108.625 173.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.36 159.91 43.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.966 0.506 . . . . 0.56999999999999995 109.651 175.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -114.32 152.62 31.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.49 -0.777 . . . . 0.56999999999999995 109.606 -173.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.25 146.57 83.44 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.203 -0.903 . . . . 0.56999999999999995 110.117 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 34.4 Cg_endo -66.83 157.98 58.62 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.345 2.03 . . . . 0.56999999999999995 112.335 -176.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.36 -101.7 0.15 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.042 -1.223 . . . . 0.56999999999999995 110.042 176.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -147.05 -41.25 0.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.901 0.88 . . . . 0.56999999999999995 111.194 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.02 4.57 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.812 -1.315 . . . . 0.56999999999999995 109.812 -175.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -29.95 17.58 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.224 1.01 . . . . 0.56999999999999995 112.423 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.55 134.79 14.47 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 120.964 -1.085 . . . . 0.56999999999999995 112.865 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.58 9.26 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.217 1.865 . . . . 0.56999999999999995 112.203 -176.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.72 148.44 47.98 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.1 0.95 . . . . 0.66000000000000003 108.885 -166.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.38 137.85 46.02 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.691 0.796 . . . . 0.56999999999999995 109.13 -168.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 15.4 m-70 -135.33 141.24 45.58 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.299 -1.0 . . . . 0.65000000000000002 108.299 -164.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.29 151.73 42.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.735 -0.839 . . . . 0.56999999999999995 108.735 -169.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -83.56 102.2 11.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.852 -0.796 . . . . 0.66000000000000003 108.852 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.85 -21.72 63.5 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.095 0.958 . . . . 0.66000000000000003 111.487 172.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.23 -38.83 88.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.611 0.642 . . . . 0.66000000000000003 110.436 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.68 126.37 29.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.345 -1.354 . . . . 0.66000000000000003 107.345 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.82 132.53 22.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.465 -0.939 . . . . 1.2 108.465 176.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -120.78 129.69 53.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.739 -1.948 . . . . 0.56999999999999995 105.739 -177.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -141.02 161.84 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.619 -0.882 . . . . 0.56999999999999995 108.619 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.78 -22.77 58.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.857 0.863 . . . . 0.66000000000000003 111.136 172.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 152.47 96.68 0.14 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.177 0.894 . . . . 0.56999999999999995 111.33 175.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.0 t -120.37 -68.54 0.9 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 118.658 -0.687 . . . . 0.56999999999999995 110.562 -178.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.79 -64.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.06 0.944 . . . . 0.56999999999999995 108.877 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 tt -94.56 -46.1 7.11 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.815 0.846 . . . . 0.56999999999999995 110.327 -170.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.67 145.58 32.22 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.077 -1.209 . . . . 0.56999999999999995 110.077 173.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 16.5 mm -77.62 138.26 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.594 -1.262 . . . . 0.56999999999999995 107.594 -171.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -74.16 105.57 5.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.684 -0.487 . . . . 0.56999999999999995 109.684 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -64.31 -33.73 76.51 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.288 0.635 . . . . 0.56999999999999995 110.887 178.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.51 -51.52 65.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.624 -1.25 . . . . 0.56999999999999995 107.624 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.82 -38.89 92.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.449 0.7 . . . . 0.56999999999999995 109.205 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.31 47.12 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.547 0.739 . . . . 0.56999999999999995 112.252 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.43 77.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.628 -0.879 . . . . 0.56999999999999995 108.628 179.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.5 m -60.88 -37.73 83.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.463 0.574 . . . . 0.56999999999999995 111.382 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.42 -58.8 6.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.17 0.441 . . . . 0.65000000000000002 109.871 172.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -68.63 -41.69 79.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.298 -0.876 . . . . 0.66000000000000003 111.635 -171.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.0 mp -65.99 -24.85 66.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.354 1.061 . . . . 0.56999999999999995 110.943 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' HA2' ' CZ2' ' A' ' 42' ' ' TRP . . . -58.54 -45.89 93.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.917 -0.873 . . . . 0.56999999999999995 110.917 169.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -70.13 -32.96 71.22 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 117.729 -1.129 . . . . 0.65000000000000002 112.239 174.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 p -60.09 -38.1 81.93 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.657 1.117 . . . . 0.56999999999999995 110.894 174.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.55 -33.07 73.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.014 0.435 . . . . 0.56999999999999995 111.181 176.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.48 -55.01 0.12 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 123.782 0.706 . . . . 0.56999999999999995 111.611 175.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 176.09 172.56 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.432 1.493 . . . . 0.56999999999999995 107.632 -166.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 161.24 75.22 0.02 OUTLIER Glycine 0 C--O 1.218 -0.847 0 N-CA-C 104.137 -3.585 . . . . 0.56999999999999995 104.137 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.14 45.13 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.314 -1.365 . . . . 0.65000000000000002 107.314 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.3 -177.13 0.99 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.966 2.106 . . . . 0.56999999999999995 106.469 -173.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -132.25 39.29 3.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.56999999999999995 109.696 -174.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -104.14 137.69 19.31 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.66000000000000003 111.197 -172.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.47 -9.49 25.96 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.837 2.358 . . . . 0.56999999999999995 113.573 -174.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -121.52 24.75 9.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.868 1.267 . . . . 0.56999999999999995 109.599 172.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.63 133.18 45.53 Favored 'General case' 0 C--N 1.343 0.309 0 O-C-N 121.082 -1.011 . . . . 0.56999999999999995 110.115 172.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -22.26 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.069 0.548 . . . . 0.56999999999999995 110.442 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.2 24.75 12.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.43 1.892 . . . . 0.56999999999999995 110.622 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' HD2' ' A' ' 140' ' ' PRO . 12.6 t80 -61.12 142.89 92.87 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 121.137 -0.977 . . . . 0.56999999999999995 109.967 173.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 44.9 Cg_endo -69.53 -171.48 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.315 2.01 . . . . 0.56999999999999995 111.235 166.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 t 43.59 68.89 0.46 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.497 1.519 . . . . 0.56999999999999995 113.151 173.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -43.38 129.22 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.772 1.629 . . . . 0.56999999999999995 113.458 -173.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.42 113.86 3.51 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.28 -1.528 . . . . 0.56999999999999995 109.28 -178.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 168.4 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.063 2.145 . . . . 0.56999999999999995 108.48 175.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.96 -145.24 18.34 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.556 -1.017 . . . . 0.56999999999999995 110.556 177.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -128.06 102.25 21.85 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.833 -1.543 . . . . 0.66000000000000003 106.833 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.81 67.09 6.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.985 2.457 . . . . 0.56999999999999995 109.481 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -165.1 -48.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.326 1.85 . . . . 0.56999999999999995 108.961 178.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -77.4 43.11 0.37 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.9 1.444 . . . . 0.56999999999999995 114.9 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -14.4 -71.95 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 128.352 2.661 . . . . 0.56999999999999995 117.06 -177.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 17.81 79.03 0.01 OUTLIER 'General case' 0 C--N 1.347 0.489 0 C-N-CA 128.324 2.649 . . . . 0.56999999999999995 112.309 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 152' ' ' LEU . 5.3 mp -31.66 117.4 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.421 1.889 . . . . 0.56999999999999995 109.762 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -92.2 -87.85 0.21 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.101 -0.476 . . . . 0.56999999999999995 110.481 -163.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -139.57 -39.06 0.47 Allowed 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 117.644 -1.17 . . . . 0.56999999999999995 111.721 177.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -58.93 -37.2 76.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 120.174 1.352 . . . . 0.66000000000000003 110.87 174.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.42 -59.31 2.83 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 124.118 0.886 . . . . 0.66000000000000003 109.109 175.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.47 -46.0 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.574 1.149 . . . . 0.56999999999999995 110.237 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.37 -47.45 76.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.495 1.118 . . . . 0.56999999999999995 109.749 -177.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -58.41 -51.53 58.14 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.995 -1.242 . . . . 0.56999999999999995 109.995 176.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -54.4 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.365 1.066 . . . . 0.56999999999999995 110.896 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -56.29 -43.5 78.93 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.546 1.139 . . . . 0.56999999999999995 109.569 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -65.14 -36.92 85.76 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.575 0.625 . . . . 0.56999999999999995 111.15 176.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tt -56.21 -46.57 79.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.813 1.645 . . . . 0.56999999999999995 112.153 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -104.88 8.06 34.56 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.406 0.683 . . . . 0.56999999999999995 112.636 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -101.11 -159.45 27.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.585 1.088 . . . . 0.56999999999999995 111.348 -167.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.7 -42.96 0.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.077 -1.062 . . . . 0.56999999999999995 111.227 -175.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.96 139.57 12.53 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.095 0.958 . . . . 1.2 108.863 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 p 167.72 63.68 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.221 2.208 . . . . 0.56999999999999995 110.193 -173.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -89.91 142.09 28.03 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.336 -0.852 . . . . 0.56999999999999995 109.238 170.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.7 t -172.48 149.7 2.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.617 . . . . 0.56999999999999995 106.944 169.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -142.48 133.99 26.53 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.237 -1.023 . . . . 1.2 108.237 176.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.46 148.91 43.81 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.127 1.371 . . . . 0.56999999999999995 108.334 -177.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 C-N-CA 124.77 1.228 . . . . 0.5 . 171.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 119.418 -0.325 . . . . 0.56999999999999995 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -96.04 -72.61 0.62 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.584 1.154 . . . . 0.56999999999999995 108.816 -177.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.96 -52.59 0.22 Allowed 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.224 1.01 . . . . 0.56999999999999995 110.688 178.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.88 96.17 19.45 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.709 1.604 . . . . 0.56999999999999995 108.548 -175.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.0 119.71 6.36 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.474 1.449 . . . . 0.56999999999999995 108.743 173.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -144.73 -67.04 0.32 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.102 -1.444 . . . . 0.56999999999999995 107.102 170.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.39 70.13 0.95 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 126.63 1.972 . . . . 0.56999999999999995 109.019 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.46 134.04 31.98 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.559 1.506 . . . . 0.56999999999999995 109.328 177.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 71.47 115.84 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.043 1.737 . . . . 0.56999999999999995 109.48 -171.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -57.12 150.11 18.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.742 0.817 . . . . 0.56999999999999995 110.251 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -65.9 -23.89 66.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.841 0.857 . . . . 0.56999999999999995 111.392 178.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t -94.16 152.63 18.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.99 0.916 . . . . 0.56999999999999995 110.364 173.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -85.62 -3.4 58.87 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.654 1.182 . . . . 0.56999999999999995 112.636 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.56 111.03 23.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.107 -1.072 . . . . 0.56999999999999995 108.107 177.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -116.15 124.78 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.551 -1.277 . . . . 0.56999999999999995 107.551 -170.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -92.6 152.23 19.7 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.599 -0.688 . . . . 0.56999999999999995 110.441 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -123.09 153.45 39.9 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.696 0.799 . . . . 0.56999999999999995 111.506 175.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.28 117.77 6.52 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.649 0.738 . . . . 1.2 110.549 174.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.2 mt -87.74 89.46 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 105.05 -2.204 . . . . 0.56999999999999995 105.05 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.89 -31.78 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.135 0.974 . . . . 0.56999999999999995 112.097 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 t -136.2 157.65 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.589 -2.375 . . . . 0.56999999999999995 104.589 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -135.21 167.42 21.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.197 1.399 . . . . 0.56999999999999995 107.663 -173.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -68.49 -175.03 0.6 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 0.56999999999999995 111.459 172.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -41.49 2.56 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.544 1.138 . . . . 1.2 111.241 -176.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -41.43 77.48 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.875 1.27 . . . . 0.66000000000000003 111.739 178.137 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.5 mt -116.41 142.56 29.66 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 125.037 1.335 . . . . 0.56999999999999995 108.015 -172.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.42 158.46 56.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.769 1.646 . . . . 0.56999999999999995 112.192 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -67.98 -36.83 80.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.374 -0.83 . . . . 0.65000000000000002 110.592 -171.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.3 tt -65.84 -40.72 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.909 0.884 . . . . 0.56999999999999995 110.814 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -62.5 -46.08 90.08 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 117.717 -1.135 . . . . 0.56999999999999995 108.272 173.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 t -54.86 -49.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.467 -1.254 . . . . 0.56999999999999995 110.701 175.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.24 -40.25 96.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.498 1.499 . . . . 0.66000000000000003 111.778 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -62.85 -46.21 88.94 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.487 1.04 . . . . 1.2 111.553 175.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.88 -42.79 89.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.483 1.113 . . . . 0.56999999999999995 109.531 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.44 -43.47 96.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.985 -1.007 . . . . 0.56999999999999995 110.637 170.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.98 -53.5 57.7 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 120.071 1.305 . . . . 0.56999999999999995 110.692 177.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -63.98 -35.93 82.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.065 1.302 . . . . 0.56999999999999995 111.928 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.25 -41.88 69.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.34 0.973 . . . . 0.56999999999999995 111.907 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -65.91 -35.17 79.88 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.519 -0.753 . . . . 0.56999999999999995 109.88 171.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -59.35 -43.22 92.83 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.113 0.87 . . . . 0.56999999999999995 109.851 171.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.8 mtp -62.16 -41.41 98.27 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 118.279 -0.867 . . . . 0.56999999999999995 110.971 176.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -61.03 -49.93 75.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.838 1.199 . . . . 0.56999999999999995 111.576 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.64 -5.63 79.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.45 1.024 . . . . 0.56999999999999995 113.88 -178.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -77.6 -21.25 52.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.831 1.315 . . . . 0.56999999999999995 110.741 170.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -97.1 -13.29 22.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.862 0.865 . . . . 0.66000000000000003 111.235 -177.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 164' ' ' TYR . 17.9 pt -142.33 150.66 55.79 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 119.859 1.209 . . . . 0.56999999999999995 111.708 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.51 12.64 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.219 2.613 . . . . 0.56999999999999995 113.452 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -79.67 137.67 37.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.817 -1.179 . . . . 0.56999999999999995 107.817 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -119.18 165.68 13.91 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.571 0.701 . . . . 0.65000000000000002 109.636 -173.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -137.7 161.95 35.17 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.092 -0.707 . . . . 0.56999999999999995 109.092 -173.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.76 -179.8 6.82 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.638 -0.875 . . . . 1.2 108.638 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -131.16 154.84 47.94 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.881 -1.155 . . . . 0.56999999999999995 107.881 177.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.46 164.6 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 124.301 1.041 . . . . 0.56999999999999995 109.256 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.79 -22.44 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.871 0.868 . . . . 0.56999999999999995 112.168 -176.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -64.81 0.81 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.381 -0.97 . . . . 0.56999999999999995 108.381 174.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.24 157.57 7.92 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.078 1.799 . . . . 0.56999999999999995 109.253 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.8 m 61.17 135.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.598 2.359 . . . . 0.56999999999999995 112.761 178.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.12 177.68 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 121.243 -0.911 . . . . 0.56999999999999995 110.586 -173.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.11 -53.89 32.31 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.275 -1.38 . . . . 0.66000000000000003 107.275 177.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -103.47 77.44 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 127.211 2.204 . . . . 0.56999999999999995 108.358 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.9 ttp -76.72 148.51 36.71 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 119.167 -2.208 . . . . 0.56999999999999995 109.564 173.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.2 140.34 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.736 -1.579 . . . . 0.56999999999999995 106.736 173.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.25 162.3 31.76 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.461 -0.656 . . . . 0.56999999999999995 111.461 177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 98' ' ' PHE . 2.8 m-85 -137.2 141.46 42.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.052 -1.462 . . . . 0.56999999999999995 107.052 -174.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.3 -174.34 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.713 1.605 . . . . 0.56999999999999995 109.305 -177.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.69 50.15 1.28 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.224 . . . . 1.2 112.461 -172.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.09 123.58 3.77 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.794 -1.322 . . . . 0.56999999999999995 109.794 -173.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 52.14 122.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.593 2.357 . . . . 0.56999999999999995 115.514 -172.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.14 159.37 44.3 Favored 'General case' 0 C--N 1.341 0.222 0 O-C-N 120.39 -1.444 . . . . 0.65000000000000002 112.193 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.9 80.86 0.34 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.522 1.534 . . . . 0.56999999999999995 110.195 175.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.57 -84.36 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.942 1.297 . . . . 0.66000000000000003 110.663 -174.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 t -171.05 -37.92 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.122 1.369 . . . . 0.56999999999999995 110.126 -177.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.76 142.0 38.16 Favored Pre-proline 0 C--N 1.343 0.284 0 C-N-CA 123.728 0.811 . . . . 0.56999999999999995 109.478 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 124.15 10.28 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.54 1.493 . . . . 0.56999999999999995 109.521 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 171.64 3.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.409 1.1 . . . . 0.56999999999999995 110.398 161.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -108.81 -44.37 4.03 Favored 'General case' 0 CA--C 1.542 0.645 1 C-N-CA 131.763 4.025 . . . . 0.66000000000000003 109.979 -171.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.96 -145.21 17.61 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-O 118.226 -1.319 . . . . 0.56999999999999995 111.166 -174.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.94 74.66 2.32 Favored 'Trans proline' 0 C--N 1.354 0.818 1 C-N-CA 125.588 4.192 . . . . 0.56999999999999995 114.042 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.48 -177.76 36.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.183 -1.967 . . . . 0.56999999999999995 108.183 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 45.01 -150.19 0.06 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.425 1.49 . . . . 0.56999999999999995 113.453 174.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.7 m -43.0 109.81 0.16 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.471 2.308 . . . . 0.56999999999999995 111.513 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD13 ' C24' ' A' ' 178' ' ' MDW . 5.6 mp -79.25 -29.65 42.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.616 1.166 . . . . 0.56999999999999995 113.319 -172.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.67 157.8 27.74 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.79 1.236 . . . . 0.56999999999999995 108.337 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -142.53 160.44 40.28 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.427 -0.795 . . . . 0.65000000000000002 110.303 174.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.63 172.85 12.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.937 0.895 . . . . 0.56999999999999995 108.723 176.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.95 153.96 46.1 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.527 -0.916 . . . . 0.56999999999999995 108.527 -177.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.23 135.56 76.24 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.424 -0.798 . . . . 0.56999999999999995 110.111 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -71.16 169.74 19.9 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.394 2.729 . . . . 0.56999999999999995 113.456 -177.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.05 -8.97 27.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.52 1.533 . . . . 0.56999999999999995 113.632 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -136.81 45.41 2.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.246 1.023 . . . . 0.56999999999999995 111.255 -163.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -77.05 0.09 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.211 1.386 . . . . 0.56999999999999995 114.185 173.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.85 -21.12 63.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.56999999999999995 110.268 167.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -47.2 145.65 4.39 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.211 -0.931 . . . . 0.56999999999999995 111.087 170.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.44 -34.29 3.88 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 125.299 1.428 . . . . 0.56999999999999995 110.922 -177.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -64.24 152.53 40.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.292 1.046 . . . . 0.66000000000000003 110.449 -164.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.83 146.01 50.43 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.824 0.821 . . . . 0.56999999999999995 109.506 -175.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -138.44 152.84 48.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.001 0.92 . . . . 0.65000000000000002 110.093 -177.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.498 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 51.3 m-85 -140.09 155.82 46.85 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.633 1.173 . . . . 0.56999999999999995 108.995 -168.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -87.32 102.58 14.65 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.187 -0.301 . . . . 0.66000000000000003 110.187 172.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -53.98 -30.71 48.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.772 1.629 . . . . 0.66000000000000003 111.733 171.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.56 -35.28 79.96 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.341 0.657 . . . . 0.66000000000000003 111.522 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -73.73 150.69 41.01 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.744 0.818 . . . . 0.66000000000000003 109.068 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -72.67 144.44 47.74 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.743 -0.598 . . . . 1.2 110.698 175.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -132.87 128.28 36.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.8 -1.556 . . . . 0.56999999999999995 106.8 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 t -124.04 144.69 49.69 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.547 -0.538 . . . . 0.56999999999999995 109.547 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.21 -33.51 75.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.66000000000000003 111.284 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.42 95.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.88 -0.888 . . . . 0.56999999999999995 110.88 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.04 138.24 8.99 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.45 0.7 . . . . 0.56999999999999995 109.276 172.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 t -76.25 54.49 0.89 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.383 2.273 . . . . 0.56999999999999995 110.786 -175.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -158.15 -44.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.486 0.714 . . . . 0.56999999999999995 112.164 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.65 -176.2 38.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.545 -1.022 . . . . 0.56999999999999995 110.545 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.25 118.27 32.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 105.782 -1.933 . . . . 0.56999999999999995 105.782 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.82 113.01 2.79 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.891 -0.781 . . . . 0.56999999999999995 108.891 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -54.14 -42.37 69.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.25 1.02 . . . . 0.56999999999999995 110.823 177.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.97 -34.06 57.6 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.451 0.569 . . . . 0.56999999999999995 111.469 -171.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -64.48 -48.55 74.79 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.569 -0.9 . . . . 0.56999999999999995 108.569 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -50.27 74.34 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.804 0.442 . . . . 0.56999999999999995 110.548 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.05 -49.24 78.16 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.456 -0.783 . . . . 0.56999999999999995 110.948 -176.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.7 m -61.89 -37.42 84.53 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 0.899 . . . . 0.56999999999999995 110.961 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -59.51 -53.8 53.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.63 0.772 . . . . 0.65000000000000002 109.817 172.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.8 -44.28 73.88 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.628 0.771 . . . . 0.66000000000000003 111.914 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.26 -28.93 70.06 Favored 'General case' 0 CA--C 1.526 0.036 0 C-N-CA 124.389 1.076 . . . . 0.56999999999999995 111.239 176.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.78 -46.56 93.3 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.623 -0.591 . . . . 0.56999999999999995 111.623 171.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -64.2 -38.41 90.96 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 117.161 0.48 . . . . 0.65000000000000002 111.243 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -34.38 69.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.707 0.632 . . . . 0.56999999999999995 112.707 174.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -22.69 65.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.343 -0.848 . . . . 0.56999999999999995 112.856 174.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.04 -13.61 4.38 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.709 1.147 . . . . 0.56999999999999995 113.464 -175.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.3 tpp -65.15 144.59 57.11 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.817 1.309 . . . . 0.56999999999999995 110.862 -171.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -97.7 -38.96 4.01 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 117.762 -1.577 . . . . 0.56999999999999995 112.038 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.0 m80 156.52 -176.4 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.893 3.677 . . . . 0.65000000000000002 108.111 -178.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.4 m -145.45 179.88 7.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.327 1.851 . . . . 0.56999999999999995 107.829 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.61 94.39 2.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.785 -1.561 . . . . 0.56999999999999995 106.785 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 8.3 t70 -154.24 138.02 10.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 107.211 -1.403 . . . . 0.66000000000000003 107.211 -179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.9 -19.57 46.21 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.978 1.785 . . . . 0.56999999999999995 113.37 -173.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -124.39 27.21 7.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.783 1.233 . . . . 0.56999999999999995 109.108 -177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' TYR . . . -59.42 138.52 57.63 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.315 0.646 . . . . 0.56999999999999995 110.369 175.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.5 p -75.02 -26.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.815 -0.439 . . . . 0.56999999999999995 109.815 168.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.35 13.41 15.53 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.615 -0.678 . . . . 0.56999999999999995 112.148 174.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -70.46 146.35 93.98 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.552 1.524 . . . . 0.56999999999999995 111.528 -174.369 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 38.2 Cg_endo -78.81 -50.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.181 1.921 . . . . 0.56999999999999995 112.693 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.5 t -67.62 120.13 13.51 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.921 -0.77 . . . . 0.56999999999999995 108.921 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -73.52 112.77 9.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.899 -0.778 . . . . 0.56999999999999995 108.899 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.76 170.54 21.91 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.805 -1.318 . . . . 0.56999999999999995 109.805 172.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.28 -53.67 0.47 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.507 2.323 . . . . 0.56999999999999995 114.029 174.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.65 108.39 2.48 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 127.162 2.315 . . . . 0.56999999999999995 108.883 170.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -53.94 111.07 2.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.758 1.623 . . . . 0.66000000000000003 110.751 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.05 -10.07 13.99 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.804 2.336 . . . . 0.56999999999999995 112.733 -177.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -96.43 -27.49 14.88 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.719 1.145 . . . . 0.56999999999999995 110.965 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -116.15 71.1 0.77 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.069 -1.086 . . . . 0.56999999999999995 108.069 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -120.95 139.0 53.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.225 1.01 . . . . 0.56999999999999995 108.871 -178.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.96 42.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.36 1.064 . . . . 0.56999999999999995 110.592 -173.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 mp 64.44 92.89 0.06 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.213 1.805 . . . . 0.56999999999999995 110.638 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 75.3 m -75.23 -79.74 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.374 0.879 . . . . 0.56999999999999995 113.374 -169.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -149.1 -49.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.333 1.053 . . . . 0.56999999999999995 108.248 -172.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -47.54 -46.48 27.76 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 126.151 1.78 . . . . 0.66000000000000003 111.749 167.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -71.79 -47.84 50.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.801 0.841 . . . . 0.66000000000000003 109.326 -174.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.16 -45.43 92.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 124.311 1.044 . . . . 0.56999999999999995 109.693 175.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -49.1 72.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.261 1.024 . . . . 0.56999999999999995 109.703 -178.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.74 72.79 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.705 -1.358 . . . . 0.56999999999999995 109.705 177.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 160' ' ' ILE . 1.6 mm -59.3 -53.99 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.178 -0.915 . . . . 0.56999999999999995 111.21 175.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.56 64.14 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.601 1.091 . . . . 0.56999999999999995 111.459 -178.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -77.33 -35.08 55.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.158 0.583 . . . . 0.56999999999999995 112.131 173.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.3 -40.85 98.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.992 1.717 . . . . 0.56999999999999995 112.749 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.534 ' CD1' HG22 ' A' ' 46' ' ' ILE . 16.8 p90 -106.65 7.14 30.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.363 0.665 . . . . 0.56999999999999995 112.503 178.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.46 -131.41 2.81 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.631 -1.788 . . . . 0.56999999999999995 108.631 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -148.22 -50.22 0.17 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.377 0.671 . . . . 0.56999999999999995 111.854 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.65 -179.89 0.06 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.937 0.895 . . . . 1.2 111.32 -169.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.18 111.76 20.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.56999999999999995 106.994 171.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.31 157.55 18.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.066 0.547 . . . . 0.56999999999999995 109.792 172.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.1 t -146.89 177.14 9.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.334 -1.358 . . . . 0.56999999999999995 107.334 168.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -63.13 145.0 56.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.429 1.092 . . . . 1.2 110.374 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.56 -42.11 17.16 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.439 0.903 . . . . 0.56999999999999995 113.439 -174.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 125.402 1.481 . . . . 0.5 . -177.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' MDW . . . . . 0.451 ' C24' HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_